10583449
10583449T1_10583449T17 NONE renin-angiotensin-aldosterone_18\JJ\1740|
10583449T1_10583449T18 NONE renin-angiotensin-aldosterone_18\JJ\1740|
10583449T3_10583449T17 NONE renin-angiotensin-aldosterone_18\JJ\1740|
10583449T3_10583449T18 NONE renin-angiotensin-aldosterone_18\JJ\1740|
10583449T8_10583449T17 NONE sodium_23\NN\14625458| (r_compound) excretion_24\NN\13466586|of|renal|sodium (r_nmod) impairment_20\NN\7296428|of|system-mediated|excretion (l_amod) system-mediated_19\JJ\1740|renin-angiotensin-aldosterone (l_nmod:npmod) renin-angiotensin-aldosterone_18\JJ\1740|
10583449T8_10583449T18 NONE sodium_23\NN\14625458| (r_compound) excretion_24\NN\13466586|of|renal|sodium (r_nmod) impairment_20\NN\7296428|of|system-mediated|excretion (l_amod) system-mediated_19\JJ\1740|renin-angiotensin-aldosterone (l_nmod:npmod) renin-angiotensin-aldosterone_18\JJ\1740|
10583449T10_10583449T19 NONE renin-angiotensin-aldosterone_19\JJ\1740|
10583449T10_10583449T20 NONE renin-angiotensin-aldosterone_19\JJ\1740|
10583449T10_10583449T21 NONE renin-angiotensin-aldosterone_19\JJ\1740| (r_amod) system_20\NN\3575240|specific|renin-angiotensin-aldosterone|raas (r_compound) blockade_24\NN\952963|to|system|remikiren (l_nmod) remikiren_27\NN\1740|by|renin-inhibitor (l_amod) renin-inhibitor_26\JJ\1740|
10583449T11_10583449T19 NONE renin-angiotensin-aldosterone_19\JJ\1740|
10583449T11_10583449T20 NONE renin-angiotensin-aldosterone_19\JJ\1740|
10583449T11_10583449T21 NONE renin-angiotensin-aldosterone_19\JJ\1740| (r_amod) system_20\NN\3575240|specific|renin-angiotensin-aldosterone|raas (r_compound) blockade_24\NN\952963|to|system|remikiren (l_nmod) remikiren_27\NN\1740|by|renin-inhibitor (l_amod) renin-inhibitor_26\JJ\1740|
10583449T12_10583449T19 CPR:4 remikiren_27\NN\1740|by|renin-inhibitor (r_nmod) blockade_24\NN\952963|to|system|remikiren (l_compound) system_20\NN\3575240|specific|renin-angiotensin-aldosterone|raas (l_amod) renin-angiotensin-aldosterone_19\JJ\1740|
10583449T12_10583449T20 CPR:4 remikiren_27\NN\1740|by|renin-inhibitor (r_nmod) blockade_24\NN\952963|to|system|remikiren (l_compound) system_20\NN\3575240|specific|renin-angiotensin-aldosterone|raas (l_amod) renin-angiotensin-aldosterone_19\JJ\1740|
10583449T12_10583449T21 CPR:4 remikiren_27\NN\1740|by|renin-inhibitor (l_amod) renin-inhibitor_26\JJ\1740|
6227474
6227474T23_6227474T33 NONE aldosterone_4\NN\14751863| (r_compound) receptors_5\NNS\5225602|of|brain|aldosterone
6227474T24_6227474T33 NONE corticosterone_10\NN\14752057|for (r_nmod) affinity_8\NN\11426530|high|corticosterone (r_dobj) reveals_6\VBZ\2137132|characterization|affinity|. (l_nsubj) characterization_0\NN\6724763|receptors (l_nmod) receptors_5\NNS\5225602|of|brain|aldosterone
6227474T14_6227474T31 NONE corticosterone_11\NN\14752057|for (r_nmod) affinity_7\NN\11426530|due|the|high|cbg|corticosterone|c (l_nmod) cbg_9\NN\1740|of
6227474T15_6227474T31 NONE steroids_28\NNS\14727670|of|competing (r_nmod) affinity_26\NN\11426530|in|the|apparent|steroids (r_nmod) alterations_22\NNS\7283608|in|significant|affinity (r_nmod) resulted_19\VBD\2633881|however|,|affinity|,|contamination|alterations|. (l_nmod) affinity_7\NN\11426530|due|the|high|cbg|corticosterone|c (l_nmod) cbg_9\NN\1740|of
6227474T16_6227474T31 NONE aldosterone-binding_31\JJ\1740| (r_amod) sites_32\NNS\8673395|for|aldosterone-binding (r_nmod) competing_29\VBG\1740|sites (r_acl) steroids_28\NNS\14727670|of|competing (r_nmod) affinity_26\NN\11426530|in|the|apparent|steroids (r_nmod) alterations_22\NNS\7283608|in|significant|affinity (r_nmod) resulted_19\VBD\2633881|however|,|affinity|,|contamination|alterations|. (l_nmod) affinity_7\NN\11426530|due|the|high|cbg|corticosterone|c (l_nmod) cbg_9\NN\1740|of
6227474T17_6227474T32 CPR:4 (nh4)2so4_8\NN\1740|with|% (r_nmod) precipitation_1\NN\13576355|selective|receptors|(nh4)2so4 (r_nsubj) reduced_9\VBD\441445|precipitation|concentrations|levels|. (l_dobj) concentrations_11\NNS\4916342|cbg (l_compound) cbg_10\NN\1740|
6227474T5_6227474T25 NONE steroid_15\NN\14727670| (r_compound) binding_16\NN\4688246|of|steroid (r_nmod) profile_13\NN\6999802|a|binding|similar (l_amod) similar_17\JJ\1740|that (l_nmod) that_19\DT\1740|to|receptor (l_nmod) receptor_24\NN\5225602|of|the|kidney|mineralocorticoid|aldosterone
6227474T7_6227474T25 NONE aldosterone_26\NN\14751863|(|greater|) (r_dep) receptor_24\NN\5225602|of|the|kidney|mineralocorticoid|aldosterone
6227474T8_6227474T25 NONE desoxycorticosterone_29\NN\1740|than|greater (r_nmod) greater_27\JJR\1740|desoxycorticosterone (r_amod) aldosterone_26\NN\14751863|(|greater|) (r_dep) receptor_24\NN\5225602|of|the|kidney|mineralocorticoid|aldosterone
6227474T9_6227474T25 NONE corticosterone_32\NN\14752057|than (r_nmod) greater_30\JJR\1740|corticosterone (r_amod) desoxycorticosterone_29\NN\1740|than|greater (r_nmod) greater_27\JJR\1740|desoxycorticosterone (r_amod) aldosterone_26\NN\14751863|(|greater|) (r_dep) receptor_24\NN\5225602|of|the|kidney|mineralocorticoid|aldosterone
6227474T10_6227474T27 NONE aldosterone_7\NN\14751863| (r_compound) receptor_8\NN\5225602|the|affinity|aldosterone|brain|,|identified|,
6227474T10_6227474T28 NONE aldosterone_7\NN\14751863| (r_compound) receptor_8\NN\5225602|the|affinity|aldosterone|brain|,|identified|, (l_acl:relcl) identified_16\VBN\699815|which|had|been|studies|receptor (l_nmod) receptor_23\NN\5225602|as|a|mineralocorticoid
6227474T11_6227474T27 NONE corticosterone_28\NN\14752057|either|or|aldosterone (r_dobj) bind_26\VB\1290422|that|receptor|may|corticosterone|vivo (l_nsubj) receptor_8\NN\5225602|the|affinity|aldosterone|brain|,|identified|,
6227474T11_6227474T28 NONE corticosterone_28\NN\14752057|either|or|aldosterone (r_dobj) bind_26\VB\1290422|that|receptor|may|corticosterone|vivo (l_nsubj) receptor_8\NN\5225602|the|affinity|aldosterone|brain|,|identified|, (l_acl:relcl) identified_16\VBN\699815|which|had|been|studies|receptor (l_nmod) receptor_23\NN\5225602|as|a|mineralocorticoid
6227474T12_6227474T27 NONE aldosterone_30\NN\14751863| (r_conj) corticosterone_28\NN\14752057|either|or|aldosterone (r_dobj) bind_26\VB\1290422|that|receptor|may|corticosterone|vivo (l_nsubj) receptor_8\NN\5225602|the|affinity|aldosterone|brain|,|identified|,
6227474T12_6227474T28 NONE aldosterone_30\NN\14751863| (r_conj) corticosterone_28\NN\14752057|either|or|aldosterone (r_dobj) bind_26\VB\1290422|that|receptor|may|corticosterone|vivo (l_nsubj) receptor_8\NN\5225602|the|affinity|aldosterone|brain|,|identified|, (l_acl:relcl) identified_16\VBN\699815|which|had|been|studies|receptor (l_nmod) receptor_23\NN\5225602|as|a|mineralocorticoid
23146691
23146691T2_23146691T15 CPR:4 emodin-6-o-β-d-glucoside_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|emodin-6-o-β-d-glucoside|responses|and|. (l_dobj) responses_4\NNS\11410625|hmgb1-induced|inflammatory (l_amod) hmgb1-induced_2\JJ\1740|
23249624
23249624T14_23249624T35 NONE threonine-protein_5\NN\1740| (r_compound) b-raf(v600e_7\NN\1740|of|the|threonine-protein|kinase|)
23249624T14_23249624T36 NONE threonine-protein_5\NN\1740| (r_compound) b-raf(v600e_7\NN\1740|of|the|threonine-protein|kinase|)
23249624T15_23249624T35 CPR:4 dabrafenib_10\NN\1740| (r_dep) inhibitor_9\NN\20090|dabrafenib (r_nmod) distribution_2\NN\5726596|b-raf(v600e|inhibitor|brain (l_nmod) b-raf(v600e_7\NN\1740|of|the|threonine-protein|kinase|)
23249624T15_23249624T36 CPR:4 dabrafenib_10\NN\1740| (r_dep) inhibitor_9\NN\20090|dabrafenib (r_nmod) distribution_2\NN\5726596|b-raf(v600e|inhibitor|brain (l_nmod) b-raf(v600e_7\NN\1740|of|the|threonine-protein|kinase|)
23249624T1_23249624T18 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|)
23249624T1_23249624T25 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|) (r_appos) braf_3\NN\1740|b-raf (r_compound) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_acl:relcl) developed_15\VBN\1753788|that|has|been|target (l_xcomp) target_18\VB\1151110|to|selectively|substitution (l_dobj) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_compound) acid_24\NN\14818238|
23249624T1_23249624T26 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|) (r_appos) braf_3\NN\1740|b-raf (r_compound) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_acl:relcl) developed_15\VBN\1753788|that|has|been|target (l_xcomp) target_18\VB\1151110|to|selectively|substitution (l_dobj) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_appos) braf(v600e_27\NN\1740|(|)|)
23249624T1_23249624T27 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|) (r_appos) braf_3\NN\1740|b-raf (r_compound) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_acl:relcl) developed_15\VBN\1753788|that|has|been|target (l_xcomp) target_18\VB\1151110|to|selectively|substitution (l_dobj) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_appos) braf(v600e_27\NN\1740|(|)|)
23249624T1_23249624T34 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|) (r_appos) braf_3\NN\1740|b-raf
23249624T3_23249624T18 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|)
23249624T3_23249624T25 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|) (r_appos) braf_3\NN\1740|b-raf (r_compound) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_acl:relcl) developed_15\VBN\1753788|that|has|been|target (l_xcomp) target_18\VB\1151110|to|selectively|substitution (l_dobj) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_compound) acid_24\NN\14818238|
23249624T3_23249624T26 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|) (r_appos) braf_3\NN\1740|b-raf (r_compound) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_acl:relcl) developed_15\VBN\1753788|that|has|been|target (l_xcomp) target_18\VB\1151110|to|selectively|substitution (l_dobj) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_appos) braf(v600e_27\NN\1740|(|)|)
23249624T3_23249624T27 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|) (r_appos) braf_3\NN\1740|b-raf (r_compound) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_acl:relcl) developed_15\VBN\1753788|that|has|been|target (l_xcomp) target_18\VB\1151110|to|selectively|substitution (l_dobj) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_appos) braf(v600e_27\NN\1740|(|)|)
23249624T3_23249624T34 NONE serine/threonine-protein_7\NN\1740| (r_compound) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|) (r_appos) braf_3\NN\1740|b-raf
23249624T8_23249624T18 NONE valine_20\NN\14605787| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (r_dobj) target_18\VB\1151110|to|selectively|substitution (r_xcomp) developed_15\VBN\1753788|that|has|been|target (r_acl:relcl) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_compound) braf_3\NN\1740|b-raf (l_appos) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|)
23249624T8_23249624T25 NONE valine_20\NN\14605787| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_compound) acid_24\NN\14818238|
23249624T8_23249624T26 NONE valine_20\NN\14605787| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_appos) braf(v600e_27\NN\1740|(|)|)
23249624T8_23249624T27 NONE valine_20\NN\14605787| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_appos) braf(v600e_27\NN\1740|(|)|)
23249624T8_23249624T34 NONE valine_20\NN\14605787| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (r_dobj) target_18\VB\1151110|to|selectively|substitution (r_xcomp) developed_15\VBN\1753788|that|has|been|target (r_acl:relcl) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_compound) braf_3\NN\1740|b-raf
23249624T9_23249624T18 NONE acid_24\NN\14818238| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (r_dobj) target_18\VB\1151110|to|selectively|substitution (r_xcomp) developed_15\VBN\1753788|that|has|been|target (r_acl:relcl) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_compound) braf_3\NN\1740|b-raf (l_appos) b-raf_9\NN\1740|(|gene|encoding|serine/threonine-protein|kinase|)
23249624T9_23249624T25 NONE acid_24\NN\14818238|
23249624T9_23249624T26 NONE acid_24\NN\14818238| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_appos) braf(v600e_27\NN\1740|(|)|)
23249624T9_23249624T27 NONE acid_24\NN\14818238| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (l_appos) braf(v600e_27\NN\1740|(|)|)
23249624T9_23249624T34 NONE acid_24\NN\14818238| (r_compound) substitution_25\NN\7337390|the|valine|glutamic|acid|braf(v600e|,|found (r_dobj) target_18\VB\1151110|to|selectively|substitution (r_xcomp) developed_15\VBN\1753788|that|has|been|target (r_acl:relcl) inhibitor_11\NN\20090|dabrafenib|is|a|braf|developed|. (l_compound) braf_3\NN\1740|b-raf
23249624T12_23249624T28 NONE dabrafenib_15\NN\1740|of (r_nmod) distribution_13\NN\5726596|the|brain|dabrafenib|mice (r_dobj) evaluate_10\VB\670261|to|distribution|,|and|see (l_conj) see_21\VB\2106506|to|restricts (l_ccomp) restricts_38\VBZ\235368|whether|efflux|delivery (l_nsubj) efflux_24\NN\13482330|active|p-glycoprotein (l_nmod) p-glycoprotein_26\NN\1740|by|p-gp|and|protein
23249624T12_23249624T29 NONE dabrafenib_15\NN\1740|of (r_nmod) distribution_13\NN\5726596|the|brain|dabrafenib|mice (r_dobj) evaluate_10\VB\670261|to|distribution|,|and|see (l_conj) see_21\VB\2106506|to|restricts (l_ccomp) restricts_38\VBZ\235368|whether|efflux|delivery (l_nsubj) efflux_24\NN\13482330|active|p-glycoprotein (l_nmod) p-glycoprotein_26\NN\1740|by|p-gp|and|protein (l_appos) p-gp_28\NN\1740|(|)
23249624T12_23249624T30 NONE dabrafenib_15\NN\1740|of (r_nmod) distribution_13\NN\5726596|the|brain|dabrafenib|mice (r_dobj) evaluate_10\VB\670261|to|distribution|,|and|see (l_conj) see_21\VB\2106506|to|restricts (l_ccomp) restricts_38\VBZ\235368|whether|efflux|delivery (l_nsubj) efflux_24\NN\13482330|active|p-glycoprotein (l_nmod) p-glycoprotein_26\NN\1740|by|p-gp|and|protein (l_conj) protein_34\NN\14944888|breast|cancer|resistance|bcrp
23249624T12_23249624T31 NONE dabrafenib_15\NN\1740|of (r_nmod) distribution_13\NN\5726596|the|brain|dabrafenib|mice (r_dobj) evaluate_10\VB\670261|to|distribution|,|and|see (l_conj) see_21\VB\2106506|to|restricts (l_ccomp) restricts_38\VBZ\235368|whether|efflux|delivery (l_nsubj) efflux_24\NN\13482330|active|p-glycoprotein (l_nmod) p-glycoprotein_26\NN\1740|by|p-gp|and|protein (l_conj) protein_34\NN\14944888|breast|cancer|resistance|bcrp (l_appos) bcrp_36\NN\1740|(|)
23249624T13_23249624T32 CPR:9 dabrafenib_13\NN\1740| (r_nsubj) substrate_17\NN\19613|that|dabrafenib|is|an|avid|p-gp (l_nmod) p-gp_20\NN\1740|for|both|and|bcrp
23249624T13_23249624T33 CPR:9 dabrafenib_13\NN\1740| (r_nsubj) substrate_17\NN\19613|that|dabrafenib|is|an|avid|p-gp (l_nmod) p-gp_20\NN\1740|for|both|and|bcrp (l_conj) bcrp_22\NN\1740|
23249624T2_23249624T19 NONE dabrafenib_21\NN\1740|of (r_nmod) area_6\NN\8630985|of|curve|(auc)(brain|auc(plasma|k(p|dabrafenib|dose (r_nmod) ratio_4\NN\13815152|the|area (r_nsubj) 0.023_31\CD\1740|vivo|,|ratio|was|,|increased|. (l_acl:relcl) increased_34\VBD\169651|which|18-fold|mice|0.42 (l_nmod) mice_41\NNS\2329401|in|a/b(-/-)bcrp1(-/- (l_amod) a/b(-/-)bcrp1(-/-_39\JJ\1740|mdr1|)
23249624T2_23249624T20 NONE dabrafenib_21\NN\1740|of (r_nmod) area_6\NN\8630985|of|curve|(auc)(brain|auc(plasma|k(p|dabrafenib|dose (r_nmod) ratio_4\NN\13815152|the|area (r_nsubj) 0.023_31\CD\1740|vivo|,|ratio|was|,|increased|. (l_acl:relcl) increased_34\VBD\169651|which|18-fold|mice|0.42 (l_nmod) mice_41\NNS\2329401|in|a/b(-/-)bcrp1(-/- (l_amod) a/b(-/-)bcrp1(-/-_39\JJ\1740|mdr1|)
23249624T4_23249624T21 NONE dabrafenib_0\NN\1740| (r_compound) exposure_2\NN\5042871|dabrafenib|plasma (r_nsubj) greater_5\JJR\1740|exposure|was|∼2-fold|a/b(-/-)bcrp1(-/-|mice|compared|;|increased (l_nmod) a/b(-/-)bcrp1(-/-_8\JJ\1740|in|mdr1|)
23249624T4_23249624T22 NONE dabrafenib_0\NN\1740| (r_compound) exposure_2\NN\5042871|dabrafenib|plasma (r_nsubj) greater_5\JJR\1740|exposure|was|∼2-fold|a/b(-/-)bcrp1(-/-|mice|compared|;|increased (l_nmod) a/b(-/-)bcrp1(-/-_8\JJ\1740|in|mdr1|)
23249624T5_23249624T23 CPR:4 vemurafenib_4\NN\1740|with|,|inhibitor|,|showed (l_appos) inhibitor_9\NN\20090|another|braf(v600e (l_compound) braf(v600e_7\NN\1740|)
23249624T5_23249624T24 CPR:4 vemurafenib_4\NN\1740|with|,|inhibitor|,|showed (l_appos) inhibitor_9\NN\20090|another|braf(v600e (l_compound) braf(v600e_7\NN\1740|)
23249624T6_23249624T23 NONE dabrafenib_11\NN\1740| (r_nsubj) showed_12\VBD\2137132|dabrafenib|penetration|dose (r_appos) vemurafenib_4\NN\1740|with|,|inhibitor|,|showed (l_appos) inhibitor_9\NN\20090|another|braf(v600e (l_compound) braf(v600e_7\NN\1740|)
23249624T6_23249624T24 NONE dabrafenib_11\NN\1740| (r_nsubj) showed_12\VBD\2137132|dabrafenib|penetration|dose (r_appos) vemurafenib_4\NN\1740|with|,|inhibitor|,|showed (l_appos) inhibitor_9\NN\20090|another|braf(v600e (l_compound) braf(v600e_7\NN\1740|)
14967461
14967461T1_14967461T22 CPR:4 gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T2_14967461T22 CPR:4 iressa_14\NN\1740|(|,|zd1839|) (r_dep) gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T3_14967461T22 CPR:4 zd1839_16\NN\1740| (r_appos) iressa_14\NN\1740|(|,|zd1839|) (r_dep) gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T4_14967461T22 CPR:4 erlotinib_19\NN\1740|tarceva|, (r_conj) gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T5_14967461T22 CPR:4 tarceva_21\NN\1740|(|,|osi-774|) (r_dep) erlotinib_19\NN\1740|tarceva|, (r_conj) gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T6_14967461T22 CPR:4 osi-774_23\NN\1740| (r_appos) tarceva_21\NN\1740|(|,|osi-774|) (r_dep) erlotinib_19\NN\1740|tarceva|, (r_conj) gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T7_14967461T22 CPR:4 cetuximab_33\NN\1740|such|imc-225 (r_nmod) antibodies_30\NNS\14728724|monoclonal|cetuximab (r_conj) gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T8_14967461T22 CPR:4 imc-225_35\NN\1740|(|,|erbitux|) (r_dep) cetuximab_33\NN\1740|such|imc-225 (r_nmod) antibodies_30\NNS\14728724|monoclonal|cetuximab (r_conj) gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T9_14967461T22 CPR:4 erbitux_37\NN\1740| (r_appos) imc-225_35\NN\1740|(|,|erbitux|) (r_dep) cetuximab_33\NN\1740|such|imc-225 (r_nmod) antibodies_30\NNS\14728724|monoclonal|cetuximab (r_conj) gefitinib_12\NN\1740|iressa|and|erlotinib|as|antibodies (r_dep) molecules_11\NNS\9465459|the|small|gefitinib (r_dobj) include_8\VBP\690614|inhibitors|molecules|. (l_nsubj) inhibitors_4\NNS\20090|epidermal|growth|factor|receptor|investigation (l_compound) receptor_3\NN\5225602|
14967461T10_14967461T23 CPR:4 ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_appos) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (l_amod) pan-erbb_14\JJ\1740|
14967461T10_14967461T24 CPR:4 ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_appos) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (l_compound) kinase_16\NN\14732946|
14967461T10_14967461T25 NONE ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_compound) kinase_28\NN\14732946|
14967461T10_14967461T26 NONE ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_dep) inhibiting_31\VBG\2510337|(|receptor|) (l_dobj) receptor_35\NN\5225602|epidermal|growth|factor|and|her2
14967461T10_14967461T27 NONE ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_dep) inhibiting_31\VBG\2510337|(|receptor|) (l_dobj) receptor_35\NN\5225602|epidermal|growth|factor|and|her2 (l_conj) her2_37\NN\1740|
14967461T11_14967461T23 NONE tyrosine_15\NN\14601829| (r_compound) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (l_amod) pan-erbb_14\JJ\1740|
14967461T11_14967461T24 NONE tyrosine_15\NN\14601829| (r_compound) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (l_compound) kinase_16\NN\14732946|
14967461T11_14967461T25 NONE tyrosine_15\NN\14601829| (r_compound) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (r_appos) ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_compound) kinase_28\NN\14732946|
14967461T11_14967461T26 NONE tyrosine_15\NN\14601829| (r_compound) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (r_appos) ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_dep) inhibiting_31\VBG\2510337|(|receptor|) (l_dobj) receptor_35\NN\5225602|epidermal|growth|factor|and|her2
14967461T11_14967461T27 NONE tyrosine_15\NN\14601829| (r_compound) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (r_appos) ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_dep) inhibiting_31\VBG\2510337|(|receptor|) (l_dobj) receptor_35\NN\5225602|epidermal|growth|factor|and|her2 (l_conj) her2_37\NN\1740|
14967461T12_14967461T23 NONE pki166_20\NN\1740|and|gw572016|,|examples (r_conj) ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_appos) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (l_amod) pan-erbb_14\JJ\1740|
14967461T12_14967461T24 NONE pki166_20\NN\1740|and|gw572016|,|examples (r_conj) ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_appos) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (l_compound) kinase_16\NN\14732946|
14967461T12_14967461T25 CPR:4 pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_compound) kinase_28\NN\14732946|
14967461T12_14967461T26 CPR:4 pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_dep) inhibiting_31\VBG\2510337|(|receptor|) (l_dobj) receptor_35\NN\5225602|epidermal|growth|factor|and|her2
14967461T12_14967461T27 CPR:4 pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_dep) inhibiting_31\VBG\2510337|(|receptor|) (l_dobj) receptor_35\NN\5225602|epidermal|growth|factor|and|her2 (l_conj) her2_37\NN\1740|
14967461T13_14967461T23 NONE gw572016_22\NN\1740| (r_conj) pki166_20\NN\1740|and|gw572016|,|examples (r_conj) ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_appos) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (l_amod) pan-erbb_14\JJ\1740|
14967461T13_14967461T24 NONE gw572016_22\NN\1740| (r_conj) pki166_20\NN\1740|and|gw572016|,|examples (r_conj) ci-1033_10\NN\1740|,|inhibitor|,|and|pki166 (l_appos) inhibitor_17\NN\20090|an|irreversible|pan-erbb|tyrosine|kinase (l_compound) kinase_16\NN\14732946|
14967461T13_14967461T25 CPR:4 gw572016_22\NN\1740| (r_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_compound) kinase_28\NN\14732946|
14967461T13_14967461T26 CPR:4 gw572016_22\NN\1740| (r_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_dep) inhibiting_31\VBG\2510337|(|receptor|) (l_dobj) receptor_35\NN\5225602|epidermal|growth|factor|and|her2
14967461T13_14967461T27 CPR:4 gw572016_22\NN\1740| (r_conj) pki166_20\NN\1740|and|gw572016|,|examples (l_appos) examples_25\NNS\5816287|both|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|dual|kinase|inhibiting (l_dep) inhibiting_31\VBG\2510337|(|receptor|) (l_dobj) receptor_35\NN\5225602|epidermal|growth|factor|and|her2 (l_conj) her2_37\NN\1740|
9231746
9231746T16_9231746T29 NONE nucleotide_6\NN\14850483| (r_compound) phosphodiesterase_7\NN\1740|of|calmodulin-stimulated|cyclic|nucleotide
9231746T4_9231746T17 NONE nucleotide_21\NN\14850483|cyclic|and|ca2|+ (r_compound) second-messenger_25\NN\1740|nucleotide (r_compound) systems_26\NNS\3575240|between|the|second-messenger (r_nmod) interaction_17\NN\37396|in|the|complex|systems (r_nmod) involved_13\VBN\2676054|interaction (r_acl) enzymes_12\NNS\14723628|of|the|key|involved (r_nmod) one_8\CD\13741022|phosphodiesterase|is|enzymes|. (l_nsubj) phosphodiesterase_3\NN\1740|calmodulin-dependent|cyclic|nucleotide|campde
9231746T4_9231746T23 NONE nucleotide_21\NN\14850483|cyclic|and|ca2|+ (r_compound) second-messenger_25\NN\1740|nucleotide (r_compound) systems_26\NNS\3575240|between|the|second-messenger (r_nmod) interaction_17\NN\37396|in|the|complex|systems (r_nmod) involved_13\VBN\2676054|interaction (r_acl) enzymes_12\NNS\14723628|of|the|key|involved (r_nmod) one_8\CD\13741022|phosphodiesterase|is|enzymes|. (l_nsubj) phosphodiesterase_3\NN\1740|calmodulin-dependent|cyclic|nucleotide|campde (l_appos) campde_5\NN\1740|(|)
9231746T5_9231746T17 NONE +_24\NN\1740| (r_conj) nucleotide_21\NN\14850483|cyclic|and|ca2|+ (r_compound) second-messenger_25\NN\1740|nucleotide (r_compound) systems_26\NNS\3575240|between|the|second-messenger (r_nmod) interaction_17\NN\37396|in|the|complex|systems (r_nmod) involved_13\VBN\2676054|interaction (r_acl) enzymes_12\NNS\14723628|of|the|key|involved (r_nmod) one_8\CD\13741022|phosphodiesterase|is|enzymes|. (l_nsubj) phosphodiesterase_3\NN\1740|calmodulin-dependent|cyclic|nucleotide|campde
9231746T5_9231746T23 NONE +_24\NN\1740| (r_conj) nucleotide_21\NN\14850483|cyclic|and|ca2|+ (r_compound) second-messenger_25\NN\1740|nucleotide (r_compound) systems_26\NNS\3575240|between|the|second-messenger (r_nmod) interaction_17\NN\37396|in|the|complex|systems (r_nmod) involved_13\VBN\2676054|interaction (r_acl) enzymes_12\NNS\14723628|of|the|key|involved (r_nmod) one_8\CD\13741022|phosphodiesterase|is|enzymes|. (l_nsubj) phosphodiesterase_3\NN\1740|calmodulin-dependent|cyclic|nucleotide|campde (l_appos) campde_5\NN\1740|(|)
9231746T6_9231746T17 NONE nucleotide_2\NN\14850483| (r_compound) phosphodiesterase_3\NN\1740|calmodulin-dependent|cyclic|nucleotide|campde
9231746T6_9231746T23 NONE nucleotide_2\NN\14850483| (r_compound) phosphodiesterase_3\NN\1740|calmodulin-dependent|cyclic|nucleotide|campde (l_appos) campde_5\NN\1740|(|)
9231746T7_9231746T21 NONE +_19\JJ\1740| (r_amod) association_21\NN\8008335|mostly|via|ca2|+|-dependent|proteins (r_nmod) occurs_15\VBZ\2623529|inhibition|association|. (r_conj) used_7\VBN\1156834|variety|have|been|inhibit|,|and|occurs (l_xcomp) inhibit_9\VB\2510337|to|campde (l_dobj) campde_10\NN\1740|
9231746T8_9231746T22 CPR:4 dihydropyridine_6\NN\1740| (r_compound) blockers_10\NNS\10101634|of|dihydropyridine|ca2|+|-channel|felodipine (l_amod) -channel_9\NN\1740|
9231746T8_9231746T24 NONE dihydropyridine_6\NN\1740| (r_compound) blockers_10\NNS\10101634|of|dihydropyridine|ca2|+|-channel|felodipine (r_nmod) effect_4\NN\34213|the|blockers|campde (l_nmod) campde_15\NN\1740|on
9231746T9_9231746T22 NONE +_8\NN\1740| (r_amod) blockers_10\NNS\10101634|of|dihydropyridine|ca2|+|-channel|felodipine (l_amod) -channel_9\NN\1740|
9231746T9_9231746T24 NONE +_8\NN\1740| (r_amod) blockers_10\NNS\10101634|of|dihydropyridine|ca2|+|-channel|felodipine (r_nmod) effect_4\NN\34213|the|blockers|campde (l_nmod) campde_15\NN\1740|on
9231746T10_9231746T22 CPR:4 felodipine_11\NN\1740|and|nicardipine (r_dep) blockers_10\NNS\10101634|of|dihydropyridine|ca2|+|-channel|felodipine (l_amod) -channel_9\NN\1740|
9231746T10_9231746T24 NONE felodipine_11\NN\1740|and|nicardipine (r_dep) blockers_10\NNS\10101634|of|dihydropyridine|ca2|+|-channel|felodipine (r_nmod) effect_4\NN\34213|the|blockers|campde (l_nmod) campde_15\NN\1740|on
9231746T11_9231746T22 CPR:4 nicardipine_13\NN\1740| (r_conj) felodipine_11\NN\1740|and|nicardipine (r_dep) blockers_10\NNS\10101634|of|dihydropyridine|ca2|+|-channel|felodipine (l_amod) -channel_9\NN\1740|
9231746T11_9231746T24 NONE nicardipine_13\NN\1740| (r_conj) felodipine_11\NN\1740|and|nicardipine (r_dep) blockers_10\NNS\10101634|of|dihydropyridine|ca2|+|-channel|felodipine (r_nmod) effect_4\NN\34213|the|blockers|campde (l_nmod) campde_15\NN\1740|on
9231746T12_9231746T25 CPR:4 felodipine_21\NN\1740|by|and|nicardipine (r_nmod) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_amod) 63-kda_5\JJ\1740|the|pde|and|60-kda (l_appos) pde_7\NN\1740|(|1b1|) (l_nummod) 1b1_8\CD\1740|
9231746T12_9231746T26 CPR:4 felodipine_21\NN\1740|by|and|nicardipine (r_nmod) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_amod) 63-kda_5\JJ\1740|the|pde|and|60-kda (l_conj) 60-kda_11\JJ\1740|pde (l_appos) pde_13\NN\1740|(|1a2|) (l_nummod) 1a2_14\CD\1740|
9231746T12_9231746T27 CPR:4 felodipine_21\NN\1740|by|and|nicardipine (r_nmod) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_compound) campde_16\NN\1740|
9231746T13_9231746T25 CPR:4 nicardipine_23\NN\1740| (r_conj) felodipine_21\NN\1740|by|and|nicardipine (r_nmod) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_amod) 63-kda_5\JJ\1740|the|pde|and|60-kda (l_appos) pde_7\NN\1740|(|1b1|) (l_nummod) 1b1_8\CD\1740|
9231746T13_9231746T26 CPR:4 nicardipine_23\NN\1740| (r_conj) felodipine_21\NN\1740|by|and|nicardipine (r_nmod) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_amod) 63-kda_5\JJ\1740|the|pde|and|60-kda (l_conj) 60-kda_11\JJ\1740|pde (l_appos) pde_13\NN\1740|(|1a2|) (l_nummod) 1a2_14\CD\1740|
9231746T13_9231746T27 CPR:4 nicardipine_23\NN\1740| (r_conj) felodipine_21\NN\1740|by|and|nicardipine (r_nmod) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_compound) campde_16\NN\1740|
9231746T14_9231746T25 NONE +_33\NN\1740| (r_compound) antagonists_34\NNS\7846|these|two|ca2|+ (r_nsubj) appear_35\VBP\2604760|that|antagonists|counteract (r_conj) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_amod) 63-kda_5\JJ\1740|the|pde|and|60-kda (l_appos) pde_7\NN\1740|(|1b1|) (l_nummod) 1b1_8\CD\1740|
9231746T14_9231746T26 NONE +_33\NN\1740| (r_compound) antagonists_34\NNS\7846|these|two|ca2|+ (r_nsubj) appear_35\VBP\2604760|that|antagonists|counteract (r_conj) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_amod) 63-kda_5\JJ\1740|the|pde|and|60-kda (l_conj) 60-kda_11\JJ\1740|pde (l_appos) pde_13\NN\1740|(|1a2|) (l_nummod) 1a2_14\CD\1740|
9231746T14_9231746T27 NONE +_33\NN\1740| (r_compound) antagonists_34\NNS\7846|these|two|ca2|+ (r_nsubj) appear_35\VBP\2604760|that|antagonists|counteract (r_conj) inhibited_19\VBN\2510337|that|isozymes|are|felodipine|inhibition|and|appear (l_nsubjpass) isozymes_17\NNS\1740|63-kda|campde (l_compound) campde_16\NN\1740|
9231746T1_9231746T18 NONE nicardipine_2\NN\1740| (r_conj) felodipine_0\NN\1740|and|nicardipine (r_nsubj) have_3\VBP\2108377|felodipine|affinities|but|bring|,|suggesting|. (l_dobj) affinities_5\NNS\11426530|similar|isozymes (l_nmod) isozymes_9\NNS\1740|for|60-kda|campde (l_compound) campde_8\NN\1740|
9231746T1_9231746T19 NONE nicardipine_2\NN\1740| (r_conj) felodipine_0\NN\1740|and|nicardipine (r_nsubj) have_3\VBP\2108377|felodipine|affinities|but|bring|,|suggesting|. (l_advcl) suggesting_19\VBG\1010118|possibility (l_dobj) possibility_21\NN\5944958|the|designing (l_acl) designing_23\VBG\1631534|of|drugs (l_dobj) drugs_25\NNS\14778436|specific|protect (l_acl:relcl) protect_28\VB\1127795|that|can|enzyme|inhibition (l_nmod) inhibition_32\NN\1068773|from|blockers (l_nmod) blockers_38\NNS\10101634|by|dihydropyridine|ca2|+|-channel (l_amod) -channel_37\JJ\1740|
9231746T2_9231746T18 CPR:4 dihydropyridine_34\NN\1740| (r_compound) blockers_38\NNS\10101634|by|dihydropyridine|ca2|+|-channel (r_nmod) inhibition_32\NN\1068773|from|blockers (r_nmod) protect_28\VB\1127795|that|can|enzyme|inhibition (r_acl:relcl) drugs_25\NNS\14778436|specific|protect (r_dobj) designing_23\VBG\1631534|of|drugs (r_acl) possibility_21\NN\5944958|the|designing (r_dobj) suggesting_19\VBG\1010118|possibility (r_advcl) have_3\VBP\2108377|felodipine|affinities|but|bring|,|suggesting|. (l_dobj) affinities_5\NNS\11426530|similar|isozymes (l_nmod) isozymes_9\NNS\1740|for|60-kda|campde (l_compound) campde_8\NN\1740|
9231746T2_9231746T19 CPR:4 dihydropyridine_34\NN\1740| (r_compound) blockers_38\NNS\10101634|by|dihydropyridine|ca2|+|-channel (l_amod) -channel_37\JJ\1740|
9231746T3_9231746T18 NONE +_36\JJ\1740| (r_amod) blockers_38\NNS\10101634|by|dihydropyridine|ca2|+|-channel (r_nmod) inhibition_32\NN\1068773|from|blockers (r_nmod) protect_28\VB\1127795|that|can|enzyme|inhibition (r_acl:relcl) drugs_25\NNS\14778436|specific|protect (r_dobj) designing_23\VBG\1631534|of|drugs (r_acl) possibility_21\NN\5944958|the|designing (r_dobj) suggesting_19\VBG\1010118|possibility (r_advcl) have_3\VBP\2108377|felodipine|affinities|but|bring|,|suggesting|. (l_dobj) affinities_5\NNS\11426530|similar|isozymes (l_nmod) isozymes_9\NNS\1740|for|60-kda|campde (l_compound) campde_8\NN\1740|
9231746T3_9231746T19 NONE +_36\JJ\1740| (r_amod) blockers_38\NNS\10101634|by|dihydropyridine|ca2|+|-channel (l_amod) -channel_37\JJ\1740|
9231746T15_9231746T18 NONE felodipine_0\NN\1740|and|nicardipine (r_nsubj) have_3\VBP\2108377|felodipine|affinities|but|bring|,|suggesting|. (l_dobj) affinities_5\NNS\11426530|similar|isozymes (l_nmod) isozymes_9\NNS\1740|for|60-kda|campde (l_compound) campde_8\NN\1740|
9231746T15_9231746T19 NONE felodipine_0\NN\1740|and|nicardipine (r_nsubj) have_3\VBP\2108377|felodipine|affinities|but|bring|,|suggesting|. (l_advcl) suggesting_19\VBG\1010118|possibility (l_dobj) possibility_21\NN\5944958|the|designing (l_acl) designing_23\VBG\1631534|of|drugs (l_dobj) drugs_25\NNS\14778436|specific|protect (l_acl:relcl) protect_28\VB\1127795|that|can|enzyme|inhibition (l_nmod) inhibition_32\NN\1068773|from|blockers (l_nmod) blockers_38\NNS\10101634|by|dihydropyridine|ca2|+|-channel (l_amod) -channel_37\JJ\1740|
17199504
17199504T11_17199504T16 NONE adenine_13\NN\14706749| (r_compound) phosphoribosyltransferase_14\NN\1740|of|recombinant|human|adenine
17199504T1_17199504T12 NONE adenine_0\NN\14706749| (r_compound) phosphoribosyltransferase_1\NN\1740|adenine
17199504T2_17199504T12 CPR:9 adenine_14\NN\14706749|of (r_nmod) conversion_12\NN\7359599|the|direct|adenine|monophosphate (r_dobj) catalyzing_9\VBG\146138|by|conversion (r_advcl) plays_2\VBZ\1072262|phosphoribosyltransferase|role|salvage|catalyzing|. (l_nsubj) phosphoribosyltransferase_1\NN\1740|adenine
17199504T3_17199504T12 CPR:9 monophosphate_17\NN\1740|to|adenosine (r_nmod) conversion_12\NN\7359599|the|direct|adenine|monophosphate (r_dobj) catalyzing_9\VBG\146138|by|conversion (r_advcl) plays_2\VBZ\1072262|phosphoribosyltransferase|role|salvage|catalyzing|. (l_nsubj) phosphoribosyltransferase_1\NN\1740|adenine
17199504T9_17199504T12 NONE purine_6\NN\14618253| (r_compound) salvage_7\NN\3076708|in|purine (r_nmod) plays_2\VBZ\1072262|phosphoribosyltransferase|role|salvage|catalyzing|. (l_nsubj) phosphoribosyltransferase_1\NN\1740|adenine
17199504T4_17199504T13 NONE purine_4\NN\14618253| (r_compound) pathway_6\NN\5483677|of|the|purine|salvage (r_nmod) involvement_1\NN\1080366|the|pathway|proliferation (r_nsubj) makes_12\VBZ\126264|involvement|target|. (l_ccomp) target_17\NN\7258332|phosphoribosyltransferase|a|potential|discovery (l_nsubj) phosphoribosyltransferase_14\NN\1740|adenine
17199504T5_17199504T13 NONE adenine_13\NN\14706749| (r_compound) phosphoribosyltransferase_14\NN\1740|adenine
17199504T6_17199504T14 NONE n-terminally_7\RB\1740| (r_advmod) his-tagged_8\JJ\1740|n-terminally (r_amod) phosphoribosyltransferase_11\NN\1740|recombinant|,|his-tagged|human|adenine
17199504T7_17199504T14 NONE his-tagged_8\JJ\1740|n-terminally (r_amod) phosphoribosyltransferase_11\NN\1740|recombinant|,|his-tagged|human|adenine
17199504T8_17199504T14 NONE adenine_10\NN\14706749| (r_compound) phosphoribosyltransferase_11\NN\1740|recombinant|,|his-tagged|human|adenine
17199504T10_17199504T15 NONE adenine_7\NN\14706749| (r_compound) phosphoribosyltransferase_8\NN\1740|of|adenine
10690753
10690753T18_10690753T37 CPR:4 felbamate_0\NN\1740| (r_compound) block_1\NN\21939|felbamate|receptors|:|selectivity (l_nmod) receptors_5\NNS\5225602|of|recombinant|n-methyl-d-aspartate
10690753T18_10690753T38 CPR:4 felbamate_0\NN\1740| (r_compound) block_1\NN\21939|felbamate|receptors|:|selectivity (l_dep) selectivity_7\NN\4916342|subunit (l_nmod) subunit_11\NN\13604718|for|the|nr2b (l_compound) nr2b_10\NN\1740|
10690753T19_10690753T37 NONE n-methyl-d-aspartate_4\NN\1740| (r_compound) receptors_5\NNS\5225602|of|recombinant|n-methyl-d-aspartate
10690753T19_10690753T38 NONE n-methyl-d-aspartate_4\NN\1740| (r_compound) receptors_5\NNS\5225602|of|recombinant|n-methyl-d-aspartate (r_nmod) block_1\NN\21939|felbamate|receptors|:|selectivity (l_dep) selectivity_7\NN\4916342|subunit (l_nmod) subunit_11\NN\13604718|for|the|nr2b (l_compound) nr2b_10\NN\1740|
10690753T7_10690753T26 NONE nmda_19\NN\1740| (r_compound) antagonists_21\NNS\7846|of|other|nmda|receptor (l_compound) receptor_20\NN\5225602|
10690753T7_10690753T29 NONE nmda_19\NN\1740| (r_compound) antagonists_21\NNS\7846|of|other|nmda|receptor (r_nmod) characteristic_16\JJ\1740|antagonists (r_amod) toxicity_15\NN\13576101|the|neurobehavioral|characteristic (r_dobj) exhibit_12\VB\2632167|to|toxicity (r_xcomp) fails_10\VBZ\1798936|exhibit (r_conj) blocks_3\VBZ\1476483|felbamate|receptors|but|fails|. (l_dobj) receptors_8\NNS\5225602|n-methyl-d-asparate
10690753T8_10690753T26 CPR:6 felbamate_2\NN\1740|the|anticonvulsant (r_nsubj) blocks_3\VBZ\1476483|felbamate|receptors|but|fails|. (l_conj) fails_10\VBZ\1798936|exhibit (l_xcomp) exhibit_12\VB\2632167|to|toxicity (l_dobj) toxicity_15\NN\13576101|the|neurobehavioral|characteristic (l_amod) characteristic_16\JJ\1740|antagonists (l_nmod) antagonists_21\NNS\7846|of|other|nmda|receptor (l_compound) receptor_20\NN\5225602|
10690753T8_10690753T29 CPR:4 felbamate_2\NN\1740|the|anticonvulsant (r_nsubj) blocks_3\VBZ\1476483|felbamate|receptors|but|fails|. (l_dobj) receptors_8\NNS\5225602|n-methyl-d-asparate
10690753T11_10690753T26 NONE n-methyl-d-asparate_4\NN\1740|nmda (r_compound) receptors_8\NNS\5225602|n-methyl-d-asparate (r_dobj) blocks_3\VBZ\1476483|felbamate|receptors|but|fails|. (l_conj) fails_10\VBZ\1798936|exhibit (l_xcomp) exhibit_12\VB\2632167|to|toxicity (l_dobj) toxicity_15\NN\13576101|the|neurobehavioral|characteristic (l_amod) characteristic_16\JJ\1740|antagonists (l_nmod) antagonists_21\NNS\7846|of|other|nmda|receptor (l_compound) receptor_20\NN\5225602|
10690753T11_10690753T29 NONE n-methyl-d-asparate_4\NN\1740|nmda (r_compound) receptors_8\NNS\5225602|n-methyl-d-asparate
10690753T16_10690753T26 NONE nmda_6\NN\1740|(|) (r_appos) n-methyl-d-asparate_4\NN\1740|nmda (r_compound) receptors_8\NNS\5225602|n-methyl-d-asparate (r_dobj) blocks_3\VBZ\1476483|felbamate|receptors|but|fails|. (l_conj) fails_10\VBZ\1798936|exhibit (l_xcomp) exhibit_12\VB\2632167|to|toxicity (l_dobj) toxicity_15\NN\13576101|the|neurobehavioral|characteristic (l_amod) characteristic_16\JJ\1740|antagonists (l_nmod) antagonists_21\NNS\7846|of|other|nmda|receptor (l_compound) receptor_20\NN\5225602|
10690753T16_10690753T29 NONE nmda_6\NN\1740|(|) (r_appos) n-methyl-d-asparate_4\NN\1740|nmda (r_compound) receptors_8\NNS\5225602|n-methyl-d-asparate
10690753T9_10690753T27 NONE nmda_14\NN\1740| (r_compound) selectivity_17\NN\4916342|to|nmda|receptor|subtype (l_compound) receptor_15\NN\5225602|
10690753T9_10690753T28 NONE nmda_14\NN\1740| (r_compound) selectivity_17\NN\4916342|to|nmda|receptor|subtype (r_nmod) related_12\JJ\1740|that|profile|could|be|selectivity (r_ccomp) possibility_3\NN\5944958|the|related (r_dobj) investigate_1\VB\644583|to|possibility|,|examined (l_parataxis) examined_20\VBD\789138|we|specificity (l_dobj) specificity_22\NN\4762633|the|block (l_nmod) block_25\NN\21939|of|felbamate|receptors (l_nmod) receptors_29\NNS\5225602|of|recombinant|nmda|composed
10690753T9_10690753T30 NONE nmda_14\NN\1740| (r_compound) selectivity_17\NN\4916342|to|nmda|receptor|subtype (r_nmod) related_12\JJ\1740|that|profile|could|be|selectivity (r_ccomp) possibility_3\NN\5944958|the|related (r_dobj) investigate_1\VB\644583|to|possibility|,|examined (l_parataxis) examined_20\VBD\789138|we|specificity (l_dobj) specificity_22\NN\4762633|the|block (l_nmod) block_25\NN\21939|of|felbamate|receptors (l_nmod) receptors_29\NNS\5225602|of|recombinant|nmda|composed (l_acl) composed_30\VBN\2620587|subunit (l_nmod) subunit_34\NN\13604718|of|the|nr1a|and|subunits (l_compound) nr1a_33\NN\1740|
10690753T9_10690753T31 NONE nmda_14\NN\1740| (r_compound) selectivity_17\NN\4916342|to|nmda|receptor|subtype (r_nmod) related_12\JJ\1740|that|profile|could|be|selectivity (r_ccomp) possibility_3\NN\5944958|the|related (r_dobj) investigate_1\VB\644583|to|possibility|,|examined (l_parataxis) examined_20\VBD\789138|we|specificity (l_dobj) specificity_22\NN\4762633|the|block (l_nmod) block_25\NN\21939|of|felbamate|receptors (l_nmod) receptors_29\NNS\5225602|of|recombinant|nmda|composed (l_acl) composed_30\VBN\2620587|subunit (l_nmod) subunit_34\NN\13604718|of|the|nr1a|and|subunits (l_conj) subunits_38\NNS\13604718|various|nr2 (l_compound) nr2_37\NN\1740|
10690753T10_10690753T27 NONE felbamate_24\NN\1740| (r_compound) block_25\NN\21939|of|felbamate|receptors (r_nmod) specificity_22\NN\4762633|the|block (r_dobj) examined_20\VBD\789138|we|specificity (r_parataxis) investigate_1\VB\644583|to|possibility|,|examined (l_dobj) possibility_3\NN\5944958|the|related (l_ccomp) related_12\JJ\1740|that|profile|could|be|selectivity (l_nmod) selectivity_17\NN\4916342|to|nmda|receptor|subtype (l_compound) receptor_15\NN\5225602|
10690753T10_10690753T28 CPR:4 felbamate_24\NN\1740| (r_compound) block_25\NN\21939|of|felbamate|receptors (l_nmod) receptors_29\NNS\5225602|of|recombinant|nmda|composed
10690753T10_10690753T30 CPR:4 felbamate_24\NN\1740| (r_compound) block_25\NN\21939|of|felbamate|receptors (l_nmod) receptors_29\NNS\5225602|of|recombinant|nmda|composed (l_acl) composed_30\VBN\2620587|subunit (l_nmod) subunit_34\NN\13604718|of|the|nr1a|and|subunits (l_compound) nr1a_33\NN\1740|
10690753T10_10690753T31 CPR:4 felbamate_24\NN\1740| (r_compound) block_25\NN\21939|of|felbamate|receptors (l_nmod) receptors_29\NNS\5225602|of|recombinant|nmda|composed (l_acl) composed_30\VBN\2620587|subunit (l_nmod) subunit_34\NN\13604718|of|the|nr1a|and|subunits (l_conj) subunits_38\NNS\13604718|various|nr2 (l_compound) nr2_37\NN\1740|
10690753T12_10690753T27 NONE nmda_28\NN\1740| (r_compound) receptors_29\NNS\5225602|of|recombinant|nmda|composed (r_nmod) block_25\NN\21939|of|felbamate|receptors (r_nmod) specificity_22\NN\4762633|the|block (r_dobj) examined_20\VBD\789138|we|specificity (r_parataxis) investigate_1\VB\644583|to|possibility|,|examined (l_dobj) possibility_3\NN\5944958|the|related (l_ccomp) related_12\JJ\1740|that|profile|could|be|selectivity (l_nmod) selectivity_17\NN\4916342|to|nmda|receptor|subtype (l_compound) receptor_15\NN\5225602|
10690753T12_10690753T28 NONE nmda_28\NN\1740| (r_compound) receptors_29\NNS\5225602|of|recombinant|nmda|composed
10690753T12_10690753T30 NONE nmda_28\NN\1740| (r_compound) receptors_29\NNS\5225602|of|recombinant|nmda|composed (l_acl) composed_30\VBN\2620587|subunit (l_nmod) subunit_34\NN\13604718|of|the|nr1a|and|subunits (l_compound) nr1a_33\NN\1740|
10690753T12_10690753T31 NONE nmda_28\NN\1740| (r_compound) receptors_29\NNS\5225602|of|recombinant|nmda|composed (l_acl) composed_30\VBN\2620587|subunit (l_nmod) subunit_34\NN\13604718|of|the|nr1a|and|subunits (l_conj) subunits_38\NNS\13604718|various|nr2 (l_compound) nr2_37\NN\1740|
10690753T13_10690753T32 CPR:4 felbamate_0\NN\1740| (r_nsubj) produced_1\VBD\1617192|felbamate|block|;|mm (l_dobj) block_6\NN\21939|a|rapid|currents (l_nmod) currents_8\NNS\11449002|of|evoked (l_acl) evoked_9\VBN\1617192|nmda (l_nmod) nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_compound) nr1a_27\NN\1740|
10690753T13_10690753T33 CPR:4 felbamate_0\NN\1740| (r_nsubj) produced_1\VBD\1617192|felbamate|block|;|mm (l_dobj) block_6\NN\21939|a|rapid|currents (l_nmod) currents_8\NNS\11449002|of|evoked (l_acl) evoked_9\VBN\1617192|nmda (l_nmod) nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c
10690753T13_10690753T34 CPR:4 felbamate_0\NN\1740| (r_nsubj) produced_1\VBD\1617192|felbamate|block|;|mm (l_dobj) block_6\NN\21939|a|rapid|currents (l_nmod) currents_8\NNS\11449002|of|evoked (l_acl) evoked_9\VBN\1617192|nmda (l_nmod) nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c (l_conj) nr2b_35\NN\1740|
10690753T13_10690753T35 CPR:4 felbamate_0\NN\1740| (r_nsubj) produced_1\VBD\1617192|felbamate|block|;|mm (l_dobj) block_6\NN\21939|a|rapid|currents (l_nmod) currents_8\NNS\11449002|of|evoked (l_acl) evoked_9\VBN\1617192|nmda (l_nmod) nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c (l_conj) nr2c_37\NN\1740|
10690753T14_10690753T32 NONE nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_compound) nr1a_27\NN\1740|
10690753T14_10690753T33 NONE nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c
10690753T14_10690753T34 NONE nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c (l_conj) nr2b_35\NN\1740|
10690753T14_10690753T35 NONE nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c (l_conj) nr2c_37\NN\1740|
10690753T15_10690753T32 NONE glycine_17\NN\14601829|microm (r_conj) nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_compound) nr1a_27\NN\1740|
10690753T15_10690753T33 NONE glycine_17\NN\14601829|microm (r_conj) nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c
10690753T15_10690753T34 NONE glycine_17\NN\14601829|microm (r_conj) nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c (l_conj) nr2b_35\NN\1740|
10690753T15_10690753T35 NONE glycine_17\NN\14601829|microm (r_conj) nmda_13\NN\1740|by|microm|and|glycine|cells (l_nmod) cells_23\NNS\3080309|in|human|embryonic|kidney|293|expressing (l_acl) expressing_24\VBG\928630|subunit (l_dobj) subunit_28\NN\13604718|the|rat|nr1a|,|and|subunits (l_conj) subunits_38\NNS\13604718|either|the|nr2a (l_compound) nr2a_33\NN\1740|,|nr2b|or|nr2c (l_conj) nr2c_37\NN\1740|
10690753T17_10690753T36 NONE nmda_36\NN\1740| (r_compound) complex_39\NN\5869584|on|the|nmda|receptor|channel (l_compound) receptor_37\NN\5225602|
10690753T1_10690753T20 CPR:4 felbamate_4\NN\1740| (r_compound) block_5\NN\21939|of|felbamate|receptors (l_nmod) receptors_8\NNS\5225602|of|nmda|containing
10690753T1_10690753T21 CPR:4 felbamate_4\NN\1740| (r_compound) block_5\NN\21939|of|felbamate|receptors (l_nmod) receptors_8\NNS\5225602|of|nmda|containing (l_acl) containing_9\VBG\2632940|subunit (l_dobj) subunit_12\NN\13604718|the|nr2b (l_compound) nr2b_11\NN\1740|
10690753T2_10690753T20 NONE nmda_7\NN\1740| (r_compound) receptors_8\NNS\5225602|of|nmda|containing
10690753T2_10690753T21 NONE nmda_7\NN\1740| (r_compound) receptors_8\NNS\5225602|of|nmda|containing (l_acl) containing_9\VBG\2632940|subunit (l_dobj) subunit_12\NN\13604718|the|nr2b (l_compound) nr2b_11\NN\1740|
10690753T3_10690753T22 CPR:4 felbamate_3\NN\1740| (r_nsubj) exhibits_4\VBZ\2632167|that|felbamate|selectivity (l_dobj) selectivity_6\NN\4916342|modest|receptors (l_nmod) receptors_9\NNS\5225602|for|nmda|composed
10690753T3_10690753T23 CPR:4 felbamate_3\NN\1740| (r_nsubj) exhibits_4\VBZ\2632167|that|felbamate|selectivity (l_dobj) selectivity_6\NN\4916342|modest|receptors (l_nmod) receptors_9\NNS\5225602|for|nmda|composed (l_acl) composed_10\VBN\2620587|subunits (l_nmod) subunits_13\NNS\13604718|of|nr1a/nr2b (l_compound) nr1a/nr2b_12\NN\1740|
10690753T3_10690753T24 CPR:4 felbamate_3\NN\1740| (r_nsubj) exhibits_4\VBZ\2632167|that|felbamate|selectivity (l_dobj) selectivity_6\NN\4916342|modest|receptors (l_nmod) receptors_9\NNS\5225602|for|nmda|composed (l_acl) composed_10\VBN\2620587|subunits (l_nmod) subunits_13\NNS\13604718|of|nr1a/nr2b (l_compound) nr1a/nr2b_12\NN\1740|
10690753T4_10690753T22 NONE nmda_8\NN\1740| (r_compound) receptors_9\NNS\5225602|for|nmda|composed
10690753T4_10690753T23 NONE nmda_8\NN\1740| (r_compound) receptors_9\NNS\5225602|for|nmda|composed (l_acl) composed_10\VBN\2620587|subunits (l_nmod) subunits_13\NNS\13604718|of|nr1a/nr2b (l_compound) nr1a/nr2b_12\NN\1740|
10690753T4_10690753T24 NONE nmda_8\NN\1740| (r_compound) receptors_9\NNS\5225602|for|nmda|composed (l_acl) composed_10\VBN\2620587|subunits (l_nmod) subunits_13\NNS\13604718|of|nr1a/nr2b (l_compound) nr1a/nr2b_12\NN\1740|
10690753T5_10690753T25 CPR:6 felbamate_15\NN\1740|of (r_nmod) profile_13\NN\6999802|for|the|favorable|clinical|felbamate|comparison (l_nmod) comparison_17\NN\635850|in|antagonists (l_nmod) antagonists_21\NNS\7846|with|nmda|receptor|show (l_compound) receptor_20\NN\5225602|
10690753T6_10690753T25 NONE nmda_19\NN\1740| (r_compound) antagonists_21\NNS\7846|with|nmda|receptor|show (l_compound) receptor_20\NN\5225602|
17378584
17378584T7_17378584T19 NONE leucyl-trna_4\JJ\1740| (r_amod) synthetase_5\NN\1740|in|leucyl-trna
17378584T8_17378584T19 NONE acid_8\NN\14818238| (r_compound) specificity_9\NN\4762633|amino|acid|and|aminoacylation (r_dobj) affecting_6\VBG\126264|specificity (r_acl) residue_2\NN\20827|a|single|synthetase|affecting|. (l_nmod) synthetase_5\NN\1740|in|leucyl-trna
17378584T4_17378584T9 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetase_29\NN\1740|of|a|class|i|aminoacyl-trna|aars|proofread (r_nmod) example_23\NN\5816287|a|rare|synthetase (r_dobj) representing_20\VBG\2664769|example (r_advcl) achieves_9\VBZ\2524171|synthetase|fidelity|site|,|representing|. (l_nsubj) synthetase_3\NN\1740|human|mitochondrial|leucyl-trna|leurs
17378584T4_17378584T10 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetase_29\NN\1740|of|a|class|i|aminoacyl-trna|aars|proofread
17378584T4_17378584T11 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetase_29\NN\1740|of|a|class|i|aminoacyl-trna|aars|proofread (l_appos) aars_31\NN\1740|(|)
17378584T4_17378584T12 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetase_29\NN\1740|of|a|class|i|aminoacyl-trna|aars|proofread (r_nmod) example_23\NN\5816287|a|rare|synthetase (r_dobj) representing_20\VBG\2664769|example (r_advcl) achieves_9\VBZ\2524171|synthetase|fidelity|site|,|representing|. (l_nsubj) synthetase_3\NN\1740|human|mitochondrial|leucyl-trna|leurs (l_appos) leurs_7\NN\1740|(|hs|mt|)
17378584T5_17378584T9 NONE leucyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|human|mitochondrial|leucyl-trna|leurs
17378584T5_17378584T10 NONE leucyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|human|mitochondrial|leucyl-trna|leurs (r_nsubj) achieves_9\VBZ\2524171|synthetase|fidelity|site|,|representing|. (l_advcl) representing_20\VBG\2664769|example (l_dobj) example_23\NN\5816287|a|rare|synthetase (l_nmod) synthetase_29\NN\1740|of|a|class|i|aminoacyl-trna|aars|proofread
17378584T5_17378584T11 NONE leucyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|human|mitochondrial|leucyl-trna|leurs (r_nsubj) achieves_9\VBZ\2524171|synthetase|fidelity|site|,|representing|. (l_advcl) representing_20\VBG\2664769|example (l_dobj) example_23\NN\5816287|a|rare|synthetase (l_nmod) synthetase_29\NN\1740|of|a|class|i|aminoacyl-trna|aars|proofread (l_appos) aars_31\NN\1740|(|)
17378584T5_17378584T12 NONE leucyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|human|mitochondrial|leucyl-trna|leurs (l_appos) leurs_7\NN\1740|(|hs|mt|)
17378584T6_17378584T17 NONE acid_33\NN\14818238| (r_compound) discrimination_34\NN\1123598|both|amino|acid|and|binding (r_dobj) affects_30\VBZ\126264|it|discrimination (r_acl) ways_27\NNS\4341686|in|two|:|affects (r_nmod) impacts_23\VBZ\1527271|that|residue|strongly|aminoacylation|ways (l_nsubj) residue_8\NN\20827|this|particular|k600 (l_dep) k600_10\NN\1740|(|leurs|and|l570|) (l_nmod) leurs_14\NNS\1740|in|hs|mt
17378584T6_17378584T18 NONE acid_33\NN\14818238| (r_compound) discrimination_34\NN\1123598|both|amino|acid|and|binding (r_dobj) affects_30\VBZ\126264|it|discrimination (r_acl) ways_27\NNS\4341686|in|two|:|affects (r_nmod) impacts_23\VBZ\1527271|that|residue|strongly|aminoacylation|ways (l_nsubj) residue_8\NN\20827|this|particular|k600 (l_dep) k600_10\NN\1740|(|leurs|and|l570|) (l_conj) l570_16\NN\1740|leurs (l_nmod) leurs_20\NNS\1740|in|e.|coli
23274887
23274887T1_23274887T21 NONE glucose_8\NN\14710501| (r_compound) tolerance_9\NN\5032565|impaired|glucose|associated (r_dobj) exhibited_3\VBD\2632167|mice|age|tolerance|. (l_nsubj) mice_0\NNS\2329401|overexpressing (l_acl) overexpressing_1\VBG\1740|pgc-1α (l_dobj) pgc-1α_2\NN\1740|
23313794
23313794T17_23313794T34 NONE pyridine_8\NN\14618253|of|2-amino-1-methyl-6-phenylimidazo|[|5-b|]|phip (r_nmod) effects_0\NNS\13245626|pyridine|histopathology|. (l_nmod) histopathology_13\NN\1740|on|,|stress|,|and|expression (l_conj) expression_19\NN\4679549|c-fos (l_nmod) c-fos_21\NN\1740|of|,|c-jun|and|p16|stomachs
23313794T17_23313794T35 NONE pyridine_8\NN\14618253|of|2-amino-1-methyl-6-phenylimidazo|[|5-b|]|phip (r_nmod) effects_0\NNS\13245626|pyridine|histopathology|. (l_nmod) histopathology_13\NN\1740|on|,|stress|,|and|expression (l_conj) expression_19\NN\4679549|c-fos (l_nmod) c-fos_21\NN\1740|of|,|c-jun|and|p16|stomachs (l_conj) c-jun_23\NN\1740|
23313794T17_23313794T36 NONE pyridine_8\NN\14618253|of|2-amino-1-methyl-6-phenylimidazo|[|5-b|]|phip (r_nmod) effects_0\NNS\13245626|pyridine|histopathology|. (l_nmod) histopathology_13\NN\1740|on|,|stress|,|and|expression (l_conj) expression_19\NN\4679549|c-fos (l_nmod) c-fos_21\NN\1740|of|,|c-jun|and|p16|stomachs (l_conj) p16_25\NN\1740|
23313794T18_23313794T34 NONE phip_10\NN\1740|(|) (r_appos) pyridine_8\NN\14618253|of|2-amino-1-methyl-6-phenylimidazo|[|5-b|]|phip (r_nmod) effects_0\NNS\13245626|pyridine|histopathology|. (l_nmod) histopathology_13\NN\1740|on|,|stress|,|and|expression (l_conj) expression_19\NN\4679549|c-fos (l_nmod) c-fos_21\NN\1740|of|,|c-jun|and|p16|stomachs
23313794T18_23313794T35 NONE phip_10\NN\1740|(|) (r_appos) pyridine_8\NN\14618253|of|2-amino-1-methyl-6-phenylimidazo|[|5-b|]|phip (r_nmod) effects_0\NNS\13245626|pyridine|histopathology|. (l_nmod) histopathology_13\NN\1740|on|,|stress|,|and|expression (l_conj) expression_19\NN\4679549|c-fos (l_nmod) c-fos_21\NN\1740|of|,|c-jun|and|p16|stomachs (l_conj) c-jun_23\NN\1740|
23313794T18_23313794T36 NONE phip_10\NN\1740|(|) (r_appos) pyridine_8\NN\14618253|of|2-amino-1-methyl-6-phenylimidazo|[|5-b|]|phip (r_nmod) effects_0\NNS\13245626|pyridine|histopathology|. (l_nmod) histopathology_13\NN\1740|on|,|stress|,|and|expression (l_conj) expression_19\NN\4679549|c-fos (l_nmod) c-fos_21\NN\1740|of|,|c-jun|and|p16|stomachs (l_conj) p16_25\NN\1740|
23313794T5_23313794T23 NONE phip-associated_6\JJ\1740| (r_amod) cancer_8\NN\14239425|of|phip-associated|stomach (r_nmod) mechanism_4\NN\13446390|the|possible|cancer (r_dobj) understand_1\VB\588888|to|mechanism (r_advcl) investigated_32\VBN\644583|understand|,|effects|were|. (l_nsubjpass) effects_11\NNS\13245626|the|phip|morphology (l_nmod) morphology_15\NN\6037666|on|,|stress|,|expression (l_conj) expression_21\NN\4679549|gene|c-fos (l_nmod) c-fos_23\NN\1740|of|,|c-jun|and|p16|stomachs
23313794T5_23313794T24 NONE phip-associated_6\JJ\1740| (r_amod) cancer_8\NN\14239425|of|phip-associated|stomach (r_nmod) mechanism_4\NN\13446390|the|possible|cancer (r_dobj) understand_1\VB\588888|to|mechanism (r_advcl) investigated_32\VBN\644583|understand|,|effects|were|. (l_nsubjpass) effects_11\NNS\13245626|the|phip|morphology (l_nmod) morphology_15\NN\6037666|on|,|stress|,|expression (l_conj) expression_21\NN\4679549|gene|c-fos (l_nmod) c-fos_23\NN\1740|of|,|c-jun|and|p16|stomachs (l_conj) c-jun_25\NN\1740|
23313794T5_23313794T25 NONE phip-associated_6\JJ\1740| (r_amod) cancer_8\NN\14239425|of|phip-associated|stomach (r_nmod) mechanism_4\NN\13446390|the|possible|cancer (r_dobj) understand_1\VB\588888|to|mechanism (r_advcl) investigated_32\VBN\644583|understand|,|effects|were|. (l_nsubjpass) effects_11\NNS\13245626|the|phip|morphology (l_nmod) morphology_15\NN\6037666|on|,|stress|,|expression (l_conj) expression_21\NN\4679549|gene|c-fos (l_nmod) c-fos_23\NN\1740|of|,|c-jun|and|p16|stomachs (l_conj) p16_27\NN\1740|
23313794T6_23313794T23 NONE phip_13\NN\1740|of (r_nmod) effects_11\NNS\13245626|the|phip|morphology (l_nmod) morphology_15\NN\6037666|on|,|stress|,|expression (l_conj) expression_21\NN\4679549|gene|c-fos (l_nmod) c-fos_23\NN\1740|of|,|c-jun|and|p16|stomachs
23313794T6_23313794T24 NONE phip_13\NN\1740|of (r_nmod) effects_11\NNS\13245626|the|phip|morphology (l_nmod) morphology_15\NN\6037666|on|,|stress|,|expression (l_conj) expression_21\NN\4679549|gene|c-fos (l_nmod) c-fos_23\NN\1740|of|,|c-jun|and|p16|stomachs (l_conj) c-jun_25\NN\1740|
23313794T6_23313794T25 NONE phip_13\NN\1740|of (r_nmod) effects_11\NNS\13245626|the|phip|morphology (l_nmod) morphology_15\NN\6037666|on|,|stress|,|expression (l_conj) expression_21\NN\4679549|gene|c-fos (l_nmod) c-fos_23\NN\1740|of|,|c-jun|and|p16|stomachs (l_conj) p16_27\NN\1740|
23313794T7_23313794T26 NONE phip_10\NN\1740|15mg/kg|body|weight (r_nsubj) induced_11\VBD\1627355|that|1|phip|changes|mucosa|;|decreased (l_parataxis) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_dobj) activities_40\NNS\30358|dismutase (l_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase
23313794T7_23313794T27 NONE phip_10\NN\1740|15mg/kg|body|weight (r_nsubj) induced_11\VBD\1627355|that|1|phip|changes|mucosa|;|decreased (l_parataxis) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_dobj) activities_40\NNS\30358|dismutase (l_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_appos) sod_33\NN\9335240|(|)
23313794T7_23313794T28 NONE phip_10\NN\1740|15mg/kg|body|weight (r_nsubj) induced_11\VBD\1627355|that|1|phip|changes|mucosa|;|decreased (l_parataxis) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_dobj) activities_40\NNS\30358|dismutase (l_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_conj) glutathioneperoxidase_36\NN\1740|gpx
23313794T7_23313794T29 NONE phip_10\NN\1740|15mg/kg|body|weight (r_nsubj) induced_11\VBD\1627355|that|1|phip|changes|mucosa|;|decreased (l_parataxis) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_dobj) activities_40\NNS\30358|dismutase (l_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_conj) glutathioneperoxidase_36\NN\1740|gpx (l_appos) gpx_38\NN\1740|(|)
23313794T7_23313794T30 NONE phip_10\NN\1740|15mg/kg|body|weight (r_nsubj) induced_11\VBD\1627355|that|1|phip|changes|mucosa|;|decreased (l_parataxis) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_advcl) increased_43\VBD\169651|while|activity|control (l_dobj) activity_48\NN\30358|catalase (l_compound) catalase_44\NN\14732946|cat
23313794T7_23313794T31 NONE phip_10\NN\1740|15mg/kg|body|weight (r_nsubj) induced_11\VBD\1627355|that|1|phip|changes|mucosa|;|decreased (l_parataxis) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_advcl) increased_43\VBD\169651|while|activity|control (l_dobj) activity_48\NN\30358|catalase (l_compound) catalase_44\NN\14732946|cat (l_appos) cat_46\NN\2120997|(|)
23313794T8_23313794T26 CPR:4 phip_22\NN\1740|10 (r_nsubj) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_dobj) activities_40\NNS\30358|dismutase (l_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase
23313794T8_23313794T27 CPR:4 phip_22\NN\1740|10 (r_nsubj) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_dobj) activities_40\NNS\30358|dismutase (l_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_appos) sod_33\NN\9335240|(|)
23313794T8_23313794T28 CPR:4 phip_22\NN\1740|10 (r_nsubj) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_dobj) activities_40\NNS\30358|dismutase (l_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_conj) glutathioneperoxidase_36\NN\1740|gpx
23313794T8_23313794T29 CPR:4 phip_22\NN\1740|10 (r_nsubj) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_dobj) activities_40\NNS\30358|dismutase (l_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_conj) glutathioneperoxidase_36\NN\1740|gpx (l_appos) gpx_38\NN\1740|(|)
23313794T8_23313794T30 CPR:3 phip_22\NN\1740|10 (r_nsubj) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_advcl) increased_43\VBD\169651|while|activity|control (l_dobj) activity_48\NN\30358|catalase (l_compound) catalase_44\NN\14732946|cat
23313794T8_23313794T31 CPR:3 phip_22\NN\1740|10 (r_nsubj) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_advcl) increased_43\VBD\169651|while|activity|control (l_dobj) activity_48\NN\30358|catalase (l_compound) catalase_44\NN\14732946|cat (l_appos) cat_46\NN\2120997|(|)
23313794T10_23313794T26 NONE superoxide_30\NN\14971519| (r_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase
23313794T10_23313794T27 NONE superoxide_30\NN\14971519| (r_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_appos) sod_33\NN\9335240|(|)
23313794T10_23313794T28 NONE superoxide_30\NN\14971519| (r_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_conj) glutathioneperoxidase_36\NN\1740|gpx
23313794T10_23313794T29 NONE superoxide_30\NN\14971519| (r_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (l_conj) glutathioneperoxidase_36\NN\1740|gpx (l_appos) gpx_38\NN\1740|(|)
23313794T10_23313794T30 NONE superoxide_30\NN\14971519| (r_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (r_compound) activities_40\NNS\30358|dismutase (r_dobj) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_advcl) increased_43\VBD\169651|while|activity|control (l_dobj) activity_48\NN\30358|catalase (l_compound) catalase_44\NN\14732946|cat
23313794T10_23313794T31 NONE superoxide_30\NN\14971519| (r_compound) dismutase_31\NN\1740|superoxide|sod|and|glutathioneperoxidase (r_compound) activities_40\NNS\30358|dismutase (r_dobj) decreased_29\VBD\169651|2|phip|significantly|activities|,|increased (l_advcl) increased_43\VBD\169651|while|activity|control (l_dobj) activity_48\NN\30358|catalase (l_compound) catalase_44\NN\14732946|cat (l_appos) cat_46\NN\2120997|(|)
23313794T11_23313794T19 NONE phip_5\NN\1740|of (r_nmod) doses_3\NNS\3740161|with|the|elevated|phip (r_nmod) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun (l_conj) c-jun_57\NN\1740|
23313794T11_23313794T32 NONE phip_5\NN\1740|of (r_nmod) doses_3\NNS\3740161|with|the|elevated|phip (r_nmod) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_dobj) mrna_48\NN\14832193|p16|and|expression (l_compound) p16_47\NN\1740|
23313794T11_23313794T33 NONE phip_5\NN\1740|of (r_nmod) doses_3\NNS\3740161|with|the|elevated|phip (r_nmod) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun
23313794T12_23313794T19 NONE malondialdehyde_7\NN\1740|mda (r_compound) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun (l_conj) c-jun_57\NN\1740|
23313794T12_23313794T32 NONE malondialdehyde_7\NN\1740|mda (r_compound) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_dobj) mrna_48\NN\14832193|p16|and|expression (l_compound) p16_47\NN\1740|
23313794T12_23313794T33 NONE malondialdehyde_7\NN\1740|mda (r_compound) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun
23313794T13_23313794T19 NONE mda_9\NN\1740|(|) (r_appos) malondialdehyde_7\NN\1740|mda (r_compound) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun (l_conj) c-jun_57\NN\1740|
23313794T13_23313794T32 NONE mda_9\NN\1740|(|) (r_appos) malondialdehyde_7\NN\1740|mda (r_compound) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_dobj) mrna_48\NN\14832193|p16|and|expression (l_compound) p16_47\NN\1740|
23313794T13_23313794T33 NONE mda_9\NN\1740|(|) (r_appos) malondialdehyde_7\NN\1740|mda (r_compound) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun
23313794T14_23313794T19 NONE carbonyl_14\NN\14818238|protein|pco (r_compound) contents_18\NNS\6481320|carbonyl (r_conj) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun (l_conj) c-jun_57\NN\1740|
23313794T14_23313794T32 NONE carbonyl_14\NN\14818238|protein|pco (r_compound) contents_18\NNS\6481320|carbonyl (r_conj) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_dobj) mrna_48\NN\14832193|p16|and|expression (l_compound) p16_47\NN\1740|
23313794T14_23313794T33 NONE carbonyl_14\NN\14818238|protein|pco (r_compound) contents_18\NNS\6481320|carbonyl (r_conj) contents_11\NNS\6481320|malondialdehyde|,|contents|and|coefficients (r_nsubjpass) raised_28\VBN\153263|doses|,|contents|were|significantly|manner|;|inhibited|. (l_parataxis) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun
23313794T16_23313794T19 CPR:3 phip_37\NN\1740|doses (r_nsubj) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun (l_conj) c-jun_57\NN\1740|
23313794T16_23313794T32 CPR:4 phip_37\NN\1740|doses (r_nsubj) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_dobj) mrna_48\NN\14832193|p16|and|expression (l_compound) p16_47\NN\1740|
23313794T16_23313794T33 CPR:3 phip_37\NN\1740|doses (r_nsubj) inhibited_46\VBD\2510337|3|phip|significantly|mrna|,|whereas|enhanced (l_advcl) enhanced_54\VBD\227165|expression|relative (l_dobj) expression_58\NN\4679549|c-fos (l_compound) c-fos_55\NN\1740|and|c-jun
23313794T2_23313794T20 CPR:3 phip_4\NN\1740| (r_nsubj) cause_6\VB\1617192|that|phip|could|injury (l_dobj) injury_8\NN\14052046|stomach|,|stress|as|activation|,|play (l_conj) activation_19\NN\13561719|the|c-fos|and|inactivation (l_nmod) c-fos_21\NN\1740|of|and|c-jun
23313794T2_23313794T21 CPR:3 phip_4\NN\1740| (r_nsubj) cause_6\VB\1617192|that|phip|could|injury (l_dobj) injury_8\NN\14052046|stomach|,|stress|as|activation|,|play (l_conj) activation_19\NN\13561719|the|c-fos|and|inactivation (l_nmod) c-fos_21\NN\1740|of|and|c-jun (l_conj) c-jun_23\NN\1740|
23313794T2_23313794T22 CPR:4 phip_4\NN\1740| (r_nsubj) cause_6\VB\1617192|that|phip|could|injury (l_dobj) injury_8\NN\14052046|stomach|,|stress|as|activation|,|play (l_conj) activation_19\NN\13561719|the|c-fos|and|inactivation (l_conj) inactivation_25\NN\13518963|p16 (l_nmod) p16_27\NN\1740|of
23313794T4_23313794T20 NONE phip-associated_38\JJ\1740| (r_amod) cancer_40\NN\14239425|of|phip-associated|stomach (r_nmod) pathogenesis_36\NN\13533470|in|the|cancer (r_nmod) role_33\NN\719494|a|pathogenesis (r_dobj) play_31\VB\1072262|which|may|role (r_acl:relcl) injury_8\NN\14052046|stomach|,|stress|as|activation|,|play (l_conj) activation_19\NN\13561719|the|c-fos|and|inactivation (l_nmod) c-fos_21\NN\1740|of|and|c-jun
23313794T4_23313794T21 NONE phip-associated_38\JJ\1740| (r_amod) cancer_40\NN\14239425|of|phip-associated|stomach (r_nmod) pathogenesis_36\NN\13533470|in|the|cancer (r_nmod) role_33\NN\719494|a|pathogenesis (r_dobj) play_31\VB\1072262|which|may|role (r_acl:relcl) injury_8\NN\14052046|stomach|,|stress|as|activation|,|play (l_conj) activation_19\NN\13561719|the|c-fos|and|inactivation (l_nmod) c-fos_21\NN\1740|of|and|c-jun (l_conj) c-jun_23\NN\1740|
23313794T4_23313794T22 NONE phip-associated_38\JJ\1740| (r_amod) cancer_40\NN\14239425|of|phip-associated|stomach (r_nmod) pathogenesis_36\NN\13533470|in|the|cancer (r_nmod) role_33\NN\719494|a|pathogenesis (r_dobj) play_31\VB\1072262|which|may|role (r_acl:relcl) injury_8\NN\14052046|stomach|,|stress|as|activation|,|play (l_conj) activation_19\NN\13561719|the|c-fos|and|inactivation (l_conj) inactivation_25\NN\13518963|p16 (l_nmod) p16_27\NN\1740|of
23632905
23632905T5_23632905T43 NONE streptozotocin-induced_7\NN\1740|and|spontaneous (r_amod) rats_13\NNS\2329401|of|streptozotocin-induced|type|1|diabetic (r_nmod) liver_5\NN\5298729|in|the|rats (r_nmod) expression_2\NN\4679549|clock|gene|liver|. (l_compound) clock_0\NN\4437953|
23632905T2_23632905T18 NONE streptozotocin_26\NN\1740|(stz)-treated (r_compound) rats_28\NNS\2329401|of|male|streptozotocin|,|rats|,|and|rats (r_nmod) livers_23\NNS\5298729|in|the|rats (r_nmod) investigated_1\VBD\644583|we|expression|livers|. (l_dobj) expression_4\NN\4679549|the|diurnal|genes|intervals|period (l_nmod) genes_7\NNS\8459252|of|clock|and|genes (l_compound) clock_6\NN\4437953|
23632905T2_23632905T22 NONE streptozotocin_26\NN\1740|(stz)-treated (r_compound) rats_28\NNS\2329401|of|male|streptozotocin|,|rats|,|and|rats (r_nmod) livers_23\NNS\5298729|in|the|rats (r_nmod) investigated_1\VBD\644583|we|expression|livers|. (l_dobj) expression_4\NN\4679549|the|diurnal|genes|intervals|period (l_nmod) genes_7\NNS\8459252|of|clock|and|genes (l_conj) genes_10\NNS\8459252|clock-controlled|ccgs
23632905T2_23632905T23 NONE streptozotocin_26\NN\1740|(stz)-treated (r_compound) rats_28\NNS\2329401|of|male|streptozotocin|,|rats|,|and|rats (r_nmod) livers_23\NNS\5298729|in|the|rats (r_nmod) investigated_1\VBD\644583|we|expression|livers|. (l_dobj) expression_4\NN\4679549|the|diurnal|genes|intervals|period (l_nmod) genes_7\NNS\8459252|of|clock|and|genes (l_conj) genes_10\NNS\8459252|clock-controlled|ccgs (l_appos) ccgs_12\NNS\1740|(|)
23632905T2_23632905T24 NONE streptozotocin_26\NN\1740|(stz)-treated (r_compound) rats_28\NNS\2329401|of|male|streptozotocin|,|rats|,|and|rats (l_conj) rats_43\NNS\2329401|iddm|treated (l_acl) treated_44\VBN\2376958|days|insulin (l_nmod) insulin_49\NN\5407119|with
23632905T3_23632905T18 NONE (stz)-treated_27\JJ\1740| (r_dep) streptozotocin_26\NN\1740|(stz)-treated (r_compound) rats_28\NNS\2329401|of|male|streptozotocin|,|rats|,|and|rats (r_nmod) livers_23\NNS\5298729|in|the|rats (r_nmod) investigated_1\VBD\644583|we|expression|livers|. (l_dobj) expression_4\NN\4679549|the|diurnal|genes|intervals|period (l_nmod) genes_7\NNS\8459252|of|clock|and|genes (l_compound) clock_6\NN\4437953|
23632905T3_23632905T22 NONE (stz)-treated_27\JJ\1740| (r_dep) streptozotocin_26\NN\1740|(stz)-treated (r_compound) rats_28\NNS\2329401|of|male|streptozotocin|,|rats|,|and|rats (r_nmod) livers_23\NNS\5298729|in|the|rats (r_nmod) investigated_1\VBD\644583|we|expression|livers|. (l_dobj) expression_4\NN\4679549|the|diurnal|genes|intervals|period (l_nmod) genes_7\NNS\8459252|of|clock|and|genes (l_conj) genes_10\NNS\8459252|clock-controlled|ccgs
23632905T3_23632905T23 NONE (stz)-treated_27\JJ\1740| (r_dep) streptozotocin_26\NN\1740|(stz)-treated (r_compound) rats_28\NNS\2329401|of|male|streptozotocin|,|rats|,|and|rats (r_nmod) livers_23\NNS\5298729|in|the|rats (r_nmod) investigated_1\VBD\644583|we|expression|livers|. (l_dobj) expression_4\NN\4679549|the|diurnal|genes|intervals|period (l_nmod) genes_7\NNS\8459252|of|clock|and|genes (l_conj) genes_10\NNS\8459252|clock-controlled|ccgs (l_appos) ccgs_12\NNS\1740|(|)
23632905T3_23632905T24 NONE (stz)-treated_27\JJ\1740| (r_dep) streptozotocin_26\NN\1740|(stz)-treated (r_compound) rats_28\NNS\2329401|of|male|streptozotocin|,|rats|,|and|rats (l_conj) rats_43\NNS\2329401|iddm|treated (l_acl) treated_44\VBN\2376958|days|insulin (l_nmod) insulin_49\NN\5407119|with
23632905T4_23632905T37 NONE stz_1\NN\1740|diabetic|and|iddm|rats|,|as|rats|, (l_conj) rats_11\NNS\2329401|insulin-substituted|iddm (l_amod) insulin-substituted_9\JJ\1740|
23632905T4_23632905T38 NONE stz_1\NN\1740|diabetic|and|iddm|rats|,|as|rats|, (r_nsubj) exhibited_13\VBD\2632167|stz|pattern|determined|;|altered|. (l_dobj) pattern_18\NN\5726345|a|significant|diurnal|expression|genes (l_nmod) genes_21\NNS\8459252|of|clock (l_compound) clock_20\NN\4437953|
23632905T4_23632905T39 NONE stz_1\NN\1740|diabetic|and|iddm|rats|,|as|rats|, (r_nsubj) exhibited_13\VBD\2632167|stz|pattern|determined|;|altered|. (l_parataxis) altered_49\VBN\126264|however|,|mesor|was|rats (l_nsubjpass) mesor_31\NN\1740|the|statistic|bmal1|and|expression (l_nmod) bmal1_40\NN\1740|of|,|per2|,
23632905T4_23632905T40 NONE stz_1\NN\1740|diabetic|and|iddm|rats|,|as|rats|, (r_nsubj) exhibited_13\VBD\2632167|stz|pattern|determined|;|altered|. (l_parataxis) altered_49\VBN\126264|however|,|mesor|was|rats (l_nsubjpass) mesor_31\NN\1740|the|statistic|bmal1|and|expression (l_nmod) bmal1_40\NN\1740|of|,|per2|, (l_appos) per2_42\NN\1740|
23632905T4_23632905T41 NONE stz_1\NN\1740|diabetic|and|iddm|rats|,|as|rats|, (r_nsubj) exhibited_13\VBD\2632167|stz|pattern|determined|;|altered|. (l_parataxis) altered_49\VBN\126264|however|,|mesor|was|rats (l_nsubjpass) mesor_31\NN\1740|the|statistic|bmal1|and|expression (l_conj) expression_47\NN\4679549|clock|transcript (l_compound) clock_45\NN\4437953|
23632905T4_23632905T42 NONE stz_1\NN\1740|diabetic|and|iddm|rats|,|as|rats|, (r_nsubj) exhibited_13\VBD\2632167|stz|pattern|determined|;|altered|. (l_parataxis) altered_49\VBN\126264|however|,|mesor|was|rats (l_nmod) rats_55\NNS\2329401|iddm (l_compound) iddm_51\NN\14187378|in|and|iddm (l_conj) iddm_54\NN\14187378|insulin-substituted (l_amod) insulin-substituted_53\JJ\1740|
23632905T1_23632905T14 NONE stz_14\NN\1740|of|diabetic|or|iddm (r_compound) rats_17\NNS\2329401|stz (r_nmod) livers_11\NNS\5298729|in|the|rats|or|those (r_nmod) rhythm_5\NN\15122011|no|diurnal|expression|livers (l_nmod) expression_8\NN\4679549|of|pparγ (l_compound) pparγ_7\NN\1740|
23632905T1_23632905T15 NONE stz_14\NN\1740|of|diabetic|or|iddm (r_compound) rats_17\NNS\2329401|stz (r_nmod) livers_11\NNS\5298729|in|the|rats|or|those (l_conj) those_20\DT\1740|in|rats (l_nmod) rats_24\NNS\2329401|of|insulin-substituted|iddm (l_amod) insulin-substituted_22\JJ\1740|
22634361
22634361T15_22634361T22 NONE af21934_7\NN\1740|of|lu|,|modulator (l_appos) modulator_15\NN\1740|a|novel|,|selective|positive|allosteric|receptor (l_nmod) receptor_19\NN\5225602|of|the|mglu₄ (l_compound) mglu₄_18\NN\1740|
22634361T14_22634361T18 CPR:5 2111_14\CD\1740| (r_nummod) lsp1_12\NNP\1740|-|2111 (r_appos) agonist_10\NN\9613191|the|group|iii|receptor-selective|orthosteric|,|lsp1 (l_amod) receptor-selective_8\JJ\1740|mglu
22634361T4_22634361T17 NONE af21934_9\NN\1740|of|lu|,|modulator (l_appos) modulator_20\NN\1740|a|novel|positive|allosteric|pam|receptor|hyperthermia (l_nmod) receptor_28\NN\5225602|of|the|mglu(4|) (l_punct) )_27\-RRB-\1740|
22634361T5_22634361T19 NONE af21934_5\NN\1740|of|lu|mg/kg (r_nmod) effect_2\NN\34213|the|anti-hyperthermic|af21934|test (r_nsubjpass) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_nmod) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T5_22634361T20 NONE af21934_5\NN\1740|of|lu|mg/kg (r_nmod) effect_2\NN\34213|the|anti-hyperthermic|af21934|test (r_nsubjpass) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_conj) serotonin-dependent_29\JJ\1740|was|not|,|persisted (l_advcl) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_nmod) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T5_22634361T21 NONE af21934_5\NN\1740|of|lu|mg/kg (r_nmod) effect_2\NN\34213|the|anti-hyperthermic|af21934|test (r_nsubjpass) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_conj) serotonin-dependent_29\JJ\1740|was|not|,|persisted (l_advcl) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_conj) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T6_22634361T19 NONE benzodiazepine_18\NN\3771443| (r_compound) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T6_22634361T20 NONE benzodiazepine_18\NN\3771443| (r_compound) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (r_nmod) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_conj) serotonin-dependent_29\JJ\1740|was|not|,|persisted (l_advcl) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_nmod) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T6_22634361T21 NONE benzodiazepine_18\NN\3771443| (r_compound) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (r_nmod) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_conj) serotonin-dependent_29\JJ\1740|was|not|,|persisted (l_advcl) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_conj) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T7_22634361T19 CPR:6 flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T7_22634361T20 NONE flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (r_nmod) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_conj) serotonin-dependent_29\JJ\1740|was|not|,|persisted (l_advcl) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_nmod) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T7_22634361T21 NONE flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (r_nmod) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_conj) serotonin-dependent_29\JJ\1740|was|not|,|persisted (l_advcl) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_conj) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T8_22634361T19 NONE serotonin-dependent_29\JJ\1740|was|not|,|persisted (r_conj) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_nmod) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T8_22634361T20 NONE serotonin-dependent_29\JJ\1740|was|not|,|persisted (l_advcl) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_nmod) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T8_22634361T21 NONE serotonin-dependent_29\JJ\1740|was|not|,|persisted (l_advcl) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_conj) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T9_22634361T19 NONE serotonin-deficient_35\JJ\1740| (r_amod) mice_36\NNS\2329401|in|serotonin-deficient (r_nmod) persisted_33\VBD\118523|as|it|mice|and|blockade (r_advcl) serotonin-dependent_29\JJ\1740|was|not|,|persisted (r_conj) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_nmod) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T9_22634361T20 NONE serotonin-deficient_35\JJ\1740| (r_amod) mice_36\NNS\2329401|in|serotonin-deficient (r_nmod) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_nmod) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T9_22634361T21 NONE serotonin-deficient_35\JJ\1740| (r_amod) mice_36\NNS\2329401|in|serotonin-deficient (r_nmod) persisted_33\VBD\118523|as|it|mice|and|blockade (l_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_conj) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T10_22634361T19 NONE 5-ht(1a_42\NN\1740| (r_compound) receptors_44\NNS\5225602|of|either|5-ht(1a|) (r_nmod) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (r_conj) persisted_33\VBD\118523|as|it|mice|and|blockade (r_advcl) serotonin-dependent_29\JJ\1740|was|not|,|persisted (r_conj) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_nmod) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T10_22634361T20 NONE 5-ht(1a_42\NN\1740| (r_compound) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T10_22634361T21 NONE 5-ht(1a_42\NN\1740| (r_compound) receptors_44\NNS\5225602|of|either|5-ht(1a|) (r_nmod) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_conj) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T11_22634361T19 NONE way100635_46\NN\1740|by (r_nmod) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (r_conj) persisted_33\VBD\118523|as|it|mice|and|blockade (r_advcl) serotonin-dependent_29\JJ\1740|was|not|,|persisted (r_conj) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_nmod) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T11_22634361T20 CPR:4 way100635_46\NN\1740|by (r_nmod) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_nmod) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T11_22634361T21 NONE way100635_46\NN\1740|by (r_nmod) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_conj) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T12_22634361T19 NONE 5-ht(2a/2c_49\NN\1740| (r_compound) receptors_51\NNS\5225602|5-ht(2a/2c|) (r_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (r_conj) persisted_33\VBD\118523|as|it|mice|and|blockade (r_advcl) serotonin-dependent_29\JJ\1740|was|not|,|persisted (r_conj) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_nmod) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T12_22634361T20 NONE 5-ht(2a/2c_49\NN\1740| (r_compound) receptors_51\NNS\5225602|5-ht(2a/2c|) (r_conj) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_nmod) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T12_22634361T21 NONE 5-ht(2a/2c_49\NN\1740| (r_compound) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T13_22634361T19 NONE ritanserin_53\NN\1740|by (r_nmod) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (r_conj) persisted_33\VBD\118523|as|it|mice|and|blockade (r_advcl) serotonin-dependent_29\JJ\1740|was|not|,|persisted (r_conj) inhibited_15\VBN\2510337|effect|was|flumazenil|and|serotonin-dependent|. (l_nmod) flumazenil_21\NN\1740|by|the|benzodiazepine|receptor|antagonist|mg/kg (l_compound) receptor_19\NN\5225602|
22634361T13_22634361T20 NONE ritanserin_53\NN\1740|by (r_nmod) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_nmod) receptors_44\NNS\5225602|of|either|5-ht(1a|) (l_punct) )_43\-RRB-\1740|
22634361T13_22634361T21 CPR:4 ritanserin_53\NN\1740|by (r_nmod) blockade_39\NN\952963|upon|receptors|way100635|,|or|receptors|ritanserin (l_conj) receptors_51\NNS\5225602|5-ht(2a/2c|) (l_punct) )_50\-RRB-\1740|
22634361T3_22634361T16 NONE glutamate_11\NN\15010703| (r_compound) receptors_12\NNS\5225602|'|metabotropic|glutamate|'
23456735
17035141
17035141T1_17035141T22 NONE cystathionine-beta-synthase_67\NN\1740|
17035141T1_17035141T30 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T1_17035141T31 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T1_17035141T32 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T1_17035141T33 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T1_17035141T34 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T1_17035141T35 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T1_17035141T36 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T1_17035141T37 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T1_17035141T38 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T1_17035141T39 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T1_17035141T40 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T1_17035141T41 NONE cystathionine-beta-synthase_67\NN\1740| (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T11_17035141T22 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T11_17035141T30 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T11_17035141T31 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T11_17035141T32 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T11_17035141T33 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T11_17035141T34 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T11_17035141T35 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T11_17035141T36 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T11_17035141T37 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T11_17035141T38 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T11_17035141T39 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T11_17035141T40 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T11_17035141T41 NONE folate_21\NN\15090742| (r_compound) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T12_17035141T22 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T12_17035141T30 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T12_17035141T31 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T12_17035141T32 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T12_17035141T33 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T12_17035141T34 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T12_17035141T35 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T12_17035141T36 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T12_17035141T37 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T12_17035141T38 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T12_17035141T39 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T12_17035141T40 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T12_17035141T41 NONE folate_25\NN\15090742| (r_compound) receptor_26\NN\5225602|folate|2 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T13_17035141T22 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T13_17035141T30 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T13_17035141T31 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T13_17035141T32 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T13_17035141T33 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T13_17035141T34 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T13_17035141T35 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T13_17035141T36 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T13_17035141T37 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T13_17035141T38 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T13_17035141T39 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T13_17035141T40 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T13_17035141T41 NONE methylenetetrahydrofolate_39\NN\1740| (r_amod) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T14_17035141T22 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T14_17035141T30 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T14_17035141T31 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T14_17035141T32 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T14_17035141T33 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T14_17035141T34 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T14_17035141T35 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T14_17035141T36 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T14_17035141T37 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T14_17035141T38 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T14_17035141T39 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T14_17035141T40 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T14_17035141T41 NONE hydroxymethyl-transferase_44\NN\1740|serine|1 (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T15_17035141T22 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T15_17035141T30 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T15_17035141T31 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T15_17035141T32 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T15_17035141T33 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T15_17035141T34 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T15_17035141T35 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T15_17035141T36 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T15_17035141T37 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T15_17035141T38 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T15_17035141T39 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T15_17035141T40 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T15_17035141T41 NONE 5,10-methylenetetrahydrofolate_47\JJ\1740| (r_amod) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (r_dep) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T16_17035141T22 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T16_17035141T30 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T16_17035141T31 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T16_17035141T32 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T16_17035141T33 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T16_17035141T34 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T16_17035141T35 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T16_17035141T36 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T16_17035141T37 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T16_17035141T38 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T16_17035141T39 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T16_17035141T40 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T16_17035141T41 NONE 5-methyltetrahydrofolate-homo-cysteine_53\NN\1740| (r_compound) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T17_17035141T22 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T17_17035141T30 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T17_17035141T31 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T17_17035141T32 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T17_17035141T33 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T17_17035141T34 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T17_17035141T35 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T17_17035141T36 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T17_17035141T37 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T17_17035141T38 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T17_17035141T39 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T17_17035141T40 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T17_17035141T41 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T18_17035141T22 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T18_17035141T30 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T18_17035141T31 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T18_17035141T32 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T18_17035141T33 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T18_17035141T34 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T18_17035141T35 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T18_17035141T36 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T18_17035141T37 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T18_17035141T38 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T18_17035141T39 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T18_17035141T40 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T18_17035141T41 NONE 5-methyltetrahydrofolate-homocysteine_56\NN\1740| (r_compound) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T19_17035141T22 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T19_17035141T30 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T19_17035141T31 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T19_17035141T32 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T19_17035141T33 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T19_17035141T34 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T19_17035141T35 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T19_17035141T36 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T19_17035141T37 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T19_17035141T38 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T19_17035141T39 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T19_17035141T40 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T19_17035141T41 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T20_17035141T22 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) cystathionine-beta-synthase_67\NN\1740|
17035141T20_17035141T30 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_nummod) 1_23\CD\13741022|
17035141T20_17035141T31 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) receptor_26\NN\5225602|folate|2 (l_nummod) 2_27\CD\13741022|
17035141T20_17035141T32 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) member_33\NN\9816771|solute|carrier|family|19|1 (l_nummod) 1_34\CD\13741022|
17035141T20_17035141T33 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_appos) transcobalamin_36\NN\1740|ii (l_nummod) ii_37\CD\13741022|
17035141T20_17035141T34 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) dehydrogenase_40\NN\1740|methylenetetrahydrofolate|1 (l_nummod) 1_41\CD\13741022|
17035141T20_17035141T35 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) hydroxymethyl-transferase_44\NN\1740|serine|1 (l_nummod) 1_45\CD\13741022|
17035141T20_17035141T36 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr
17035141T20_17035141T37 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_dep) reductase_48\NN\14732946|,|5,10-methylenetetrahydrofolate|mthfr (l_appos) mthfr_50\NN\1740|(|)
17035141T20_17035141T38 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) methyltransferase_54\NN\1740|5-methyltetrahydrofolate-homo-cysteine
17035141T20_17035141T39 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (r_conj) receptor_22\NN\5225602|folate|1|,|receptor|,|member|,|transcobalamin|,|dehydrogenase|,|hydroxymethyl-transferase|reductase|,|methyltransferase|,|reductase|,|methyltransferase|,|and|cystathionine-beta-synthase (l_conj) reductase_58\NN\14732946|5-methyltetrahydrofolate-homocysteine|methyltransferase
17035141T20_17035141T40 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt
17035141T20_17035141T41 NONE betaine-homocysteine_60\NN\1740| (r_compound) methyltransferase_61\NN\1740|betaine-homocysteine|bhmt (l_appos) bhmt_63\NN\1740|(|)
17035141T2_17035141T23 NONE nucleotide_4\JJ\1740| (r_amod) polymorphisms_5\NNS\11418750|only|single|nucleotide|snps|bhmt (l_nmod) bhmt_10\NNP\1740|in
17035141T4_17035141T23 NONE folate-containing_27\NN\1740| (r_amod) supplements_29\NNS\6365467|folate-containing|nutritional (r_dobj) took_26\VBD\2367363|when|mothers|supplements|conception (r_advcl) strongest_23\JJS\1740|associated|;|significance|was|took|. (l_ccomp) associated_13\VBN\628491|results|polymorphisms|were|significantly|set (l_nsubjpass) polymorphisms_5\NNS\11418750|only|single|nucleotide|snps|bhmt (l_nmod) bhmt_10\NNP\1740|in
17035141T6_17035141T26 NONE folate_3\NN\15090742| (r_compound) genes_5\NNS\8459252|in|folate|pathway (r_nmod) snps_1\NNS\11493266|other|genes (r_nsubj) significant_8\JJ\1740|snps|were|marginally|analyses|stratified|. (l_advcl) stratified_13\VBN\650353|when|supplementation (l_nmod) supplementation_16\NN\5108947|by|maternal|,|mthfr|,|or|transmission (l_conj) mthfr_18\NN\1740|
17035141T6_17035141T27 NONE folate_3\NN\15090742| (r_compound) genes_5\NNS\8459252|in|folate|pathway (r_nmod) snps_1\NNS\11493266|other|genes (r_nsubj) significant_8\JJ\1740|snps|were|marginally|analyses|stratified|. (l_advcl) stratified_13\VBN\650353|when|supplementation (l_nmod) supplementation_16\NN\5108947|by|maternal|,|mthfr|,|or|transmission (l_conj) transmission_23\NN\121166|bhmt|allele (l_compound) bhmt_21\NN\1740|
10047461
10047461T15_10047461T61 NONE thymidylate_17\NN\1740| (r_compound) tomudex_20\NN\1740|by|the|thymidylate|synthase|inhibitor (r_nmod) induced_14\VBN\1627355|tomudex (r_acl) replication_13\NN\1019524|of|dna|induced (r_nmod) inhibition_10\NN\1068773|replication (r_conj) arrest_8\NN\88481|with|cell|cycle|and|inhibition (r_nmod) associated_4\VBN\628491|activation|is|arrest|. (l_nsubjpass) activation_2\NN\13561719|cyclin|e-cdk2 (l_compound) e-cdk2_1\NN\1740|
10047461T15_10047461T62 NONE thymidylate_17\NN\1740| (r_compound) tomudex_20\NN\1740|by|the|thymidylate|synthase|inhibitor (l_compound) synthase_18\NN\1740|
10047461T15_10047461T63 NONE thymidylate_17\NN\1740| (r_compound) tomudex_20\NN\1740|by|the|thymidylate|synthase|inhibitor (r_nmod) induced_14\VBN\1627355|tomudex (r_acl) replication_13\NN\1019524|of|dna|induced (r_nmod) inhibition_10\NN\1068773|replication (r_conj) arrest_8\NN\88481|with|cell|cycle|and|inhibition (r_nmod) associated_4\VBN\628491|activation|is|arrest|. (l_nsubjpass) activation_2\NN\13561719|cyclin|e-cdk2 (l_compound) e-cdk2_1\NN\1740|
10047461T16_10047461T61 NONE tomudex_20\NN\1740|by|the|thymidylate|synthase|inhibitor (r_nmod) induced_14\VBN\1627355|tomudex (r_acl) replication_13\NN\1019524|of|dna|induced (r_nmod) inhibition_10\NN\1068773|replication (r_conj) arrest_8\NN\88481|with|cell|cycle|and|inhibition (r_nmod) associated_4\VBN\628491|activation|is|arrest|. (l_nsubjpass) activation_2\NN\13561719|cyclin|e-cdk2 (l_compound) e-cdk2_1\NN\1740|
10047461T16_10047461T62 CPR:4 tomudex_20\NN\1740|by|the|thymidylate|synthase|inhibitor (l_compound) synthase_18\NN\1740|
10047461T16_10047461T63 NONE tomudex_20\NN\1740|by|the|thymidylate|synthase|inhibitor (r_nmod) induced_14\VBN\1627355|tomudex (r_acl) replication_13\NN\1019524|of|dna|induced (r_nmod) inhibition_10\NN\1068773|replication (r_conj) arrest_8\NN\88481|with|cell|cycle|and|inhibition (r_nmod) associated_4\VBN\628491|activation|is|arrest|. (l_nsubjpass) activation_2\NN\13561719|cyclin|e-cdk2 (l_compound) e-cdk2_1\NN\1740|
10047461T1_10047461T50 CPR:4 tomudex_0\NNP\1740|(|zd1694|) (r_nsubj) inhibitor_10\NN\20090|tomudex|is|a|specific|antifolate-based|synthase|active|. (l_compound) synthase_9\NN\1740|thymidylate
10047461T12_10047461T50 NONE thymidylate_8\NN\1740| (r_compound) synthase_9\NN\1740|thymidylate
10047461T14_10047461T50 NONE zd1694_2\CD\1740| (r_appos) tomudex_0\NNP\1740|(|zd1694|) (r_nsubj) inhibitor_10\NN\20090|tomudex|is|a|specific|antifolate-based|synthase|active|. (l_compound) synthase_9\NN\1740|thymidylate
10047461T9_10047461T46 NONE thymidylate_22\NN\1740| (r_compound) synthase_23\NN\1740|of|thymidylate
10047461T10_10047461T46 CPR:4 tomudex_25\NN\1740|by (r_nmod) inhibition_20\NN\1068773|of|the|potent|synthase|tomudex (l_nmod) synthase_23\NN\1740|of|thymidylate
10047461T11_10047461T47 NONE tomudex_8\NN\1740|with (r_nmod) treatment_6\NN\654885|following|the|initial|2-h|tomudex (r_nmod) hours_1\NNS\15118228|twenty-four|treatment|,|cells|, (l_appos) cells_17\NNS\3080309|human|a253|head|carcinoma|,|expressing (l_acl) expressing_20\VBG\928630|not|p53 (l_dobj) p53_21\NN\1740|and|p21(waf1
10047461T11_10047461T48 NONE tomudex_8\NN\1740|with (r_nmod) treatment_6\NN\654885|following|the|initial|2-h|tomudex (r_nmod) hours_1\NNS\15118228|twenty-four|treatment|,|cells|, (l_appos) cells_17\NNS\3080309|human|a253|head|carcinoma|,|expressing (l_acl) expressing_20\VBG\928630|not|p53 (l_dobj) p53_21\NN\1740|and|p21(waf1 (l_conj) p21(waf1_23\NN\1740|)
10047461T11_10047461T49 NONE tomudex_8\NN\1740|with (r_nmod) treatment_6\NN\654885|following|the|initial|2-h|tomudex (r_nmod) hours_1\NNS\15118228|twenty-four|treatment|,|cells|, (l_appos) cells_17\NNS\3080309|human|a253|head|carcinoma|,|expressing (l_acl) expressing_20\VBG\928630|not|p53 (l_dobj) p53_21\NN\1740|and|p21(waf1 (l_conj) p21(waf1_23\NN\1740|)
10047461T13_10047461T54 CPR:4 tomudex_0\NN\1740| (r_compound) treatment_1\NN\654885|tomudex (r_nsubj) resulted_2\VBD\2633881|treatment|decrease|,|increase|. (l_nmod) decrease_5\NN\7296428|in|the|expression (l_nmod) expression_9\NN\4679549|in|p27(kip1 (l_compound) p27(kip1_7\NN\1740|) (l_punct) )_8\-RRB-\1740|
10047461T13_10047461T55 CPR:3 tomudex_0\NN\1740| (r_compound) treatment_1\NN\654885|tomudex (r_nsubj) resulted_2\VBD\2633881|treatment|decrease|,|increase|. (l_nmod) increase_13\NN\13576355|with|an|expression|h (l_nmod) expression_20\NN\4679549|in|e|protein|and|activities (l_compound) e_16\NN\14724645|cyclin|and|cdk2
10047461T13_10047461T56 CPR:3 tomudex_0\NN\1740| (r_compound) treatment_1\NN\654885|tomudex (r_nsubj) resulted_2\VBD\2633881|treatment|decrease|,|increase|. (l_nmod) increase_13\NN\13576355|with|an|expression|h (l_nmod) expression_20\NN\4679549|in|e|protein|and|activities (l_compound) e_16\NN\14724645|cyclin|and|cdk2 (l_conj) cdk2_18\NN\1740|
10047461T13_10047461T57 CPR:3 tomudex_0\NN\1740| (r_compound) treatment_1\NN\654885|tomudex (r_nsubj) resulted_2\VBD\2633881|treatment|decrease|,|increase|. (l_nmod) increase_13\NN\13576355|with|an|expression|h (l_nmod) expression_20\NN\4679549|in|e|protein|and|activities (l_conj) activities_23\NNS\30358|kinase (l_compound) kinase_22\NN\14732946|
10047461T2_10047461T30 CPR:3 tomudex_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|growth|tomudex (r_conj) rescue_4\NN\45907|with|dthyd|overexpression|and|inhibition (l_nmod) overexpression_9\NN\1740|from|cyclin|e-cdk2|protein (l_compound) e-cdk2_7\NN\1740|
10047461T2_10047461T31 CPR:3 tomudex_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|growth|tomudex (r_conj) rescue_4\NN\45907|with|dthyd|overexpression|and|inhibition (l_nmod) overexpression_9\NN\1740|from|cyclin|e-cdk2|protein (l_compound) e-cdk2_7\NN\1740|
10047461T2_10047461T32 CPR:3 tomudex_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|growth|tomudex (r_conj) rescue_4\NN\45907|with|dthyd|overexpression|and|inhibition (r_nmod) studies_1\NNS\635850|the|rescue (r_nsubj) indicate_15\VBP\952524|studies|associated|. (l_ccomp) associated_23\VBN\628491|that|expression|is|inhibition (l_nsubjpass) expression_21\NN\4679549|increased|cyclin|e-cdk2|protein (l_compound) e-cdk2_19\NN\1740|
10047461T2_10047461T33 CPR:3 tomudex_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|growth|tomudex (r_conj) rescue_4\NN\45907|with|dthyd|overexpression|and|inhibition (r_nmod) studies_1\NNS\635850|the|rescue (r_nsubj) indicate_15\VBP\952524|studies|associated|. (l_ccomp) associated_23\VBN\628491|that|expression|is|inhibition (l_nsubjpass) expression_21\NN\4679549|increased|cyclin|e-cdk2|protein (l_compound) e-cdk2_19\NN\1740|
10047461T2_10047461T34 CPR:4 tomudex_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|growth|tomudex (r_conj) rescue_4\NN\45907|with|dthyd|overexpression|and|inhibition (r_nmod) studies_1\NNS\635850|the|rescue (r_nsubj) indicate_15\VBP\952524|studies|associated|. (l_ccomp) associated_23\VBN\628491|that|expression|is|inhibition (l_nmod) inhibition_26\NN\1068773|with|effective|synthase|and|imbalance (l_nmod) synthase_29\NN\1740|of|thymidylate
10047461T3_10047461T30 NONE thymidylate_28\NN\1740| (r_compound) synthase_29\NN\1740|of|thymidylate (r_nmod) inhibition_26\NN\1068773|with|effective|synthase|and|imbalance (r_nmod) associated_23\VBN\628491|that|expression|is|inhibition (r_ccomp) indicate_15\VBP\952524|studies|associated|. (l_nsubj) studies_1\NNS\635850|the|rescue (l_nmod) rescue_4\NN\45907|with|dthyd|overexpression|and|inhibition (l_nmod) overexpression_9\NN\1740|from|cyclin|e-cdk2|protein (l_compound) e-cdk2_7\NN\1740|
10047461T3_10047461T31 NONE thymidylate_28\NN\1740| (r_compound) synthase_29\NN\1740|of|thymidylate (r_nmod) inhibition_26\NN\1068773|with|effective|synthase|and|imbalance (r_nmod) associated_23\VBN\628491|that|expression|is|inhibition (r_ccomp) indicate_15\VBP\952524|studies|associated|. (l_nsubj) studies_1\NNS\635850|the|rescue (l_nmod) rescue_4\NN\45907|with|dthyd|overexpression|and|inhibition (l_nmod) overexpression_9\NN\1740|from|cyclin|e-cdk2|protein (l_compound) e-cdk2_7\NN\1740|
10047461T3_10047461T32 NONE thymidylate_28\NN\1740| (r_compound) synthase_29\NN\1740|of|thymidylate (r_nmod) inhibition_26\NN\1068773|with|effective|synthase|and|imbalance (r_nmod) associated_23\VBN\628491|that|expression|is|inhibition (l_nsubjpass) expression_21\NN\4679549|increased|cyclin|e-cdk2|protein (l_compound) e-cdk2_19\NN\1740|
10047461T3_10047461T33 NONE thymidylate_28\NN\1740| (r_compound) synthase_29\NN\1740|of|thymidylate (r_nmod) inhibition_26\NN\1068773|with|effective|synthase|and|imbalance (r_nmod) associated_23\VBN\628491|that|expression|is|inhibition (l_nsubjpass) expression_21\NN\4679549|increased|cyclin|e-cdk2|protein (l_compound) e-cdk2_19\NN\1740|
10047461T3_10047461T34 NONE thymidylate_28\NN\1740| (r_compound) synthase_29\NN\1740|of|thymidylate
10047461T6_10047461T37 NONE thymidylate_16\NN\1740| (r_compound) synthase_17\NN\1740|of|thymidylate
10047461T6_10047461T38 NONE thymidylate_16\NN\1740| (r_compound) synthase_17\NN\1740|of|thymidylate (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (r_nmod) consequence_12\NN\34213|as|a|inhibition (r_nmod) induced_9\VBN\1627355|that|fragmentation|is|consequence (r_ccomp) suggest_2\VBP\1010118|results|induced|correlate|. (l_ccomp) correlate_25\VB\2657219|may|reduction (l_nmod) reduction_28\NN\351485|with|the|expression|and|increase (l_nmod) expression_32\NN\4679549|of|p27(kip1 (l_compound) p27(kip1_30\NN\1740|) (l_punct) )_31\-RRB-\1740|
10047461T6_10047461T39 NONE thymidylate_16\NN\1740| (r_compound) synthase_17\NN\1740|of|thymidylate (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (r_nmod) consequence_12\NN\34213|as|a|inhibition (r_nmod) induced_9\VBN\1627355|that|fragmentation|is|consequence (r_ccomp) suggest_2\VBP\1010118|results|induced|correlate|. (l_ccomp) correlate_25\VB\2657219|may|reduction (l_nmod) reduction_28\NN\351485|with|the|expression|and|increase (l_conj) increase_35\NN\13576355|the|activities (l_nmod) activities_42\NNS\30358|in|e (l_compound) e_38\NN\14724645|cyclin|and|kinase
10047461T6_10047461T40 NONE thymidylate_16\NN\1740| (r_compound) synthase_17\NN\1740|of|thymidylate (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (r_nmod) consequence_12\NN\34213|as|a|inhibition (r_nmod) induced_9\VBN\1627355|that|fragmentation|is|consequence (r_ccomp) suggest_2\VBP\1010118|results|induced|correlate|. (l_ccomp) correlate_25\VB\2657219|may|reduction (l_nmod) reduction_28\NN\351485|with|the|expression|and|increase (l_conj) increase_35\NN\13576355|the|activities (l_nmod) activities_42\NNS\30358|in|e (l_compound) e_38\NN\14724645|cyclin|and|kinase (l_conj) kinase_41\NN\14732946|cdk2 (l_compound) cdk2_40\NN\1740|
10047461T6_10047461T41 NONE thymidylate_16\NN\1740| (r_compound) synthase_17\NN\1740|of|thymidylate (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (r_nmod) consequence_12\NN\34213|as|a|inhibition (r_nmod) induced_9\VBN\1627355|that|fragmentation|is|consequence (r_ccomp) suggest_2\VBP\1010118|results|induced|correlate|. (l_ccomp) correlate_25\VB\2657219|may|reduction (l_nmod) reduction_28\NN\351485|with|the|expression|and|increase (l_conj) increase_35\NN\13576355|the|activities (l_nmod) activities_42\NNS\30358|in|e (l_compound) e_38\NN\14724645|cyclin|and|kinase (l_conj) kinase_41\NN\14732946|cdk2
10047461T7_10047461T37 CPR:4 tomudex_19\NN\1740|by (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (l_nmod) synthase_17\NN\1740|of|thymidylate
10047461T7_10047461T38 CPR:4 tomudex_19\NN\1740|by (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (r_nmod) consequence_12\NN\34213|as|a|inhibition (r_nmod) induced_9\VBN\1627355|that|fragmentation|is|consequence (r_ccomp) suggest_2\VBP\1010118|results|induced|correlate|. (l_ccomp) correlate_25\VB\2657219|may|reduction (l_nmod) reduction_28\NN\351485|with|the|expression|and|increase (l_nmod) expression_32\NN\4679549|of|p27(kip1 (l_compound) p27(kip1_30\NN\1740|) (l_punct) )_31\-RRB-\1740|
10047461T7_10047461T39 CPR:3 tomudex_19\NN\1740|by (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (r_nmod) consequence_12\NN\34213|as|a|inhibition (r_nmod) induced_9\VBN\1627355|that|fragmentation|is|consequence (r_ccomp) suggest_2\VBP\1010118|results|induced|correlate|. (l_ccomp) correlate_25\VB\2657219|may|reduction (l_nmod) reduction_28\NN\351485|with|the|expression|and|increase (l_conj) increase_35\NN\13576355|the|activities (l_nmod) activities_42\NNS\30358|in|e (l_compound) e_38\NN\14724645|cyclin|and|kinase
10047461T7_10047461T40 CPR:3 tomudex_19\NN\1740|by (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (r_nmod) consequence_12\NN\34213|as|a|inhibition (r_nmod) induced_9\VBN\1627355|that|fragmentation|is|consequence (r_ccomp) suggest_2\VBP\1010118|results|induced|correlate|. (l_ccomp) correlate_25\VB\2657219|may|reduction (l_nmod) reduction_28\NN\351485|with|the|expression|and|increase (l_conj) increase_35\NN\13576355|the|activities (l_nmod) activities_42\NNS\30358|in|e (l_compound) e_38\NN\14724645|cyclin|and|kinase (l_conj) kinase_41\NN\14732946|cdk2 (l_compound) cdk2_40\NN\1740|
10047461T7_10047461T41 CPR:3 tomudex_19\NN\1740|by (r_nmod) inhibition_14\NN\1068773|of|synthase|tomudex|and|fragmentation (r_nmod) consequence_12\NN\34213|as|a|inhibition (r_nmod) induced_9\VBN\1627355|that|fragmentation|is|consequence (r_ccomp) suggest_2\VBP\1010118|results|induced|correlate|. (l_ccomp) correlate_25\VB\2657219|may|reduction (l_nmod) reduction_28\NN\351485|with|the|expression|and|increase (l_conj) increase_35\NN\13576355|the|activities (l_nmod) activities_42\NNS\30358|in|e (l_compound) e_38\NN\14724645|cyclin|and|kinase (l_conj) kinase_41\NN\14732946|cdk2
10047461T8_10047461T45 NONE tomudex_15\NN\1740|by (r_nmod) damage_13\NN\7296428|dna|tomudex (r_conj) inhibition_10\NN\1068773|with|growth|and|damage (r_nmod) associated_7\VBN\628491|inhibition (r_acl) proteins_6\NNS\14944888|in|cell|cycle|regulatory|associated (r_nmod) changes_1\NNS\7283608|the|proteins (r_nsubj) dependent_19\JJ\1740|changes|are|not|p53|. (l_nmod:npmod) p53_18\NN\1740|
17015640
17015640T17_17015640T33 CPR:4 licofelone_0\NN\1740|,|inhibitor|, (l_appos) inhibitor_4\NN\20090|a|balanced|cyclooxygenase (l_nmod) cyclooxygenase_6\NN\14732946|of|and|5-lipoxygenase
17015640T17_17015640T34 CPR:4 licofelone_0\NN\1740|,|inhibitor|, (l_appos) inhibitor_4\NN\20090|a|balanced|cyclooxygenase (l_nmod) cyclooxygenase_6\NN\14732946|of|and|5-lipoxygenase (l_conj) 5-lipoxygenase_8\NN\1740|
17015640T1_17015640T26 NONE licofelone_0\NN\1740|,|drug|, (r_nsubj) have_20\VB\2108377|licofelone|may|profile|. (l_dobj) profile_24\NN\6999802|a|better|cardiovascular|inhibitors|and|tolerability (l_acl:relcl) inhibitors_27\NNS\20090|that|cycloxygenase-2|effect (l_compound) cycloxygenase-2_26\NN\1740|
17015640T1_17015640T27 CPR:4 licofelone_0\NN\1740|,|drug|, (r_nsubj) have_20\VB\2108377|licofelone|may|profile|. (l_dobj) profile_24\NN\6999802|a|better|cardiovascular|inhibitors|and|tolerability (l_acl:relcl) inhibitors_27\NNS\20090|that|cycloxygenase-2|effect (l_nmod) effect_33\NN\34213|due|to|blockade-mediated|antithrombotic (l_amod) blockade-mediated_31\JJ\1740|cycloxygenase-1 (l_nmod:npmod) cycloxygenase-1_30\NN\1740|
17015640T1_17015640T29 CPR:4 licofelone_0\NN\1740|,|drug|, (l_appos) drug_5\NN\14778436|a|dual|anti-inflammatory|inhibits (l_acl:relcl) inhibits_7\VBZ\2510337|that|enzymes (l_dobj) enzymes_17\NNS\14723628|5-lipoxygenase|cyclooxygenase (l_compound) 5-lipoxygenase_8\NN\1740|lox|and
17015640T1_17015640T30 CPR:4 licofelone_0\NN\1740|,|drug|, (l_appos) drug_5\NN\14778436|a|dual|anti-inflammatory|inhibits (l_acl:relcl) inhibits_7\VBZ\2510337|that|enzymes (l_dobj) enzymes_17\NNS\14723628|5-lipoxygenase|cyclooxygenase (l_compound) 5-lipoxygenase_8\NN\1740|lox|and (l_appos) lox_10\NN\14648100|(|)
17015640T1_17015640T31 CPR:4 licofelone_0\NN\1740|,|drug|, (l_appos) drug_5\NN\14778436|a|dual|anti-inflammatory|inhibits (l_acl:relcl) inhibits_7\VBZ\2510337|that|enzymes (l_dobj) enzymes_17\NNS\14723628|5-lipoxygenase|cyclooxygenase (l_compound) cyclooxygenase_13\NN\14732946|cox
17015640T1_17015640T32 CPR:4 licofelone_0\NN\1740|,|drug|, (l_appos) drug_5\NN\14778436|a|dual|anti-inflammatory|inhibits (l_acl:relcl) inhibits_7\VBZ\2510337|that|enzymes (l_dobj) enzymes_17\NNS\14723628|5-lipoxygenase|cyclooxygenase (l_compound) cyclooxygenase_13\NN\14732946|cox (l_appos) cox_15\NN\14732946|(|)
17015640T11_17015640T28 NONE licofelone_6\NN\1740|of (r_nmod) effect_4\NN\34213|the|anti-inflammatory|licofelone|lesions (r_dobj) examined_1\VBD\789138|we|effect|inhibitor|. (l_advcl) inhibitor_25\NN\20090|compared|with|a|selective|cox-2|,|rofecoxib (l_nmod) cox-2_27\NN\14737847|of
17015640T12_17015640T28 CPR:4 rofecoxib_29\NN\3124700| (r_appos) inhibitor_25\NN\20090|compared|with|a|selective|cox-2|,|rofecoxib (l_nmod) cox-2_27\NN\14737847|of
17015640T16_17015640T18 CPR:4 licofelone_0\NN\1740| (r_nsubj) reduced_1\VBD\441445|licofelone|ratio|. (l_dobj) ratio_3\NN\13815152|intima/media|arteries|,|infiltration|,|expression|,|and|activation (l_conj) expression_23\NN\4679549|protein-1|gene (l_compound) protein-1_18\NN\1740|monocyte|chemoattractant|mcp-1
17015640T16_17015640T19 CPR:4 licofelone_0\NN\1740| (r_nsubj) reduced_1\VBD\441445|licofelone|ratio|. (l_dobj) ratio_3\NN\13815152|intima/media|arteries|,|infiltration|,|expression|,|and|activation (l_conj) expression_23\NN\4679549|protein-1|gene (l_compound) protein-1_18\NN\1740|monocyte|chemoattractant|mcp-1 (l_appos) mcp-1_20\NN\1740|(|)
17015640T16_17015640T20 CPR:4 licofelone_0\NN\1740| (r_nsubj) reduced_1\VBD\441445|licofelone|ratio|. (l_dobj) ratio_3\NN\13815152|intima/media|arteries|,|infiltration|,|expression|,|and|activation (l_conj) activation_27\NN\13561719|the|factor-kappab|atheroma (l_nmod) factor-kappab_30\NN\1740|of|nuclear
17015640T2_17015640T21 CPR:4 licofelone_2\NN\1740| (r_nsubj) inhibited_3\VBD\2510337|moreover|,|licofelone|expression|lesions|. (l_dobj) expression_8\NN\4679549|cox-2|protein (l_compound) cox-2_4\NN\14737847|and|5-lox
17015640T2_17015640T22 CPR:4 licofelone_2\NN\1740| (r_nsubj) inhibited_3\VBD\2510337|moreover|,|licofelone|expression|lesions|. (l_dobj) expression_8\NN\4679549|cox-2|protein (l_compound) cox-2_4\NN\14737847|and|5-lox (l_conj) 5-lox_6\NN\1740|
17015640T3_17015640T23 CPR:4 rofecoxib_0\NN\3124700| (r_nsubj) diminished_2\VBD\169651|rofecoxib|only|expression|atheroma|. (l_dobj) expression_5\NN\4679549|cox-2|protein|and|expression (l_compound) cox-2_3\NN\14737847|
17015640T3_17015640T24 CPR:4 rofecoxib_0\NN\3124700| (r_nsubj) diminished_2\VBD\169651|rofecoxib|only|expression|atheroma|. (l_dobj) expression_5\NN\4679549|cox-2|protein|and|expression (l_conj) expression_9\NN\4679549|mcp-1|gene (l_compound) mcp-1_7\NN\1740|
17015640T5_17015640T25 CPR:4 licofelone_0\NN\1740| (r_nsubj) abolished_2\VBD\1740|licofelone|almost|activity|inhibiting|and|prevented|. (l_dobj) activity_4\NN\30358|5-lox (l_compound) 5-lox_3\NN\1740|
17015640T6_17015640T25 CPR:9 b4_8\NN\1740|leukotriene (r_compound) generation_9\NN\7942152|b4|neutrophils (r_dobj) inhibiting_6\VBG\2510337|by|generation (r_advcl) abolished_2\VBD\1740|licofelone|almost|activity|inhibiting|and|prevented|. (l_dobj) activity_4\NN\30358|5-lox (l_compound) 5-lox_3\NN\1740|
17015640T7_17015640T25 CPR:9 b2_17\NN\1740| (r_compound) production_18\NN\30358|platelet|thromboxane|b2|blood (r_dobj) prevented_14\VBD\1740|production (r_conj) abolished_2\VBD\1740|licofelone|almost|activity|inhibiting|and|prevented|. (l_dobj) activity_4\NN\30358|5-lox (l_compound) 5-lox_3\NN\1740|
12668276
12668276T4_12668276T25 NONE hormone_1\NN\5404728| (r_compound) genes_3\NNS\8459252|thyroid|hormone|receptors/thr|cancer|. (l_compound) receptors/thr_2\NNS\1740|
12668276T4_12668276T26 NONE hormone_1\NN\5404728| (r_compound) genes_3\NNS\8459252|thyroid|hormone|receptors/thr|cancer|. (l_compound) receptors/thr_2\NNS\1740|
2568212
2568212T35_2568212T40 NONE histamine_1\NN\14739004| (r_compound) antagonists_3\NNS\7846|nonsedating|histamine|h1-receptor|. (l_compound) h1-receptor_2\NN\1740|
2568212T3_2568212T36 NONE histamine_18\NN\14739004| (r_compound) antagonists_20\NNS\7846|of|the|nonsedating|histamine|h1-receptor|terfenadine (l_compound) h1-receptor_19\NN\1740|
2568212T13_2568212T36 CPR:6 terfenadine_21\NN\1740|,|astemizole|,|loratadine|,|and|acrivastine (r_dep) antagonists_20\NNS\7846|of|the|nonsedating|histamine|h1-receptor|terfenadine (l_compound) h1-receptor_19\NN\1740|
2568212T14_2568212T36 CPR:6 astemizole_23\NN\1740| (r_conj) terfenadine_21\NN\1740|,|astemizole|,|loratadine|,|and|acrivastine (r_dep) antagonists_20\NNS\7846|of|the|nonsedating|histamine|h1-receptor|terfenadine (l_compound) h1-receptor_19\NN\1740|
2568212T15_2568212T36 CPR:6 loratadine_25\NN\1740| (r_conj) terfenadine_21\NN\1740|,|astemizole|,|loratadine|,|and|acrivastine (r_dep) antagonists_20\NNS\7846|of|the|nonsedating|histamine|h1-receptor|terfenadine (l_compound) h1-receptor_19\NN\1740|
2568212T16_2568212T36 CPR:6 acrivastine_28\NN\1740| (r_conj) terfenadine_21\NN\1740|,|astemizole|,|loratadine|,|and|acrivastine (r_dep) antagonists_20\NNS\7846|of|the|nonsedating|histamine|h1-receptor|terfenadine (l_compound) h1-receptor_19\NN\1740|
2568212T17_2568212T37 CPR:6 terfenadine_0\NN\1740|and|astemizole (r_nsubj) unrelated_5\JJ\1740|terfenadine|are|chemically|antagonists|. (l_nmod) antagonists_9\NNS\7846|to|histamine|h1-receptor|diphenhydramine (l_compound) h1-receptor_8\NN\1740|
2568212T18_2568212T37 CPR:6 astemizole_2\NN\1740| (r_conj) terfenadine_0\NN\1740|and|astemizole (r_nsubj) unrelated_5\JJ\1740|terfenadine|are|chemically|antagonists|. (l_nmod) antagonists_9\NNS\7846|to|histamine|h1-receptor|diphenhydramine (l_compound) h1-receptor_8\NN\1740|
2568212T19_2568212T37 NONE histamine_7\NN\14739004| (r_compound) antagonists_9\NNS\7846|to|histamine|h1-receptor|diphenhydramine (l_compound) h1-receptor_8\NN\1740|
2568212T20_2568212T37 CPR:6 diphenhydramine_12\NN\2720725|such|and|chlorpheniramine (r_nmod) antagonists_9\NNS\7846|to|histamine|h1-receptor|diphenhydramine (l_compound) h1-receptor_8\NN\1740|
2568212T21_2568212T37 CPR:6 chlorpheniramine_14\NN\1740| (r_conj) diphenhydramine_12\NN\2720725|such|and|chlorpheniramine (r_nmod) antagonists_9\NNS\7846|to|histamine|h1-receptor|diphenhydramine (l_compound) h1-receptor_8\NN\1740|
2568212T26_2568212T38 NONE histamine_2\NN\14739004| (r_compound) antagonists_4\NNS\7846|like|other|histamine|h1-receptor (l_compound) h1-receptor_3\NN\1740|
2568212T26_2568212T39 NONE histamine_2\NN\14739004| (r_compound) antagonists_4\NNS\7846|like|other|histamine|h1-receptor (r_nmod) block_8\VBP\1476483|antagonists|,|they|competitively|sites|than|inhibiting|. (l_dobj) sites_11\NNS\8673395|histamine|receptor (l_compound) receptor_10\NN\5225602|
2568212T27_2568212T38 NONE histamine_9\NN\14739004| (r_compound) sites_11\NNS\8673395|histamine|receptor (r_dobj) block_8\VBP\1476483|antagonists|,|they|competitively|sites|than|inhibiting|. (l_nmod) antagonists_4\NNS\7846|like|other|histamine|h1-receptor (l_compound) h1-receptor_3\NN\1740|
2568212T27_2568212T39 NONE histamine_9\NN\14739004| (r_compound) sites_11\NNS\8673395|histamine|receptor (l_compound) receptor_10\NN\5225602|
2568212T28_2568212T38 NONE histamine_15\NN\14739004| (r_compound) release_16\NN\3748886|histamine (r_dobj) inhibiting_14\VBG\2510337|release (r_conj) block_8\VBP\1476483|antagonists|,|they|competitively|sites|than|inhibiting|. (l_nmod) antagonists_4\NNS\7846|like|other|histamine|h1-receptor (l_compound) h1-receptor_3\NN\1740|
2568212T28_2568212T39 NONE histamine_15\NN\14739004| (r_compound) release_16\NN\3748886|histamine (r_dobj) inhibiting_14\VBG\2510337|release (r_conj) block_8\VBP\1476483|antagonists|,|they|competitively|sites|than|inhibiting|. (l_dobj) sites_11\NNS\8673395|histamine|receptor (l_compound) receptor_10\NN\5225602|
12123767
12123767T9_12123767T19 NONE mexiletine_13\NN\2715941|by (r_nmod) rescued_11\VBN\2551832|mexiletine (r_acl) defect_10\NN\14462666|with|expression|rescued (r_nmod) mutation_4\NN\4475|a|novel|scn5a|arrhythmia|,|m1766l|,|defect|. (l_appos) m1766l_6\NN\1740|
12123767T9_12123767T20 NONE mexiletine_13\NN\2715941|by (r_nmod) rescued_11\VBN\2551832|mexiletine (r_acl) defect_10\NN\14462666|with|expression|rescued (r_nmod) mutation_4\NN\4475|a|novel|scn5a|arrhythmia|,|m1766l|,|defect|. (l_compound) scn5a_2\NN\1740|
12123767T5_12123767T15 NONE sodium_6\NN\14625458| (r_compound) gene_8\NN\8459252|in|the|cardiac|sodium|channel|,|scn5a (l_appos) scn5a_10\NN\1740|
12123767T1_12123767T10 NONE sodium_11\NN\14625458| (r_compound) channel_12\NN\6251781|sodium (r_compound) expression_13\NN\4679549|in|the|channel (r_nmod) decrease_8\NN\7296428|a|significant|expression (r_dobj) caused_5\VBD\1617192|mutation|decrease (l_nsubj) mutation_4\NN\4475|the|m1766l (l_compound) m1766l_3\NN\1740|
12123767T3_12123767T11 CPR:3 sodium_19\NN\14625458| (r_compound) current_20\NN\11449002|in|the|persistent|late|sodium (r_nmod) increase_14\NN\13576355|a|10-fold|current (r_dobj) showed_11\VBD\2137132|addition|,|m1766l|also|increase|. (l_nsubj) m1766l_9\NN\1740|
12123767T4_12123767T12 NONE sodium_28\NN\14625458| (r_compound) channelopathy_29\NN\1740|the|first|sodium|rescued (r_dobj) represents_25\VBZ\2664769|channelopathy (r_conj) contribute_10\VB\126264|that|dysfunction|may|basis|,|displays|,|and|represents (l_nsubj) dysfunction_8\NN\14204950|m1766l-scn5a|channel (l_compound) m1766l-scn5a_6\NN\1740|
12123767T4_12123767T13 NONE sodium_28\NN\14625458| (r_compound) channelopathy_29\NN\1740|the|first|sodium|rescued (r_dobj) represents_25\VBZ\2664769|channelopathy (r_conj) contribute_10\VB\126264|that|dysfunction|may|basis|,|displays|,|and|represents (l_nsubj) dysfunction_8\NN\14204950|m1766l-scn5a|channel (l_compound) m1766l-scn5a_6\NN\1740|
3345199
3345199T24_3345199T35 NONE ammonium_6\NN\14743582| (r_compound) compounds_7\NNS\5869584|of|some|mono-|ammonium (r_nmod) effects_0\NNS\13245626|compounds|reactivatability|vitro|. (l_nmod) reactivatability_10\NN\1740|on|the|acetylcholinesterase (l_nmod) acetylcholinesterase_14\NN\1740|of|soman-inhibited|human
3345199T25_3345199T35 CPR:4 soman-inhibited_12\JJ\1740| (r_amod) acetylcholinesterase_14\NN\1740|of|soman-inhibited|human
3345199T6_3345199T26 CPR:3 oximes_18\NNS\14727670|by (r_nmod) reactivation_16\NN\1740|to|oximes (r_nmod) resistant_14\JJ\1740|reactivation|dealkylation (r_xcomp) becomes_13\VBZ\146138|acetylcholinesterase|rapidly|resistant|. (l_nsubj) acetylcholinesterase_0\NN\1740|ache|inhibited
3345199T6_3345199T32 CPR:3 oximes_18\NNS\14727670|by (r_nmod) reactivation_16\NN\1740|to|oximes (r_nmod) resistant_14\JJ\1740|reactivation|dealkylation (r_xcomp) becomes_13\VBZ\146138|acetylcholinesterase|rapidly|resistant|. (l_nsubj) acetylcholinesterase_0\NN\1740|ache|inhibited (l_appos) ache_2\NN\14322699|(|)
3345199T8_3345199T26 NONE soman-enzyme_24\JJ\1740| (r_amod) complex_25\NN\5869584|of|the|soman-enzyme (r_nmod) dealkylation_21\NN\1740|due|to|complex (r_nmod) resistant_14\JJ\1740|reactivation|dealkylation (r_xcomp) becomes_13\VBZ\146138|acetylcholinesterase|rapidly|resistant|. (l_nsubj) acetylcholinesterase_0\NN\1740|ache|inhibited
3345199T8_3345199T32 NONE soman-enzyme_24\JJ\1740| (r_amod) complex_25\NN\5869584|of|the|soman-enzyme (r_nmod) dealkylation_21\NN\1740|due|to|complex (r_nmod) resistant_14\JJ\1740|reactivation|dealkylation (r_xcomp) becomes_13\VBZ\146138|acetylcholinesterase|rapidly|resistant|. (l_nsubj) acetylcholinesterase_0\NN\1740|ache|inhibited (l_appos) ache_2\NN\14322699|(|)
3345199T16_3345199T26 CPR:4 organophosphate_7\NN\14919948| (r_compound) soman_8\NN\14970136|by|the|organophosphate|(|1,2,2-trimethyl-propylmethylphosphonofluoridate (r_nmod) inhibited_4\VBN\2510337|soman (r_acl) acetylcholinesterase_0\NN\1740|ache|inhibited
3345199T16_3345199T32 CPR:4 organophosphate_7\NN\14919948| (r_compound) soman_8\NN\14970136|by|the|organophosphate|(|1,2,2-trimethyl-propylmethylphosphonofluoridate (r_nmod) inhibited_4\VBN\2510337|soman (r_acl) acetylcholinesterase_0\NN\1740|ache|inhibited (l_appos) ache_2\NN\14322699|(|)
3345199T17_3345199T26 CPR:4 soman_8\NN\14970136|by|the|organophosphate|(|1,2,2-trimethyl-propylmethylphosphonofluoridate (r_nmod) inhibited_4\VBN\2510337|soman (r_acl) acetylcholinesterase_0\NN\1740|ache|inhibited
3345199T17_3345199T32 CPR:4 soman_8\NN\14970136|by|the|organophosphate|(|1,2,2-trimethyl-propylmethylphosphonofluoridate (r_nmod) inhibited_4\VBN\2510337|soman (r_acl) acetylcholinesterase_0\NN\1740|ache|inhibited (l_appos) ache_2\NN\14322699|(|)
3345199T18_3345199T26 CPR:4 1,2,2-trimethyl-propylmethylphosphonofluoridate_10\NN\1740|) (r_appos) soman_8\NN\14970136|by|the|organophosphate|(|1,2,2-trimethyl-propylmethylphosphonofluoridate (r_nmod) inhibited_4\VBN\2510337|soman (r_acl) acetylcholinesterase_0\NN\1740|ache|inhibited
3345199T18_3345199T32 CPR:4 1,2,2-trimethyl-propylmethylphosphonofluoridate_10\NN\1740|) (r_appos) soman_8\NN\14970136|by|the|organophosphate|(|1,2,2-trimethyl-propylmethylphosphonofluoridate (r_nmod) inhibited_4\VBN\2510337|soman (r_acl) acetylcholinesterase_0\NN\1740|ache|inhibited (l_appos) ache_2\NN\14322699|(|)
3345199T9_3345199T33 NONE ammonium_8\NN\14743582| (r_compound) compounds_9\NNS\5869584|of|the|four|mono-|ammonium|tetramethylammonium (r_nmod) effect_1\NN\34213|the|compounds|reactivatability (l_nmod) reactivatability_22\NN\1740|on|the|ache (l_nmod) ache_27\NN\14322699|of|soman-inhibited|,|solubilized|erythrocytes
3345199T10_3345199T33 NONE tetramethylammonium_10\NN\1740|tma|,|hexamethonium|,|decamethonium|and|suxamethonium (r_dep) compounds_9\NNS\5869584|of|the|four|mono-|ammonium|tetramethylammonium (r_nmod) effect_1\NN\34213|the|compounds|reactivatability (l_nmod) reactivatability_22\NN\1740|on|the|ache (l_nmod) ache_27\NN\14322699|of|soman-inhibited|,|solubilized|erythrocytes
3345199T11_3345199T33 NONE tma_12\NN\1740|(|) (r_appos) tetramethylammonium_10\NN\1740|tma|,|hexamethonium|,|decamethonium|and|suxamethonium (r_dep) compounds_9\NNS\5869584|of|the|four|mono-|ammonium|tetramethylammonium (r_nmod) effect_1\NN\34213|the|compounds|reactivatability (l_nmod) reactivatability_22\NN\1740|on|the|ache (l_nmod) ache_27\NN\14322699|of|soman-inhibited|,|solubilized|erythrocytes
3345199T12_3345199T33 NONE hexamethonium_15\NN\1740| (r_conj) tetramethylammonium_10\NN\1740|tma|,|hexamethonium|,|decamethonium|and|suxamethonium (r_dep) compounds_9\NNS\5869584|of|the|four|mono-|ammonium|tetramethylammonium (r_nmod) effect_1\NN\34213|the|compounds|reactivatability (l_nmod) reactivatability_22\NN\1740|on|the|ache (l_nmod) ache_27\NN\14322699|of|soman-inhibited|,|solubilized|erythrocytes
3345199T13_3345199T33 NONE decamethonium_17\NN\1740| (r_conj) tetramethylammonium_10\NN\1740|tma|,|hexamethonium|,|decamethonium|and|suxamethonium (r_dep) compounds_9\NNS\5869584|of|the|four|mono-|ammonium|tetramethylammonium (r_nmod) effect_1\NN\34213|the|compounds|reactivatability (l_nmod) reactivatability_22\NN\1740|on|the|ache (l_nmod) ache_27\NN\14322699|of|soman-inhibited|,|solubilized|erythrocytes
3345199T14_3345199T33 NONE suxamethonium_19\NN\1740| (r_conj) tetramethylammonium_10\NN\1740|tma|,|hexamethonium|,|decamethonium|and|suxamethonium (r_dep) compounds_9\NNS\5869584|of|the|four|mono-|ammonium|tetramethylammonium (r_nmod) effect_1\NN\34213|the|compounds|reactivatability (l_nmod) reactivatability_22\NN\1740|on|the|ache (l_nmod) ache_27\NN\14322699|of|soman-inhibited|,|solubilized|erythrocytes
3345199T15_3345199T33 CPR:4 soman-inhibited_24\JJ\1740| (r_amod) ache_27\NN\14322699|of|soman-inhibited|,|solubilized|erythrocytes
3345199T1_3345199T27 NONE oxime_29\NN\14727670| (r_compound) hi_30\NN\6630017|by|the|oxime|6 (r_nmod) reactivation_26\NN\1740|hi|degrees|followed (l_acl) followed_38\VBN\1835496|assay (l_nmod) assay_41\NN\5733583|by|ache (l_compound) ache_40\NN\14322699|
3345199T23_3345199T27 NONE soman-inhibition_10\NN\1740|(|degree|,|aging|,|reactivation|) (l_appos) reactivation_26\NN\1740|hi|degrees|followed (l_acl) followed_38\VBN\1835496|assay (l_nmod) assay_41\NN\5733583|by|ache (l_compound) ache_40\NN\14322699|
3345199T7_3345199T30 CPR:4 soman-inhibited_15\JJ\1740| (r_amod) ache_16\NN\14322699|of|soman-inhibited
23489628
23489628T2_23489628T11 CPR:4 benzamide_6\NN\1740| (r_compound) derivatives_7\NNS\5802185|of|n-(thiophen-2-yl|)|benzamide (r_nmod) identification_0\NN\151497|and|synthesis|derivatives|inhibitors|. (l_nmod) inhibitors_11\NNS\20090|as|braf(v600e (l_compound) braf(v600e_9\NN\1740|)
23489628T2_23489628T12 CPR:4 benzamide_6\NN\1740| (r_compound) derivatives_7\NNS\5802185|of|n-(thiophen-2-yl|)|benzamide (r_nmod) identification_0\NN\151497|and|synthesis|derivatives|inhibitors|. (l_nmod) inhibitors_11\NNS\20090|as|braf(v600e (l_compound) braf(v600e_9\NN\1740|)
23489628T1_23489628T5 CPR:4 benzamide_18\NN\1740| (r_compound) derivatives_19\NNS\5802185|of|n-(thiophen-2-yl|)|benzamide (r_nmod) series_14\NN\8456993|a|derivatives (r_dobj) identify_12\VB\699815|to|series|inhibitors (l_nmod) inhibitors_24\NNS\20090|as|potent|braf(v600e (l_compound) braf(v600e_22\NN\1740|)
23489628T1_23489628T6 CPR:4 benzamide_18\NN\1740| (r_compound) derivatives_19\NNS\5802185|of|n-(thiophen-2-yl|)|benzamide (r_nmod) series_14\NN\8456993|a|derivatives (r_dobj) identify_12\VB\699815|to|series|inhibitors (l_nmod) inhibitors_24\NNS\20090|as|potent|braf(v600e (l_compound) braf(v600e_22\NN\1740|)
12003347
12003347T10_12003347T30 NONE (6r)-5,6,7,8-tetrahydro-l-biopterin_5\NN\1740|bh4 (r_nsubj) cofactor_11\NN\14818238|that|(6r)-5,6,7,8-tetrahydro-l-biopterin|is|a|nos (l_nmod) nos_13\NNP\7204911|of
12003347T13_12003347T30 NONE bh4_7\NN\1740|(|) (r_appos) (6r)-5,6,7,8-tetrahydro-l-biopterin_5\NN\1740|bh4 (r_nsubj) cofactor_11\NN\14818238|that|(6r)-5,6,7,8-tetrahydro-l-biopterin|is|a|nos (l_nmod) nos_13\NNP\7204911|of
12003347T11_12003347T26 NONE bh4_15\NN\1740| (r_nsubj) affects_16\VBZ\126264|which|bh4|catalysis (l_dobj) catalysis_18\NN\13446390|nos (l_compound) nos_17\NN\7204911|
12003347T12_12003347T27 NONE bh4_35\NN\1740| (r_dobj) involve_34\VBP\2676054|that|directly|bh4 (r_conj) debated_27\VBN\813044|that|are|actively|,|and|involve (r_acl:relcl) aspects_21\NNS\5849789|on|those|catalysis|debated (r_nmod) emphasis_18\NN\14434681|with|special|aspects (r_nmod) give_2\VBP\2327200|first|we|description|,|emphasis|. (l_dobj) description_6\NN\6722453|a|brief|general|structure (l_nmod) structure_9\NN\21939|of|the|and|mechanism|nos (l_nmod) nos_14\NN\7204911|of
12003347T14_12003347T28 NONE nadph_13\NN\1740|of (r_nmod) oxidation_11\NN\13447361|i.e.|the|nos-catalyzed|nadph|absence (l_amod) nos-catalyzed_10\JJ\1740|
12003347T15_12003347T28 NONE no_26\DT\7204911| (r_neg) production_27\NN\30358|in|no (r_nmod) result_24\VB\2633881|that|does|not|production (r_acl:relcl) substrate_18\NN\19613|of|or|pterin|result (r_nmod) absence_16\NN\14449405|in|the|substrate (r_nmod) oxidation_11\NN\13447361|i.e.|the|nos-catalyzed|nadph|absence (l_amod) nos-catalyzed_10\JJ\1740|
12003347T16_12003347T29 CPR:9 no_9\NN\7204911| (r_nsubj) product_14\NN\3076708|on|whether|no|is|the|actual|reaction|catalysis|,|as (l_nmod) catalysis_17\NN\13446390|of|nos (l_compound) nos_16\NN\7204911|
12003347T17_12003347T29 NONE no-mediated_25\JJ\1740| (r_amod) autoinhibition_26\NN\1740|of|no-mediated (r_nmod) phenomenon_23\NN\29677|the|autoinhibition (r_conj) debate_6\NN\7140659|the|ongoing|product|phenomenon (l_advcl) product_14\NN\3076708|on|whether|no|is|the|actual|reaction|catalysis|,|as (l_nmod) catalysis_17\NN\13446390|of|nos (l_compound) nos_16\NN\7204911|
12003347T1_12003347T23 NONE bh4_20\NN\1740| (r_nsubj) exerts_21\VBZ\1158872|that|bh4|nos (l_nmod) nos_23\NNP\7204911|on
12003347T18_12003347T23 NONE bh4_5\NN\1740|of (r_nmod) function_3\NN\13783581|the|bh4|hydroxylation (r_dobj) describe_1\VBP\1001294|we|function|,|and|discuss|. (l_conj) discuss_13\VBP\1033527|effects (l_dobj) effects_18\NNS\13245626|the|allosteric|exerts (l_acl:relcl) exerts_21\VBZ\1158872|that|bh4|nos (l_nmod) nos_23\NNP\7204911|on
12003347T19_12003347T23 NONE acid_9\NN\14818238| (r_compound) hydroxylation_10\NN\1740|in|aromatic|amino|acid (r_nmod) function_3\NN\13783581|the|bh4|hydroxylation (r_dobj) describe_1\VBP\1001294|we|function|,|and|discuss|. (l_conj) discuss_13\VBP\1033527|effects (l_dobj) effects_18\NNS\13245626|the|allosteric|exerts (l_acl:relcl) exerts_21\VBZ\1158872|that|bh4|nos (l_nmod) nos_23\NNP\7204911|on
12003347T4_12003347T24 NONE bh4_5\NN\1740| (r_nsubj) transform_7\VB\126264|how|bh4|might|dimer|synthase (l_dobj) dimer_10\NN\14818238|the|nos (l_compound) nos_9\NN\7204911|
12003347T4_12003347T25 NONE bh4_5\NN\1740| (r_nsubj) transform_7\VB\126264|how|bh4|might|dimer|synthase (l_nmod) synthase_15\NN\1740|into|an|efficient|s-nitrosoglutathione
12003347T5_12003347T24 NONE s-nitrosoglutathione_14\NN\1740| (r_compound) synthase_15\NN\1740|into|an|efficient|s-nitrosoglutathione (r_nmod) transform_7\VB\126264|how|bh4|might|dimer|synthase (l_dobj) dimer_10\NN\14818238|the|nos (l_compound) nos_9\NN\7204911|
12003347T5_12003347T25 NONE s-nitrosoglutathione_14\NN\1740| (r_compound) synthase_15\NN\1740|into|an|efficient|s-nitrosoglutathione
12003347T6_12003347T24 NONE bh4_29\NN\1740|of (r_nmod) role_27\NN\719494|of|the|bh4|synthesis (r_nmod) aspects_24\NNS\5849789|on|some|speculative|role (r_nmod) touch_19\VBP\2106506|briefly|aspects (r_conj) illustrate_3\VBP\955601|finally|,|we|transform|,|and|touch|. (l_ccomp) transform_7\VB\126264|how|bh4|might|dimer|synthase (l_dobj) dimer_10\NN\14818238|the|nos (l_compound) nos_9\NN\7204911|
12003347T6_12003347T25 NONE bh4_29\NN\1740|of (r_nmod) role_27\NN\719494|of|the|bh4|synthesis (r_nmod) aspects_24\NNS\5849789|on|some|speculative|role (r_nmod) touch_19\VBP\2106506|briefly|aspects (r_conj) illustrate_3\VBP\955601|finally|,|we|transform|,|and|touch|. (l_ccomp) transform_7\VB\126264|how|bh4|might|dimer|synthase (l_nmod) synthase_15\NN\1740|into|an|efficient|s-nitrosoglutathione
12003347T7_12003347T24 NONE no_31\NN\7204911| (r_compound) synthesis_32\NN\13446390|in|no (r_nmod) role_27\NN\719494|of|the|bh4|synthesis (r_nmod) aspects_24\NNS\5849789|on|some|speculative|role (r_nmod) touch_19\VBP\2106506|briefly|aspects (r_conj) illustrate_3\VBP\955601|finally|,|we|transform|,|and|touch|. (l_ccomp) transform_7\VB\126264|how|bh4|might|dimer|synthase (l_dobj) dimer_10\NN\14818238|the|nos (l_compound) nos_9\NN\7204911|
12003347T7_12003347T25 NONE no_31\NN\7204911| (r_compound) synthesis_32\NN\13446390|in|no (r_nmod) role_27\NN\719494|of|the|bh4|synthesis (r_nmod) aspects_24\NNS\5849789|on|some|speculative|role (r_nmod) touch_19\VBP\2106506|briefly|aspects (r_conj) illustrate_3\VBP\955601|finally|,|we|transform|,|and|touch|. (l_ccomp) transform_7\VB\126264|how|bh4|might|dimer|synthase (l_nmod) synthase_15\NN\1740|into|an|efficient|s-nitrosoglutathione
23264615
23264615T3_23264615T29 CPR:9 prostaglandins_23\NNS\5414534|pg (r_dobj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (l_nmod) synthase_29\NN\1740|via|pg|2|ptgs2 (l_nummod) 2_30\CD\13741022|
23264615T3_23264615T30 CPR:9 prostaglandins_23\NNS\5414534|pg (r_dobj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (l_nmod) synthase_29\NN\1740|via|pg|2|ptgs2 (l_appos) ptgs2_32\NN\1740|(|)
23264615T3_23264615T31 NONE prostaglandins_23\NNS\5414534|pg (r_dobj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (l_conj) cortisol_35\NN\14751417|dehydrogenase (l_nmod) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (l_nummod) 1_42\CD\13741022|
23264615T3_23264615T32 NONE prostaglandins_23\NNS\5414534|pg (r_dobj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (l_conj) cortisol_35\NN\14751417|dehydrogenase (l_nmod) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (l_appos) hsd11b1_44\NN\1740|(|)
23264615T3_23264615T37 NONE prostaglandins_23\NNS\5414534|pg (r_dobj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (r_conj) secretes_9\VBZ\67999|pregnancy|,|conceptus|interferon-τ|and|produce (l_dobj) interferon-τ_10\NN\1740|ifnt
23264615T3_23264615T39 NONE prostaglandins_23\NNS\5414534|pg (r_dobj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (r_conj) secretes_9\VBZ\67999|pregnancy|,|conceptus|interferon-τ|and|produce (l_dobj) interferon-τ_10\NN\1740|ifnt (l_appos) ifnt_12\NN\1740|(|)
23264615T7_23264615T29 NONE cortisol_35\NN\14751417|dehydrogenase (r_conj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (l_nmod) synthase_29\NN\1740|via|pg|2|ptgs2 (l_nummod) 2_30\CD\13741022|
23264615T7_23264615T30 NONE cortisol_35\NN\14751417|dehydrogenase (r_conj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (l_nmod) synthase_29\NN\1740|via|pg|2|ptgs2 (l_appos) ptgs2_32\NN\1740|(|)
23264615T7_23264615T31 CPR:9 cortisol_35\NN\14751417|dehydrogenase (l_nmod) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (l_nummod) 1_42\CD\13741022|
23264615T7_23264615T32 CPR:9 cortisol_35\NN\14751417|dehydrogenase (l_nmod) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (l_appos) hsd11b1_44\NN\1740|(|)
23264615T7_23264615T37 NONE cortisol_35\NN\14751417|dehydrogenase (r_conj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (r_conj) secretes_9\VBZ\67999|pregnancy|,|conceptus|interferon-τ|and|produce (l_dobj) interferon-τ_10\NN\1740|ifnt
23264615T7_23264615T39 NONE cortisol_35\NN\14751417|dehydrogenase (r_conj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (r_conj) secretes_9\VBZ\67999|pregnancy|,|conceptus|interferon-τ|and|produce (l_dobj) interferon-τ_10\NN\1740|ifnt (l_appos) ifnt_12\NN\1740|(|)
23264615T8_23264615T29 NONE hydroxysteroid_37\NN\1740| (r_compound) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (r_nmod) cortisol_35\NN\14751417|dehydrogenase (r_conj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (l_nmod) synthase_29\NN\1740|via|pg|2|ptgs2 (l_nummod) 2_30\CD\13741022|
23264615T8_23264615T30 NONE hydroxysteroid_37\NN\1740| (r_compound) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (r_nmod) cortisol_35\NN\14751417|dehydrogenase (r_conj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (l_nmod) synthase_29\NN\1740|via|pg|2|ptgs2 (l_appos) ptgs2_32\NN\1740|(|)
23264615T8_23264615T31 NONE hydroxysteroid_37\NN\1740| (r_compound) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (l_nummod) 1_42\CD\13741022|
23264615T8_23264615T32 NONE hydroxysteroid_37\NN\1740| (r_compound) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (l_appos) hsd11b1_44\NN\1740|(|)
23264615T8_23264615T37 NONE hydroxysteroid_37\NN\1740| (r_compound) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (r_nmod) cortisol_35\NN\14751417|dehydrogenase (r_conj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (r_conj) secretes_9\VBZ\67999|pregnancy|,|conceptus|interferon-τ|and|produce (l_dobj) interferon-τ_10\NN\1740|ifnt
23264615T8_23264615T39 NONE hydroxysteroid_37\NN\1740| (r_compound) dehydrogenase_41\NN\1740|via|hydroxysteroid|(|11-β|)|1|hsd11b1 (r_nmod) cortisol_35\NN\14751417|dehydrogenase (r_conj) produce_22\VBP\1617192|conceptus|prostaglandins|synthase|and|cortisol|. (r_conj) secretes_9\VBZ\67999|pregnancy|,|conceptus|interferon-τ|and|produce (l_dobj) interferon-τ_10\NN\1740|ifnt (l_appos) ifnt_12\NN\1740|(|)
23264615T9_23264615T33 NONE progesterone_1\NN\14747338|ovarian (r_nsubj) induces_2\VBZ\1627355|progesterone|and|stimulates|. (l_conj) stimulates_7\VBZ\137313|pg|expression (l_nsubj) pg_4\NN\1740|and|ifnt (l_conj) ifnt_6\NN\1740|
23264615T9_23264615T34 NONE progesterone_1\NN\14747338|ovarian (r_nsubj) induces_2\VBZ\1627355|progesterone|and|stimulates|. (l_conj) stimulates_7\VBZ\137313|pg|expression (l_dobj) expression_10\NN\4679549|endometrial|hsd11b1|and|activity|as|genes (l_compound) hsd11b1_9\NN\1740|
23264615T9_23264615T35 NONE progesterone_1\NN\14747338|ovarian (r_nsubj) induces_2\VBZ\1627355|progesterone|and|stimulates|. (l_conj) stimulates_7\VBZ\137313|pg|expression (l_dobj) expression_10\NN\4679549|endometrial|hsd11b1|and|activity|as|genes (l_conj) activity_13\NN\30358|keto-reductase (l_compound) keto-reductase_12\NN\1740|
23264615T10_23264615T33 NONE keto-reductase_12\NN\1740| (r_compound) activity_13\NN\30358|keto-reductase (r_conj) expression_10\NN\4679549|endometrial|hsd11b1|and|activity|as|genes (r_dobj) stimulates_7\VBZ\137313|pg|expression (l_nsubj) pg_4\NN\1740|and|ifnt (l_conj) ifnt_6\NN\1740|
23264615T10_23264615T34 NONE keto-reductase_12\NN\1740| (r_compound) activity_13\NN\30358|keto-reductase (r_conj) expression_10\NN\4679549|endometrial|hsd11b1|and|activity|as|genes (l_compound) hsd11b1_9\NN\1740|
23264615T10_23264615T35 NONE keto-reductase_12\NN\1740|
23264615T11_23264615T36 CPR:9 cortisol_13\NN\14751417|hsd11b1-derived (l_amod) hsd11b1-derived_12\JJ\1740|
23264615T12_23264615T38 NONE cortisol_9\NN\14751417| (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) pf_11\NN\1740|915275 (l_nummod) 915275_12\CD\1740|pf (l_appos) pf_14\NN\1740|(|;|inhibitor|) (l_appos) inhibitor_18\NN\20090|a|selective|hsd11b1 (l_nmod) hsd11b1_20\NN\1740|of
23264615T12_23264615T40 NONE cortisol_9\NN\14751417| (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) meloxicam_27\NN\1740|inhibitor (l_dep) inhibitor_31\NN\20090|(|a|selective|ptgs2|) (l_nmod) ptgs2_33\NN\1740|of
23264615T12_23264615T41 NONE cortisol_9\NN\14751417| (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_42\NN\1740|recombinant|ovine
23264615T12_23264615T42 NONE cortisol_9\NN\14751417| (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_45\NN\1740|and|pf
23264615T13_23264615T38 CPR:4 915275_12\CD\1740|pf (l_appos) pf_14\NN\1740|(|;|inhibitor|) (l_appos) inhibitor_18\NN\20090|a|selective|hsd11b1 (l_nmod) hsd11b1_20\NN\1740|of
23264615T13_23264615T40 NONE 915275_12\CD\1740|pf (r_nummod) pf_11\NN\1740|915275 (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) meloxicam_27\NN\1740|inhibitor (l_dep) inhibitor_31\NN\20090|(|a|selective|ptgs2|) (l_nmod) ptgs2_33\NN\1740|of
23264615T13_23264615T41 NONE 915275_12\CD\1740|pf (r_nummod) pf_11\NN\1740|915275 (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_42\NN\1740|recombinant|ovine
23264615T13_23264615T42 NONE 915275_12\CD\1740|pf (r_nummod) pf_11\NN\1740|915275 (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_45\NN\1740|and|pf
23264615T14_23264615T38 NONE cortisol_23\NN\14751417|and|pf (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) pf_11\NN\1740|915275 (l_nummod) 915275_12\CD\1740|pf (l_appos) pf_14\NN\1740|(|;|inhibitor|) (l_appos) inhibitor_18\NN\20090|a|selective|hsd11b1 (l_nmod) hsd11b1_20\NN\1740|of
23264615T14_23264615T40 NONE cortisol_23\NN\14751417|and|pf (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) meloxicam_27\NN\1740|inhibitor (l_dep) inhibitor_31\NN\20090|(|a|selective|ptgs2|) (l_nmod) ptgs2_33\NN\1740|of
23264615T14_23264615T41 NONE cortisol_23\NN\14751417|and|pf (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_42\NN\1740|recombinant|ovine
23264615T14_23264615T42 NONE cortisol_23\NN\14751417|and|pf (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_45\NN\1740|and|pf
23264615T15_23264615T38 NONE meloxicam_27\NN\1740|inhibitor (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) pf_11\NN\1740|915275 (l_nummod) 915275_12\CD\1740|pf (l_appos) pf_14\NN\1740|(|;|inhibitor|) (l_appos) inhibitor_18\NN\20090|a|selective|hsd11b1 (l_nmod) hsd11b1_20\NN\1740|of
23264615T15_23264615T40 CPR:4 meloxicam_27\NN\1740|inhibitor (l_dep) inhibitor_31\NN\20090|(|a|selective|ptgs2|) (l_nmod) ptgs2_33\NN\1740|of
23264615T15_23264615T41 NONE meloxicam_27\NN\1740|inhibitor (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_42\NN\1740|recombinant|ovine
23264615T15_23264615T42 NONE meloxicam_27\NN\1740|inhibitor (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_45\NN\1740|and|pf
23264615T16_23264615T38 NONE cortisol_36\NN\14751417|and|meloxicam (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) pf_11\NN\1740|915275 (l_nummod) 915275_12\CD\1740|pf (l_appos) pf_14\NN\1740|(|;|inhibitor|) (l_appos) inhibitor_18\NN\20090|a|selective|hsd11b1 (l_nmod) hsd11b1_20\NN\1740|of
23264615T16_23264615T40 NONE cortisol_36\NN\14751417|and|meloxicam (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) meloxicam_27\NN\1740|inhibitor (l_dep) inhibitor_31\NN\20090|(|a|selective|ptgs2|) (l_nmod) ptgs2_33\NN\1740|of
23264615T16_23264615T41 NONE cortisol_36\NN\14751417|and|meloxicam (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_42\NN\1740|recombinant|ovine
23264615T16_23264615T42 NONE cortisol_36\NN\14751417|and|meloxicam (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_45\NN\1740|and|pf
23264615T17_23264615T38 NONE meloxicam_38\NN\1740| (r_conj) cortisol_36\NN\14751417|and|meloxicam (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) pf_11\NN\1740|915275 (l_nummod) 915275_12\CD\1740|pf (l_appos) pf_14\NN\1740|(|;|inhibitor|) (l_appos) inhibitor_18\NN\20090|a|selective|hsd11b1 (l_nmod) hsd11b1_20\NN\1740|of
23264615T17_23264615T40 NONE meloxicam_38\NN\1740| (r_conj) cortisol_36\NN\14751417|and|meloxicam (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) meloxicam_27\NN\1740|inhibitor (l_dep) inhibitor_31\NN\20090|(|a|selective|ptgs2|) (l_nmod) ptgs2_33\NN\1740|of
23264615T17_23264615T41 NONE meloxicam_38\NN\1740| (r_conj) cortisol_36\NN\14751417|and|meloxicam (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_42\NN\1740|recombinant|ovine
23264615T17_23264615T42 NONE meloxicam_38\NN\1740| (r_conj) cortisol_36\NN\14751417|and|meloxicam (r_conj) vehicle_7\NN\3100490|,|cortisol|,|pf|,|cortisol|,|meloxicam|,|cortisol|,|ifnt|,|or|ifnt (l_conj) ifnt_45\NN\1740|and|pf
23264615T18_23264615T20 CPR:3 cortisol_0\NN\14751417|and|ifnt (r_nsubj) stimulated_3\VBD\137313|cortisol|hsd11b1|,|increased|,|and|up-regulated|. (l_dobj) hsd11b1_5\NN\1740|endometrial|expression
23264615T18_23264615T21 CPR:3 cortisol_0\NN\14751417|and|ifnt (r_nsubj) stimulated_3\VBD\137313|cortisol|hsd11b1|,|increased|,|and|up-regulated|. (l_conj) increased_10\VBD\169651|activity (l_dobj) activity_13\NN\30358|endometrial|ptgs2|and|amount (l_compound) ptgs2_12\NN\1740|
23264615T18_23264615T43 NONE cortisol_0\NN\14751417|and|ifnt (l_conj) ifnt_2\NN\1740|
23264615T1_23264615T22 NONE cortisol_3\NN\14751417|of|and|ifnt (l_conj) ifnt_5\NN\1740|
23264615T1_23264615T23 NONE cortisol_3\NN\14751417|of|and|ifnt (r_nmod) effects_1\NNS\13245626|some|cortisol (r_nsubjpass) mediated_7\VBN\761713|effects|were|pg|. (l_nmod) pg_10\NN\1740|by|ptgs2-derived (l_amod) ptgs2-derived_9\JJ\1740|
23264615T2_23264615T24 NONE 915275_8\NN\1740|pf|or|ifnt (l_conj) ifnt_12\NN\1740|recombinant|ovine
23264615T4_23264615T27 CPR:9 cortisol_5\NN\14751417|hsd11b1-derived (l_amod) hsd11b1-derived_4\JJ\1740|
23264615T4_23264615T28 NONE cortisol_5\NN\14751417|hsd11b1-derived (r_nsubj) mediates_6\VBZ\761713|that|cortisol|,|part|,|actions|function (r_ccomp) suggest_2\VBP\1010118|results|mediates|and|support|. (l_conj) support_22\VBP\2199590|hypothesis (l_dobj) hypothesis_24\NN\7162194|the|regulate (l_ccomp) regulate_33\VBP\296178|that|ifnt|coordinately|functions (l_nsubj) ifnt_26\NN\1740|,|pg|,|and|cortisol
23264615T5_23264615T27 NONE progesterone_14\NN\14747338|of|ovarian|and|conceptus (r_nmod) actions_11\NNS\30358|progesterone (r_dobj) mediates_6\VBZ\761713|that|cortisol|,|part|,|actions|function (l_nsubj) cortisol_5\NN\14751417|hsd11b1-derived (l_amod) hsd11b1-derived_4\JJ\1740|
23264615T5_23264615T28 NONE progesterone_14\NN\14747338|of|ovarian|and|conceptus (r_nmod) actions_11\NNS\30358|progesterone (r_dobj) mediates_6\VBZ\761713|that|cortisol|,|part|,|actions|function (r_ccomp) suggest_2\VBP\1010118|results|mediates|and|support|. (l_conj) support_22\VBP\2199590|hypothesis (l_dobj) hypothesis_24\NN\7162194|the|regulate (l_ccomp) regulate_33\VBP\296178|that|ifnt|coordinately|functions (l_nsubj) ifnt_26\NN\1740|,|pg|,|and|cortisol
23264615T6_23264615T27 NONE cortisol_31\NN\14751417| (r_conj) ifnt_26\NN\1740|,|pg|,|and|cortisol (r_nsubj) regulate_33\VBP\296178|that|ifnt|coordinately|functions (r_ccomp) hypothesis_24\NN\7162194|the|regulate (r_dobj) support_22\VBP\2199590|hypothesis (r_conj) suggest_2\VBP\1010118|results|mediates|and|support|. (l_ccomp) mediates_6\VBZ\761713|that|cortisol|,|part|,|actions|function (l_nsubj) cortisol_5\NN\14751417|hsd11b1-derived (l_amod) hsd11b1-derived_4\JJ\1740|
23264615T6_23264615T28 NONE cortisol_31\NN\14751417| (r_conj) ifnt_26\NN\1740|,|pg|,|and|cortisol
22718571
22718571T12_22718571T20 NONE swertiamarin_3\NN\1740|of (r_nmod) activity_1\NN\30358|anti-diabetic|swertiamarin (r_nsubj) due_5\JJ\1740|activity|is|metabolite|. (l_nmod) metabolite_9\NN\20090|to|an|active|,|gentianine|,|upregulates (l_acl:relcl) upregulates_14\VBZ\1740|that|expression (l_dobj) expression_17\NN\4679549|ppar-γ|gene|cells (l_compound) ppar-γ_15\NN\1740|
22718571T13_22718571T20 CPR:3 gentianine_11\NN\1740| (r_appos) metabolite_9\NN\20090|to|an|active|,|gentianine|,|upregulates (l_acl:relcl) upregulates_14\VBZ\1740|that|expression (l_dobj) expression_17\NN\4679549|ppar-γ|gene|cells (l_compound) ppar-γ_15\NN\1740|
22718571T6_22718571T14 NONE swertiamarin_0\NN\1740| (r_compound) treatment_1\NN\654885|swertiamarin (r_nsubj) had_2\VBD\2108377|treatment|effect|adipogenesis|;|was (l_nmod) adipogenesis_7\NN\1740|on|,|or|expression (l_conj) expression_12\NN\4679549|the|mrna|ppar-γ (l_nmod) ppar-γ_14\NN\1740|of|and|glut-4
22718571T6_22718571T15 NONE swertiamarin_0\NN\1740| (r_compound) treatment_1\NN\654885|swertiamarin (r_nsubj) had_2\VBD\2108377|treatment|effect|adipogenesis|;|was (l_nmod) adipogenesis_7\NN\1740|on|,|or|expression (l_conj) expression_12\NN\4679549|the|mrna|ppar-γ (l_nmod) ppar-γ_14\NN\1740|of|and|glut-4 (l_conj) glut-4_16\NN\1740|
22718571T6_22718571T16 CPR:3 swertiamarin_0\NN\1740| (r_compound) treatment_1\NN\654885|swertiamarin (r_nsubj) had_2\VBD\2108377|treatment|effect|adipogenesis|;|was (l_parataxis) was_21\VBD\836236|however|,|there|increase|. (l_nsubj) increase_24\NN\13576355|a|significant|expression (l_nmod) expression_28\NN\4679549|in|the|mrna|adiponectin (l_nmod) adiponectin_30\NN\1740|of
22718571T8_22718571T17 CPR:3 gentianine_7\NN\1740|with (r_nmod) treatment_5\NN\654885|gentianine (r_nsubj) increased_9\VBD\169651|hand|,|treatment|significantly|adipogenesis|,|associated|. (l_ccomp) associated_14\VBN\628491|which|was|increase (l_nmod) increase_18\NN\13576355|with|a|significant|expression (l_nmod) expression_22\NN\4679549|in|the|mrna|ppar-γ (l_nmod) ppar-γ_24\NN\1740|of|,|glut-4|and|adiponectin
22718571T8_22718571T18 CPR:3 gentianine_7\NN\1740|with (r_nmod) treatment_5\NN\654885|gentianine (r_nsubj) increased_9\VBD\169651|hand|,|treatment|significantly|adipogenesis|,|associated|. (l_ccomp) associated_14\VBN\628491|which|was|increase (l_nmod) increase_18\NN\13576355|with|a|significant|expression (l_nmod) expression_22\NN\4679549|in|the|mrna|ppar-γ (l_nmod) ppar-γ_24\NN\1740|of|,|glut-4|and|adiponectin (l_conj) glut-4_26\NN\1740|
22718571T8_22718571T19 CPR:3 gentianine_7\NN\1740|with (r_nmod) treatment_5\NN\654885|gentianine (r_nsubj) increased_9\VBD\169651|hand|,|treatment|significantly|adipogenesis|,|associated|. (l_ccomp) associated_14\VBN\628491|which|was|increase (l_nmod) increase_18\NN\13576355|with|a|significant|expression (l_nmod) expression_22\NN\4679549|in|the|mrna|ppar-γ (l_nmod) ppar-γ_24\NN\1740|of|,|glut-4|and|adiponectin (l_conj) adiponectin_28\NN\1740|
15465035
15465035T17_15465035T29 NONE guanylyl_15\JJ\1740| (r_compound) cyclase_16\NN\1740|guanylyl (r_compound) pathway_17\NN\5483677|on|oxide-soluble|cyclase (r_nmod) dependent_11\JJ\1740|effect|is|not|pathway|. (l_nsubj) effect_2\NN\34213|the|inhibitory|nitroprusside|activation (l_nmod) activation_8\NN\13561719|on|hif-1 (l_compound) hif-1_7\NN\1740|
15465035T17_15465035T30 NONE guanylyl_15\JJ\1740| (r_compound) cyclase_16\NN\1740|guanylyl
15465035T18_15465035T29 CPR:4 nitroprusside_5\NN\1740|of|sodium (r_nmod) effect_2\NN\34213|the|inhibitory|nitroprusside|activation (l_nmod) activation_8\NN\13561719|on|hif-1 (l_compound) hif-1_7\NN\1740|
15465035T18_15465035T30 NONE nitroprusside_5\NN\1740|of|sodium (r_nmod) effect_2\NN\34213|the|inhibitory|nitroprusside|activation (r_nsubj) dependent_11\JJ\1740|effect|is|not|pathway|. (l_nmod) pathway_17\NN\5483677|on|oxide-soluble|cyclase (l_compound) cyclase_16\NN\1740|guanylyl
15465035T19_15465035T29 NONE oxide-soluble_14\JJ\1740|nitric (r_amod) pathway_17\NN\5483677|on|oxide-soluble|cyclase (r_nmod) dependent_11\JJ\1740|effect|is|not|pathway|. (l_nsubj) effect_2\NN\34213|the|inhibitory|nitroprusside|activation (l_nmod) activation_8\NN\13561719|on|hif-1 (l_compound) hif-1_7\NN\1740|
15465035T19_15465035T30 NONE oxide-soluble_14\JJ\1740|nitric (r_amod) pathway_17\NN\5483677|on|oxide-soluble|cyclase (l_compound) cyclase_16\NN\1740|guanylyl
15465035T1_15465035T20 NONE o(2)-regulated_12\JJ\1740| (r_amod) genes_13\NNS\8459252|of|o(2)-regulated (r_nmod) expression_10\NN\4679549|the|genes (r_dobj) activate_8\VBP\1641914|that|expression (r_acl:relcl) factors_6\NNS\7326557|of|the|important|transcription|activate (r_nmod) one_0\CD\13741022|factors (r_nsubj) factor_16\NN\7326557|one|is|hypoxia-inducible|1|hif-1|. (l_nummod) 1_17\CD\13741022|
15465035T1_15465035T21 NONE o(2)-regulated_12\JJ\1740| (r_amod) genes_13\NNS\8459252|of|o(2)-regulated (r_nmod) expression_10\NN\4679549|the|genes (r_dobj) activate_8\VBP\1641914|that|expression (r_acl:relcl) factors_6\NNS\7326557|of|the|important|transcription|activate (r_nmod) one_0\CD\13741022|factors (r_nsubj) factor_16\NN\7326557|one|is|hypoxia-inducible|1|hif-1|. (l_appos) hif-1_19\NN\1740|(|)
15465035T5_15465035T22 NONE nitroglycerin_9\NN\15015501|ntg|,|dinitrate|,|and|nitroprusside (r_dep) nitrates_8\NNS\14818238|of|the|used|nitroglycerin (r_nmod) effect_3\NN\34213|the|nitrates|responses (l_nmod) responses_29\NNS\11410625|on|hif-1-mediated|transcriptional|hypoxia (l_amod) hif-1-mediated_27\JJ\1740|
15465035T6_15465035T22 NONE ntg_11\NN\1740|(|) (r_appos) nitroglycerin_9\NN\15015501|ntg|,|dinitrate|,|and|nitroprusside (r_dep) nitrates_8\NNS\14818238|of|the|used|nitroglycerin (r_nmod) effect_3\NN\34213|the|nitrates|responses (l_nmod) responses_29\NNS\11410625|on|hif-1-mediated|transcriptional|hypoxia (l_amod) hif-1-mediated_27\JJ\1740|
15465035T7_15465035T22 NONE dinitrate_15\NN\1740|isosorbide|isdn (r_conj) nitroglycerin_9\NN\15015501|ntg|,|dinitrate|,|and|nitroprusside (r_dep) nitrates_8\NNS\14818238|of|the|used|nitroglycerin (r_nmod) effect_3\NN\34213|the|nitrates|responses (l_nmod) responses_29\NNS\11410625|on|hif-1-mediated|transcriptional|hypoxia (l_amod) hif-1-mediated_27\JJ\1740|
15465035T8_15465035T22 NONE isdn_17\NN\1740|(|) (r_appos) dinitrate_15\NN\1740|isosorbide|isdn (r_conj) nitroglycerin_9\NN\15015501|ntg|,|dinitrate|,|and|nitroprusside (r_dep) nitrates_8\NNS\14818238|of|the|used|nitroglycerin (r_nmod) effect_3\NN\34213|the|nitrates|responses (l_nmod) responses_29\NNS\11410625|on|hif-1-mediated|transcriptional|hypoxia (l_amod) hif-1-mediated_27\JJ\1740|
15465035T9_15465035T22 NONE nitroprusside_22\NN\1740|sodium|snp (r_conj) nitroglycerin_9\NN\15015501|ntg|,|dinitrate|,|and|nitroprusside (r_dep) nitrates_8\NNS\14818238|of|the|used|nitroglycerin (r_nmod) effect_3\NN\34213|the|nitrates|responses (l_nmod) responses_29\NNS\11410625|on|hif-1-mediated|transcriptional|hypoxia (l_amod) hif-1-mediated_27\JJ\1740|
15465035T10_15465035T22 NONE snp_24\NN\11493266|(|) (r_appos) nitroprusside_22\NN\1740|sodium|snp (r_conj) nitroglycerin_9\NN\15015501|ntg|,|dinitrate|,|and|nitroprusside (r_dep) nitrates_8\NNS\14818238|of|the|used|nitroglycerin (r_nmod) effect_3\NN\34213|the|nitrates|responses (l_nmod) responses_29\NNS\11410625|on|hif-1-mediated|transcriptional|hypoxia (l_amod) hif-1-mediated_27\JJ\1740|
15465035T11_15465035T23 CPR:4 snp_9\NN\11493266|only (r_nsubj) inhibits_10\VBZ\2510337|that|nitrates|,|snp|activation|response (l_dobj) activation_12\NN\13561719|hif-1 (l_compound) hif-1_11\NN\1740|
15465035T12_15465035T24 NONE ntg_3\NN\1740|or|isdn (r_nsubj) affect_8\VB\126264|contrast|,|ntg|does|not|activity|. (l_dobj) activity_10\NN\30358|hif-1 (l_compound) hif-1_9\NN\1740|
15465035T13_15465035T24 NONE isdn_5\NN\1740| (r_conj) ntg_3\NN\1740|or|isdn (r_nsubj) affect_8\VB\126264|contrast|,|ntg|does|not|activity|. (l_dobj) activity_10\NN\30358|hif-1 (l_compound) hif-1_9\NN\1740|
15465035T14_15465035T25 CPR:4 snp_0\NN\11493266| (r_nsubj) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_nmod) hif-1alpha_5\NN\1740|of|,|subunit|,
15465035T14_15465035T26 CPR:4 snp_0\NN\11493266| (r_nsubj) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_nmod) hif-1alpha_5\NN\1740|of|,|subunit|, (l_appos) subunit_9\NN\13604718|the|regulatory|hif-1 (l_nmod) hif-1_11\NN\1740|of
15465035T14_15465035T27 CPR:4 snp_0\NN\11493266| (r_nsubj) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_conj) activation_16\NN\13561719|the|transcriptional|hif-1alpha (l_nmod) hif-1alpha_18\NN\1740|of
15465035T14_15465035T28 NONE snp_0\NN\11493266| (r_nsubj) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_nmod) mechanism_21\NN\13446390|via|a|dependent (l_acl:relcl) dependent_25\JJ\1740|that|is|not|no (l_nmod) no_28\NN\7204911|on|either|or|cyclase (l_conj) cyclase_32\NN\1740|soluble|guanylate
15465035T15_15465035T25 NONE no_28\NN\7204911|on|either|or|cyclase (r_nmod) dependent_25\JJ\1740|that|is|not|no (r_acl:relcl) mechanism_21\NN\13446390|via|a|dependent (r_nmod) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_nmod) hif-1alpha_5\NN\1740|of|,|subunit|,
15465035T15_15465035T26 NONE no_28\NN\7204911|on|either|or|cyclase (r_nmod) dependent_25\JJ\1740|that|is|not|no (r_acl:relcl) mechanism_21\NN\13446390|via|a|dependent (r_nmod) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_nmod) hif-1alpha_5\NN\1740|of|,|subunit|, (l_appos) subunit_9\NN\13604718|the|regulatory|hif-1 (l_nmod) hif-1_11\NN\1740|of
15465035T15_15465035T27 NONE no_28\NN\7204911|on|either|or|cyclase (r_nmod) dependent_25\JJ\1740|that|is|not|no (r_acl:relcl) mechanism_21\NN\13446390|via|a|dependent (r_nmod) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_conj) activation_16\NN\13561719|the|transcriptional|hif-1alpha (l_nmod) hif-1alpha_18\NN\1740|of
15465035T15_15465035T28 NONE no_28\NN\7204911|on|either|or|cyclase (l_conj) cyclase_32\NN\1740|soluble|guanylate
15465035T16_15465035T25 NONE guanylate_31\NN\1740| (r_compound) cyclase_32\NN\1740|soluble|guanylate (r_conj) no_28\NN\7204911|on|either|or|cyclase (r_nmod) dependent_25\JJ\1740|that|is|not|no (r_acl:relcl) mechanism_21\NN\13446390|via|a|dependent (r_nmod) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_nmod) hif-1alpha_5\NN\1740|of|,|subunit|,
15465035T16_15465035T26 NONE guanylate_31\NN\1740| (r_compound) cyclase_32\NN\1740|soluble|guanylate (r_conj) no_28\NN\7204911|on|either|or|cyclase (r_nmod) dependent_25\JJ\1740|that|is|not|no (r_acl:relcl) mechanism_21\NN\13446390|via|a|dependent (r_nmod) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_nmod) hif-1alpha_5\NN\1740|of|,|subunit|, (l_appos) subunit_9\NN\13604718|the|regulatory|hif-1 (l_nmod) hif-1_11\NN\1740|of
15465035T16_15465035T27 NONE guanylate_31\NN\1740| (r_compound) cyclase_32\NN\1740|soluble|guanylate (r_conj) no_28\NN\7204911|on|either|or|cyclase (r_nmod) dependent_25\JJ\1740|that|is|not|no (r_acl:relcl) mechanism_21\NN\13446390|via|a|dependent (r_nmod) inhibits_1\VBZ\2510337|snp|accumulation|mechanism|. (l_dobj) accumulation_3\NN\13497135|the|hif-1alpha|and|activation (l_conj) activation_16\NN\13561719|the|transcriptional|hif-1alpha (l_nmod) hif-1alpha_18\NN\1740|of
15465035T16_15465035T28 NONE guanylate_31\NN\1740| (r_compound) cyclase_32\NN\1740|soluble|guanylate
23291559
23291559T8_23291559T24 NONE phenobarbital-induced_18\JJ\1740| (r_amod) hyperplasia_20\NN\14365950|phenobarbital-induced|hepatic (r_dobj) attenuates_17\VBZ\224901|which|hyperplasia (r_ccomp) activates_4\VBZ\1641914|car|specifically|gene|,|attenuates|. (l_nsubj) car_2\NN\3791235|nuclear|receptor (l_compound) receptor_1\NN\5225602|
23291559T8_23291559T25 NONE phenobarbital-induced_18\JJ\1740| (r_amod) hyperplasia_20\NN\14365950|phenobarbital-induced|hepatic (r_dobj) attenuates_17\VBZ\224901|which|hyperplasia (r_ccomp) activates_4\VBZ\1641914|car|specifically|gene|,|attenuates|. (l_nsubj) car_2\NN\3791235|nuclear|receptor
23291559T8_23291559T26 NONE phenobarbital-induced_18\JJ\1740| (r_amod) hyperplasia_20\NN\14365950|phenobarbital-induced|hepatic (r_dobj) attenuates_17\VBZ\224901|which|hyperplasia (r_ccomp) activates_4\VBZ\1641914|car|specifically|gene|,|attenuates|. (l_dobj) gene_10\NN\8459252|the|two-pore|channel|kcnk1|livers (l_compound) channel_8\NN\6251781|k+
23291559T8_23291559T27 NONE phenobarbital-induced_18\JJ\1740| (r_amod) hyperplasia_20\NN\14365950|phenobarbital-induced|hepatic (r_dobj) attenuates_17\VBZ\224901|which|hyperplasia (r_ccomp) activates_4\VBZ\1641914|car|specifically|gene|,|attenuates|. (l_dobj) gene_10\NN\8459252|the|two-pore|channel|kcnk1|livers (l_compound) kcnk1_9\NN\1740|
23291559T9_23291559T24 NONE k+_7\NN\1740| (r_compound) channel_8\NN\6251781|k+ (r_compound) gene_10\NN\8459252|the|two-pore|channel|kcnk1|livers (r_dobj) activates_4\VBZ\1641914|car|specifically|gene|,|attenuates|. (l_nsubj) car_2\NN\3791235|nuclear|receptor (l_compound) receptor_1\NN\5225602|
23291559T9_23291559T25 NONE k+_7\NN\1740| (r_compound) channel_8\NN\6251781|k+ (r_compound) gene_10\NN\8459252|the|two-pore|channel|kcnk1|livers (r_dobj) activates_4\VBZ\1641914|car|specifically|gene|,|attenuates|. (l_nsubj) car_2\NN\3791235|nuclear|receptor
23291559T9_23291559T26 NONE k+_7\NN\1740| (r_compound) channel_8\NN\6251781|k+
23291559T9_23291559T27 NONE k+_7\NN\1740| (r_compound) channel_8\NN\6251781|k+ (r_compound) gene_10\NN\8459252|the|two-pore|channel|kcnk1|livers (l_compound) kcnk1_9\NN\1740|
23291559T1_23291559T10 CPR:3 phenobarbital_24\NN\2792049| (r_compound) treatment_25\NN\654885|after|phenobarbital (r_nmod) induced_16\VBN\1627355|kcnk1|is|specifically|livers|treatment|. (l_nsubjpass) kcnk1_0\NN\1740|,|member|,
23291559T1_23291559T16 CPR:3 phenobarbital_24\NN\2792049| (r_compound) treatment_25\NN\654885|after|phenobarbital (r_nmod) induced_16\VBN\1627355|kcnk1|is|specifically|livers|treatment|. (l_nsubjpass) kcnk1_0\NN\1740|,|member|, (l_appos) member_3\NN\9816771|a|family (l_nmod) family_6\NN\8189659|of|the|channels (l_nmod) channels_12\NNS\6251781|of|two-pore|k(+|)|ion
23291559T4_23291559T10 NONE )_10\-RRB-\1740| (r_punct) channels_12\NNS\6251781|of|two-pore|k(+|)|ion (r_nmod) family_6\NN\8189659|of|the|channels (r_nmod) member_3\NN\9816771|a|family (r_appos) kcnk1_0\NN\1740|,|member|,
23291559T4_23291559T16 NONE )_10\-RRB-\1740| (r_punct) channels_12\NNS\6251781|of|two-pore|k(+|)|ion
23291559T2_23291559T12 CPR:3 phenobarbital-inducible_21\JJ\1740| (r_amod) factor_23\NN\7326557|as|a|phenobarbital-inducible|antihyperplasia (r_nmod) characterized_17\VBN\609683|kcnk1|factor (r_conj) determined_4\VBN\1645601|here|,|we|have|mechanism|and|characterized|. (l_dobj) mechanism_7\NN\13446390|the|molecular|activation (l_nmod) activation_11\NN\13561719|of|this|male-specific|gene (l_nmod) gene_15\NN\8459252|of|the|kcnk1 (l_compound) kcnk1_14\NN\1740|
23291559T2_23291559T13 CPR:3 phenobarbital-inducible_21\JJ\1740| (r_amod) factor_23\NN\7326557|as|a|phenobarbital-inducible|antihyperplasia (r_nmod) characterized_17\VBN\609683|kcnk1|factor (l_dobj) kcnk1_18\NN\1740|
23291559T3_23291559T14 CPR:3 phenobarbital_3\NN\2792049|by (r_nmod) activation_1\NN\13561719|upon|phenobarbital (r_nmod) binds_8\VBZ\1290422|activation|,|car|element|. (l_nsubj) car_7\NN\3791235|nuclear|receptor (l_compound) receptor_6\NN\5225602|
23291559T3_23291559T15 CPR:3 phenobarbital_3\NN\2792049|by (r_nmod) activation_1\NN\13561719|upon|phenobarbital (r_nmod) binds_8\VBZ\1290422|activation|,|car|element|. (l_nsubj) car_7\NN\3791235|nuclear|receptor
23291559T3_23291559T17 NONE phenobarbital_3\NN\2792049|by (r_nmod) activation_1\NN\13561719|upon|phenobarbital (r_nmod) binds_8\VBZ\1290422|activation|,|car|element|. (l_dobj) element_12\NN\5867413|the|97-bp|response|-2441/-2345|promoter (l_nmod) promoter_19\NN\9773962|within|the|kcnk1
23291559T5_23291559T18 NONE phenobarbital_24\NN\2792049| (r_compound) treatment_25\NN\654885|after|phenobarbital (r_nmod) those_15\DT\1740|compared|with|males|treatment (r_advcl) progressed_2\VBD\252019|hyperplasia|further|livers|those|. (l_nmod) livers_5\NNS\5298729|in|the|mice (l_nmod) mice_12\NNS\2329401|of|-/-|male (l_amod) -/-_9\JJ\1740|kcnk1|(|) (l_nmod:npmod) kcnk1_7\NN\1740|
23291559T5_23291559T19 NONE phenobarbital_24\NN\2792049| (r_compound) treatment_25\NN\654885|after|phenobarbital (r_nmod) those_15\DT\1740|compared|with|males|treatment (l_nmod) males_22\NNS\15388|of|kcnk1|/+|) (l_compound) kcnk1_17\NN\1740|
23291559T6_23291559T20 NONE phenobarbital-induced_4\JJ\1740| (r_amod) hyperplasia_5\NN\14365950|phenobarbital-induced (r_dobj) suppresses_3\VBZ\2510337|thus|,|kcnk1|hyperplasia|. (l_nsubj) kcnk1_2\NN\1740|
23291559T7_23291559T21 CPR:3 phenobarbital_4\NN\2792049| (r_compound) treatment_5\NN\654885|phenobarbital (r_nsubj) induces_6\VBZ\1627355|that|treatment|kcnk1|elicit (l_dobj) kcnk1_7\NNP\1740|
23347684
8667211
8667211T2_8667211T15 NONE pgs_53\NNS\1740|of (r_nmod) group_51\NN\2137|by|this|pgs (r_nmod) produced_48\VBN\1617192|group (r_acl) flow_47\NN\7311115|of|gastric|mucosa|blood|produced (r_nmod) increase_42\NN\13576355|the|flow (r_conj) inhibition_39\NN\1068773|in|gastric|acid|secretion|and|increase (r_nmod) involvement_32\NN\1080366|ca|inhibition (r_dobj) suggested_31\VBD\1010118|which|involvement (r_ccomp) inhibit_18\VBP\2510337|that|prostaglandins|anhydrase|and|,|suggested (l_dobj) anhydrase_20\NN\1740|carbonic|ca
8667211T2_8667211T20 NONE pgs_53\NNS\1740|of (r_nmod) group_51\NN\2137|by|this|pgs (r_nmod) produced_48\VBN\1617192|group (r_acl) flow_47\NN\7311115|of|gastric|mucosa|blood|produced (r_nmod) increase_42\NN\13576355|the|flow (r_conj) inhibition_39\NN\1068773|in|gastric|acid|secretion|and|increase (r_nmod) involvement_32\NN\1080366|ca|inhibition (r_dobj) suggested_31\VBD\1010118|which|involvement (r_ccomp) inhibit_18\VBP\2510337|that|prostaglandins|anhydrase|and|,|suggested (l_dobj) anhydrase_20\NN\1740|carbonic|ca (l_appos) ca_22\NN\14625458|(|)
8667211T2_8667211T24 NONE pgs_53\NNS\1740|of (r_nmod) group_51\NN\2137|by|this|pgs (r_nmod) produced_48\VBN\1617192|group (r_acl) flow_47\NN\7311115|of|gastric|mucosa|blood|produced (r_nmod) increase_42\NN\13576355|the|flow (r_conj) inhibition_39\NN\1068773|in|gastric|acid|secretion|and|increase (r_nmod) involvement_32\NN\1080366|ca|inhibition (l_nmod) ca_34\NN\14625458|of
8667211T6_8667211T15 CPR:4 prostaglandins_9\NNS\5414534|vasodilating|pgs|e1 (r_nsubj) inhibit_18\VBP\2510337|that|prostaglandins|anhydrase|and|,|suggested (l_dobj) anhydrase_20\NN\1740|carbonic|ca
8667211T6_8667211T20 CPR:4 prostaglandins_9\NNS\5414534|vasodilating|pgs|e1 (r_nsubj) inhibit_18\VBP\2510337|that|prostaglandins|anhydrase|and|,|suggested (l_dobj) anhydrase_20\NN\1740|carbonic|ca (l_appos) ca_22\NN\14625458|(|)
8667211T6_8667211T24 NONE prostaglandins_9\NNS\5414534|vasodilating|pgs|e1 (r_nsubj) inhibit_18\VBP\2510337|that|prostaglandins|anhydrase|and|,|suggested (l_ccomp) suggested_31\VBD\1010118|which|involvement (l_dobj) involvement_32\NN\1080366|ca|inhibition (l_nmod) ca_34\NN\14625458|of
8667211T9_8667211T15 CPR:4 pgs_11\NNS\1740|(|) (r_appos) prostaglandins_9\NNS\5414534|vasodilating|pgs|e1 (r_nsubj) inhibit_18\VBP\2510337|that|prostaglandins|anhydrase|and|,|suggested (l_dobj) anhydrase_20\NN\1740|carbonic|ca
8667211T9_8667211T20 CPR:4 pgs_11\NNS\1740|(|) (r_appos) prostaglandins_9\NNS\5414534|vasodilating|pgs|e1 (r_nsubj) inhibit_18\VBP\2510337|that|prostaglandins|anhydrase|and|,|suggested (l_dobj) anhydrase_20\NN\1740|carbonic|ca (l_appos) ca_22\NN\14625458|(|)
8667211T9_8667211T24 NONE pgs_11\NNS\1740|(|) (r_appos) prostaglandins_9\NNS\5414534|vasodilating|pgs|e1 (r_nsubj) inhibit_18\VBP\2510337|that|prostaglandins|anhydrase|and|,|suggested (l_ccomp) suggested_31\VBD\1010118|which|involvement (l_dobj) involvement_32\NN\1080366|ca|inhibition (l_nmod) ca_34\NN\14625458|of
8667211T7_8667211T27 NONE pg_16\NN\1740| (r_compound) production_17\NN\30358|pg (r_conj) activity_12\NN\30358|the|cyclooxygenase|and|production (l_nmod) cyclooxygenase_14\NN\14732946|of
8667211T7_8667211T28 NONE pg_16\NN\1740| (r_compound) production_17\NN\30358|pg (r_conj) activity_12\NN\30358|the|cyclooxygenase|and|production (r_dobj) reduce_10\VBP\441445|which|activity (r_acl:relcl) nsaids_5\NNS\2721538|the|used|,|reduce|, (r_nsubj) activated_19\VBD\1641914|that|nsaids|ca|manner|mechanism (l_dobj) ca_20\NN\14625458|i (l_nummod) i_21\CD\14622893|and|ca
8667211T7_8667211T29 NONE pg_16\NN\1740| (r_compound) production_17\NN\30358|pg (r_conj) activity_12\NN\30358|the|cyclooxygenase|and|production (r_dobj) reduce_10\VBP\441445|which|activity (r_acl:relcl) nsaids_5\NNS\2721538|the|used|,|reduce|, (r_nsubj) activated_19\VBD\1641914|that|nsaids|ca|manner|mechanism (l_dobj) ca_20\NN\14625458|i (l_nummod) i_21\CD\14622893|and|ca (l_conj) ca_23\NN\14625458|ii (l_nummod) ii_24\CD\13741022|
8667211T8_8667211T30 NONE histamine_0\NN\14739004|and|ca|added (r_nsubj) amplified_6\VBD\157844|histamine|effect|. (l_dobj) effect_9\NN\34213|the|activating|latter|ca (l_nmod) ca_14\NN\14625458|on|ii (l_nummod) ii_15\CD\13741022|
8667211T10_8667211T30 CPR:3 ca_2\NN\14625458| (r_conj) histamine_0\NN\14739004|and|ca|added (r_nsubj) amplified_6\VBD\157844|histamine|effect|. (l_dobj) effect_9\NN\34213|the|activating|latter|ca (l_nmod) ca_14\NN\14625458|on|ii (l_nummod) ii_15\CD\13741022|
8667211T11_8667211T31 CPR:4 acetazolamide_4\NN\1740| (r_conj) pge2_2\NN\1740|of|or|acetazolamide (r_nmod) association_0\NN\8008335|pge2|nsaids (r_nsubj) reduced_7\VBD\441445|association|activation|. (l_dobj) activation_9\NN\13561719|nsaid-induced|ca (l_nmod) ca_11\NN\14625458|of|i|and|ca (l_nummod) i_12\CD\14622893|
8667211T11_8667211T32 CPR:4 acetazolamide_4\NN\1740| (r_conj) pge2_2\NN\1740|of|or|acetazolamide (r_nmod) association_0\NN\8008335|pge2|nsaids (r_nsubj) reduced_7\VBD\441445|association|activation|. (l_dobj) activation_9\NN\13561719|nsaid-induced|ca (l_nmod) ca_11\NN\14625458|of|i|and|ca (l_conj) ca_14\NN\14625458|ii (l_nummod) ii_15\CD\13741022|
8667211T1_8667211T13 CPR:4 acetazolamide_6\NN\1740|of (r_nmod) effect_4\NN\34213|the|inhibitory|acetazolamide|ca (l_nmod) ca_8\NN\14625458|on|i|and|ca (l_nummod) i_9\CD\14622893|
8667211T1_8667211T14 CPR:4 acetazolamide_6\NN\1740|of (r_nmod) effect_4\NN\34213|the|inhibitory|acetazolamide|ca (l_nmod) ca_8\NN\14625458|on|i|and|ca (l_conj) ca_11\NN\14625458|ii (l_nummod) ii_12\CD\13741022|
8667211T12_8667211T13 CPR:3 indomethacin_0\NN\3828465| (r_nsubj) abolished_1\VBD\1740|indomethacin|effect|. (l_dobj) effect_4\NN\34213|the|inhibitory|acetazolamide|ca (l_nmod) ca_8\NN\14625458|on|i|and|ca (l_nummod) i_9\CD\14622893|
8667211T12_8667211T14 CPR:3 indomethacin_0\NN\3828465| (r_nsubj) abolished_1\VBD\1740|indomethacin|effect|. (l_dobj) effect_4\NN\34213|the|inhibitory|acetazolamide|ca (l_nmod) ca_8\NN\14625458|on|i|and|ca (l_conj) ca_11\NN\14625458|ii (l_nummod) ii_12\CD\13741022|
10752671
10752671T1_10752671T8 CPR:4 flutamide_0\NN\1740|,|inhibitor (l_appos) inhibitor_5\NN\20090|an|effective|competitive|receptor (l_nmod) receptor_9\NN\5225602|of|the|androgen|used
10752671T5_10752671T9 CPR:3 flutamide_6\NN\1740| (r_dobj) given_5\VBN\2327200|flutamide|agent|dose (r_acl) rats_4\NNS\2329401|of|given (r_nmod) liver_2\NN\5298729|in|the|rats (r_nmod) detected_24\VBN\2163746|liver|,|foci|were|rats|. (l_nsubjpass) foci_22\NNS\5704266|gamma-glutamyltraspeptidase-positive (l_amod) gamma-glutamyltraspeptidase-positive_21\JJ\1740|
3058238
3058238T1_3058238T24 NONE estrogen_9\NN\14745635| (r_compound) receptor_10\NN\5225602|estrogen
9633680
9633680T4_9633680T17 CPR:9 levodopa_0\NN\14604959| (r_nsubjpass) absorbed_2\VBN\1540449|levodopa|is|bowel|and|catabolized|. (l_conj) catabolized_10\VBN\238867|is|rapidly|decarboxylase (l_nmod) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase
9633680T4_9633680T18 CPR:9 levodopa_0\NN\14604959| (r_nsubjpass) absorbed_2\VBN\1540449|levodopa|is|bowel|and|catabolized|. (l_conj) catabolized_10\VBN\238867|is|rapidly|decarboxylase (l_nmod) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase (l_appos) aadc_15\NN\1740|(|)
9633680T4_9633680T19 CPR:9 levodopa_0\NN\14604959| (r_nsubjpass) absorbed_2\VBN\1540449|levodopa|is|bowel|and|catabolized|. (l_conj) catabolized_10\VBN\238867|is|rapidly|decarboxylase (l_nmod) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase (l_conj) catechol-o-methyltransferase_18\NN\1740|comt
9633680T4_9633680T20 CPR:9 levodopa_0\NN\14604959| (r_nsubjpass) absorbed_2\VBN\1540449|levodopa|is|bowel|and|catabolized|. (l_conj) catabolized_10\VBN\238867|is|rapidly|decarboxylase (l_nmod) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase (l_conj) catechol-o-methyltransferase_18\NN\1740|comt (l_appos) comt_20\NN\1740|(|)
9633680T5_9633680T17 NONE aromatic-l-amino-acid_12\JJ\1740| (r_amod) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase
9633680T5_9633680T18 NONE aromatic-l-amino-acid_12\JJ\1740| (r_amod) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase (l_appos) aadc_15\NN\1740|(|)
9633680T5_9633680T19 NONE aromatic-l-amino-acid_12\JJ\1740| (r_amod) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase (l_conj) catechol-o-methyltransferase_18\NN\1740|comt
9633680T5_9633680T20 NONE aromatic-l-amino-acid_12\JJ\1740| (r_amod) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase (l_conj) catechol-o-methyltransferase_18\NN\1740|comt (l_appos) comt_20\NN\1740|(|)
9633680T6_9633680T17 NONE catechol-o-methyltransferase_18\NN\1740|comt (r_conj) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase
9633680T6_9633680T18 NONE catechol-o-methyltransferase_18\NN\1740|comt (r_conj) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase (l_appos) aadc_15\NN\1740|(|)
9633680T6_9633680T19 NONE catechol-o-methyltransferase_18\NN\1740|comt
9633680T6_9633680T20 NONE catechol-o-methyltransferase_18\NN\1740|comt (l_appos) comt_20\NN\1740|(|)
9633680T7_9633680T17 NONE catechol-o-methyltransferase_18\NN\1740|comt (r_conj) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase
9633680T7_9633680T18 NONE catechol-o-methyltransferase_18\NN\1740|comt (r_conj) decarboxylase_13\NN\14732946|by|aromatic-l-amino-acid|aadc|and|catechol-o-methyltransferase (l_appos) aadc_15\NN\1740|(|)
9633680T7_9633680T19 NONE catechol-o-methyltransferase_18\NN\1740|comt
9633680T7_9633680T20 NONE catechol-o-methyltransferase_18\NN\1740|comt (l_appos) comt_20\NN\1740|(|)
9633680T8_9633680T21 CPR:9 levodopa_6\NN\14604959| (r_dobj) degrade_5\VBP\1799794|because|aadc|levodopa (l_nsubj) aadc_2\NN\1740|gastric|and|comt
9633680T8_9633680T22 CPR:9 levodopa_6\NN\14604959| (r_dobj) degrade_5\VBP\1799794|because|aadc|levodopa (l_nsubj) aadc_2\NN\1740|gastric|and|comt (l_conj) comt_4\NN\1740|
9633680T8_9633680T23 NONE levodopa_6\NN\14604959| (r_dobj) degrade_5\VBP\1799794|because|aadc|levodopa (r_advcl) given_11\VBN\2327200|degrade|,|drug|is|inhibitors|. (l_nmod) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (l_nmod) aadc_15\NN\1740|of
9633680T8_9633680T24 NONE levodopa_6\NN\14604959| (r_dobj) degrade_5\VBP\1799794|because|aadc|levodopa (r_advcl) given_11\VBN\2327200|degrade|,|drug|is|inhibitors|. (l_nmod) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (l_conj) enter_28\VB\2471690|inhibitors|will|also|use (l_nsubj) inhibitors_23\NNS\20090|comt (l_nmod) comt_25\NN\1740|of
9633680T9_9633680T21 NONE carbidopa_17\NN\1740|(|or|benserazide|) (r_appos) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (r_nmod) given_11\VBN\2327200|degrade|,|drug|is|inhibitors|. (l_advcl) degrade_5\VBP\1799794|because|aadc|levodopa (l_nsubj) aadc_2\NN\1740|gastric|and|comt
9633680T9_9633680T22 NONE carbidopa_17\NN\1740|(|or|benserazide|) (r_appos) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (r_nmod) given_11\VBN\2327200|degrade|,|drug|is|inhibitors|. (l_advcl) degrade_5\VBP\1799794|because|aadc|levodopa (l_nsubj) aadc_2\NN\1740|gastric|and|comt (l_conj) comt_4\NN\1740|
9633680T9_9633680T23 CPR:4 carbidopa_17\NN\1740|(|or|benserazide|) (r_appos) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (l_nmod) aadc_15\NN\1740|of
9633680T9_9633680T24 NONE carbidopa_17\NN\1740|(|or|benserazide|) (r_appos) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (l_conj) enter_28\VB\2471690|inhibitors|will|also|use (l_nsubj) inhibitors_23\NNS\20090|comt (l_nmod) comt_25\NN\1740|of
9633680T10_9633680T21 NONE benserazide_19\NN\1740| (r_conj) carbidopa_17\NN\1740|(|or|benserazide|) (r_appos) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (r_nmod) given_11\VBN\2327200|degrade|,|drug|is|inhibitors|. (l_advcl) degrade_5\VBP\1799794|because|aadc|levodopa (l_nsubj) aadc_2\NN\1740|gastric|and|comt
9633680T10_9633680T22 NONE benserazide_19\NN\1740| (r_conj) carbidopa_17\NN\1740|(|or|benserazide|) (r_appos) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (r_nmod) given_11\VBN\2327200|degrade|,|drug|is|inhibitors|. (l_advcl) degrade_5\VBP\1799794|because|aadc|levodopa (l_nsubj) aadc_2\NN\1740|gastric|and|comt (l_conj) comt_4\NN\1740|
9633680T10_9633680T23 CPR:4 benserazide_19\NN\1740| (r_conj) carbidopa_17\NN\1740|(|or|benserazide|) (r_appos) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (l_nmod) aadc_15\NN\1740|of
9633680T10_9633680T24 NONE benserazide_19\NN\1740| (r_conj) carbidopa_17\NN\1740|(|or|benserazide|) (r_appos) inhibitors_13\NNS\20090|with|aadc|carbidopa|,|and|enter (l_conj) enter_28\VB\2471690|inhibitors|will|also|use (l_nsubj) inhibitors_23\NNS\20090|comt (l_nmod) comt_25\NN\1740|of
9633680T11_9633680T25 NONE levodopa_8\NN\14604959|of|exogenous (r_nmod) decarboxylation_5\NN\13446390|of|levodopa|dopamine (r_nmod) site_3\NN\8673395|the|exact|decarboxylation (r_nsubj) unknown_15\JJ\1740|although|site|is (r_advcl) located_21\JJ\1740|unknown|,|aadc|is|terminals|. (l_nsubj) aadc_19\NN\1740|most|striatal
9633680T12_9633680T25 NONE dopamine_10\NN\14807737|to|brain (r_nmod) decarboxylation_5\NN\13446390|of|levodopa|dopamine (r_nmod) site_3\NN\8673395|the|exact|decarboxylation (r_nsubj) unknown_15\JJ\1740|although|site|is (r_advcl) located_21\JJ\1740|unknown|,|aadc|is|terminals|. (l_nsubj) aadc_19\NN\1740|most|striatal
9633680T13_9633680T26 NONE dopamine_14\NN\14807737| (r_compound) receptors_15\NNS\5225602|postsynaptic|dopamine
9633680T14_9633680T26 NONE levodopa_22\NN\14604959|of (r_nmod) action_20\NN\30358|the|antiparkinsonian|levodopa (r_dobj) mediating_17\VBG\761713|action (r_conj) stimulating_12\VBG\137313|receptors|and|mediating (l_dobj) receptors_15\NNS\5225602|postsynaptic|dopamine
9633680T15_9633680T27 NONE dopamine_0\NN\14807737| (r_compound) agonists_1\NNS\9613191|dopamine (r_nsubj) act_2\VBP\1619354|agonists|directly|receptors|,|obviating|. (l_nmod) receptors_7\NNS\5225602|on|postsynaptic|dopamine
9633680T16_9633680T27 NONE dopamine_6\NN\14807737| (r_compound) receptors_7\NNS\5225602|on|postsynaptic|dopamine
23221868
23221868T21_23221868T29 NONE rufinamide_0\NN\1740| (r_nsubj) attenuates_1\VBZ\224901|rufinamide|allodynia|and|stabilizes|. (l_conj) stabilizes_14\VBZ\126264|state (l_dobj) state_19\NN\8491826|channel|inactivated (l_compound) channel_17\NN\6251781|voltage-gated|sodium
23221868T22_23221868T29 NONE sodium_16\NN\14625458| (r_compound) channel_17\NN\6251781|voltage-gated|sodium
23221868T9_23221868T24 NONE sodium_3\NN\14625458| (r_compound) channels_4\NNS\6251781|voltage-gated|sodium
23221868T4_23221868T23 NONE sodium_0\NN\14625458| (r_compound) blockers_2\NNS\10101634|sodium|channel|used (l_compound) channel_1\NN\6251781|
23221868T13_23221868T27 NONE rufinamide_5\NN\1740|of (r_nmod) effect_3\NN\34213|the|rufinamide|currents (r_dobj) compared_1\VBD\644583|we|effect|using|. (l_xcomp) using_9\VBG\1156834|clamp|cells (l_nmod) cells_15\NNS\3080309|in|expressing|and|neurons|amitriptyline (l_acl) expressing_16\VBG\928630|isoform (l_dobj) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) channel_20\NN\6251781|
23221868T13_23221868T28 NONE rufinamide_5\NN\1740|of (r_nmod) effect_3\NN\34213|the|rufinamide|currents (r_dobj) compared_1\VBD\644583|we|effect|using|. (l_xcomp) using_9\VBG\1156834|clamp|cells (l_nmod) cells_15\NNS\3080309|in|expressing|and|neurons|amitriptyline (l_acl) expressing_16\VBG\928630|isoform (l_dobj) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) nav1.7_21\NN\1740|
23221868T14_23221868T27 NONE sodium_7\NN\14625458| (r_compound) currents_8\NNS\11449002|on|sodium (r_nmod) effect_3\NN\34213|the|rufinamide|currents (r_dobj) compared_1\VBD\644583|we|effect|using|. (l_xcomp) using_9\VBG\1156834|clamp|cells (l_nmod) cells_15\NNS\3080309|in|expressing|and|neurons|amitriptyline (l_acl) expressing_16\VBG\928630|isoform (l_dobj) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) channel_20\NN\6251781|
23221868T14_23221868T28 NONE sodium_7\NN\14625458| (r_compound) currents_8\NNS\11449002|on|sodium (r_nmod) effect_3\NN\34213|the|rufinamide|currents (r_dobj) compared_1\VBD\644583|we|effect|using|. (l_xcomp) using_9\VBG\1156834|clamp|cells (l_nmod) cells_15\NNS\3080309|in|expressing|and|neurons|amitriptyline (l_acl) expressing_16\VBG\928630|isoform (l_dobj) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) nav1.7_21\NN\1740|
23221868T15_23221868T27 NONE sodium_19\NN\14625458| (r_compound) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) channel_20\NN\6251781|
23221868T15_23221868T28 NONE sodium_19\NN\14625458| (r_compound) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) nav1.7_21\NN\1740|
23221868T16_23221868T27 NONE amitriptyline_31\NN\4482543|to|and|mexiletine (r_nmod) cells_15\NNS\3080309|in|expressing|and|neurons|amitriptyline (l_acl) expressing_16\VBG\928630|isoform (l_dobj) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) channel_20\NN\6251781|
23221868T16_23221868T28 NONE amitriptyline_31\NN\4482543|to|and|mexiletine (r_nmod) cells_15\NNS\3080309|in|expressing|and|neurons|amitriptyline (l_acl) expressing_16\VBG\928630|isoform (l_dobj) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) nav1.7_21\NN\1740|
23221868T17_23221868T27 NONE mexiletine_33\NN\2715941| (r_conj) amitriptyline_31\NN\4482543|to|and|mexiletine (r_nmod) cells_15\NNS\3080309|in|expressing|and|neurons|amitriptyline (l_acl) expressing_16\VBG\928630|isoform (l_dobj) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) channel_20\NN\6251781|
23221868T17_23221868T28 NONE mexiletine_33\NN\2715941| (r_conj) amitriptyline_31\NN\4482543|to|and|mexiletine (r_nmod) cells_15\NNS\3080309|in|expressing|and|neurons|amitriptyline (l_acl) expressing_16\VBG\928630|isoform (l_dobj) isoform_22\NN\1740|the|voltage-gated|sodium|channel|nav1.7 (l_compound) nav1.7_21\NN\1740|
23221868T5_23221868T25 NONE sodium_12\NN\14625458| (r_compound) channel_13\NN\6251781|voltage-gated|sodium
23221868T5_23221868T26 NONE sodium_12\NN\14625458| (r_compound) channel_13\NN\6251781|voltage-gated|sodium (r_compound) nav1.7_14\NN\1740|of|channel
7986344
7986344T13_7986344T23 NONE guanidine-denatured_3\JJ\1740| (r_amod) wild-type_5\JJ\1740|of|guanidine-denatured|disulfide-intact|and|a. (l_conj) a._11\.\1740|mutant|bovine|pancreatic|ribonuclease
7986344T14_7986344T23 NONE disulfide-intact_4\JJ\1740| (r_amod) wild-type_5\JJ\1740|of|guanidine-denatured|disulfide-intact|and|a. (l_conj) a._11\.\1740|mutant|bovine|pancreatic|ribonuclease
7986344T1_7986344T15 NONE proline-42-to-alanine_16\NN\1740|
7986344T1_7986344T16 NONE proline-42-to-alanine_16\NN\1740| (r_compound) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_appos) pro42ala_19\NN\1740|(|)
7986344T1_7986344T20 NONE proline-42-to-alanine_16\NN\1740| (r_compound) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (r_conj) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant
7986344T1_7986344T22 NONE proline-42-to-alanine_16\NN\1740| (r_compound) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (r_conj) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_appos) a_12\NN\13649268|(|rnase|)
7986344T2_7986344T15 NONE proline-42-to-alanine_16\NN\1740|
7986344T2_7986344T16 NONE proline-42-to-alanine_16\NN\1740| (r_compound) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_appos) pro42ala_19\NN\1740|(|)
7986344T2_7986344T20 NONE proline-42-to-alanine_16\NN\1740| (r_compound) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (r_conj) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant
7986344T2_7986344T22 NONE proline-42-to-alanine_16\NN\1740| (r_compound) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (r_conj) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_appos) a_12\NN\13649268|(|rnase|)
7986344T3_7986344T15 NONE tyrosine_26\NN\14601829| (r_compound) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_compound) proline-42-to-alanine_16\NN\1740|
7986344T3_7986344T16 NONE tyrosine_26\NN\14601829| (r_compound) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_appos) pro42ala_19\NN\1740|(|)
7986344T3_7986344T20 NONE tyrosine_26\NN\14601829| (r_compound) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant
7986344T3_7986344T22 NONE tyrosine_26\NN\14601829| (r_compound) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_appos) a_12\NN\13649268|(|rnase|)
7986344T4_7986344T15 CPR:4 monophosphate_30\NN\1740|2'-cytidine|2'cmp (r_compound) binding_35\NN\4688246|monophosphate|inhibitor (r_conj) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_compound) proline-42-to-alanine_16\NN\1740|
7986344T4_7986344T16 CPR:4 monophosphate_30\NN\1740|2'-cytidine|2'cmp (r_compound) binding_35\NN\4688246|monophosphate|inhibitor (r_conj) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_appos) pro42ala_19\NN\1740|(|)
7986344T4_7986344T20 CPR:4 monophosphate_30\NN\1740|2'-cytidine|2'cmp (r_compound) binding_35\NN\4688246|monophosphate|inhibitor (r_conj) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant
7986344T4_7986344T22 CPR:4 monophosphate_30\NN\1740|2'-cytidine|2'cmp (r_compound) binding_35\NN\4688246|monophosphate|inhibitor (r_conj) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_appos) a_12\NN\13649268|(|rnase|)
7986344T5_7986344T15 CPR:4 2'cmp_32\NN\1740|(|) (r_appos) monophosphate_30\NN\1740|2'-cytidine|2'cmp (r_compound) binding_35\NN\4688246|monophosphate|inhibitor (r_conj) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_compound) proline-42-to-alanine_16\NN\1740|
7986344T5_7986344T16 CPR:4 2'cmp_32\NN\1740|(|) (r_appos) monophosphate_30\NN\1740|2'-cytidine|2'cmp (r_compound) binding_35\NN\4688246|monophosphate|inhibitor (r_conj) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_appos) pro42ala_19\NN\1740|(|)
7986344T5_7986344T20 CPR:4 2'cmp_32\NN\1740|(|) (r_appos) monophosphate_30\NN\1740|2'-cytidine|2'cmp (r_compound) binding_35\NN\4688246|monophosphate|inhibitor (r_conj) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant
7986344T5_7986344T22 CPR:4 2'cmp_32\NN\1740|(|) (r_appos) monophosphate_30\NN\1740|2'-cytidine|2'cmp (r_compound) binding_35\NN\4688246|monophosphate|inhibitor (r_conj) burial_27\NN\7451463|tyrosine|and|binding (r_dobj) monitoring_25\VBG\2169352|by|burial (r_advcl) studied_23\VBN\630380|kinetics|have|been|monitoring|. (l_nsubjpass) kinetics_2\NNS\6100236|the|refolding|a (l_nmod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_appos) a_12\NN\13649268|(|rnase|)
7986344T6_7986344T15 NONE guanidine-denatured_4\JJ\1740| (r_amod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_compound) proline-42-to-alanine_16\NN\1740|
7986344T6_7986344T16 NONE guanidine-denatured_4\JJ\1740| (r_amod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_appos) pro42ala_19\NN\1740|(|)
7986344T6_7986344T20 NONE guanidine-denatured_4\JJ\1740| (r_amod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant
7986344T6_7986344T22 NONE guanidine-denatured_4\JJ\1740| (r_amod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_appos) a_12\NN\13649268|(|rnase|)
7986344T9_7986344T15 NONE disulfide-intact_5\JJ\1740| (r_amod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_compound) proline-42-to-alanine_16\NN\1740|
7986344T9_7986344T16 NONE disulfide-intact_5\JJ\1740| (r_amod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_conj) mutant_17\NN\4475|its|proline-42-to-alanine|pro42ala (l_appos) pro42ala_19\NN\1740|(|)
7986344T9_7986344T20 NONE disulfide-intact_5\JJ\1740| (r_amod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant
7986344T9_7986344T22 NONE disulfide-intact_5\JJ\1740| (r_amod) a_9\NN\13649268|of|guanidine-denatured|disulfide-intact|bovine|pancreatic|ribonuclease|a|and|mutant (l_appos) a_12\NN\13649268|(|rnase|)
7986344T7_7986344T17 CPR:4 2'cmp_15\NN\1740|of|the|inhibitor (r_nmod) presence_11\NN\13954253|in|the|2'cmp (r_nmod) faster_8\JJR\1740|rate|is|presence|absence|,|indicating|. (l_nsubj) rate_2\NN\13815152|the|folding|a (l_nmod) a_6\NN\13649268|for|wild-type|rnase
7986344T8_7986344T17 NONE 2'cmp_33\NN\1740|by (r_nmod) stabilized_31\VBN\126264|that|structure|is|2'cmp (r_ccomp) indicating_21\VBG\952524|stabilized (r_advcl) faster_8\JJR\1740|rate|is|presence|absence|,|indicating|. (l_nsubj) rate_2\NN\13815152|the|folding|a (l_nmod) a_6\NN\13649268|for|wild-type|rnase
7986344T10_7986344T18 NONE 2'cmp_5\NN\1740| (r_compound) binding_6\NN\4688246|by|2'cmp|species (l_nmod) species_11\NNS\7992450|to|the|major|slow-folding|a (l_nmod) a_15\NN\13649268|of|pro42ala|rnase (l_compound) pro42ala_13\NN\1740|
7986344T10_7986344T19 NONE 2'cmp_5\NN\1740| (r_compound) binding_6\NN\4688246|by|2'cmp|species (l_nmod) species_11\NNS\7992450|to|the|major|slow-folding|a (l_nmod) a_15\NN\13649268|of|pro42ala|rnase
7986344T10_7986344T21 NONE 2'cmp_5\NN\1740| (r_compound) binding_6\NN\4688246|by|2'cmp|species (r_nmod) monitored_3\VBN\2169352|binding (r_acl) rate_2\NN\13815152|the|folding|monitored (r_nsubj) faster_17\JJR\1740|rate|is|rate|;|however|decreased|. (l_parataxis) decreased_42\VBN\169651|,|rate|is|significantly|rate|,|indicating (l_advcl) indicating_53\VBG\952524|fold (l_ccomp) fold_63\VBP\356258|that|species|state|conformations|step (l_nsubj) species_60\NNS\7992450|major|slow-folding|pro42ala (l_nmod) pro42ala_62\NN\1740|of
7986344T11_7986344T18 NONE tyrosine_24\NN\14601829| (r_compound) burial_25\NN\7451463|by|tyrosine (r_nmod) monitored_22\VBN\2169352|burial (r_acl) rate_21\NN\13815152|than|the|folding|monitored (r_nmod) faster_17\JJR\1740|rate|is|rate|;|however|decreased|. (l_nsubj) rate_2\NN\13815152|the|folding|monitored (l_acl) monitored_3\VBN\2169352|binding (l_nmod) binding_6\NN\4688246|by|2'cmp|species (l_nmod) species_11\NNS\7992450|to|the|major|slow-folding|a (l_nmod) a_15\NN\13649268|of|pro42ala|rnase (l_compound) pro42ala_13\NN\1740|
7986344T11_7986344T19 NONE tyrosine_24\NN\14601829| (r_compound) burial_25\NN\7451463|by|tyrosine (r_nmod) monitored_22\VBN\2169352|burial (r_acl) rate_21\NN\13815152|than|the|folding|monitored (r_nmod) faster_17\JJR\1740|rate|is|rate|;|however|decreased|. (l_nsubj) rate_2\NN\13815152|the|folding|monitored (l_acl) monitored_3\VBN\2169352|binding (l_nmod) binding_6\NN\4688246|by|2'cmp|species (l_nmod) species_11\NNS\7992450|to|the|major|slow-folding|a (l_nmod) a_15\NN\13649268|of|pro42ala|rnase
7986344T11_7986344T21 NONE tyrosine_24\NN\14601829| (r_compound) burial_25\NN\7451463|by|tyrosine (r_nmod) monitored_22\VBN\2169352|burial (r_acl) rate_21\NN\13815152|than|the|folding|monitored (r_nmod) faster_17\JJR\1740|rate|is|rate|;|however|decreased|. (l_parataxis) decreased_42\VBN\169651|,|rate|is|significantly|rate|,|indicating (l_advcl) indicating_53\VBG\952524|fold (l_ccomp) fold_63\VBP\356258|that|species|state|conformations|step (l_nsubj) species_60\NNS\7992450|major|slow-folding|pro42ala (l_nmod) pro42ala_62\NN\1740|of
7986344T12_7986344T18 NONE tyrosine_50\NN\14601829| (r_compound) burial_51\NN\7451463|by|tyrosine (r_nmod) monitored_48\VBN\2169352|burial (r_acl) rate_47\NN\13815152|over|the|folding|monitored (r_nmod) decreased_42\VBN\169651|,|rate|is|significantly|rate|,|indicating (r_parataxis) faster_17\JJR\1740|rate|is|rate|;|however|decreased|. (l_nsubj) rate_2\NN\13815152|the|folding|monitored (l_acl) monitored_3\VBN\2169352|binding (l_nmod) binding_6\NN\4688246|by|2'cmp|species (l_nmod) species_11\NNS\7992450|to|the|major|slow-folding|a (l_nmod) a_15\NN\13649268|of|pro42ala|rnase (l_compound) pro42ala_13\NN\1740|
7986344T12_7986344T19 NONE tyrosine_50\NN\14601829| (r_compound) burial_51\NN\7451463|by|tyrosine (r_nmod) monitored_48\VBN\2169352|burial (r_acl) rate_47\NN\13815152|over|the|folding|monitored (r_nmod) decreased_42\VBN\169651|,|rate|is|significantly|rate|,|indicating (r_parataxis) faster_17\JJR\1740|rate|is|rate|;|however|decreased|. (l_nsubj) rate_2\NN\13815152|the|folding|monitored (l_acl) monitored_3\VBN\2169352|binding (l_nmod) binding_6\NN\4688246|by|2'cmp|species (l_nmod) species_11\NNS\7992450|to|the|major|slow-folding|a (l_nmod) a_15\NN\13649268|of|pro42ala|rnase
7986344T12_7986344T21 NONE tyrosine_50\NN\14601829| (r_compound) burial_51\NN\7451463|by|tyrosine (r_nmod) monitored_48\VBN\2169352|burial (r_acl) rate_47\NN\13815152|over|the|folding|monitored (r_nmod) decreased_42\VBN\169651|,|rate|is|significantly|rate|,|indicating (l_advcl) indicating_53\VBG\952524|fold (l_ccomp) fold_63\VBP\356258|that|species|state|conformations|step (l_nsubj) species_60\NNS\7992450|major|slow-folding|pro42ala (l_nmod) pro42ala_62\NN\1740|of
23360475
15650315
15650315T12_15650315T30 CPR:6 pranlukast_0\NN\1740|,|antagonist|, (r_nsubj) inhibits_7\VBZ\2510337|pranlukast|production|mechanism|. (l_nmod) mechanism_12\NN\13446390|via|a|distinct (l_amod) distinct_13\JJ\1740|antagonism (l_nmod) antagonism_17\NN\24720|from|leukotriene|receptor (l_compound) receptor_16\NN\5225602|
15650315T12_15650315T31 CPR:6 pranlukast_0\NN\1740|,|antagonist|, (l_appos) antagonist_5\NN\7846|a|leukotriene|receptor (l_compound) receptor_4\NN\5225602|
15650315T12_15650315T32 CPR:4 pranlukast_0\NN\1740|,|antagonist|, (r_nsubj) inhibits_7\VBZ\2510337|pranlukast|production|mechanism|. (l_dobj) production_9\NN\30358|interleukin-5 (l_compound) interleukin-5_8\NN\1740|
15650315T13_15650315T30 NONE leukotriene_15\NN\1740| (r_compound) antagonism_17\NN\24720|from|leukotriene|receptor (l_compound) receptor_16\NN\5225602|
15650315T13_15650315T31 NONE leukotriene_15\NN\1740| (r_compound) antagonism_17\NN\24720|from|leukotriene|receptor (r_nmod) distinct_13\JJ\1740|antagonism (r_amod) mechanism_12\NN\13446390|via|a|distinct (r_nmod) inhibits_7\VBZ\2510337|pranlukast|production|mechanism|. (l_nsubj) pranlukast_0\NN\1740|,|antagonist|, (l_appos) antagonist_5\NN\7846|a|leukotriene|receptor (l_compound) receptor_4\NN\5225602|
15650315T13_15650315T32 NONE leukotriene_15\NN\1740| (r_compound) antagonism_17\NN\24720|from|leukotriene|receptor (r_nmod) distinct_13\JJ\1740|antagonism (r_amod) mechanism_12\NN\13446390|via|a|distinct (r_nmod) inhibits_7\VBZ\2510337|pranlukast|production|mechanism|. (l_dobj) production_9\NN\30358|interleukin-5 (l_compound) interleukin-5_8\NN\1740|
15650315T14_15650315T30 NONE leukotriene_3\NN\1740| (r_compound) antagonist_5\NN\7846|a|leukotriene|receptor (r_appos) pranlukast_0\NN\1740|,|antagonist|, (r_nsubj) inhibits_7\VBZ\2510337|pranlukast|production|mechanism|. (l_nmod) mechanism_12\NN\13446390|via|a|distinct (l_amod) distinct_13\JJ\1740|antagonism (l_nmod) antagonism_17\NN\24720|from|leukotriene|receptor (l_compound) receptor_16\NN\5225602|
15650315T14_15650315T31 NONE leukotriene_3\NN\1740| (r_compound) antagonist_5\NN\7846|a|leukotriene|receptor (l_compound) receptor_4\NN\5225602|
15650315T14_15650315T32 NONE leukotriene_3\NN\1740| (r_compound) antagonist_5\NN\7846|a|leukotriene|receptor (r_appos) pranlukast_0\NN\1740|,|antagonist|, (r_nsubj) inhibits_7\VBZ\2510337|pranlukast|production|mechanism|. (l_dobj) production_9\NN\30358|interleukin-5 (l_compound) interleukin-5_8\NN\1740|
15650315T1_15650315T23 CPR:6 pranlukast_2\NN\1740|,|antagonist|, (l_appos) antagonist_12\NN\7846|a|receptor (l_compound) receptor_7\NN\5225602|cysteinyl|leukotriene|1|cysltr1 (l_nummod) 1_8\CD\13741022|
15650315T1_15650315T25 CPR:6 pranlukast_2\NN\1740|,|antagonist|, (l_appos) antagonist_12\NN\7846|a|receptor (l_compound) receptor_7\NN\5225602|cysteinyl|leukotriene|1|cysltr1 (l_appos) cysltr1_10\NN\1740|(|)
15650315T6_15650315T23 NONE leukotriene_6\NN\1740| (r_compound) receptor_7\NN\5225602|cysteinyl|leukotriene|1|cysltr1 (l_nummod) 1_8\CD\13741022|
15650315T6_15650315T25 NONE leukotriene_6\NN\1740| (r_compound) receptor_7\NN\5225602|cysteinyl|leukotriene|1|cysltr1 (l_appos) cysltr1_10\NN\1740|(|)
15650315T5_15650315T21 CPR:4 pranlukast-induced_11\NN\1740| (r_amod) inhibition_16\NN\1068773|of|pranlukast-induced|interleukin-5|inflammation (l_compound) interleukin-5_12\NN\1740|il-5
15650315T5_15650315T22 CPR:4 pranlukast-induced_11\NN\1740| (r_amod) inhibition_16\NN\1068773|of|pranlukast-induced|interleukin-5|inflammation (l_compound) interleukin-5_12\NN\1740|il-5 (l_appos) il-5_14\NN\1740|(|)
15650315T9_15650315T28 CPR:4 pranlukast_7\NN\1740|with|alone (r_nmod) pretreatment_2\NN\1740|tissues|pranlukast (r_nsubj) decreased_10\VBD\169651|results|:|pretreatment|significantly|amount|%|. (l_dobj) amount_12\NN\13329641|the|protein|medium (l_nmod) protein_15\NN\14944888|of|il-5 (l_compound) il-5_14\NN\1740|
15650315T2_15650315T16 CPR:4 pranlukast-induced_0\JJ\1740| (r_amod) inhibition_1\NN\1068773|pranlukast-induced|expression (l_nmod) expression_5\NN\4679549|of|il-5|mrna (l_compound) il-5_3\NN\1740|
15650315T2_15650315T17 NONE pranlukast-induced_0\JJ\1740| (r_amod) inhibition_1\NN\1068773|pranlukast-induced|expression (r_nsubjpass) noted_7\VBN\1009240|inhibition|was|cells|,|irrespective|. (l_advmod) irrespective_12\RB\1740|status (l_nmod) status_18\NN\24720|of|their|cysltr1|expression (l_compound) cysltr1_15\NN\1740|
15650315T3_15650315T18 NONE leukotrienes_4\NNS\1740|cysteinyl (r_nsubj) failed_7\VBD\1798936|addition|,|leukotrienes|se|upregulate|. (l_xcomp) upregulate_9\VB\1740|to|production (l_dobj) production_12\NN\30358|the|il-5 (l_compound) il-5_11\NN\1740|
15650315T4_15650315T19 CPR:4 pranlukast_6\NN\1740| (r_nsubj) inhibits_7\VBZ\2510337|that|pranlukast|synthesis|mechanism (l_dobj) synthesis_9\NN\13446390|il-5 (l_compound) il-5_8\NN\1740|
15650315T4_15650315T20 CPR:6 pranlukast_6\NN\1740| (r_nsubj) inhibits_7\VBZ\2510337|that|pranlukast|synthesis|mechanism (l_nmod) mechanism_12\NN\13446390|via|a|distinct (l_amod) distinct_13\JJ\1740|antagonism (l_nmod) antagonism_16\NN\24720|from|cysltr1 (l_compound) cysltr1_15\NN\1740|
23517912
23517912T19_23517912T44 NONE fisetin_0\NN\1740| (r_nsubj) regulates_1\VBZ\296178|fisetin|obesity|targeting|. (l_advcl) targeting_4\VBG\1151110|by|signaling (l_dobj) signaling_6\NN\33020|mtorc1 (l_compound) mtorc1_5\NN\1740|
23517912T9_23517912T28 NONE fisetin_8\NN\1740| (r_nsubj) prevents_9\VBZ\1740|that|fisetin|obesity|regulation (l_nmod) regulation_13\NN\6652242|through|signaling (l_nmod) signaling_16\NN\33020|of|the|target (l_nmod) target_19\NN\7258332|of|mammalian|complex (l_nmod) complex_22\NN\5869584|of|rapamycin|1|mtorc1|,|mediator (l_nummod) 1_23\CD\13741022|
23517912T9_23517912T29 NONE fisetin_8\NN\1740| (r_nsubj) prevents_9\VBZ\1740|that|fisetin|obesity|regulation (l_nmod) regulation_13\NN\6652242|through|signaling (l_nmod) signaling_16\NN\33020|of|the|target (l_nmod) target_19\NN\7258332|of|mammalian|complex (l_nmod) complex_22\NN\5869584|of|rapamycin|1|mtorc1|,|mediator (l_appos) mtorc1_25\NN\1740|(|)
23517912T13_23517912T28 NONE rapamycin_21\NN\1740| (r_compound) complex_22\NN\5869584|of|rapamycin|1|mtorc1|,|mediator (l_nummod) 1_23\CD\13741022|
23517912T13_23517912T29 NONE rapamycin_21\NN\1740| (r_compound) complex_22\NN\5869584|of|rapamycin|1|mtorc1|,|mediator (l_appos) mtorc1_25\NN\1740|(|)
23517912T14_23517912T30 NONE fisetin_3\NN\1740| (r_nsubj) regulates_4\VBZ\296178|whether|fisetin|signaling (l_dobj) signaling_6\NN\33020|mtorc1 (l_compound) mtorc1_5\NN\1740|
23517912T14_23517912T31 NONE fisetin_3\NN\1740| (r_nsubj) regulates_4\VBZ\296178|whether|fisetin|signaling (r_ccomp) evaluate_1\VB\670261|to|regulates (r_advcl) investigated_9\VBD\644583|evaluate|,|we|phosphorylation|. (l_dobj) phosphorylation_11\NN\1740|the|and|activity|kinase (l_conj) activity_14\NN\30358|kinase (l_compound) kinase_13\NN\14732946|
23517912T14_23517912T32 NONE fisetin_3\NN\1740| (r_nsubj) regulates_4\VBZ\296178|whether|fisetin|signaling (r_ccomp) evaluate_1\VB\670261|to|regulates (r_advcl) investigated_9\VBD\644583|evaluate|,|we|phosphorylation|. (l_dobj) phosphorylation_11\NN\1740|the|and|activity|kinase (l_nmod) kinase_21\NN\14732946|of|the|70-kda|ribosomal|protein|s6|1|s6k1|and|mtorc1|preadipocytes (l_nummod) 1_22\CD\13741022|
23517912T14_23517912T33 NONE fisetin_3\NN\1740| (r_nsubj) regulates_4\VBZ\296178|whether|fisetin|signaling (r_ccomp) evaluate_1\VB\670261|to|regulates (r_advcl) investigated_9\VBD\644583|evaluate|,|we|phosphorylation|. (l_dobj) phosphorylation_11\NN\1740|the|and|activity|kinase (l_nmod) kinase_21\NN\14732946|of|the|70-kda|ribosomal|protein|s6|1|s6k1|and|mtorc1|preadipocytes (l_appos) s6k1_24\NN\1740|(|)
23517912T14_23517912T34 NONE fisetin_3\NN\1740| (r_nsubj) regulates_4\VBZ\296178|whether|fisetin|signaling (r_ccomp) evaluate_1\VB\670261|to|regulates (r_advcl) investigated_9\VBD\644583|evaluate|,|we|phosphorylation|. (l_dobj) phosphorylation_11\NN\1740|the|and|activity|kinase (l_nmod) kinase_21\NN\14732946|of|the|70-kda|ribosomal|protein|s6|1|s6k1|and|mtorc1|preadipocytes (l_conj) mtorc1_27\NN\1740|
23517912T15_23517912T35 CPR:4 fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin|preadipocytes (r_nsubj) reduced_4\VBD\441445|treatment|phosphorylation|manner|. (l_dobj) phosphorylation_6\NN\1740|the|s6k1 (l_nmod) s6k1_8\NN\1740|of|and|mtorc1
23517912T15_23517912T36 CPR:4 fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin|preadipocytes (r_nsubj) reduced_4\VBD\441445|treatment|phosphorylation|manner|. (l_dobj) phosphorylation_6\NN\1740|the|s6k1 (l_nmod) s6k1_8\NN\1740|of|and|mtorc1 (l_conj) mtorc1_10\NN\1740|
23517912T16_23517912T37 CPR:4 fisetin_6\NN\1740| (r_nsubj) regulates_8\VBZ\296178|of|how|fisetin|negatively|signaling (l_dobj) signaling_10\NN\33020|mtorc1 (l_compound) mtorc1_9\NN\1740|
23517912T16_23517912T38 NONE fisetin_6\NN\1740| (r_nsubj) regulates_8\VBZ\296178|of|how|fisetin|negatively|signaling (r_acl) understanding_3\NN\5804793|our|regulates (r_dobj) further_1\VB\2554922|to|understanding (r_advcl) analyzed_13\VBD\78760|further|,|we|phosphorylation|. (l_dobj) phosphorylation_15\NN\1740|the|s6k1|cells (l_nmod) s6k1_17\NN\1740|of|,|mtor|and|akt
23517912T16_23517912T39 NONE fisetin_6\NN\1740| (r_nsubj) regulates_8\VBZ\296178|of|how|fisetin|negatively|signaling (r_acl) understanding_3\NN\5804793|our|regulates (r_dobj) further_1\VB\2554922|to|understanding (r_advcl) analyzed_13\VBD\78760|further|,|we|phosphorylation|. (l_dobj) phosphorylation_15\NN\1740|the|s6k1|cells (l_nmod) s6k1_17\NN\1740|of|,|mtor|and|akt (l_conj) mtor_19\NN\1740|
23517912T16_23517912T40 NONE fisetin_6\NN\1740| (r_nsubj) regulates_8\VBZ\296178|of|how|fisetin|negatively|signaling (r_acl) understanding_3\NN\5804793|our|regulates (r_dobj) further_1\VB\2554922|to|understanding (r_advcl) analyzed_13\VBD\78760|further|,|we|phosphorylation|. (l_dobj) phosphorylation_15\NN\1740|the|s6k1|cells (l_nmod) s6k1_17\NN\1740|of|,|mtor|and|akt (l_conj) akt_21\NN\1740|
23517912T16_23517912T41 NONE fisetin_6\NN\1740| (r_nsubj) regulates_8\VBZ\296178|of|how|fisetin|negatively|signaling (r_acl) understanding_3\NN\5804793|our|regulates (r_dobj) further_1\VB\2554922|to|understanding (r_advcl) analyzed_13\VBD\78760|further|,|we|phosphorylation|. (l_dobj) phosphorylation_15\NN\1740|the|s6k1|cells (l_nmod) cells_25\NNS\3080309|in|fisetin-treated|tsc2-knockdown (l_amod) tsc2-knockdown_24\JJ\1740|
23517912T17_23517912T37 NONE fisetin-treated_23\JJ\1740| (r_amod) cells_25\NNS\3080309|in|fisetin-treated|tsc2-knockdown (r_nmod) phosphorylation_15\NN\1740|the|s6k1|cells (r_dobj) analyzed_13\VBD\78760|further|,|we|phosphorylation|. (l_advcl) further_1\VB\2554922|to|understanding (l_dobj) understanding_3\NN\5804793|our|regulates (l_acl) regulates_8\VBZ\296178|of|how|fisetin|negatively|signaling (l_dobj) signaling_10\NN\33020|mtorc1 (l_compound) mtorc1_9\NN\1740|
23517912T17_23517912T38 NONE fisetin-treated_23\JJ\1740| (r_amod) cells_25\NNS\3080309|in|fisetin-treated|tsc2-knockdown (r_nmod) phosphorylation_15\NN\1740|the|s6k1|cells (l_nmod) s6k1_17\NN\1740|of|,|mtor|and|akt
23517912T17_23517912T39 NONE fisetin-treated_23\JJ\1740| (r_amod) cells_25\NNS\3080309|in|fisetin-treated|tsc2-knockdown (r_nmod) phosphorylation_15\NN\1740|the|s6k1|cells (l_nmod) s6k1_17\NN\1740|of|,|mtor|and|akt (l_conj) mtor_19\NN\1740|
23517912T17_23517912T40 NONE fisetin-treated_23\JJ\1740| (r_amod) cells_25\NNS\3080309|in|fisetin-treated|tsc2-knockdown (r_nmod) phosphorylation_15\NN\1740|the|s6k1|cells (l_nmod) s6k1_17\NN\1740|of|,|mtor|and|akt (l_conj) akt_21\NN\1740|
23517912T17_23517912T41 NONE fisetin-treated_23\JJ\1740| (r_amod) cells_25\NNS\3080309|in|fisetin-treated|tsc2-knockdown (l_amod) tsc2-knockdown_24\JJ\1740|
23517912T18_23517912T42 CPR:4 fisetin_4\NN\1740| (r_compound) treatment_5\NN\654885|fisetin (r_nsubj) inhibits_6\VBZ\2510337|that|treatment|activity|manner (l_dobj) activity_8\NN\30358|mtorc1 (l_compound) mtorc1_7\NN\1740|
23517912T18_23517912T43 CPR:4 fisetin_4\NN\1740| (r_compound) treatment_5\NN\654885|fisetin (r_nsubj) inhibits_6\VBZ\2510337|that|treatment|activity|manner (l_nmod) manner_12\NN\4916342|in|an|akt-dependent (l_amod) akt-dependent_11\JJ\1740|
23517912T2_23517912T21 NONE fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin (r_nsubj) inhibited_2\VBD\2510337|treatment|differentiation|,|consistent|. (l_advmod) consistent_6\JJ\1740|effect (l_nmod) effect_10\NN\34213|with|the|negative|fisetin|mtor (l_nmod) mtor_14\NN\1740|on
23517912T4_23517912T21 CPR:4 fisetin_12\NN\1740|of (r_nmod) effect_10\NN\34213|with|the|negative|fisetin|mtor (l_nmod) mtor_14\NN\1740|on
23517912T5_23517912T22 NONE fisetin_4\NN\1740|of (r_nmod) effect_2\NN\34213|the|inhibitory|fisetin|adipogenesis (r_nsubj) dependent_8\JJ\1740|effect|is|activity|,|suggesting|. (l_nmod) activity_11\NN\30358|of|mtor (l_compound) mtor_10\NN\1740|
23517912T5_23517912T23 NONE fisetin_4\NN\1740|of (r_nmod) effect_2\NN\34213|the|inhibitory|fisetin|adipogenesis (r_nsubj) dependent_8\JJ\1740|effect|is|activity|,|suggesting|. (l_advcl) suggesting_13\VBG\1010118|inhibits (l_ccomp) inhibits_16\VBZ\2510337|that|fisetin|adipogenesis|differentiation|targeting (l_advcl) targeting_28\VBG\1151110|by|signaling (l_dobj) signaling_30\NN\33020|mtorc1 (l_compound) mtorc1_29\NN\1740|
23517912T6_23517912T22 NONE fisetin_15\NN\1740| (r_nsubj) inhibits_16\VBZ\2510337|that|fisetin|adipogenesis|differentiation|targeting (r_ccomp) suggesting_13\VBG\1010118|inhibits (r_advcl) dependent_8\JJ\1740|effect|is|activity|,|suggesting|. (l_nmod) activity_11\NN\30358|of|mtor (l_compound) mtor_10\NN\1740|
23517912T6_23517912T23 NONE fisetin_15\NN\1740| (r_nsubj) inhibits_16\VBZ\2510337|that|fisetin|adipogenesis|differentiation|targeting (l_advcl) targeting_28\VBG\1151110|by|signaling (l_dobj) signaling_30\NN\33020|mtorc1 (l_compound) mtorc1_29\NN\1740|
23517912T7_23517912T22 NONE triglycerides_23\NNS\14885088|of|intracellular (r_nmod) accumulation_20\NN\13497135|the|triglycerides (r_conj) adipogenesis_17\NN\1740|and|accumulation (r_dobj) inhibits_16\VBZ\2510337|that|fisetin|adipogenesis|differentiation|targeting (r_ccomp) suggesting_13\VBG\1010118|inhibits (r_advcl) dependent_8\JJ\1740|effect|is|activity|,|suggesting|. (l_nmod) activity_11\NN\30358|of|mtor (l_compound) mtor_10\NN\1740|
23517912T7_23517912T23 NONE triglycerides_23\NNS\14885088|of|intracellular (r_nmod) accumulation_20\NN\13497135|the|triglycerides (r_conj) adipogenesis_17\NN\1740|and|accumulation (r_dobj) inhibits_16\VBZ\2510337|that|fisetin|adipogenesis|differentiation|targeting (l_advcl) targeting_28\VBG\1151110|by|signaling (l_dobj) signaling_30\NN\33020|mtorc1 (l_compound) mtorc1_29\NN\1740|
23517912T10_23517912T24 CPR:4 fisetin_4\NN\1740| (r_nsubj) suppressed_6\VBD\2510337|that|fisetin|efficiently|phosphorylation (l_dobj) phosphorylation_8\NN\1740|the|akt (l_nmod) akt_10\NN\1740|of|,|s6k1|and|mtorc1|tissue
23517912T10_23517912T25 CPR:4 fisetin_4\NN\1740| (r_nsubj) suppressed_6\VBD\2510337|that|fisetin|efficiently|phosphorylation (l_dobj) phosphorylation_8\NN\1740|the|akt (l_nmod) akt_10\NN\1740|of|,|s6k1|and|mtorc1|tissue (l_conj) s6k1_12\NN\1740|
23517912T10_23517912T26 CPR:4 fisetin_4\NN\1740| (r_nsubj) suppressed_6\VBD\2510337|that|fisetin|efficiently|phosphorylation (l_dobj) phosphorylation_8\NN\1740|the|akt (l_nmod) akt_10\NN\1740|of|,|s6k1|and|mtorc1|tissue (l_conj) mtorc1_14\NN\1740|
23517912T11_23517912T27 CPR:4 fisetin_11\NN\1740|by (r_nmod) inhibition_6\NN\1068773|signaling|fisetin (l_nmod) signaling_9\NN\33020|of|mtorc1 (l_compound) mtorc1_8\NN\1740|
23511897
23511897T9_23511897T32 NONE cholesterol_7\NN\15058310|of (r_nmod) source_5\NN\8620061|as|a|cholesterol|steroidogenesis (r_nmod) lipoprotein_2\NN\14731135|high|density|source|:|study
23511897T9_23511897T33 NONE cholesterol_7\NN\15058310|of (r_nmod) source_5\NN\8620061|as|a|cholesterol|steroidogenesis (r_nmod) lipoprotein_2\NN\14731135|high|density|source|:|study (l_dep) study_13\NN\635850|a|individuals (l_nmod) individuals_15\NNS\7347|in|hdl-c. (l_nmod) hdl-c._19\NN\1740|with|low|plasma
23511897T6_23511897T17 NONE cholesterol_8\NN\15058310|of|lipoprotein-derived (l_amod) lipoprotein-derived_7\JJ\1740|
23511897T8_23511897T17 NONE steroid_13\NN\14727670| (r_compound) production_14\NN\30358|for|steroid|humans (r_nmod) delivery_5\NN\315986|the|cholesterol|adrenals|production (l_nmod) cholesterol_8\NN\15058310|of|lipoprotein-derived (l_amod) lipoprotein-derived_7\JJ\1740|
23511897T2_23511897T16 NONE hormone_5\NN\5404728| (r_compound) profiles_6\NNS\6999802|steroid|hormone|urine (r_nsubjpass) assessed_10\VBN\670261|study|profiles|were|subjects|. (l_nmod) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_acl) suffering_14\VBG\2110220|mutations (l_nmod) mutations_17\NNS\4475|from|functional|a1 (l_nmod) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|,
23511897T2_23511897T18 NONE hormone_5\NN\5404728| (r_compound) profiles_6\NNS\6999802|steroid|hormone|urine (r_nsubjpass) assessed_10\VBN\670261|study|profiles|were|subjects|. (l_nmod) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_acl) suffering_14\VBG\2110220|mutations (l_nmod) mutations_17\NNS\4475|from|functional|a1 (l_nmod) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_appos) abca1_25\NN\1740|(|)
23511897T2_23511897T19 NONE hormone_5\NN\5404728| (r_compound) profiles_6\NNS\6999802|steroid|hormone|urine (r_nsubjpass) assessed_10\VBN\670261|study|profiles|were|subjects|. (l_nmod) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_acl) suffering_14\VBG\2110220|mutations (l_nmod) mutations_17\NNS\4475|from|functional|a1 (l_nmod) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_conj) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|=
23511897T2_23511897T20 NONE hormone_5\NN\5404728| (r_compound) profiles_6\NNS\6999802|steroid|hormone|urine (r_nsubjpass) assessed_10\VBN\670261|study|profiles|were|subjects|. (l_nmod) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_acl) suffering_14\VBG\2110220|mutations (l_nmod) mutations_17\NNS\4475|from|functional|a1 (l_nmod) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_conj) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (l_appos) lcat_38\NN\1740|(|)
23511897T2_23511897T21 NONE hormone_5\NN\5404728| (r_compound) profiles_6\NNS\6999802|steroid|hormone|urine (r_nsubjpass) assessed_10\VBN\670261|study|profiles|were|subjects|. (l_nmod) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_compound) hdl_54\NN\14939230|
23511897T2_23511897T22 NONE hormone_5\NN\5404728| (r_compound) profiles_6\NNS\6999802|steroid|hormone|urine (r_nsubjpass) assessed_10\VBN\670261|study|profiles|were|subjects|. (l_nmod) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_appos) hdl-c_57\NN\1740|(|)
23511897T2_23511897T23 NONE hormone_5\NN\5404728| (r_compound) profiles_6\NNS\6999802|steroid|hormone|urine (r_nsubjpass) assessed_10\VBN\670261|study|profiles|were|subjects|. (l_nmod) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_nmod) mutations_61\NNS\4475|without|abca1/lcat (l_compound) abca1/lcat_60\NN\1740|
23511897T2_23511897T24 NONE hormone_5\NN\5404728| (r_compound) profiles_6\NNS\6999802|steroid|hormone|urine (r_nsubjpass) assessed_10\VBN\670261|study|profiles|were|subjects|. (l_nmod) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_nmod) mutations_61\NNS\4475|without|abca1/lcat (l_compound) abca1/lcat_60\NN\1740|
23511897T3_23511897T16 NONE atp_19\NN\14964590| (r_compound) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|,
23511897T3_23511897T18 NONE atp_19\NN\14964590| (r_compound) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_appos) abca1_25\NN\1740|(|)
23511897T3_23511897T19 NONE atp_19\NN\14964590| (r_compound) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_conj) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|=
23511897T3_23511897T20 NONE atp_19\NN\14964590| (r_compound) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_conj) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (l_appos) lcat_38\NN\1740|(|)
23511897T3_23511897T21 NONE atp_19\NN\14964590| (r_compound) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (r_nmod) mutations_17\NNS\4475|from|functional|a1 (r_nmod) suffering_14\VBG\2110220|mutations (r_acl) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_compound) hdl_54\NN\14939230|
23511897T3_23511897T22 NONE atp_19\NN\14964590| (r_compound) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (r_nmod) mutations_17\NNS\4475|from|functional|a1 (r_nmod) suffering_14\VBG\2110220|mutations (r_acl) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_appos) hdl-c_57\NN\1740|(|)
23511897T3_23511897T23 NONE atp_19\NN\14964590| (r_compound) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (r_nmod) mutations_17\NNS\4475|from|functional|a1 (r_nmod) suffering_14\VBG\2110220|mutations (r_acl) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_nmod) mutations_61\NNS\4475|without|abca1/lcat (l_compound) abca1/lcat_60\NN\1740|
23511897T3_23511897T24 NONE atp_19\NN\14964590| (r_compound) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (r_nmod) mutations_17\NNS\4475|from|functional|a1 (r_nmod) suffering_14\VBG\2110220|mutations (r_acl) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_nmod) mutations_61\NNS\4475|without|abca1/lcat (l_compound) abca1/lcat_60\NN\1740|
23511897T4_23511897T16 NONE cholesterol_35\NN\15058310| (r_compound) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (r_conj) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|,
23511897T4_23511897T18 NONE cholesterol_35\NN\15058310| (r_compound) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (r_conj) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_appos) abca1_25\NN\1740|(|)
23511897T4_23511897T19 NONE cholesterol_35\NN\15058310| (r_compound) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|=
23511897T4_23511897T20 NONE cholesterol_35\NN\15058310| (r_compound) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (l_appos) lcat_38\NN\1740|(|)
23511897T4_23511897T21 NONE cholesterol_35\NN\15058310| (r_compound) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (r_conj) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (r_nmod) mutations_17\NNS\4475|from|functional|a1 (r_nmod) suffering_14\VBG\2110220|mutations (r_acl) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_compound) hdl_54\NN\14939230|
23511897T4_23511897T22 NONE cholesterol_35\NN\15058310| (r_compound) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (r_conj) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (r_nmod) mutations_17\NNS\4475|from|functional|a1 (r_nmod) suffering_14\VBG\2110220|mutations (r_acl) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_appos) hdl-c_57\NN\1740|(|)
23511897T4_23511897T23 NONE cholesterol_35\NN\15058310| (r_compound) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (r_conj) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (r_nmod) mutations_17\NNS\4475|from|functional|a1 (r_nmod) suffering_14\VBG\2110220|mutations (r_acl) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_nmod) mutations_61\NNS\4475|without|abca1/lcat (l_compound) abca1/lcat_60\NN\1740|
23511897T4_23511897T24 NONE cholesterol_35\NN\15058310| (r_compound) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (r_conj) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (r_nmod) mutations_17\NNS\4475|from|functional|a1 (r_nmod) suffering_14\VBG\2110220|mutations (r_acl) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_conj) subjects_51\NNS\6598915|in|11|cholesterol (l_nmod) cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_nmod) mutations_61\NNS\4475|without|abca1/lcat (l_compound) abca1/lcat_60\NN\1740|
23511897T5_23511897T16 NONE cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (r_nmod) subjects_51\NNS\6598915|in|11|cholesterol (r_conj) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_acl) suffering_14\VBG\2110220|mutations (l_nmod) mutations_17\NNS\4475|from|functional|a1 (l_nmod) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|,
23511897T5_23511897T18 NONE cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (r_nmod) subjects_51\NNS\6598915|in|11|cholesterol (r_conj) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_acl) suffering_14\VBG\2110220|mutations (l_nmod) mutations_17\NNS\4475|from|functional|a1 (l_nmod) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_appos) abca1_25\NN\1740|(|)
23511897T5_23511897T19 NONE cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (r_nmod) subjects_51\NNS\6598915|in|11|cholesterol (r_conj) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_acl) suffering_14\VBG\2110220|mutations (l_nmod) mutations_17\NNS\4475|from|functional|a1 (l_nmod) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_conj) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|=
23511897T5_23511897T20 NONE cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (r_nmod) subjects_51\NNS\6598915|in|11|cholesterol (r_conj) subjects_13\NNS\6598915|in|male|suffering|as|subjects (l_acl) suffering_14\VBG\2110220|mutations (l_nmod) mutations_17\NNS\4475|from|functional|a1 (l_nmod) a1_23\NN\1740|in|atp|binding|cassette|transporter|abca1|=|,|acyltransferase|, (l_conj) acyltransferase_36\NN\1740|lecithin|:|cholesterol|lcat|= (l_appos) lcat_38\NN\1740|(|)
23511897T5_23511897T21 NONE cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_compound) hdl_54\NN\14939230|
23511897T5_23511897T22 NONE cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_appos) hdl-c_57\NN\1740|(|)
23511897T5_23511897T23 NONE cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_nmod) mutations_61\NNS\4475|without|abca1/lcat (l_compound) abca1/lcat_60\NN\1740|
23511897T5_23511897T24 NONE cholesterol_55\NN\15058310|with|low|hdl|hdl-c|mutations (l_nmod) mutations_61\NNS\4475|without|abca1/lcat (l_compound) abca1/lcat_60\NN\1740|
23511897T7_23511897T29 NONE steroids_12\NNS\14727670|of|17-ketogenic (r_nmod) excretion_9\NN\13466586|urinary|steroids (r_nsubjpass) reduced_14\VBN\441445|groups|,|excretion|was|%|controls|. (l_nmod) groups_2\NNS\2137|in|all|levels (l_nmod) levels_6\NNS\4916342|with|low|hdl-c (l_compound) hdl-c_5\NN\1740|
23511897T1_23511897T11 NONE cholesterol_11\NN\15058310| (r_compound) donor_12\NN\9608709|as|a|cholesterol|steroidogenesis (r_nmod) role_6\NN\719494|to|a|hdl|donor (l_nmod) hdl_8\NN\14939230|for
15953344
15953344T10_15953344T23 NONE monocarboxylate_0\NN\1740| (r_compound) transporters_1\NNS\4490091|monocarboxylate|system|:|distribution
15953344T1_15953344T11 NONE monocarboxylate_0\NN\1740| (r_compound) transporters_1\NNS\4490091|monocarboxylate|mcts
15953344T1_15953344T14 NONE monocarboxylate_0\NN\1740| (r_compound) transporters_1\NNS\4490091|monocarboxylate|mcts (l_appos) mcts_3\NNS\1740|(|)
15953344T2_15953344T11 CPR:9 monocarboxylates_14\NNS\1740|of|lactate (r_nmod) transport_12\NN\3575240|in|the|monocarboxylates (r_nmod) involved_9\VBN\2676054|transport (r_acl) carriers_8\NNS\9629752|transporters|are|proton-linked|membrane|involved|. (l_nsubj) transporters_1\NNS\4490091|monocarboxylate|mcts
15953344T2_15953344T14 CPR:9 monocarboxylates_14\NNS\1740|of|lactate (r_nmod) transport_12\NN\3575240|in|the|monocarboxylates (r_nmod) involved_9\VBN\2676054|transport (r_acl) carriers_8\NNS\9629752|transporters|are|proton-linked|membrane|involved|. (l_nsubj) transporters_1\NNS\4490091|monocarboxylate|mcts (l_appos) mcts_3\NNS\1740|(|)
15953344T4_15953344T11 CPR:9 lactate_17\NN\14850483|such|,|pyruvate|,|as|bodies (r_nmod) monocarboxylates_14\NNS\1740|of|lactate (r_nmod) transport_12\NN\3575240|in|the|monocarboxylates (r_nmod) involved_9\VBN\2676054|transport (r_acl) carriers_8\NNS\9629752|transporters|are|proton-linked|membrane|involved|. (l_nsubj) transporters_1\NNS\4490091|monocarboxylate|mcts
15953344T4_15953344T14 CPR:9 lactate_17\NN\14850483|such|,|pyruvate|,|as|bodies (r_nmod) monocarboxylates_14\NNS\1740|of|lactate (r_nmod) transport_12\NN\3575240|in|the|monocarboxylates (r_nmod) involved_9\VBN\2676054|transport (r_acl) carriers_8\NNS\9629752|transporters|are|proton-linked|membrane|involved|. (l_nsubj) transporters_1\NNS\4490091|monocarboxylate|mcts (l_appos) mcts_3\NNS\1740|(|)
15953344T6_15953344T11 CPR:9 pyruvate_19\NN\1740| (r_conj) lactate_17\NN\14850483|such|,|pyruvate|,|as|bodies (r_nmod) monocarboxylates_14\NNS\1740|of|lactate (r_nmod) transport_12\NN\3575240|in|the|monocarboxylates (r_nmod) involved_9\VBN\2676054|transport (r_acl) carriers_8\NNS\9629752|transporters|are|proton-linked|membrane|involved|. (l_nsubj) transporters_1\NNS\4490091|monocarboxylate|mcts
15953344T6_15953344T14 CPR:9 pyruvate_19\NN\1740| (r_conj) lactate_17\NN\14850483|such|,|pyruvate|,|as|bodies (r_nmod) monocarboxylates_14\NNS\1740|of|lactate (r_nmod) transport_12\NN\3575240|in|the|monocarboxylates (r_nmod) involved_9\VBN\2676054|transport (r_acl) carriers_8\NNS\9629752|transporters|are|proton-linked|membrane|involved|. (l_nsubj) transporters_1\NNS\4490091|monocarboxylate|mcts (l_appos) mcts_3\NNS\1740|(|)
15953344T7_15953344T11 CPR:9 ketone_24\NN\14727670| (r_compound) bodies_25\NNS\19128|ketone (r_conj) lactate_17\NN\14850483|such|,|pyruvate|,|as|bodies (r_nmod) monocarboxylates_14\NNS\1740|of|lactate (r_nmod) transport_12\NN\3575240|in|the|monocarboxylates (r_nmod) involved_9\VBN\2676054|transport (r_acl) carriers_8\NNS\9629752|transporters|are|proton-linked|membrane|involved|. (l_nsubj) transporters_1\NNS\4490091|monocarboxylate|mcts
15953344T7_15953344T14 CPR:9 ketone_24\NN\14727670| (r_compound) bodies_25\NNS\19128|ketone (r_conj) lactate_17\NN\14850483|such|,|pyruvate|,|as|bodies (r_nmod) monocarboxylates_14\NNS\1740|of|lactate (r_nmod) transport_12\NN\3575240|in|the|monocarboxylates (r_nmod) involved_9\VBN\2676054|transport (r_acl) carriers_8\NNS\9629752|transporters|are|proton-linked|membrane|involved|. (l_nsubj) transporters_1\NNS\4490091|monocarboxylate|mcts (l_appos) mcts_3\NNS\1740|(|)
15953344T8_15953344T20 NONE monocarboxylate_6\NN\1740| (r_compound) transporter_7\NN\4490091|the|predominant|neuronal|monocarboxylate
15953344T8_15953344T21 NONE monocarboxylate_6\NN\1740| (r_compound) transporter_7\NN\4490091|the|predominant|neuronal|monocarboxylate (r_nsubj) mct2_9\NN\1740|contrast|,|transporter|is|.
15953344T9_15953344T22 CPR:9 monocarboxylates_17\NNS\1740|of|and|transporters (r_nmod) role_15\NN\719494|a|particular|monocarboxylates|transmission (r_dobj) suggesting_12\VBG\1010118|role (r_advcl) located_7\JJ\1740|interestingly|,|part|is|sites|,|suggesting|. (l_nsubj) part_2\NN\31921|immunoreactivity (l_nmod) immunoreactivity_5\NN\1740|of|mct2 (l_compound) mct2_4\NN\1740|
23085085
23085085T1_23085085T3 NONE acetyl_12\NN\14594708| (r_compound) groups_13\NNS\2137|acetyl (r_dobj) removes_11\VBZ\2012344|that|groups|residues|regulate (r_acl:relcl) enzyme_9\NN\14723628|deacetylase|is|a|nuclear|removes|. (l_nsubj) deacetylase_1\NN\1740|histone|3|hdac3 (l_nummod) 3_2\CD\13741022|
23085085T1_23085085T4 NONE acetyl_12\NN\14594708| (r_compound) groups_13\NNS\2137|acetyl (r_dobj) removes_11\VBZ\2012344|that|groups|residues|regulate (l_nmod) residues_16\NNS\20827|from|lysine|histones (l_nmod) histones_18\NNS\14736972|in|and|proteins
23085085T1_23085085T7 NONE acetyl_12\NN\14594708| (r_compound) groups_13\NNS\2137|acetyl (r_dobj) removes_11\VBZ\2012344|that|groups|residues|regulate (r_acl:relcl) enzyme_9\NN\14723628|deacetylase|is|a|nuclear|removes|. (l_nsubj) deacetylase_1\NN\1740|histone|3|hdac3 (l_appos) hdac3_4\NN\1740|(|)
23085085T2_23085085T3 NONE lysine_15\NN\14605787| (r_compound) residues_16\NNS\20827|from|lysine|histones (r_nmod) removes_11\VBZ\2012344|that|groups|residues|regulate (r_acl:relcl) enzyme_9\NN\14723628|deacetylase|is|a|nuclear|removes|. (l_nsubj) deacetylase_1\NN\1740|histone|3|hdac3 (l_nummod) 3_2\CD\13741022|
23085085T2_23085085T4 NONE lysine_15\NN\14605787| (r_compound) residues_16\NNS\20827|from|lysine|histones (l_nmod) histones_18\NNS\14736972|in|and|proteins
23085085T2_23085085T7 NONE lysine_15\NN\14605787| (r_compound) residues_16\NNS\20827|from|lysine|histones (r_nmod) removes_11\VBZ\2012344|that|groups|residues|regulate (r_acl:relcl) enzyme_9\NN\14723628|deacetylase|is|a|nuclear|removes|. (l_nsubj) deacetylase_1\NN\1740|histone|3|hdac3 (l_appos) hdac3_4\NN\1740|(|)
23534412
23534412T2_23534412T9 NONE epinephrine-induced_14\JJ\1740| (r_conj) collagen-_12\NN\1740|and|epinephrine-induced
23534412T3_23534412T9 NONE acid-induced_23\JJ\1740| (r_amod) death_24\NN\7296428|against|arachidonic|acid-induced|mice (r_nmod) protection_20\NN\407535|%|death (r_conj) protection_10\NN\407535|%|thromboembolism|and|protection (l_nmod) thromboembolism_16\NN\14100769|against|collagen-|pulmonary (l_amod) collagen-_12\NN\1740|and|epinephrine-induced
23534412T5_23534412T10 NONE adp_6\NN\14964590|and|aggregation (l_conj) aggregation_10\NN\31264|collagen-induced|platelet (l_amod) collagen-induced_8\JJ\1740|
23534412T6_23534412T11 NONE adp_9\NN\14964590|to|and|collagen (l_conj) collagen_11\NN\15026716|
23578689
10947967
10947967T1_10947967T12 NONE c-terminal_0\JJ\1740| (r_amod) amidation_1\NN\1740|c-terminal|,|modification|, (r_nsubj) entails_14\VBZ\2635547|amidation|action|. (l_dobj) action_17\NN\30358|sequential|enzymic|alpha-mono-oxygenase (l_nmod) alpha-mono-oxygenase_20\NN\1740|by|peptidylglycine|pam|and|lyase
10947967T1_10947967T15 NONE c-terminal_0\JJ\1740| (r_amod) amidation_1\NN\1740|c-terminal|,|modification|, (r_nsubj) entails_14\VBZ\2635547|amidation|action|. (l_dobj) action_17\NN\30358|sequential|enzymic|alpha-mono-oxygenase (l_nmod) alpha-mono-oxygenase_20\NN\1740|by|peptidylglycine|pam|and|lyase (l_appos) pam_22\NN\1740|(|,|ec|)
10947967T1_10947967T16 NONE c-terminal_0\JJ\1740| (r_amod) amidation_1\NN\1740|c-terminal|,|modification|, (r_nsubj) entails_14\VBZ\2635547|amidation|action|. (l_dobj) action_17\NN\30358|sequential|enzymic|alpha-mono-oxygenase (l_nmod) alpha-mono-oxygenase_20\NN\1740|by|peptidylglycine|pam|and|lyase (l_appos) pam_22\NN\1740|(|,|ec|) (l_appos) ec_24\NN\8294696|1.14.17.3 (l_nummod) 1.14.17.3_25\CD\1740|
10947967T1_10947967T17 NONE c-terminal_0\JJ\1740| (r_amod) amidation_1\NN\1740|c-terminal|,|modification|, (r_nsubj) entails_14\VBZ\2635547|amidation|action|. (l_dobj) action_17\NN\30358|sequential|enzymic|alpha-mono-oxygenase (l_nmod) alpha-mono-oxygenase_20\NN\1740|by|peptidylglycine|pam|and|lyase (l_conj) lyase_29\NN\1740|peptidylamidoglycolate|pgl
10947967T1_10947967T18 NONE c-terminal_0\JJ\1740| (r_amod) amidation_1\NN\1740|c-terminal|,|modification|, (r_nsubj) entails_14\VBZ\2635547|amidation|action|. (l_dobj) action_17\NN\30358|sequential|enzymic|alpha-mono-oxygenase (l_nmod) alpha-mono-oxygenase_20\NN\1740|by|peptidylglycine|pam|and|lyase (l_conj) lyase_29\NN\1740|peptidylamidoglycolate|pgl (l_appos) pgl_31\NN\1740|(|,|ec|)
10947967T1_10947967T19 NONE c-terminal_0\JJ\1740| (r_amod) amidation_1\NN\1740|c-terminal|,|modification|, (r_nsubj) entails_14\VBZ\2635547|amidation|action|. (l_dobj) action_17\NN\30358|sequential|enzymic|alpha-mono-oxygenase (l_nmod) alpha-mono-oxygenase_20\NN\1740|by|peptidylglycine|pam|and|lyase (l_conj) lyase_29\NN\1740|peptidylamidoglycolate|pgl (l_appos) pgl_31\NN\1740|(|,|ec|) (l_appos) ec_33\NN\8294696|4.3.2.5 (l_nummod) 4.3.2.5_34\CD\1740|
10947967T8_10947967T21 CPR:4 acid_10\NN\14818238|4-oxo-5-acetamido-6-(2-thienyl)-hex-2-enoic (r_conj) acid_7\NN\14818238|by|4-oxo-5-acetamido-6-phenyl-hex-2-enoic|and|acid (r_nmod) inactivation_4\NN\13518963|for|pam|acid (l_compound) pam_3\NN\1740|
10947967T3_10947967T11 CPR:4 acid_8\NN\14818238|by|4-oxo-5-acetamido-6-(2-thienyl)-hex-2-enoic (r_nmod) inactivation_5\NN\13518963|pam|acid (l_compound) pam_4\NN\1740|
10947967T4_10947967T13 CPR:4 acid_6\NN\14818238|2|,|4-dioxo-5-acetamido-6-phenylhexanoic|,|inhibitor|, (r_nsubj) exhibits_18\VBZ\2632167|contrast|,|acid|degree|binding|. (l_nmod) binding_25\NN\4688246|in|sites (l_nmod) sites_29\NNS\8673395|to|the|ascorbate|pam (l_nmod) pam_32\NNS\1740|of|both|and|dopamine-beta-hydroxylase
10947967T4_10947967T14 CPR:4 acid_6\NN\14818238|2|,|4-dioxo-5-acetamido-6-phenylhexanoic|,|inhibitor|, (r_nsubj) exhibits_18\VBZ\2632167|contrast|,|acid|degree|binding|. (l_nmod) binding_25\NN\4688246|in|sites (l_nmod) sites_29\NNS\8673395|to|the|ascorbate|pam (l_nmod) pam_32\NNS\1740|of|both|and|dopamine-beta-hydroxylase (l_conj) dopamine-beta-hydroxylase_34\NN\1740|
10947967T5_10947967T13 NONE ascorbate_16\NN\1740|to (r_nmod) respect_14\NN\5817845|with|ascorbate (r_nmod) inhibitor_12\NN\20090|which|is|a|competitive|respect (r_acl:relcl) acid_6\NN\14818238|2|,|4-dioxo-5-acetamido-6-phenylhexanoic|,|inhibitor|, (r_nsubj) exhibits_18\VBZ\2632167|contrast|,|acid|degree|binding|. (l_nmod) binding_25\NN\4688246|in|sites (l_nmod) sites_29\NNS\8673395|to|the|ascorbate|pam (l_nmod) pam_32\NNS\1740|of|both|and|dopamine-beta-hydroxylase
10947967T5_10947967T14 NONE ascorbate_16\NN\1740|to (r_nmod) respect_14\NN\5817845|with|ascorbate (r_nmod) inhibitor_12\NN\20090|which|is|a|competitive|respect (r_acl:relcl) acid_6\NN\14818238|2|,|4-dioxo-5-acetamido-6-phenylhexanoic|,|inhibitor|, (r_nsubj) exhibits_18\VBZ\2632167|contrast|,|acid|degree|binding|. (l_nmod) binding_25\NN\4688246|in|sites (l_nmod) sites_29\NNS\8673395|to|the|ascorbate|pam (l_nmod) pam_32\NNS\1740|of|both|and|dopamine-beta-hydroxylase (l_conj) dopamine-beta-hydroxylase_34\NN\1740|
10947967T6_10947967T13 NONE ascorbate_28\NN\1740| (r_compound) sites_29\NNS\8673395|to|the|ascorbate|pam (l_nmod) pam_32\NNS\1740|of|both|and|dopamine-beta-hydroxylase
10947967T6_10947967T14 NONE ascorbate_28\NN\1740| (r_compound) sites_29\NNS\8673395|to|the|ascorbate|pam (l_nmod) pam_32\NNS\1740|of|both|and|dopamine-beta-hydroxylase (l_conj) dopamine-beta-hydroxylase_34\NN\1740|
10947967T7_10947967T13 NONE dopamine-beta-hydroxylase_34\NN\1740| (r_conj) pam_32\NNS\1740|of|both|and|dopamine-beta-hydroxylase
10947967T7_10947967T14 NONE dopamine-beta-hydroxylase_34\NN\1740|
14757703
14757703T23_14757703T36 NONE 12177a_11\NN\1740| (r_compound) cardiostimulation_12\NN\1740|cgp|12177a (r_dobj) enhances_9\VBZ\227165|overexpression|cardiostimulation|:|implications|. (l_dep) implications_14\NNS\5774614|pharmacology (l_nmod) pharmacology_21\NN\6043075|for|'|putative|4-adrenoceptor (l_compound) 4-adrenoceptor_20\NN\1740|'|beta
14757703T23_14757703T37 NONE 12177a_11\NN\1740| (r_compound) cardiostimulation_12\NN\1740|cgp|12177a (r_dobj) enhances_9\VBZ\227165|overexpression|cardiostimulation|:|implications|. (l_nsubj) overexpression_0\NN\1740|1-adrenoceptors|myocytes (l_nmod) 1-adrenoceptors_3\NNS\1740|of|beta
14757703T14_14757703T27 CPR:3 12177a_1\CD\1740| (r_nummod) cgp_0\NN\1740|12177a (r_nsubj) mediates_2\VBZ\761713|cgp|cardiostimulation|activation|;|reported|. (l_parataxis) reported_19\VBN\831651|however|,|it|has|recently|been|abolishes (l_ccomp) abolishes_26\VBZ\1740|that|disruption|effect (l_nsubj) disruption_21\NN\1066163|gene (l_nmod) gene_25\NN\8459252|of|the|beta(1)-adrenoceptor (l_compound) beta(1)-adrenoceptor_24\NN\1740|
14757703T14_14757703T35 CPR:3 12177a_1\CD\1740| (r_nummod) cgp_0\NN\1740|12177a (r_nsubj) mediates_2\VBZ\761713|cgp|cardiostimulation|activation|;|reported|. (l_nmod) activation_5\NN\13561719|by|beta(4)-adrenoceptor (l_nmod) beta(4)-adrenoceptor_11\NN\1740|of|the|'|putative|'
14757703T15_14757703T33 NONE isoprenaline_19\NN\1740|of|and|12177a (r_nmod) potency_17\NN\5196375|the|inotropic|isoprenaline|propranolol (r_dobj) observed_14\VBD\2163746|potency (r_conj) have_1\VBP\2108377|beta(1)-adrenoceptors|and|observed (l_dobj) beta(1)-adrenoceptors_4\NNS\1740|overexpressed|cardiomyocytes
14757703T16_14757703T33 NONE 12177a_22\NN\1740|cgp (r_conj) isoprenaline_19\NN\1740|of|and|12177a (r_nmod) potency_17\NN\5196375|the|inotropic|isoprenaline|propranolol (r_dobj) observed_14\VBD\2163746|potency (r_conj) have_1\VBP\2108377|beta(1)-adrenoceptors|and|observed (l_dobj) beta(1)-adrenoceptors_4\NNS\1740|overexpressed|cardiomyocytes
14757703T17_14757703T33 NONE propranolol_30\NN\1740|(|in|the|presence|of|microm|) (r_nmod) potency_17\NN\5196375|the|inotropic|isoprenaline|propranolol (r_dobj) observed_14\VBD\2163746|potency (r_conj) have_1\VBP\2108377|beta(1)-adrenoceptors|and|observed (l_dobj) beta(1)-adrenoceptors_4\NNS\1740|overexpressed|cardiomyocytes
14757703T21_14757703T34 NONE isoprenaline_7\NN\1740|of (r_nmod) potency_5\NN\5196375|the|inotropic|isoprenaline (r_dobj) enhanced_2\VBD\227165|overexpression|potency|11.7-fold|pd(2|and|12177a|5.9-fold|,|respectively|. (l_nsubj) overexpression_1\NN\1740|beta(1)-adrenoceptor (l_compound) beta(1)-adrenoceptor_0\NN\1740|
14757703T1_14757703T24 NONE 12177a_5\NN\1740| (r_nummod) cgp_4\NN\1740|of|12177a (r_nmod) effects_2\NNS\13245626|the|cardiostimulant|cgp (r_nsubjpass) enhanced_7\VBN\227165|effects|were|ibmx|and|decreased|. (l_nmod) ibmx_9\NN\1740|by|inhibitor (l_appos) inhibitor_12\NN\20090|(|phosphodiesterase|) (l_compound) phosphodiesterase_11\NN\1740|
14757703T2_14757703T24 NONE rp-camps_17\NN\1740|by|antagonist (r_nmod) decreased_15\VBN\169651|rp-camps (r_conj) enhanced_7\VBN\227165|effects|were|ibmx|and|decreased|. (l_nmod) ibmx_9\NN\1740|by|inhibitor (l_appos) inhibitor_12\NN\20090|(|phosphodiesterase|) (l_compound) phosphodiesterase_11\NN\1740|
14757703T3_14757703T24 NONE camp_19\NN\3763727| (r_compound) antagonist_20\NN\7846|(|camp|) (r_appos) rp-camps_17\NN\1740|by|antagonist (r_nmod) decreased_15\VBN\169651|rp-camps (r_conj) enhanced_7\VBN\227165|effects|were|ibmx|and|decreased|. (l_nmod) ibmx_9\NN\1740|by|inhibitor (l_appos) inhibitor_12\NN\20090|(|phosphodiesterase|) (l_compound) phosphodiesterase_11\NN\1740|
14757703T6_14757703T25 CPR:3 12177a_1\CD\1740|not|isoprenaline (r_nummod) cgp_0\NN\1740|12177a (r_nsubj) initiated_5\VBD\1617192|cgp|arrhythmias|concentrations|overexpression|. (l_nmod) overexpression_12\NN\1740|following|beta(1)-adrenoceptor (l_compound) beta(1)-adrenoceptor_11\NN\1740|
14757703T7_14757703T25 NONE isoprenaline_4\NN\1740| (r_conj) 12177a_1\CD\1740|not|isoprenaline (r_nummod) cgp_0\NN\1740|12177a (r_nsubj) initiated_5\VBD\1617192|cgp|arrhythmias|concentrations|overexpression|. (l_nmod) overexpression_12\NN\1740|following|beta(1)-adrenoceptor (l_compound) beta(1)-adrenoceptor_11\NN\1740|
14757703T8_14757703T26 CPR:3 (125)i-cyanopindolol_0\NN\1740| (r_compound) binding_2\NN\4688246|(125)i-cyanopindolol|saturation|myocytes (r_nsubj) demonstrated_7\VBD\2137132|binding|increase|. (l_dobj) increase_10\NN\13576355|18-fold|beta(1)-adrenoceptors (l_nmod) beta(1)-adrenoceptors_12\NNS\1740|in
14757703T9_14757703T28 CPR:3 12177a_1\NN\1740| (r_compound) binding_3\NN\4688246|(3)h-cgp|12177a|saturation (r_nsubj) increased_11\VBD\169651|binding|,|presence|,|5-fold|overexpression|. (l_nmod) overexpression_15\NN\1740|following|beta(1)-adrenoceptors (l_nmod) beta(1)-adrenoceptors_17\NNS\1740|of
14757703T10_14757703T28 CPR:3 propranolol_9\NN\1740|of (r_nmod) presence_7\NN\13954253|in|the|propranolol (r_nmod) increased_11\VBD\169651|binding|,|presence|,|5-fold|overexpression|. (l_nmod) overexpression_15\NN\1740|following|beta(1)-adrenoceptors (l_nmod) beta(1)-adrenoceptors_17\NNS\1740|of
14757703T11_14757703T29 NONE 12177a_7\NN\1740|by|cgp (r_nmod) cardiostimulation_4\NN\1740|enhanced|12177a|(|presence|myocytes|,|mediated (l_nmod) myocytes_18\NNS\1740|in|rat|ventricular|overexpressing (l_acl) overexpressing_19\VBG\1740|beta(1)-adrenoceptors (l_dobj) beta(1)-adrenoceptors_20\NNS\1740|
14757703T11_14757703T30 NONE 12177a_7\NN\1740|by|cgp (r_nmod) cardiostimulation_4\NN\1740|enhanced|12177a|(|presence|myocytes|,|mediated (l_acl) mediated_22\VBN\761713|pathway (l_nmod) pathway_27\NN\5483677|by|a|gs/camp|signalling (l_compound) gs/camp_25\NN\1740|
14757703T12_14757703T29 NONE propranolol_13\NN\1740|of (r_nmod) presence_11\NN\13954253|in|the|propranolol|) (r_nmod) cardiostimulation_4\NN\1740|enhanced|12177a|(|presence|myocytes|,|mediated (l_nmod) myocytes_18\NNS\1740|in|rat|ventricular|overexpressing (l_acl) overexpressing_19\VBG\1740|beta(1)-adrenoceptors (l_dobj) beta(1)-adrenoceptors_20\NNS\1740|
14757703T12_14757703T30 NONE propranolol_13\NN\1740|of (r_nmod) presence_11\NN\13954253|in|the|propranolol|) (r_nmod) cardiostimulation_4\NN\1740|enhanced|12177a|(|presence|myocytes|,|mediated (l_acl) mediated_22\VBN\761713|pathway (l_nmod) pathway_27\NN\5483677|by|a|gs/camp|signalling (l_compound) gs/camp_25\NN\1740|
14757703T13_14757703T29 NONE gs/camp_25\NN\1740| (r_compound) pathway_27\NN\5483677|by|a|gs/camp|signalling (r_nmod) mediated_22\VBN\761713|pathway (r_acl) cardiostimulation_4\NN\1740|enhanced|12177a|(|presence|myocytes|,|mediated (l_nmod) myocytes_18\NNS\1740|in|rat|ventricular|overexpressing (l_acl) overexpressing_19\VBG\1740|beta(1)-adrenoceptors (l_dobj) beta(1)-adrenoceptors_20\NNS\1740|
14757703T13_14757703T30 NONE gs/camp_25\NN\1740|
11972287
11972287T8_11972287T15 CPR:3 m-cpbg_5\NN\1740|by (r_nmod) stimulation_3\NN\242808|central|5-ht3|receptor|m-cpbg (l_compound) 5-ht3_1\NN\1740|
11972287T9_11972287T15 NONE glucose_8\NN\14710501|blood|rats (r_dobj) increases_6\VBZ\169651|stimulation|glucose|. (l_nsubj) stimulation_3\NN\242808|central|5-ht3|receptor|m-cpbg (l_compound) 5-ht3_1\NN\1740|
11972287T1_11972287T13 NONE glucose_20\NN\14710501|of|blood (r_nmod) control_17\NN\5190804|on|the|glucose|rats (r_nmod) role_10\NN\719494|the|receptors|control (l_nmod) receptors_14\NNS\5225602|of|central|5-ht3 (l_compound) 5-ht3_13\NN\1740|
11972287T2_11972287T11 CPR:5 m-cpbg_2\NN\1740|of|,|agonist|, (l_appos) agonist_8\NN\9613191|a|selective|5-ht3|receptor (l_compound) 5-ht3_6\NN\1740|
11972287T3_11972287T11 NONE glucose_16\NN\14710501|in|blood (r_nmod) increase_13\NN\13576355|a|significant|glucose|rats (r_dobj) induced_10\VBD\1627355|injections|increase|. (l_nsubj) injections_0\NNS\320852|m-cpbg (l_nmod) m-cpbg_2\NN\1740|of|,|agonist|, (l_appos) agonist_8\NN\9613191|a|selective|5-ht3|receptor (l_compound) 5-ht3_6\NN\1740|
11972287T4_11972287T12 CPR:5 m-cpbg_4\NN\1740| (r_compound) administration_6\NN\1133281|of|m-cpbg|central (r_nmod) effect_2\NN\34213|the|hyperglycemic|administration (r_nsubjpass) blocked_8\VBN\1476483|effect|was|pretreatment|,|indicating|. (l_nmod) pretreatment_10\NN\1740|by|ondansetron (l_nmod) ondansetron_12\NN\1740|with|,|antagonist (l_appos) antagonist_18\NN\7846|a|specific|5-ht3|receptor (l_compound) 5-ht3_16\NN\1740|
11972287T4_11972287T14 NONE m-cpbg_4\NN\1740| (r_compound) administration_6\NN\1133281|of|m-cpbg|central (r_nmod) effect_2\NN\34213|the|hyperglycemic|administration (r_nsubjpass) blocked_8\VBN\1476483|effect|was|pretreatment|,|indicating|. (l_advcl) indicating_20\VBG\952524|result (l_ccomp) result_30\NN\34213|that|effects|were|a|interaction (l_nmod) interaction_33\NN\37396|of|its|receptors (l_nmod) receptors_36\NNS\5225602|with|5-ht3 (l_compound) 5-ht3_35\NN\1740|
11972287T5_11972287T12 NONE m-cpbg_27\NN\1740|with (r_nmod) obtained_25\VBN\2210855|here|m-cpbg (r_acl) effects_23\NNS\13245626|the|obtained (r_nsubj) result_30\NN\34213|that|effects|were|a|interaction (r_ccomp) indicating_20\VBG\952524|result (r_advcl) blocked_8\VBN\1476483|effect|was|pretreatment|,|indicating|. (l_nmod) pretreatment_10\NN\1740|by|ondansetron (l_nmod) ondansetron_12\NN\1740|with|,|antagonist (l_appos) antagonist_18\NN\7846|a|specific|5-ht3|receptor (l_compound) 5-ht3_16\NN\1740|
11972287T5_11972287T14 NONE m-cpbg_27\NN\1740|with (r_nmod) obtained_25\VBN\2210855|here|m-cpbg (r_acl) effects_23\NNS\13245626|the|obtained (r_nsubj) result_30\NN\34213|that|effects|were|a|interaction (l_nmod) interaction_33\NN\37396|of|its|receptors (l_nmod) receptors_36\NNS\5225602|with|5-ht3 (l_compound) 5-ht3_35\NN\1740|
23629516
23629516T2_23629516T19 NONE tcpp_21\NN\1740|by (r_nmod) induced_19\VBN\1627355|deiodinase|were|significantly|tcpp|,|induced|. (l_advcl) induced_25\VBD\1627355|while|tdcpp|cyp3a37 (l_dobj) cyp3a37_26\NN\1740|and|cyp2h1
23629516T2_23629516T20 NONE tcpp_21\NN\1740|by (r_nmod) induced_19\VBN\1627355|deiodinase|were|significantly|tcpp|,|induced|. (l_advcl) induced_25\VBD\1627355|while|tdcpp|cyp3a37 (l_dobj) cyp3a37_26\NN\1740|and|cyp2h1 (l_conj) cyp2h1_28\NN\1740|
23629516T2_23629516T21 CPR:3 tcpp_21\NN\1740|by (r_nmod) induced_19\VBN\1627355|deiodinase|were|significantly|tcpp|,|induced|. (l_nsubjpass) deiodinase_2\NN\1740|type|i|,|protein|and|mrna|levels
23629516T2_23629516T22 CPR:3 tcpp_21\NN\1740|by (r_nmod) induced_19\VBN\1627355|deiodinase|were|significantly|tcpp|,|induced|. (l_nsubjpass) deiodinase_2\NN\1740|type|i|,|protein|and|mrna|levels (l_conj) protein_7\NN\14944888|liver|fatty-acid|binding
23629516T2_23629516T23 CPR:3 tcpp_21\NN\1740|by (r_nmod) induced_19\VBN\1627355|deiodinase|were|significantly|tcpp|,|induced|. (l_nsubjpass) deiodinase_2\NN\1740|type|i|,|protein|and|mrna|levels (l_conj) mrna_15\NN\14832193|cytochrome|p450|(|cyp|)|3a37 (l_compound) 3a37_14\NN\1740|
23629516T3_23629516T19 CPR:3 tdcpp_24\NN\1740| (r_nsubj) induced_25\VBD\1627355|while|tdcpp|cyp3a37 (l_dobj) cyp3a37_26\NN\1740|and|cyp2h1
23629516T3_23629516T20 CPR:3 tdcpp_24\NN\1740| (r_nsubj) induced_25\VBD\1627355|while|tdcpp|cyp3a37 (l_dobj) cyp3a37_26\NN\1740|and|cyp2h1 (l_conj) cyp2h1_28\NN\1740|
23629516T3_23629516T21 NONE tdcpp_24\NN\1740| (r_nsubj) induced_25\VBD\1627355|while|tdcpp|cyp3a37 (r_advcl) induced_19\VBN\1627355|deiodinase|were|significantly|tcpp|,|induced|. (l_nsubjpass) deiodinase_2\NN\1740|type|i|,|protein|and|mrna|levels
23629516T3_23629516T22 NONE tdcpp_24\NN\1740| (r_nsubj) induced_25\VBD\1627355|while|tdcpp|cyp3a37 (r_advcl) induced_19\VBN\1627355|deiodinase|were|significantly|tcpp|,|induced|. (l_nsubjpass) deiodinase_2\NN\1740|type|i|,|protein|and|mrna|levels (l_conj) protein_7\NN\14944888|liver|fatty-acid|binding
23629516T3_23629516T23 NONE tdcpp_24\NN\1740| (r_nsubj) induced_25\VBD\1627355|while|tdcpp|cyp3a37 (r_advcl) induced_19\VBN\1627355|deiodinase|were|significantly|tcpp|,|induced|. (l_nsubjpass) deiodinase_2\NN\1740|type|i|,|protein|and|mrna|levels (l_conj) mrna_15\NN\14832193|cytochrome|p450|(|cyp|)|3a37 (l_compound) 3a37_14\NN\1740|
21631396
21631396T13_21631396T35 CPR:4 pseudoephedrine_0\NN\14712692| (r_nsubj) inhibits_1\VBZ\2510337|pseudoephedrine|activation|targeting|. (l_advcl) targeting_5\VBG\1151110|by|pathways (l_dobj) pathways_12\NNS\5483677|nf-kappab|signaling (l_compound) nf-kappab_6\NN\1740|,|nfat|and|ap-1
21631396T13_21631396T36 CPR:4 pseudoephedrine_0\NN\14712692| (r_nsubj) inhibits_1\VBZ\2510337|pseudoephedrine|activation|targeting|. (l_advcl) targeting_5\VBG\1151110|by|pathways (l_dobj) pathways_12\NNS\5483677|nf-kappab|signaling (l_compound) nf-kappab_6\NN\1740|,|nfat|and|ap-1 (l_conj) nfat_8\NN\1740|
21631396T13_21631396T37 CPR:4 pseudoephedrine_0\NN\14712692| (r_nsubj) inhibits_1\VBZ\2510337|pseudoephedrine|activation|targeting|. (l_advcl) targeting_5\VBG\1151110|by|pathways (l_dobj) pathways_12\NNS\5483677|nf-kappab|signaling (l_compound) nf-kappab_6\NN\1740|,|nfat|and|ap-1 (l_conj) ap-1_10\NN\1740|
21631396T9_21631396T23 CPR:4 pse_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|that|pse|transcription (l_dobj) transcription_17\NN\6349220|interleukin-2|cells (l_compound) interleukin-2_5\NN\1740|il-2|and|alpha-gene
21631396T9_21631396T24 CPR:4 pse_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|that|pse|transcription (l_dobj) transcription_17\NN\6349220|interleukin-2|cells (l_compound) interleukin-2_5\NN\1740|il-2|and|alpha-gene (l_appos) il-2_7\NN\1740|(|)
21631396T9_21631396T25 CPR:3 pse_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|that|pse|transcription (l_dobj) transcription_17\NN\6349220|interleukin-2|cells (l_compound) interleukin-2_5\NN\1740|il-2|and|alpha-gene (l_conj) alpha-gene_16\NN\1740|factor|(|tnf|)
21631396T11_21631396T26 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors
21631396T11_21631396T27 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_appos) nf-kappab_24\NN\1740|(|)
21631396T11_21631396T28 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_conj) cells_32\NNS\3080309|nuclear|factor|of|activated|t|nfat
21631396T11_21631396T29 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_conj) cells_32\NNS\3080309|nuclear|factor|of|activated|t|nfat (l_appos) nfat_34\NN\1740|(|)
21631396T11_21631396T30 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_conj) factors_44\NNS\7326557|protein-1|transcription (l_compound) protein-1_39\NN\1740|activator|ap-1
21631396T11_21631396T31 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_conj) factors_44\NNS\7326557|protein-1|transcription (l_compound) protein-1_39\NN\1740|activator|ap-1 (l_appos) ap-1_41\NN\1740|(|)
21631396T11_21631396T32 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_conj) found_46\VBD\2426171|inhibited (l_ccomp) inhibited_49\VBD\2510337|that|pse|activity|affecting (l_dobj) activity_52\NN\30358|nf-kappab-dependent|transcriptional (l_amod) nf-kappab-dependent_50\JJ\1740|
21631396T11_21631396T33 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_conj) found_46\VBD\2426171|inhibited (l_ccomp) inhibited_49\VBD\2510337|that|pse|activity|affecting (l_advcl) affecting_54\VBG\126264|without|phosphorylation (l_dobj) phosphorylation_57\NN\1740|either|the|,|degradation|or|activity (l_conj) degradation_60\NN\199130|the|protein (l_nmod) protein_66\NN\14944888|of|the|cytoplasmic|nf-kappab|inhibitory|,|ikappabalpha
21631396T11_21631396T34 NONE pse_7\NN\1740|of (r_nmod) mechanisms_5\NNS\13446390|the|inhibitory|pse|level (r_dobj) characterize_2\VB\609683|to|further|mechanisms (r_advcl) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_conj) found_46\VBD\2426171|inhibited (l_ccomp) inhibited_49\VBD\2510337|that|pse|activity|affecting (l_advcl) affecting_54\VBG\126264|without|phosphorylation (l_dobj) phosphorylation_57\NN\1740|either|the|,|degradation|or|activity (l_conj) degradation_60\NN\199130|the|protein (l_nmod) protein_66\NN\14944888|of|the|cytoplasmic|nf-kappab|inhibitory|,|ikappabalpha (l_appos) ikappabalpha_68\NN\1740|
21631396T12_21631396T26 NONE pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (r_ccomp) found_46\VBD\2426171|inhibited (r_conj) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors
21631396T12_21631396T27 NONE pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (r_ccomp) found_46\VBD\2426171|inhibited (r_conj) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_appos) nf-kappab_24\NN\1740|(|)
21631396T12_21631396T28 NONE pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (r_ccomp) found_46\VBD\2426171|inhibited (r_conj) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_conj) cells_32\NNS\3080309|nuclear|factor|of|activated|t|nfat
21631396T12_21631396T29 NONE pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (r_ccomp) found_46\VBD\2426171|inhibited (r_conj) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_conj) cells_32\NNS\3080309|nuclear|factor|of|activated|t|nfat (l_appos) nfat_34\NN\1740|(|)
21631396T12_21631396T30 NONE pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (r_ccomp) found_46\VBD\2426171|inhibited (r_conj) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_conj) factors_44\NNS\7326557|protein-1|transcription (l_compound) protein-1_39\NN\1740|activator|ap-1
21631396T12_21631396T31 NONE pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (r_ccomp) found_46\VBD\2426171|inhibited (r_conj) examined_14\VBD\789138|characterize|,|we|activities|and|found|. (l_dobj) activities_17\NNS\30358|the|transcriptional|b (l_nmod) b_22\NN\1355326|of|nuclear|factor|kappa|nf-kappab|,|cells|,|and|factors (l_conj) factors_44\NNS\7326557|protein-1|transcription (l_compound) protein-1_39\NN\1740|activator|ap-1 (l_appos) ap-1_41\NN\1740|(|)
21631396T12_21631396T32 CPR:4 pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (l_dobj) activity_52\NN\30358|nf-kappab-dependent|transcriptional (l_amod) nf-kappab-dependent_50\JJ\1740|
21631396T12_21631396T33 NONE pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (l_advcl) affecting_54\VBG\126264|without|phosphorylation (l_dobj) phosphorylation_57\NN\1740|either|the|,|degradation|or|activity (l_conj) degradation_60\NN\199130|the|protein (l_nmod) protein_66\NN\14944888|of|the|cytoplasmic|nf-kappab|inhibitory|,|ikappabalpha
21631396T12_21631396T34 NONE pse_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|that|pse|activity|affecting (l_advcl) affecting_54\VBG\126264|without|phosphorylation (l_dobj) phosphorylation_57\NN\1740|either|the|,|degradation|or|activity (l_conj) degradation_60\NN\199130|the|protein (l_nmod) protein_66\NN\14944888|of|the|cytoplasmic|nf-kappab|inhibitory|,|ikappabalpha (l_appos) ikappabalpha_68\NN\1740|
21631396T2_21631396T14 CPR:4 pse_11\NN\1740|by (r_nmod) inhibited_9\VBN\2510337|however|,|phosphorylation|was|clearly|pse|cells|. (l_nsubjpass) phosphorylation_2\NN\1740|subunit (l_nmod) subunit_6\NN\13604718|of|the|p65/rela (l_compound) p65/rela_5\NN\1740|
21631396T2_21631396T15 CPR:4 pse_11\NN\1740|by (r_nmod) inhibited_9\VBN\2510337|however|,|phosphorylation|was|clearly|pse|cells|. (l_nsubjpass) phosphorylation_2\NN\1740|subunit (l_nmod) subunit_6\NN\13604718|of|the|p65/rela (l_compound) p65/rela_5\NN\1740|
21631396T3_21631396T16 CPR:4 pse_3\NN\1740| (r_nsubj) inhibited_4\VBD\2510337|addition|,|pse|activity|interfering|. (l_dobj) activity_7\NN\30358|the|transcriptional|nfat (l_nmod) nfat_9\NN\1740|of
21631396T3_21631396T17 NONE pse_3\NN\1740| (r_nsubj) inhibited_4\VBD\2510337|addition|,|pse|activity|interfering|. (l_advcl) interfering_11\VBG\2451370|without|event (l_nmod) event_17\NN\23100|with|the|calcium-induced|nfat|dephosphorylation|,|represents (l_compound) nfat_15\NN\1740|
21631396T4_21631396T16 NONE calcium-induced_14\JJ\1740| (r_amod) event_17\NN\23100|with|the|calcium-induced|nfat|dephosphorylation|,|represents (r_nmod) interfering_11\VBG\2451370|without|event (r_advcl) inhibited_4\VBD\2510337|addition|,|pse|activity|interfering|. (l_dobj) activity_7\NN\30358|the|transcriptional|nfat (l_nmod) nfat_9\NN\1740|of
21631396T4_21631396T17 CPR:3 calcium-induced_14\JJ\1740| (r_amod) event_17\NN\23100|with|the|calcium-induced|nfat|dephosphorylation|,|represents (l_compound) nfat_15\NN\1740|
21631396T5_21631396T18 NONE pse_22\NN\1740| (r_nsubj) inhibited_23\VBD\2510337|that|pse|activation (r_ccomp) found_20\VBD\2426171|we|also|inhibited (r_conj) cooperates_1\VBZ\2413480|nfat|c-jun|activate|,|and|found|. (l_nsubj) nfat_0\NN\1740|
21631396T5_21631396T19 NONE pse_22\NN\1740| (r_nsubj) inhibited_23\VBD\2510337|that|pse|activation (r_ccomp) found_20\VBD\2426171|we|also|inhibited (r_conj) cooperates_1\VBZ\2413480|nfat|c-jun|activate|,|and|found|. (l_nmod) c-jun_3\NN\1740|with|,|compound|,
21631396T5_21631396T20 NONE pse_22\NN\1740| (r_nsubj) inhibited_23\VBD\2510337|that|pse|activation (r_ccomp) found_20\VBD\2426171|we|also|inhibited (r_conj) cooperates_1\VBZ\2413480|nfat|c-jun|activate|,|and|found|. (l_nmod) c-jun_3\NN\1740|with|,|compound|, (l_appos) compound_6\NN\5869584|a|complex (l_nmod) complex_10\NN\5869584|of|the|ap-1 (l_compound) ap-1_9\NN\1740|
21631396T5_21631396T21 CPR:4 pse_22\NN\1740| (r_nsubj) inhibited_23\VBD\2510337|that|pse|activation (l_dobj) activation_26\NN\13561719|both|jnk|and|activity (l_compound) jnk_25\NN\1740|
21631396T5_21631396T22 CPR:4 pse_22\NN\1740| (r_nsubj) inhibited_23\VBD\2510337|that|pse|activation (l_dobj) activation_26\NN\13561719|both|jnk|and|activity (l_conj) activity_30\NN\30358|ap-1|transcriptional (l_compound) ap-1_28\NN\1740|
17651117
17651117T1_17651117T5 NONE chloride_30\NN\14818238| (r_compound) tubing_31\NN\3089014|in|polyvinyl|chloride (r_nmod) cd62p_16\NN\1740|to|,|cd42b|,|or|c|tubing
17651117T1_17651117T6 NONE chloride_30\NN\14818238| (r_compound) tubing_31\NN\3089014|in|polyvinyl|chloride (r_nmod) cd62p_16\NN\1740|to|,|cd42b|,|or|c|tubing (l_conj) cd42b_18\NN\1740|
17651117T1_17651117T7 NONE chloride_30\NN\14818238| (r_compound) tubing_31\NN\3089014|in|polyvinyl|chloride (r_nmod) cd62p_16\NN\1740|to|,|cd42b|,|or|c|tubing (l_conj) c_24\NN\13714184|junctional|adhesion|molecule|jam-c
17651117T1_17651117T8 NONE chloride_30\NN\14818238| (r_compound) tubing_31\NN\3089014|in|polyvinyl|chloride (r_nmod) cd62p_16\NN\1740|to|,|cd42b|,|or|c|tubing (l_conj) c_24\NN\13714184|junctional|adhesion|molecule|jam-c (l_appos) jam-c_26\NN\1740|(|)
23219339
23219339T16_23219339T23 NONE nmda_11\NN\1740| (r_compound) receptors_12\NNS\5225602|of|nr2b-containing|nmda
23219339T16_23219339T24 NONE nmda_11\NN\1740| (r_compound) receptors_12\NNS\5225602|of|nr2b-containing|nmda (l_amod) nr2b-containing_10\JJ\1740|
23219339T17_23219339T23 NONE oxymatrine_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|neuroprotective|oxymatrine|excitotoxicity|down-regulation|. (l_nmod) down-regulation_8\NN\1740|through|receptors (l_nmod) receptors_12\NNS\5225602|of|nr2b-containing|nmda
23219339T17_23219339T24 NONE oxymatrine_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|neuroprotective|oxymatrine|excitotoxicity|down-regulation|. (l_nmod) down-regulation_8\NN\1740|through|receptors (l_nmod) receptors_12\NNS\5225602|of|nr2b-containing|nmda (l_amod) nr2b-containing_10\JJ\1740|
23219339T14_23219339T21 CPR:4 omt_5\NN\1740| (r_nsubj) decreased_6\VBD\169651|that|omt|expression|and|repaired (l_dobj) expression_8\NN\4679549|the|bax (l_nmod) bax_10\NN\1740|of
23219339T2_23219339T22 NONE calcium_12\NN\14625458| (r_compound) overload_13\NN\3679986|the|calcium|neurons (r_dobj) inhibited_10\VBD\2510337|overload|challenging (r_conj) reversed_4\VBD\109660|furthermore|,|omt|significantly|up-regulation|and|inhibited|. (l_dobj) up-regulation_6\NN\1740|the|nr2b (l_nmod) nr2b_8\NN\1740|of
23219339T3_23219339T22 NONE nmda_21\NN\1740|the (r_dobj) challenging_19\VBG\869596|after|nmda (r_advcl) inhibited_10\VBD\2510337|overload|challenging (r_conj) reversed_4\VBD\109660|furthermore|,|omt|significantly|up-regulation|and|inhibited|. (l_dobj) up-regulation_6\NN\1740|the|nr2b (l_nmod) nr2b_8\NN\1740|of
23219339T15_23219339T22 CPR:4 omt_2\NN\1740| (r_nsubj) reversed_4\VBD\109660|furthermore|,|omt|significantly|up-regulation|and|inhibited|. (l_dobj) up-regulation_6\NN\1740|the|nr2b (l_nmod) nr2b_8\NN\1740|of
23219339T4_23219339T18 CPR:4 omt_0\NN\1740| (r_nsubj) showed_1\VBD\2137132|omt|protection|neurons|down-regulation|. (l_nmod) down-regulation_9\NN\1740|via|nr2b|and|up-regulation (l_nmod) nr2b_11\NN\1740|of|containing
23219339T4_23219339T19 CPR:4 omt_0\NN\1740| (r_nsubj) showed_1\VBD\2137132|omt|protection|neurons|down-regulation|. (l_nmod) down-regulation_9\NN\1740|via|nr2b|and|up-regulation (l_nmod) nr2b_11\NN\1740|of|containing (l_acl) containing_12\VBG\2632940|receptors (l_dobj) receptors_14\NNS\5225602|nmda
23219339T4_23219339T20 CPR:3 omt_0\NN\1740| (r_nsubj) showed_1\VBD\2137132|omt|protection|neurons|down-regulation|. (l_nmod) down-regulation_9\NN\1740|via|nr2b|and|up-regulation (l_conj) up-regulation_16\NN\1740|family (l_nmod) family_19\NN\8189659|of|bcl-2 (l_compound) bcl-2_18\NN\1740|
23219339T5_23219339T18 NONE nmda_13\NN\1740| (r_compound) receptors_14\NNS\5225602|nmda (r_dobj) containing_12\VBG\2632940|receptors (r_acl) nr2b_11\NN\1740|of|containing
23219339T5_23219339T19 NONE nmda_13\NN\1740| (r_compound) receptors_14\NNS\5225602|nmda
23219339T5_23219339T20 NONE nmda_13\NN\1740| (r_compound) receptors_14\NNS\5225602|nmda (r_dobj) containing_12\VBG\2632940|receptors (r_acl) nr2b_11\NN\1740|of|containing (r_nmod) down-regulation_9\NN\1740|via|nr2b|and|up-regulation (l_conj) up-regulation_16\NN\1740|family (l_nmod) family_19\NN\8189659|of|bcl-2 (l_compound) bcl-2_18\NN\1740|
10443304
10443304T5_10443304T8 NONE sodium_11\NN\14625458| (r_compound) channel_12\NN\6251781|sodium
10443304T5_10443304T9 NONE sodium_11\NN\14625458| (r_compound) channel_12\NN\6251781|sodium (r_compound) scn5a_13\NN\1740|of|the|channel
10443304T6_10443304T10 NONE sodium_10\NN\14625458| (r_compound) channel_11\NN\6251781|of|the|sodium
10443304T7_10443304T11 NONE sodium_11\NN\14625458| (r_compound) channel_12\NN\6251781|of|the|sodium
23422569
23422569T23_23422569T52 NONE nadph_2\NN\1740| (r_compound) activation_4\NN\13561719|nadph|oxidase (r_dobj) inhibits_1\VBZ\2510337|sirt1|activation|and|protects|:|implications|. (l_nsubj) sirt1_0\NN\1740|
23422569T23_23422569T53 NONE nadph_2\NN\1740| (r_compound) activation_4\NN\13561719|nadph|oxidase (l_compound) oxidase_3\NN\14732946|
23422569T13_23422569T46 NONE nadph_7\NN\1740| (r_compound) oxidase_8\NN\14732946|of|nadph
23422569T9_23422569T42 NONE nad(+)-dependent_10\JJ\1740| (r_amod) sirt1_12\NN\1740|of|the|conserved|nad(+)-dependent|deacetylase
23422569T9_23422569T43 NONE nad(+)-dependent_10\JJ\1740| (r_amod) sirt1_12\NN\1740|of|the|conserved|nad(+)-dependent|deacetylase (r_nmod) activity_5\NN\30358|the|sirt1 (r_nsubj) declines_13\VBZ\146138|that|activity|age|and|confer (l_conj) confer_22\VBP\813978|that|activators|effects (l_nsubj) activators_19\NNS\19613|pharmacological|sirt1 (l_nmod) sirt1_21\NN\1740|of
23422569T11_23422569T44 NONE nadph_7\NN\1740| (r_compound) production_9\NN\30358|nadph|oxidase-dependent|species (r_dobj) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (l_nsubj) dysregulation_3\NN\1740|sirt1 (l_nmod) sirt1_5\NN\1740|of
23422569T11_23422569T45 NONE nadph_7\NN\1740| (r_compound) production_9\NN\30358|nadph|oxidase-dependent|species (l_amod) oxidase-dependent_8\JJ\1740|
23422569T11_23422569T47 NONE nadph_7\NN\1740| (r_compound) production_9\NN\30358|nadph|oxidase-dependent|species (r_dobj) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (r_ccomp) determine_1\VB\1645601|to|promotes (r_dep) assessed_22\VBD\670261|determine|we|effects|. (l_dobj) effects_24\NNS\13245626|the|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (l_nmod) sirt1_31\NN\1740|of
23422569T12_23422569T44 NONE oxygen_12\NN\14622893| (r_compound) species_13\NNS\7992450|of|reactive|oxygen|ros (r_nmod) production_9\NN\30358|nadph|oxidase-dependent|species (r_dobj) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (l_nsubj) dysregulation_3\NN\1740|sirt1 (l_nmod) sirt1_5\NN\1740|of
23422569T12_23422569T45 CPR:9 oxygen_12\NN\14622893| (r_compound) species_13\NNS\7992450|of|reactive|oxygen|ros (r_nmod) production_9\NN\30358|nadph|oxidase-dependent|species (l_amod) oxidase-dependent_8\JJ\1740|
23422569T12_23422569T47 NONE oxygen_12\NN\14622893| (r_compound) species_13\NNS\7992450|of|reactive|oxygen|ros (r_nmod) production_9\NN\30358|nadph|oxidase-dependent|species (r_dobj) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (r_ccomp) determine_1\VB\1645601|to|promotes (r_dep) assessed_22\VBD\670261|determine|we|effects|. (l_dobj) effects_24\NNS\13245626|the|inhibitors (l_nmod) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (l_nmod) sirt1_31\NN\1740|of
23422569T14_23422569T44 NONE nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (r_nmod) effects_24\NNS\13245626|the|inhibitors (r_dobj) assessed_22\VBD\670261|determine|we|effects|. (l_dep) determine_1\VB\1645601|to|promotes (l_ccomp) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (l_nsubj) dysregulation_3\NN\1740|sirt1 (l_nmod) sirt1_5\NN\1740|of
23422569T14_23422569T45 NONE nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (r_nmod) effects_24\NNS\13245626|the|inhibitors (r_dobj) assessed_22\VBD\670261|determine|we|effects|. (l_dep) determine_1\VB\1645601|to|promotes (l_ccomp) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (l_dobj) production_9\NN\30358|nadph|oxidase-dependent|species (l_amod) oxidase-dependent_8\JJ\1740|
23422569T14_23422569T47 CPR:4 nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (l_nmod) sirt1_31\NN\1740|of
23422569T15_23422569T44 NONE sirtinol_35\NN\1740| (r_appos) nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (r_nmod) effects_24\NNS\13245626|the|inhibitors (r_dobj) assessed_22\VBD\670261|determine|we|effects|. (l_dep) determine_1\VB\1645601|to|promotes (l_ccomp) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (l_nsubj) dysregulation_3\NN\1740|sirt1 (l_nmod) sirt1_5\NN\1740|of
23422569T15_23422569T45 NONE sirtinol_35\NN\1740| (r_appos) nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (r_nmod) effects_24\NNS\13245626|the|inhibitors (r_dobj) assessed_22\VBD\670261|determine|we|effects|. (l_dep) determine_1\VB\1645601|to|promotes (l_ccomp) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (l_dobj) production_9\NN\30358|nadph|oxidase-dependent|species (l_amod) oxidase-dependent_8\JJ\1740|
23422569T15_23422569T47 CPR:4 sirtinol_35\NN\1740| (r_appos) nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (l_nmod) sirt1_31\NN\1740|of
23422569T16_23422569T44 NONE ex527_37\NN\1740| (r_appos) nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (r_nmod) effects_24\NNS\13245626|the|inhibitors (r_dobj) assessed_22\VBD\670261|determine|we|effects|. (l_dep) determine_1\VB\1645601|to|promotes (l_ccomp) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (l_nsubj) dysregulation_3\NN\1740|sirt1 (l_nmod) sirt1_5\NN\1740|of
23422569T16_23422569T45 NONE ex527_37\NN\1740| (r_appos) nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (r_nmod) effects_24\NNS\13245626|the|inhibitors (r_dobj) assessed_22\VBD\670261|determine|we|effects|. (l_dep) determine_1\VB\1645601|to|promotes (l_ccomp) promotes_6\VBZ\2556126|whether|dysregulation|production|and|impairs (l_dobj) production_9\NN\30358|nadph|oxidase-dependent|species (l_amod) oxidase-dependent_8\JJ\1740|
23422569T16_23422569T47 CPR:4 ex527_37\NN\1740| (r_appos) nicotinamide_33\NN\1740|(|,|sirtinol|,|ex527|) (r_dep) inhibitors_29\NNS\20090|of|three|different|sirt1|nicotinamide|segments (l_nmod) sirt1_31\NN\1740|of
23422569T17_23422569T48 NONE acetylcholine_18\NN\14807558|and|a23187 (r_dep) vasodilators_17\NNS\3198383|to|the|endothelium-dependent|acetylcholine (r_nmod) relaxation_13\NN\13497135|by|the|reduced|vasodilators (r_nmod) shown_8\VBN\2137132|as|relaxation (r_advcl) induced_3\VBD\1627355|inhibition|dysfunction|,|shown|. (l_nsubj) inhibition_0\NN\1068773|sirt1 (l_nmod) sirt1_2\NN\1740|of
23422569T18_23422569T48 NONE calcium_21\NN\14625458| (r_compound) a23187_23\NN\1740|the|calcium|ionophore (r_conj) acetylcholine_18\NN\14807558|and|a23187 (r_dep) vasodilators_17\NNS\3198383|to|the|endothelium-dependent|acetylcholine (r_nmod) relaxation_13\NN\13497135|by|the|reduced|vasodilators (r_nmod) shown_8\VBN\2137132|as|relaxation (r_advcl) induced_3\VBD\1627355|inhibition|dysfunction|,|shown|. (l_nsubj) inhibition_0\NN\1068773|sirt1 (l_nmod) sirt1_2\NN\1740|of
23422569T19_23422569T48 NONE a23187_23\NN\1740|the|calcium|ionophore (r_conj) acetylcholine_18\NN\14807558|and|a23187 (r_dep) vasodilators_17\NNS\3198383|to|the|endothelium-dependent|acetylcholine (r_nmod) relaxation_13\NN\13497135|by|the|reduced|vasodilators (r_nmod) shown_8\VBN\2137132|as|relaxation (r_advcl) induced_3\VBD\1627355|inhibition|dysfunction|,|shown|. (l_nsubj) inhibition_0\NN\1068773|sirt1 (l_nmod) sirt1_2\NN\1740|of
23422569T20_23422569T49 NONE nadph_15\NN\1740| (r_compound) apocynin_18\NN\1740|with|the|nadph|oxidase|inhibitor|or|dismutase (r_nmod) treatment_9\NN\654885|by|vessels|apocynin (r_nmod) prevented_7\VBN\1740|dysfunction|was|treatment|. (l_nsubjpass) dysfunction_1\NN\14204950|endothelial|induced (l_acl) induced_2\VBN\1627355|inhibition (l_nmod) inhibition_5\NN\1068773|by|sirt1 (l_compound) sirt1_4\NN\1740|
23422569T20_23422569T50 NONE nadph_15\NN\1740| (r_compound) apocynin_18\NN\1740|with|the|nadph|oxidase|inhibitor|or|dismutase (l_compound) oxidase_16\NN\14732946|
23422569T20_23422569T51 NONE nadph_15\NN\1740| (r_compound) apocynin_18\NN\1740|with|the|nadph|oxidase|inhibitor|or|dismutase (l_conj) dismutase_21\NN\1740|superoxide
23422569T21_23422569T49 NONE apocynin_18\NN\1740|with|the|nadph|oxidase|inhibitor|or|dismutase (r_nmod) treatment_9\NN\654885|by|vessels|apocynin (r_nmod) prevented_7\VBN\1740|dysfunction|was|treatment|. (l_nsubjpass) dysfunction_1\NN\14204950|endothelial|induced (l_acl) induced_2\VBN\1627355|inhibition (l_nmod) inhibition_5\NN\1068773|by|sirt1 (l_compound) sirt1_4\NN\1740|
23422569T21_23422569T50 CPR:4 apocynin_18\NN\1740|with|the|nadph|oxidase|inhibitor|or|dismutase (l_compound) oxidase_16\NN\14732946|
23422569T21_23422569T51 NONE apocynin_18\NN\1740|with|the|nadph|oxidase|inhibitor|or|dismutase (l_conj) dismutase_21\NN\1740|superoxide
23422569T22_23422569T49 NONE superoxide_20\NN\14971519| (r_compound) dismutase_21\NN\1740|superoxide (r_conj) apocynin_18\NN\1740|with|the|nadph|oxidase|inhibitor|or|dismutase (r_nmod) treatment_9\NN\654885|by|vessels|apocynin (r_nmod) prevented_7\VBN\1740|dysfunction|was|treatment|. (l_nsubjpass) dysfunction_1\NN\14204950|endothelial|induced (l_acl) induced_2\VBN\1627355|inhibition (l_nmod) inhibition_5\NN\1068773|by|sirt1 (l_compound) sirt1_4\NN\1740|
23422569T22_23422569T50 NONE superoxide_20\NN\14971519| (r_compound) dismutase_21\NN\1740|superoxide (r_conj) apocynin_18\NN\1740|with|the|nadph|oxidase|inhibitor|or|dismutase (l_compound) oxidase_16\NN\14732946|
23422569T22_23422569T51 NONE superoxide_20\NN\14971519| (r_compound) dismutase_21\NN\1740|superoxide
23422569T1_23422569T24 CPR:9 superoxide_6\NN\14971519| (r_compound) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (r_dobj) increased_4\VBD\169651|inhibition|significantly|production|,|prevented|. (l_nsubj) inhibition_0\NN\1068773|sirt1 (l_nmod) sirt1_2\NN\1740|of
23422569T1_23422569T25 NONE superoxide_6\NN\14971519| (r_compound) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (l_conj) activity_12\NN\30358|enhanced|nadph|oxidase (l_compound) oxidase_11\NN\14732946|
23422569T1_23422569T26 NONE superoxide_6\NN\14971519| (r_compound) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (l_conj) expression_16\NN\4679549|mrna|subunits (l_nmod) subunits_19\NNS\13604718|of|its|p22(phox (l_dep) p22(phox_20\NN\1740|)|and|nox4 (l_punct) )_21\-RRB-\1740|
23422569T1_23422569T27 NONE superoxide_6\NN\14971519| (r_compound) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (l_conj) expression_16\NN\4679549|mrna|subunits (l_nmod) subunits_19\NNS\13604718|of|its|p22(phox (l_dep) p22(phox_20\NN\1740|)|and|nox4 (l_conj) nox4_23\NN\1740|
23422569T2_23422569T24 NONE nadph_10\NN\1740| (r_compound) activity_12\NN\30358|enhanced|nadph|oxidase (r_conj) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (r_dobj) increased_4\VBD\169651|inhibition|significantly|production|,|prevented|. (l_nsubj) inhibition_0\NN\1068773|sirt1 (l_nmod) sirt1_2\NN\1740|of
23422569T2_23422569T25 NONE nadph_10\NN\1740| (r_compound) activity_12\NN\30358|enhanced|nadph|oxidase (l_compound) oxidase_11\NN\14732946|
23422569T2_23422569T26 NONE nadph_10\NN\1740| (r_compound) activity_12\NN\30358|enhanced|nadph|oxidase (r_conj) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (l_conj) expression_16\NN\4679549|mrna|subunits (l_nmod) subunits_19\NNS\13604718|of|its|p22(phox (l_dep) p22(phox_20\NN\1740|)|and|nox4 (l_punct) )_21\-RRB-\1740|
23422569T2_23422569T27 NONE nadph_10\NN\1740| (r_compound) activity_12\NN\30358|enhanced|nadph|oxidase (r_conj) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (l_conj) expression_16\NN\4679549|mrna|subunits (l_nmod) subunits_19\NNS\13604718|of|its|p22(phox (l_dep) p22(phox_20\NN\1740|)|and|nox4 (l_conj) nox4_23\NN\1740|
23422569T3_23422569T24 NONE resveratrol_29\NN\1740|by (r_nmod) prevented_27\VBN\1740|which|were|resveratrol (r_advcl) increased_4\VBD\169651|inhibition|significantly|production|,|prevented|. (l_nsubj) inhibition_0\NN\1068773|sirt1 (l_nmod) sirt1_2\NN\1740|of
23422569T3_23422569T25 CPR:4 resveratrol_29\NN\1740|by (r_nmod) prevented_27\VBN\1740|which|were|resveratrol (r_advcl) increased_4\VBD\169651|inhibition|significantly|production|,|prevented|. (l_dobj) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (l_conj) activity_12\NN\30358|enhanced|nadph|oxidase (l_compound) oxidase_11\NN\14732946|
23422569T3_23422569T26 CPR:4 resveratrol_29\NN\1740|by (r_nmod) prevented_27\VBN\1740|which|were|resveratrol (r_advcl) increased_4\VBD\169651|inhibition|significantly|production|,|prevented|. (l_dobj) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (l_conj) expression_16\NN\4679549|mrna|subunits (l_nmod) subunits_19\NNS\13604718|of|its|p22(phox (l_dep) p22(phox_20\NN\1740|)|and|nox4 (l_punct) )_21\-RRB-\1740|
23422569T3_23422569T27 CPR:4 resveratrol_29\NN\1740|by (r_nmod) prevented_27\VBN\1740|which|were|resveratrol (r_advcl) increased_4\VBD\169651|inhibition|significantly|production|,|prevented|. (l_dobj) production_7\NN\30358|vascular|superoxide|,|activity|,|and|expression (l_conj) expression_16\NN\4679549|mrna|subunits (l_nmod) subunits_19\NNS\13604718|of|its|p22(phox (l_dep) p22(phox_20\NN\1740|)|and|nox4 (l_conj) nox4_23\NN\1740|
23422569T4_23422569T28 NONE resveratrol_11\NN\1740|of (r_nmod) effects_9\NNS\13245626|the|resveratrol (r_dobj) mimicked_7\VBD\1742886|activation|effects|prevented|. (l_nsubj) activation_6\NN\13561719|peroxisome|receptor-α (l_compound) receptor-α_2\NN\1740|proliferator-activated|pparα
23422569T4_23422569T29 NONE resveratrol_11\NN\1740|of (r_nmod) effects_9\NNS\13245626|the|resveratrol (r_dobj) mimicked_7\VBD\1742886|activation|effects|prevented|. (l_nsubj) activation_6\NN\13561719|peroxisome|receptor-α (l_compound) receptor-α_2\NN\1740|proliferator-activated|pparα (l_appos) pparα_4\NN\1740|(|)
23422569T4_23422569T30 NONE resveratrol_11\NN\1740|of (r_nmod) effects_9\NNS\13245626|the|resveratrol (r_dobj) mimicked_7\VBD\1742886|activation|effects|prevented|. (l_advcl) prevented_15\VBD\1740|while|inhibition|effects (l_nsubj) inhibition_14\NN\1068773|pparα (l_compound) pparα_13\NN\1740|
23422569T4_23422569T31 CPR:3 resveratrol_11\NN\1740|of (r_nmod) effects_9\NNS\13245626|the|resveratrol (r_dobj) mimicked_7\VBD\1742886|activation|effects|prevented|. (l_advcl) prevented_15\VBD\1740|while|inhibition|effects (l_dobj) effects_17\NNS\13245626|the|activator (l_nmod) activator_21\NN\19613|of|this|sirt1 (l_compound) sirt1_20\NN\1740|
23422569T5_23422569T32 NONE nicotinamide_5\NN\1740| (r_conj) pparα_3\NN\1740|with|and|nicotinamide (r_nmod) co-precipitated_1\VBN\1740|pparα (r_acl) sirt1_0\NN\1740|co-precipitated
23422569T5_23422569T33 NONE nicotinamide_5\NN\1740| (r_conj) pparα_3\NN\1740|with|and|nicotinamide
23422569T5_23422569T34 NONE nicotinamide_5\NN\1740| (r_conj) pparα_3\NN\1740|with|and|nicotinamide (r_nmod) co-precipitated_1\VBN\1740|pparα (r_acl) sirt1_0\NN\1740|co-precipitated (r_nsubj) increased_6\VBD\169651|sirt1|acetylation|. (l_dobj) acetylation_8\NN\13426948|the|coactivator|,|suppressed (l_nmod) coactivator_12\NN\1740|of|the|pparα|pgc-1α (l_compound) pparα_11\NN\1740|
23422569T5_23422569T35 CPR:3 nicotinamide_5\NN\1740| (r_conj) pparα_3\NN\1740|with|and|nicotinamide (r_nmod) co-precipitated_1\VBN\1740|pparα (r_acl) sirt1_0\NN\1740|co-precipitated (r_nsubj) increased_6\VBD\169651|sirt1|acetylation|. (l_dobj) acetylation_8\NN\13426948|the|coactivator|,|suppressed (l_nmod) coactivator_12\NN\1740|of|the|pparα|pgc-1α (l_dep) pgc-1α_13\NN\1740|
23422569T6_23422569T32 NONE resveratrol_19\NN\1740|by (r_nmod) suppressed_17\VBN\2510337|which|was|resveratrol (r_acl:relcl) acetylation_8\NN\13426948|the|coactivator|,|suppressed (r_dobj) increased_6\VBD\169651|sirt1|acetylation|. (l_nsubj) sirt1_0\NN\1740|co-precipitated
23422569T6_23422569T33 NONE resveratrol_19\NN\1740|by (r_nmod) suppressed_17\VBN\2510337|which|was|resveratrol (r_acl:relcl) acetylation_8\NN\13426948|the|coactivator|,|suppressed (r_dobj) increased_6\VBD\169651|sirt1|acetylation|. (l_nsubj) sirt1_0\NN\1740|co-precipitated (l_acl) co-precipitated_1\VBN\1740|pparα (l_nmod) pparα_3\NN\1740|with|and|nicotinamide
23422569T6_23422569T34 NONE resveratrol_19\NN\1740|by (r_nmod) suppressed_17\VBN\2510337|which|was|resveratrol (r_acl:relcl) acetylation_8\NN\13426948|the|coactivator|,|suppressed (l_nmod) coactivator_12\NN\1740|of|the|pparα|pgc-1α (l_compound) pparα_11\NN\1740|
23422569T6_23422569T35 CPR:4 resveratrol_19\NN\1740|by (r_nmod) suppressed_17\VBN\2510337|which|was|resveratrol (r_acl:relcl) acetylation_8\NN\13426948|the|coactivator|,|suppressed (l_nmod) coactivator_12\NN\1740|of|the|pparα|pgc-1α (l_dep) pgc-1α_13\NN\1740|
23422569T7_23422569T36 NONE nadph_12\NN\1740| (r_nmod:npmod) oxidase-derived_13\JJ\1740|nadph (r_amod) production_15\NN\30358|oxidase-derived|ros|wall (r_dobj) up-regulates_11\VBZ\1740|production|,|mimicking (r_conj) induces_7\VBZ\1627355|conclusion|,|activity|dysfunction|and|up-regulates|. (l_nsubj) activity_4\NN\30358|impaired|sirt1 (l_nmod) sirt1_6\NN\1740|of
23422569T7_23422569T37 NONE nadph_12\NN\1740| (r_nmod:npmod) oxidase-derived_13\JJ\1740|nadph
23422569T8_23422569T38 NONE nadph_27\NN\1740| (r_nmod:npmod) oxidase-driven_28\JJ\1740|nadph (r_amod) production_30\NN\30358|in|both|decreased|oxidase-driven|ros|and|inactivation (r_nmod) resulting_23\VBG\2633881|production (r_advcl) involves_12\VBZ\2676054|moreover|,|mechanism|acetylation|,|resulting|. (l_nsubj) mechanism_4\NN\13446390|a|new|controlling (l_acl) controlling_6\VBG\2422663|for|function|activation (l_nmod) activation_11\NN\13561719|after|sirt1 (l_compound) sirt1_10\NN\1740|
23422569T8_23422569T39 NONE nadph_27\NN\1740| (r_nmod:npmod) oxidase-driven_28\JJ\1740|nadph (r_amod) production_30\NN\30358|in|both|decreased|oxidase-driven|ros|and|inactivation (r_nmod) resulting_23\VBG\2633881|production (r_advcl) involves_12\VBZ\2676054|moreover|,|mechanism|acetylation|,|resulting|. (l_dobj) acetylation_16\NN\13426948|a|decreased|pgc-1α|and|activation (l_compound) pgc-1α_15\NN\1740|
23422569T8_23422569T40 NONE nadph_27\NN\1740| (r_nmod:npmod) oxidase-driven_28\JJ\1740|nadph (r_amod) production_30\NN\30358|in|both|decreased|oxidase-driven|ros|and|inactivation (r_nmod) resulting_23\VBG\2633881|production (r_advcl) involves_12\VBZ\2676054|moreover|,|mechanism|acetylation|,|resulting|. (l_dobj) acetylation_16\NN\13426948|a|decreased|pgc-1α|and|activation (l_conj) activation_21\NN\13561719|the|subsequent|pparα (l_compound) pparα_20\NN\1740|
23422569T8_23422569T41 NONE nadph_27\NN\1740| (r_nmod:npmod) oxidase-driven_28\JJ\1740|nadph
23422569T10_23422569T38 NONE no_32\DT\7204911| (r_neg) inactivation_33\NN\13518963|no (r_conj) production_30\NN\30358|in|both|decreased|oxidase-driven|ros|and|inactivation (r_nmod) resulting_23\VBG\2633881|production (r_advcl) involves_12\VBZ\2676054|moreover|,|mechanism|acetylation|,|resulting|. (l_nsubj) mechanism_4\NN\13446390|a|new|controlling (l_acl) controlling_6\VBG\2422663|for|function|activation (l_nmod) activation_11\NN\13561719|after|sirt1 (l_compound) sirt1_10\NN\1740|
23422569T10_23422569T39 NONE no_32\DT\7204911| (r_neg) inactivation_33\NN\13518963|no (r_conj) production_30\NN\30358|in|both|decreased|oxidase-driven|ros|and|inactivation (r_nmod) resulting_23\VBG\2633881|production (r_advcl) involves_12\VBZ\2676054|moreover|,|mechanism|acetylation|,|resulting|. (l_dobj) acetylation_16\NN\13426948|a|decreased|pgc-1α|and|activation (l_compound) pgc-1α_15\NN\1740|
23422569T10_23422569T40 NONE no_32\DT\7204911| (r_neg) inactivation_33\NN\13518963|no (r_conj) production_30\NN\30358|in|both|decreased|oxidase-driven|ros|and|inactivation (r_nmod) resulting_23\VBG\2633881|production (r_advcl) involves_12\VBZ\2676054|moreover|,|mechanism|acetylation|,|resulting|. (l_dobj) acetylation_16\NN\13426948|a|decreased|pgc-1α|and|activation (l_conj) activation_21\NN\13561719|the|subsequent|pparα (l_compound) pparα_20\NN\1740|
23422569T10_23422569T41 NONE no_32\DT\7204911| (r_neg) inactivation_33\NN\13518963|no (r_conj) production_30\NN\30358|in|both|decreased|oxidase-driven|ros|and|inactivation (l_amod) oxidase-driven_28\JJ\1740|nadph
3299141
3299141T19_3299141T35 NONE l-glutamate_2\NN\1740| (r_compound) decarboxylase_3\NN\14732946|of|l-glutamate|and|immunoreactivity|ganglia
3299141T19_3299141T36 NONE l-glutamate_2\NN\1740| (r_compound) decarboxylase_3\NN\14732946|of|l-glutamate|and|immunoreactivity|ganglia (l_conj) immunoreactivity_7\NN\1740|transaminase (l_compound) transaminase_6\NN\15077571|gaba
3299141T20_3299141T35 NONE gaba_5\NN\14601829| (r_compound) transaminase_6\NN\15077571|gaba (r_compound) immunoreactivity_7\NN\1740|transaminase (r_conj) decarboxylase_3\NN\14732946|of|l-glutamate|and|immunoreactivity|ganglia
3299141T20_3299141T36 NONE gaba_5\NN\14601829| (r_compound) transaminase_6\NN\15077571|gaba
3299141T6_3299141T24 NONE l-glutamate_3\NN\1740| (r_compound) decarboxylase_4\NN\14732946|l-glutamate|and|(gaba)-transaminase
3299141T6_3299141T31 NONE l-glutamate_3\NN\1740| (r_compound) decarboxylase_4\NN\14732946|l-glutamate|and|(gaba)-transaminase (l_conj) (gaba)-transaminase_7\NN\1740|gamma-aminobutyrate
3299141T14_3299141T24 NONE gamma-aminobutyrate_6\NN\1740| (r_compound) (gaba)-transaminase_7\NN\1740|gamma-aminobutyrate (r_conj) decarboxylase_4\NN\14732946|l-glutamate|and|(gaba)-transaminase
3299141T14_3299141T31 NONE gamma-aminobutyrate_6\NN\1740| (r_compound) (gaba)-transaminase_7\NN\1740|gamma-aminobutyrate
3299141T15_3299141T24 NONE (gaba)-transaminase_7\NN\1740|gamma-aminobutyrate (r_conj) decarboxylase_4\NN\14732946|l-glutamate|and|(gaba)-transaminase
3299141T15_3299141T31 NONE (gaba)-transaminase_7\NN\1740|gamma-aminobutyrate
3299141T12_3299141T29 NONE glutamate_5\NN\15010703| (r_compound) decarboxylase-_6\NN\1740|several|glutamate|or|cells
3299141T12_3299141T30 NONE glutamate_5\NN\15010703| (r_compound) decarboxylase-_6\NN\1740|several|glutamate|or|cells (l_conj) cells_11\NNS\3080309|gaba-transaminase-immunoreactive|principal|nerve (l_amod) gaba-transaminase-immunoreactive_8\JJ\1740|
3299141T13_3299141T29 NONE gaba-transaminase-immunoreactive_8\JJ\1740| (r_amod) cells_11\NNS\3080309|gaba-transaminase-immunoreactive|principal|nerve (r_conj) decarboxylase-_6\NN\1740|several|glutamate|or|cells
3299141T13_3299141T30 NONE gaba-transaminase-immunoreactive_8\JJ\1740|
3299141T16_3299141T32 NONE glutamate_21\NN\15010703| (r_compound) decarboxylase_22\NN\14732946|to|glutamate|or|gaba-transaminase
3299141T16_3299141T33 NONE glutamate_21\NN\15010703| (r_compound) decarboxylase_22\NN\14732946|to|glutamate|or|gaba-transaminase (l_conj) gaba-transaminase_24\NN\1740|
3299141T17_3299141T32 NONE gaba-transaminase_24\NN\1740| (r_conj) decarboxylase_22\NN\14732946|to|glutamate|or|gaba-transaminase
3299141T17_3299141T33 NONE gaba-transaminase_24\NN\1740|
3299141T1_3299141T21 NONE tyrosine_14\NN\14601829| (r_compound) hydroxylase_15\NN\1740|to|tyrosine
3299141T1_3299141T34 NONE tyrosine_14\NN\14601829| (r_compound) hydroxylase_15\NN\1740|to|tyrosine (r_nmod) immunoreactivity_12\NN\1740|hydroxylase (r_dobj) showed_11\VBD\2137132|sections|,|clusters|also|immunoreactivity|,|suggesting|. (l_nsubj) clusters_9\NNS\7959269|the|small|decarboxylase-immunoreactive|cell (l_amod) decarboxylase-immunoreactive_7\JJ\1740|glutamate
3299141T2_3299141T21 NONE gaba_26\NN\14601829|for|both|and|catecholamine (r_compound) synthesis_29\NN\13446390|gaba (r_nmod) enzymes_23\NNS\14723628|the|synthesis (r_dobj) contain_21\VBP\2632940|that|cells|enzymes (r_ccomp) suggesting_17\VBG\1010118|contain (r_advcl) showed_11\VBD\2137132|sections|,|clusters|also|immunoreactivity|,|suggesting|. (l_dobj) immunoreactivity_12\NN\1740|hydroxylase (l_nmod) hydroxylase_15\NN\1740|to|tyrosine
3299141T2_3299141T34 NONE gaba_26\NN\14601829|for|both|and|catecholamine (r_compound) synthesis_29\NN\13446390|gaba (r_nmod) enzymes_23\NNS\14723628|the|synthesis (r_dobj) contain_21\VBP\2632940|that|cells|enzymes (r_ccomp) suggesting_17\VBG\1010118|contain (r_advcl) showed_11\VBD\2137132|sections|,|clusters|also|immunoreactivity|,|suggesting|. (l_nsubj) clusters_9\NNS\7959269|the|small|decarboxylase-immunoreactive|cell (l_amod) decarboxylase-immunoreactive_7\JJ\1740|glutamate
3299141T3_3299141T21 NONE catecholamine_28\NN\5407119| (r_conj) gaba_26\NN\14601829|for|both|and|catecholamine (r_compound) synthesis_29\NN\13446390|gaba (r_nmod) enzymes_23\NNS\14723628|the|synthesis (r_dobj) contain_21\VBP\2632940|that|cells|enzymes (r_ccomp) suggesting_17\VBG\1010118|contain (r_advcl) showed_11\VBD\2137132|sections|,|clusters|also|immunoreactivity|,|suggesting|. (l_dobj) immunoreactivity_12\NN\1740|hydroxylase (l_nmod) hydroxylase_15\NN\1740|to|tyrosine
3299141T3_3299141T34 NONE catecholamine_28\NN\5407119| (r_conj) gaba_26\NN\14601829|for|both|and|catecholamine (r_compound) synthesis_29\NN\13446390|gaba (r_nmod) enzymes_23\NNS\14723628|the|synthesis (r_dobj) contain_21\VBP\2632940|that|cells|enzymes (r_ccomp) suggesting_17\VBG\1010118|contain (r_advcl) showed_11\VBD\2137132|sections|,|clusters|also|immunoreactivity|,|suggesting|. (l_nsubj) clusters_9\NNS\7959269|the|small|decarboxylase-immunoreactive|cell (l_amod) decarboxylase-immunoreactive_7\JJ\1740|glutamate
3299141T18_3299141T21 NONE glutamate_6\NN\15010703| (r_nmod:npmod) decarboxylase-immunoreactive_7\JJ\1740|glutamate (r_amod) clusters_9\NNS\7959269|the|small|decarboxylase-immunoreactive|cell (r_nsubj) showed_11\VBD\2137132|sections|,|clusters|also|immunoreactivity|,|suggesting|. (l_dobj) immunoreactivity_12\NN\1740|hydroxylase (l_nmod) hydroxylase_15\NN\1740|to|tyrosine
3299141T18_3299141T34 NONE glutamate_6\NN\15010703| (r_nmod:npmod) decarboxylase-immunoreactive_7\JJ\1740|glutamate
3299141T4_3299141T22 NONE gaba-transaminase_13\NN\1740|
3299141T5_3299141T23 NONE gaba-transaminase_2\NN\1740|
3299141T7_3299141T25 NONE gaba-transaminase_16\NN\1740|
3299141T8_3299141T26 NONE gaba-transaminase_9\NN\1740|
3299141T9_3299141T27 NONE gaba-transaminase_4\NN\1740|
3299141T10_3299141T28 NONE gaba-transaminase_0\NN\1740|
15177307
15177307T11_15177307T14 CPR:4 lumiracoxib_10\NN\1740|of|,|inhibitor (l_appos) inhibitor_16\NN\20090|an|oral|cox-2|selective (l_compound) cox-2_14\NN\14737847|
15177307T6_15177307T12 CPR:4 lumiracoxib_28\NN\1740|prexige (r_dep) inhibitor_27\NN\20090|of|the|novel|cyclooxygenase-2|selective|lumiracoxib (l_compound) cyclooxygenase-2_22\NN\14737847|cox-2
15177307T6_15177307T13 CPR:4 lumiracoxib_28\NN\1740|prexige (r_dep) inhibitor_27\NN\20090|of|the|novel|cyclooxygenase-2|selective|lumiracoxib (l_compound) cyclooxygenase-2_22\NN\14737847|cox-2 (l_appos) cox-2_24\NN\14737847|(|)
15177307T7_15177307T12 CPR:4 prexige_30\NN\1740|(|) (r_appos) lumiracoxib_28\NN\1740|prexige (r_dep) inhibitor_27\NN\20090|of|the|novel|cyclooxygenase-2|selective|lumiracoxib (l_compound) cyclooxygenase-2_22\NN\14737847|cox-2
15177307T7_15177307T13 CPR:4 prexige_30\NN\1740|(|) (r_appos) lumiracoxib_28\NN\1740|prexige (r_dep) inhibitor_27\NN\20090|of|the|novel|cyclooxygenase-2|selective|lumiracoxib (l_compound) cyclooxygenase-2_22\NN\14737847|cox-2 (l_appos) cox-2_24\NN\14737847|(|)
23542147
23542147T5_23542147T35 NONE ethanol_0\NN\14708720| (r_compound) extract_1\NN\14589223|ethanol|l. (r_nsubj) suppresses_6\VBZ\2510337|extract|production|inhibiting|. (l_advcl) inhibiting_13\VBG\2510337|by|activation (l_dobj) activation_15\NN\13561719|nf-κb (l_compound) nf-κb_14\NN\1740|
23542147T3_23542147T27 NONE e2_15\NN\1740|prostaglandin|pge2 (r_compound) production_19\NN\30358|against|(lps)-induced|e2|macrophages|,|and|production (l_conj) production_38\NN\30358|interleukin|monocytes (l_compound) interleukin_26\NN\14943950|6|il-6|and|factor (l_nummod) 6_27\CD\13741022|
23542147T3_23542147T28 NONE e2_15\NN\1740|prostaglandin|pge2 (r_compound) production_19\NN\30358|against|(lps)-induced|e2|macrophages|,|and|production (l_conj) production_38\NN\30358|interleukin|monocytes (l_compound) interleukin_26\NN\14943950|6|il-6|and|factor (l_appos) il-6_29\NN\1740|(|)
23542147T3_23542147T29 NONE e2_15\NN\1740|prostaglandin|pge2 (r_compound) production_19\NN\30358|against|(lps)-induced|e2|macrophages|,|and|production (l_conj) production_38\NN\30358|interleukin|monocytes (l_compound) interleukin_26\NN\14943950|6|il-6|and|factor (l_conj) factor_34\NN\7326557|tumor|necrosis|tnf
23542147T3_23542147T30 NONE e2_15\NN\1740|prostaglandin|pge2 (r_compound) production_19\NN\30358|against|(lps)-induced|e2|macrophages|,|and|production (l_conj) production_38\NN\30358|interleukin|monocytes (l_compound) interleukin_26\NN\14943950|6|il-6|and|factor (l_conj) factor_34\NN\7326557|tumor|necrosis|tnf (l_appos) tnf_36\NN\14828193|(|)
23542147T4_23542147T27 NONE pge2_17\NN\1740|(|) (r_appos) e2_15\NN\1740|prostaglandin|pge2 (r_compound) production_19\NN\30358|against|(lps)-induced|e2|macrophages|,|and|production (l_conj) production_38\NN\30358|interleukin|monocytes (l_compound) interleukin_26\NN\14943950|6|il-6|and|factor (l_nummod) 6_27\CD\13741022|
23542147T4_23542147T28 NONE pge2_17\NN\1740|(|) (r_appos) e2_15\NN\1740|prostaglandin|pge2 (r_compound) production_19\NN\30358|against|(lps)-induced|e2|macrophages|,|and|production (l_conj) production_38\NN\30358|interleukin|monocytes (l_compound) interleukin_26\NN\14943950|6|il-6|and|factor (l_appos) il-6_29\NN\1740|(|)
23542147T4_23542147T29 NONE pge2_17\NN\1740|(|) (r_appos) e2_15\NN\1740|prostaglandin|pge2 (r_compound) production_19\NN\30358|against|(lps)-induced|e2|macrophages|,|and|production (l_conj) production_38\NN\30358|interleukin|monocytes (l_compound) interleukin_26\NN\14943950|6|il-6|and|factor (l_conj) factor_34\NN\7326557|tumor|necrosis|tnf
23542147T4_23542147T30 NONE pge2_17\NN\1740|(|) (r_appos) e2_15\NN\1740|prostaglandin|pge2 (r_compound) production_19\NN\30358|against|(lps)-induced|e2|macrophages|,|and|production (l_conj) production_38\NN\30358|interleukin|monocytes (l_compound) interleukin_26\NN\14943950|6|il-6|and|factor (l_conj) factor_34\NN\7326557|tumor|necrosis|tnf (l_appos) tnf_36\NN\14828193|(|)
23542147T1_23542147T9 NONE pge2_8\NN\1740|,|il-6|and|tnf (l_conj) il-6_10\NN\1740|
23542147T1_23542147T10 NONE pge2_8\NN\1740|,|il-6|and|tnf (l_conj) tnf_12\NN\14828193|
23542147T2_23542147T20 NONE ser536_36\NN\1740|on (r_nmod) phosphorylated_34\VBN\1740|ser536 (r_acl) p65_33\NN\1740|of|phosphorylated (r_nmod) form_31\NN\6286395|a|p65 (r_dobj) containing_29\VBG\2632940|form (r_acl) complex_28\NN\5869584|selectively|by|an|nf-κb|containing (r_nmod) transcribed_23\VBN\1020356|which|is|not|complex (r_acl:relcl) gene_18\NN\8459252|the|icam-1|,|transcribed|, (r_nsubj) change_40\VB\46534|gene|did|not (r_parataxis) confirmed_2\VBN\1011725|this|was|ability|,|whereas|change|. (l_nmod) ability_5\NN\4723816|by|their|abrogate (l_acl) abrogate_8\VB\2427334|to|selectively|induction (l_dobj) induction_10\NN\7450842|the|transcription (l_nmod) transcription_13\NN\6349220|of|il-8 (l_compound) il-8_12\NN\1740|
23542147T2_23542147T21 NONE ser536_36\NN\1740|on (r_nmod) phosphorylated_34\VBN\1740|ser536 (r_acl) p65_33\NN\1740|of|phosphorylated (r_nmod) form_31\NN\6286395|a|p65 (r_dobj) containing_29\VBG\2632940|form (r_acl) complex_28\NN\5869584|selectively|by|an|nf-κb|containing (r_nmod) transcribed_23\VBN\1020356|which|is|not|complex (r_acl:relcl) gene_18\NN\8459252|the|icam-1|,|transcribed|, (l_compound) icam-1_17\NN\1740|
23542147T2_23542147T22 NONE ser536_36\NN\1740|on (r_nmod) phosphorylated_34\VBN\1740|ser536 (r_acl) p65_33\NN\1740|of|phosphorylated (r_nmod) form_31\NN\6286395|a|p65 (r_dobj) containing_29\VBG\2632940|form (r_acl) complex_28\NN\5869584|selectively|by|an|nf-κb|containing (l_compound) nf-κb_27\NN\1740|
23542147T2_23542147T23 NONE ser536_36\NN\1740|on (r_nmod) phosphorylated_34\VBN\1740|ser536 (r_acl) p65_33\NN\1740|of|phosphorylated
10847421
8302852
8302852T15_8302852T27 NONE cocaine-sensitive_1\JJ\1740| (r_amod) transporter_4\NN\4490091|a|cocaine-sensitive|drosophila|serotonin|:|cloning|.
8302852T16_8302852T27 NONE serotonin_3\NN\14807737| (r_compound) transporter_4\NN\4490091|a|cocaine-sensitive|drosophila|serotonin|:|cloning|.
8302852T4_8302852T17 NONE cocaine-sensitive_1\JJ\1740| (r_amod) cdna_12\NN\14830364|a|cocaine-sensitive|,|high-affinity|drosophila|serotonin|5-hydroxytryptamine|)|transporter|,|denoted|, (l_acl) denoted_14\VBN\1030132|dsert1 (l_xcomp) dsert1_15\NN\1740|
8302852T4_8302852T20 NONE cocaine-sensitive_1\JJ\1740| (r_amod) cdna_12\NN\14830364|a|cocaine-sensitive|,|high-affinity|drosophila|serotonin|5-hydroxytryptamine|)|transporter|,|denoted|, (l_compound) transporter_11\NN\4490091|
8302852T8_8302852T17 NONE serotonin_5\NN\14807737| (r_compound) cdna_12\NN\14830364|a|cocaine-sensitive|,|high-affinity|drosophila|serotonin|5-hydroxytryptamine|)|transporter|,|denoted|, (l_acl) denoted_14\VBN\1030132|dsert1 (l_xcomp) dsert1_15\NN\1740|
8302852T8_8302852T20 NONE serotonin_5\NN\14807737| (r_compound) cdna_12\NN\14830364|a|cocaine-sensitive|,|high-affinity|drosophila|serotonin|5-hydroxytryptamine|)|transporter|,|denoted|, (l_compound) transporter_11\NN\4490091|
8302852T10_8302852T17 NONE 5-hydroxytryptamine_7\NN\14807737|(|5ht (r_compound) cdna_12\NN\14830364|a|cocaine-sensitive|,|high-affinity|drosophila|serotonin|5-hydroxytryptamine|)|transporter|,|denoted|, (l_acl) denoted_14\VBN\1030132|dsert1 (l_xcomp) dsert1_15\NN\1740|
8302852T10_8302852T20 NONE 5-hydroxytryptamine_7\NN\14807737|(|5ht (r_compound) cdna_12\NN\14830364|a|cocaine-sensitive|,|high-affinity|drosophila|serotonin|5-hydroxytryptamine|)|transporter|,|denoted|, (l_compound) transporter_11\NN\4490091|
8302852T13_8302852T17 NONE 5ht_9\NN\1740|; (r_dep) 5-hydroxytryptamine_7\NN\14807737|(|5ht (r_compound) cdna_12\NN\14830364|a|cocaine-sensitive|,|high-affinity|drosophila|serotonin|5-hydroxytryptamine|)|transporter|,|denoted|, (l_acl) denoted_14\VBN\1030132|dsert1 (l_xcomp) dsert1_15\NN\1740|
8302852T13_8302852T20 NONE 5ht_9\NN\1740|; (r_dep) 5-hydroxytryptamine_7\NN\14807737|(|5ht (r_compound) cdna_12\NN\14830364|a|cocaine-sensitive|,|high-affinity|drosophila|serotonin|5-hydroxytryptamine|)|transporter|,|denoted|, (l_compound) transporter_11\NN\4490091|
8302852T1_8302852T18 NONE monoamines_6\NNS\14739004|of|other (r_nmod) transport_3\NN\3575240|little|monoamines (r_dobj) shows_1\VBZ\2137132|dsert1|transport|and|dependent|. (l_nsubj) dsert1_0\NNP\1740|
8302852T2_8302852T18 NONE na+_9\NN\1740|is|and|cl- (r_nmod:npmod) dependent_12\JJ\1740|na+ (r_conj) shows_1\VBZ\2137132|dsert1|transport|and|dependent|. (l_nsubj) dsert1_0\NNP\1740|
8302852T3_8302852T18 NONE cl-_11\JJ\1740| (r_conj) na+_9\NN\1740|is|and|cl- (r_nmod:npmod) dependent_12\JJ\1740|na+ (r_conj) shows_1\VBZ\2137132|dsert1|transport|and|dependent|. (l_nsubj) dsert1_0\NNP\1740|
8302852T5_8302852T19 NONE 5ht_19\NN\1740|mammalian|,|norepinephrine|,|and|dopamine (r_compound) transporters_25\NNS\4490091|5ht (r_conj) dsert1_16\NN\1740|among|and|transporters
8302852T5_8302852T21 NONE 5ht_19\NN\1740|mammalian|,|norepinephrine|,|and|dopamine (r_compound) transporters_25\NNS\4490091|5ht
8302852T6_8302852T19 NONE norepinephrine_21\NN\14807929| (r_conj) 5ht_19\NN\1740|mammalian|,|norepinephrine|,|and|dopamine (r_compound) transporters_25\NNS\4490091|5ht (r_conj) dsert1_16\NN\1740|among|and|transporters
8302852T6_8302852T21 NONE norepinephrine_21\NN\14807929| (r_conj) 5ht_19\NN\1740|mammalian|,|norepinephrine|,|and|dopamine (r_compound) transporters_25\NNS\4490091|5ht
8302852T7_8302852T19 NONE dopamine_24\NN\14807737| (r_conj) 5ht_19\NN\1740|mammalian|,|norepinephrine|,|and|dopamine (r_compound) transporters_25\NNS\4490091|5ht (r_conj) dsert1_16\NN\1740|among|and|transporters
8302852T7_8302852T21 NONE dopamine_24\NN\14807737| (r_conj) 5ht_19\NN\1740|mammalian|,|norepinephrine|,|and|dopamine (r_compound) transporters_25\NNS\4490091|5ht
8302852T9_8302852T22 NONE catecholamine_20\NN\5407119| (r_compound) transporters_21\NNS\4490091|of|mammalian|catecholamine (r_nmod) those_17\DT\1740|to|transporters (r_nmod) similar_15\JJ\1740|interestingly|,|properties|are|more|those|transporters|. (l_nsubj) properties_4\NNS\32613|the|pharmacological|dsert1|,|sensitivity|, (l_nmod) dsert1_6\NN\1740|of
8302852T9_8302852T23 NONE catecholamine_20\NN\5407119| (r_compound) transporters_21\NNS\4490091|of|mammalian|catecholamine
8302852T9_8302852T24 NONE catecholamine_20\NN\5407119| (r_compound) transporters_21\NNS\4490091|of|mammalian|catecholamine (r_nmod) those_17\DT\1740|to|transporters (r_nmod) similar_15\JJ\1740|interestingly|,|properties|are|more|those|transporters|. (l_nmod) transporters_26\NNS\4490091|than|to|mammalian|5ht
8302852T11_8302852T22 NONE 5ht_25\NN\1740| (r_compound) transporters_26\NNS\4490091|than|to|mammalian|5ht (r_nmod) similar_15\JJ\1740|interestingly|,|properties|are|more|those|transporters|. (l_nsubj) properties_4\NNS\32613|the|pharmacological|dsert1|,|sensitivity|, (l_nmod) dsert1_6\NN\1740|of
8302852T11_8302852T23 NONE 5ht_25\NN\1740| (r_compound) transporters_26\NNS\4490091|than|to|mammalian|5ht (r_nmod) similar_15\JJ\1740|interestingly|,|properties|are|more|those|transporters|. (l_nmod) those_17\DT\1740|to|transporters (l_nmod) transporters_21\NNS\4490091|of|mammalian|catecholamine
8302852T11_8302852T24 NONE 5ht_25\NN\1740| (r_compound) transporters_26\NNS\4490091|than|to|mammalian|5ht
8302852T14_8302852T25 NONE 5ht_14\NN\1740| (r_compound) transporters_15\NNS\4490091|of|5ht (r_nmod) diversity_12\NN\4751098|of|the|transporters (r_nmod) knowledge_9\NN\23100|to|our|diversity (r_nmod) adds_5\VBZ\156601|cloning|significantly|knowledge|regard|. (l_nsubj) cloning_0\NN\638080|and|characterization|dsert1 (l_nmod) dsert1_4\NN\1740|of
8302852T14_8302852T26 NONE 5ht_14\NN\1740| (r_compound) transporters_15\NNS\4490091|of|5ht
9015795
9015795T24_9015795T38 NONE dopamine_6\NN\14807737| (r_compound) receptors_8\NNS\5225602|for|dopamine|d2
9015795T24_9015795T39 NONE dopamine_6\NN\14807737| (r_compound) receptors_8\NNS\5225602|for|dopamine|d2 (r_nmod) affinity_4\NN\11426530|low|receptors (r_dobj) have_2\VBP\2108377|neuroleptics|affinity|or|selective|. (l_conj) selective_11\JJ\1740|are|receptors (l_nmod) receptors_14\NNS\5225602|for|d4
9015795T20_9015795T35 NONE dopamine_16\NN\14807737|and|serotonin (r_compound) receptors_19\NNS\5225602|at|the|relevant|dopamine
9015795T22_9015795T35 NONE serotonin_18\NN\14807737| (r_conj) dopamine_16\NN\14807737|and|serotonin (r_compound) receptors_19\NNS\5225602|at|the|relevant|dopamine
9015795T23_9015795T37 NONE dopamine_19\NN\14807737| (r_compound) receptor_21\NN\5225602|at|the|dopamine|d2
9015795T1_9015795T25 NONE dopamine_6\NN\14807737| (r_compound) d2_7\NN\1740|dopamine|and|d4 (r_compound) receptors_10\NNS\5225602|for|d2|,|as|receptors
9015795T1_9015795T26 NONE dopamine_6\NN\14807737| (r_compound) d2_7\NN\1740|dopamine|and|d4 (r_compound) receptors_10\NNS\5225602|for|d2|,|as|receptors (l_conj) receptors_18\NNS\5225602|for|serotonin|5-ht2a
9015795T2_9015795T25 NONE serotonin_16\NN\14807737| (r_compound) receptors_18\NNS\5225602|for|serotonin|5-ht2a (r_conj) receptors_10\NNS\5225602|for|d2|,|as|receptors
9015795T2_9015795T26 NONE serotonin_16\NN\14807737| (r_compound) receptors_18\NNS\5225602|for|serotonin|5-ht2a
9015795T3_9015795T27 NONE clozapine_3\NN\3713736| (r_nsubj) revealed_4\VBD\2137132|example|,|clozapine|value|receptor|,|agreeing|. (l_nmod) receptor_15\NN\5225602|at|the|dopamine|d4
9015795T3_9015795T28 NONE clozapine_3\NN\3713736| (r_nsubj) revealed_4\VBD\2137132|example|,|clozapine|value|receptor|,|agreeing|. (l_advcl) agreeing_17\VBG\797697|value (l_nmod) value_20\NN\5856066|with|the|measured (l_acl) measured_22\VBN\697589|directly|[3h]-clozapine (l_nmod) [3h]-clozapine_24\NN\1740|with|d4 (l_nmod) d4_26\NN\1740|at
9015795T4_9015795T27 NONE dopamine_13\NN\14807737| (r_compound) receptor_15\NN\5225602|at|the|dopamine|d4
9015795T4_9015795T28 NONE dopamine_13\NN\14807737| (r_compound) receptor_15\NN\5225602|at|the|dopamine|d4 (r_nmod) revealed_4\VBD\2137132|example|,|clozapine|value|receptor|,|agreeing|. (l_advcl) agreeing_17\VBG\797697|value (l_nmod) value_20\NN\5856066|with|the|measured (l_acl) measured_22\VBN\697589|directly|[3h]-clozapine (l_nmod) [3h]-clozapine_24\NN\1740|with|d4 (l_nmod) d4_26\NN\1740|at
9015795T5_9015795T27 NONE [3h]-clozapine_24\NN\1740|with|d4 (r_nmod) measured_22\VBN\697589|directly|[3h]-clozapine (r_acl) value_20\NN\5856066|with|the|measured (r_nmod) agreeing_17\VBG\797697|value (r_advcl) revealed_4\VBD\2137132|example|,|clozapine|value|receptor|,|agreeing|. (l_nmod) receptor_15\NN\5225602|at|the|dopamine|d4
9015795T5_9015795T28 NONE [3h]-clozapine_24\NN\1740|with|d4 (l_nmod) d4_26\NN\1740|at
9015795T6_9015795T29 NONE clozapine_3\NN\3713736| (r_nsubj) competes_4\VBZ\1740|because|clozapine|dopamine (r_advcl) derived_24\VBN\634472|however|,|competes|,|concentration|can|be|nm|,|agreeing|. (l_nsubjpass) concentration_12\NN\4916342|the|in|clozapine|occupy (l_dep) occupy_17\VB\2413480|(|to|receptors|) (l_dobj) receptors_20\NNS\5225602|dopamine|d4
9015795T7_9015795T29 NONE dopamine_7\NN\14807737|with|endogenous (r_nmod) competes_4\VBZ\1740|because|clozapine|dopamine (r_advcl) derived_24\VBN\634472|however|,|competes|,|concentration|can|be|nm|,|agreeing|. (l_nsubjpass) concentration_12\NN\4916342|the|in|clozapine|occupy (l_dep) occupy_17\VB\2413480|(|to|receptors|) (l_dobj) receptors_20\NNS\5225602|dopamine|d4
9015795T8_9015795T29 NONE clozapine_14\NN\3713736|of (r_nmod) concentration_12\NN\4916342|the|in|clozapine|occupy (l_dep) occupy_17\VB\2413480|(|to|receptors|) (l_dobj) receptors_20\NNS\5225602|dopamine|d4
9015795T9_9015795T29 NONE dopamine_18\NN\14807737| (r_compound) receptors_20\NNS\5225602|dopamine|d4
9015795T10_9015795T30 NONE remoxipride_3\NN\1740|,|clozapine|,|perlapine|,|seroquel|,|and|melperone (r_dep) neuroleptics_2\NNS\4470232|the|atypical|remoxipride (r_nsubj) had_13\VBD\2108377|neuroleptics|affinity|constants|. (l_dobj) affinity_15\NN\11426530|low|receptor (l_nmod) receptor_20\NN\5225602|for|the|dopamine|d2
9015795T11_9015795T30 NONE clozapine_5\NN\3713736| (r_conj) remoxipride_3\NN\1740|,|clozapine|,|perlapine|,|seroquel|,|and|melperone (r_dep) neuroleptics_2\NNS\4470232|the|atypical|remoxipride (r_nsubj) had_13\VBD\2108377|neuroleptics|affinity|constants|. (l_dobj) affinity_15\NN\11426530|low|receptor (l_nmod) receptor_20\NN\5225602|for|the|dopamine|d2
9015795T12_9015795T30 NONE perlapine_7\NN\1740| (r_conj) remoxipride_3\NN\1740|,|clozapine|,|perlapine|,|seroquel|,|and|melperone (r_dep) neuroleptics_2\NNS\4470232|the|atypical|remoxipride (r_nsubj) had_13\VBD\2108377|neuroleptics|affinity|constants|. (l_dobj) affinity_15\NN\11426530|low|receptor (l_nmod) receptor_20\NN\5225602|for|the|dopamine|d2
9015795T13_9015795T30 NONE seroquel_9\NN\1740| (r_conj) remoxipride_3\NN\1740|,|clozapine|,|perlapine|,|seroquel|,|and|melperone (r_dep) neuroleptics_2\NNS\4470232|the|atypical|remoxipride (r_nsubj) had_13\VBD\2108377|neuroleptics|affinity|constants|. (l_dobj) affinity_15\NN\11426530|low|receptor (l_nmod) receptor_20\NN\5225602|for|the|dopamine|d2
9015795T14_9015795T30 NONE melperone_12\NN\1740| (r_conj) remoxipride_3\NN\1740|,|clozapine|,|perlapine|,|seroquel|,|and|melperone (r_dep) neuroleptics_2\NNS\4470232|the|atypical|remoxipride (r_nsubj) had_13\VBD\2108377|neuroleptics|affinity|constants|. (l_dobj) affinity_15\NN\11426530|low|receptor (l_nmod) receptor_20\NN\5225602|for|the|dopamine|d2
9015795T15_9015795T30 NONE dopamine_18\NN\14807737| (r_compound) receptor_20\NN\5225602|for|the|dopamine|d2
9015795T17_9015795T31 NONE dopamine_12\NN\14807737| (r_compound) receptors_14\NNS\5225602|at|dopamine|d2
9015795T18_9015795T31 NONE dopamine_24\NN\14807737|by|endogenous (r_nmod) displacement_21\NN\197772|to|dopamine (r_nmod) resistant_19\JJ\1740|them|more|displacement (r_ccomp) making_16\VBG\126264|resistant (r_advcl) have_3\VBP\2108377|neuroleptics|values|receptors|,|making|. (l_nmod) receptors_14\NNS\5225602|at|dopamine|d2
9015795T19_9015795T34 NONE dopamine_19\NN\14807737| (r_compound) receptors_21\NNS\5225602|for|dopamine|d2
9015795T19_9015795T36 NONE dopamine_19\NN\14807737| (r_compound) receptors_21\NNS\5225602|for|dopamine|d2 (r_nmod) affinity_17\NN\11426530|a|low|receptors (r_dobj) have_14\VBP\2108377|that|affinity (r_acl:relcl) those_12\DT\1740|have|and|those (l_conj) those_23\DT\1740|selective (l_acl:relcl) selective_26\JJ\1740|that|are|receptors (l_nmod) receptors_30\NNS\5225602|for|dopamine|d4
9015795T21_9015795T34 NONE dopamine_28\NN\14807737| (r_compound) receptors_30\NNS\5225602|for|dopamine|d4 (r_nmod) selective_26\JJ\1740|that|are|receptors (r_acl:relcl) those_23\DT\1740|selective (r_conj) those_12\DT\1740|have|and|those (l_acl:relcl) have_14\VBP\2108377|that|affinity (l_dobj) affinity_17\NN\11426530|a|low|receptors (l_nmod) receptors_21\NNS\5225602|for|dopamine|d2
9015795T21_9015795T36 NONE dopamine_28\NN\14807737| (r_compound) receptors_30\NNS\5225602|for|dopamine|d4
7678677
7678677T14_7678677T19 CPR:6 alprenolol_0\NN\1740|and|bromoacetylalprenololmenthane (r_nsubj) antagonists_7\NNS\7846|alprenolol|are|competitive|reversible|1-adrenoceptors|. (l_nmod) 1-adrenoceptors_11\NNS\1740|at|the|beta|atria
7678677T15_7678677T19 CPR:6 bromoacetylalprenololmenthane_2\NN\1740| (r_conj) alprenolol_0\NN\1740|and|bromoacetylalprenololmenthane (r_nsubj) antagonists_7\NNS\7846|alprenolol|are|competitive|reversible|1-adrenoceptors|. (l_nmod) 1-adrenoceptors_11\NNS\1740|at|the|beta|atria
7678677T1_7678677T16 CPR:4 baam_2\NN\1740| (r_conj) alprenolol_0\NN\1740|and|baam|10(-7 (r_nsubj) inhibited_16\VBD\2510337|alprenolol|response|slightly|,|indicative|. (l_advcl) indicative_25\JJ\1740|which|is|activity (l_nmod) activity_28\NN\30358|of|membrane-stabilizing|independent (l_amod) independent_29\JJ\1740|blockade (l_nmod) blockade_32\NN\952963|of|beta-adrenoceptor (l_compound) beta-adrenoceptor_31\NN\5608868|
7678677T13_7678677T16 CPR:4 alprenolol_0\NN\1740|and|baam|10(-7 (r_nsubj) inhibited_16\VBD\2510337|alprenolol|response|slightly|,|indicative|. (l_advcl) indicative_25\JJ\1740|which|is|activity (l_nmod) activity_28\NN\30358|of|membrane-stabilizing|independent (l_amod) independent_29\JJ\1740|blockade (l_nmod) blockade_32\NN\952963|of|beta-adrenoceptor (l_compound) beta-adrenoceptor_31\NN\5608868|
7678677T3_7678677T17 CPR:6 alprenolol_0\NN\1740|and|baam (r_nsubj) caused_4\VBD\1617192|alprenolol|also|antagonism|,|and|reversible (l_conj) reversible_18\JJ\1740|antagonism|was|slowly|. (l_nsubj) antagonism_15\NN\24720|this|beta|1-adrenoceptor (l_amod) 1-adrenoceptor_14\NN\1740|
7678677T4_7678677T17 CPR:6 baam_2\NN\1740| (r_conj) alprenolol_0\NN\1740|and|baam (r_nsubj) caused_4\VBD\1617192|alprenolol|also|antagonism|,|and|reversible (l_conj) reversible_18\JJ\1740|antagonism|was|slowly|. (l_nsubj) antagonism_15\NN\24720|this|beta|1-adrenoceptor (l_amod) 1-adrenoceptor_14\NN\1740|
7678677T6_7678677T17 CPR:5 isoprenaline_8\NN\1740| (r_compound) responses_9\NNS\11410625|of|isoprenaline (r_nmod) antagonism_6\NN\24720|surmountable|responses (r_dobj) caused_4\VBD\1617192|alprenolol|also|antagonism|,|and|reversible (l_conj) reversible_18\JJ\1740|antagonism|was|slowly|. (l_nsubj) antagonism_15\NN\24720|this|beta|1-adrenoceptor (l_amod) 1-adrenoceptor_14\NN\1740|
7678677T10_7678677T18 CPR:6 alprenolol_3\NN\1740|and|baam (r_nsubj) antagonists_12\NNS\7846|that|alprenolol|are|competitive|reversible|beta|1-adrenoceptor|atria (l_compound) 1-adrenoceptor_11\NN\1740|
7678677T11_7678677T18 CPR:6 baam_5\NNP\1740| (r_conj) alprenolol_3\NN\1740|and|baam (r_nsubj) antagonists_12\NNS\7846|that|alprenolol|are|competitive|reversible|beta|1-adrenoceptor|atria (l_compound) 1-adrenoceptor_11\NN\1740|
23179966
23179966T12_23179966T31 NONE glutamate_3\NN\15010703| (r_compound) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors
23179966T12_23179966T32 NONE glutamate_3\NN\15010703| (r_compound) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (l_appos) mglurs_6\NNS\1740|(|)
23179966T12_23179966T33 NONE glutamate_3\NN\15010703| (r_compound) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (l_conj) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (l_punct) )_11\-RRB-\1740|
23179966T12_23179966T34 NONE glutamate_3\NN\15010703| (r_compound) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_xcomp) form_17\VB\1617192|to|heterodimers (l_dobj) heterodimers_18\NNS\1740|modulate (l_acl:relcl) modulate_20\VBP\1724459|that|signaling|differentially (l_dobj) signaling_23\NN\33020|g-protein-mediated|intracellular (l_amod) g-protein-mediated_21\JJ\1740|
23179966T12_23179966T35 NONE glutamate_3\NN\15010703| (r_compound) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_dep) compared_25\VBN\644583|homomers (l_nmod) homomers_31\NNS\1740|to|mglur2 (l_compound) mglur2_27\NN\1740|and|5-ht(2a
23179966T12_23179966T36 NONE glutamate_3\NN\15010703| (r_compound) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_dep) compared_25\VBN\644583|homomers (l_nmod) homomers_31\NNS\1740|to|mglur2 (l_compound) mglur2_27\NN\1740|and|5-ht(2a (l_conj) 5-ht(2a_29\NN\1740|) (l_punct) )_30\-RRB-\1740|
23179966T13_23179966T31 NONE serotonin_9\NN\14807737| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors
23179966T13_23179966T32 NONE serotonin_9\NN\14807737| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (l_appos) mglurs_6\NNS\1740|(|)
23179966T13_23179966T33 NONE serotonin_9\NN\14807737| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (l_punct) )_11\-RRB-\1740|
23179966T13_23179966T34 NONE serotonin_9\NN\14807737| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_xcomp) form_17\VB\1617192|to|heterodimers (l_dobj) heterodimers_18\NNS\1740|modulate (l_acl:relcl) modulate_20\VBP\1724459|that|signaling|differentially (l_dobj) signaling_23\NN\33020|g-protein-mediated|intracellular (l_amod) g-protein-mediated_21\JJ\1740|
23179966T13_23179966T35 NONE serotonin_9\NN\14807737| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_dep) compared_25\VBN\644583|homomers (l_nmod) homomers_31\NNS\1740|to|mglur2 (l_compound) mglur2_27\NN\1740|and|5-ht(2a
23179966T13_23179966T36 NONE serotonin_9\NN\14807737| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_dep) compared_25\VBN\644583|homomers (l_nmod) homomers_31\NNS\1740|to|mglur2 (l_compound) mglur2_27\NN\1740|and|5-ht(2a (l_conj) 5-ht(2a_29\NN\1740|) (l_punct) )_30\-RRB-\1740|
23179966T14_23179966T31 NONE 5-ht(2a_10\NN\1740| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors
23179966T14_23179966T32 NONE 5-ht(2a_10\NN\1740| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (l_appos) mglurs_6\NNS\1740|(|)
23179966T14_23179966T33 NONE 5-ht(2a_10\NN\1740| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (l_punct) )_11\-RRB-\1740|
23179966T14_23179966T34 NONE 5-ht(2a_10\NN\1740| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_xcomp) form_17\VB\1617192|to|heterodimers (l_dobj) heterodimers_18\NNS\1740|modulate (l_acl:relcl) modulate_20\VBP\1724459|that|signaling|differentially (l_dobj) signaling_23\NN\33020|g-protein-mediated|intracellular (l_amod) g-protein-mediated_21\JJ\1740|
23179966T14_23179966T35 NONE 5-ht(2a_10\NN\1740| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_dep) compared_25\VBN\644583|homomers (l_nmod) homomers_31\NNS\1740|to|mglur2 (l_compound) mglur2_27\NN\1740|and|5-ht(2a
23179966T14_23179966T36 NONE 5-ht(2a_10\NN\1740| (r_compound) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (r_conj) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (r_nsubjpass) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_dep) compared_25\VBN\644583|homomers (l_nmod) homomers_31\NNS\1740|to|mglur2 (l_compound) mglur2_27\NN\1740|and|5-ht(2a (l_conj) 5-ht(2a_29\NN\1740|) (l_punct) )_30\-RRB-\1740|
23179966T15_23179966T31 NONE 5-ht(2a_29\NN\1740|) (r_conj) mglur2_27\NN\1740|and|5-ht(2a (r_compound) homomers_31\NNS\1740|to|mglur2 (r_nmod) compared_25\VBN\644583|homomers (r_dep) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_nsubjpass) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors
23179966T15_23179966T32 NONE 5-ht(2a_29\NN\1740|) (r_conj) mglur2_27\NN\1740|and|5-ht(2a (r_compound) homomers_31\NNS\1740|to|mglur2 (r_nmod) compared_25\VBN\644583|homomers (r_dep) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_nsubjpass) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (l_appos) mglurs_6\NNS\1740|(|)
23179966T15_23179966T33 NONE 5-ht(2a_29\NN\1740|) (r_conj) mglur2_27\NN\1740|and|5-ht(2a (r_compound) homomers_31\NNS\1740|to|mglur2 (r_nmod) compared_25\VBN\644583|homomers (r_dep) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_nsubjpass) receptors_4\NNS\5225602|type|ii|metabotropic|glutamate|mglurs|and|receptors (l_conj) receptors_12\NNS\5225602|serotonin|5-ht(2a|) (l_punct) )_11\-RRB-\1740|
23179966T15_23179966T34 NONE 5-ht(2a_29\NN\1740|) (r_conj) mglur2_27\NN\1740|and|5-ht(2a (r_compound) homomers_31\NNS\1740|to|mglur2 (r_nmod) compared_25\VBN\644583|homomers (r_dep) reported_15\VBN\831651|receptors|have|been|form|compared|. (l_xcomp) form_17\VB\1617192|to|heterodimers (l_dobj) heterodimers_18\NNS\1740|modulate (l_acl:relcl) modulate_20\VBP\1724459|that|signaling|differentially (l_dobj) signaling_23\NN\33020|g-protein-mediated|intracellular (l_amod) g-protein-mediated_21\JJ\1740|
23179966T15_23179966T35 NONE 5-ht(2a_29\NN\1740|) (r_conj) mglur2_27\NN\1740|and|5-ht(2a
23179966T15_23179966T36 NONE 5-ht(2a_29\NN\1740|) (l_punct) )_30\-RRB-\1740|
23179966T17_23179966T37 NONE 5-ht(2a_11\NN\1740|) (r_conj) d(2_8\NN\1740|)|and|5-ht(2a (r_compound) receptors_13\NNS\5225602|d(2
23179966T20_23179966T38 NONE n-methyl-d-aspartate_20\NN\1740|with|nmda|,|d(2|)|and|5-ht(2 (r_compound) receptors_30\NNS\5225602|n-methyl-d-aspartate
23179966T21_23179966T38 NONE nmda_22\NN\1740|(|) (r_appos) n-methyl-d-aspartate_20\NN\1740|with|nmda|,|d(2|)|and|5-ht(2 (r_compound) receptors_30\NNS\5225602|n-methyl-d-aspartate
23179966T22_23179966T38 NONE 5-ht(2_28\NN\1740|) (r_conj) n-methyl-d-aspartate_20\NN\1740|with|nmda|,|d(2|)|and|5-ht(2 (r_compound) receptors_30\NNS\5225602|n-methyl-d-aspartate
23179966T1_23179966T39 NONE dopamine_28\NN\14807737| (r_compound) affinity_30\NN\11426530|with|high|dopamine|receptor (r_nmod) antipsychotics_25\NNS\4470232|by|affinity|and|cortex (r_nmod) induced_21\VBN\1627355|homer1a|is|striatum|antipsychotics|antipsychotics|. (l_nsubjpass) homer1a_0\NN\1740|,|member|, (l_appos) member_4\NN\9816771|the|inducible|family (l_nmod) family_8\NN\8189659|of|the|homer|proteins|implicated (l_compound) homer_7\NN\131090|
23179966T2_23179966T28 NONE dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|,
23179966T2_23179966T29 NONE dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|, (l_conj) glycogen-synthase-kinase-3_7\NN\1740|gsk-3
23179966T2_23179966T30 NONE dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|, (l_conj) glycogen-synthase-kinase-3_7\NN\1740|gsk-3 (l_appos) gsk-3_9\NN\1740|(|)
23179966T3_23179966T28 NONE serotonin_26\NN\14807737| (r_conj) dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|,
23179966T3_23179966T29 NONE serotonin_26\NN\14807737| (r_conj) dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|, (l_conj) glycogen-synthase-kinase-3_7\NN\1740|gsk-3
23179966T3_23179966T30 NONE serotonin_26\NN\14807737| (r_conj) dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|, (l_conj) glycogen-synthase-kinase-3_7\NN\1740|gsk-3 (l_appos) gsk-3_9\NN\1740|(|)
23179966T4_23179966T28 NONE glutamate_29\NN\15010703| (r_conj) dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|,
23179966T4_23179966T29 NONE glutamate_29\NN\15010703| (r_conj) dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|, (l_conj) glycogen-synthase-kinase-3_7\NN\1740|gsk-3
23179966T4_23179966T30 NONE glutamate_29\NN\15010703| (r_conj) dopamine_24\NN\14807737|,|serotonin|,|and|glutamate (r_compound) neurotransmission_30\NN\1740|dopamine (r_dobj) targeting_23\VBG\1151110|neurotransmission (r_acl) antipsychotics_21\NNS\4470232|of|,|targeting (r_nmod) action_19\NN\30358|of|antipsychotics (r_nmod) mechanism_17\NN\13446390|in|the|action (r_nmod) involved_14\VBN\2676054|molecules|could|be|mechanism|. (l_nsubjpass) molecules_1\NNS\9465459|signaling|,|akt (l_nmod) akt_5\NN\1740|such|and|glycogen-synthase-kinase-3|, (l_conj) glycogen-synthase-kinase-3_7\NN\1740|gsk-3 (l_appos) gsk-3_9\NN\1740|(|)
23294255
23294255T1_23294255T4 NONE serine_2\NN\14601829| (r_compound) plasmin_4\NN\14732946|the|trypsin-like|serine|protease (l_compound) protease_3\NN\14732946|
23294255T1_23294255T6 NONE serine_2\NN\14601829| (r_compound) plasmin_4\NN\14732946|the|trypsin-like|serine|protease
23294255T1_23294255T7 NONE serine_2\NN\14601829| (r_compound) plasmin_4\NN\14732946|the|trypsin-like|serine|protease (l_amod) trypsin-like_1\JJ\1740|
23294255T2_23294255T8 NONE serine_31\NN\14601829| (r_compound) proteases_32\NNS\14732946|for|all|other|tested|trypsin-like|serine (r_nmod) determined_24\VBN\1645601|values|were|proteases|,|exception (r_parataxis) binds_5\VBZ\1290422|inhibitor|plasmin|constant|,|whereas|determined|. (l_nmod) plasmin_7\NN\14732946|to
23294255T2_23294255T9 NONE serine_31\NN\14601829| (r_compound) proteases_32\NNS\14732946|for|all|other|tested|trypsin-like|serine
23294255T2_23294255T10 NONE serine_31\NN\14601829| (r_compound) proteases_32\NNS\14732946|for|all|other|tested|trypsin-like|serine (r_nmod) determined_24\VBN\1645601|values|were|proteases|,|exception (l_nmod) exception_36\NN\5706954|with|the|trypsin (l_nmod) trypsin_38\NN\14732946|of|,|inhibited
15635044
15635044T2_15635044T46 NONE acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T3_15635044T46 NONE leu/phe(7.38_8\NN\1740|) (r_appos) acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T4_15635044T46 NONE leu/phe(7.38_8\NN\1740|) (r_appos) acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T5_15635044T46 NONE leu/phe(7.43_11\NN\1740|) (r_conj) acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T6_15635044T46 NONE leu/phe(7.43_11\NN\1740|) (r_conj) acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T7_15635044T46 NONE ala/pro(7.46_14\NN\1740|) (r_conj) acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T8_15635044T46 NONE ala/pro(7.46_14\NN\1740|) (r_conj) acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T9_15635044T46 NONE pro/cys(7.47_18\NN\1740|) (r_conj) acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T10_15635044T46 NONE pro/cys(7.47_18\NN\1740|) (r_conj) acids_6\NNS\14818238|four|amino|,|leu/phe(7.38|,|leu/phe(7.43|,|ala/pro(7.46|,|and|pro/cys(7.47|tmh7 (l_nmod) tmh7_21\NN\1740|in
15635044T1_15635044T20 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (r_parataxis) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T1_15635044T21 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (r_parataxis) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T1_15635044T22 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (r_parataxis) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T1_15635044T23 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T1_15635044T24 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T1_15635044T25 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T1_15635044T27 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T1_15635044T28 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T1_15635044T29 NONE acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T1_15635044T31 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T1_15635044T48 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (r_parataxis) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_nsubj) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T1_15635044T49 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (r_parataxis) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_nsubj) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T1_15635044T50 NONE acids_75\NNS\14818238|amino|positions (r_nsubj) important_85\JJ\1740|that|acids|are|more|position|recognition (r_ccomp) indicating_72\VBG\952524|important (r_advcl) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (r_parataxis) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_nsubj) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
15635044T11_15635044T20 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T11_15635044T21 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T11_15635044T22 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T11_15635044T23 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T11_15635044T24 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T11_15635044T25 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T11_15635044T27 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T11_15635044T28 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T11_15635044T29 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nsubj) acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T11_15635044T31 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T11_15635044T48 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T11_15635044T49 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T11_15635044T50 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
15635044T12_15635044T20 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T12_15635044T21 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T12_15635044T22 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T12_15635044T23 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T12_15635044T24 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T12_15635044T25 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T12_15635044T27 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T12_15635044T28 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T12_15635044T29 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nsubj) acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T12_15635044T31 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T12_15635044T48 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T12_15635044T49 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T12_15635044T50 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
15635044T13_15635044T20 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T13_15635044T21 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T13_15635044T22 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T13_15635044T23 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T13_15635044T24 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T13_15635044T25 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T13_15635044T27 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T13_15635044T28 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T13_15635044T29 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nsubj) acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T13_15635044T31 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T13_15635044T48 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T13_15635044T49 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T13_15635044T50 NONE pro(7.31)-pro(7.32)-ser(7.33_6\CD\1740| (r_compound) motif_8\NN\3178782|(|pro(7.31)-pro(7.32)-ser(7.33|) (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
15635044T14_15635044T20 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T14_15635044T21 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T14_15635044T22 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T14_15635044T23 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T14_15635044T24 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T14_15635044T25 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T14_15635044T27 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T14_15635044T28 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T14_15635044T29 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nsubj) acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T14_15635044T31 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T14_15635044T48 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T14_15635044T49 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T14_15635044T50 NONE ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
15635044T15_15635044T20 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T15_15635044T21 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T15_15635044T22 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T15_15635044T23 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T15_15635044T24 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T15_15635044T25 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T15_15635044T27 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T15_15635044T28 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T15_15635044T29 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nsubj) acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T15_15635044T31 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T15_15635044T48 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T15_15635044T49 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T15_15635044T50 NONE leu(7.38_14\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
15635044T16_15635044T20 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T16_15635044T21 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T16_15635044T22 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T16_15635044T23 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T16_15635044T24 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T16_15635044T25 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T16_15635044T27 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T16_15635044T28 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T16_15635044T29 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nsubj) acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T16_15635044T31 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T16_15635044T48 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T16_15635044T49 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T16_15635044T50 NONE leu(7.43_17\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
15635044T17_15635044T20 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T17_15635044T21 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T17_15635044T22 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T17_15635044T23 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T17_15635044T24 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T17_15635044T25 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T17_15635044T27 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T17_15635044T28 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T17_15635044T29 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nsubj) acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T17_15635044T31 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T17_15635044T48 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T17_15635044T49 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T17_15635044T50 NONE ala(7.46_20\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
15635044T18_15635044T20 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_dobj) sensitivity_39\NN\5651971|an|increased|gnrh-i (l_nmod) gnrh-i_41\NN\1740|to
15635044T18_15635044T21 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_dobj) gnrh-ii_51\NN\1740|
15635044T18_15635044T22 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_advcl) indicating_43\VBG\952524|critical (l_ccomp) critical_48\JJ\1740|that|residues|are|discriminating (l_advcl) discriminating_50\VBG\650353|for|gnrh-ii|gnrh-i. (l_nmod) gnrh-i._53\NN\1740|from
15635044T18_15635044T23 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i
15635044T18_15635044T24 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [trp(8)]gnrh-i_56\NN\1740|
15635044T18_15635044T25 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_nsubj) [trp(7)]gnrh-i_54\NN\1740|and|[trp(8)]gnrh-i|not|[his(5)]gnrh-i (l_conj) [his(5)]gnrh-i_59\NN\1740|
15635044T18_15635044T27 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_dobj) gmgnrhr-2_67\NN\1740|wild-type
15635044T18_15635044T28 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) activating_65\VBG\1641914|in|gmgnrhr-2|gnrh-i (l_nmod) gnrh-i_70\NN\1740|than|native
15635044T18_15635044T29 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nsubj) acids_75\NNS\14818238|amino|positions (l_nmod) positions_77\NNS\8620061|at|7|gnrhs (l_nmod) gnrhs_82\NNS\1740|of
15635044T18_15635044T31 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (r_nsubj) exhibited_34\VBD\2632167|furthermore|,|mutation|sensitivity|,|indicating|exhibit|. (l_parataxis) exhibit_60\VBP\2632167|[trp(7)]gnrh-i|potency|activating|,|indicating (l_advcl) indicating_72\VBG\952524|important (l_ccomp) important_85\JJ\1740|that|acids|are|more|position|recognition (l_nmod) recognition_91\NN\13932421|for|differential|type (l_nmod) type_93\NN\5839024|by|i|type|gnrhrs (l_dep) gnrhrs_98\NNS\1740|ii
15635044T18_15635044T48 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (l_nmod) el3_12\NN\1740|in
15635044T18_15635044T49 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gnrhr_30\NN\1740|of|rat|)
15635044T18_15635044T50 NONE pro(7.47_24\CD\1740|) (r_conj) ser-glu-pro_10\NN\1740|to|el3|and|leu(7.38|,|leu(7.43|,|ala(7.46|,|and|pro(7.47 (r_nmod) mutation_4\NN\4475|a|combinatory|motif|ser-glu-pro|those (l_nmod) those_27\DT\1740|to|gnrhr|gmgnrh-2 (l_nmod) gmgnrh-2_33\NN\1740|in
18058577
18058577T4_18058577T6 NONE folate_9\NN\15090742| (r_compound) alpha_11\NN\6828818|against|the|folate|receptor
18058577T3_18058577T5 NONE folate_12\NN\15090742| (r_compound) alpha_14\NN\6828818|against|folate|receptor
9732824
9732824T2_9732824T12 CPR:4 finasteride_5\NN\1740| (r_dep) inhibitor_4\NN\20090|both|the|5|alpha-reductase|finasteride|and|antagonists (l_compound) alpha-reductase_3\NN\1740|
9732824T2_9732824T13 NONE finasteride_5\NN\1740| (r_dep) inhibitor_4\NN\20090|both|the|5|alpha-reductase|finasteride|and|antagonists (l_conj) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (l_compound) 1-adrenoceptor_8\NN\1740|
9732824T3_9732824T12 NONE alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (r_conj) inhibitor_4\NN\20090|both|the|5|alpha-reductase|finasteride|and|antagonists (l_compound) alpha-reductase_3\NN\1740|
9732824T3_9732824T13 CPR:6 alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (l_compound) 1-adrenoceptor_8\NN\1740|
9732824T4_9732824T12 NONE doxazosin_14\NN\2721160| (r_conj) alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (r_conj) inhibitor_4\NN\20090|both|the|5|alpha-reductase|finasteride|and|antagonists (l_compound) alpha-reductase_3\NN\1740|
9732824T4_9732824T13 CPR:6 doxazosin_14\NN\2721160| (r_conj) alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (l_compound) 1-adrenoceptor_8\NN\1740|
9732824T5_9732824T12 NONE prazosin_16\NN\2698769| (r_conj) alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (r_conj) inhibitor_4\NN\20090|both|the|5|alpha-reductase|finasteride|and|antagonists (l_compound) alpha-reductase_3\NN\1740|
9732824T5_9732824T13 CPR:6 prazosin_16\NN\2698769| (r_conj) alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (l_compound) 1-adrenoceptor_8\NN\1740|
9732824T6_9732824T12 NONE tamsulosin_18\NN\1740| (r_conj) alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (r_conj) inhibitor_4\NN\20090|both|the|5|alpha-reductase|finasteride|and|antagonists (l_compound) alpha-reductase_3\NN\1740|
9732824T6_9732824T13 CPR:6 tamsulosin_18\NN\1740| (r_conj) alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (l_compound) 1-adrenoceptor_8\NN\1740|
9732824T7_9732824T12 NONE terazosin_20\NN\2698769| (r_conj) alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (r_conj) inhibitor_4\NN\20090|both|the|5|alpha-reductase|finasteride|and|antagonists (l_compound) alpha-reductase_3\NN\1740|
9732824T7_9732824T13 CPR:6 terazosin_20\NN\2698769| (r_conj) alfuzosin_12\NN\1740|e.g.|,|doxazosin|,|prazosin|,|tamsulosin|and|terazosin|) (r_appos) antagonists_9\NNS\7846|alpha|1-adrenoceptor|(|alfuzosin (l_compound) 1-adrenoceptor_8\NN\1740|
9732824T1_9732824T9 NONE finasteride_46\NN\1740|than (r_nmod) effectively_44\RB\1740|more|finasteride|and|irrespective (r_advmod) relieving_41\VBG\205885|luts|effectively (r_advcl) provide_31\VBP\2199590|relief|doses|,|relieving (r_conj) reduce_10\VBP\441445|antagonists|,|hand|,|component|and|provide|. (l_nsubj) antagonists_3\NNS\7846|the|alpha|1-adrenoceptor (l_amod) 1-adrenoceptor_2\NN\1740|
23221006
23221006T16_23221006T28 NONE cation/carnitine_3\NN\1740| (r_compound) transporter_4\NN\4490091|of|organic|cation/carnitine|1 (l_nummod) 1_5\CD\13741022|
23221006T16_23221006T29 NONE cation/carnitine_3\NN\1740| (r_compound) transporter_4\NN\4490091|of|organic|cation/carnitine|1 (r_nmod) role_0\NN\719494|transporter|uptake|and|effect|. (l_conj) effect_12\NN\34213|inhibitory|respiration (l_nmod) respiration_16\NN\13514314|on|complex|i|mitochondria (l_nummod) i_15\CD\14622893|
23221006T17_23221006T28 CPR:9 phenformin_9\NN\1740|of (r_nmod) uptake_7\NN\13440063|in|phenformin (r_nmod) role_0\NN\719494|transporter|uptake|and|effect|. (l_nmod) transporter_4\NN\4490091|of|organic|cation/carnitine|1 (l_nummod) 1_5\CD\13741022|
23221006T17_23221006T29 CPR:4 phenformin_9\NN\1740|of (r_nmod) uptake_7\NN\13440063|in|phenformin (r_nmod) role_0\NN\719494|transporter|uptake|and|effect|. (l_conj) effect_12\NN\34213|inhibitory|respiration (l_nmod) respiration_16\NN\13514314|on|complex|i|mitochondria (l_nummod) i_15\CD\14622893|
23221006T1_23221006T27 CPR:4 phenformin_0\NN\1740| (r_nsubj) causes_1\VBZ\1617192|phenformin|acidosis|situations|due (l_punct) due_7\JJ\1740|inhibition (l_nmod) inhibition_9\NN\1068773|to|i. (l_nmod) i._15\.\1740|complex
23221006T6_23221006T24 NONE phenformin_6\NN\1740|of|and|[(14)c]tetraethylammonium (r_nmod) uptake_4\NN\13440063|phenformin|and|inhibition (l_conj) inhibition_15\NN\1068773|complex|i|phenformin (l_compound) i_14\CD\14622893|
23221006T7_23221006T24 NONE [(14)c]tetraethylammonium_8\NN\1740|tea (r_conj) phenformin_6\NN\1740|of|and|[(14)c]tetraethylammonium (r_nmod) uptake_4\NN\13440063|phenformin|and|inhibition (l_conj) inhibition_15\NN\1068773|complex|i|phenformin (l_compound) i_14\CD\14622893|
23221006T8_23221006T24 NONE tea_10\NN\7881800|(|) (r_appos) [(14)c]tetraethylammonium_8\NN\1740|tea (r_conj) phenformin_6\NN\1740|of|and|[(14)c]tetraethylammonium (r_nmod) uptake_4\NN\13440063|phenformin|and|inhibition (l_conj) inhibition_15\NN\1068773|complex|i|phenformin (l_compound) i_14\CD\14622893|
23221006T9_23221006T24 CPR:4 phenformin_17\NN\1740|by (r_nmod) inhibition_15\NN\1068773|complex|i|phenformin (l_compound) i_14\CD\14622893|
23221006T11_23221006T25 NONE tea_8\NN\7881800|of (r_nmod) uptake_6\NN\13440063|for|tea (r_nmod) observed_4\VBN\2163746|characteristics|were|also|uptake|;|lower|. (l_parataxis) lower_28\JJR\1740|however|,|uptake|was|that|,|comparable|,|suggesting (l_nsubj) uptake_12\NN\13440063|phenformin|mitochondria (l_nmod) mitochondria_16\NN\5445668|into|mice (l_nmod) mice_26\NNS\2329401|of|transporter|knockout (l_compound) transporter_20\NN\4490091|organic|cation/carnitine|1|octn1 (l_nummod) 1_21\CD\13741022|
23221006T11_23221006T26 NONE tea_8\NN\7881800|of (r_nmod) uptake_6\NN\13440063|for|tea (r_nmod) observed_4\VBN\2163746|characteristics|were|also|uptake|;|lower|. (l_parataxis) lower_28\JJR\1740|however|,|uptake|was|that|,|comparable|,|suggesting (l_nsubj) uptake_12\NN\13440063|phenformin|mitochondria (l_nmod) mitochondria_16\NN\5445668|into|mice (l_nmod) mice_26\NNS\2329401|of|transporter|knockout (l_compound) transporter_20\NN\4490091|organic|cation/carnitine|1|octn1 (l_appos) octn1_23\NN\1740|(|)
23221006T12_23221006T25 NONE phenformin_14\NN\1740|of (r_nmod) uptake_12\NN\13440063|phenformin|mitochondria (l_nmod) mitochondria_16\NN\5445668|into|mice (l_nmod) mice_26\NNS\2329401|of|transporter|knockout (l_compound) transporter_20\NN\4490091|organic|cation/carnitine|1|octn1 (l_nummod) 1_21\CD\13741022|
23221006T12_23221006T26 NONE phenformin_14\NN\1740|of (r_nmod) uptake_12\NN\13440063|phenformin|mitochondria (l_nmod) mitochondria_16\NN\5445668|into|mice (l_nmod) mice_26\NNS\2329401|of|transporter|knockout (l_compound) transporter_20\NN\4490091|organic|cation/carnitine|1|octn1 (l_appos) octn1_23\NN\1740|(|)
23221006T13_23221006T25 NONE cation/carnitine_19\NN\1740| (r_compound) transporter_20\NN\4490091|organic|cation/carnitine|1|octn1 (l_nummod) 1_21\CD\13741022|
23221006T13_23221006T26 NONE cation/carnitine_19\NN\1740| (r_compound) transporter_20\NN\4490091|organic|cation/carnitine|1|octn1 (l_appos) octn1_23\NN\1740|(|)
23221006T14_23221006T25 NONE tea_38\NN\7881800|of (r_nmod) uptake_36\NN\13440063|tea (r_nsubj) comparable_40\JJ\1740|whereas|uptake|was|strains (r_advcl) lower_28\JJR\1740|however|,|uptake|was|that|,|comparable|,|suggesting (l_nsubj) uptake_12\NN\13440063|phenformin|mitochondria (l_nmod) mitochondria_16\NN\5445668|into|mice (l_nmod) mice_26\NNS\2329401|of|transporter|knockout (l_compound) transporter_20\NN\4490091|organic|cation/carnitine|1|octn1 (l_nummod) 1_21\CD\13741022|
23221006T14_23221006T26 NONE tea_38\NN\7881800|of (r_nmod) uptake_36\NN\13440063|tea (r_nsubj) comparable_40\JJ\1740|whereas|uptake|was|strains (r_advcl) lower_28\JJR\1740|however|,|uptake|was|that|,|comparable|,|suggesting (l_nsubj) uptake_12\NN\13440063|phenformin|mitochondria (l_nmod) mitochondria_16\NN\5445668|into|mice (l_nmod) mice_26\NNS\2329401|of|transporter|knockout (l_compound) transporter_20\NN\4490091|organic|cation/carnitine|1|octn1 (l_appos) octn1_23\NN\1740|(|)
23221006T2_23221006T18 NONE oxygen_4\NN\14622893| (r_compound) consumption_5\NN\13440063|of|oxygen (r_nmod) inhibition_0\NN\1068773|phenformin|consumption|respiration (l_nmod) respiration_9\NN\13514314|via|complex|i|mitochondria (l_nummod) i_8\CD\14622893|
23221006T2_23221006T19 NONE oxygen_4\NN\14622893| (r_compound) consumption_5\NN\13440063|of|oxygen (r_nmod) inhibition_0\NN\1068773|phenformin|consumption|respiration (r_nsubj) greater_16\JJR\1740|inhibition|was|that|,|similar|. (l_advcl) similar_33\JJ\1740|whereas|effect|was|particles (l_nsubj) effect_25\NN\34213|inhibitory|phenformin|respiration (l_nmod) respiration_31\NN\13514314|on|complex|i (l_nummod) i_30\CD\14622893|
23221006T3_23221006T18 NONE phenformin_27\NN\1740|of (r_nmod) effect_25\NN\34213|inhibitory|phenformin|respiration (r_nsubj) similar_33\JJ\1740|whereas|effect|was|particles (r_advcl) greater_16\JJR\1740|inhibition|was|that|,|similar|. (l_nsubj) inhibition_0\NN\1068773|phenformin|consumption|respiration (l_nmod) respiration_9\NN\13514314|via|complex|i|mitochondria (l_nummod) i_8\CD\14622893|
23221006T3_23221006T19 CPR:4 phenformin_27\NN\1740|of (r_nmod) effect_25\NN\34213|inhibitory|phenformin|respiration (l_nmod) respiration_31\NN\13514314|on|complex|i (l_nummod) i_30\CD\14622893|
23221006T15_23221006T18 CPR:4 phenformin_2\NN\1740|by (r_nmod) inhibition_0\NN\1068773|phenformin|consumption|respiration (l_nmod) respiration_9\NN\13514314|via|complex|i|mitochondria (l_nummod) i_8\CD\14622893|
23221006T15_23221006T19 NONE phenformin_2\NN\1740|by (r_nmod) inhibition_0\NN\1068773|phenformin|consumption|respiration (r_nsubj) greater_16\JJR\1740|inhibition|was|that|,|similar|. (l_advcl) similar_33\JJ\1740|whereas|effect|was|particles (l_nsubj) effect_25\NN\34213|inhibitory|phenformin|respiration (l_nmod) respiration_31\NN\13514314|on|complex|i (l_nummod) i_30\CD\14622893|
23221006T4_23221006T20 NONE phenformin_7\NN\1740|of (r_nmod) infusion_5\NN\14589223|by|iv|phenformin (r_nmod) provoked_2\VBN\1617192|infusion (r_acl) acidosis_1\NN\14204950|lactic|provoked (r_nsubj) weaker_9\JJR\1740|acidosis|was|mice|that|. (l_nmod) mice_13\NNS\2329401|in|octn1(-/- (l_compound) octn1(-/-_11\NN\1740|)
23221006T5_23221006T21 CPR:9 phenformin_6\NN\1740|of (r_nmod) uptake_4\NN\13440063|phenformin|mitochondria (r_nsubjpass) mediated_14\VBN\761713|that|uptake|is|partly|octn1|and|relevant (l_nmod) octn1_16\NN\1740|by
23221006T5_23221006T22 CPR:4 phenformin_6\NN\1740|of (r_nmod) uptake_4\NN\13440063|phenformin|mitochondria (r_nsubjpass) mediated_14\VBN\761713|that|uptake|is|partly|octn1|and|relevant (l_conj) relevant_19\JJ\1740|functionally|potential (l_nmod) potential_23\NN\14481929|to|its|inhibition|respiration (l_nmod) respiration_27\NN\13514314|of|complex|i (l_nummod) i_26\CD\14622893|
23418368
23418368T1_23418368T3 NONE cholesterol_25\NN\15058310|ldl|abc (l_compound) ldl_24\NN\14939230|
23418368T1_23418368T12 NONE cholesterol_25\NN\15058310|ldl|abc (r_conj) pressure_18\NN\11419404|blood|bp|,|and|cholesterol (r_conj) a(1c_11\NN\1740|hemoglobin|)|a1c|,|pressure (l_punct) )_12\-RRB-\1740|
23418368T1_23418368T14 NONE cholesterol_25\NN\15058310|ldl|abc (r_conj) pressure_18\NN\11419404|blood|bp|,|and|cholesterol (r_conj) a(1c_11\NN\1740|hemoglobin|)|a1c|,|pressure (l_appos) a1c_14\NN\1740|(|)
23418368T2_23418368T10 NONE cholesterol_10\NN\15058310|ldl (r_conj) a1c_4\NN\1740|measures|were|,|bp|,|and|cholesterol|,|accordance|,|and|use|.
23418368T2_23418368T11 NONE cholesterol_10\NN\15058310|ldl (l_compound) ldl_9\NN\14939230|
14505791
14505791T17_14505791T21 CPR:6 cetirizine_7\NN\1740|of|racemic|and|levocetirizine|,|antagonists (l_appos) antagonists_14\NNS\7846|two|histamine|h1-receptor (l_compound) h1-receptor_13\NN\1740|
14505791T18_14505791T21 CPR:6 levocetirizine_9\NN\1740| (r_conj) cetirizine_7\NN\1740|of|racemic|and|levocetirizine|,|antagonists (l_appos) antagonists_14\NNS\7846|two|histamine|h1-receptor (l_compound) h1-receptor_13\NN\1740|
14505791T19_14505791T21 NONE histamine_12\NN\14739004| (r_compound) antagonists_14\NNS\7846|two|histamine|h1-receptor (l_compound) h1-receptor_13\NN\1740|
14505791T3_14505791T20 NONE histamine_2\NN\14739004| (r_compound) antagonist_4\NN\7846|the|potent|histamine|h(1)-receptor|cetirizine (l_punct) h(1)-receptor_3\NN\1740|
14505791T6_14505791T20 CPR:6 xyzal_21\NN\1740|under|the|trademark|and|dextrocetirizine (r_nmod) available_17\JJ\1740|now|xyzal (r_advmod) mixture_12\NN\19613|antagonist|is|a|racemic|levocetirizine|available|. (l_nsubj) antagonist_4\NN\7846|the|potent|histamine|h(1)-receptor|cetirizine (l_punct) h(1)-receptor_3\NN\1740|
14505791T7_14505791T20 CPR:6 dextrocetirizine_23\NN\1740| (r_conj) xyzal_21\NN\1740|under|the|trademark|and|dextrocetirizine (r_nmod) available_17\JJ\1740|now|xyzal (r_advmod) mixture_12\NN\19613|antagonist|is|a|racemic|levocetirizine|available|. (l_nsubj) antagonist_4\NN\7846|the|potent|histamine|h(1)-receptor|cetirizine (l_punct) h(1)-receptor_3\NN\1740|
14505791T10_14505791T20 CPR:6 cetirizine_5\NN\1740|zyrtec (r_dep) antagonist_4\NN\7846|the|potent|histamine|h(1)-receptor|cetirizine (l_punct) h(1)-receptor_3\NN\1740|
14505791T11_14505791T20 CPR:6 zyrtec_7\NNP\1740|(|) (r_appos) cetirizine_5\NN\1740|zyrtec (r_dep) antagonist_4\NN\7846|the|potent|histamine|h(1)-receptor|cetirizine (l_punct) h(1)-receptor_3\NN\1740|
14505791T15_14505791T20 CPR:6 levocetirizine_14\NN\1740|of|( (r_nmod) mixture_12\NN\19613|antagonist|is|a|racemic|levocetirizine|available|. (l_nsubj) antagonist_4\NN\7846|the|potent|histamine|h(1)-receptor|cetirizine (l_punct) h(1)-receptor_3\NN\1740|
23249751
23249751T1_23249751T4 NONE 2'-o-methyl_8\JJ\1740| (r_amod) oligonucleotide_9\NN\1740|a|complementary|2'-o-methyl|tethered (r_dobj) using_5\VBG\1156834|oligonucleotide (r_advcl) capturing_3\VBG\1686132|by|risc|using (l_dobj) risc_4\NNP\4932278|
14523001
14523001T8_14523001T25 NONE arginine/lysine_4\NN\1740| (r_compound) transporter_5\NN\4490091|of|the|arginine/lysine|,|cat-1
14523001T8_14523001T26 NONE arginine/lysine_4\NN\1740| (r_compound) transporter_5\NN\4490091|of|the|arginine/lysine|,|cat-1 (l_appos) cat-1_7\NN\1740|
14523001T9_14523001T25 NONE arginine/lysine_4\NN\1740| (r_compound) transporter_5\NN\4490091|of|the|arginine/lysine|,|cat-1
14523001T9_14523001T26 NONE arginine/lysine_4\NN\1740| (r_compound) transporter_5\NN\4490091|of|the|arginine/lysine|,|cat-1 (l_appos) cat-1_7\NN\1740|
14523001T3_14523001T18 CPR:9 acids_8\NNS\14818238|for|the|essential|amino|,|arginine (r_nmod) transporter_3\NN\4490091|the|acids (r_appos) cat-1_0\NN\1740|,|transporter|,
14523001T4_14523001T18 CPR:9 arginine_10\NN\14605787|and|lysine (r_appos) acids_8\NNS\14818238|for|the|essential|amino|,|arginine (r_nmod) transporter_3\NN\4490091|the|acids (r_appos) cat-1_0\NN\1740|,|transporter|,
14523001T5_14523001T18 CPR:9 lysine_12\NN\14605787| (r_conj) arginine_10\NN\14605787|and|lysine (r_appos) acids_8\NNS\14818238|for|the|essential|amino|,|arginine (r_nmod) transporter_3\NN\4490091|the|acids (r_appos) cat-1_0\NN\1740|,|transporter|,
14523001T6_14523001T20 NONE acid_6\NN\14818238| (r_compound) depletion_7\NN\351638|by|amino|acid|and|response (l_conj) response_12\NN\11410625|the|unfolded|protein|upr|,|caused
14523001T6_14523001T21 NONE acid_6\NN\14818238| (r_compound) depletion_7\NN\351638|by|amino|acid|and|response (l_conj) response_12\NN\11410625|the|unfolded|protein|upr|,|caused (l_appos) upr_14\NN\1740|(|)
14523001T2_14523001T11 NONE acid_6\NN\14818238| (r_compound) depletion_7\NN\351638|by|amino|acid (r_nmod) stimulation_1\NN\242808|the|transcription|depletion (r_nsubj) requires_8\VBZ\754942|stimulation|activation|. (l_dobj) activation_9\NN\13561719|kinase (l_nmod) kinase_12\NN\14732946|of|gcn2|,|phosphorylates (l_compound) gcn2_11\NN\1740|
14523001T2_14523001T12 NONE acid_6\NN\14818238| (r_compound) depletion_7\NN\351638|by|amino|acid (r_nmod) stimulation_1\NN\242808|the|transcription|depletion (r_nsubj) requires_8\VBZ\754942|stimulation|activation|. (l_dobj) activation_9\NN\13561719|kinase (l_nmod) kinase_12\NN\14732946|of|gcn2|,|phosphorylates
14523001T2_14523001T13 NONE acid_6\NN\14818238| (r_compound) depletion_7\NN\351638|by|amino|acid (r_nmod) stimulation_1\NN\242808|the|transcription|depletion (r_nsubj) requires_8\VBZ\754942|stimulation|activation|. (l_dobj) activation_9\NN\13561719|kinase (l_nmod) kinase_12\NN\14732946|of|gcn2|,|phosphorylates (l_acl:relcl) phosphorylates_15\VBZ\1740|which|eif2alpha (l_dobj) eif2alpha_16\NN\1740|
23519392
23519392T9_23519392T22 NONE pregnane_0\NN\1740| (r_compound) receptor_2\NN\5225602|pregnane|x
23519392T9_23519392T23 NONE pregnane_0\NN\1740| (r_compound) receptor_2\NN\5225602|pregnane|x (r_nsubj) mediates_3\VBZ\761713|receptor|dyslipidemia|. (l_dobj) dyslipidemia_4\NN\1740|induced (l_acl) induced_5\VBN\1627355|amprenavir (l_nmod) amprenavir_11\NN\1740|by|the|hiv|protease|inhibitor|mice (l_compound) protease_9\NN\14732946|
23519392T10_23519392T22 NONE amprenavir_11\NN\1740|by|the|hiv|protease|inhibitor|mice (r_nmod) induced_5\VBN\1627355|amprenavir (r_acl) dyslipidemia_4\NN\1740|induced (r_dobj) mediates_3\VBZ\761713|receptor|dyslipidemia|. (l_nsubj) receptor_2\NN\5225602|pregnane|x
23519392T10_23519392T23 CPR:4 amprenavir_11\NN\1740|by|the|hiv|protease|inhibitor|mice (l_compound) protease_9\NN\14732946|
23519392T4_23519392T15 NONE pregnane_10\NN\1740| (r_compound) receptor_12\NN\5225602|pregnane|x|pxr|,|acts
23519392T4_23519392T16 NONE pregnane_10\NN\1740| (r_compound) receptor_12\NN\5225602|pregnane|x|pxr|,|acts (l_appos) pxr_14\NN\1740|(|)
23519392T5_23519392T18 CPR:5 amprenavir_7\NNP\1740|,|pi (r_dobj) identified_6\VBD\699815|study|,|we|amprenavir|,|agonist|. (l_nmod) agonist_19\NN\9613191|as|a|potent|pxr-selective (l_amod) pxr-selective_18\JJ\1740|
23519392T6_23519392T19 NONE amprenavir_24\NN\1740|with (r_nmod) interaction_22\NN\37396|of|amprenavir (r_nmod) points_20\NNS\5868954|interaction (r_dobj) constitute_19\VBP\1647229|that|points (r_acl:relcl) residues_10\NNS\20827|several|key|pocket|constitute (l_nmod) pocket_15\NN\3993180|within|the|ligand|binding|pxr (l_nmod) pxr_17\NN\1740|of
23519392T7_23519392T20 CPR:3 amprenavir_0\NN\1740| (r_nsubj) activated_2\VBD\1641914|amprenavir|efficiently|pxr|and|induced|. (l_dobj) pxr_3\NN\1740|
23519392T7_23519392T21 CPR:3 amprenavir_0\NN\1740| (r_nsubj) activated_2\VBD\1641914|amprenavir|efficiently|pxr|and|induced|. (l_conj) induced_5\VBD\1627355|expression|and (l_dobj) expression_9\NN\4679549|pxr|target|gene (l_compound) pxr_6\NN\1740|
23519392T1_23519392T12 NONE cholesterol_8\NN\15058310|plasma|total|and|cholesterol (r_compound) levels_14\NNS\4916342|cholesterol (r_dobj) increased_5\VBD\169651|exposure|significantly|levels|mice|. (l_nmod) mice_17\NNS\2329401|in|wild-type|,|but|mice (l_conj) mice_23\NNS\2329401|not|in|pxr-deficient (l_amod) pxr-deficient_22\JJ\1740|
23519392T2_23519392T12 NONE cholesterol_13\NN\15058310|atherogenic|low-density|lipoprotein (r_conj) cholesterol_8\NN\15058310|plasma|total|and|cholesterol (r_compound) levels_14\NNS\4916342|cholesterol (r_dobj) increased_5\VBD\169651|exposure|significantly|levels|mice|. (l_nmod) mice_17\NNS\2329401|in|wild-type|,|but|mice (l_conj) mice_23\NNS\2329401|not|in|pxr-deficient (l_amod) pxr-deficient_22\JJ\1740|
23519392T8_23519392T12 NONE amprenavir_3\NN\1740|to (r_nmod) exposure_1\NN\5042871|short-term|amprenavir (r_nsubj) increased_5\VBD\169651|exposure|significantly|levels|mice|. (l_nmod) mice_17\NNS\2329401|in|wild-type|,|but|mice (l_conj) mice_23\NNS\2329401|not|in|pxr-deficient (l_amod) pxr-deficient_22\JJ\1740|
23519392T3_23519392T13 CPR:3 amprenavir-mediated_0\JJ\1740| (r_amod) activation_2\NN\13561719|amprenavir-mediated|pxr (l_compound) pxr_1\NN\1740|
19337422
19337422T1_19337422T15 CPR:4 tolvaptan_0\NN\1740| (r_nsubj) blocker_12\NN\10101634|tolvaptan|is|a|selective|arginine|vasopressin|)|v(2|)|receptor|used|. (l_compound) receptor_11\NN\5225602|
19337422T4_19337422T15 NONE vasopressin_5\NN\5407119|avp (r_compound) blocker_12\NN\10101634|tolvaptan|is|a|selective|arginine|vasopressin|)|v(2|)|receptor|used|. (l_compound) receptor_11\NN\5225602|
19337422T7_19337422T15 NONE avp_7\NN\1740|( (r_appos) vasopressin_5\NN\5407119|avp (r_compound) blocker_12\NN\10101634|tolvaptan|is|a|selective|arginine|vasopressin|)|v(2|)|receptor|used|. (l_compound) receptor_11\NN\5225602|
19337422T8_19337422T16 CPR:3 tolvaptan_3\NN\1740|of (r_nmod) use_1\NN\407535|prolonged|tolvaptan (r_nsubj) leads_4\VBZ\1752884|use|levels|. (l_nmod) levels_8\NNS\4916342|to|increased|endogenous|avp|and|over-stimulation (l_nmod) avp_10\NN\1740|of
19337422T8_19337422T17 CPR:3 tolvaptan_3\NN\1740|of (r_nmod) use_1\NN\407535|prolonged|tolvaptan (r_nsubj) leads_4\VBZ\1752884|use|levels|. (l_nmod) levels_8\NNS\4916342|to|increased|endogenous|avp|and|over-stimulation (l_conj) over-stimulation_13\NN\1740|perhaps|receptors (l_nmod) receptors_17\NNS\5225602|of|v(1a|)
19337422T9_19337422T16 NONE avp_10\NN\1740|of
19337422T9_19337422T17 NONE avp_10\NN\1740|of (r_nmod) levels_8\NNS\4916342|to|increased|endogenous|avp|and|over-stimulation (l_conj) over-stimulation_13\NN\1740|perhaps|receptors (l_nmod) receptors_17\NNS\5225602|of|v(1a|)
19337422T11_19337422T18 CPR:9 tolvaptan_3\NN\1740| (r_nsubjpass) metabolized_5\VBN\1740|addition|,|tolvaptan|is|system|;|aware (l_nmod) system_9\NN\3575240|by|the|cyp3a4 (l_compound) cyp3a4_8\NN\1740|
19337422T2_19337422T13 NONE tolvaptan_0\NN\1740| (r_nsubj) breakthrough_3\NN\5807306|tolvaptan|is|a|therapy|combats|. (l_advcl) combats_12\VBZ\1090335|as|it|directly|levels (l_dobj) levels_15\NNS\4916342|elevated|avp|associated (l_compound) avp_14\NN\1740|
19337422T2_19337422T14 NONE tolvaptan_0\NN\1740| (r_nsubj) breakthrough_3\NN\5807306|tolvaptan|is|a|therapy|combats|. (l_advcl) combats_12\VBZ\1090335|as|it|directly|levels (l_dobj) levels_15\NNS\4916342|elevated|avp|associated (l_acl) associated_16\VBN\628491|syndrome (l_nmod) syndrome_19\NN\5870365|with|the|secretion (l_nmod) secretion_22\NN\13526110|of|inappropriate|hormone|,|failure|,|and|cirrhosis (l_nmod) hormone_25\NN\5404728|of|antidiuretic
19337422T3_19337422T13 NONE avp_14\NN\1740|
19337422T3_19337422T14 NONE avp_14\NN\1740| (r_compound) levels_15\NNS\4916342|elevated|avp|associated (l_acl) associated_16\VBN\628491|syndrome (l_nmod) syndrome_19\NN\5870365|with|the|secretion (l_nmod) secretion_22\NN\13526110|of|inappropriate|hormone|,|failure|,|and|cirrhosis (l_nmod) hormone_25\NN\5404728|of|antidiuretic
22717743
23600432
23600432T1_23600432T8 CPR:9 acid_13\NN\14818238|arachidonic|aa (r_compound) cascade_17\NN\9475292|of|the|acid (r_nmod) enzyme_9\NN\14723628|5-lipoxygenase|is|a|crucial|cascade|and|catalyzes (l_nsubj) 5-lipoxygenase_2\NN\1740|5-lo
23600432T1_23600432T9 NONE acid_13\NN\14818238|arachidonic|aa (r_compound) cascade_17\NN\9475292|of|the|acid (r_nmod) enzyme_9\NN\14723628|5-lipoxygenase|is|a|crucial|cascade|and|catalyzes (l_conj) catalyzes_19\VBZ\146138|formation (l_dobj) formation_21\NN\7938773|the|leukotrienes|help (l_nmod) help_30\NN\407535|with|the|flap (l_nmod) flap_32\NN\3122748|of|,|protein
23600432T1_23600432T10 NONE acid_13\NN\14818238|arachidonic|aa (r_compound) cascade_17\NN\9475292|of|the|acid (r_nmod) enzyme_9\NN\14723628|5-lipoxygenase|is|a|crucial|cascade|and|catalyzes (l_conj) catalyzes_19\VBZ\146138|formation (l_dobj) formation_21\NN\7938773|the|leukotrienes|help (l_nmod) help_30\NN\407535|with|the|flap (l_nmod) flap_32\NN\3122748|of|,|protein (l_appos) protein_36\NN\14944888|the|5-lo-activating
23600432T1_23600432T11 CPR:9 acid_13\NN\14818238|arachidonic|aa (r_compound) cascade_17\NN\9475292|of|the|acid (r_nmod) enzyme_9\NN\14723628|5-lipoxygenase|is|a|crucial|cascade|and|catalyzes (l_nsubj) 5-lipoxygenase_2\NN\1740|5-lo (l_appos) 5-lo_4\NN\1740|(|)
15732037
15732037T6_15732037T33 NONE carvedilol_0\NN\2832168| (r_nsubj) modulates_1\VBZ\1724459|carvedilol|expression|. (l_dobj) expression_3\NN\4679549|the|factor-1alpha|model (l_nmod) factor-1alpha_6\NN\1740|of|hypoxia-inducible|and|factor
15732037T6_15732037T34 NONE carvedilol_0\NN\2832168| (r_nsubj) modulates_1\VBZ\1724459|carvedilol|expression|. (l_dobj) expression_3\NN\4679549|the|factor-1alpha|model (l_nmod) factor-1alpha_6\NN\1740|of|hypoxia-inducible|and|factor (l_conj) factor_11\NN\7326557|vascular|endothelial|growth
15732037T1_15732037T20 CPR:4 carvedilol_2\NN\2832168|with (r_nmod) treatment_0\NN\654885|carvedilol (r_nsubj) reversed_3\VBD\109660|treatment|protein|values|. (l_dobj) protein_5\NN\14944888|both|and|mrna|hif-1alpha (l_nmod) hif-1alpha_9\NN\1740|of|,|vegf|,|bnp|,|and|ngf-beta
15732037T1_15732037T21 CPR:4 carvedilol_2\NN\2832168|with (r_nmod) treatment_0\NN\654885|carvedilol (r_nsubj) reversed_3\VBD\109660|treatment|protein|values|. (l_dobj) protein_5\NN\14944888|both|and|mrna|hif-1alpha (l_nmod) hif-1alpha_9\NN\1740|of|,|vegf|,|bnp|,|and|ngf-beta (l_conj) vegf_11\NN\1740|
15732037T1_15732037T22 CPR:4 carvedilol_2\NN\2832168|with (r_nmod) treatment_0\NN\654885|carvedilol (r_nsubj) reversed_3\VBD\109660|treatment|protein|values|. (l_dobj) protein_5\NN\14944888|both|and|mrna|hif-1alpha (l_nmod) hif-1alpha_9\NN\1740|of|,|vegf|,|bnp|,|and|ngf-beta (l_conj) bnp_13\NN\1740|
15732037T1_15732037T23 CPR:3 carvedilol_2\NN\2832168|with (r_nmod) treatment_0\NN\654885|carvedilol (r_nsubj) reversed_3\VBD\109660|treatment|protein|values|. (l_dobj) protein_5\NN\14944888|both|and|mrna|hif-1alpha (l_nmod) hif-1alpha_9\NN\1740|of|,|vegf|,|bnp|,|and|ngf-beta (l_conj) ngf-beta_16\NN\1740|
15732037T2_15732037T24 CPR:4 carvedilol_21\NN\2832168| (r_nsubj) normalized_23\VBD\109660|carvedilol|again|labeling|. (r_conj) observed_15\VBN\2163746|labeling|was|group|and|normalized (l_nsubjpass) labeling_2\NN\1740|increased|immunohistochemical|hif-1alpha (l_nmod) hif-1alpha_4\NN\1740|of|,|vegf|,|and|bnp|myocardium
15732037T2_15732037T25 CPR:4 carvedilol_21\NN\2832168| (r_nsubj) normalized_23\VBD\109660|carvedilol|again|labeling|. (r_conj) observed_15\VBN\2163746|labeling|was|group|and|normalized (l_nsubjpass) labeling_2\NN\1740|increased|immunohistochemical|hif-1alpha (l_nmod) hif-1alpha_4\NN\1740|of|,|vegf|,|and|bnp|myocardium (l_conj) vegf_6\NN\1740|
15732037T2_15732037T26 CPR:4 carvedilol_21\NN\2832168| (r_nsubj) normalized_23\VBD\109660|carvedilol|again|labeling|. (r_conj) observed_15\VBN\2163746|labeling|was|group|and|normalized (l_nsubjpass) labeling_2\NN\1740|increased|immunohistochemical|hif-1alpha (l_nmod) hif-1alpha_4\NN\1740|of|,|vegf|,|and|bnp|myocardium (l_conj) bnp_9\NN\1740|
15732037T3_15732037T29 CPR:4 carvedilol_2\NN\2832168|with (r_nmod) treatment_0\NN\654885|carvedilol (r_nsubjpass) associated_4\VBN\628491|treatment|is|reversal|. (l_nmod) reversal_7\NN\199130|with|a|regulation (l_nmod) regulation_10\NN\6652242|of|abnormal|hif-1alpha (l_nmod) hif-1alpha_12\NN\1740|of|and|vegf|myocardium
15732037T3_15732037T30 CPR:4 carvedilol_2\NN\2832168|with (r_nmod) treatment_0\NN\654885|carvedilol (r_nsubjpass) associated_4\VBN\628491|treatment|is|reversal|. (l_nmod) reversal_7\NN\199130|with|a|regulation (l_nmod) regulation_10\NN\6652242|of|abnormal|hif-1alpha (l_nmod) hif-1alpha_12\NN\1740|of|and|vegf|myocardium (l_conj) vegf_14\NN\1740|
23358258
23358258T6_23358258T12 NONE xanthine_5\NN\14727670| (r_compound) derivatives_6\NNS\5802185|of|xanthine (r_nmod) evaluation_3\NN\874067|synthesis|derivatives|peptidase|. (l_nmod) peptidase_9\NN\14732946|on|dipeptidyl|4 (l_nummod) 4_10\CD\13741022|
23358258T1_23358258T7 CPR:4 xanthine_3\NN\14727670| (r_compound) derivatives_4\NNS\5802185|of|xanthine|inserted (r_nmod) series_1\NN\8456993|a|derivatives (r_nsubjpass) synthesized_18\VBN\193486|series|was|and|evaluated|. (l_conj) evaluated_20\VBN\670261|inhibitors (l_nmod) inhibitors_22\NNS\20090|as|peptidase|treatment (l_nmod) peptidase_25\NN\14732946|of|dipeptidyl|4|dpp-4 (l_nummod) 4_26\CD\13741022|
23358258T1_23358258T8 CPR:4 xanthine_3\NN\14727670| (r_compound) derivatives_4\NNS\5802185|of|xanthine|inserted (r_nmod) series_1\NN\8456993|a|derivatives (r_nsubjpass) synthesized_18\VBN\193486|series|was|and|evaluated|. (l_conj) evaluated_20\VBN\670261|inhibitors (l_nmod) inhibitors_22\NNS\20090|as|peptidase|treatment (l_nmod) peptidase_25\NN\14732946|of|dipeptidyl|4|dpp-4 (l_appos) dpp-4_28\NN\1740|(|)
23358258T4_23358258T7 NONE methylene_8\NN\14621446|a (r_nsubjpass) inserted_10\VBN\1296462|which|methylene|was|position (r_acl:relcl) derivatives_4\NNS\5802185|of|xanthine|inserted (r_nmod) series_1\NN\8456993|a|derivatives (r_nsubjpass) synthesized_18\VBN\193486|series|was|and|evaluated|. (l_conj) evaluated_20\VBN\670261|inhibitors (l_nmod) inhibitors_22\NNS\20090|as|peptidase|treatment (l_nmod) peptidase_25\NN\14732946|of|dipeptidyl|4|dpp-4 (l_nummod) 4_26\CD\13741022|
23358258T4_23358258T8 NONE methylene_8\NN\14621446|a (r_nsubjpass) inserted_10\VBN\1296462|which|methylene|was|position (r_acl:relcl) derivatives_4\NNS\5802185|of|xanthine|inserted (r_nmod) series_1\NN\8456993|a|derivatives (r_nsubjpass) synthesized_18\VBN\193486|series|was|and|evaluated|. (l_conj) evaluated_20\VBN\670261|inhibitors (l_nmod) inhibitors_22\NNS\20090|as|peptidase|treatment (l_nmod) peptidase_25\NN\14732946|of|dipeptidyl|4|dpp-4 (l_appos) dpp-4_28\NN\1740|(|)
23358258T5_23358258T7 CPR:4 xanthine_15\NN\14727670| (r_compound) scaffold_16\NN\3961939|of|xanthine (r_nmod) position_12\NN\8620061|at|8|scaffold (r_nmod) inserted_10\VBN\1296462|which|methylene|was|position (r_acl:relcl) derivatives_4\NNS\5802185|of|xanthine|inserted (r_nmod) series_1\NN\8456993|a|derivatives (r_nsubjpass) synthesized_18\VBN\193486|series|was|and|evaluated|. (l_conj) evaluated_20\VBN\670261|inhibitors (l_nmod) inhibitors_22\NNS\20090|as|peptidase|treatment (l_nmod) peptidase_25\NN\14732946|of|dipeptidyl|4|dpp-4 (l_nummod) 4_26\CD\13741022|
23358258T5_23358258T8 CPR:4 xanthine_15\NN\14727670| (r_compound) scaffold_16\NN\3961939|of|xanthine (r_nmod) position_12\NN\8620061|at|8|scaffold (r_nmod) inserted_10\VBN\1296462|which|methylene|was|position (r_acl:relcl) derivatives_4\NNS\5802185|of|xanthine|inserted (r_nmod) series_1\NN\8456993|a|derivatives (r_nsubjpass) synthesized_18\VBN\193486|series|was|and|evaluated|. (l_conj) evaluated_20\VBN\670261|inhibitors (l_nmod) inhibitors_22\NNS\20090|as|peptidase|treatment (l_nmod) peptidase_25\NN\14732946|of|dipeptidyl|4|dpp-4 (l_appos) dpp-4_28\NN\1740|(|)
23466229
23466229T5_23466229T10 CPR:4 pf-04859989_0\NNP\1740|template|:|identification (l_appos) identification_9\NN\151497|series|. (l_nmod) series_13\NNS\8456993|of|new|pyrazole|inhibitors|efficiency (l_nmod) inhibitors_18\NNS\20090|of|irreversible|kat|ii (l_nummod) ii_17\CD\13741022|
23466229T6_23466229T10 CPR:4 pyrazole_12\NN\1740| (r_compound) series_13\NNS\8456993|of|new|pyrazole|inhibitors|efficiency (l_nmod) inhibitors_18\NNS\20090|of|irreversible|kat|ii (l_nummod) ii_17\CD\13741022|
23466229T4_23466229T7 CPR:4 pyrazole_12\NN\1740| (r_compound) series_13\NN\8456993|of|a|new|pyrazole|inhibitors (l_nmod) inhibitors_18\NNS\20090|of|irreversible|kat|ii (l_nummod) ii_17\CD\13741022|
23466229T1_23466229T8 CPR:4 dihydroquinolinone_12\NN\1740| (r_compound) core_13\NN\7996689|from|a|dihydroquinolinone (r_nmod) modification_1\NN\191142|the|scaffold|core|core (r_nsubj) led_18\VBD\1752884|modification|discovery|. (l_nmod) discovery_20\NN\30358|to|series (l_nmod) series_24\NN\8456993|of|a|new|inhibitors|properties (l_nmod) inhibitors_29\NNS\20090|of|potent|kat|ii (l_nummod) ii_28\CD\13741022|
23466229T2_23466229T8 CPR:4 tetrahydropyrazolopyridinone_16\NN\1740| (r_compound) core_17\NN\7996689|to|a|tetrahydropyrazolopyridinone (r_nmod) modification_1\NN\191142|the|scaffold|core|core (r_nsubj) led_18\VBD\1752884|modification|discovery|. (l_nmod) discovery_20\NN\30358|to|series (l_nmod) series_24\NN\8456993|of|a|new|inhibitors|properties (l_nmod) inhibitors_29\NNS\20090|of|potent|kat|ii (l_nummod) ii_28\CD\13741022|
23277230
23277230T1_23277230T19 CPR:4 fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin (r_nsubj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_dobj) decline_5\NN\13458571|a|significant|levels (l_nmod) levels_8\NNS\4916342|in|the|glucose (l_nmod) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) hemoglobin_14\NN\14888884|glycosylated|hba1c
23277230T1_23277230T20 CPR:4 fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin (r_nsubj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_dobj) decline_5\NN\13458571|a|significant|levels (l_nmod) levels_8\NNS\4916342|in|the|glucose (l_nmod) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) hemoglobin_14\NN\14888884|glycosylated|hba1c (l_appos) hba1c_16\NN\1740|(|)
23277230T1_23277230T21 CPR:4 fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin (r_nsubj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_dobj) decline_5\NN\13458571|a|significant|levels (l_nmod) levels_8\NNS\4916342|in|the|glucose (l_nmod) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) unit_21\NN\13576101|nf-kb|p65|pancreas (l_compound) nf-kb_19\NN\1740|
23277230T1_23277230T22 CPR:4 fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin (r_nsubj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_dobj) decline_5\NN\13458571|a|significant|levels (l_nmod) levels_8\NNS\4916342|in|the|glucose (l_nmod) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) unit_21\NN\13576101|nf-kb|p65|pancreas (l_compound) p65_20\NN\1740|
23277230T1_23277230T23 CPR:4 fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin (r_nsubj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_dobj) decline_5\NN\13458571|a|significant|levels (l_nmod) levels_8\NNS\4916342|in|the|glucose (l_nmod) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) il-1β_27\NN\1740|plasma|,
23277230T1_23277230T24 CPR:3 fisetin_0\NN\1740| (r_compound) treatment_1\NN\654885|fisetin (r_nsubj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_nmod) elevation_40\NN\7445480|with|an|insulin (l_nmod) insulin_43\NN\5407119|in|plasma
23277230T2_23277230T19 NONE glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) hemoglobin_14\NN\14888884|glycosylated|hba1c
23277230T2_23277230T20 NONE glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) hemoglobin_14\NN\14888884|glycosylated|hba1c (l_appos) hba1c_16\NN\1740|(|)
23277230T2_23277230T21 NONE glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) unit_21\NN\13576101|nf-kb|p65|pancreas (l_compound) nf-kb_19\NN\1740|
23277230T2_23277230T22 NONE glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) unit_21\NN\13576101|nf-kb|p65|pancreas (l_compound) p65_20\NN\1740|
23277230T2_23277230T23 NONE glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) il-1β_27\NN\1740|plasma|,
23277230T2_23277230T24 NONE glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (r_nmod) levels_8\NNS\4916342|in|the|glucose (r_nmod) decline_5\NN\13458571|a|significant|levels (r_dobj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_nmod) elevation_40\NN\7445480|with|an|insulin (l_nmod) insulin_43\NN\5407119|in|plasma
23277230T3_23277230T19 NONE oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) hemoglobin_14\NN\14888884|glycosylated|hba1c
23277230T3_23277230T20 NONE oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) hemoglobin_14\NN\14888884|glycosylated|hba1c (l_appos) hba1c_16\NN\1740|(|)
23277230T3_23277230T21 NONE oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) unit_21\NN\13576101|nf-kb|p65|pancreas (l_compound) nf-kb_19\NN\1740|
23277230T3_23277230T22 NONE oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) unit_21\NN\13576101|nf-kb|p65|pancreas (l_compound) p65_20\NN\1740|
23277230T3_23277230T23 NONE oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) il-1β_27\NN\1740|plasma|,
23277230T3_23277230T24 NONE oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (r_nmod) levels_8\NNS\4916342|in|the|glucose (r_nmod) decline_5\NN\13458571|a|significant|levels (r_dobj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_nmod) elevation_40\NN\7445480|with|an|insulin (l_nmod) insulin_43\NN\5407119|in|plasma
23277230T4_23277230T19 NONE no_36\NN\7204911|(|) (r_appos) oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) hemoglobin_14\NN\14888884|glycosylated|hba1c
23277230T4_23277230T20 NONE no_36\NN\7204911|(|) (r_appos) oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) hemoglobin_14\NN\14888884|glycosylated|hba1c (l_appos) hba1c_16\NN\1740|(|)
23277230T4_23277230T21 NONE no_36\NN\7204911|(|) (r_appos) oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) unit_21\NN\13576101|nf-kb|p65|pancreas (l_compound) nf-kb_19\NN\1740|
23277230T4_23277230T22 NONE no_36\NN\7204911|(|) (r_appos) oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) unit_21\NN\13576101|nf-kb|p65|pancreas (l_compound) p65_20\NN\1740|
23277230T4_23277230T23 NONE no_36\NN\7204911|(|) (r_appos) oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (l_conj) il-1β_27\NN\1740|plasma|,
23277230T4_23277230T24 NONE no_36\NN\7204911|(|) (r_appos) oxide_34\NN\14818238|serum|nitric|no (r_conj) glucose_11\NN\14710501|of|blood|,|hemoglobin|,|unit|and|il-1β|oxide (r_nmod) levels_8\NNS\4916342|in|the|glucose (r_nmod) decline_5\NN\13458571|a|significant|levels (r_dobj) showed_2\VBD\2137132|treatment|decline|elevation|. (l_nmod) elevation_40\NN\7445480|with|an|insulin (l_nmod) insulin_43\NN\5407119|in|plasma
23434931
23434931T1_23434931T11 NONE tunicamycin_15\NN\1740|of (r_nmod) treatment_13\NN\654885|by|tunicamycin (r_nmod) undergo_5\VB\109660|to|stress|treatment (r_xcomp) induced_3\VBN\1627355|undergo (r_acl) cells_2\NNS\3080309|in|lymphoblastoid|induced (r_nmod) observed_27\VBN\2163746|cells|,|change|were|cells|that|=|,|suggesting|. (l_nsubjpass) change_19\NN\7283608|higher|fold|tcf7l2|levels (l_nmod) tcf7l2_21\NN\1740|of|and
23434931T1_23434931T12 NONE tunicamycin_15\NN\1740|of (r_nmod) treatment_13\NN\654885|by|tunicamycin (r_nmod) undergo_5\VB\109660|to|stress|treatment (r_xcomp) induced_3\VBN\1627355|undergo (r_acl) cells_2\NNS\3080309|in|lymphoblastoid|induced (r_nmod) observed_27\VBN\2163746|cells|,|change|were|cells|that|=|,|suggesting|. (l_nsubjpass) change_19\NN\7283608|higher|fold|tcf7l2|levels (l_nmod) levels_25\NNS\4916342|mrna (l_compound) mrna_24\NN\14832193|vegfa (l_compound) vegfa_23\NN\1740|
23434931T1_23434931T13 NONE tunicamycin_15\NN\1740|of (r_nmod) treatment_13\NN\654885|by|tunicamycin (r_nmod) undergo_5\VB\109660|to|stress|treatment (r_xcomp) induced_3\VBN\1627355|undergo (r_acl) cells_2\NNS\3080309|in|lymphoblastoid|induced (r_nmod) observed_27\VBN\2163746|cells|,|change|were|cells|that|=|,|suggesting|. (l_parataxis) =_38\JJ\1740|(|p|0.02|tcf7l2|;|=|) (l_nmod) tcf7l2_41\NN\1740|for
23434931T1_23434931T14 NONE tunicamycin_15\NN\1740|of (r_nmod) treatment_13\NN\654885|by|tunicamycin (r_nmod) undergo_5\VB\109660|to|stress|treatment (r_xcomp) induced_3\VBN\1627355|undergo (r_acl) cells_2\NNS\3080309|in|lymphoblastoid|induced (r_nmod) observed_27\VBN\2163746|cells|,|change|were|cells|that|=|,|suggesting|. (l_parataxis) =_38\JJ\1740|(|p|0.02|tcf7l2|;|=|) (l_dep) =_44\JJ\1740|p|0.004|vegfa (l_nmod) vegfa_47\NN\1740|for
23434931T2_23434931T3 NONE oxygen-induced_2\JJ\1740| (r_amod) retinopathy_3\NN\14252864|oxygen-induced|oir (r_compound) mice_7\NNS\2329401|of|retinopathy|model (r_nmod) retinas_0\NNS\5426243|mice (r_nsubj) had_14\VBD\2108377|retinas|levels|controls|=|. (l_dobj) levels_20\NNS\4916342|higher|mrna (l_compound) mrna_19\NN\14832193|tcf7l2 (l_compound) tcf7l2_16\NN\1740|and|vegfa (l_conj) vegfa_18\NN\1740|
23434931T2_23434931T4 NONE oxygen-induced_2\JJ\1740| (r_amod) retinopathy_3\NN\14252864|oxygen-induced|oir (r_compound) mice_7\NNS\2329401|of|retinopathy|model (r_nmod) retinas_0\NNS\5426243|mice (r_nsubj) had_14\VBD\2108377|retinas|levels|controls|=|. (l_parataxis) =_25\JJ\1740|(|p|2.9e-04|tcf7l2|;|=|) (l_nmod) tcf7l2_28\NN\1740|for
23434931T2_23434931T5 NONE oxygen-induced_2\JJ\1740| (r_amod) retinopathy_3\NN\14252864|oxygen-induced|oir (r_compound) mice_7\NNS\2329401|of|retinopathy|model (r_nmod) retinas_0\NNS\5426243|mice (r_nsubj) had_14\VBD\2108377|retinas|levels|controls|=|. (l_parataxis) =_25\JJ\1740|(|p|2.9e-04|tcf7l2|;|=|) (l_parataxis) =_31\JJ\1740|p|1.9e-07|vegfa (l_nmod) vegfa_34\NN\1740|for
23434931T2_23434931T18 NONE oxygen-induced_2\JJ\1740| (r_amod) retinopathy_3\NN\14252864|oxygen-induced|oir (r_compound) mice_7\NNS\2329401|of|retinopathy|model (r_nmod) retinas_0\NNS\5426243|mice (r_nsubj) had_14\VBD\2108377|retinas|levels|controls|=|. (l_dobj) levels_20\NNS\4916342|higher|mrna (l_compound) mrna_19\NN\14832193|tcf7l2 (l_compound) tcf7l2_16\NN\1740|and|vegfa
23495691
23495691T2_23495691T7 NONE camp_7\NN\3763727| (r_compound) pathway_8\NN\5483677|of|the|camp (r_nmod) nature_4\NN\4723816|due|to|the|ubiquitous|pathway (r_nmod) act_24\VB\1619354|nature|,|inhibitors|would|and|,|increasing|. (l_nsubj) inhibitors_11\NNS\20090|general|proteins|pka (l_nmod) pka_18\NN\1740|such|,|epac|and|pdes
23495691T2_23495691T8 NONE camp_7\NN\3763727| (r_compound) pathway_8\NN\5483677|of|the|camp (r_nmod) nature_4\NN\4723816|due|to|the|ubiquitous|pathway (r_nmod) act_24\VB\1619354|nature|,|inhibitors|would|and|,|increasing|. (l_nsubj) inhibitors_11\NNS\20090|general|proteins|pka (l_nmod) pka_18\NN\1740|such|,|epac|and|pdes (l_conj) epac_20\NN\1740|
23495691T2_23495691T9 NONE camp_7\NN\3763727| (r_compound) pathway_8\NN\5483677|of|the|camp (r_nmod) nature_4\NN\4723816|due|to|the|ubiquitous|pathway (r_nmod) act_24\VB\1619354|nature|,|inhibitors|would|and|,|increasing|. (l_nsubj) inhibitors_11\NNS\20090|general|proteins|pka (l_nmod) pka_18\NN\1740|such|,|epac|and|pdes (l_conj) pdes_22\NNS\1740|
23495691T3_23495691T7 NONE camp_13\NN\3763727| (r_compound) proteins_15\NNS\14944888|of|camp|signaling (r_nmod) inhibitors_11\NNS\20090|general|proteins|pka (l_nmod) pka_18\NN\1740|such|,|epac|and|pdes
23495691T3_23495691T8 NONE camp_13\NN\3763727| (r_compound) proteins_15\NNS\14944888|of|camp|signaling (r_nmod) inhibitors_11\NNS\20090|general|proteins|pka (l_nmod) pka_18\NN\1740|such|,|epac|and|pdes (l_conj) epac_20\NN\1740|
23495691T3_23495691T9 NONE camp_13\NN\3763727| (r_compound) proteins_15\NNS\14944888|of|camp|signaling (r_nmod) inhibitors_11\NNS\20090|general|proteins|pka (l_nmod) pka_18\NN\1740|such|,|epac|and|pdes (l_conj) pdes_22\NNS\1740|
23597450
23597450T13_23597450T36 CPR:4 prunetin_3\NN\1740|of (r_nmod) effect_1\NN\34213|anti-inflammatory|prunetin|suppression|. (l_nmod) suppression_6\NN\13489037|via|the|pathway (l_nmod) pathway_9\NN\5483677|of|nf-κb (l_compound) nf-κb_8\NN\1740|
23597450T8_23597450T21 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions
23597450T8_23597450T22 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_appos) inos_5\NN\1740|(|)
23597450T8_23597450T23 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_conj) cyclooxygenase-2_8\NN\14737847|cox-2
23597450T8_23597450T24 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_conj) cyclooxygenase-2_8\NN\14737847|cox-2 (l_appos) cox-2_10\NN\14737847|(|)
23597450T8_23597450T25 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_conj) factor-α_15\NN\1740|tumor|necrosis|tnf-α
23597450T8_23597450T26 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_conj) factor-α_15\NN\1740|tumor|necrosis|tnf-α (l_appos) tnf-α_17\NN\1740|(|)
23597450T8_23597450T27 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_conj) interleukin-6_20\NN\1740|il-6
23597450T8_23597450T28 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_conj) interleukin-6_20\NN\1740|il-6 (l_appos) il-6_22\NN\1740|(|)
23597450T8_23597450T29 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_conj) expressions_30\NNS\4679549|interleukin-1β (l_compound) interleukin-1β_26\NN\1740|il-1β
23597450T8_23597450T30 NONE oxide_2\NN\14818238| (r_compound) synthase_3\NN\1740|inducible|nitric|oxide|inos|,|cyclooxygenase-2|,|factor-α|,|interleukin-6|,|and|expressions (l_conj) expressions_30\NNS\4679549|interleukin-1β (l_compound) interleukin-1β_26\NN\1740|il-1β (l_appos) il-1β_28\NN\1740|(|)
23597450T10_23597450T34 CPR:4 prunetin_4\NN\1740| (r_nsubj) inhibits_5\VBZ\2510337|that|prunetin|production|suppression (l_nmod) suppression_15\NN\13489037|through|the|inos|level (l_nmod) inos_17\NN\1740|of|and|cox-2
23597450T10_23597450T35 CPR:4 prunetin_4\NN\1740| (r_nsubj) inhibits_5\VBZ\2510337|that|prunetin|production|suppression (l_nmod) suppression_15\NN\13489037|through|the|inos|level (l_nmod) inos_17\NN\1740|of|and|cox-2 (l_conj) cox-2_19\NN\14737847|
23597450T11_23597450T34 NONE oxide_8\NN\14818238|lps-induced|nitric|and|e2 (r_compound) production_12\NN\30358|oxide (r_dobj) inhibits_5\VBZ\2510337|that|prunetin|production|suppression (l_nmod) suppression_15\NN\13489037|through|the|inos|level (l_nmod) inos_17\NN\1740|of|and|cox-2
23597450T11_23597450T35 NONE oxide_8\NN\14818238|lps-induced|nitric|and|e2 (r_compound) production_12\NN\30358|oxide (r_dobj) inhibits_5\VBZ\2510337|that|prunetin|production|suppression (l_nmod) suppression_15\NN\13489037|through|the|inos|level (l_nmod) inos_17\NN\1740|of|and|cox-2 (l_conj) cox-2_19\NN\14737847|
23597450T12_23597450T34 NONE e2_11\NN\1740|prostaglandin (r_conj) oxide_8\NN\14818238|lps-induced|nitric|and|e2 (r_compound) production_12\NN\30358|oxide (r_dobj) inhibits_5\VBZ\2510337|that|prunetin|production|suppression (l_nmod) suppression_15\NN\13489037|through|the|inos|level (l_nmod) inos_17\NN\1740|of|and|cox-2
23597450T12_23597450T35 NONE e2_11\NN\1740|prostaglandin (r_conj) oxide_8\NN\14818238|lps-induced|nitric|and|e2 (r_compound) production_12\NN\30358|oxide (r_dobj) inhibits_5\VBZ\2510337|that|prunetin|production|suppression (l_nmod) suppression_15\NN\13489037|through|the|inos|level (l_nmod) inos_17\NN\1740|of|and|cox-2 (l_conj) cox-2_19\NN\14737847|
23597450T2_23597450T14 CPR:4 prunetin_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|addition|,|prunetin|responses|modulating|. (l_dobj) responses_7\NNS\11410625|nf-κb-dependent|inflammatory (l_amod) nf-κb-dependent_5\JJ\1740|
23597450T2_23597450T15 NONE prunetin_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|addition|,|prunetin|responses|modulating|. (l_advcl) modulating_9\VBG\1724459|by|signaling (l_dobj) signaling_15\NN\33020|kinase (l_compound) kinase_11\NN\14732946|iκb|(ikk)-inhibitor
23597450T2_23597450T16 NONE prunetin_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|addition|,|prunetin|responses|modulating|. (l_advcl) modulating_9\VBG\1724459|by|signaling (l_dobj) signaling_15\NN\33020|kinase (l_compound) kinase_11\NN\14732946|iκb|(ikk)-inhibitor (l_dep) (ikk)-inhibitor_12\NN\1740|κbα|(iκbα)-nf-κb
23597450T2_23597450T17 NONE prunetin_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|addition|,|prunetin|responses|modulating|. (l_advcl) modulating_9\VBG\1724459|by|signaling (l_dobj) signaling_15\NN\33020|kinase (l_compound) kinase_11\NN\14732946|iκb|(ikk)-inhibitor (l_dep) (ikk)-inhibitor_12\NN\1740|κbα|(iκbα)-nf-κb (l_dep) κbα_13\NN\1740|
23597450T2_23597450T18 NONE prunetin_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|addition|,|prunetin|responses|modulating|. (l_advcl) modulating_9\VBG\1724459|by|signaling (l_dobj) signaling_15\NN\33020|kinase (l_compound) kinase_11\NN\14732946|iκb|(ikk)-inhibitor (l_dep) (ikk)-inhibitor_12\NN\1740|κbα|(iκbα)-nf-κb (l_dep) (iκbα)-nf-κb_14\NN\1740|
23597450T2_23597450T19 NONE prunetin_3\NN\1740| (r_nsubj) inhibits_4\VBZ\2510337|addition|,|prunetin|responses|modulating|. (l_advcl) modulating_9\VBG\1724459|by|signaling (l_dobj) signaling_15\NN\33020|kinase (l_compound) kinase_11\NN\14732946|iκb|(ikk)-inhibitor (l_dep) (ikk)-inhibitor_12\NN\1740|κbα|(iκbα)-nf-κb (l_dep) (iκbα)-nf-κb_14\NN\1740|
23597450T3_23597450T20 CPR:4 prunetin_5\NN\1740| (r_nsubj) reduced_7\VBD\441445|consistent|,|prunetin|significantly|levels|. (l_dobj) levels_9\NNS\4916342|serum|cytokines|and|mortality (l_nmod) cytokines_12\NNS\14728724|of|inflammatory
23060524
23060524T5_23060524T13 NONE streptozotocin-induced_27\JJ\1740| (r_amod) diabetic_28\JJ\1740|streptozotocin-induced (r_amod) e-deficient_30\JJ\1740|diabetic|apolipoprotein|apoe(-/- (r_amod) mice_35\NNS\2329401|e-deficient (r_conj) nondiabetic_25\JJ\1740|in|and|mice (r_nmod) atherosclerosis_23\NN\14108324|on|early-stage|nondiabetic (r_nmod) effect_7\NN\34213|the|lipopolysaccharide|atherosclerosis (l_nmod) lipopolysaccharide_11\NN\1740|of|rhodobacter|sphaeroides|rs-lps|,|antagonist|, (l_appos) antagonist_19\NN\7846|an|established|tlr4 (l_compound) tlr4_18\NN\1740|
23060524T5_23060524T15 NONE streptozotocin-induced_27\JJ\1740| (r_amod) diabetic_28\JJ\1740|streptozotocin-induced (r_amod) e-deficient_30\JJ\1740|diabetic|apolipoprotein|apoe(-/-
23060524T5_23060524T16 NONE streptozotocin-induced_27\JJ\1740| (r_amod) diabetic_28\JJ\1740|streptozotocin-induced (r_amod) e-deficient_30\JJ\1740|diabetic|apolipoprotein|apoe(-/- (l_dep) apoe(-/-_32\JJ\1740|(|)|)
23060524T3_23060524T8 NONE cholesterol_26\NN\15058310|serum|and|triglyceride (r_compound) levels_29\NNS\4916342|cholesterol (r_dobj) lowered_24\VBD\1850315|levels|mice (r_conj) inhibited_13\VBD\2510337|that|antagonist|inflammation|and|lowered (l_nsubj) antagonist_12\NN\7846|tlr4 (l_compound) tlr4_11\NN\1740|
23060524T3_23060524T9 NONE cholesterol_26\NN\15058310|serum|and|triglyceride (r_compound) levels_29\NNS\4916342|cholesterol (r_dobj) lowered_24\VBD\1850315|levels|mice (r_conj) inhibited_13\VBD\2510337|that|antagonist|inflammation|and|lowered (l_dobj) inflammation_15\NN\14299637|vascular|and|atherogenesis|mice (l_nmod) mice_22\NNS\2329401|in|diabetic|apoe(-/- (l_amod) apoe(-/-_20\JJ\1740|)
23060524T3_23060524T10 NONE cholesterol_26\NN\15058310|serum|and|triglyceride (r_compound) levels_29\NNS\4916342|cholesterol (r_dobj) lowered_24\VBD\1850315|levels|mice (l_nmod) mice_34\NNS\2329401|in|nondiabetic|apoe(-/- (l_amod) apoe(-/-_32\JJ\1740|)
23060524T4_23060524T8 NONE triglyceride_28\NN\14885088| (r_conj) cholesterol_26\NN\15058310|serum|and|triglyceride (r_compound) levels_29\NNS\4916342|cholesterol (r_dobj) lowered_24\VBD\1850315|levels|mice (r_conj) inhibited_13\VBD\2510337|that|antagonist|inflammation|and|lowered (l_nsubj) antagonist_12\NN\7846|tlr4 (l_compound) tlr4_11\NN\1740|
23060524T4_23060524T9 NONE triglyceride_28\NN\14885088| (r_conj) cholesterol_26\NN\15058310|serum|and|triglyceride (r_compound) levels_29\NNS\4916342|cholesterol (r_dobj) lowered_24\VBD\1850315|levels|mice (r_conj) inhibited_13\VBD\2510337|that|antagonist|inflammation|and|lowered (l_dobj) inflammation_15\NN\14299637|vascular|and|atherogenesis|mice (l_nmod) mice_22\NNS\2329401|in|diabetic|apoe(-/- (l_amod) apoe(-/-_20\JJ\1740|)
23060524T4_23060524T10 NONE triglyceride_28\NN\14885088| (r_conj) cholesterol_26\NN\15058310|serum|and|triglyceride (r_compound) levels_29\NNS\4916342|cholesterol (r_dobj) lowered_24\VBD\1850315|levels|mice (l_nmod) mice_34\NNS\2329401|in|nondiabetic|apoe(-/- (l_amod) apoe(-/-_32\JJ\1740|)
23373869
12904467
12904467T12_12904467T23 NONE kainate-receptor-mediated_4\JJ\1740| (r_amod) currents_6\NNS\11449002|of|glur5|kainate-receptor-mediated|synaptic (l_compound) glur5_3\NN\1740|
12904467T12_12904467T24 NONE kainate-receptor-mediated_4\JJ\1740|
12904467T13_12904467T23 CPR:6 topiramate_8\NN\1740|by (r_nmod) antagonism_1\NN\24720|selective|currents|topiramate|neurons|. (l_nmod) currents_6\NNS\11449002|of|glur5|kainate-receptor-mediated|synaptic (l_compound) glur5_3\NN\1740|
12904467T13_12904467T24 CPR:6 topiramate_8\NN\1740|by (r_nmod) antagonism_1\NN\24720|selective|currents|topiramate|neurons|. (l_nmod) currents_6\NNS\11449002|of|glur5|kainate-receptor-mediated|synaptic (l_amod) kainate-receptor-mediated_4\JJ\1740|
12904467T3_12904467T16 NONE ampa/kainate_14\NN\1740| (r_compound) receptors_15\NNS\5225602|including|ampa/kainate (r_nmod) types_11\NNS\5839024|with|various|ion|channel|,|receptors (l_compound) channel_10\NN\6251781|
12904467T3_12904467T17 NONE ampa/kainate_14\NN\1740| (r_compound) receptors_15\NNS\5225602|including|ampa/kainate
12904467T4_12904467T16 NONE ampa/kainate_14\NN\1740| (r_compound) receptors_15\NNS\5225602|including|ampa/kainate (r_nmod) types_11\NNS\5839024|with|various|ion|channel|,|receptors (l_compound) channel_10\NN\6251781|
12904467T4_12904467T17 NONE ampa/kainate_14\NN\1740| (r_compound) receptors_15\NNS\5225602|including|ampa/kainate
12904467T5_12904467T18 CPR:4 topiramate_13\NN\1740|concentrations (r_nsubj) inhibited_25\VBD\2510337|recordings|,|topiramate|selectively|currents|. (l_dobj) currents_30\NNS\11449002|isolated|excitatory|synaptic|mediated (l_acl) mediated_31\VBN\761713|receptors (l_nmod) receptors_34\NNS\5225602|by|kainate|containing
12904467T5_12904467T19 CPR:4 topiramate_13\NN\1740|concentrations (r_nsubj) inhibited_25\VBD\2510337|recordings|,|topiramate|selectively|currents|. (l_dobj) currents_30\NNS\11449002|isolated|excitatory|synaptic|mediated (l_acl) mediated_31\VBN\761713|receptors (l_nmod) receptors_34\NNS\5225602|by|kainate|containing (l_acl) containing_35\VBG\2632940|subunit (l_dobj) subunit_38\NN\13604718|the|glur5 (l_compound) glur5_37\NN\1740|
12904467T6_12904467T18 NONE kainate_33\NN\1740| (r_compound) receptors_34\NNS\5225602|by|kainate|containing
12904467T6_12904467T19 NONE kainate_33\NN\1740| (r_compound) receptors_34\NNS\5225602|by|kainate|containing (l_acl) containing_35\VBG\2632940|subunit (l_dobj) subunit_38\NN\13604718|the|glur5 (l_compound) glur5_37\NN\1740|
12904467T7_12904467T20 CPR:4 topiramate_0\NN\1740| (r_nsubj) depressed_3\VBD\1819147|topiramate|also|partially|epscs|,|but|efficacy|. (l_dobj) epscs_6\NNS\1740|ampa-receptor-mediated (l_amod) ampa-receptor-mediated_5\JJ\1740|predominantly
12904467T8_12904467T20 NONE ampa-receptor-mediated_5\JJ\1740|predominantly
12904467T10_12904467T21 NONE kainate_3\NN\1740| (r_compound) receptors_4\NNS\5225602|of|glur5|kainate (l_compound) glur5_2\NN\1740|
12904467T10_12904467T22 NONE kainate_3\NN\1740| (r_compound) receptors_4\NNS\5225602|of|glur5|kainate
12904467T11_12904467T21 CPR:4 topiramate_15\NN\1740|of (r_nmod) activity_13\NN\30358|the|anticonvulsant|topiramate (r_dobj) underlying_10\VBG\2604760|activity (r_acl) mechanism_9\NN\13446390|a|key|underlying (r_dobj) represent_6\VB\2664769|inhibition|could|mechanism|. (l_nsubj) inhibition_0\NN\1068773|receptors (l_nmod) receptors_4\NNS\5225602|of|glur5|kainate (l_compound) glur5_2\NN\1740|
12904467T11_12904467T22 CPR:4 topiramate_15\NN\1740|of (r_nmod) activity_13\NN\30358|the|anticonvulsant|topiramate (r_dobj) underlying_10\VBG\2604760|activity (r_acl) mechanism_9\NN\13446390|a|key|underlying (r_dobj) represent_6\VB\2664769|inhibition|could|mechanism|. (l_nsubj) inhibition_0\NN\1068773|receptors (l_nmod) receptors_4\NNS\5225602|of|glur5|kainate
12904467T2_12904467T14 NONE kainate_9\NN\1740| (r_compound) receptors_10\NNS\5225602|glur5|kainate (l_compound) glur5_8\NN\1740|
12904467T2_12904467T15 NONE kainate_9\NN\1740| (r_compound) receptors_10\NNS\5225602|glur5|kainate
17079868
17079868T6_17079868T21 NONE methionine_0\NN\14605787| (r_compound) polymorphisms_3\NNS\11418750|methionine|synthase|reductase (l_compound) reductase_2\NN\14732946|
17079868T6_17079868T22 NONE methionine_0\NN\14605787| (r_compound) polymorphisms_3\NNS\11418750|methionine|synthase|reductase (r_nsubjpass) associated_5\VBN\628491|polymorphisms|are|levels|. (l_nmod) levels_9\NNS\4916342|with|serum|osteocalcin|women (l_compound) osteocalcin_8\NN\1740|
17079868T2_17079868T7 NONE methionine_0\NN\14605787| (r_compound) reductase_2\NN\14732946|methionine|synthase|mtrr
17079868T2_17079868T10 NONE methionine_0\NN\14605787| (r_compound) reductase_2\NN\14732946|methionine|synthase|mtrr (l_appos) mtrr_4\NN\1740|(|)
17079868T4_17079868T7 CPR:9 hcy_14\NN\1740|of (r_nmod) conversion_12\NN\7359599|in|the|hcy|methionine (r_nmod) involved_9\VBN\2676054|conversion (r_acl) enzyme_8\NN\14723628|reductase|is|an|involved|. (l_nsubj) reductase_2\NN\14732946|methionine|synthase|mtrr
17079868T4_17079868T10 CPR:9 hcy_14\NN\1740|of (r_nmod) conversion_12\NN\7359599|in|the|hcy|methionine (r_nmod) involved_9\VBN\2676054|conversion (r_acl) enzyme_8\NN\14723628|reductase|is|an|involved|. (l_nsubj) reductase_2\NN\14732946|methionine|synthase|mtrr (l_appos) mtrr_4\NN\1740|(|)
17079868T5_17079868T7 CPR:9 methionine_16\NN\14605787|to (r_nmod) conversion_12\NN\7359599|in|the|hcy|methionine (r_nmod) involved_9\VBN\2676054|conversion (r_acl) enzyme_8\NN\14723628|reductase|is|an|involved|. (l_nsubj) reductase_2\NN\14732946|methionine|synthase|mtrr
17079868T5_17079868T10 CPR:9 methionine_16\NN\14605787|to (r_nmod) conversion_12\NN\7359599|in|the|hcy|methionine (r_nmod) involved_9\VBN\2676054|conversion (r_acl) enzyme_8\NN\14723628|reductase|is|an|involved|. (l_nsubj) reductase_2\NN\14732946|methionine|synthase|mtrr (l_appos) mtrr_4\NN\1740|(|)
23623751
23623751T15_23623751T28 NONE dopamine_12\NN\14807737| (r_compound) transporter_13\NN\4490091|dopamine
23623751T16_23623751T28 NONE methylphenidate_1\NN\4320126| (r_compound) treatment_2\NN\654885|adolescence|methylphenidate|model|:|function (l_dep) function_14\NN\13783581|transporter|and|distribution|adulthood|. (l_compound) transporter_13\NN\4490091|dopamine
23623751T1_23623751T21 CPR:4 methylphenidate_0\NN\4320126|,|inhibitor|, (l_appos) inhibitor_3\NN\20090|an|transporters|dat (l_nmod) transporters_8\NNS\4490091|dopamine
23623751T1_23623751T24 CPR:4 methylphenidate_0\NN\4320126|,|inhibitor|, (l_appos) inhibitor_3\NN\20090|an|transporters|dat (l_dep) dat_10\NN\2757810|(|and|net|,|respectively|)
23623751T1_23623751T25 CPR:4 methylphenidate_0\NN\4320126|,|inhibitor|, (l_appos) inhibitor_3\NN\20090|an|transporters|dat (l_dep) dat_10\NN\2757810|(|and|net|,|respectively|) (l_conj) net_12\JJ\1740|
23623751T7_23623751T21 NONE dopamine_5\NN\14807737|of|and|norepinephrine (r_compound) transporters_8\NNS\4490091|dopamine
23623751T7_23623751T24 NONE dopamine_5\NN\14807737|of|and|norepinephrine (r_compound) transporters_8\NNS\4490091|dopamine (r_nmod) inhibitor_3\NN\20090|an|transporters|dat (l_dep) dat_10\NN\2757810|(|and|net|,|respectively|)
23623751T7_23623751T25 NONE dopamine_5\NN\14807737|of|and|norepinephrine (r_compound) transporters_8\NNS\4490091|dopamine (r_nmod) inhibitor_3\NN\20090|an|transporters|dat (l_dep) dat_10\NN\2757810|(|and|net|,|respectively|) (l_conj) net_12\JJ\1740|
23623751T8_23623751T21 NONE norepinephrine_7\NN\14807929| (r_conj) dopamine_5\NN\14807737|of|and|norepinephrine (r_compound) transporters_8\NNS\4490091|dopamine
23623751T8_23623751T24 NONE norepinephrine_7\NN\14807929| (r_conj) dopamine_5\NN\14807737|of|and|norepinephrine (r_compound) transporters_8\NNS\4490091|dopamine (r_nmod) inhibitor_3\NN\20090|an|transporters|dat (l_dep) dat_10\NN\2757810|(|and|net|,|respectively|)
23623751T8_23623751T25 NONE norepinephrine_7\NN\14807929| (r_conj) dopamine_5\NN\14807737|of|and|norepinephrine (r_compound) transporters_8\NNS\4490091|dopamine (r_nmod) inhibitor_3\NN\20090|an|transporters|dat (l_dep) dat_10\NN\2757810|(|and|net|,|respectively|) (l_conj) net_12\JJ\1740|
23623751T11_23623751T26 NONE methylphenidate_5\NN\4320126| (r_compound) treatment_6\NN\654885|methylphenidate|shr (r_nsubj) enhanced_10\VBD\227165|that|treatment|self-administration|adulthood|,|and|play (l_conj) play_24\VBP\1072262|alterations|role|response (l_nsubj) alterations_17\NNS\7283608|function (l_nmod) function_20\NN\13783581|in|dat|cortex (l_compound) dat_19\NN\2757810|
23623751T12_23623751T26 NONE cocaine_11\NN\3492717| (r_compound) self-administration_12\NN\1740|cocaine (r_dobj) enhanced_10\VBD\227165|that|treatment|self-administration|adulthood|,|and|play (l_conj) play_24\VBP\1072262|alterations|role|response (l_nsubj) alterations_17\NNS\7283608|function (l_nmod) function_20\NN\13783581|in|dat|cortex (l_compound) dat_19\NN\2757810|
23623751T14_23623751T27 NONE methylphenidate_23\NN\4320126|of (r_nmod) dose_21\NN\3740161|a|relevant|methylphenidate (r_dobj) received_17\VBD\2210855|study|,|rats|dose|1.5mg/kg|adolescence|and|then|assessed|. (l_dep) assessed_44\VBN\670261|function|were|adulthood (l_nsubjpass) function_39\NN\13783581|dat|and|expression (l_compound) dat_38\NN\2757810|ofc
23623751T3_23623751T17 CPR:3 methylphenidate_0\NN\4320126| (r_nsubj) increased_1\VBD\169651|methylphenidate|vmax|and|decreased|. (l_dobj) vmax_3\NN\1740|dat|mpfc (l_compound) dat_2\NN\2757810|
23623751T3_23623751T18 CPR:4 methylphenidate_0\NN\4320126| (r_nsubj) increased_1\VBD\169651|methylphenidate|vmax|and|decreased|. (l_conj) decreased_8\VBD\169651|vmax|ofc (l_dobj) vmax_10\NN\1740|dat (l_compound) dat_9\NN\2757810|
23623751T4_23623751T19 CPR:4 methylphenidate_2\NN\4320126| (r_nsubj) decreased_3\VBD\169651|also|,|methylphenidate|km|wis|ofc|. (l_dobj) km_5\NN\13649268|dat (l_compound) dat_4\NN\2757810|
23623751T5_23623751T20 NONE methylphenidate_2\NN\4320126| (r_nsubj) alter_5\VB\126264|further|,|methylphenidate|did|not|localization|,|indicating|. (l_dobj) localization_8\NN\151497|dat|cellular (l_compound) dat_6\NN\2757810|
23623751T5_23623751T22 NONE methylphenidate_2\NN\4320126| (r_nsubj) alter_5\VB\126264|further|,|methylphenidate|did|not|localization|,|indicating|. (l_advcl) indicating_10\VBG\952524|regulated (l_ccomp) regulated_16\VBD\296178|that|treatment|function|manner (l_dobj) function_18\NN\13783581|dat|mpfc (l_compound) dat_17\NN\2757810|
23623751T6_23623751T20 NONE methylphenidate_12\NN\4320126| (r_compound) treatment_13\NN\654885|methylphenidate|adolescence (r_nsubj) regulated_16\VBD\296178|that|treatment|function|manner (r_ccomp) indicating_10\VBG\952524|regulated (r_advcl) alter_5\VB\126264|further|,|methylphenidate|did|not|localization|,|indicating|. (l_dobj) localization_8\NN\151497|dat|cellular (l_compound) dat_6\NN\2757810|
23623751T6_23623751T22 NONE methylphenidate_12\NN\4320126| (r_compound) treatment_13\NN\654885|methylphenidate|adolescence (r_nsubj) regulated_16\VBD\296178|that|treatment|function|manner (l_dobj) function_18\NN\13783581|dat|mpfc (l_compound) dat_17\NN\2757810|
23623751T9_23623751T23 CPR:3 methylphenidate_15\NN\4320126| (r_compound) treatment_16\NN\654885|of|methylphenidate|adolescence (r_nmod) consequence_13\NN\34213|thus|,|increase|was|an|shr-specific|term|treatment|,|responsible|. (l_nsubj) increase_3\NN\13576355|the|function (l_nmod) function_7\NN\13783581|in|mpfc|dat (l_compound) dat_6\NN\2757810|
23623751T10_23623751T23 NONE cocaine_35\NN\3492717| (r_compound) self-administration_36\NN\1740|in|cocaine (r_nmod) increases_33\NNS\13576355|including|the|observed|self-administration (r_nmod) alterations_27\NNS\7283608|for|the|treatment-induced|behavior|increases (r_nmod) responsible_23\JJ\1740|which|may|be|alterations (r_acl:relcl) consequence_13\NN\34213|thus|,|increase|was|an|shr-specific|term|treatment|,|responsible|. (l_nsubj) increase_3\NN\13576355|the|function (l_nmod) function_7\NN\13783581|in|mpfc|dat (l_compound) dat_6\NN\2757810|
6146346
6146346T9_6146346T13 CPR:6 astemizole_0\NN\1740|,|antagonist|:|effect|. (l_appos) antagonist_6\NN\7846|a|potent|histamine|h1-receptor (l_compound) h1-receptor_5\NN\1740|
6146346T10_6146346T13 NONE histamine_16\NN\14739004| (r_conj) antigen_14\NN\20090|and|histamine (r_nmod:npmod) induced_17\JJ\1740|antigen (r_amod) responses_20\NNS\11410625|on|induced|skin|weal|and|relationship (r_nmod) effect_8\NN\34213|rhinoconjunctivitis|,|responses (r_dep) astemizole_0\NN\1740|,|antagonist|:|effect|. (l_appos) antagonist_6\NN\7846|a|potent|histamine|h1-receptor (l_compound) h1-receptor_5\NN\1740|
6146346T11_6146346T13 NONE histamine_4\NN\14739004| (r_compound) antagonist_6\NN\7846|a|potent|histamine|h1-receptor (l_compound) h1-receptor_5\NN\1740|
6146346T5_6146346T12 CPR:6 astemizole_3\NN\1740|of|,|antagonist (l_appos) antagonist_14\NN\7846|a|new|,|acting|,|oral|histamine|h1-receptor (l_compound) h1-receptor_13\NN\1740|
6146346T7_6146346T12 NONE histamine_12\NN\14739004| (r_compound) antagonist_14\NN\7846|a|new|,|acting|,|oral|histamine|h1-receptor (l_compound) h1-receptor_13\NN\1740|
23383871
23383871T3_23383871T5 NONE estrogen_10\NN\14745635| (r_compound) receptor_11\NN\5225602|estrogen|er (l_appos) er_13\NN\14625458|(|)
23383871T3_23383871T16 NONE estrogen_10\NN\14745635| (r_compound) receptor_11\NN\5225602|estrogen|er
23383871T4_23383871T17 NONE estrogen_43\NN\14745635| (r_compound) assays_46\NNS\5733583|in|estrogen|receptor|transactivation (l_compound) receptor_44\NN\5225602|
23383871T1_23383871T11 NONE steroid_27\NN\14727670| (r_compound) compounds_29\NNS\5869584|the|steroid|test|having (r_nsubjpass) separated_35\VBN\1850315|whereas|compounds|were|those (r_advcl) found_20\VBN\2426171|moreover|,|clustered|,|compounds|were|cluster|,|separated|. (l_advcl) clustered_9\VBN\2428924|when|profiles|were|hierarchically|using (l_nsubjpass) profiles_6\NNS\6999802|the|erα-coregulator|binding (l_compound) erα-coregulator_4\NN\1740|
23383871T2_23383871T11 NONE cyclohexene_40\NN\1740| (r_compound) a-ring_41\NN\1740|with|a|cyclohexene (r_nmod) those_37\DT\1740|from|a-ring (r_nmod) separated_35\VBN\1850315|whereas|compounds|were|those (r_advcl) found_20\VBN\2426171|moreover|,|clustered|,|compounds|were|cluster|,|separated|. (l_advcl) clustered_9\VBN\2428924|when|profiles|were|hierarchically|using (l_nsubjpass) profiles_6\NNS\6999802|the|erα-coregulator|binding (l_compound) erα-coregulator_4\NN\1740|
15963006
15963006T5_15963006T7 NONE muscarinic_11\JJ\1740| (r_amod) receptors_12\NNS\5225602|of|muscarinic
15963006T6_15963006T8 NONE oxybutynin_5\NN\1740|of (r_nmod) s-isomer_3\NN\1740|the|oxybutynin|,|as|antagonists (l_conj) antagonists_14\NNS\7846|selective|muscarinic|receptor (l_compound) receptor_13\NN\5225602|m2
23261645
23261645T12_23261645T19 NONE jaspamide_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|jaspamide|function|. (l_nmod) function_7\NN\13783581|on|human|cardiomyocyte|and|activity (l_conj) activity_12\NN\30358|cardiac|channel (l_compound) channel_11\NN\6251781|ion
23261645T7_23261645T13 NONE jaspamide_0\NN\1740| (r_nsubjpass) tested_2\VBN\670261|jaspamide|was|assay|determine|. (l_xcomp) determine_9\VB\1645601|to|effect (l_dobj) effect_11\NN\34213|its|channels (l_nmod) channels_16\NNS\6251781|on|selected|cardiac|ion
23261645T10_23261645T14 CPR:4 jaspamide_0\NN\1740| (r_nsubj) inhibited_2\VBD\2510337|jaspamide|also|channels|;|affected|. (l_dobj) channels_4\NNS\6251781|other|cav1.2 (l_nmod) cav1.2_6\NN\1740|including|,|cav3.2|,|and|hcn2
23261645T10_23261645T15 CPR:4 jaspamide_0\NN\1740| (r_nsubj) inhibited_2\VBD\2510337|jaspamide|also|channels|;|affected|. (l_dobj) channels_4\NNS\6251781|other|cav1.2 (l_nmod) cav1.2_6\NN\1740|including|,|cav3.2|,|and|hcn2 (l_conj) cav3.2_8\NN\1740|
23261645T10_23261645T16 CPR:4 jaspamide_0\NN\1740| (r_nsubj) inhibited_2\VBD\2510337|jaspamide|also|channels|;|affected|. (l_dobj) channels_4\NNS\6251781|other|cav1.2 (l_nmod) cav1.2_6\NN\1740|including|,|cav3.2|,|and|hcn2 (l_conj) hcn2_11\NN\1740|
23261645T10_23261645T17 NONE jaspamide_0\NN\1740| (r_nsubj) inhibited_2\VBD\2510337|jaspamide|also|channels|;|affected|. (l_parataxis) affected_23\VBN\126264|however|,|channel|was|minimally (l_nsubjpass) channel_20\NN\6251781|the|kv11.1|(|herg|) (l_compound) kv11.1_16\NN\1740|
23261645T10_23261645T18 NONE jaspamide_0\NN\1740| (r_nsubj) inhibited_2\VBD\2510337|jaspamide|also|channels|;|affected|. (l_parataxis) affected_23\VBN\126264|however|,|channel|was|minimally (l_nsubjpass) channel_20\NN\6251781|the|kv11.1|(|herg|) (l_compound) herg_18\NN\1740|
11031122
11031122T8_11031122T21 NONE fumarate_0\NN\1740| (r_compound) reductase_1\NN\14732946|fumarate
11031122T1_11031122T9 NONE fumarate_0\NN\1740| (r_compound) reductase_1\NN\14732946|fumarate|frd
11031122T1_11031122T15 NONE fumarate_0\NN\1740| (r_compound) reductase_1\NN\14732946|fumarate|frd (l_appos) frd_3\NN\1740|(|)
11031122T5_11031122T9 CPR:9 fumarate_10\NN\1740| (r_compound) respiration_11\NN\13514314|in|fumarate|induced (r_nmod) enzyme_8\NN\14723628|reductase|is|the|key|respiration|. (l_nsubj) reductase_1\NN\14732946|fumarate|frd
11031122T5_11031122T15 CPR:9 fumarate_10\NN\1740| (r_compound) respiration_11\NN\13514314|in|fumarate|induced (r_nmod) enzyme_8\NN\14723628|reductase|is|the|key|respiration|. (l_nsubj) reductase_1\NN\14732946|fumarate|frd (l_appos) frd_3\NN\1740|(|)
11031122T6_11031122T17 NONE copper_23\NN\14821043|of (r_nmod) export_21\NN\3076708|with|the|copper (r_nmod) associated_18\VBN\628491|export (r_acl) copa_15\NN\1740|and|copp|associated (r_appos) genes_13\NNS\8459252|two|control|,|copa|out (r_conj) gene_2\NN\8459252|the|frda|coding|,|and|genes|, (l_compound) frda_1\NN\1740|
11031122T6_11031122T18 NONE copper_23\NN\14821043|of (r_nmod) export_21\NN\3076708|with|the|copper (r_nmod) associated_18\VBN\628491|export (r_acl) copa_15\NN\1740|and|copp|associated (r_appos) genes_13\NNS\8459252|two|control|,|copa|out (r_conj) gene_2\NN\8459252|the|frda|coding|,|and|genes|, (l_acl) coding_3\VBG\1588493|a (l_nmod) a_6\NN\13649268|for|subunit|frd (l_nmod) frd_8\NN\1740|of
11031122T6_11031122T19 CPR:9 copper_23\NN\14821043|of (r_nmod) export_21\NN\3076708|with|the|copper (r_nmod) associated_18\VBN\628491|export (r_acl) copa_15\NN\1740|and|copp|associated
11031122T6_11031122T20 CPR:9 copper_23\NN\14821043|of (r_nmod) export_21\NN\3076708|with|the|copper (r_nmod) associated_18\VBN\628491|export (r_acl) copa_15\NN\1740|and|copp|associated (l_conj) copp_17\NN\1740|
11031122T7_11031122T17 NONE chloramphenicol_35\NN\2716866| (r_compound) cassette_37\NN\3094503|of|the|chloramphenicol|acetyltransferase (r_nmod) insertion_32\NN\6598915|by|cassette|genes (r_nmod) inactivated_30\VBN\1097743|gene|were|insertion|. (l_nsubjpass) gene_2\NN\8459252|the|frda|coding|,|and|genes|, (l_compound) frda_1\NN\1740|
11031122T7_11031122T18 NONE chloramphenicol_35\NN\2716866| (r_compound) cassette_37\NN\3094503|of|the|chloramphenicol|acetyltransferase (r_nmod) insertion_32\NN\6598915|by|cassette|genes (r_nmod) inactivated_30\VBN\1097743|gene|were|insertion|. (l_nsubjpass) gene_2\NN\8459252|the|frda|coding|,|and|genes|, (l_acl) coding_3\VBG\1588493|a (l_nmod) a_6\NN\13649268|for|subunit|frd (l_nmod) frd_8\NN\1740|of
11031122T7_11031122T19 NONE chloramphenicol_35\NN\2716866| (r_compound) cassette_37\NN\3094503|of|the|chloramphenicol|acetyltransferase (r_nmod) insertion_32\NN\6598915|by|cassette|genes (r_nmod) inactivated_30\VBN\1097743|gene|were|insertion|. (l_nsubjpass) gene_2\NN\8459252|the|frda|coding|,|and|genes|, (l_conj) genes_13\NNS\8459252|two|control|,|copa|out (l_appos) copa_15\NN\1740|and|copp|associated
11031122T7_11031122T20 NONE chloramphenicol_35\NN\2716866| (r_compound) cassette_37\NN\3094503|of|the|chloramphenicol|acetyltransferase (r_nmod) insertion_32\NN\6598915|by|cassette|genes (r_nmod) inactivated_30\VBN\1097743|gene|were|insertion|. (l_nsubjpass) gene_2\NN\8459252|the|frda|coding|,|and|genes|, (l_conj) genes_13\NNS\8459252|two|control|,|copa|out (l_appos) copa_15\NN\1740|and|copp|associated (l_conj) copp_17\NN\1740|
11031122T2_11031122T14 CPR:4 morantel_31\NN\1740|(|,|oxantel|and|thiabendazole|) (r_dep) anthelmintics_29\NNS\3740161|by|three|morantel (r_nmod) inhibited_26\VBN\2510337|growth|can|be|anthelmintics (r_conj) immunogenic_12\JJ\1740|given|that|frd|is|patients|and|inhibited (l_nsubj) frd_2\NN\1740|,|present|,
11031122T3_11031122T14 CPR:4 oxantel_33\NN\1740| (r_conj) morantel_31\NN\1740|(|,|oxantel|and|thiabendazole|) (r_dep) anthelmintics_29\NNS\3740161|by|three|morantel (r_nmod) inhibited_26\VBN\2510337|growth|can|be|anthelmintics (r_conj) immunogenic_12\JJ\1740|given|that|frd|is|patients|and|inhibited (l_nsubj) frd_2\NN\1740|,|present|,
11031122T4_11031122T14 CPR:4 thiabendazole_35\NN\2720201| (r_conj) morantel_31\NN\1740|(|,|oxantel|and|thiabendazole|) (r_dep) anthelmintics_29\NNS\3740161|by|three|morantel (r_nmod) inhibited_26\VBN\2510337|growth|can|be|anthelmintics (r_conj) immunogenic_12\JJ\1740|given|that|frd|is|patients|and|inhibited (l_nsubj) frd_2\NN\1740|,|present|,
11716850
11716850T38_11716850T70 NONE sulfonylureas_24\NNS\2719105|with|the|and|nateglinide (r_nmod) comparison_21\NN\635850|sulfonylureas (r_dep) effects_1\NNS\13245626|the|mitiglinide|channels|:|comparison|. (l_nmod) channels_16\NNS\6251781|on|atp-sensitive|k+|and|secretion
11716850T38_11716850T71 NONE sulfonylureas_24\NNS\2719105|with|the|and|nateglinide (r_nmod) comparison_21\NN\635850|sulfonylureas (r_dep) effects_1\NNS\13245626|the|mitiglinide|channels|:|comparison|. (l_nmod) channels_16\NNS\6251781|on|atp-sensitive|k+|and|secretion (l_conj) secretion_19\NN\13526110|insulin (l_compound) insulin_18\NN\5407119|
11716850T39_11716850T70 NONE mitiglinide_3\NN\1740|of|kad-1229|)|,|drug|, (r_nmod) effects_1\NNS\13245626|the|mitiglinide|channels|:|comparison|. (l_nmod) channels_16\NNS\6251781|on|atp-sensitive|k+|and|secretion
11716850T39_11716850T71 NONE mitiglinide_3\NN\1740|of|kad-1229|)|,|drug|, (r_nmod) effects_1\NNS\13245626|the|mitiglinide|channels|:|comparison|. (l_nmod) channels_16\NNS\6251781|on|atp-sensitive|k+|and|secretion (l_conj) secretion_19\NN\13526110|insulin (l_compound) insulin_18\NN\5407119|
11716850T40_11716850T70 NONE nateglinide_26\NN\1740| (r_conj) sulfonylureas_24\NNS\2719105|with|the|and|nateglinide (r_nmod) comparison_21\NN\635850|sulfonylureas (r_dep) effects_1\NNS\13245626|the|mitiglinide|channels|:|comparison|. (l_nmod) channels_16\NNS\6251781|on|atp-sensitive|k+|and|secretion
11716850T40_11716850T71 NONE nateglinide_26\NN\1740| (r_conj) sulfonylureas_24\NNS\2719105|with|the|and|nateglinide (r_nmod) comparison_21\NN\635850|sulfonylureas (r_dep) effects_1\NNS\13245626|the|mitiglinide|channels|:|comparison|. (l_nmod) channels_16\NNS\6251781|on|atp-sensitive|k+|and|secretion (l_conj) secretion_19\NN\13526110|insulin (l_compound) insulin_18\NN\5407119|
11716850T41_11716850T70 NONE kad-1229_5\NN\1740|( (r_appos) mitiglinide_3\NN\1740|of|kad-1229|)|,|drug|, (r_nmod) effects_1\NNS\13245626|the|mitiglinide|channels|:|comparison|. (l_nmod) channels_16\NNS\6251781|on|atp-sensitive|k+|and|secretion
11716850T41_11716850T71 NONE kad-1229_5\NN\1740|( (r_appos) mitiglinide_3\NN\1740|of|kad-1229|)|,|drug|, (r_nmod) effects_1\NNS\13245626|the|mitiglinide|channels|:|comparison|. (l_nmod) channels_16\NNS\6251781|on|atp-sensitive|k+|and|secretion (l_conj) secretion_19\NN\13526110|insulin (l_compound) insulin_18\NN\5407119|
11716850T1_11716850T42 CPR:4 mitiglinide_0\NN\1740|kad-1229|)|,|drug|, (r_nsubjpass) thought_11\VBN\670261|mitiglinide|is|stimulate|. (l_xcomp) stimulate_13\VB\137313|to|secretion|closing (l_advcl) closing_17\VBG\146138|by|channels (l_dobj) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells
11716850T1_11716850T62 CPR:3 mitiglinide_0\NN\1740|kad-1229|)|,|drug|, (r_nsubjpass) thought_11\VBN\670261|mitiglinide|is|stimulate|. (l_xcomp) stimulate_13\VB\137313|to|secretion|closing (l_dobj) secretion_15\NN\13526110|insulin (l_compound) insulin_14\NN\5407119|
11716850T3_11716850T42 NONE atp-sensitive_19\JJ\1740| (r_amod) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells
11716850T3_11716850T62 NONE atp-sensitive_19\JJ\1740| (r_amod) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells (r_dobj) closing_17\VBG\146138|by|channels (r_advcl) stimulate_13\VB\137313|to|secretion|closing (l_dobj) secretion_15\NN\13526110|insulin (l_compound) insulin_14\NN\5407119|
11716850T8_11716850T42 NONE k+_20\NN\1740| (r_compound) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells
11716850T8_11716850T62 NONE k+_20\NN\1740| (r_compound) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells (r_dobj) closing_17\VBG\146138|by|channels (r_advcl) stimulate_13\VB\137313|to|secretion|closing (l_dobj) secretion_15\NN\13526110|insulin (l_compound) insulin_14\NN\5407119|
11716850T9_11716850T42 NONE k(atp_22\NN\1740| (r_compound) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells
11716850T9_11716850T62 NONE k(atp_22\NN\1740| (r_compound) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells (r_dobj) closing_17\VBG\146138|by|channels (r_advcl) stimulate_13\VB\137313|to|secretion|closing (l_dobj) secretion_15\NN\13526110|insulin (l_compound) insulin_14\NN\5407119|
11716850T12_11716850T42 NONE k(atp_22\NN\1740| (r_compound) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells
11716850T12_11716850T62 NONE k(atp_22\NN\1740| (r_compound) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells (r_dobj) closing_17\VBG\146138|by|channels (r_advcl) stimulate_13\VB\137313|to|secretion|closing (l_dobj) secretion_15\NN\13526110|insulin (l_compound) insulin_14\NN\5407119|
11716850T15_11716850T42 CPR:4 kad-1229_2\CD\1740|( (r_appos) mitiglinide_0\NN\1740|kad-1229|)|,|drug|, (r_nsubjpass) thought_11\VBN\670261|mitiglinide|is|stimulate|. (l_xcomp) stimulate_13\VB\137313|to|secretion|closing (l_advcl) closing_17\VBG\146138|by|channels (l_dobj) channels_25\NNS\6251781|the|atp-sensitive|k+|(|k(atp|)|)|beta-cells
11716850T15_11716850T62 CPR:3 kad-1229_2\CD\1740|( (r_appos) mitiglinide_0\NN\1740|kad-1229|)|,|drug|, (r_nsubjpass) thought_11\VBN\670261|mitiglinide|is|stimulate|. (l_xcomp) stimulate_13\VB\137313|to|secretion|closing (l_dobj) secretion_15\NN\13526110|insulin (l_compound) insulin_14\NN\5407119|
11716850T26_11716850T48 NONE k(atp_7\NN\1740| (r_compound) channels_9\NNS\6251781|for|the|various|k(atp|)
11716850T27_11716850T48 NONE k(atp_7\NN\1740| (r_compound) channels_9\NNS\6251781|for|the|various|k(atp|)
11716850T28_11716850T49 NONE mitiglinide_9\NN\1740|of (r_nmod) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted
11716850T28_11716850T50 NONE mitiglinide_9\NN\1740|of (r_nmod) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T28_11716850T51 NONE mitiglinide_9\NN\1740|of (r_nmod) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T28_11716850T52 NONE mitiglinide_9\NN\1740|of (r_nmod) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T28_11716850T53 NONE mitiglinide_9\NN\1740|of (r_nmod) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T28_11716850T54 NONE mitiglinide_9\NN\1740|of (r_nmod) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T28_11716850T55 NONE mitiglinide_9\NN\1740|of (r_nmod) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T29_11716850T49 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted
11716850T29_11716850T50 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T29_11716850T51 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T29_11716850T52 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T29_11716850T53 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T29_11716850T54 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T29_11716850T55 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T30_11716850T49 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted
11716850T30_11716850T50 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T30_11716850T51 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T30_11716850T52 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T30_11716850T53 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T30_11716850T54 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T30_11716850T55 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T31_11716850T49 NONE meglitinide-related_34\JJ\1740| (r_amod) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted
11716850T31_11716850T50 NONE meglitinide-related_34\JJ\1740| (r_amod) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T31_11716850T51 NONE meglitinide-related_34\JJ\1740| (r_amod) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T31_11716850T52 NONE meglitinide-related_34\JJ\1740| (r_amod) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T31_11716850T53 NONE meglitinide-related_34\JJ\1740| (r_amod) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T31_11716850T54 NONE meglitinide-related_34\JJ\1740| (r_amod) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T31_11716850T55 NONE meglitinide-related_34\JJ\1740| (r_amod) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T32_11716850T49 NONE nateglinide_37\NN\1740| (r_appos) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted
11716850T32_11716850T50 NONE nateglinide_37\NN\1740| (r_appos) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T32_11716850T51 NONE nateglinide_37\NN\1740| (r_appos) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|)
11716850T32_11716850T52 NONE nateglinide_37\NN\1740| (r_appos) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T32_11716850T53 NONE nateglinide_37\NN\1740| (r_appos) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2a_19\NN\1740|
11716850T32_11716850T54 NONE nateglinide_37\NN\1740| (r_appos) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T32_11716850T55 NONE nateglinide_37\NN\1740| (r_appos) compound_35\NN\5869584|to|another|meglitinide-related|,|nateglinide (r_nmod) compared_30\VBD\644583|them|compound (r_conj) examined_5\VBD\789138|study|,|we|effects|,|and|compared|. (l_dobj) effects_7\NNS\13245626|the|mitiglinide|channels (l_nmod) channels_15\NNS\6251781|on|various|cloned|k(atp|)|kir6.2/sur1|reconstituted (l_dep) kir6.2/sur1_17\NN\1740|(|,|kir6.2/sur2a|,|and|kir6.2/sur2b|) (l_conj) kir6.2/sur2b_22\NN\1740|
11716850T33_11716850T56 CPR:4 mitiglinide_8\NN\1740| (r_nsubj) inhibits_9\VBZ\2510337|that|mitiglinide|currents|manner|value|but|inhibit (l_dobj) currents_13\NNS\11449002|the|kir6.2/sur1|channel (l_compound) kir6.2/sur1_11\NN\1740|
11716850T33_11716850T57 CPR:4 mitiglinide_8\NN\1740| (r_nsubj) inhibits_9\VBZ\2510337|that|mitiglinide|currents|manner|value|but|inhibit (l_dobj) currents_13\NNS\11449002|the|kir6.2/sur1|channel (l_compound) kir6.2/sur1_11\NN\1740|
11716850T33_11716850T58 NONE mitiglinide_8\NN\1740| (r_nsubj) inhibits_9\VBZ\2510337|that|mitiglinide|currents|manner|value|but|inhibit (l_conj) inhibit_29\VB\2510337|does|not|significantly|currents|doses (l_dobj) currents_35\NNS\11449002|kir6.2/sur2a|channel (l_compound) kir6.2/sur2a_31\NN\1740|either|or|kir6.2/sur2b
11716850T33_11716850T59 NONE mitiglinide_8\NN\1740| (r_nsubj) inhibits_9\VBZ\2510337|that|mitiglinide|currents|manner|value|but|inhibit (l_conj) inhibit_29\VB\2510337|does|not|significantly|currents|doses (l_dobj) currents_35\NNS\11449002|kir6.2/sur2a|channel (l_compound) kir6.2/sur2a_31\NN\1740|either|or|kir6.2/sur2b
11716850T33_11716850T60 NONE mitiglinide_8\NN\1740| (r_nsubj) inhibits_9\VBZ\2510337|that|mitiglinide|currents|manner|value|but|inhibit (l_conj) inhibit_29\VB\2510337|does|not|significantly|currents|doses (l_dobj) currents_35\NNS\11449002|kir6.2/sur2a|channel (l_compound) kir6.2/sur2a_31\NN\1740|either|or|kir6.2/sur2b (l_conj) kir6.2/sur2b_33\NN\1740|
11716850T33_11716850T61 NONE mitiglinide_8\NN\1740| (r_nsubj) inhibits_9\VBZ\2510337|that|mitiglinide|currents|manner|value|but|inhibit (l_conj) inhibit_29\VB\2510337|does|not|significantly|currents|doses (l_dobj) currents_35\NNS\11449002|kir6.2/sur2a|channel (l_compound) kir6.2/sur2a_31\NN\1740|either|or|kir6.2/sur2b (l_conj) kir6.2/sur2b_33\NN\1740|
11716850T34_11716850T63 CPR:4 nateglinide_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|nateglinide|channels|nm|,|and|inhibits|. (l_dobj) channels_5\NNS\6251781|kir6.2/sur1 (l_compound) kir6.2/sur1_2\NN\1740|and|kir6.2/sur2b
11716850T34_11716850T64 CPR:4 nateglinide_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|nateglinide|channels|nm|,|and|inhibits|. (l_dobj) channels_5\NNS\6251781|kir6.2/sur1 (l_compound) kir6.2/sur1_2\NN\1740|and|kir6.2/sur2b
11716850T34_11716850T65 CPR:4 nateglinide_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|nateglinide|channels|nm|,|and|inhibits|. (l_dobj) channels_5\NNS\6251781|kir6.2/sur1 (l_compound) kir6.2/sur1_2\NN\1740|and|kir6.2/sur2b (l_conj) kir6.2/sur2b_4\NN\1740|
11716850T34_11716850T66 CPR:4 nateglinide_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|nateglinide|channels|nm|,|and|inhibits|. (l_dobj) channels_5\NNS\6251781|kir6.2/sur1 (l_compound) kir6.2/sur1_2\NN\1740|and|kir6.2/sur2b (l_conj) kir6.2/sur2b_4\NN\1740|
11716850T34_11716850T67 CPR:4 nateglinide_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|nateglinide|channels|nm|,|and|inhibits|. (l_conj) inhibits_11\VBZ\2510337|channels|concentrations (l_dobj) channels_13\NNS\6251781|kir6.2/sur2a (l_compound) kir6.2/sur2a_12\NN\1740|
11716850T34_11716850T68 CPR:4 nateglinide_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|nateglinide|channels|nm|,|and|inhibits|. (l_conj) inhibits_11\VBZ\2510337|channels|concentrations (l_dobj) channels_13\NNS\6251781|kir6.2/sur2a (l_compound) kir6.2/sur2a_12\NN\1740|
11716850T2_11716850T43 NONE [3h]glibenclamide_22\NN\1740|of (r_nmod) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (l_nmod) sur1_24\NN\1740|to
11716850T2_11716850T69 NONE [3h]glibenclamide_22\NN\1740|of (r_nmod) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (r_dobj) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (r_ccomp) revealed_15\VBD\2137132|experiments|inhibit|. (l_nsubj) experiments_1\NNS\641820|binding|mitiglinide|sur1 (l_nmod) sur1_10\NN\1740|to|expressed
11716850T4_11716850T43 NONE mitiglinide_29\NN\1740|,|nm|;|nateglinide|;|repaglinide|) (r_dep) values_27\NNS\5941423|(|ic50|:|mitiglinide|, (r_dep) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (l_dobj) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (l_nmod) sur1_24\NN\1740|to
11716850T4_11716850T69 NONE mitiglinide_29\NN\1740|,|nm|;|nateglinide|;|repaglinide|) (r_dep) values_27\NNS\5941423|(|ic50|:|mitiglinide|, (r_dep) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (r_ccomp) revealed_15\VBD\2137132|experiments|inhibit|. (l_nsubj) experiments_1\NNS\641820|binding|mitiglinide|sur1 (l_nmod) sur1_10\NN\1740|to|expressed
11716850T5_11716850T43 NONE nateglinide_34\NN\1740|,|microm (r_dep) mitiglinide_29\NN\1740|,|nm|;|nateglinide|;|repaglinide|) (r_dep) values_27\NNS\5941423|(|ic50|:|mitiglinide|, (r_dep) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (l_dobj) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (l_nmod) sur1_24\NN\1740|to
11716850T5_11716850T69 NONE nateglinide_34\NN\1740|,|microm (r_dep) mitiglinide_29\NN\1740|,|nm|;|nateglinide|;|repaglinide|) (r_dep) values_27\NNS\5941423|(|ic50|:|mitiglinide|, (r_dep) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (r_ccomp) revealed_15\VBD\2137132|experiments|inhibit|. (l_nsubj) experiments_1\NNS\641820|binding|mitiglinide|sur1 (l_nmod) sur1_10\NN\1740|to|expressed
11716850T6_11716850T43 NONE repaglinide_39\NN\1740|,|microm (r_dep) mitiglinide_29\NN\1740|,|nm|;|nateglinide|;|repaglinide|) (r_dep) values_27\NNS\5941423|(|ic50|:|mitiglinide|, (r_dep) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (l_dobj) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (l_nmod) sur1_24\NN\1740|to
11716850T6_11716850T69 NONE repaglinide_39\NN\1740|,|microm (r_dep) mitiglinide_29\NN\1740|,|nm|;|nateglinide|;|repaglinide|) (r_dep) values_27\NNS\5941423|(|ic50|:|mitiglinide|, (r_dep) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (r_ccomp) revealed_15\VBD\2137132|experiments|inhibit|. (l_nsubj) experiments_1\NNS\641820|binding|mitiglinide|sur1 (l_nmod) sur1_10\NN\1740|to|expressed
11716850T7_11716850T43 NONE glibenclamide_51\NN\1740| (r_compound) site_53\NN\8673395|a|glibenclamide|binding (r_dobj) share_49\VBP\2660631|that|they|site (r_ccomp) suggesting_45\VBG\1010118|share (r_advcl) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (l_dobj) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (l_nmod) sur1_24\NN\1740|to
11716850T7_11716850T69 NONE glibenclamide_51\NN\1740| (r_compound) site_53\NN\8673395|a|glibenclamide|binding (r_dobj) share_49\VBP\2660631|that|they|site (r_ccomp) suggesting_45\VBG\1010118|share (r_advcl) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (r_ccomp) revealed_15\VBD\2137132|experiments|inhibit|. (l_nsubj) experiments_1\NNS\641820|binding|mitiglinide|sur1 (l_nmod) sur1_10\NN\1740|to|expressed
11716850T35_11716850T43 NONE mitiglinide_3\NN\1740|on|,|nateglinide|,|and|repaglinide (r_nmod) experiments_1\NNS\641820|binding|mitiglinide|sur1 (r_nsubj) revealed_15\VBD\2137132|experiments|inhibit|. (l_ccomp) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (l_dobj) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (l_nmod) sur1_24\NN\1740|to
11716850T35_11716850T69 NONE mitiglinide_3\NN\1740|on|,|nateglinide|,|and|repaglinide (r_nmod) experiments_1\NNS\641820|binding|mitiglinide|sur1 (l_nmod) sur1_10\NN\1740|to|expressed
11716850T36_11716850T43 NONE nateglinide_5\NN\1740| (r_conj) mitiglinide_3\NN\1740|on|,|nateglinide|,|and|repaglinide (r_nmod) experiments_1\NNS\641820|binding|mitiglinide|sur1 (r_nsubj) revealed_15\VBD\2137132|experiments|inhibit|. (l_ccomp) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (l_dobj) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (l_nmod) sur1_24\NN\1740|to
11716850T36_11716850T69 NONE nateglinide_5\NN\1740| (r_conj) mitiglinide_3\NN\1740|on|,|nateglinide|,|and|repaglinide (r_nmod) experiments_1\NNS\641820|binding|mitiglinide|sur1 (l_nmod) sur1_10\NN\1740|to|expressed
11716850T37_11716850T43 NONE repaglinide_8\NN\1740| (r_conj) mitiglinide_3\NN\1740|on|,|nateglinide|,|and|repaglinide (r_nmod) experiments_1\NNS\641820|binding|mitiglinide|sur1 (r_nsubj) revealed_15\VBD\2137132|experiments|inhibit|. (l_ccomp) inhibit_18\VBP\2510337|that|they|binding|values|suggesting (l_dobj) binding_20\NN\4688246|the|[3h]glibenclamide|sur1 (l_nmod) sur1_24\NN\1740|to
11716850T37_11716850T69 NONE repaglinide_8\NN\1740| (r_conj) mitiglinide_3\NN\1740|on|,|nateglinide|,|and|repaglinide (r_nmod) experiments_1\NNS\641820|binding|mitiglinide|sur1 (l_nmod) sur1_10\NN\1740|to|expressed
11716850T10_11716850T44 NONE glucose_4\NN\14710501|to|,|mitiglinide|,|tolbutamide|,|and|glibenclamide (r_nmod) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T11_11716850T44 NONE mitiglinide_6\NN\1740| (r_conj) glucose_4\NN\14710501|to|,|mitiglinide|,|tolbutamide|,|and|glibenclamide (r_nmod) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T13_11716850T44 NONE tolbutamide_8\NN\14914301| (r_conj) glucose_4\NN\14710501|to|,|mitiglinide|,|tolbutamide|,|and|glibenclamide (r_nmod) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T14_11716850T44 NONE glibenclamide_11\NN\1740| (r_conj) glucose_4\NN\14710501|to|,|mitiglinide|,|tolbutamide|,|and|glibenclamide (r_nmod) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T16_11716850T44 NONE mitiglinide_17\NN\1740|chronic|,|nateglinide|,|or|repaglinide (r_compound) treatment_23\NN\654885|after|mitiglinide (r_nmod) cells_14\NNS\3080309|in|min6|treatment (r_nmod) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T17_11716850T44 NONE nateglinide_19\NN\1740| (r_conj) mitiglinide_17\NN\1740|chronic|,|nateglinide|,|or|repaglinide (r_compound) treatment_23\NN\654885|after|mitiglinide (r_nmod) cells_14\NNS\3080309|in|min6|treatment (r_nmod) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T18_11716850T44 NONE repaglinide_22\NN\1740| (r_conj) mitiglinide_17\NN\1740|chronic|,|nateglinide|,|or|repaglinide (r_compound) treatment_23\NN\654885|after|mitiglinide (r_nmod) cells_14\NNS\3080309|in|min6|treatment (r_nmod) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T19_11716850T44 NONE tolbutamide_30\NN\14914301|and|glibenclamide (r_compound) treatment_33\NN\654885|after|chronic|tolbutamide (r_nmod) those_27\DT\1740|to|treatment (r_nmod) comparable_25\JJ\1740|responses|were|those|. (l_nsubj) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T20_11716850T44 NONE glibenclamide_32\NN\1740| (r_conj) tolbutamide_30\NN\14914301|and|glibenclamide (r_compound) treatment_33\NN\654885|after|chronic|tolbutamide (r_nmod) those_27\DT\1740|to|treatment (r_nmod) comparable_25\JJ\1740|responses|were|those|. (l_nsubj) responses_2\NNS\11410625|the|insulin|glucose|cells (l_compound) insulin_1\NN\5407119|
11716850T21_11716850T45 NONE sulfonylureas_8\NNS\2719105|to|the (r_nmod) similar_5\JJ\1740|sulfonylureas (r_advcl) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T21_11716850T46 NONE sulfonylureas_8\NNS\2719105|to|the (r_nmod) similar_5\JJ\1740|sulfonylureas (r_advcl) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T21_11716850T47 NONE sulfonylureas_8\NNS\2719105|to|the (r_nmod) similar_5\JJ\1740|sulfonylureas (r_advcl) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_appos) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|)
11716850T22_11716850T45 NONE mitiglinide_10\NN\1740| (r_nsubj) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T22_11716850T46 NONE mitiglinide_10\NN\1740| (r_nsubj) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T22_11716850T47 NONE mitiglinide_10\NN\1740| (r_nsubj) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_appos) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|)
11716850T23_11716850T45 NONE k(atp_24\NN\1740| (r_compound) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|) (r_appos) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T23_11716850T46 NONE k(atp_24\NN\1740| (r_compound) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|) (r_appos) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T23_11716850T47 NONE k(atp_24\NN\1740| (r_compound) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|)
11716850T24_11716850T45 NONE k(atp_24\NN\1740| (r_compound) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|) (r_appos) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T24_11716850T46 NONE k(atp_24\NN\1740| (r_compound) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|) (r_appos) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T24_11716850T47 NONE k(atp_24\NN\1740| (r_compound) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|)
11716850T25_11716850T45 NONE mitiglinide_31\NN\1740| (r_nsubj) drug_38\NN\14778436|that|mitiglinide|may|be|a|useful|anti-diabetic (r_ccomp) suggest_29\VBP\1010118|drug (r_conj) indicate_2\VBP\952524|results|specific|,|and|suggest|. (l_ccomp) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T25_11716850T46 NONE mitiglinide_31\NN\1740| (r_nsubj) drug_38\NN\14778436|that|mitiglinide|may|be|a|useful|anti-diabetic (r_ccomp) suggest_29\VBP\1010118|drug (r_conj) indicate_2\VBP\952524|results|specific|,|and|suggest|. (l_ccomp) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_compound) kir6.2/sur1_16\NN\1740|
11716850T25_11716850T47 CPR:5 mitiglinide_31\NN\1740| (r_nsubj) drug_38\NN\14778436|that|mitiglinide|may|be|a|useful|anti-diabetic (r_ccomp) suggest_29\VBP\1010118|drug (r_conj) indicate_2\VBP\952524|results|specific|,|and|suggest|. (l_ccomp) specific_13\JJ\1740|that|,|similar|,|mitiglinide|is|highly|complex (l_nmod) complex_17\NN\5869584|to|the|kir6.2/sur1|,|channel (l_appos) channel_26\NN\6251781|i.e.|,|the|pancreatic|beta-cell|k(atp|)
10381000
10381000T7_10381000T16 NONE tryptophan_0\NN\14605787| (r_compound) mrna_2\NN\14832193|tryptophan|hydroxylase (l_compound) hydroxylase_1\NN\1740|
10381000T3_10381000T8 NONE tryptophan_15\NN\14605787| (r_compound) hydroxylase_16\NN\1740|for|tryptophan|tph|,|enzyme
10381000T3_10381000T9 NONE tryptophan_15\NN\14605787| (r_compound) hydroxylase_16\NN\1740|for|tryptophan|tph|,|enzyme (l_appos) tph_18\NN\1740|(|)
10381000T4_10381000T8 CPR:9 5-ht_25\NN\1740| (r_compound) biosynthesis_26\NN\13565379|in|5-ht (r_nmod) enzyme_23\NN\14723628|the|rate-limiting|biosynthesis (r_appos) hydroxylase_16\NN\1740|for|tryptophan|tph|,|enzyme
10381000T4_10381000T9 CPR:9 5-ht_25\NN\1740| (r_compound) biosynthesis_26\NN\13565379|in|5-ht (r_nmod) enzyme_23\NN\14723628|the|rate-limiting|biosynthesis (r_appos) hydroxylase_16\NN\1740|for|tryptophan|tph|,|enzyme (l_appos) tph_18\NN\1740|(|)
10381000T5_10381000T12 CPR:9 tetrahydrobiopterin_26\NN\1740|of|the|bh4|,|cofactor (r_nmod) synthesis_23\NN\13446390|in|tetrahydrobiopterin (r_nmod) enzyme_21\NN\14723628|the|rate|limiting|synthesis (r_appos) cyclohydrolase_12\NN\1740|for|gtp|i|,|enzyme (l_nummod) i_13\NN\14622893|gtpch
10381000T5_10381000T13 CPR:9 tetrahydrobiopterin_26\NN\1740|of|the|bh4|,|cofactor (r_nmod) synthesis_23\NN\13446390|in|tetrahydrobiopterin (r_nmod) enzyme_21\NN\14723628|the|rate|limiting|synthesis (r_appos) cyclohydrolase_12\NN\1740|for|gtp|i|,|enzyme (l_nummod) i_13\NN\14622893|gtpch (l_appos) gtpch_15\NN\1740|(|)
10381000T5_10381000T14 NONE tetrahydrobiopterin_26\NN\1740|of|the|bh4|,|cofactor (l_appos) cofactor_33\NN\14818238|the|obligate|tph (l_nmod) tph_35\NN\1740|for
10381000T6_10381000T12 CPR:9 bh4_28\NN\1740|(|) (r_appos) tetrahydrobiopterin_26\NN\1740|of|the|bh4|,|cofactor (r_nmod) synthesis_23\NN\13446390|in|tetrahydrobiopterin (r_nmod) enzyme_21\NN\14723628|the|rate|limiting|synthesis (r_appos) cyclohydrolase_12\NN\1740|for|gtp|i|,|enzyme (l_nummod) i_13\NN\14622893|gtpch
10381000T6_10381000T13 CPR:9 bh4_28\NN\1740|(|) (r_appos) tetrahydrobiopterin_26\NN\1740|of|the|bh4|,|cofactor (r_nmod) synthesis_23\NN\13446390|in|tetrahydrobiopterin (r_nmod) enzyme_21\NN\14723628|the|rate|limiting|synthesis (r_appos) cyclohydrolase_12\NN\1740|for|gtp|i|,|enzyme (l_nummod) i_13\NN\14622893|gtpch (l_appos) gtpch_15\NN\1740|(|)
10381000T6_10381000T14 NONE bh4_28\NN\1740|(|) (r_appos) tetrahydrobiopterin_26\NN\1740|of|the|bh4|,|cofactor (l_appos) cofactor_33\NN\14818238|the|obligate|tph (l_nmod) tph_35\NN\1740|for
11071707
11071707T2_11071707T34 NONE amphetamine-type_11\JJ\1740| (r_amod) effects_13\NNS\13245626|amphetamine-type|subjective (r_dobj) produce_10\VBP\1617192|which|effects|humans (r_acl:relcl) stimulants_7\NNS\5816287|of|these|,|produce (r_nmod) dose_4\NN\3740161|the|oral|stimulants|, (r_nsubj) correlated_17\VBD\2657219|importantly|,|dose|potency|releasing|,|and|decrease|. (l_conj) decrease_32\VB\169651|did|not|prolactin (l_dobj) prolactin_34\NN\5410315|plasma|,|effect
11071707T3_11071707T34 NONE ne_24\NNS\14622893|,|not|da (r_dobj) releasing_23\VBG\1435380|in|ne (r_advcl) correlated_17\VBD\2657219|importantly|,|dose|potency|releasing|,|and|decrease|. (l_conj) decrease_32\VB\169651|did|not|prolactin (l_dobj) prolactin_34\NN\5410315|plasma|,|effect
11071707T4_11071707T34 NONE da_27\NN\10484858| (r_conj) ne_24\NNS\14622893|,|not|da (r_dobj) releasing_23\VBG\1435380|in|ne (r_advcl) correlated_17\VBD\2657219|importantly|,|dose|potency|releasing|,|and|decrease|. (l_conj) decrease_32\VB\169651|did|not|prolactin (l_dobj) prolactin_34\NN\5410315|plasma|,|effect
11071707T5_11071707T34 NONE da_40\NN\10484858| (r_compound) release_41\NN\3748886|by|da (r_nmod) mediated_38\VBN\761713|release (r_acl) effect_37\NN\34213|an|mediated (r_appos) prolactin_34\NN\5410315|plasma|,|effect
23360232
23360232T2_23360232T5 NONE peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_compound) rgd_20\NN\1740|cyclic|crgd
23360232T2_23360232T6 NONE peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_compound) rgd_20\NN\1740|cyclic|crgd (l_appos) crgd_22\NN\1740|(|)
23360232T2_23360232T7 NONE peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_acl) targeting_25\VBG\1151110|integrins (l_dobj) integrins_29\NNS\1740|αvβ3 (l_compound) αvβ3_26\NN\1740|and|αvβ5
23360232T2_23360232T8 NONE peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_acl) targeting_25\VBG\1151110|integrins (l_dobj) integrins_29\NNS\1740|αvβ3
23360232T3_23360232T5 NONE histidine-lysine_11\NN\1740|(hk):sirna (r_compound) nanoplexes_13\NNS\1740|of|histidine-lysine|modified (l_acl) modified_14\VBN\109660|peg (l_nmod) peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_compound) rgd_20\NN\1740|cyclic|crgd
23360232T3_23360232T6 NONE histidine-lysine_11\NN\1740|(hk):sirna (r_compound) nanoplexes_13\NNS\1740|of|histidine-lysine|modified (l_acl) modified_14\VBN\109660|peg (l_nmod) peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_compound) rgd_20\NN\1740|cyclic|crgd (l_appos) crgd_22\NN\1740|(|)
23360232T3_23360232T7 NONE histidine-lysine_11\NN\1740|(hk):sirna (r_compound) nanoplexes_13\NNS\1740|of|histidine-lysine|modified (l_acl) modified_14\VBN\109660|peg (l_nmod) peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_acl) targeting_25\VBG\1151110|integrins (l_dobj) integrins_29\NNS\1740|αvβ3 (l_compound) αvβ3_26\NN\1740|and|αvβ5
23360232T3_23360232T8 NONE histidine-lysine_11\NN\1740|(hk):sirna (r_compound) nanoplexes_13\NNS\1740|of|histidine-lysine|modified (l_acl) modified_14\VBN\109660|peg (l_nmod) peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_acl) targeting_25\VBG\1151110|integrins (l_dobj) integrins_29\NNS\1740|αvβ3
23360232T4_23360232T5 NONE histidine-lysine_11\NN\1740|(hk):sirna (r_compound) nanoplexes_13\NNS\1740|of|histidine-lysine|modified (l_acl) modified_14\VBN\109660|peg (l_nmod) peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_compound) rgd_20\NN\1740|cyclic|crgd
23360232T4_23360232T6 NONE histidine-lysine_11\NN\1740|(hk):sirna (r_compound) nanoplexes_13\NNS\1740|of|histidine-lysine|modified (l_acl) modified_14\VBN\109660|peg (l_nmod) peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_compound) rgd_20\NN\1740|cyclic|crgd (l_appos) crgd_22\NN\1740|(|)
23360232T4_23360232T7 NONE histidine-lysine_11\NN\1740|(hk):sirna (r_compound) nanoplexes_13\NNS\1740|of|histidine-lysine|modified (l_acl) modified_14\VBN\109660|peg (l_nmod) peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_acl) targeting_25\VBG\1151110|integrins (l_dobj) integrins_29\NNS\1740|αvβ3 (l_compound) αvβ3_26\NN\1740|and|αvβ5
23360232T4_23360232T8 NONE histidine-lysine_11\NN\1740|(hk):sirna (r_compound) nanoplexes_13\NNS\1740|of|histidine-lysine|modified (l_acl) modified_14\VBN\109660|peg (l_nmod) peg_16\NN\3940256|with|and|ligand (l_conj) ligand_24\NN\20090|a|rgd|targeting (l_acl) targeting_25\VBG\1151110|integrins (l_dobj) integrins_29\NNS\1740|αvβ3
10988273
10988273T11_10988273T21 NONE imidazoline_10\NN\1740| (r_compound) ligand_12\NN\20090|the|imidazoline|receptor|rilmenidine (r_nsubjpass) suggested_16\VBN\1010118|basis|,|ligand|has|been|decrease|. (l_xcomp) decrease_18\VB\169651|to|pressure|activating (l_advcl) activating_24\VBG\1641914|by|alpha(2a)-adrenoceptors (l_dobj) alpha(2a)-adrenoceptors_26\NNS\1740|central
10988273T11_10988273T27 NONE imidazoline_10\NN\1740| (r_compound) ligand_12\NN\20090|the|imidazoline|receptor|rilmenidine (l_compound) receptor_11\NN\5225602|
10988273T13_10988273T21 CPR:3 rilmenidine_13\NN\1740| (r_dep) ligand_12\NN\20090|the|imidazoline|receptor|rilmenidine (r_nsubjpass) suggested_16\VBN\1010118|basis|,|ligand|has|been|decrease|. (l_xcomp) decrease_18\VB\169651|to|pressure|activating (l_advcl) activating_24\VBG\1641914|by|alpha(2a)-adrenoceptors (l_dobj) alpha(2a)-adrenoceptors_26\NNS\1740|central
10988273T13_10988273T27 NONE rilmenidine_13\NN\1740| (r_dep) ligand_12\NN\20090|the|imidazoline|receptor|rilmenidine (l_compound) receptor_11\NN\5225602|
10988273T10_10988273T25 CPR:3 rilmenidine_18\NN\1740|by (r_nmod) activated_16\VBN\1641914|that|alpha(2a)-adrenoceptors|are|equally|rilmenidine (l_nsubjpass) alpha(2a)-adrenoceptors_13\NNS\1740|rabbit
10988273T12_10988273T28 NONE [(3)h]norepinephrine_25\NN\1740| (r_compound) release_26\NN\3748886|the|evoked|[(3)h]norepinephrine (r_dobj) inhibiting_17\VBG\2510337|in|release|and|antagonists|counteracting (r_acl) potencies_12\NNS\5196375|the|agonists|inhibiting (l_nmod) agonists_15\NNS\9613191|of|alpha(2)-adrenoceptor (l_compound) alpha(2)-adrenoceptor_14\NN\1740|
10988273T12_10988273T29 NONE [(3)h]norepinephrine_25\NN\1740| (r_compound) release_26\NN\3748886|the|evoked|[(3)h]norepinephrine (r_dobj) inhibiting_17\VBG\2510337|in|release|and|antagonists|counteracting (l_advcl) counteracting_31\VBG\2367363|in|inhibition (l_dobj) inhibition_34\NN\1068773|the|alpha(2)-adrenoceptor-mediated|induced (l_amod) alpha(2)-adrenoceptor-mediated_33\JJ\1740|
10988273T14_10988273T28 NONE moxonidine_37\NN\1740|by (r_nmod) induced_35\VBN\1627355|moxonidine (r_acl) inhibition_34\NN\1068773|the|alpha(2)-adrenoceptor-mediated|induced (r_dobj) counteracting_31\VBG\2367363|in|inhibition (r_advcl) inhibiting_17\VBG\2510337|in|release|and|antagonists|counteracting (r_acl) potencies_12\NNS\5196375|the|agonists|inhibiting (l_nmod) agonists_15\NNS\9613191|of|alpha(2)-adrenoceptor (l_compound) alpha(2)-adrenoceptor_14\NN\1740|
10988273T14_10988273T29 CPR:4 moxonidine_37\NN\1740|by (r_nmod) induced_35\VBN\1627355|moxonidine (r_acl) inhibition_34\NN\1068773|the|alpha(2)-adrenoceptor-mediated|induced (l_amod) alpha(2)-adrenoceptor-mediated_33\JJ\1740|
10988273T1_10988273T30 CPR:6 rauwolscine_31\NN\1740|with|,|phentolamine|,|and|idazoxan (r_nmod) sharing_27\VBG\2660631|property|rauwolscine (r_advcl) antagonists_22\NNS\7846|whereas|appendages|they|are|alpha(2)-autoreceptors|,|sharing (l_nmod) alpha(2)-autoreceptors_25\NNS\1740|at|the
10988273T2_10988273T30 CPR:6 phentolamine_33\NN\4537602| (r_conj) rauwolscine_31\NN\1740|with|,|phentolamine|,|and|idazoxan (r_nmod) sharing_27\VBG\2660631|property|rauwolscine (r_advcl) antagonists_22\NNS\7846|whereas|appendages|they|are|alpha(2)-autoreceptors|,|sharing (l_nmod) alpha(2)-autoreceptors_25\NNS\1740|at|the
10988273T3_10988273T30 CPR:6 idazoxan_36\NN\1740| (r_conj) rauwolscine_31\NN\1740|with|,|phentolamine|,|and|idazoxan (r_nmod) sharing_27\VBG\2660631|property|rauwolscine (r_advcl) antagonists_22\NNS\7846|whereas|appendages|they|are|alpha(2)-autoreceptors|,|sharing (l_nmod) alpha(2)-autoreceptors_25\NNS\1740|at|the
10988273T15_10988273T30 CPR:6 rilmenidine_6\NN\1740|and|oxymetazoline (r_nsubj) agonists_12\NNS\9613191|artery|,|rilmenidine|are|potent|full|,|antagonists|. (l_advcl) antagonists_22\NNS\7846|whereas|appendages|they|are|alpha(2)-autoreceptors|,|sharing (l_nmod) alpha(2)-autoreceptors_25\NNS\1740|at|the
10988273T16_10988273T30 CPR:6 oxymetazoline_8\NN\1740| (r_conj) rilmenidine_6\NN\1740|and|oxymetazoline (r_nsubj) agonists_12\NNS\9613191|artery|,|rilmenidine|are|potent|full|,|antagonists|. (l_advcl) antagonists_22\NNS\7846|whereas|appendages|they|are|alpha(2)-autoreceptors|,|sharing (l_nmod) alpha(2)-autoreceptors_25\NNS\1740|at|the
10988273T5_10988273T17 NONE acid_8\NN\14818238| (r_compound) sequence_9\NN\8457976|amino|acid (r_conj) nucleotide_5\NN\14850483|a|partial|and|sequence|alpha(2a)-adrenoceptor (l_nmod) alpha(2a)-adrenoceptor_13\NN\1740|of|the|rabbit|region
10988273T5_10988273T18 NONE acid_8\NN\14818238| (r_compound) sequence_9\NN\8457976|amino|acid (r_conj) nucleotide_5\NN\14850483|a|partial|and|sequence|alpha(2a)-adrenoceptor (l_nmod) alpha(2a)-adrenoceptor_13\NN\1740|of|the|rabbit|region (l_appos) region_16\NN\27167|(|a|known (l_acl) known_17\VBN\2110220|influence (l_xcomp) influence_20\VB\137313|to|substantially|characteristics (l_dobj) characteristics_23\NNS\5849040|the|pharmacological|alpha(2)-adrenoceptor (l_nmod) alpha(2)-adrenoceptor_26\NN\1740|of|the|)
10988273T5_10988273T19 NONE acid_8\NN\14818238| (r_compound) sequence_9\NN\8457976|amino|acid (r_conj) nucleotide_5\NN\14850483|a|partial|and|sequence|alpha(2a)-adrenoceptor (r_nsubj) revealed_28\VBD\2137132|addition|,|nucleotide|differences|. (l_dobj) differences_30\NNS\4723816|marked|rabbit (l_nmod) rabbit_33\NN\2323902|between|the|and|alpha(2a)-adrenoceptor (l_conj) alpha(2a)-adrenoceptor_37\NN\1740|the|human
10988273T6_10988273T20 CPR:6 rilmenidine_24\NN\1740|both|and|oxymetazoline (r_nsubj) exhibit_27\VBP\2632167|which|,|however|,|rilmenidine|properties (r_acl:relcl) alpha(2a)-autoreceptors_16\NN\1740|with|,|exhibit
10988273T7_10988273T20 CPR:5 oxymetazoline_26\NN\1740| (r_conj) rilmenidine_24\NN\1740|both|and|oxymetazoline (r_nsubj) exhibit_27\VBP\2632167|which|,|however|,|rilmenidine|properties (r_acl:relcl) alpha(2a)-autoreceptors_16\NN\1740|with|,|exhibit
10988273T8_10988273T22 CPR:6 rilmenidine_4\NN\1740|of (r_nmod) property_2\NN\32613|the|antagonistic|rilmenidine|alpha(2a)-adrenoceptors (l_nmod) alpha(2a)-adrenoceptors_7\NNS\1740|at|human
10988273T8_10988273T23 NONE rilmenidine_4\NN\1740|of (r_nmod) property_2\NN\32613|the|antagonistic|rilmenidine|alpha(2a)-adrenoceptors (r_nsubj) indicates_8\VBZ\952524|property|activation|. (l_ccomp) activation_32\NN\13561719|that|contrast|,|property|is|not|due|alpha(2a)-adrenoceptors|but|involved (l_nmod) alpha(2a)-adrenoceptors_34\NNS\1740|of
10988273T8_10988273T24 NONE rilmenidine_4\NN\1740|of (r_nmod) property_2\NN\32613|the|antagonistic|rilmenidine|alpha(2a)-adrenoceptors (r_nsubj) indicates_8\VBZ\952524|property|activation|. (l_ccomp) activation_32\NN\13561719|that|contrast|,|property|is|not|due|alpha(2a)-adrenoceptors|but|involved (l_conj) involved_44\VBN\2676054|receptors|are|probably (l_nsubjpass) receptors_40\NNS\5225602|other|presumably|i(1)-imidazoline|,
10988273T9_10988273T22 NONE i(1)-imidazoline_39\NN\1740| (r_compound) receptors_40\NNS\5225602|other|presumably|i(1)-imidazoline|, (r_nsubjpass) involved_44\VBN\2676054|receptors|are|probably (r_conj) activation_32\NN\13561719|that|contrast|,|property|is|not|due|alpha(2a)-adrenoceptors|but|involved (r_ccomp) indicates_8\VBZ\952524|property|activation|. (l_nsubj) property_2\NN\32613|the|antagonistic|rilmenidine|alpha(2a)-adrenoceptors (l_nmod) alpha(2a)-adrenoceptors_7\NNS\1740|at|human
10988273T9_10988273T23 NONE i(1)-imidazoline_39\NN\1740| (r_compound) receptors_40\NNS\5225602|other|presumably|i(1)-imidazoline|, (r_nsubjpass) involved_44\VBN\2676054|receptors|are|probably (r_conj) activation_32\NN\13561719|that|contrast|,|property|is|not|due|alpha(2a)-adrenoceptors|but|involved (l_nmod) alpha(2a)-adrenoceptors_34\NNS\1740|of
10988273T9_10988273T24 NONE i(1)-imidazoline_39\NN\1740| (r_compound) receptors_40\NNS\5225602|other|presumably|i(1)-imidazoline|,
15932636
15932636T23_15932636T37 NONE diethylcarbamazine_0\NN\1740| (r_compound) activity_1\NN\30358|diethylcarbamazine|microfilariae (r_nsubj) dependent_7\JJ\1740|activity|is|synthase|. (l_nmod) synthase_11\NN\1740|on|inducible|nitric-oxide|and|pathway (l_conj) pathway_15\NN\5483677|the|cyclooxygenase (l_compound) cyclooxygenase_14\NN\14732946|
15932636T23_15932636T38 NONE diethylcarbamazine_0\NN\1740| (r_compound) activity_1\NN\30358|diethylcarbamazine|microfilariae (r_nsubj) dependent_7\JJ\1740|activity|is|synthase|. (l_nmod) synthase_11\NN\1740|on|inducible|nitric-oxide|and|pathway
15932636T24_15932636T37 NONE nitric-oxide_10\JJ\1740| (r_amod) synthase_11\NN\1740|on|inducible|nitric-oxide|and|pathway (l_conj) pathway_15\NN\5483677|the|cyclooxygenase (l_compound) cyclooxygenase_14\NN\14732946|
15932636T24_15932636T38 NONE nitric-oxide_10\JJ\1740| (r_amod) synthase_11\NN\1740|on|inducible|nitric-oxide|and|pathway
15932636T12_15932636T31 NONE oxide_9\NN\14818238|nitric|and|cyclooxygenase (l_conj) cyclooxygenase_11\NN\14732946|cox
15932636T12_15932636T32 NONE oxide_9\NN\14818238|nitric|and|cyclooxygenase (l_conj) cyclooxygenase_11\NN\14732946|cox (l_appos) cox_13\NN\14732946|(|)
15932636T14_15932636T31 NONE dec_20\NNP\15209706|of (r_nmod) activity_18\NN\30358|to|the|dec|microfilariae (r_nmod) contribution_5\NN\786195|the|pathways|activity (l_nmod) pathways_15\NNS\5483677|of|the|oxide (l_compound) oxide_9\NN\14818238|nitric|and|cyclooxygenase (l_conj) cyclooxygenase_11\NN\14732946|cox
15932636T14_15932636T32 NONE dec_20\NNP\15209706|of (r_nmod) activity_18\NN\30358|to|the|dec|microfilariae (r_nmod) contribution_5\NN\786195|the|pathways|activity (l_nmod) pathways_15\NNS\5483677|of|the|oxide (l_compound) oxide_9\NN\14818238|nitric|and|cyclooxygenase (l_conj) cyclooxygenase_11\NN\14732946|cox (l_appos) cox_13\NN\14732946|(|)
15932636T18_15932636T33 NONE oxide_7\NN\14818238|for|inducible|nitric (r_nmod) role_3\NN\719494|a|oxide|activity (r_dobj) investigate_1\VB\644583|to|role (r_advcl) administered_17\VBN\2436349|investigate|,|dec|were|mice|. (l_nmod) mice_21\NNS\2329401|to|microfilaraemic|inos-/-|and|strain (l_amod) inos-/-_20\JJ\1740|
15932636T19_15932636T33 NONE dec_13\NNP\15209706|and|ivermectin (r_nsubjpass) administered_17\VBN\2436349|investigate|,|dec|were|mice|. (l_nmod) mice_21\NNS\2329401|to|microfilaraemic|inos-/-|and|strain (l_amod) inos-/-_20\JJ\1740|
15932636T20_15932636T33 NONE ivermectin_15\NNP\1740| (r_conj) dec_13\NNP\15209706|and|ivermectin (r_nsubjpass) administered_17\VBN\2436349|investigate|,|dec|were|mice|. (l_nmod) mice_21\NNS\2329401|to|microfilaraemic|inos-/-|and|strain (l_amod) inos-/-_20\JJ\1740|
15932636T21_15932636T34 NONE dec_10\NN\15209706|of (r_nmod) effect_8\NN\34213|any|dec|production (l_nmod) production_13\NN\30358|on|the|proteins (l_nmod) proteins_23\NNS\14944888|of|cox|synthase (l_compound) cox_15\NN\14732946|and
15932636T21_15932636T35 NONE dec_10\NN\15209706|of (r_nmod) effect_8\NN\34213|any|dec|production (l_nmod) production_13\NN\30358|on|the|proteins (l_nmod) proteins_23\NNS\14944888|of|cox|synthase (l_compound) synthase_19\NN\1740|inducible|nitric-oxide|inos
15932636T21_15932636T36 NONE dec_10\NN\15209706|of (r_nmod) effect_8\NN\34213|any|dec|production (l_nmod) production_13\NN\30358|on|the|proteins (l_nmod) proteins_23\NNS\14944888|of|cox|synthase (l_compound) synthase_19\NN\1740|inducible|nitric-oxide|inos (l_appos) inos_21\NN\1740|(|)
15932636T22_15932636T34 NONE nitric-oxide_18\NN\1740| (r_compound) synthase_19\NN\1740|inducible|nitric-oxide|inos (r_compound) proteins_23\NNS\14944888|of|cox|synthase (l_compound) cox_15\NN\14732946|and
15932636T22_15932636T35 NONE nitric-oxide_18\NN\1740| (r_compound) synthase_19\NN\1740|inducible|nitric-oxide|inos
15932636T22_15932636T36 NONE nitric-oxide_18\NN\1740| (r_compound) synthase_19\NN\1740|inducible|nitric-oxide|inos (l_appos) inos_21\NN\1740|(|)
15932636T2_15932636T25 NONE dexamethasone_4\NN\2721538|with|or|indomethacin (r_nmod) pre-treatment_0\NN\1740|animals|dexamethasone (r_nsubj) reduced_7\VBD\441445|pre-treatment|efficacy|%|,|respectively|,|supporting|. (l_advcl) supporting_21\VBG\2199590|role|vivo (l_dobj) role_23\NN\719494|a|pathways (l_nmod) pathways_30\NNS\5483677|for|the|acid (l_compound) acid_27\NN\14818238|arachidonic|and|cyclooxygenase (l_conj) cyclooxygenase_29\NN\14732946|
15932636T3_15932636T25 NONE indomethacin_6\NN\3828465| (r_conj) dexamethasone_4\NN\2721538|with|or|indomethacin (r_nmod) pre-treatment_0\NN\1740|animals|dexamethasone (r_nsubj) reduced_7\VBD\441445|pre-treatment|efficacy|%|,|respectively|,|supporting|. (l_advcl) supporting_21\VBG\2199590|role|vivo (l_dobj) role_23\NN\719494|a|pathways (l_nmod) pathways_30\NNS\5483677|for|the|acid (l_compound) acid_27\NN\14818238|arachidonic|and|cyclooxygenase (l_conj) cyclooxygenase_29\NN\14732946|
15932636T4_15932636T25 NONE acid_27\NN\14818238|arachidonic|and|cyclooxygenase (l_conj) cyclooxygenase_29\NN\14732946|
15932636T5_15932636T26 CPR:4 dec_7\NNP\15209706|with (r_nmod) treatment_5\NN\654885|dec (r_nsubj) results_8\VBZ\2633881|that|treatment|reduction (l_nmod) reduction_11\NN\351485|in|a|amount (l_nmod) amount_14\NN\13329641|in|the|protein (l_nmod) protein_17\NN\14944888|of|cox-1|cells (l_compound) cox-1_16\NN\14737847|
15932636T6_15932636T27 NONE dec_11\NNP\15209706| (r_nsubj) showed_12\VBD\2137132|additionally|,|mice|,|dec|activity|,|unaffected|. (l_nmod) mice_4\NNS\2329401|in|inos-/-|infected (l_amod) inos-/-_3\JJ\1740|
15932636T7_15932636T27 NONE ivermectin_24\NNP\1740| (r_appos) drug_22\NN\14778436|of|another|antifilarial|,|ivermectin|, (r_nmod) efficacy_18\NN\5199286|the|drug (r_nsubj) unaffected_27\JJ\1740|whereas|efficacy|was (r_advcl) showed_12\VBD\2137132|additionally|,|mice|,|dec|activity|,|unaffected|. (l_nmod) mice_4\NNS\2329401|in|inos-/-|infected (l_amod) inos-/-_3\JJ\1740|
15932636T8_15932636T28 NONE acid_11\NN\14818238| (r_compound) pathway_13\NN\5483677|of|the|arachidonic|acid|metabolic (r_nmod) role_7\NN\719494|the|important|pathway|mechanism (r_dobj) confirm_4\VBP\1011725|results|role|vivo|and|show|. (l_conj) show_23\VBP\2137132|targets (l_ccomp) targets_36\VBZ\1151110|that|in|addition|effects|,|it|pathway (l_nmod) effects_29\NNS\13245626|to|its|pathway (l_nmod) pathway_33\NN\5483677|on|the|5-lipoxygenase (l_compound) 5-lipoxygenase_32\NN\1740|
15932636T8_15932636T29 NONE acid_11\NN\14818238| (r_compound) pathway_13\NN\5483677|of|the|arachidonic|acid|metabolic (r_nmod) role_7\NN\719494|the|important|pathway|mechanism (r_dobj) confirm_4\VBP\1011725|results|role|vivo|and|show|. (l_conj) show_23\VBP\2137132|targets (l_ccomp) targets_36\VBZ\1151110|that|in|addition|effects|,|it|pathway (l_dobj) pathway_39\NN\5483677|the|cyclooxygenase|and|cox-1 (l_compound) cyclooxygenase_38\NN\14732946|
15932636T8_15932636T30 NONE acid_11\NN\14818238| (r_compound) pathway_13\NN\5483677|of|the|arachidonic|acid|metabolic (r_nmod) role_7\NN\719494|the|important|pathway|mechanism (r_dobj) confirm_4\VBP\1011725|results|role|vivo|and|show|. (l_conj) show_23\VBP\2137132|targets (l_ccomp) targets_36\VBZ\1151110|that|in|addition|effects|,|it|pathway (l_dobj) pathway_39\NN\5483677|the|cyclooxygenase|and|cox-1 (l_conj) cox-1_41\NN\14737847|
23260346
23260346T1_23260346T10 CPR:4 darapladib_10\NN\1740|including|,|currently (r_nmod) described_7\VBN\1001294|inhibitors|have|been|,|darapladib|. (l_nsubjpass) inhibitors_1\NNS\20090|several|lp-pla(2 (l_nmod) lp-pla(2_3\NN\1740|of|) (l_punct) )_4\-RRB-\1740|
23260346T2_23260346T12 NONE darapladib_3\NN\1740|and|inhibitors (l_conj) inhibitors_8\NNS\20090|other|lp-pla(2|) (l_punct) )_7\-RRB-\1740|
23260346T2_23260346T13 NONE darapladib_3\NN\1740|and|inhibitors (r_nsubj) display_9\VBP\2137132|that|darapladib|family (l_nmod) family_15\NN\8189659|across|the|larger|serine|hydrolase (l_compound) hydrolase_14\NN\1740|
23260346T3_23260346T12 NONE serine_13\NN\14601829| (r_compound) family_15\NN\8189659|across|the|larger|serine|hydrolase (r_nmod) display_9\VBP\2137132|that|darapladib|family (l_nsubj) darapladib_3\NN\1740|and|inhibitors (l_conj) inhibitors_8\NNS\20090|other|lp-pla(2|) (l_punct) )_7\-RRB-\1740|
23260346T3_23260346T13 NONE serine_13\NN\14601829| (r_compound) family_15\NN\8189659|across|the|larger|serine|hydrolase (l_compound) hydrolase_14\NN\1740|
23260346T4_23260346T17 CPR:4 darapladib_4\NN\1740|both|and|class (r_nsubj) inactivate_14\VBP\1097743|that|darapladib|lp-pla(2|tissues|selectivity (l_dobj) lp-pla(2_15\NN\1740|) (l_punct) )_16\-RRB-\1740|
23260346T5_23260346T17 CPR:4 carbamate_12\NN\15010703| (r_compound) inhibitors_13\NNS\20090|of|distinct|carbamate (r_nmod) class_8\NN\7951464|a|novel|inhibitors (r_conj) darapladib_4\NN\1740|both|and|class (r_nsubj) inactivate_14\VBP\1097743|that|darapladib|lp-pla(2|tissues|selectivity (l_dobj) lp-pla(2_15\NN\1740|) (l_punct) )_16\-RRB-\1740|
19427182
19427182T20_19427182T33 NONE atp-binding_0\JJ\1740| (r_amod) a1_3\NN\1740|atp-binding|cassette|transporter
19427182T21_19427182T33 CPR:9 alpha-tocopherol_8\NN\1740| (r_compound) secretion_9\NN\13526110|in|hepatic|alpha-tocopherol (r_nmod) involved_5\VBN\2676054|a1|is|secretion|. (l_nsubjpass) a1_3\NN\1740|atp-binding|cassette|transporter
19427182T9_19427182T24 NONE e_17\NN\14724645| (r_compound) deficiency_18\NN\14449126|for|familial|isolated|vitamin|e (r_nmod) responsible_12\JJ\1740|deficiency (r_amod) gene_11\NN\8459252|of|the|responsible (r_nmod) product_8\NN\3076708|the|gene (r_appos) protein_2\NN\14944888|alpha-tocopherol|transfer|alpha-ttp|,|product|, (l_appos) alpha-ttp_4\NN\1740|(|)
19427182T9_19427182T32 NONE e_17\NN\14724645| (r_compound) deficiency_18\NN\14449126|for|familial|isolated|vitamin|e (r_nmod) responsible_12\JJ\1740|deficiency (r_amod) gene_11\NN\8459252|of|the|responsible (r_nmod) product_8\NN\3076708|the|gene (r_appos) protein_2\NN\14944888|alpha-tocopherol|transfer|alpha-ttp|,|product|,
19427182T10_19427182T24 CPR:9 alpha-tocopherol_28\NN\1740| (r_compound) level_29\NN\4916342|the|plasma|alpha-tocopherol (r_dobj) maintaining_25\VBG\2202928|in|level|mediating (r_advcl) plays_20\VBZ\1072262|protein|role|maintaining|. (l_nsubj) protein_2\NN\14944888|alpha-tocopherol|transfer|alpha-ttp|,|product|, (l_appos) alpha-ttp_4\NN\1740|(|)
19427182T10_19427182T32 CPR:9 alpha-tocopherol_28\NN\1740| (r_compound) level_29\NN\4916342|the|plasma|alpha-tocopherol (r_dobj) maintaining_25\VBG\2202928|in|level|mediating (r_advcl) plays_20\VBZ\1072262|protein|role|maintaining|. (l_nsubj) protein_2\NN\14944888|alpha-tocopherol|transfer|alpha-ttp|,|product|,
19427182T11_19427182T24 CPR:9 alpha-tocopherol_35\NN\1740|of (r_nmod) secretion_33\NN\13526110|the|alpha-tocopherol|liver (r_dobj) mediating_31\VBG\761713|by|secretion (r_advcl) maintaining_25\VBG\2202928|in|level|mediating (r_advcl) plays_20\VBZ\1072262|protein|role|maintaining|. (l_nsubj) protein_2\NN\14944888|alpha-tocopherol|transfer|alpha-ttp|,|product|, (l_appos) alpha-ttp_4\NN\1740|(|)
19427182T11_19427182T32 CPR:9 alpha-tocopherol_35\NN\1740|of (r_nmod) secretion_33\NN\13526110|the|alpha-tocopherol|liver (r_dobj) mediating_31\VBG\761713|by|secretion (r_advcl) maintaining_25\VBG\2202928|in|level|mediating (r_advcl) plays_20\VBZ\1072262|protein|role|maintaining|. (l_nsubj) protein_2\NN\14944888|alpha-tocopherol|transfer|alpha-ttp|,|product|,
19427182T18_19427182T24 NONE alpha-tocopherol_0\NN\1740| (r_compound) protein_2\NN\14944888|alpha-tocopherol|transfer|alpha-ttp|,|product|, (l_appos) alpha-ttp_4\NN\1740|(|)
19427182T18_19427182T32 NONE alpha-tocopherol_0\NN\1740| (r_compound) protein_2\NN\14944888|alpha-tocopherol|transfer|alpha-ttp|,|product|,
19427182T15_19427182T26 NONE acetate_6\NN\15010703|[(3)h]alpha-tocopheryl|and|mcarh7777 (r_compound) cells_9\NNS\3080309|acetate|express (l_acl:relcl) express_12\VBP\928630|that|stably|protein (l_dobj) protein_15\NN\14944888|alpha-tocopherol|transfer|alpha-ttp
19427182T15_19427182T27 NONE acetate_6\NN\15010703|[(3)h]alpha-tocopheryl|and|mcarh7777 (r_compound) cells_9\NNS\3080309|acetate|express (l_acl:relcl) express_12\VBP\928630|that|stably|protein (l_dobj) protein_15\NN\14944888|alpha-tocopherol|transfer|alpha-ttp (l_appos) alpha-ttp_17\NN\1740|(|)
19427182T16_19427182T26 NONE alpha-tocopherol_13\NN\1740| (r_compound) protein_15\NN\14944888|alpha-tocopherol|transfer|alpha-ttp
19427182T16_19427182T27 NONE alpha-tocopherol_13\NN\1740| (r_compound) protein_15\NN\14944888|alpha-tocopherol|transfer|alpha-ttp (l_appos) alpha-ttp_17\NN\1740|(|)
19427182T17_19427182T28 NONE atp-binding_15\JJ\1740| (r_amod) a1_18\NN\1740|atp-binding|cassette|transporter (r_nmod:npmod) (abca1)-secreted_19\NN\1740|a1 (r_amod) lipids_20\NNS\14944888|of|the|(abca1)-secreted (r_nmod) acceptor_12\NN\14818238|a|direct|lipids (r_appos) a-i_5\NN\1740|of|apolipoprotein|apoa-i|,|acceptor|,
19427182T17_19427182T29 NONE atp-binding_15\JJ\1740| (r_amod) a1_18\NN\1740|atp-binding|cassette|transporter (r_nmod:npmod) (abca1)-secreted_19\NN\1740|a1 (r_amod) lipids_20\NNS\14944888|of|the|(abca1)-secreted (r_nmod) acceptor_12\NN\14818238|a|direct|lipids (r_appos) a-i_5\NN\1740|of|apolipoprotein|apoa-i|,|acceptor|, (l_appos) apoa-i_7\NN\1740|(|)
19427182T17_19427182T30 NONE atp-binding_15\JJ\1740| (r_amod) a1_18\NN\1740|atp-binding|cassette|transporter
19427182T17_19427182T31 NONE atp-binding_15\JJ\1740| (r_amod) a1_18\NN\1740|atp-binding|cassette|transporter (r_nmod:npmod) (abca1)-secreted_19\NN\1740|a1
19427182T19_19427182T28 CPR:9 alpha-tocopherol_23\NN\1740| (r_compound) secretion_24\NN\13526110|alpha-tocopherol (r_dobj) increased_22\VBD\169651|first|,|addition|secretion|manner|. (l_nsubj) addition_2\NN\3081021|a-i (l_nmod) a-i_5\NN\1740|of|apolipoprotein|apoa-i|,|acceptor|,
19427182T19_19427182T29 CPR:9 alpha-tocopherol_23\NN\1740| (r_compound) secretion_24\NN\13526110|alpha-tocopherol (r_dobj) increased_22\VBD\169651|first|,|addition|secretion|manner|. (l_nsubj) addition_2\NN\3081021|a-i (l_nmod) a-i_5\NN\1740|of|apolipoprotein|apoa-i|,|acceptor|, (l_appos) apoa-i_7\NN\1740|(|)
19427182T19_19427182T30 CPR:9 alpha-tocopherol_23\NN\1740| (r_compound) secretion_24\NN\13526110|alpha-tocopherol (r_dobj) increased_22\VBD\169651|first|,|addition|secretion|manner|. (l_nsubj) addition_2\NN\3081021|a-i (l_nmod) a-i_5\NN\1740|of|apolipoprotein|apoa-i|,|acceptor|, (l_appos) acceptor_12\NN\14818238|a|direct|lipids (l_nmod) lipids_20\NNS\14944888|of|the|(abca1)-secreted (l_amod) (abca1)-secreted_19\NN\1740|a1 (l_nmod:npmod) a1_18\NN\1740|atp-binding|cassette|transporter
19427182T19_19427182T31 CPR:9 alpha-tocopherol_23\NN\1740| (r_compound) secretion_24\NN\13526110|alpha-tocopherol (r_dobj) increased_22\VBD\169651|first|,|addition|secretion|manner|. (l_nsubj) addition_2\NN\3081021|a-i (l_nmod) a-i_5\NN\1740|of|apolipoprotein|apoa-i|,|acceptor|, (l_appos) acceptor_12\NN\14818238|a|direct|lipids (l_nmod) lipids_20\NNS\14944888|of|the|(abca1)-secreted (l_amod) (abca1)-secreted_19\NN\1740|a1
19427182T2_19427182T22 CPR:4 probucol_2\NN\1740|,|compound (l_appos) compound_6\NN\5869584|an|antiatherogenic|reported (l_acl) reported_7\VBN\831651|inactivator (l_xcomp) inactivator_11\NN\1740|to|be|an|abca1 (l_nmod) abca1_13\NN\1740|of
19427182T4_19427182T22 NONE alpha-tocopherol_16\NN\1740| (r_compound) secretion_17\NN\13526110|hepatic|alpha-tocopherol (r_dobj) reduced_14\VBD\441445|second|,|probucol|secretion|. (l_nsubj) probucol_2\NN\1740|,|compound (l_appos) compound_6\NN\5869584|an|antiatherogenic|reported (l_acl) reported_7\VBN\831651|inactivator (l_xcomp) inactivator_11\NN\1740|to|be|an|abca1 (l_nmod) abca1_13\NN\1740|of
19427182T5_19427182T23 CPR:9 alpha-tocopherol_5\NN\1740| (r_compound) secretion_6\NN\13526110|hepatic|alpha-tocopherol (r_dobj) suppressed_3\VBD\2510337|third|,|abca1-rnai|secretion|. (l_nsubj) abca1-rnai_2\NN\1740|
19427182T8_19427182T25 CPR:9 alpha-tocopherol_11\NN\1740| (r_compound) secretion_12\NN\13526110|in|hepatic|alpha-tocopherol (r_nmod) involved_8\VBN\2676054|that|abca1|is|substantially|secretion (l_nsubjpass) abca1_5\NN\1740|
23411208
23411208T10_23411208T17 NONE α-tocopherol-associated_2\NN\1740| (r_amod) protein_3\NN\14944888|α-tocopherol-associated|tap
23411208T10_23411208T18 NONE α-tocopherol-associated_2\NN\1740| (r_amod) protein_3\NN\14944888|α-tocopherol-associated|tap (l_appos) tap_5\NN\7371293|(|)
23411208T1_23411208T11 NONE α-tocopherol_13\NN\1740|of|,|form (r_nmod) activity_11\NN\30358|the|anticancer|α-tocopherol|e. (r_dobj) demonstrated_8\VBN\2137132|decade|,|studies|have|activity|found (l_parataxis) found_31\VBN\2426171|protein|was|one|. (l_nsubjpass) protein_26\NN\14944888|α-tocopherol-associated|tap
23411208T1_23411208T12 NONE α-tocopherol_13\NN\1740|of|,|form (r_nmod) activity_11\NN\30358|the|anticancer|α-tocopherol|e. (r_dobj) demonstrated_8\VBN\2137132|decade|,|studies|have|activity|found (l_parataxis) found_31\VBN\2426171|protein|was|one|. (l_nsubjpass) protein_26\NN\14944888|α-tocopherol-associated|tap (l_appos) tap_28\NN\7371293|(|)
23411208T1_23411208T13 NONE α-tocopherol_13\NN\1740|of|,|form (r_nmod) activity_11\NN\30358|the|anticancer|α-tocopherol|e. (r_dobj) demonstrated_8\VBN\2137132|decade|,|studies|have|activity|found (l_parataxis) found_31\VBN\2426171|protein|was|one|. (l_xcomp) one_34\CD\13741022|to|be|proteins (l_nmod) proteins_40\NNS\14944888|of|the|major|α-tocopherol|binding|serum
23411208T2_23411208T11 NONE e._24\NN\1740|of|vitamin (r_nmod) activity_11\NN\30358|the|anticancer|α-tocopherol|e. (r_dobj) demonstrated_8\VBN\2137132|decade|,|studies|have|activity|found (l_parataxis) found_31\VBN\2426171|protein|was|one|. (l_nsubjpass) protein_26\NN\14944888|α-tocopherol-associated|tap
23411208T2_23411208T12 NONE e._24\NN\1740|of|vitamin (r_nmod) activity_11\NN\30358|the|anticancer|α-tocopherol|e. (r_dobj) demonstrated_8\VBN\2137132|decade|,|studies|have|activity|found (l_parataxis) found_31\VBN\2426171|protein|was|one|. (l_nsubjpass) protein_26\NN\14944888|α-tocopherol-associated|tap (l_appos) tap_28\NN\7371293|(|)
23411208T2_23411208T13 NONE e._24\NN\1740|of|vitamin (r_nmod) activity_11\NN\30358|the|anticancer|α-tocopherol|e. (r_dobj) demonstrated_8\VBN\2137132|decade|,|studies|have|activity|found (l_parataxis) found_31\VBN\2426171|protein|was|one|. (l_xcomp) one_34\CD\13741022|to|be|proteins (l_nmod) proteins_40\NNS\14944888|of|the|major|α-tocopherol|binding|serum
23411208T3_23411208T11 NONE α-tocopherol-associated_25\NN\1740| (r_amod) protein_26\NN\14944888|α-tocopherol-associated|tap
23411208T3_23411208T12 NONE α-tocopherol-associated_25\NN\1740| (r_amod) protein_26\NN\14944888|α-tocopherol-associated|tap (l_appos) tap_28\NN\7371293|(|)
23411208T3_23411208T13 NONE α-tocopherol-associated_25\NN\1740| (r_amod) protein_26\NN\14944888|α-tocopherol-associated|tap (r_nsubjpass) found_31\VBN\2426171|protein|was|one|. (l_xcomp) one_34\CD\13741022|to|be|proteins (l_nmod) proteins_40\NNS\14944888|of|the|major|α-tocopherol|binding|serum
23411208T4_23411208T11 NONE α-tocopherol_38\NN\1740| (r_compound) proteins_40\NNS\14944888|of|the|major|α-tocopherol|binding|serum (r_nmod) one_34\CD\13741022|to|be|proteins (r_xcomp) found_31\VBN\2426171|protein|was|one|. (l_nsubjpass) protein_26\NN\14944888|α-tocopherol-associated|tap
23411208T4_23411208T12 NONE α-tocopherol_38\NN\1740| (r_compound) proteins_40\NNS\14944888|of|the|major|α-tocopherol|binding|serum (r_nmod) one_34\CD\13741022|to|be|proteins (r_xcomp) found_31\VBN\2426171|protein|was|one|. (l_nsubjpass) protein_26\NN\14944888|α-tocopherol-associated|tap (l_appos) tap_28\NN\7371293|(|)
23411208T4_23411208T13 NONE α-tocopherol_38\NN\1740| (r_compound) proteins_40\NNS\14944888|of|the|major|α-tocopherol|binding|serum
17979301
17979301T41_17979301T60 NONE monophosphate_15\NN\1740|with|cyclic|guanosine|and|inhibitors (r_nmod) interaction_11\NN\37396|for|high-affinity|monophosphate (r_nmod) provide_8\VBP\2199590|that|interaction (r_acl:relcl) acids_2\NNS\14818238|critical|amino|site|provide|. (l_nmod) site_6\NN\8673395|in|phosphodiesterase-5|catalytic (l_compound) phosphodiesterase-5_4\NN\1740|
17979301T42_17979301T60 NONE acids_2\NNS\14818238|critical|amino|site|provide|. (l_nmod) site_6\NN\8673395|in|phosphodiesterase-5|catalytic (l_compound) phosphodiesterase-5_4\NN\1740|
17979301T3_17979301T52 NONE cgmp_16\NN\1740|(|) (r_appos) monophosphate_14\NN\1740|for|cyclic|guanosine|cgmp (r_nmod) affinity_10\NN\11426530|for|phosphodiesterase|catalytic-site|monophosphate|and|potency (l_compound) phosphodiesterase_4\NN\1740|5|pde5 (l_nummod) 5_5\CD\13741022|
17979301T3_17979301T53 NONE cgmp_16\NN\1740|(|) (r_appos) monophosphate_14\NN\1740|for|cyclic|guanosine|cgmp (r_nmod) affinity_10\NN\11426530|for|phosphodiesterase|catalytic-site|monophosphate|and|potency (l_compound) phosphodiesterase_4\NN\1740|5|pde5 (l_appos) pde5_7\NN\1740|(|)
17979301T39_17979301T52 NONE monophosphate_14\NN\1740|for|cyclic|guanosine|cgmp (r_nmod) affinity_10\NN\11426530|for|phosphodiesterase|catalytic-site|monophosphate|and|potency (l_compound) phosphodiesterase_4\NN\1740|5|pde5 (l_nummod) 5_5\CD\13741022|
17979301T39_17979301T53 NONE monophosphate_14\NN\1740|for|cyclic|guanosine|cgmp (r_nmod) affinity_10\NN\11426530|for|phosphodiesterase|catalytic-site|monophosphate|and|potency (l_compound) phosphodiesterase_4\NN\1740|5|pde5 (l_appos) pde5_7\NN\1740|(|)
17979301T24_17979301T51 NONE hydrogen_13\NN\14622893| (r_amod) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T25_17979301T51 NONE tyr-612_19\NN\1740|with (r_nmod) interactions_17\NNS\37396|hydrophobic|tyr-612 (r_conj) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T26_17979301T51 NONE hydrogen_21\NN\14622893| (r_compound) bonds_22\NNS\11426530|hydrogen|gln-817 (r_conj) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T27_17979301T51 NONE gln-817_24\NN\1740|with|,|clamp (r_nmod) bonds_22\NNS\11426530|hydrogen|gln-817 (r_conj) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T28_17979301T51 NONE phe-820_31\NN\1740|by|and|val-782 (r_nmod) formed_29\VBN\1617192|phe-820 (r_acl) clamp_28\NN\3525827|a|hydrophobic|formed (r_appos) gln-817_24\NN\1740|with|,|clamp (r_nmod) bonds_22\NNS\11426530|hydrogen|gln-817 (r_conj) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T29_17979301T51 NONE val-782_33\NN\1740| (r_conj) phe-820_31\NN\1740|by|and|val-782 (r_nmod) formed_29\VBN\1617192|phe-820 (r_acl) clamp_28\NN\3525827|a|hydrophobic|formed (r_appos) gln-817_24\NN\1740|with|,|clamp (r_nmod) bonds_22\NNS\11426530|hydrogen|gln-817 (r_conj) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T30_17979301T51 NONE his-613_38\NN\1740|with|,|leu-765|,|and|phe-786 (r_nmod) contacts_36\NNS\39021|his-613 (r_conj) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T31_17979301T51 NONE leu-765_40\NN\1740| (r_conj) his-613_38\NN\1740|with|,|leu-765|,|and|phe-786 (r_nmod) contacts_36\NNS\39021|his-613 (r_conj) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T32_17979301T51 NONE phe-786_43\NN\1740| (r_conj) his-613_38\NN\1740|with|,|leu-765|,|and|phe-786 (r_nmod) contacts_36\NNS\39021|his-613 (r_conj) bond_14\NN\11426530|a|hydrogen|and|interactions|,|bonds|,|and|contacts (r_dobj) reveal_11\VBP\2137132|structures|bond|sung|. (l_nsubj) structures_1\NNS\21939|cocrystal|domain|inhibitors (l_nmod) domain_8\NN\13934596|of|pde5|catalytic|(|c|)
17979301T33_17979301T57 NONE cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) y612a_30\NN\1740|for
17979301T33_17979301T58 NONE cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) q817a_42\NN\1740|for
17979301T33_17979301T59 NONE cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_conj) 59-_45\CD\1740|,|448-|,|71-|,|137-|,|and|93-fold|f820a (l_nmod) f820a_56\NN\1740|for
17979301T34_17979301T57 NONE vardenafil_5\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) y612a_30\NN\1740|for
17979301T34_17979301T58 NONE vardenafil_5\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) q817a_42\NN\1740|for
17979301T34_17979301T59 NONE vardenafil_5\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_conj) 59-_45\CD\1740|,|448-|,|71-|,|137-|,|and|93-fold|f820a (l_nmod) f820a_56\NN\1740|for
17979301T35_17979301T57 NONE sildenafil_7\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) y612a_30\NN\1740|for
17979301T35_17979301T58 NONE sildenafil_7\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) q817a_42\NN\1740|for
17979301T35_17979301T59 NONE sildenafil_7\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_conj) 59-_45\CD\1740|,|448-|,|71-|,|137-|,|and|93-fold|f820a (l_nmod) f820a_56\NN\1740|for
17979301T36_17979301T57 NONE tadalafil_9\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) y612a_30\NN\1740|for
17979301T36_17979301T58 CPR:9 tadalafil_9\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) q817a_42\NN\1740|for
17979301T36_17979301T59 NONE tadalafil_9\NN\4537602| (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_conj) 59-_45\CD\1740|,|448-|,|71-|,|137-|,|and|93-fold|f820a (l_nmod) f820a_56\NN\1740|for
17979301T37_17979301T57 NONE 3-isobutyl-1-methylxanthine_12\NN\1740|ibmx (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) y612a_30\NN\1740|for
17979301T37_17979301T58 NONE 3-isobutyl-1-methylxanthine_12\NN\1740|ibmx (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) q817a_42\NN\1740|for
17979301T37_17979301T59 NONE 3-isobutyl-1-methylxanthine_12\NN\1740|ibmx (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_conj) 59-_45\CD\1740|,|448-|,|71-|,|137-|,|and|93-fold|f820a (l_nmod) f820a_56\NN\1740|for
17979301T38_17979301T57 NONE ibmx_14\NN\1740|(|) (r_appos) 3-isobutyl-1-methylxanthine_12\NN\1740|ibmx (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) y612a_30\NN\1740|for
17979301T38_17979301T58 NONE ibmx_14\NN\1740|(|) (r_appos) 3-isobutyl-1-methylxanthine_12\NN\1740|ibmx (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_nmod) q817a_42\NN\1740|for
17979301T38_17979301T59 NONE ibmx_14\NN\1740|(|) (r_appos) 3-isobutyl-1-methylxanthine_12\NN\1740|ibmx (r_conj) cgmp_3\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|3-isobutyl-1-methylxanthine (r_nmod) affinities_1\NNS\11426530|catalytic-site|cgmp (r_nsubjpass) weakened_18\VBN\126264|affinities|were|respectively|14-|y612a|;|63-|q817a|;|and|59-|. (l_conj) 59-_45\CD\1740|,|448-|,|71-|,|137-|,|and|93-fold|f820a (l_nmod) f820a_56\NN\1740|for
17979301T9_17979301T43 NONE cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|ibmx (r_nmod) affinity_0\NN\11426530|v782a|cgmp (l_nmod) v782a_2\NN\1740|of
17979301T10_17979301T43 NONE vardenafil_6\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|ibmx (r_nmod) affinity_0\NN\11426530|v782a|cgmp (l_nmod) v782a_2\NN\1740|of
17979301T11_17979301T43 NONE sildenafil_8\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|ibmx (r_nmod) affinity_0\NN\11426530|v782a|cgmp (l_nmod) v782a_2\NN\1740|of
17979301T12_17979301T43 NONE tadalafil_10\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|ibmx (r_nmod) affinity_0\NN\11426530|v782a|cgmp (l_nmod) v782a_2\NN\1740|of
17979301T13_17979301T43 NONE ibmx_13\NN\1740| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|tadalafil|,|or|ibmx (r_nmod) affinity_0\NN\11426530|v782a|cgmp (l_nmod) v782a_2\NN\1740|of
17979301T14_17979301T44 NONE cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a
17979301T14_17979301T45 NONE cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) h613a_15\NN\1740|
17979301T14_17979301T46 NONE cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) l765a_17\NN\1740|
17979301T14_17979301T47 NONE cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) f786a_20\NN\1740|
17979301T14_17979301T48 NONE cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (r_nmod) change_0\NN\7283608|affinity (r_nsubj) less_22\JJR\1740|change|was|,|but|weakened (l_conj) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (l_nsubjpass) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a
17979301T14_17979301T49 NONE cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (r_nmod) change_0\NN\7283608|affinity (r_nsubj) less_22\JJR\1740|change|was|,|but|weakened (l_conj) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (l_nsubjpass) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a (l_conj) f786a_29\NN\1740|
17979301T15_17979301T44 NONE vardenafil_6\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a
17979301T15_17979301T45 NONE vardenafil_6\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) h613a_15\NN\1740|
17979301T15_17979301T46 NONE vardenafil_6\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) l765a_17\NN\1740|
17979301T15_17979301T47 NONE vardenafil_6\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) f786a_20\NN\1740|
17979301T15_17979301T48 NONE vardenafil_6\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (r_nmod) change_0\NN\7283608|affinity (r_nsubj) less_22\JJR\1740|change|was|,|but|weakened (l_conj) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (l_nsubjpass) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a
17979301T15_17979301T49 NONE vardenafil_6\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (r_nmod) change_0\NN\7283608|affinity (r_nsubj) less_22\JJR\1740|change|was|,|but|weakened (l_conj) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (l_nsubjpass) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a (l_conj) f786a_29\NN\1740|
17979301T16_17979301T44 NONE sildenafil_8\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a
17979301T16_17979301T45 NONE sildenafil_8\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) h613a_15\NN\1740|
17979301T16_17979301T46 NONE sildenafil_8\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) l765a_17\NN\1740|
17979301T16_17979301T47 NONE sildenafil_8\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) f786a_20\NN\1740|
17979301T16_17979301T48 NONE sildenafil_8\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (r_nmod) change_0\NN\7283608|affinity (r_nsubj) less_22\JJR\1740|change|was|,|but|weakened (l_conj) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (l_nsubjpass) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a
17979301T16_17979301T49 NONE sildenafil_8\NN\4537602| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (r_nmod) change_0\NN\7283608|affinity (r_nsubj) less_22\JJR\1740|change|was|,|but|weakened (l_conj) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (l_nsubjpass) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a (l_conj) f786a_29\NN\1740|
17979301T17_17979301T44 NONE ibmx_11\NN\1740| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a
17979301T17_17979301T45 NONE ibmx_11\NN\1740| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) h613a_15\NN\1740|
17979301T17_17979301T46 NONE ibmx_11\NN\1740| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) l765a_17\NN\1740|
17979301T17_17979301T47 NONE ibmx_11\NN\1740| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) f786a_20\NN\1740|
17979301T17_17979301T48 NONE ibmx_11\NN\1740| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (r_nmod) change_0\NN\7283608|affinity (r_nsubj) less_22\JJR\1740|change|was|,|but|weakened (l_conj) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (l_nsubjpass) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a
17979301T17_17979301T49 NONE ibmx_11\NN\1740| (r_conj) cgmp_4\NN\1740|for|,|vardenafil|,|sildenafil|,|or|ibmx (r_nmod) affinity_2\NN\11426530|in|cgmp|y612f (r_nmod) change_0\NN\7283608|affinity (r_nsubj) less_22\JJR\1740|change|was|,|but|weakened (l_conj) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (l_nsubjpass) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a (l_conj) f786a_29\NN\1740|
17979301T18_17979301T44 NONE tadalafil_31\NN\4537602|for (r_nmod) affinity_25\NN\11426530|h613a|tadalafil (r_nsubjpass) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (r_conj) less_22\JJR\1740|change|was|,|but|weakened (l_nsubj) change_0\NN\7283608|affinity (l_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a
17979301T18_17979301T45 NONE tadalafil_31\NN\4537602|for (r_nmod) affinity_25\NN\11426530|h613a|tadalafil (r_nsubjpass) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (r_conj) less_22\JJR\1740|change|was|,|but|weakened (l_nsubj) change_0\NN\7283608|affinity (l_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) h613a_15\NN\1740|
17979301T18_17979301T46 NONE tadalafil_31\NN\4537602|for (r_nmod) affinity_25\NN\11426530|h613a|tadalafil (r_nsubjpass) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (r_conj) less_22\JJR\1740|change|was|,|but|weakened (l_nsubj) change_0\NN\7283608|affinity (l_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) l765a_17\NN\1740|
17979301T18_17979301T47 NONE tadalafil_31\NN\4537602|for (r_nmod) affinity_25\NN\11426530|h613a|tadalafil (r_nsubjpass) weakened_33\VBN\126264|affinity|was|37-|,|respectively|. (r_conj) less_22\JJR\1740|change|was|,|but|weakened (l_nsubj) change_0\NN\7283608|affinity (l_nmod) affinity_2\NN\11426530|in|cgmp|y612f (l_nmod) y612f_13\NN\1740|in|,|h613a|,|l765a|,|or|f786a (l_conj) f786a_20\NN\1740|
17979301T18_17979301T48 NONE tadalafil_31\NN\4537602|for (r_nmod) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a
17979301T18_17979301T49 NONE tadalafil_31\NN\4537602|for (r_nmod) affinity_25\NN\11426530|h613a|tadalafil (l_nmod) h613a_27\NN\1740|of|or|f786a (l_conj) f786a_29\NN\1740|
17979301T19_17979301T50 NONE cgmp_10\NN\1740|for|and|inhibitors (r_nmod) residues_8\NNS\20827|of|pde5|catalytic-site|cgmp (l_compound) pde5_6\NN\1740|
17979301T20_17979301T50 NONE tyr-612_16\NN\1740|,|gln-817|,|and|phe-820 (r_nsubj) contacts_29\NNS\39021|that|tyr-612|are|the|important|cgmp|studied (r_ccomp) indicate_14\VBP\952524|contacts (r_conj) quantify_2\VBP\947077|results|role|,|indicate|,|and|identify|. (l_dobj) role_4\NN\719494|the|residues (l_nmod) residues_8\NNS\20827|of|pde5|catalytic-site|cgmp (l_compound) pde5_6\NN\1740|
17979301T21_17979301T50 NONE gln-817_18\NN\1740| (r_conj) tyr-612_16\NN\1740|,|gln-817|,|and|phe-820 (r_nsubj) contacts_29\NNS\39021|that|tyr-612|are|the|important|cgmp|studied (r_ccomp) indicate_14\VBP\952524|contacts (r_conj) quantify_2\VBP\947077|results|role|,|indicate|,|and|identify|. (l_dobj) role_4\NN\719494|the|residues (l_nmod) residues_8\NNS\20827|of|pde5|catalytic-site|cgmp (l_compound) pde5_6\NN\1740|
17979301T22_17979301T50 NONE phe-820_21\NN\1740| (r_conj) tyr-612_16\NN\1740|,|gln-817|,|and|phe-820 (r_nsubj) contacts_29\NNS\39021|that|tyr-612|are|the|important|cgmp|studied (r_ccomp) indicate_14\VBP\952524|contacts (r_conj) quantify_2\VBP\947077|results|role|,|indicate|,|and|identify|. (l_dobj) role_4\NN\719494|the|residues (l_nmod) residues_8\NNS\20827|of|pde5|catalytic-site|cgmp (l_compound) pde5_6\NN\1740|
17979301T23_17979301T50 NONE cgmp_26\NN\1740|or|inhibitor (r_compound) contacts_29\NNS\39021|that|tyr-612|are|the|important|cgmp|studied (r_ccomp) indicate_14\VBP\952524|contacts (r_conj) quantify_2\VBP\947077|results|role|,|indicate|,|and|identify|. (l_dobj) role_4\NN\719494|the|residues (l_nmod) residues_8\NNS\20827|of|pde5|catalytic-site|cgmp (l_compound) pde5_6\NN\1740|
23360412
23360412T10_23360412T23 NONE dcbn_4\NN\1740|of (r_nmod) toxicity_2\NN\13576101|the|tissue-selective|dcbn|mucosa (r_nsubj) dependent_11\JJ\1740|toxicity|is|largely|bioactivation|. (l_nmod) bioactivation_15\NN\1740|on|target|tissue|cyp2a5 (l_nmod) cyp2a5_17\NN\1740|by
23360412T12_23360412T24 NONE dcbn_21\NN\1740| (r_dobj) activating_20\VBG\1641914|of|dcbn (r_advcl) capable_18\JJ\1740|are|activating (r_conj) expressed_12\VBN\928630|orthologues|are|both|mucosa|and|capable|. (l_nsubj) orthologues_2\NNS\1740|the|human|cyp2a5|, (l_nmod) cyp2a5_4\NN\1740|of|,|cyp2a6
23360412T12_23360412T25 NONE dcbn_21\NN\1740| (r_dobj) activating_20\VBG\1641914|of|dcbn (r_advcl) capable_18\JJ\1740|are|activating (r_conj) expressed_12\VBN\928630|orthologues|are|both|mucosa|and|capable|. (l_nsubj) orthologues_2\NNS\1740|the|human|cyp2a5|, (l_nmod) cyp2a5_4\NN\1740|of|,|cyp2a6 (l_conj) cyp2a6_6\NN\1740|and|cyp2a13
23360412T12_23360412T26 NONE dcbn_21\NN\1740| (r_dobj) activating_20\VBG\1641914|of|dcbn (r_advcl) capable_18\JJ\1740|are|activating (r_conj) expressed_12\VBN\928630|orthologues|are|both|mucosa|and|capable|. (l_nsubj) orthologues_2\NNS\1740|the|human|cyp2a5|, (l_nmod) cyp2a5_4\NN\1740|of|,|cyp2a6 (l_conj) cyp2a6_6\NN\1740|and|cyp2a13 (l_conj) cyp2a13_8\NN\1740|
23360412T19_23360412T27 CPR:4 8-methoxypsoralen_11\NN\1740|by|,|inhibitor (l_appos) inhibitor_16\NN\20090|a|known|cyp2a (l_compound) cyp2a_15\NN\1740|
23360412T5_23360412T22 NONE gs-dcbn_7\NN\1740|and|metabolites (r_nsubjpass) generated_15\VBN\1617192|that|gs-dcbn|were|mucosa (r_ccomp) indicated_5\VBD\952524|studies|generated|. (l_nsubj) studies_1\NNS\635850|further|mice (l_nmod) mice_4\NNS\2329401|in|cyp2a5-null (l_amod) cyp2a5-null_3\JJ\1740|
8600944
8600944T11_8600944T18 CPR:4 gcs_0\NNS\15286249| (r_compound) therapy_1\NN\657604|gcs (r_nsubj) results_2\VBZ\2633881|therapy|expression|. (l_nmod) expression_6\NN\4679549|in|reduced|mrna|interleukin-4|cells (l_nmod) interleukin-4_8\NN\1740|of|il-4|and|il-5
8600944T11_8600944T22 CPR:4 gcs_0\NNS\15286249| (r_compound) therapy_1\NN\657604|gcs (r_nsubj) results_2\VBZ\2633881|therapy|expression|. (l_nmod) expression_6\NN\4679549|in|reduced|mrna|interleukin-4|cells (l_nmod) interleukin-4_8\NN\1740|of|il-4|and|il-5 (l_appos) il-4_10\NN\1740|(|)
8600944T11_8600944T25 CPR:4 gcs_0\NNS\15286249| (r_compound) therapy_1\NN\657604|gcs (r_nsubj) results_2\VBZ\2633881|therapy|expression|. (l_nmod) expression_6\NN\4679549|in|reduced|mrna|interleukin-4|cells (l_nmod) interleukin-4_8\NN\1740|of|il-4|and|il-5 (l_conj) il-5_13\NN\1740|
8600944T11_8600944T28 NONE gcs_0\NNS\15286249| (r_compound) therapy_1\NN\657604|gcs (r_nsubj) results_2\VBZ\2633881|therapy|expression|. (l_nmod) expression_6\NN\4679549|in|reduced|mrna|interleukin-4|cells (l_nmod) cells_15\NNS\3080309|in|lavage|but|ifn-gamma (l_conj) ifn-gamma_25\NN\1740|not|of
8600944T7_8600944T29 CPR:4 gcs_17\NNS\15286249|by (r_nmod) inhibition_11\NN\1068773|cytokines|gcs (l_nmod) cytokines_15\NNS\14728724|of|three
8600944T9_8600944T30 CPR:4 dexamethasone_0\NN\2721538|dex (r_nsubj) inhibited_4\VBD\2510337|dexamethasone|production|. (l_dobj) production_7\NN\30358|the|anti-cd3-induced|il-4|clones (l_amod) anti-cd3-induced_6\JJ\1740|
8600944T9_8600944T31 CPR:4 dexamethasone_0\NN\2721538|dex (r_nsubj) inhibited_4\VBD\2510337|dexamethasone|production|. (l_dobj) production_7\NN\30358|the|anti-cd3-induced|il-4|clones (l_nmod) il-4_9\NN\1740|of|,|il-5|and|ifn-gamma
8600944T9_8600944T32 CPR:4 dexamethasone_0\NN\2721538|dex (r_nsubj) inhibited_4\VBD\2510337|dexamethasone|production|. (l_dobj) production_7\NN\30358|the|anti-cd3-induced|il-4|clones (l_nmod) il-4_9\NN\1740|of|,|il-5|and|ifn-gamma (l_conj) il-5_11\NN\1740|
8600944T9_8600944T33 CPR:4 dexamethasone_0\NN\2721538|dex (r_nsubj) inhibited_4\VBD\2510337|dexamethasone|production|. (l_dobj) production_7\NN\30358|the|anti-cd3-induced|il-4|clones (l_nmod) il-4_9\NN\1740|of|,|il-5|and|ifn-gamma (l_conj) ifn-gamma_13\NN\1740|
8600944T10_8600944T30 CPR:4 dex_2\NN\1740|(|) (r_appos) dexamethasone_0\NN\2721538|dex (r_nsubj) inhibited_4\VBD\2510337|dexamethasone|production|. (l_dobj) production_7\NN\30358|the|anti-cd3-induced|il-4|clones (l_amod) anti-cd3-induced_6\JJ\1740|
8600944T10_8600944T31 CPR:4 dex_2\NN\1740|(|) (r_appos) dexamethasone_0\NN\2721538|dex (r_nsubj) inhibited_4\VBD\2510337|dexamethasone|production|. (l_dobj) production_7\NN\30358|the|anti-cd3-induced|il-4|clones (l_nmod) il-4_9\NN\1740|of|,|il-5|and|ifn-gamma
8600944T10_8600944T32 CPR:4 dex_2\NN\1740|(|) (r_appos) dexamethasone_0\NN\2721538|dex (r_nsubj) inhibited_4\VBD\2510337|dexamethasone|production|. (l_dobj) production_7\NN\30358|the|anti-cd3-induced|il-4|clones (l_nmod) il-4_9\NN\1740|of|,|il-5|and|ifn-gamma (l_conj) il-5_11\NN\1740|
8600944T10_8600944T33 CPR:4 dex_2\NN\1740|(|) (r_appos) dexamethasone_0\NN\2721538|dex (r_nsubj) inhibited_4\VBD\2510337|dexamethasone|production|. (l_dobj) production_7\NN\30358|the|anti-cd3-induced|il-4|clones (l_nmod) il-4_9\NN\1740|of|,|il-5|and|ifn-gamma (l_conj) ifn-gamma_13\NN\1740|
8600944T12_8600944T37 CPR:3 dex_0\NN\1740| (r_nsubj) enhanced_1\VBD\227165|dex|ifn-gamma/il-4|mean|. (l_dobj) ifn-gamma/il-4_4\NN\1740|the|ratio
8600944T12_8600944T38 CPR:3 dex_0\NN\1740| (r_nsubj) enhanced_1\VBD\227165|dex|ifn-gamma/il-4|mean|. (l_dobj) ifn-gamma/il-4_4\NN\1740|the|ratio
8600944T1_8600944T15 NONE dex_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_nmod) producers_47\NNS\10284064|in|high|il-2 (l_compound) il-2_46\NN\1740|
8600944T1_8600944T16 CPR:4 dex_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_dobj) production_51\NN\30358|il-2 (l_compound) il-2_50\NN\1740|
8600944T1_8600944T17 CPR:3 dex_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_conj) enhanced_54\VBD\227165|alpha (l_dobj) alpha_56\NN\6828818|il-2r|expression|and|proliferation
8600944T1_8600944T39 NONE dex_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (r_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (r_parataxis) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_advcl) effects_11\NNS\13245626|based|on|the|gcs|production (l_nmod) production_16\NN\30358|on|il-2|and|alpha (l_compound) il-2_15\NN\1740|
8600944T1_8600944T40 NONE dex_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (r_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (r_parataxis) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_advcl) effects_11\NNS\13245626|based|on|the|gcs|production (l_nmod) production_16\NN\30358|on|il-2|and|alpha (l_conj) alpha_19\NN\6828818|il-2r|expression|and|proliferation
8600944T1_8600944T41 NONE dex_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (r_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_nmod) producers_29\NNS\10284064|in|low|il-2 (l_compound) il-2_28\NN\1740|
8600944T1_8600944T42 NONE dex_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (r_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_dobj) production_33\NN\30358|il-2 (l_compound) il-2_32\NN\1740|
8600944T1_8600944T43 NONE dex_48\NN\1740| (r_nsubj) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (r_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_conj) decreased_35\VBD\169651|alpha (l_dobj) alpha_37\NN\6828818|il-2r|expression|and|proliferation
8600944T13_8600944T15 NONE gcs_13\NNS\15286249|of (r_nmod) effects_11\NNS\13245626|based|on|the|gcs|production (r_advcl) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_parataxis) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_nmod) producers_47\NNS\10284064|in|high|il-2 (l_compound) il-2_46\NN\1740|
8600944T13_8600944T16 NONE gcs_13\NNS\15286249|of (r_nmod) effects_11\NNS\13245626|based|on|the|gcs|production (r_advcl) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_parataxis) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_dobj) production_51\NN\30358|il-2 (l_compound) il-2_50\NN\1740|
8600944T13_8600944T17 NONE gcs_13\NNS\15286249|of (r_nmod) effects_11\NNS\13245626|based|on|the|gcs|production (r_advcl) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_parataxis) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_conj) enhanced_54\VBD\227165|alpha (l_dobj) alpha_56\NN\6828818|il-2r|expression|and|proliferation
8600944T13_8600944T39 NONE gcs_13\NNS\15286249|of (r_nmod) effects_11\NNS\13245626|based|on|the|gcs|production (l_nmod) production_16\NN\30358|on|il-2|and|alpha (l_compound) il-2_15\NN\1740|
8600944T13_8600944T40 NONE gcs_13\NNS\15286249|of (r_nmod) effects_11\NNS\13245626|based|on|the|gcs|production (l_nmod) production_16\NN\30358|on|il-2|and|alpha (l_conj) alpha_19\NN\6828818|il-2r|expression|and|proliferation
8600944T13_8600944T41 NONE gcs_13\NNS\15286249|of (r_nmod) effects_11\NNS\13245626|based|on|the|gcs|production (r_advcl) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_nmod) producers_29\NNS\10284064|in|low|il-2 (l_compound) il-2_28\NN\1740|
8600944T13_8600944T42 NONE gcs_13\NNS\15286249|of (r_nmod) effects_11\NNS\13245626|based|on|the|gcs|production (r_advcl) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_dobj) production_33\NN\30358|il-2 (l_compound) il-2_32\NN\1740|
8600944T13_8600944T43 NONE gcs_13\NNS\15286249|of (r_nmod) effects_11\NNS\13245626|based|on|the|gcs|production (r_advcl) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_parataxis) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_conj) decreased_35\VBD\169651|alpha (l_dobj) alpha_37\NN\6828818|il-2r|expression|and|proliferation
8600944T14_8600944T15 NONE dex_30\NN\1740| (r_nsubj) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_parataxis) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_nmod) producers_47\NNS\10284064|in|high|il-2 (l_compound) il-2_46\NN\1740|
8600944T14_8600944T16 NONE dex_30\NN\1740| (r_nsubj) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_parataxis) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_dobj) production_51\NN\30358|il-2 (l_compound) il-2_50\NN\1740|
8600944T14_8600944T17 NONE dex_30\NN\1740| (r_nsubj) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_parataxis) inhibited_49\VBD\2510337|2|producers|dex|production|partially|and|enhanced (l_conj) enhanced_54\VBD\227165|alpha (l_dobj) alpha_56\NN\6828818|il-2r|expression|and|proliferation
8600944T14_8600944T39 NONE dex_30\NN\1740| (r_nsubj) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (r_parataxis) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_advcl) effects_11\NNS\13245626|based|on|the|gcs|production (l_nmod) production_16\NN\30358|on|il-2|and|alpha (l_compound) il-2_15\NN\1740|
8600944T14_8600944T40 NONE dex_30\NN\1740| (r_nsubj) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (r_parataxis) distinguished_7\VBN\618878|interestingly|,|categories|were|effects|;|blocked (l_advcl) effects_11\NNS\13245626|based|on|the|gcs|production (l_nmod) production_16\NN\30358|on|il-2|and|alpha (l_conj) alpha_19\NN\6828818|il-2r|expression|and|proliferation
8600944T14_8600944T41 NONE dex_30\NN\1740| (r_nsubj) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_nmod) producers_29\NNS\10284064|in|low|il-2 (l_compound) il-2_28\NN\1740|
8600944T14_8600944T42 CPR:4 dex_30\NN\1740| (r_nsubj) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_dobj) production_33\NN\30358|il-2 (l_compound) il-2_32\NN\1740|
8600944T14_8600944T43 CPR:4 dex_30\NN\1740| (r_nsubj) blocked_31\VBD\1476483|1|producers|dex|production|and|decreased|;|inhibited|. (l_conj) decreased_35\VBD\169651|alpha (l_dobj) alpha_37\NN\6828818|il-2r|expression|and|proliferation
8600944T2_8600944T19 NONE dex-induced_6\JJ\1740| (r_amod) increase_7\NN\13576355|the|dex-induced|proliferation (r_dobj) blocked_4\VBD\1476483|anti-il-2|increase|. (l_nsubj) anti-il-2_0\NN\1740|and|alpha
8600944T2_8600944T20 NONE dex-induced_6\JJ\1740| (r_amod) increase_7\NN\13576355|the|dex-induced|proliferation (r_dobj) blocked_4\VBD\1476483|anti-il-2|increase|. (l_nsubj) anti-il-2_0\NN\1740|and|alpha (l_conj) alpha_3\NN\6828818|anti-il2r
8600944T3_8600944T23 CPR:4 dex_26\NN\1740|by (r_nmod) inhibition_24\NN\1068773|to|dex (r_nmod) sensitive_22\JJ\1740|conclusion|,|production|was|more|inhibition|that|,|account|. (l_nsubj) production_4\NN\30358|the|il-4|clones (l_nmod) il-4_6\NN\1740|of|and|il-5
8600944T3_8600944T24 CPR:4 dex_26\NN\1740|by (r_nmod) inhibition_24\NN\1068773|to|dex (r_nmod) sensitive_22\JJ\1740|conclusion|,|production|was|more|inhibition|that|,|account|. (l_nsubj) production_4\NN\30358|the|il-4|clones (l_nmod) il-4_6\NN\1740|of|and|il-5 (l_conj) il-5_8\NN\1740|
8600944T3_8600944T26 CPR:4 dex_26\NN\1740|by (r_nmod) inhibition_24\NN\1068773|to|dex (r_nmod) sensitive_22\JJ\1740|conclusion|,|production|was|more|inhibition|that|,|account|. (l_nmod) that_28\DT\1740|than|ifn-gamma (l_nmod) ifn-gamma_30\NN\1740|of
8600944T4_8600944T27 NONE dex_4\NN\1740|of (r_nmod) effects_2\NNS\13245626|the|differential|dex|proliferation (l_nmod) proliferation_7\NN\13489037|on|the|producers|vitro (l_nmod) producers_13\NNS\10284064|of|high|il-2 (l_compound) il-2_12\NN\1740|
8600944T5_8600944T27 NONE steroids_31\NNS\14727670|with (r_nmod) treated_29\VBN\2376958|steroids (r_acl) patients_28\NNS\9898892|in|treated (r_nmod) outgrowth_20\NN\11410625|a|selective|cells|vivo|patients (r_dobj) implicate_17\VB\2677097|effects|may|outgrowth|. (l_nsubj) effects_2\NNS\13245626|the|differential|dex|proliferation (l_nmod) proliferation_7\NN\13489037|on|the|producers|vitro (l_nmod) producers_13\NNS\10284064|of|high|il-2 (l_compound) il-2_12\NN\1740|
23273219
23273219T3_23273219T12 CPR:4 n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone_8\NN\1740| (r_compound) derivatives_9\NNS\5802185|of|novel|n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone (r_nmod) synthesis_0\NN\13446390|,|modeling|and|evaluation|derivatives|inhibitors|. (l_nmod) inhibitors_12\NNS\20090|as|dual|cholinesterases (l_nmod) cholinesterases_14\NNS\14732946|for|and|aggregation
23273219T3_23273219T13 CPR:4 n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone_8\NN\1740| (r_compound) derivatives_9\NNS\5802185|of|novel|n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone (r_nmod) synthesis_0\NN\13446390|,|modeling|and|evaluation|derivatives|inhibitors|. (l_nmod) inhibitors_12\NNS\20090|as|dual|cholinesterases (l_nmod) cholinesterases_14\NNS\14732946|for|and|aggregation (l_conj) aggregation_17\NN\31264|aβ (l_compound) aβ_16\NN\1740|
23273219T2_23273219T4 CPR:4 n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazones_14\NN\1740|of (r_nmod) group_12\NN\2137|a|n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazones (r_nsubjpass) designed_16\VBN\1631534|develop|,|group|was|,|synthesized|and|tested|. (l_conj) tested_20\VBN\670261|ability (l_nmod) ability_23\NN\4723816|for|their|inhibit (l_acl) inhibit_25\VB\2510337|to|acetylcholinesterase (l_dobj) acetylcholinesterase_26\NN\1740|,|butyrylcholinesterase|and|aggregation|peptides|1
23273219T2_23273219T5 CPR:4 n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazones_14\NN\1740|of (r_nmod) group_12\NN\2137|a|n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazones (r_nsubjpass) designed_16\VBN\1631534|develop|,|group|was|,|synthesized|and|tested|. (l_conj) tested_20\VBN\670261|ability (l_nmod) ability_23\NN\4723816|for|their|inhibit (l_acl) inhibit_25\VB\2510337|to|acetylcholinesterase (l_dobj) acetylcholinesterase_26\NN\1740|,|butyrylcholinesterase|and|aggregation|peptides|1 (l_conj) butyrylcholinesterase_28\NN\1740|
23273219T2_23273219T6 NONE n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazones_14\NN\1740|of (r_nmod) group_12\NN\2137|a|n'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazones (r_nsubjpass) designed_16\VBN\1631534|develop|,|group|was|,|synthesized|and|tested|. (l_conj) tested_20\VBN\670261|ability (l_nmod) ability_23\NN\4723816|for|their|inhibit (l_acl) inhibit_25\VB\2510337|to|acetylcholinesterase (l_dobj) acetylcholinesterase_26\NN\1740|,|butyrylcholinesterase|and|aggregation|peptides|1 (l_appos) 1_36\CD\13741022|(|-|-|) (l_punct) )_49\-RRB-\1740|
23273219T1_23273219T9 NONE rifampicin_23\NN\1740| (r_dep) compound_22\NN\5869584|as|the|reference|rifampicin (r_nmod) potential_18\NN\14481929|with|a|similar|compound (r_nmod) exhibited_7\VBD\2632167|that|compounds|activity|potential|,|makes (r_ccomp) showed_3\VBD\2137132|results|exhibited|. (l_nsubj) results_2\NNS\34213|aggregation (l_compound) aggregation_1\NN\31264|β-amyloid (l_compound) β-amyloid_0\NN\1740|
23273219T1_23273219T10 CPR:4 rifampicin_23\NN\1740| (r_dep) compound_22\NN\5869584|as|the|reference|rifampicin (r_nmod) potential_18\NN\14481929|with|a|similar|compound (r_nmod) exhibited_7\VBD\2632167|that|compounds|activity|potential|,|makes (l_dobj) activity_13\NN\30358|remarkable|aβ|fibril|aggregation|inhibition (l_compound) aβ_9\NN\1740|
23188819
23188819T1_23188819T2 NONE zinc_9\NN\14625458| (r_compound) metallopeptidase_10\NN\1740|enzyme|is|a|conserved|zinc (l_nsubj) enzyme_1\NN\14723628|insulin-degrading|ide
23188819T1_23188819T9 NONE zinc_9\NN\14625458| (r_compound) metallopeptidase_10\NN\1740|enzyme|is|a|conserved|zinc (l_nsubj) enzyme_1\NN\14723628|insulin-degrading|ide (l_appos) ide_3\NN\1740|(|)
23188819T1_23188819T12 NONE zinc_9\NN\14625458| (r_compound) metallopeptidase_10\NN\1740|enzyme|is|a|conserved|zinc
22931530
22931530T5_22931530T9 CPR:4 α-amino-α´-halomethylketones_0\NNS\1740|: (r_amod) methodologies_3\NNS\6166748|α-amino-α´-halomethylketones|synthetic|and|applications|inhibitors|. (l_nmod) inhibitors_12\NNS\20090|as|serine (l_compound) serine_8\NN\14601829|and|protease (l_conj) protease_11\NN\14732946|cysteine
22931530T6_22931530T9 NONE cysteine_10\NN\14601829| (r_compound) protease_11\NN\14732946|cysteine
22931530T7_22931530T9 NONE serine_8\NN\14601829|and|protease (l_conj) protease_11\NN\14732946|cysteine
22931530T3_22931530T8 NONE serine_14\NN\14601829|and|cysteine (r_compound) proteases_17\NNS\14732946|of|relevant|serine
22931530T4_22931530T8 NONE cysteine_16\NN\14601829| (r_conj) serine_14\NN\14601829|and|cysteine (r_compound) proteases_17\NNS\14732946|of|relevant|serine
3124610
3124610T1_3124610T16 NONE diphosphate_23\NN\1740| (r_compound) activity_26\NN\30358|its|adenosine|diphosphate|ribosyl|transferase (r_dobj) deliver_20\VB\941990|in|to|activity|cytosol (r_advcl) pass_12\VB\1835496|addition|,|toxin|toxin|must|compartment|deliver|. (l_nsubj) toxin_4\NN\15032376|il-2|, (l_compound) il-2_3\NN\1740|
3124610T1_3124610T18 NONE diphosphate_23\NN\1740| (r_compound) activity_26\NN\30358|its|adenosine|diphosphate|ribosyl|transferase (l_compound) transferase_25\NN\14732946|
3124610T2_3124610T16 NONE ribosyl_24\NN\1740| (r_compound) activity_26\NN\30358|its|adenosine|diphosphate|ribosyl|transferase (r_dobj) deliver_20\VB\941990|in|to|activity|cytosol (r_advcl) pass_12\VB\1835496|addition|,|toxin|toxin|must|compartment|deliver|. (l_nsubj) toxin_4\NN\15032376|il-2|, (l_compound) il-2_3\NN\1740|
3124610T2_3124610T18 NONE ribosyl_24\NN\1740| (r_compound) activity_26\NN\30358|its|adenosine|diphosphate|ribosyl|transferase (l_compound) transferase_25\NN\14732946|
23253172
23253172T4_23253172T16 NONE corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) vasotocin_12\NN\1740|arginine|avt
23253172T4_23253172T17 NONE corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) vasotocin_12\NN\1740|arginine|avt (l_appos) avt_14\NN\1740|(|,|homologue|)
23253172T4_23253172T18 NONE corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) vasotocin_12\NN\1740|arginine|avt (l_appos) avt_14\NN\1740|(|,|homologue|) (l_appos) homologue_18\NN\1740|the|avian|vasopressin (l_nmod) vasopressin_21\NN\5407119|to|arginine
23253172T4_23253172T19 NONE corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf
23253172T4_23253172T20 NONE corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf (l_appos) crf_27\NN\1740|(|)
23253172T5_23253172T16 NONE cort_8\NN\1740|(|) (r_appos) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) vasotocin_12\NN\1740|arginine|avt
23253172T5_23253172T17 NONE cort_8\NN\1740|(|) (r_appos) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) vasotocin_12\NN\1740|arginine|avt (l_appos) avt_14\NN\1740|(|,|homologue|)
23253172T5_23253172T18 NONE cort_8\NN\1740|(|) (r_appos) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) vasotocin_12\NN\1740|arginine|avt (l_appos) avt_14\NN\1740|(|,|homologue|) (l_appos) homologue_18\NN\1740|the|avian|vasopressin (l_nmod) vasopressin_21\NN\5407119|to|arginine
23253172T5_23253172T19 NONE cort_8\NN\1740|(|) (r_appos) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf
23253172T5_23253172T20 NONE cort_8\NN\1740|(|) (r_appos) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf (l_appos) crf_27\NN\1740|(|)
23253172T6_23253172T16 NONE vasotocin_12\NN\1740|arginine|avt
23253172T6_23253172T17 NONE vasotocin_12\NN\1740|arginine|avt (l_appos) avt_14\NN\1740|(|,|homologue|)
23253172T6_23253172T18 NONE vasotocin_12\NN\1740|arginine|avt (l_appos) avt_14\NN\1740|(|,|homologue|) (l_appos) homologue_18\NN\1740|the|avian|vasopressin (l_nmod) vasopressin_21\NN\5407119|to|arginine
23253172T6_23253172T19 NONE vasotocin_12\NN\1740|arginine|avt (r_conj) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf
23253172T6_23253172T20 NONE vasotocin_12\NN\1740|arginine|avt (r_conj) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf (l_appos) crf_27\NN\1740|(|)
23253172T7_23253172T16 NONE avt_14\NN\1740|(|,|homologue|) (r_appos) vasotocin_12\NN\1740|arginine|avt
23253172T7_23253172T17 NONE avt_14\NN\1740|(|,|homologue|)
23253172T7_23253172T18 NONE avt_14\NN\1740|(|,|homologue|) (l_appos) homologue_18\NN\1740|the|avian|vasopressin (l_nmod) vasopressin_21\NN\5407119|to|arginine
23253172T7_23253172T19 NONE avt_14\NN\1740|(|,|homologue|) (r_appos) vasotocin_12\NN\1740|arginine|avt (r_conj) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf
23253172T7_23253172T20 NONE avt_14\NN\1740|(|,|homologue|) (r_appos) vasotocin_12\NN\1740|arginine|avt (r_conj) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf (l_appos) crf_27\NN\1740|(|)
23253172T8_23253172T16 NONE vasopressin_21\NN\5407119|to|arginine (r_nmod) homologue_18\NN\1740|the|avian|vasopressin (r_appos) avt_14\NN\1740|(|,|homologue|) (r_appos) vasotocin_12\NN\1740|arginine|avt
23253172T8_23253172T17 NONE vasopressin_21\NN\5407119|to|arginine (r_nmod) homologue_18\NN\1740|the|avian|vasopressin (r_appos) avt_14\NN\1740|(|,|homologue|)
23253172T8_23253172T18 NONE vasopressin_21\NN\5407119|to|arginine
23253172T8_23253172T19 NONE vasopressin_21\NN\5407119|to|arginine (r_nmod) homologue_18\NN\1740|the|avian|vasopressin (r_appos) avt_14\NN\1740|(|,|homologue|) (r_appos) vasotocin_12\NN\1740|arginine|avt (r_conj) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf
23253172T8_23253172T20 NONE vasopressin_21\NN\5407119|to|arginine (r_nmod) homologue_18\NN\1740|the|avian|vasopressin (r_appos) avt_14\NN\1740|(|,|homologue|) (r_appos) vasotocin_12\NN\1740|arginine|avt (r_conj) corticosterone_6\NN\14752057|of|cort|,|vasotocin|and|factor (l_conj) factor_25\NN\7326557|corticotrophin-releasing|crf (l_appos) crf_27\NN\1740|(|)
23253172T9_23253172T21 NONE cort_3\NN\1740|,|avt|and|crf|all (l_conj) avt_5\NN\1740|
23253172T9_23253172T22 NONE cort_3\NN\1740|,|avt|and|crf|all (l_conj) crf_7\NN\1740|
23253172T10_23253172T21 NONE avt_5\NN\1740|
23253172T10_23253172T22 NONE avt_5\NN\1740| (r_conj) cort_3\NN\1740|,|avt|and|crf|all (l_conj) crf_7\NN\1740|
23253172T2_23253172T13 NONE oestrogen_48\NN\14745635| (r_compound) concentrations_49\NNS\4916342|in|local|oestrogen (r_nmod) changes_45\NNS\7283608|in|targeted|rapid|concentrations (r_nmod) result_40\VB\2633881|which|modulation|can|changes (r_acl:relcl) modes_30\NNS\4916342|result (r_dobj) suggesting_29\VBG\1010118|modes (r_conj) highlighting_21\VBG\514463|complexity|and|suggesting (l_dobj) complexity_23\NN\4723816|the|link (l_nmod) link_27\NN\13792579|of|the|stress-aromatase (l_compound) stress-aromatase_26\NN\1740|
12213829
12213829T24_12213829T53 NONE katp_3\NN\1740| (r_compound) channels_4\NNS\6251781|of|katp (r_nmod) modulation_1\NN\7044917|sur-dependent|channels|peptide|. (l_amod) sur-dependent_0\JJ\1740|
12213829T24_12213829T54 NONE katp_3\NN\1740| (r_compound) channels_4\NNS\6251781|of|katp
12213829T24_12213829T55 NONE katp_3\NN\1740| (r_compound) channels_4\NNS\6251781|of|katp (r_nmod) modulation_1\NN\7044917|sur-dependent|channels|peptide|. (l_nmod) peptide_9\NN\14724264|by|an|n-terminal|kir6.2 (l_compound) kir6.2_8\NN\1740|
12213829T25_12213829T53 NONE n-terminal_7\JJ\1740| (r_amod) peptide_9\NN\14724264|by|an|n-terminal|kir6.2 (r_nmod) modulation_1\NN\7044917|sur-dependent|channels|peptide|. (l_amod) sur-dependent_0\JJ\1740|
12213829T25_12213829T54 NONE n-terminal_7\JJ\1740| (r_amod) peptide_9\NN\14724264|by|an|n-terminal|kir6.2 (r_nmod) modulation_1\NN\7044917|sur-dependent|channels|peptide|. (l_nmod) channels_4\NNS\6251781|of|katp
12213829T25_12213829T55 NONE n-terminal_7\JJ\1740| (r_amod) peptide_9\NN\14724264|by|an|n-terminal|kir6.2 (l_compound) kir6.2_8\NN\1740|
12213829T7_12213829T27 NONE k(atp_25\NN\1740|) (r_compound) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (l_compound) k(ir)6.0/sur_24\NN\1740|
12213829T7_12213829T29 NONE k(atp_25\NN\1740|) (r_compound) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (l_compound) k(ir)6.0/sur_24\NN\1740|
12213829T7_12213829T31 NONE k(atp_25\NN\1740|) (r_compound) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp
12213829T7_12213829T50 NONE k(atp_25\NN\1740|) (r_compound) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (r_nmod) gating_22\NN\1740|channels (r_dobj) probe_21\VB\789138|to|gating (r_xcomp) used_19\VBN\1156834|ntp|were|probe|. (l_nsubjpass) ntp_0\NN\1740|and|ctp|,|peptides|,|respectively|, (l_appos) peptides_5\NNS\14724264|synthetic|based (l_prep) based_6\VBN\2694933|sequences (l_nmod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (l_nmod) k(ir)6.0_14\NN\1740|of
12213829T8_12213829T27 NONE k(atp_25\NN\1740|) (r_compound) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (l_compound) k(ir)6.0/sur_24\NN\1740|
12213829T8_12213829T29 NONE k(atp_25\NN\1740|) (r_compound) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (l_compound) k(ir)6.0/sur_24\NN\1740|
12213829T8_12213829T31 NONE k(atp_25\NN\1740|) (r_compound) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp
12213829T8_12213829T50 NONE k(atp_25\NN\1740|) (r_compound) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (r_nmod) gating_22\NN\1740|channels (r_dobj) probe_21\VB\789138|to|gating (r_xcomp) used_19\VBN\1156834|ntp|were|probe|. (l_nsubjpass) ntp_0\NN\1740|and|ctp|,|peptides|,|respectively|, (l_appos) peptides_5\NNS\14724264|synthetic|based (l_prep) based_6\VBN\2694933|sequences (l_nmod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (l_nmod) k(ir)6.0_14\NN\1740|of
12213829T16_12213829T27 NONE n-_9\JJ\1740|and|c-terminal (r_amod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (r_nmod) based_6\VBN\2694933|sequences (r_prep) peptides_5\NNS\14724264|synthetic|based (r_appos) ntp_0\NN\1740|and|ctp|,|peptides|,|respectively|, (r_nsubjpass) used_19\VBN\1156834|ntp|were|probe|. (l_xcomp) probe_21\VB\789138|to|gating (l_dobj) gating_22\NN\1740|channels (l_nmod) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (l_compound) k(ir)6.0/sur_24\NN\1740|
12213829T16_12213829T29 NONE n-_9\JJ\1740|and|c-terminal (r_amod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (r_nmod) based_6\VBN\2694933|sequences (r_prep) peptides_5\NNS\14724264|synthetic|based (r_appos) ntp_0\NN\1740|and|ctp|,|peptides|,|respectively|, (r_nsubjpass) used_19\VBN\1156834|ntp|were|probe|. (l_xcomp) probe_21\VB\789138|to|gating (l_dobj) gating_22\NN\1740|channels (l_nmod) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (l_compound) k(ir)6.0/sur_24\NN\1740|
12213829T16_12213829T31 NONE n-_9\JJ\1740|and|c-terminal (r_amod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (r_nmod) based_6\VBN\2694933|sequences (r_prep) peptides_5\NNS\14724264|synthetic|based (r_appos) ntp_0\NN\1740|and|ctp|,|peptides|,|respectively|, (r_nsubjpass) used_19\VBN\1156834|ntp|were|probe|. (l_xcomp) probe_21\VB\789138|to|gating (l_dobj) gating_22\NN\1740|channels (l_nmod) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp
12213829T16_12213829T50 NONE n-_9\JJ\1740|and|c-terminal (r_amod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (l_nmod) k(ir)6.0_14\NN\1740|of
12213829T18_12213829T27 NONE c-terminal_11\JJ\1740| (r_conj) n-_9\JJ\1740|and|c-terminal (r_amod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (r_nmod) based_6\VBN\2694933|sequences (r_prep) peptides_5\NNS\14724264|synthetic|based (r_appos) ntp_0\NN\1740|and|ctp|,|peptides|,|respectively|, (r_nsubjpass) used_19\VBN\1156834|ntp|were|probe|. (l_xcomp) probe_21\VB\789138|to|gating (l_dobj) gating_22\NN\1740|channels (l_nmod) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (l_compound) k(ir)6.0/sur_24\NN\1740|
12213829T18_12213829T29 NONE c-terminal_11\JJ\1740| (r_conj) n-_9\JJ\1740|and|c-terminal (r_amod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (r_nmod) based_6\VBN\2694933|sequences (r_prep) peptides_5\NNS\14724264|synthetic|based (r_appos) ntp_0\NN\1740|and|ctp|,|peptides|,|respectively|, (r_nsubjpass) used_19\VBN\1156834|ntp|were|probe|. (l_xcomp) probe_21\VB\789138|to|gating (l_dobj) gating_22\NN\1740|channels (l_nmod) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp (l_compound) k(ir)6.0/sur_24\NN\1740|
12213829T18_12213829T31 NONE c-terminal_11\JJ\1740| (r_conj) n-_9\JJ\1740|and|c-terminal (r_amod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (r_nmod) based_6\VBN\2694933|sequences (r_prep) peptides_5\NNS\14724264|synthetic|based (r_appos) ntp_0\NN\1740|and|ctp|,|peptides|,|respectively|, (r_nsubjpass) used_19\VBN\1156834|ntp|were|probe|. (l_xcomp) probe_21\VB\789138|to|gating (l_dobj) gating_22\NN\1740|channels (l_nmod) channels_27\NNS\6251781|of|k(ir)6.0/sur|k(atp
12213829T18_12213829T50 NONE c-terminal_11\JJ\1740| (r_conj) n-_9\JJ\1740|and|c-terminal (r_amod) sequences_12\NNS\8457976|on|the|n-|k(ir)6.0 (l_nmod) k(ir)6.0_14\NN\1740|of
12213829T15_12213829T45 CPR:4 atp_20\NN\14964590| (r_compound) inhibition_21\NN\1068773|the|atp|k(ir)6.2/sur1 (l_nmod) k(ir)6.2/sur1_23\NN\1740|of
12213829T15_12213829T46 CPR:4 atp_20\NN\14964590| (r_compound) inhibition_21\NN\1068773|the|atp|k(ir)6.2/sur1 (l_nmod) k(ir)6.2/sur1_23\NN\1740|of
12213829T15_12213829T47 NONE atp_20\NN\14964590| (r_compound) inhibition_21\NN\1068773|the|atp|k(ir)6.2/sur1 (r_dobj) attenuated_18\VBD\224901|inhibition (r_conj) increased_3\VBD\169651|ntp|dose-dependently|probability|p(o(max|and|attenuated|,|but|had|. (l_conj) had_26\VBD\2108377|effect|channels (l_nmod) channels_32\NNS\6251781|on|homomeric|k(ir)6.2 (l_compound) k(ir)6.2_31\CD\1740|
12213829T19_12213829T48 NONE )_14\-RRB-\1740| (r_punct) nucleotide(s_13\NNS\1740|of|stimulatory|mg(-|)|) (r_nmod) absence_8\NN\14449405|in|the|nucleotide(s (r_nmod) silent_5\JJ\1740|normally|absence (r_amod) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (l_compound) k(ir)6.1/sur1_2\NN\1740|
12213829T19_12213829T49 NONE )_14\-RRB-\1740| (r_punct) nucleotide(s_13\NNS\1740|of|stimulatory|mg(-|)|) (r_nmod) absence_8\NN\14449405|in|the|nucleotide(s (r_nmod) silent_5\JJ\1740|normally|absence (r_amod) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (l_compound) k(ir)6.1/sur1_2\NN\1740|
12213829T19_12213829T51 NONE )_14\-RRB-\1740| (r_punct) nucleotide(s_13\NNS\1740|of|stimulatory|mg(-|)|) (r_nmod) absence_8\NN\14449405|in|the|nucleotide(s (r_nmod) silent_5\JJ\1740|normally|absence (r_amod) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (r_dobj) opened_1\VBD\146138|ntp|channels|and|attenuated|. (l_conj) attenuated_16\VBD\224901|coupling (l_dobj) coupling_18\NN\3091374|the|binding|closure (l_nmod) closure_27\NN\280853|with|k(atp|)|pore (l_punct) )_25\-RRB-\1740|
12213829T20_12213829T48 NONE sulfonylurea_21\NN\2719105| (r_compound) binding_22\NN\4688246|of|high-affinity|sulfonylurea (r_nmod) coupling_18\NN\3091374|the|binding|closure (r_dobj) attenuated_16\VBD\224901|coupling (r_conj) opened_1\VBD\146138|ntp|channels|and|attenuated|. (l_dobj) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (l_compound) k(ir)6.1/sur1_2\NN\1740|
12213829T20_12213829T49 NONE sulfonylurea_21\NN\2719105| (r_compound) binding_22\NN\4688246|of|high-affinity|sulfonylurea (r_nmod) coupling_18\NN\3091374|the|binding|closure (r_dobj) attenuated_16\VBD\224901|coupling (r_conj) opened_1\VBD\146138|ntp|channels|and|attenuated|. (l_dobj) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (l_compound) k(ir)6.1/sur1_2\NN\1740|
12213829T20_12213829T51 NONE sulfonylurea_21\NN\2719105| (r_compound) binding_22\NN\4688246|of|high-affinity|sulfonylurea (r_nmod) coupling_18\NN\3091374|the|binding|closure (l_nmod) closure_27\NN\280853|with|k(atp|)|pore (l_punct) )_25\-RRB-\1740|
12213829T21_12213829T48 NONE k(atp_24\NN\1740| (r_compound) closure_27\NN\280853|with|k(atp|)|pore (r_nmod) coupling_18\NN\3091374|the|binding|closure (r_dobj) attenuated_16\VBD\224901|coupling (r_conj) opened_1\VBD\146138|ntp|channels|and|attenuated|. (l_dobj) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (l_compound) k(ir)6.1/sur1_2\NN\1740|
12213829T21_12213829T49 NONE k(atp_24\NN\1740| (r_compound) closure_27\NN\280853|with|k(atp|)|pore (r_nmod) coupling_18\NN\3091374|the|binding|closure (r_dobj) attenuated_16\VBD\224901|coupling (r_conj) opened_1\VBD\146138|ntp|channels|and|attenuated|. (l_dobj) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (l_compound) k(ir)6.1/sur1_2\NN\1740|
12213829T21_12213829T51 NONE k(atp_24\NN\1740| (r_compound) closure_27\NN\280853|with|k(atp|)|pore (l_punct) )_25\-RRB-\1740|
12213829T22_12213829T48 NONE k(atp_24\NN\1740| (r_compound) closure_27\NN\280853|with|k(atp|)|pore (r_nmod) coupling_18\NN\3091374|the|binding|closure (r_dobj) attenuated_16\VBD\224901|coupling (r_conj) opened_1\VBD\146138|ntp|channels|and|attenuated|. (l_dobj) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (l_compound) k(ir)6.1/sur1_2\NN\1740|
12213829T22_12213829T49 NONE k(atp_24\NN\1740| (r_compound) closure_27\NN\280853|with|k(atp|)|pore (r_nmod) coupling_18\NN\3091374|the|binding|closure (r_dobj) attenuated_16\VBD\224901|coupling (r_conj) opened_1\VBD\146138|ntp|channels|and|attenuated|. (l_dobj) channels_3\NNS\6251781|k(ir)6.1/sur1|silent (l_compound) k(ir)6.1/sur1_2\NN\1740|
12213829T22_12213829T51 NONE k(atp_24\NN\1740| (r_compound) closure_27\NN\280853|with|k(atp|)|pore (l_punct) )_25\-RRB-\1740|
12213829T1_12213829T26 NONE deltank(atp_19\NN\1740| (r_compound) channels_21\NNS\6251781|to|deltank(atp|)
12213829T1_12213829T52 NONE deltank(atp_19\NN\1740| (r_compound) channels_21\NNS\6251781|to|deltank(atp|) (r_nmod) application_15\NN\947128|ntp|channels (r_nsubj) decreased_22\VBD\169651|application|p(o(max|+ (r_conj) resemble_2\VBP\2657219|effects|those|,|and|decreased|. (l_xcomp) those_3\DT\1740|seen (l_acl) seen_4\VBN\2106506|deletions (l_nmod) deletions_7\NNS\13508333|with|n-terminal|deltan|k(ir)6.0 (l_nmod) k(ir)6.0_12\NN\1740|of
12213829T2_12213829T26 CPR:4 atp_32\NN\14964590|for (r_nmod) p(o(max_24\NN\1740|their|)|)|and|ic(50|atp (r_dobj) decreased_22\VBD\169651|application|p(o(max|+ (l_nsubj) application_15\NN\947128|ntp|channels (l_nmod) channels_21\NNS\6251781|to|deltank(atp|)
12213829T2_12213829T52 NONE atp_32\NN\14964590|for (r_nmod) p(o(max_24\NN\1740|their|)|)|and|ic(50|atp (r_dobj) decreased_22\VBD\169651|application|p(o(max|+ (r_conj) resemble_2\VBP\2657219|effects|those|,|and|decreased|. (l_xcomp) those_3\DT\1740|seen (l_acl) seen_4\VBN\2106506|deletions (l_nmod) deletions_7\NNS\13508333|with|n-terminal|deltan|k(ir)6.0 (l_nmod) k(ir)6.0_12\NN\1740|of
12213829T3_12213829T26 NONE )_39\-RRB-\1740| (r_punct) +_38\NN\1740|absence|mg(2|) (r_nmod) decreased_22\VBD\169651|application|p(o(max|+ (l_nsubj) application_15\NN\947128|ntp|channels (l_nmod) channels_21\NNS\6251781|to|deltank(atp|)
12213829T3_12213829T52 NONE )_39\-RRB-\1740| (r_punct) +_38\NN\1740|absence|mg(2|) (r_nmod) decreased_22\VBD\169651|application|p(o(max|+ (r_conj) resemble_2\VBP\2657219|effects|those|,|and|decreased|. (l_xcomp) those_3\DT\1740|seen (l_acl) seen_4\VBN\2106506|deletions (l_nmod) deletions_7\NNS\13508333|with|n-terminal|deltan|k(ir)6.0 (l_nmod) k(ir)6.0_12\NN\1740|of
12213829T23_12213829T26 NONE n-terminal_6\JJ\1740| (r_amod) deletions_7\NNS\13508333|with|n-terminal|deltan|k(ir)6.0 (r_nmod) seen_4\VBN\2106506|deletions (r_acl) those_3\DT\1740|seen (r_xcomp) resemble_2\VBP\2657219|effects|those|,|and|decreased|. (l_conj) decreased_22\VBD\169651|application|p(o(max|+ (l_nsubj) application_15\NN\947128|ntp|channels (l_nmod) channels_21\NNS\6251781|to|deltank(atp|)
12213829T23_12213829T52 NONE n-terminal_6\JJ\1740| (r_amod) deletions_7\NNS\13508333|with|n-terminal|deltan|k(ir)6.0 (l_nmod) k(ir)6.0_12\NN\1740|of
12213829T6_12213829T28 NONE n_3\NN\14622893| (r_compound) terminus_4\NN\8566028|the|k(ir|)|n|and|segment (l_punct) )_2\-RRB-\1740|
12213829T6_12213829T30 NONE n_3\NN\14622893| (r_compound) terminus_4\NN\8566028|the|k(ir|)|n|and|segment (l_conj) segment_8\NN\3892891|the|tmd0-l0|sur1 (l_nmod) sur1_10\NN\1740|of
12213829T9_12213829T32 NONE glibenclamide_10\NN\1740| (r_compound) binding_11\NN\4688246|for|glibenclamide (r_nmod) required_8\VBN\754942|to|be|binding (r_xcomp) reported_5\VBN\831651|linker|has|been|required|,|and|exhibit|. (l_conj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_nsubj) channels_15\NNS\6251781|deltank(ir)6.2/sur1 (l_compound) deltank(ir)6.2/sur1_14\NN\1740|
12213829T9_12213829T33 NONE glibenclamide_10\NN\1740| (r_compound) binding_11\NN\4688246|for|glibenclamide (r_nmod) required_8\VBN\754942|to|be|binding (r_xcomp) reported_5\VBN\831651|linker|has|been|required|,|and|exhibit|. (l_conj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_nsubj) channels_15\NNS\6251781|deltank(ir)6.2/sur1 (l_compound) deltank(ir)6.2/sur1_14\NN\1740|
12213829T9_12213829T34 NONE glibenclamide_10\NN\1740| (r_compound) binding_11\NN\4688246|for|glibenclamide (r_nmod) required_8\VBN\754942|to|be|binding (r_xcomp) reported_5\VBN\831651|linker|has|been|required|,|and|exhibit|. (l_conj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_dobj) labeling_18\NN\1740|reduced|k(ir|(125)i-azidoglibenclamide (l_nmod) k(ir_20\NN\1740|of|) (l_punct) )_21\-RRB-\1740|
12213829T9_12213829T35 NONE glibenclamide_10\NN\1740| (r_compound) binding_11\NN\4688246|for|glibenclamide (r_nmod) required_8\VBN\754942|to|be|binding (r_xcomp) reported_5\VBN\831651|linker|has|been|required|,|and|exhibit|. (l_conj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_advcl) implying_25\VBG\943837|that (l_ccomp) that_26\IN\1740|terminus|are|proximity (l_dep) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (l_punct) )_29\-RRB-\1740|
12213829T9_12213829T36 NONE glibenclamide_10\NN\1740| (r_compound) binding_11\NN\4688246|for|glibenclamide (r_nmod) required_8\VBN\754942|to|be|binding (r_xcomp) reported_5\VBN\831651|linker|has|been|required|,|and|exhibit|. (l_conj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_advcl) implying_25\VBG\943837|that (l_ccomp) that_26\IN\1740|terminus|are|proximity (l_dep) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (l_nmod) sur1_35\NN\1740|of
12213829T10_12213829T32 NONE (125)i-azidoglibenclamide_23\NN\1740|with (r_nmod) labeling_18\NN\1740|reduced|k(ir|(125)i-azidoglibenclamide (r_dobj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_nsubj) channels_15\NNS\6251781|deltank(ir)6.2/sur1 (l_compound) deltank(ir)6.2/sur1_14\NN\1740|
12213829T10_12213829T33 NONE (125)i-azidoglibenclamide_23\NN\1740|with (r_nmod) labeling_18\NN\1740|reduced|k(ir|(125)i-azidoglibenclamide (r_dobj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_nsubj) channels_15\NNS\6251781|deltank(ir)6.2/sur1 (l_compound) deltank(ir)6.2/sur1_14\NN\1740|
12213829T10_12213829T34 NONE (125)i-azidoglibenclamide_23\NN\1740|with (r_nmod) labeling_18\NN\1740|reduced|k(ir|(125)i-azidoglibenclamide (l_nmod) k(ir_20\NN\1740|of|) (l_punct) )_21\-RRB-\1740|
12213829T10_12213829T35 NONE (125)i-azidoglibenclamide_23\NN\1740|with (r_nmod) labeling_18\NN\1740|reduced|k(ir|(125)i-azidoglibenclamide (r_dobj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_advcl) implying_25\VBG\943837|that (l_ccomp) that_26\IN\1740|terminus|are|proximity (l_dep) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (l_punct) )_29\-RRB-\1740|
12213829T10_12213829T36 NONE (125)i-azidoglibenclamide_23\NN\1740|with (r_nmod) labeling_18\NN\1740|reduced|k(ir|(125)i-azidoglibenclamide (r_dobj) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_advcl) implying_25\VBG\943837|that (l_ccomp) that_26\IN\1740|terminus|are|proximity (l_dep) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (l_nmod) sur1_35\NN\1740|of
12213829T11_12213829T32 NONE n_30\NN\14622893| (r_compound) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (r_dep) that_26\IN\1740|terminus|are|proximity (r_ccomp) implying_25\VBG\943837|that (r_advcl) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_nsubj) channels_15\NNS\6251781|deltank(ir)6.2/sur1 (l_compound) deltank(ir)6.2/sur1_14\NN\1740|
12213829T11_12213829T33 NONE n_30\NN\14622893| (r_compound) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (r_dep) that_26\IN\1740|terminus|are|proximity (r_ccomp) implying_25\VBG\943837|that (r_advcl) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_nsubj) channels_15\NNS\6251781|deltank(ir)6.2/sur1 (l_compound) deltank(ir)6.2/sur1_14\NN\1740|
12213829T11_12213829T34 NONE n_30\NN\14622893| (r_compound) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (r_dep) that_26\IN\1740|terminus|are|proximity (r_ccomp) implying_25\VBG\943837|that (r_advcl) exhibit_16\VBP\2632167|channels|labeling|,|implying (l_dobj) labeling_18\NN\1740|reduced|k(ir|(125)i-azidoglibenclamide (l_nmod) k(ir_20\NN\1740|of|) (l_punct) )_21\-RRB-\1740|
12213829T11_12213829T35 NONE n_30\NN\14622893| (r_compound) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (l_punct) )_29\-RRB-\1740|
12213829T11_12213829T36 NONE n_30\NN\14622893| (r_compound) terminus_31\NN\8566028|the|k(ir|)|n|and|l0|sur1 (l_nmod) sur1_35\NN\1740|of
12213829T12_12213829T37 NONE n_9\NN\14622893| (r_compound) terminus_10\NN\8566028|with|the|k(ir|)|n (l_punct) )_8\-RRB-\1740|
12213829T12_12213829T38 NONE n_9\NN\14622893| (r_compound) terminus_10\NN\8566028|with|the|k(ir|)|n (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (l_nmod) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|)
12213829T12_12213829T39 NONE n_9\NN\14622893| (r_compound) terminus_10\NN\8566028|with|the|k(ir|)|n (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel
12213829T12_12213829T40 NONE n_9\NN\14622893| (r_compound) terminus_10\NN\8566028|with|the|k(ir|)|n (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel (l_conj) msba_29\NN\1740|
12213829T12_12213829T41 NONE n_9\NN\14622893| (r_compound) terminus_10\NN\8566028|with|the|k(ir|)|n (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel (l_conj) channel_34\NN\6251781|the|kcsa (l_compound) kcsa_33\NN\1740|
12213829T12_12213829T42 NONE n_9\NN\14622893| (r_compound) terminus_10\NN\8566028|with|the|k(ir|)|n (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_dobj) core_42\NN\7996689|the|mdr-like|sur (l_amod) mdr-like_41\JJ\1740|
12213829T12_12213829T43 NONE n_9\NN\14622893| (r_compound) terminus_10\NN\8566028|with|the|k(ir|)|n (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_dobj) core_42\NN\7996689|the|mdr-like|sur (l_nmod) sur_44\NN\1740|of
12213829T12_12213829T44 NONE n_9\NN\14622893| (r_compound) terminus_10\NN\8566028|with|the|k(ir|)|n (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_nmod) pore_49\NN\13911429|with|the|k(ir|) (l_punct) )_48\-RRB-\1740|
12213829T13_12213829T37 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (l_nmod) terminus_10\NN\8566028|with|the|k(ir|)|n (l_punct) )_8\-RRB-\1740|
12213829T13_12213829T38 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|)
12213829T13_12213829T39 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel
12213829T13_12213829T40 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel (l_conj) msba_29\NN\1740|
12213829T13_12213829T41 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel (l_conj) channel_34\NN\6251781|the|kcsa (l_compound) kcsa_33\NN\1740|
12213829T13_12213829T42 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_dobj) core_42\NN\7996689|the|mdr-like|sur (l_amod) mdr-like_41\JJ\1740|
12213829T13_12213829T43 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_dobj) core_42\NN\7996689|the|mdr-like|sur (l_nmod) sur_44\NN\1740|of
12213829T13_12213829T44 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_nmod) pore_49\NN\13911429|with|the|k(ir|) (l_punct) )_48\-RRB-\1740|
12213829T14_12213829T37 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (l_nmod) terminus_10\NN\8566028|with|the|k(ir|)|n (l_punct) )_8\-RRB-\1740|
12213829T14_12213829T38 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|)
12213829T14_12213829T39 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel
12213829T14_12213829T40 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel (l_conj) msba_29\NN\1740|
12213829T14_12213829T41 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_nmod) btucd_27\NN\1740|of|,|msba|,|and|channel (l_conj) channel_34\NN\6251781|the|kcsa (l_compound) kcsa_33\NN\1740|
12213829T14_12213829T42 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_dobj) core_42\NN\7996689|the|mdr-like|sur (l_amod) mdr-like_41\JJ\1740|
12213829T14_12213829T43 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_dobj) core_42\NN\7996689|the|mdr-like|sur (l_nmod) sur_44\NN\1740|of
12213829T14_12213829T44 NONE k(atp_13\NN\1740| (r_compound) channels_15\NNS\6251781|in|ligand-inhibited|k(atp|) (r_nmod) interacts_4\VBZ\2367363|that|l0|terminus|channels (r_ccomp) hypothesize_1\VBP\719734|we|interacts|and|put|. (l_conj) put_17\VBD\1850315|forward|model (l_dobj) model_20\NN\5888929|a|,|architecture (l_nmod) architecture_25\NN\2913152|based|on|the|btucd|,|links (l_acl:relcl) links_39\VBZ\628491|which|tmd0-l0|core|pore (l_nmod) pore_49\NN\13911429|with|the|k(ir|) (l_punct) )_48\-RRB-\1740|
23530018
23530018T24_23530018T36 NONE chalcogenopyrylium_0\NN\1740| (r_compound) dyes_1\NNS\14984973|chalcogenopyrylium|modulators|. (l_nmod) modulators_4\NNS\1740|as|differential|transport (l_nmod) transport_8\NN\3575240|of|organic|anion|mrp1 (l_nmod) mrp1_10\NN\1740|by|,|mrp2|and|mrp4
23530018T24_23530018T37 NONE chalcogenopyrylium_0\NN\1740| (r_compound) dyes_1\NNS\14984973|chalcogenopyrylium|modulators|. (l_nmod) modulators_4\NNS\1740|as|differential|transport (l_nmod) transport_8\NN\3575240|of|organic|anion|mrp1 (l_nmod) mrp1_10\NN\1740|by|,|mrp2|and|mrp4 (l_conj) mrp2_12\NN\1740|
23530018T24_23530018T38 NONE chalcogenopyrylium_0\NN\1740| (r_compound) dyes_1\NNS\14984973|chalcogenopyrylium|modulators|. (l_nmod) modulators_4\NNS\1740|as|differential|transport (l_nmod) transport_8\NN\3575240|of|organic|anion|mrp1 (l_nmod) mrp1_10\NN\1740|by|,|mrp2|and|mrp4 (l_conj) mrp4_14\NN\1740|
23530018T16_23530018T25 NONE atp-dependent_8\JJ\1740| (r_amod) efflux_9\NN\13482330|the|atp-dependent|compounds (r_dobj) mediate_6\VBP\761713|proteins|efflux|. (l_nsubj) proteins_2\NNS\14944888|multidrug|resistance|mrps
23530018T16_23530018T29 NONE atp-dependent_8\JJ\1740| (r_amod) efflux_9\NN\13482330|the|atp-dependent|compounds (r_dobj) mediate_6\VBP\761713|proteins|efflux|. (l_nsubj) proteins_2\NNS\14944888|multidrug|resistance|mrps (l_appos) mrps_4\NNS\1740|(|)
23530018T9_23530018T30 NONE chalcogenopyrylium_3\NN\1740| (r_compound) dyes_4\NNS\14984973|of|chalcogenopyrylium|cgps (r_nmod) classes_1\NNS\7951464|five|dyes (r_nsubjpass) examined_9\VBN\789138|classes|were|ability|. (l_nmod) ability_12\NN\4723816|for|their|modulate (l_acl) modulate_14\VB\1724459|to|transport (l_dobj) transport_15\NN\3575240|glucuronide|vesicles (l_nmod) glucuronide_18\NN\1740|of|[(3)h]estradiol|e217βg|substrate (l_appos) substrate_26\NN\19613|(|a|prototypical|mrp|) (l_compound) mrp_25\NN\1740|
23530018T9_23530018T31 NONE chalcogenopyrylium_3\NN\1740| (r_compound) dyes_4\NNS\14984973|of|chalcogenopyrylium|cgps (r_nmod) classes_1\NNS\7951464|five|dyes (r_nsubjpass) examined_9\VBN\789138|classes|were|ability|. (l_nmod) ability_12\NN\4723816|for|their|modulate (l_acl) modulate_14\VB\1724459|to|transport (l_dobj) transport_15\NN\3575240|glucuronide|vesicles (l_nmod) vesicles_32\NNS\5515670|into|mrp-enriched|inside-out|membrane (l_amod) mrp-enriched_29\JJ\1740|
23530018T10_23530018T30 NONE cgps_6\NNS\1740|(|) (r_appos) dyes_4\NNS\14984973|of|chalcogenopyrylium|cgps (r_nmod) classes_1\NNS\7951464|five|dyes (r_nsubjpass) examined_9\VBN\789138|classes|were|ability|. (l_nmod) ability_12\NN\4723816|for|their|modulate (l_acl) modulate_14\VB\1724459|to|transport (l_dobj) transport_15\NN\3575240|glucuronide|vesicles (l_nmod) glucuronide_18\NN\1740|of|[(3)h]estradiol|e217βg|substrate (l_appos) substrate_26\NN\19613|(|a|prototypical|mrp|) (l_compound) mrp_25\NN\1740|
23530018T10_23530018T31 NONE cgps_6\NNS\1740|(|) (r_appos) dyes_4\NNS\14984973|of|chalcogenopyrylium|cgps (r_nmod) classes_1\NNS\7951464|five|dyes (r_nsubjpass) examined_9\VBN\789138|classes|were|ability|. (l_nmod) ability_12\NN\4723816|for|their|modulate (l_acl) modulate_14\VB\1724459|to|transport (l_dobj) transport_15\NN\3575240|glucuronide|vesicles (l_nmod) vesicles_32\NNS\5515670|into|mrp-enriched|inside-out|membrane (l_amod) mrp-enriched_29\JJ\1740|
23530018T11_23530018T30 CPR:9 glucuronide_18\NN\1740|of|[(3)h]estradiol|e217βg|substrate (l_appos) substrate_26\NN\19613|(|a|prototypical|mrp|) (l_compound) mrp_25\NN\1740|
23530018T11_23530018T31 NONE glucuronide_18\NN\1740|of|[(3)h]estradiol|e217βg|substrate (r_nmod) transport_15\NN\3575240|glucuronide|vesicles (l_nmod) vesicles_32\NNS\5515670|into|mrp-enriched|inside-out|membrane (l_amod) mrp-enriched_29\JJ\1740|
23530018T12_23530018T30 CPR:9 e217βg_20\NN\1740|(|) (r_appos) glucuronide_18\NN\1740|of|[(3)h]estradiol|e217βg|substrate (l_appos) substrate_26\NN\19613|(|a|prototypical|mrp|) (l_compound) mrp_25\NN\1740|
23530018T12_23530018T31 NONE e217βg_20\NN\1740|(|) (r_appos) glucuronide_18\NN\1740|of|[(3)h]estradiol|e217βg|substrate (r_nmod) transport_15\NN\3575240|glucuronide|vesicles (l_nmod) vesicles_32\NNS\5515670|into|mrp-enriched|inside-out|membrane (l_amod) mrp-enriched_29\JJ\1740|
23530018T15_23530018T32 CPR:4 cgps_3\NNS\1740|sixteen|34 (r_nsubj) inhibited_4\VBD\2510337|cgps|uptake|%|μm|. (l_dobj) uptake_7\NN\13440063|mrp1-mediated|e217βg (l_amod) mrp1-mediated_5\JJ\1740|
23530018T17_23530018T32 CPR:9 e217βg_6\NN\1740| (r_compound) uptake_7\NN\13440063|mrp1-mediated|e217βg (l_amod) mrp1-mediated_5\JJ\1740|
23530018T19_23530018T33 CPR:4 cgps_11\NNS\1740|of|16 (r_nmod) 4_8\CD\13741022|only|cgps|μm (r_nsubj) inhibited_17\VBD\2510337|tested|,|4|efflux|%|iii-1|inhibited|. (l_dobj) efflux_20\NN\13482330|mrp1-mediated|calcein (l_amod) mrp1-mediated_18\JJ\1740|
23530018T20_23530018T33 CPR:9 calcein_19\NN\1740| (r_compound) efflux_20\NN\13482330|mrp1-mediated|calcein (l_amod) mrp1-mediated_18\JJ\1740|
23530018T21_23530018T34 CPR:4 cgps_2\NNS\1740|these|five (r_nsubj) inhibited_4\VBD\2510337|cgps|also|uptake|. (l_dobj) uptake_6\NN\13440063|[(3)h]e217βg|mrp4 (l_nmod) mrp4_8\NN\1740|by
23530018T22_23530018T34 CPR:9 [(3)h]e217βg_5\NN\1740| (r_compound) uptake_6\NN\13440063|[(3)h]e217βg|mrp4 (l_nmod) mrp4_8\NN\1740|by
23530018T1_23530018T35 NONE cgp_41\NN\1740| (r_compound) i-5_42\CD\1740|cgp (r_nsubj) had_43\VBD\2108377|while|i-5|effect (r_advcl) varied_7\VBD\2666239|contrast|,|effects|two|,|had|. (l_nsubj) effects_4\NNS\13245626|their|mrp2 (l_nmod) mrp2_6\NN\1740|on
23530018T23_23530018T35 NONE e217βg_16\NN\1740| (r_compound) transport_17\NN\3575240|e217βg (r_dobj) inhibiting_15\VBG\2510337|transport (r_acl) two_9\CD\13741022|with|v-4|inhibiting|ic50|,|stimulating (r_nmod) varied_7\VBD\2666239|contrast|,|effects|two|,|had|. (l_nsubj) effects_4\NNS\13245626|their|mrp2 (l_nmod) mrp2_6\NN\1740|on
23530018T2_23530018T26 NONE chalcogen_20\NN\1740| (r_compound) atom_21\NN\19613|except|for|their|chalcogen|se (r_nmod) identical_16\JJ\1740|strikingly|,|had|,|they|are|structurally|atom|. (l_advcl) had_6\VBD\2108377|although|v-3|effects|activity (l_nmod) activity_11\NN\30358|on|mrp2 (l_compound) mrp2_10\NN\1740|
23530018T3_23530018T26 NONE se_23\NN\14724645|(|versus|te|) (r_dep) atom_21\NN\19613|except|for|their|chalcogen|se (r_nmod) identical_16\JJ\1740|strikingly|,|had|,|they|are|structurally|atom|. (l_advcl) had_6\VBD\2108377|although|v-3|effects|activity (l_nmod) activity_11\NN\30358|on|mrp2 (l_compound) mrp2_10\NN\1740|
23530018T4_23530018T26 NONE te_25\NN\14622893| (r_conj) se_23\NN\14724645|(|versus|te|) (r_dep) atom_21\NN\19613|except|for|their|chalcogen|se (r_nmod) identical_16\JJ\1740|strikingly|,|had|,|they|are|structurally|atom|. (l_advcl) had_6\VBD\2108377|although|v-3|effects|activity (l_nmod) activity_11\NN\30358|on|mrp2 (l_compound) mrp2_10\NN\1740|
23530018T5_23530018T27 NONE methine_13\NN\1740|or|trimethine (r_compound) linkage_16\NN\13791389|with|their|distinctive|methine|moieties (r_nmod) identify_6\VB\699815|to|cgps|linkage|class|and|show (l_nmod) class_26\NN\7951464|as|a|potent|modulators (l_nmod) modulators_29\NNS\1740|of|mrp (l_compound) mrp_28\NN\1740|
23530018T5_23530018T28 NONE methine_13\NN\1740|or|trimethine (r_compound) linkage_16\NN\13791389|with|their|distinctive|methine|moieties (r_nmod) identify_6\VB\699815|to|cgps|linkage|class|and|show (l_conj) show_32\VB\2137132|also|determinant (l_ccomp) determinant_52\NN\5686481|that|structure|,|differences|can|be|the|sole|stimulate (l_advcl) stimulate_58\VB\137313|of|whether|compound|will|or|inhibit|mrp2 (l_dobj) mrp2_61\NN\1740|
23530018T6_23530018T27 NONE trimethine_15\NN\1740| (r_conj) methine_13\NN\1740|or|trimethine (r_compound) linkage_16\NN\13791389|with|their|distinctive|methine|moieties (r_nmod) identify_6\VB\699815|to|cgps|linkage|class|and|show (l_nmod) class_26\NN\7951464|as|a|potent|modulators (l_nmod) modulators_29\NNS\1740|of|mrp (l_compound) mrp_28\NN\1740|
23530018T6_23530018T28 NONE trimethine_15\NN\1740| (r_conj) methine_13\NN\1740|or|trimethine (r_compound) linkage_16\NN\13791389|with|their|distinctive|methine|moieties (r_nmod) identify_6\VB\699815|to|cgps|linkage|class|and|show (l_conj) show_32\VB\2137132|also|determinant (l_ccomp) determinant_52\NN\5686481|that|structure|,|differences|can|be|the|sole|stimulate (l_advcl) stimulate_58\VB\137313|of|whether|compound|will|or|inhibit|mrp2 (l_dobj) mrp2_61\NN\1740|
23530018T7_23530018T27 NONE pyrylium_20\NN\1740| (r_compound) moieties_21\NNS\13736799|between|two|disubstituted|pyrylium (r_nmod) linkage_16\NN\13791389|with|their|distinctive|methine|moieties (r_nmod) identify_6\VB\699815|to|cgps|linkage|class|and|show (l_nmod) class_26\NN\7951464|as|a|potent|modulators (l_nmod) modulators_29\NNS\1740|of|mrp (l_compound) mrp_28\NN\1740|
23530018T7_23530018T28 NONE pyrylium_20\NN\1740| (r_compound) moieties_21\NNS\13736799|between|two|disubstituted|pyrylium (r_nmod) linkage_16\NN\13791389|with|their|distinctive|methine|moieties (r_nmod) identify_6\VB\699815|to|cgps|linkage|class|and|show (l_conj) show_32\VB\2137132|also|determinant (l_ccomp) determinant_52\NN\5686481|that|structure|,|differences|can|be|the|sole|stimulate (l_advcl) stimulate_58\VB\137313|of|whether|compound|will|or|inhibit|mrp2 (l_dobj) mrp2_61\NN\1740|
23530018T8_23530018T27 NONE chalcogen_46\NN\1740| (r_compound) atom_47\NN\19613|with|a|chalcogen (r_nmod) associated_43\VBN\628491|atom (r_acl) electronegativity_42\NN\4944048|in|the|associated (r_nmod) differences_39\NNS\4723816|electronegativity (r_nsubj) determinant_52\NN\5686481|that|structure|,|differences|can|be|the|sole|stimulate (r_ccomp) show_32\VB\2137132|also|determinant (r_conj) identify_6\VB\699815|to|cgps|linkage|class|and|show (l_nmod) class_26\NN\7951464|as|a|potent|modulators (l_nmod) modulators_29\NNS\1740|of|mrp (l_compound) mrp_28\NN\1740|
23530018T8_23530018T28 NONE chalcogen_46\NN\1740| (r_compound) atom_47\NN\19613|with|a|chalcogen (r_nmod) associated_43\VBN\628491|atom (r_acl) electronegativity_42\NN\4944048|in|the|associated (r_nmod) differences_39\NNS\4723816|electronegativity (r_nsubj) determinant_52\NN\5686481|that|structure|,|differences|can|be|the|sole|stimulate (l_advcl) stimulate_58\VB\137313|of|whether|compound|will|or|inhibit|mrp2 (l_dobj) mrp2_61\NN\1740|
16789740
16789740T4_16789740T13 CPR:4 sulfonamides_6\NNS\2716205|of|anthranilic|acid (r_nmod) discovery_0\NN\30358|and|optimization|sulfonamides|inhibitors|:|basis|. (l_dep) basis_15\NN\13790712|a|structural|reduction (l_nmod) reduction_18\NN\351485|for|the|binding (l_nmod) binding_21\NN\4688246|of|albumin (l_compound) albumin_20\NN\14736972|
16789740T4_16789740T14 NONE sulfonamides_6\NNS\2716205|of|anthranilic|acid (r_nmod) discovery_0\NN\30358|and|optimization|sulfonamides|inhibitors|:|basis|. (l_nmod) inhibitors_8\NNS\20090|as|aminopeptidase-2 (l_nmod) aminopeptidase-2_11\NN\1740|of|methionine
16789740T5_16789740T13 NONE methionine_10\NN\14605787| (r_compound) aminopeptidase-2_11\NN\1740|of|methionine (r_nmod) inhibitors_8\NNS\20090|as|aminopeptidase-2 (r_nmod) discovery_0\NN\30358|and|optimization|sulfonamides|inhibitors|:|basis|. (l_dep) basis_15\NN\13790712|a|structural|reduction (l_nmod) reduction_18\NN\351485|for|the|binding (l_nmod) binding_21\NN\4688246|of|albumin (l_compound) albumin_20\NN\14736972|
16789740T5_16789740T14 NONE methionine_10\NN\14605787| (r_compound) aminopeptidase-2_11\NN\1740|of|methionine
16789740T1_16789740T6 NONE methionine_0\NN\14605787| (r_compound) aminopeptidase-2_1\NN\1740|methionine|metap2
16789740T1_16789740T9 NONE methionine_0\NN\14605787| (r_compound) aminopeptidase-2_1\NN\1740|methionine|metap2 (l_appos) metap2_3\NN\1740|(|)
16789740T2_16789740T7 NONE sulfonamides_19\NNS\2716205|of|anthranilic|acid|affinities (r_nmod) series_15\NN\8456993|a|sulfonamides (r_nsubjpass) identified_27\VBN\699815|part|,|series|were|screening|. (l_nmod) part_1\NN\31921|as|effort (l_nmod) effort_4\NN\407535|of|an|discover (l_acl) discover_6\VB\2163746|to|inhibitors (l_dobj) inhibitors_10\NNS\20090|active|reversible|metap2 (l_nmod) metap2_12\NN\1740|of
16789740T2_16789740T8 NONE sulfonamides_19\NNS\2716205|of|anthranilic|acid|affinities (l_nmod) affinities_22\NNS\11426530|with|micromolar|metap2 (l_nmod) metap2_25\NN\1740|for|human
16789740T3_16789740T11 NONE methionine_40\NN\14605787| (r_compound) processing_41\NN\29677|methionine (r_conj) proliferation_38\NN\13489037|both|and|processing (r_compound) assays_42\NNS\5733583|in|proliferation (r_nmod) showed_32\VBD\2137132|which|activity|assays (r_acl:relcl) improvements_26\NNS\7359599|with|significant|parameters|,|showed (r_nmod) compounds_23\NNS\5869584|of|improvements (r_nmod) identification_21\NN\151497|the|compounds (r_dobj) allowed_19\VBD\797697|modifications|identification|. (l_nsubj) modifications_0\NNS\191142|information (l_nmod) information_4\NN\6598915|based|on|structural|binding (l_nmod) binding_7\NN\4688246|on|the|compounds|metap2 (l_nmod) metap2_13\NN\1740|to|both|and|domain
16789740T3_16789740T12 NONE methionine_40\NN\14605787| (r_compound) processing_41\NN\29677|methionine (r_conj) proliferation_38\NN\13489037|both|and|processing (r_compound) assays_42\NNS\5733583|in|proliferation (r_nmod) showed_32\VBD\2137132|which|activity|assays (r_acl:relcl) improvements_26\NNS\7359599|with|significant|parameters|,|showed (r_nmod) compounds_23\NNS\5869584|of|improvements (r_nmod) identification_21\NN\151497|the|compounds (r_dobj) allowed_19\VBD\797697|modifications|identification|. (l_nsubj) modifications_0\NNS\191142|information (l_nmod) information_4\NN\6598915|based|on|structural|binding (l_nmod) binding_7\NN\4688246|on|the|compounds|metap2 (l_nmod) metap2_13\NN\1740|to|both|and|domain (l_conj) domain_15\NN\13934596|iii|albumin (l_nmod) albumin_18\NN\14736972|of
17161452
17161452T12_17161452T23 NONE warfarin_0\NN\2718259| (r_compound) dose_1\NN\3740161|warfarin|and|pharmacogenomics|-|rationale (l_conj) pharmacogenomics_4\NN\1740|the|cyp2c9 (l_nmod) cyp2c9_6\NN\1740|of|and|vkorc1
17161452T12_17161452T24 NONE warfarin_0\NN\2718259| (r_compound) dose_1\NN\3740161|warfarin|and|pharmacogenomics|-|rationale (l_conj) pharmacogenomics_4\NN\1740|the|cyp2c9 (l_nmod) cyp2c9_6\NN\1740|of|and|vkorc1 (l_conj) vkorc1_8\NN\1740|
17161452T4_17161452T16 CPR:9 warfarin_7\NN\2718259| (r_compound) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1
17161452T4_17161452T17 NONE warfarin_7\NN\2718259| (r_compound) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1 (l_appos) vkorc1_22\NN\1740|vitamin|k|complex|1 (l_nummod) 1_21\CD\13741022|
17161452T4_17161452T18 NONE warfarin_7\NN\2718259| (r_compound) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1 (l_appos) vkorc1_22\NN\1740|vitamin|k|complex|1
17161452T5_17161452T16 NONE warfarin_12\NN\2718259| (r_compound) enzyme_14\NN\14723628|warfarin|target (r_conj) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1
17161452T5_17161452T17 NONE warfarin_12\NN\2718259| (r_compound) enzyme_14\NN\14723628|warfarin|target (r_conj) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1 (l_appos) vkorc1_22\NN\1740|vitamin|k|complex|1 (l_nummod) 1_21\CD\13741022|
17161452T5_17161452T18 NONE warfarin_12\NN\2718259| (r_compound) enzyme_14\NN\14723628|warfarin|target (r_conj) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1 (l_appos) vkorc1_22\NN\1740|vitamin|k|complex|1
17161452T6_17161452T16 NONE epoxide_18\NN\1740| (r_compound) complex_20\NN\5869584|epoxide|reductase (r_compound) vkorc1_22\NN\1740|vitamin|k|complex|1 (r_appos) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1
17161452T6_17161452T17 NONE epoxide_18\NN\1740| (r_compound) complex_20\NN\5869584|epoxide|reductase (r_compound) vkorc1_22\NN\1740|vitamin|k|complex|1 (l_nummod) 1_21\CD\13741022|
17161452T6_17161452T18 NONE epoxide_18\NN\1740| (r_compound) complex_20\NN\5869584|epoxide|reductase (r_compound) vkorc1_22\NN\1740|vitamin|k|complex|1
17161452T7_17161452T16 NONE warfarin_28\NN\2718259| (r_compound) dose_30\NN\3740161|on|warfarin|maintenance (r_nmod) influence_26\NN\5190804|their|dose (r_dobj) confirmed_24\VBD\1011725|analysis|influence|. (l_nsubj) analysis_1\NN\633864|pharmacogenetic|genes (l_nmod) genes_4\NNS\8459252|of|two|,|cyp2c9|, (l_appos) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1
17161452T7_17161452T17 NONE warfarin_28\NN\2718259| (r_compound) dose_30\NN\3740161|on|warfarin|maintenance (r_nmod) influence_26\NN\5190804|their|dose (r_dobj) confirmed_24\VBD\1011725|analysis|influence|. (l_nsubj) analysis_1\NN\633864|pharmacogenetic|genes (l_nmod) genes_4\NNS\8459252|of|two|,|cyp2c9|, (l_appos) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1 (l_appos) vkorc1_22\NN\1740|vitamin|k|complex|1 (l_nummod) 1_21\CD\13741022|
17161452T7_17161452T18 NONE warfarin_28\NN\2718259| (r_compound) dose_30\NN\3740161|on|warfarin|maintenance (r_nmod) influence_26\NN\5190804|their|dose (r_dobj) confirmed_24\VBD\1011725|analysis|influence|. (l_nsubj) analysis_1\NN\633864|pharmacogenetic|genes (l_nmod) genes_4\NNS\8459252|of|two|,|cyp2c9|, (l_appos) cyp2c9_10\NN\1740|the|warfarin|enzyme|and|enzyme|,|vkorc1 (l_appos) vkorc1_22\NN\1740|vitamin|k|complex|1
17161452T8_17161452T19 CPR:9 warfarin_28\NN\2718259| (r_compound) dose_29\NN\3740161|in|the|mean|warfarin (r_nmod) decrease_24\NN\7296428|with|a|significant|dose (r_nmod) associated_20\VBN\628491|possession|is|decrease|. (l_nsubjpass) possession_0\NN\803617|* (l_nmod) *_3\NN\1740|of|cyp2c9|2|alleles|,|result|, (l_compound) cyp2c9_2\NN\1740|
17161452T8_17161452T20 CPR:9 warfarin_28\NN\2718259| (r_compound) dose_29\NN\3740161|in|the|mean|warfarin (r_nmod) decrease_24\NN\7296428|with|a|significant|dose (r_nmod) associated_20\VBN\628491|possession|is|decrease|. (l_nsubjpass) possession_0\NN\803617|* (l_nmod) *_3\NN\1740|of|cyp2c9|2|alleles|,|result|, (l_nummod) 2_4\CD\13741022|or|* (l_conj) *_7\NN\1740|cyp2c9|3 (l_compound) cyp2c9_6\NN\1740|
17161452T9_17161452T21 NONE nucleotide_2\JJ\1740| (r_amod) polymorphisms_3\NNS\11418750|several|single|nucleotide|snps|vkorc1 (l_nmod) vkorc1_8\NN\1740|in
17161452T10_17161452T21 NONE warfarin_12\NN\2718259| (r_compound) dose_13\NN\3740161|with|warfarin (r_nmod) associated_10\VBN\628491|polymorphisms|are|dose|range|. (l_nsubjpass) polymorphisms_3\NNS\11418750|several|single|nucleotide|snps|vkorc1 (l_nmod) vkorc1_8\NN\1740|in
17161452T11_17161452T13 NONE warfarin_14\NN\2718259| (r_compound) dose_15\NN\3740161|in|warfarin (r_nmod) variation_12\NN\7296428|of|the|interindividual|dose (r_nmod) fraction_8\NN\14806838|a|large|variation (r_dobj) explain_5\VBP\831651|haplotypes|fraction|,|and|has (l_conj) has_19\VBZ\2108377|vkorc1|effect|. (l_dobj) effect_24\NN\34213|an|greater|cyp2c9 (l_nmod) cyp2c9_26\NN\1740|than
17161452T11_17161452T22 NONE warfarin_14\NN\2718259| (r_compound) dose_15\NN\3740161|in|warfarin (r_nmod) variation_12\NN\7296428|of|the|interindividual|dose (r_nmod) fraction_8\NN\14806838|a|large|variation (r_dobj) explain_5\VBP\831651|haplotypes|fraction|,|and|has (l_conj) has_19\VBZ\2108377|vkorc1|effect|. (l_nsubj) vkorc1_18\NN\1740|
17161452T2_17161452T14 NONE warfarin_17\NN\2718259| (r_compound) dosage_18\NN\13576355|the|warfarin (r_dobj) estimate_15\VB\637259|to|dosage (r_acl:relcl) algorithms_0\NNS\5846932|incorporating|estimate|, (l_acl) incorporating_1\VBG\1461328|factors (l_dobj) factors_13\NNS\7326557|cyp2c9 (l_compound) cyp2c9_4\NN\1740|genetic|(|and|vkorc1|)|,|demographic
17161452T2_17161452T15 NONE warfarin_17\NN\2718259| (r_compound) dosage_18\NN\13576355|the|warfarin (r_dobj) estimate_15\VB\637259|to|dosage (r_acl:relcl) algorithms_0\NNS\5846932|incorporating|estimate|, (l_acl) incorporating_1\VBG\1461328|factors (l_dobj) factors_13\NNS\7326557|cyp2c9 (l_compound) cyp2c9_4\NN\1740|genetic|(|and|vkorc1|)|,|demographic (l_conj) vkorc1_6\NN\1740|
17161452T3_17161452T14 NONE warfarin_29\NN\2718259| (r_compound) induction_30\NN\7450842|during|warfarin (r_nmod) dose_27\NN\3740161|of|over|induction (r_nmod) risk_24\NN\14541044|the|dose (r_dobj) minimize_22\VB\441445|algorithms|could|potentially|risk|. (l_nsubj) algorithms_0\NNS\5846932|incorporating|estimate|, (l_acl) incorporating_1\VBG\1461328|factors (l_dobj) factors_13\NNS\7326557|cyp2c9 (l_compound) cyp2c9_4\NN\1740|genetic|(|and|vkorc1|)|,|demographic
17161452T3_17161452T15 NONE warfarin_29\NN\2718259| (r_compound) induction_30\NN\7450842|during|warfarin (r_nmod) dose_27\NN\3740161|of|over|induction (r_nmod) risk_24\NN\14541044|the|dose (r_dobj) minimize_22\VB\441445|algorithms|could|potentially|risk|. (l_nsubj) algorithms_0\NNS\5846932|incorporating|estimate|, (l_acl) incorporating_1\VBG\1461328|factors (l_dobj) factors_13\NNS\7326557|cyp2c9 (l_compound) cyp2c9_4\NN\1740|genetic|(|and|vkorc1|)|,|demographic (l_conj) vkorc1_6\NN\1740|
16434489
16434489T13_16434489T37 CPR:4 dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibits_4\VBZ\2510337|dasatinib|kitd816v|. (l_dobj) kitd816v_5\NN\1740|,|mutation
16434489T13_16434489T38 CPR:4 dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibits_4\VBZ\2510337|dasatinib|kitd816v|. (l_dobj) kitd816v_5\NN\1740|,|mutation
16434489T14_16434489T37 NONE bms-354825_2\CD\1740|(|) (r_appos) dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibits_4\VBZ\2510337|dasatinib|kitd816v|. (l_dobj) kitd816v_5\NN\1740|,|mutation
16434489T14_16434489T38 CPR:4 bms-354825_2\CD\1740|(|) (r_appos) dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibits_4\VBZ\2510337|dasatinib|kitd816v|. (l_dobj) kitd816v_5\NN\1740|,|mutation
16434489T15_16434489T37 NONE imatinib-resistant_8\JJ\1740| (r_amod) mutation_10\NN\4475|an|imatinib-resistant|activating|triggers (r_appos) kitd816v_5\NN\1740|,|mutation
16434489T15_16434489T38 NONE imatinib-resistant_8\JJ\1740| (r_amod) mutation_10\NN\4475|an|imatinib-resistant|activating|triggers (r_appos) kitd816v_5\NN\1740|,|mutation
16434489T6_16434489T22 NONE imatinib_6\NN\1740|to (r_nmod) resistant_4\JJ\1740|mutation|is|inherently|imatinib|and|,|remains|. (l_conj) remains_13\VBZ\2604760|date|,|there|therapy (l_nsubj) therapy_17\NN\657604|no|effective|curative|mastocytosis (l_nmod) mastocytosis_20\NN\1740|for|systemic|associated (l_acl) associated_21\VBN\628491|kitd816v (l_nmod) kitd816v_23\NN\1740|with
16434489T6_16434489T23 NONE imatinib_6\NN\1740|to (r_nmod) resistant_4\JJ\1740|mutation|is|inherently|imatinib|and|,|remains|. (l_conj) remains_13\VBZ\2604760|date|,|there|therapy (l_nsubj) therapy_17\NN\657604|no|effective|curative|mastocytosis (l_nmod) mastocytosis_20\NN\1740|for|systemic|associated (l_acl) associated_21\VBN\628491|kitd816v (l_nmod) kitd816v_23\NN\1740|with
16434489T7_16434489T24 CPR:4 dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_amod) src/abl_9\JJ\1740|
16434489T7_16434489T25 CPR:4 dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_amod) src/abl_9\JJ\1740|
16434489T7_16434489T26 NONE dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_acl:relcl) has_12\VBZ\2108377|that|activity|isoforms|vitro (l_nmod) isoforms_18\NNS\1740|against|multiple|imatinib-resistant|bcr-abl (l_amod) bcr-abl_17\JJ\1740|
16434489T7_16434489T27 NONE dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_acl:relcl) has_12\VBZ\2108377|that|activity|isoforms|vitro (l_nmod) isoforms_18\NNS\1740|against|multiple|imatinib-resistant|bcr-abl (l_amod) bcr-abl_17\JJ\1740|
16434489T8_16434489T24 CPR:4 bms-354825_2\CD\1740|(|) (r_appos) dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_amod) src/abl_9\JJ\1740|
16434489T8_16434489T25 CPR:4 bms-354825_2\CD\1740|(|) (r_appos) dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_amod) src/abl_9\JJ\1740|
16434489T8_16434489T26 NONE bms-354825_2\CD\1740|(|) (r_appos) dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_acl:relcl) has_12\VBZ\2108377|that|activity|isoforms|vitro (l_nmod) isoforms_18\NNS\1740|against|multiple|imatinib-resistant|bcr-abl (l_amod) bcr-abl_17\JJ\1740|
16434489T8_16434489T27 NONE bms-354825_2\CD\1740|(|) (r_appos) dasatinib_0\NN\1740|bms-354825 (r_nsubj) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_acl:relcl) has_12\VBZ\2108377|that|activity|isoforms|vitro (l_nmod) isoforms_18\NNS\1740|against|multiple|imatinib-resistant|bcr-abl (l_amod) bcr-abl_17\JJ\1740|
16434489T9_16434489T24 NONE imatinib-resistant_16\JJ\1740| (r_amod) isoforms_18\NNS\1740|against|multiple|imatinib-resistant|bcr-abl (r_nmod) has_12\VBZ\2108377|that|activity|isoforms|vitro (r_acl:relcl) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_amod) src/abl_9\JJ\1740|
16434489T9_16434489T25 NONE imatinib-resistant_16\JJ\1740| (r_amod) isoforms_18\NNS\1740|against|multiple|imatinib-resistant|bcr-abl (r_nmod) has_12\VBZ\2108377|that|activity|isoforms|vitro (r_acl:relcl) inhibitor_10\NN\20090|dasatinib|is|a|novel|bioavailable|src/abl|has|showing|. (l_amod) src/abl_9\JJ\1740|
16434489T9_16434489T26 NONE imatinib-resistant_16\JJ\1740| (r_amod) isoforms_18\NNS\1740|against|multiple|imatinib-resistant|bcr-abl (l_amod) bcr-abl_17\JJ\1740|
16434489T9_16434489T27 NONE imatinib-resistant_16\JJ\1740| (r_amod) isoforms_18\NNS\1740|against|multiple|imatinib-resistant|bcr-abl (l_amod) bcr-abl_17\JJ\1740|
16434489T11_16434489T30 CPR:4 dasatinib_10\NN\1740|of (r_nmod) activity_8\NN\30358|significant|inhibitory|dasatinib|kit (l_nmod) kit_14\NN\2974697|against|both|wild-type|and|mutation|range
16434489T11_16434489T32 CPR:4 dasatinib_10\NN\1740|of (r_nmod) activity_8\NN\30358|significant|inhibitory|dasatinib|kit (l_nmod) kit_14\NN\2974697|against|both|wild-type|and|mutation|range (l_conj) mutation_18\NN\4475|the|kitd816v (l_compound) kitd816v_17\NN\1740|
16434489T11_16434489T33 CPR:4 dasatinib_10\NN\1740|of (r_nmod) activity_8\NN\30358|significant|inhibitory|dasatinib|kit (l_nmod) kit_14\NN\2974697|against|both|wild-type|and|mutation|range (l_conj) mutation_18\NN\4475|the|kitd816v (l_compound) kitd816v_17\NN\1740|
16434489T11_16434489T34 NONE dasatinib_10\NN\1740|of (r_nmod) activity_8\NN\30358|significant|inhibitory|dasatinib|kit (r_dobj) demonstrate_5\VBP\2137132|study|,|we|activity|assays|. (l_nmod) assays_29\NNS\5733583|in|vitro|cell-based|kinase (l_compound) kinase_28\NN\14732946|
16434489T12_16434489T35 CPR:4 dasatinib_2\NN\1740| (r_nsubj) leads_3\VBZ\1752884|additionally|,|dasatinib|inhibition|. (l_nmod) inhibition_6\NN\1068773|to|growth|line (l_nmod) line_13\NN\8426461|of|a|kitd816v-harboring|human|masto-cytosis|cell (l_amod) kitd816v-harboring_9\JJ\1740|
16434489T12_16434489T36 CPR:4 dasatinib_2\NN\1740| (r_nsubj) leads_3\VBZ\1752884|additionally|,|dasatinib|inhibition|. (l_nmod) inhibition_6\NN\1068773|to|growth|line (l_nmod) line_13\NN\8426461|of|a|kitd816v-harboring|human|masto-cytosis|cell (l_amod) kitd816v-harboring_9\JJ\1740|
16434489T2_16434489T16 NONE imatinib_18\NN\1740| (r_nsubj) binds_19\VBZ\1290422|which|imatinib (r_acl:relcl) loop_15\NN\3323703|of|the|kit|activation|binds (r_nmod) conformation_10\NN\13897996|the|inactive|loop (r_dobj) destabilizes_7\VBZ\109660|that|mutation|conformation|,|but|predicted (l_nsubj) mutation_6\NN\4475|the|kitd816v (l_compound) kitd816v_5\NN\1740|
16434489T2_16434489T17 NONE imatinib_18\NN\1740| (r_nsubj) binds_19\VBZ\1290422|which|imatinib (r_acl:relcl) loop_15\NN\3323703|of|the|kit|activation|binds (r_nmod) conformation_10\NN\13897996|the|inactive|loop (r_dobj) destabilizes_7\VBZ\109660|that|mutation|conformation|,|but|predicted (l_nsubj) mutation_6\NN\4475|the|kitd816v (l_compound) kitd816v_5\NN\1740|
16434489T2_16434489T18 NONE imatinib_18\NN\1740| (r_nsubj) binds_19\VBZ\1290422|which|imatinib (r_acl:relcl) loop_15\NN\3323703|of|the|kit|activation|binds
16434489T2_16434489T20 NONE imatinib_18\NN\1740| (r_nsubj) binds_19\VBZ\1290422|which|imatinib (r_acl:relcl) loop_15\NN\3323703|of|the|kit|activation|binds (r_nmod) conformation_10\NN\13897996|the|inactive|loop (r_dobj) destabilizes_7\VBZ\109660|that|mutation|conformation|,|but|predicted (l_conj) predicted_25\VBN\916909|it|is|not|impair (l_xcomp) impair_27\VB\258857|to|binding (l_dobj) binding_28\NN\4688246|kit|dasatinib (l_nmod) kit_30\NN\2974697|of
16434489T3_16434489T16 NONE dasatinib_32\NN\1740|by (r_nmod) binding_28\NN\4688246|kit|dasatinib (r_dobj) impair_27\VB\258857|to|binding (r_xcomp) predicted_25\VBN\916909|it|is|not|impair (r_conj) destabilizes_7\VBZ\109660|that|mutation|conformation|,|but|predicted (l_nsubj) mutation_6\NN\4475|the|kitd816v (l_compound) kitd816v_5\NN\1740|
16434489T3_16434489T17 NONE dasatinib_32\NN\1740|by (r_nmod) binding_28\NN\4688246|kit|dasatinib (r_dobj) impair_27\VB\258857|to|binding (r_xcomp) predicted_25\VBN\916909|it|is|not|impair (r_conj) destabilizes_7\VBZ\109660|that|mutation|conformation|,|but|predicted (l_nsubj) mutation_6\NN\4475|the|kitd816v (l_compound) kitd816v_5\NN\1740|
16434489T3_16434489T18 NONE dasatinib_32\NN\1740|by (r_nmod) binding_28\NN\4688246|kit|dasatinib (r_dobj) impair_27\VB\258857|to|binding (r_xcomp) predicted_25\VBN\916909|it|is|not|impair (r_conj) destabilizes_7\VBZ\109660|that|mutation|conformation|,|but|predicted (l_dobj) conformation_10\NN\13897996|the|inactive|loop (l_nmod) loop_15\NN\3323703|of|the|kit|activation|binds
16434489T3_16434489T20 NONE dasatinib_32\NN\1740|by (r_nmod) binding_28\NN\4688246|kit|dasatinib (l_nmod) kit_30\NN\2974697|of
16434489T5_16434489T21 NONE dasatinib_2\NN\1740| (r_nsubj) utility_7\NN\8186047|moreover|,|dasatinib|may|be|of|clinical|settings|. (l_nmod) settings_11\NNS\8567235|in|other|disease|driven (l_acl) driven_12\VBN\1224744|mutations (l_nmod) mutations_16\NNS\4475|activating|kit (l_compound) kit_15\NN\2974697|
23600800
23600800T1_23600800T6 NONE atp-gated_0\JJ\1740| (r_amod) receptors_2\NNS\5225602|atp-gated|p2x3|neurons
23600800T3_23600800T16 NONE calcium/calmodulin-dependent_7\JJ\1740| (r_amod) cask_11\NN\13756125|of|calcium/calmodulin-dependent|serine|protein|kinase (l_compound) kinase_10\NN\14732946|
23600800T3_23600800T17 NONE calcium/calmodulin-dependent_7\JJ\1740| (r_amod) cask_11\NN\13756125|of|calcium/calmodulin-dependent|serine|protein|kinase
23600800T3_23600800T18 NONE calcium/calmodulin-dependent_7\JJ\1740| (r_amod) cask_11\NN\13756125|of|calcium/calmodulin-dependent|serine|protein|kinase (r_nmod) role_5\NN\719494|the|cask|interacting (l_acl) interacting_13\VBG\2367363|in|and|controlling (l_conj) controlling_15\VBG\2422663|receptor (l_dobj) receptor_17\NN\5225602|p2x3|expression|ganglia
23600800T4_23600800T16 NONE serine_8\NN\14601829| (r_compound) cask_11\NN\13756125|of|calcium/calmodulin-dependent|serine|protein|kinase (l_compound) kinase_10\NN\14732946|
23600800T4_23600800T17 NONE serine_8\NN\14601829| (r_compound) cask_11\NN\13756125|of|calcium/calmodulin-dependent|serine|protein|kinase
23600800T4_23600800T18 NONE serine_8\NN\14601829| (r_compound) cask_11\NN\13756125|of|calcium/calmodulin-dependent|serine|protein|kinase (r_nmod) role_5\NN\719494|the|cask|interacting (l_acl) interacting_13\VBG\2367363|in|and|controlling (l_conj) controlling_15\VBG\2422663|receptor (l_dobj) receptor_17\NN\5225602|p2x3|expression|ganglia
23600800T5_23600800T25 NONE serine_7\NN\14601829| (r_compound) phosphorylation_8\NN\1740|serine|receptors|,|associated (r_dobj) increased_6\VBD\169651|expression|phosphorylation|. (l_nsubj) expression_2\NN\4679549|recombinant|p2x3/cask|cells (l_compound) p2x3/cask_1\NN\1740|
23600800T5_23600800T26 NONE serine_7\NN\14601829| (r_compound) phosphorylation_8\NN\1740|serine|receptors|,|associated (r_dobj) increased_6\VBD\169651|expression|phosphorylation|. (l_nsubj) expression_2\NN\4679549|recombinant|p2x3/cask|cells (l_compound) p2x3/cask_1\NN\1740|
23600800T5_23600800T27 NONE serine_7\NN\14601829| (r_compound) phosphorylation_8\NN\1740|serine|receptors|,|associated (l_nmod) receptors_11\NNS\5225602|of|p2x3 (l_compound) p2x3_10\NN\1740|
23600800T2_23600800T33 CPR:3 mg-132_12\NN\1740|by|the|proteasomal|inhibitor (r_nmod) reversed_7\VBN\109660|reduction|was|mg-132|. (l_nsubjpass) reduction_1\NN\351485|the|levels (l_nmod) levels_5\NNS\4916342|of|p2x3|expression (l_compound) p2x3_3\NN\1740|
23152189
23152189T20_23152189T34 CPR:4 tcdd_0\NN\1740| (r_nsubj) decreased_1\VBD\169651|tcdd|expression|,|followed|. (l_dobj) expression_3\NN\4679549|the|transporter (l_nmod) transporter_7\NN\4490091|of|the|glucose|,|slc2a1|,|and|most
23152189T20_23152189T35 CPR:4 tcdd_0\NN\1740| (r_nsubj) decreased_1\VBD\169651|tcdd|expression|,|followed|. (l_dobj) expression_3\NN\4679549|the|transporter (l_nmod) transporter_7\NN\4490091|of|the|glucose|,|slc2a1|,|and|most (l_appos) slc2a1_9\NN\1740|
23152189T21_23152189T34 NONE glucose_6\NN\14710501| (r_compound) transporter_7\NN\4490091|of|the|glucose|,|slc2a1|,|and|most
23152189T21_23152189T35 NONE glucose_6\NN\14710501| (r_compound) transporter_7\NN\4490091|of|the|glucose|,|slc2a1|,|and|most (l_appos) slc2a1_9\NN\1740|
23152189T22_23152189T34 NONE pyruvate_26\NN\1740|including (r_nmod) intermediates_23\NNS\14806838|in|glycolytic|,|pyruvate (r_nmod) decreases_20\NNS\7296428|by|intermediates (r_nmod) followed_18\VBN\1835496|decreases (r_advcl) decreased_1\VBD\169651|tcdd|expression|,|followed|. (l_dobj) expression_3\NN\4679549|the|transporter (l_nmod) transporter_7\NN\4490091|of|the|glucose|,|slc2a1|,|and|most
23152189T22_23152189T35 NONE pyruvate_26\NN\1740|including (r_nmod) intermediates_23\NNS\14806838|in|glycolytic|,|pyruvate (r_nmod) decreases_20\NNS\7296428|by|intermediates (r_nmod) followed_18\VBN\1835496|decreases (r_advcl) decreased_1\VBD\169651|tcdd|expression|,|followed|. (l_dobj) expression_3\NN\4679549|the|transporter (l_nmod) transporter_7\NN\4490091|of|the|glucose|,|slc2a1|,|and|most (l_appos) slc2a1_9\NN\1740|
23152189T1_23152189T36 NONE gsh/glutathione_9\NN\1740| (r_compound) ratio_11\NN\13815152|the|gsh/glutathione|disulfide (r_conj) activity_6\NN\30358|glutathione|reductase|and|ratio (l_compound) reductase_5\NN\14732946|
23152189T2_23152189T36 NONE disulfide_10\NN\1740| (r_compound) ratio_11\NN\13815152|the|gsh/glutathione|disulfide (r_conj) activity_6\NN\30358|glutathione|reductase|and|ratio (l_compound) reductase_5\NN\14732946|
23152189T3_23152189T36 CPR:4 tcdd_15\NN\1740|by (r_nmod) decreased_13\VBN\169651|activity|were|tcdd|,|leading|. (l_nsubjpass) activity_6\NN\30358|glutathione|reductase|and|ratio (l_compound) reductase_5\NN\14732946|
23152189T4_23152189T36 NONE atp_31\NN\14964590| (r_compound) production_32\NN\30358|atp (r_conj) potential_29\NN\14481929|by|decreased|inner|mitochondrial|membrane|and|production|,|and|production (r_nmod) characterized_23\VBN\609683|potential (r_acl) dysfunction_21\NN\14204950|to|mitochondrial|,|characterized (r_nmod) leading_18\VBG\1752884|ultimately|dysfunction (r_xcomp) decreased_13\VBN\169651|activity|were|tcdd|,|leading|. (l_nsubjpass) activity_6\NN\30358|glutathione|reductase|and|ratio (l_compound) reductase_5\NN\14732946|
23152189T5_23152189T36 NONE oxygen_40\NN\14622893| (r_compound) species_41\NNS\7992450|of|the|reactive|oxygen|ros|,|peroxide (r_nmod) production_36\NN\30358|increased|species (r_conj) potential_29\NN\14481929|by|decreased|inner|mitochondrial|membrane|and|production|,|and|production (r_nmod) characterized_23\VBN\609683|potential (r_acl) dysfunction_21\NN\14204950|to|mitochondrial|,|characterized (r_nmod) leading_18\VBG\1752884|ultimately|dysfunction (r_xcomp) decreased_13\VBN\169651|activity|were|tcdd|,|leading|. (l_nsubjpass) activity_6\NN\30358|glutathione|reductase|and|ratio (l_compound) reductase_5\NN\14732946|
23152189T6_23152189T36 NONE peroxide_47\NN\14780040|hydrogen (r_appos) species_41\NNS\7992450|of|the|reactive|oxygen|ros|,|peroxide (r_nmod) production_36\NN\30358|increased|species (r_conj) potential_29\NN\14481929|by|decreased|inner|mitochondrial|membrane|and|production|,|and|production (r_nmod) characterized_23\VBN\609683|potential (r_acl) dysfunction_21\NN\14204950|to|mitochondrial|,|characterized (r_nmod) leading_18\VBG\1752884|ultimately|dysfunction (r_xcomp) decreased_13\VBN\169651|activity|were|tcdd|,|leading|. (l_nsubjpass) activity_6\NN\30358|glutathione|reductase|and|ratio (l_compound) reductase_5\NN\14732946|
23152189T26_23152189T36 NONE glutathione_1\NN\1740|mitochondrial|gsh (r_compound) activity_6\NN\30358|glutathione|reductase|and|ratio (l_compound) reductase_5\NN\14732946|
23152189T27_23152189T36 NONE gsh_3\NN\1740|(|) (r_appos) glutathione_1\NN\1740|mitochondrial|gsh (r_compound) activity_6\NN\30358|glutathione|reductase|and|ratio (l_compound) reductase_5\NN\14732946|
23152189T7_23152189T30 NONE hydrocarbon_1\NN\14727670| (r_compound) receptor_2\NN\5225602|aryl|hydrocarbon|ahr
23152189T7_23152189T31 NONE hydrocarbon_1\NN\14727670| (r_compound) receptor_2\NN\5225602|aryl|hydrocarbon|ahr (l_appos) ahr_4\NN\1740|(|)
23152189T7_23152189T32 NONE hydrocarbon_1\NN\14727670| (r_compound) receptor_2\NN\5225602|aryl|hydrocarbon|ahr (r_compound) antagonists_6\NNS\7846|receptor (r_nsubj) blocked_7\VBD\1476483|antagonists|response|,|suggesting|. (l_advcl) suggesting_26\VBG\1010118|regulation (l_dobj) regulation_27\NN\6652242|ahr (l_nmod) ahr_30\NN\1740|by|the
23152189T8_23152189T30 NONE tcdd_14\NN\1740|to (r_nmod) response_9\NN\11410625|the|transcripts|tcdd|,|and|endpoints (r_dobj) blocked_7\VBD\1476483|antagonists|response|,|suggesting|. (l_nsubj) antagonists_6\NNS\7846|receptor (l_compound) receptor_2\NN\5225602|aryl|hydrocarbon|ahr
23152189T8_23152189T31 NONE tcdd_14\NN\1740|to (r_nmod) response_9\NN\11410625|the|transcripts|tcdd|,|and|endpoints (r_dobj) blocked_7\VBD\1476483|antagonists|response|,|suggesting|. (l_nsubj) antagonists_6\NNS\7846|receptor (l_compound) receptor_2\NN\5225602|aryl|hydrocarbon|ahr (l_appos) ahr_4\NN\1740|(|)
23152189T8_23152189T32 NONE tcdd_14\NN\1740|to (r_nmod) response_9\NN\11410625|the|transcripts|tcdd|,|and|endpoints (r_dobj) blocked_7\VBD\1476483|antagonists|response|,|suggesting|. (l_advcl) suggesting_26\VBG\1010118|regulation (l_dobj) regulation_27\NN\6652242|ahr (l_nmod) ahr_30\NN\1740|by|the
23152189T9_23152189T30 NONE atp_21\NN\14964590|of|decreased|production (r_nmod) endpoints_18\NNS\8566028|the|atp (r_conj) response_9\NN\11410625|the|transcripts|tcdd|,|and|endpoints (r_dobj) blocked_7\VBD\1476483|antagonists|response|,|suggesting|. (l_nsubj) antagonists_6\NNS\7846|receptor (l_compound) receptor_2\NN\5225602|aryl|hydrocarbon|ahr
23152189T9_23152189T31 NONE atp_21\NN\14964590|of|decreased|production (r_nmod) endpoints_18\NNS\8566028|the|atp (r_conj) response_9\NN\11410625|the|transcripts|tcdd|,|and|endpoints (r_dobj) blocked_7\VBD\1476483|antagonists|response|,|suggesting|. (l_nsubj) antagonists_6\NNS\7846|receptor (l_compound) receptor_2\NN\5225602|aryl|hydrocarbon|ahr (l_appos) ahr_4\NN\1740|(|)
23152189T9_23152189T32 NONE atp_21\NN\14964590|of|decreased|production (r_nmod) endpoints_18\NNS\8566028|the|atp (r_conj) response_9\NN\11410625|the|transcripts|tcdd|,|and|endpoints (r_dobj) blocked_7\VBD\1476483|antagonists|response|,|suggesting|. (l_advcl) suggesting_26\VBG\1010118|regulation (l_dobj) regulation_27\NN\6652242|ahr (l_nmod) ahr_30\NN\1740|by|the
23152189T10_23152189T33 NONE tcdd-mediated_12\JJ\1740| (r_amod) acceleration_13\NN\7296428|the|tcdd-mediated|formation (r_dobj) blocked_10\VBD\1476483|cotreatment|acceleration|. (l_nsubj) cotreatment_0\NN\1740|cells|antioxidants (l_nmod) antioxidants_5\NNS\14724436|with|chemical|or|catalase (l_conj) catalase_9\NN\14732946|the|enzyme
14501155
14501155T8_14501155T22 NONE 53857_9\CD\1740| (r_nummod) ly_8\NN\1740|53857 (r_nmod:tmod) antagonist_7\NN\7846|the|5-ht(2a/2b/2c)-receptor|ly (r_conj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (l_compound) 5-ht(1/2/5/7)-receptor_1\NN\1740|
14501155T8_14501155T23 CPR:6 53857_9\CD\1740| (r_nummod) ly_8\NN\1740|53857 (r_nmod:tmod) antagonist_7\NN\7846|the|5-ht(2a/2b/2c)-receptor|ly (l_compound) 5-ht(2a/2b/2c)-receptor_6\NN\1740|
14501155T8_14501155T24 NONE 53857_9\CD\1740| (r_nummod) ly_8\NN\1740|53857 (r_nmod:tmod) antagonist_7\NN\7846|the|5-ht(2a/2b/2c)-receptor|ly (r_conj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (r_nsubj) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_advcl) affect_26\VB\126264|while|(-)-propranolol|did|not|it (l_nsubj) (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (l_compound) 5-ht(1a/1b)-receptor_16\NN\1740|
14501155T8_14501155T25 NONE 53857_9\CD\1740| (r_nummod) ly_8\NN\1740|53857 (r_nmod:tmod) antagonist_7\NN\7846|the|5-ht(2a/2b/2c)-receptor|ly (r_conj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (r_nsubj) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_advcl) affect_26\VB\126264|while|(-)-propranolol|did|not|it (l_nsubj) (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (l_conj) antagonist_22\NN\7846|the|5-ht(3/4)-receptor|tropisetron (l_compound) 5-ht(3/4)-receptor_21\NN\1740|
14501155T9_14501155T22 NONE clomipramine-induced_11\JJ\1740| (r_amod) hyperglycemia_12\NN\14299637|clomipramine-induced (r_dobj) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_nsubj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (l_compound) 5-ht(1/2/5/7)-receptor_1\NN\1740|
14501155T9_14501155T23 NONE clomipramine-induced_11\JJ\1740| (r_amod) hyperglycemia_12\NN\14299637|clomipramine-induced (r_dobj) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_nsubj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (l_conj) antagonist_7\NN\7846|the|5-ht(2a/2b/2c)-receptor|ly (l_compound) 5-ht(2a/2b/2c)-receptor_6\NN\1740|
14501155T9_14501155T24 NONE clomipramine-induced_11\JJ\1740| (r_amod) hyperglycemia_12\NN\14299637|clomipramine-induced (r_dobj) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_advcl) affect_26\VB\126264|while|(-)-propranolol|did|not|it (l_nsubj) (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (l_compound) 5-ht(1a/1b)-receptor_16\NN\1740|
14501155T9_14501155T25 NONE clomipramine-induced_11\JJ\1740| (r_amod) hyperglycemia_12\NN\14299637|clomipramine-induced (r_dobj) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_advcl) affect_26\VB\126264|while|(-)-propranolol|did|not|it (l_nsubj) (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (l_conj) antagonist_22\NN\7846|the|5-ht(3/4)-receptor|tropisetron (l_compound) 5-ht(3/4)-receptor_21\NN\1740|
14501155T10_14501155T22 NONE (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (r_nsubj) affect_26\VB\126264|while|(-)-propranolol|did|not|it (r_advcl) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_nsubj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (l_compound) 5-ht(1/2/5/7)-receptor_1\NN\1740|
14501155T10_14501155T23 NONE (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (r_nsubj) affect_26\VB\126264|while|(-)-propranolol|did|not|it (r_advcl) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_nsubj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (l_conj) antagonist_7\NN\7846|the|5-ht(2a/2b/2c)-receptor|ly (l_compound) 5-ht(2a/2b/2c)-receptor_6\NN\1740|
14501155T10_14501155T24 CPR:6 (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (l_compound) 5-ht(1a/1b)-receptor_16\NN\1740|
14501155T10_14501155T25 NONE (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (l_conj) antagonist_22\NN\7846|the|5-ht(3/4)-receptor|tropisetron (l_compound) 5-ht(3/4)-receptor_21\NN\1740|
14501155T11_14501155T22 NONE tropisetron_23\NN\1740| (r_dep) antagonist_22\NN\7846|the|5-ht(3/4)-receptor|tropisetron (r_conj) (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (r_nsubj) affect_26\VB\126264|while|(-)-propranolol|did|not|it (r_advcl) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_nsubj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (l_compound) 5-ht(1/2/5/7)-receptor_1\NN\1740|
14501155T11_14501155T23 NONE tropisetron_23\NN\1740| (r_dep) antagonist_22\NN\7846|the|5-ht(3/4)-receptor|tropisetron (r_conj) (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (r_nsubj) affect_26\VB\126264|while|(-)-propranolol|did|not|it (r_advcl) enhanced_10\VBD\227165|methysergide|hyperglycemia|,|affect|. (l_nsubj) methysergide_3\NN\1740|the|5-ht(1/2/5/7)-receptor|antagonist|and|antagonist (l_conj) antagonist_7\NN\7846|the|5-ht(2a/2b/2c)-receptor|ly (l_compound) 5-ht(2a/2b/2c)-receptor_6\NN\1740|
14501155T11_14501155T24 NONE tropisetron_23\NN\1740| (r_dep) antagonist_22\NN\7846|the|5-ht(3/4)-receptor|tropisetron (r_conj) (-)-propranolol_18\NN\1740|the|5-ht(1a/1b)-receptor|antagonist|and|antagonist (l_compound) 5-ht(1a/1b)-receptor_16\NN\1740|
14501155T11_14501155T25 CPR:6 tropisetron_23\NN\1740| (r_dep) antagonist_22\NN\7846|the|5-ht(3/4)-receptor|tropisetron (l_compound) 5-ht(3/4)-receptor_21\NN\1740|
14501155T13_14501155T26 CPR:6 206553_4\CD\1740| (r_nummod) sb_3\NN\14625458|206553 (r_dep) antagonist_2\NN\7846|the|5-ht(2b/2c)-receptor|sb (l_compound) 5-ht(2b/2c)-receptor_1\NN\1740|
14501155T13_14501155T27 NONE 206553_4\CD\1740| (r_nummod) sb_3\NN\14625458|206553 (r_dep) antagonist_2\NN\7846|the|5-ht(2b/2c)-receptor|sb (r_nsubj) facilitated_5\VBD\2547586|antagonist|hyperglycemia|,|although|. (l_advcl) although_11\IN\1740|ketanserin|was|effect (l_nsubj) ketanserin_15\NN\1740|the|5-ht(2a)-receptor|antagonist (l_compound) 5-ht(2a)-receptor_13\NN\1740|
14501155T14_14501155T26 NONE clomipramine_9\NN\4482543|by (r_nmod) induced_7\VBN\1627355|clomipramine (r_acl) hyperglycemia_6\NN\14299637|induced (r_dobj) facilitated_5\VBD\2547586|antagonist|hyperglycemia|,|although|. (l_nsubj) antagonist_2\NN\7846|the|5-ht(2b/2c)-receptor|sb (l_compound) 5-ht(2b/2c)-receptor_1\NN\1740|
14501155T14_14501155T27 NONE clomipramine_9\NN\4482543|by (r_nmod) induced_7\VBN\1627355|clomipramine (r_acl) hyperglycemia_6\NN\14299637|induced (r_dobj) facilitated_5\VBD\2547586|antagonist|hyperglycemia|,|although|. (l_advcl) although_11\IN\1740|ketanserin|was|effect (l_nsubj) ketanserin_15\NN\1740|the|5-ht(2a)-receptor|antagonist (l_compound) 5-ht(2a)-receptor_13\NN\1740|
14501155T15_14501155T26 NONE ketanserin_15\NN\1740|the|5-ht(2a)-receptor|antagonist (r_nsubj) although_11\IN\1740|ketanserin|was|effect (r_advcl) facilitated_5\VBD\2547586|antagonist|hyperglycemia|,|although|. (l_nsubj) antagonist_2\NN\7846|the|5-ht(2b/2c)-receptor|sb (l_compound) 5-ht(2b/2c)-receptor_1\NN\1740|
14501155T15_14501155T27 CPR:6 ketanserin_15\NN\1740|the|5-ht(2a)-receptor|antagonist (l_compound) 5-ht(2a)-receptor_13\NN\1740|
14501155T17_14501155T28 CPR:4 clomipramine_4\NN\4482543| (r_nsubj) induces_5\VBZ\1627355|that|clomipramine|hyperglycemia|mice|blocking (l_advcl) blocking_10\VBG\1476483|by|receptors|,|results (l_nmod) receptors_17\NNS\5225602|5-ht(2b (l_compound) 5-ht(2b_12\NN\1740|the|)|and/or|5-ht(2c (l_punct) )_13\-RRB-\1740|
14501155T17_14501155T29 CPR:4 clomipramine_4\NN\4482543| (r_nsubj) induces_5\VBZ\1627355|that|clomipramine|hyperglycemia|mice|blocking (l_advcl) blocking_10\VBG\1476483|by|receptors|,|results (l_nmod) receptors_17\NNS\5225602|5-ht(2b (l_compound) 5-ht(2b_12\NN\1740|the|)|and/or|5-ht(2c (l_conj) 5-ht(2c_15\NN\1740|) (l_punct) )_16\-RRB-\1740|
14501155T18_14501155T28 NONE adrenaline_24\NN\14807929| (r_compound) release_25\NN\3748886|of|adrenaline (r_nmod) facilitation_22\NN\13920835|in|release (r_nmod) results_20\VBZ\2633881|which|facilitation (r_ccomp) blocking_10\VBG\1476483|by|receptors|,|results (l_nmod) receptors_17\NNS\5225602|5-ht(2b (l_compound) 5-ht(2b_12\NN\1740|the|)|and/or|5-ht(2c (l_punct) )_13\-RRB-\1740|
14501155T18_14501155T29 NONE adrenaline_24\NN\14807929| (r_compound) release_25\NN\3748886|of|adrenaline (r_nmod) facilitation_22\NN\13920835|in|release (r_nmod) results_20\VBZ\2633881|which|facilitation (r_ccomp) blocking_10\VBG\1476483|by|receptors|,|results (l_nmod) receptors_17\NNS\5225602|5-ht(2b (l_compound) 5-ht(2b_12\NN\1740|the|)|and/or|5-ht(2c (l_conj) 5-ht(2c_15\NN\1740|) (l_punct) )_16\-RRB-\1740|
12826271
12826271T7_12826271T11 CPR:3 diclofenac_2\NN\1740|with (r_nmod) treatment_0\NN\654885|diclofenac (r_nsubj) resulted_3\VBD\2633881|treatment|condensation|24hr|and|activated|,|indicating|. (l_conj) activated_22\VBD\1641914|caspase-3|hr (l_dobj) caspase-3_23\NN\1740|
12826271T7_12826271T12 NONE diclofenac_2\NN\1740|with (r_nmod) treatment_0\NN\654885|diclofenac (r_nsubj) resulted_3\VBD\2633881|treatment|condensation|24hr|and|activated|,|indicating|. (l_advcl) indicating_28\VBG\952524|cause (l_ccomp) cause_32\VB\1617192|that|diclofenac|may|apoptosis|activation (l_nmod) activation_38\NN\13561719|via|cascade (l_nmod) cascade_42\NN\9475292|of|the|caspase (l_compound) caspase_41\NN\14999106|
12826271T8_12826271T11 NONE diclofenac_30\NN\1740| (r_nsubj) cause_32\VB\1617192|that|diclofenac|may|apoptosis|activation (r_ccomp) indicating_28\VBG\952524|cause (r_advcl) resulted_3\VBD\2633881|treatment|condensation|24hr|and|activated|,|indicating|. (l_conj) activated_22\VBD\1641914|caspase-3|hr (l_dobj) caspase-3_23\NN\1740|
12826271T8_12826271T12 CPR:3 diclofenac_30\NN\1740| (r_nsubj) cause_32\VB\1617192|that|diclofenac|may|apoptosis|activation (l_nmod) activation_38\NN\13561719|via|cascade (l_nmod) cascade_42\NN\9475292|of|the|caspase (l_compound) caspase_41\NN\14999106|
23423570
23423570T5_23423570T18 CPR:3 high-glucose_0\JJ\1740| (r_amod) environment_1\NN\13927383|high-glucose (r_nsubj) enhanced_2\VBD\227165|environment|stress|:|insights|. (l_dobj) stress_4\NN\7083732|oxidative|and|secretion (l_conj) secretion_8\NN\13526110|increased|interleukin-8|keratinocytes (l_compound) interleukin-8_7\NN\1740|
23423570T3_23423570T7 CPR:3 high-glucose_14\JJ\1740| (r_amod) environment_15\NN\13927383|high-glucose (r_nsubj) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_dobj) production_18\NN\30358|il-8 (l_compound) il-8_17\NN\1740|
23423570T3_23423570T8 NONE high-glucose_14\JJ\1740| (r_amod) environment_15\NN\13927383|high-glucose (r_nsubj) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_nmod) pathway_33\NN\5483677|via|receptor|-extracelluar|kinase (l_compound) receptor_23\NN\5225602|epidermal|growth|factor|egfr
23423570T3_23423570T9 NONE high-glucose_14\JJ\1740| (r_amod) environment_15\NN\13927383|high-glucose (r_nsubj) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_nmod) pathway_33\NN\5483677|via|receptor|-extracelluar|kinase (l_compound) receptor_23\NN\5225602|epidermal|growth|factor|egfr (l_appos) egfr_25\NN\1740|(|)
23423570T3_23423570T10 NONE high-glucose_14\JJ\1740| (r_amod) environment_15\NN\13927383|high-glucose (r_nsubj) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_nmod) pathway_33\NN\5483677|via|receptor|-extracelluar|kinase (l_compound) kinase_29\NN\14732946|signal-regulated|erk
23423570T3_23423570T11 NONE high-glucose_14\JJ\1740| (r_amod) environment_15\NN\13927383|high-glucose (r_nsubj) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_nmod) pathway_33\NN\5483677|via|receptor|-extracelluar|kinase (l_compound) kinase_29\NN\14732946|signal-regulated|erk (l_appos) erk_31\NN\1740|(|)
23423570T4_23423570T7 NONE oxygen_37\NN\14622893| (r_compound) species_38\NNS\7992450|reactive|oxygen (r_nmod:npmod) (ros)-dependent_39\JJ\1740|species (r_amod) manner_40\NN\4916342|in|a|(ros)-dependent (r_nmod) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_dobj) production_18\NN\30358|il-8 (l_compound) il-8_17\NN\1740|
23423570T4_23423570T8 NONE oxygen_37\NN\14622893| (r_compound) species_38\NNS\7992450|reactive|oxygen (r_nmod:npmod) (ros)-dependent_39\JJ\1740|species (r_amod) manner_40\NN\4916342|in|a|(ros)-dependent (r_nmod) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_nmod) pathway_33\NN\5483677|via|receptor|-extracelluar|kinase (l_compound) receptor_23\NN\5225602|epidermal|growth|factor|egfr
23423570T4_23423570T9 NONE oxygen_37\NN\14622893| (r_compound) species_38\NNS\7992450|reactive|oxygen (r_nmod:npmod) (ros)-dependent_39\JJ\1740|species (r_amod) manner_40\NN\4916342|in|a|(ros)-dependent (r_nmod) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_nmod) pathway_33\NN\5483677|via|receptor|-extracelluar|kinase (l_compound) receptor_23\NN\5225602|epidermal|growth|factor|egfr (l_appos) egfr_25\NN\1740|(|)
23423570T4_23423570T10 NONE oxygen_37\NN\14622893| (r_compound) species_38\NNS\7992450|reactive|oxygen (r_nmod:npmod) (ros)-dependent_39\JJ\1740|species (r_amod) manner_40\NN\4916342|in|a|(ros)-dependent (r_nmod) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_nmod) pathway_33\NN\5483677|via|receptor|-extracelluar|kinase (l_compound) kinase_29\NN\14732946|signal-regulated|erk
23423570T4_23423570T11 NONE oxygen_37\NN\14622893| (r_compound) species_38\NNS\7992450|reactive|oxygen (r_nmod:npmod) (ros)-dependent_39\JJ\1740|species (r_amod) manner_40\NN\4916342|in|a|(ros)-dependent (r_nmod) enhanced_16\VBD\227165|that|environment|production|pathway|manner|keratinocytes (l_nmod) pathway_33\NN\5483677|via|receptor|-extracelluar|kinase (l_compound) kinase_29\NN\14732946|signal-regulated|erk (l_appos) erk_31\NN\1740|(|)
23423570T2_23423570T6 CPR:3 high-glucose_11\JJ\1740| (r_amod) environment_12\NN\13927383|in|high-glucose (r_nmod) increased_9\VBN\169651|conclusion|,|production|are|environment|level|and|contributed|. (l_nsubjpass) production_4\NN\30358|il-8|and|infiltration (l_compound) il-8_3\NN\1740|
23362262
23362262T4_23362262T51 NONE rapamycin_11\NN\1740| (r_compound) complexes_12\NNS\5869584|of|rapamycin (r_nmod) target_9\NN\7258332|to|mechanistic|complexes (r_nmod) integrates_4\VBZ\1461328|β|smad|target|arrest|. (l_nsubj) β_3\NN\1740|transforming|growth|factor
23362262T4_23362262T52 NONE rapamycin_11\NN\1740| (r_compound) complexes_12\NNS\5869584|of|rapamycin (r_nmod) target_9\NN\7258332|to|mechanistic|complexes (r_nmod) integrates_4\VBZ\1461328|β|smad|target|arrest|. (l_xcomp) arrest_14\VB\1212572|to|abundance|hypertrophy (l_dobj) abundance_16\NN\5108740|deptor (l_compound) deptor_15\NN\1740|
23362262T4_23362262T53 NONE rapamycin_11\NN\1740| (r_compound) complexes_12\NNS\5869584|of|rapamycin (r_nmod) target_9\NN\7258332|to|mechanistic|complexes (r_nmod) integrates_4\VBZ\1461328|β|smad|target|arrest|. (l_dobj) smad_5\NN\1740|3 (l_nummod) 3_6\CD\13741022|
23362262T4_23362262T54 NONE rapamycin_11\NN\1740|
23362262T1_23362262T6 NONE rapamycin_18\NN\1740|of|mtor
23362262T1_23362262T18 NONE rapamycin_18\NN\1740|of|mtor (l_appos) mtor_20\NN\1740|(|)
23362262T1_23362262T29 NONE rapamycin_18\NN\1740|of|mtor (r_nmod) target_16\NN\7258332|noncanonical|mechanistic|rapamycin (r_conj) smad_11\NN\1740|transforming|growth|factor|β|(tgfβ)-stimulated|canonical|3|and|target (l_compound) β_8\NN\1740|
23362262T1_23362262T36 NONE rapamycin_18\NN\1740|of|mtor (r_nmod) target_16\NN\7258332|noncanonical|mechanistic|rapamycin (r_conj) smad_11\NN\1740|transforming|growth|factor|β|(tgfβ)-stimulated|canonical|3|and|target (l_amod) (tgfβ)-stimulated_9\NN\1740|
23362262T1_23362262T45 NONE rapamycin_18\NN\1740|of|mtor (r_nmod) target_16\NN\7258332|noncanonical|mechanistic|rapamycin (r_conj) smad_11\NN\1740|transforming|growth|factor|β|(tgfβ)-stimulated|canonical|3|and|target (l_nummod) 3_12\CD\13741022|
23362262T2_23362262T43 CPR:4 ,_5\,\1740| (r_punct) found_7\VBD\2426171|using|,|we|necessary|. (l_advcl) using_0\VBG\1156834|pp242 (l_dobj) pp242_4\NN\1740|the|mtor|inhibitor (l_compound) mtor_2\NN\1740|
23362262T2_23362262T44 NONE ,_5\,\1740| (r_punct) found_7\VBD\2426171|using|,|we|necessary|. (l_ccomp) necessary_20\JJ\1740|that|activation|was|suppression (l_nsubj) activation_14\NN\13561719|tgfβ-induced|early|torc1 (l_amod) tgfβ-induced_9\JJ\1740|
23362262T2_23362262T46 NONE ,_5\,\1740| (r_punct) found_7\VBD\2426171|using|,|we|necessary|. (l_ccomp) necessary_20\JJ\1740|that|activation|was|suppression (l_nsubj) activation_14\NN\13561719|tgfβ-induced|early|torc1 (l_nmod) torc1_16\NN\1740|of|and|torc2
23362262T2_23362262T47 NONE ,_5\,\1740| (r_punct) found_7\VBD\2426171|using|,|we|necessary|. (l_ccomp) necessary_20\JJ\1740|that|activation|was|suppression (l_nsubj) activation_14\NN\13561719|tgfβ-induced|early|torc1 (l_nmod) torc1_16\NN\1740|of|and|torc2 (l_conj) torc2_18\NN\1740|
23362262T2_23362262T48 NONE ,_5\,\1740| (r_punct) found_7\VBD\2426171|using|,|we|necessary|. (l_ccomp) necessary_20\JJ\1740|that|activation|was|suppression (l_nmod) suppression_23\NN\13489037|for|deptor (l_compound) deptor_22\NN\1740|
23362262T3_23362262T5 NONE pp242-induced_0\JJ\1740| (r_amod) reversal_1\NN\199130|pp242-induced|suppression|tgfβ (r_nsubjpass) associated_8\VBN\628491|reversal|was|inhibition|. (l_nmod) inhibition_12\NN\1068773|with|a|significant|protein (l_nmod) protein_15\NN\14944888|of|tgfβ-stimulated|synthesis|hypertrophy (l_amod) tgfβ-stimulated_14\JJ\1740|
23362262T3_23362262T49 CPR:3 pp242-induced_0\JJ\1740| (r_amod) reversal_1\NN\199130|pp242-induced|suppression|tgfβ (l_nmod) suppression_4\NN\13489037|of|deptor (l_compound) deptor_3\NN\1740|
23362262T3_23362262T50 NONE pp242-induced_0\JJ\1740| (r_amod) reversal_1\NN\199130|pp242-induced|suppression|tgfβ (l_nmod) tgfβ_6\NN\1740|by
16293341
16293341T8_16293341T14 NONE melanotan_2\NN\1740|of|,|nle(4|, (l_appos) nle(4_5\NN\1740|[|)|,|d-phe(7)]-alpha-msh (l_appos) d-phe(7)]-alpha-msh_8\NN\1740|
16293341T8_16293341T15 NONE melanotan_2\NN\1740|of|,|nle(4|, (r_nmod) effect_0\NN\34213|melanotan|synthesis|. (l_nmod) synthesis_12\NN\13446390|on|melanin|humans (l_nmod) humans_14\NNS\31264|in|alleles (l_nmod) alleles_18\NNS\5436752|with|mc1r|variant (l_compound) mc1r_16\NN\1740|
16293341T9_16293341T14 NONE d-phe(7)]-alpha-msh_8\NN\1740|
16293341T9_16293341T15 NONE d-phe(7)]-alpha-msh_8\NN\1740| (r_appos) nle(4_5\NN\1740|[|)|,|d-phe(7)]-alpha-msh (r_appos) melanotan_2\NN\1740|of|,|nle(4|, (r_nmod) effect_0\NN\34213|melanotan|synthesis|. (l_nmod) synthesis_12\NN\13446390|on|melanin|humans (l_nmod) humans_14\NNS\31264|in|alleles (l_nmod) alleles_18\NNS\5436752|with|mc1r|variant (l_compound) mc1r_16\NN\1740|
16293341T1_16293341T10 NONE melanotan_0\NN\1740|ndp-msh (l_appos) ndp-msh_2\NN\1740|(|)
16293341T1_16293341T12 NONE melanotan_0\NN\1740|ndp-msh (r_nsubj) binds_4\VBZ\1290422|melanotan|receptor|increase|. (l_dobj) receptor_7\NN\5225602|the|mc1
16293341T2_16293341T10 NONE ndp-msh_2\NN\1740|(|)
16293341T2_16293341T12 NONE ndp-msh_2\NN\1740|(|) (r_appos) melanotan_0\NN\1740|ndp-msh (r_nsubj) binds_4\VBZ\1290422|melanotan|receptor|increase|. (l_dobj) receptor_7\NN\5225602|the|mc1
16293341T3_16293341T11 NONE melanotan_13\NN\1740|of (r_nmod) effects_11\NNS\13245626|the|melanotan|individuals (l_nmod) individuals_15\NNS\7347|in|genotypes (l_nmod) genotypes_19\NNS\7941170|with|variant|mc1r (l_compound) mc1r_18\NN\1740|
16293341T4_16293341T11 NONE melanotan_34\NN\1740| (r_compound) efficacy_36\NN\5199286|melanotan|binding (r_dobj) decrease_33\VBP\169651|that|alleles|efficacy|,|affect (r_ccomp) suggested_25\VBN\1010118|as|it|has|been|studies|decrease (r_advcl) investigated_9\VBD\644583|study|,|we|effects|,|suggested|. (l_dobj) effects_11\NNS\13245626|the|melanotan|individuals (l_nmod) individuals_15\NNS\7347|in|genotypes (l_nmod) genotypes_19\NNS\7941170|with|variant|mc1r (l_compound) mc1r_18\NN\1740|
16293341T7_16293341T13 NONE melanotan_4\NN\1740| (r_nsubj) increases_6\VBZ\169651|that|melanotan|effectively|content|most (l_dobj) content_9\NN\7951464|the|melanin|skin|individuals (l_nmod) individuals_14\NNS\7347|in|those|alleles|and|therefore|,|those (l_nmod) alleles_18\NNS\5436752|with|mc1r|variant (l_compound) mc1r_16\NN\1740|
15963471
15963471T27_15963471T47 NONE thiazolidinediones_2\NNS\1740|of (r_nmod) effect_0\NN\34213|thiazolidinediones|transporter-1|. (l_nmod) transporter-1_6\NN\1740|on|equilibrative|nucleoside|cells
15963471T1_15963471T30 NONE thiazolidinediones_0\NNS\1740| (r_nsubj) class_4\NN\7951464|thiazolidinediones|are|a|new|agents (l_nmod) agents_7\NNS\7347|of|anti-diabetic|increase (l_acl:relcl) increase_9\VBP\169651|which|sensitivity|binding|. (l_advcl) binding_13\VBG\1290422|by|gamma|and|stimulating (l_nmod) gamma_19\NN\6828818|to|the|peroxisome|proliferator-activated|receptor|ppar(gamma
15963471T1_15963471T36 NONE thiazolidinediones_0\NNS\1740| (r_nsubj) class_4\NN\7951464|thiazolidinediones|are|a|new|agents (l_nmod) agents_7\NNS\7347|of|anti-diabetic|increase (l_acl:relcl) increase_9\VBP\169651|which|sensitivity|binding|. (l_advcl) binding_13\VBG\1290422|by|gamma|and|stimulating (l_nmod) gamma_19\NN\6828818|to|the|peroxisome|proliferator-activated|receptor|ppar(gamma (l_appos) ppar(gamma_21\NN\1740|(|)|) (l_punct) )_22\-RRB-\1740|
15963471T1_15963471T40 CPR:3 thiazolidinediones_0\NNS\1740| (r_nsubj) class_4\NN\7951464|thiazolidinediones|are|a|new|agents (l_nmod) agents_7\NNS\7347|of|anti-diabetic|increase (l_acl:relcl) increase_9\VBP\169651|which|sensitivity|binding|. (l_advcl) binding_13\VBG\1290422|by|gamma|and|stimulating (l_conj) stimulating_25\VBG\137313|expression (l_dobj) expression_27\NN\4679549|the|genes (l_nmod) genes_30\NNS\8459252|of|insulin-responsive|involved (l_amod) insulin-responsive_29\JJ\1740|
15963471T1_15963471T44 CPR:3 thiazolidinediones_0\NNS\1740| (r_nsubj) class_4\NN\7951464|thiazolidinediones|are|a|new|agents (l_nmod) agents_7\NNS\7347|of|anti-diabetic|increase (l_acl:relcl) increase_9\VBP\169651|which|sensitivity|binding|. (l_dobj) sensitivity_11\NN\5651971|insulin (l_compound) insulin_10\NN\5407119|
15963471T17_15963471T30 NONE glucose_33\NN\14710501|in|and|metabolism (r_nmod) involved_31\VBN\2676054|glucose (r_acl) genes_30\NNS\8459252|of|insulin-responsive|involved (r_nmod) expression_27\NN\4679549|the|genes (r_dobj) stimulating_25\VBG\137313|expression (r_conj) binding_13\VBG\1290422|by|gamma|and|stimulating (l_nmod) gamma_19\NN\6828818|to|the|peroxisome|proliferator-activated|receptor|ppar(gamma
15963471T17_15963471T36 NONE glucose_33\NN\14710501|in|and|metabolism (r_nmod) involved_31\VBN\2676054|glucose (r_acl) genes_30\NNS\8459252|of|insulin-responsive|involved (r_nmod) expression_27\NN\4679549|the|genes (r_dobj) stimulating_25\VBG\137313|expression (r_conj) binding_13\VBG\1290422|by|gamma|and|stimulating (l_nmod) gamma_19\NN\6828818|to|the|peroxisome|proliferator-activated|receptor|ppar(gamma (l_appos) ppar(gamma_21\NN\1740|(|)|) (l_punct) )_22\-RRB-\1740|
15963471T17_15963471T40 NONE glucose_33\NN\14710501|in|and|metabolism (r_nmod) involved_31\VBN\2676054|glucose (r_acl) genes_30\NNS\8459252|of|insulin-responsive|involved (l_amod) insulin-responsive_29\JJ\1740|
15963471T17_15963471T44 NONE glucose_33\NN\14710501|in|and|metabolism (r_nmod) involved_31\VBN\2676054|glucose (r_acl) genes_30\NNS\8459252|of|insulin-responsive|involved (r_nmod) expression_27\NN\4679549|the|genes (r_dobj) stimulating_25\VBG\137313|expression (r_conj) binding_13\VBG\1290422|by|gamma|and|stimulating (r_advcl) increase_9\VBP\169651|which|sensitivity|binding|. (l_dobj) sensitivity_11\NN\5651971|insulin (l_compound) insulin_10\NN\5407119|
15963471T18_15963471T43 NONE thiazolidinediones_8\NNS\1740|of|three|,|troglitazone|, (r_nmod) effects_5\NNS\13245626|the|thiazolidinediones|ent1 (l_nmod) ent1_17\NN\1740|on|cells
15963471T19_15963471T43 NONE troglitazone_10\NN\1740|,|pioglitazone (r_appos) thiazolidinediones_8\NNS\1740|of|three|,|troglitazone|, (r_nmod) effects_5\NNS\13245626|the|thiazolidinediones|ent1 (l_nmod) ent1_17\NN\1740|on|cells
15963471T20_15963471T43 NONE pioglitazone_12\NN\1740|and|ciglitazone (r_conj) troglitazone_10\NN\1740|,|pioglitazone (r_appos) thiazolidinediones_8\NNS\1740|of|three|,|troglitazone|, (r_nmod) effects_5\NNS\13245626|the|thiazolidinediones|ent1 (l_nmod) ent1_17\NN\1740|on|cells
15963471T21_15963471T43 NONE ciglitazone_14\NN\1740| (r_conj) pioglitazone_12\NN\1740|and|ciglitazone (r_conj) troglitazone_10\NN\1740|,|pioglitazone (r_appos) thiazolidinediones_8\NNS\1740|of|three|,|troglitazone|, (r_nmod) effects_5\NNS\13245626|the|thiazolidinediones|ent1 (l_nmod) ent1_17\NN\1740|on|cells
15963471T22_15963471T45 NONE thiazolidinediones_6\NNS\1740|with (r_nmod) incubating_1\VBG\252019|hasmcs|48h|thiazolidinediones (r_csubj) had_7\VBD\2108377|although|incubating|effect|mrna (l_nmod) mrna_12\NN\14832193|on|ent1|and|protein|levels (l_compound) ent1_11\NN\1740|
15963471T23_15963471T45 NONE troglitazone_17\NN\1740| (r_nsubj) inhibited_19\VBD\2510337|had|,|troglitazone|acutely|uptake|values|,|respectively|. (l_advcl) had_7\VBD\2108377|although|incubating|effect|mrna (l_nmod) mrna_12\NN\14832193|on|ent1|and|protein|levels (l_compound) ent1_11\NN\1740|
15963471T24_15963471T45 NONE [3h]adenosine_20\NN\1740| (r_compound) uptake_21\NN\13440063|[3h]adenosine|and|binding|hasmcs (r_dobj) inhibited_19\VBD\2510337|had|,|troglitazone|acutely|uptake|values|,|respectively|. (l_advcl) had_7\VBD\2108377|although|incubating|effect|mrna (l_nmod) mrna_12\NN\14832193|on|ent1|and|protein|levels (l_compound) ent1_11\NN\1740|
15963471T25_15963471T45 NONE [3h]nbmpr_23\NN\1740| (r_compound) binding_24\NN\4688246|[3h]nbmpr (r_conj) uptake_21\NN\13440063|[3h]adenosine|and|binding|hasmcs (r_dobj) inhibited_19\VBD\2510337|had|,|troglitazone|acutely|uptake|values|,|respectively|. (l_advcl) had_7\VBD\2108377|although|incubating|effect|mrna (l_nmod) mrna_12\NN\14832193|on|ent1|and|protein|levels (l_compound) ent1_11\NN\1740|
15963471T2_15963471T28 NONE troglitazone_13\NN\1740| (r_nsubj) inhibitor_17\NN\20090|that|troglitazone|was|a|competitive|ent1 (r_ccomp) revealed_11\VBD\2137132|studies|inhibitor (r_conj) ppar(gamma)-independent_7\NN\1740|effect|was|and|revealed|.
15963471T2_15963471T29 CPR:4 troglitazone_13\NN\1740| (r_nsubj) inhibitor_17\NN\20090|that|troglitazone|was|a|competitive|ent1 (l_nmod) ent1_19\NN\1740|of
15963471T2_15963471T46 NONE troglitazone_13\NN\1740| (r_nsubj) inhibitor_17\NN\20090|that|troglitazone|was|a|competitive|ent1 (r_ccomp) revealed_11\VBD\2137132|studies|inhibitor (r_conj) ppar(gamma)-independent_7\NN\1740|effect|was|and|revealed|. (l_nsubj) effect_1\NN\34213|the|troglitazone|ent1 (l_nmod) ent1_5\NN\1740|on
15963471T26_15963471T28 NONE troglitazone_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|troglitazone|ent1 (r_nsubj) ppar(gamma)-independent_7\NN\1740|effect|was|and|revealed|.
15963471T26_15963471T29 NONE troglitazone_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|troglitazone|ent1 (r_nsubj) ppar(gamma)-independent_7\NN\1740|effect|was|and|revealed|. (l_conj) revealed_11\VBD\2137132|studies|inhibitor (l_ccomp) inhibitor_17\NN\20090|that|troglitazone|was|a|competitive|ent1 (l_nmod) ent1_19\NN\1740|of
15963471T26_15963471T46 NONE troglitazone_3\NN\1740|of (r_nmod) effect_1\NN\34213|the|troglitazone|ent1 (l_nmod) ent1_5\NN\1740|on
15963471T10_15963471T31 CPR:4 troglitazone_5\NN\1740|of (r_nmod) structure_3\NN\21939|in|troglitazone (r_nmod) difference_1\NN\4723816|the|structure (r_nsubj) account_8\VB\2604760|difference|did|not|effect|inhibit|. (l_nmod) effect_12\NN\34213|for|its|inhibitory|ent1 (l_nmod) ent1_14\NN\1740|on
15963471T11_15963471T31 NONE e_17\NN\14724645|vitamin (r_nsubj) inhibit_20\VB\2510337|because|e|did|not|uptake (r_advcl) account_8\VB\2604760|difference|did|not|effect|inhibit|. (l_nmod) effect_12\NN\34213|for|its|inhibitory|ent1 (l_nmod) ent1_14\NN\1740|on
15963471T12_15963471T31 NONE [3h]adenosine_21\NN\1740| (r_compound) uptake_22\NN\13440063|[3h]adenosine|hasmcs (r_dobj) inhibit_20\VB\2510337|because|e|did|not|uptake (r_advcl) account_8\VB\2604760|difference|did|not|effect|inhibit|. (l_nmod) effect_12\NN\34213|for|its|inhibitory|ent1 (l_nmod) ent1_14\NN\1740|on
15963471T13_15963471T32 NONE troglitazone_17\NN\1740| (r_nsubj) inhibited_18\VBD\2510337|that|troglitazone|ent1|but|had (r_ccomp) found_15\VBN\2426171|using|,|it|was|inhibited|. (l_advcl) using_0\VBG\1156834|cells (l_dobj) cells_6\NNS\3080309|transporter|deficient|pk15ntd|expressing (l_compound) transporter_3\NN\4490091|the|nucleoside
15963471T13_15963471T33 NONE troglitazone_17\NN\1740| (r_nsubj) inhibited_18\VBD\2510337|that|troglitazone|ent1|but|had (r_ccomp) found_15\VBN\2426171|using|,|it|was|inhibited|. (l_advcl) using_0\VBG\1156834|cells (l_dobj) cells_6\NNS\3080309|transporter|deficient|pk15ntd|expressing (l_acl) expressing_8\VBG\928630|stably|ent1 (l_dobj) ent1_9\NN\1740|and|ent2
15963471T13_15963471T34 NONE troglitazone_17\NN\1740| (r_nsubj) inhibited_18\VBD\2510337|that|troglitazone|ent1|but|had (r_ccomp) found_15\VBN\2426171|using|,|it|was|inhibited|. (l_advcl) using_0\VBG\1156834|cells (l_dobj) cells_6\NNS\3080309|transporter|deficient|pk15ntd|expressing (l_acl) expressing_8\VBG\928630|stably|ent1 (l_dobj) ent1_9\NN\1740|and|ent2 (l_conj) ent2_11\NN\1740|
15963471T13_15963471T35 CPR:4 troglitazone_17\NN\1740| (r_nsubj) inhibited_18\VBD\2510337|that|troglitazone|ent1|but|had (l_dobj) ent1_19\NN\1740|
15963471T13_15963471T37 NONE troglitazone_17\NN\1740| (r_nsubj) inhibited_18\VBD\2510337|that|troglitazone|ent1|but|had (l_conj) had_21\VBD\2108377|effect (l_dobj) effect_23\NN\34213|no|ent2 (l_nmod) ent2_25\NN\1740|on
15963471T14_15963471T38 CPR:4 troglitazone_8\NN\1740| (r_nsubj) enhance_10\VB\227165|that|troglitazone|may|effect|inhibiting (l_advcl) inhibiting_17\VBG\2510337|by|ent1 (l_dobj) ent1_18\NN\1740|
15963471T15_15963471T38 NONE adenosine_15\NN\14964367|of (r_nmod) effect_13\NN\34213|the|vasodilatory|adenosine (r_dobj) enhance_10\VB\227165|that|troglitazone|may|effect|inhibiting (l_advcl) inhibiting_17\VBG\2510337|by|ent1 (l_dobj) ent1_18\NN\1740|
15963471T16_15963471T39 CPR:4 troglitazone_2\NN\1740| (r_nsubj) inhibitor_6\NN\20090|pharmacologically|,|troglitazone|is|a|novel|ent1|. (l_nmod) ent1_8\NN\1740|of
20618322
20618322T2_20618322T13 NONE histamine_6\NN\14739004| (r_compound) gene_9\NN\8459252|of|the|human|histamine|h4|receptor (l_compound) receptor_8\NN\5225602|
20618322T1_20618322T3 NONE histamine_15\NN\14739004| (r_compound) receptor_17\NN\5225602|the|histamine|h4|hrh4 (l_appos) hrh4_19\NN\1740|(|)
20618322T1_20618322T12 NONE histamine_15\NN\14739004| (r_compound) receptor_17\NN\5225602|the|histamine|h4|hrh4
14530799
14530799T11_14530799T30 NONE memantine_9\NN\1740|of (r_nmod) activity_7\NN\30358|for|the|therapeutic|memantine (r_nmod) basis_3\NN\13790712|the|neurobiological|activity (r_nsubjpass) understood_13\VBN\588888|while|basis|is|not|fully (r_advcl) inhibitor_21\NN\20090|understood|,|drug|is|not|a|cholinesterase|and|,|therefore|,|acts|. (l_compound) cholinesterase_20\NN\14732946|
14530799T14_14530799T31 NONE memantine_0\NN\1740| (r_nsubj) interact_2\VB\2367363|memantine|can|variety|. (l_nmod) variety_5\NN\7951464|with|a|channels (l_nmod) channels_9\NNS\6251781|of|ligand-gated|ion
14530799T15_14530799T32 NONE nmda_2\NN\1740| (r_compound) receptors_3\NNS\5225602|nmda
14530799T16_14530799T32 NONE memantine_11\NN\1740|of (r_nmod) target_9\NN\7258332|to|be|a|key|memantine|concentrations (r_xcomp) appear_4\VBP\2604760|however|,|receptors|target|. (l_nsubj) receptors_3\NNS\5225602|nmda
14530799T17_14530799T33 CPR:6 memantine_0\NN\1740| (r_nsubj) antagonist_10\NN\7846|memantine|is|an|uncompetitive|)|nmda|receptor|. (l_compound) receptor_9\NN\5225602|
14530799T18_14530799T33 NONE nmda_8\NN\1740| (r_compound) antagonist_10\NN\7846|memantine|is|an|uncompetitive|)|nmda|receptor|. (l_compound) receptor_9\NN\5225602|
14530799T19_14530799T34 NONE nmda_2\NN\1740| (r_compound) antagonists_4\NNS\7846|like|other|nmda|receptor (l_compound) receptor_3\NN\5225602|
14530799T20_14530799T34 CPR:6 memantine_6\NN\1740|concentrations (r_nsubj) inhibit_11\VB\2510337|antagonists|,|memantine|can|mechanisms|. (l_nmod) antagonists_4\NNS\7846|like|other|nmda|receptor (l_compound) receptor_3\NN\5225602|
14530799T2_14530799T24 NONE nmda_2\NN\1740| (r_compound) receptors_3\NNS\5225602|of|nmda
14530799T2_14530799T25 NONE nmda_2\NN\1740| (r_compound) receptors_3\NNS\5225602|of|nmda (r_nmod) blockade_0\NN\952963|receptors|memantine (r_nsubj) confer_8\VB\813978|blockade|could|theoretically|activity|ad|inhibiting|. (l_advcl) inhibiting_14\VBG\2510337|by|excitotoxicity (l_dobj) excitotoxicity_21\NN\1740|the|"|weak|"|receptor-dependent|hypothesized (l_amod) receptor-dependent_20\JJ\1740|nmda
14530799T3_14530799T24 CPR:4 memantine_5\NN\1740|by (r_nmod) blockade_0\NN\952963|receptors|memantine (l_nmod) receptors_3\NNS\5225602|of|nmda
14530799T3_14530799T25 CPR:4 memantine_5\NN\1740|by (r_nmod) blockade_0\NN\952963|receptors|memantine (r_nsubj) confer_8\VB\813978|blockade|could|theoretically|activity|ad|inhibiting|. (l_advcl) inhibiting_14\VBG\2510337|by|excitotoxicity (l_dobj) excitotoxicity_21\NN\1740|the|"|weak|"|receptor-dependent|hypothesized (l_amod) receptor-dependent_20\JJ\1740|nmda
14530799T4_14530799T24 NONE nmda_19\NN\1740| (r_nmod:npmod) receptor-dependent_20\JJ\1740|nmda (r_amod) excitotoxicity_21\NN\1740|the|"|weak|"|receptor-dependent|hypothesized (r_dobj) inhibiting_14\VBG\2510337|by|excitotoxicity (r_advcl) confer_8\VB\813978|blockade|could|theoretically|activity|ad|inhibiting|. (l_nsubj) blockade_0\NN\952963|receptors|memantine (l_nmod) receptors_3\NNS\5225602|of|nmda
14530799T4_14530799T25 NONE nmda_19\NN\1740| (r_nmod:npmod) receptor-dependent_20\JJ\1740|nmda
14530799T5_14530799T26 CPR:4 memantine_8\NN\1740| (r_nsubj) abrogates_9\VBZ\2427334|that|memantine|toxicity|and|inhibits (l_dobj) toxicity_14\NN\13576101|beta-amyloid (l_compound) beta-amyloid_10\NN\1740|abeta
14530799T5_14530799T27 CPR:4 memantine_8\NN\1740| (r_nsubj) abrogates_9\VBZ\2427334|that|memantine|toxicity|and|inhibits (l_dobj) toxicity_14\NN\13576101|beta-amyloid (l_compound) beta-amyloid_10\NN\1740|abeta (l_appos) abeta_12\NN\1740|(|)
14530799T5_14530799T28 CPR:4 memantine_8\NN\1740| (r_nsubj) abrogates_9\VBZ\2427334|that|memantine|toxicity|and|inhibits (l_conj) inhibits_17\VBZ\2510337|possibly|production (l_dobj) production_19\NN\30358|abeta (l_compound) abeta_18\NN\1740|
14530799T6_14530799T29 CPR:6 memantine_15\NN\1740|of (r_nmod) tolerability_13\NN\1740|the|better|memantine|antagonists (l_nmod) antagonists_20\NNS\7846|over|other|nmda|receptor|,|those (l_compound) receptor_19\NN\5225602|
14530799T7_14530799T29 NONE nmda_18\NN\1740| (r_compound) antagonists_20\NNS\7846|over|other|nmda|receptor|,|those (l_compound) receptor_19\NN\5225602|
14530799T8_14530799T29 NONE phencyclidine_38\NN\3479647|(|,|ketamine|,|mk-801|) (r_dep) agents_36\NNS\7347|such|dissociative|anesthetic-like|phencyclidine (r_nmod) mechanism_31\NN\13446390|by|a|similar|channel|blocking|agents (r_nmod) act_25\VBP\1619354|that|mechanism (r_acl:relcl) those_23\DT\1740|particularly|act (r_appos) antagonists_20\NNS\7846|over|other|nmda|receptor|,|those (l_compound) receptor_19\NN\5225602|
14530799T9_14530799T29 NONE ketamine_40\NN\3054098| (r_appos) phencyclidine_38\NN\3479647|(|,|ketamine|,|mk-801|) (r_dep) agents_36\NNS\7347|such|dissociative|anesthetic-like|phencyclidine (r_nmod) mechanism_31\NN\13446390|by|a|similar|channel|blocking|agents (r_nmod) act_25\VBP\1619354|that|mechanism (r_acl:relcl) those_23\DT\1740|particularly|act (r_appos) antagonists_20\NNS\7846|over|other|nmda|receptor|,|those (l_compound) receptor_19\NN\5225602|
14530799T10_14530799T29 NONE mk-801_42\NN\1740| (r_appos) phencyclidine_38\NN\3479647|(|,|ketamine|,|mk-801|) (r_dep) agents_36\NNS\7347|such|dissociative|anesthetic-like|phencyclidine (r_nmod) mechanism_31\NN\13446390|by|a|similar|channel|blocking|agents (r_nmod) act_25\VBP\1619354|that|mechanism (r_acl:relcl) those_23\DT\1740|particularly|act (r_appos) antagonists_20\NNS\7846|over|other|nmda|receptor|,|those (l_compound) receptor_19\NN\5225602|
17020418
17020418T1_17020418T22 CPR:9 estrogens_0\NNS\14745635| (r_nsubjpass) biosynthesised_2\VBN\1740|estrogens|are|androgens|complex|. (l_nmod) complex_9\NN\5869584|by|the|cyp450|enzyme|called (l_compound) cyp450_7\NN\1740|
17020418T1_17020418T24 CPR:9 estrogens_0\NNS\14745635| (r_nsubjpass) biosynthesised_2\VBN\1740|estrogens|are|androgens|complex|. (l_nmod) complex_9\NN\5869584|by|the|cyp450|enzyme|called (l_acl) called_10\VBN\1029852|aromatase (l_xcomp) aromatase_11\NN\1740|
17020418T6_17020418T22 NONE androgens_4\NNS\14745635|from (r_nmod) biosynthesised_2\VBN\1740|estrogens|are|androgens|complex|. (l_nmod) complex_9\NN\5869584|by|the|cyp450|enzyme|called (l_compound) cyp450_7\NN\1740|
17020418T6_17020418T24 CPR:9 androgens_4\NNS\14745635|from (r_nmod) biosynthesised_2\VBN\1740|estrogens|are|androgens|complex|. (l_nmod) complex_9\NN\5869584|by|the|cyp450|enzyme|called (l_acl) called_10\VBN\1029852|aromatase (l_xcomp) aromatase_11\NN\1740|
17020418T5_17020418T19 CPR:9 estrogen_11\NN\14745635| (r_compound) production_12\NN\30358|for|local|estrogen|tissue (r_nmod) source_8\NN\8620061|cancer|,|aromatase|is|the|production|. (l_nsubj) aromatase_5\NN\1740|intratumoural
17020418T7_17020418T20 NONE estrogens_13\NNS\14745635|of (r_nmod) effects_11\NNS\13245626|growth|stimulatory|estrogens|cancer (r_dobj) reducing_8\VBG\441445|for|effects (r_acl) approach_6\NN\940842|inhibition|is|an|important|reducing|. (l_nsubj) inhibition_0\NN\1068773|aromatase (l_nmod) aromatase_2\NN\1740|of
17020418T8_17020418T20 NONE estrogen-dependent_15\JJ\1740| (r_amod) cancer_17\NN\14239425|in|estrogen-dependent|breast (r_nmod) effects_11\NNS\13245626|growth|stimulatory|estrogens|cancer (r_dobj) reducing_8\VBG\441445|for|effects (r_acl) approach_6\NN\940842|inhibition|is|an|important|reducing|. (l_nsubj) inhibition_0\NN\1068773|aromatase (l_nmod) aromatase_2\NN\1740|of
17020418T9_17020418T21 CPR:4 anastrozole_7\NN\1740|,|letrozole|and|exemestane (r_dep) inhibitors_6\NNS\20090|the|potent|third-generation|aromatase|anastrozole (l_compound) aromatase_5\NN\1740|
17020418T10_17020418T21 CPR:4 letrozole_9\NN\1740| (r_conj) anastrozole_7\NN\1740|,|letrozole|and|exemestane (r_dep) inhibitors_6\NNS\20090|the|potent|third-generation|aromatase|anastrozole (l_compound) aromatase_5\NN\1740|
17020418T11_17020418T21 NONE anti-estrogen_24\JJ\1740| (r_amod) therapy_25\NN\657604|anti-estrogen|alone (r_dobj) failing_23\VBG\1798936|therapy|,|or|therapies (r_acl) patients_22\NNS\9898892|in|postmenopausal|failing (r_nmod) therapy_19\NN\657604|as|endocrine|patients (r_nmod) introduced_13\VBN\831651|inhibitors|were|market|therapy|. (l_nsubjpass) inhibitors_6\NNS\20090|the|potent|third-generation|aromatase|anastrozole (l_compound) aromatase_5\NN\1740|
17020418T12_17020418T23 CPR:4 anastrozole_0\NN\1740|and|letrozole (r_nsubj) inhibitors_7\NNS\20090|anastrozole|are|both|non-steroidal|aromatase|compete|. (l_compound) aromatase_6\NN\1740|
17020418T13_17020418T23 CPR:4 letrozole_2\NN\1740| (r_conj) anastrozole_0\NN\1740|and|letrozole (r_nsubj) inhibitors_7\NNS\20090|anastrozole|are|both|non-steroidal|aromatase|compete|. (l_compound) aromatase_6\NN\1740|
17020418T14_17020418T23 NONE non-steroidal_5\JJ\1740| (r_amod) inhibitors_7\NNS\20090|anastrozole|are|both|non-steroidal|aromatase|compete|. (l_compound) aromatase_6\NN\1740|
17020418T15_17020418T26 NONE steroidal_4\JJ\1740| (r_amod) inhibitor_5\NN\20090|exemestane|is|a|mechanism-based|steroidal|mimics|. (l_acl:relcl) mimics_7\VBZ\1742886|that|substrate|,|converted (l_conj) converted_12\VBN\126264|is|enzyme|intermediate|,|and|results (l_conj) results_22\VBZ\2633881|inactivation (l_nmod) inactivation_24\NN\13518963|in|aromatase (l_nmod) aromatase_26\NN\1740|of
17020418T2_17020418T16 NONE estrogen-dependent_18\JJ\1740| (r_amod) cancer_20\NN\14239425|with|metastatic|estrogen-dependent|breast (r_nmod) women_15\NNS\9605289|of|postmenopausal|cancer (r_nmod) treatment_12\NN\654885|for|the|women (r_nmod) therapy_9\NN\657604|as|first-line|treatment (r_nmod) approved_6\VBN\803325|inhibitors|are|currently|therapy|. (l_nsubjpass) inhibitors_3\NNS\20090|these|third-generation|aromatase (l_compound) aromatase_2\NN\1740|
17020418T3_17020418T17 NONE tamoxifen_14\NN\2714883|with (r_nmod) treatment_12\NN\654885|after|tamoxifen (r_conj) therapy_8\NN\657604|as|initial|,|or|treatment (r_nmod) use_1\NN\407535|the|inhibitor|therapy|, (l_nmod) inhibitor_5\NN\20090|of|an|aromatase (l_compound) aromatase_4\NN\1740|
12881227
12881227T10_12881227T35 NONE na+/h+_7\NN\1740| (r_compound) exchange_8\NN\11409059|of|na+/h+|nhe
12881227T10_12881227T40 NONE na+/h+_7\NN\1740| (r_compound) exchange_8\NN\11409059|of|na+/h+|nhe (l_appos) nhe_10\NN\1740|(|)
12881227T12_12881227T35 NONE na+/h+_7\NN\1740| (r_compound) exchange_8\NN\11409059|of|na+/h+|nhe
12881227T12_12881227T40 NONE na+/h+_7\NN\1740| (r_compound) exchange_8\NN\11409059|of|na+/h+|nhe (l_appos) nhe_10\NN\1740|(|)
12881227T8_12881227T31 CPR:4 n-dimethyl)-amiloride_2\NN\1740|5-(n|,|microm|,|concentration|, (l_appos) concentration_11\NN\4916342|a|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|that|selectively|isoforms (l_dobj) isoforms_17\NNS\1740|the|nhe|nhe1 (l_compound) nhe_16\NN\1740|
12881227T8_12881227T32 CPR:4 n-dimethyl)-amiloride_2\NN\1740|5-(n|,|microm|,|concentration|, (l_appos) concentration_11\NN\4916342|a|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|that|selectively|isoforms (l_dobj) isoforms_17\NNS\1740|the|nhe|nhe1 (l_dep) nhe1_18\NN\1740|and|nhe2|,|not|nhe3
12881227T8_12881227T33 CPR:4 n-dimethyl)-amiloride_2\NN\1740|5-(n|,|microm|,|concentration|, (l_appos) concentration_11\NN\4916342|a|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|that|selectively|isoforms (l_dobj) isoforms_17\NNS\1740|the|nhe|nhe1 (l_dep) nhe1_18\NN\1740|and|nhe2|,|not|nhe3 (l_conj) nhe2_20\NN\1740|
12881227T8_12881227T34 CPR:4 n-dimethyl)-amiloride_2\NN\1740|5-(n|,|microm|,|concentration|, (l_appos) concentration_11\NN\4916342|a|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|that|selectively|isoforms (l_dobj) isoforms_17\NNS\1740|the|nhe|nhe1 (l_dep) nhe1_18\NN\1740|and|nhe2|,|not|nhe3 (l_conj) nhe3_24\NN\1740|
12881227T9_12881227T31 CPR:4 dma_7\NN\1740| (r_appos) microm_5\NN\1740|(|50|;|dma|) (r_dep) n-dimethyl)-amiloride_2\NN\1740|5-(n|,|microm|,|concentration|, (l_appos) concentration_11\NN\4916342|a|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|that|selectively|isoforms (l_dobj) isoforms_17\NNS\1740|the|nhe|nhe1 (l_compound) nhe_16\NN\1740|
12881227T9_12881227T32 CPR:4 dma_7\NN\1740| (r_appos) microm_5\NN\1740|(|50|;|dma|) (r_dep) n-dimethyl)-amiloride_2\NN\1740|5-(n|,|microm|,|concentration|, (l_appos) concentration_11\NN\4916342|a|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|that|selectively|isoforms (l_dobj) isoforms_17\NNS\1740|the|nhe|nhe1 (l_dep) nhe1_18\NN\1740|and|nhe2|,|not|nhe3
12881227T9_12881227T33 CPR:4 dma_7\NN\1740| (r_appos) microm_5\NN\1740|(|50|;|dma|) (r_dep) n-dimethyl)-amiloride_2\NN\1740|5-(n|,|microm|,|concentration|, (l_appos) concentration_11\NN\4916342|a|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|that|selectively|isoforms (l_dobj) isoforms_17\NNS\1740|the|nhe|nhe1 (l_dep) nhe1_18\NN\1740|and|nhe2|,|not|nhe3 (l_conj) nhe2_20\NN\1740|
12881227T9_12881227T34 CPR:4 dma_7\NN\1740| (r_appos) microm_5\NN\1740|(|50|;|dma|) (r_dep) n-dimethyl)-amiloride_2\NN\1740|5-(n|,|microm|,|concentration|, (l_appos) concentration_11\NN\4916342|a|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|that|selectively|isoforms (l_dobj) isoforms_17\NNS\1740|the|nhe|nhe1 (l_dep) nhe1_18\NN\1740|and|nhe2|,|not|nhe3 (l_conj) nhe3_24\NN\1740|
12881227T11_12881227T36 CPR:4 dma_4\NN\1740|mm|,|concentration|, (l_appos) concentration_8\NN\4916342|a|higher|inhibits (l_acl:relcl) inhibits_10\VBZ\2510337|that|nhe1 (l_dobj) nhe1_11\NN\1740|,|nhe2|,|and|nhe3
12881227T11_12881227T37 CPR:4 dma_4\NN\1740|mm|,|concentration|, (l_appos) concentration_8\NN\4916342|a|higher|inhibits (l_acl:relcl) inhibits_10\VBZ\2510337|that|nhe1 (l_dobj) nhe1_11\NN\1740|,|nhe2|,|and|nhe3 (l_conj) nhe2_13\NN\1740|
12881227T11_12881227T38 CPR:4 dma_4\NN\1740|mm|,|concentration|, (l_appos) concentration_8\NN\4916342|a|higher|inhibits (l_acl:relcl) inhibits_10\VBZ\2510337|that|nhe1 (l_dobj) nhe1_11\NN\1740|,|nhe2|,|and|nhe3 (l_conj) nhe3_16\NN\1740|
12881227T13_12881227T39 CPR:4 s1611_2\NN\1740|and|s3226|,|inhibitors|,|dose (l_appos) inhibitors_8\NNS\20090|both|specific|nhe3|,|or|perfusion (l_nmod) nhe3_10\NN\1740|of|only
12881227T14_12881227T39 CPR:4 s3226_4\NN\1740| (r_conj) s1611_2\NN\1740|and|s3226|,|inhibitors|,|dose (l_appos) inhibitors_8\NNS\20090|both|specific|nhe3|,|or|perfusion (l_nmod) nhe3_10\NN\1740|of|only
12881227T15_12881227T39 NONE na+-free_16\JJ\1740| (r_amod) solutions_17\NNS\14586258|with|na+-free (r_nmod) perfusion_14\NN\320852|solutions (r_conj) inhibitors_8\NNS\20090|both|specific|nhe3|,|or|perfusion (l_nmod) nhe3_10\NN\1740|of|only
12881227T16_12881227T39 NONE co2-sensitive_29\JJ\1740| (r_conj) ph-stat_27\NN\1740|and|co2-sensitive (r_amod) electrode_30\NN\3088707|by|ph-stat (r_nmod) measured_25\VBN\697589|as|electrode (r_advcl) increased_21\VBD\169651|moreover|,|s1611|dependently|dbs|,|measured|,|affecting|affect (l_nsubj) s1611_2\NN\1740|and|s3226|,|inhibitors|,|dose (l_appos) inhibitors_8\NNS\20090|both|specific|nhe3|,|or|perfusion (l_nmod) nhe3_10\NN\1740|of|only
12881227T17_12881227T39 NONE indomethacin_40\NN\3828465|with|microm|,|dids|,|or|methazolamide (r_nmod) coperfusion_36\NN\1740|indomethacin (r_nsubj) affect_52\VB\126264|coperfusion|did|not|dbs|. (r_parataxis) increased_21\VBD\169651|moreover|,|s1611|dependently|dbs|,|measured|,|affecting|affect (l_nsubj) s1611_2\NN\1740|and|s3226|,|inhibitors|,|dose (l_appos) inhibitors_8\NNS\20090|both|specific|nhe3|,|or|perfusion (l_nmod) nhe3_10\NN\1740|of|only
12881227T18_12881227T39 NONE methazolamide_49\NN\1740|mm (r_conj) indomethacin_40\NN\3828465|with|microm|,|dids|,|or|methazolamide (r_nmod) coperfusion_36\NN\1740|indomethacin (r_nsubj) affect_52\VB\126264|coperfusion|did|not|dbs|. (r_parataxis) increased_21\VBD\169651|moreover|,|s1611|dependently|dbs|,|measured|,|affecting|affect (l_nsubj) s1611_2\NN\1740|and|s3226|,|inhibitors|,|dose (l_appos) inhibitors_8\NNS\20090|both|specific|nhe3|,|or|perfusion (l_nmod) nhe3_10\NN\1740|of|only
12881227T19_12881227T39 NONE s3226-induced_53\JJ\1740| (r_amod) dbs_54\NN\14622893|s3226-induced (r_dobj) affect_52\VB\126264|coperfusion|did|not|dbs|. (r_parataxis) increased_21\VBD\169651|moreover|,|s1611|dependently|dbs|,|measured|,|affecting|affect (l_nsubj) s1611_2\NN\1740|and|s3226|,|inhibitors|,|dose (l_appos) inhibitors_8\NNS\20090|both|specific|nhe3|,|or|perfusion (l_nmod) nhe3_10\NN\1740|of|only
12881227T1_12881227T41 NONE s3226-induced_28\JJ\1740| (r_amod) dbs_29\NN\14622893|s3226-induced (r_dobj) inhibited_27\VBD\2510337|nevertheless|,|coperfusion|dependently|dbs|. (l_nsubj) coperfusion_2\NN\1740|acid|,|dose (l_nmod) acid_11\NN\14818238|with|mm|5-nitro-2-(3-phenylpropylamino|)|benzoic|,|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|which|regulator (l_dobj) regulator_20\NN\3096960|the|cystic|fibrosis|transmembrane|conductor|cftr
12881227T1_12881227T42 NONE s3226-induced_28\JJ\1740| (r_amod) dbs_29\NN\14622893|s3226-induced (r_dobj) inhibited_27\VBD\2510337|nevertheless|,|coperfusion|dependently|dbs|. (l_nsubj) coperfusion_2\NN\1740|acid|,|dose (l_nmod) acid_11\NN\14818238|with|mm|5-nitro-2-(3-phenylpropylamino|)|benzoic|,|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|which|regulator (l_dobj) regulator_20\NN\3096960|the|cystic|fibrosis|transmembrane|conductor|cftr (l_appos) cftr_22\NN\5439413|(|)
12881227T20_12881227T41 CPR:4 acid_11\NN\14818238|with|mm|5-nitro-2-(3-phenylpropylamino|)|benzoic|,|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|which|regulator (l_dobj) regulator_20\NN\3096960|the|cystic|fibrosis|transmembrane|conductor|cftr
12881227T20_12881227T42 CPR:4 acid_11\NN\14818238|with|mm|5-nitro-2-(3-phenylpropylamino|)|benzoic|,|inhibits (l_acl:relcl) inhibits_14\VBZ\2510337|which|regulator (l_dobj) regulator_20\NN\3096960|the|cystic|fibrosis|transmembrane|conductor|cftr (l_appos) cftr_22\NN\5439413|(|)
12881227T2_12881227T21 NONE prostaglandin_12\NN\5414534| (r_compound) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (r_nsubjpass) involved_28\VBN\2676054|synthesis|was|not (r_parataxis) increased_8\VBD\169651|conclusion|,|inhibition|dbs|,|whereas|involved|. (l_nsubj) inhibition_7\NN\1068773|only|specific|apical|nhe3 (l_compound) nhe3_6\NN\1740|
12881227T2_12881227T22 NONE prostaglandin_12\NN\5414534| (r_compound) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (l_conj) activation_17\NN\13561719|na+-hco3-|cotransporter (l_compound) cotransporter_16\NN\1740|
12881227T2_12881227T23 NONE prostaglandin_12\NN\5414534| (r_compound) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (l_conj) formation_22\NN\7938773|hco3-|anhydrase (l_nmod) anhydrase_25\NN\1740|by|carbonic
12881227T3_12881227T21 NONE na+-hco3-_15\NN\1740| (r_amod) activation_17\NN\13561719|na+-hco3-|cotransporter (r_conj) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (r_nsubjpass) involved_28\VBN\2676054|synthesis|was|not (r_parataxis) increased_8\VBD\169651|conclusion|,|inhibition|dbs|,|whereas|involved|. (l_nsubj) inhibition_7\NN\1068773|only|specific|apical|nhe3 (l_compound) nhe3_6\NN\1740|
12881227T3_12881227T22 NONE na+-hco3-_15\NN\1740| (r_amod) activation_17\NN\13561719|na+-hco3-|cotransporter (l_compound) cotransporter_16\NN\1740|
12881227T3_12881227T23 NONE na+-hco3-_15\NN\1740| (r_amod) activation_17\NN\13561719|na+-hco3-|cotransporter (r_conj) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (l_conj) formation_22\NN\7938773|hco3-|anhydrase (l_nmod) anhydrase_25\NN\1740|by|carbonic
12881227T4_12881227T21 NONE na+-hco3-_15\NN\1740| (r_amod) activation_17\NN\13561719|na+-hco3-|cotransporter (r_conj) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (r_nsubjpass) involved_28\VBN\2676054|synthesis|was|not (r_parataxis) increased_8\VBD\169651|conclusion|,|inhibition|dbs|,|whereas|involved|. (l_nsubj) inhibition_7\NN\1068773|only|specific|apical|nhe3 (l_compound) nhe3_6\NN\1740|
12881227T4_12881227T22 NONE na+-hco3-_15\NN\1740| (r_amod) activation_17\NN\13561719|na+-hco3-|cotransporter (l_compound) cotransporter_16\NN\1740|
12881227T4_12881227T23 NONE na+-hco3-_15\NN\1740| (r_amod) activation_17\NN\13561719|na+-hco3-|cotransporter (r_conj) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (l_conj) formation_22\NN\7938773|hco3-|anhydrase (l_nmod) anhydrase_25\NN\1740|by|carbonic
12881227T5_12881227T21 NONE hco3-_21\NN\1740|intracellular (r_compound) formation_22\NN\7938773|hco3-|anhydrase (r_conj) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (r_nsubjpass) involved_28\VBN\2676054|synthesis|was|not (r_parataxis) increased_8\VBD\169651|conclusion|,|inhibition|dbs|,|whereas|involved|. (l_nsubj) inhibition_7\NN\1068773|only|specific|apical|nhe3 (l_compound) nhe3_6\NN\1740|
12881227T5_12881227T22 NONE hco3-_21\NN\1740|intracellular (r_compound) formation_22\NN\7938773|hco3-|anhydrase (r_conj) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (l_conj) activation_17\NN\13561719|na+-hco3-|cotransporter (l_compound) cotransporter_16\NN\1740|
12881227T5_12881227T23 CPR:9 hco3-_21\NN\1740|intracellular (r_compound) formation_22\NN\7938773|hco3-|anhydrase (l_nmod) anhydrase_25\NN\1740|by|carbonic
12881227T6_12881227T21 NONE carbonic_24\JJ\1740| (r_amod) anhydrase_25\NN\1740|by|carbonic (r_nmod) formation_22\NN\7938773|hco3-|anhydrase (r_conj) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (r_nsubjpass) involved_28\VBN\2676054|synthesis|was|not (r_parataxis) increased_8\VBD\169651|conclusion|,|inhibition|dbs|,|whereas|involved|. (l_nsubj) inhibition_7\NN\1068773|only|specific|apical|nhe3 (l_compound) nhe3_6\NN\1740|
12881227T6_12881227T22 NONE carbonic_24\JJ\1740| (r_amod) anhydrase_25\NN\1740|by|carbonic (r_nmod) formation_22\NN\7938773|hco3-|anhydrase (r_conj) synthesis_13\NN\13446390|prostaglandin|,|activation|,|or|formation (l_conj) activation_17\NN\13561719|na+-hco3-|cotransporter (l_compound) cotransporter_16\NN\1740|
12881227T6_12881227T23 NONE carbonic_24\JJ\1740| (r_amod) anhydrase_25\NN\1740|by|carbonic
15070163
15070163T4_15070163T13 NONE e2_12\NN\1740|of|prostaglandin|pge2 (r_nmod) release_9\NN\3748886|of|(lps)-induced|e2|reflecting (l_acl) reflecting_16\VBG\923793|release (l_dobj) release_20\NN\3748886|cyclooxygenase|(cox)-2-mediated|pge2 (l_amod) (cox)-2-mediated_18\JJ\1740|
15070163T5_15070163T13 NONE pge2_14\NN\1740|(|) (r_appos) e2_12\NN\1740|of|prostaglandin|pge2 (r_nmod) release_9\NN\3748886|of|(lps)-induced|e2|reflecting (l_acl) reflecting_16\VBG\923793|release (l_dobj) release_20\NN\3748886|cyclooxygenase|(cox)-2-mediated|pge2 (l_amod) (cox)-2-mediated_18\JJ\1740|
15070163T6_15070163T13 CPR:9 pge2_19\NN\1740| (r_compound) release_20\NN\3748886|cyclooxygenase|(cox)-2-mediated|pge2 (l_amod) (cox)-2-mediated_18\JJ\1740|
15070163T7_15070163T13 NONE rofecoxib-like_34\JJ\1740| (r_amod) compound_36\NN\5869584|rofecoxib-like|research|l745337 (r_conj) 1520l_32\CD\1740|for|the|extract|and|compound (r_nmod) microg/ml_23\NN\1740|ic50-values|were|47|and|microg/ml|,|1520l|,|respectively|. (l_nsubj) ic50-values_1\NN\1740|the|obtained (l_acl) obtained_2\VBN\2210855|inhibition (l_nmod) inhibition_5\NN\1068773|for|the|release (l_nmod) release_9\NN\3748886|of|(lps)-induced|e2|reflecting (l_acl) reflecting_16\VBG\923793|release (l_dobj) release_20\NN\3748886|cyclooxygenase|(cox)-2-mediated|pge2 (l_amod) (cox)-2-mediated_18\JJ\1740|
15070163T8_15070163T13 NONE l745337_37\CD\1740| (r_dep) compound_36\NN\5869584|rofecoxib-like|research|l745337 (r_conj) 1520l_32\CD\1740|for|the|extract|and|compound (r_nmod) microg/ml_23\NN\1740|ic50-values|were|47|and|microg/ml|,|1520l|,|respectively|. (l_nsubj) ic50-values_1\NN\1740|the|obtained (l_acl) obtained_2\VBN\2210855|inhibition (l_nmod) inhibition_5\NN\1068773|for|the|release (l_nmod) release_9\NN\3748886|of|(lps)-induced|e2|reflecting (l_acl) reflecting_16\VBG\923793|release (l_dobj) release_20\NN\3748886|cyclooxygenase|(cox)-2-mediated|pge2 (l_amod) (cox)-2-mediated_18\JJ\1740|
15070163T1_15070163T11 CPR:9 pge2_9\NN\1740| (r_compound) release_10\NN\3748886|cox-2-mediated|pge2 (l_amod) cox-2-mediated_8\JJ\1740|
15070163T2_15070163T11 NONE salicin_15\NN\1740|than|or|salicylate (r_nmod) other_13\JJ\1740|salicin (r_amod) compounds_12\NNS\5869584|through|other (r_nmod) inhibits_7\VBZ\2510337|that|extract|release|compounds (l_dobj) release_10\NN\3748886|cox-2-mediated|pge2 (l_amod) cox-2-mediated_8\JJ\1740|
15070163T3_15070163T11 NONE salicylate_17\NN\3828465| (r_conj) salicin_15\NN\1740|than|or|salicylate (r_nmod) other_13\JJ\1740|salicin (r_amod) compounds_12\NNS\5869584|through|other (r_nmod) inhibits_7\VBZ\2510337|that|extract|release|compounds (l_dobj) release_10\NN\3748886|cox-2-mediated|pge2 (l_amod) cox-2-mediated_8\JJ\1740|
23194532
23194532T7_23194532T13 NONE glutathione_16\NN\1740| (r_compound) peroxidase_17\NN\14971234|glutathione|gsh-px (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver
23194532T7_23194532T14 NONE glutathione_16\NN\1740| (r_compound) peroxidase_17\NN\14971234|glutathione|gsh-px
23194532T7_23194532T15 NONE glutathione_16\NN\1740| (r_compound) peroxidase_17\NN\14971234|glutathione|gsh-px (l_appos) gsh-px_19\NN\1740|(|)
23194532T7_23194532T16 NONE glutathione_16\NN\1740| (r_compound) peroxidase_17\NN\14971234|glutathione|gsh-px (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver (l_conj) reductase_23\NN\14732946|glutathione|gsh-rd
23194532T7_23194532T17 NONE glutathione_16\NN\1740| (r_compound) peroxidase_17\NN\14971234|glutathione|gsh-px (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver (l_conj) reductase_23\NN\14732946|glutathione|gsh-rd (l_appos) gsh-rd_25\NN\1740|(|)
23194532T8_23194532T13 NONE gsh-px_19\NN\1740|(|) (r_appos) peroxidase_17\NN\14971234|glutathione|gsh-px (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver
23194532T8_23194532T14 NONE gsh-px_19\NN\1740|(|) (r_appos) peroxidase_17\NN\14971234|glutathione|gsh-px
23194532T8_23194532T15 NONE gsh-px_19\NN\1740|(|)
23194532T8_23194532T16 NONE gsh-px_19\NN\1740|(|) (r_appos) peroxidase_17\NN\14971234|glutathione|gsh-px (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver (l_conj) reductase_23\NN\14732946|glutathione|gsh-rd
23194532T8_23194532T17 NONE gsh-px_19\NN\1740|(|) (r_appos) peroxidase_17\NN\14971234|glutathione|gsh-px (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver (l_conj) reductase_23\NN\14732946|glutathione|gsh-rd (l_appos) gsh-rd_25\NN\1740|(|)
23194532T9_23194532T13 NONE glutathione_22\NN\1740| (r_compound) reductase_23\NN\14732946|glutathione|gsh-rd (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver
23194532T9_23194532T14 NONE glutathione_22\NN\1740| (r_compound) reductase_23\NN\14732946|glutathione|gsh-rd (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver (l_conj) peroxidase_17\NN\14971234|glutathione|gsh-px
23194532T9_23194532T15 NONE glutathione_22\NN\1740| (r_compound) reductase_23\NN\14732946|glutathione|gsh-rd (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver (l_conj) peroxidase_17\NN\14971234|glutathione|gsh-px (l_appos) gsh-px_19\NN\1740|(|)
23194532T9_23194532T16 NONE glutathione_22\NN\1740| (r_compound) reductase_23\NN\14732946|glutathione|gsh-rd
23194532T9_23194532T17 NONE glutathione_22\NN\1740| (r_compound) reductase_23\NN\14732946|glutathione|gsh-rd (l_appos) gsh-rd_25\NN\1740|(|)
23194532T10_23194532T13 NONE gsh-rd_25\NN\1740|(|) (r_appos) reductase_23\NN\14732946|glutathione|gsh-rd (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver
23194532T10_23194532T14 NONE gsh-rd_25\NN\1740|(|) (r_appos) reductase_23\NN\14732946|glutathione|gsh-rd (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver (l_conj) peroxidase_17\NN\14971234|glutathione|gsh-px
23194532T10_23194532T15 NONE gsh-rd_25\NN\1740|(|) (r_appos) reductase_23\NN\14732946|glutathione|gsh-rd (r_conj) catalase_14\NN\14732946|of|,|peroxidase|and|reductase|liver (l_conj) peroxidase_17\NN\14971234|glutathione|gsh-px (l_appos) gsh-px_19\NN\1740|(|)
23194532T10_23194532T16 NONE gsh-rd_25\NN\1740|(|) (r_appos) reductase_23\NN\14732946|glutathione|gsh-rd
23194532T10_23194532T17 NONE gsh-rd_25\NN\1740|(|)
23454300
23402364
23402364T1_23402364T37 NONE oxide_1\NN\14818238| (r_compound) products_2\NNS\3076708|nitric|oxide|vp-16 (r_nsubj) displayed_5\VBD\2137132|products|cleavage|. (l_dobj) cleavage_10\NN\24720|diminished|ii-dependent|dna|and|cytotoxicity (l_amod) ii-dependent_9\JJ\1740|topoisomerase
23402364T2_23402364T37 CPR:4 vp-16_4\NN\1740|of (r_nmod) products_2\NNS\3076708|nitric|oxide|vp-16 (r_nsubj) displayed_5\VBD\2137132|products|cleavage|. (l_dobj) cleavage_10\NN\24720|diminished|ii-dependent|dna|and|cytotoxicity (l_amod) ii-dependent_9\JJ\1740|topoisomerase
23402364T3_23402364T38 NONE oxide_4\NN\14818238| (r_compound) synthase_5\NN\1740|of|nitric|oxide
23402364T4_23402364T38 NONE vp-16_11\NN\1740| (r_compound) resistance_12\NN\37396|in|vp-16|cells (r_nmod) resulted_9\VBD\2633881|induction|resistance|. (l_nsubj) induction_1\NN\7450842|lps-mediated|synthase|macrophages (l_nmod) synthase_5\NN\1740|of|nitric|oxide
23402364T5_23402364T39 NONE (·)no_2\NN\1740| (r_compound) products_3\NNS\3076708|(·)no|derived (l_acl) derived_4\VBN\634472|inos (l_nmod) inos_6\NN\1740|from
23402364T6_23402364T39 NONE vp-16_10\NN\1740|with (r_nmod) reacted_8\VBD\2367363|furthermore|,|products|rapidly|vp-16|leading|. (l_nsubj) products_3\NNS\3076708|(·)no|derived (l_acl) derived_4\VBN\634472|inos (l_nmod) inos_6\NN\1740|from
15866288
15866288T7_15866288T17 CPR:4 amiloride_11\NN\1740|by (r_nmod) inhibition_2\NN\1068773|of|activator|amiloride|cornea (l_nmod) activator_6\NN\19613|of|urokinase-type|plasminogen|u-pa
15866288T7_15866288T18 CPR:4 amiloride_11\NN\1740|by (r_nmod) inhibition_2\NN\1068773|of|activator|amiloride|cornea (l_nmod) activator_6\NN\19613|of|urokinase-type|plasminogen|u-pa (l_appos) u-pa_8\NN\1740|(|)
15866288T6_15866288T9 CPR:4 amiloride_12\NN\1740|,|inhibitor|, (r_nsubj) decreases_20\VBZ\169651|that|amiloride|effectively|activity|and|affects (l_dobj) activity_22\NN\30358|u-pa|cornea (l_compound) u-pa_21\NN\1740|
15866288T6_15866288T15 CPR:4 amiloride_12\NN\1740|,|inhibitor|, (l_appos) inhibitor_17\NN\20090|a|specific|u-pa (l_compound) u-pa_16\NN\1740|
15866288T3_15866288T12 NONE amiloride_13\NN\1740|of (r_nmod) effects_11\NNS\13245626|the|amiloride (r_conj) studies_6\NNS\635850|comparative|histochemical|u-pa|and|effects (l_nmod) u-pa_8\NN\1740|of
15866288T4_15866288T12 CPR:9 z-gly-gly-arg-7-amino-4-trifluoromethylcoumarin_27\NN\1740|the|substrate (r_dobj) using_22\VBG\1156834|z-gly-gly-arg-7-amino-4-trifluoromethylcoumarin (r_xcomp) performed_15\VBN\2367363|therefore|,|studies|were|corneas|using|. (l_nsubjpass) studies_6\NNS\635850|comparative|histochemical|u-pa|and|effects (l_nmod) u-pa_8\NN\1740|of
15866288T1_15866288T10 CPR:4 amiloride_1\NN\1740| (r_nsubjpass) dropped_3\VBN\1850315|when|amiloride|was|surface|day|and|daily (r_advcl) inhibited_34\VBN\2510337|dropped|,|activity|was|strongly|. (l_nsubjpass) activity_25\NN\30358|u-pa|cornea (l_compound) u-pa_24\NN\1740|
15866288T2_15866288T11 CPR:4 amiloride_6\NN\1740|of (r_nmod) application_4\NN\947128|early|amiloride (r_nsubj) inhibited_7\VBD\2510337|conclusion|,|application|activity|and|diminished|. (l_dobj) activity_9\NN\30358|u-pa|corneas (l_compound) u-pa_8\NN\1740|
23571107
23571107T1_23571107T23 NONE guanosine_10\NN\14964367| (r_compound) activity_13\NN\30358|via|its|ras|guanosine|triphosphatase|-activating (r_nmod) neurofibromin_5\NN\1740|,|activity
23571107T1_23571107T24 NONE guanosine_10\NN\14964367| (r_compound) activity_13\NN\30358|via|its|ras|guanosine|triphosphatase|-activating (l_compound) ras_9\NN\5501711|
23571107T1_23571107T25 NONE guanosine_10\NN\14964367| (r_compound) activity_13\NN\30358|via|its|ras|guanosine|triphosphatase|-activating (l_amod) triphosphatase_11\JJ\1740|
23571107T1_23571107T26 NONE guanosine_10\NN\14964367| (r_compound) activity_13\NN\30358|via|its|ras|guanosine|triphosphatase|-activating (r_nmod) neurofibromin_5\NN\1740|,|activity (r_nsubj) controls_15\VBZ\2422663|that|neurofibromin|,|signaling (l_dobj) signaling_24\NN\33020|erk1/2-dependent|receptor|chondrocytes (l_amod) erk1/2-dependent_16\JJ\1740|
23571107T1_23571107T27 NONE guanosine_10\NN\14964367| (r_compound) activity_13\NN\30358|via|its|ras|guanosine|triphosphatase|-activating (r_nmod) neurofibromin_5\NN\1740|,|activity (r_nsubj) controls_15\VBZ\2422663|that|neurofibromin|,|signaling (l_dobj) signaling_24\NN\33020|erk1/2-dependent|receptor|chondrocytes (l_compound) receptor_20\NN\5225602|fibroblast|growth|factor|fgfr
23571107T1_23571107T28 NONE guanosine_10\NN\14964367| (r_compound) activity_13\NN\30358|via|its|ras|guanosine|triphosphatase|-activating (r_nmod) neurofibromin_5\NN\1740|,|activity (r_nsubj) controls_15\VBZ\2422663|that|neurofibromin|,|signaling (l_dobj) signaling_24\NN\33020|erk1/2-dependent|receptor|chondrocytes (l_compound) receptor_20\NN\5225602|fibroblast|growth|factor|fgfr (l_appos) fgfr_22\NN\1740|(|)
23380568
23380568T1_23380568T10 NONE cholesterol_8\NN\15058310|total (r_conj) age_3\NN\4916342|for|,|sex|,|cholesterol|,|hdl-cholesterol|and|triglyceride (l_conj) hdl-cholesterol_10\NN\1740|
23380568T1_23380568T12 NONE cholesterol_8\NN\15058310|total (r_conj) age_3\NN\4916342|for|,|sex|,|cholesterol|,|hdl-cholesterol|and|triglyceride (r_nmod) adjusting_1\VBG\126264|after|age (r_advcl) increased_17\VBN\169651|adjusting|,|max-imt|was|significantly|tertile|mm|. (l_nmod) tertile_21\NN\1740|in|the|highest|pcsk9 (l_nmod) pcsk9_24\NN\1740|of|serum
23380568T2_23380568T10 NONE triglyceride_12\NN\14885088| (r_conj) age_3\NN\4916342|for|,|sex|,|cholesterol|,|hdl-cholesterol|and|triglyceride (l_conj) hdl-cholesterol_10\NN\1740|
23380568T2_23380568T12 NONE triglyceride_12\NN\14885088| (r_conj) age_3\NN\4916342|for|,|sex|,|cholesterol|,|hdl-cholesterol|and|triglyceride (r_nmod) adjusting_1\VBG\126264|after|age (r_advcl) increased_17\VBN\169651|adjusting|,|max-imt|was|significantly|tertile|mm|. (l_nmod) tertile_21\NN\1740|in|the|highest|pcsk9 (l_nmod) pcsk9_24\NN\1740|of|serum
23411172
23411172T6_23411172T24 CPR:4 polyphenols_1\NNS\1740|apple (r_nsubj) suppress_2\VBP\2510337|polyphenols|presentation|. (l_dobj) presentation_4\NN\1027379|antigen|ovalbumin|cells (l_nmod) ovalbumin_6\NN\7809096|of
23411172T2_23411172T10 CPR:4 procyanidin-treated_13\JJ\1740| (r_amod) cells_14\NNS\3080309|fractionated|procyanidin-treated (r_conj) ap_10\NN\1740|in|the|and|cells (r_nmod) observed_7\VBN\2163746|decrease|was|ap|presence|,|but|observed|. (l_nsubjpass) decrease_2\NN\7296428|a|significant|expression (l_nmod) expression_5\NN\4679549|in|hla-dr (l_compound) hla-dr_4\NN\1740|
23411172T2_23411172T11 NONE procyanidin-treated_13\JJ\1740| (r_amod) cells_14\NNS\3080309|fractionated|procyanidin-treated (r_conj) ap_10\NN\1740|in|the|and|cells (r_nmod) observed_7\VBN\2163746|decrease|was|ap|presence|,|but|observed|. (l_nmod) presence_17\NN\13954253|in|the|ovalbumin (l_nmod) ovalbumin_19\NN\7809096|of|ova
23411172T2_23411172T12 NONE procyanidin-treated_13\JJ\1740| (r_amod) cells_14\NNS\3080309|fractionated|procyanidin-treated (r_conj) ap_10\NN\1740|in|the|and|cells (r_nmod) observed_7\VBN\2163746|decrease|was|ap|presence|,|but|observed|. (l_nmod) presence_17\NN\13954253|in|the|ovalbumin (l_nmod) ovalbumin_19\NN\7809096|of|ova (l_appos) ova_21\NN\5456945|(|)
23411172T2_23411172T13 NONE procyanidin-treated_13\JJ\1740| (r_amod) cells_14\NNS\3080309|fractionated|procyanidin-treated (r_conj) ap_10\NN\1740|in|the|and|cells (r_nmod) observed_7\VBN\2163746|decrease|was|ap|presence|,|but|observed|. (l_conj) observed_31\VBN\2163746|effect|was (l_nsubjpass) effect_26\NN\34213|no|expression (l_nmod) expression_29\NN\4679549|on|cd86 (l_compound) cd86_28\NN\1740|
23411172T4_23411172T21 CPR:3 procyanidin_12\NN\1740| (r_compound) cells_14\NNS\3080309|in|the|procyanidin|trimers-treated (r_nmod) found_9\VBN\2426171|furthermore|,|up-regulation|was|cells|presence|. (l_nsubjpass) up-regulation_3\NN\1740|the|il-12 (l_nmod) il-12_5\NN\1740|of|and|tnf-α
23411172T4_23411172T22 CPR:3 procyanidin_12\NN\1740| (r_compound) cells_14\NNS\3080309|in|the|procyanidin|trimers-treated (r_nmod) found_9\VBN\2426171|furthermore|,|up-regulation|was|cells|presence|. (l_nsubjpass) up-regulation_3\NN\1740|the|il-12 (l_nmod) il-12_5\NN\1740|of|and|tnf-α (l_conj) tnf-α_7\NN\1740|
23411172T4_23411172T23 NONE procyanidin_12\NN\1740| (r_compound) cells_14\NNS\3080309|in|the|procyanidin|trimers-treated (r_nmod) found_9\VBN\2426171|furthermore|,|up-regulation|was|cells|presence|. (l_nmod) presence_17\NN\13954253|in|the|ova (l_nmod) ova_19\NN\5456945|of
23193186
23193186T5_23193186T9 NONE glucose_7\NN\14710501| (r_compound) concentration_8\NN\4916342|the|average|plasma|glucose (r_dobj) raised_3\VBD\153263|model|concentration|mg/dl|mg/dl|and|led|. (l_conj) led_16\VBD\1752884|expression (l_nmod) expression_20\NN\4679549|to|decreased|gene|glut1 (l_nmod) glut1_24\NN\1740|of|glucose|transporter (l_compound) transporter_23\NN\4490091|
23193186T5_23193186T10 NONE glucose_7\NN\14710501| (r_compound) concentration_8\NN\4916342|the|average|plasma|glucose (r_dobj) raised_3\VBD\153263|model|concentration|mg/dl|mg/dl|and|led|. (l_conj) led_16\VBD\1752884|expression (l_nmod) expression_20\NN\4679549|to|decreased|gene|glut1 (l_nmod) glut1_24\NN\1740|of|glucose|transporter
23193186T6_23193186T9 NONE glucose_22\NN\14710501| (r_compound) glut1_24\NN\1740|of|glucose|transporter (l_compound) transporter_23\NN\4490091|
23193186T6_23193186T10 NONE glucose_22\NN\14710501| (r_compound) glut1_24\NN\1740|of|glucose|transporter
19389876
19389876T1_19389876T18 CPR:9 ambrisentan_0\NN\1740| (r_nsubj) antagonist_9\NN\7846|ambrisentan|is|an|a|receptor|metabolized|. (l_acl:relcl) metabolized_12\VBN\1740|that|is|primarily|glucuronidation|but|undergoes (l_conj) undergoes_18\VBZ\109660|also|metabolism|cyp3a4 (l_nmod) cyp3a4_22\NN\1740|by
19389876T1_19389876T19 CPR:6 ambrisentan_0\NN\1740| (r_nsubj) antagonist_9\NN\7846|ambrisentan|is|an|a|receptor|metabolized|. (l_compound) receptor_8\NN\5225602|
19389876T4_19389876T20 CPR:4 ketoconazole_3\NN\1740|,|inhibitor|, (l_appos) inhibitor_8\NN\20090|the|archetypal|strong|cyp3a4 (l_nmod) cyp3a4_10\NN\1740|of
19389876T5_19389876T20 NONE ambrisentan_18\NN\1740|of|and|metabolite (r_nmod) profile_16\NN\6999802|the|pharmacokinetic|ambrisentan (r_dobj) alter_13\VB\126264|for|ketoconazole|to|profile (l_nsubj) ketoconazole_3\NN\1740|,|inhibitor|, (l_appos) inhibitor_8\NN\20090|the|archetypal|strong|cyp3a4 (l_nmod) cyp3a4_10\NN\1740|of
19389876T6_19389876T20 NONE ambrisentan_25\NN\1740|4-hydroxymethyl (r_appos) metabolite_22\NN\20090|its|oxidative|,|ambrisentan|, (r_conj) ambrisentan_18\NN\1740|of|and|metabolite (r_nmod) profile_16\NN\6999802|the|pharmacokinetic|ambrisentan (r_dobj) alter_13\VB\126264|for|ketoconazole|to|profile (l_nsubj) ketoconazole_3\NN\1740|,|inhibitor|, (l_appos) inhibitor_8\NN\20090|the|archetypal|strong|cyp3a4 (l_nmod) cyp3a4_10\NN\1740|of
19389876T2_19389876T17 NONE ambrisentan_16\NN\1740|of (r_nmod) pharmacokinetics_11\NNS\6054892|on|the|or|profile|ambrisentan (r_nmod) had_4\VBD\2108377|summary|,|ketoconazole|effect|pharmacokinetics|;|necessary (l_parataxis) necessary_27\JJ\1740|therefore|,|changes|should|be|administered|. (l_advcl) administered_32\VBN\2436349|when|drug|is|inhibitors (l_nmod) inhibitors_37\NNS\20090|concomitantly|with|known|cyp3a4 (l_compound) cyp3a4_36\NN\1740|
19389876T3_19389876T17 NONE ambrisentan_23\NN\1740| (r_compound) dose_24\NN\3740161|in|ambrisentan (r_nmod) changes_21\NNS\7283608|no|dose (r_nsubj) necessary_27\JJ\1740|therefore|,|changes|should|be|administered|. (l_advcl) administered_32\VBN\2436349|when|drug|is|inhibitors (l_nmod) inhibitors_37\NNS\20090|concomitantly|with|known|cyp3a4 (l_compound) cyp3a4_36\NN\1740|
19389876T14_19389876T17 CPR:4 ketoconazole_3\NN\1740| (r_nsubj) had_4\VBD\2108377|summary|,|ketoconazole|effect|pharmacokinetics|;|necessary (l_parataxis) necessary_27\JJ\1740|therefore|,|changes|should|be|administered|. (l_advcl) administered_32\VBN\2436349|when|drug|is|inhibitors (l_nmod) inhibitors_37\NNS\20090|concomitantly|with|known|cyp3a4 (l_compound) cyp3a4_36\NN\1740|
23087261
23087261T4_23087261T24 NONE lysine_0\NN\14605787| (r_nmod:npmod) 48-linked_1\JJ\1740|lysine (r_amod) polyubiquitination_2\NN\1740|48-linked|transporter-1 (l_nmod) transporter-1_6\NN\1740|of|organic|anion
23087261T4_23087261T25 NONE lysine_0\NN\14605787| (r_nmod:npmod) 48-linked_1\JJ\1740|lysine (r_amod) polyubiquitination_2\NN\1740|48-linked|transporter-1 (r_nsubj) essential_8\JJ\1740|polyubiquitination|is|endocytosis|. (l_nmod) endocytosis_14\NN\1740|for|its|c-regulated (l_amod) c-regulated_13\JJ\1740|protein|kinase
23087261T1_23087261T7 NONE lysine_15\NN\14605787| (r_compound) linkage_17\NN\13791389|through|lysine|48 (r_nmod) consists_8\VBZ\2603699|that|ubiquitination|chains|,|linkage (l_nsubj) ubiquitination_5\NN\1740|oat1 (l_nmod) oat1_7\NN\1740|of
23087261T2_23087261T8 NONE lys48-linked_17\JJ\1740| (r_amod) chains_19\NNS\4181228|of|lys48-linked|polyubiquitin (r_nmod) formation_15\NN\7938773|the|chains (r_dobj) prevents_13\VBZ\1740|which|formation (r_acl:relcl) mutant_7\NN\4475|with|the|dominant|negative|ub-k48r|,|prevents|, (r_nmod) transfection_0\NN\1740|cells|mutant (r_nsubj) abolishes_21\VBZ\1740|transfection|oat1|. (l_dobj) oat1_23\NN\1740|pkc-stimulated|ubiquitination (l_amod) pkc-stimulated_22\JJ\1740|
23087261T2_23087261T9 NONE lys48-linked_17\JJ\1740| (r_amod) chains_19\NNS\4181228|of|lys48-linked|polyubiquitin (r_nmod) formation_15\NN\7938773|the|chains (r_dobj) prevents_13\VBZ\1740|which|formation (r_acl:relcl) mutant_7\NN\4475|with|the|dominant|negative|ub-k48r|,|prevents|, (r_nmod) transfection_0\NN\1740|cells|mutant (r_nsubj) abolishes_21\VBZ\1740|transfection|oat1|. (l_dobj) oat1_23\NN\1740|pkc-stimulated|ubiquitination
23087261T3_23087261T10 NONE lys48-linked_10\JJ\1740| (r_amod) polyubiquitination_11\NN\1740|lys48-linked (r_nsubj) essential_13\JJ\1740|that|polyubiquitination|is|trafficking (l_nmod) trafficking_17\NN\1740|for|pkc-regulated|oat1 (l_amod) pkc-regulated_15\JJ\1740|
23087261T3_23087261T11 NONE lys48-linked_10\JJ\1740| (r_amod) polyubiquitination_11\NN\1740|lys48-linked (r_nsubj) essential_13\JJ\1740|that|polyubiquitination|is|trafficking (l_nmod) trafficking_17\NN\1740|for|pkc-regulated|oat1 (l_compound) oat1_16\NN\1740|
14725487
14725487T2_14725487T22 CPR:5 formoterol_21\NN\1740|of|the|beta(2)-adrenoceptor|agonist|eformoterol (l_compound) beta(2)-adrenoceptor_19\NN\1740|
14725487T4_14725487T22 CPR:5 eformoterol_23\NN\1740|[|] (r_appos) formoterol_21\NN\1740|of|the|beta(2)-adrenoceptor|agonist|eformoterol (l_compound) beta(2)-adrenoceptor_19\NN\1740|
14725487T8_14725487T22 NONE arformoterol_6\NN\1740|r-formoterol|,|form (l_appos) form_16\NN\6286395|a|single|isomer|formoterol (l_nmod) formoterol_21\NN\1740|of|the|beta(2)-adrenoceptor|agonist|eformoterol (l_compound) beta(2)-adrenoceptor_19\NN\1740|
14725487T9_14725487T22 NONE r-formoterol_10\NN\1740|[|r|,|] (r_appos) arformoterol_6\NN\1740|r-formoterol|,|form (l_appos) form_16\NN\6286395|a|single|isomer|formoterol (l_nmod) formoterol_21\NN\1740|of|the|beta(2)-adrenoceptor|agonist|eformoterol (l_compound) beta(2)-adrenoceptor_19\NN\1740|
23199882
23643542
15673388
15673388T7_15673388T12 NONE quinidine_6\NN\2715941|of (r_nmod) effect_4\NN\34213|into|the|quinidine|syndrome (l_nmod) syndrome_10\NN\5870365|in|qt|caused (l_acl) caused_11\VBN\1617192|mutation (l_nmod) mutation_14\NN\4475|by|a|herg (l_nmod) herg_16\NN\1740|in
15673388T5_15673388T8 CPR:4 quinidine_14\NN\2715941|of (r_nmod) efficacy_12\NN\5199286|the|quinidine (r_dobj) assess_10\VB\670261|to|efficacy|suppressing (l_advcl) suppressing_16\VBG\2510337|in|ikr|and|modulating (l_dobj) ikr_17\NN\1740|
15673388T1_15673388T11 NONE quinidine_29\NN\2715941|of (r_nmod) ic50_27\NN\1740|in|quinidine (r_nmod) increase_25\NN\13576355|only|a|5.8-fold|ic50 (r_conj) increase_16\NN\13576355|a|20-fold|ic50|but|increase (r_dobj) causes_13\VBZ\1617192|mutation|increase (r_ccomp) indicate_10\VBP\952524|data|causes|. (l_nsubj) data_0\NNS\7951464|expression (l_nmod) expression_3\NN\4679549|from|heterologous|genes (l_nmod) genes_9\NNS\8459252|of|wild-type|herg (l_compound) herg_8\NN\1740|
15673388T2_15673388T9 CPR:4 quinidine_3\NN\2715941|oral (r_nsubj) effective_5\JJ\1740|quinidine|is|suppressing (l_advcl) suppressing_7\VBG\2510337|in|gain|and|restoring (l_dobj) gain_9\NN\13576355|the|function|ikr (l_nmod) ikr_13\NN\1740|in|responsible
15673388T2_15673388T10 NONE quinidine_3\NN\2715941|oral (r_nsubj) effective_5\JJ\1740|quinidine|is|suppressing (l_advcl) suppressing_7\VBG\2510337|in|gain|and|restoring (l_dobj) gain_9\NN\13576355|the|function|ikr (l_nmod) ikr_13\NN\1740|in|responsible (l_amod) responsible_14\JJ\1740|cases (l_nmod) cases_17\NNS\7283608|for|some|syndrome|mutation (l_nmod) mutation_24\NN\4475|with|a|herg (l_nmod) herg_26\NN\1740|in
23621521
23354070
23354070T7_23354070T14 NONE palinurin_15\NN\1740|by|the|marine|compound (r_nmod) regulation_10\NN\6652242|allosteric|palinurin (r_dep) evidence_0\NN\5816287|mode|:|regulation|. (l_nmod) mode_5\NN\4916342|for|a|new|binding|gsk-3 (l_nmod) gsk-3_7\NN\1740|to
23354070T2_23354070T10 CPR:4 sesquiterpene_12\NN\1740| (r_compound) palinurin_13\NN\1740|of|the|marine|natural|sesquiterpene (r_nmod) isolation_4\NN\14414294|the|and|characterization|palinurin|inhibitor (l_nmod) inhibitor_17\NN\20090|as|a|gsk-3β (l_compound) gsk-3β_16\NN\1740|
23354070T3_23354070T10 CPR:4 palinurin_13\NN\1740|of|the|marine|natural|sesquiterpene (r_nmod) isolation_4\NN\14414294|the|and|characterization|palinurin|inhibitor (l_nmod) inhibitor_17\NN\20090|as|a|gsk-3β (l_compound) gsk-3β_16\NN\1740|
23354070T4_23354070T11 CPR:4 palinurin_13\NN\1740|by (r_nmod) inhibition_11\NN\1068773|gsk-3β|palinurin (l_compound) gsk-3β_10\NN\1740|
23354070T5_23354070T11 NONE atp_20\NN\14964590|by|nor|substrate (r_nmod) competed_17\VBN\1740|that|inhibition|can|not|be|out|atp (l_nsubjpass) inhibition_11\NN\1068773|gsk-3β|palinurin (l_compound) gsk-3β_10\NN\1740|
23354070T6_23354070T13 CPR:4 palinurin_14\NN\1740|of (r_nmod) binding_12\NN\4688246|palinurin (r_nsubj) leads_15\VBZ\1752884|which|binding|inhibition (l_nmod) inhibition_18\NN\1068773|to|gsk-3β (l_compound) gsk-3β_17\NN\1740|
1375507
1375507T20_1375507T34 CPR:4 prostacyclin_0\NN\1740| (r_compound) analogues_1\NNS\4743605|prostacyclin (r_nsubj) inhibit_2\VBP\2510337|analogues|expression|mechanism|. (l_dobj) expression_5\NN\4679549|tissue|factor|line (l_compound) factor_4\NN\7326557|
1375507T21_1375507T34 NONE amp-dependent_16\JJ\1740|cyclic (r_amod) mechanism_17\NN\13446390|via|a|amp-dependent (r_nmod) inhibit_2\VBP\2510337|analogues|expression|mechanism|. (l_dobj) expression_5\NN\4679549|tissue|factor|line (l_compound) factor_4\NN\7326557|
1375507T12_1375507T28 CPR:4 prostacyclin_11\NN\1740|of|,|inhibitor|, (r_nmod) analogues_9\NNS\4743605|stable|prostacyclin (r_nsubj) inhibit_22\VB\2510337|whether|analogues|could|expression (l_dobj) expression_25\NN\4679549|tissue|factor|cells (l_compound) factor_24\NN\7326557|
1375507T13_1375507T32 CPR:4 iloprost_5\NN\1740|with|,|ciprostene|,|and|carbacyclin (r_nmod) preincubation_0\NN\1740|minutes|iloprost (r_nsubj) led_11\VBD\1752884|preincubation|inhibition|. (l_nmod) inhibition_15\NN\1068773|to|a|dose-dependent|expression (l_nmod) expression_19\NN\4679549|of|tissue|factor|induced (l_compound) factor_18\NN\7326557|
1375507T14_1375507T32 CPR:4 ciprostene_7\NN\1740| (r_conj) iloprost_5\NN\1740|with|,|ciprostene|,|and|carbacyclin (r_nmod) preincubation_0\NN\1740|minutes|iloprost (r_nsubj) led_11\VBD\1752884|preincubation|inhibition|. (l_nmod) inhibition_15\NN\1068773|to|a|dose-dependent|expression (l_nmod) expression_19\NN\4679549|of|tissue|factor|induced (l_compound) factor_18\NN\7326557|
1375507T15_1375507T32 CPR:4 carbacyclin_10\NN\1740| (r_conj) iloprost_5\NN\1740|with|,|ciprostene|,|and|carbacyclin (r_nmod) preincubation_0\NN\1740|minutes|iloprost (r_nsubj) led_11\VBD\1752884|preincubation|inhibition|. (l_nmod) inhibition_15\NN\1068773|to|a|dose-dependent|expression (l_nmod) expression_19\NN\4679549|of|tissue|factor|induced (l_compound) factor_18\NN\7326557|
1375507T16_1375507T33 NONE iloprost_0\NN\1740| (r_nsubj) potent_4\JJ\1740|iloprost|was|the|most|:|occurred|. (l_parataxis) occurred_9\VBD\2623529|inhibition|nm (l_nmod) nm_12\NN\13649268|at|5|,|concentration (l_appos) concentration_15\NN\4916342|a|close (l_amod) close_16\JJ\1740|constant (l_nmod) constant_21\NN\5855125|to|the|reported|dissociation|iloprost (l_nmod) iloprost_23\NN\1740|for|binding (l_acl) binding_24\VBG\1290422|receptor (l_nmod) receptor_29\NN\5225602|to|the|platelet|prostacyclin
1375507T17_1375507T33 NONE iloprost_23\NN\1740|for|binding (l_acl) binding_24\VBG\1290422|receptor (l_nmod) receptor_29\NN\5225602|to|the|platelet|prostacyclin
1375507T18_1375507T33 NONE prostacyclin_28\NN\1740| (r_compound) receptor_29\NN\5225602|to|the|platelet|prostacyclin
1375507T19_1375507T22 NONE cicaprost_5\NNP\1740| (r_appos) analogue_3\NN\4743605|an|active|,|cicaprost|, (r_nsubj) effective_9\JJ\1740|analogue|was|equally|expression|. (l_nmod) expression_14\NN\4679549|against|endotoxin-induced|tissue|factor (l_compound) factor_13\NN\7326557|
1375507T5_1375507T24 CPR:4 isobutylmethylxanthine_5\NN\1740|by|,|inhibitor (l_appos) inhibitor_8\NN\20090|an|phosphodiesterase (l_nmod) phosphodiesterase_10\NN\1740|of
1375507T6_1375507T25 CPR:4 isobutylmethylxanthine_13\NN\1740|by (r_nmod) potentiated_11\VBN\229605|effects|were|also|isobutylmethylxanthine|and|mimicked|. (l_nsubjpass) effects_2\NNS\13245626|the|inhibitory|iloprost|expression (l_nmod) expression_8\NN\4679549|on|tissue|factor (l_compound) factor_7\NN\7326557|
1375507T7_1375507T25 CPR:4 forskolin_17\NN\1740|by|and|amp|not|gmp (r_nmod) mimicked_15\VBN\1742886|forskolin (r_conj) potentiated_11\VBN\229605|effects|were|also|isobutylmethylxanthine|and|mimicked|. (l_nsubjpass) effects_2\NNS\13245626|the|inhibitory|iloprost|expression (l_nmod) expression_8\NN\4679549|on|tissue|factor (l_compound) factor_7\NN\7326557|
1375507T8_1375507T25 CPR:4 amp_21\NN\13633375|dibutyryl|cyclic (r_conj) forskolin_17\NN\1740|by|and|amp|not|gmp (r_nmod) mimicked_15\VBN\1742886|forskolin (r_conj) potentiated_11\VBN\229605|effects|were|also|isobutylmethylxanthine|and|mimicked|. (l_nsubjpass) effects_2\NNS\13245626|the|inhibitory|iloprost|expression (l_nmod) expression_8\NN\4679549|on|tissue|factor (l_compound) factor_7\NN\7326557|
1375507T9_1375507T25 NONE gmp_26\NN\1740|dibutyryl|cyclic (r_conj) forskolin_17\NN\1740|by|and|amp|not|gmp (r_nmod) mimicked_15\VBN\1742886|forskolin (r_conj) potentiated_11\VBN\229605|effects|were|also|isobutylmethylxanthine|and|mimicked|. (l_nsubjpass) effects_2\NNS\13245626|the|inhibitory|iloprost|expression (l_nmod) expression_8\NN\4679549|on|tissue|factor (l_compound) factor_7\NN\7326557|
1375507T10_1375507T26 CPR:4 prostacyclin_4\NN\1740| (r_nsubj) play_6\VB\1072262|that|prostacyclin|may|role|downregulating|,|part|elevation (l_advcl) downregulating_10\VBG\1740|in|expression (l_dobj) expression_13\NN\4679549|tissue|factor|monocytes (l_compound) factor_12\NN\7326557|
1375507T11_1375507T26 CPR:4 amp_28\NN\13633375|of|cyclic (r_nmod) levels_25\NNS\4916342|of|intracellular|amp (r_nmod) elevation_22\NN\7445480|via|levels (r_nmod) play_6\VB\1072262|that|prostacyclin|may|role|downregulating|,|part|elevation (l_advcl) downregulating_10\VBG\1740|in|expression (l_dobj) expression_13\NN\4679549|tissue|factor|monocytes (l_compound) factor_12\NN\7326557|
12110374
12110374T19_12110374T39 NONE dopamine_0\NN\14807737| (r_compound) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_amod) receptor-induced_3\JJ\1740|)
12110374T19_12110374T40 NONE dopamine_0\NN\14807737| (r_compound) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_amod) cox-2-mediated_4\JJ\1740|
12110374T19_12110374T41 NONE dopamine_0\NN\14807737| (r_compound) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_nmod) cells_15\NNS\3080309|in|d(2)-transfected|chinese|hamster|ovary (l_amod) d(2)-transfected_11\JJ\1740|
12110374T20_12110374T39 NONE ca(2+)-mobilizing_21\JJ\1740| (r_amod) agent_22\NN\7347|of|a|ca(2+)-mobilizing (r_nmod) administration_18\NN\1133281|without|simultaneous|agent (r_nmod) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_amod) receptor-induced_3\JJ\1740|)
12110374T20_12110374T40 NONE ca(2+)-mobilizing_21\JJ\1740| (r_amod) agent_22\NN\7347|of|a|ca(2+)-mobilizing (r_nmod) administration_18\NN\1133281|without|simultaneous|agent (r_nmod) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_amod) cox-2-mediated_4\JJ\1740|
12110374T20_12110374T41 NONE ca(2+)-mobilizing_21\JJ\1740| (r_amod) agent_22\NN\7347|of|a|ca(2+)-mobilizing (r_nmod) administration_18\NN\1133281|without|simultaneous|agent (r_nmod) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_nmod) cells_15\NNS\3080309|in|d(2)-transfected|chinese|hamster|ovary (l_amod) d(2)-transfected_11\JJ\1740|
12110374T21_12110374T39 NONE )_9\-RRB-\1740| (r_punct) e(2_8\NN\1740|of|prostaglandin|) (r_nmod) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_amod) receptor-induced_3\JJ\1740|)
12110374T21_12110374T40 CPR:9 )_9\-RRB-\1740| (r_punct) e(2_8\NN\1740|of|prostaglandin|) (r_nmod) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_amod) cox-2-mediated_4\JJ\1740|
12110374T21_12110374T41 NONE )_9\-RRB-\1740| (r_punct) e(2_8\NN\1740|of|prostaglandin|) (r_nmod) production_5\NN\30358|dopamine|d(2|receptor-induced|cox-2-mediated|e(2|cells|administration|. (l_nmod) cells_15\NNS\3080309|in|d(2)-transfected|chinese|hamster|ovary (l_amod) d(2)-transfected_11\JJ\1740|
12110374T3_12110374T32 NONE acid_21\NN\14818238|arachidonic (r_appos) precursor_18\NN\14580897|of|the|prostaglandin|e(2|)|(|pge(2|)|)|,|acid|, (r_nmod) liberation_8\NN\35189|the|precursor|cells (l_nmod) cells_27\NNS\3080309|in|chinese|hamster|ovary|transfected (l_acl) transfected_28\VBN\1740|receptor (l_nmod) receptor_35\NN\5225602|with|the|rat|dopamine|d(2|)|isoform (l_appos) isoform_38\NN\1740|(|long|) (l_punct) )_39\-RRB-\1740|
12110374T8_12110374T32 NONE dopamine_32\NN\14807737| (r_compound) receptor_35\NN\5225602|with|the|rat|dopamine|d(2|)|isoform (l_appos) isoform_38\NN\1740|(|long|) (l_punct) )_39\-RRB-\1740|
12110374T9_12110374T32 NONE ca(2+)-releasing_47\NN\1740| (r_amod) agent_48\NN\7347|of|a|ca(2+)-releasing (r_nmod) administration_44\NN\1133281|also|without|concomitant|agent (r_nmod) stimulates_6\VBZ\137313|that|dopamine|liberation|,|administration|nilsson (l_dobj) liberation_8\NN\35189|the|precursor|cells (l_nmod) cells_27\NNS\3080309|in|chinese|hamster|ovary|transfected (l_acl) transfected_28\VBN\1740|receptor (l_nmod) receptor_35\NN\5225602|with|the|rat|dopamine|d(2|)|isoform (l_appos) isoform_38\NN\1740|(|long|) (l_punct) )_39\-RRB-\1740|
12110374T15_12110374T32 NONE )_13\-RRB-\1740| (r_punct) precursor_18\NN\14580897|of|the|prostaglandin|e(2|)|(|pge(2|)|)|,|acid|, (r_nmod) liberation_8\NN\35189|the|precursor|cells (l_nmod) cells_27\NNS\3080309|in|chinese|hamster|ovary|transfected (l_acl) transfected_28\VBN\1740|receptor (l_nmod) receptor_35\NN\5225602|with|the|rat|dopamine|d(2|)|isoform (l_appos) isoform_38\NN\1740|(|long|) (l_punct) )_39\-RRB-\1740|
12110374T17_12110374T32 NONE )_16\-RRB-\1740| (r_punct) precursor_18\NN\14580897|of|the|prostaglandin|e(2|)|(|pge(2|)|)|,|acid|, (r_nmod) liberation_8\NN\35189|the|precursor|cells (l_nmod) cells_27\NNS\3080309|in|chinese|hamster|ovary|transfected (l_acl) transfected_28\VBN\1740|receptor (l_nmod) receptor_35\NN\5225602|with|the|rat|dopamine|d(2|)|isoform (l_appos) isoform_38\NN\1740|(|long|) (l_punct) )_39\-RRB-\1740|
12110374T10_12110374T33 NONE dopamine_8\NN\14807737|, (r_nsubj) induces_16\VBZ\1627355|that|dopamine|conditions|,|also|increase|,|effect|counteracted (l_parataxis) counteracted_50\VBN\2367363|effect|was|eticlopride (l_nmod) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_punct) )_54\-RRB-\1740|
12110374T10_12110374T34 NONE dopamine_8\NN\14807737|, (r_nsubj) induces_16\VBZ\1627355|that|dopamine|conditions|,|also|increase|,|effect|counteracted (l_parataxis) counteracted_50\VBN\2367363|effect|was|eticlopride (l_nmod) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) toxin_59\NN\15032376|pertussis
12110374T10_12110374T35 NONE dopamine_8\NN\14807737|, (r_nsubj) induces_16\VBZ\1627355|that|dopamine|conditions|,|also|increase|,|effect|counteracted (l_parataxis) counteracted_50\VBN\2367363|effect|was|eticlopride (l_nmod) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) desensitization_79\NN\13458571|pkc|obtained (l_compound) pkc_78\NN\1740|
12110374T11_12110374T33 NONE )_25\-RRB-\1740| (r_punct) pge(2_24\NN\1740|of|) (r_nmod) production_22\NN\30358|in|the|pge(2 (r_nmod) increase_19\NN\13576355|a|concentration-dependent|production (r_dobj) induces_16\VBZ\1627355|that|dopamine|conditions|,|also|increase|,|effect|counteracted (l_parataxis) counteracted_50\VBN\2367363|effect|was|eticlopride (l_nmod) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_punct) )_54\-RRB-\1740|
12110374T11_12110374T34 NONE )_25\-RRB-\1740| (r_punct) pge(2_24\NN\1740|of|) (r_nmod) production_22\NN\30358|in|the|pge(2 (r_nmod) increase_19\NN\13576355|a|concentration-dependent|production (r_dobj) induces_16\VBZ\1627355|that|dopamine|conditions|,|also|increase|,|effect|counteracted (l_parataxis) counteracted_50\VBN\2367363|effect|was|eticlopride (l_nmod) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) toxin_59\NN\15032376|pertussis
12110374T11_12110374T35 NONE )_25\-RRB-\1740| (r_punct) pge(2_24\NN\1740|of|) (r_nmod) production_22\NN\30358|in|the|pge(2 (r_nmod) increase_19\NN\13576355|a|concentration-dependent|production (r_dobj) induces_16\VBZ\1627355|that|dopamine|conditions|,|also|increase|,|effect|counteracted (l_parataxis) counteracted_50\VBN\2367363|effect|was|eticlopride (l_nmod) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) desensitization_79\NN\13458571|pkc|obtained (l_compound) pkc_78\NN\1740|
12110374T12_12110374T33 CPR:6 eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_punct) )_54\-RRB-\1740|
12110374T12_12110374T34 NONE eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) toxin_59\NN\15032376|pertussis
12110374T12_12110374T35 NONE eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) desensitization_79\NN\13458571|pkc|obtained (l_compound) pkc_78\NN\1740|
12110374T13_12110374T33 NONE )_67\-RRB-\1740| (r_punct) release_68\NN\3748886|of|intracellular|ca(2|+|)|tmb-8 (r_nmod) inhibitor_62\NN\20090|the|release (r_appos) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_punct) )_54\-RRB-\1740|
12110374T13_12110374T34 NONE )_67\-RRB-\1740| (r_punct) release_68\NN\3748886|of|intracellular|ca(2|+|)|tmb-8 (r_nmod) inhibitor_62\NN\20090|the|release (r_appos) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) toxin_59\NN\15032376|pertussis
12110374T13_12110374T35 NONE )_67\-RRB-\1740| (r_punct) release_68\NN\3748886|of|intracellular|ca(2|+|)|tmb-8 (r_nmod) inhibitor_62\NN\20090|the|release (r_appos) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) desensitization_79\NN\13458571|pkc|obtained (l_compound) pkc_78\NN\1740|
12110374T14_12110374T33 NONE ca(2+)-free_73\JJ\1740| (r_amod) medium_75\NN\3575240|in|ca(2+)-free|experimental (r_nmod) incubation_71\NN\654885|medium (r_appos) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_punct) )_54\-RRB-\1740|
12110374T14_12110374T34 NONE ca(2+)-free_73\JJ\1740| (r_amod) medium_75\NN\3575240|in|ca(2+)-free|experimental (r_nmod) incubation_71\NN\654885|medium (r_appos) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) toxin_59\NN\15032376|pertussis
12110374T14_12110374T35 NONE ca(2+)-free_73\JJ\1740| (r_amod) medium_75\NN\3575240|in|ca(2+)-free|experimental (r_nmod) incubation_71\NN\654885|medium (r_appos) eticlopride_56\NN\1740|by|the|d(2|)|antagonist|,|toxin|,|inhibitor|,|incubation|,|and|desensitization (l_conj) desensitization_79\NN\13458571|pkc|obtained (l_compound) pkc_78\NN\1740|
12110374T1_12110374T22 CPR:4 salicylate_33\NN\3828465|valeryl (r_appos) inhibitor_30\NN\20090|not|by|the|specific|cox-1|,|salicylate (l_compound) cox-1_29\NN\14737847|
12110374T1_12110374T36 NONE salicylate_33\NN\3828465|valeryl (r_appos) inhibitor_30\NN\20090|not|by|the|specific|cox-1|,|salicylate (r_conj) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (r_conj) inhibitor_11\NN\20090|by|the|non-specific|cyclooxygenase|,|indomethacin|,|and|inhibitor (l_compound) cyclooxygenase_7\NN\14732946|cox
12110374T1_12110374T37 NONE salicylate_33\NN\3828465|valeryl (r_appos) inhibitor_30\NN\20090|not|by|the|specific|cox-1|,|salicylate (r_conj) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (r_conj) inhibitor_11\NN\20090|by|the|non-specific|cyclooxygenase|,|indomethacin|,|and|inhibitor (l_compound) cyclooxygenase_7\NN\14732946|cox (l_appos) cox_9\NN\14732946|(|)
12110374T1_12110374T38 NONE salicylate_33\NN\3828465|valeryl (r_appos) inhibitor_30\NN\20090|not|by|the|specific|cox-1|,|salicylate (r_conj) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (l_compound) cox-2_19\NN\14737847|
12110374T16_12110374T22 NONE indomethacin_13\NN\3828465| (r_appos) inhibitor_11\NN\20090|by|the|non-specific|cyclooxygenase|,|indomethacin|,|and|inhibitor (l_conj) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (l_conj) inhibitor_30\NN\20090|not|by|the|specific|cox-1|,|salicylate (l_compound) cox-1_29\NN\14737847|
12110374T16_12110374T36 CPR:4 indomethacin_13\NN\3828465| (r_appos) inhibitor_11\NN\20090|by|the|non-specific|cyclooxygenase|,|indomethacin|,|and|inhibitor (l_compound) cyclooxygenase_7\NN\14732946|cox
12110374T16_12110374T37 CPR:4 indomethacin_13\NN\3828465| (r_appos) inhibitor_11\NN\20090|by|the|non-specific|cyclooxygenase|,|indomethacin|,|and|inhibitor (l_compound) cyclooxygenase_7\NN\14732946|cox (l_appos) cox_9\NN\14732946|(|)
12110374T16_12110374T38 NONE indomethacin_13\NN\3828465| (r_appos) inhibitor_11\NN\20090|by|the|non-specific|cyclooxygenase|,|indomethacin|,|and|inhibitor (l_conj) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (l_compound) cox-2_19\NN\14737847|
12110374T18_12110374T22 NONE ns-398_22\NN\1740| (r_appos) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (l_conj) inhibitor_30\NN\20090|not|by|the|specific|cox-1|,|salicylate (l_compound) cox-1_29\NN\14737847|
12110374T18_12110374T36 NONE ns-398_22\NN\1740| (r_appos) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (r_conj) inhibitor_11\NN\20090|by|the|non-specific|cyclooxygenase|,|indomethacin|,|and|inhibitor (l_compound) cyclooxygenase_7\NN\14732946|cox
12110374T18_12110374T37 NONE ns-398_22\NN\1740| (r_appos) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (r_conj) inhibitor_11\NN\20090|by|the|non-specific|cyclooxygenase|,|indomethacin|,|and|inhibitor (l_compound) cyclooxygenase_7\NN\14732946|cox (l_appos) cox_9\NN\14732946|(|)
12110374T18_12110374T38 CPR:4 ns-398_22\NN\1740| (r_appos) inhibitor_20\NN\20090|by|the|selective|cox-2|,|ns-398|,|but|inhibitor (l_compound) cox-2_19\NN\14737847|
12110374T2_12110374T23 CPR:4 quinacrine_8\NN\2721948| (r_appos) inhibitor_6\NN\20090|both|the|non-specific|phospholipase|a(2|)|,|quinacrine|,|and|inhibitor (l_punct) )_5\-RRB-\1740|
12110374T2_12110374T24 NONE quinacrine_8\NN\2721948| (r_appos) inhibitor_6\NN\20090|both|the|non-specific|phospholipase|a(2|)|,|quinacrine|,|and|inhibitor (l_conj) inhibitor_12\NN\20090|an|cpla(2|and|ipla(2|,|aacof3|, (l_nmod) cpla(2_14\NN\1740|of|) (l_punct) )_15\-RRB-\1740|
12110374T2_12110374T25 NONE quinacrine_8\NN\2721948| (r_appos) inhibitor_6\NN\20090|both|the|non-specific|phospholipase|a(2|)|,|quinacrine|,|and|inhibitor (l_conj) inhibitor_12\NN\20090|an|cpla(2|and|ipla(2|,|aacof3|, (l_conj) ipla(2_17\NN\1740|) (l_punct) )_18\-RRB-\1740|
12110374T2_12110374T26 NONE quinacrine_8\NN\2721948| (r_appos) inhibitor_6\NN\20090|both|the|non-specific|phospholipase|a(2|)|,|quinacrine|,|and|inhibitor (r_nsubj) counteracted_22\VBD\2367363|inhibitor|effect|;|ineffective|. (l_parataxis) ineffective_47\JJ\1740|contrast|,|inhibitor|were (l_nsubj) inhibitor_33\NN\20090|a|selective|ipla(2|)|,|bel|,|and|inhibitor (l_punct) )_32\-RRB-\1740|
12110374T2_12110374T27 NONE quinacrine_8\NN\2721948| (r_appos) inhibitor_6\NN\20090|both|the|non-specific|phospholipase|a(2|)|,|quinacrine|,|and|inhibitor (r_nsubj) counteracted_22\VBD\2367363|inhibitor|effect|;|ineffective|. (l_parataxis) ineffective_47\JJ\1740|contrast|,|inhibitor|were (l_nsubj) inhibitor_33\NN\20090|a|selective|ipla(2|)|,|bel|,|and|inhibitor (l_conj) inhibitor_42\NN\20090|a|selective|spla(2|)|,|tapc|, (l_punct) )_41\-RRB-\1740|
12110374T5_12110374T28 CPR:3 dopamine_6\NN\14807737| (r_nsubj) interact_8\VB\2367363|that|dopamine|may|metabolism|means (l_nmod) means_13\NNS\44150|by|activation (l_nmod) activation_18\NN\13561719|of|d(2|)|receptor (l_compound) receptor_17\NN\5225602|
12110374T5_12110374T29 NONE dopamine_6\NN\14807737| (r_nsubj) interact_8\VB\2367363|that|dopamine|may|metabolism|means (r_ccomp) assumptions_4\NNS\6753299|previous|interact (r_dobj) reinforce_2\VBP\220869|results|assumptions|,|and|implicate|. (l_conj) implicate_21\VBP\2677097|involvement (l_dobj) involvement_23\NN\1080366|an|cpla(2|effect (l_nmod) cpla(2_25\NN\1740|of|)|and|cox-2 (l_punct) )_26\-RRB-\1740|
12110374T5_12110374T30 NONE dopamine_6\NN\14807737| (r_nsubj) interact_8\VB\2367363|that|dopamine|may|metabolism|means (r_ccomp) assumptions_4\NNS\6753299|previous|interact (r_dobj) reinforce_2\VBP\220869|results|assumptions|,|and|implicate|. (l_conj) implicate_21\VBP\2677097|involvement (l_dobj) involvement_23\NN\1080366|an|cpla(2|effect (l_nmod) cpla(2_25\NN\1740|of|)|and|cox-2 (l_conj) cox-2_28\NN\14737847|
12110374T6_12110374T28 NONE eicosanoid_10\NN\1740| (r_compound) metabolism_11\NN\13526110|with|eicosanoid (r_nmod) interact_8\VB\2367363|that|dopamine|may|metabolism|means (l_nmod) means_13\NNS\44150|by|activation (l_nmod) activation_18\NN\13561719|of|d(2|)|receptor (l_compound) receptor_17\NN\5225602|
12110374T6_12110374T29 NONE eicosanoid_10\NN\1740| (r_compound) metabolism_11\NN\13526110|with|eicosanoid (r_nmod) interact_8\VB\2367363|that|dopamine|may|metabolism|means (r_ccomp) assumptions_4\NNS\6753299|previous|interact (r_dobj) reinforce_2\VBP\220869|results|assumptions|,|and|implicate|. (l_conj) implicate_21\VBP\2677097|involvement (l_dobj) involvement_23\NN\1080366|an|cpla(2|effect (l_nmod) cpla(2_25\NN\1740|of|)|and|cox-2 (l_punct) )_26\-RRB-\1740|
12110374T6_12110374T30 NONE eicosanoid_10\NN\1740| (r_compound) metabolism_11\NN\13526110|with|eicosanoid (r_nmod) interact_8\VB\2367363|that|dopamine|may|metabolism|means (r_ccomp) assumptions_4\NNS\6753299|previous|interact (r_dobj) reinforce_2\VBP\220869|results|assumptions|,|and|implicate|. (l_conj) implicate_21\VBP\2677097|involvement (l_dobj) involvement_23\NN\1080366|an|cpla(2|effect (l_nmod) cpla(2_25\NN\1740|of|)|and|cox-2 (l_conj) cox-2_28\NN\14737847|
12110374T7_12110374T31 NONE dopamine-induced_6\JJ\1740| (r_amod) production_9\NN\30358|of|dopamine-induced|pge(2|) (r_nmod) measurement_4\NN\407535|production (r_nsubj) serve_11\VB\2669789|that|measurement|may|way (l_nmod) way_15\NN\4916342|as|a|convenient|study (l_acl:relcl) study_17\VB\630380|to|function|vitro (l_dobj) function_21\NN\13783581|d(2|)|receptor (l_compound) receptor_20\NN\5225602|
23522835
23522835T7_23522835T16 NONE cisplatin-resistant_11\JJ\1740| (r_amod) cells_15\NNS\3080309|against|cisplatin-resistant|human|gastric|cancer (r_nmod) effects_9\NNS\13245626|their|chemosensitizing|cells (r_conj) identification_2\NN\151497|in|inhibitors|and|effects|. (l_nmod) inhibitors_5\NNS\20090|of|poly(adp-ribose)polymerase-1 (l_compound) poly(adp-ribose)polymerase-1_4\NN\1740|
23522835T8_23522835T16 NONE poly(adp-ribose)polymerase-1_4\NN\1740|
23522835T1_23522835T9 NONE poly(adp-ribose)polymerase-1_0\NN\1740|parp-1
23522835T1_23522835T11 NONE poly(adp-ribose)polymerase-1_0\NN\1740|parp-1 (l_appos) parp-1_2\NN\1740|(
23522835T2_23522835T10 NONE cisplatin_20\NN\1740|such (r_nmod) agents_17\NNS\7347|of|dna-modifying|anticancer|cisplatin (r_nmod) resistance_13\NN\37396|the|agents (r_dobj) circumvent_11\VBP\1119169|resistance (r_conj) potentiate_6\VBP\229605|that|inhibitors|effects|and|circumvent (l_nsubj) inhibitors_5\NNS\20090|parp-1 (l_compound) parp-1_4\NN\1740|
23522835T3_23522835T14 NONE cisplatin_6\NN\1740|of (r_nmod) chemosensitization_4\NN\1740|the|cisplatin|pre-treatment (l_nmod) pre-treatment_8\NN\1740|by|inhibitors|cells (l_nmod) inhibitors_11\NNS\20090|of|parp-1 (l_compound) parp-1_10\NN\1740|
23522835T4_23522835T14 NONE cisplatin-resistant_13\JJ\1740| (r_amod) cells_17\NNS\3080309|in|cisplatin-resistant|human|gastric|cancer (r_nmod) pre-treatment_8\NN\1740|by|inhibitors|cells (l_nmod) inhibitors_11\NNS\20090|of|parp-1 (l_compound) parp-1_10\NN\1740|
23522835T5_23522835T15 NONE )_11\-RRB-\1740| (r_punct) poly(adp-ribose_10\NN\1740|of|) (r_nmod) formation_8\NN\7938773|the|poly(adp-ribose (r_dobj) suppress_6\VBP\2510337|that|inhibitors|formation|and|enhance (l_nsubj) inhibitors_5\NNS\20090|parp-1 (l_compound) parp-1_4\NN\1740|
23522835T6_23522835T15 NONE cisplatin_17\NN\1740|of (r_nmod) cytotoxicity_15\NN\13583478|the|cisplatin (r_dobj) enhance_13\VBP\227165|cytotoxicity (r_conj) suppress_6\VBP\2510337|that|inhibitors|formation|and|enhance (l_nsubj) inhibitors_5\NNS\20090|parp-1 (l_compound) parp-1_4\NN\1740|
17333137
17333137T14_17333137T24 NONE rolipram_3\NN\1740|of (r_nmod) profile_1\NN\6999802|antipsychotic|rolipram|:|efficacy (l_dep) efficacy_5\NN\5199286|rats|and|sensitivity|. (l_conj) sensitivity_10\NN\5651971|reduced|mice (l_nmod) mice_12\NNS\2329401|in|deficient (l_amod) deficient_13\JJ\1740|enzyme (l_nmod) enzyme_20\NN\14723628|in|the|phosphodiesterase-4b (l_compound) phosphodiesterase-4b_16\NN\1740|pde4b
17333137T14_17333137T25 NONE rolipram_3\NN\1740|of (r_nmod) profile_1\NN\6999802|antipsychotic|rolipram|:|efficacy (l_dep) efficacy_5\NN\5199286|rats|and|sensitivity|. (l_conj) sensitivity_10\NN\5651971|reduced|mice (l_nmod) mice_12\NNS\2329401|in|deficient (l_amod) deficient_13\JJ\1740|enzyme (l_nmod) enzyme_20\NN\14723628|in|the|phosphodiesterase-4b (l_compound) phosphodiesterase-4b_16\NN\1740|pde4b (l_appos) pde4b_18\NN\1740|(|)
17333137T6_17333137T18 NONE nucleotide_26\NN\14850483| (r_amod) polymorphisms_27\NNS\11418750|of|several|single|nucleotide|snps|pde4b|associated (l_nmod) pde4b_32\NN\1740|in
17333137T6_17333137T21 NONE nucleotide_26\NN\14850483| (r_amod) polymorphisms_27\NNS\11418750|of|several|single|nucleotide|snps|pde4b|associated (r_nmod) association_22\NN\8008335|an|polymorphisms (r_dobj) suggesting_20\VBG\1010118|as|association (r_advcl) provide_4\VBP\2199590|studies|evidence|suggesting (l_dobj) evidence_5\NN\5816287|phosphodiesterase-4b (l_nmod) phosphodiesterase-4b_8\NN\1740|for|reduced|pde4b|factor
17333137T6_17333137T22 NONE nucleotide_26\NN\14850483| (r_amod) polymorphisms_27\NNS\11418750|of|several|single|nucleotide|snps|pde4b|associated (r_nmod) association_22\NN\8008335|an|polymorphisms (r_dobj) suggesting_20\VBG\1010118|as|association (r_advcl) provide_4\VBP\2199590|studies|evidence|suggesting (l_dobj) evidence_5\NN\5816287|phosphodiesterase-4b (l_nmod) phosphodiesterase-4b_8\NN\1740|for|reduced|pde4b|factor (l_appos) pde4b_10\NN\1740|(|)
17333137T7_17333137T19 CPR:4 rolipram_14\NN\1740|of|,|inhibitor (l_appos) inhibitor_19\NN\20090|a|nonsubtype-selective|pde4 (l_compound) pde4_18\NN\1740|
17333137T7_17333137T20 NONE rolipram_14\NN\1740|of|,|inhibitor (r_nmod) activity_12\NN\30358|the|rolipram (r_dobj) assess_10\VB\670261|to|activity|,|models|and|use (l_conj) use_34\VB\1156834|to|pde4b|mice|begin (l_dobj) pde4b_35\NN\1740|
17333137T8_17333137T19 NONE rolipram_51\NN\1740|of (r_nmod) activity_49\NN\30358|in|the|rolipram (r_nmod) involved_46\VBN\2676054|activity (r_acl) subtypes_45\NNS\1740|the|involved (r_dobj) understand_43\VB\588888|to|subtypes (r_xcomp) begin_41\VB\941990|to|understand (r_xcomp) use_34\VB\1156834|to|pde4b|mice|begin (r_conj) assess_10\VB\670261|to|activity|,|models|and|use (l_dobj) activity_12\NN\30358|the|rolipram (l_nmod) rolipram_14\NN\1740|of|,|inhibitor (l_appos) inhibitor_19\NN\20090|a|nonsubtype-selective|pde4 (l_compound) pde4_18\NN\1740|
17333137T8_17333137T20 NONE rolipram_51\NN\1740|of (r_nmod) activity_49\NN\30358|in|the|rolipram (r_nmod) involved_46\VBN\2676054|activity (r_acl) subtypes_45\NNS\1740|the|involved (r_dobj) understand_43\VB\588888|to|subtypes (r_xcomp) begin_41\VB\941990|to|understand (r_xcomp) use_34\VB\1156834|to|pde4b|mice|begin (l_dobj) pde4b_35\NN\1740|
17333137T1_17333137T15 NONE rolipram_68\NN\1740|of (r_nmod) activity_66\NN\30358|with|the|rolipram (r_nmod) involved_57\VBN\2676054|pde4b|is|,|part|,|activity (l_nsubjpass) pde4b_55\NN\1740|
17333137T1_17333137T23 NONE rolipram_68\NN\1740|of (r_nmod) activity_66\NN\30358|with|the|rolipram (r_nmod) involved_57\VBN\2676054|pde4b|is|,|part|,|activity (r_ccomp) suggesting_54\VBG\1010118|involved (r_xcomp) reduced_38\VBN\441445|however|,|mice|,|sensitivity|was|,|resulting|,|suggesting|. (r_parataxis) suppressed_7\VBD\2510337|mice|,|rolipram|dose-dependently|car|=|;|reduced (l_nmod) mice_3\NNS\2329401|in|pde4b|wild-type (l_compound) pde4b_1\NN\1740|
17333137T12_17333137T15 NONE rolipram_5\NN\1740| (r_nsubj) suppressed_7\VBD\2510337|mice|,|rolipram|dose-dependently|car|=|;|reduced (l_parataxis) reduced_38\VBN\441445|however|,|mice|,|sensitivity|was|,|resulting|,|suggesting|. (l_xcomp) suggesting_54\VBG\1010118|involved (l_ccomp) involved_57\VBN\2676054|pde4b|is|,|part|,|activity (l_nsubjpass) pde4b_55\NN\1740|
17333137T12_17333137T23 NONE rolipram_5\NN\1740| (r_nsubj) suppressed_7\VBD\2510337|mice|,|rolipram|dose-dependently|car|=|;|reduced (l_nmod) mice_3\NNS\2329401|in|pde4b|wild-type (l_compound) pde4b_1\NN\1740|
17333137T13_17333137T15 NONE rolipram_26\NN\1740|to (r_nmod) sensitivity_24\NN\5651971|their|rolipram|doses (r_nsubjpass) reduced_38\VBN\441445|however|,|mice|,|sensitivity|was|,|resulting|,|suggesting|. (l_xcomp) suggesting_54\VBG\1010118|involved (l_ccomp) involved_57\VBN\2676054|pde4b|is|,|part|,|activity (l_nsubjpass) pde4b_55\NN\1740|
17333137T13_17333137T23 NONE rolipram_26\NN\1740|to (r_nmod) sensitivity_24\NN\5651971|their|rolipram|doses (r_nsubjpass) reduced_38\VBN\441445|however|,|mice|,|sensitivity|was|,|resulting|,|suggesting|. (r_parataxis) suppressed_7\VBD\2510337|mice|,|rolipram|dose-dependently|car|=|;|reduced (l_nmod) mice_3\NNS\2329401|in|pde4b|wild-type (l_compound) pde4b_1\NN\1740|
17333137T4_17333137T16 NONE rolipram_10\NN\1740|of (r_nmod) effects_8\NNS\13245626|the|antipsychotic|rolipram|car (r_dobj) mediates_5\VBZ\761713|that|pde4b|effects|and|play (l_nsubj) pde4b_4\NN\1740|
17333137T4_17333137T17 NONE rolipram_10\NN\1740|of (r_nmod) effects_8\NNS\13245626|the|antipsychotic|rolipram|car (r_dobj) mediates_5\VBZ\761713|that|pde4b|effects|and|play (l_conj) play_23\VB\1072262|that|pathway|may|role|pathophysiology (l_nsubj) pathway_21\NN\5483677|the|pde4b-regulated|cyclic|adenosine|monophosphate|signaling (l_amod) pde4b-regulated_16\JJ\1740|
17333137T5_17333137T16 NONE monophosphate_19\NN\1740| (r_compound) pathway_21\NN\5483677|the|pde4b-regulated|cyclic|adenosine|monophosphate|signaling (r_nsubj) play_23\VB\1072262|that|pathway|may|role|pathophysiology (r_conj) mediates_5\VBZ\761713|that|pde4b|effects|and|play (l_nsubj) pde4b_4\NN\1740|
17333137T5_17333137T17 CPR:9 monophosphate_19\NN\1740| (r_compound) pathway_21\NN\5483677|the|pde4b-regulated|cyclic|adenosine|monophosphate|signaling (l_amod) pde4b-regulated_16\JJ\1740|
23411259
23393220
23393220T33_23393220T49 NONE monoamine_3\NN\14739004| (r_compound) harmaline_7\NN\1740|between|monoamine|oxidase|a|inhibitor|and|n-dimethyltryptamine (r_nmod) interactions_1\NNS\37396|pharmacokinetic|harmaline|,|and|impact|. (l_conj) impact_15\NN\7339329|the|status (l_nmod) status_18\NN\24720|of|cyp2d6 (l_compound) cyp2d6_17\NN\1740|
23393220T33_23393220T50 NONE monoamine_3\NN\14739004| (r_compound) harmaline_7\NN\1740|between|monoamine|oxidase|a|inhibitor|and|n-dimethyltryptamine (l_compound) a_5\NN\13649268|
23393220T34_23393220T49 NONE harmaline_7\NN\1740|between|monoamine|oxidase|a|inhibitor|and|n-dimethyltryptamine (r_nmod) interactions_1\NNS\37396|pharmacokinetic|harmaline|,|and|impact|. (l_conj) impact_15\NN\7339329|the|status (l_nmod) status_18\NN\24720|of|cyp2d6 (l_compound) cyp2d6_17\NN\1740|
23393220T34_23393220T50 CPR:4 harmaline_7\NN\1740|between|monoamine|oxidase|a|inhibitor|and|n-dimethyltryptamine (l_compound) a_5\NN\13649268|
23393220T35_23393220T49 NONE n-dimethyltryptamine_11\NN\1740|5-methoxy-n|, (r_conj) harmaline_7\NN\1740|between|monoamine|oxidase|a|inhibitor|and|n-dimethyltryptamine (r_nmod) interactions_1\NNS\37396|pharmacokinetic|harmaline|,|and|impact|. (l_conj) impact_15\NN\7339329|the|status (l_nmod) status_18\NN\24720|of|cyp2d6 (l_compound) cyp2d6_17\NN\1740|
23393220T35_23393220T50 NONE n-dimethyltryptamine_11\NN\1740|5-methoxy-n|, (r_conj) harmaline_7\NN\1740|between|monoamine|oxidase|a|inhibitor|and|n-dimethyltryptamine (l_compound) a_5\NN\13649268|
23393220T17_23393220T43 NONE monoamine_8\NN\14739004| (r_compound) a_10\NN\13649268|monoamine|oxidase|mao-a
23393220T17_23393220T44 NONE monoamine_8\NN\14739004| (r_compound) a_10\NN\13649268|monoamine|oxidase|mao-a (l_appos) mao-a_12\NN\1740|(|)
23393220T18_23393220T43 CPR:4 harmaline_15\NN\1740|inhibitor|mg/kg (l_compound) inhibitor_14\NN\20090|of|a (l_compound) a_10\NN\13649268|monoamine|oxidase|mao-a
23393220T18_23393220T44 CPR:4 harmaline_15\NN\1740|inhibitor|mg/kg (l_compound) inhibitor_14\NN\20090|of|a (l_compound) a_10\NN\13649268|monoamine|oxidase|mao-a (l_appos) mao-a_12\NN\1740|(|)
23393220T19_23393220T43 NONE 5-meo-dmt_24\NN\1740|to|mg/kg|and|bufotenine (r_nmod) exposure_22\NN\5042871|systemic|5-meo-dmt (r_dobj) increases_20\VBZ\169651|that|coadministration|exposure (l_nsubj) coadministration_6\NN\1740|harmaline (l_nmod) harmaline_15\NN\1740|inhibitor|mg/kg (l_compound) inhibitor_14\NN\20090|of|a (l_compound) a_10\NN\13649268|monoamine|oxidase|mao-a
23393220T19_23393220T44 NONE 5-meo-dmt_24\NN\1740|to|mg/kg|and|bufotenine (r_nmod) exposure_22\NN\5042871|systemic|5-meo-dmt (r_dobj) increases_20\VBZ\169651|that|coadministration|exposure (l_nsubj) coadministration_6\NN\1740|harmaline (l_nmod) harmaline_15\NN\1740|inhibitor|mg/kg (l_compound) inhibitor_14\NN\20090|of|a (l_compound) a_10\NN\13649268|monoamine|oxidase|mao-a (l_appos) mao-a_12\NN\1740|(|)
23393220T21_23393220T45 NONE harmaline_6\NN\1740|and|5-meo-dmt (r_compound) interactions_13\NNS\37396|harmaline|pharmacokinetic (r_dobj) delineating_5\VBG\2137132|at|interactions|levels|,|as|impact (l_conj) impact_23\NN\7339329|the|cyp2d6 (l_nmod) cyp2d6_25\NN\1740|of|affects
23393220T22_23393220T45 NONE 5-meo-dmt_8\NN\1740| (r_conj) harmaline_6\NN\1740|and|5-meo-dmt (r_compound) interactions_13\NNS\37396|harmaline|pharmacokinetic (r_dobj) delineating_5\VBG\2137132|at|interactions|levels|,|as|impact (l_conj) impact_23\NN\7339329|the|cyp2d6 (l_nmod) cyp2d6_25\NN\1740|of|affects
23393220T23_23393220T45 NONE harmaline_28\NN\1740| (r_compound) pk_29\NN\1740|harmaline (r_dobj) affects_27\VBZ\126264|that|pk|and|determines (r_acl:relcl) cyp2d6_25\NN\1740|of|affects
23393220T24_23393220T45 NONE 5-meo-dmt_32\NN\1740| (r_compound) o-demethylation_33\NN\1740|5-meo-dmt|produce (r_dobj) determines_31\VBZ\1645601|o-demethylation (r_conj) affects_27\VBZ\126264|that|pk|and|determines (r_acl:relcl) cyp2d6_25\NN\1740|of|affects
23393220T25_23393220T45 NONE o-demethylation_33\NN\1740|5-meo-dmt|produce (r_dobj) determines_31\VBZ\1645601|o-demethylation (r_conj) affects_27\VBZ\126264|that|pk|and|determines (r_acl:relcl) cyp2d6_25\NN\1740|of|affects
23393220T26_23393220T45 NONE bufotenine_36\NN\1740| (r_dobj) produce_35\VB\1617192|to|bufotenine (r_acl) o-demethylation_33\NN\1740|5-meo-dmt|produce (r_dobj) determines_31\VBZ\1645601|o-demethylation (r_conj) affects_27\VBZ\126264|that|pk|and|determines (r_acl:relcl) cyp2d6_25\NN\1740|of|affects
23393220T28_23393220T46 CPR:4 harmaline_10\NN\1740|by|mg/kg (r_nmod) inhibition_4\NN\1068773|elimination|harmaline (l_nmod) elimination_8\NN\391599|of|mao-a-mediated|metabolic (l_amod) mao-a-mediated_6\JJ\1740|
23393220T29_23393220T46 NONE 5-meo-dmt_31\NN\1740|to|mg/kg (r_nmod) exposure_29\NN\5042871|in|systemic|5-meo-dmt (r_nmod) increase_24\NN\13576355|to|a|sharp|exposure|combinations (r_nmod) led_20\VBD\1752884|that|inhibition|increase (l_nsubj) inhibition_4\NN\1068773|elimination|harmaline (l_nmod) elimination_8\NN\391599|of|mao-a-mediated|metabolic (l_amod) mao-a-mediated_6\JJ\1740|
23393220T30_23393220T47 NONE 5-meo-dmt_5\NN\1740| (r_compound) pk_6\NN\1740|on|5-meo-dmt (r_nmod) effect_3\NN\34213|a|pronounced|pk (r_nsubjpass) associated_8\VBN\628491|effect|was|exposure|. (l_nmod) exposure_11\NN\5042871|with|greater|harmaline|mice (l_nmod) mice_16\NNS\2329401|in|wild-type|mice (l_nmod) mice_22\NNS\2329401|than|cyp2d6-humanized (l_amod) cyp2d6-humanized_18\NN\1740|tg-cyp2d6
23393220T30_23393220T48 NONE 5-meo-dmt_5\NN\1740| (r_compound) pk_6\NN\1740|on|5-meo-dmt (r_nmod) effect_3\NN\34213|a|pronounced|pk (r_nsubjpass) associated_8\VBN\628491|effect|was|exposure|. (l_nmod) exposure_11\NN\5042871|with|greater|harmaline|mice (l_nmod) mice_16\NNS\2329401|in|wild-type|mice (l_nmod) mice_22\NNS\2329401|than|cyp2d6-humanized (l_amod) cyp2d6-humanized_18\NN\1740|tg-cyp2d6 (l_appos) tg-cyp2d6_20\NN\1740|(|)
23393220T31_23393220T47 NONE harmaline_13\NN\1740|to (r_nmod) exposure_11\NN\5042871|with|greater|harmaline|mice (l_nmod) mice_16\NNS\2329401|in|wild-type|mice (l_nmod) mice_22\NNS\2329401|than|cyp2d6-humanized (l_amod) cyp2d6-humanized_18\NN\1740|tg-cyp2d6
23393220T31_23393220T48 NONE harmaline_13\NN\1740|to (r_nmod) exposure_11\NN\5042871|with|greater|harmaline|mice (l_nmod) mice_16\NNS\2329401|in|wild-type|mice (l_nmod) mice_22\NNS\2329401|than|cyp2d6-humanized (l_amod) cyp2d6-humanized_18\NN\1740|tg-cyp2d6 (l_appos) tg-cyp2d6_20\NN\1740|(|)
23393220T2_23393220T36 NONE bufotenine_10\NN\1740| (r_compound) concentrations_11\NNS\4916342|blood|bufotenine|higher (l_acl:relcl) higher_15\JJR\1740|that|were|generally|mice (l_nmod) mice_18\NNS\2329401|in|tg-cyp2d6 (l_compound) tg-cyp2d6_17\NN\1740|
23393220T32_23393220T36 NONE harmaline_0\NN\1740|mg/kg (r_nsubj) increased_6\VBD\169651|harmaline|also|concentrations|. (l_dobj) concentrations_11\NNS\4916342|blood|bufotenine|higher (l_acl:relcl) higher_15\JJR\1740|that|were|generally|mice (l_nmod) mice_18\NNS\2329401|in|tg-cyp2d6 (l_compound) tg-cyp2d6_17\NN\1740|
23393220T5_23393220T37 CPR:4 harmaline_6\NN\1740|of (r_nmod) effect_4\NN\34213|the|in|inhibitory|harmaline|formation (l_nmod) formation_10\NN\7938773|on|cyp2d6-catalyzed|bufotenine (l_amod) cyp2d6-catalyzed_8\JJ\1740|
23393220T5_23393220T38 CPR:4 harmaline_6\NN\1740|of (r_nmod) effect_4\NN\34213|the|in|inhibitory|harmaline|formation (r_nsubjpass) confirmed_12\VBN\1011725|effect|was|study|. (l_nmod) study_16\NN\635850|by|in|using (l_acl) using_17\VBG\1156834|cyp2d6 (l_dobj) cyp2d6_19\NN\1740|purified
23393220T6_23393220T37 CPR:9 bufotenine_9\NN\1740| (r_compound) formation_10\NN\7938773|on|cyp2d6-catalyzed|bufotenine (l_amod) cyp2d6-catalyzed_8\JJ\1740|
23393220T6_23393220T38 CPR:9 bufotenine_9\NN\1740| (r_compound) formation_10\NN\7938773|on|cyp2d6-catalyzed|bufotenine (r_nmod) effect_4\NN\34213|the|in|inhibitory|harmaline|formation (r_nsubjpass) confirmed_12\VBN\1011725|effect|was|study|. (l_nmod) study_16\NN\635850|by|in|using (l_acl) using_17\VBG\1156834|cyp2d6 (l_dobj) cyp2d6_19\NN\1740|purified
23393220T8_23393220T39 CPR:9 5-meo-dmt_15\NN\1740| (r_compound) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed
23393220T8_23393220T40 CPR:9 5-meo-dmt_15\NN\1740| (r_compound) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed (l_conj) cyp2d6-catalyzed_14\JJ\1740|
23393220T8_23393220T41 CPR:9 5-meo-dmt_15\NN\1740| (r_compound) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (r_nmod) inhibition_10\NN\1068773|including|the|metabolism (r_nmod) model_7\NN\5888929|a|unified|pk|inhibition (r_nsubjpass) developed_20\VBN\1753788|findings|,|model|was|describe|. (l_xcomp) describe_22\VB\1001294|to|profiles|models (l_nmod) models_38\NNS\5888929|in|wild-type|mouse (l_amod) wild-type_34\JJ\1740|both|and|tg-cyp2d6 (l_conj) tg-cyp2d6_36\NN\1740|
23393220T9_23393220T39 CPR:4 harmaline_18\NN\1740|by (r_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed
23393220T9_23393220T40 CPR:4 harmaline_18\NN\1740|by (r_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed (l_conj) cyp2d6-catalyzed_14\JJ\1740|
23393220T9_23393220T41 CPR:4 harmaline_18\NN\1740|by (r_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (r_nmod) inhibition_10\NN\1068773|including|the|metabolism (r_nmod) model_7\NN\5888929|a|unified|pk|inhibition (r_nsubjpass) developed_20\VBN\1753788|findings|,|model|was|describe|. (l_xcomp) describe_22\VB\1001294|to|profiles|models (l_nmod) models_38\NNS\5888929|in|wild-type|mouse (l_amod) wild-type_34\JJ\1740|both|and|tg-cyp2d6 (l_conj) tg-cyp2d6_36\NN\1740|
23393220T10_23393220T39 CPR:4 harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (r_xcomp) developed_20\VBN\1753788|findings|,|model|was|describe|. (l_nsubjpass) model_7\NN\5888929|a|unified|pk|inhibition (l_nmod) inhibition_10\NN\1068773|including|the|metabolism (l_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed
23393220T10_23393220T40 CPR:4 harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (r_xcomp) developed_20\VBN\1753788|findings|,|model|was|describe|. (l_nsubjpass) model_7\NN\5888929|a|unified|pk|inhibition (l_nmod) inhibition_10\NN\1068773|including|the|metabolism (l_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed (l_conj) cyp2d6-catalyzed_14\JJ\1740|
23393220T10_23393220T41 CPR:4 harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (l_nmod) models_38\NNS\5888929|in|wild-type|mouse (l_amod) wild-type_34\JJ\1740|both|and|tg-cyp2d6 (l_conj) tg-cyp2d6_36\NN\1740|
23393220T11_23393220T39 CPR:9 5-meo-dmt_26\NN\1740| (r_conj) harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (r_xcomp) developed_20\VBN\1753788|findings|,|model|was|describe|. (l_nsubjpass) model_7\NN\5888929|a|unified|pk|inhibition (l_nmod) inhibition_10\NN\1068773|including|the|metabolism (l_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed
23393220T11_23393220T40 CPR:9 5-meo-dmt_26\NN\1740| (r_conj) harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (r_xcomp) developed_20\VBN\1753788|findings|,|model|was|describe|. (l_nsubjpass) model_7\NN\5888929|a|unified|pk|inhibition (l_nmod) inhibition_10\NN\1068773|including|the|metabolism (l_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed (l_conj) cyp2d6-catalyzed_14\JJ\1740|
23393220T11_23393220T41 CPR:9 5-meo-dmt_26\NN\1740| (r_conj) harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (l_nmod) models_38\NNS\5888929|in|wild-type|mouse (l_amod) wild-type_34\JJ\1740|both|and|tg-cyp2d6 (l_conj) tg-cyp2d6_36\NN\1740|
23393220T12_23393220T39 NONE bufotenine_29\NN\1740| (r_conj) harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (r_xcomp) developed_20\VBN\1753788|findings|,|model|was|describe|. (l_nsubjpass) model_7\NN\5888929|a|unified|pk|inhibition (l_nmod) inhibition_10\NN\1068773|including|the|metabolism (l_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed
23393220T12_23393220T40 NONE bufotenine_29\NN\1740| (r_conj) harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (r_xcomp) developed_20\VBN\1753788|findings|,|model|was|describe|. (l_nsubjpass) model_7\NN\5888929|a|unified|pk|inhibition (l_nmod) inhibition_10\NN\1068773|including|the|metabolism (l_nmod) metabolism_16\NN\13526110|of|mao-a-|5-meo-dmt|harmaline (l_amod) mao-a-_12\NN\1740|and|cyp2d6-catalyzed (l_conj) cyp2d6-catalyzed_14\JJ\1740|
23393220T12_23393220T41 NONE bufotenine_29\NN\1740| (r_conj) harmaline_24\NN\1740|blood|,|5-meo-dmt|,|and|bufotenine (r_compound) profiles_31\NNS\6999802|harmaline|pk (r_dobj) describe_22\VB\1001294|to|profiles|models (l_nmod) models_38\NNS\5888929|in|wild-type|mouse (l_amod) wild-type_34\JJ\1740|both|and|tg-cyp2d6 (l_conj) tg-cyp2d6_36\NN\1740|
23393220T13_23393220T42 NONE harmaline_9\NN\1740|and|5-meo-dmt (r_compound) interactions_13\NNS\37396|harmaline|pk|doses (r_dobj) predict_8\VB\916909|to|interactions|,|define|,|and|drive (l_conj) define_18\VB\2604760|impact (l_dobj) impact_20\NN\7339329|the|status (l_nmod) status_23\NN\24720|of|cyp2d6 (l_compound) cyp2d6_22\NN\1740|
23393220T14_23393220T42 NONE 5-meo-dmt_11\NN\1740| (r_conj) harmaline_9\NN\1740|and|5-meo-dmt (r_compound) interactions_13\NNS\37396|harmaline|pk|doses (r_dobj) predict_8\VB\916909|to|interactions|,|define|,|and|drive (l_conj) define_18\VB\2604760|impact (l_dobj) impact_20\NN\7339329|the|status (l_nmod) status_23\NN\24720|of|cyp2d6 (l_compound) cyp2d6_22\NN\1740|
23393220T15_23393220T42 NONE harmaline-5-meo-dmt_27\NN\1740| (r_compound) pharmacodynamics_28\NNS\1740|harmaline-5-meo-dmt (r_dobj) drive_26\VB\1224744|pharmacodynamics (r_conj) predict_8\VB\916909|to|interactions|,|define|,|and|drive (l_conj) define_18\VB\2604760|impact (l_dobj) impact_20\NN\7339329|the|status (l_nmod) status_23\NN\24720|of|cyp2d6 (l_compound) cyp2d6_22\NN\1740|
23393220T16_23393220T42 NONE harmaline-5-meo-dmt_27\NN\1740| (r_compound) pharmacodynamics_28\NNS\1740|harmaline-5-meo-dmt (r_dobj) drive_26\VB\1224744|pharmacodynamics (r_conj) predict_8\VB\916909|to|interactions|,|define|,|and|drive (l_conj) define_18\VB\2604760|impact (l_dobj) impact_20\NN\7339329|the|status (l_nmod) status_23\NN\24720|of|cyp2d6 (l_compound) cyp2d6_22\NN\1740|
22921426
22921426T16_22921426T25 NONE )_6\-RRB-\1740| (r_punct) +_5\NN\1740|pb(2|) (r_nsubj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr
22921426T16_22921426T26 NONE )_6\-RRB-\1740| (r_punct) +_5\NN\1740|pb(2|) (r_nsubj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr (l_appos) ryr_35\NN\1740|(|)
22921426T16_22921426T27 NONE )_6\-RRB-\1740| (r_punct) +_5\NN\1740|pb(2|) (r_nsubj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r
22921426T16_22921426T28 NONE )_6\-RRB-\1740| (r_punct) +_5\NN\1740|pb(2|) (r_nsubj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (l_appos) ip(3)r_43\NN\1740|(|)
22921426T17_22921426T25 NONE [ca(2+)](i_8\NN\1740|) (r_dobj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr
22921426T17_22921426T26 NONE [ca(2+)](i_8\NN\1740|) (r_dobj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr (l_appos) ryr_35\NN\1740|(|)
22921426T17_22921426T27 NONE [ca(2+)](i_8\NN\1740|) (r_dobj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r
22921426T17_22921426T28 NONE [ca(2+)](i_8\NN\1740|) (r_dobj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (l_appos) ip(3)r_43\NN\1740|(|)
22921426T18_22921426T25 NONE [ca(2+)](er_12\NN\1740|) (r_dobj) decreased_11\VBD\169651|[ca(2+)](er|linearly|manner (r_conj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr
22921426T18_22921426T26 NONE [ca(2+)](er_12\NN\1740|) (r_dobj) decreased_11\VBD\169651|[ca(2+)](er|linearly|manner (r_conj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr (l_appos) ryr_35\NN\1740|(|)
22921426T18_22921426T27 NONE [ca(2+)](er_12\NN\1740|) (r_dobj) decreased_11\VBD\169651|[ca(2+)](er|linearly|manner (r_conj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r
22921426T18_22921426T28 NONE [ca(2+)](er_12\NN\1740|) (r_dobj) decreased_11\VBD\169651|[ca(2+)](er|linearly|manner (r_conj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (l_appos) ip(3)r_43\NN\1740|(|)
22921426T19_22921426T25 NONE )_25\-RRB-\1740| (r_punct) +_24\NN\1740|pb(2|) (r_compound) addition_26\NN\3081021|+ (r_conj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr
22921426T19_22921426T26 NONE )_25\-RRB-\1740| (r_punct) +_24\NN\1740|pb(2|) (r_compound) addition_26\NN\3081021|+ (r_conj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr (l_appos) ryr_35\NN\1740|(|)
22921426T19_22921426T27 NONE )_25\-RRB-\1740| (r_punct) +_24\NN\1740|pb(2|) (r_compound) addition_26\NN\3081021|+ (r_conj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r
22921426T19_22921426T28 NONE )_25\-RRB-\1740| (r_punct) +_24\NN\1740|pb(2|) (r_compound) addition_26\NN\3081021|+ (r_conj) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (l_appos) ip(3)r_43\NN\1740|(|)
22921426T20_22921426T25 NONE ryanodine_32\NN\1740| (r_compound) receptor_33\NN\5225602|ryanodine|ryr
22921426T20_22921426T26 NONE ryanodine_32\NN\1740| (r_compound) receptor_33\NN\5225602|ryanodine|ryr (l_appos) ryr_35\NN\1740|(|)
22921426T20_22921426T27 NONE ryanodine_32\NN\1740| (r_compound) receptor_33\NN\5225602|ryanodine|ryr (r_compound) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r
22921426T20_22921426T28 NONE ryanodine_32\NN\1740| (r_compound) receptor_33\NN\5225602|ryanodine|ryr (r_compound) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (l_appos) ip(3)r_43\NN\1740|(|)
22921426T21_22921426T25 NONE inositol-1,4,5-triphosphate_40\NN\1740| (r_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (r_compound) antagonist_45\NN\7846|an|receptor (r_conj) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr
22921426T21_22921426T26 NONE inositol-1,4,5-triphosphate_40\NN\1740| (r_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (r_compound) antagonist_45\NN\7846|an|receptor (r_conj) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr (l_appos) ryr_35\NN\1740|(|)
22921426T21_22921426T27 NONE inositol-1,4,5-triphosphate_40\NN\1740| (r_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r
22921426T21_22921426T28 NONE inositol-1,4,5-triphosphate_40\NN\1740| (r_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (l_appos) ip(3)r_43\NN\1740|(|)
22921426T22_22921426T25 NONE [ca(2+)](i_49\NN\1740|) (r_dobj) increase_48\VB\169651|did|not|[ca(2+)](i (r_advcl) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr
22921426T22_22921426T26 NONE [ca(2+)](i_49\NN\1740|) (r_dobj) increase_48\VB\169651|did|not|[ca(2+)](i (r_advcl) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_compound) receptor_33\NN\5225602|ryanodine|ryr (l_appos) ryr_35\NN\1740|(|)
22921426T22_22921426T27 NONE [ca(2+)](i_49\NN\1740|) (r_dobj) increase_48\VB\169651|did|not|[ca(2+)](i (r_advcl) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r
22921426T22_22921426T28 NONE [ca(2+)](i_49\NN\1740|) (r_dobj) increase_48\VB\169651|did|not|[ca(2+)](i (r_advcl) increased_7\VBD\169651|that|+|[ca(2+)](i|and|decreased|,|and|addition|applying|increase (l_nmod) applying_29\NN\1740|after|the|antagonist (l_nmod) antagonist_37\NN\7846|of|a|receptor|and|antagonist (l_conj) antagonist_45\NN\7846|an|receptor (l_compound) receptor_41\NN\5225602|inositol-1,4,5-triphosphate|ip(3)r (l_appos) ip(3)r_43\NN\1740|(|)
11299519
11299519T1_11299519T3 CPR:9 steroids_23\NNS\14727670|of|sex|and|gametes (r_nmod) production_20\NN\30358|for|the|steroids (r_nmod) important_17\JJ\1740|hormone|is|production|. (l_nsubj) hormone_1\NN\5404728|follicle-stimulating|fsh|,|glycoprotein|,
11299519T1_11299519T8 CPR:9 steroids_23\NNS\14727670|of|sex|and|gametes (r_nmod) production_20\NN\30358|for|the|steroids (r_nmod) important_17\JJ\1740|hormone|is|production|. (l_nsubj) hormone_1\NN\5404728|follicle-stimulating|fsh|,|glycoprotein|, (l_appos) fsh_3\NN\5410315|(|)
11299519T2_11299519T9 CPR:9 steroid_28\NN\14727670| (r_compound) production_29\NN\30358|of|impaired|sex|steroid (r_nmod) degrees_24\NNS\4916342|varying|production (r_conj) infertility_21\NN\14034177|and|degrees (r_nsubj) occur_30\VBP\2623529|although|infertility|types (r_advcl) tend_6\VBP\2604760|humans|have|,|occur|. (l_nsubj) humans_0\NNS\31264|mutations (l_nmod) mutations_5\NNS\4475|with|fsh|beta|gene (l_compound) beta_3\NN\6828818|
11299519T2_11299519T10 NONE steroid_28\NN\14727670| (r_compound) production_29\NN\30358|of|impaired|sex|steroid (r_nmod) degrees_24\NNS\4916342|varying|production (r_conj) infertility_21\NN\14034177|and|degrees (r_nsubj) occur_30\VBP\2623529|although|infertility|types (r_advcl) tend_6\VBP\2604760|humans|have|,|occur|. (l_xcomp) have_8\VB\2108377|to|phenotype|those (l_nmod) those_14\DT\1740|than|mutations (l_nmod) mutations_18\NNS\4475|with|fshr|gene (l_compound) fshr_16\NN\1740|
23414340
23414340T24_23414340T52 NONE glutathione_1\NN\1740| (r_compound) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_nummod) 1_4\CD\13741022|
23414340T24_23414340T53 NONE glutathione_1\NN\1740| (r_compound) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_appos) gsto1_6\NN\1740|(|)
23414340T24_23414340T54 NONE glutathione_1\NN\1740| (r_compound) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_conj) methyltransferase_10\NN\1740|arsenic
23414340T28_23414340T52 NONE s-transferase_2\NN\1740| (r_compound) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_nummod) 1_4\CD\13741022|
23414340T28_23414340T53 NONE s-transferase_2\NN\1740| (r_compound) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_appos) gsto1_6\NN\1740|(|)
23414340T28_23414340T54 NONE s-transferase_2\NN\1740| (r_compound) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_conj) methyltransferase_10\NN\1740|arsenic
23414340T30_23414340T52 NONE arsenic_9\JJ\1740| (r_amod) methyltransferase_10\NN\1740|arsenic (r_conj) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_nummod) 1_4\CD\13741022|
23414340T30_23414340T53 NONE arsenic_9\JJ\1740| (r_amod) methyltransferase_10\NN\1740|arsenic (r_conj) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_appos) gsto1_6\NN\1740|(|)
23414340T30_23414340T54 NONE arsenic_9\JJ\1740| (r_amod) methyltransferase_10\NN\1740|arsenic
23414340T31_23414340T52 CPR:9 )_19\-RRB-\1740| (r_punct) reduction_20\NN\351485|dmas(v|) (r_dobj) catalyze_17\VB\146138|to|reduction (r_xcomp) thought_15\VBN\670261|catalyze (r_conj) shown_13\VBN\2137132|although|omega|have|been|or|thought (l_nsubjpass) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_nummod) 1_4\CD\13741022|
23414340T31_23414340T53 NONE )_19\-RRB-\1740| (r_punct) reduction_20\NN\351485|dmas(v|) (r_dobj) catalyze_17\VB\146138|to|reduction (r_xcomp) thought_15\VBN\670261|catalyze (r_conj) shown_13\VBN\2137132|although|omega|have|been|or|thought (l_nsubjpass) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_appos) gsto1_6\NN\1740|(|)
23414340T31_23414340T54 CPR:9 )_19\-RRB-\1740| (r_punct) reduction_20\NN\351485|dmas(v|) (r_dobj) catalyze_17\VB\146138|to|reduction (r_xcomp) thought_15\VBN\670261|catalyze (r_conj) shown_13\VBN\2137132|although|omega|have|been|or|thought (l_nsubjpass) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_conj) methyltransferase_10\NN\1740|arsenic
23414340T32_23414340T52 NONE )_26\-RRB-\1740| (r_punct) reduction_27\NN\351485|in|dmas(v|)|vivo (r_nmod) role_23\NN\719494|their|reduction (r_nsubj) uncertain_36\JJ\1740|shown|,|role|is|. (l_advcl) shown_13\VBN\2137132|although|omega|have|been|or|thought (l_nsubjpass) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_nummod) 1_4\CD\13741022|
23414340T32_23414340T53 NONE )_26\-RRB-\1740| (r_punct) reduction_27\NN\351485|in|dmas(v|)|vivo (r_nmod) role_23\NN\719494|their|reduction (r_nsubj) uncertain_36\JJ\1740|shown|,|role|is|. (l_advcl) shown_13\VBN\2137132|although|omega|have|been|or|thought (l_nsubjpass) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_appos) gsto1_6\NN\1740|(|)
23414340T32_23414340T54 NONE )_26\-RRB-\1740| (r_punct) reduction_27\NN\351485|in|dmas(v|)|vivo (r_nmod) role_23\NN\719494|their|reduction (r_nsubj) uncertain_36\JJ\1740|shown|,|role|is|. (l_advcl) shown_13\VBN\2137132|although|omega|have|been|or|thought (l_nsubjpass) omega_3\NN\7291312|glutathione|s-transferase|1|gsto1|and|methyltransferase (l_conj) methyltransferase_10\NN\1740|arsenic
23414340T2_23414340T47 NONE glutathione_4\NN\1740|gsh (r_compound) depletors_8\NNS\1740|with|glutathione|phorone (r_nmod) pretreatment_0\NN\1740|rats|depletors (r_nsubj) delayed_14\VBD\439958|pretreatment|elimination|,|whereas|effect|. (l_parataxis) effect_36\NN\34213|adenosine|was|without (l_nsubj) adenosine_33\NN\14964367|the|indirect|methyltransferase|inhibitor|periodate-oxidized (l_compound) methyltransferase_30\NN\1740|
23414340T3_23414340T47 NONE gsh_6\NN\1740|(|) (r_appos) glutathione_4\NN\1740|gsh (r_compound) depletors_8\NNS\1740|with|glutathione|phorone (r_nmod) pretreatment_0\NN\1740|rats|depletors (r_nsubj) delayed_14\VBD\439958|pretreatment|elimination|,|whereas|effect|. (l_parataxis) effect_36\NN\34213|adenosine|was|without (l_nsubj) adenosine_33\NN\14964367|the|indirect|methyltransferase|inhibitor|periodate-oxidized (l_compound) methyltransferase_30\NN\1740|
23414340T4_23414340T47 NONE phorone_10\NN\1740|(|or|bso|) (r_dep) depletors_8\NNS\1740|with|glutathione|phorone (r_nmod) pretreatment_0\NN\1740|rats|depletors (r_nsubj) delayed_14\VBD\439958|pretreatment|elimination|,|whereas|effect|. (l_parataxis) effect_36\NN\34213|adenosine|was|without (l_nsubj) adenosine_33\NN\14964367|the|indirect|methyltransferase|inhibitor|periodate-oxidized (l_compound) methyltransferase_30\NN\1740|
23414340T5_23414340T47 NONE bso_12\NN\1740| (r_conj) phorone_10\NN\1740|(|or|bso|) (r_dep) depletors_8\NNS\1740|with|glutathione|phorone (r_nmod) pretreatment_0\NN\1740|rats|depletors (r_nsubj) delayed_14\VBD\439958|pretreatment|elimination|,|whereas|effect|. (l_parataxis) effect_36\NN\34213|adenosine|was|without (l_nsubj) adenosine_33\NN\14964367|the|indirect|methyltransferase|inhibitor|periodate-oxidized (l_compound) methyltransferase_30\NN\1740|
23414340T6_23414340T47 NONE )_19\-RRB-\1740| (r_punct) dmas(v_18\NN\1740|of|) (r_nmod) elimination_16\NN\391599|the|dmas(v|and|accumulation (r_dobj) delayed_14\VBD\439958|pretreatment|elimination|,|whereas|effect|. (l_parataxis) effect_36\NN\34213|adenosine|was|without (l_nsubj) adenosine_33\NN\14964367|the|indirect|methyltransferase|inhibitor|periodate-oxidized (l_compound) methyltransferase_30\NN\1740|
23414340T7_23414340T47 NONE dmas_25\NNS\1740|of|rbc-bound (r_nmod) accumulation_22\NN\13497135|the|dmas (r_conj) elimination_16\NN\391599|the|dmas(v|and|accumulation (r_dobj) delayed_14\VBD\439958|pretreatment|elimination|,|whereas|effect|. (l_parataxis) effect_36\NN\34213|adenosine|was|without (l_nsubj) adenosine_33\NN\14964367|the|indirect|methyltransferase|inhibitor|periodate-oxidized (l_compound) methyltransferase_30\NN\1740|
23414340T8_23414340T47 NONE periodate-oxidized_32\JJ\1740| (r_amod) adenosine_33\NN\14964367|the|indirect|methyltransferase|inhibitor|periodate-oxidized (l_compound) methyltransferase_30\NN\1740|
23414340T9_23414340T47 CPR:4 adenosine_33\NN\14964367|the|indirect|methyltransferase|inhibitor|periodate-oxidized (l_compound) methyltransferase_30\NN\1740|
23414340T17_23414340T48 CPR:4 aurothioglucose_8\NN\1740|(|and|sb(iii|) (r_dep) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr
23414340T17_23414340T49 CPR:4 aurothioglucose_8\NN\1740|(|and|sb(iii|) (r_dep) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr (l_appos) trr_4\NN\1740|(|)
23414340T17_23414340T50 NONE aurothioglucose_8\NN\1740|(|and|sb(iii|) (r_dep) inhibitors_6\NNS\20090|reductase|aurothioglucose (r_nsubj) inhibited_13\VBD\2510337|although|inhibitors|reduction (r_advcl) failed_33\VBD\1798936|inhibited|,|trr|support|. (l_nsubj) trr_21\NN\1740|recombinant|rat|plus|nadph|,|or|added
23414340T18_23414340T48 CPR:4 )_11\-RRB-\1740| (r_punct) sb(iii_10\NN\1740|) (r_conj) aurothioglucose_8\NN\1740|(|and|sb(iii|) (r_dep) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr
23414340T18_23414340T49 CPR:4 )_11\-RRB-\1740| (r_punct) sb(iii_10\NN\1740|) (r_conj) aurothioglucose_8\NN\1740|(|and|sb(iii|) (r_dep) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr (l_appos) trr_4\NN\1740|(|)
23414340T18_23414340T50 NONE )_11\-RRB-\1740| (r_punct) sb(iii_10\NN\1740|) (r_conj) aurothioglucose_8\NN\1740|(|and|sb(iii|) (r_dep) inhibitors_6\NNS\20090|reductase|aurothioglucose (r_nsubj) inhibited_13\VBD\2510337|although|inhibitors|reduction (r_advcl) failed_33\VBD\1798936|inhibited|,|trr|support|. (l_nsubj) trr_21\NN\1740|recombinant|rat|plus|nadph|,|or|added
23414340T19_23414340T48 NONE )_16\-RRB-\1740| (r_punct) reduction_17\NN\351485|cytosolic|dmas(v|) (r_dobj) inhibited_13\VBD\2510337|although|inhibitors|reduction (l_nsubj) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr
23414340T19_23414340T49 NONE )_16\-RRB-\1740| (r_punct) reduction_17\NN\351485|cytosolic|dmas(v|) (r_dobj) inhibited_13\VBD\2510337|although|inhibitors|reduction (l_nsubj) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr (l_appos) trr_4\NN\1740|(|)
23414340T19_23414340T50 NONE )_16\-RRB-\1740| (r_punct) reduction_17\NN\351485|cytosolic|dmas(v|) (r_dobj) inhibited_13\VBD\2510337|although|inhibitors|reduction (r_advcl) failed_33\VBD\1798936|inhibited|,|trr|support|. (l_nsubj) trr_21\NN\1740|recombinant|rat|plus|nadph|,|or|added
23414340T21_23414340T48 NONE nadph_23\NN\1740| (r_conj) trr_21\NN\1740|recombinant|rat|plus|nadph|,|or|added (r_nsubj) failed_33\VBD\1798936|inhibited|,|trr|support|. (l_advcl) inhibited_13\VBD\2510337|although|inhibitors|reduction (l_nsubj) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr
23414340T21_23414340T49 NONE nadph_23\NN\1740| (r_conj) trr_21\NN\1740|recombinant|rat|plus|nadph|,|or|added (r_nsubj) failed_33\VBD\1798936|inhibited|,|trr|support|. (l_advcl) inhibited_13\VBD\2510337|although|inhibitors|reduction (l_nsubj) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr (l_appos) trr_4\NN\1740|(|)
23414340T21_23414340T50 NONE nadph_23\NN\1740| (r_conj) trr_21\NN\1740|recombinant|rat|plus|nadph|,|or|added
23414340T22_23414340T48 NONE )_37\-RRB-\1740| (r_punct) reduction_38\NN\351485|dmas(v|) (r_dobj) support_35\VB\2199590|to|reduction (r_xcomp) failed_33\VBD\1798936|inhibited|,|trr|support|. (l_advcl) inhibited_13\VBD\2510337|although|inhibitors|reduction (l_nsubj) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr
23414340T22_23414340T49 NONE )_37\-RRB-\1740| (r_punct) reduction_38\NN\351485|dmas(v|) (r_dobj) support_35\VB\2199590|to|reduction (r_xcomp) failed_33\VBD\1798936|inhibited|,|trr|support|. (l_advcl) inhibited_13\VBD\2510337|although|inhibitors|reduction (l_nsubj) inhibitors_6\NNS\20090|reductase|aurothioglucose (l_compound) reductase_2\NN\14732946|thioredoxin|trr (l_appos) trr_4\NN\1740|(|)
23414340T22_23414340T50 NONE )_37\-RRB-\1740| (r_punct) reduction_38\NN\351485|dmas(v|) (r_dobj) support_35\VB\2199590|to|reduction (r_xcomp) failed_33\VBD\1798936|inhibited|,|trr|support|. (l_nsubj) trr_21\NN\1740|recombinant|rat|plus|nadph|,|or|added
17692748
17692748T6_17692748T15 CPR:5 dexmedetomidine_31\NN\1740|(|) (r_appos) agonist_29\NN\9613191|by|a|potent|acting|receptor|dexmedetomidine (l_compound) receptor_25\NN\5225602|alpha2|adrenergic|ar
17692748T6_17692748T17 CPR:5 dexmedetomidine_31\NN\1740|(|) (r_appos) agonist_29\NN\9613191|by|a|potent|acting|receptor|dexmedetomidine (l_compound) receptor_25\NN\5225602|alpha2|adrenergic|ar (l_appos) ar_27\NN\14622893|(|)
17692748T2_17692748T14 NONE dexmedetomidine_0\NN\1740| (r_nsubj) effective_2\JJ\1740|dexmedetomidine|was|blocking|. (l_advcl) blocking_4\VBG\1476483|in|actions|subjects (l_nmod) subjects_14\NNS\6598915|even|in|all|7|homozygous (l_acl:relcl) homozygous_17\JJ\1740|who|were|polymorphism (l_nmod) polymorphism_23\NN\11418750|for|the|del322|-|325|ar (l_nmod) ar_27\NN\14622893|in|the|alpha2c|,|mutation
17692748T3_17692748T14 NONE cocaine_9\NN\3492717|of (r_nmod) actions_7\NNS\30358|these|sympathomimetic|cocaine (r_dobj) blocking_4\VBG\1476483|in|actions|subjects (l_nmod) subjects_14\NNS\6598915|even|in|all|7|homozygous (l_acl:relcl) homozygous_17\JJ\1740|who|were|polymorphism (l_nmod) polymorphism_23\NN\11418750|for|the|del322|-|325|ar (l_nmod) ar_27\NN\14622893|in|the|alpha2c|,|mutation
17692748T4_17692748T16 NONE dexmedetomidine_12\NN\1740|with (r_nmod) sympatholysis_10\NN\1740|central|dexmedetomidine (r_nsubj) constitutes_13\VBZ\1647229|that|sympatholysis|countermeasure (l_dobj) countermeasure_17\NN\174412|a|effective|actions (l_nmod) actions_22\NNS\30358|for|cocaine|sympathomimetic|system (l_nmod) system_27\NN\3575240|on|the|human|cardiovascular|,|individuals (l_nmod) individuals_31\NNS\7347|even|in|carrying (l_acl) carrying_32\VBG\1850315|polymorphism (l_dobj) polymorphism_37\NN\11418750|the|alpha2cdel322|-|325 (l_compound) alpha2cdel322_34\NN\1740|
23063069
23276627
23276627T1_23276627T10 NONE 1-methyladenine_1\NN\1740|cytotoxic|1-mea|and|3-methylcytosine (r_compound) lesions_10\NNS\14204950|1-methyladenine|induced (r_nsubjpass) repaired_28\VBN\205885|lesions|are|protein|. (l_nmod) protein_37\NN\14944888|by|the|escherichia|coli|alkb|homolog (l_dep) alkb_38\NN\1740|and
23276627T1_23276627T11 NONE 1-methyladenine_1\NN\1740|cytotoxic|1-mea|and|3-methylcytosine (r_compound) lesions_10\NNS\14204950|1-methyladenine|induced (r_nsubjpass) repaired_28\VBN\205885|lesions|are|protein|. (l_nmod) protein_37\NN\14944888|by|the|escherichia|coli|alkb|homolog (l_conj) homolog_42\NN\1740|a|human|,|alkbh3 (l_appos) alkbh3_44\NN\1740|
23276627T3_23276627T10 NONE 1-mea_3\NN\1740|(|) (r_appos) 1-methyladenine_1\NN\1740|cytotoxic|1-mea|and|3-methylcytosine (r_compound) lesions_10\NNS\14204950|1-methyladenine|induced (r_nsubjpass) repaired_28\VBN\205885|lesions|are|protein|. (l_nmod) protein_37\NN\14944888|by|the|escherichia|coli|alkb|homolog (l_dep) alkb_38\NN\1740|and
23276627T3_23276627T11 NONE 1-mea_3\NN\1740|(|) (r_appos) 1-methyladenine_1\NN\1740|cytotoxic|1-mea|and|3-methylcytosine (r_compound) lesions_10\NNS\14204950|1-methyladenine|induced (r_nsubjpass) repaired_28\VBN\205885|lesions|are|protein|. (l_nmod) protein_37\NN\14944888|by|the|escherichia|coli|alkb|homolog (l_conj) homolog_42\NN\1740|a|human|,|alkbh3 (l_appos) alkbh3_44\NN\1740|
23276627T4_23276627T10 NONE 3-methylcytosine_6\NN\1740|3-mec (r_conj) 1-methyladenine_1\NN\1740|cytotoxic|1-mea|and|3-methylcytosine (r_compound) lesions_10\NNS\14204950|1-methyladenine|induced (r_nsubjpass) repaired_28\VBN\205885|lesions|are|protein|. (l_nmod) protein_37\NN\14944888|by|the|escherichia|coli|alkb|homolog (l_dep) alkb_38\NN\1740|and
23276627T4_23276627T11 NONE 3-methylcytosine_6\NN\1740|3-mec (r_conj) 1-methyladenine_1\NN\1740|cytotoxic|1-mea|and|3-methylcytosine (r_compound) lesions_10\NNS\14204950|1-methyladenine|induced (r_nsubjpass) repaired_28\VBN\205885|lesions|are|protein|. (l_nmod) protein_37\NN\14944888|by|the|escherichia|coli|alkb|homolog (l_conj) homolog_42\NN\1740|a|human|,|alkbh3 (l_appos) alkbh3_44\NN\1740|
23276627T5_23276627T10 NONE 3-mec_8\NN\1740|(|) (r_appos) 3-methylcytosine_6\NN\1740|3-mec (r_conj) 1-methyladenine_1\NN\1740|cytotoxic|1-mea|and|3-methylcytosine (r_compound) lesions_10\NNS\14204950|1-methyladenine|induced (r_nsubjpass) repaired_28\VBN\205885|lesions|are|protein|. (l_nmod) protein_37\NN\14944888|by|the|escherichia|coli|alkb|homolog (l_dep) alkb_38\NN\1740|and
23276627T5_23276627T11 NONE 3-mec_8\NN\1740|(|) (r_appos) 3-methylcytosine_6\NN\1740|3-mec (r_conj) 1-methyladenine_1\NN\1740|cytotoxic|1-mea|and|3-methylcytosine (r_compound) lesions_10\NNS\14204950|1-methyladenine|induced (r_nsubjpass) repaired_28\VBN\205885|lesions|are|protein|. (l_nmod) protein_37\NN\14944888|by|the|escherichia|coli|alkb|homolog (l_conj) homolog_42\NN\1740|a|human|,|alkbh3 (l_appos) alkbh3_44\NN\1740|
23276627T6_23276627T12 NONE methanesulfonate_29\NN\1740|to|methyl|mms (r_nmod) exposure_26\NN\5042871|during|methanesulfonate (r_nmod) differences_13\NNS\4723816|lesion-accumulation|exposure (r_dobj) measuring_12\VBG\697589|by|differences (r_advcl) demonstrate_3\VBP\2137132|here|,|we|repair|vivo|measuring|. (l_dobj) repair_5\NN\248977|alkb-mediated|rna (l_amod) alkb-mediated_4\JJ\1740|
23276627T6_23276627T13 NONE methanesulfonate_29\NN\1740|to|methyl|mms (r_nmod) exposure_26\NN\5042871|during|methanesulfonate (r_nmod) differences_13\NNS\4723816|lesion-accumulation|exposure (l_nmod) lesion-accumulation_15\NN\1740|in|strains (l_nmod) strains_24\NNS\7358060|in|two|independent|alkb-proficient|e.|coli (l_amod) alkb-proficient_19\JJ\1740|and|deficient
23276627T7_23276627T12 NONE mms_31\NN\13649268|(|) (r_appos) methanesulfonate_29\NN\1740|to|methyl|mms (r_nmod) exposure_26\NN\5042871|during|methanesulfonate (r_nmod) differences_13\NNS\4723816|lesion-accumulation|exposure (r_dobj) measuring_12\VBG\697589|by|differences (r_advcl) demonstrate_3\VBP\2137132|here|,|we|repair|vivo|measuring|. (l_dobj) repair_5\NN\248977|alkb-mediated|rna (l_amod) alkb-mediated_4\JJ\1740|
23276627T7_23276627T13 NONE mms_31\NN\13649268|(|) (r_appos) methanesulfonate_29\NN\1740|to|methyl|mms (r_nmod) exposure_26\NN\5042871|during|methanesulfonate (r_nmod) differences_13\NNS\4723816|lesion-accumulation|exposure (l_nmod) lesion-accumulation_15\NN\1740|in|strains (l_nmod) strains_24\NNS\7358060|in|two|independent|alkb-proficient|e.|coli (l_amod) alkb-proficient_19\JJ\1740|and|deficient
11430635
11430635T14_11430635T39 CPR:3 indomethacin_0\NN\3828465| (r_nsubj) activates_1\VBZ\1641914|indomethacin|anhydrase|and|antagonizes|. (l_dobj) anhydrase_3\NN\1740|carbonic
11430635T14_11430635T40 CPR:3 indomethacin_0\NN\3828465| (r_nsubj) activates_1\VBZ\1641914|indomethacin|anhydrase|and|antagonizes|. (l_conj) antagonizes_5\VBZ\1787955|effect|,|mechanism (l_dobj) effect_7\NN\34213|the|acetazolamide (l_nmod) acetazolamide_14\NN\1740|of|the|specific|anhydrase|inhibitor (l_compound) anhydrase_12\NN\1740|carbonic
11430635T15_11430635T39 CPR:4 acetazolamide_14\NN\1740|of|the|specific|anhydrase|inhibitor (r_nmod) effect_7\NN\34213|the|acetazolamide (r_dobj) antagonizes_5\VBZ\1787955|effect|,|mechanism (r_conj) activates_1\VBZ\1641914|indomethacin|anhydrase|and|antagonizes|. (l_dobj) anhydrase_3\NN\1740|carbonic
11430635T15_11430635T40 CPR:4 acetazolamide_14\NN\1740|of|the|specific|anhydrase|inhibitor (l_compound) anhydrase_12\NN\1740|carbonic
11430635T16_11430635T39 NONE carbonic_2\JJ\1740| (r_amod) anhydrase_3\NN\1740|carbonic
11430635T16_11430635T40 NONE carbonic_2\JJ\1740| (r_amod) anhydrase_3\NN\1740|carbonic (r_dobj) activates_1\VBZ\1641914|indomethacin|anhydrase|and|antagonizes|. (l_conj) antagonizes_5\VBZ\1787955|effect|,|mechanism (l_dobj) effect_7\NN\34213|the|acetazolamide (l_nmod) acetazolamide_14\NN\1740|of|the|specific|anhydrase|inhibitor (l_compound) anhydrase_12\NN\1740|carbonic
11430635T17_11430635T39 NONE carbonic_11\JJ\1740| (r_amod) anhydrase_12\NN\1740|carbonic (r_compound) acetazolamide_14\NN\1740|of|the|specific|anhydrase|inhibitor (r_nmod) effect_7\NN\34213|the|acetazolamide (r_dobj) antagonizes_5\VBZ\1787955|effect|,|mechanism (r_conj) activates_1\VBZ\1641914|indomethacin|anhydrase|and|antagonizes|. (l_dobj) anhydrase_3\NN\1740|carbonic
11430635T17_11430635T40 NONE carbonic_11\JJ\1740| (r_amod) anhydrase_12\NN\1740|carbonic
11430635T4_11430635T22 NONE carbonic_22\JJ\1740| (r_amod) anhydrase_23\NN\1740|carbonic|ca
11430635T4_11430635T24 NONE carbonic_22\JJ\1740| (r_amod) anhydrase_23\NN\1740|carbonic|ca (l_appos) ca_25\NN\14625458|(|)
11430635T8_11430635T22 NONE indomethacin_10\NN\3828465|of|,|acetazolamide|and|combination (r_nmod) effect_8\NN\34213|the|indomethacin|isozymes (l_nmod) isozymes_27\NNS\1740|on|anhydrase (l_compound) anhydrase_23\NN\1740|carbonic|ca
11430635T8_11430635T24 NONE indomethacin_10\NN\3828465|of|,|acetazolamide|and|combination (r_nmod) effect_8\NN\34213|the|indomethacin|isozymes (l_nmod) isozymes_27\NNS\1740|on|anhydrase (l_compound) anhydrase_23\NN\1740|carbonic|ca (l_appos) ca_25\NN\14625458|(|)
11430635T11_11430635T22 NONE acetazolamide_12\NN\1740| (r_conj) indomethacin_10\NN\3828465|of|,|acetazolamide|and|combination (r_nmod) effect_8\NN\34213|the|indomethacin|isozymes (l_nmod) isozymes_27\NNS\1740|on|anhydrase (l_compound) anhydrase_23\NN\1740|carbonic|ca
11430635T11_11430635T24 NONE acetazolamide_12\NN\1740| (r_conj) indomethacin_10\NN\3828465|of|,|acetazolamide|and|combination (r_nmod) effect_8\NN\34213|the|indomethacin|isozymes (l_nmod) isozymes_27\NNS\1740|on|anhydrase (l_compound) anhydrase_23\NN\1740|carbonic|ca (l_appos) ca_25\NN\14625458|(|)
11430635T6_11430635T30 NONE indomethacin_8\NN\3828465|of|and|acetazolamide (r_nmod) administration_6\NN\1133281|of|single|indomethacin (r_nmod) effects_1\NNS\13245626|the|administration|ca (l_nmod) ca_14\NN\14625458|on|red|cell|and|secretion
11430635T7_11430635T30 NONE acetazolamide_10\NN\1740| (r_conj) indomethacin_8\NN\3828465|of|and|acetazolamide (r_nmod) administration_6\NN\1133281|of|single|indomethacin (r_nmod) effects_1\NNS\13245626|the|administration|ca (l_nmod) ca_14\NN\14625458|on|red|cell|and|secretion
11430635T9_11430635T31 CPR:3 indomethacin_2\NN\3828465|,|and (r_nsubj) induces_10\VBZ\1627355|indomethacin|.|increase (l_dobj) increase_12\NN\13576355|an|activity (l_nmod) activity_20\NN\30358|in|erythorcyte|ca (l_compound) ca_15\NN\14625458|i|and|ca (l_nummod) i_16\CD\14622893|
11430635T9_11430635T32 CPR:3 indomethacin_2\NN\3828465|,|and (r_nsubj) induces_10\VBZ\1627355|indomethacin|.|increase (l_dobj) increase_12\NN\13576355|an|activity (l_nmod) activity_20\NN\30358|in|erythorcyte|ca (l_compound) ca_15\NN\14625458|i|and|ca (l_conj) ca_18\NN\14625458|ii (l_nummod) ii_19\CD\13741022|
11430635T10_11430635T33 CPR:4 acetazolamide_0\NN\1740|,|inhibitor|, (l_appos) inhibitor_4\NN\20090|a|specific|ca (l_nmod) ca_6\NN\14625458|of
11430635T10_11430635T34 CPR:4 acetazolamide_0\NN\1740|,|inhibitor|, (r_nsubj) reduces_8\VBZ\441445|acetazolamide|activity|. (l_dobj) activity_10\NN\30358|the|ca|cells (l_nmod) ca_12\NN\14625458|of|i|and|ca (l_nummod) i_13\CD\14622893|
11430635T10_11430635T35 CPR:4 acetazolamide_0\NN\1740|,|inhibitor|, (r_nsubj) reduces_8\VBZ\441445|acetazolamide|activity|. (l_dobj) activity_10\NN\30358|the|ca|cells (l_nmod) ca_12\NN\14625458|of|i|and|ca (l_conj) ca_15\NN\14625458|ii (l_nummod) ii_16\CD\13741022|
11430635T12_11430635T36 CPR:3 indomethacin_0\NN\3828465| (r_nsubj) antagonizes_2\VBZ\1787955|indomethacin|completely|activity|,|abolishes|. (l_dobj) activity_4\NN\30358|ca (l_compound) ca_3\NN\14625458|
11430635T12_11430635T37 CPR:3 indomethacin_0\NN\3828465| (r_nsubj) antagonizes_2\VBZ\1787955|indomethacin|completely|activity|,|abolishes|. (l_dep) abolishes_7\VBZ\1740|i.e.|effect (l_dobj) effect_10\NN\34213|the|inhibitory|acetazolamide|ca (l_nmod) ca_14\NN\14625458|on
11430635T13_11430635T36 CPR:4 acetazolamide_12\NN\1740|of (r_nmod) effect_10\NN\34213|the|inhibitory|acetazolamide|ca (r_dobj) abolishes_7\VBZ\1740|i.e.|effect (r_dep) antagonizes_2\VBZ\1787955|indomethacin|completely|activity|,|abolishes|. (l_dobj) activity_4\NN\30358|ca (l_compound) ca_3\NN\14625458|
11430635T13_11430635T37 CPR:4 acetazolamide_12\NN\1740|of (r_nmod) effect_10\NN\34213|the|inhibitory|acetazolamide|ca (l_nmod) ca_14\NN\14625458|on
11430635T1_11430635T18 CPR:4 indomethacin_6\NN\3828465|,|inhibitor|, (l_appos) inhibitor_14\NN\20090|a|known|cyclooxygenase (l_compound) cyclooxygenase_10\NN\14732946|cox
11430635T1_11430635T19 CPR:4 indomethacin_6\NN\3828465|,|inhibitor|, (l_appos) inhibitor_14\NN\20090|a|known|cyclooxygenase (l_compound) cyclooxygenase_10\NN\14732946|cox (l_appos) cox_12\NN\14732946|(|)
11430635T1_11430635T20 CPR:3 indomethacin_6\NN\3828465|,|inhibitor|, (r_nsubj) activator_19\NN\19613|that|indomethacin|is|also|an|ca (l_nmod) ca_21\NNP\14625458|of
11430635T2_11430635T21 CPR:3 indomethacin_5\NN\3828465| (r_nsubj) activator_10\NN\19613|that|indomethacin|is|only|an|ca|but|antagonizes (l_nmod) ca_12\NN\14625458|of
11430635T3_11430635T21 CPR:4 acetazolamide_19\NN\1740|of|,|inhibitor (r_nmod) effect_17\NN\34213|the|acetazolamide (r_dobj) antagonizes_15\VBZ\1787955|also|effect (r_conj) activator_10\NN\19613|that|indomethacin|is|only|an|ca|but|antagonizes (l_nmod) ca_12\NN\14625458|of
11430635T5_11430635T23 NONE indomethacin_47\NN\3828465|by (r_nmod) induced_45\VBN\1627355|indomethacin (r_acl) activation_44\NN\13561719|ca|induced (r_nsubj) cause_49\VB\1617192|that|:|firstly|,|activation|might|changes|;|synthetized (r_ccomp) suggest_38\VBP\1010118|view|,|results|cause|. (l_nmod) view_1\NN\6208021|in|role (l_nmod) role_4\NN\719494|of|the|ca|balance|as|fact (l_nmod) ca_6\NN\14625458|of
11430635T5_11430635T25 CPR:3 indomethacin_47\NN\3828465|by (r_nmod) induced_45\VBN\1627355|indomethacin (r_acl) activation_44\NN\13561719|ca|induced (l_compound) ca_43\NN\14625458|
11430635T5_11430635T26 NONE indomethacin_47\NN\3828465|by (r_nmod) induced_45\VBN\1627355|indomethacin (r_acl) activation_44\NN\13561719|ca|induced (r_nsubj) cause_49\VB\1617192|that|:|firstly|,|activation|might|changes|;|synthetized (l_dobj) changes_50\NNS\7283608|activity (l_nmod) activity_53\NN\30358|in|cox (l_compound) cox_52\NN\14732946|
11430635T5_11430635T27 NONE indomethacin_47\NN\3828465|by (r_nmod) induced_45\VBN\1627355|indomethacin (r_acl) activation_44\NN\13561719|ca|induced (r_nsubj) cause_49\VB\1617192|that|:|firstly|,|activation|might|changes|;|synthetized (l_parataxis) synthetized_59\VBN\1740|secondly|,|pgs|are|consequence|,|hypothesis (l_nmod) consequence_62\NN\34213|as|a|changes (l_nmod) changes_65\NNS\7283608|of|the|activity (l_nmod) activity_68\NN\30358|in|cox (l_compound) cox_67\NN\14732946|
12606421
12606421T21_12606421T56 NONE hormone_1\NN\5404728| (r_compound) expression_4\NN\4679549|gonadotropin-releasing|hormone|gene|development|. (l_compound) gene_3\NN\8459252|receptor (l_compound) receptor_2\NN\5225602|
12606421T14_12606421T23 NONE gnrh_4\NN\1740| (r_compound) receptor_5\NN\5225602|of|the|gnrh|gnrh-r (r_nmod) expression_1\NN\4679549|appropriate|receptor|gonadotropes (r_nsubj) critical_12\JJ\1740|expression|is|signaling|. (l_nmod) signaling_15\NN\33020|for|gnrh|and|secretion (l_conj) secretion_20\NN\13526110|for|gonadotropin|and|development (l_compound) gonadotropin_19\NN\5407119|
12606421T14_12606421T45 NONE gnrh_4\NN\1740| (r_compound) receptor_5\NN\5225602|of|the|gnrh|gnrh-r
12606421T14_12606421T49 NONE gnrh_4\NN\1740| (r_compound) receptor_5\NN\5225602|of|the|gnrh|gnrh-r (l_appos) gnrh-r_7\NN\1740|(|)
12606421T14_12606421T54 NONE gnrh_4\NN\1740| (r_compound) receptor_5\NN\5225602|of|the|gnrh|gnrh-r (r_nmod) expression_1\NN\4679549|appropriate|receptor|gonadotropes (r_nsubj) critical_12\JJ\1740|expression|is|signaling|. (l_nmod) signaling_15\NN\33020|for|gnrh|and|secretion (l_compound) gnrh_14\NN\1740|
12606421T15_12606421T23 NONE gnrh-r_7\NN\1740|(|) (r_appos) receptor_5\NN\5225602|of|the|gnrh|gnrh-r (r_nmod) expression_1\NN\4679549|appropriate|receptor|gonadotropes (r_nsubj) critical_12\JJ\1740|expression|is|signaling|. (l_nmod) signaling_15\NN\33020|for|gnrh|and|secretion (l_conj) secretion_20\NN\13526110|for|gonadotropin|and|development (l_compound) gonadotropin_19\NN\5407119|
12606421T15_12606421T45 NONE gnrh-r_7\NN\1740|(|) (r_appos) receptor_5\NN\5225602|of|the|gnrh|gnrh-r
12606421T15_12606421T49 NONE gnrh-r_7\NN\1740|(|)
12606421T15_12606421T54 NONE gnrh-r_7\NN\1740|(|) (r_appos) receptor_5\NN\5225602|of|the|gnrh|gnrh-r (r_nmod) expression_1\NN\4679549|appropriate|receptor|gonadotropes (r_nsubj) critical_12\JJ\1740|expression|is|signaling|. (l_nmod) signaling_15\NN\33020|for|gnrh|and|secretion (l_compound) gnrh_14\NN\1740|
12606421T19_12606421T23 NONE gnrh_14\NN\1740| (r_compound) signaling_15\NN\33020|for|gnrh|and|secretion (l_conj) secretion_20\NN\13526110|for|gonadotropin|and|development (l_compound) gonadotropin_19\NN\5407119|
12606421T19_12606421T45 NONE gnrh_14\NN\1740| (r_compound) signaling_15\NN\33020|for|gnrh|and|secretion (r_nmod) critical_12\JJ\1740|expression|is|signaling|. (l_nsubj) expression_1\NN\4679549|appropriate|receptor|gonadotropes (l_nmod) receptor_5\NN\5225602|of|the|gnrh|gnrh-r
12606421T19_12606421T49 NONE gnrh_14\NN\1740| (r_compound) signaling_15\NN\33020|for|gnrh|and|secretion (r_nmod) critical_12\JJ\1740|expression|is|signaling|. (l_nsubj) expression_1\NN\4679549|appropriate|receptor|gonadotropes (l_nmod) receptor_5\NN\5225602|of|the|gnrh|gnrh-r (l_appos) gnrh-r_7\NN\1740|(|)
12606421T19_12606421T54 NONE gnrh_14\NN\1740|
12606421T9_12606421T37 NONE gnrh-r_13\NN\1740|
12606421T16_12606421T50 NONE gnrh_8\NN\1740|of|the|endogenous
12606421T16_12606421T51 NONE gnrh_8\NN\1740|of|the|endogenous (r_nmod) role_4\NN\719494|the|gnrh|changes (l_nmod) changes_12\NNS\7283608|on|the|maturational|gnrh-r (l_nmod) gnrh-r_14\NN\1740|of|and|expression
12606421T16_12606421T52 NONE gnrh_8\NN\1740|of|the|endogenous (r_nmod) role_4\NN\719494|the|gnrh|changes (l_nmod) changes_12\NNS\7283608|on|the|maturational|gnrh-r (l_nmod) gnrh-r_14\NN\1740|of|and|expression (l_conj) expression_19\NN\4679549|gonadotropin|subunit|gene (l_compound) gonadotropin_16\NN\5407119|
12606421T17_12606421T50 NONE gnrh-r_14\NN\1740|of|and|expression (r_nmod) changes_12\NNS\7283608|on|the|maturational|gnrh-r (r_nmod) role_4\NN\719494|the|gnrh|changes (l_nmod) gnrh_8\NN\1740|of|the|endogenous
12606421T17_12606421T51 NONE gnrh-r_14\NN\1740|of|and|expression
12606421T17_12606421T52 NONE gnrh-r_14\NN\1740|of|and|expression (l_conj) expression_19\NN\4679549|gonadotropin|subunit|gene (l_compound) gonadotropin_16\NN\5407119|
12606421T18_12606421T53 NONE gnrh-r_9\NN\1740|
12606421T20_12606421T55 NONE gnrh-r_6\NN\1740|
12606421T1_12606421T22 NONE gnrh-r_10\NN\1740|
12606421T2_12606421T30 NONE gnrh-r_7\NN\1740|of|the
12606421T2_12606421T31 NONE gnrh-r_7\NN\1740|of|the (r_nmod) activation_4\NN\13561719|developmental|gnrh-r|and|expression (l_conj) expression_12\NN\4679549|gonadotropin|subunit|gene (l_compound) gonadotropin_9\NN\5407119|
12606421T2_12606421T32 NONE gnrh-r_7\NN\1740|of|the (r_nmod) activation_4\NN\13561719|developmental|gnrh-r|and|expression (r_nsubj) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nmod:npmod) gnrh_14\NN\1740|
12606421T2_12606421T33 NONE gnrh-r_7\NN\1740|of|the (r_nmod) activation_4\NN\13561719|developmental|gnrh-r|and|expression (r_nsubj) dependent_15\JJ\1740|whether|activation|is|gnrh (r_ccomp) ascertain_1\VB\664483|to|dependent (r_advcl) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_dobj) effect_21\NN\34213|the|blocking (l_acl) blocking_23\VBG\1476483|of|action|treating (l_dobj) action_27\NN\30358|the|endogenous|gnrh (l_compound) gnrh_26\NN\1740|
12606421T2_12606421T34 NONE gnrh-r_7\NN\1740|of|the (r_nmod) activation_4\NN\13561719|developmental|gnrh-r|and|expression (r_nsubj) dependent_15\JJ\1740|whether|activation|is|gnrh (r_ccomp) ascertain_1\VB\664483|to|dependent (r_advcl) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_dobj) effect_21\NN\34213|the|blocking (l_acl) blocking_23\VBG\1476483|of|action|treating (l_advcl) treating_29\VBG\2376958|by|rats|cetrorelix|infantile (l_nmod) cetrorelix_38\NN\1740|with|the|specific|gnrh|antagonist|weight/week (l_compound) gnrh_36\NN\1740|
12606421T3_12606421T30 NONE gnrh_14\NN\1740| (r_nmod:npmod) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nsubj) activation_4\NN\13561719|developmental|gnrh-r|and|expression (l_nmod) gnrh-r_7\NN\1740|of|the
12606421T3_12606421T31 NONE gnrh_14\NN\1740| (r_nmod:npmod) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nsubj) activation_4\NN\13561719|developmental|gnrh-r|and|expression (l_conj) expression_12\NN\4679549|gonadotropin|subunit|gene (l_compound) gonadotropin_9\NN\5407119|
12606421T3_12606421T32 NONE gnrh_14\NN\1740|
12606421T3_12606421T33 NONE gnrh_14\NN\1740| (r_nmod:npmod) dependent_15\JJ\1740|whether|activation|is|gnrh (r_ccomp) ascertain_1\VB\664483|to|dependent (r_advcl) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_dobj) effect_21\NN\34213|the|blocking (l_acl) blocking_23\VBG\1476483|of|action|treating (l_dobj) action_27\NN\30358|the|endogenous|gnrh (l_compound) gnrh_26\NN\1740|
12606421T3_12606421T34 NONE gnrh_14\NN\1740| (r_nmod:npmod) dependent_15\JJ\1740|whether|activation|is|gnrh (r_ccomp) ascertain_1\VB\664483|to|dependent (r_advcl) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_dobj) effect_21\NN\34213|the|blocking (l_acl) blocking_23\VBG\1476483|of|action|treating (l_advcl) treating_29\VBG\2376958|by|rats|cetrorelix|infantile (l_nmod) cetrorelix_38\NN\1740|with|the|specific|gnrh|antagonist|weight/week (l_compound) gnrh_36\NN\1740|
12606421T4_12606421T30 NONE gnrh_26\NN\1740| (r_compound) action_27\NN\30358|the|endogenous|gnrh (r_dobj) blocking_23\VBG\1476483|of|action|treating (r_acl) effect_21\NN\34213|the|blocking (r_dobj) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_advcl) ascertain_1\VB\664483|to|dependent (l_ccomp) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nsubj) activation_4\NN\13561719|developmental|gnrh-r|and|expression (l_nmod) gnrh-r_7\NN\1740|of|the
12606421T4_12606421T31 NONE gnrh_26\NN\1740| (r_compound) action_27\NN\30358|the|endogenous|gnrh (r_dobj) blocking_23\VBG\1476483|of|action|treating (r_acl) effect_21\NN\34213|the|blocking (r_dobj) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_advcl) ascertain_1\VB\664483|to|dependent (l_ccomp) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nsubj) activation_4\NN\13561719|developmental|gnrh-r|and|expression (l_conj) expression_12\NN\4679549|gonadotropin|subunit|gene (l_compound) gonadotropin_9\NN\5407119|
12606421T4_12606421T32 NONE gnrh_26\NN\1740| (r_compound) action_27\NN\30358|the|endogenous|gnrh (r_dobj) blocking_23\VBG\1476483|of|action|treating (r_acl) effect_21\NN\34213|the|blocking (r_dobj) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_advcl) ascertain_1\VB\664483|to|dependent (l_ccomp) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nmod:npmod) gnrh_14\NN\1740|
12606421T4_12606421T33 NONE gnrh_26\NN\1740|
12606421T4_12606421T34 NONE gnrh_26\NN\1740| (r_compound) action_27\NN\30358|the|endogenous|gnrh (r_dobj) blocking_23\VBG\1476483|of|action|treating (l_advcl) treating_29\VBG\2376958|by|rats|cetrorelix|infantile (l_nmod) cetrorelix_38\NN\1740|with|the|specific|gnrh|antagonist|weight/week (l_compound) gnrh_36\NN\1740|
12606421T5_12606421T30 NONE gnrh_36\NN\1740| (r_compound) cetrorelix_38\NN\1740|with|the|specific|gnrh|antagonist|weight/week (r_nmod) treating_29\VBG\2376958|by|rats|cetrorelix|infantile (r_advcl) blocking_23\VBG\1476483|of|action|treating (r_acl) effect_21\NN\34213|the|blocking (r_dobj) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_advcl) ascertain_1\VB\664483|to|dependent (l_ccomp) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nsubj) activation_4\NN\13561719|developmental|gnrh-r|and|expression (l_nmod) gnrh-r_7\NN\1740|of|the
12606421T5_12606421T31 NONE gnrh_36\NN\1740| (r_compound) cetrorelix_38\NN\1740|with|the|specific|gnrh|antagonist|weight/week (r_nmod) treating_29\VBG\2376958|by|rats|cetrorelix|infantile (r_advcl) blocking_23\VBG\1476483|of|action|treating (r_acl) effect_21\NN\34213|the|blocking (r_dobj) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_advcl) ascertain_1\VB\664483|to|dependent (l_ccomp) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nsubj) activation_4\NN\13561719|developmental|gnrh-r|and|expression (l_conj) expression_12\NN\4679549|gonadotropin|subunit|gene (l_compound) gonadotropin_9\NN\5407119|
12606421T5_12606421T32 NONE gnrh_36\NN\1740| (r_compound) cetrorelix_38\NN\1740|with|the|specific|gnrh|antagonist|weight/week (r_nmod) treating_29\VBG\2376958|by|rats|cetrorelix|infantile (r_advcl) blocking_23\VBG\1476483|of|action|treating (r_acl) effect_21\NN\34213|the|blocking (r_dobj) studied_19\VBN\630380|ascertain|,|we|have|effect|. (l_advcl) ascertain_1\VB\664483|to|dependent (l_ccomp) dependent_15\JJ\1740|whether|activation|is|gnrh (l_nmod:npmod) gnrh_14\NN\1740|
12606421T5_12606421T33 NONE gnrh_36\NN\1740| (r_compound) cetrorelix_38\NN\1740|with|the|specific|gnrh|antagonist|weight/week (r_nmod) treating_29\VBG\2376958|by|rats|cetrorelix|infantile (r_advcl) blocking_23\VBG\1476483|of|action|treating (l_dobj) action_27\NN\30358|the|endogenous|gnrh (l_compound) gnrh_26\NN\1740|
12606421T5_12606421T34 NONE gnrh_36\NN\1740|
12606421T6_12606421T35 CPR:4 cetrorelix_0\NN\1740| (r_nsubj) blocked_2\VBD\1476483|cetrorelix|completely|rise|. (l_dobj) rise_4\NN\7324673|the|levels (l_nmod) levels_6\NNS\4916342|of|species (l_nmod) species_12\NNS\7992450|of|the|two|abundant|,|kb|,|mrna|,|infantile (l_nmod) mrna_23\NN\14832193|of|the|gnrh-r (l_compound) gnrh-r_22\NN\1740|
12606421T7_12606421T35 NONE gnrh-r_22\NN\1740|
12606421T8_12606421T36 CPR:4 cetrorelix_0\NN\1740| (r_nsubj) abolished_2\VBD\1740|cetrorelix|also|rise|periods|. (l_dobj) rise_5\NN\7324673|the|developmental|mrnas (l_nmod) mrnas_11\NNS\14832193|of|the|subunit (l_compound) subunit_10\NN\13604718|gonadotropin|beta (l_compound) beta_9\NN\6828818|
12606421T10_12606421T38 NONE gnrh-r_18\NN\1740|of|and
12606421T10_12606421T39 NONE gnrh-r_18\NN\1740|of|and (r_nmod) induction_16\NN\7450842|by|a|progressive|gnrh-r|expression (l_nmod) expression_23\NN\4679549|gene (l_compound) gene_22\NN\8459252|gonadotropin|subunit (l_compound) gonadotropin_20\NN\5407119|
12606421T11_12606421T40 NONE gnrh-r_3\NN\1740|of|and|genes
12606421T11_12606421T41 NONE gnrh-r_3\NN\1740|of|and|genes (l_conj) genes_8\NNS\8459252|subunit (l_compound) subunit_7\NN\13604718|beta (l_compound) beta_6\NN\6828818|gonadotropin
12606421T11_12606421T42 NONE gnrh-r_3\NN\1740|of|and|genes (r_nmod) activation_1\NN\13561719|developmental|gnrh-r (r_nsubj) dependent_11\JJ\1740|activation|is|gnrh|. (l_nmod:npmod) gnrh_10\NN\1740|
12606421T12_12606421T40 NONE gnrh_10\NN\1740| (r_nmod:npmod) dependent_11\JJ\1740|activation|is|gnrh|. (l_nsubj) activation_1\NN\13561719|developmental|gnrh-r (l_nmod) gnrh-r_3\NN\1740|of|and|genes
12606421T12_12606421T41 NONE gnrh_10\NN\1740| (r_nmod:npmod) dependent_11\JJ\1740|activation|is|gnrh|. (l_nsubj) activation_1\NN\13561719|developmental|gnrh-r (l_nmod) gnrh-r_3\NN\1740|of|and|genes (l_conj) genes_8\NNS\8459252|subunit (l_compound) subunit_7\NN\13604718|beta (l_compound) beta_6\NN\6828818|gonadotropin
12606421T12_12606421T42 NONE gnrh_10\NN\1740|
12606421T13_12606421T43 NONE gnrh-independent_2\JJ\1740|
12606421T13_12606421T44 NONE gnrh-independent_2\JJ\1740| (r_amod) regulation_3\NN\6652242|the|apparent|gnrh-independent|levels (l_nmod) levels_9\NNS\4916342|of|the|mrna (l_compound) mrna_8\NN\14832193|alpha-glycoprotein|subunit (l_compound) alpha-glycoprotein_6\NN\1740|
16840830
16840830T1_16840830T12 NONE lysine_32\NN\14605787|of (r_nmod) replacement_30\NN\196485|in|a|lysine|acid (r_nmod) results_27\VBZ\2633881|that|replacement (r_acl:relcl) transition_14\NN\199130|a|heterozygous|a|to|g|codon|results (l_nmod) codon_16\NN\8459252|at|557|aag-->gag|exon (l_nummod) 557_17\CD\1740|
16840830T1_16840830T13 NONE lysine_32\NN\14605787|of (r_nmod) replacement_30\NN\196485|in|a|lysine|acid (r_nmod) results_27\VBZ\2633881|that|replacement (r_acl:relcl) transition_14\NN\199130|a|heterozygous|a|to|g|codon|results (l_nmod) codon_16\NN\8459252|at|557|aag-->gag|exon (l_appos) aag-->gag_19\NN\1740|(|)
16840830T1_16840830T14 NONE lysine_32\NN\14605787|of (r_nmod) replacement_30\NN\196485|in|a|lysine|acid (r_nmod) results_27\VBZ\2633881|that|replacement (r_acl:relcl) transition_14\NN\199130|a|heterozygous|a|to|g|codon|results (l_nmod) codon_16\NN\8459252|at|557|aag-->gag|exon (l_nmod) exon_22\NN\14830364|of|10|men1 (l_nmod) men1_25\NN\1740|of
16840830T2_16840830T12 NONE acid_35\NN\14818238|by|glutamic (r_nmod) replacement_30\NN\196485|in|a|lysine|acid (r_nmod) results_27\VBZ\2633881|that|replacement (r_acl:relcl) transition_14\NN\199130|a|heterozygous|a|to|g|codon|results (l_nmod) codon_16\NN\8459252|at|557|aag-->gag|exon (l_nummod) 557_17\CD\1740|
16840830T2_16840830T13 NONE acid_35\NN\14818238|by|glutamic (r_nmod) replacement_30\NN\196485|in|a|lysine|acid (r_nmod) results_27\VBZ\2633881|that|replacement (r_acl:relcl) transition_14\NN\199130|a|heterozygous|a|to|g|codon|results (l_nmod) codon_16\NN\8459252|at|557|aag-->gag|exon (l_appos) aag-->gag_19\NN\1740|(|)
16840830T2_16840830T14 NONE acid_35\NN\14818238|by|glutamic (r_nmod) replacement_30\NN\196485|in|a|lysine|acid (r_nmod) results_27\VBZ\2633881|that|replacement (r_acl:relcl) transition_14\NN\199130|a|heterozygous|a|to|g|codon|results (l_nmod) codon_16\NN\8459252|at|557|aag-->gag|exon (l_nmod) exon_22\NN\14830364|of|10|men1 (l_nmod) men1_25\NN\1740|of
16840830T3_16840830T5 NONE acid_29\NN\14818238|of|aspartic (r_nmod) substitution_26\NN\7337390|in|a|acid|tyrosine (r_nmod) results_23\VBZ\2633881|that|substitution (r_acl:relcl) mutation_12\NN\4475|a|heterozygous|codon|gac-->tat|results (l_appos) gac-->tat_20\NN\1740|(|)
16840830T4_16840830T5 NONE tyrosine_31\NN\14601829|by (r_nmod) substitution_26\NN\7337390|in|a|acid|tyrosine (r_nmod) results_23\VBZ\2633881|that|substitution (r_acl:relcl) mutation_12\NN\4475|a|heterozygous|codon|gac-->tat|results (l_appos) gac-->tat_20\NN\1740|(|)
23580394
23328072
23322769
23322769T1_23322769T8 NONE cholesterol_3\NN\15058310|ldl|ldl-c (l_compound) ldl_2\NN\14939230|
23322769T1_23322769T11 NONE cholesterol_3\NN\15058310|ldl|ldl-c (l_appos) ldl-c_5\NN\1740|(|)
23322769T5_23322769T16 NONE cholesterol_20\NN\15058310|low|hdl|hdl-c (r_nsubj) factor_28\NN\7326557|shown|;|cholesterol|is|an|independent|risk|cad|. (l_ccomp) shown_3\VBN\2137132|studies|have|factor (l_ccomp) factor_14\NN\7326557|that|level|is|not|the|only|risk|cad (l_nsubj) level_8\NN\4916342|a|high|ldl-c (l_compound) ldl-c_7\NN\1740|
23322769T5_23322769T17 NONE cholesterol_20\NN\15058310|low|hdl|hdl-c (l_compound) hdl_19\NN\14939230|
23322769T5_23322769T18 NONE cholesterol_20\NN\15058310|low|hdl|hdl-c (l_appos) hdl-c_22\NN\1740|(|)
23322769T6_23322769T19 NONE cholesterol_15\NN\15058310| (r_compound) transport_16\NN\3575240|reverse|cholesterol|tissues|liver|excretion (r_dobj) mediates_13\VBZ\761713|that|transport (r_acl:relcl) component_9\NN\5867413|a-i|is|the|major|protein|hdl-c|mediates|. (l_nsubj) a-i_1\NN\1740|apolipoprotein|apoa-i
23322769T6_23322769T20 NONE cholesterol_15\NN\15058310| (r_compound) transport_16\NN\3575240|reverse|cholesterol|tissues|liver|excretion (r_dobj) mediates_13\VBZ\761713|that|transport (r_acl:relcl) component_9\NN\5867413|a-i|is|the|major|protein|hdl-c|mediates|. (l_nsubj) a-i_1\NN\1740|apolipoprotein|apoa-i (l_appos) apoa-i_3\NN\1740|(|)
23322769T6_23322769T21 NONE cholesterol_15\NN\15058310| (r_compound) transport_16\NN\3575240|reverse|cholesterol|tissues|liver|excretion (r_dobj) mediates_13\VBZ\761713|that|transport (r_acl:relcl) component_9\NN\5867413|a-i|is|the|major|protein|hdl-c|mediates|. (l_nmod) hdl-c_11\NN\1740|of
23322769T2_23322769T12 CPR:4 a_13\NN\13649268|the|enzyme|inhibitor|manumycin (r_conj) sirna_7\NN\1740|by|and|a (r_nmod) repression_0\NN\13996300|farnesyltransferase|sirna (l_nmod) farnesyltransferase_2\NN\1740|of|fnta
23322769T2_23322769T13 CPR:4 a_13\NN\13649268|the|enzyme|inhibitor|manumycin (r_conj) sirna_7\NN\1740|by|and|a (r_nmod) repression_0\NN\13996300|farnesyltransferase|sirna (l_nmod) farnesyltransferase_2\NN\1740|of|fnta (l_appos) fnta_4\NN\1740|(|)
23322769T2_23322769T14 CPR:3 a_13\NN\13649268|the|enzyme|inhibitor|manumycin (r_conj) sirna_7\NN\1740|by|and|a (r_nmod) repression_0\NN\13996300|farnesyltransferase|sirna (r_nsubj) caused_14\VBD\1617192|repression|elevation|. (l_dobj) elevation_15\NN\7445480|secretion (l_nmod) secretion_18\NN\13526110|of|apoa-i|hepatocytes (l_compound) apoa-i_17\NN\1740|
23322769T2_23322769T15 CPR:3 a_13\NN\13649268|the|enzyme|inhibitor|manumycin (r_conj) sirna_7\NN\1740|by|and|a (r_nmod) repression_0\NN\13996300|farnesyltransferase|sirna (r_nsubj) caused_14\VBD\1617192|repression|elevation|. (l_dobj) elevation_15\NN\7445480|secretion (l_nmod) secretion_18\NN\13526110|of|apoa-i|hepatocytes (l_nmod) hepatocytes_20\NNS\1740|from|and|mice (l_conj) mice_24\NNS\2329401|from|transgenic|expressing (l_acl) expressing_25\VBG\928630|transgenes (l_dobj) transgenes_32\NNS\5436752|hapoa-i (l_compound) hapoa-i_26\NN\1740|and|protein
23322769T3_23322769T12 NONE ester_29\NN\14727670| (r_compound) protein_31\NN\14944888|cholesterol|ester|transfer (r_conj) hapoa-i_26\NN\1740|and|protein (r_compound) transgenes_32\NNS\5436752|hapoa-i (r_dobj) expressing_25\VBG\928630|transgenes (r_acl) mice_24\NNS\2329401|from|transgenic|expressing (r_conj) hepatocytes_20\NNS\1740|from|and|mice (r_nmod) secretion_18\NN\13526110|of|apoa-i|hepatocytes (r_nmod) elevation_15\NN\7445480|secretion (r_dobj) caused_14\VBD\1617192|repression|elevation|. (l_nsubj) repression_0\NN\13996300|farnesyltransferase|sirna (l_nmod) farnesyltransferase_2\NN\1740|of|fnta
23322769T3_23322769T13 NONE ester_29\NN\14727670| (r_compound) protein_31\NN\14944888|cholesterol|ester|transfer (r_conj) hapoa-i_26\NN\1740|and|protein (r_compound) transgenes_32\NNS\5436752|hapoa-i (r_dobj) expressing_25\VBG\928630|transgenes (r_acl) mice_24\NNS\2329401|from|transgenic|expressing (r_conj) hepatocytes_20\NNS\1740|from|and|mice (r_nmod) secretion_18\NN\13526110|of|apoa-i|hepatocytes (r_nmod) elevation_15\NN\7445480|secretion (r_dobj) caused_14\VBD\1617192|repression|elevation|. (l_nsubj) repression_0\NN\13996300|farnesyltransferase|sirna (l_nmod) farnesyltransferase_2\NN\1740|of|fnta (l_appos) fnta_4\NN\1740|(|)
23322769T3_23322769T14 NONE ester_29\NN\14727670| (r_compound) protein_31\NN\14944888|cholesterol|ester|transfer (r_conj) hapoa-i_26\NN\1740|and|protein (r_compound) transgenes_32\NNS\5436752|hapoa-i (r_dobj) expressing_25\VBG\928630|transgenes (r_acl) mice_24\NNS\2329401|from|transgenic|expressing (r_conj) hepatocytes_20\NNS\1740|from|and|mice (r_nmod) secretion_18\NN\13526110|of|apoa-i|hepatocytes (l_compound) apoa-i_17\NN\1740|
23322769T3_23322769T15 NONE ester_29\NN\14727670| (r_compound) protein_31\NN\14944888|cholesterol|ester|transfer (r_conj) hapoa-i_26\NN\1740|and|protein
22874922
22874922T1_22874922T7 NONE )_25\-RRB-\1740| (r_punct) mapk_15\NN\1740|including|,|pi3|k|,|wnt/β-catenin|,|and|ca(2|+|) (r_nmod) elements_6\NNS\11524662|the|various|participate|,|mapk|, (l_acl:relcl) participate_8\VBP\2367363|that|signaling (l_nmod) signaling_12\NN\33020|in|non-canonical|tgf-β (l_compound) tgf-β_11\NN\1740|
22874922T1_22874922T8 NONE )_25\-RRB-\1740| (r_punct) mapk_15\NN\1740|including|,|pi3|k|,|wnt/β-catenin|,|and|ca(2|+|)
22874922T1_22874922T9 NONE )_25\-RRB-\1740| (r_punct) mapk_15\NN\1740|including|,|pi3|k|,|wnt/β-catenin|,|and|ca(2|+|) (l_conj) k_18\NN\13608598|
22874922T1_22874922T10 NONE )_25\-RRB-\1740| (r_punct) mapk_15\NN\1740|including|,|pi3|k|,|wnt/β-catenin|,|and|ca(2|+|) (l_conj) wnt/β-catenin_20\NN\1740|
22874922T1_22874922T11 NONE )_25\-RRB-\1740| (r_punct) mapk_15\NN\1740|including|,|pi3|k|,|wnt/β-catenin|,|and|ca(2|+|) (l_conj) wnt/β-catenin_20\NN\1740|
12065695
12065695T12_12065695T24 CPR:4 n-[2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide_0\NN\1740|ns-398|,|inhibitor|, (l_appos) inhibitor_8\NN\20090|a|selective|cyclooxygenase-2 (l_compound) cyclooxygenase-2_7\NN\14737847|
12065695T13_12065695T24 CPR:4 ns-398_2\NN\1740|(|) (r_appos) n-[2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide_0\NN\1740|ns-398|,|inhibitor|, (l_appos) inhibitor_8\NN\20090|a|selective|cyclooxygenase-2 (l_compound) cyclooxygenase-2_7\NN\14737847|
12065695T1_12065695T14 NONE )_13\-RRB-\1740| (r_punct) j(2_12\NN\1740|15-deoxy-delta(12,14)-prostaglandin|) (r_appos) ligands_10\NNS\20090|the|ppargamma|j(2|and|troglitazone (r_nsubj) reduced_16\VBD\441445|ligands|proliferation|and|induced|. (r_conj) expressed_3\VBD\928630|cells|mrna|,|and|reduced (l_dobj) mrna_5\NN\14832193|ppargamma (l_compound) ppargamma_4\NN\1740|
12065695T1_12065695T15 NONE )_13\-RRB-\1740| (r_punct) j(2_12\NN\1740|15-deoxy-delta(12,14)-prostaglandin|) (r_appos) ligands_10\NNS\20090|the|ppargamma|j(2|and|troglitazone (l_compound) ppargamma_9\NN\1740|
12065695T2_12065695T14 NONE troglitazone_15\NN\1740| (r_conj) ligands_10\NNS\20090|the|ppargamma|j(2|and|troglitazone (r_nsubj) reduced_16\VBD\441445|ligands|proliferation|and|induced|. (r_conj) expressed_3\VBD\928630|cells|mrna|,|and|reduced (l_dobj) mrna_5\NN\14832193|ppargamma (l_compound) ppargamma_4\NN\1740|
12065695T2_12065695T15 NONE troglitazone_15\NN\1740| (r_conj) ligands_10\NNS\20090|the|ppargamma|j(2|and|troglitazone (l_compound) ppargamma_9\NN\1740|
23313557
23313557T11_23313557T42 NONE acid_16\NN\14818238| (r_compound) handling_17\NN\623162|of|bile|acid|liver (r_nmod) control_13\NN\5190804|in|the|handling (r_nmod) involved_10\VBN\2676054|control (r_acl) pathways_9\NNS\5483677|with|the|regulatory|involved (r_nmod) interaction_3\NN\37396|fxr-dependent|glucocorticoids|pathways|. (l_amod) fxr-dependent_0\JJ\1740|and|-independent
23313557T10_23313557T39 NONE gw4064_20\NN\1740|of (r_nmod) effect_18\NN\34213|the|regulatory|gw4064|genes (r_dobj) inhibited_15\VBD\2510337|effect (r_conj) induced_5\VBD\1627355|cells|,|gcs|expression|,|and|inhibited|. (l_dobj) expression_8\NN\4679549|a|decreased|fxr (l_nmod) fxr_10\NN\1740|of|and|shp
23313557T10_23313557T40 NONE gw4064_20\NN\1740|of (r_nmod) effect_18\NN\34213|the|regulatory|gw4064|genes (r_dobj) inhibited_15\VBD\2510337|effect (r_conj) induced_5\VBD\1627355|cells|,|gcs|expression|,|and|inhibited|. (l_dobj) expression_8\NN\4679549|a|decreased|fxr (l_nmod) fxr_10\NN\1740|of|and|shp (l_conj) shp_12\NN\1740|
23313557T10_23313557T41 NONE gw4064_20\NN\1740|of (r_nmod) effect_18\NN\34213|the|regulatory|gw4064|genes (l_nmod) genes_23\NNS\8459252|on|fxr-target (l_amod) fxr-target_22\JJ\1740|
23313557T1_23313557T12 NONE gw4064_12\NN\1740| (r_nsubj) caused_13\VBD\1617192|cells|,|transfected|,|gw4064|up-regulation|. (l_advcl) transfected_8\VBN\1740|only|when|they|were|fxr+rxr (l_nmod) fxr+rxr_10\NN\1740|with
23313557T1_23313557T13 NONE gw4064_12\NN\1740| (r_nsubj) caused_13\VBD\1617192|cells|,|transfected|,|gw4064|up-regulation|. (l_advcl) transfected_8\VBN\1740|only|when|they|were|fxr+rxr (l_nmod) fxr+rxr_10\NN\1740|with
23313557T1_23313557T14 CPR:3 gw4064_12\NN\1740| (r_nsubj) caused_13\VBD\1617192|cells|,|transfected|,|gw4064|up-regulation|. (l_dobj) up-regulation_14\NN\1740|shp|,|and|down-regulation (l_nmod) shp_16\NN\1740|of|and|ostβ
23313557T1_23313557T15 CPR:3 gw4064_12\NN\1740| (r_nsubj) caused_13\VBD\1617192|cells|,|transfected|,|gw4064|up-regulation|. (l_dobj) up-regulation_14\NN\1740|shp|,|and|down-regulation (l_nmod) shp_16\NN\1740|of|and|ostβ (l_conj) ostβ_18\NN\1740|
23313557T1_23313557T16 CPR:4 gw4064_12\NN\1740| (r_nsubj) caused_13\VBD\1617192|cells|,|transfected|,|gw4064|up-regulation|. (l_dobj) up-regulation_14\NN\1740|shp|,|and|down-regulation (l_conj) down-regulation_22\NN\1740|a|cyp27a1 (l_nmod) cyp27a1_24\NN\1740|of
23313557T5_23313557T21 CPR:3 gw4064-induced_8\JJ\1740| (r_amod) activation_10\NN\13561719|on|gw4064-induced|fxr (l_compound) fxr_9\NN\1740|
23313557T6_23313557T21 NONE chenodeoxycholate_13\NN\1740|and|gw4064 (r_nsubj) have_16\VBP\2108377|whereas|chenodeoxycholate|effect (r_advcl) have_3\VBP\2108377|moreover|,|gcs|effect|activation|,|have|. (l_nmod) activation_10\NN\13561719|on|gw4064-induced|fxr (l_compound) fxr_9\NN\1740|
23313557T7_23313557T21 NONE gw4064_15\NN\1740| (r_conj) chenodeoxycholate_13\NN\1740|and|gw4064 (r_nsubj) have_16\VBP\2108377|whereas|chenodeoxycholate|effect (r_advcl) have_3\VBP\2108377|moreover|,|gcs|effect|activation|,|have|. (l_nmod) activation_10\NN\13561719|on|gw4064-induced|fxr (l_compound) fxr_9\NN\1740|
15078100
15078100T14_15078100T24 NONE quinone_3\NN\14818238| (r_compound) oxidoreductase_4\NN\14732946|of|quinone|2 (l_nummod) 2_5\CD\13741022|
15078100T15_15078100T24 CPR:4 quinolines_12\NNS\1740|by|the|antimalarial (r_nmod) inhibition_8\NN\1068773|its|quinolines (r_conj) mechanism_1\NN\13446390|kinetic|oxidoreductase|and|inhibition|. (l_nmod) oxidoreductase_4\NN\14732946|of|quinone|2 (l_nummod) 2_5\CD\13741022|
15078100T1_15078100T16 NONE quinone_0\NN\14818238| (r_compound) oxidoreductase_1\NN\14732946|quinone|2|qr2|purified (l_nummod) 2_2\CD\13741022|
15078100T1_15078100T20 NONE quinone_0\NN\14818238| (r_compound) oxidoreductase_1\NN\14732946|quinone|2|qr2|purified (l_appos) qr2_4\NN\1740|(|)
15078100T6_15078100T16 NONE quinoline_22\NN\1740| (r_compound) compounds_24\NNS\5869584|of|the|quinoline|antimalarial (r_nmod) target_19\NN\7258332|to|be|a|potential|compounds (r_xcomp) shown_14\VBN\2137132|oxidoreductase|was|recently|target|graves|. (l_nsubjpass) oxidoreductase_1\NN\14732946|quinone|2|qr2|purified (l_nummod) 2_2\CD\13741022|
15078100T6_15078100T20 NONE quinoline_22\NN\1740| (r_compound) compounds_24\NNS\5869584|of|the|quinoline|antimalarial (r_nmod) target_19\NN\7258332|to|be|a|potential|compounds (r_xcomp) shown_14\VBN\2137132|oxidoreductase|was|recently|target|graves|. (l_nsubjpass) oxidoreductase_1\NN\14732946|quinone|2|qr2|purified (l_appos) qr2_4\NN\1740|(|)
15078100T8_15078100T19 CPR:9 menadione_6\NN\15092751|of (r_nmod) reduction_4\NN\351485|the|two-electron|menadione (r_dobj) catalyzes_1\VBZ\146138|qr2|reduction|oxidation|. (l_nsubj) qr2_0\NN\1740|
15078100T9_15078100T19 CPR:9 n-alkylated_11\JJ\1740|or|n-ribosylated (r_amod) nicotinamides_14\NNS\1740|of|n-alkylated (r_nmod) oxidation_9\NN\13447361|via|the|nicotinamides (r_nmod) catalyzes_1\VBZ\146138|qr2|reduction|oxidation|. (l_nsubj) qr2_0\NN\1740|
15078100T10_15078100T19 CPR:9 nicotinamides_14\NNS\1740|of|n-alkylated (r_nmod) oxidation_9\NN\13447361|via|the|nicotinamides (r_nmod) catalyzes_1\VBZ\146138|qr2|reduction|oxidation|. (l_nsubj) qr2_0\NN\1740|
15078100T11_15078100T21 CPR:4 quinolines_12\NNS\1740|by|the (r_nmod) inhibition_7\NN\1068773|of|qr2|quinolines (l_nmod) qr2_9\NN\1740|of
15078100T11_15078100T22 CPR:4 quinolines_12\NNS\1740|by|the (r_nmod) inhibition_7\NN\1068773|of|qr2|quinolines (r_nmod) mechanism_3\NN\13446390|the|and|consequences|inhibition (r_dobj) investigate_1\VB\644583|to|mechanism|further|,|used|. (l_parataxis) used_17\VBN\1156834|we|have|kinetics|define (l_advcl) define_23\VB\2604760|to|mechanism (l_dobj) mechanism_25\NN\13446390|the|qr2 (l_nmod) qr2_27\NN\1740|of
15078100T7_15078100T17 CPR:4 quinolines_12\NNS\1740|of|the (r_nmod) potency_9\NN\5196375|on|the|possible|in|quinolines (r_nmod) shed_2\VBD\173338|studies|light|potency|and|provide|. (l_conj) provide_14\VBP\2199590|foundation (l_dobj) foundation_16\NN\31921|a|studies (l_nmod) studies_19\NNS\635850|for|future|aimed (l_acl) aimed_20\VBN\1987160|creating (l_nmod) creating_22\VBG\2367363|at|inhibitors|and|understanding (l_dobj) inhibitors_26\NNS\20090|potent|qr2 (l_compound) qr2_25\NN\1740|
15078100T7_15078100T18 NONE quinolines_12\NNS\1740|of|the (r_nmod) potency_9\NN\5196375|on|the|possible|in|quinolines (r_nmod) shed_2\VBD\173338|studies|light|potency|and|provide|. (l_conj) provide_14\VBP\2199590|foundation (l_dobj) foundation_16\NN\31921|a|studies (l_nmod) studies_19\NNS\635850|for|future|aimed (l_acl) aimed_20\VBN\1987160|creating (l_nmod) creating_22\VBG\2367363|at|inhibitors|and|understanding (l_conj) understanding_29\VBG\588888|at|significance (l_dobj) significance_32\NN\5168261|the|physiological|qr2 (l_nmod) qr2_34\NN\1740|of
16437532
16437532T11_16437532T39 CPR:4 donepezil_28\NN\1740|,|galantamine|and|rivastigmine (r_appos) drugs_26\NNS\14778436|the|cholinergic|,|donepezil|, (r_dobj) consider_23\VB\689344|introduction|,|clinicians|would|drugs|pharmacotherapy|. (l_nmod) introduction_4\NN\235435|since|the|inhibitor|1997 (l_nmod) inhibitor_9\NN\20090|of|the|first|cholinesterase|chei (l_compound) cholinesterase_8\NN\14732946|
16437532T12_16437532T39 CPR:4 galantamine_30\NN\1740| (r_conj) donepezil_28\NN\1740|,|galantamine|and|rivastigmine (r_appos) drugs_26\NNS\14778436|the|cholinergic|,|donepezil|, (r_dobj) consider_23\VB\689344|introduction|,|clinicians|would|drugs|pharmacotherapy|. (l_nmod) introduction_4\NN\235435|since|the|inhibitor|1997 (l_nmod) inhibitor_9\NN\20090|of|the|first|cholinesterase|chei (l_compound) cholinesterase_8\NN\14732946|
16437532T15_16437532T39 CPR:4 rivastigmine_32\NN\1740| (r_conj) donepezil_28\NN\1740|,|galantamine|and|rivastigmine (r_appos) drugs_26\NNS\14778436|the|cholinergic|,|donepezil|, (r_dobj) consider_23\VB\689344|introduction|,|clinicians|would|drugs|pharmacotherapy|. (l_nmod) introduction_4\NN\235435|since|the|inhibitor|1997 (l_nmod) inhibitor_9\NN\20090|of|the|first|cholinesterase|chei (l_compound) cholinesterase_8\NN\14732946|
16437532T25_16437532T40 CPR:9 acetylcholine_17\NN\14807558|of|,|neurotransmitter (r_nmod) breakdown_15\NN\553173|the|acetylcholine (r_dobj) inhibiting_13\VBG\2510337|by|breakdown|, (r_advcl) work_11\VBP\2524171|they|inhibiting|blocking (l_advcl) blocking_27\VBG\1476483|by|acetylcholinesterase (l_dobj) acetylcholinesterase_30\NN\1740|the|enzyme
23578390
23578390T10_23578390T20 NONE fluoride_1\NN\14904359|sodium (r_nsubj) induces_2\VBZ\1627355|fluoride|apoptosis|mechanism|. (l_nmod) mechanism_9\NN\13446390|via|a|jnk-dependent (l_amod) jnk-dependent_8\JJ\1740|
23578390T6_23578390T12 CPR:3 naf_5\NN\1740|to|4mm (r_nmod) exposure_0\NN\5042871|cells|naf|24h (r_nsubj) induced_8\VBD\1627355|exposure|activation|,|and|resulted|. (l_dobj) activation_10\NN\13561719|caspase-3|,|alterations (l_compound) caspase-3_9\NN\1740|
23578390T6_23578390T13 NONE naf_5\NN\1740|to|4mm (r_nmod) exposure_0\NN\5042871|cells|naf|24h (r_nsubj) induced_8\VBD\1627355|exposure|activation|,|and|resulted|. (l_conj) resulted_16\VBD\2633881|translocation (l_nmod) translocation_19\NN\13526110|in|the|bax|mitochondria|and|release|,|indicating (l_nmod) bax_21\NN\1740|of
23578390T6_23578390T14 NONE naf_5\NN\1740|to|4mm (r_nmod) exposure_0\NN\5042871|cells|naf|24h (r_nsubj) induced_8\VBD\1627355|exposure|activation|,|and|resulted|. (l_conj) resulted_16\VBD\2633881|translocation (l_nmod) translocation_19\NN\13526110|in|the|bax|mitochondria|and|release|,|indicating (l_conj) release_27\NN\3748886|the|c|space|cytosol (l_nmod) c_30\NN\13714184|of|cytochrome
23578390T7_23578390T12 NONE fluoride-mediated_42\JJ\1740| (r_amod) apoptosis_43\NN\11486178|fluoride-mediated (r_nsubj) mitochondria-dependent_45\JJ\1740|that|apoptosis|is (r_ccomp) indicating_40\VBG\952524|mitochondria-dependent (r_acl) translocation_19\NN\13526110|in|the|bax|mitochondria|and|release|,|indicating (r_nmod) resulted_16\VBD\2633881|translocation (r_conj) induced_8\VBD\1627355|exposure|activation|,|and|resulted|. (l_dobj) activation_10\NN\13561719|caspase-3|,|alterations (l_compound) caspase-3_9\NN\1740|
23578390T7_23578390T13 NONE fluoride-mediated_42\JJ\1740| (r_amod) apoptosis_43\NN\11486178|fluoride-mediated (r_nsubj) mitochondria-dependent_45\JJ\1740|that|apoptosis|is (r_ccomp) indicating_40\VBG\952524|mitochondria-dependent (r_acl) translocation_19\NN\13526110|in|the|bax|mitochondria|and|release|,|indicating (l_nmod) bax_21\NN\1740|of
23578390T7_23578390T14 NONE fluoride-mediated_42\JJ\1740| (r_amod) apoptosis_43\NN\11486178|fluoride-mediated (r_nsubj) mitochondria-dependent_45\JJ\1740|that|apoptosis|is (r_ccomp) indicating_40\VBG\952524|mitochondria-dependent (r_acl) translocation_19\NN\13526110|in|the|bax|mitochondria|and|release|,|indicating (l_conj) release_27\NN\3748886|the|c|space|cytosol (l_nmod) c_30\NN\13714184|of|cytochrome
23578390T8_23578390T15 CPR:3 fluoride_0\NN\14904359| (r_compound) treatment_1\NN\654885|fluoride (r_nsubj) increased_3\VBD\169651|treatment|also|phosphorylation|,|and|suppressed|respectively|. (l_dobj) phosphorylation_4\NN\1740|jnk (l_nmod) jnk_6\NN\1740|of|and|erk|,|not|p38
23578390T8_23578390T16 CPR:3 fluoride_0\NN\14904359| (r_compound) treatment_1\NN\654885|fluoride (r_nsubj) increased_3\VBD\169651|treatment|also|phosphorylation|,|and|suppressed|respectively|. (l_dobj) phosphorylation_4\NN\1740|jnk (l_nmod) jnk_6\NN\1740|of|and|erk|,|not|p38 (l_conj) erk_8\NN\1740|
23578390T8_23578390T17 NONE fluoride_0\NN\14904359| (r_compound) treatment_1\NN\654885|fluoride (r_nsubj) increased_3\VBD\169651|treatment|also|phosphorylation|,|and|suppressed|respectively|. (l_dobj) phosphorylation_4\NN\1740|jnk (l_nmod) jnk_6\NN\1740|of|and|erk|,|not|p38 (l_conj) p38_12\NN\1740|
23578390T8_23578390T18 NONE fluoride_0\NN\14904359| (r_compound) treatment_1\NN\654885|fluoride (r_nsubj) increased_3\VBD\169651|treatment|also|phosphorylation|,|and|suppressed|respectively|. (l_conj) suppressed_23\VBN\2510337|apoptosis|was|or|treatment|, (l_nmod) treatment_25\NN\654885|by|inhibitors (l_nmod) inhibitors_30\NNS\20090|jnk (l_compound) jnk_27\NN\1740|with|or|erk
23578390T8_23578390T19 NONE fluoride_0\NN\14904359| (r_compound) treatment_1\NN\654885|fluoride (r_nsubj) increased_3\VBD\169651|treatment|also|phosphorylation|,|and|suppressed|respectively|. (l_conj) suppressed_23\VBN\2510337|apoptosis|was|or|treatment|, (l_nmod) treatment_25\NN\654885|by|inhibitors (l_nmod) inhibitors_30\NNS\20090|jnk (l_compound) jnk_27\NN\1740|with|or|erk (l_conj) erk_29\NN\1740|
23578390T9_23578390T15 NONE fluoride_18\NN\14904359|by (r_nmod) induced_16\VBN\1627355|fluoride (r_acl) apoptosis_15\NN\11486178|induced (r_nsubjpass) suppressed_23\VBN\2510337|apoptosis|was|or|treatment|, (r_conj) increased_3\VBD\169651|treatment|also|phosphorylation|,|and|suppressed|respectively|. (l_dobj) phosphorylation_4\NN\1740|jnk (l_nmod) jnk_6\NN\1740|of|and|erk|,|not|p38
23578390T9_23578390T16 NONE fluoride_18\NN\14904359|by (r_nmod) induced_16\VBN\1627355|fluoride (r_acl) apoptosis_15\NN\11486178|induced (r_nsubjpass) suppressed_23\VBN\2510337|apoptosis|was|or|treatment|, (r_conj) increased_3\VBD\169651|treatment|also|phosphorylation|,|and|suppressed|respectively|. (l_dobj) phosphorylation_4\NN\1740|jnk (l_nmod) jnk_6\NN\1740|of|and|erk|,|not|p38 (l_conj) erk_8\NN\1740|
23578390T9_23578390T17 NONE fluoride_18\NN\14904359|by (r_nmod) induced_16\VBN\1627355|fluoride (r_acl) apoptosis_15\NN\11486178|induced (r_nsubjpass) suppressed_23\VBN\2510337|apoptosis|was|or|treatment|, (r_conj) increased_3\VBD\169651|treatment|also|phosphorylation|,|and|suppressed|respectively|. (l_dobj) phosphorylation_4\NN\1740|jnk (l_nmod) jnk_6\NN\1740|of|and|erk|,|not|p38 (l_conj) p38_12\NN\1740|
23578390T9_23578390T18 NONE fluoride_18\NN\14904359|by (r_nmod) induced_16\VBN\1627355|fluoride (r_acl) apoptosis_15\NN\11486178|induced (r_nsubjpass) suppressed_23\VBN\2510337|apoptosis|was|or|treatment|, (l_nmod) treatment_25\NN\654885|by|inhibitors (l_nmod) inhibitors_30\NNS\20090|jnk (l_compound) jnk_27\NN\1740|with|or|erk
23578390T9_23578390T19 NONE fluoride_18\NN\14904359|by (r_nmod) induced_16\VBN\1627355|fluoride (r_acl) apoptosis_15\NN\11486178|induced (r_nsubjpass) suppressed_23\VBN\2510337|apoptosis|was|or|treatment|, (l_nmod) treatment_25\NN\654885|by|inhibitors (l_nmod) inhibitors_30\NNS\20090|jnk (l_compound) jnk_27\NN\1740|with|or|erk (l_conj) erk_29\NN\1740|
23578390T2_23578390T11 NONE naf_7\NN\1740| (r_nsubj) induces_8\VBZ\1627355|that|naf|apoptosis|odontoblasts|pathway (l_nmod) pathway_17\NN\5483677|through|a|jnk-dependent|mitochondrial (l_amod) jnk-dependent_15\JJ\1740|
6872937
6872937T21_6872937T39 NONE beta_37\NN\6828818|[|estradiol-17|e2|] (r_dep) steroidal_34\JJ\1740|beta|and|nonsteroidal (r_dep) of_33\IN\1740|steroidal|rats (r_acl) actions_32\NNS\30358|the|uterotropic|of|and|actions (r_dobj) inhibit_29\VB\2510337|whether|antiestrogen|could|actions (l_nsubj) antiestrogen_11\NN\1740|the|dihydroxylated|ly117018|,|affinity|, (l_nmod) affinity_17\NN\11426530|with|a|high|receptor|and|activity (l_nmod) receptor_21\NN\5225602|for|the|estrogen
6872937T26_6872937T39 NONE e2_39\NN\1740|(|) (r_appos) beta_37\NN\6828818|[|estradiol-17|e2|] (r_dep) steroidal_34\JJ\1740|beta|and|nonsteroidal (r_dep) of_33\IN\1740|steroidal|rats (r_acl) actions_32\NNS\30358|the|uterotropic|of|and|actions (r_dobj) inhibit_29\VB\2510337|whether|antiestrogen|could|actions (l_nsubj) antiestrogen_11\NN\1740|the|dihydroxylated|ly117018|,|affinity|, (l_nmod) affinity_17\NN\11426530|with|a|high|receptor|and|activity (l_nmod) receptor_21\NN\5225602|for|the|estrogen
6872937T27_6872937T39 NONE trianisylchloroethylene_48\NN\1740|tace (r_compound) estrogens_53\NNS\14745635|trianisylchloroethylene (r_conj) ici_45\NN\1740|[|3188|and|estrogens (r_dep) nonsteroidal_43\JJ\1740|ici (r_conj) steroidal_34\JJ\1740|beta|and|nonsteroidal (r_dep) of_33\IN\1740|steroidal|rats (r_acl) actions_32\NNS\30358|the|uterotropic|of|and|actions (r_dobj) inhibit_29\VB\2510337|whether|antiestrogen|could|actions (l_nsubj) antiestrogen_11\NN\1740|the|dihydroxylated|ly117018|,|affinity|, (l_nmod) affinity_17\NN\11426530|with|a|high|receptor|and|activity (l_nmod) receptor_21\NN\5225602|for|the|estrogen
6872937T28_6872937T39 NONE tace_50\NN\1740|(|)|] (r_appos) trianisylchloroethylene_48\NN\1740|tace (r_compound) estrogens_53\NNS\14745635|trianisylchloroethylene (r_conj) ici_45\NN\1740|[|3188|and|estrogens (r_dep) nonsteroidal_43\JJ\1740|ici (r_conj) steroidal_34\JJ\1740|beta|and|nonsteroidal (r_dep) of_33\IN\1740|steroidal|rats (r_acl) actions_32\NNS\30358|the|uterotropic|of|and|actions (r_dobj) inhibit_29\VB\2510337|whether|antiestrogen|could|actions (l_nsubj) antiestrogen_11\NN\1740|the|dihydroxylated|ly117018|,|affinity|, (l_nmod) affinity_17\NN\11426530|with|a|high|receptor|and|activity (l_nmod) receptor_21\NN\5225602|for|the|estrogen
6872937T29_6872937T39 NONE tamoxifen_63\NN\2714883|of|and|monohydroxytamoxifen (r_nmod) actions_61\NNS\30358|also|the|uterotropic|tamoxifen|mouse (r_conj) actions_32\NNS\30358|the|uterotropic|of|and|actions (r_dobj) inhibit_29\VB\2510337|whether|antiestrogen|could|actions (l_nsubj) antiestrogen_11\NN\1740|the|dihydroxylated|ly117018|,|affinity|, (l_nmod) affinity_17\NN\11426530|with|a|high|receptor|and|activity (l_nmod) receptor_21\NN\5225602|for|the|estrogen
6872937T30_6872937T39 NONE monohydroxytamoxifen_65\NN\1740| (r_conj) tamoxifen_63\NN\2714883|of|and|monohydroxytamoxifen (r_nmod) actions_61\NNS\30358|also|the|uterotropic|tamoxifen|mouse (r_conj) actions_32\NNS\30358|the|uterotropic|of|and|actions (r_dobj) inhibit_29\VB\2510337|whether|antiestrogen|could|actions (l_nsubj) antiestrogen_11\NN\1740|the|dihydroxylated|ly117018|,|affinity|, (l_nmod) affinity_17\NN\11426530|with|a|high|receptor|and|activity (l_nmod) receptor_21\NN\5225602|for|the|estrogen
6872937T34_6872937T39 NONE ly117018_12\NN\1740| (r_dep) antiestrogen_11\NN\1740|the|dihydroxylated|ly117018|,|affinity|, (l_nmod) affinity_17\NN\11426530|with|a|high|receptor|and|activity (l_nmod) receptor_21\NN\5225602|for|the|estrogen
6872937T24_6872937T40 NONE monohydroxytamoxifen_6\NN\1740|and|ly117018 (r_nsubj) act_10\VBP\1619354|that|monohydroxytamoxifen|probably|mechanism (l_nmod) mechanism_14\NN\13446390|through|the|same|action (l_nmod) action_16\NN\30358|of|receptor (l_nmod) receptor_20\NN\5225602|via|the|estrogen
6872937T25_6872937T40 NONE ly117018_8\NNP\1740| (r_conj) monohydroxytamoxifen_6\NN\1740|and|ly117018 (r_nsubj) act_10\VBP\1619354|that|monohydroxytamoxifen|probably|mechanism (l_nmod) mechanism_14\NN\13446390|through|the|same|action (l_nmod) action_16\NN\30358|of|receptor (l_nmod) receptor_20\NN\5225602|via|the|estrogen
11511858
11511858T7_11511858T11 NONE androgen_24\NN\14745635| (r_compound) gene_26\NN\8459252|of|a|single|androgen|receptor|encoded (l_compound) receptor_25\NN\5225602|
11511858T8_11511858T12 NONE androgen_20\NN\14745635| (r_compound) receptor_21\NN\5225602|such|the|androgen (r_nmod) receptors_15\NNS\5225602|nuclear|,|receptor|,
11511858T8_11511858T13 NONE androgen_20\NN\14745635| (r_compound) receptor_21\NN\5225602|such|the|androgen
11511858T9_11511858T15 NONE androgens_21\NNS\14745635| (r_nsubjpass) metabolized_23\VBN\1740|which|androgens|are|tissues (r_acl:relcl) mechanism_18\NN\13446390|the|metabolized (r_dobj) illuminated_16\VBN\280930|addition|,|work|has|mechanism|. (l_nmod) addition_1\NN\3081021|in|studies (l_nmod) studies_3\NNS\635850|to|focused (l_acl) focused_4\VBN\628491|mechanisms (l_nmod) mechanisms_7\NNS\13446390|on|the|function (l_nmod) function_11\NN\13783581|of|nuclear|receptor (l_compound) receptor_10\NN\5225602|
23165754
23165754T1_23165754T14 NONE tyrosine_8\NN\14601829| (r_compound) ephb4_11\NN\1740|for|the|tyrosine|kinase|receptor|and|ligand (l_compound) receptor_10\NN\5225602|
23165754T1_23165754T19 NONE tyrosine_8\NN\14601829| (r_compound) ephb4_11\NN\1740|for|the|tyrosine|kinase|receptor|and|ligand
23165754T1_23165754T20 NONE tyrosine_8\NN\14601829| (r_compound) ephb4_11\NN\1740|for|the|tyrosine|kinase|receptor|and|ligand (l_conj) ligand_14\NN\20090|its|,|ephrinb2|, (l_appos) ephrinb2_16\NN\1740|
23439561
23439561T15_23439561T55 NONE nadph_0\NN\1740| (r_compound) nox5-s_2\NNS\1740|nadph|oxidase|and|κb1
23439561T15_23439561T56 NONE nadph_0\NN\1740| (r_compound) nox5-s_2\NNS\1740|nadph|oxidase|and|κb1 (l_conj) κb1_6\NN\1740|nuclear|factor
23439561T15_23439561T57 NONE nadph_0\NN\1740| (r_compound) nox5-s_2\NNS\1740|nadph|oxidase|and|κb1 (r_nsubj) mediate_7\VBP\761713|nox5-s|expression|. (l_dobj) expression_13\NN\4679549|acid-induced|microsomal|prostaglandin|e|synthase-1|cells (l_compound) synthase-1_12\NN\1740|
23439561T16_23439561T55 NONE e_11\NN\14724645| (r_compound) expression_13\NN\4679549|acid-induced|microsomal|prostaglandin|e|synthase-1|cells (r_dobj) mediate_7\VBP\761713|nox5-s|expression|. (l_nsubj) nox5-s_2\NNS\1740|nadph|oxidase|and|κb1
23439561T16_23439561T56 NONE e_11\NN\14724645| (r_compound) expression_13\NN\4679549|acid-induced|microsomal|prostaglandin|e|synthase-1|cells (r_dobj) mediate_7\VBP\761713|nox5-s|expression|. (l_nsubj) nox5-s_2\NNS\1740|nadph|oxidase|and|κb1 (l_conj) κb1_6\NN\1740|nuclear|factor
23439561T16_23439561T57 NONE e_11\NN\14724645| (r_compound) expression_13\NN\4679549|acid-induced|microsomal|prostaglandin|e|synthase-1|cells (l_compound) synthase-1_12\NN\1740|
23439561T3_23439561T18 CPR:9 e2_3\NN\1740|(cox-2)-derived|prostaglandin|pge2 (l_amod) (cox-2)-derived_1\NN\1740|cycloxygenase-2 (l_nmod:npmod) cycloxygenase-2_0\NN\1740|
23439561T3_23439561T25 CPR:9 e2_3\NN\1740|(cox-2)-derived|prostaglandin|pge2 (l_amod) (cox-2)-derived_1\NN\1740|cycloxygenase-2
23439561T5_23439561T18 CPR:9 pge2_5\NN\1740|(|) (r_appos) e2_3\NN\1740|(cox-2)-derived|prostaglandin|pge2 (l_amod) (cox-2)-derived_1\NN\1740|cycloxygenase-2 (l_nmod:npmod) cycloxygenase-2_0\NN\1740|
23439561T5_23439561T25 CPR:9 pge2_5\NN\1740|(|) (r_appos) e2_3\NN\1740|(cox-2)-derived|prostaglandin|pge2 (l_amod) (cox-2)-derived_1\NN\1740|cycloxygenase-2
23439561T6_23439561T36 CPR:9 pge2_7\NN\1740| (r_compound) production_8\NN\30358|acid-induced|pge2 (r_dobj) mediates_5\VBZ\761713|that|cox-2|production (l_nsubj) cox-2_4\NN\14737847|
23439561T7_23439561T37 NONE e_2\NN\14724645| (r_compound) synthase_3\NN\1740|the|prostaglandin|e|pges|responsible
23439561T7_23439561T38 NONE e_2\NN\14724645| (r_compound) synthase_3\NN\1740|the|prostaglandin|e|pges|responsible (l_appos) pges_5\NN\1740|(|)
23439561T8_23439561T37 NONE pge2_10\NN\1740| (r_compound) production_11\NN\30358|for|acid-induced|pge2|be (r_nmod) responsible_7\JJ\1740|production (r_amod) synthase_3\NN\1740|the|prostaglandin|e|pges|responsible
23439561T8_23439561T38 NONE pge2_10\NN\1740| (r_compound) production_11\NN\30358|for|acid-induced|pge2|be (r_nmod) responsible_7\JJ\1740|production (r_amod) synthase_3\NN\1740|the|prostaglandin|e|pges|responsible (l_appos) pges_5\NN\1740|(|)
23439561T9_23439561T47 NONE pge2_15\NN\1740| (r_compound) production_16\NN\30358|in|pge2|and|incorporation (r_nmod) increase_13\NN\13576355|acid-induced|production (r_dobj) blocked_11\VBD\1476483|knockdown|increase|. (l_nsubj) knockdown_0\NN\1173038|mpges1|rna (l_nmod) mpges1_2\NN\1740|of
23439561T9_23439561T48 NONE pge2_15\NN\1740| (r_compound) production_16\NN\30358|in|pge2|and|incorporation (r_nmod) increase_13\NN\13576355|acid-induced|production (r_dobj) blocked_11\VBD\1476483|knockdown|increase|. (l_nsubj) knockdown_0\NN\1173038|mpges1|rna (l_nmod) rna_7\NN\14994328|by|mpges1|small|interfering|sirna (l_compound) mpges1_4\NN\1740|
23439561T10_23439561T47 NONE thymidine_18\NN\14964367| (r_compound) incorporation_19\NN\1237415|thymidine (r_conj) production_16\NN\30358|in|pge2|and|incorporation (r_nmod) increase_13\NN\13576355|acid-induced|production (r_dobj) blocked_11\VBD\1476483|knockdown|increase|. (l_nsubj) knockdown_0\NN\1173038|mpges1|rna (l_nmod) mpges1_2\NN\1740|of
23439561T10_23439561T48 NONE thymidine_18\NN\14964367| (r_compound) incorporation_19\NN\1237415|thymidine (r_conj) production_16\NN\30358|in|pge2|and|incorporation (r_nmod) increase_13\NN\13576355|acid-induced|production (r_dobj) blocked_11\VBD\1476483|knockdown|increase|. (l_nsubj) knockdown_0\NN\1173038|mpges1|rna (l_nmod) rna_7\NN\14994328|by|mpges1|small|interfering|sirna (l_compound) mpges1_4\NN\1740|
23439561T11_23439561T49 NONE nadph_2\NN\1740| (r_compound) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|,
23439561T11_23439561T50 NONE nadph_2\NN\1740| (r_compound) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (l_appos) nox5-s_5\NN\1740|
23439561T11_23439561T51 NONE nadph_2\NN\1740| (r_compound) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (l_appos) variant_8\NN\7366289|a|lacking (l_acl) lacking_9\VBG\1740|domains (l_dobj) domains_11\NNS\13934596|calcium-binding
23439561T11_23439561T52 NONE nadph_2\NN\1740| (r_compound) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (r_nmod) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) sirna_15\NN\1740|by|nox5 (l_compound) nox5_14\NN\1740|
23439561T11_23439561T53 NONE nadph_2\NN\1740| (r_compound) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (r_nmod) knockdown_0\NN\1173038|oxidase|sirna (r_nsubj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_dobj) increase_19\NN\13576355|acid-induced|expression (l_nmod) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (l_compound) mpges1_21\NN\1740|
23439561T12_23439561T49 NONE calcium-binding_10\JJ\1740| (r_amod) domains_11\NNS\13934596|calcium-binding (r_dobj) lacking_9\VBG\1740|domains (r_acl) variant_8\NN\7366289|a|lacking (r_appos) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|,
23439561T12_23439561T50 NONE calcium-binding_10\JJ\1740| (r_amod) domains_11\NNS\13934596|calcium-binding (r_dobj) lacking_9\VBG\1740|domains (r_acl) variant_8\NN\7366289|a|lacking (r_appos) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (l_appos) nox5-s_5\NN\1740|
23439561T12_23439561T51 NONE calcium-binding_10\JJ\1740| (r_amod) domains_11\NNS\13934596|calcium-binding
23439561T12_23439561T52 NONE calcium-binding_10\JJ\1740| (r_amod) domains_11\NNS\13934596|calcium-binding (r_dobj) lacking_9\VBG\1740|domains (r_acl) variant_8\NN\7366289|a|lacking (r_appos) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (r_nmod) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) sirna_15\NN\1740|by|nox5 (l_compound) nox5_14\NN\1740|
23439561T12_23439561T53 NONE calcium-binding_10\JJ\1740| (r_amod) domains_11\NNS\13934596|calcium-binding (r_dobj) lacking_9\VBG\1740|domains (r_acl) variant_8\NN\7366289|a|lacking (r_appos) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (r_nmod) knockdown_0\NN\1173038|oxidase|sirna (r_nsubj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_dobj) increase_19\NN\13576355|acid-induced|expression (l_nmod) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (l_compound) mpges1_21\NN\1740|
23439561T13_23439561T49 NONE thymidine_24\NN\14964367| (r_compound) incorporation_25\NN\1237415|thymidine (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_19\NN\13576355|acid-induced|expression (r_dobj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|,
23439561T13_23439561T50 NONE thymidine_24\NN\14964367| (r_compound) incorporation_25\NN\1237415|thymidine (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_19\NN\13576355|acid-induced|expression (r_dobj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (l_appos) nox5-s_5\NN\1740|
23439561T13_23439561T51 NONE thymidine_24\NN\14964367| (r_compound) incorporation_25\NN\1237415|thymidine (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_19\NN\13576355|acid-induced|expression (r_dobj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (l_appos) variant_8\NN\7366289|a|lacking (l_acl) lacking_9\VBG\1740|domains (l_dobj) domains_11\NNS\13934596|calcium-binding
23439561T13_23439561T52 NONE thymidine_24\NN\14964367| (r_compound) incorporation_25\NN\1237415|thymidine (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_19\NN\13576355|acid-induced|expression (r_dobj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) sirna_15\NN\1740|by|nox5 (l_compound) nox5_14\NN\1740|
23439561T13_23439561T53 NONE thymidine_24\NN\14964367| (r_compound) incorporation_25\NN\1237415|thymidine (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (l_compound) mpges1_21\NN\1740|
23439561T14_23439561T49 NONE pge2_28\NN\1740| (r_compound) production_29\NN\30358|pge2 (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_19\NN\13576355|acid-induced|expression (r_dobj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|,
23439561T14_23439561T50 NONE pge2_28\NN\1740| (r_compound) production_29\NN\30358|pge2 (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_19\NN\13576355|acid-induced|expression (r_dobj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (l_appos) nox5-s_5\NN\1740|
23439561T14_23439561T51 NONE pge2_28\NN\1740| (r_compound) production_29\NN\30358|pge2 (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_19\NN\13576355|acid-induced|expression (r_dobj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) oxidase_3\NN\14732946|of|nadph|,|nox5-s|,|variant|, (l_appos) variant_8\NN\7366289|a|lacking (l_acl) lacking_9\VBG\1740|domains (l_dobj) domains_11\NNS\13934596|calcium-binding
23439561T14_23439561T52 NONE pge2_28\NN\1740| (r_compound) production_29\NN\30358|pge2 (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_19\NN\13576355|acid-induced|expression (r_dobj) inhibited_17\VBD\2510337|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|oxidase|sirna (l_nmod) sirna_15\NN\1740|by|nox5 (l_compound) nox5_14\NN\1740|
23439561T14_23439561T53 NONE pge2_28\NN\1740| (r_compound) production_29\NN\30358|pge2 (r_conj) expression_22\NN\4679549|in|mpges1|,|incorporation|,|and|production (l_compound) mpges1_21\NN\1740|
23439561T1_23439561T21 NONE thymidine_15\NN\14964367| (r_compound) incorporation_16\NN\1237415|thymidine (r_conj) expression_13\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_10\NN\13576355|acid-induced|expression (r_dobj) decreased_8\VBD\169651|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|p50|sirna (l_nmod) p50_3\NN\1740|of|nf-κb1 (l_compound) nf-κb1_2\NN\1740|
23439561T1_23439561T22 NONE thymidine_15\NN\14964367| (r_compound) incorporation_16\NN\1237415|thymidine (r_conj) expression_13\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_10\NN\13576355|acid-induced|expression (r_dobj) decreased_8\VBD\169651|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|p50|sirna (l_nmod) p50_3\NN\1740|of|nf-κb1
23439561T1_23439561T23 NONE thymidine_15\NN\14964367| (r_compound) incorporation_16\NN\1237415|thymidine (r_conj) expression_13\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_10\NN\13576355|acid-induced|expression (r_dobj) decreased_8\VBD\169651|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|p50|sirna (l_nmod) sirna_6\NN\1740|by|p50 (l_compound) p50_5\NN\1740|
23439561T1_23439561T24 NONE thymidine_15\NN\14964367| (r_compound) incorporation_16\NN\1237415|thymidine (r_conj) expression_13\NN\4679549|in|mpges1|,|incorporation|,|and|production (l_compound) mpges1_12\NN\1740|
23439561T2_23439561T21 NONE pge2_19\NN\1740| (r_compound) production_20\NN\30358|pge2 (r_conj) expression_13\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_10\NN\13576355|acid-induced|expression (r_dobj) decreased_8\VBD\169651|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|p50|sirna (l_nmod) p50_3\NN\1740|of|nf-κb1 (l_compound) nf-κb1_2\NN\1740|
23439561T2_23439561T22 NONE pge2_19\NN\1740| (r_compound) production_20\NN\30358|pge2 (r_conj) expression_13\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_10\NN\13576355|acid-induced|expression (r_dobj) decreased_8\VBD\169651|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|p50|sirna (l_nmod) p50_3\NN\1740|of|nf-κb1
23439561T2_23439561T23 NONE pge2_19\NN\1740| (r_compound) production_20\NN\30358|pge2 (r_conj) expression_13\NN\4679549|in|mpges1|,|incorporation|,|and|production (r_nmod) increase_10\NN\13576355|acid-induced|expression (r_dobj) decreased_8\VBD\169651|knockdown|significantly|increase|. (l_nsubj) knockdown_0\NN\1173038|p50|sirna (l_nmod) sirna_6\NN\1740|by|p50 (l_compound) p50_5\NN\1740|
23439561T2_23439561T24 NONE pge2_19\NN\1740| (r_compound) production_20\NN\30358|pge2 (r_conj) expression_13\NN\4679549|in|mpges1|,|incorporation|,|and|production (l_compound) mpges1_12\NN\1740|
23439561T4_23439561T30 CPR:9 pge2_8\NN\1740| (r_compound) production_9\NN\30358|in|pge2|and|proliferation (r_nmod) increase_6\NN\13576355|acid-induced|production (r_dobj) mediates_4\VBZ\761713|that|mpges1|increase (l_nsubj) mpges1_3\NN\1740|
23085095
23085095T11_23085095T21 NONE buspirone_35\NN\3771443|of|a|specific|probe (r_nmod) method_30\NN\5616786|by|a|novel|spectrometric|buspirone (r_nmod) determined_20\VBN\1645601|method (r_acl) activity_11\NN\30358|the|and|expression|3a|determined (l_nmod) 3a_17\NN\1740|of|cytochrome|p450|rats
23085095T12_23085095T21 NONE aconitine_5\NN\1740|of|toxic (r_nmod) exposure_1\NN\5042871|the|aconitine (r_nsubj) impact_9\VB\1527271|exposure|does|not|significantly|activity|. (l_dobj) activity_11\NN\30358|the|and|expression|3a|determined (l_nmod) 3a_17\NN\1740|of|cytochrome|p450|rats
23085095T5_23085095T18 NONE buspirone_23\NN\3771443|the|probe (r_dobj) using_20\VBG\1156834|buspirone|rats (r_xcomp) explore_4\VB\789138|to|effects|,|cyp3a|using (l_nmod) cyp3a_19\NN\1740|on
23085095T7_23085095T19 NONE buspirone_19\NN\3771443| (r_compound) metabolism_20\NN\13526110|in|buspirone|and|blot (r_dobj) using_16\VBG\1156834|metabolism (r_xcomp) measured_15\VBN\697589|activity|were|also|using|. (l_nsubjpass) activity_1\NN\30358|cyp3a|and|levels|microsomes (l_compound) cyp3a_0\NN\1740|
23085095T1_23085095T20 NONE 1-(2-pyrimidinyl)piperazine_21\NN\1740|of|and|6'-hydroxybuspirone (r_nmod) formation_19\NN\7938773|in|the|1-(2-pyrimidinyl)piperazine (r_nmod) change_16\NN\7283608|since|no|formation (r_nmod) had_8\VBD\2108377|dose|effect|activity|change|. (l_nmod) activity_13\NN\30358|on|cyp3a (l_compound) cyp3a_12\NN\1740|
23085095T2_23085095T20 NONE 6'-hydroxybuspirone_23\NN\1740| (r_conj) 1-(2-pyrimidinyl)piperazine_21\NN\1740|of|and|6'-hydroxybuspirone (r_nmod) formation_19\NN\7938773|in|the|1-(2-pyrimidinyl)piperazine (r_nmod) change_16\NN\7283608|since|no|formation (r_nmod) had_8\VBD\2108377|dose|effect|activity|change|. (l_nmod) activity_13\NN\30358|on|cyp3a (l_compound) cyp3a_12\NN\1740|
15955565
15955565T2_15955565T10 NONE adp_3\NN\14964590|by|and|atp (r_nmod) activation_1\NN\13561719|platelet|adp (r_nsubj) plays_6\VBZ\1072262|activation|role|haemostasis|,|and|targets (l_conj) targets_22\NNS\7258332|receptors|are|potential|drugs|. (l_nsubj) receptors_19\NNS\5225602|their|so-called|p2
15955565T3_15955565T10 NONE atp_5\NN\14964590| (r_conj) adp_3\NN\14964590|by|and|atp (r_nmod) activation_1\NN\13561719|platelet|adp (r_nsubj) plays_6\VBZ\1072262|activation|role|haemostasis|,|and|targets (l_conj) targets_22\NNS\7258332|receptors|are|potential|drugs|. (l_nsubj) receptors_19\NNS\5225602|their|so-called|p2
15955565T1_15955565T15 NONE atp-gated_1\JJ\1740| (r_amod) channel_2\NN\6251781|the|atp-gated|p2x1 (l_dep) p2x1_3\NN\1740|and|receptors
15955565T1_15955565T16 NONE atp-gated_1\JJ\1740| (r_amod) channel_2\NN\6251781|the|atp-gated|p2x1 (l_dep) p2x1_3\NN\1740|and|receptors (l_conj) receptors_13\NNS\5225602|the|p2y1|p2y12|adp (l_compound) p2y1_9\NN\1740|protein-coupled|and
15955565T1_15955565T17 NONE atp-gated_1\JJ\1740| (r_amod) channel_2\NN\6251781|the|atp-gated|p2x1 (l_dep) p2x1_3\NN\1740|and|receptors (l_conj) receptors_13\NNS\5225602|the|p2y1|p2y12|adp (l_compound) p2y12_11\NN\1740|
15955565T1_15955565T18 NONE atp-gated_1\JJ\1740| (r_amod) channel_2\NN\6251781|the|atp-gated|p2x1 (l_dep) p2x1_3\NN\1740|and|receptors (l_conj) receptors_13\NNS\5225602|the|p2y1|p2y12|adp
15955565T4_15955565T19 NONE adp-induced_6\JJ\1740| (r_amod) change_8\NN\7283608|for|adp-induced|shape|and|aggregation (r_nmod) responsible_4\JJ\1740|receptor|is|change|,|responsible|. (l_nsubj) receptor_2\NN\5225602|the|p2y1 (l_compound) p2y1_1\NN\1740|
15955565T4_15955565T20 NONE adp-induced_6\JJ\1740| (r_amod) change_8\NN\7283608|for|adp-induced|shape|and|aggregation (r_nmod) responsible_4\JJ\1740|receptor|is|change|,|responsible|. (l_advcl) responsible_20\JJ\1740|while|receptor|is|completion (l_nsubj) receptor_18\NN\5225602|the|p2y12 (l_compound) p2y12_17\NN\1740|
15955565T4_15955565T21 NONE adp-induced_6\JJ\1740| (r_amod) change_8\NN\7283608|for|adp-induced|shape|and|aggregation (r_nmod) responsible_4\JJ\1740|receptor|is|change|,|responsible|. (l_advcl) responsible_20\JJ\1740|while|receptor|is|completion (l_nmod) completion_23\NN\556313|for|the|and|amplification|response (l_nmod) response_28\NN\11410625|of|the|adp (l_nmod) adp_30\NN\14964590|to|and|agonists (l_conj) agonists_35\NNS\9613191|to|all|platelet|,|a2 (l_nmod) a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (l_conj) thrombin_44\NN\14735953|
15955565T4_15955565T22 NONE adp-induced_6\JJ\1740| (r_amod) change_8\NN\7283608|for|adp-induced|shape|and|aggregation (r_nmod) responsible_4\JJ\1740|receptor|is|change|,|responsible|. (l_advcl) responsible_20\JJ\1740|while|receptor|is|completion (l_nmod) completion_23\NN\556313|for|the|and|amplification|response (l_nmod) response_28\NN\11410625|of|the|adp (l_nmod) adp_30\NN\14964590|to|and|agonists (l_conj) agonists_35\NNS\9613191|to|all|platelet|,|a2 (l_nmod) a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (l_conj) collagen_47\NN\15026716|
15955565T5_15955565T19 NONE adp_30\NN\14964590|to|and|agonists (r_nmod) response_28\NN\11410625|of|the|adp (r_nmod) completion_23\NN\556313|for|the|and|amplification|response (r_nmod) responsible_20\JJ\1740|while|receptor|is|completion (r_advcl) responsible_4\JJ\1740|receptor|is|change|,|responsible|. (l_nsubj) receptor_2\NN\5225602|the|p2y1 (l_compound) p2y1_1\NN\1740|
15955565T5_15955565T20 NONE adp_30\NN\14964590|to|and|agonists (r_nmod) response_28\NN\11410625|of|the|adp (r_nmod) completion_23\NN\556313|for|the|and|amplification|response (r_nmod) responsible_20\JJ\1740|while|receptor|is|completion (l_nsubj) receptor_18\NN\5225602|the|p2y12 (l_compound) p2y12_17\NN\1740|
15955565T5_15955565T21 NONE adp_30\NN\14964590|to|and|agonists (l_conj) agonists_35\NNS\9613191|to|all|platelet|,|a2 (l_nmod) a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (l_conj) thrombin_44\NN\14735953|
15955565T5_15955565T22 NONE adp_30\NN\14964590|to|and|agonists (l_conj) agonists_35\NNS\9613191|to|all|platelet|,|a2 (l_nmod) a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (l_conj) collagen_47\NN\15026716|
15955565T6_15955565T19 NONE a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (r_nmod) agonists_35\NNS\9613191|to|all|platelet|,|a2 (r_conj) adp_30\NN\14964590|to|and|agonists (r_nmod) response_28\NN\11410625|of|the|adp (r_nmod) completion_23\NN\556313|for|the|and|amplification|response (r_nmod) responsible_20\JJ\1740|while|receptor|is|completion (r_advcl) responsible_4\JJ\1740|receptor|is|change|,|responsible|. (l_nsubj) receptor_2\NN\5225602|the|p2y1 (l_compound) p2y1_1\NN\1740|
15955565T6_15955565T20 NONE a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (r_nmod) agonists_35\NNS\9613191|to|all|platelet|,|a2 (r_conj) adp_30\NN\14964590|to|and|agonists (r_nmod) response_28\NN\11410625|of|the|adp (r_nmod) completion_23\NN\556313|for|the|and|amplification|response (r_nmod) responsible_20\JJ\1740|while|receptor|is|completion (l_nsubj) receptor_18\NN\5225602|the|p2y12 (l_compound) p2y12_17\NN\1740|
15955565T6_15955565T21 NONE a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (l_conj) thrombin_44\NN\14735953|
15955565T6_15955565T22 NONE a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (l_conj) collagen_47\NN\15026716|
15955565T7_15955565T19 NONE txa2_41\NN\1740|(|) (r_appos) a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (r_nmod) agonists_35\NNS\9613191|to|all|platelet|,|a2 (r_conj) adp_30\NN\14964590|to|and|agonists (r_nmod) response_28\NN\11410625|of|the|adp (r_nmod) completion_23\NN\556313|for|the|and|amplification|response (r_nmod) responsible_20\JJ\1740|while|receptor|is|completion (r_advcl) responsible_4\JJ\1740|receptor|is|change|,|responsible|. (l_nsubj) receptor_2\NN\5225602|the|p2y1 (l_compound) p2y1_1\NN\1740|
15955565T7_15955565T20 NONE txa2_41\NN\1740|(|) (r_appos) a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (r_nmod) agonists_35\NNS\9613191|to|all|platelet|,|a2 (r_conj) adp_30\NN\14964590|to|and|agonists (r_nmod) response_28\NN\11410625|of|the|adp (r_nmod) completion_23\NN\556313|for|the|and|amplification|response (r_nmod) responsible_20\JJ\1740|while|receptor|is|completion (l_nsubj) receptor_18\NN\5225602|the|p2y12 (l_compound) p2y12_17\NN\1740|
15955565T7_15955565T21 NONE txa2_41\NN\1740|(|) (r_appos) a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (l_conj) thrombin_44\NN\14735953|
15955565T7_15955565T22 NONE txa2_41\NN\1740|(|) (r_appos) a2_39\NN\1740|including|thromboxane|txa2|,|thrombin|,|and|collagen (l_conj) collagen_47\NN\15026716|
15955565T8_15955565T25 NONE ticlopidine_25\NN\1740|like|or|clopidogrel (r_nmod) drugs_23\NNS\14778436|of|antithrombotic|ticlopidine|,|proved (r_nmod) target_20\NN\7258332|role|,|receptor|is|a|well-established|drugs|. (l_nsubj) receptor_16\NN\5225602|the|p2y12 (l_compound) p2y12_15\NN\1740|
15955565T9_15955565T25 NONE clopidogrel_27\NN\1740| (r_conj) ticlopidine_25\NN\1740|like|or|clopidogrel (r_nmod) drugs_23\NNS\14778436|of|antithrombotic|ticlopidine|,|proved (r_nmod) target_20\NN\7258332|role|,|receptor|is|a|well-established|drugs|. (l_nsubj) receptor_16\NN\5225602|the|p2y12 (l_compound) p2y12_15\NN\1740|
20427668
20427668T4_20427668T13 NONE corticosteroid_22\NN\14745635| (r_compound) feedback_23\NN\13518963|in|rapid|basal|corticosteroid|and|interaction (l_conj) interaction_26\NN\37396|its|drive (l_nmod) drive_34\NN\45250|with|hormone (l_compound) hormone_30\NN\5404728|corticotrophin|releasing|crh
20427668T4_20427668T14 NONE corticosteroid_22\NN\14745635| (r_compound) feedback_23\NN\13518963|in|rapid|basal|corticosteroid|and|interaction (l_conj) interaction_26\NN\37396|its|drive (l_nmod) drive_34\NN\45250|with|hormone (l_compound) hormone_30\NN\5404728|corticotrophin|releasing|crh (l_appos) crh_32\NN\1740|(|)
20427668T7_20427668T17 CPR:4 prednisolone_0\NN\2721538| (r_nsubj) inhibited_2\VBD\2510337|prednisolone|also|secretion|response|,|inferring|. (l_nmod) response_8\NN\11410625|in|stimulation (l_nmod) stimulation_12\NN\242808|to|exogenous|crh (l_compound) crh_11\NN\1740|
20427668T8_20427668T17 CPR:9 cortisol_5\NN\14751417| (r_conj) acth_3\NN\5407119|and|cortisol (r_compound) secretion_6\NN\13526110|acth (r_dobj) inhibited_2\VBD\2510337|prednisolone|also|secretion|response|,|inferring|. (l_nmod) response_8\NN\11410625|in|stimulation (l_nmod) stimulation_12\NN\242808|to|exogenous|crh (l_compound) crh_11\NN\1740|
20427668T1_20427668T9 NONE corticosteroid_11\NN\14745635| (r_compound) effect_13\NN\34213|the|rapid|corticosteroid|inhibitory (r_nsubj) targeted_15\VBD\1151110|that|effect|specifically|secretion (r_ccomp) suggesting_7\VBG\1010118|targeted (r_advcl) unaffected_5\JJ\1740|concentrations|were|,|suggesting|. (l_nsubj) concentrations_3\NNS\4916342|circulating|peptide (l_compound) peptide_2\NN\14724264|pomc (l_compound) pomc_1\NN\1740|
20427668T2_20427668T10 NONE prednisolone_0\NN\2721538| (r_compound) feedback_2\NN\13518963|prednisolone|fast (r_nsubjpass) reduced_5\VBN\441445|feedback|was|only|pretreatment|,|suggesting|. (l_nmod) pretreatment_10\NN\1740|by|glucocorticoid|receptor|antagonist|and|antagonism (l_compound) receptor_8\NN\5225602|
20427668T2_20427668T11 NONE prednisolone_0\NN\2721538| (r_compound) feedback_2\NN\13518963|prednisolone|fast (r_nsubjpass) reduced_5\VBN\441445|feedback|was|only|pretreatment|,|suggesting|. (l_nmod) pretreatment_10\NN\1740|by|glucocorticoid|receptor|antagonist|and|antagonism (l_conj) antagonism_16\NN\24720|not|by|mineralocorticoid|receptor (l_compound) receptor_15\NN\5225602|
20427668T2_20427668T12 NONE prednisolone_0\NN\2721538| (r_compound) feedback_2\NN\13518963|prednisolone|fast (r_nsubjpass) reduced_5\VBN\441445|feedback|was|only|pretreatment|,|suggesting|. (l_advcl) suggesting_18\VBG\1010118|pathway (l_dobj) pathway_22\NN\5483677|a|receptor-mediated (l_amod) receptor-mediated_21\JJ\1740|glucocorticoid
17661345
17661345T1_17661345T9 NONE indoleamine_0\NN\1740| (r_compound) 2,3-dioxygenase_1\NN\1740|indoleamine|ido|,|enzyme|,
17661345T1_17661345T16 NONE indoleamine_0\NN\1740| (r_compound) 2,3-dioxygenase_1\NN\1740|indoleamine|ido|,|enzyme|, (l_appos) ido_3\NN\6894544|(|)
17661345T6_17661345T9 CPR:9 tryptophan_7\NN\14605787| (r_compound) enzyme_9\NN\14723628|a|tryptophan|catabolizing (r_appos) 2,3-dioxygenase_1\NN\1740|indoleamine|ido|,|enzyme|,
17661345T6_17661345T16 CPR:9 tryptophan_7\NN\14605787| (r_compound) enzyme_9\NN\14723628|a|tryptophan|catabolizing (r_appos) 2,3-dioxygenase_1\NN\1740|indoleamine|ido|,|enzyme|, (l_appos) ido_3\NN\6894544|(|)
17661345T3_17661345T14 NONE acid_13\NN\14818238|quinolinic (r_dobj) generating_11\VBG\1617192|by|acid (r_advcl) leads_7\VBZ\1752884|neurotoxicity|generating (r_conj) induced_3\VBN\1627355|expression|is|ifn-gamma|and|leads|. (l_nsubjpass) expression_1\NN\4679549|ido (l_compound) ido_0\NN\6894544|
17661345T3_17661345T15 NONE acid_13\NN\14818238|quinolinic (r_dobj) generating_11\VBG\1617192|by|acid (r_advcl) leads_7\VBZ\1752884|neurotoxicity|generating (r_conj) induced_3\VBN\1627355|expression|is|ifn-gamma|and|leads|. (l_nmod) ifn-gamma_5\NN\1740|by
17661345T7_17661345T27 NONE tryptophanyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|tryptophanyl-trna|wrs|,|coinduced|,
17661345T7_17661345T28 NONE tryptophanyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|tryptophanyl-trna|wrs|,|coinduced|, (l_appos) wrs_5\NN\1740|(|)
17661345T7_17661345T29 NONE tryptophanyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|tryptophanyl-trna|wrs|,|coinduced|, (l_acl:relcl) coinduced_10\VBN\1740|which|is|ido|ifn-gamma (l_nmod) ido_12\NN\6894544|with
17661345T7_17661345T30 NONE tryptophanyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|tryptophanyl-trna|wrs|,|coinduced|, (l_acl:relcl) coinduced_10\VBN\1740|which|is|ido|ifn-gamma (l_nmod) ifn-gamma_14\NN\1740|by
17661345T7_17661345T31 NONE tryptophanyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|tryptophanyl-trna|wrs|,|coinduced|, (r_nsubjpass) downregulated_17\VBN\1740|however|,|synthetase|is|il-4|. (l_nmod) il-4_19\NN\1740|by|and|il-13
17661345T7_17661345T32 NONE tryptophanyl-trna_2\JJ\1740| (r_amod) synthetase_3\NN\1740|tryptophanyl-trna|wrs|,|coinduced|, (r_nsubjpass) downregulated_17\VBN\1740|however|,|synthetase|is|il-4|. (l_nmod) il-4_19\NN\1740|by|and|il-13 (l_conj) il-13_21\NN\1740|
17661345T8_17661345T10 NONE phosphatidylinositol_1\NN\1740| (r_compound) 3-kinase_2\NN\1740|phosphatidylinositol|pi3|k (r_compound) pathway_7\NN\5483677|the|3-kinase (r_nsubj) differentiated_9\VBD\618878|pathway|further|regulation|,|eliminated|. (l_advcl) eliminated_23\VBD\1619929|as|inhibiting|induction|,|enhanced (l_csubj) inhibiting_18\VBG\2510337|pathway (l_dobj) pathway_22\NN\5483677|the|pi3|k (l_compound) k_21\NN\13608598|
17661345T8_17661345T11 NONE phosphatidylinositol_1\NN\1740| (r_compound) 3-kinase_2\NN\1740|phosphatidylinositol|pi3|k (r_compound) pathway_7\NN\5483677|the|3-kinase (r_nsubj) differentiated_9\VBD\618878|pathway|further|regulation|,|eliminated|. (l_advcl) eliminated_23\VBD\1619929|as|inhibiting|induction|,|enhanced (l_dobj) induction_25\NN\7450842|ifn-gamma|ido (l_compound) ifn-gamma_24\NN\1740|
17661345T8_17661345T12 NONE phosphatidylinositol_1\NN\1740| (r_compound) 3-kinase_2\NN\1740|phosphatidylinositol|pi3|k (r_compound) pathway_7\NN\5483677|the|3-kinase (r_nsubj) differentiated_9\VBD\618878|pathway|further|regulation|,|eliminated|. (l_advcl) eliminated_23\VBD\1619929|as|inhibiting|induction|,|enhanced (l_dobj) induction_25\NN\7450842|ifn-gamma|ido (l_nmod) ido_27\NN\6894544|of
17661345T8_17661345T13 NONE phosphatidylinositol_1\NN\1740| (r_compound) 3-kinase_2\NN\1740|phosphatidylinositol|pi3|k (r_compound) pathway_7\NN\5483677|the|3-kinase (r_nsubj) differentiated_9\VBD\618878|pathway|further|regulation|,|eliminated|. (l_advcl) eliminated_23\VBD\1619929|as|inhibiting|induction|,|enhanced (l_advcl) enhanced_33\VBD\227165|whereas|inhibition|greatly|expression (l_dobj) expression_35\NN\4679549|wrs (l_compound) wrs_34\NN\1740|
17661345T8_17661345T40 NONE phosphatidylinositol_1\NN\1740| (r_compound) 3-kinase_2\NN\1740|phosphatidylinositol|pi3|k
17661345T8_17661345T41 NONE phosphatidylinositol_1\NN\1740| (r_compound) 3-kinase_2\NN\1740|phosphatidylinositol|pi3|k (l_appos) k_5\NN\13608598|)
23418674
23418674T2_23418674T10 CPR:5 etoac_6\NN\1740| (r_compound) extract_7\NN\14589223|both|the|etoac|and|berberine (r_nsubj) able_11\JJ\1740|that|extract|were|activate|,|and|contains (l_xcomp) activate_13\VB\1641914|to|pparα/β/γ (l_dobj) pparα/β/γ_14\NN\1740|
23418674T2_23418674T12 NONE etoac_6\NN\1740| (r_compound) extract_7\NN\14589223|both|the|etoac|and|berberine (r_nsubj) able_11\JJ\1740|that|extract|were|activate|,|and|contains (l_conj) contains_19\VBZ\2632940|coptis|agonists|berberine (l_dobj) agonists_22\NNS\9613191|potential|natural|ppars (l_nmod) ppars_24\NNS\1740|of
23418674T3_23418674T10 CPR:5 berberine_9\NN\1740| (r_conj) extract_7\NN\14589223|both|the|etoac|and|berberine (r_nsubj) able_11\JJ\1740|that|extract|were|activate|,|and|contains (l_xcomp) activate_13\VB\1641914|to|pparα/β/γ (l_dobj) pparα/β/γ_14\NN\1740|
23418674T3_23418674T12 NONE berberine_9\NN\1740| (r_conj) extract_7\NN\14589223|both|the|etoac|and|berberine (r_nsubj) able_11\JJ\1740|that|extract|were|activate|,|and|contains (l_conj) contains_19\VBZ\2632940|coptis|agonists|berberine (l_dobj) agonists_22\NNS\9613191|potential|natural|ppars (l_nmod) ppars_24\NNS\1740|of
23418674T4_23418674T10 CPR:5 berberine_26\NN\1740|besides (r_nmod) contains_19\VBZ\2632940|coptis|agonists|berberine (r_conj) able_11\JJ\1740|that|extract|were|activate|,|and|contains (l_xcomp) activate_13\VB\1641914|to|pparα/β/γ (l_dobj) pparα/β/γ_14\NN\1740|
23418674T4_23418674T12 CPR:5 berberine_26\NN\1740|besides (r_nmod) contains_19\VBZ\2632940|coptis|agonists|berberine (l_dobj) agonists_22\NNS\9613191|potential|natural|ppars (l_nmod) ppars_24\NNS\1740|of
23153456
23153456T1_23153456T22 NONE oxide_36\NN\14818238| (r_compound) synthase_37\NN\1740|inducible|nitric|oxide|inos (r_conj) cxcl9_29\NN\1740|,|cxcl10|,|and|synthase (r_dep) targets_28\NNS\7258332|its|downstream|pro-inflammatory|cxcl9 (r_conj) stat1_23\NN\1740|and|targets (r_dobj) activating_22\VBG\1641914|robustly|stat1 (r_acl) cytokine_20\NN\14728724|into|a|activating (r_nmod) converts_17\VBZ\126264|that|,|ifnα|,|il-22|cytokine (l_nmod) ifnα_14\NN\1740|upon
23153456T1_23153456T23 NONE oxide_36\NN\14818238| (r_compound) synthase_37\NN\1740|inducible|nitric|oxide|inos (r_conj) cxcl9_29\NN\1740|,|cxcl10|,|and|synthase (r_dep) targets_28\NNS\7258332|its|downstream|pro-inflammatory|cxcl9 (r_conj) stat1_23\NN\1740|and|targets (r_dobj) activating_22\VBG\1641914|robustly|stat1 (r_acl) cytokine_20\NN\14728724|into|a|activating (r_nmod) converts_17\VBZ\126264|that|,|ifnα|,|il-22|cytokine (l_nsubj) il-22_16\NN\1740|
23153456T1_23153456T24 NONE oxide_36\NN\14818238| (r_compound) synthase_37\NN\1740|inducible|nitric|oxide|inos (r_conj) cxcl9_29\NN\1740|,|cxcl10|,|and|synthase (r_dep) targets_28\NNS\7258332|its|downstream|pro-inflammatory|cxcl9 (r_conj) stat1_23\NN\1740|and|targets (r_dobj) activating_22\VBG\1641914|robustly|stat1 (r_acl) cytokine_20\NN\14728724|into|a|activating
23153456T1_23153456T25 NONE oxide_36\NN\14818238| (r_compound) synthase_37\NN\1740|inducible|nitric|oxide|inos (r_conj) cxcl9_29\NN\1740|,|cxcl10|,|and|synthase (r_dep) targets_28\NNS\7258332|its|downstream|pro-inflammatory|cxcl9 (r_conj) stat1_23\NN\1740|and|targets
23153456T1_23153456T26 NONE oxide_36\NN\14818238| (r_compound) synthase_37\NN\1740|inducible|nitric|oxide|inos (r_conj) cxcl9_29\NN\1740|,|cxcl10|,|and|synthase
23153456T1_23153456T27 NONE oxide_36\NN\14818238| (r_compound) synthase_37\NN\1740|inducible|nitric|oxide|inos (r_conj) cxcl9_29\NN\1740|,|cxcl10|,|and|synthase (l_conj) cxcl10_31\NN\1740|
23153456T1_23153456T28 NONE oxide_36\NN\14818238| (r_compound) synthase_37\NN\1740|inducible|nitric|oxide|inos
23153456T1_23153456T29 NONE oxide_36\NN\14818238| (r_compound) synthase_37\NN\1740|inducible|nitric|oxide|inos (l_appos) inos_39\NN\1740|(|)
23153456T2_23153456T3 NONE acid_7\NN\14818238|polyinosinic|:|polycytidylic|and|b18r (r_appos) mimic_3\NN\10200365|the|viral|acid (r_dobj) using_0\VBG\1156834|mimic (r_advcl) demonstrate_15\VBP\2137132|using|we|furthermore|capability|. (l_dobj) capability_17\NN\5200169|the|ifn|promote (l_nmod) ifn_20\NN\1740|of|endogenous
23153456T2_23153456T4 NONE acid_7\NN\14818238|polyinosinic|:|polycytidylic|and|b18r (r_appos) mimic_3\NN\10200365|the|viral|acid (r_dobj) using_0\VBG\1156834|mimic (r_advcl) demonstrate_15\VBP\2137132|using|we|furthermore|capability|. (l_dobj) capability_17\NN\5200169|the|ifn|promote (l_acl) promote_22\VB\2556126|to|activation (l_dobj) activation_25\NN\13561719|stat1|and|expression (l_compound) stat1_24\NN\1740|il-22-induced (l_amod) il-22-induced_23\JJ\1740|
23153456T2_23153456T5 NONE acid_7\NN\14818238|polyinosinic|:|polycytidylic|and|b18r (r_appos) mimic_3\NN\10200365|the|viral|acid (r_dobj) using_0\VBG\1156834|mimic (r_advcl) demonstrate_15\VBP\2137132|using|we|furthermore|capability|. (l_dobj) capability_17\NN\5200169|the|ifn|promote (l_acl) promote_22\VB\2556126|to|activation (l_dobj) activation_25\NN\13561719|stat1|and|expression (l_compound) stat1_24\NN\1740|il-22-induced
23153456T2_23153456T6 NONE acid_7\NN\14818238|polyinosinic|:|polycytidylic|and|b18r (r_appos) mimic_3\NN\10200365|the|viral|acid (r_dobj) using_0\VBG\1156834|mimic (r_advcl) demonstrate_15\VBP\2137132|using|we|furthermore|capability|. (l_dobj) capability_17\NN\5200169|the|ifn|promote (l_acl) promote_22\VB\2556126|to|activation (l_dobj) activation_25\NN\13561719|stat1|and|expression (l_conj) expression_27\NN\4679549|cxcl10 (l_nmod) cxcl10_29\NN\1740|of
23153456T2_23153456T34 NONE acid_7\NN\14818238|polyinosinic|:|polycytidylic|and|b18r (l_conj) b18r_12\NN\1740|the|ifnα/β|antagonist (l_compound) ifnα/β_10\NN\1740|
23580446
23580446T3_23580446T7 CPR:9 prostanoids_1\NNS\1740|cyclooxygenase(cox)-2-derived (l_amod) cyclooxygenase(cox)-2-derived_0\NN\1740|
23580446T4_23580446T27 CPR:9 pge2_2\NN\1740| (r_compound) synthesis_3\NN\13446390|platelet-induced|cox-2-dependent|pge2|cells (l_amod) cox-2-dependent_1\JJ\1740|
23580446T4_23580446T28 NONE pge2_2\NN\1740| (r_compound) synthesis_3\NN\13446390|platelet-induced|cox-2-dependent|pge2|cells (r_nsubjpass) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T4_23580446T29 NONE pge2_2\NN\1740| (r_compound) synthesis_3\NN\13446390|platelet-induced|cox-2-dependent|pge2|cells (r_nsubjpass) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T4_23580446T30 NONE pge2_2\NN\1740| (r_compound) synthesis_3\NN\13446390|platelet-induced|cox-2-dependent|pge2|cells (r_nsubjpass) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T4_23580446T31 NONE pge2_2\NN\1740| (r_compound) synthesis_3\NN\13446390|platelet-induced|cox-2-dependent|pge2|cells (r_nsubjpass) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_conj) upregulation_15\NN\1740|cyclinb1 (l_nmod) cyclinb1_17\NN\1740|of
23580446T4_23580446T32 NONE pge2_2\NN\1740| (r_compound) synthesis_3\NN\13446390|platelet-induced|cox-2-dependent|pge2|cells (r_nsubjpass) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_advcl) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (l_nmod) rofecoxib(a_25\NN\1740|by|inhibitor (l_appos) inhibitor_28\NN\20090|selective|cox-2|) (l_compound) cox-2_27\NN\14737847|
23580446T5_23580446T27 NONE rofecoxib(a_25\NN\1740|by|inhibitor (r_nmod) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nsubjpass) synthesis_3\NN\13446390|platelet-induced|cox-2-dependent|pge2|cells (l_amod) cox-2-dependent_1\JJ\1740|
23580446T5_23580446T28 CPR:3 rofecoxib(a_25\NN\1740|by|inhibitor (r_nmod) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T5_23580446T29 CPR:3 rofecoxib(a_25\NN\1740|by|inhibitor (r_nmod) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T5_23580446T30 CPR:3 rofecoxib(a_25\NN\1740|by|inhibitor (r_nmod) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T5_23580446T31 CPR:4 rofecoxib(a_25\NN\1740|by|inhibitor (r_nmod) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_conj) upregulation_15\NN\1740|cyclinb1 (l_nmod) cyclinb1_17\NN\1740|of
23580446T5_23580446T32 CPR:4 rofecoxib(a_25\NN\1740|by|inhibitor (l_appos) inhibitor_28\NN\20090|selective|cox-2|) (l_compound) cox-2_27\NN\14737847|
23580446T6_23580446T27 NONE pge2_34\NN\1740|by|exogenous (r_nmod) rescued_31\VBN\2551832|pge2 (r_conj) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nsubjpass) synthesis_3\NN\13446390|platelet-induced|cox-2-dependent|pge2|cells (l_amod) cox-2-dependent_1\JJ\1740|
23580446T6_23580446T28 NONE pge2_34\NN\1740|by|exogenous (r_nmod) rescued_31\VBN\2551832|pge2 (r_conj) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T6_23580446T29 NONE pge2_34\NN\1740|by|exogenous (r_nmod) rescued_31\VBN\2551832|pge2 (r_conj) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T6_23580446T30 NONE pge2_34\NN\1740|by|exogenous (r_nmod) rescued_31\VBN\2551832|pge2 (r_conj) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_nmod) p21(waf1/cip1_12\NN\1740|of|)
23580446T6_23580446T31 NONE pge2_34\NN\1740|by|exogenous (r_nmod) rescued_31\VBN\2551832|pge2 (r_conj) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (r_advcl) involved_8\VBN\2676054|synthesis|was|downregulation|,|prevented|. (l_nmod) downregulation_10\NN\1740|in|p21(waf1/cip1|and|upregulation (l_conj) upregulation_15\NN\1740|cyclinb1 (l_nmod) cyclinb1_17\NN\1740|of
23580446T6_23580446T32 NONE pge2_34\NN\1740|by|exogenous (r_nmod) rescued_31\VBN\2551832|pge2 (r_conj) prevented_23\VBN\1740|since|effects|were|rofecoxib(a|and|rescued (l_nmod) rofecoxib(a_25\NN\1740|by|inhibitor (l_appos) inhibitor_28\NN\20090|selective|cox-2|) (l_compound) cox-2_27\NN\14737847|
23580446T1_23580446T10 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (l_compound) galectin-3_2\NN\1740|
23580446T1_23580446T11 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (l_appos) form_7\NN\6286395|a|dominant-negative|galectin-3,gal-3c (l_nmod) galectin-3,gal-3c_9\NN\1740|of
23580446T1_23580446T12 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (l_appos) form_7\NN\6286395|a|dominant-negative|galectin-3,gal-3c (l_nmod) galectin-3,gal-3c_9\NN\1740|of
23580446T1_23580446T13 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (l_conj) antibody_13\NN\14728724|anti-galectin-3|m3/38 (l_compound) anti-galectin-3_12\NN\1740|
23580446T1_23580446T14 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (r_nmod) inhibitors_0\NNS\20090|function(β-lactose|or|adhesion(revacept (l_conj) adhesion(revacept_20\NN\1740|collagen|receptor-mediated|platelet|,|gpvi-fc|) (l_amod) receptor-mediated_18\JJ\1740|
23580446T1_23580446T15 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (r_nmod) inhibitors_0\NNS\20090|function(β-lactose|or|adhesion(revacept (l_conj) adhesion(revacept_20\NN\1740|collagen|receptor-mediated|platelet|,|gpvi-fc|) (l_appos) gpvi-fc_26\NN\1740|a|dimeric|collagen|receptor (l_compound) receptor_25\NN\5225602|
23580446T1_23580446T16 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (r_nmod) inhibitors_0\NNS\20090|function(β-lactose|or|adhesion(revacept (l_conj) adhesion(revacept_20\NN\1740|collagen|receptor-mediated|platelet|,|gpvi-fc|) (l_appos) gpvi-fc_26\NN\1740|a|dimeric|collagen|receptor
23580446T1_23580446T17 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (r_nmod) inhibitors_0\NNS\20090|function(β-lactose|or|adhesion(revacept (l_conj) adhesion(revacept_20\NN\1740|collagen|receptor-mediated|platelet|,|gpvi-fc|) (l_appos) gpvi-fc_26\NN\1740|a|dimeric|collagen|receptor
23580446T1_23580446T18 NONE function(β-lactose_3\NN\1740|of|galectin-3|,|form|,|and|antibody|) (r_nmod) inhibitors_0\NNS\20090|function(β-lactose|or|adhesion(revacept (r_nsubj) prevented_28\VBD\1740|inhibitors|expression|. (l_dobj) expression_31\NN\4679549|aberrant|cox-2 (l_compound) cox-2_30\NN\14737847|
23580446T2_23580446T19 NONE rofecoxib_11\NN\3124700|than (r_nmod) effective_9\JJ\1740|inhibition|was|more|rofecoxib|preventing|suggesting|. (l_xcomp) suggesting_20\VBG\1010118|induced (l_ccomp) induced_30\VBD\1627355|that|contact|synergistically|modifications (l_nsubj) contact_24\NN\39021|direct|cell-cell|and|expression (l_conj) expression_28\NN\4679549|aberrant|cox-2 (l_compound) cox-2_27\NN\14737847|
23594301
23207409
11330337
11330337T41_11330337T55 NONE [3h]-oxotremorine-m_3\NN\1740|of|and|benzilate (r_compound) binding_7\VBG\1290422|[3h]-oxotremorine-m|receptors (l_nmod) receptors_10\NNS\5225602|to|muscarinic|membranes (l_nmod) membranes_14\NNS\4188643|in|rat|brain|inhibitors (l_nmod) inhibitors_17\NNS\20090|with|acetylcholinesterase (l_compound) acetylcholinesterase_16\NN\1740|
11330337T41_11330337T56 NONE [3h]-oxotremorine-m_3\NN\1740|of|and|benzilate (r_compound) binding_7\VBG\1290422|[3h]-oxotremorine-m|receptors (l_nmod) receptors_10\NNS\5225602|to|muscarinic|membranes
11330337T42_11330337T55 NONE benzilate_6\NN\1740|[3h]-quinuclinidyl (r_conj) [3h]-oxotremorine-m_3\NN\1740|of|and|benzilate (r_compound) binding_7\VBG\1290422|[3h]-oxotremorine-m|receptors (l_nmod) receptors_10\NNS\5225602|to|muscarinic|membranes (l_nmod) membranes_14\NNS\4188643|in|rat|brain|inhibitors (l_nmod) inhibitors_17\NNS\20090|with|acetylcholinesterase (l_compound) acetylcholinesterase_16\NN\1740|
11330337T42_11330337T56 NONE benzilate_6\NN\1740|[3h]-quinuclinidyl (r_conj) [3h]-oxotremorine-m_3\NN\1740|of|and|benzilate (r_compound) binding_7\VBG\1290422|[3h]-oxotremorine-m|receptors (l_nmod) receptors_10\NNS\5225602|to|muscarinic|membranes
11330337T24_11330337T49 NONE [3h]-oxotremorine-m_23\NN\1740|both|and|[3h]-quinuclinidyl (r_compound) binding_27\NN\4688246|[3h]-oxotremorine-m|benzilate (r_dobj) displace_21\VB\1850315|to|binding|membranes (r_acl) ability_19\NN\4723816|by|their|displace (r_nmod) assessed_16\VBN\670261|study|,|capacity|was|ability|. (l_nsubjpass) capacity_6\NN\5202497|the|inhibitors|interact (l_nmod) inhibitors_9\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_8\NN\1740|
11330337T24_11330337T51 NONE [3h]-oxotremorine-m_23\NN\1740|both|and|[3h]-quinuclinidyl (r_compound) binding_27\NN\4688246|[3h]-oxotremorine-m|benzilate (r_dobj) displace_21\VB\1850315|to|binding|membranes (r_acl) ability_19\NN\4723816|by|their|displace (r_nmod) assessed_16\VBN\670261|study|,|capacity|was|ability|. (l_nsubjpass) capacity_6\NN\5202497|the|inhibitors|interact (l_acl) interact_11\VB\2367363|to|receptors (l_nmod) receptors_14\NNS\5225602|with|muscarinic
11330337T25_11330337T49 NONE benzilate_26\NN\1740| (r_compound) binding_27\NN\4688246|[3h]-oxotremorine-m|benzilate (r_dobj) displace_21\VB\1850315|to|binding|membranes (r_acl) ability_19\NN\4723816|by|their|displace (r_nmod) assessed_16\VBN\670261|study|,|capacity|was|ability|. (l_nsubjpass) capacity_6\NN\5202497|the|inhibitors|interact (l_nmod) inhibitors_9\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_8\NN\1740|
11330337T25_11330337T51 NONE benzilate_26\NN\1740| (r_compound) binding_27\NN\4688246|[3h]-oxotremorine-m|benzilate (r_dobj) displace_21\VB\1850315|to|binding|membranes (r_acl) ability_19\NN\4723816|by|their|displace (r_nmod) assessed_16\VBN\670261|study|,|capacity|was|ability|. (l_nsubjpass) capacity_6\NN\5202497|the|inhibitors|interact (l_acl) interact_11\VB\2367363|to|receptors (l_nmod) receptors_14\NNS\5225602|with|muscarinic
11330337T28_11330337T54 NONE [3h]-oxotremorine-m_15\NN\1740| (r_compound) binding_16\NN\4688246|[3h]-oxotremorine-m (r_dobj) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T29_11330337T54 NONE ambenonium_21\NN\1740|(|>|neostigmine (r_nsubj) =_24\JJ\1740|ambenonium|pyridostigmine|tacrine|>|physostigmine|>|edrophonium|=|) (r_parataxis) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T30_11330337T54 NONE neostigmine_23\NN\2718084| (r_conj) ambenonium_21\NN\1740|(|>|neostigmine (r_nsubj) =_24\JJ\1740|ambenonium|pyridostigmine|tacrine|>|physostigmine|>|edrophonium|=|) (r_parataxis) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T31_11330337T54 NONE pyridostigmine_25\NN\1740| (r_dobj) =_24\JJ\1740|ambenonium|pyridostigmine|tacrine|>|physostigmine|>|edrophonium|=|) (r_parataxis) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T32_11330337T54 NONE tacrine_27\NN\1740|= (r_dep) =_24\JJ\1740|ambenonium|pyridostigmine|tacrine|>|physostigmine|>|edrophonium|=|) (r_parataxis) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T33_11330337T54 NONE physostigmine_29\NN\14712692| (r_conj) =_24\JJ\1740|ambenonium|pyridostigmine|tacrine|>|physostigmine|>|edrophonium|=|) (r_parataxis) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T34_11330337T54 NONE edrophonium_31\NN\1740| (r_conj) =_24\JJ\1740|ambenonium|pyridostigmine|tacrine|>|physostigmine|>|edrophonium|=|) (r_parataxis) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T35_11330337T54 NONE galanthamine_33\NN\1740| (r_compound) desoxypeganine_35\NN\1740|galanthamine|> (r_dobj) =_32\JJ\1740|desoxypeganine (r_dep) =_24\JJ\1740|ambenonium|pyridostigmine|tacrine|>|physostigmine|>|edrophonium|=|) (r_parataxis) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T36_11330337T54 NONE desoxypeganine_35\NN\1740|galanthamine|> (r_dobj) =_32\JJ\1740|desoxypeganine (r_dep) =_24\JJ\1740|ambenonium|pyridostigmine|tacrine|>|physostigmine|>|edrophonium|=|) (r_parataxis) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T37_11330337T54 NONE ambenonium_39\NN\1740|only|and|tacrine (r_nsubj) displaced_42\VBP\1850315|whereas|ambenonium|binding (r_advcl) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T38_11330337T54 NONE tacrine_41\NN\1740| (r_conj) ambenonium_39\NN\1740|only|and|tacrine (r_nsubj) displaced_42\VBP\1850315|whereas|ambenonium|binding (r_advcl) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T39_11330337T54 NONE benzilate_44\NN\1740| (r_compound) binding_45\NN\4688246|[3h]-quinuclinidyl|benzilate (r_dobj) displaced_42\VBP\1850315|whereas|ambenonium|binding (r_advcl) displaced_14\VBD\1850315|series|binding|potency|=|displaced|. (l_nsubj) series_1\NN\8456993|a|compounds|, (l_nmod) compounds_3\NNS\5869584|of|,|representative (l_appos) representative_5\NN\10351874|classes (l_nmod) classes_9\NNS\7951464|of|the|principal|inhibitors (l_nmod) inhibitors_12\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_11\NN\1740|
11330337T2_11330337T43 CPR:4 tacrine_10\NN\1740|of|and|ambenonium (r_nmod) exception_8\NN\5706954|with|the|tacrine|, (r_nmod) displace_15\VB\1850315|exception|to|[3h]-oxotremorine-m|preference (r_acl:relcl) capacity_1\NN\5202497|the|inhibitors|,|displace (l_nmod) inhibitors_4\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_3\NN\1740|
11330337T2_11330337T44 NONE tacrine_10\NN\1740|of|and|ambenonium (r_nmod) exception_8\NN\5706954|with|the|tacrine|, (r_nmod) displace_15\VB\1850315|exception|to|[3h]-oxotremorine-m|preference (r_acl:relcl) capacity_1\NN\5202497|the|inhibitors|,|displace (r_nsubj) predicts_23\VBZ\916909|capacity|act|. (l_ccomp) act_29\VB\1619354|that|compounds|could|agonists|receptors (l_nmod) receptors_35\NNS\5225602|at|muscarinic
11330337T3_11330337T43 CPR:4 ambenonium_12\NN\1740| (r_conj) tacrine_10\NN\1740|of|and|ambenonium (r_nmod) exception_8\NN\5706954|with|the|tacrine|, (r_nmod) displace_15\VB\1850315|exception|to|[3h]-oxotremorine-m|preference (r_acl:relcl) capacity_1\NN\5202497|the|inhibitors|,|displace (l_nmod) inhibitors_4\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_3\NN\1740|
11330337T3_11330337T44 NONE ambenonium_12\NN\1740| (r_conj) tacrine_10\NN\1740|of|and|ambenonium (r_nmod) exception_8\NN\5706954|with|the|tacrine|, (r_nmod) displace_15\VB\1850315|exception|to|[3h]-oxotremorine-m|preference (r_acl:relcl) capacity_1\NN\5202497|the|inhibitors|,|displace (r_nsubj) predicts_23\VBZ\916909|capacity|act|. (l_ccomp) act_29\VB\1619354|that|compounds|could|agonists|receptors (l_nmod) receptors_35\NNS\5225602|at|muscarinic
11330337T4_11330337T43 NONE [3h]-oxotremorine-m_17\NN\1740|bound (r_dobj) displace_15\VB\1850315|exception|to|[3h]-oxotremorine-m|preference (r_acl:relcl) capacity_1\NN\5202497|the|inhibitors|,|displace (l_nmod) inhibitors_4\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_3\NN\1740|
11330337T4_11330337T44 NONE [3h]-oxotremorine-m_17\NN\1740|bound (r_dobj) displace_15\VB\1850315|exception|to|[3h]-oxotremorine-m|preference (r_acl:relcl) capacity_1\NN\5202497|the|inhibitors|,|displace (r_nsubj) predicts_23\VBZ\916909|capacity|act|. (l_ccomp) act_29\VB\1619354|that|compounds|could|agonists|receptors (l_nmod) receptors_35\NNS\5225602|at|muscarinic
11330337T5_11330337T43 NONE benzilate_22\NN\1740|to|[3h]quinuclinidyl (r_nmod) preference_19\NN\7497473|in|benzilate (r_nmod) displace_15\VB\1850315|exception|to|[3h]-oxotremorine-m|preference (r_acl:relcl) capacity_1\NN\5202497|the|inhibitors|,|displace (l_nmod) inhibitors_4\NNS\20090|of|acetylcholinesterase (l_compound) acetylcholinesterase_3\NN\1740|
11330337T5_11330337T44 NONE benzilate_22\NN\1740|to|[3h]quinuclinidyl (r_nmod) preference_19\NN\7497473|in|benzilate (r_nmod) displace_15\VB\1850315|exception|to|[3h]-oxotremorine-m|preference (r_acl:relcl) capacity_1\NN\5202497|the|inhibitors|,|displace (r_nsubj) predicts_23\VBZ\916909|capacity|act|. (l_ccomp) act_29\VB\1619354|that|compounds|could|agonists|receptors (l_nmod) receptors_35\NNS\5225602|at|muscarinic
11330337T6_11330337T45 CPR:4 ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T6_11330337T46 CPR:4 ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T7_11330337T45 CPR:4 neostigmine_13\NN\2718084|> (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T7_11330337T46 CPR:4 neostigmine_13\NN\2718084|> (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T8_11330337T45 CPR:4 physostigmine_15\NN\14712692| (r_dobj) =_14\JJ\1740|physostigmine (r_punct) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T8_11330337T46 CPR:4 physostigmine_15\NN\14712692| (r_dobj) =_14\JJ\1740|physostigmine (r_punct) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T9_11330337T45 CPR:4 tacrine_17\NN\1740|= (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T9_11330337T46 CPR:4 tacrine_17\NN\1740|= (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T10_11330337T45 CPR:4 pyridostigmine_19\NN\1740| (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T10_11330337T46 CPR:4 pyridostigmine_19\NN\1740| (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T11_11330337T45 CPR:4 edrophonium_21\NN\1740| (r_dobj) =_20\JJ\1740|edrophonium (r_amod) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T11_11330337T46 CPR:4 edrophonium_21\NN\1740| (r_dobj) =_20\JJ\1740|edrophonium (r_amod) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T12_11330337T45 CPR:4 galanthamine_23\NN\1740| (r_dobj) =_22\JJ\1740|galanthamine (r_punct) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T12_11330337T46 CPR:4 galanthamine_23\NN\1740| (r_dobj) =_22\JJ\1740|galanthamine (r_punct) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T13_11330337T45 CPR:4 desoxypeganine_25\NN\1740| (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T13_11330337T46 CPR:4 desoxypeganine_25\NN\1740| (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T14_11330337T45 CPR:4 parathion_27\NN\14919948| (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T14_11330337T46 CPR:4 parathion_27\NN\14919948| (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T15_11330337T45 CPR:4 gramine_29\NN\1740|> (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T15_11330337T46 CPR:4 gramine_29\NN\1740|> (r_appos) ambenonium_11\NN\1740|(|neostigmine|=|tacrine|>|pyridostigmine|=|=|>|desoxypeganine|>|parathion|gramine|) (r_dep) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (r_nsubj) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_ccomp) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T16_11330337T45 NONE [3h]-oxotremorine-m_41\NN\1740| (r_dobj) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (r_ccomp) indicated_31\VBD\952524|moreover|,|order|displaced|. (l_nsubj) order_4\NN\7168131|the|rank|potency|inhibiting|ambenonium (l_acl) inhibiting_8\VBG\2510337|in|acetylcholinesterase (l_dobj) acetylcholinesterase_9\NN\1740|
11330337T16_11330337T46 NONE [3h]-oxotremorine-m_41\NN\1740| (r_dobj) displaced_40\VBD\1850315|that|inhibitors|also|[3h]-oxotremorine-m|extent (l_nsubj) inhibitors_36\NNS\20090|the|effective|acetylcholinesterase (l_nmod) acetylcholinesterase_38\NN\1740|of
11330337T17_11330337T47 NONE [3h]-oxotremorine-m_7\NN\1740| (r_compound) binding_8\NN\4688246|[3h]-oxotremorine-m (r_dobj) displace_6\VB\1850315|to|binding (r_acl) capacity_1\NN\5202497|the|inhibitors|displace (r_nsubj) preclude_9\VBP\2629256|capacity|utilisation|prevention|,|required|. (l_parataxis) required_26\VBN\754942|latter|being|estimate (l_xcomp) estimate_28\VB\637259|to|binding (l_dobj) binding_30\NN\4688246|the|acetylcholine|receptors (l_nmod) receptors_36\NNS\5225602|to|[3h]-oxotremorine-m-labelled|muscarinic
11330337T18_11330337T47 NONE acetylcholine_16\NN\14807558| (r_compound) catabolism_17\NN\13526110|of|acetylcholine|membranes (r_nmod) prevention_14\NN\1073995|for|the|catabolism (r_nmod) preclude_9\VBP\2629256|capacity|utilisation|prevention|,|required|. (l_parataxis) required_26\VBN\754942|latter|being|estimate (l_xcomp) estimate_28\VB\637259|to|binding (l_dobj) binding_30\NN\4688246|the|acetylcholine|receptors (l_nmod) receptors_36\NNS\5225602|to|[3h]-oxotremorine-m-labelled|muscarinic
11330337T19_11330337T47 NONE [3h]-oxotremorine-m-labelled_34\NN\1740| (r_amod) receptors_36\NNS\5225602|to|[3h]-oxotremorine-m-labelled|muscarinic
11330337T20_11330337T48 NONE acetylcholine_20\NN\14807558|of (r_nmod) catabolism_18\NN\13526110|acetylcholine (r_dobj) prevent_17\VB\1740|however|,|fasciculin-2|did|catabolism|membranes|isotherm|,|permitting|. (l_nsubj) fasciculin-2_2\NN\1740|,|inhibitor|, (l_appos) inhibitor_7\NN\20090|a|potent|peptide|acetylcholinesterase|ic50 (l_nmod) acetylcholinesterase_9\NN\1740|of
11330337T20_11330337T50 NONE acetylcholine_20\NN\14807558|of (r_nmod) catabolism_18\NN\13526110|acetylcholine (r_dobj) prevent_17\VB\1740|however|,|fasciculin-2|did|catabolism|membranes|isotherm|,|permitting|. (l_advcl) permitting_35\VBG\797697|thus|estimation (l_dobj) estimation_37\NN\6472025|an|affinity (l_nmod) affinity_42\NN\11426530|of|the|"|global|"|acetylcholine|ki|receptors (l_nmod) receptors_54\NNS\5225602|for|[3h]-oxotremorine-m-labelled|muscarinic|brain
11330337T21_11330337T48 NONE [3h]-oxotremorine-m_31\NN\1740| (r_compound) binding_32\NN\4688246|of|[3h]-oxotremorine-m (r_nmod) isotherm_29\NN\8589801|with|an|atypical|inhibition|binding (r_nmod) prevent_17\VB\1740|however|,|fasciculin-2|did|catabolism|membranes|isotherm|,|permitting|. (l_nsubj) fasciculin-2_2\NN\1740|,|inhibitor|, (l_appos) inhibitor_7\NN\20090|a|potent|peptide|acetylcholinesterase|ic50 (l_nmod) acetylcholinesterase_9\NN\1740|of
11330337T21_11330337T50 NONE [3h]-oxotremorine-m_31\NN\1740| (r_compound) binding_32\NN\4688246|of|[3h]-oxotremorine-m (r_nmod) isotherm_29\NN\8589801|with|an|atypical|inhibition|binding (r_nmod) prevent_17\VB\1740|however|,|fasciculin-2|did|catabolism|membranes|isotherm|,|permitting|. (l_advcl) permitting_35\VBG\797697|thus|estimation (l_dobj) estimation_37\NN\6472025|an|affinity (l_nmod) affinity_42\NN\11426530|of|the|"|global|"|acetylcholine|ki|receptors (l_nmod) receptors_54\NNS\5225602|for|[3h]-oxotremorine-m-labelled|muscarinic|brain
11330337T22_11330337T48 NONE acetylcholine_45\NN\14807558|of (r_nmod) affinity_42\NN\11426530|of|the|"|global|"|acetylcholine|ki|receptors (r_nmod) estimation_37\NN\6472025|an|affinity (r_dobj) permitting_35\VBG\797697|thus|estimation (r_advcl) prevent_17\VB\1740|however|,|fasciculin-2|did|catabolism|membranes|isotherm|,|permitting|. (l_nsubj) fasciculin-2_2\NN\1740|,|inhibitor|, (l_appos) inhibitor_7\NN\20090|a|potent|peptide|acetylcholinesterase|ic50 (l_nmod) acetylcholinesterase_9\NN\1740|of
11330337T22_11330337T50 NONE acetylcholine_45\NN\14807558|of (r_nmod) affinity_42\NN\11426530|of|the|"|global|"|acetylcholine|ki|receptors (l_nmod) receptors_54\NNS\5225602|for|[3h]-oxotremorine-m-labelled|muscarinic|brain
11330337T23_11330337T48 NONE [3h]-oxotremorine-m-labelled_52\NN\1740| (r_amod) receptors_54\NNS\5225602|for|[3h]-oxotremorine-m-labelled|muscarinic|brain (r_nmod) affinity_42\NN\11426530|of|the|"|global|"|acetylcholine|ki|receptors (r_nmod) estimation_37\NN\6472025|an|affinity (r_dobj) permitting_35\VBG\797697|thus|estimation (r_advcl) prevent_17\VB\1740|however|,|fasciculin-2|did|catabolism|membranes|isotherm|,|permitting|. (l_nsubj) fasciculin-2_2\NN\1740|,|inhibitor|, (l_appos) inhibitor_7\NN\20090|a|potent|peptide|acetylcholinesterase|ic50 (l_nmod) acetylcholinesterase_9\NN\1740|of
11330337T23_11330337T50 NONE [3h]-oxotremorine-m-labelled_52\NN\1740| (r_amod) receptors_54\NNS\5225602|for|[3h]-oxotremorine-m-labelled|muscarinic|brain
23474645
11319232
11319232T10_11319232T38 NONE acyl-coa_0\NN\1740| (r_compound) isoforms_2\NNS\1740|acyl-coa|synthetase|1 (l_dep) 1_3\CD\13741022|,|4|,|and|5 (l_conj) 5_8\CD\13741022|
11319232T1_11319232T27 NONE acyl-coas_18\NNS\1740|of (r_nmod) use_16\NN\407535|the|acyl-coas|pathways (r_dobj) regulate_14\VB\296178|that|isoforms|might|use (l_nsubj) isoforms_12\NNS\1740|synthetase|acs|,|ec|) (l_compound) synthetase_6\NN\1740|acyl-coa
11319232T1_11319232T30 NONE acyl-coas_18\NNS\1740|of (r_nmod) use_16\NN\407535|the|acyl-coas|pathways (r_dobj) regulate_14\VB\296178|that|isoforms|might|use (l_nsubj) isoforms_12\NNS\1740|synthetase|acs|,|ec|) (l_compound) acs_8\NNS\14622893|(
11319232T6_11319232T27 NONE acyl-coa_5\NN\1740| (r_compound) synthetase_6\NN\1740|acyl-coa
11319232T6_11319232T30 NONE acyl-coa_5\NN\1740| (r_compound) synthetase_6\NN\1740|acyl-coa (r_compound) isoforms_12\NNS\1740|synthetase|acs|,|ec|) (l_compound) acs_8\NNS\14622893|(
11319232T7_11319232T31 CPR:4 n-ethylmaleimide_5\NN\1740|,|inhibitor|, (l_appos) inhibitor_8\NN\20090|an|acs4 (l_nmod) acs4_10\NN\1740|of
11319232T7_11319232T32 CPR:4 n-ethylmaleimide_5\NN\1740|,|inhibitor|, (r_nsubj) inhibited_12\VBD\2510337|consistent|,|n-ethylmaleimide|activity|%|mam|and|%|. (l_dobj) activity_14\NN\30358|acs (l_compound) acs_13\NN\14622893|
11319232T8_11319232T33 CPR:4 troglitazone_0\NN\1740|,|inhibitor|, (l_appos) inhibitor_5\NN\20090|a|second|acs4 (l_compound) acs4_4\NN\1740|
11319232T8_11319232T34 CPR:4 troglitazone_0\NN\1740|,|inhibitor|, (r_nsubj) inhibited_7\VBD\2510337|troglitazone|activity|%|and|%|. (l_dobj) activity_9\NN\30358|acs (l_compound) acs_8\NN\14622893|
11319232T2_11319232T11 NONE triacsin-sensitive_30\JJ\1740| (r_amod) acs_31\NN\14622893|a|unidentified|triacsin-sensitive
11319232T2_11319232T35 NONE triacsin-sensitive_30\JJ\1740| (r_amod) acs_31\NN\14622893|a|unidentified|triacsin-sensitive (r_nsubj) present_33\JJ\1740|that|acs|is|mitochondria (r_ccomp) suggesting_25\VBG\1010118|present (r_advcl) inhibited_12\VBD\2510337|c|activity|similarly|reticulum|,|suggesting|. (l_nsubj) c_1\NN\13714184|triacsin|,|inhibitor|, (l_appos) inhibitor_5\NN\20090|a|competitive|acs1 (l_nmod) acs1_8\NN\1740|of|both|and|acs4
11319232T2_11319232T36 NONE triacsin-sensitive_30\JJ\1740| (r_amod) acs_31\NN\14622893|a|unidentified|triacsin-sensitive (r_nsubj) present_33\JJ\1740|that|acs|is|mitochondria (r_ccomp) suggesting_25\VBG\1010118|present (r_advcl) inhibited_12\VBD\2510337|c|activity|similarly|reticulum|,|suggesting|. (l_nsubj) c_1\NN\13714184|triacsin|,|inhibitor|, (l_appos) inhibitor_5\NN\20090|a|competitive|acs1 (l_nmod) acs1_8\NN\1740|of|both|and|acs4 (l_conj) acs4_10\NN\1740|
11319232T2_11319232T37 NONE triacsin-sensitive_30\JJ\1740| (r_amod) acs_31\NN\14622893|a|unidentified|triacsin-sensitive (r_nsubj) present_33\JJ\1740|that|acs|is|mitochondria (r_ccomp) suggesting_25\VBG\1010118|present (r_advcl) inhibited_12\VBD\2510337|c|activity|similarly|reticulum|,|suggesting|. (l_dobj) activity_14\NN\30358|acs (l_compound) acs_13\NN\14622893|
11319232T9_11319232T11 NONE c_1\NN\13714184|triacsin|,|inhibitor|, (r_nsubj) inhibited_12\VBD\2510337|c|activity|similarly|reticulum|,|suggesting|. (l_advcl) suggesting_25\VBG\1010118|present (l_ccomp) present_33\JJ\1740|that|acs|is|mitochondria (l_nsubj) acs_31\NN\14622893|a|unidentified|triacsin-sensitive
11319232T9_11319232T35 CPR:4 c_1\NN\13714184|triacsin|,|inhibitor|, (l_appos) inhibitor_5\NN\20090|a|competitive|acs1 (l_nmod) acs1_8\NN\1740|of|both|and|acs4
11319232T9_11319232T36 CPR:4 c_1\NN\13714184|triacsin|,|inhibitor|, (l_appos) inhibitor_5\NN\20090|a|competitive|acs1 (l_nmod) acs1_8\NN\1740|of|both|and|acs4 (l_conj) acs4_10\NN\1740|
11319232T9_11319232T37 CPR:4 c_1\NN\13714184|triacsin|,|inhibitor|, (r_nsubj) inhibited_12\VBD\2510337|c|activity|similarly|reticulum|,|suggesting|. (l_dobj) activity_14\NN\30358|acs (l_compound) acs_13\NN\14622893|
11319232T3_11319232T17 CPR:3 sucrose_6\NN\14836642|high (r_compound) diet_7\NN\7560652|a|sucrose (r_conj) chow_2\NN\7971582|normal|or|diet (r_dobj) re-feeding_0\VBG\1740|chow|h|fast (r_nsubj) increased_15\VBD\169651|re-feeding|expression|1.5|,|consistent|. (l_dobj) expression_21\NN\4679549|acs1|protein (l_compound) acs1_17\NN\1740|both|and|acs4
11319232T3_11319232T18 CPR:3 sucrose_6\NN\14836642|high (r_compound) diet_7\NN\7560652|a|sucrose (r_conj) chow_2\NN\7971582|normal|or|diet (r_dobj) re-feeding_0\VBG\1740|chow|h|fast (r_nsubj) increased_15\VBD\169651|re-feeding|expression|1.5|,|consistent|. (l_dobj) expression_21\NN\4679549|acs1|protein (l_compound) acs1_17\NN\1740|both|and|acs4 (l_conj) acs4_19\NN\1740|
11319232T4_11319232T19 CPR:9 triacylglycerol_11\NN\1740| (r_compound) synthesis_12\NN\13446390|to|triacylglycerol (r_nmod) linked_9\VBN\628491|that|acs1|may|be|synthesis (l_nsubjpass) acs1_4\NN\1740|and|acs4
11319232T4_11319232T20 CPR:9 triacylglycerol_11\NN\1740| (r_compound) synthesis_12\NN\13446390|to|triacylglycerol (r_nmod) linked_9\VBN\628491|that|acs1|may|be|synthesis (l_nsubjpass) acs1_4\NN\1740|and|acs4 (l_conj) acs4_6\NN\1740|
11319232T5_11319232T21 NONE acyl-coas_7\NNS\1740| (r_nsubjpass) channeled_11\VBN\2077656|that|acyl-coas|may|be|functionally|pathways (l_nmod) pathways_15\NNS\5483677|to|specific|metabolic|isoforms (l_nmod) isoforms_19\NNS\1740|through|different|acs|locations (l_compound) acs_18\NN\14622893|
23532634
23532634T11_23532634T32 NONE cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T11_23532634T33 NONE cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T11_23532634T34 NONE cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T12_23532634T32 NONE dhea-s_6\NN\1740|dhea-s0 (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T12_23532634T33 NONE dhea-s_6\NN\1740|dhea-s0 (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T12_23532634T34 NONE dhea-s_6\NN\1740|dhea-s0 (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T13_23532634T32 NONE dhea-s0_8\NN\1740|(|) (r_appos) dhea-s_6\NN\1740|dhea-s0 (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T13_23532634T33 NONE dhea-s0_8\NN\1740|(|) (r_appos) dhea-s_6\NN\1740|dhea-s0 (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T13_23532634T34 NONE dhea-s0_8\NN\1740|(|) (r_appos) dhea-s_6\NN\1740|dhea-s0 (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T14_23532634T32 NONE cortisol_11\NN\14751417| (r_compound) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T14_23532634T33 NONE cortisol_11\NN\14751417| (r_compound) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T14_23532634T34 NONE cortisol_11\NN\14751417| (r_compound) globulin_13\NN\14736972|cortisol|binding|cbg (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T15_23532634T32 NONE cortisol_22\NN\14751417|calculated|free|equation (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T15_23532634T33 NONE cortisol_22\NN\14751417|calculated|free|equation (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T15_23532634T34 NONE cortisol_22\NN\14751417|calculated|free|equation (r_conj) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T16_23532634T32 NONE cortisol_35\NN\14751417| (r_compound) index_36\NN\13850304|free|cortisol|fci (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T16_23532634T33 NONE cortisol_35\NN\14751417| (r_compound) index_36\NN\13850304|free|cortisol|fci (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T16_23532634T34 NONE cortisol_35\NN\14751417| (r_compound) index_36\NN\13850304|free|cortisol|fci (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T17_23532634T32 NONE cortisol_42\NN\14751417|60-min|cor60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T17_23532634T33 NONE cortisol_42\NN\14751417|60-min|cor60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T17_23532634T34 NONE cortisol_42\NN\14751417|60-min|cor60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T18_23532634T32 NONE dhea-s_48\NN\1740|dhea-s60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T18_23532634T33 NONE dhea-s_48\NN\1740|dhea-s60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T18_23532634T34 NONE dhea-s_48\NN\1740|dhea-s60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T19_23532634T32 NONE dhea-s60_50\NN\1740|(|) (r_appos) dhea-s_48\NN\1740|dhea-s60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T19_23532634T33 NONE dhea-s60_50\NN\1740|(|) (r_appos) dhea-s_48\NN\1740|dhea-s60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T19_23532634T34 NONE dhea-s60_50\NN\1740|(|) (r_appos) dhea-s_48\NN\1740|dhea-s60 (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T20_23532634T32 NONE cortisol_54\NN\14751417|delta|δcor (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T20_23532634T33 NONE cortisol_54\NN\14751417|delta|δcor (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T20_23532634T34 NONE cortisol_54\NN\14751417|delta|δcor (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T21_23532634T32 NONE δcor_56\NN\1740|(|) (r_appos) cortisol_54\NN\14751417|delta|δcor (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T21_23532634T33 NONE δcor_56\NN\1740|(|) (r_appos) cortisol_54\NN\14751417|delta|δcor (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T21_23532634T34 NONE δcor_56\NN\1740|(|) (r_appos) cortisol_54\NN\14751417|delta|δcor (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T22_23532634T32 NONE dhea-s_60\NN\1740|delta|δdhea-s (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T22_23532634T33 NONE dhea-s_60\NN\1740|delta|δdhea-s (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T22_23532634T34 NONE dhea-s_60\NN\1740|delta|δdhea-s (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T23_23532634T32 NONE δdhea-s_62\NN\1740|(|) (r_appos) dhea-s_60\NN\1740|delta|δdhea-s (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg
23532634T23_23532634T33 NONE δdhea-s_62\NN\1740|(|) (r_appos) dhea-s_60\NN\1740|delta|δdhea-s (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) globulin_13\NN\14736972|cortisol|binding|cbg (l_appos) cbg_15\NN\1740|(|)
23532634T23_23532634T34 NONE δdhea-s_62\NN\1740|(|) (r_appos) dhea-s_60\NN\1740|delta|δdhea-s (r_conj) =_29\JJ\1740||,|index|,|cortisol|,|and|dhea-s|,|cortisol|,|dhea-s (r_amod) responses_64\NNS\11410625|= (r_dep) cortisol_1\NN\14751417|baseline|cor0|,|dhea-s|,|globulin|,|acth|,|cortisol||responses (l_conj) acth_18\NN\5407119|
23532634T1_23532634T28 CPR:9 cortisol_11\NN\14751417| (r_compound) values_12\NNS\5941423|the|peak|acth-stimulated|cortisol (l_amod) acth-stimulated_10\JJ\1740|
23532634T3_23532634T29 NONE dhea-s_10\NN\1740| (r_compound) levels_11\NNS\4916342|dhea-s (r_conj) fci_7\NN\1740|of|cfc|,|,|and|levels (r_nmod) predictors_3\NNS\10756433|the|fci (r_nsubj) levels_15\NNS\4916342|however|,|predictors|were|serum|creatinine|hyperthyroidism|,|and|levels|. (l_conj) levels_24\NNS\4916342|creatinine|euthyroidism (l_compound) creatinine_21\NN\1740|both|and|transaminase (l_conj) transaminase_23\NN\15077571|
23532634T4_23532634T29 NONE creatinine_14\NN\1740| (r_compound) levels_15\NNS\4916342|however|,|predictors|were|serum|creatinine|hyperthyroidism|,|and|levels|. (l_conj) levels_24\NNS\4916342|creatinine|euthyroidism (l_compound) creatinine_21\NN\1740|both|and|transaminase (l_conj) transaminase_23\NN\15077571|
23532634T5_23532634T29 NONE creatinine_21\NN\1740|both|and|transaminase (l_conj) transaminase_23\NN\15077571|
23532634T6_23532634T30 CPR:9 cortisol_2\NN\14751417| (r_compound) cortisol_5\NN\14751417|acth-stimulated|peak|cortisol|,|delta|,|and|dhea-s|levels (l_amod) acth-stimulated_0\JJ\1740|
23532634T7_23532634T30 CPR:9 cortisol_5\NN\14751417|acth-stimulated|peak|cortisol|,|delta|,|and|dhea-s|levels (l_amod) acth-stimulated_0\JJ\1740|
23532634T8_23532634T30 CPR:9 dhea-s_9\NN\1740|delta (r_conj) cortisol_5\NN\14751417|acth-stimulated|peak|cortisol|,|delta|,|and|dhea-s|levels (l_amod) acth-stimulated_0\JJ\1740|
10999950
10999950T9_10999950T34 CPR:4 u50,488h_26\NN\1740| (r_compound) treatment_27\NN\654885|after|prolonged|u50,488h (r_nmod) underwent_22\VBD\109660|that|receptor|down-regulation|treatment (l_nsubj) receptor_8\NN\5225602|the|human|kappa-opioid|hkor|expressed
10999950T9_10999950T38 CPR:4 u50,488h_26\NN\1740| (r_compound) treatment_27\NN\654885|after|prolonged|u50,488h (r_nmod) underwent_22\VBD\109660|that|receptor|down-regulation|treatment (l_nsubj) receptor_8\NN\5225602|the|human|kappa-opioid|hkor|expressed (l_appos) hkor_10\NN\1740|(|)
10999950T10_10999950T33 CPR:4 488h_2\NN\1740| (r_appos) u50_0\NN\1740|,|488h (r_nsubj) caused_3\VBD\1617192|u50|down-regulation|,|did|. (l_dobj) down-regulation_6\NN\1740|a|significant|hkor (l_nmod) hkor_9\NN\1740|of|the
10999950T11_10999950T33 NONE etorphine_12\NN\1740| (r_nsubj) did_13\VBD\1640855|although|etorphine|not (r_advcl) caused_3\VBD\1617192|u50|down-regulation|,|did|. (l_dobj) down-regulation_6\NN\1740|a|significant|hkor (l_nmod) hkor_9\NN\1740|of|the
10999950T12_10999950T35 NONE u50,488h_1\NN\1740|neither|nor|etorphine (r_nsubj) caused_4\VBD\1617192|u50,488h|down-regulation|. (l_dobj) down-regulation_5\NN\1740|receptor (l_nmod) receptor_10\NN\5225602|of|the|rat|kappa-opioid
10999950T13_10999950T35 NONE etorphine_3\NN\1740| (r_conj) u50,488h_1\NN\1740|neither|nor|etorphine (r_nsubj) caused_4\VBD\1617192|u50,488h|down-regulation|. (l_dobj) down-regulation_5\NN\1740|receptor (l_nmod) receptor_10\NN\5225602|of|the|rat|kappa-opioid
10999950T14_10999950T37 NONE u50,488h-induced_15\JJ\1740| (r_amod) down-regulation_16\NN\1740|u50,488h-induced|hkor (r_dobj) reduced_14\VBD\441445|expression|significantly|down-regulation|. (l_nsubj) expression_0\NN\4679549|mutants (l_nmod) mutants_5\NNS\4475|of|the|dominant|negative|arrestin-2(319 (l_dep) arrestin-2(319_6\NN\1740|418|)|or|i-k44a
10999950T14_10999950T39 NONE u50,488h-induced_15\JJ\1740| (r_amod) down-regulation_16\NN\1740|u50,488h-induced|hkor (r_dobj) reduced_14\VBD\441445|expression|significantly|down-regulation|. (l_nsubj) expression_0\NN\4679549|mutants (l_nmod) mutants_5\NNS\4475|of|the|dominant|negative|arrestin-2(319 (l_dep) arrestin-2(319_6\NN\1740|418|)|or|i-k44a (l_conj) i-k44a_12\NN\1740|dynamin
10999950T14_10999950T40 NONE u50,488h-induced_15\JJ\1740| (r_amod) down-regulation_16\NN\1740|u50,488h-induced|hkor (r_dobj) reduced_14\VBD\441445|expression|significantly|down-regulation|. (l_nsubj) expression_0\NN\4679549|mutants (l_nmod) mutants_5\NNS\4475|of|the|dominant|negative|arrestin-2(319 (l_dep) arrestin-2(319_6\NN\1740|418|)|or|i-k44a (l_conj) i-k44a_12\NN\1740|dynamin
10999950T14_10999950T41 CPR:4 u50,488h-induced_15\JJ\1740| (r_amod) down-regulation_16\NN\1740|u50,488h-induced|hkor (l_nmod) hkor_19\NN\1740|of|the
10999950T15_10999950T42 NONE etorphine_8\NN\1740| (r_dobj) permitted_7\VBD\797697|coexpression|etorphine|induce|,|did|. (l_nsubj) coexpression_0\NN\1740|grk2 (l_nmod) grk2_2\NN\1740|of|or|grk2|and|arrestin-2
10999950T15_10999950T43 NONE etorphine_8\NN\1740| (r_dobj) permitted_7\VBD\797697|coexpression|etorphine|induce|,|did|. (l_nsubj) coexpression_0\NN\1740|grk2 (l_nmod) grk2_2\NN\1740|of|or|grk2|and|arrestin-2 (l_conj) grk2_4\NN\1740|
10999950T15_10999950T44 NONE etorphine_8\NN\1740| (r_dobj) permitted_7\VBD\797697|coexpression|etorphine|induce|,|did|. (l_nsubj) coexpression_0\NN\1740|grk2 (l_nmod) grk2_2\NN\1740|of|or|grk2|and|arrestin-2 (l_conj) arrestin-2_6\NN\1740|
10999950T15_10999950T45 CPR:4 etorphine_8\NN\1740| (r_dobj) permitted_7\VBD\797697|coexpression|etorphine|induce|,|did|. (l_xcomp) induce_10\VB\1627355|to|down-regulation (l_dobj) down-regulation_11\NN\1740|hkor (l_nmod) hkor_14\NN\1740|of|the
10999950T15_10999950T46 NONE etorphine_8\NN\1740| (r_dobj) permitted_7\VBD\797697|coexpression|etorphine|induce|,|did|. (l_advcl) did_24\VBD\1640855|although|expression|not (l_nsubj) expression_17\NN\4679549|arrestin-2 (l_nmod) arrestin-2_19\NN\1740|of|or|dynamin|alone
10999950T15_10999950T47 NONE etorphine_8\NN\1740| (r_dobj) permitted_7\VBD\797697|coexpression|etorphine|induce|,|did|. (l_advcl) did_24\VBD\1640855|although|expression|not (l_nsubj) expression_17\NN\4679549|arrestin-2 (l_nmod) arrestin-2_19\NN\1740|of|or|dynamin|alone (l_conj) dynamin_21\NN\1740|i (l_nummod) i_22\CD\14622893|
10999950T16_10999950T48 CPR:4 u50,488h-induced_10\JJ\1740| (r_amod) down-regulation_11\NN\1740|u50,488h-induced (r_dobj) blunted_9\VBD\224901|expression|down-regulation|. (l_nsubj) expression_0\NN\4679549|mutants (l_nmod) mutants_5\NNS\4475|of|the|dominant|negative|rab5a-n133i (l_dep) rab5a-n133i_6\NN\1740|or|rab7-n125i
10999950T16_10999950T49 CPR:4 u50,488h-induced_10\JJ\1740| (r_amod) down-regulation_11\NN\1740|u50,488h-induced (r_dobj) blunted_9\VBD\224901|expression|down-regulation|. (l_nsubj) expression_0\NN\4679549|mutants (l_nmod) mutants_5\NNS\4475|of|the|dominant|negative|rab5a-n133i (l_dep) rab5a-n133i_6\NN\1740|or|rab7-n125i
10999950T16_10999950T50 CPR:4 u50,488h-induced_10\JJ\1740| (r_amod) down-regulation_11\NN\1740|u50,488h-induced (r_dobj) blunted_9\VBD\224901|expression|down-regulation|. (l_nsubj) expression_0\NN\4679549|mutants (l_nmod) mutants_5\NNS\4475|of|the|dominant|negative|rab5a-n133i (l_dep) rab5a-n133i_6\NN\1740|or|rab7-n125i (l_conj) rab7-n125i_8\NN\1740|
10999950T16_10999950T51 CPR:4 u50,488h-induced_10\JJ\1740| (r_amod) down-regulation_11\NN\1740|u50,488h-induced (r_dobj) blunted_9\VBD\224901|expression|down-regulation|. (l_nsubj) expression_0\NN\4679549|mutants (l_nmod) mutants_5\NNS\4475|of|the|dominant|negative|rab5a-n133i (l_dep) rab5a-n133i_6\NN\1740|or|rab7-n125i (l_conj) rab7-n125i_8\NN\1740|
10999950T1_10999950T17 NONE ]_14\-RRB-\1740| (r_punct) ester_11\NN\14727670|[|(|2s|,|3s)trans-epoxysuccinyl-l-leucylamido-3-methylbutane|ethyl|or|chloroquine|] (r_dep) inhibitors_4\NNS\20090|with|lysosomal|enzyme|ester|or|inhibitors (l_conj) inhibitors_17\NNS\20090|proteasome|i (l_compound) proteasome_16\NN\1740|
10999950T1_10999950T18 NONE ]_14\-RRB-\1740| (r_punct) ester_11\NN\14727670|[|(|2s|,|3s)trans-epoxysuccinyl-l-leucylamido-3-methylbutane|ethyl|or|chloroquine|] (r_dep) inhibitors_4\NNS\20090|with|lysosomal|enzyme|ester|or|inhibitors (l_conj) inhibitors_17\NNS\20090|proteasome|i (l_dep) i_21\NN\14622893|(|proteasome|inhibitor|,|mg-132|,|or|lactacystin|) (l_compound) proteasome_19\NN\1740|
10999950T2_10999950T17 NONE mg-132_23\NN\1740| (r_conj) i_21\NN\14622893|(|proteasome|inhibitor|,|mg-132|,|or|lactacystin|) (r_dep) inhibitors_17\NNS\20090|proteasome|i (l_compound) proteasome_16\NN\1740|
10999950T2_10999950T18 CPR:4 mg-132_23\NN\1740| (r_conj) i_21\NN\14622893|(|proteasome|inhibitor|,|mg-132|,|or|lactacystin|) (l_compound) proteasome_19\NN\1740|
10999950T3_10999950T17 NONE lactacystin_26\NN\1740| (r_conj) i_21\NN\14622893|(|proteasome|inhibitor|,|mg-132|,|or|lactacystin|) (r_dep) inhibitors_17\NNS\20090|proteasome|i (l_compound) proteasome_16\NN\1740|
10999950T3_10999950T18 CPR:4 lactacystin_26\NN\1740| (r_conj) i_21\NN\14622893|(|proteasome|inhibitor|,|mg-132|,|or|lactacystin|) (l_compound) proteasome_19\NN\1740|
10999950T4_10999950T17 NONE u50,488h-induced_32\JJ\1740| (r_amod) down-regulation_33\NN\1740|of|u50,488h-induced (r_nmod) extent_30\NN\13939892|the|down-regulation (r_dobj) decreased_28\VBD\169651|pretreatment|extent|. (l_nsubj) pretreatment_0\NN\1740|inhibitors (l_nmod) inhibitors_4\NNS\20090|with|lysosomal|enzyme|ester|or|inhibitors (l_conj) inhibitors_17\NNS\20090|proteasome|i (l_compound) proteasome_16\NN\1740|
10999950T4_10999950T18 NONE u50,488h-induced_32\JJ\1740| (r_amod) down-regulation_33\NN\1740|of|u50,488h-induced (r_nmod) extent_30\NN\13939892|the|down-regulation (r_dobj) decreased_28\VBD\169651|pretreatment|extent|. (l_nsubj) pretreatment_0\NN\1740|inhibitors (l_nmod) inhibitors_4\NNS\20090|with|lysosomal|enzyme|ester|or|inhibitors (l_conj) inhibitors_17\NNS\20090|proteasome|i (l_dep) i_21\NN\14622893|(|proteasome|inhibitor|,|mg-132|,|or|lactacystin|) (l_compound) proteasome_19\NN\1740|
10999950T5_10999950T19 NONE chloroquine_3\NN\2721948|of|and|inhibitor (l_conj) inhibitor_6\NN\20090|proteasome|i (l_compound) proteasome_5\NN\1740|
10999950T6_10999950T19 NONE u50,488h-induced_9\JJ\1740| (r_amod) down-regulation_10\NN\1740|u50,488h-induced (r_dobj) abolished_8\VBD\1740|combination|down-regulation|. (l_nsubj) combination_1\NN\7951464|a|chloroquine (l_nmod) chloroquine_3\NN\2721948|of|and|inhibitor (l_conj) inhibitor_6\NN\20090|proteasome|i (l_compound) proteasome_5\NN\1740|
10999950T7_10999950T20 CPR:4 u50,488h-induced_4\JJ\1740| (r_amod) down-regulation_5\NN\1740|u50,488h-induced|hkor (l_nmod) hkor_8\NN\1740|of|the
10999950T7_10999950T21 NONE u50,488h-induced_4\JJ\1740| (r_amod) down-regulation_5\NN\1740|u50,488h-induced|hkor (r_nsubj) involves_9\VBZ\2676054|that|down-regulation|mechanisms|and (l_dobj) mechanisms_20\NNS\13446390|grk- (l_amod) grk-_10\NN\1740|,|arrestin-2-|,|dynamin-|,|rab5-|,|and|rab7-dependent
10999950T7_10999950T22 NONE u50,488h-induced_4\JJ\1740| (r_amod) down-regulation_5\NN\1740|u50,488h-induced|hkor (r_nsubj) involves_9\VBZ\2676054|that|down-regulation|mechanisms|and (l_dobj) mechanisms_20\NNS\13446390|grk- (l_amod) grk-_10\NN\1740|,|arrestin-2-|,|dynamin-|,|rab5-|,|and|rab7-dependent (l_conj) arrestin-2-_12\NN\1740|
10999950T7_10999950T23 NONE u50,488h-induced_4\JJ\1740| (r_amod) down-regulation_5\NN\1740|u50,488h-induced|hkor (r_nsubj) involves_9\VBZ\2676054|that|down-regulation|mechanisms|and (l_dobj) mechanisms_20\NNS\13446390|grk- (l_amod) grk-_10\NN\1740|,|arrestin-2-|,|dynamin-|,|rab5-|,|and|rab7-dependent (l_conj) dynamin-_14\NN\1740|
10999950T7_10999950T24 NONE u50,488h-induced_4\JJ\1740| (r_amod) down-regulation_5\NN\1740|u50,488h-induced|hkor (r_nsubj) involves_9\VBZ\2676054|that|down-regulation|mechanisms|and (l_dobj) mechanisms_20\NNS\13446390|grk- (l_amod) grk-_10\NN\1740|,|arrestin-2-|,|dynamin-|,|rab5-|,|and|rab7-dependent (l_conj) rab5-_16\NN\1740|
10999950T7_10999950T25 NONE u50,488h-induced_4\JJ\1740| (r_amod) down-regulation_5\NN\1740|u50,488h-induced|hkor (r_nsubj) involves_9\VBZ\2676054|that|down-regulation|mechanisms|and (l_dobj) mechanisms_20\NNS\13446390|grk- (l_amod) grk-_10\NN\1740|,|arrestin-2-|,|dynamin-|,|rab5-|,|and|rab7-dependent (l_conj) rab7-dependent_19\JJ\1740|
10999950T7_10999950T26 NONE u50,488h-induced_4\JJ\1740| (r_amod) down-regulation_5\NN\1740|u50,488h-induced|hkor (r_nsubj) involves_9\VBZ\2676054|that|down-regulation|mechanisms|and (r_ccomp) indicate_2\VBP\952524|results|involves|seem|. (l_ccomp) seem_23\VBP\2604760|receptors|trafficked (l_xcomp) trafficked_26\VBN\2260362|to|be|lysosomes|degradation (l_nmod) lysosomes_28\NNS\5445668|to|and|proteasomes (l_conj) proteasomes_30\NNS\1740|
10999950T8_10999950T27 CPR:4 u50,488h-induced_2\JJ\1740| (r_amod) internalization_3\NN\5752544|u50,488h-induced|and|down-regulation|hkor (l_nmod) hkor_8\NN\1740|of|the
7944828
7944828T29_7944828T47 CPR:5 2-(2-aminoethyl)-quinoline_0\NN\1740|d-1997 (r_nsubj) agonist_6\NN\9613191|2-(2-aminoethyl)-quinoline|a|novel|receptors|. (l_nmod) receptors_9\NNS\5225602|at|5-hydroxytryptamine1-like|artery
7944828T30_7944828T47 CPR:5 d-1997_2\NN\1740|(|): (r_appos) 2-(2-aminoethyl)-quinoline_0\NN\1740|d-1997 (r_nsubj) agonist_6\NN\9613191|2-(2-aminoethyl)-quinoline|a|novel|receptors|. (l_nmod) receptors_9\NNS\5225602|at|5-hydroxytryptamine1-like|artery
7944828T31_7944828T47 NONE 5-hydroxytryptamine1-like_8\JJ\1740| (r_amod) receptors_9\NNS\5225602|at|5-hydroxytryptamine1-like|artery
7944828T13_7944828T46 NONE d-1997_4\NN\1740|of (r_nmod) effects_2\NNS\13245626|the|contractile|d-1997|artery (r_nsubjpass) compared_10\VBN\644583|effects|were|those|. (l_nmod) those_12\DT\1740|with|produced (l_acl) produced_13\VBN\1617192|5-hydroxytryptamine (l_nmod) 5-hydroxytryptamine_15\NN\14807737|by|5-ht|and|quipazine (l_conj) quipazine_24\NN\1740|the|agonist (l_compound) agonist_23\NN\9613191|5-ht|receptor (l_compound) receptor_22\NN\5225602|
7944828T14_7944828T46 NONE 5-hydroxytryptamine_15\NN\14807737|by|5-ht|and|quipazine (l_conj) quipazine_24\NN\1740|the|agonist (l_compound) agonist_23\NN\9613191|5-ht|receptor (l_compound) receptor_22\NN\5225602|
7944828T15_7944828T46 NONE 5-ht_17\NN\1740|(|) (r_appos) 5-hydroxytryptamine_15\NN\14807737|by|5-ht|and|quipazine (l_conj) quipazine_24\NN\1740|the|agonist (l_compound) agonist_23\NN\9613191|5-ht|receptor (l_compound) receptor_22\NN\5225602|
7944828T16_7944828T46 NONE 5-ht_21\NN\1740| (r_compound) agonist_23\NN\9613191|5-ht|receptor (l_compound) receptor_22\NN\5225602|
7944828T17_7944828T46 NONE quipazine_24\NN\1740|the|agonist (l_compound) agonist_23\NN\9613191|5-ht|receptor (l_compound) receptor_22\NN\5225602|
7944828T2_7944828T32 CPR:6 ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_compound) receptor_17\NN\5225602|5-ht2
7944828T2_7944828T33 NONE ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4
7944828T2_7944828T34 NONE ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4 (l_conj) 5-ht4_30\NN\1740|
7944828T2_7944828T35 NONE ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_conj) spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (l_compound) 5-ht1a_44\NN\1740|
7944828T2_7944828T36 NONE ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_compound) beta-adrenoceptor_56\NN\5608868|
7944828T2_7944828T37 NONE ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b
7944828T2_7944828T38 NONE ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b (l_conj) 5-ht1b_64\NN\1740|
7944828T2_7944828T39 NONE ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (l_compound) 1-adrenoceptor_78\NN\1740|
7944828T3_7944828T32 NONE tropisetron_35\NN\1740|(|;|microm|) (r_dep) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_compound) receptor_17\NN\5225602|5-ht2
7944828T3_7944828T33 CPR:6 tropisetron_35\NN\1740|(|;|microm|) (r_dep) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4
7944828T3_7944828T34 CPR:6 tropisetron_35\NN\1740|(|;|microm|) (r_dep) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4 (l_conj) 5-ht4_30\NN\1740|
7944828T3_7944828T35 NONE tropisetron_35\NN\1740|(|;|microm|) (r_dep) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_conj) spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (l_compound) 5-ht1a_44\NN\1740|
7944828T3_7944828T36 NONE tropisetron_35\NN\1740|(|;|microm|) (r_dep) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_compound) beta-adrenoceptor_56\NN\5608868|
7944828T3_7944828T37 NONE tropisetron_35\NN\1740|(|;|microm|) (r_dep) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b
7944828T3_7944828T38 NONE tropisetron_35\NN\1740|(|;|microm|) (r_dep) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b (l_conj) 5-ht1b_64\NN\1740|
7944828T3_7944828T39 NONE tropisetron_35\NN\1740|(|;|microm|) (r_dep) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (l_compound) 1-adrenoceptor_78\NN\1740|
7944828T4_7944828T32 NONE spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (r_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_compound) receptor_17\NN\5225602|5-ht2
7944828T4_7944828T33 NONE spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (r_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4
7944828T4_7944828T34 NONE spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (r_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4 (l_conj) 5-ht4_30\NN\1740|
7944828T4_7944828T35 CPR:6 spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (l_compound) 5-ht1a_44\NN\1740|
7944828T4_7944828T36 NONE spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (r_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_compound) beta-adrenoceptor_56\NN\5608868|
7944828T4_7944828T37 NONE spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (r_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b
7944828T4_7944828T38 NONE spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (r_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b (l_conj) 5-ht1b_64\NN\1740|
7944828T4_7944828T39 NONE spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (r_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (l_compound) 1-adrenoceptor_78\NN\1740|
7944828T6_7944828T32 NONE (+/-)-pindolol_67\NN\1740|microm (r_dep) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_compound) receptor_17\NN\5225602|5-ht2
7944828T6_7944828T33 NONE (+/-)-pindolol_67\NN\1740|microm (r_dep) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4
7944828T6_7944828T34 NONE (+/-)-pindolol_67\NN\1740|microm (r_dep) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4 (l_conj) 5-ht4_30\NN\1740|
7944828T6_7944828T35 NONE (+/-)-pindolol_67\NN\1740|microm (r_dep) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_conj) spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (l_compound) 5-ht1a_44\NN\1740|
7944828T6_7944828T36 CPR:4 (+/-)-pindolol_67\NN\1740|microm (r_dep) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_compound) beta-adrenoceptor_56\NN\5608868|
7944828T6_7944828T37 NONE (+/-)-pindolol_67\NN\1740|microm (r_dep) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b
7944828T6_7944828T38 NONE (+/-)-pindolol_67\NN\1740|microm (r_dep) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b (l_conj) 5-ht1b_64\NN\1740|
7944828T6_7944828T39 NONE (+/-)-pindolol_67\NN\1740|microm (r_dep) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (l_compound) 1-adrenoceptor_78\NN\1740|
7944828T7_7944828T32 NONE prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_compound) receptor_17\NN\5225602|5-ht2
7944828T7_7944828T33 NONE prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4
7944828T7_7944828T34 NONE prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4 (l_conj) 5-ht4_30\NN\1740|
7944828T7_7944828T35 NONE prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_conj) spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (l_compound) 5-ht1a_44\NN\1740|
7944828T7_7944828T36 NONE prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_compound) beta-adrenoceptor_56\NN\5608868|
7944828T7_7944828T37 NONE prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b
7944828T7_7944828T38 NONE prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (r_conj) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b (l_conj) 5-ht1b_64\NN\1740|
7944828T7_7944828T39 CPR:6 prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (l_compound) 1-adrenoceptor_78\NN\1740|
7944828T28_7944828T32 NONE d-1997_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|d-1997|artery (r_nsubjpass) modified_10\VBN\109660|effects|were|not|incubation|. (l_nmod) incubation_12\NN\654885|by|ketanserin (l_nmod) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_compound) receptor_17\NN\5225602|5-ht2
7944828T28_7944828T33 NONE d-1997_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|d-1997|artery (r_nsubjpass) modified_10\VBN\109660|effects|were|not|incubation|. (l_nmod) incubation_12\NN\654885|by|ketanserin (l_nmod) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4
7944828T28_7944828T34 NONE d-1997_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|d-1997|artery (r_nsubjpass) modified_10\VBN\109660|effects|were|not|incubation|. (l_nmod) incubation_12\NN\654885|by|ketanserin (l_nmod) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_compound) 5-ht3_28\NN\1740|and|5-ht4 (l_conj) 5-ht4_30\NN\1740|
7944828T28_7944828T35 NONE d-1997_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|d-1997|artery (r_nsubjpass) modified_10\VBN\109660|effects|were|not|incubation|. (l_nmod) incubation_12\NN\654885|by|ketanserin (l_nmod) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) ics205930_33\NN\1740|the|5-ht3|receptor|antagonist|tropisetron|,|spiroxatrine|, (l_conj) spiroxatrine_47\NN\1740|the|5-ht1a|receptor|antagonist|microm (l_compound) 5-ht1a_44\NN\1740|
7944828T28_7944828T36 NONE d-1997_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|d-1997|artery (r_nsubjpass) modified_10\VBN\109660|effects|were|not|incubation|. (l_nmod) incubation_12\NN\654885|by|ketanserin (l_nmod) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_compound) beta-adrenoceptor_56\NN\5608868|
7944828T28_7944828T37 NONE d-1997_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|d-1997|artery (r_nsubjpass) modified_10\VBN\109660|effects|were|not|incubation|. (l_nmod) incubation_12\NN\654885|by|ketanserin (l_nmod) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b
7944828T28_7944828T38 NONE d-1997_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|d-1997|artery (r_nsubjpass) modified_10\VBN\109660|effects|were|not|incubation|. (l_nmod) incubation_12\NN\654885|by|ketanserin (l_nmod) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) blocker_57\NN\10101634|the|beta-adrenoceptor|affinity|(+/-)-pindolol (l_nmod) affinity_60\NN\11426530|with|high|sites (l_nmod) sites_66\NNS\8673395|for|5-ht1a|binding (l_compound) 5-ht1a_62\NN\1740|and|5-ht1b (l_conj) 5-ht1b_64\NN\1740|
7944828T28_7944828T39 NONE d-1997_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|d-1997|artery (r_nsubjpass) modified_10\VBN\109660|effects|were|not|incubation|. (l_nmod) incubation_12\NN\654885|by|ketanserin (l_nmod) ketanserin_19\NN\1740|with|either|the|receptor|antagonist|microm|,|ics205930|blocker|,|or|prazosin (l_conj) prazosin_80\NN\2698769|the|alpha|1-adrenoceptor|antagonist|microm (l_compound) 1-adrenoceptor_78\NN\1740|
7944828T8_7944828T40 CPR:5 d-1997-induced_4\JJ\1740| (r_amod) responses_5\NNS\11410625|the|d-1997-induced (r_nsubjpass) antagonized_10\VBN\1787955|contrast|,|responses|were|and|methiothepin|. (l_nmod) methiothepin_19\NN\1740|by|the|5-ht1-like|microm (l_amod) 5-ht1-like_14\JJ\1740|mixed|and|5-ht2|receptor|antagonist
7944828T8_7944828T41 CPR:5 d-1997-induced_4\JJ\1740| (r_amod) responses_5\NNS\11410625|the|d-1997-induced (r_nsubjpass) antagonized_10\VBN\1787955|contrast|,|responses|were|and|methiothepin|. (l_nmod) methiothepin_19\NN\1740|by|the|5-ht1-like|microm (l_amod) 5-ht1-like_14\JJ\1740|mixed|and|5-ht2|receptor|antagonist (l_dep) receptor_17\NN\5225602|
7944828T10_7944828T40 CPR:6 methiothepin_19\NN\1740|by|the|5-ht1-like|microm (l_amod) 5-ht1-like_14\JJ\1740|mixed|and|5-ht2|receptor|antagonist
7944828T10_7944828T41 CPR:6 methiothepin_19\NN\1740|by|the|5-ht1-like|microm (l_amod) 5-ht1-like_14\JJ\1740|mixed|and|5-ht2|receptor|antagonist (l_dep) receptor_17\NN\5225602|
7944828T11_7944828T42 CPR:3 d-1997_4\NN\1740| (r_nsubj) contracts_5\VBZ\884011|that|d-1997|artery|stimulating (l_advcl) stimulating_11\VBG\137313|by|receptors (l_dobj) receptors_13\NNS\5225602|5-ht1-like|unrelated
7944828T11_7944828T43 CPR:3 d-1997_4\NN\1740| (r_nsubj) contracts_5\VBZ\884011|that|d-1997|artery|stimulating (l_advcl) stimulating_11\VBG\137313|by|receptors (l_dobj) receptors_13\NNS\5225602|5-ht1-like|unrelated (l_amod) unrelated_14\JJ\1740|subtypes (l_nmod) subtypes_22\NNS\1740|5-ht1a|receptor (l_compound) 5-ht1a_18\NN\1740|to|either|the|or|5-ht1b
7944828T11_7944828T44 CPR:3 d-1997_4\NN\1740| (r_nsubj) contracts_5\VBZ\884011|that|d-1997|artery|stimulating (l_advcl) stimulating_11\VBG\137313|by|receptors (l_dobj) receptors_13\NNS\5225602|5-ht1-like|unrelated (l_amod) unrelated_14\JJ\1740|subtypes (l_nmod) subtypes_22\NNS\1740|5-ht1a|receptor (l_compound) 5-ht1a_18\NN\1740|to|either|the|or|5-ht1b (l_conj) 5-ht1b_20\NN\1740|
20230007
20230007T22_20230007T45 NONE steroids_3\NNS\14727670|of|anabolic-androgenic|and|glucocorticoids (r_nmod) effect_0\NN\34213|steroids|kinetics|. (l_nmod) kinetics_8\NNS\6100236|on|the|translocation (l_nmod) translocation_14\NN\13526110|of|har|hgr|nucleocytoplasmic (l_compound) har_10\NN\1740|and
20230007T22_20230007T46 NONE steroids_3\NNS\14727670|of|anabolic-androgenic|and|glucocorticoids (r_nmod) effect_0\NN\34213|steroids|kinetics|. (l_nmod) kinetics_8\NNS\6100236|on|the|translocation (l_nmod) translocation_14\NN\13526110|of|har|hgr|nucleocytoplasmic (l_compound) hgr_12\NN\1740|
20230007T18_20230007T29 NONE androgen_7\NN\14745635| (r_compound) receptor_8\NN\5225602|the|human|androgen|har|and|receptor
20230007T18_20230007T30 NONE androgen_7\NN\14745635| (r_compound) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (l_appos) har_10\NN\1740|(|)
20230007T18_20230007T31 NONE androgen_7\NN\14745635| (r_compound) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (l_conj) receptor_16\NN\5225602|the|human|glucocorticoid|hgr
20230007T18_20230007T32 NONE androgen_7\NN\14745635| (r_compound) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (l_conj) receptor_16\NN\5225602|the|human|glucocorticoid|hgr (l_appos) hgr_18\NN\1740|(|)
20230007T18_20230007T33 NONE androgen_7\NN\14745635| (r_compound) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (r_dobj) using_4\VBG\1156834|receptor (r_acl) studies_3\NNS\635850|translocation|using (r_nsubjpass) performed_21\VBN\2367363|here|,|studies|were|aid|. (l_xcomp) aid_23\VB\2556126|to|identifying (l_advcl) identifying_25\VBG\699815|in|mechanism (l_dobj) mechanism_27\NN\13446390|the|activating (l_acl:relcl) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (l_dobj) har_37\NN\1740|
20230007T18_20230007T34 NONE androgen_7\NN\14745635| (r_compound) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (r_dobj) using_4\VBG\1156834|receptor (r_acl) studies_3\NNS\635850|translocation|using (r_nsubjpass) performed_21\VBN\2367363|here|,|studies|were|aid|. (l_xcomp) aid_23\VB\2556126|to|identifying (l_advcl) identifying_25\VBG\699815|in|mechanism (l_dobj) mechanism_27\NN\13446390|the|activating (l_acl:relcl) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (l_conj) interacting_40\VBG\2367363|potentially|hgr (l_nmod) hgr_42\NN\1740|with
20230007T18_20230007T35 NONE androgen_7\NN\14745635| (r_compound) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (r_dobj) using_4\VBG\1156834|receptor (r_acl) studies_3\NNS\635850|translocation|using (r_nsubjpass) performed_21\VBN\2367363|here|,|studies|were|aid|. (l_xcomp) aid_23\VB\2556126|to|identifying (l_advcl) identifying_25\VBG\699815|in|mechanism (l_dobj) mechanism_27\NN\13446390|the|activating (l_acl:relcl) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (l_conj) interacting_48\VBG\2367363|how|ligands|were|hgr (l_nmod) hgr_51\NN\1740|with|the|and|har
20230007T18_20230007T36 NONE androgen_7\NN\14745635| (r_compound) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (r_dobj) using_4\VBG\1156834|receptor (r_acl) studies_3\NNS\635850|translocation|using (r_nsubjpass) performed_21\VBN\2367363|here|,|studies|were|aid|. (l_xcomp) aid_23\VB\2556126|to|identifying (l_advcl) identifying_25\VBG\699815|in|mechanism (l_dobj) mechanism_27\NN\13446390|the|activating (l_acl:relcl) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (l_conj) interacting_48\VBG\2367363|how|ligands|were|hgr (l_nmod) hgr_51\NN\1740|with|the|and|har (l_conj) har_53\NN\1740|
20230007T19_20230007T29 NONE steroids_31\NNS\14727670|anabolic-androgenic|aas (r_nsubj) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (r_acl:relcl) mechanism_27\NN\13446390|the|activating (r_dobj) identifying_25\VBG\699815|in|mechanism (r_advcl) aid_23\VB\2556126|to|identifying (r_xcomp) performed_21\VBN\2367363|here|,|studies|were|aid|. (l_nsubjpass) studies_3\NNS\635850|translocation|using (l_acl) using_4\VBG\1156834|receptor (l_dobj) receptor_8\NN\5225602|the|human|androgen|har|and|receptor
20230007T19_20230007T30 NONE steroids_31\NNS\14727670|anabolic-androgenic|aas (r_nsubj) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (r_acl:relcl) mechanism_27\NN\13446390|the|activating (r_dobj) identifying_25\VBG\699815|in|mechanism (r_advcl) aid_23\VB\2556126|to|identifying (r_xcomp) performed_21\VBN\2367363|here|,|studies|were|aid|. (l_nsubjpass) studies_3\NNS\635850|translocation|using (l_acl) using_4\VBG\1156834|receptor (l_dobj) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (l_appos) har_10\NN\1740|(|)
20230007T19_20230007T31 NONE steroids_31\NNS\14727670|anabolic-androgenic|aas (r_nsubj) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (r_acl:relcl) mechanism_27\NN\13446390|the|activating (r_dobj) identifying_25\VBG\699815|in|mechanism (r_advcl) aid_23\VB\2556126|to|identifying (r_xcomp) performed_21\VBN\2367363|here|,|studies|were|aid|. (l_nsubjpass) studies_3\NNS\635850|translocation|using (l_acl) using_4\VBG\1156834|receptor (l_dobj) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (l_conj) receptor_16\NN\5225602|the|human|glucocorticoid|hgr
20230007T19_20230007T32 NONE steroids_31\NNS\14727670|anabolic-androgenic|aas (r_nsubj) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (r_acl:relcl) mechanism_27\NN\13446390|the|activating (r_dobj) identifying_25\VBG\699815|in|mechanism (r_advcl) aid_23\VB\2556126|to|identifying (r_xcomp) performed_21\VBN\2367363|here|,|studies|were|aid|. (l_nsubjpass) studies_3\NNS\635850|translocation|using (l_acl) using_4\VBG\1156834|receptor (l_dobj) receptor_8\NN\5225602|the|human|androgen|har|and|receptor (l_conj) receptor_16\NN\5225602|the|human|glucocorticoid|hgr (l_appos) hgr_18\NN\1740|(|)
20230007T19_20230007T33 CPR:3 steroids_31\NNS\14727670|anabolic-androgenic|aas (r_nsubj) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (l_dobj) har_37\NN\1740|
20230007T19_20230007T34 NONE steroids_31\NNS\14727670|anabolic-androgenic|aas (r_nsubj) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (l_conj) interacting_40\VBG\2367363|potentially|hgr (l_nmod) hgr_42\NN\1740|with
20230007T19_20230007T35 NONE steroids_31\NNS\14727670|anabolic-androgenic|aas (r_nsubj) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (l_conj) interacting_48\VBG\2367363|how|ligands|were|hgr (l_nmod) hgr_51\NN\1740|with|the|and|har
20230007T19_20230007T36 NONE steroids_31\NNS\14727670|anabolic-androgenic|aas (r_nsubj) activating_36\VBG\1641914|which|steroids|were|har|and|interacting|and|interacting (l_conj) interacting_48\VBG\2367363|how|ligands|were|hgr (l_nmod) hgr_51\NN\1740|with|the|and|har (l_conj) har_53\NN\1740|
20230007T20_20230007T44 NONE testosterone_0\NN\14747587|test (r_nsubj) had_4\VBD\2108377|testosterone|rate|. (l_dobj) rate_8\NN\13815152|the|fastest|translocation|har (l_nmod) har_11\NN\1740|for|the|min(-1
20230007T21_20230007T44 NONE test_2\NN\5798043|(|) (r_appos) testosterone_0\NN\14747587|test (r_nsubj) had_4\VBD\2108377|testosterone|rate|. (l_dobj) rate_8\NN\13815152|the|fastest|translocation|har (l_nmod) har_11\NN\1740|for|the|min(-1
20230007T1_20230007T23 NONE steroids_3\NNS\14727670|the|other|endogenous|,|androstenedione|, (r_nsubj) had_15\VBD\2108377|steroids|rates|. (l_dobj) rates_20\NNS\13308999|lower|har|transport (l_compound) har_18\NN\1740|
20230007T2_20230007T23 NONE androstenedione_5\NN\1740|ane|and|dihydrotestosterone (r_appos) steroids_3\NNS\14727670|the|other|endogenous|,|androstenedione|, (r_nsubj) had_15\VBD\2108377|steroids|rates|. (l_dobj) rates_20\NNS\13308999|lower|har|transport (l_compound) har_18\NN\1740|
20230007T3_20230007T23 NONE ane_7\NN\1740|(|) (r_appos) androstenedione_5\NN\1740|ane|and|dihydrotestosterone (r_appos) steroids_3\NNS\14727670|the|other|endogenous|,|androstenedione|, (r_nsubj) had_15\VBD\2108377|steroids|rates|. (l_dobj) rates_20\NNS\13308999|lower|har|transport (l_compound) har_18\NN\1740|
20230007T4_20230007T23 NONE dihydrotestosterone_10\NN\1740|dht (r_conj) androstenedione_5\NN\1740|ane|and|dihydrotestosterone (r_appos) steroids_3\NNS\14727670|the|other|endogenous|,|androstenedione|, (r_nsubj) had_15\VBD\2108377|steroids|rates|. (l_dobj) rates_20\NNS\13308999|lower|har|transport (l_compound) har_18\NN\1740|
20230007T5_20230007T23 NONE dht_12\NN\1740|(|) (r_appos) dihydrotestosterone_10\NN\1740|dht (r_conj) androstenedione_5\NN\1740|ane|and|dihydrotestosterone (r_appos) steroids_3\NNS\14727670|the|other|endogenous|,|androstenedione|, (r_nsubj) had_15\VBD\2108377|steroids|rates|. (l_dobj) rates_20\NNS\13308999|lower|har|transport (l_compound) har_18\NN\1740|
20230007T6_20230007T24 NONE steroids_8\NNS\14727670|for|the|exogenous|methyltrienelone (r_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T7_20230007T24 NONE methyltrienelone_9\NN\1740|met|,|nandrolone|,|and|oxandrolone (r_dep) steroids_8\NNS\14727670|for|the|exogenous|methyltrienelone (r_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T8_20230007T24 NONE met_11\NN\1740|(|) (r_appos) methyltrienelone_9\NN\1740|met|,|nandrolone|,|and|oxandrolone (r_dep) steroids_8\NNS\14727670|for|the|exogenous|methyltrienelone (r_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T9_20230007T24 NONE nandrolone_14\NN\14747587|nan (r_conj) methyltrienelone_9\NN\1740|met|,|nandrolone|,|and|oxandrolone (r_dep) steroids_8\NNS\14727670|for|the|exogenous|methyltrienelone (r_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T10_20230007T24 NONE nan_16\NN\10142747|(|) (r_appos) nandrolone_14\NN\14747587|nan (r_conj) methyltrienelone_9\NN\1740|met|,|nandrolone|,|and|oxandrolone (r_dep) steroids_8\NNS\14727670|for|the|exogenous|methyltrienelone (r_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T11_20230007T24 NONE oxandrolone_20\NN\1740|oxa (r_conj) methyltrienelone_9\NN\1740|met|,|nandrolone|,|and|oxandrolone (r_dep) steroids_8\NNS\14727670|for|the|exogenous|methyltrienelone (r_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T12_20230007T24 NONE oxa_22\NN\1740|(|) (r_appos) oxandrolone_20\NN\1740|oxa (r_conj) methyltrienelone_9\NN\1740|met|,|nandrolone|,|and|oxandrolone (r_dep) steroids_8\NNS\14727670|for|the|exogenous|methyltrienelone (r_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T13_20230007T24 NONE testosterone_29\NN\14747587|of (r_nmod) that_27\DT\1740|than|testosterone (r_nmod) lower_25\JJR\1740|rates|are|that|and|similar|. (l_nsubj) rates_1\NNS\13308999|the|transport (l_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T14_20230007T24 NONE steroids_37\NNS\14727670|of|the|endogenous|ane (r_nmod) those_33\DT\1740|to|steroids (r_nmod) similar_31\JJ\1740|those (r_conj) lower_25\JJR\1740|rates|are|that|and|similar|. (l_nsubj) rates_1\NNS\13308999|the|transport (l_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T15_20230007T24 NONE ane_38\NN\1740|and|dht (r_dep) steroids_37\NNS\14727670|of|the|endogenous|ane (r_nmod) those_33\DT\1740|to|steroids (r_nmod) similar_31\JJ\1740|those (r_conj) lower_25\JJR\1740|rates|are|that|and|similar|. (l_nsubj) rates_1\NNS\13308999|the|transport (l_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T16_20230007T24 NONE dht_40\NN\1740| (r_conj) ane_38\NN\1740|and|dht (r_dep) steroids_37\NNS\14727670|of|the|endogenous|ane (r_nmod) those_33\DT\1740|to|steroids (r_nmod) similar_31\JJ\1740|those (r_conj) lower_25\JJR\1740|rates|are|that|and|similar|. (l_nsubj) rates_1\NNS\13308999|the|transport (l_nmod) transport_4\NN\3575240|of|har|steroids (l_compound) har_3\NN\1740|
20230007T17_20230007T28 NONE nhr_8\NN\1740|
23530595
23258671
23230273
23230273T1_23230273T18 NONE ser-2_16\NN\1740|at|domain (r_nmod) phosphorylation_14\NN\1740|ser-2 (r_dobj) mediates_13\VBZ\761713|phosphorylation (r_conj) associates_3\VBZ\628491|cbc|physically|complexes|recruit|and|mediates|. (l_nsubj) cbc_1\NN\652803|the
23230273T1_23230273T19 NONE ser-2_16\NN\1740|at|domain (l_nmod) domain_20\NN\13934596|of|the|c-terminal|ctd|polymerase (l_nmod) polymerase_26\NN\14732946|of|rna|ii (l_nummod) ii_27\CD\13741022|
23230273T2_23230273T18 NONE c-terminal_19\JJ\1740| (r_amod) domain_20\NN\13934596|of|the|c-terminal|ctd|polymerase (r_nmod) ser-2_16\NN\1740|at|domain (r_nmod) phosphorylation_14\NN\1740|ser-2 (r_dobj) mediates_13\VBZ\761713|phosphorylation (r_conj) associates_3\VBZ\628491|cbc|physically|complexes|recruit|and|mediates|. (l_nsubj) cbc_1\NN\652803|the
23230273T2_23230273T19 NONE c-terminal_19\JJ\1740| (r_amod) domain_20\NN\13934596|of|the|c-terminal|ctd|polymerase (l_nmod) polymerase_26\NN\14732946|of|rna|ii (l_nummod) ii_27\CD\13741022|
23423713
23423713T23_23423713T40 NONE vanadium_9\NN\14625458|by (r_nmod) modulation_0\NN\7044917|p450|vanadium|tissue|. (l_nmod) p450_3\NN\1740|of|cytochrome|1|cyp1 (l_nummod) 1_4\CD\13741022|
23423713T23_23423713T41 NONE vanadium_9\NN\14625458|by (r_nmod) modulation_0\NN\7044917|p450|vanadium|tissue|. (l_nmod) p450_3\NN\1740|of|cytochrome|1|cyp1 (l_appos) cyp1_6\NN\1740|(|)
23423713T16_23423713T38 NONE vanadium_12\NN\14625458|of|v(5 (r_nmod) effect_10\NN\34213|the|vanadium|cyp1 (l_nmod) cyp1_19\NN\1740|on|expression|liver
23423713T18_23423713T38 NONE )_16\-RRB-\1740| (r_punct) +_15\JJ\1740|) (r_punct) v(5_14\NN\1740|(|+|) (r_appos) vanadium_12\NN\14625458|of|v(5 (r_nmod) effect_10\NN\34213|the|vanadium|cyp1 (l_nmod) cyp1_19\NN\1740|on|expression|liver
23423713T12_23423713T31 NONE )_5\-RRB-\1740| (r_punct) +_4\JJ\1740|vivo|,|v(5|)|alone (r_nsubj) alter_10\VB\126264|+|did|not|significantly|mrna|. (l_dobj) mrna_17\NN\14832193|cyp1a1|,|protein|,|or|levels (l_compound) cyp1a1_11\NN\1740|,|cyp1a2|,|or|cyp1b1
23423713T12_23423713T32 NONE )_5\-RRB-\1740| (r_punct) +_4\JJ\1740|vivo|,|v(5|)|alone (r_nsubj) alter_10\VB\126264|+|did|not|significantly|mrna|. (l_dobj) mrna_17\NN\14832193|cyp1a1|,|protein|,|or|levels (l_compound) cyp1a1_11\NN\1740|,|cyp1a2|,|or|cyp1b1 (l_conj) cyp1a2_13\NN\1740|
23423713T12_23423713T33 NONE )_5\-RRB-\1740| (r_punct) +_4\JJ\1740|vivo|,|v(5|)|alone (r_nsubj) alter_10\VB\126264|+|did|not|significantly|mrna|. (l_dobj) mrna_17\NN\14832193|cyp1a1|,|protein|,|or|levels (l_compound) cyp1a1_11\NN\1740|,|cyp1a2|,|or|cyp1b1 (l_conj) cyp1b1_16\NN\1740|
23423713T13_23423713T34 CPR:3 )_5\-RRB-\1740| (r_punct) +_4\CD\1740|) (r_nummod) v(5_3\NN\1740|to|+|and|tcdd (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1
23423713T13_23423713T35 CPR:3 )_5\-RRB-\1740| (r_punct) +_4\CD\1740|) (r_nummod) v(5_3\NN\1740|to|+|and|tcdd (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1 (l_conj) cyp1a2_21\NN\1740|
23423713T13_23423713T36 CPR:3 )_5\-RRB-\1740| (r_punct) +_4\CD\1740|) (r_nummod) v(5_3\NN\1740|to|+|and|tcdd (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1 (l_conj) cyp1b1_24\NN\1740|
23423713T14_23423713T34 CPR:3 tcdd_7\NN\1740| (r_conj) v(5_3\NN\1740|to|+|and|tcdd (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1
23423713T14_23423713T35 CPR:3 tcdd_7\NN\1740| (r_conj) v(5_3\NN\1740|to|+|and|tcdd (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1 (l_conj) cyp1a2_21\NN\1740|
23423713T14_23423713T36 CPR:3 tcdd_7\NN\1740| (r_conj) v(5_3\NN\1740|to|+|and|tcdd (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1 (l_conj) cyp1b1_24\NN\1740|
23423713T15_23423713T34 CPR:3 )_11\-RRB-\1740| (r_punct) +_10\CC\1740|,|v(5|) (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1
23423713T15_23423713T35 CPR:3 )_11\-RRB-\1740| (r_punct) +_10\CC\1740|,|v(5|) (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1 (l_conj) cyp1a2_21\NN\1740|
23423713T15_23423713T36 CPR:3 )_11\-RRB-\1740| (r_punct) +_10\CC\1740|,|v(5|) (r_nmod) co-exposure_1\NN\1740|upon|v(5|+ (r_nmod) potentiated_13\VBD\229605|co-exposure|significantly|induction||h. (l_dobj) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1 (l_conj) cyp1b1_24\NN\1740|
23423713T17_23423713T34 CPR:3 tcdd-mediated_15\JJ\1740| (r_amod) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1
23423713T17_23423713T35 CPR:3 tcdd-mediated_15\JJ\1740| (r_amod) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1 (l_conj) cyp1a2_21\NN\1740|
23423713T17_23423713T36 CPR:3 tcdd-mediated_15\JJ\1740| (r_amod) induction_16\NN\7450842|the|tcdd-mediated|levels (l_nmod) levels_32\NNS\4916342|of|the|mrna (l_compound) mrna_25\NN\14832193|cyp1a1|,|protein|,|and|activity (l_compound) cyp1a1_19\NN\1740|,|cyp1a2|,|and|cyp1b1 (l_conj) cyp1b1_24\NN\1740|
23423713T19_23423713T37 CPR:4 )_5\-RRB-\1740| (r_punct) v(5_3\NN\1740|+|) (r_nsubj) decreased_6\VBD\169651|vitro|,|v(5|induction|. (l_dobj) induction_9\NN\7450842|the|tcdd-mediated|mrna (l_nmod) mrna_12\NN\14832193|of|cyp1a1|,|protein|and|activity|levels (l_compound) cyp1a1_11\NN\1740|
23423713T20_23423713T37 CPR:3 tcdd-mediated_8\JJ\1740| (r_amod) induction_9\NN\7450842|the|tcdd-mediated|mrna (l_nmod) mrna_12\NN\14832193|of|cyp1a1|,|protein|and|activity|levels (l_compound) cyp1a1_11\NN\1740|
23423713T21_23423713T39 CPR:4 )_4\-RRB-\1740| (r_punct) +_3\CC\1740|) (r_nummod) v(5_2\NN\1740|+ (r_nsubj) inhibited_6\VBD\2510337|furthermore|,|v(5|significantly|activity|. (l_dobj) activity_11\NN\30358|the|tcdd-induced|ahr-dependent|luciferase (l_amod) ahr-dependent_9\JJ\1740|
23423713T22_23423713T39 CPR:3 tcdd-induced_8\JJ\1740| (r_amod) activity_11\NN\30358|the|tcdd-induced|ahr-dependent|luciferase (l_amod) ahr-dependent_9\JJ\1740|
23423713T1_23423713T24 CPR:3 )_2\-RRB-\1740| (r_punct) +_1\CC\1740|) (r_cc) v(5_0\NN\1740|+ (r_nsubj) increased_4\VBD\169651|v(5|also|levels|animals|h. (l_dobj) levels_10\NNS\4916342|hemoglobin (l_compound) hemoglobin_6\NN\14888884|serum|hb
23423713T1_23423713T25 CPR:3 )_2\-RRB-\1740| (r_punct) +_1\CC\1740|) (r_cc) v(5_0\NN\1740|+ (r_nsubj) increased_4\VBD\169651|v(5|also|levels|animals|h. (l_dobj) levels_10\NNS\4916342|hemoglobin (l_compound) hemoglobin_6\NN\14888884|serum|hb (l_appos) hb_8\NN\14888884|(|)
23423713T2_23423713T26 NONE tcdd_13\NN\1740|of (r_nmod) presence_11\NN\13954253|in|the|tcdd (r_conj) treatment_1\NN\654885|upon|hepatocytes|hb|or|presence (l_nmod) hb_6\NN\14888884|with|alone
23423713T2_23423713T27 CPR:3 tcdd_13\NN\1740|of (r_nmod) presence_11\NN\13954253|in|the|tcdd (r_conj) treatment_1\NN\654885|upon|hepatocytes|hb|or|presence (r_nmod) was_16\VBD\836236|treatment|,|there|increase|. (l_nsubj) increase_18\NN\13576355|an|activity (l_nmod) activity_23\NN\30358|in|the|ahr-dependent|luciferase (l_amod) ahr-dependent_21\JJ\1740|
23423713T3_23423713T28 NONE )_12\-RRB-\1740| (r_punct) +_11\NNP\1740|) (r_nummod) v(5_10\NN\1740|with|+ (r_nmod) treated_4\VBN\2376958|when|hepatocytes|were|2|h|v(5|presence|,|followed (l_advcl) followed_19\VBN\1835496|replacement (l_nmod) replacement_21\NN\196485|by|medium|medium (l_nmod) medium_27\NN\3575240|with|new|containing (l_acl) containing_28\VBG\2632940|hb (l_dobj) hb_29\NN\14888884|
23423713T4_23423713T28 NONE tcdd_17\NN\1740|of (r_nmod) presence_15\NN\13954253|in|the|tcdd (r_nmod) treated_4\VBN\2376958|when|hepatocytes|were|2|h|v(5|presence|,|followed (l_advcl) followed_19\VBN\1835496|replacement (l_nmod) replacement_21\NN\196485|by|medium|medium (l_nmod) medium_27\NN\3575240|with|new|containing (l_acl) containing_28\VBG\2632940|hb (l_dobj) hb_29\NN\14888884|
23423713T5_23423713T28 NONE tcdd-mediated_37\JJ\1740| (r_amod) effect_38\NN\34213|to|the|tcdd-mediated (r_nmod) potentiation_34\NN\13564910|further|effect (r_nsubj) was_32\VBD\836236|treated|,|there|potentiation|. (l_advcl) treated_4\VBN\2376958|when|hepatocytes|were|2|h|v(5|presence|,|followed (l_advcl) followed_19\VBN\1835496|replacement (l_nmod) replacement_21\NN\196485|by|medium|medium (l_nmod) medium_27\NN\3575240|with|new|containing (l_acl) containing_28\VBG\2632940|hb (l_dobj) hb_29\NN\14888884|
23423713T6_23423713T29 NONE )_15\-RRB-\1740| (r_punct) +_14\JJ\1740|by|v(5|) (r_nmod) modulation_9\NN\7044917|a|differential|cyp1a1|+ (l_nmod) cyp1a1_11\NN\1740|of
23423713T6_23423713T30 NONE )_15\-RRB-\1740| (r_punct) +_14\JJ\1740|by|v(5|) (r_nmod) modulation_9\NN\7044917|a|differential|cyp1a1|+ (r_attr) is_6\VBZ\836236|that|there|modulation|livers (r_ccomp) demonstrates_3\VBZ\2137132|study|is|and|demonstrates|. (l_conj) demonstrates_24\VBZ\2137132|hb|modulator (l_dobj) hb_25\NN\14888884|
23601753
23601753T3_23601753T16 NONE calcium_20\NN\14625458| (r_compound) loop_22\NN\3323703|the|calcium|binding|trypsinogen (r_dobj) cleaving_18\VBG\1556346|by|loop (r_advcl) promotes_15\VBZ\2556126|also|degradation|cleaving (r_conj) stimulates_1\VBZ\137313|ctrc|autoactivation|processing|but|promotes|. (l_nsubj) ctrc_0\NN\1740|
23601753T3_23601753T17 NONE calcium_20\NN\14625458| (r_compound) loop_22\NN\3323703|the|calcium|binding|trypsinogen
23601753T4_23601753T27 NONE tetra-aspartate_1\JJ\1740| (r_amod) motif_2\NN\3178782|the|tetra-aspartate|peptide
23601753T5_23601753T27 NONE calcium_9\NN\14625458|mm|,|stimulates (r_dobj) binds_8\VBZ\1290422|motif|calcium|. (l_nsubj) motif_2\NN\3178782|the|tetra-aspartate|peptide
23601753T2_23601753T6 NONE calcium_15\NN\14625458|by (r_nmod) stimulated_13\VBN\137313|binding|,|autoactivation|was|not|calcium|. (l_nsubjpass) autoactivation_4\NN\1740|mutants (l_nmod) mutants_6\NNS\4475|of|g (l_dep) g_8\NN\13717155|d22|and|k23_i24insidk
23601753T2_23601753T7 NONE calcium_15\NN\14625458|by (r_nmod) stimulated_13\VBN\137313|binding|,|autoactivation|was|not|calcium|. (l_nsubjpass) autoactivation_4\NN\1740|mutants (l_nmod) mutants_6\NNS\4475|of|g (l_dep) g_8\NN\13717155|d22|and|k23_i24insidk (l_conj) k23_i24insidk_10\NNP\1740|
23535394
23535394T4_23535394T12 NONE sodium_5\NN\14625458|voltage-gated|,|potassium|and|calcium (r_compound) channels_10\NNS\6251781|with|sodium
23535394T5_23535394T12 NONE potassium_7\NN\14625458| (r_conj) sodium_5\NN\14625458|voltage-gated|,|potassium|and|calcium (r_compound) channels_10\NNS\6251781|with|sodium
23535394T6_23535394T12 NONE calcium_9\NN\14625458| (r_conj) sodium_5\NN\14625458|voltage-gated|,|potassium|and|calcium (r_compound) channels_10\NNS\6251781|with|sodium
23535394T1_23535394T10 NONE saxitoxin_6\NNP\15036321|'s (r_nmod:poss) ability_8\NN\4723816|of|saxitoxin|bind (l_acl) bind_10\VB\1290422|to|channel|,|blocking (l_nmod) channel_15\NN\6251781|to|the|voltage-gated|sodium
23535394T2_23535394T10 NONE sodium_14\NN\14625458| (r_compound) channel_15\NN\6251781|to|the|voltage-gated|sodium
23535394T3_23535394T11 NONE saxitoxin_3\NN\15036321| (r_compound) research_4\NN\633864|in|saxitoxin (r_nmod) advances_1\NNS\7311115|recent|research (r_nsubjpass) discussed_6\VBN\1033527|advances|are|,|biology|. (l_nmod) biology_11\NN\6037298|including|the|molecular|synthesis|,|targets (l_conj) targets_18\NNS\7258332|new|protein|,|association (l_conj) association_20\NN\8008335|motifs|and|methods (l_nmod) motifs_23\NNS\3178782|with|metal-binding
23375813
23375813T6_23375813T10 CPR:4 3'-r/s-hydroxyvoacamine_0\NN\1740|,|inhibitor|. (l_appos) inhibitor_5\NN\20090|a|potent|acetylcholinesterase|divaricata (l_compound) acetylcholinesterase_4\NN\1740|
23375813T3_23375813T7 CPR:4 alkaloid_9\NN\14727670| (r_compound) 3'-r/s-hydroxyvoacamine_10\NN\1740|the|bisindole|alkaloid (r_nsubjpass) isolated_12\VBN\2512305|guided|,|3'-r/s-hydroxyvoacamine|was|extract|. (l_advcl) guided_0\VBN\2441022|activity (l_nmod) activity_5\NN\30358|by|the|acetylcholinesterase|inhibiting (l_compound) acetylcholinesterase_3\NN\1740|
23375813T5_23375813T7 CPR:4 3'-r/s-hydroxyvoacamine_10\NN\1740|the|bisindole|alkaloid (r_nsubjpass) isolated_12\VBN\2512305|guided|,|3'-r/s-hydroxyvoacamine|was|extract|. (l_advcl) guided_0\VBN\2441022|activity (l_nmod) activity_5\NN\30358|by|the|acetylcholinesterase|inhibiting (l_compound) acetylcholinesterase_3\NN\1740|
15526004
15526004T1_15526004T3 NONE methotrexate_28\NN\2722166|of|and|etanercept (l_conj) etanercept_33\NN\2724966|the|tnf|inhibitor (l_compound) tnf_31\NN\14828193|
15526004T2_15526004T4 NONE nucleotide_7\JJ\1740| (r_amod) polymorphisms_8\NNS\11418750|for|the|following|single|nucleotide|snps|tnf (l_dep) tnf_13\NN\14828193|(|-308|)|;|lymphotoxin-alpha|;|and|h/r|;|f/v|;|and|na
15526004T2_15526004T5 NONE nucleotide_7\JJ\1740| (r_amod) polymorphisms_8\NNS\11418750|for|the|following|single|nucleotide|snps|tnf (l_dep) tnf_13\NN\14828193|(|-308|)|;|lymphotoxin-alpha|;|and|h/r|;|f/v|;|and|na (l_conj) lymphotoxin-alpha_23\NN\1740|lta|lta
15526004T2_15526004T6 NONE nucleotide_7\JJ\1740| (r_amod) polymorphisms_8\NNS\11418750|for|the|following|single|nucleotide|snps|tnf (l_dep) tnf_13\NN\14828193|(|-308|)|;|lymphotoxin-alpha|;|and|h/r|;|f/v|;|and|na (l_conj) lymphotoxin-alpha_23\NN\1740|lta|lta (l_appos) lta_25\NN\1740|(|)
15526004T2_15526004T7 NONE nucleotide_7\JJ\1740| (r_amod) polymorphisms_8\NNS\11418750|for|the|following|single|nucleotide|snps|tnf (l_dep) tnf_13\NN\14828193|(|-308|)|;|lymphotoxin-alpha|;|and|h/r|;|f/v|;|and|na (l_conj) lymphotoxin-alpha_23\NN\1740|lta|lta (l_dep) lta_28\NN\1740|(|+|249|,|and|+|720|)
15526004T2_15526004T8 NONE nucleotide_7\JJ\1740| (r_amod) polymorphisms_8\NNS\11418750|for|the|following|single|nucleotide|snps|tnf (l_dep) tnf_13\NN\14828193|(|-308|)|;|lymphotoxin-alpha|;|and|h/r|;|f/v|;|and|na (l_conj) h/r_46\NN\1740|fcgr2a|131 (l_compound) fcgr2a_44\NN\1740|fc|gamma|receptors (l_compound) receptors_43\NNS\5225602|
15526004T2_15526004T9 NONE nucleotide_7\JJ\1740| (r_amod) polymorphisms_8\NNS\11418750|for|the|following|single|nucleotide|snps|tnf (l_dep) tnf_13\NN\14828193|(|-308|)|;|lymphotoxin-alpha|;|and|h/r|;|f/v|;|and|na (l_conj) h/r_46\NN\1740|fcgr2a|131 (l_compound) fcgr2a_44\NN\1740|fc|gamma|receptors
15526004T2_15526004T10 NONE nucleotide_7\JJ\1740| (r_amod) polymorphisms_8\NNS\11418750|for|the|following|single|nucleotide|snps|tnf (l_dep) tnf_13\NN\14828193|(|-308|)|;|lymphotoxin-alpha|;|and|h/r|;|f/v|;|and|na (l_conj) f/v_50\NN\1740|fcgr3a|176 (l_compound) fcgr3a_48\NN\1740|
15526004T2_15526004T11 NONE nucleotide_7\JJ\1740| (r_amod) polymorphisms_8\NNS\11418750|for|the|following|single|nucleotide|snps|tnf (l_dep) tnf_13\NN\14828193|(|-308|)|;|lymphotoxin-alpha|;|and|h/r|;|f/v|;|and|na (l_conj) na_54\NN\14625458|fcgr3b|1/2 (l_compound) fcgr3b_53\NN\1740|
23644411
23644411T13_23644411T18 NONE glycosides_11\NNS\14727670|of|the|steroidal (r_nmod) mode_5\NN\4916342|into|the|action|glycosides (r_nmod) insight_2\NN\5710020|mode (r_dobj) gain_1\VB\2238085|to|insight|production (l_dobj) production_18\NN\30358|,|oxide|,|and|expression (l_conj) expression_21\NN\4679549|genes|beta-1 (l_nmod) beta-1_28\NN\1740|for|transforming|growth|factor|tgf-β|and|receptors
23644411T13_23644411T19 NONE glycosides_11\NNS\14727670|of|the|steroidal (r_nmod) mode_5\NN\4916342|into|the|action|glycosides (r_nmod) insight_2\NN\5710020|mode (r_dobj) gain_1\VB\2238085|to|insight|production (l_dobj) production_18\NN\30358|,|oxide|,|and|expression (l_conj) expression_21\NN\4679549|genes|beta-1 (l_nmod) beta-1_28\NN\1740|for|transforming|growth|factor|tgf-β|and|receptors (l_appos) tgf-β_30\NN\1740|(|)
23644411T14_23644411T18 NONE oxide_14\NN\14818238|nitric|no (r_compound) production_18\NN\30358|,|oxide|,|and|expression (l_conj) expression_21\NN\4679549|genes|beta-1 (l_nmod) beta-1_28\NN\1740|for|transforming|growth|factor|tgf-β|and|receptors
23644411T14_23644411T19 NONE oxide_14\NN\14818238|nitric|no (r_compound) production_18\NN\30358|,|oxide|,|and|expression (l_conj) expression_21\NN\4679549|genes|beta-1 (l_nmod) beta-1_28\NN\1740|for|transforming|growth|factor|tgf-β|and|receptors (l_appos) tgf-β_30\NN\1740|(|)
23644411T15_23644411T18 NONE no_16\NN\7204911|(|) (r_appos) oxide_14\NN\14818238|nitric|no (r_compound) production_18\NN\30358|,|oxide|,|and|expression (l_conj) expression_21\NN\4679549|genes|beta-1 (l_nmod) beta-1_28\NN\1740|for|transforming|growth|factor|tgf-β|and|receptors
23644411T15_23644411T19 NONE no_16\NN\7204911|(|) (r_appos) oxide_14\NN\14818238|nitric|no (r_compound) production_18\NN\30358|,|oxide|,|and|expression (l_conj) expression_21\NN\4679549|genes|beta-1 (l_nmod) beta-1_28\NN\1740|for|transforming|growth|factor|tgf-β|and|receptors (l_appos) tgf-β_30\NN\1740|(|)
23644411T1_23644411T17 CPR:3 glycoalkaloids_10\NNS\1740|the|two|isolated|steroidal|1 (r_conj) extracts_4\NNS\14589223|fractionated|bulb|and|glycoalkaloids (r_nsubj) induced_18\VBD\1627355|extracts|production|culture (l_dobj) production_20\NN\30358|no|and|expression (l_conj) expression_26\NN\4679549|tgf-β|receptor|i|mrna (l_nummod) i_24\CD\14622893|
23644411T2_23644411T17 NONE no_19\DT\7204911| (r_neg) production_20\NN\30358|no|and|expression (l_conj) expression_26\NN\4679549|tgf-β|receptor|i|mrna (l_nummod) i_24\CD\14622893|
23395981
23395981T9_23395981T23 NONE alcohol_0\NN\7881800| (r_nsubj) modulates_1\VBZ\1724459|alcohol|expression|. (l_dobj) expression_2\NN\4679549|methyltranferases (l_nmod) methyltranferases_5\NNS\1740|of|dna|and|proteins|fibroblasts
23395981T9_23395981T24 NONE alcohol_0\NN\7881800| (r_nsubj) modulates_1\VBZ\1724459|alcohol|expression|. (l_dobj) expression_2\NN\4679549|methyltranferases (l_nmod) methyltranferases_5\NNS\1740|of|dna|and|proteins|fibroblasts (l_conj) proteins_10\NNS\14944888|methyl|cpg-/cpg|domain-binding
23395981T10_23395981T23 NONE cpg-/cpg_8\NN\1740| (r_compound) proteins_10\NNS\14944888|methyl|cpg-/cpg|domain-binding (r_conj) methyltranferases_5\NNS\1740|of|dna|and|proteins|fibroblasts
23395981T10_23395981T24 NONE cpg-/cpg_8\NN\1740| (r_compound) proteins_10\NNS\14944888|methyl|cpg-/cpg|domain-binding
23395981T11_23395981T23 NONE cpg-/cpg_8\NN\1740| (r_compound) proteins_10\NNS\14944888|methyl|cpg-/cpg|domain-binding (r_conj) methyltranferases_5\NNS\1740|of|dna|and|proteins|fibroblasts
23395981T11_23395981T24 NONE cpg-/cpg_8\NN\1740| (r_compound) proteins_10\NNS\14944888|methyl|cpg-/cpg|domain-binding
23395981T2_23395981T12 NONE alcohol_10\NN\7881800| (r_nsubj) alters_11\VBZ\126264|that|alcohol|methylation|,|and|modulates (l_conj) modulates_17\VBZ\1724459|expression (l_dobj) expression_18\NN\4679549|methyltransferases (l_nmod) methyltransferases_22\NNS\1740|of|the|dna|dnmts|and|proteins
23395981T2_23395981T13 NONE alcohol_10\NN\7881800| (r_nsubj) alters_11\VBZ\126264|that|alcohol|methylation|,|and|modulates (l_conj) modulates_17\VBZ\1724459|expression (l_dobj) expression_18\NN\4679549|methyltransferases (l_nmod) methyltransferases_22\NNS\1740|of|the|dna|dnmts|and|proteins (l_appos) dnmts_24\NNS\1740|(|)
23395981T2_23395981T14 NONE alcohol_10\NN\7881800| (r_nsubj) alters_11\VBZ\126264|that|alcohol|methylation|,|and|modulates (l_conj) modulates_17\VBZ\1724459|expression (l_dobj) expression_18\NN\4679549|methyltransferases (l_nmod) methyltransferases_22\NNS\1740|of|the|dna|dnmts|and|proteins (l_conj) proteins_30\NNS\14944888|various|cpg-binding
23395981T3_23395981T12 NONE cpg-binding_29\JJ\1740|methyl (r_amod) proteins_30\NNS\14944888|various|cpg-binding (r_conj) methyltransferases_22\NNS\1740|of|the|dna|dnmts|and|proteins
23395981T3_23395981T13 NONE cpg-binding_29\JJ\1740|methyl (r_amod) proteins_30\NNS\14944888|various|cpg-binding (r_conj) methyltransferases_22\NNS\1740|of|the|dna|dnmts|and|proteins (l_appos) dnmts_24\NNS\1740|(|)
23395981T3_23395981T14 NONE cpg-binding_29\JJ\1740|methyl (r_amod) proteins_30\NNS\14944888|various|cpg-binding
23395981T6_23395981T15 CPR:4 ethanol_3\NN\14708720| (r_nsubj) induced_4\VBD\1627355|addition|,|ethanol|degradation|. (l_dobj) degradation_5\NN\199130|methyltransferases (l_nmod) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins
23395981T6_23395981T16 CPR:4 ethanol_3\NN\14708720| (r_nsubj) induced_4\VBD\1627355|addition|,|ethanol|degradation|. (l_dobj) degradation_5\NN\199130|methyltransferases (l_nmod) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_dep) dnmt-1_10\NN\1740|(|,|dnmt-3a|,|and|dnmt-3b|)
23395981T6_23395981T17 CPR:4 ethanol_3\NN\14708720| (r_nsubj) induced_4\VBD\1627355|addition|,|ethanol|degradation|. (l_dobj) degradation_5\NN\199130|methyltransferases (l_nmod) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_dep) dnmt-1_10\NN\1740|(|,|dnmt-3a|,|and|dnmt-3b|) (l_conj) dnmt-3a_12\NN\1740|
23395981T6_23395981T18 CPR:4 ethanol_3\NN\14708720| (r_nsubj) induced_4\VBD\1627355|addition|,|ethanol|degradation|. (l_dobj) degradation_5\NN\199130|methyltransferases (l_nmod) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_dep) dnmt-1_10\NN\1740|(|,|dnmt-3a|,|and|dnmt-3b|) (l_conj) dnmt-3b_15\NN\1740|
23395981T6_23395981T19 CPR:4 ethanol_3\NN\14708720| (r_nsubj) induced_4\VBD\1627355|addition|,|ethanol|degradation|. (l_dobj) degradation_5\NN\199130|methyltransferases (l_nmod) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_conj) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway
23395981T6_23395981T20 CPR:4 ethanol_3\NN\14708720| (r_nsubj) induced_4\VBD\1627355|addition|,|ethanol|degradation|. (l_dobj) degradation_5\NN\199130|methyltransferases (l_nmod) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_conj) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (l_dep) mecp-2_26\NN\1740|(|,|mbd-2|and|mbd-3|)
23395981T6_23395981T21 CPR:4 ethanol_3\NN\14708720| (r_nsubj) induced_4\VBD\1627355|addition|,|ethanol|degradation|. (l_dobj) degradation_5\NN\199130|methyltransferases (l_nmod) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_conj) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (l_dep) mecp-2_26\NN\1740|(|,|mbd-2|and|mbd-3|) (l_conj) mbd-2_28\NN\1740|
23395981T6_23395981T22 CPR:4 ethanol_3\NN\14708720| (r_nsubj) induced_4\VBD\1627355|addition|,|ethanol|degradation|. (l_dobj) degradation_5\NN\199130|methyltransferases (l_nmod) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_conj) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (l_dep) mecp-2_26\NN\1740|(|,|mbd-2|and|mbd-3|) (l_conj) mbd-3_30\NN\1740|
23395981T7_23395981T15 NONE cpg-binding_23\JJ\1740| (r_amod) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (r_conj) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins
23395981T7_23395981T16 NONE cpg-binding_23\JJ\1740| (r_amod) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (r_conj) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_dep) dnmt-1_10\NN\1740|(|,|dnmt-3a|,|and|dnmt-3b|)
23395981T7_23395981T17 NONE cpg-binding_23\JJ\1740| (r_amod) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (r_conj) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_dep) dnmt-1_10\NN\1740|(|,|dnmt-3a|,|and|dnmt-3b|) (l_conj) dnmt-3a_12\NN\1740|
23395981T7_23395981T18 NONE cpg-binding_23\JJ\1740| (r_amod) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (r_conj) methyltransferases_8\NNS\1740|of|dna|dnmt-1|,|as|proteins (l_dep) dnmt-1_10\NN\1740|(|,|dnmt-3a|,|and|dnmt-3b|) (l_conj) dnmt-3b_15\NN\1740|
23395981T7_23395981T19 NONE cpg-binding_23\JJ\1740| (r_amod) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway
23395981T7_23395981T20 NONE cpg-binding_23\JJ\1740| (r_amod) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (l_dep) mecp-2_26\NN\1740|(|,|mbd-2|and|mbd-3|)
23395981T7_23395981T21 NONE cpg-binding_23\JJ\1740| (r_amod) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (l_dep) mecp-2_26\NN\1740|(|,|mbd-2|and|mbd-3|) (l_conj) mbd-2_28\NN\1740|
23395981T7_23395981T22 NONE cpg-binding_23\JJ\1740| (r_amod) proteins_24\NNS\14944888|the|methyl|cpg-binding|mecp-2|,|cells|pathway (l_dep) mecp-2_26\NN\1740|(|,|mbd-2|and|mbd-3|) (l_conj) mbd-3_30\NN\1740|
15224175
15224175T55_15224175T63 NONE ergotamine_18\NN\14712692|to (r_nmod) vasoconstriction_16\NN\1149911|the|external|carotid|ergotamine|dogs (r_dobj) mediate_12\VBP\761713|receptors|vasoconstriction|. (l_nsubj) receptors_1\NNS\5225602|5-ht1b|,|alpha2a/2c-|and|alpha1-adrenoceptors (l_compound) 5-ht1b_0\NN\1740|
15224175T55_15224175T64 NONE ergotamine_18\NN\14712692|to (r_nmod) vasoconstriction_16\NN\1149911|the|external|carotid|ergotamine|dogs (r_dobj) mediate_12\VBP\761713|receptors|vasoconstriction|. (l_nsubj) receptors_1\NNS\5225602|5-ht1b|,|alpha2a/2c-|and|alpha1-adrenoceptors (l_conj) alpha1-adrenoceptors_11\NNS\1740|,|extent|,
15224175T37_15224175T56 NONE ergotamine_6\NN\14712692| (r_nsubj) produces_7\VBZ\1617192|that|ergotamine|vasoconstriction|dogs|receptors (l_nmod) receptors_16\NNS\5225602|via|5-ht1b/1d|and|alpha2-adrenoceptors (l_compound) 5-ht1b/1d_15\NN\1740|
15224175T37_15224175T57 NONE ergotamine_6\NN\14712692| (r_nsubj) produces_7\VBZ\1617192|that|ergotamine|vasoconstriction|dogs|receptors (l_nmod) receptors_16\NNS\5225602|via|5-ht1b/1d|and|alpha2-adrenoceptors (l_conj) alpha2-adrenoceptors_18\NNS\1740|
15224175T1_15224175T61 NONE prazosin_132\NN\2698769|microg/kg|+|brl44408 (r_conj) sb224289_126\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T1_15224175T62 NONE prazosin_132\NN\2698769|microg/kg|+|brl44408 (r_conj) sb224289_126\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T2_15224175T61 NONE brl44408_138\NN\1740|microg/kg (r_conj) prazosin_132\NN\2698769|microg/kg|+|brl44408 (r_conj) sb224289_126\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T2_15224175T62 NONE brl44408_138\NN\1740|microg/kg (r_conj) prazosin_132\NN\2698769|microg/kg|+|brl44408 (r_conj) sb224289_126\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T3_15224175T61 NONE sb224289_146\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T3_15224175T62 NONE sb224289_146\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T4_15224175T61 NONE prazosin_152\NN\2698769|microg/kg)+ (r_conj) sb224289_146\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T4_15224175T62 NONE prazosin_152\NN\2698769|microg/kg)+ (r_conj) sb224289_146\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T5_15224175T61 NONE imiloxan_156\NN\1740|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T5_15224175T62 NONE imiloxan_156\NN\1740|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T6_15224175T61 NONE sb224289_165\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T6_15224175T62 NONE sb224289_165\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T7_15224175T61 NONE prazosin_171\NN\2698769|microg/kg|+|mk912 (r_conj) sb224289_165\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T7_15224175T62 NONE prazosin_171\NN\2698769|microg/kg|+|mk912 (r_conj) sb224289_165\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T8_15224175T61 NONE mk912_177\NN\1740|microg/kg (r_conj) prazosin_171\NN\2698769|microg/kg|+|mk912 (r_conj) sb224289_165\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T8_15224175T62 NONE mk912_177\NN\1740|microg/kg (r_conj) prazosin_171\NN\2698769|microg/kg|+|mk912 (r_conj) sb224289_165\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T38_15224175T61 CPR:6 sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T38_15224175T62 NONE sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T39_15224175T61 NONE brl15572_39\NN\1740|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T39_15224175T62 CPR:6 brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T40_15224175T61 NONE rauwolscine_47\NN\1740|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T40_15224175T62 NONE rauwolscine_47\NN\1740|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T41_15224175T61 NONE sb224289_55\NN\1740|+|brl15572|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T41_15224175T62 NONE sb224289_55\NN\1740|+|brl15572|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T42_15224175T61 NONE brl15572_57\NN\1740| (r_conj) sb224289_55\NN\1740|+|brl15572|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T42_15224175T62 NONE brl15572_57\NN\1740| (r_conj) sb224289_55\NN\1740|+|brl15572|microg/kg (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T43_15224175T61 NONE sb224289_64\NN\1740|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T43_15224175T62 NONE sb224289_64\NN\1740|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T44_15224175T61 NONE rauwolscine_66\NN\1740|microg/kg (r_conj) sb224289_64\NN\1740|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T44_15224175T62 NONE rauwolscine_66\NN\1740|microg/kg (r_conj) sb224289_64\NN\1740|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T45_15224175T61 NONE brl15572_73\NN\1740|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T45_15224175T62 NONE brl15572_73\NN\1740|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T46_15224175T61 NONE rauwolscine_75\NN\1740|microg/kg (r_conj) brl15572_73\NN\1740|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T46_15224175T62 NONE rauwolscine_75\NN\1740|microg/kg (r_conj) brl15572_73\NN\1740|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T47_15224175T61 NONE rauwolscine_82\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T47_15224175T62 NONE rauwolscine_82\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T48_15224175T61 NONE prazosin_88\NN\2698769|microg/kg (r_conj) rauwolscine_82\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T48_15224175T62 NONE prazosin_88\NN\2698769|microg/kg (r_conj) rauwolscine_82\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T49_15224175T61 NONE sb224289_96\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T49_15224175T62 NONE sb224289_96\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T50_15224175T61 NONE prazosin_102\NN\2698769|microg/kg (r_conj) sb224289_96\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T50_15224175T62 NONE prazosin_102\NN\2698769|microg/kg (r_conj) sb224289_96\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T51_15224175T61 NONE sb224289_108\NN\1740|microg/kg|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T51_15224175T62 NONE sb224289_108\NN\1740|microg/kg|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T52_15224175T61 NONE rauwolscine_114\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_108\NN\1740|microg/kg|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T52_15224175T62 NONE rauwolscine_114\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_108\NN\1740|microg/kg|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T53_15224175T61 NONE prazosin_120\NN\2698769|microg/kg (r_conj) rauwolscine_114\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_108\NN\1740|microg/kg|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T53_15224175T62 NONE prazosin_120\NN\2698769|microg/kg (r_conj) rauwolscine_114\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_108\NN\1740|microg/kg|+|rauwolscine (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T54_15224175T61 NONE sb224289_126\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_dep) microg/kg_34\NN\1740|(|300|;|5-ht1b|) (l_appos) 5-ht1b_36\NN\1740|
15224175T54_15224175T62 NONE sb224289_126\NN\1740|microg/kg|+|prazosin (r_conj) sb224289_31\NN\1740|microg/kg|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|brl15572|,|rauwolscine|,|sb224289|,|sb224289|,|sb224289|,|sb224289|imiloxan|,|or|sb224289 (l_conj) brl15572_39\NN\1740|microg/kg (l_dep) microg/kg_42\NN\1740|(|300|;|5-ht1d|) (l_appos) 5-ht1d_44\NN\1740|
15224175T36_15224175T58 NONE ergotamine_7\NN\14712692|by (r_nmod) elicited_5\VBN\1617192|ergotamine|dogs (r_acl) vasoconstriction_4\NN\1149911|the|cranio-selective|elicited (r_nsubjpass) mediated_12\VBN\761713|thus|,|vasoconstriction|is|predominantly|receptors|. (l_nmod) receptors_15\NNS\5225602|by|5-ht1b|as|subtypes|and|,|extent|,|alpha1-adrenoceptors (l_compound) 5-ht1b_14\NN\1740|
15224175T36_15224175T59 NONE ergotamine_7\NN\14712692|by (r_nmod) elicited_5\VBN\1617192|ergotamine|dogs (r_acl) vasoconstriction_4\NN\1149911|the|cranio-selective|elicited (r_nsubjpass) mediated_12\VBN\761713|thus|,|vasoconstriction|is|predominantly|receptors|. (l_nmod) receptors_15\NNS\5225602|by|5-ht1b|as|subtypes|and|,|extent|,|alpha1-adrenoceptors (l_conj) subtypes_20\NNS\1740|alpha2a/2c-adrenoceptor (l_compound) alpha2a/2c-adrenoceptor_19\NN\1740|
15224175T36_15224175T60 NONE ergotamine_7\NN\14712692|by (r_nmod) elicited_5\VBN\1617192|ergotamine|dogs (r_acl) vasoconstriction_4\NN\1149911|the|cranio-selective|elicited (r_nsubjpass) mediated_12\VBN\761713|thus|,|vasoconstriction|is|predominantly|receptors|. (l_nmod) receptors_15\NNS\5225602|by|5-ht1b|as|subtypes|and|,|extent|,|alpha1-adrenoceptors (l_conj) alpha1-adrenoceptors_29\NNS\1740|by
23231502
23231502T23_23231502T32 NONE peptidyl-prolyl_0\JJ\1740| (r_amod) a1_2\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1
23231502T23_23231502T33 NONE peptidyl-prolyl_0\JJ\1740| (r_amod) a1_2\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1 (l_appos) pin1_4\NN\1740|(|)
23231502T12_23231502T28 NONE peptidyl-prolyl_5\JJ\1740| (r_amod) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|,
23231502T12_23231502T29 NONE peptidyl-prolyl_5\JJ\1740| (r_amod) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|, (l_appos) pin1_9\NN\1740|(|)
23231502T13_23231502T28 CPR:9 pser/pthr-pro_23\NN\1740| (r_compound) moieties_24\NNS\13736799|of|pser/pthr-pro|proteins (r_nmod) bond_21\NN\11426530|of|the|peptide|moieties (r_nmod) conversion_17\NN\7359599|the|bond (r_dobj) catalyzes_15\VBZ\146138|that|conversion (r_acl:relcl) enzyme_13\NN\14723628|an|catalyzes (r_appos) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|,
23231502T13_23231502T29 CPR:9 pser/pthr-pro_23\NN\1740| (r_compound) moieties_24\NNS\13736799|of|pser/pthr-pro|proteins (r_nmod) bond_21\NN\11426530|of|the|peptide|moieties (r_nmod) conversion_17\NN\7359599|the|bond (r_dobj) catalyzes_15\VBZ\146138|that|conversion (r_acl:relcl) enzyme_13\NN\14723628|an|catalyzes (r_appos) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|, (l_appos) pin1_9\NN\1740|(|)
23231502T14_23231502T28 CPR:9 pser/pthr-pro_23\NN\1740| (r_compound) moieties_24\NNS\13736799|of|pser/pthr-pro|proteins (r_nmod) bond_21\NN\11426530|of|the|peptide|moieties (r_nmod) conversion_17\NN\7359599|the|bond (r_dobj) catalyzes_15\VBZ\146138|that|conversion (r_acl:relcl) enzyme_13\NN\14723628|an|catalyzes (r_appos) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|,
23231502T14_23231502T29 CPR:9 pser/pthr-pro_23\NN\1740| (r_compound) moieties_24\NNS\13736799|of|pser/pthr-pro|proteins (r_nmod) bond_21\NN\11426530|of|the|peptide|moieties (r_nmod) conversion_17\NN\7359599|the|bond (r_dobj) catalyzes_15\VBZ\146138|that|conversion (r_acl:relcl) enzyme_13\NN\14723628|an|catalyzes (r_appos) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|, (l_appos) pin1_9\NN\1740|(|)
23231502T15_23231502T28 CPR:9 pser/pthr-pro_23\NN\1740| (r_compound) moieties_24\NNS\13736799|of|pser/pthr-pro|proteins (r_nmod) bond_21\NN\11426530|of|the|peptide|moieties (r_nmod) conversion_17\NN\7359599|the|bond (r_dobj) catalyzes_15\VBZ\146138|that|conversion (r_acl:relcl) enzyme_13\NN\14723628|an|catalyzes (r_appos) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|,
23231502T15_23231502T29 CPR:9 pser/pthr-pro_23\NN\1740| (r_compound) moieties_24\NNS\13736799|of|pser/pthr-pro|proteins (r_nmod) bond_21\NN\11426530|of|the|peptide|moieties (r_nmod) conversion_17\NN\7359599|the|bond (r_dobj) catalyzes_15\VBZ\146138|that|conversion (r_acl:relcl) enzyme_13\NN\14723628|an|catalyzes (r_appos) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|, (l_appos) pin1_9\NN\1740|(|)
23231502T16_23231502T28 NONE hne_37\NN\1740| (r_compound) modification_38\NN\191142|to|hne (r_nmod) susceptible_35\JJ\1740|that|a1|is|highly|modification (l_nsubj) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|,
23231502T16_23231502T29 NONE hne_37\NN\1740| (r_compound) modification_38\NN\191142|to|hne (r_nmod) susceptible_35\JJ\1740|that|a1|is|highly|modification (l_nsubj) a1_7\NN\1740|peptidyl-prolyl|cis/trans-isomerase|pin1|,|enzyme|, (l_appos) pin1_9\NN\1740|(|)
23231502T17_23231502T30 NONE hne_5\NN\1740|with (r_nmod) incubation_0\NN\654885|pin1|hne|followed (l_nmod) pin1_3\NN\1740|of|purified
23231502T18_23231502T30 NONE his-157_22\CD\1740|and|cys-113 (r_dep) residues_21\NNS\20827|at|the|active|site|his-157 (r_nmod) detection_13\NN\5708432|in|adducts|residues (r_nmod) resulted_11\VBD\2633881|incubation|detection|. (l_nsubj) incubation_0\NN\654885|pin1|hne|followed (l_nmod) pin1_3\NN\1740|of|purified
23231502T19_23231502T30 NONE cys-113_24\NN\1740| (r_conj) his-157_22\CD\1740|and|cys-113 (r_dep) residues_21\NNS\20827|at|the|active|site|his-157 (r_nmod) detection_13\NN\5708432|in|adducts|residues (r_nmod) resulted_11\VBD\2633881|incubation|detection|. (l_nsubj) incubation_0\NN\654885|pin1|hne|followed (l_nmod) pin1_3\NN\1740|of|purified
23231502T1_23231502T24 NONE biotin_18\NN\15090742|with (r_nmod) conjugation_16\NN\14418395|by|chemistry|biotin|followed (l_acl) followed_19\VBN\1835496|pulldown (l_nmod) pulldown_22\NN\1740|by|streptavidin-based|and|blotting (l_conj) blotting_25\NN\1740|western|antibody (l_nmod) antibody_28\NN\14728724|with|anti-pin1 (l_amod) anti-pin1_27\JJ\1740|
23231502T1_23231502T31 NONE biotin_18\NN\15090742|with (r_nmod) conjugation_16\NN\14418395|by|chemistry|biotin|followed (r_nmod) judged_12\VBN\698855|as|conjugation (r_advcl) adducted_2\VBN\1448100|pin1|was|cells|judged|. (l_nsubjpass) pin1_0\NN\1740|
23231502T22_23231502T24 NONE 8-alkynyl-hne_10\NN\1740|with (r_nmod) treated_8\VBN\2376958|8-alkynyl-hne (r_acl) cells_7\NNS\3080309|in|mda-mb-231|breast|cancer|treated (r_nmod) adducted_2\VBN\1448100|pin1|was|cells|judged|. (l_advcl) judged_12\VBN\698855|as|conjugation (l_nmod) conjugation_16\NN\14418395|by|chemistry|biotin|followed (l_acl) followed_19\VBN\1835496|pulldown (l_nmod) pulldown_22\NN\1740|by|streptavidin-based|and|blotting (l_conj) blotting_25\NN\1740|western|antibody (l_nmod) antibody_28\NN\14728724|with|anti-pin1 (l_amod) anti-pin1_27\JJ\1740|
23231502T22_23231502T31 NONE 8-alkynyl-hne_10\NN\1740|with (r_nmod) treated_8\VBN\2376958|8-alkynyl-hne (r_acl) cells_7\NNS\3080309|in|mda-mb-231|breast|cancer|treated (r_nmod) adducted_2\VBN\1448100|pin1|was|cells|judged|. (l_nsubjpass) pin1_0\NN\1740|
23231502T2_23231502T25 NONE cys-113_9\NN\1740|of (r_nmod) adduction_7\NN\331950|the|cys-113|site|treatment (l_nmod) site_14\NN\8673395|in|the|pin1|active (l_compound) pin1_12\NN\1740|
23231502T3_23231502T25 NONE hne_16\NN\1740| (r_compound) treatment_17\NN\654885|upon|hne|cells (r_nmod) adduction_7\NN\331950|the|cys-113|site|treatment (l_nmod) site_14\NN\8673395|in|the|pin1|active (l_compound) pin1_12\NN\1740|
23231502T4_23231502T26 NONE hne-induced_12\JJ\1740| (r_amod) toxicity_13\NN\13576101|from|hne-induced (r_nmod) protected_8\VBD\1127795|knockdown|partially|cells|toxicity|. (l_nsubj) knockdown_1\NN\1173038|sirna|pin1|cells (l_nmod) pin1_3\NN\1740|of
23231502T5_23231502T27 NONE polyphenols_17\NNS\1740|of|green|tea (r_nmod) effects_13\NNS\13245626|for|the|chemopreventive|polyphenols (r_nmod) target_9\NN\7258332|that|pin1|is|an|important|molecular|effects (l_nsubj) pin1_4\NN\1740|
23214423
19228178
19228178T9_19228178T16 CPR:5 ramelteon_2\NN\1740|of|,|agonist|:|drug (l_appos) agonist_8\NN\9613191|a|selective|receptor (l_compound) receptor_7\NN\5225602|mt1/mt2 (l_compound) mt1/mt2_6\NN\1740|
19228178T9_19228178T17 CPR:5 ramelteon_2\NN\1740|of|,|agonist|:|drug (l_appos) agonist_8\NN\9613191|a|selective|receptor (l_compound) receptor_7\NN\5225602|mt1/mt2 (l_compound) mt1/mt2_6\NN\1740|
19228178T1_19228178T10 NONE acid_10\NN\14818238| (r_compound) modulators_17\NNS\1740|gamma-aminobutyric|acid|a|(|gaba(a|)|)|receptor (l_compound) receptor_16\NN\5225602|
19228178T2_19228178T11 CPR:5 ramelteon_0\NN\1740|rozerem (r_nsubj) agonist_24\NN\9613191|ramelteon|is|an|mt(1)/mt(2|receptor|. (l_compound) mt(1)/mt(2_21\NN\1740|active|melatonin|)
19228178T2_19228178T12 CPR:5 ramelteon_0\NN\1740|rozerem (r_nsubj) agonist_24\NN\9613191|ramelteon|is|an|mt(1)/mt(2|receptor|. (l_compound) mt(1)/mt(2_21\NN\1740|active|melatonin|) (l_punct) )_22\-RRB-\1740|
19228178T3_19228178T11 NONE rozerem_2\NNP\1740|(|;|limited|) (r_dep) ramelteon_0\NN\1740|rozerem (r_nsubj) agonist_24\NN\9613191|ramelteon|is|an|mt(1)/mt(2|receptor|. (l_compound) mt(1)/mt(2_21\NN\1740|active|melatonin|)
19228178T3_19228178T12 NONE rozerem_2\NNP\1740|(|;|limited|) (r_dep) ramelteon_0\NN\1740|rozerem (r_nsubj) agonist_24\NN\9613191|ramelteon|is|an|mt(1)/mt(2|receptor|. (l_compound) mt(1)/mt(2_21\NN\1740|active|melatonin|) (l_punct) )_22\-RRB-\1740|
19228178T4_19228178T11 NONE melatonin_20\NN\5407119| (r_compound) mt(1)/mt(2_21\NN\1740|active|melatonin|)
19228178T4_19228178T12 NONE melatonin_20\NN\5407119| (r_compound) mt(1)/mt(2_21\NN\1740|active|melatonin|) (l_punct) )_22\-RRB-\1740|
19228178T5_19228178T13 NONE ramelteon_11\NN\1740| (r_nsubj) chronohypnotic_14\NN\1740|hypnotics|,|ramelteon|is|a|acts|.|" (l_nmod) hypnotics_3\NNS\3247620|unlike|the|sedative|target (l_acl:relcl) target_5\VBP\1151110|that|complexes (l_dobj) complexes_9\NNS\5869584|gaba(a|)|receptor (l_compound) receptor_8\NN\5225602|
19228178T5_19228178T14 CPR:5 ramelteon_11\NN\1740| (r_nsubj) chronohypnotic_14\NN\1740|hypnotics|,|ramelteon|is|a|acts|.|" (l_acl:relcl) acts_16\VBZ\1619354|that|receptors (l_nmod) receptors_25\NNS\5225602|mt(1|,|located (l_compound) mt(1_20\NN\1740|on|the|melatonin|)|and|mt(2 (l_punct) )_21\-RRB-\1740|
19228178T5_19228178T15 CPR:5 ramelteon_11\NN\1740| (r_nsubj) chronohypnotic_14\NN\1740|hypnotics|,|ramelteon|is|a|acts|.|" (l_acl:relcl) acts_16\VBZ\1619354|that|receptors (l_nmod) receptors_25\NNS\5225602|mt(1|,|located (l_compound) mt(1_20\NN\1740|on|the|melatonin|)|and|mt(2 (l_conj) mt(2_23\NN\1740|) (l_punct) )_24\-RRB-\1740|
19228178T6_19228178T13 NONE melatonin_19\NN\5407119| (r_compound) mt(1_20\NN\1740|on|the|melatonin|)|and|mt(2 (r_compound) receptors_25\NNS\5225602|mt(1|,|located (r_nmod) acts_16\VBZ\1619354|that|receptors (r_acl:relcl) chronohypnotic_14\NN\1740|hypnotics|,|ramelteon|is|a|acts|.|" (l_nmod) hypnotics_3\NNS\3247620|unlike|the|sedative|target (l_acl:relcl) target_5\VBP\1151110|that|complexes (l_dobj) complexes_9\NNS\5869584|gaba(a|)|receptor (l_compound) receptor_8\NN\5225602|
19228178T6_19228178T14 NONE melatonin_19\NN\5407119| (r_compound) mt(1_20\NN\1740|on|the|melatonin|)|and|mt(2 (l_punct) )_21\-RRB-\1740|
19228178T6_19228178T15 NONE melatonin_19\NN\5407119| (r_compound) mt(1_20\NN\1740|on|the|melatonin|)|and|mt(2 (l_conj) mt(2_23\NN\1740|) (l_punct) )_24\-RRB-\1740|
23274894
23274894T10_23274894T26 NONE glucose-stimulated_7\JJ\1740| (r_amod) secretion_9\NN\13526110|of|basal|glucose-stimulated|insulin (r_nmod) regulator_4\NN\3096960|a|negative|secretion (r_appos) g6pc2_0\NN\1740|:|regulator|.
23274894T10_23274894T27 CPR:3 glucose-stimulated_7\JJ\1740| (r_amod) secretion_9\NN\13526110|of|basal|glucose-stimulated|insulin (l_compound) insulin_8\NN\5407119|
23274894T6_23274894T15 NONE glucose_24\NN\14710501| (r_compound) tolerance_25\NN\5032565|glucose (r_conj) sensitivity_22\NN\5651971|not|insulin|or|tolerance (r_conj) linked_7\VBN\628491|studies|have|polymorphisms|variations|,|sensitivity|. (l_dobj) polymorphisms_8\NNS\11418750|g6pc2 (l_nmod) g6pc2_10\NN\1740|in
23274894T6_23274894T16 NONE glucose_24\NN\14710501| (r_compound) tolerance_25\NN\5032565|glucose (r_conj) sensitivity_22\NN\5651971|not|insulin|or|tolerance (l_compound) insulin_21\NN\5407119|
23274894T7_23274894T17 NONE glucose-6-phosphatase_7\NN\1740| (r_compound) subunit_9\NN\13604718|an|islet-specific|,|reticulum-resident|glucose-6-phosphatase|catalytic (r_dobj) encodes_1\VBZ\115157|g6pc2|subunit|. (l_nsubj) g6pc2_0\NN\1740|
23274894T7_23274894T18 NONE glucose-6-phosphatase_7\NN\1740| (r_compound) subunit_9\NN\13604718|an|islet-specific|,|reticulum-resident|glucose-6-phosphatase|catalytic
23274894T8_23274894T20 NONE glucose_9\NN\14710501| (r_compound) tolerance_10\NN\5032565|glucose (r_conj) sensitivity_7\NN\5651971|on|insulin|and|tolerance (r_nmod) had_2\VBD\2108377|deletion|effect|sensitivity|,|reduced|. (l_nsubj) deletion_1\NN\13508333|g6pc2 (l_compound) g6pc2_0\NN\1740|
23274894T8_23274894T21 NONE glucose_9\NN\14710501| (r_compound) tolerance_10\NN\5032565|glucose (r_conj) sensitivity_7\NN\5651971|on|insulin|and|tolerance (l_compound) insulin_6\NN\5407119|
23274894T8_23274894T22 NONE glucose_9\NN\14710501| (r_compound) tolerance_10\NN\5032565|glucose (r_conj) sensitivity_7\NN\5651971|on|insulin|and|tolerance (r_nmod) had_2\VBD\2108377|deletion|effect|sensitivity|,|reduced|. (l_advcl) reduced_16\VBN\441445|whereas|fat|was|mice|,|observations (l_nmod) mice_24\NNS\2329401|in|female|knockout|chow (l_compound) knockout_20\NN\10787470|g6pc2|ko (l_compound) g6pc2_19\NN\1740|
23274894T9_23274894T23 NONE glucose-stimulated_12\JJ\1740| (r_amod) secretion_14\NN\13526110|for|glucose-stimulated|insulin|gsis (r_nmod) curve_10\NN\13863771|in|the|dose-response|secretion (r_nmod) shift_6\NN\7446404|in|a|leftward|curve (r_nmod) resulted_2\VBD\2633881|deletion|shift|. (l_nsubj) deletion_1\NN\13508333|g6pc2 (l_compound) g6pc2_0\NN\1740|
23274894T9_23274894T24 CPR:3 glucose-stimulated_12\JJ\1740| (r_amod) secretion_14\NN\13526110|for|glucose-stimulated|insulin|gsis (l_compound) insulin_13\NN\5407119|
23274894T1_23274894T11 NONE glucose_16\NN\14710501| (r_compound) levels_17\NNS\4916342|blood|glucose (r_nsubjpass) reduced_19\VBN\441445|consequence|,|conditions|,|levels|were|mice|,|consistent|. (l_nmod) mice_23\NNS\2329401|in|ko (l_amod) ko_22\JJ\1740|g6pc2 (l_nmod:npmod) g6pc2_21\NN\1740|
23274894T1_23274894T25 NONE glucose_16\NN\14710501| (r_compound) levels_17\NNS\4916342|blood|glucose (r_nsubjpass) reduced_19\VBN\441445|consequence|,|conditions|,|levels|were|mice|,|consistent|. (l_nmod) conditions_6\NNS\14512817|under|fasting|identical (l_acl:relcl) identical_13\JJ\1740|which|levels|were (l_nsubj) levels_11\NNS\4916342|plasma|insulin (l_compound) insulin_10\NN\5407119|
23274894T2_23274894T12 NONE glucose-6-phosphatase_0\NN\1740|
23274894T2_23274894T13 NONE glucose-6-phosphatase_0\NN\1740| (r_amod) activity_1\NN\30358|glucose-6-phosphatase (r_nsubjpass) reduced_3\VBN\441445|activity|was|,|elevated|. (l_advcl) elevated_11\JJ\1740|whereas|levels|were|islets (l_nmod) islets_13\NN\1740|in|isolated (l_acl) isolated_14\VBN\2512305|mice (l_nmod) mice_18\NNS\2329401|from|g6pc2|ko (l_compound) g6pc2_16\NN\1740|
23274894T3_23274894T12 NONE calcium_8\NN\14625458| (r_compound) levels_9\NNS\4916342|basal|cytoplasmic|calcium (r_nsubj) elevated_11\JJ\1740|whereas|levels|were|islets (r_advcl) reduced_3\VBN\441445|activity|was|,|elevated|. (l_nsubjpass) activity_1\NN\30358|glucose-6-phosphatase (l_amod) glucose-6-phosphatase_0\NN\1740|
23274894T3_23274894T13 NONE calcium_8\NN\14625458| (r_compound) levels_9\NNS\4916342|basal|cytoplasmic|calcium (r_nsubj) elevated_11\JJ\1740|whereas|levels|were|islets (l_nmod) islets_13\NN\1740|in|isolated (l_acl) isolated_14\VBN\2512305|mice (l_nmod) mice_18\NNS\2329401|from|g6pc2|ko (l_compound) g6pc2_16\NN\1740|
23274894T4_23274894T14 CPR:9 glucose-6-phosphate_18\NN\1740| (r_dobj) hydrolyzing_17\VBG\109660|by|glucose-6-phosphate|,|reducing (r_advcl) acts_15\VBZ\1619354|that|hydrolyzing (r_acl:relcl) regulator_10\NN\3096960|a|novel|,|negative|gsis|acts (r_dobj) represents_5\VBZ\2664769|that|g6pc2|regulator (l_nsubj) g6pc2_4\NN\1740|
11287128
11287128T1_11287128T3 CPR:4 ca_7\NN\14625458| (r_compound) ufh_8\NN\1740|of|ca (r_nmod) presence_5\NN\13954253|in|the|ufh (r_nmod) accelerated_9\VBD\226566|contrast|,|presence|inhibition|10-fold|efficiently|. (l_dobj) inhibition_11\NN\1068773|the|xa|antithrombin (l_nmod) xa_14\NN\1740|of|factor
11287128T1_11287128T4 CPR:4 ca_7\NN\14625458| (r_compound) ufh_8\NN\1740|of|ca (r_nmod) presence_5\NN\13954253|in|the|ufh (r_nmod) accelerated_9\VBD\226566|contrast|,|presence|inhibition|10-fold|efficiently|. (l_dobj) inhibition_11\NN\1068773|the|xa|antithrombin (l_nmod) antithrombin_16\NN\1740|by
23481236
23481236T16_23481236T45 NONE glucose_1\NN\14710501| (r_compound) regulation_2\NN\6652242|normal|glucose (r_nsubjpass) achieved_4\VBN\2524171|regulation|is|having|. (l_advcl) having_6\VBG\2108377|by|secretion (l_dobj) secretion_9\NN\13526110|adequate|insulin|and|uptake/disposal (l_compound) insulin_8\NN\5407119|
23481236T21_23481236T45 NONE glucose_12\NN\14710501| (r_compound) uptake/disposal_13\NN\1740|effective|glucose (r_conj) secretion_9\NN\13526110|adequate|insulin|and|uptake/disposal (l_compound) insulin_8\NN\5407119|
23481236T9_23481236T37 NONE tyrosine_30\NN\14601829| (r_compound) 1b_32\NN\1740|protein|tyrosine|phosphatase|ptp1b|,|regulator (r_dobj) up-regulate_28\VB\1740|1b (r_conj) attenuate_15\VB\224901|lipids|may|signaling|pathway|and|up-regulate|. (l_dobj) signaling_17\NN\33020|insulin (l_compound) insulin_16\NN\5407119|
23481236T9_23481236T38 NONE tyrosine_30\NN\14601829| (r_compound) 1b_32\NN\1740|protein|tyrosine|phosphatase|ptp1b|,|regulator (r_dobj) up-regulate_28\VB\1740|1b (r_conj) attenuate_15\VB\224901|lipids|may|signaling|pathway|and|up-regulate|. (l_nmod) pathway_26\NN\5483677|through|the|b (l_compound) b_22\NN\1355326|protein|kinase|akt
23481236T9_23481236T39 NONE tyrosine_30\NN\14601829| (r_compound) 1b_32\NN\1740|protein|tyrosine|phosphatase|ptp1b|,|regulator (r_dobj) up-regulate_28\VB\1740|1b (r_conj) attenuate_15\VB\224901|lipids|may|signaling|pathway|and|up-regulate|. (l_nmod) pathway_26\NN\5483677|through|the|b (l_compound) b_22\NN\1355326|protein|kinase|akt (l_appos) akt_24\NN\1740|(|)
23481236T9_23481236T40 NONE tyrosine_30\NN\14601829| (r_compound) 1b_32\NN\1740|protein|tyrosine|phosphatase|ptp1b|,|regulator
23481236T9_23481236T41 NONE tyrosine_30\NN\14601829| (r_compound) 1b_32\NN\1740|protein|tyrosine|phosphatase|ptp1b|,|regulator (l_appos) ptp1b_34\NN\1740|(|)
23481236T9_23481236T42 NONE tyrosine_30\NN\14601829| (r_compound) 1b_32\NN\1740|protein|tyrosine|phosphatase|ptp1b|,|regulator (l_appos) regulator_39\NN\3096960|a|negative|signaling (l_nmod) signaling_42\NN\33020|of|insulin (l_compound) insulin_41\NN\5407119|
23481236T10_23481236T43 NONE triglycerides_7\NNS\14885088|[|tags|,|diglycerides|] (r_dep) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_compound) insulin_22\NN\5407119|
23481236T10_23481236T44 NONE triglycerides_7\NNS\14885088|[|tags|,|diglycerides|] (r_dep) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_conj) phosphorylation_27\NN\1740|ptp1b (l_nmod) ptp1b_29\NN\1740|of
23481236T11_23481236T43 NONE tags_9\NNS\7272172|(|) (r_appos) triglycerides_7\NNS\14885088|[|tags|,|diglycerides|] (r_dep) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_compound) insulin_22\NN\5407119|
23481236T11_23481236T44 NONE tags_9\NNS\7272172|(|) (r_appos) triglycerides_7\NNS\14885088|[|tags|,|diglycerides|] (r_dep) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_conj) phosphorylation_27\NN\1740|ptp1b (l_nmod) ptp1b_29\NN\1740|of
23481236T12_23481236T43 NONE diglycerides_12\NNS\1740|dags (r_conj) triglycerides_7\NNS\14885088|[|tags|,|diglycerides|] (r_dep) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_compound) insulin_22\NN\5407119|
23481236T12_23481236T44 NONE diglycerides_12\NNS\1740|dags (r_conj) triglycerides_7\NNS\14885088|[|tags|,|diglycerides|] (r_dep) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_conj) phosphorylation_27\NN\1740|ptp1b (l_nmod) ptp1b_29\NN\1740|of
23481236T13_23481236T43 NONE dags_14\NNS\13717155|(|) (r_appos) diglycerides_12\NNS\1740|dags (r_conj) triglycerides_7\NNS\14885088|[|tags|,|diglycerides|] (r_dep) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_compound) insulin_22\NN\5407119|
23481236T13_23481236T44 NONE dags_14\NNS\13717155|(|) (r_appos) diglycerides_12\NNS\1740|dags (r_conj) triglycerides_7\NNS\14885088|[|tags|,|diglycerides|] (r_dep) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_conj) phosphorylation_27\NN\1740|ptp1b (l_nmod) ptp1b_29\NN\1740|of
23481236T14_23481236T43 NONE ceramides_18\NNS\1740| (r_conj) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_compound) insulin_22\NN\5407119|
23481236T14_23481236T44 NONE ceramides_18\NNS\1740| (r_conj) metabolites_5\NNS\20090|of|lipid|triglycerides|and|ceramides (r_nmod) accumulation_2\NN\13497135|metabolites (r_dobj) studied_1\VBD\630380|we|accumulation|relation|. (l_nmod) relation_20\NN\2137|in|signaling (l_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_conj) phosphorylation_27\NN\1740|ptp1b (l_nmod) ptp1b_29\NN\1740|of
23481236T15_23481236T43 NONE acids_48\NNS\14818238|free|fatty|ffas|μm (r_dep) saturated_42\JJ\1740|with|three|and|unsaturated|acids (r_nmod) cells_35\NNS\3080309|by|preincubating|rat|skeletal|muscle|myotubes|saturated (r_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_compound) insulin_22\NN\5407119|
23481236T15_23481236T44 NONE acids_48\NNS\14818238|free|fatty|ffas|μm (r_dep) saturated_42\JJ\1740|with|three|and|unsaturated|acids (r_nmod) cells_35\NNS\3080309|by|preincubating|rat|skeletal|muscle|myotubes|saturated (r_nmod) signaling_23\NN\33020|to|insulin|and|expression|and|phosphorylation|cells (l_conj) phosphorylation_27\NN\1740|ptp1b (l_nmod) ptp1b_29\NN\1740|of
23481236T17_23481236T46 CPR:4 wortmannin_8\NN\1740|of|,|inhibitor (l_appos) inhibitor_11\NN\20090|an|3-kinases (l_nmod) 3-kinases_14\NNS\1740|of|phosphatidylinositol|and|thus|akt
23481236T17_23481236T47 CPR:4 wortmannin_8\NN\1740|of|,|inhibitor (l_appos) inhibitor_11\NN\20090|an|3-kinases (l_nmod) 3-kinases_14\NNS\1740|of|phosphatidylinositol|and|thus|akt (l_conj) akt_17\NN\1740|nm
23481236T18_23481236T46 NONE phosphatidylinositol_13\NN\1740| (r_compound) 3-kinases_14\NNS\1740|of|phosphatidylinositol|and|thus|akt
23481236T18_23481236T47 NONE phosphatidylinositol_13\NN\1740| (r_compound) 3-kinases_14\NNS\1740|of|phosphatidylinositol|and|thus|akt (l_conj) akt_17\NN\1740|nm
23481236T1_23481236T48 NONE tyrosine_34\NN\14601829|152 (r_conj) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (r_nmod) assessed_17\VBN\670261|as|akt (r_advcl) remained_13\VBD\2604760|cells|sensitive|assessed (r_conj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_dobj) expression_8\NN\4679549|ptp1b (l_compound) ptp1b_7\NN\1740|
23481236T1_23481236T49 NONE tyrosine_34\NN\14601829|152 (r_conj) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (r_nmod) assessed_17\VBN\670261|as|akt (r_advcl) remained_13\VBD\2604760|cells|sensitive|assessed (l_xcomp) sensitive_15\JJ\1740|insulin (l_nmod:npmod) insulin_14\NN\5407119|
23481236T1_23481236T50 NONE tyrosine_34\NN\14601829|152 (r_conj) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation
23481236T1_23481236T51 NONE tyrosine_34\NN\14601829|152 (r_conj) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (l_conj) ptp1b_22\NN\1740|
23481236T19_23481236T48 NONE dags_3\NNS\13717155|,|tags|and (r_dobj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_dobj) expression_8\NN\4679549|ptp1b (l_compound) ptp1b_7\NN\1740|
23481236T19_23481236T49 NONE dags_3\NNS\13717155|,|tags|and (r_dobj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_conj) remained_13\VBD\2604760|cells|sensitive|assessed (l_xcomp) sensitive_15\JJ\1740|insulin (l_nmod:npmod) insulin_14\NN\5407119|
23481236T19_23481236T50 NONE dags_3\NNS\13717155|,|tags|and (r_dobj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_conj) remained_13\VBD\2604760|cells|sensitive|assessed (l_advcl) assessed_17\VBN\670261|as|akt (l_nmod) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation
23481236T19_23481236T51 NONE dags_3\NNS\13717155|,|tags|and (r_dobj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_conj) remained_13\VBD\2604760|cells|sensitive|assessed (l_advcl) assessed_17\VBN\670261|as|akt (l_nmod) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (l_conj) ptp1b_22\NN\1740|
23481236T20_23481236T48 NONE tags_5\NNS\7272172| (r_conj) dags_3\NNS\13717155|,|tags|and (r_dobj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_dobj) expression_8\NN\4679549|ptp1b (l_compound) ptp1b_7\NN\1740|
23481236T20_23481236T49 NONE tags_5\NNS\7272172| (r_conj) dags_3\NNS\13717155|,|tags|and (r_dobj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_conj) remained_13\VBD\2604760|cells|sensitive|assessed (l_xcomp) sensitive_15\JJ\1740|insulin (l_nmod:npmod) insulin_14\NN\5407119|
23481236T20_23481236T50 NONE tags_5\NNS\7272172| (r_conj) dags_3\NNS\13717155|,|tags|and (r_dobj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_conj) remained_13\VBD\2604760|cells|sensitive|assessed (l_advcl) assessed_17\VBN\670261|as|akt (l_nmod) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation
23481236T20_23481236T51 NONE tags_5\NNS\7272172| (r_conj) dags_3\NNS\13717155|,|tags|and (r_dobj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_conj) remained_13\VBD\2604760|cells|sensitive|assessed (l_advcl) assessed_17\VBN\670261|as|akt (l_nmod) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (l_conj) ptp1b_22\NN\1740|
23481236T22_23481236T48 NONE serine_25\NN\14601829| (r_compound) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (r_nmod) assessed_17\VBN\670261|as|akt (r_advcl) remained_13\VBD\2604760|cells|sensitive|assessed (r_conj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_dobj) expression_8\NN\4679549|ptp1b (l_compound) ptp1b_7\NN\1740|
23481236T22_23481236T49 NONE serine_25\NN\14601829| (r_compound) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (r_nmod) assessed_17\VBN\670261|as|akt (r_advcl) remained_13\VBD\2604760|cells|sensitive|assessed (l_xcomp) sensitive_15\JJ\1740|insulin (l_nmod:npmod) insulin_14\NN\5407119|
23481236T22_23481236T50 NONE serine_25\NN\14601829| (r_compound) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation
23481236T22_23481236T51 NONE serine_25\NN\14601829| (r_compound) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (l_conj) ptp1b_22\NN\1740|
23481236T23_23481236T48 NONE ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (r_nmod) assessed_17\VBN\670261|as|akt (r_advcl) remained_13\VBD\2604760|cells|sensitive|assessed (r_conj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_dobj) expression_8\NN\4679549|ptp1b (l_compound) ptp1b_7\NN\1740|
23481236T23_23481236T49 NONE ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (r_nmod) assessed_17\VBN\670261|as|akt (r_advcl) remained_13\VBD\2604760|cells|sensitive|assessed (l_xcomp) sensitive_15\JJ\1740|insulin (l_nmod:npmod) insulin_14\NN\5407119|
23481236T23_23481236T50 NONE ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation
23481236T23_23481236T51 NONE ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (l_conj) ptp1b_22\NN\1740|
23481236T24_23481236T48 NONE ser_31\NN\1740|398 (r_conj) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (r_nmod) assessed_17\VBN\670261|as|akt (r_advcl) remained_13\VBD\2604760|cells|sensitive|assessed (r_conj) increased_2\VBD\169651|ffas|dags|expression|significantly|,|but|remained|. (l_dobj) expression_8\NN\4679549|ptp1b (l_compound) ptp1b_7\NN\1740|
23481236T24_23481236T49 NONE ser_31\NN\1740|398 (r_conj) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (r_nmod) assessed_17\VBN\670261|as|akt (r_advcl) remained_13\VBD\2604760|cells|sensitive|assessed (l_xcomp) sensitive_15\JJ\1740|insulin (l_nmod:npmod) insulin_14\NN\5407119|
23481236T24_23481236T50 NONE ser_31\NN\1740|398 (r_conj) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation
23481236T24_23481236T51 NONE ser_31\NN\1740|398 (r_conj) ser_27\NN\1740|at|serine|(|)|50|,|ser|and|tyrosine (r_nmod) phosphorylation_23\NN\1740|ser (r_dep) akt_20\NN\1740|by|robust|and|ptp1b|phosphorylation (l_conj) ptp1b_22\NN\1740|
23481236T2_23481236T25 CPR:3 acids_4\NNS\14818238|palmitic (r_nsubj) increased_5\VBD\169651|acids|ceramides|,|up-regulated|,|and|had|. (l_conj) up-regulated_8\VBD\1740|ptp1b (l_dobj) ptp1b_9\NN\1740|
23481236T2_23481236T26 CPR:3 acids_4\NNS\14818238|palmitic (r_nsubj) increased_5\VBD\169651|acids|ceramides|,|up-regulated|,|and|had|. (l_conj) had_12\VBD\2108377|phosphorylation|ser (l_dobj) phosphorylation_16\NN\1740|akt (l_compound) akt_13\NN\1740|and|ptp1b
23481236T2_23481236T27 CPR:3 acids_4\NNS\14818238|palmitic (r_nsubj) increased_5\VBD\169651|acids|ceramides|,|up-regulated|,|and|had|. (l_conj) had_12\VBD\2108377|phosphorylation|ser (l_dobj) phosphorylation_16\NN\1740|akt (l_compound) akt_13\NN\1740|and|ptp1b (l_conj) ptp1b_15\NN\1740|
23481236T3_23481236T25 NONE ceramides_6\NNS\1740| (r_dobj) increased_5\VBD\169651|acids|ceramides|,|up-regulated|,|and|had|. (l_conj) up-regulated_8\VBD\1740|ptp1b (l_dobj) ptp1b_9\NN\1740|
23481236T3_23481236T26 NONE ceramides_6\NNS\1740| (r_dobj) increased_5\VBD\169651|acids|ceramides|,|up-regulated|,|and|had|. (l_conj) had_12\VBD\2108377|phosphorylation|ser (l_dobj) phosphorylation_16\NN\1740|akt (l_compound) akt_13\NN\1740|and|ptp1b
23481236T3_23481236T27 NONE ceramides_6\NNS\1740| (r_dobj) increased_5\VBD\169651|acids|ceramides|,|up-regulated|,|and|had|. (l_conj) had_12\VBD\2108377|phosphorylation|ser (l_dobj) phosphorylation_16\NN\1740|akt (l_compound) akt_13\NN\1740|and|ptp1b (l_conj) ptp1b_15\NN\1740|
23481236T4_23481236T25 NONE ser_18\NN\1740|at|50|impaired (r_nmod) had_12\VBD\2108377|phosphorylation|ser (r_conj) increased_5\VBD\169651|acids|ceramides|,|up-regulated|,|and|had|. (l_conj) up-regulated_8\VBD\1740|ptp1b (l_dobj) ptp1b_9\NN\1740|
23481236T4_23481236T26 NONE ser_18\NN\1740|at|50|impaired (r_nmod) had_12\VBD\2108377|phosphorylation|ser (l_dobj) phosphorylation_16\NN\1740|akt (l_compound) akt_13\NN\1740|and|ptp1b
23481236T4_23481236T27 NONE ser_18\NN\1740|at|50|impaired (r_nmod) had_12\VBD\2108377|phosphorylation|ser (l_dobj) phosphorylation_16\NN\1740|akt (l_compound) akt_13\NN\1740|and|ptp1b (l_conj) ptp1b_15\NN\1740|
23481236T6_23481236T30 CPR:4 ceramides_4\NNS\1740| (r_dobj) increased_3\VBD\169651|that|ceramides (r_acl:relcl) ffas_1\NNS\1740|only|increased (r_nsubj) caused_5\VBD\1617192|ffas|impairment|. (l_dobj) impairment_6\NN\7296428|akt (l_nmod) akt_8\NN\1740|of|and|ptp1b|phosphorylation|ser
23481236T6_23481236T31 CPR:4 ceramides_4\NNS\1740| (r_dobj) increased_3\VBD\169651|that|ceramides (r_acl:relcl) ffas_1\NNS\1740|only|increased (r_nsubj) caused_5\VBD\1617192|ffas|impairment|. (l_dobj) impairment_6\NN\7296428|akt (l_nmod) akt_8\NN\1740|of|and|ptp1b|phosphorylation|ser (l_conj) ptp1b_10\NN\1740|
23481236T7_23481236T30 NONE ser_13\NN\1740|at|50 (r_nmod) akt_8\NN\1740|of|and|ptp1b|phosphorylation|ser
23481236T7_23481236T31 NONE ser_13\NN\1740|at|50 (r_nmod) akt_8\NN\1740|of|and|ptp1b|phosphorylation|ser (l_conj) ptp1b_10\NN\1740|
23481236T8_23481236T35 NONE ser_8\NN\1740|at|50 (r_nmod) levels_6\NNS\4916342|between|ptp1b|phosphorylation|ser|and|effect (l_compound) ptp1b_4\NN\1740|
23481236T8_23481236T36 NONE ser_8\NN\1740|at|50 (r_nmod) levels_6\NNS\4916342|between|ptp1b|phosphorylation|ser|and|effect (l_conj) effect_13\NN\34213|its|negative|signaling (l_nmod) signaling_16\NN\33020|on|insulin (l_compound) insulin_15\NN\5407119|
11585753
11585753T8_11585753T24 NONE zd1839_4\NN\1740|iressa (r_dep) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (r_nsubj) inhibits_10\VBZ\2510337|inhibitor|signaling|and|suppresses|. (l_conj) suppresses_14\VBZ\2510337|growth (l_dobj) growth_16\NN\13526110|the|cells (l_nmod) cells_20\NNS\3080309|of|her2-overexpressing|tumor (l_amod) her2-overexpressing_18\JJ\1740|
11585753T8_11585753T25 CPR:4 zd1839_4\NN\1740|iressa (r_dep) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (l_compound) kinase_2\NN\14732946|
11585753T8_11585753T26 CPR:4 zd1839_4\NN\1740|iressa (r_dep) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (r_nsubj) inhibits_10\VBZ\2510337|inhibitor|signaling|and|suppresses|. (l_dobj) signaling_12\NN\33020|her2-driven (l_amod) her2-driven_11\JJ\1740|
11585753T9_11585753T24 CPR:4 iressa_7\NN\1740|(|"|"|) (r_appos) zd1839_4\NN\1740|iressa (r_dep) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (r_nsubj) inhibits_10\VBZ\2510337|inhibitor|signaling|and|suppresses|. (l_conj) suppresses_14\VBZ\2510337|growth (l_dobj) growth_16\NN\13526110|the|cells (l_nmod) cells_20\NNS\3080309|of|her2-overexpressing|tumor (l_amod) her2-overexpressing_18\JJ\1740|
11585753T9_11585753T25 CPR:4 iressa_7\NN\1740|(|"|"|) (r_appos) zd1839_4\NN\1740|iressa (r_dep) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (l_compound) kinase_2\NN\14732946|
11585753T9_11585753T26 CPR:4 iressa_7\NN\1740|(|"|"|) (r_appos) zd1839_4\NN\1740|iressa (r_dep) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (r_nsubj) inhibits_10\VBZ\2510337|inhibitor|signaling|and|suppresses|. (l_dobj) signaling_12\NN\33020|her2-driven (l_amod) her2-driven_11\JJ\1740|
11585753T10_11585753T24 NONE tyrosine_1\NN\14601829| (r_compound) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (r_nsubj) inhibits_10\VBZ\2510337|inhibitor|signaling|and|suppresses|. (l_conj) suppresses_14\VBZ\2510337|growth (l_dobj) growth_16\NN\13526110|the|cells (l_nmod) cells_20\NNS\3080309|of|her2-overexpressing|tumor (l_amod) her2-overexpressing_18\JJ\1740|
11585753T10_11585753T25 CPR:9 tyrosine_1\NN\14601829| (r_compound) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (l_compound) kinase_2\NN\14732946|
11585753T10_11585753T26 NONE tyrosine_1\NN\14601829| (r_compound) inhibitor_3\NN\20090|the|tyrosine|kinase|zd1839 (r_nsubj) inhibits_10\VBZ\2510337|inhibitor|signaling|and|suppresses|. (l_dobj) signaling_12\NN\33020|her2-driven (l_amod) her2-driven_11\JJ\1740|
11585753T2_11585753T13 CPR:4 zd1839_0\NN\1740|iressa|,|inhibitor|, (l_appos) inhibitor_11\NN\20090|a|quinazoline|tyrosine|kinase|selective (l_compound) kinase_10\NN\14732946|
11585753T2_11585753T14 CPR:4 zd1839_0\NN\1740|iressa|,|inhibitor|, (l_appos) inhibitor_11\NN\20090|a|quinazoline|tyrosine|kinase|selective (l_amod) selective_12\JJ\1740|egfr (l_nmod) egfr_15\NN\1740|for|the
11585753T3_11585753T13 CPR:4 iressa_3\NN\1740|(|"|"|) (r_appos) zd1839_0\NN\1740|iressa|,|inhibitor|, (l_appos) inhibitor_11\NN\20090|a|quinazoline|tyrosine|kinase|selective (l_compound) kinase_10\NN\14732946|
11585753T3_11585753T14 CPR:4 iressa_3\NN\1740|(|"|"|) (r_appos) zd1839_0\NN\1740|iressa|,|inhibitor|, (l_appos) inhibitor_11\NN\20090|a|quinazoline|tyrosine|kinase|selective (l_amod) selective_12\JJ\1740|egfr (l_nmod) egfr_15\NN\1740|for|the
11585753T4_11585753T13 CPR:9 tyrosine_9\NN\14601829| (r_compound) inhibitor_11\NN\20090|a|quinazoline|tyrosine|kinase|selective (l_compound) kinase_10\NN\14732946|
11585753T4_11585753T14 NONE tyrosine_9\NN\14601829| (r_compound) inhibitor_11\NN\20090|a|quinazoline|tyrosine|kinase|selective (l_amod) selective_12\JJ\1740|egfr (l_nmod) egfr_15\NN\1740|for|the
11585753T6_11585753T17 NONE zd1839_20\NN\1740|to (r_nmod) sensitive_18\JJ\1740|panel|,|tumors|were|particularly|zd1839|. (l_nsubj) tumors_15\NNS\14234074|her2-overexpressing (l_amod) her2-overexpressing_14\JJ\1740|
11585753T7_11585753T18 NONE phosphatidylinositol_29\NN\1740| (r_compound) 3-kinase_30\NN\1740|with|phosphatidylinositol (r_nmod) association_25\NN\8008335|of|her3|3-kinase (r_nmod) loss_23\NN\13252973|by|the|association|,|and|down-regulation (r_nmod) accompanied_20\VBN\1835496|loss (r_advcl) associated_8\VBN\628491|inhibition|was|dephosphorylation|accompanied|. (l_nmod) dephosphorylation_11\NN\1740|with|the|egfr|, (l_nmod) egfr_13\NN\1740|of|,|her2|,|and|her3
11585753T7_11585753T19 NONE phosphatidylinositol_29\NN\1740| (r_compound) 3-kinase_30\NN\1740|with|phosphatidylinositol (r_nmod) association_25\NN\8008335|of|her3|3-kinase (r_nmod) loss_23\NN\13252973|by|the|association|,|and|down-regulation (r_nmod) accompanied_20\VBN\1835496|loss (r_advcl) associated_8\VBN\628491|inhibition|was|dephosphorylation|accompanied|. (l_nmod) dephosphorylation_11\NN\1740|with|the|egfr|, (l_nmod) egfr_13\NN\1740|of|,|her2|,|and|her3 (l_conj) her2_15\NN\1740|
11585753T7_11585753T20 NONE phosphatidylinositol_29\NN\1740| (r_compound) 3-kinase_30\NN\1740|with|phosphatidylinositol (r_nmod) association_25\NN\8008335|of|her3|3-kinase (r_nmod) loss_23\NN\13252973|by|the|association|,|and|down-regulation (r_nmod) accompanied_20\VBN\1835496|loss (r_advcl) associated_8\VBN\628491|inhibition|was|dephosphorylation|accompanied|. (l_nmod) dephosphorylation_11\NN\1740|with|the|egfr|, (l_nmod) egfr_13\NN\1740|of|,|her2|,|and|her3 (l_conj) her3_18\NN\1740|
11585753T7_11585753T21 CPR:9 phosphatidylinositol_29\NN\1740| (r_compound) 3-kinase_30\NN\1740|with|phosphatidylinositol
11585753T7_11585753T22 NONE phosphatidylinositol_29\NN\1740| (r_compound) 3-kinase_30\NN\1740|with|phosphatidylinositol (r_nmod) association_25\NN\8008335|of|her3|3-kinase (r_nmod) loss_23\NN\13252973|by|the|association|,|and|down-regulation (l_conj) down-regulation_33\NN\1740|activity (l_nmod) activity_36\NN\30358|of|akt (l_compound) akt_35\NN\1740|
11585753T1_11585753T11 NONE tyrosine_15\NN\14601829| (r_compound) kinase_16\NN\14732946|tyrosine (r_compound) signaling_17\NN\33020|of|her|family|kinase (l_compound) her_13\NN\1740|
11585753T1_11585753T12 CPR:9 tyrosine_15\NN\14601829| (r_compound) kinase_16\NN\14732946|tyrosine
11585753T1_11585753T23 NONE tyrosine_15\NN\14601829| (r_compound) kinase_16\NN\14732946|tyrosine (r_compound) signaling_17\NN\33020|of|her|family|kinase (r_nmod) inhibition_11\NN\1068773|to|the|signaling (r_nmod) susceptible_8\JJ\1740|that|tumors|are|particularly|inhibition (l_nsubj) tumors_5\NNS\14234074|her2-overexpressing (l_amod) her2-overexpressing_4\JJ\1740|
23414235
23414235T3_23414235T16 CPR:4 vegfrecine_0\NN\1740|,|inhibitor (l_appos) inhibitor_3\NN\20090|an|kinases|isolated (l_nmod) kinases_8\NNS\14732946|of|vegf|receptor|tyrosine
23414235T4_23414235T16 NONE tyrosine_7\NN\14601829| (r_compound) kinases_8\NNS\14732946|of|vegf|receptor|tyrosine
23414235T1_23414235T5 NONE tyrosine_6\NN\14601829| (r_compound) kinases_7\NNS\14732946|of|vegf|receptor|tyrosine
23414235T2_23414235T5 CPR:4 vegfrecine_9\NN\1740|(|1 (r_appos) inhibitor_2\NN\20090|a|new|kinases|,|vegfrecine|, (l_nmod) kinases_7\NNS\14732946|of|vegf|receptor|tyrosine
16757355
16757355T10_16757355T38 CPR:4 sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature
16757355T10_16757355T39 CPR:4 sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (l_dep) vegfr/pdgfr_23\NN\1740|
16757355T10_16757355T40 CPR:4 sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (l_dep) vegfr/pdgfr_23\NN\1740|
16757355T10_16757355T41 CPR:4 sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T10_16757355T42 CPR:4 sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T10_16757355T43 CPR:4 sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T11_16757355T38 NONE tyrosine_21\NN\14601829| (r_compound) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature
16757355T11_16757355T39 NONE tyrosine_21\NN\14601829| (r_compound) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (l_dep) vegfr/pdgfr_23\NN\1740|
16757355T11_16757355T40 NONE tyrosine_21\NN\14601829| (r_compound) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (l_dep) vegfr/pdgfr_23\NN\1740|
16757355T11_16757355T41 NONE tyrosine_21\NN\14601829| (r_compound) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (r_conj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T11_16757355T42 NONE tyrosine_21\NN\14601829| (r_compound) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (r_conj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T11_16757355T43 NONE tyrosine_21\NN\14601829| (r_compound) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (r_conj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T12_16757355T38 CPR:4 9006_5\CD\1740| (r_nummod) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature
16757355T12_16757355T39 CPR:4 9006_5\CD\1740| (r_nummod) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (l_dep) vegfr/pdgfr_23\NN\1740|
16757355T12_16757355T40 CPR:4 9006_5\CD\1740| (r_nummod) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (l_dep) vegfr/pdgfr_23\NN\1740|
16757355T12_16757355T41 CPR:4 9006_5\CD\1740| (r_nummod) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T12_16757355T42 CPR:4 9006_5\CD\1740| (r_nummod) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T12_16757355T43 CPR:4 9006_5\CD\1740| (r_nummod) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T13_16757355T38 CPR:4 nexavar_7\NN\1740| (r_appos) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature
16757355T13_16757355T39 CPR:4 nexavar_7\NN\1740| (r_appos) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (l_dep) vegfr/pdgfr_23\NN\1740|
16757355T13_16757355T40 CPR:4 nexavar_7\NN\1740| (r_appos) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_conj) kinases_22\NNS\14732946|tyrosine|vegfr/pdgfr|vasculature (l_dep) vegfr/pdgfr_23\NN\1740|
16757355T13_16757355T41 CPR:4 nexavar_7\NN\1740| (r_appos) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T13_16757355T42 CPR:4 nexavar_7\NN\1740| (r_appos) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T13_16757355T43 CPR:4 nexavar_7\NN\1740| (r_appos) bay_2\NN\9225146|(|43|-|9006|,|nexavar|) (r_appos) sorafenib_0\NN\1740|bay|,|inhibitor|. (l_appos) inhibitor_12\NN\20090|a|dual-action|targets (l_acl:relcl) targets_14\VBZ\1151110|that|pathway (l_dobj) pathway_16\NN\5483677|raf/mek/erk|cells|and|kinases (l_compound) raf/mek/erk_15\NN\1740|
16757355T1_16757355T14 NONE tyrosine_5\NN\14601829| (r_compound) kinases_6\NNS\14732946|several|receptor|tyrosine|,|acting|,
16757355T1_16757355T21 NONE tyrosine_5\NN\14601829| (r_compound) kinases_6\NNS\14732946|several|receptor|tyrosine|,|acting|, (l_acl) acting_8\VBG\1619354|upstream (l_advmod) upstream_9\RB\1740|ras (l_nmod) ras_11\NN\5501711|of
16757355T5_16757355T30 CPR:4 urea_5\NN\14727670|of|biaryl|inhibits (l_acl:relcl) inhibits_7\VBZ\2510337|that|kinase (l_dobj) kinase_9\NN\14732946|c-raf (l_compound) c-raf_8\NN\1740|
16757355T5_16757355T31 CPR:4 urea_5\NN\14727670|of|biaryl|inhibits (l_acl:relcl) inhibits_7\VBZ\2510337|that|kinase (l_dobj) kinase_9\NN\14732946|c-raf
16757355T9_16757355T32 CPR:4 sorafenib_0\NN\1740| (r_nsubj) inhibited_1\VBD\2510337|sorafenib|activity|. (l_dobj) activity_4\NN\30358|the|kinase|c-raf (l_compound) kinase_3\NN\14732946|
16757355T9_16757355T33 CPR:4 sorafenib_0\NN\1740| (r_nsubj) inhibited_1\VBD\2510337|sorafenib|activity|. (l_dobj) activity_4\NN\30358|the|kinase|c-raf (l_nmod) c-raf_7\NN\1740|of|both|and|b-raf|type
16757355T9_16757355T34 CPR:4 sorafenib_0\NN\1740| (r_nsubj) inhibited_1\VBD\2510337|sorafenib|activity|. (l_dobj) activity_4\NN\30358|the|kinase|c-raf (l_nmod) c-raf_7\NN\1740|of|both|and|b-raf|type (l_conj) b-raf_9\NN\1740|
16757355T9_16757355T35 CPR:4 sorafenib_0\NN\1740| (r_nsubj) inhibited_1\VBD\2510337|sorafenib|activity|. (l_dobj) activity_4\NN\30358|the|kinase|c-raf (l_nmod) c-raf_7\NN\1740|of|both|and|b-raf|type (l_dep) type_12\NN\5839024|(|wild|and|mutant|) (l_conj) mutant_15\NN\4475|v600e (l_compound) v600e_14\NN\1740|
16757355T2_16757355T15 CPR:4 sorafenib_3\NN\1740|of (r_nmod) characterization_1\NN\6724763|further|sorafenib (r_nsubj) revealed_4\VBD\2137132|characterization|inhibitor|. (l_ccomp) inhibitor_11\NN\20090|that|molecule|was|a|multikinase|targeted (l_acl:relcl) targeted_13\VBD\1151110|that|family (l_dobj) family_20\NN\8189659|the|vascular|endothelial|growth|factor|receptor|vegfr-2|and|family|,|play (l_compound) receptor_19\NN\5225602|
16757355T2_16757355T16 CPR:4 sorafenib_3\NN\1740|of (r_nmod) characterization_1\NN\6724763|further|sorafenib (r_nsubj) revealed_4\VBD\2137132|characterization|inhibitor|. (l_ccomp) inhibitor_11\NN\20090|that|molecule|was|a|multikinase|targeted (l_acl:relcl) targeted_13\VBD\1151110|that|family (l_dobj) family_20\NN\8189659|the|vascular|endothelial|growth|factor|receptor|vegfr-2|and|family|,|play (l_dep) vegfr-2_22\NN\1740|(|and|vegfr-3|)
16757355T2_16757355T17 CPR:4 sorafenib_3\NN\1740|of (r_nmod) characterization_1\NN\6724763|further|sorafenib (r_nsubj) revealed_4\VBD\2137132|characterization|inhibitor|. (l_ccomp) inhibitor_11\NN\20090|that|molecule|was|a|multikinase|targeted (l_acl:relcl) targeted_13\VBD\1151110|that|family (l_dobj) family_20\NN\8189659|the|vascular|endothelial|growth|factor|receptor|vegfr-2|and|family|,|play (l_dep) vegfr-2_22\NN\1740|(|and|vegfr-3|) (l_conj) vegfr-3_24\NN\1740|
16757355T2_16757355T18 CPR:4 sorafenib_3\NN\1740|of (r_nmod) characterization_1\NN\6724763|further|sorafenib (r_nsubj) revealed_4\VBD\2137132|characterization|inhibitor|. (l_ccomp) inhibitor_11\NN\20090|that|molecule|was|a|multikinase|targeted (l_acl:relcl) targeted_13\VBD\1151110|that|family (l_dobj) family_20\NN\8189659|the|vascular|endothelial|growth|factor|receptor|vegfr-2|and|family|,|play (l_conj) family_31\NN\8189659|platelet-derived|growth|factor|receptor|pdgfr-beta (l_compound) receptor_30\NN\5225602|
16757355T2_16757355T19 CPR:4 sorafenib_3\NN\1740|of (r_nmod) characterization_1\NN\6724763|further|sorafenib (r_nsubj) revealed_4\VBD\2137132|characterization|inhibitor|. (l_ccomp) inhibitor_11\NN\20090|that|molecule|was|a|multikinase|targeted (l_acl:relcl) targeted_13\VBD\1151110|that|family (l_dobj) family_20\NN\8189659|the|vascular|endothelial|growth|factor|receptor|vegfr-2|and|family|,|play (l_conj) family_31\NN\8189659|platelet-derived|growth|factor|receptor|pdgfr-beta (l_dep) pdgfr-beta_33\NN\1740|(|and|kit|)
16757355T2_16757355T20 CPR:4 sorafenib_3\NN\1740|of (r_nmod) characterization_1\NN\6724763|further|sorafenib (r_nsubj) revealed_4\VBD\2137132|characterization|inhibitor|. (l_ccomp) inhibitor_11\NN\20090|that|molecule|was|a|multikinase|targeted (l_acl:relcl) targeted_13\VBD\1151110|that|family (l_dobj) family_20\NN\8189659|the|vascular|endothelial|growth|factor|receptor|vegfr-2|and|family|,|play (l_conj) family_31\NN\8189659|platelet-derived|growth|factor|receptor|pdgfr-beta (l_dep) pdgfr-beta_33\NN\1740|(|and|kit|) (l_conj) kit_35\NN\2974697|
16757355T3_16757355T22 CPR:4 sorafenib_2\NN\1740| (r_nsubj) inhibit_4\VB\2510337|thus|,|sorafenib|may|growth|mechanism|acting|. (l_advcl) acting_12\VBG\1619354|tumor (l_nmod) tumor_17\NN\14234074|directly|on|the|(|inhibition|and/or|angiogenesis (l_nmod) inhibition_20\NN\1068773|through|raf|) (l_nmod) raf_22\NN\8196024|of|and|kit|signaling
16757355T3_16757355T23 CPR:4 sorafenib_2\NN\1740| (r_nsubj) inhibit_4\VB\2510337|thus|,|sorafenib|may|growth|mechanism|acting|. (l_advcl) acting_12\VBG\1619354|tumor (l_nmod) tumor_17\NN\14234074|directly|on|the|(|inhibition|and/or|angiogenesis (l_nmod) inhibition_20\NN\1068773|through|raf|) (l_nmod) raf_22\NN\8196024|of|and|kit|signaling (l_conj) kit_24\NN\2974697|
16757355T3_16757355T24 CPR:4 sorafenib_2\NN\1740| (r_nsubj) inhibit_4\VB\2510337|thus|,|sorafenib|may|growth|mechanism|acting|. (l_advcl) acting_12\VBG\1619354|tumor (l_nmod) tumor_17\NN\14234074|directly|on|the|(|inhibition|and/or|angiogenesis (l_conj) angiogenesis_30\NN\13489037|on|tumor|(|inhibition (l_nmod) inhibition_33\NN\1068773|through|signaling|) (l_nmod) signaling_38\NN\33020|of|vegfr (l_compound) vegfr_35\NN\1740|and|pdgfr
16757355T3_16757355T25 CPR:4 sorafenib_2\NN\1740| (r_nsubj) inhibit_4\VB\2510337|thus|,|sorafenib|may|growth|mechanism|acting|. (l_advcl) acting_12\VBG\1619354|tumor (l_nmod) tumor_17\NN\14234074|directly|on|the|(|inhibition|and/or|angiogenesis (l_conj) angiogenesis_30\NN\13489037|on|tumor|(|inhibition (l_nmod) inhibition_33\NN\1068773|through|signaling|) (l_nmod) signaling_38\NN\33020|of|vegfr (l_compound) vegfr_35\NN\1740|and|pdgfr (l_conj) pdgfr_37\NN\1740|
23608109
23608109T1_23608109T2 NONE crizotinib_33\NN\1740| (r_conj) inhibitors_28\NNS\20090|with|egfr|tyrosine|kinase|tkis|and|crizotinib|, (r_nmod) targeted_23\VBN\1151110|targets|have|successfully|been|inhibitors|respectively|. (l_nsubjpass) targets_1\NNS\7258332|few|mutations (l_nmod) mutations_10\NNS\4475|like|receptor|and|rearrangements (l_compound) receptor_6\NN\5225602|epidermal|growth|factor|egfr
23608109T1_23608109T3 NONE crizotinib_33\NN\1740| (r_conj) inhibitors_28\NNS\20090|with|egfr|tyrosine|kinase|tkis|and|crizotinib|, (r_nmod) targeted_23\VBN\1151110|targets|have|successfully|been|inhibitors|respectively|. (l_nsubjpass) targets_1\NNS\7258332|few|mutations (l_nmod) mutations_10\NNS\4475|like|receptor|and|rearrangements (l_compound) receptor_6\NN\5225602|epidermal|growth|factor|egfr (l_appos) egfr_8\NN\1740|(|)
23608109T1_23608109T4 NONE crizotinib_33\NN\1740| (r_conj) inhibitors_28\NNS\20090|with|egfr|tyrosine|kinase|tkis|and|crizotinib|, (r_nmod) targeted_23\VBN\1151110|targets|have|successfully|been|inhibitors|respectively|. (l_nsubjpass) targets_1\NNS\7258332|few|mutations (l_nmod) mutations_10\NNS\4475|like|receptor|and|rearrangements (l_conj) rearrangements_19\NNS\939628|kinase|)|gene (l_compound) kinase_14\NN\14732946|anaplastic|lymphoma|alk
23608109T1_23608109T5 NONE crizotinib_33\NN\1740| (r_conj) inhibitors_28\NNS\20090|with|egfr|tyrosine|kinase|tkis|and|crizotinib|, (r_nmod) targeted_23\VBN\1151110|targets|have|successfully|been|inhibitors|respectively|. (l_nsubjpass) targets_1\NNS\7258332|few|mutations (l_nmod) mutations_10\NNS\4475|like|receptor|and|rearrangements (l_conj) rearrangements_19\NNS\939628|kinase|)|gene (l_compound) kinase_14\NN\14732946|anaplastic|lymphoma|alk (l_appos) alk_16\NN\1740|(
23608109T1_23608109T6 NONE crizotinib_33\NN\1740| (r_conj) inhibitors_28\NNS\20090|with|egfr|tyrosine|kinase|tkis|and|crizotinib|, (l_compound) egfr_25\NN\1740|
23608109T1_23608109T7 NONE crizotinib_33\NN\1740| (r_conj) inhibitors_28\NNS\20090|with|egfr|tyrosine|kinase|tkis|and|crizotinib|, (l_compound) kinase_27\NN\14732946|
23318726
23318726T19_23318726T33 NONE butein_0\NN\1740| (r_nsubj) protects_1\VBZ\1127795|butein|cells|toxicity|expressions|. (l_nmod) expressions_16\NNS\4679549|via|pathway-dependent|heme|oxygenase-1 (l_compound) oxygenase-1_15\NN\1740|
23318726T19_23318726T34 NONE butein_0\NN\1740| (r_nsubj) protects_1\VBZ\1127795|butein|cells|toxicity|expressions|. (l_nmod) expressions_16\NNS\4679549|via|pathway-dependent|heme|oxygenase-1 (l_amod) pathway-dependent_13\JJ\1740|nrf2 (l_nmod:npmod) nrf2_12\NN\1740|
23318726T20_23318726T33 NONE peroxide-induced_8\JJ\1740|hydrogen (r_amod) toxicity_10\NN\13576101|from|peroxide-induced|oxidative (r_nmod) protects_1\VBZ\1127795|butein|cells|toxicity|expressions|. (l_nmod) expressions_16\NNS\4679549|via|pathway-dependent|heme|oxygenase-1 (l_compound) oxygenase-1_15\NN\1740|
23318726T20_23318726T34 NONE peroxide-induced_8\JJ\1740|hydrogen (r_amod) toxicity_10\NN\13576101|from|peroxide-induced|oxidative (r_nmod) protects_1\VBZ\1127795|butein|cells|toxicity|expressions|. (l_nmod) expressions_16\NNS\4679549|via|pathway-dependent|heme|oxygenase-1 (l_amod) pathway-dependent_13\JJ\1740|nrf2 (l_nmod:npmod) nrf2_12\NN\1740|
23318726T14_23318726T27 CPR:3 butein_0\NN\1740| (r_nsubj) increased_2\VBD\169651|butein|also|expression|. (l_dobj) expression_9\NN\4679549|oxygenase-1|protein|and|activity (l_compound) oxygenase-1_4\NN\1740|heme|ho-1
23318726T14_23318726T28 CPR:3 butein_0\NN\1740| (r_nsubj) increased_2\VBD\169651|butein|also|expression|. (l_dobj) expression_9\NN\4679549|oxygenase-1|protein|and|activity (l_compound) oxygenase-1_4\NN\1740|heme|ho-1 (l_appos) ho-1_6\NN\1740|(|)
23318726T14_23318726T29 CPR:3 butein_0\NN\1740| (r_nsubj) increased_2\VBD\169651|butein|also|expression|. (l_dobj) expression_9\NN\4679549|oxygenase-1|protein|and|activity (l_conj) activity_12\NN\30358|ho (l_compound) ho_11\NN\14625458|
23318726T15_23318726T27 NONE heme_3\NN\14989820| (r_compound) oxygenase-1_4\NN\1740|heme|ho-1
23318726T15_23318726T28 NONE heme_3\NN\14989820| (r_compound) oxygenase-1_4\NN\1740|heme|ho-1 (l_appos) ho-1_6\NN\1740|(|)
23318726T15_23318726T29 NONE heme_3\NN\14989820| (r_compound) oxygenase-1_4\NN\1740|heme|ho-1 (r_compound) expression_9\NN\4679549|oxygenase-1|protein|and|activity (l_conj) activity_12\NN\30358|ho (l_compound) ho_11\NN\14625458|
23318726T16_23318726T30 NONE butein-dependent_3\JJ\1740| (r_amod) expression_5\NN\4679549|butein-dependent|ho-1 (l_compound) ho-1_4\NN\1740|
23318726T17_23318726T30 NONE h2o2-induced_12\JJ\1740| (r_amod) death_14\NN\7296428|of|h2o2-induced|cell|and|generation (r_nmod) inhibition_10\NN\1068773|for|the|death (r_nmod) required_7\VBN\754942|addition|,|expression|was|inhibition|. (l_nsubjpass) expression_5\NN\4679549|butein-dependent|ho-1 (l_compound) ho-1_4\NN\1740|
23318726T18_23318726T21 CPR:3 butein_2\NN\1740| (r_compound) treatment_3\NN\654885|butein (r_nsubj) caused_4\VBD\1617192|furthermore|,|treatment|accumulation|and|increased|. (l_conj) increased_16\VBD\169651|activity (l_dobj) activity_19\NN\30358|the|promoter|elements (l_nmod) elements_23\NNS\11524662|of|antioxidant|response|ares
23318726T18_23318726T22 CPR:3 butein_2\NN\1740| (r_compound) treatment_3\NN\654885|butein (r_nsubj) caused_4\VBD\1617192|furthermore|,|treatment|accumulation|and|increased|. (l_conj) increased_16\VBD\169651|activity (l_dobj) activity_19\NN\30358|the|promoter|elements (l_nmod) elements_23\NNS\11524662|of|antioxidant|response|ares (l_appos) ares_25\NNS\13600404|(|)
23318726T18_23318726T31 CPR:3 butein_2\NN\1740| (r_compound) treatment_3\NN\654885|butein (r_nsubj) caused_4\VBD\1617192|furthermore|,|treatment|accumulation|and|increased|. (l_dobj) accumulation_6\NN\13497135|nuclear|factor (l_nmod) factor_10\NN\7326557|of|nuclear|factor-e2-related|2|nrf2 (l_nummod) 2_11\CD\13741022|
23318726T18_23318726T32 CPR:3 butein_2\NN\1740| (r_compound) treatment_3\NN\654885|butein (r_nsubj) caused_4\VBD\1617192|furthermore|,|treatment|accumulation|and|increased|. (l_dobj) accumulation_6\NN\13497135|nuclear|factor (l_nmod) factor_10\NN\7326557|of|nuclear|factor-e2-related|2|nrf2 (l_appos) nrf2_13\NN\1740|(|)
23318726T2_23318726T23 NONE nh2-terminal_7\JJ\1740| (r_amod) kinase_8\NN\14732946|c-jun|nh2-terminal|jnk
23318726T2_23318726T24 NONE nh2-terminal_7\JJ\1740| (r_amod) kinase_8\NN\14732946|c-jun|nh2-terminal|jnk (l_appos) jnk_10\NN\1740|(|)
23318726T2_23318726T25 NONE nh2-terminal_7\JJ\1740| (r_amod) kinase_8\NN\14732946|c-jun|nh2-terminal|jnk (r_compound) inhibitor_12\NN\20090|with|a|kinase (r_nmod) treatment_0\NN\654885|cells|inhibitor (r_nsubj) reduced_14\VBD\441445|treatment|also|expression|,|and|led|. (l_dobj) expression_17\NN\4679549|butein-induced|ho-1 (l_compound) ho-1_16\NN\1740|
23318726T2_23318726T26 NONE nh2-terminal_7\JJ\1740| (r_amod) kinase_8\NN\14732946|c-jun|nh2-terminal|jnk (r_compound) inhibitor_12\NN\20090|with|a|kinase (r_nmod) treatment_0\NN\654885|cells|inhibitor (r_nsubj) reduced_14\VBD\441445|treatment|also|expression|,|and|led|. (l_conj) led_22\VBD\1752884|treatment|phosphorylation (l_nmod) phosphorylation_26\NN\1740|to|increased|jnk (l_compound) jnk_25\NN\1740|
23318726T3_23318726T23 NONE butein-induced_15\JJ\1740| (r_amod) expression_17\NN\4679549|butein-induced|ho-1 (r_dobj) reduced_14\VBD\441445|treatment|also|expression|,|and|led|. (l_nsubj) treatment_0\NN\654885|cells|inhibitor (l_nmod) inhibitor_12\NN\20090|with|a|kinase (l_compound) kinase_8\NN\14732946|c-jun|nh2-terminal|jnk
23318726T3_23318726T24 NONE butein-induced_15\JJ\1740| (r_amod) expression_17\NN\4679549|butein-induced|ho-1 (r_dobj) reduced_14\VBD\441445|treatment|also|expression|,|and|led|. (l_nsubj) treatment_0\NN\654885|cells|inhibitor (l_nmod) inhibitor_12\NN\20090|with|a|kinase (l_compound) kinase_8\NN\14732946|c-jun|nh2-terminal|jnk (l_appos) jnk_10\NN\1740|(|)
23318726T3_23318726T25 CPR:3 butein-induced_15\JJ\1740| (r_amod) expression_17\NN\4679549|butein-induced|ho-1 (l_compound) ho-1_16\NN\1740|
23318726T3_23318726T26 NONE butein-induced_15\JJ\1740| (r_amod) expression_17\NN\4679549|butein-induced|ho-1 (r_dobj) reduced_14\VBD\441445|treatment|also|expression|,|and|led|. (l_conj) led_22\VBD\1752884|treatment|phosphorylation (l_nmod) phosphorylation_26\NN\1740|to|increased|jnk (l_compound) jnk_25\NN\1740|
23318726T4_23318726T23 NONE butein_20\NN\1740| (r_compound) treatment_21\NN\654885|butein (r_nsubj) led_22\VBD\1752884|treatment|phosphorylation (r_conj) reduced_14\VBD\441445|treatment|also|expression|,|and|led|. (l_nsubj) treatment_0\NN\654885|cells|inhibitor (l_nmod) inhibitor_12\NN\20090|with|a|kinase (l_compound) kinase_8\NN\14732946|c-jun|nh2-terminal|jnk
23318726T4_23318726T24 NONE butein_20\NN\1740| (r_compound) treatment_21\NN\654885|butein (r_nsubj) led_22\VBD\1752884|treatment|phosphorylation (r_conj) reduced_14\VBD\441445|treatment|also|expression|,|and|led|. (l_nsubj) treatment_0\NN\654885|cells|inhibitor (l_nmod) inhibitor_12\NN\20090|with|a|kinase (l_compound) kinase_8\NN\14732946|c-jun|nh2-terminal|jnk (l_appos) jnk_10\NN\1740|(|)
23318726T4_23318726T25 NONE butein_20\NN\1740| (r_compound) treatment_21\NN\654885|butein (r_nsubj) led_22\VBD\1752884|treatment|phosphorylation (r_conj) reduced_14\VBD\441445|treatment|also|expression|,|and|led|. (l_dobj) expression_17\NN\4679549|butein-induced|ho-1 (l_compound) ho-1_16\NN\1740|
23318726T4_23318726T26 CPR:3 butein_20\NN\1740| (r_compound) treatment_21\NN\654885|butein (r_nsubj) led_22\VBD\1752884|treatment|phosphorylation (l_nmod) phosphorylation_26\NN\1740|to|increased|jnk (l_compound) jnk_25\NN\1740|
14613270
14613270T1_14613270T2 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) neoepitope_30\NN\1740|col2|-|3/4c(long|mono|)|c2c|reflecting (l_dep) reflecting_35\VBG\923793|(|cleavage|) (l_dobj) cleavage_37\NN\24720|collagenase|cii (l_compound) collagenase_36\NN\14732946|
14613270T1_14613270T3 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) neoepitope_30\NN\1740|col2|-|3/4c(long|mono|)|c2c|reflecting (l_dep) reflecting_35\VBG\923793|(|cleavage|) (l_dobj) cleavage_37\NN\24720|collagenase|cii (l_nmod) cii_40\NN\1740|of|cartilage
14613270T1_14613270T5 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) c-propeptide_43\NN\1740|procollagen (l_nmod) procollagen_47\NN\1740|of|type|ii|piicp|marker
14613270T1_14613270T6 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) c-propeptide_43\NN\1740|procollagen (l_nmod) procollagen_47\NN\1740|of|type|ii|piicp|marker (l_appos) piicp_49\NN\1740|(|)
14613270T1_14613270T7 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) epitope_66\NN\8622950|the|846|aggrecan (l_nmod) aggrecan_68\NN\1740|of|turnover
14613270T1_14613270T36 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope
14613270T1_14613270T37 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_appos) tnfalpha_8\NN\1740|(|)
14613270T1_14613270T38 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) interleukin-10_11\NN\1740|il-10
14613270T1_14613270T39 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) interleukin-10_11\NN\1740|il-10 (l_appos) il-10_13\NN\1740|(|)
14613270T1_14613270T40 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) metalloproteinase_17\NN\1740|matrix|1|mmp-1 (l_nummod) 1_18\CD\13741022|
14613270T1_14613270T41 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) metalloproteinase_17\NN\1740|matrix|1|mmp-1 (l_appos) mmp-1_20\NN\1740|(|)
14613270T1_14613270T42 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) mmp-3_23\NN\1740|
14613270T1_14613270T43 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) neoepitope_30\NN\1740|col2|-|3/4c(long|mono|)|c2c|reflecting (l_compound) 3/4c(long_27\NN\1740|
14613270T1_14613270T44 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) neoepitope_30\NN\1740|col2|-|3/4c(long|mono|)|c2c|reflecting
14613270T1_14613270T45 NONE sulfate_58\NN\15010703|keratan|ks (r_conj) alpha_6\NN\6828818|of|tumor|necrosis|factor|tnfalpha|,|interleukin-10|,|metalloproteinase|,|mmp-3|,|neoepitope|,|c-propeptide|,|sulfate|,|and|epitope (l_conj) neoepitope_30\NN\1740|col2|-|3/4c(long|mono|)|c2c|reflecting (l_appos) c2c_32\NN\1740|(|)
22902307
19683471
19683471T3_19683471T27 NONE serine_18\NN\14601829| (r_compound) phosphorylation_19\NN\1740|substrates|serine (l_compound) substrates_14\NNS\19613|insulin|receptor|irs (l_appos) irs_16\NNS\8337324|(|)
19683471T3_19683471T28 NONE serine_18\NN\14601829| (r_compound) phosphorylation_19\NN\1740|substrates|serine (r_conj) kinases_10\NNS\14732946|of|stress-regulated|serine|and|phosphorylation (r_nmod) role_6\NN\719494|kinases|. (r_dep) mechanisms_1\NNS\13446390|cellular|resistance|:|role (l_nmod) resistance_4\NN\37396|of|insulin (l_compound) insulin_3\NN\5407119|
19683471T3_19683471T29 NONE serine_18\NN\14601829| (r_compound) phosphorylation_19\NN\1740|substrates|serine (r_conj) kinases_10\NNS\14732946|of|stress-regulated|serine|and|phosphorylation
19683471T3_19683471T30 NONE serine_18\NN\14601829| (r_compound) phosphorylation_19\NN\1740|substrates|serine (l_compound) substrates_14\NNS\19613|insulin|receptor|irs
19683471T4_19683471T27 NONE serine_9\NN\14601829| (r_compound) kinases_10\NNS\14732946|of|stress-regulated|serine|and|phosphorylation (l_conj) phosphorylation_19\NN\1740|substrates|serine (l_compound) substrates_14\NNS\19613|insulin|receptor|irs (l_appos) irs_16\NNS\8337324|(|)
19683471T4_19683471T28 NONE serine_9\NN\14601829| (r_compound) kinases_10\NNS\14732946|of|stress-regulated|serine|and|phosphorylation (r_nmod) role_6\NN\719494|kinases|. (r_dep) mechanisms_1\NNS\13446390|cellular|resistance|:|role (l_nmod) resistance_4\NN\37396|of|insulin (l_compound) insulin_3\NN\5407119|
19683471T4_19683471T29 NONE serine_9\NN\14601829| (r_compound) kinases_10\NNS\14732946|of|stress-regulated|serine|and|phosphorylation
19683471T4_19683471T30 NONE serine_9\NN\14601829| (r_compound) kinases_10\NNS\14732946|of|stress-regulated|serine|and|phosphorylation (l_conj) phosphorylation_19\NN\1740|substrates|serine (l_compound) substrates_14\NNS\19613|insulin|receptor|irs
19683471T1_19683471T5 NONE serine_6\NN\14601829| (r_compound) phosphorylation_7\NN\1740|substrates|serine (l_compound) substrates_2\NNS\19613|insulin|receptor|irs
19683471T1_19683471T6 NONE serine_6\NN\14601829| (r_compound) phosphorylation_7\NN\1740|substrates|serine (r_nsubj) mechanism_13\NN\13446390|phosphorylation|is|a|time-controlled|physiological|feedback|signaling|hijacked|. (l_nmod) signaling_16\NN\33020|in|insulin (l_compound) insulin_15\NN\5407119|
19683471T1_19683471T7 NONE serine_6\NN\14601829| (r_compound) phosphorylation_7\NN\1740|substrates|serine (r_nsubj) mechanism_13\NN\13446390|phosphorylation|is|a|time-controlled|physiological|feedback|signaling|hijacked|. (l_acl:relcl) hijacked_19\VBN\1213614|that|is|stresses|promote (l_xcomp) promote_26\VB\2556126|to|resistance (l_dobj) resistance_28\NN\37396|insulin (l_compound) insulin_27\NN\5407119|
19683471T1_19683471T14 NONE serine_6\NN\14601829| (r_compound) phosphorylation_7\NN\1740|substrates|serine (l_compound) substrates_2\NNS\19613|insulin|receptor|irs (l_appos) irs_4\NNS\8337324|(|)
19683471T2_19683471T8 NONE serine_25\NN\14601829| (r_compound) phosphorylation_26\NN\1740|uncontrolled|irs|serine (r_dobj) induce_22\VBP\1627355|kinases|phosphorylation|. (l_nsubj) kinases_0\NNS\14732946|,|ikkbeta
19683471T2_19683471T9 NONE serine_25\NN\14601829| (r_compound) phosphorylation_26\NN\1740|uncontrolled|irs|serine (r_dobj) induce_22\VBP\1627355|kinases|phosphorylation|. (l_nsubj) kinases_0\NNS\14732946|,|ikkbeta (l_nmod) ikkbeta_3\NN\1740|including|,|jnk|,|erk|,|mtor|,|and|s6|k|,|activated
19683471T2_19683471T10 NONE serine_25\NN\14601829| (r_compound) phosphorylation_26\NN\1740|uncontrolled|irs|serine (r_dobj) induce_22\VBP\1627355|kinases|phosphorylation|. (l_nsubj) kinases_0\NNS\14732946|,|ikkbeta (l_nmod) ikkbeta_3\NN\1740|including|,|jnk|,|erk|,|mtor|,|and|s6|k|,|activated (l_conj) jnk_5\NN\1740|
19683471T2_19683471T11 NONE serine_25\NN\14601829| (r_compound) phosphorylation_26\NN\1740|uncontrolled|irs|serine (r_dobj) induce_22\VBP\1627355|kinases|phosphorylation|. (l_nsubj) kinases_0\NNS\14732946|,|ikkbeta (l_nmod) ikkbeta_3\NN\1740|including|,|jnk|,|erk|,|mtor|,|and|s6|k|,|activated (l_conj) erk_7\NN\1740|
19683471T2_19683471T12 NONE serine_25\NN\14601829| (r_compound) phosphorylation_26\NN\1740|uncontrolled|irs|serine (r_dobj) induce_22\VBP\1627355|kinases|phosphorylation|. (l_nsubj) kinases_0\NNS\14732946|,|ikkbeta (l_nmod) ikkbeta_3\NN\1740|including|,|jnk|,|erk|,|mtor|,|and|s6|k|,|activated (l_conj) mtor_9\NN\1740|
19683471T2_19683471T13 NONE serine_25\NN\14601829| (r_compound) phosphorylation_26\NN\1740|uncontrolled|irs|serine (r_dobj) induce_22\VBP\1627355|kinases|phosphorylation|. (l_nsubj) kinases_0\NNS\14732946|,|ikkbeta (l_nmod) ikkbeta_3\NN\1740|including|,|jnk|,|erk|,|mtor|,|and|s6|k|,|activated (l_conj) k_13\NN\13608598|
19683471T2_19683471T15 NONE serine_25\NN\14601829| (r_compound) phosphorylation_26\NN\1740|uncontrolled|irs|serine (r_dobj) induce_22\VBP\1627355|kinases|phosphorylation|. (l_nsubj) kinases_0\NNS\14732946|,|ikkbeta (l_nmod) ikkbeta_3\NN\1740|including|,|jnk|,|erk|,|mtor|,|and|s6|k|,|activated (l_acl) activated_15\VBN\1641914|inducers (l_nmod) inducers_18\NNS\14778436|by|the|resistance (l_nmod) resistance_21\NN\37396|of|insulin (l_compound) insulin_20\NN\5407119|
19683471T2_19683471T16 NONE serine_25\NN\14601829| (r_compound) phosphorylation_26\NN\1740|uncontrolled|irs|serine (l_compound) irs_24\NN\8337324|
19780818
19780818T5_19780818T27 NONE potassium_1\NN\14625458| (r_compound) subunit_3\NN\13604718|the|potassium|channel|kvbeta3 (l_dep) kvbeta3_4\NN\1740|
19780818T5_19780818T28 NONE potassium_1\NN\14625458| (r_compound) subunit_3\NN\13604718|the|potassium|channel|kvbeta3 (r_nsubj) interacts_5\VBZ\2367363|subunit|pannexin|and|attenuates|. (l_nmod) pannexin_7\NN\1740|with|1 (l_nummod) 1_8\CD\13741022|
19780818T3_19780818T13 NONE potassium_8\NN\14625458| (r_compound) channel_9\NN\6251781|potassium (r_compound) subunit_10\NN\13604718|protein|is|the|channel (l_nsubj) protein_3\NN\14944888|a|candidate|regulatory|panx1 (l_nmod) panx1_5\NN\1740|of
19780818T3_19780818T14 NONE potassium_8\NN\14625458| (r_compound) channel_9\NN\6251781|potassium (r_compound) subunit_10\NN\13604718|protein|is|the|channel (r_compound) kvbeta3_11\NN\1740|subunit|,|identified|.
19780818T4_19780818T20 NONE potassium_10\NN\14625458| (r_compound) channels_11\NNS\6251781|of|inactivating|potassium (r_nmod) inactivation_5\NN\13518963|channels (r_dobj) accelerate_4\VB\226566|to|inactivation|conditions (r_xcomp) known_2\VBN\2110220|kvbeta3|is|accelerate|. (l_nsubjpass) kvbeta3_0\NN\1740|
19780818T4_19780818T21 NONE potassium_10\NN\14625458| (r_compound) channels_11\NNS\6251781|of|inactivating|potassium
19780818T1_19780818T7 NONE carbenoxolone_6\NN\1740|and|probenecid (r_dep) blockers_5\NNS\10101634|the|panx1|channel|carbenoxolone (r_nsubj) effective_11\JJ\1740|furthermore|,|blockers|were|less|inhibiting|co-expressed|. (l_advcl) inhibiting_13\VBG\2510337|in|currents (l_dobj) currents_15\NNS\11449002|panx1 (l_compound) panx1_14\NN\1740|
19780818T1_19780818T8 NONE carbenoxolone_6\NN\1740|and|probenecid (r_dep) blockers_5\NNS\10101634|the|panx1|channel|carbenoxolone (r_nsubj) effective_11\JJ\1740|furthermore|,|blockers|were|less|inhibiting|co-expressed|. (l_advcl) co-expressed_19\VBN\1740|when|kvbeta3|was (l_nsubjpass) kvbeta3_17\NN\1740|
19780818T1_19780818T26 CPR:4 carbenoxolone_6\NN\1740|and|probenecid (r_dep) blockers_5\NNS\10101634|the|panx1|channel|carbenoxolone (l_compound) panx1_3\NN\1740|
19780818T2_19780818T7 NONE probenecid_8\NN\3740161| (r_conj) carbenoxolone_6\NN\1740|and|probenecid (r_dep) blockers_5\NNS\10101634|the|panx1|channel|carbenoxolone (r_nsubj) effective_11\JJ\1740|furthermore|,|blockers|were|less|inhibiting|co-expressed|. (l_advcl) inhibiting_13\VBG\2510337|in|currents (l_dobj) currents_15\NNS\11449002|panx1 (l_compound) panx1_14\NN\1740|
19780818T2_19780818T8 NONE probenecid_8\NN\3740161| (r_conj) carbenoxolone_6\NN\1740|and|probenecid (r_dep) blockers_5\NNS\10101634|the|panx1|channel|carbenoxolone (r_nsubj) effective_11\JJ\1740|furthermore|,|blockers|were|less|inhibiting|co-expressed|. (l_advcl) co-expressed_19\VBN\1740|when|kvbeta3|was (l_nsubjpass) kvbeta3_17\NN\1740|
19780818T2_19780818T26 CPR:4 probenecid_8\NN\3740161| (r_conj) carbenoxolone_6\NN\1740|and|probenecid (r_dep) blockers_5\NNS\10101634|the|panx1|channel|carbenoxolone (l_compound) panx1_3\NN\1740|
23435367
23435367T1_23435367T9 CPR:9 steroid_20\NN\14727670| (r_compound) hormone_21\NN\5404728|steroid (r_compound) synthesis_22\NN\13446390|including|hormone|tissues (r_nmod) processes_17\NNS\407535|in|various|metabolic|,|synthesis (r_nmod) involved_13\VBN\2676054|that|is|processes (r_acl:relcl) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_nummod) 1_1\CD\13741022|
23435367T1_23435367T10 CPR:9 steroid_20\NN\14727670| (r_compound) hormone_21\NN\5404728|steroid (r_compound) synthesis_22\NN\13446390|including|hormone|tissues (r_nmod) processes_17\NNS\407535|in|various|metabolic|,|synthesis (r_nmod) involved_13\VBN\2676054|that|is|processes (r_acl:relcl) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_appos) fdx1_3\NN\1740|(|;|adrenodoxin|)
23435367T1_23435367T11 CPR:9 steroid_20\NN\14727670| (r_compound) hormone_21\NN\5404728|steroid (r_compound) synthesis_22\NN\13446390|including|hormone|tissues (r_nmod) processes_17\NNS\407535|in|various|metabolic|,|synthesis (r_nmod) involved_13\VBN\2676054|that|is|processes (r_acl:relcl) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_appos) fdx1_3\NN\1740|(|;|adrenodoxin|) (l_appos) adrenodoxin_5\NN\1740|
23435367T2_23435367T9 CPR:9 hormone_21\NN\5404728|steroid (r_compound) synthesis_22\NN\13446390|including|hormone|tissues (r_nmod) processes_17\NNS\407535|in|various|metabolic|,|synthesis (r_nmod) involved_13\VBN\2676054|that|is|processes (r_acl:relcl) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_nummod) 1_1\CD\13741022|
23435367T2_23435367T10 CPR:9 hormone_21\NN\5404728|steroid (r_compound) synthesis_22\NN\13446390|including|hormone|tissues (r_nmod) processes_17\NNS\407535|in|various|metabolic|,|synthesis (r_nmod) involved_13\VBN\2676054|that|is|processes (r_acl:relcl) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_appos) fdx1_3\NN\1740|(|;|adrenodoxin|)
23435367T2_23435367T11 CPR:9 hormone_21\NN\5404728|steroid (r_compound) synthesis_22\NN\13446390|including|hormone|tissues (r_nmod) processes_17\NNS\407535|in|various|metabolic|,|synthesis (r_nmod) involved_13\VBN\2676054|that|is|processes (r_acl:relcl) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_appos) fdx1_3\NN\1740|(|;|adrenodoxin|) (l_appos) adrenodoxin_5\NN\1740|
23435367T3_23435367T9 NONE iron-sulfur_9\JJ\1740| (r_amod) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_nummod) 1_1\CD\13741022|
23435367T3_23435367T10 NONE iron-sulfur_9\JJ\1740| (r_amod) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_appos) fdx1_3\NN\1740|(|;|adrenodoxin|)
23435367T3_23435367T11 NONE iron-sulfur_9\JJ\1740| (r_amod) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_appos) fdx1_3\NN\1740|(|;|adrenodoxin|) (l_appos) adrenodoxin_5\NN\1740|
23435367T4_23435367T9 NONE iron-sulfur_9\JJ\1740| (r_amod) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_nummod) 1_1\CD\13741022|
23435367T4_23435367T10 NONE iron-sulfur_9\JJ\1740| (r_amod) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_appos) fdx1_3\NN\1740|(|;|adrenodoxin|)
23435367T4_23435367T11 NONE iron-sulfur_9\JJ\1740| (r_amod) protein_10\NN\14944888|ferredoxin|is|an|iron-sulfur|involved|. (l_nsubj) ferredoxin_0\NN\1740|1|fdx1 (l_appos) fdx1_3\NN\1740|(|;|adrenodoxin|) (l_appos) adrenodoxin_5\NN\1740|
23435367T5_23435367T19 CPR:3 8br-camp_16\NN\1740| (r_compound) treatment_17\NN\654885|8br-camp (r_conj) family_14\NN\8189659|by|the|nr5a|and|treatment (r_nmod) activated_10\VBN\1641914|that|transcription|was|synergistically|family|sites (l_nsubjpass) transcription_5\NN\6349220|fdx1 (l_nmod) fdx1_7\NN\1740|of
23435367T5_23435367T20 NONE 8br-camp_16\NN\1740| (r_compound) treatment_17\NN\654885|8br-camp (r_conj) family_14\NN\8189659|by|the|nr5a|and|treatment (l_compound) nr5a_13\NN\1740|
23435367T5_23435367T21 NONE 8br-camp_16\NN\1740| (r_compound) treatment_17\NN\654885|8br-camp (r_conj) family_14\NN\8189659|by|the|nr5a|and|treatment (r_nmod) activated_10\VBN\1641914|that|transcription|was|synergistically|family|sites (l_nmod) sites_22\NNS\8673395|through|two|sf-1|binding|and|sequence (l_compound) sf-1_20\NN\1740|
23435367T5_23435367T22 NONE 8br-camp_16\NN\1740| (r_compound) treatment_17\NN\654885|8br-camp (r_conj) family_14\NN\8189659|by|the|nr5a|and|treatment (r_nmod) activated_10\VBN\1641914|that|transcription|was|synergistically|family|sites (l_nmod) sites_22\NNS\8673395|through|two|sf-1|binding|and|sequence (l_conj) sequence_26\NN\8457976|a|cre-like|line (l_amod) cre-like_25\JJ\1740|
23435367T6_23435367T23 NONE progesterone_4\NN\14747338| (r_compound) production_5\NN\30358|progesterone|cells (r_dobj) attenuated_3\VBD\224901|knockdown|production|. (l_nsubj) knockdown_0\NN\1173038|fdx1 (l_nmod) fdx1_2\NN\1740|of
23435367T7_23435367T24 CPR:3 camp_13\NN\3763727| (r_compound) signaling_14\NN\33020|camp (r_conj) family_11\NN\8189659|by|the|nr5a|and|signaling (r_nmod) regulated_7\VBN\296178|transcription|is|family|,|and|participates (l_nsubjpass) transcription_3\NN\6349220|fdx1 (l_nmod) fdx1_5\NN\1740|of
23435367T7_23435367T25 NONE camp_13\NN\3763727| (r_compound) signaling_14\NN\33020|camp (r_conj) family_11\NN\8189659|by|the|nr5a|and|signaling (l_compound) nr5a_10\NN\1740|
23435367T8_23435367T24 CPR:9 steroid_19\NN\14727670| (r_compound) production_21\NN\30358|in|steroid|hormone|cells (r_nmod) participates_17\VBZ\2367363|production (r_conj) regulated_7\VBN\296178|transcription|is|family|,|and|participates (l_nsubjpass) transcription_3\NN\6349220|fdx1 (l_nmod) fdx1_5\NN\1740|of
23435367T8_23435367T25 NONE steroid_19\NN\14727670| (r_compound) production_21\NN\30358|in|steroid|hormone|cells (r_nmod) participates_17\VBZ\2367363|production (r_conj) regulated_7\VBN\296178|transcription|is|family|,|and|participates (l_nmod) family_11\NN\8189659|by|the|nr5a|and|signaling (l_compound) nr5a_10\NN\1740|
23500776
23500776T12_23500776T22 CPR:3 hydrocarbons_19\NNS\14727670|to|polycyclic|aromatic (r_nmod) exposed_15\VBN\2110927|orally|hydrocarbons (r_acl) rats_13\NNS\2329401|of|exposed (r_nmod) lymphocytes_6\NNS\5449959|in|peripheral|blood|,|liver|rats (r_nmod) induction_2\NN\7450842|erod|activity|lymphocytes|. (l_compound) erod_0\NN\1740|
23500776T3_23500776T19 CPR:3 hydrocarbons_21\NNS\14727670|to|planar|halogenated|aromatic|phh (r_nmod) exposure_14\NN\5042871|under|repeated|oral|hydrocarbons (r_nmod) induction_10\NN\7450842|of|multi-matrix|p450|activity|exposure (l_compound) p450_8\NN\1740|cytochrome
23500776T5_23500776T19 CPR:3 pah_25\NN\1740| (r_appos) phh_23\NNS\1740|(|,|pah|) (r_appos) hydrocarbons_21\NNS\14727670|to|planar|halogenated|aromatic|phh (r_nmod) exposure_14\NN\5042871|under|repeated|oral|hydrocarbons (r_nmod) induction_10\NN\7450842|of|multi-matrix|p450|activity|exposure (l_compound) p450_8\NN\1740|cytochrome
23500776T9_23500776T16 NONE erod_0\NN\1740|
23500776T9_23500776T17 NONE erod_0\NN\1740| (r_compound) activity_1\NN\30358|erod|,|reflecting|, (l_acl) reflecting_3\VBG\923793|activities (l_dobj) activities_9\NNS\30358|exclusively|cyp1a1 (l_compound) cyp1a1_6\NN\1740|and|cyp1b1
23500776T9_23500776T18 NONE erod_0\NN\1740| (r_compound) activity_1\NN\30358|erod|,|reflecting|, (l_acl) reflecting_3\VBG\923793|activities (l_dobj) activities_9\NNS\30358|exclusively|cyp1a1 (l_compound) cyp1a1_6\NN\1740|and|cyp1b1 (l_conj) cyp1b1_8\NN\1740|
23500776T10_23500776T20 NONE erod_9\NN\1740|
23500776T1_23500776T13 NONE erod_29\NN\1740|
23500776T1_23500776T14 NONE erod_29\NN\1740| (r_compound) activity_30\NN\30358|erod|liver (r_dobj) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_ccomp) found_36\VBN\2426171|which|was|represent (l_xcomp) represent_38\VB\2664769|to|% (l_dobj) %_40\NN\1740|98|activities (l_nmod) activities_45\NNS\30358|of|the|observed|erod|matrices (l_compound) erod_44\NN\1740|
23500776T1_23500776T15 NONE erod_29\NN\1740| (r_compound) activity_30\NN\30358|erod|liver (r_dobj) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_conj) evaluating_55\VBG\670261|ii|exposure (l_dobj) exposure_57\NN\5042871|oral|groups|pah (l_nmod) pah_72\NN\1740|to|cyp|inducing|and|phh (l_compound) cyp_70\NN\1740|
23500776T1_23500776T21 NONE erod_29\NN\1740| (r_compound) activity_30\NN\30358|erod|liver (r_dobj) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (r_acl) approach_23\NN\940842|as|a|sensitive|evaluating (r_nmod) considered_15\VBN\689344|that|activity|should|be|approach (l_nsubjpass) activity_10\NN\30358|erod|pbl (l_compound) erod_9\NN\1740|
23500776T2_23500776T13 NONE erod_44\NN\1740| (r_compound) activities_45\NNS\30358|of|the|observed|erod|matrices (r_nmod) %_40\NN\1740|98|activities (r_dobj) represent_38\VB\2664769|to|% (r_xcomp) found_36\VBN\2426171|which|was|represent (r_ccomp) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_dobj) activity_30\NN\30358|erod|liver (l_compound) erod_29\NN\1740|
23500776T2_23500776T14 NONE erod_44\NN\1740|
23500776T2_23500776T15 NONE erod_44\NN\1740| (r_compound) activities_45\NNS\30358|of|the|observed|erod|matrices (r_nmod) %_40\NN\1740|98|activities (r_dobj) represent_38\VB\2664769|to|% (r_xcomp) found_36\VBN\2426171|which|was|represent (r_ccomp) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_conj) evaluating_55\VBG\670261|ii|exposure (l_dobj) exposure_57\NN\5042871|oral|groups|pah (l_nmod) pah_72\NN\1740|to|cyp|inducing|and|phh (l_compound) cyp_70\NN\1740|
23500776T2_23500776T21 NONE erod_44\NN\1740| (r_compound) activities_45\NNS\30358|of|the|observed|erod|matrices (r_nmod) %_40\NN\1740|98|activities (r_dobj) represent_38\VB\2664769|to|% (r_xcomp) found_36\VBN\2426171|which|was|represent (r_ccomp) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (r_acl) approach_23\NN\940842|as|a|sensitive|evaluating (r_nmod) considered_15\VBN\689344|that|activity|should|be|approach (l_nsubjpass) activity_10\NN\30358|erod|pbl (l_compound) erod_9\NN\1740|
23500776T4_23500776T13 NONE phh_74\NN\1740| (r_conj) pah_72\NN\1740|to|cyp|inducing|and|phh (r_nmod) exposure_57\NN\5042871|oral|groups|pah (r_dobj) evaluating_55\VBG\670261|ii|exposure (r_conj) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_dobj) activity_30\NN\30358|erod|liver (l_compound) erod_29\NN\1740|
23500776T4_23500776T14 NONE phh_74\NN\1740| (r_conj) pah_72\NN\1740|to|cyp|inducing|and|phh (r_nmod) exposure_57\NN\5042871|oral|groups|pah (r_dobj) evaluating_55\VBG\670261|ii|exposure (r_conj) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_ccomp) found_36\VBN\2426171|which|was|represent (l_xcomp) represent_38\VB\2664769|to|% (l_dobj) %_40\NN\1740|98|activities (l_nmod) activities_45\NNS\30358|of|the|observed|erod|matrices (l_compound) erod_44\NN\1740|
23500776T4_23500776T15 NONE phh_74\NN\1740| (r_conj) pah_72\NN\1740|to|cyp|inducing|and|phh (l_compound) cyp_70\NN\1740|
23500776T4_23500776T21 NONE phh_74\NN\1740| (r_conj) pah_72\NN\1740|to|cyp|inducing|and|phh (r_nmod) exposure_57\NN\5042871|oral|groups|pah (r_dobj) evaluating_55\VBG\670261|ii|exposure (r_conj) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (r_acl) approach_23\NN\940842|as|a|sensitive|evaluating (r_nmod) considered_15\VBN\689344|that|activity|should|be|approach (l_nsubjpass) activity_10\NN\30358|erod|pbl (l_compound) erod_9\NN\1740|
23500776T11_23500776T13 NONE erod_9\NN\1740| (r_compound) activity_10\NN\30358|erod|pbl (r_nsubjpass) considered_15\VBN\689344|that|activity|should|be|approach (l_nmod) approach_23\NN\940842|as|a|sensitive|evaluating (l_acl) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_dobj) activity_30\NN\30358|erod|liver (l_compound) erod_29\NN\1740|
23500776T11_23500776T14 NONE erod_9\NN\1740| (r_compound) activity_10\NN\30358|erod|pbl (r_nsubjpass) considered_15\VBN\689344|that|activity|should|be|approach (l_nmod) approach_23\NN\940842|as|a|sensitive|evaluating (l_acl) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_ccomp) found_36\VBN\2426171|which|was|represent (l_xcomp) represent_38\VB\2664769|to|% (l_dobj) %_40\NN\1740|98|activities (l_nmod) activities_45\NNS\30358|of|the|observed|erod|matrices (l_compound) erod_44\NN\1740|
23500776T11_23500776T15 NONE erod_9\NN\1740| (r_compound) activity_10\NN\30358|erod|pbl (r_nsubjpass) considered_15\VBN\689344|that|activity|should|be|approach (l_nmod) approach_23\NN\940842|as|a|sensitive|evaluating (l_acl) evaluating_28\VBG\670261|for|i|activity|,|found|and|evaluating (l_conj) evaluating_55\VBG\670261|ii|exposure (l_dobj) exposure_57\NN\5042871|oral|groups|pah (l_nmod) pah_72\NN\1740|to|cyp|inducing|and|phh (l_compound) cyp_70\NN\1740|
23500776T11_23500776T21 NONE erod_9\NN\1740|
23377618
23377618T8_23377618T13 NONE glucose_8\NN\14710501| (r_conj) albumin_6\NN\14736972|of|and|glucose
23377618T8_23377618T14 NONE glucose_8\NN\14710501| (r_conj) albumin_6\NN\14736972|of|and|glucose (r_nmod) rates_4\NNS\13308999|the|production|albumin|,|as|activity|, (l_conj) activity_14\NN\30358|cyp2e1 (l_compound) cyp2e1_13\NN\1740|
22532499
22532499T8_22532499T13 NONE 2-(n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose_11\NN\1740|of|hepatocytes (l_nmod) hepatocytes_16\NNS\1740|in|tnf-α-treated|fl83b|mouse (l_amod) tnf-α-treated_13\JJ\1740|
22532499T3_22532499T10 NONE glucose_0\NN\14710501| (r_compound) test_2\NN\5798043|glucose|uptake (r_nsubj) showed_3\VBD\2137132|test|exhibits|. (l_ccomp) exhibits_13\VBZ\2632167|that|extract|activity|,|increment|hepatocytes|compared (l_nmod) hepatocytes_31\NNS\1740|in|the|insulin-resistant|fl83b|mouse (l_amod) insulin-resistant_28\JJ\1740|
22532499T3_22532499T11 NONE glucose_0\NN\14710501| (r_compound) test_2\NN\5798043|glucose|uptake (r_nsubj) showed_3\VBD\2137132|test|exhibits|. (l_ccomp) exhibits_13\VBZ\2632167|that|extract|activity|,|increment|hepatocytes|compared (l_advcl) compared_33\VBN\644583|as|group (l_nmod) group_38\NN\2137|with|the|tnf-α-treated|control (l_amod) tnf-α-treated_36\JJ\1740|
22532499T4_22532499T10 NONE glucose_16\NN\14710501| (r_compound) activity_18\NN\30358|the|highest|glucose|uptake (r_dobj) exhibits_13\VBZ\2632167|that|extract|activity|,|increment|hepatocytes|compared (l_nmod) hepatocytes_31\NNS\1740|in|the|insulin-resistant|fl83b|mouse (l_amod) insulin-resistant_28\JJ\1740|
22532499T4_22532499T11 NONE glucose_16\NN\14710501| (r_compound) activity_18\NN\30358|the|highest|glucose|uptake (r_dobj) exhibits_13\VBZ\2632167|that|extract|activity|,|increment|hepatocytes|compared (l_advcl) compared_33\VBN\644583|as|group (l_nmod) group_38\NN\2137|with|the|tnf-α-treated|control (l_amod) tnf-α-treated_36\JJ\1740|
22532499T6_22532499T12 NONE glucose_14\NN\14710501| (r_compound) improvement_16\NN\7359599|the|same|glucose|uptake|cells|pwfe (l_nmod) cells_19\NNS\3080309|in|insulin-resistant (l_amod) insulin-resistant_18\JJ\1740|
22532499T7_22532499T9 NONE vescalagin_3\NN\1740| (r_nsubj) component_7\NN\5867413|that|vescalagin|is|an|active|pwfe|alleviate (l_acl:relcl) alleviate_12\VB\205885|that|may|resistance (l_dobj) resistance_15\NN\37396|the|insulin|hepatocytes (l_compound) insulin_14\NN\5407119|
16547651
16547651T1_16547651T19 NONE acetohydroxyacid_0\JJ\1740| (r_compound) synthase_1\NN\1740|acetohydroxyacid|ahas
16547651T1_16547651T21 NONE acetohydroxyacid_0\JJ\1740| (r_compound) synthase_1\NN\1740|acetohydroxyacid|ahas (r_compound) inhibitors_5\NNS\20090|synthase (r_nsubj) interfere_6\VBP\2451370|inhibitors|biosynthesis|inhibiting|. (l_advcl) inhibiting_13\VBG\2510337|by|ahas (l_dobj) ahas_14\NNS\1740|
16547651T1_16547651T25 NONE acetohydroxyacid_0\JJ\1740| (r_compound) synthase_1\NN\1740|acetohydroxyacid|ahas (l_appos) ahas_3\NN\1740|(|)
16547651T13_16547651T19 NONE acid_10\NN\14818238|amino (r_compound) biosynthesis_11\NN\13565379|with|branched-chain|acid (r_nmod) interfere_6\VBP\2451370|inhibitors|biosynthesis|inhibiting|. (l_nsubj) inhibitors_5\NNS\20090|synthase (l_compound) synthase_1\NN\1740|acetohydroxyacid|ahas
16547651T13_16547651T21 NONE acid_10\NN\14818238|amino (r_compound) biosynthesis_11\NN\13565379|with|branched-chain|acid (r_nmod) interfere_6\VBP\2451370|inhibitors|biosynthesis|inhibiting|. (l_advcl) inhibiting_13\VBG\2510337|by|ahas (l_dobj) ahas_14\NNS\1740|
16547651T13_16547651T25 NONE acid_10\NN\14818238|amino (r_compound) biosynthesis_11\NN\13565379|with|branched-chain|acid (r_nmod) interfere_6\VBP\2451370|inhibitors|biosynthesis|inhibiting|. (l_nsubj) inhibitors_5\NNS\20090|synthase (l_compound) synthase_1\NN\1740|acetohydroxyacid|ahas (l_appos) ahas_3\NN\1740|(|)
16547651T6_16547651T22 CPR:4 glyphosate_0\NN\1740| (r_nsubj) affects_1\VBZ\126264|glyphosate|biosynthesis|inhibiting|. (l_advcl) inhibiting_7\VBG\2510337|by|synthase (l_dobj) synthase_9\NN\1740|5-enolpyruvylshikimate-3-phosphate|epsps
16547651T6_16547651T23 CPR:4 glyphosate_0\NN\1740| (r_nsubj) affects_1\VBZ\126264|glyphosate|biosynthesis|inhibiting|. (l_advcl) inhibiting_7\VBG\2510337|by|synthase (l_dobj) synthase_9\NN\1740|5-enolpyruvylshikimate-3-phosphate|epsps (l_appos) epsps_11\NN\1740|(|)
16547651T7_16547651T22 NONE acid_4\NN\14818238| (r_compound) biosynthesis_5\NN\13565379|aromatic|amino|acid (r_dobj) affects_1\VBZ\126264|glyphosate|biosynthesis|inhibiting|. (l_advcl) inhibiting_7\VBG\2510337|by|synthase (l_dobj) synthase_9\NN\1740|5-enolpyruvylshikimate-3-phosphate|epsps
16547651T7_16547651T23 NONE acid_4\NN\14818238| (r_compound) biosynthesis_5\NN\13565379|aromatic|amino|acid (r_dobj) affects_1\VBZ\126264|glyphosate|biosynthesis|inhibiting|. (l_advcl) inhibiting_7\VBG\2510337|by|synthase (l_dobj) synthase_9\NN\1740|5-enolpyruvylshikimate-3-phosphate|epsps (l_appos) epsps_11\NN\1740|(|)
16547651T8_16547651T22 NONE 5-enolpyruvylshikimate-3-phosphate_8\NN\1740| (r_compound) synthase_9\NN\1740|5-enolpyruvylshikimate-3-phosphate|epsps
16547651T8_16547651T23 NONE 5-enolpyruvylshikimate-3-phosphate_8\NN\1740| (r_compound) synthase_9\NN\1740|5-enolpyruvylshikimate-3-phosphate|epsps (l_appos) epsps_11\NN\1740|(|)
16547651T9_16547651T24 CPR:4 glufosinate_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|glufosinate|synthetase|and|blocks|. (l_dobj) synthetase_3\NN\1740|glutamine
16547651T10_16547651T24 NONE glutamine_2\NN\14601829| (r_compound) synthetase_3\NN\1740|glutamine
16547651T11_16547651T24 CPR:9 glutamine_8\NN\14601829|of (r_nmod) biosynthesis_6\NN\13565379|glutamine (r_dobj) blocks_5\VBZ\1476483|biosynthesis (r_conj) inhibits_1\VBZ\2510337|glufosinate|synthetase|and|blocks|. (l_dobj) synthetase_3\NN\1740|glutamine
16547651T12_16547651T28 NONE imidazolinone-tolerant_0\NN\1740| (r_amod) crops_1\NNS\914632|imidazolinone-tolerant (r_nsubjpass) commercialized_4\VBN\1164273|crops|have|been|based|. (l_prep) based_5\VBN\2694933|variants (l_nmod) variants_10\NNS\7366289|on|these|ahas|gene (l_compound) ahas_8\NN\1740|
16547651T14_16547651T29 NONE glyphosate_21\NN\1740|to (r_nmod) tolerance_19\NN\5032565|for|target-based|glyphosate (r_nmod) transform_15\VB\126264|to|plants|tolerance (r_xcomp) used_13\VBN\1156834|gene|have|been|transform|. (l_nsubjpass) gene_4\NN\8459252|a|modified|maize|epsps|and|gene|sp. (l_compound) epsps_3\NNS\1740|
16547651T14_16547651T30 NONE glyphosate_21\NN\1740|to (r_nmod) tolerance_19\NN\5032565|for|target-based|glyphosate (r_nmod) transform_15\VB\126264|to|plants|tolerance (r_xcomp) used_13\VBN\1156834|gene|have|been|transform|. (l_nsubjpass) gene_4\NN\8459252|a|modified|maize|epsps|and|gene|sp. (l_conj) gene_7\NN\8459252|cp4-epsps (l_compound) cp4-epsps_6\NN\1740|
16547651T15_16547651T31 NONE glyphosate_13\NN\1740| (r_compound) oxidoreductase_14\NN\14732946|glyphosate (r_dobj) encode_12\VB\115157|to|oxidoreductase|detoxify (r_xcomp) employed_10\VBN\1740|gene|has|also|been|encode|. (l_nsubjpass) gene_2\NN\8459252|a|gox|isolated (l_compound) gox_1\NN\1740|
16547651T15_16547651T32 NONE glyphosate_13\NN\1740| (r_compound) oxidoreductase_14\NN\14732946|glyphosate
16547651T16_16547651T31 NONE glyphosate_17\NN\1740| (r_dobj) detoxify_16\VB\173338|to|glyphosate|plants (r_advcl) encode_12\VB\115157|to|oxidoreductase|detoxify (r_xcomp) employed_10\VBN\1740|gene|has|also|been|encode|. (l_nsubjpass) gene_2\NN\8459252|a|gox|isolated (l_compound) gox_1\NN\1740|
16547651T16_16547651T32 NONE glyphosate_17\NN\1740| (r_dobj) detoxify_16\VB\173338|to|glyphosate|plants (r_advcl) encode_12\VB\115157|to|oxidoreductase|detoxify (l_dobj) oxidoreductase_14\NN\14732946|glyphosate
16547651T17_16547651T33 NONE glyphosate-tolerant_0\NN\1740| (r_compound) crops_1\NNS\914632|glyphosate-tolerant|transgene (l_nmod) transgene_4\NN\5436752|with|epsps|alone|or|epsps (l_compound) epsps_3\NNP\1740|
16547651T17_16547651T34 NONE glyphosate-tolerant_0\NN\1740| (r_compound) crops_1\NNS\914632|glyphosate-tolerant|transgene (l_nmod) transgene_4\NN\5436752|with|epsps|alone|or|epsps (l_conj) epsps_8\NNS\1740|both|and|transgenes
16547651T17_16547651T35 NONE glyphosate-tolerant_0\NN\1740| (r_compound) crops_1\NNS\914632|glyphosate-tolerant|transgene (l_nmod) transgene_4\NN\5436752|with|epsps|alone|or|epsps (l_conj) epsps_8\NNS\1740|both|and|transgenes (l_conj) transgenes_11\NNS\5436752|gox (l_compound) gox_10\NNP\1740|
16547651T2_16547651T20 NONE phosphinothricin_23\NN\1740| (r_compound) n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify
16547651T2_16547651T36 NONE phosphinothricin_23\NN\1740| (r_compound) n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify (r_dobj) encode_22\VB\115157|to|n-acetyltransferase (r_xcomp) inserted_18\VBN\1296462|similarly|,|bar|respectively|,|have|been|plants|encode|. (l_nsubjpass) bar_2\NN\4105893|and|genes|isolated|,
16547651T2_16547651T37 NONE phosphinothricin_23\NN\1740| (r_compound) n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify (r_dobj) encode_22\VB\115157|to|n-acetyltransferase (r_xcomp) inserted_18\VBN\1296462|similarly|,|bar|respectively|,|have|been|plants|encode|. (l_nsubjpass) bar_2\NN\4105893|and|genes|isolated|, (l_conj) genes_5\NNS\8459252|pat (l_compound) pat_4\NN\7371293|
16547651T3_16547651T20 NONE n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify
16547651T3_16547651T36 NONE n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify (r_dobj) encode_22\VB\115157|to|n-acetyltransferase (r_xcomp) inserted_18\VBN\1296462|similarly|,|bar|respectively|,|have|been|plants|encode|. (l_nsubjpass) bar_2\NN\4105893|and|genes|isolated|,
16547651T3_16547651T37 NONE n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify (r_dobj) encode_22\VB\115157|to|n-acetyltransferase (r_xcomp) inserted_18\VBN\1296462|similarly|,|bar|respectively|,|have|been|plants|encode|. (l_nsubjpass) bar_2\NN\4105893|and|genes|isolated|, (l_conj) genes_5\NNS\8459252|pat (l_compound) pat_4\NN\7371293|
16547651T4_16547651T20 NONE glufosinate_27\NN\1740| (r_dobj) detoxify_26\VB\173338|to|glufosinate (r_acl) n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify
16547651T4_16547651T36 NONE glufosinate_27\NN\1740| (r_dobj) detoxify_26\VB\173338|to|glufosinate (r_acl) n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify (r_dobj) encode_22\VB\115157|to|n-acetyltransferase (r_xcomp) inserted_18\VBN\1296462|similarly|,|bar|respectively|,|have|been|plants|encode|. (l_nsubjpass) bar_2\NN\4105893|and|genes|isolated|,
16547651T4_16547651T37 NONE glufosinate_27\NN\1740| (r_dobj) detoxify_26\VB\173338|to|glufosinate (r_acl) n-acetyltransferase_24\NN\1740|phosphinothricin|detoxify (r_dobj) encode_22\VB\115157|to|n-acetyltransferase (r_xcomp) inserted_18\VBN\1296462|similarly|,|bar|respectively|,|have|been|plants|encode|. (l_nsubjpass) bar_2\NN\4105893|and|genes|isolated|, (l_conj) genes_5\NNS\8459252|pat (l_compound) pat_4\NN\7371293|
10796631
17588737
17588737T14_17588737T30 NONE phenolic_19\JJ\1740| (r_amod) compounds_20\NNS\5869584|of|phenolic (r_nmod) effects_17\NNS\13245626|protective|compounds (r_dep) associated_6\VBN\628491|apoptosis|is|up-regulation|:|effects|. (l_nmod) up-regulation_8\NN\1740|with|p66shc|cells (l_nmod) p66shc_10\NN\1740|of
17588737T3_17588737T15 NONE tyrosol_28\NN\1740|of|and|acid|,|compounds (r_nmod) effects_26\NNS\13245626|the|tyrosol (r_conj) alterations_7\NNS\7283608|the|balance|,|and|effects (l_nmod) balance_11\NN\13934900|of|the|redox|induced (l_acl) induced_12\VBN\1627355|fraction (l_nmod) fraction_16\NN\14806838|by|the|lipid|oxldl|cells (l_nmod) oxldl_18\NN\1740|of
17588737T5_17588737T15 NONE acid_31\NN\14818238|protocatechuic (r_conj) tyrosol_28\NN\1740|of|and|acid|,|compounds (r_nmod) effects_26\NNS\13245626|the|tyrosol (r_conj) alterations_7\NNS\7283608|the|balance|,|and|effects (l_nmod) balance_11\NN\13934900|of|the|redox|induced (l_acl) induced_12\VBN\1627355|fraction (l_nmod) fraction_16\NN\14806838|by|the|lipid|oxldl|cells (l_nmod) oxldl_18\NN\1740|of
17588737T6_17588737T15 NONE phenolic_35\JJ\1740| (r_amod) compounds_36\NNS\5869584|two|dietary|phenolic (r_appos) tyrosol_28\NN\1740|of|and|acid|,|compounds (r_nmod) effects_26\NNS\13245626|the|tyrosol (r_conj) alterations_7\NNS\7283608|the|balance|,|and|effects (l_nmod) balance_11\NN\13934900|of|the|redox|induced (l_acl) induced_12\VBN\1627355|fraction (l_nmod) fraction_16\NN\14806838|by|the|lipid|oxldl|cells (l_nmod) oxldl_18\NN\1740|of
17588737T7_17588737T18 NONE o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_nsubj) lipids_4\NNS\14944888|oxidized|extracted (l_acl) extracted_5\VBN\173338|oxldl (l_nmod) oxldl_7\NN\1740|from|lipe
17588737T7_17588737T19 NONE o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_nsubj) lipids_4\NNS\14944888|oxidized|extracted (l_acl) extracted_5\VBN\173338|oxldl (l_nmod) oxldl_7\NN\1740|from|lipe (l_appos) lipe_9\NN\1740|(|)
17588737T7_17588737T20 NONE o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (l_dep) lipe_44\NN\1740|vs.|control
17588737T7_17588737T21 NONE o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (l_conj) depletion_56\NN\351638|gsh|decrease (l_dep) decrease_62\NN\7296428|(|about|a|26|%|,|p<.05|:|lipe|) (l_appos) lipe_66\NN\1740|vs.|control
17588737T7_17588737T22 NONE o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_conj) impairing_73\VBG\258857|by|activities (l_dobj) activities_75\NNS\30358|the|dismutase (l_nmod) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase
17588737T7_17588737T23 NONE o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_conj) impairing_73\VBG\258857|by|activities (l_dobj) activities_75\NNS\30358|the|dismutase (l_nmod) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (l_conj) catalase_80\NN\14732946|
17588737T7_17588737T24 NONE o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_conj) impairing_73\VBG\258857|by|activities (l_dobj) activities_75\NNS\30358|the|dismutase (l_nmod) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (l_conj) peroxidase_83\NN\14971234|glutathione
17588737T8_17588737T18 NONE h2o2_37\NN\1740| (r_conj) o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_nsubj) lipids_4\NNS\14944888|oxidized|extracted (l_acl) extracted_5\VBN\173338|oxldl (l_nmod) oxldl_7\NN\1740|from|lipe
17588737T8_17588737T19 NONE h2o2_37\NN\1740| (r_conj) o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_nsubj) lipids_4\NNS\14944888|oxidized|extracted (l_acl) extracted_5\VBN\173338|oxldl (l_nmod) oxldl_7\NN\1740|from|lipe (l_appos) lipe_9\NN\1740|(|)
17588737T8_17588737T20 NONE h2o2_37\NN\1740| (r_conj) o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (l_dep) lipe_44\NN\1740|vs.|control
17588737T8_17588737T21 NONE h2o2_37\NN\1740| (r_conj) o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (l_conj) depletion_56\NN\351638|gsh|decrease (l_dep) decrease_62\NN\7296428|(|about|a|26|%|,|p<.05|:|lipe|) (l_appos) lipe_66\NN\1740|vs.|control
17588737T8_17588737T22 NONE h2o2_37\NN\1740| (r_conj) o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_conj) impairing_73\VBG\258857|by|activities (l_dobj) activities_75\NNS\30358|the|dismutase (l_nmod) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase
17588737T8_17588737T23 NONE h2o2_37\NN\1740| (r_conj) o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_conj) impairing_73\VBG\258857|by|activities (l_dobj) activities_75\NNS\30358|the|dismutase (l_nmod) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (l_conj) catalase_80\NN\14732946|
17588737T8_17588737T24 NONE h2o2_37\NN\1740| (r_conj) o*2_35\NN\1740|and|h2o2 (r_compound) production_38\NN\30358|of|o*2 (r_nmod) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (r_dep) overproduction_23\NN\913705|ros|% (r_dobj) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (r_advcl) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_conj) impairing_73\VBG\258857|by|activities (l_dobj) activities_75\NNS\30358|the|dismutase (l_nmod) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (l_conj) peroxidase_83\NN\14971234|glutathione
17588737T9_17588737T18 NONE superoxide_77\NN\14971519| (r_compound) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (r_nmod) activities_75\NNS\30358|the|dismutase (r_dobj) impairing_73\VBG\258857|by|activities (r_conj) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_nsubj) lipids_4\NNS\14944888|oxidized|extracted (l_acl) extracted_5\VBN\173338|oxldl (l_nmod) oxldl_7\NN\1740|from|lipe
17588737T9_17588737T19 NONE superoxide_77\NN\14971519| (r_compound) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (r_nmod) activities_75\NNS\30358|the|dismutase (r_dobj) impairing_73\VBG\258857|by|activities (r_conj) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_nsubj) lipids_4\NNS\14944888|oxidized|extracted (l_acl) extracted_5\VBN\173338|oxldl (l_nmod) oxldl_7\NN\1740|from|lipe (l_appos) lipe_9\NN\1740|(|)
17588737T9_17588737T20 NONE superoxide_77\NN\14971519| (r_compound) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (r_nmod) activities_75\NNS\30358|the|dismutase (r_dobj) impairing_73\VBG\258857|by|activities (r_conj) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_advcl) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (l_dobj) overproduction_23\NN\913705|ros|% (l_dep) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (l_dep) lipe_44\NN\1740|vs.|control
17588737T9_17588737T21 NONE superoxide_77\NN\14971519| (r_compound) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (r_nmod) activities_75\NNS\30358|the|dismutase (r_dobj) impairing_73\VBG\258857|by|activities (r_conj) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_advcl) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (l_conj) depletion_56\NN\351638|gsh|decrease (l_dep) decrease_62\NN\7296428|(|about|a|26|%|,|p<.05|:|lipe|) (l_appos) lipe_66\NN\1740|vs.|control
17588737T9_17588737T22 NONE superoxide_77\NN\14971519| (r_compound) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase
17588737T9_17588737T23 NONE superoxide_77\NN\14971519| (r_compound) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (l_conj) catalase_80\NN\14732946|
17588737T9_17588737T24 NONE superoxide_77\NN\14971519| (r_compound) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (l_conj) peroxidase_83\NN\14971234|glutathione
17588737T10_17588737T18 NONE glutathione_82\NN\1740| (r_compound) peroxidase_83\NN\14971234|glutathione (r_conj) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (r_nmod) activities_75\NNS\30358|the|dismutase (r_dobj) impairing_73\VBG\258857|by|activities (r_conj) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_nsubj) lipids_4\NNS\14944888|oxidized|extracted (l_acl) extracted_5\VBN\173338|oxldl (l_nmod) oxldl_7\NN\1740|from|lipe
17588737T10_17588737T19 NONE glutathione_82\NN\1740| (r_compound) peroxidase_83\NN\14971234|glutathione (r_conj) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (r_nmod) activities_75\NNS\30358|the|dismutase (r_dobj) impairing_73\VBG\258857|by|activities (r_conj) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_nsubj) lipids_4\NNS\14944888|oxidized|extracted (l_acl) extracted_5\VBN\173338|oxldl (l_nmod) oxldl_7\NN\1740|from|lipe (l_appos) lipe_9\NN\1740|(|)
17588737T10_17588737T20 NONE glutathione_82\NN\1740| (r_compound) peroxidase_83\NN\14971234|glutathione (r_conj) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (r_nmod) activities_75\NNS\30358|the|dismutase (r_dobj) impairing_73\VBG\258857|by|activities (r_conj) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_advcl) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (l_dobj) overproduction_23\NN\913705|ros|% (l_dep) %_28\NN\1740|(|about|a|100|and|%|increase|production|,|respectively|,|p<.05|:|lipe|) (l_dep) lipe_44\NN\1740|vs.|control
17588737T10_17588737T21 NONE glutathione_82\NN\1740| (r_compound) peroxidase_83\NN\14971234|glutathione (r_conj) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (r_nmod) activities_75\NNS\30358|the|dismutase (r_dobj) impairing_73\VBG\258857|by|activities (r_conj) induced_11\VBD\1627355|that|lipids|stress|determining|and|impairing (l_advcl) determining_15\VBG\1645601|by|,|h|,|overproduction|and|,|h|,|depletion|, (l_conj) depletion_56\NN\351638|gsh|decrease (l_dep) decrease_62\NN\7296428|(|about|a|26|%|,|p<.05|:|lipe|) (l_appos) lipe_66\NN\1740|vs.|control
17588737T10_17588737T22 NONE glutathione_82\NN\1740| (r_compound) peroxidase_83\NN\14971234|glutathione (r_conj) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase
17588737T10_17588737T23 NONE glutathione_82\NN\1740| (r_compound) peroxidase_83\NN\14971234|glutathione (r_conj) dismutase_78\NN\1740|of|superoxide|,|catalase|and|peroxidase (l_conj) catalase_80\NN\14732946|
17588737T10_17588737T24 NONE glutathione_82\NN\1740| (r_compound) peroxidase_83\NN\14971234|glutathione
17588737T11_17588737T25 NONE glutathione_13\NN\1740| (r_compound) peroxidase_14\NN\14971234|of|glutathione|h|,|reductase
17588737T11_17588737T26 NONE glutathione_13\NN\1740| (r_compound) peroxidase_14\NN\14971234|of|glutathione|h|,|reductase (l_conj) reductase_25\NN\14732946|glutathione|and|synthetase|h
17588737T11_17588737T27 NONE glutathione_13\NN\1740| (r_compound) peroxidase_14\NN\14971234|of|glutathione|h|,|reductase (l_conj) reductase_25\NN\14732946|glutathione|and|synthetase|h (l_conj) synthetase_28\NN\1740|gamma-glutamylcysteine
17588737T12_17588737T25 NONE glutathione_24\NN\1740| (r_compound) reductase_25\NN\14732946|glutathione|and|synthetase|h (r_conj) peroxidase_14\NN\14971234|of|glutathione|h|,|reductase
17588737T12_17588737T26 NONE glutathione_24\NN\1740| (r_compound) reductase_25\NN\14732946|glutathione|and|synthetase|h
17588737T12_17588737T27 NONE glutathione_24\NN\1740| (r_compound) reductase_25\NN\14732946|glutathione|and|synthetase|h (l_conj) synthetase_28\NN\1740|gamma-glutamylcysteine
17588737T13_17588737T25 NONE gamma-glutamylcysteine_27\NN\1740| (r_compound) synthetase_28\NN\1740|gamma-glutamylcysteine (r_conj) reductase_25\NN\14732946|glutathione|and|synthetase|h (r_conj) peroxidase_14\NN\14971234|of|glutathione|h|,|reductase
17588737T13_17588737T26 NONE gamma-glutamylcysteine_27\NN\1740| (r_compound) synthetase_28\NN\1740|gamma-glutamylcysteine (r_conj) reductase_25\NN\14732946|glutathione|and|synthetase|h
17588737T13_17588737T27 NONE gamma-glutamylcysteine_27\NN\1740| (r_compound) synthetase_28\NN\1740|gamma-glutamylcysteine
17588737T1_17588737T16 CPR:4 phenolics_7\NNS\14902141|by|dietary|inhibited (r_nmod) counteracted_4\VBN\2367363|effects|were|fully|phenolics|,|rendered|. (l_conj) rendered_16\VBD\120316|unnecessary|and|blocked (l_conj) blocked_25\VBD\1476483|signals (l_dobj) signals_28\NNS\33020|the|intracellular|leading (l_acl) leading_29\VBG\1752884|overexpression (l_nmod) overexpression_32\NN\1740|to|the|and|rearrangement|molecule (l_nmod) molecule_38\NN\9465459|of|p66shc|signalling (l_compound) p66shc_36\NN\1740|
17588737T2_17588737T16 NONE glutathione-associated_21\JJ\1740| (r_amod) enzymes_22\NNS\14723628|of|glutathione-associated (r_nmod) transcription_19\NN\6349220|the|reactive|enzymes (r_nsubj) unnecessary_23\JJ\1740|transcription (r_xcomp) rendered_16\VBD\120316|unnecessary|and|blocked (l_conj) blocked_25\VBD\1476483|signals (l_dobj) signals_28\NNS\33020|the|intracellular|leading (l_acl) leading_29\VBG\1752884|overexpression (l_nmod) overexpression_32\NN\1740|to|the|and|rearrangement|molecule (l_nmod) molecule_38\NN\9465459|of|p66shc|signalling (l_compound) p66shc_36\NN\1740|
23551063
23551063T13_23551063T31 NONE udp-glucuronosyltransferases_12\NNS\1740|by|recombinant|human|and|microsomes
23551063T14_23551063T31 CPR:9 7-hydroxy-4-trifluoromethylcoumarin_8\NN\1740|of (r_nmod) glucuronidation_6\NN\1740|for|the|7-hydroxy-4-trifluoromethylcoumarin|udp-glucuronosyltransferases (l_nmod) udp-glucuronosyltransferases_12\NNS\1740|by|recombinant|human|and|microsomes
23551063T6_23551063T17 NONE udp-glucuronosyltransferases_3\NN\1740|ugts
23551063T6_23551063T20 NONE udp-glucuronosyltransferases_3\NN\1740|ugts (l_appos) ugts_5\NNS\1740|(|)
23551063T7_23551063T18 CPR:9 7-hydroxy-4-trifluoromethylcoumarin_39\NN\1740|of|hfc|ugts (l_nmod) ugts_45\NNS\1740|for|several
23551063T8_23551063T18 CPR:9 hfc_41\NN\14871968|(|) (r_appos) 7-hydroxy-4-trifluoromethylcoumarin_39\NN\1740|of|hfc|ugts (l_nmod) ugts_45\NNS\1740|for|several
23551063T9_23551063T19 CPR:9 hfc_14\NN\14871968| (r_compound) activity_16\NN\30358|for|hfc|glucuronidation (r_nmod) screen_8\VB\2533282|to|ugts|activity (l_dobj) ugts_12\NNS\1740|11|recombinant|human
23551063T11_23551063T21 CPR:9 hfc_14\NN\14871968| (r_compound) catalysts_16\NNS\14723079|the|active|hfc|glucuronidation (r_nsubj) ugt1a10_18\NN\1740|4|,|catalysts|were|followed|,|whereas||catalyst|.
23551063T11_23551063T22 CPR:9 hfc_14\NN\14871968| (r_compound) catalysts_16\NNS\14723079|the|active|hfc|glucuronidation (r_nsubj) ugt1a10_18\NN\1740|4|,|catalysts|were|followed|,|whereas||catalyst|. (l_acl) followed_19\VBN\1835496|ugt1a6 (l_nmod) ugt1a6_21\NN\1740|by|>|ugt1a7|ugt2a1
23551063T11_23551063T23 CPR:9 hfc_14\NN\14871968| (r_compound) catalysts_16\NNS\14723079|the|active|hfc|glucuronidation (r_nsubj) ugt1a10_18\NN\1740|4|,|catalysts|were|followed|,|whereas||catalyst|. (l_acl) followed_19\VBN\1835496|ugt1a6 (l_nmod) ugt1a6_21\NN\1740|by|>|ugt1a7|ugt2a1 (l_appos) ugt1a7_23\NN\1740|
23551063T11_23551063T24 CPR:9 hfc_14\NN\14871968| (r_compound) catalysts_16\NNS\14723079|the|active|hfc|glucuronidation (r_nsubj) ugt1a10_18\NN\1740|4|,|catalysts|were|followed|,|whereas||catalyst|. (l_acl) followed_19\VBN\1835496|ugt1a6 (l_nmod) ugt1a6_21\NN\1740|by|>|ugt1a7|ugt2a1 (l_nmod) ugt2a1_25\NN\1740|>
23551063T11_23551063T25 CPR:9 hfc_14\NN\14871968| (r_compound) catalysts_16\NNS\14723079|the|active|hfc|glucuronidation (r_nsubj) ugt1a10_18\NN\1740|4|,|catalysts|were|followed|,|whereas||catalyst|. (l_dep) catalyst_38\NN\14723079|µm|ugt1a6|was|better|ugts (l_nsubj) ugt1a6_32\NN\1740|
23551063T11_23551063T26 CPR:9 hfc_14\NN\14871968| (r_compound) catalysts_16\NNS\14723079|the|active|hfc|glucuronidation (r_nsubj) ugt1a10_18\NN\1740|4|,|catalysts|were|followed|,|whereas||catalyst|. (l_dep) catalyst_38\NN\14723079|µm|ugt1a6|was|better|ugts (l_nmod) ugts_43\NNS\1740|than|the|other|recombinant
23551063T12_23551063T27 NONE hfc_22\NN\14871968| (r_compound) activity_24\NN\30358|no|hfc|glucuronidation (r_dobj) exhibited_20\VBD\2632167|whereas|ugt1a1|activity (r_advcl) low_14\JJ\1740|activities|were|,|exhibited|. (l_nsubj) activities_1\NNS\30358|the|ugts (l_nmod) ugts_3\NNS\1740|of|1a3 (l_dep) 1a3_4\NN\1740|,|1a8|,|1a9|,|2b4|and|2b7 (l_conj) 2b7_12\NN\1740|
23551063T12_23551063T28 NONE hfc_22\NN\14871968| (r_compound) activity_24\NN\30358|no|hfc|glucuronidation (r_dobj) exhibited_20\VBD\2632167|whereas|ugt1a1|activity (l_nsubj) ugt1a1_17\NN\1740|and|ugt2b17
23551063T12_23551063T29 NONE hfc_22\NN\14871968| (r_compound) activity_24\NN\30358|no|hfc|glucuronidation (r_dobj) exhibited_20\VBD\2632167|whereas|ugt1a1|activity (l_nsubj) ugt1a1_17\NN\1740|and|ugt2b17 (l_conj) ugt2b17_19\NN\1740|
23551063T1_23551063T15 CPR:9 hfc_11\NN\14871968|toward|both|and|acid (r_nmod) vmax_5\NN\1740|a|higher|and|values|hfc|ugts (l_nmod) ugts_18\NNS\1740|than|the|other
23551063T1_23551063T30 CPR:9 hfc_11\NN\14871968|toward|both|and|acid (r_nmod) vmax_5\NN\1740|a|higher|and|values|hfc|ugts (r_dobj) exhibited_1\VBD\2632167|ugt1a6|vmax|. (l_nsubj) ugt1a6_0\NN\1740|
23551063T2_23551063T15 CPR:9 udp-glucuronic_13\JJ\1740| (r_amod) acid_14\NN\14818238|udp-glucuronic (r_conj) hfc_11\NN\14871968|toward|both|and|acid (r_nmod) vmax_5\NN\1740|a|higher|and|values|hfc|ugts (l_nmod) ugts_18\NNS\1740|than|the|other
23551063T2_23551063T30 CPR:9 udp-glucuronic_13\JJ\1740| (r_amod) acid_14\NN\14818238|udp-glucuronic (r_conj) hfc_11\NN\14871968|toward|both|and|acid (r_nmod) vmax_5\NN\1740|a|higher|and|values|hfc|ugts (r_dobj) exhibited_1\VBD\2632167|ugt1a6|vmax|. (l_nsubj) ugt1a6_0\NN\1740|
23551063T3_23551063T15 CPR:9 acid_14\NN\14818238|udp-glucuronic (r_conj) hfc_11\NN\14871968|toward|both|and|acid (r_nmod) vmax_5\NN\1740|a|higher|and|values|hfc|ugts (l_nmod) ugts_18\NNS\1740|than|the|other
23551063T3_23551063T30 CPR:9 acid_14\NN\14818238|udp-glucuronic (r_conj) hfc_11\NN\14871968|toward|both|and|acid (r_nmod) vmax_5\NN\1740|a|higher|and|values|hfc|ugts (r_dobj) exhibited_1\VBD\2632167|ugt1a6|vmax|. (l_nsubj) ugt1a6_0\NN\1740|
23551063T5_23551063T16 NONE hfc_22\NN\14871968| (r_compound) determination_25\NN\43195|hfc|activity|samples (r_conj) screenings_11\NNS\6887726|for|fast|activity|ugts|and|determination (l_nmod) ugts_13\NNS\1740|of|1a6 (l_dep) 1a6_14\NN\1740|,|1a7|,|1a10|and|2a1 (l_conj) 2a1_20\NN\1740|
10403635
10403635T35_10403635T54 NONE pyridostigmine_2\NN\1740|,|physostigmine|,|eptastigmine|and|phosphotriesterase (l_conj) phosphotriesterase_8\NN\1740|
10403635T36_10403635T54 NONE physostigmine_4\NN\14712692| (r_conj) pyridostigmine_2\NN\1740|,|physostigmine|,|eptastigmine|and|phosphotriesterase (l_conj) phosphotriesterase_8\NN\1740|
10403635T37_10403635T54 NONE eptastigmine_6\NN\1740| (r_conj) pyridostigmine_2\NN\1740|,|physostigmine|,|eptastigmine|and|phosphotriesterase (l_conj) phosphotriesterase_8\NN\1740|
10403635T38_10403635T54 NONE sarin_12\NN\14970136| (r_compound) intoxication_13\NN\14034177|in|acute|sarin (r_nmod) success_0\NN\7283608|treatments|intoxication|. (l_nmod) treatments_9\NNS\654885|of|pyridostigmine (l_compound) pyridostigmine_2\NN\1740|,|physostigmine|,|eptastigmine|and|phosphotriesterase (l_conj) phosphotriesterase_8\NN\1740|
10403635T16_10403635T40 CPR:9 acetylcholine_32\NN\14807558| (r_compound) levels_33\NNS\4916342|to|increased|synaptic|acetylcholine (r_nmod) leads_28\VBZ\1752884|which|levels (r_acl:relcl) inhibition_16\NN\1068773|to|their|irreversible|acetylcholinesterase|,|leads (l_nmod) acetylcholinesterase_18\NN\1740|of|ache|system
10403635T16_10403635T42 CPR:9 acetylcholine_32\NN\14807558| (r_compound) levels_33\NNS\4916342|to|increased|synaptic|acetylcholine (r_nmod) leads_28\VBZ\1752884|which|levels (r_acl:relcl) inhibition_16\NN\1068773|to|their|irreversible|acetylcholinesterase|,|leads (l_nmod) acetylcholinesterase_18\NN\1740|of|ache|system (l_appos) ache_20\NN\14322699|(|)
10403635T20_10403635T40 CPR:4 organophosphorus_4\NN\1740|op (r_compound) compounds_8\NNS\5869584|of|organophosphorus (r_nmod) toxicity_2\NN\13576101|the|acute|compounds|mammals (r_nsubj) due_12\JJ\1740|toxicity|is|inhibition|. (l_nmod) inhibition_16\NN\1068773|to|their|irreversible|acetylcholinesterase|,|leads (l_nmod) acetylcholinesterase_18\NN\1740|of|ache|system
10403635T20_10403635T42 CPR:4 organophosphorus_4\NN\1740|op (r_compound) compounds_8\NNS\5869584|of|organophosphorus (r_nmod) toxicity_2\NN\13576101|the|acute|compounds|mammals (r_nsubj) due_12\JJ\1740|toxicity|is|inhibition|. (l_nmod) inhibition_16\NN\1068773|to|their|irreversible|acetylcholinesterase|,|leads (l_nmod) acetylcholinesterase_18\NN\1740|of|ache|system (l_appos) ache_20\NN\14322699|(|)
10403635T21_10403635T49 NONE pyridostigmine_9\NN\1740|administered|,|physostigmine|,|eptastigmine|,|and|hydrolase (l_conj) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication
10403635T21_10403635T50 NONE pyridostigmine_9\NN\1740|administered|,|physostigmine|,|eptastigmine|,|and|hydrolase (l_conj) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication (l_appos) phosphotriesterase_20\NN\1740|
10403635T22_10403635T49 NONE physostigmine_11\NN\14712692| (r_conj) pyridostigmine_9\NN\1740|administered|,|physostigmine|,|eptastigmine|,|and|hydrolase (l_conj) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication
10403635T22_10403635T50 NONE physostigmine_11\NN\14712692| (r_conj) pyridostigmine_9\NN\1740|administered|,|physostigmine|,|eptastigmine|,|and|hydrolase (l_conj) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication (l_appos) phosphotriesterase_20\NN\1740|
10403635T23_10403635T49 NONE eptastigmine_13\NN\1740| (r_conj) pyridostigmine_9\NN\1740|administered|,|physostigmine|,|eptastigmine|,|and|hydrolase (l_conj) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication
10403635T23_10403635T50 NONE eptastigmine_13\NN\1740| (r_conj) pyridostigmine_9\NN\1740|administered|,|physostigmine|,|eptastigmine|,|and|hydrolase (l_conj) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication (l_appos) phosphotriesterase_20\NN\1740|
10403635T24_10403635T49 NONE organophosphate_17\NN\14919948| (r_compound) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication
10403635T24_10403635T50 NONE organophosphate_17\NN\14919948| (r_compound) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication (l_appos) phosphotriesterase_20\NN\1740|
10403635T25_10403635T49 NONE sarin_24\NN\14970136| (r_compound) intoxication_25\NN\14034177|in|acute|sarin (r_nmod) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication
10403635T25_10403635T50 NONE sarin_24\NN\14970136| (r_compound) intoxication_25\NN\14034177|in|acute|sarin (r_nmod) hydrolase_18\NN\1740|an|organophosphate|,|phosphotriesterase|,|intoxication (l_appos) phosphotriesterase_20\NN\1740|
10403635T27_10403635T51 NONE pyridostigmine_3\NN\1740|weight|)|,|physostigmine|,|eptastigmine|or|phosphotriesterase (l_conj) phosphotriesterase_30\NN\1740|u/g
10403635T28_10403635T51 NONE physostigmine_11\NN\14712692|weight|) (r_conj) pyridostigmine_3\NN\1740|weight|)|,|physostigmine|,|eptastigmine|or|phosphotriesterase (l_conj) phosphotriesterase_30\NN\1740|u/g
10403635T29_10403635T51 NONE physostigmine_20\NN\14712692| (r_compound) eptastigmine_22\NN\1740|the|physostigmine|derivative|weight|) (r_conj) pyridostigmine_3\NN\1740|weight|)|,|physostigmine|,|eptastigmine|or|phosphotriesterase (l_conj) phosphotriesterase_30\NN\1740|u/g
10403635T30_10403635T51 NONE eptastigmine_22\NN\1740|the|physostigmine|derivative|weight|) (r_conj) pyridostigmine_3\NN\1740|weight|)|,|physostigmine|,|eptastigmine|or|phosphotriesterase (l_conj) phosphotriesterase_30\NN\1740|u/g
10403635T31_10403635T51 NONE sarin_49\NN\14970136|of (r_nmod) administration_47\NN\1133281|prior|to|the|.|sarin (r_nmod) received_2\VBD\2210855|mice|pyridostigmine|min|administration|. (l_dobj) pyridostigmine_3\NN\1740|weight|)|,|physostigmine|,|eptastigmine|or|phosphotriesterase (l_conj) phosphotriesterase_30\NN\1740|u/g
10403635T32_10403635T52 NONE physostigmine_0\NN\14712692| (r_nsubjpass) administered_3\VBN\2436349|physostigmine|was|also|phosphotriesterase|. (l_nmod) phosphotriesterase_5\NN\1740|with
10403635T33_10403635T53 NONE sarin_7\NNP\14970136| (r_compound) intoxication_8\NN\14034177|in|sarin (r_nmod) antidote_5\NN\4074482|phosphotriesterase|was|the|effective|intoxication|. (l_nsubj) phosphotriesterase_0\NN\1740|
10403635T34_10403635T39 NONE sarin_4\NNP\14970136|for (r_nmod) value_2\NN\5856066|the|ld50|sarin (r_nsubj) increased_5\VBD\169651|value|3.4-fold|mice|. (l_nmod) mice_8\NNS\2329401|in|receiving (l_acl) receiving_9\VBG\2210855|phosphotriesterase (l_dobj) phosphotriesterase_10\NN\1740|
10403635T8_10403635T41 NONE physostigmine_4\NN\14712692| (r_conj) phosphotriesterase_2\NN\1740|both|the|and|physostigmine
10403635T8_10403635T43 NONE physostigmine_4\NN\14712692| (r_conj) phosphotriesterase_2\NN\1740|both|the|and|physostigmine (r_compound) treatments_5\NNS\654885|phosphotriesterase (r_nsubj) protected_6\VBD\1127795|treatments|activities|. (l_dobj) activities_10\NNS\30358|the|brain|ache|measured (l_compound) ache_9\NN\14322699|
10403635T9_10403635T41 NONE sarin_15\NN\14970136| (r_compound) exposure_16\NN\5042871|sarin (r_dep) h_13\NN\14622893|24|after|exposure (r_nmod) measured_11\VBN\697589|h (r_acl) activities_10\NNS\30358|the|brain|ache|measured (r_dobj) protected_6\VBD\1127795|treatments|activities|. (l_nsubj) treatments_5\NNS\654885|phosphotriesterase (l_compound) phosphotriesterase_2\NN\1740|both|the|and|physostigmine
10403635T9_10403635T43 NONE sarin_15\NN\14970136| (r_compound) exposure_16\NN\5042871|sarin (r_dep) h_13\NN\14622893|24|after|exposure (r_nmod) measured_11\VBN\697589|h (r_acl) activities_10\NNS\30358|the|brain|ache|measured (l_compound) ache_9\NN\14322699|
10403635T10_10403635T44 NONE physostigmine-treated_3\JJ\1740| (r_conj) phosphotriesterase_1\NN\1740|and|physostigmine-treated
10403635T10_10403635T45 NONE physostigmine-treated_3\JJ\1740| (r_conj) phosphotriesterase_1\NN\1740|and|physostigmine-treated (r_amod) mice_4\NNS\2329401|in|phosphotriesterase (r_nmod) needed_17\VBN\2604760|mice|,|dose|,|respectively|,|was|cause|. (l_xcomp) cause_19\VB\1617192|to|inhibition (l_dobj) inhibition_23\NN\1068773|a|%|activity (l_nmod) activity_27\NN\30358|of|brain|ache (l_compound) ache_26\NN\14322699|
10403635T11_10403635T44 NONE sarin_11\NN\14970136| (r_compound) dose_12\NN\3740161|a|higher|sarin (r_nsubjpass) needed_17\VBN\2604760|mice|,|dose|,|respectively|,|was|cause|. (l_nmod) mice_4\NNS\2329401|in|phosphotriesterase (l_amod) phosphotriesterase_1\NN\1740|and|physostigmine-treated
10403635T11_10403635T45 CPR:4 sarin_11\NN\14970136| (r_compound) dose_12\NN\3740161|a|higher|sarin (r_nsubjpass) needed_17\VBN\2604760|mice|,|dose|,|respectively|,|was|cause|. (l_xcomp) cause_19\VB\1617192|to|inhibition (l_dobj) inhibition_23\NN\1068773|a|%|activity (l_nmod) activity_27\NN\30358|of|brain|ache (l_compound) ache_26\NN\14322699|
10403635T12_10403635T46 NONE phosphotriesterase-physostigmine_5\NN\1740|of
10403635T13_10403635T46 NONE sarin_11\NN\14970136|for (r_nmod) value_9\NN\5856066|the|ld50|sarin (r_dobj) increased_6\VBD\169651|moreover|,|combination|value|4.3-fold|. (l_nsubj) combination_3\NN\7951464|the|phosphotriesterase-physostigmine (l_nmod) phosphotriesterase-physostigmine_5\NN\1740|of
10403635T14_10403635T47 NONE phosphotriesterase-ephysostigmine_4\NN\1740|with
10403635T15_10403635T48 NONE physostigmine_5\NN\14712692| (r_conj) phosphotriesterase_3\NN\1740|and|physostigmine
10403635T17_10403635T48 NONE sarin_12\NN\14970136| (r_compound) intoxication_13\NN\14034177|against|sarin (r_nmod) treatments_10\NNS\654885|conclusion|,|phosphotriesterase|were|the|effective|intoxication|. (l_nsubj) phosphotriesterase_3\NN\1740|and|physostigmine
23288052
23293962
23293962T3_23293962T4 NONE iron_14\NN\14625458| (r_compound) homoeostasis_15\NN\1740|of|iron (r_nmod) enzyme_12\NN\14723628|matriptase-2|is|the|key|homoeostasis|modulating|. (l_nsubj) matriptase-2_0\NN\1740|,|protease|,
23293962T3_23293962T8 NONE iron_14\NN\14625458| (r_compound) homoeostasis_15\NN\1740|of|iron (r_nmod) enzyme_12\NN\14723628|matriptase-2|is|the|key|homoeostasis|modulating|. (l_acl) modulating_16\VBG\1724459|expression (l_dobj) expression_18\NN\4679549|the|hepcidin (l_nmod) hepcidin_24\NN\1740|of|the|liver|peptide|hormone
23293962T3_23293962T18 NONE iron_14\NN\14625458| (r_compound) homoeostasis_15\NN\1740|of|iron (r_nmod) enzyme_12\NN\14723628|matriptase-2|is|the|key|homoeostasis|modulating|. (l_nsubj) matriptase-2_0\NN\1740|,|protease|, (l_appos) protease_7\NN\14732946|a|identified|cell|surface
23293962T1_23293962T5 NONE iron_32\NN\14625458| (r_compound) homoeostasis_33\NN\1740|of|iron (r_nmod) mechanism_30\NN\13446390|into|the|regulatory|homoeostasis (r_nmod) insights_26\NNS\5710020|new|mechanism (r_dobj) provides_24\VBZ\2199590|insights|,|importance (r_conj) characterized_10\VBN\609683|taken|,|results|have|hai-2|inhibitor|and|provides|. (l_dobj) hai-2_11\NN\1740|
23293962T1_23293962T6 NONE iron_32\NN\14625458| (r_compound) homoeostasis_33\NN\1740|of|iron (r_nmod) mechanism_30\NN\13446390|into|the|regulatory|homoeostasis (r_nmod) insights_26\NNS\5710020|new|mechanism (r_dobj) provides_24\VBZ\2199590|insights|,|importance (r_conj) characterized_10\VBN\609683|taken|,|results|have|hai-2|inhibitor|and|provides|. (l_nmod) inhibitor_14\NN\20090|as|an|matriptase-2 (l_nmod) matriptase-2_16\NN\1740|of|modulates
23293962T1_23293962T7 NONE iron_32\NN\14625458| (r_compound) homoeostasis_33\NN\1740|of|iron (r_nmod) mechanism_30\NN\13446390|into|the|regulatory|homoeostasis (r_nmod) insights_26\NNS\5710020|new|mechanism (r_dobj) provides_24\VBZ\2199590|insights|,|importance (r_conj) characterized_10\VBN\609683|taken|,|results|have|hai-2|inhibitor|and|provides|. (l_nmod) inhibitor_14\NN\20090|as|an|matriptase-2 (l_nmod) matriptase-2_16\NN\1740|of|modulates (l_acl:relcl) modulates_18\VBZ\1724459|that|synthesis (l_dobj) synthesis_20\NN\13446390|the|hepcidin (l_nmod) hepcidin_22\NN\1740|of
23293962T2_23293962T5 NONE iron_42\NN\14625458| (r_compound) diseases_44\NNS\14061805|of|iron|overload (r_nmod) treatment_40\NN\654885|for|a|diseases (r_nmod) importance_37\NN\5138488|with|clinical|treatment (r_nmod) provides_24\VBZ\2199590|insights|,|importance (r_conj) characterized_10\VBN\609683|taken|,|results|have|hai-2|inhibitor|and|provides|. (l_dobj) hai-2_11\NN\1740|
23293962T2_23293962T6 NONE iron_42\NN\14625458| (r_compound) diseases_44\NNS\14061805|of|iron|overload (r_nmod) treatment_40\NN\654885|for|a|diseases (r_nmod) importance_37\NN\5138488|with|clinical|treatment (r_nmod) provides_24\VBZ\2199590|insights|,|importance (r_conj) characterized_10\VBN\609683|taken|,|results|have|hai-2|inhibitor|and|provides|. (l_nmod) inhibitor_14\NN\20090|as|an|matriptase-2 (l_nmod) matriptase-2_16\NN\1740|of|modulates
23293962T2_23293962T7 NONE iron_42\NN\14625458| (r_compound) diseases_44\NNS\14061805|of|iron|overload (r_nmod) treatment_40\NN\654885|for|a|diseases (r_nmod) importance_37\NN\5138488|with|clinical|treatment (r_nmod) provides_24\VBZ\2199590|insights|,|importance (r_conj) characterized_10\VBN\609683|taken|,|results|have|hai-2|inhibitor|and|provides|. (l_nmod) inhibitor_14\NN\20090|as|an|matriptase-2 (l_nmod) matriptase-2_16\NN\1740|of|modulates (l_acl:relcl) modulates_18\VBZ\1724459|that|synthesis (l_dobj) synthesis_20\NN\13446390|the|hepcidin (l_nmod) hepcidin_22\NN\1740|of
16554356
16554356T3_16554356T10 NONE loperamide-loaded_8\JJ\1740| (r_amod) hsa-np_9\NN\1740|to|loperamide-loaded (r_nmod) linkers_6\NNS\1740|via|hsa-np (r_nmod) bound_4\VBN\1831531|e|was|chemically|linkers|. (l_nsubjpass) e_1\NN\14724645|apolipoprotein
16554356T3_16554356T11 NONE loperamide-loaded_8\JJ\1740| (r_amod) hsa-np_9\NN\1740|to|loperamide-loaded
23454835
23454835T6_23454835T11 NONE aoh_0\NN\1740| (r_compound) treatment_1\NN\654885|aoh (r_nsubj) induced_3\VBD\1627355|treatment|also|bridges|,|suggesting|. (l_dobj) bridges_7\NNS\4341686|abnormal|aurora|b (l_compound) b_6\NN\1355326|
23563205
23563205T1_23563205T10 CPR:3 thiazolidinediones_18\NNS\1740|of (r_nmod) series_16\NN\8456993|by|a|thiazolidinediones (r_nmod) activation_2\NN\13561719|between|pparγ|and|downregulation|series (l_nmod) pparγ_4\NN\1740|of
23563205T1_23563205T11 CPR:4 thiazolidinediones_18\NNS\1740|of (r_nmod) series_16\NN\8456993|by|a|thiazolidinediones (r_nmod) activation_2\NN\13561719|between|pparγ|and|downregulation|series (l_conj) downregulation_7\NN\1740|resistin|line (l_compound) resistin_6\NN\1740|
14507899
14507899T15_14507899T16 CPR:5 ins37217_4\NN\1740|agonist (l_compound) agonist_3\NN\9613191|p2y(2|)|receptor (l_compound) receptor_2\NN\5225602|
10446934
10446934T28_10446934T48 NONE angiotensin-converting_0\JJ\1740| (r_amod) inhibition_2\NN\1068773|angiotensin-converting|enzyme|and|blockade (l_compound) enzyme_1\NN\14723628|
10446934T28_10446934T49 NONE angiotensin-converting_0\JJ\1740| (r_amod) inhibition_2\NN\1068773|angiotensin-converting|enzyme|and|blockade (r_nsubj) modify_7\VBP\109660|inhibition|relationship|mechanisms|rats|. (l_nmod) rats_15\NNS\2329401|in|genes (l_nmod) genes_21\NNS\8459252|with|renin (l_compound) renin_18\NN\14999106|human|and|angiotensinogen
10446934T28_10446934T50 NONE angiotensin-converting_0\JJ\1740| (r_amod) inhibition_2\NN\1068773|angiotensin-converting|enzyme|and|blockade (r_nsubj) modify_7\VBP\109660|inhibition|relationship|mechanisms|rats|. (l_nmod) rats_15\NNS\2329401|in|genes (l_nmod) genes_21\NNS\8459252|with|renin (l_compound) renin_18\NN\14999106|human|and|angiotensinogen (l_conj) angiotensinogen_20\NN\1740|
10446934T28_10446934T51 NONE angiotensin-converting_0\JJ\1740| (r_amod) inhibition_2\NN\1068773|angiotensin-converting|enzyme|and|blockade (l_conj) blockade_6\NN\952963|at1|receptor (l_compound) at1_4\NN\1740|
10446934T17_10446934T40 NONE angiotensin-converting_9\JJ\1740| (r_amod) enzyme_10\NN\14723628|angiotensin-converting|ace
10446934T17_10446934T43 NONE angiotensin-converting_9\JJ\1740| (r_amod) enzyme_10\NN\14723628|angiotensin-converting|ace (l_appos) ace_12\NN\13741022|(|)
10446934T17_10446934T44 NONE angiotensin-converting_9\JJ\1740| (r_amod) enzyme_10\NN\14723628|angiotensin-converting|ace (r_compound) inhibition_14\NN\1068773|to|chronic|enzyme|and|blockade (l_conj) blockade_18\NN\952963|at1|receptor (l_compound) at1_16\NN\1740|
10446934T20_10446934T45 NONE renin-angiotensin_1\NN\1740|renal|and|oxide
10446934T20_10446934T46 NONE renin-angiotensin_1\NN\1740|renal|and|oxide
10446934T21_10446934T45 NONE oxide_4\NN\14818238|nitric|no (r_conj) renin-angiotensin_1\NN\1740|renal|and|oxide
10446934T21_10446934T46 NONE oxide_4\NN\14818238|nitric|no (r_conj) renin-angiotensin_1\NN\1740|renal|and|oxide
10446934T22_10446934T45 NONE no_6\NN\7204911|(|) (r_appos) oxide_4\NN\14818238|nitric|no (r_conj) renin-angiotensin_1\NN\1740|renal|and|oxide
10446934T22_10446934T46 NONE no_6\NN\7204911|(|) (r_appos) oxide_4\NN\14818238|nitric|no (r_conj) renin-angiotensin_1\NN\1740|renal|and|oxide
10446934T8_10446934T30 CPR:3 losartan_15\NN\1740|and|cilazapril (r_compound) treatments_18\NNS\654885|by|losartan (r_nmod) increased_13\VBN\169651|were|treatments (r_conj) downregulated_8\VBN\1740|genes|were|dtgr|and|increased|,|whereas|observed|. (l_nsubjpass) genes_6\NNS\8459252|human|renin (l_compound) renin_3\NN\14999106|and|angiotensinogen
10446934T8_10446934T31 CPR:3 losartan_15\NN\1740|and|cilazapril (r_compound) treatments_18\NNS\654885|by|losartan (r_nmod) increased_13\VBN\169651|were|treatments (r_conj) downregulated_8\VBN\1740|genes|were|dtgr|and|increased|,|whereas|observed|. (l_nsubjpass) genes_6\NNS\8459252|human|renin (l_compound) renin_3\NN\14999106|and|angiotensinogen (l_conj) angiotensinogen_5\NN\1740|
10446934T8_10446934T32 NONE losartan_15\NN\1740|and|cilazapril (r_compound) treatments_18\NNS\654885|by|losartan (r_nmod) increased_13\VBN\169651|were|treatments (r_conj) downregulated_8\VBN\1740|genes|were|dtgr|and|increased|,|whereas|observed|. (l_parataxis) observed_34\VBN\2163746|changes|were (l_nsubjpass) changes_22\NNS\7283608|no|expression (l_nmod) expression_25\NN\4679549|in|the|ace (l_nmod) ace_28\NN\13741022|of|rat|and|at1a|genes
10446934T8_10446934T33 NONE losartan_15\NN\1740|and|cilazapril (r_compound) treatments_18\NNS\654885|by|losartan (r_nmod) increased_13\VBN\169651|were|treatments (r_conj) downregulated_8\VBN\1740|genes|were|dtgr|and|increased|,|whereas|observed|. (l_parataxis) observed_34\VBN\2163746|changes|were (l_nsubjpass) changes_22\NNS\7283608|no|expression (l_nmod) expression_25\NN\4679549|in|the|ace (l_nmod) ace_28\NN\13741022|of|rat|and|at1a|genes (l_conj) at1a_30\NN\1740|
10446934T9_10446934T30 CPR:3 cilazapril_17\NN\1740| (r_conj) losartan_15\NN\1740|and|cilazapril (r_compound) treatments_18\NNS\654885|by|losartan (r_nmod) increased_13\VBN\169651|were|treatments (r_conj) downregulated_8\VBN\1740|genes|were|dtgr|and|increased|,|whereas|observed|. (l_nsubjpass) genes_6\NNS\8459252|human|renin (l_compound) renin_3\NN\14999106|and|angiotensinogen
10446934T9_10446934T31 CPR:3 cilazapril_17\NN\1740| (r_conj) losartan_15\NN\1740|and|cilazapril (r_compound) treatments_18\NNS\654885|by|losartan (r_nmod) increased_13\VBN\169651|were|treatments (r_conj) downregulated_8\VBN\1740|genes|were|dtgr|and|increased|,|whereas|observed|. (l_nsubjpass) genes_6\NNS\8459252|human|renin (l_compound) renin_3\NN\14999106|and|angiotensinogen (l_conj) angiotensinogen_5\NN\1740|
10446934T9_10446934T32 NONE cilazapril_17\NN\1740| (r_conj) losartan_15\NN\1740|and|cilazapril (r_compound) treatments_18\NNS\654885|by|losartan (r_nmod) increased_13\VBN\169651|were|treatments (r_conj) downregulated_8\VBN\1740|genes|were|dtgr|and|increased|,|whereas|observed|. (l_parataxis) observed_34\VBN\2163746|changes|were (l_nsubjpass) changes_22\NNS\7283608|no|expression (l_nmod) expression_25\NN\4679549|in|the|ace (l_nmod) ace_28\NN\13741022|of|rat|and|at1a|genes
10446934T9_10446934T33 NONE cilazapril_17\NN\1740| (r_conj) losartan_15\NN\1740|and|cilazapril (r_compound) treatments_18\NNS\654885|by|losartan (r_nmod) increased_13\VBN\169651|were|treatments (r_conj) downregulated_8\VBN\1740|genes|were|dtgr|and|increased|,|whereas|observed|. (l_parataxis) observed_34\VBN\2163746|changes|were (l_nsubjpass) changes_22\NNS\7283608|no|expression (l_nmod) expression_25\NN\4679549|in|the|ace (l_nmod) ace_28\NN\13741022|of|rat|and|at1a|genes (l_conj) at1a_30\NN\1740|
10446934T10_10446934T34 NONE no_1\NN\7204911| (r_compound) synthase_2\NN\1740|endothelial|no
10446934T11_10446934T34 CPR:3 cilazapril_7\NN\1740|by (r_nmod) increased_5\VBN\169651|expression|was|cilazapril|not (l_nsubjpass) expression_3\NN\4679549|synthase (l_compound) synthase_2\NN\1740|endothelial|no
10446934T13_10446934T35 NONE no_2\NN\7204911| (r_compound) synthase_3\NN\1740|neither|inducible|no|nor|expression
10446934T13_10446934T36 NONE no_2\NN\7204911| (r_compound) synthase_3\NN\1740|neither|inducible|no|nor|expression (l_conj) expression_9\NN\4679549|synthase|gene (l_compound) synthase_7\NN\1740|neural|no
10446934T14_10446934T35 NONE no_6\NN\7204911| (r_compound) synthase_7\NN\1740|neural|no (r_compound) expression_9\NN\4679549|synthase|gene (r_conj) synthase_3\NN\1740|neither|inducible|no|nor|expression
10446934T14_10446934T36 NONE no_6\NN\7204911| (r_compound) synthase_7\NN\1740|neural|no
10446934T15_10446934T37 NONE sodium_6\NN\14625458| (r_compound) excretion_7\NN\13466586|sodium (r_dobj) enhanced_5\VBD\227165|therefore|,|inhibition|excretion|increasing|,|decreased|. (l_nsubj) inhibition_4\NN\1068773|submaximal|ace (l_compound) ace_3\NN\13741022|
10446934T15_10446934T38 NONE sodium_6\NN\14625458| (r_compound) excretion_7\NN\13466586|sodium (r_dobj) enhanced_5\VBD\227165|therefore|,|inhibition|excretion|increasing|,|decreased|. (l_advcl) decreased_20\VBD\169651|whereas|blockade|reabsorption (l_nsubj) blockade_19\NN\952963|submaximal|at1|receptor (l_compound) at1_17\NN\1740|
10446934T16_10446934T37 NONE sodium_22\NN\14625458|tubular|and|water (r_compound) reabsorption_25\NN\13526110|sodium (r_dobj) decreased_20\VBD\169651|whereas|blockade|reabsorption (r_advcl) enhanced_5\VBD\227165|therefore|,|inhibition|excretion|increasing|,|decreased|. (l_nsubj) inhibition_4\NN\1068773|submaximal|ace (l_compound) ace_3\NN\13741022|
10446934T16_10446934T38 NONE sodium_22\NN\14625458|tubular|and|water (r_compound) reabsorption_25\NN\13526110|sodium (r_dobj) decreased_20\VBD\169651|whereas|blockade|reabsorption (l_nsubj) blockade_19\NN\952963|submaximal|at1|receptor (l_compound) at1_17\NN\1740|
10446934T18_10446934T39 NONE no_8\NN\7204911| (r_compound) synthase_9\NN\1740|no (r_compound) expression_10\NN\4679549|increased|endothelial|synthase|,|related (r_dobj) involve_5\VB\2676054|effects|may|expression|. (l_nsubj) effects_3\NNS\13245626|the|ace|inhibitor (l_compound) ace_1\NN\13741022|
10446934T18_10446934T41 NONE no_8\NN\7204911| (r_compound) synthase_9\NN\1740|no
10446934T18_10446934T42 NONE no_8\NN\7204911| (r_compound) synthase_9\NN\1740|no (r_compound) expression_10\NN\4679549|increased|endothelial|synthase|,|related (l_amod) related_13\JJ\1740|perhaps|inhibition (l_nmod) inhibition_16\NN\1068773|to|the|degradation (l_nmod) degradation_19\NN\199130|of|bradykinin (l_compound) bradykinin_18\NN\1740|
10446934T19_10446934T39 NONE bradykinin_18\NN\1740| (r_compound) degradation_19\NN\199130|of|bradykinin (r_nmod) inhibition_16\NN\1068773|to|the|degradation (r_nmod) related_13\JJ\1740|perhaps|inhibition (r_amod) expression_10\NN\4679549|increased|endothelial|synthase|,|related (r_dobj) involve_5\VB\2676054|effects|may|expression|. (l_nsubj) effects_3\NNS\13245626|the|ace|inhibitor (l_compound) ace_1\NN\13741022|
10446934T19_10446934T41 NONE bradykinin_18\NN\1740| (r_compound) degradation_19\NN\199130|of|bradykinin (r_nmod) inhibition_16\NN\1068773|to|the|degradation (r_nmod) related_13\JJ\1740|perhaps|inhibition (r_amod) expression_10\NN\4679549|increased|endothelial|synthase|,|related (l_compound) synthase_9\NN\1740|no
10446934T19_10446934T42 NONE bradykinin_18\NN\1740|
10328230
10328230T15_10328230T24 CPR:4 batimastat_8\NN\1740|by|and|captopril (r_nmod) inhibition_0\NN\1068773|a|batimastat (l_nmod) a_3\NN\13649268|of|gelatinase|mmp-2
10328230T15_10328230T25 CPR:4 batimastat_8\NN\1740|by|and|captopril (r_nmod) inhibition_0\NN\1068773|a|batimastat (l_nmod) a_3\NN\13649268|of|gelatinase|mmp-2 (l_appos) mmp-2_5\NN\1740|(|)
10328230T16_10328230T24 CPR:4 captopril_10\NN\2673637| (r_conj) batimastat_8\NN\1740|by|and|captopril (r_nmod) inhibition_0\NN\1068773|a|batimastat (l_nmod) a_3\NN\13649268|of|gelatinase|mmp-2
10328230T16_10328230T25 CPR:4 captopril_10\NN\2673637| (r_conj) batimastat_8\NN\1740|by|and|captopril (r_nmod) inhibition_0\NN\1068773|a|batimastat (l_nmod) a_3\NN\13649268|of|gelatinase|mmp-2 (l_appos) mmp-2_5\NN\1740|(|)
10328230T1_10328230T17 NONE angiotensin-converting_18\JJ\1740| (r_amod) inhibitor_20\NN\20090|the|angiotensin-converting|enzyme|,|captopril|, (l_compound) enzyme_19\NN\14723628|
10328230T1_10328230T20 NONE angiotensin-converting_18\JJ\1740| (r_amod) inhibitor_20\NN\20090|the|angiotensin-converting|enzyme|,|captopril|, (r_conj) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (r_nmod) effects_4\NNS\13245626|the|inhibitor|activity (l_nmod) activity_26\NN\30358|on|metalloproteinase|cells|vitro|,|and|growth (l_compound) metalloproteinase_25\NN\1740|
10328230T1_10328230T21 NONE angiotensin-converting_18\JJ\1740| (r_amod) inhibitor_20\NN\20090|the|angiotensin-converting|enzyme|,|captopril|, (r_conj) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (l_compound) metalloproteinase_9\NN\1740|
10328230T4_10328230T17 CPR:4 captopril_22\NN\2673637| (r_appos) inhibitor_20\NN\20090|the|angiotensin-converting|enzyme|,|captopril|, (l_compound) enzyme_19\NN\14723628|
10328230T4_10328230T20 NONE captopril_22\NN\2673637| (r_appos) inhibitor_20\NN\20090|the|angiotensin-converting|enzyme|,|captopril|, (r_conj) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (r_nmod) effects_4\NNS\13245626|the|inhibitor|activity (l_nmod) activity_26\NN\30358|on|metalloproteinase|cells|vitro|,|and|growth (l_compound) metalloproteinase_25\NN\1740|
10328230T4_10328230T21 NONE captopril_22\NN\2673637| (r_appos) inhibitor_20\NN\20090|the|angiotensin-converting|enzyme|,|captopril|, (r_conj) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (l_compound) metalloproteinase_9\NN\1740|
10328230T13_10328230T17 NONE batimastat_12\NN\1740|bb-94 (r_appos) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (l_conj) inhibitor_20\NN\20090|the|angiotensin-converting|enzyme|,|captopril|, (l_compound) enzyme_19\NN\14723628|
10328230T13_10328230T20 NONE batimastat_12\NN\1740|bb-94 (r_appos) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (r_nmod) effects_4\NNS\13245626|the|inhibitor|activity (l_nmod) activity_26\NN\30358|on|metalloproteinase|cells|vitro|,|and|growth (l_compound) metalloproteinase_25\NN\1740|
10328230T13_10328230T21 CPR:4 batimastat_12\NN\1740|bb-94 (r_appos) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (l_compound) metalloproteinase_9\NN\1740|
10328230T14_10328230T17 NONE bb-94_14\NN\1740|(|) (r_appos) batimastat_12\NN\1740|bb-94 (r_appos) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (l_conj) inhibitor_20\NN\20090|the|angiotensin-converting|enzyme|,|captopril|, (l_compound) enzyme_19\NN\14723628|
10328230T14_10328230T20 NONE bb-94_14\NN\1740|(|) (r_appos) batimastat_12\NN\1740|bb-94 (r_appos) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (r_nmod) effects_4\NNS\13245626|the|inhibitor|activity (l_nmod) activity_26\NN\30358|on|metalloproteinase|cells|vitro|,|and|growth (l_compound) metalloproteinase_25\NN\1740|
10328230T14_10328230T21 CPR:4 bb-94_14\NN\1740|(|) (r_appos) batimastat_12\NN\1740|bb-94 (r_appos) inhibitor_10\NN\20090|of|the|synthetic|matrix|metalloproteinase|,|batimastat|and|inhibitor (l_compound) metalloproteinase_9\NN\1740|
10328230T9_10328230T22 CPR:4 captopril_4\NN\2673637| (r_compound) treatment_5\NN\654885|captopril (r_nsubj) resulted_6\VBD\2633881|that|treatment|transcription (l_nmod) transcription_9\NN\6349220|in|decreased|and|levels|a|cells (l_nmod) a_15\NN\13649268|of|gelatinase
10328230T10_10328230T23 CPR:4 bb-94_1\NN\1740|both|and|captopril (r_nsubj) prevented_5\VBD\1740|bb-94|also|degradation|. (l_dobj) degradation_7\NN\199130|substrate|gelatinase (l_nmod) gelatinase_9\NN\1740|by|a (l_dep) a_10\NN\13649268|and|b|released (l_conj) b_12\NN\1355326|
10328230T5_10328230T19 NONE bb-94_21\NN\1740|of|and|captopril|and|combination (r_nmod) effect_19\NN\34213|the|anti-tumor|bb-94 (r_dobj) underlie_14\VB\2604760|moreover|,|blockade|may|effect|. (l_nsubj) blockade_2\NN\952963|invasion (l_nmod) invasion_4\NN\975452|of|,|angiogenesis|and|processes|mediated (l_acl) mediated_10\VBN\761713|metalloproteinases (l_nmod) metalloproteinases_12\NNS\1740|by
10328230T6_10328230T19 NONE captopril_23\NN\2673637| (r_conj) bb-94_21\NN\1740|of|and|captopril|and|combination (r_nmod) effect_19\NN\34213|the|anti-tumor|bb-94 (r_dobj) underlie_14\VB\2604760|moreover|,|blockade|may|effect|. (l_nsubj) blockade_2\NN\952963|invasion (l_nmod) invasion_4\NN\975452|of|,|angiogenesis|and|processes|mediated (l_acl) mediated_10\VBN\761713|metalloproteinases (l_nmod) metalloproteinases_12\NNS\1740|by
23531031
23531031T12_23531031T22 NONE iodide_5\NN\14904359| (r_compound) symporter_6\NN\1740|sodium|iodide|nis (r_compound) expression_10\NN\4679549|symporter (r_dobj) affects_3\VBZ\126264|inhibition|expression|and|induces|. (l_nsubj) inhibition_2\NN\1068773|histone|deacetylase (l_compound) deacetylase_1\NN\1740|
23531031T12_23531031T23 NONE iodide_5\NN\14904359| (r_compound) symporter_6\NN\1740|sodium|iodide|nis
23531031T12_23531031T24 NONE iodide_5\NN\14904359| (r_compound) symporter_6\NN\1740|sodium|iodide|nis (l_appos) nis_8\NN\14625458|(|)
23531031T13_23531031T22 NONE ¹³¹i_13\CD\1740| (r_compound) cytotoxicity_14\NN\13583478|¹³¹i (r_dobj) induces_12\VBZ\1627355|cytotoxicity|cells (r_conj) affects_3\VBZ\126264|inhibition|expression|and|induces|. (l_nsubj) inhibition_2\NN\1068773|histone|deacetylase (l_compound) deacetylase_1\NN\1740|
23531031T13_23531031T23 NONE ¹³¹i_13\CD\1740| (r_compound) cytotoxicity_14\NN\13583478|¹³¹i (r_dobj) induces_12\VBZ\1627355|cytotoxicity|cells (r_conj) affects_3\VBZ\126264|inhibition|expression|and|induces|. (l_dobj) expression_10\NN\4679549|symporter (l_compound) symporter_6\NN\1740|sodium|iodide|nis
23531031T13_23531031T24 NONE ¹³¹i_13\CD\1740| (r_compound) cytotoxicity_14\NN\13583478|¹³¹i (r_dobj) induces_12\VBZ\1627355|cytotoxicity|cells (r_conj) affects_3\VBZ\126264|inhibition|expression|and|induces|. (l_dobj) expression_10\NN\4679549|symporter (l_compound) symporter_6\NN\1740|sodium|iodide|nis (l_appos) nis_8\NN\14625458|(|)
23531031T10_23531031T18 NONE radioiodine_7\NN\1740| (r_compound) treatment_8\NN\654885|to|radioiodine (r_nmod) resistance_1\NN\37396|the|cancer|treatment (r_nsubj) absence_14\NN\14449405|resistance|is|principally|due|the|expression|silencing|. (l_nmod) expression_16\NN\4679549|of|symporter|, (l_nmod) symporter_21\NN\1740|of|the|sodium|iodide|nis
23531031T10_23531031T19 NONE radioiodine_7\NN\1740| (r_compound) treatment_8\NN\654885|to|radioiodine (r_nmod) resistance_1\NN\37396|the|cancer|treatment (r_nsubj) absence_14\NN\14449405|resistance|is|principally|due|the|expression|silencing|. (l_nmod) expression_16\NN\4679549|of|symporter|, (l_nmod) symporter_21\NN\1740|of|the|sodium|iodide|nis (l_appos) nis_23\NN\14625458|(|)
23531031T11_23531031T18 NONE iodide_20\NN\14904359| (r_compound) symporter_21\NN\1740|of|the|sodium|iodide|nis
23531031T11_23531031T19 NONE iodide_20\NN\14904359| (r_compound) symporter_21\NN\1740|of|the|sodium|iodide|nis (l_appos) nis_23\NN\14625458|(|)
23531031T1_23531031T14 CPR:4 lbh589_32\NN\1740| (r_dep) inhibitor_31\NN\20090|with|the|histone|deacetylase|lbh589 (l_compound) deacetylase_30\NN\1740|
23531031T4_23531031T17 CPR:3 lbh589_8\NN\1740|with (r_nmod) treatment_6\NN\654885|lbh589 (r_nsubj) leads_9\VBZ\1752884|that|treatment|expression|,|and|expression (l_nmod) expression_13\NN\4679549|to|nis|rna|shown (l_compound) nis_11\NN\14625458|
2571203
2571203T1_2571203T14 NONE cyclosporine_21\NN\1740| (r_compound) csa_22\NN\1740|a|cyclosporine|and|prednisone|immunosuppression|=|;|anti-tac|and|anti-tac (r_appos) groups_12\NNS\2137|in|three|patients|:|csa (r_nmod) lymphocytes_9\NNS\5449959|on|peripheral|blood|small|groups (r_nmod) examined_4\VBN\789138|expression|was|lymphocytes|. (l_nsubjpass) expression_2\NN\4679549|il-2|r (l_compound) r_1\NN\13635336|
2571203T2_2571203T14 NONE csa_22\NN\1740|a|cyclosporine|and|prednisone|immunosuppression|=|;|anti-tac|and|anti-tac (r_appos) groups_12\NNS\2137|in|three|patients|:|csa (r_nmod) lymphocytes_9\NNS\5449959|on|peripheral|blood|small|groups (r_nmod) examined_4\VBN\789138|expression|was|lymphocytes|. (l_nsubjpass) expression_2\NN\4679549|il-2|r (l_compound) r_1\NN\13635336|
2571203T3_2571203T14 NONE prednisone_24\NN\2721538| (r_conj) csa_22\NN\1740|a|cyclosporine|and|prednisone|immunosuppression|=|;|anti-tac|and|anti-tac (r_appos) groups_12\NNS\2137|in|three|patients|:|csa (r_nmod) lymphocytes_9\NNS\5449959|on|peripheral|blood|small|groups (r_nmod) examined_4\VBN\789138|expression|was|lymphocytes|. (l_nsubjpass) expression_2\NN\4679549|il-2|r (l_compound) r_1\NN\13635336|
2571203T4_2571203T14 NONE csa_39\NN\1740|with|and|prednisone (r_nmod) anti-tac_37\NN\1740|b|csa|immunosuppression|=|; (r_conj) csa_22\NN\1740|a|cyclosporine|and|prednisone|immunosuppression|=|;|anti-tac|and|anti-tac (r_appos) groups_12\NNS\2137|in|three|patients|:|csa (r_nmod) lymphocytes_9\NNS\5449959|on|peripheral|blood|small|groups (r_nmod) examined_4\VBN\789138|expression|was|lymphocytes|. (l_nsubjpass) expression_2\NN\4679549|il-2|r (l_compound) r_1\NN\13635336|
2571203T5_2571203T14 NONE prednisone_41\NN\2721538| (r_conj) csa_39\NN\1740|with|and|prednisone (r_nmod) anti-tac_37\NN\1740|b|csa|immunosuppression|=|; (r_conj) csa_22\NN\1740|a|cyclosporine|and|prednisone|immunosuppression|=|;|anti-tac|and|anti-tac (r_appos) groups_12\NNS\2137|in|three|patients|:|csa (r_nmod) lymphocytes_9\NNS\5449959|on|peripheral|blood|small|groups (r_nmod) examined_4\VBN\789138|expression|was|lymphocytes|. (l_nsubjpass) expression_2\NN\4679549|il-2|r (l_compound) r_1\NN\13635336|
2571203T6_2571203T14 NONE azathioprine_57\NN\3740161|with|and|prednisone (r_nmod) anti-tac_55\NN\1740|c|azathioprine|immunosuppression (r_conj) csa_22\NN\1740|a|cyclosporine|and|prednisone|immunosuppression|=|;|anti-tac|and|anti-tac (r_appos) groups_12\NNS\2137|in|three|patients|:|csa (r_nmod) lymphocytes_9\NNS\5449959|on|peripheral|blood|small|groups (r_nmod) examined_4\VBN\789138|expression|was|lymphocytes|. (l_nsubjpass) expression_2\NN\4679549|il-2|r (l_compound) r_1\NN\13635336|
2571203T7_2571203T14 NONE prednisone_59\NN\2721538| (r_conj) azathioprine_57\NN\3740161|with|and|prednisone (r_nmod) anti-tac_55\NN\1740|c|azathioprine|immunosuppression (r_conj) csa_22\NN\1740|a|cyclosporine|and|prednisone|immunosuppression|=|;|anti-tac|and|anti-tac (r_appos) groups_12\NNS\2137|in|three|patients|:|csa (r_nmod) lymphocytes_9\NNS\5449959|on|peripheral|blood|small|groups (r_nmod) examined_4\VBN\789138|expression|was|lymphocytes|. (l_nsubjpass) expression_2\NN\4679549|il-2|r (l_compound) r_1\NN\13635336|
14984733
14984733T12_14984733T27 NONE phosphatidylserine_12\NN\1740| (r_compound) synthase_13\NN\1740|of|phosphatidylserine
14984733T13_14984733T27 NONE phosphatidylserine_2\NN\1740|of (r_nmod) externalization_0\NN\5734559|phosphatidylserine|apoptosis (r_nsubj) require_8\VB\754942|externalization|does|not|specifically|isoform|. (l_dobj) isoform_10\NN\1740|either|synthase (l_nmod) synthase_13\NN\1740|of|phosphatidylserine
14984733T1_14984733T22 CPR:9 phosphatidylserine_0\NN\1740|ptdser (r_nsubjpass) made_5\VBN\126264|phosphatidylserine|is|cells|synthases|. (l_nmod) synthases_12\NNS\1740|by|two|ptdser|,|pss1
14984733T1_14984733T25 CPR:9 phosphatidylserine_0\NN\1740|ptdser (r_nsubjpass) made_5\VBN\126264|phosphatidylserine|is|cells|synthases|. (l_nmod) synthases_12\NNS\1740|by|two|ptdser|,|pss1 (l_appos) pss1_14\NN\1740|and|pss2
14984733T1_14984733T26 CPR:9 phosphatidylserine_0\NN\1740|ptdser (r_nsubjpass) made_5\VBN\126264|phosphatidylserine|is|cells|synthases|. (l_nmod) synthases_12\NNS\1740|by|two|ptdser|,|pss1 (l_appos) pss1_14\NN\1740|and|pss2 (l_conj) pss2_16\NN\1740|
14984733T7_14984733T22 NONE ptdser_2\NN\1740|(|) (r_appos) phosphatidylserine_0\NN\1740|ptdser (r_nsubjpass) made_5\VBN\126264|phosphatidylserine|is|cells|synthases|. (l_nmod) synthases_12\NNS\1740|by|two|ptdser|,|pss1
14984733T7_14984733T25 NONE ptdser_2\NN\1740|(|) (r_appos) phosphatidylserine_0\NN\1740|ptdser (r_nsubjpass) made_5\VBN\126264|phosphatidylserine|is|cells|synthases|. (l_nmod) synthases_12\NNS\1740|by|two|ptdser|,|pss1 (l_appos) pss1_14\NN\1740|and|pss2
14984733T7_14984733T26 NONE ptdser_2\NN\1740|(|) (r_appos) phosphatidylserine_0\NN\1740|ptdser (r_nsubjpass) made_5\VBN\126264|phosphatidylserine|is|cells|synthases|. (l_nmod) synthases_12\NNS\1740|by|two|ptdser|,|pss1 (l_appos) pss1_14\NN\1740|and|pss2 (l_conj) pss2_16\NN\1740|
14984733T10_14984733T22 NONE ptdser_11\NN\1740| (r_compound) synthases_12\NNS\1740|by|two|ptdser|,|pss1
14984733T10_14984733T25 NONE ptdser_11\NN\1740| (r_compound) synthases_12\NNS\1740|by|two|ptdser|,|pss1 (l_appos) pss1_14\NN\1740|and|pss2
14984733T10_14984733T26 NONE ptdser_11\NN\1740| (r_compound) synthases_12\NNS\1740|by|two|ptdser|,|pss1 (l_appos) pss1_14\NN\1740|and|pss2 (l_conj) pss2_16\NN\1740|
14984733T8_14984733T20 NONE staurosporine_4\NN\1740|with (r_nmod) induced_1\VBD\1627355|we|apoptosis|staurosporine|lines|determine|. (l_nmod) lines_14\NNS\8426461|in|four|ovary|cell|deficient (l_acl:relcl) deficient_17\JJ\1740|that|are|pss1 (l_nmod) pss1_19\NN\1740|in|and/or|pss2
14984733T8_14984733T21 NONE staurosporine_4\NN\1740|with (r_nmod) induced_1\VBD\1627355|we|apoptosis|staurosporine|lines|determine|. (l_nmod) lines_14\NNS\8426461|in|four|ovary|cell|deficient (l_acl:relcl) deficient_17\JJ\1740|that|are|pss1 (l_nmod) pss1_19\NN\1740|in|and/or|pss2 (l_conj) pss2_21\NN\1740|
14984733T9_14984733T20 NONE ptdser_25\NN\1740|generated (r_nsubjpass) required_33\VBN\754942|if|ptdser|is|externalization (r_ccomp) determine_23\VB\1645601|to|required (r_advcl) induced_1\VBD\1627355|we|apoptosis|staurosporine|lines|determine|. (l_nmod) lines_14\NNS\8426461|in|four|ovary|cell|deficient (l_acl:relcl) deficient_17\JJ\1740|that|are|pss1 (l_nmod) pss1_19\NN\1740|in|and/or|pss2
14984733T9_14984733T21 NONE ptdser_25\NN\1740|generated (r_nsubjpass) required_33\VBN\754942|if|ptdser|is|externalization (r_ccomp) determine_23\VB\1645601|to|required (r_advcl) induced_1\VBD\1627355|we|apoptosis|staurosporine|lines|determine|. (l_nmod) lines_14\NNS\8426461|in|four|ovary|cell|deficient (l_acl:relcl) deficient_17\JJ\1740|that|are|pss1 (l_nmod) pss1_19\NN\1740|in|and/or|pss2 (l_conj) pss2_21\NN\1740|
14984733T2_14984733T14 NONE ptdser_27\NN\1740|of (r_nmod) amounts_25\NNS\13329641|normal|ptdser (r_dobj) externalized_23\VBD\726300|cells|amounts|. (l_nsubj) cells_0\NNS\3080309|deficient|,|as|cells|, (l_acl:relcl) deficient_3\JJ\1740|that|were|pss1 (l_nmod) pss1_6\NN\1740|in|either|or|pss2
14984733T2_14984733T15 NONE ptdser_27\NN\1740|of (r_nmod) amounts_25\NNS\13329641|normal|ptdser (r_dobj) externalized_23\VBD\726300|cells|amounts|. (l_nsubj) cells_0\NNS\3080309|deficient|,|as|cells|, (l_acl:relcl) deficient_3\JJ\1740|that|were|pss1 (l_nmod) pss1_6\NN\1740|in|either|or|pss2 (l_conj) pss2_8\NN\1740|
14984733T2_14984733T16 NONE ptdser_27\NN\1740|of (r_nmod) amounts_25\NNS\13329641|normal|ptdser (r_dobj) externalized_23\VBD\726300|cells|amounts|. (l_nsubj) cells_0\NNS\3080309|deficient|,|as|cells|, (l_conj) cells_13\NNS\3080309|deficient (l_acl:relcl) deficient_16\JJ\1740|that|were|pss1 (l_nmod) pss1_19\NN\1740|in|both|and|pss2
14984733T2_14984733T17 NONE ptdser_27\NN\1740|of (r_nmod) amounts_25\NNS\13329641|normal|ptdser (r_dobj) externalized_23\VBD\726300|cells|amounts|. (l_nsubj) cells_0\NNS\3080309|deficient|,|as|cells|, (l_conj) cells_13\NNS\3080309|deficient (l_acl:relcl) deficient_16\JJ\1740|that|were|pss1 (l_nmod) pss1_19\NN\1740|in|both|and|pss2 (l_conj) pss2_21\NN\1740|
14984733T6_14984733T18 CPR:9 ptdser_19\NN\1740|of|externalized (r_nmod) pool_17\NN\3302121|the|ptdser (r_dobj) generating_15\VBG\1617192|for|pool (r_advcl) required_13\VBN\754942|moreover|,|level|is|not|generating|. (l_nsubjpass) level_4\NN\4916342|a|normal|expression (l_nmod) expression_6\NN\4679549|of|pss1 (l_nmod) pss1_8\NN\1740|of|and/or|pss2
14984733T6_14984733T19 CPR:9 ptdser_19\NN\1740|of|externalized (r_nmod) pool_17\NN\3302121|the|ptdser (r_dobj) generating_15\VBG\1617192|for|pool (r_advcl) required_13\VBN\754942|moreover|,|level|is|not|generating|. (l_nsubjpass) level_4\NN\4916342|a|normal|expression (l_nmod) expression_6\NN\4679549|of|pss1 (l_nmod) pss1_8\NN\1740|of|and/or|pss2 (l_conj) pss2_10\NN\1740|
23207322
17561836
17561836T3_17561836T18 NONE tyrosine_2\NN\14601829| (r_compound) kinases_3\NNS\14732946|eph|receptor|tyrosine (l_compound) receptor_1\NN\5225602|
17561836T3_17561836T19 NONE tyrosine_2\NN\14601829| (r_compound) kinases_3\NNS\14732946|eph|receptor|tyrosine
17561836T2_17561836T12 NONE tyrosine_12\NN\14601829| (r_compound) hydroxylase_13\NN\1740|tyrosine|th|and/or|marker
17561836T2_17561836T13 NONE tyrosine_12\NN\14601829| (r_compound) hydroxylase_13\NN\1740|tyrosine|th|and/or|marker (l_appos) th_15\NN\15163157|(|)
17561836T2_17561836T14 NONE tyrosine_12\NN\14601829| (r_compound) hydroxylase_13\NN\1740|tyrosine|th|and/or|marker (l_conj) marker_20\NN\21939|the|beta-gal|ephb1 (l_nmod) ephb1_22\NN\1740|for
17561836T2_17561836T15 NONE tyrosine_12\NN\14601829| (r_compound) hydroxylase_13\NN\1740|tyrosine|th|and/or|marker (r_dobj) expressing_11\VBG\928630|hydroxylase (r_acl) neurons_10\NNS\5430628|of|sn|expressing (r_nmod) comparison_7\NN\635850|a|direct|neurons (r_conj) data_3\NNS\7951464|in|hybridization|and|comparison (r_nsubj) revealed_23\VBD\2137132|data|expressed|. (l_ccomp) expressed_28\VBN\928630|that|ephb1|is|not|neurons|,|but|restricted (l_nsubjpass) ephb1_25\NN\1740|
17561836T2_17561836T16 NONE tyrosine_12\NN\14601829| (r_compound) hydroxylase_13\NN\1740|tyrosine|th|and/or|marker (r_dobj) expressing_11\VBG\928630|hydroxylase (r_acl) neurons_10\NNS\5430628|of|sn|expressing (r_nmod) comparison_7\NN\635850|a|direct|neurons (r_conj) data_3\NNS\7951464|in|hybridization|and|comparison (r_nsubj) revealed_23\VBD\2137132|data|expressed|. (l_ccomp) expressed_28\VBN\928630|that|ephb1|is|not|neurons|,|but|restricted (l_nmod) neurons_31\NNS\5430628|in|th+|compacta (l_amod) th+_30\JJ\1740|
17561836T1_17561836T17 NONE dopamine_52\NN\14807737| (r_compound) neurons_53\NNS\5430628|of|nigrostriatal|dopamine (r_nmod) distribution_49\NN\5726596|in|the|neurons (r_nmod) are_44\VBP\836236|there|changes|distribution (r_conj) affected_42\VBN\126264|volume|is|not|significantly|nor|are (r_parataxis) exhibit_10\VBP\2632167|that|mice|decrease|,|whereas|affected (l_nsubj) mice_9\NNS\2329401|ephb1|null (l_compound) ephb1_7\NN\1740|
17561836T1_17561836T20 NONE dopamine_52\NN\14807737| (r_compound) neurons_53\NNS\5430628|of|nigrostriatal|dopamine (r_nmod) distribution_49\NN\5726596|in|the|neurons (r_nmod) are_44\VBP\836236|there|changes|distribution (r_conj) affected_42\VBN\126264|volume|is|not|significantly|nor|are (l_nsubjpass) volume_31\NN\33615|the|and|number|neurons (l_nmod) neurons_36\NNS\5430628|of|th+|snc (l_amod) th+_35\JJ\1740|
11160515
16484281
16484281T17_16484281T32 NONE alcohol-preferring_19\JJ\1740| (r_amod) rats_20\NNS\2329401|of|alcohol-preferring (r_nmod) cortex_17\NN\5462674|in|the|prelimbic|rats (r_nmod) astrocytes_13\NNS\5467432|of|synthetase-immunoreactive|cortex (l_amod) synthetase-immunoreactive_12\JJ\1740|glutamine
16484281T18_16484281T32 CPR:3 ethanol_3\NN\14708720| (r_compound) consumption_4\NN\13440063|from|free-choice|ethanol (r_nmod) withdrawal_0\NN\7206096|consumption (r_nsubj) results_5\VBZ\2633881|withdrawal|density|. (l_nmod) density_9\NN\4941325|in|increased|packing|astrocytes (l_nmod) astrocytes_13\NNS\5467432|of|synthetase-immunoreactive|cortex (l_amod) synthetase-immunoreactive_12\JJ\1740|glutamine
16484281T19_16484281T32 NONE glutamine_11\NN\14601829| (r_nmod:npmod) synthetase-immunoreactive_12\JJ\1740|glutamine
16484281T7_16484281T26 CPR:9 glutamate_17\NN\15010703|of|released|and|conversion (l_conj) conversion_20\NN\7359599|its|glutamine|enzyme (l_nmod) enzyme_25\NN\14723628|through|the|synthetase (l_dep) synthetase_27\NN\1740|glutamine|gs
16484281T7_16484281T27 CPR:9 glutamate_17\NN\15010703|of|released|and|conversion (l_conj) conversion_20\NN\7359599|its|glutamine|enzyme (l_nmod) enzyme_25\NN\14723628|through|the|synthetase (l_dep) synthetase_27\NN\1740|glutamine|gs (l_appos) gs_29\NN\13717155|(|)
16484281T8_16484281T26 CPR:9 glutamine_22\NN\14601829|to (r_nmod) conversion_20\NN\7359599|its|glutamine|enzyme (l_nmod) enzyme_25\NN\14723628|through|the|synthetase (l_dep) synthetase_27\NN\1740|glutamine|gs
16484281T8_16484281T27 CPR:9 glutamine_22\NN\14601829|to (r_nmod) conversion_20\NN\7359599|its|glutamine|enzyme (l_nmod) enzyme_25\NN\14723628|through|the|synthetase (l_dep) synthetase_27\NN\1740|glutamine|gs (l_appos) gs_29\NN\13717155|(|)
16484281T9_16484281T26 NONE glutamine_26\NN\14601829| (r_compound) synthetase_27\NN\1740|glutamine|gs
16484281T9_16484281T27 NONE glutamine_26\NN\14601829| (r_compound) synthetase_27\NN\1740|glutamine|gs (l_appos) gs_29\NN\13717155|(|)
16484281T10_16484281T28 NONE ethanol_9\NN\14708720| (r_compound) drinking_10\NN\838098|from|free-choice|ethanol (r_nmod) withdrawal_6\NN\7206096|drinking (r_nsubj) causes_11\VBZ\1617192|if|withdrawal|changes (l_dobj) changes_12\NNS\7283608|numbers (l_nmod) numbers_15\NNS\508091|in|the|astrocytes (l_nmod) astrocytes_17\NNS\5467432|of|expressing|or|protein (l_acl) expressing_18\VBG\928630|gs (l_dobj) gs_19\NN\13717155|
16484281T10_16484281T29 NONE ethanol_9\NN\14708720| (r_compound) drinking_10\NN\838098|from|free-choice|ethanol (r_nmod) withdrawal_6\NN\7206096|drinking (r_nsubj) causes_11\VBZ\1617192|if|withdrawal|changes (l_dobj) changes_12\NNS\7283608|numbers (l_nmod) numbers_15\NNS\508091|in|the|astrocytes (l_nmod) astrocytes_17\NNS\5467432|of|expressing|or|protein (l_conj) protein_23\NN\14944888|the|cytoskeletal|astrocytes (l_nmod) astrocytes_25\NNS\5467432|of|protein (l_dep) protein_29\NN\14944888|glial|fibrillary|acidic|gfap
16484281T10_16484281T30 NONE ethanol_9\NN\14708720| (r_compound) drinking_10\NN\838098|from|free-choice|ethanol (r_nmod) withdrawal_6\NN\7206096|drinking (r_nsubj) causes_11\VBZ\1617192|if|withdrawal|changes (l_dobj) changes_12\NNS\7283608|numbers (l_nmod) numbers_15\NNS\508091|in|the|astrocytes (l_nmod) astrocytes_17\NNS\5467432|of|expressing|or|protein (l_conj) protein_23\NN\14944888|the|cytoskeletal|astrocytes (l_nmod) astrocytes_25\NNS\5467432|of|protein (l_dep) protein_29\NN\14944888|glial|fibrillary|acidic|gfap (l_appos) gfap_31\NN\1740|(|)
16484281T2_16484281T21 NONE ethanol_0\NN\14708720| (r_compound) withdrawal_1\NN\7206096|ethanol (r_nsubj) increased_3\VBD\169651|withdrawal|significantly|density|compared|. (l_dobj) density_6\NN\4941325|the|packing|astrocytes|plc (l_nmod) astrocytes_11\NNS\5467432|of|gs- (l_amod) gs-_8\NN\1740|and|gfap-ir
16484281T2_16484281T22 NONE ethanol_0\NN\14708720| (r_compound) withdrawal_1\NN\7206096|ethanol (r_nsubj) increased_3\VBD\169651|withdrawal|significantly|density|compared|. (l_dobj) density_6\NN\4941325|the|packing|astrocytes|plc (l_nmod) astrocytes_11\NNS\5467432|of|gs- (l_amod) gs-_8\NN\1740|and|gfap-ir (l_conj) gfap-ir_10\JJ\1740|
16484281T3_16484281T23 NONE ethanol_11\NN\14708720| (r_compound) consumption_12\NN\13440063|between|the|pre-withdrawal|ethanol|and|density (l_conj) density_16\NN\4941325|the|packing|astrocytes (l_nmod) astrocytes_19\NNS\5467432|of|gs-ir (l_amod) gs-ir_18\NN\1740|
16484281T4_16484281T24 NONE ethanol_20\NN\14708720| (r_compound) consumption_21\NN\13440063|from|free-choice|ethanol (r_nmod) withdrawal_17\NN\7206096|with|consumption (r_nmod) associated_15\VBN\628491|withdrawal (r_acl) activation_14\NN\13561719|of|the|glutamatergic|associated (r_nmod) regulation_10\NN\6652242|in|the|activation (r_nmod) involvement_5\NN\1080366|the|astrocytes|regulation (r_dobj) suggest_3\VBP\1010118|results|involvement|and|point|. (l_conj) point_23\VBP\831651|adaptations (l_nmod) adaptations_26\NNS\6362953|to|differential|gs|drinking (l_nmod) gs_28\NN\13717155|of|and|gfap
16484281T4_16484281T25 NONE ethanol_20\NN\14708720| (r_compound) consumption_21\NN\13440063|from|free-choice|ethanol (r_nmod) withdrawal_17\NN\7206096|with|consumption (r_nmod) associated_15\VBN\628491|withdrawal (r_acl) activation_14\NN\13561719|of|the|glutamatergic|associated (r_nmod) regulation_10\NN\6652242|in|the|activation (r_nmod) involvement_5\NN\1080366|the|astrocytes|regulation (r_dobj) suggest_3\VBP\1010118|results|involvement|and|point|. (l_conj) point_23\VBP\831651|adaptations (l_nmod) adaptations_26\NNS\6362953|to|differential|gs|drinking (l_nmod) gs_28\NN\13717155|of|and|gfap (l_conj) gfap_30\NN\1740|
16484281T5_16484281T24 NONE alcohol_33\NN\7881800| (r_compound) drinking_34\NN\838098|to|prolonged|alcohol|plc (r_nmod) adaptations_26\NNS\6362953|to|differential|gs|drinking (l_nmod) gs_28\NN\13717155|of|and|gfap
16484281T5_16484281T25 NONE alcohol_33\NN\7881800| (r_compound) drinking_34\NN\838098|to|prolonged|alcohol|plc (r_nmod) adaptations_26\NNS\6362953|to|differential|gs|drinking (l_nmod) gs_28\NN\13717155|of|and|gfap (l_conj) gfap_30\NN\1740|
17059881
17059881T7_17059881T12 NONE dopamine_0\NN\14807737| (r_compound) occupancy_3\NN\1053920|dopamine|d2|receptor|risperidone|:|implications (l_compound) receptor_2\NN\5225602|
17059881T8_17059881T12 NONE risperidone_5\NN\1740|by (r_nmod) occupancy_3\NN\1053920|dopamine|d2|receptor|risperidone|:|implications (l_compound) receptor_2\NN\5225602|
17059881T5_17059881T9 NONE dopamine_9\NN\14807737| (r_compound) occupancy_12\NN\1053920|dopamine|d2|receptor|risperidone|and|levels (l_compound) receptor_11\NN\5225602|
17059881T6_17059881T9 NONE risperidone_14\NN\1740|by (r_nmod) occupancy_12\NN\1053920|dopamine|d2|receptor|risperidone|and|levels (l_compound) receptor_11\NN\5225602|
17059881T1_17059881T11 NONE risperidone_17\NN\1740|with (r_nmod) treatment_15\NN\654885|of|risperidone (r_nmod) beginning_13\NN\7283608|at|the|treatment (r_nmod) occupancy_10\NN\1053920|d2|receptor|beginning (l_compound) receptor_9\NN\5225602|
23481176
12699699
12699699T1_12699699T11 NONE nadph-cytochrome_11\NN\1740| (r_compound) reductase_13\NN\14732946|of|either|nadph-cytochrome|p450|or|reductase (r_nmod) presence_8\NN\13954253|in|the|reductase (r_nmod) underwent_4\VBD\109660|protein|reduction|presence|but|exhibit|. (l_nsubj) protein_3\NN\14944888|the|isolated|ylr205c (l_compound) ylr205c_2\NN\1740|
12699699T1_12699699T12 NONE nadph-cytochrome_11\NN\1740| (r_compound) reductase_13\NN\14732946|of|either|nadph-cytochrome|p450|or|reductase
12699699T1_12699699T14 NONE nadph-cytochrome_11\NN\1740| (r_compound) reductase_13\NN\14732946|of|either|nadph-cytochrome|p450|or|reductase (l_conj) reductase_16\NN\14732946|nadh-putidaredoxin-putidaredoxin
12699699T1_12699699T15 NONE nadph-cytochrome_11\NN\1740| (r_compound) reductase_13\NN\14732946|of|either|nadph-cytochrome|p450|or|reductase (r_nmod) presence_8\NN\13954253|in|the|reductase (r_nmod) underwent_4\VBD\109660|protein|reduction|presence|but|exhibit|. (l_conj) exhibit_20\VB\2632167|did|not|activity (l_dobj) activity_23\NN\30358|heme|oxygenase (l_compound) oxygenase_22\NN\14971969|
12699699T2_12699699T11 NONE nadh-putidaredoxin-putidaredoxin_15\NN\1740| (r_compound) reductase_16\NN\14732946|nadh-putidaredoxin-putidaredoxin (r_conj) reductase_13\NN\14732946|of|either|nadph-cytochrome|p450|or|reductase (r_nmod) presence_8\NN\13954253|in|the|reductase (r_nmod) underwent_4\VBD\109660|protein|reduction|presence|but|exhibit|. (l_nsubj) protein_3\NN\14944888|the|isolated|ylr205c (l_compound) ylr205c_2\NN\1740|
12699699T2_12699699T12 NONE nadh-putidaredoxin-putidaredoxin_15\NN\1740| (r_compound) reductase_16\NN\14732946|nadh-putidaredoxin-putidaredoxin (r_conj) reductase_13\NN\14732946|of|either|nadph-cytochrome|p450|or|reductase
12699699T2_12699699T14 NONE nadh-putidaredoxin-putidaredoxin_15\NN\1740| (r_compound) reductase_16\NN\14732946|nadh-putidaredoxin-putidaredoxin
12699699T2_12699699T15 NONE nadh-putidaredoxin-putidaredoxin_15\NN\1740| (r_compound) reductase_16\NN\14732946|nadh-putidaredoxin-putidaredoxin (r_conj) reductase_13\NN\14732946|of|either|nadph-cytochrome|p450|or|reductase (r_nmod) presence_8\NN\13954253|in|the|reductase (r_nmod) underwent_4\VBD\109660|protein|reduction|presence|but|exhibit|. (l_conj) exhibit_20\VB\2632167|did|not|activity (l_dobj) activity_23\NN\30358|heme|oxygenase (l_compound) oxygenase_22\NN\14971969|
12699699T3_12699699T16 CPR:3 h(2)o(2)-dependent_4\NN\1740| (r_compound) activities_6\NNS\30358|modest|h(2)o(2)-dependent|peroxidase (l_compound) peroxidase_5\NN\14971234|
12699699T4_12699699T16 CPR:9 guaiacol_8\NN\1740|with|,|iodide|,|and|acid (r_nmod) exhibited_2\VBD\2632167|protein|activities|guaiacol|. (l_dobj) activities_6\NNS\30358|modest|h(2)o(2)-dependent|peroxidase (l_compound) peroxidase_5\NN\14971234|
12699699T5_12699699T16 CPR:9 iodide_11\NN\14904359|potassium (r_conj) guaiacol_8\NN\1740|with|,|iodide|,|and|acid (r_nmod) exhibited_2\VBD\2632167|protein|activities|guaiacol|. (l_dobj) activities_6\NNS\30358|modest|h(2)o(2)-dependent|peroxidase (l_compound) peroxidase_5\NN\14971234|
12699699T6_12699699T16 CPR:9 acid_15\NN\14818238|2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic|abts (r_conj) guaiacol_8\NN\1740|with|,|iodide|,|and|acid (r_nmod) exhibited_2\VBD\2632167|protein|activities|guaiacol|. (l_dobj) activities_6\NNS\30358|modest|h(2)o(2)-dependent|peroxidase (l_compound) peroxidase_5\NN\14971234|
12699699T7_12699699T16 CPR:9 abts_17\NN\1740|(|) (r_appos) acid_15\NN\14818238|2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic|abts (r_conj) guaiacol_8\NN\1740|with|,|iodide|,|and|acid (r_nmod) exhibited_2\VBD\2632167|protein|activities|guaiacol|. (l_dobj) activities_6\NNS\30358|modest|h(2)o(2)-dependent|peroxidase (l_compound) peroxidase_5\NN\14971234|
23419036
23019274
23019274T5_23019274T16 NONE acid_38\NN\14818238|aristolochic|(aa)-induced (r_compound) injury_41\NN\14052046|acid|kidney|mice (r_conj) reperfusion_35\NN\1740|in|ischemia|and|injury (r_nmod) markers_32\NNS\21939|to|other|standard|reperfusion (r_nmod) relative_28\JJ\1740|markers (r_amod) sensitivity_25\NN\5651971|the|kim-1|relative (r_dobj) compare_23\VBP\644583|sensitivity (r_conj) report_3\VBP\831651|here|,|we|development|and|compare|. (l_dobj) development_5\NN\248977|the|and|validation|assays (l_nmod) assays_11\NNS\5733583|of|two|different|assessment (l_nmod) assessment_14\NN\5732756|for|quantitative|kim-1 (l_nmod) kim-1_18\NN\1740|of|mouse|urinary|ukim-1
23019274T5_23019274T17 NONE acid_38\NN\14818238|aristolochic|(aa)-induced (r_compound) injury_41\NN\14052046|acid|kidney|mice (r_conj) reperfusion_35\NN\1740|in|ischemia|and|injury (r_nmod) markers_32\NNS\21939|to|other|standard|reperfusion (r_nmod) relative_28\JJ\1740|markers (r_amod) sensitivity_25\NN\5651971|the|kim-1|relative (r_dobj) compare_23\VBP\644583|sensitivity (r_conj) report_3\VBP\831651|here|,|we|development|and|compare|. (l_dobj) development_5\NN\248977|the|and|validation|assays (l_nmod) assays_11\NNS\5733583|of|two|different|assessment (l_nmod) assessment_14\NN\5732756|for|quantitative|kim-1 (l_nmod) kim-1_18\NN\1740|of|mouse|urinary|ukim-1 (l_appos) ukim-1_20\NN\1740|(|)
23019274T5_23019274T18 NONE acid_38\NN\14818238|aristolochic|(aa)-induced (r_compound) injury_41\NN\14052046|acid|kidney|mice (r_conj) reperfusion_35\NN\1740|in|ischemia|and|injury (r_nmod) markers_32\NNS\21939|to|other|standard|reperfusion (r_nmod) relative_28\JJ\1740|markers (r_amod) sensitivity_25\NN\5651971|the|kim-1|relative (l_nmod) kim-1_27\NN\1740|of
23019274T1_23019274T9 NONE creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (r_nsubj) change_37\VB\46534|whereas|creatinine|did|not (r_advcl) elevated_12\VBN\2391803|ischemia|,|ukim-1|was|significantly|13-fold|,|change|. (l_nsubj) ukim-1_9\NN\1740|
23019274T1_23019274T10 NONE creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (l_conj) n-acetyl-β-glucosaminidase_27\NN\1740|nag
23019274T1_23019274T11 NONE creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (l_conj) n-acetyl-β-glucosaminidase_27\NN\1740|nag (l_appos) nag_29\NN\9631463|(|)
23019274T2_23019274T9 NONE urea_24\NN\14727670| (r_compound) nitrogen_25\NN\14622893|blood|urea (r_conj) creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (r_nsubj) change_37\VB\46534|whereas|creatinine|did|not (r_advcl) elevated_12\VBN\2391803|ischemia|,|ukim-1|was|significantly|13-fold|,|change|. (l_nsubj) ukim-1_9\NN\1740|
23019274T2_23019274T10 NONE urea_24\NN\14727670| (r_compound) nitrogen_25\NN\14622893|blood|urea (r_conj) creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (l_conj) n-acetyl-β-glucosaminidase_27\NN\1740|nag
23019274T2_23019274T11 NONE urea_24\NN\14727670| (r_compound) nitrogen_25\NN\14622893|blood|urea (r_conj) creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (l_conj) n-acetyl-β-glucosaminidase_27\NN\1740|nag (l_appos) nag_29\NN\9631463|(|)
23019274T3_23019274T9 NONE nitrogen_25\NN\14622893|blood|urea (r_conj) creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (r_nsubj) change_37\VB\46534|whereas|creatinine|did|not (r_advcl) elevated_12\VBN\2391803|ischemia|,|ukim-1|was|significantly|13-fold|,|change|. (l_nsubj) ukim-1_9\NN\1740|
23019274T3_23019274T10 NONE nitrogen_25\NN\14622893|blood|urea (r_conj) creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (l_conj) n-acetyl-β-glucosaminidase_27\NN\1740|nag
23019274T3_23019274T11 NONE nitrogen_25\NN\14622893|blood|urea (r_conj) creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (l_conj) n-acetyl-β-glucosaminidase_27\NN\1740|nag (l_appos) nag_29\NN\9631463|(|)
23019274T4_23019274T9 NONE n-acetyl-β-glucosaminidase_27\NN\1740|nag (r_conj) creatinine_18\NN\1740|serum|scr|,|nitrogen|,|n-acetyl-β-glucosaminidase|,|and|levels (r_nsubj) change_37\VB\46534|whereas|creatinine|did|not (r_advcl) elevated_12\VBN\2391803|ischemia|,|ukim-1|was|significantly|13-fold|,|change|. (l_nsubj) ukim-1_9\NN\1740|
23019274T4_23019274T10 NONE n-acetyl-β-glucosaminidase_27\NN\1740|nag
23019274T4_23019274T11 NONE n-acetyl-β-glucosaminidase_27\NN\1740|nag (l_appos) nag_29\NN\9631463|(|)
12871155
12871155T1_12871155T17 CPR:4 pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_appos) ache_3\NN\14322699|(|)
12871155T1_12871155T18 CPR:4 pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche
12871155T1_12871155T19 CPR:4 pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase
12871155T1_12871155T20 CPR:4 pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche (l_appos) buche_8\NN\1740|(|)
12871155T3_12871155T17 CPR:4 [1,8]naphthyridines_23\NNS\1740|6 (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_appos) ache_3\NN\14322699|(|)
12871155T3_12871155T18 CPR:4 [1,8]naphthyridines_23\NNS\1740|6 (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche
12871155T3_12871155T19 CPR:4 [1,8]naphthyridines_23\NNS\1740|6 (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase
12871155T3_12871155T20 CPR:4 [1,8]naphthyridines_23\NNS\1740|6 (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche (l_appos) buche_8\NN\1740|(|)
12871155T4_12871155T17 CPR:4 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines_30\NN\1740| (r_compound) -_32\NN\1740|4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines|(11 (r_appos) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_appos) ache_3\NN\14322699|(|)
12871155T4_12871155T18 CPR:4 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines_30\NN\1740| (r_compound) -_32\NN\1740|4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines|(11 (r_appos) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche
12871155T4_12871155T19 CPR:4 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines_30\NN\1740| (r_compound) -_32\NN\1740|4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines|(11 (r_appos) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase
12871155T4_12871155T20 CPR:4 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines_30\NN\1740| (r_compound) -_32\NN\1740|4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines|(11 (r_appos) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche (l_appos) buche_8\NN\1740|(|)
12871155T5_12871155T17 CPR:4 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine_34\NN\1740|(|14|, (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_appos) ache_3\NN\14322699|(|)
12871155T5_12871155T18 CPR:4 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine_34\NN\1740|(|14|, (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche
12871155T5_12871155T19 CPR:4 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine_34\NN\1740|(|14|, (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase
12871155T5_12871155T20 CPR:4 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine_34\NN\1740|(|14|, (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche (l_appos) buche_8\NN\1740|(|)
12871155T6_12871155T17 CPR:4 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline_39\NN\1740|(15)/ (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_appos) ache_3\NN\14322699|(|)
12871155T6_12871155T18 CPR:4 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline_39\NN\1740|(15)/ (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche
12871155T6_12871155T19 CPR:4 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline_39\NN\1740|(15)/ (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase
12871155T6_12871155T20 CPR:4 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline_39\NN\1740|(15)/ (r_dep) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche (l_appos) buche_8\NN\1740|(|)
12871155T7_12871155T17 CPR:4 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]thieno[2,3-b]pyridine_41\NN\1740|( (r_compound) 16_43\CD\13745420|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]thieno[2,3-b]pyridine|) (r_appos) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_appos) ache_3\NN\14322699|(|)
12871155T7_12871155T18 CPR:4 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]thieno[2,3-b]pyridine_41\NN\1740|( (r_compound) 16_43\CD\13745420|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]thieno[2,3-b]pyridine|) (r_appos) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche
12871155T7_12871155T19 CPR:4 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]thieno[2,3-b]pyridine_41\NN\1740|( (r_compound) 16_43\CD\13745420|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]thieno[2,3-b]pyridine|) (r_appos) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase
12871155T7_12871155T20 CPR:4 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]thieno[2,3-b]pyridine_41\NN\1740|( (r_compound) 16_43\CD\13745420|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]thieno[2,3-b]pyridine|) (r_appos) pyrano[2,3-b]quinolines_16\NN\1740|of|2|[1,8]naphthyridines|,|-|13)/|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5h-cyclohepta[e]furo[2,3-b]pyridine|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|16 (r_nmod) series_14\NN\8456993|of|a|pyrano[2,3-b]quinolines (r_nmod) activities_11\NNS\30358|acetylcholinesterase|inhibitory|series (l_compound) acetylcholinesterase_1\NN\1740|the|ache|and|butyrylcholinesterase (l_conj) butyrylcholinesterase_6\NN\1740|buche (l_appos) buche_8\NN\1740|(|)
12871155T14_12871155T21 CPR:4 tacrine_30\NN\1740|than (r_nmod) active_28\JJ\1740|though|less|tacrine (r_advcl) competitive_3\JJ\1740|compounds|are|and|,|cases|,|inhibitors|,|compound|active|. (l_conj) inhibitors_12\NNS\20090|non-competitive|ache (l_nmod) ache_14\NN\14322699|for
12871155T2_12871155T15 CPR:4 tacrine_17\NN\1740|than (r_nmod) active_15\JJ\1740|less|tacrine (r_amod) compounds_8\NNS\5869584|in|11|,|active (r_nmod) significant_6\JJ\1740|activity|is|only|compounds|. (l_nsubj) activity_3\NN\30358|the|buche|inhibitory (l_compound) buche_1\NN\1740|
20104269
20104269T3_20104269T19 NONE acid_23\NN\14818238|chenodeoxycholic (r_nmod:npmod) (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (r_nmod) involvement_3\NN\1080366|the|receptor|expression (l_nmod) receptor_8\NN\5225602|of|the|farnesoid|x|fxr|,|receptor|,
20104269T3_20104269T20 NONE acid_23\NN\14818238|chenodeoxycholic (r_nmod:npmod) (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (r_nmod) involvement_3\NN\1080366|the|receptor|expression (l_nmod) receptor_8\NN\5225602|of|the|farnesoid|x|fxr|,|receptor|, (l_appos) fxr_10\NN\1740|(|)
20104269T3_20104269T21 NONE acid_23\NN\14818238|chenodeoxycholic (r_nmod:npmod) (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (r_nmod) involvement_3\NN\1080366|the|receptor|expression (l_nmod) receptor_8\NN\5225602|of|the|farnesoid|x|fxr|,|receptor|, (l_appos) receptor_15\NN\5225602|a|nuclear|acids
20104269T3_20104269T22 CPR:3 acid_23\NN\14818238|chenodeoxycholic (r_nmod:npmod) (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (l_nmod) cdx2_27\NN\1740|of|and|muc2|cells
20104269T3_20104269T23 CPR:3 acid_23\NN\14818238|chenodeoxycholic (r_nmod:npmod) (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (l_nmod) cdx2_27\NN\1740|of|and|muc2|cells (l_conj) muc2_29\NN\1740|
20104269T4_20104269T19 NONE (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (r_nmod) involvement_3\NN\1080366|the|receptor|expression (l_nmod) receptor_8\NN\5225602|of|the|farnesoid|x|fxr|,|receptor|,
20104269T4_20104269T20 NONE (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (r_nmod) involvement_3\NN\1080366|the|receptor|expression (l_nmod) receptor_8\NN\5225602|of|the|farnesoid|x|fxr|,|receptor|, (l_appos) fxr_10\NN\1740|(|)
20104269T4_20104269T21 NONE (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (r_nmod) involvement_3\NN\1080366|the|receptor|expression (l_nmod) receptor_8\NN\5225602|of|the|farnesoid|x|fxr|,|receptor|, (l_appos) receptor_15\NN\5225602|a|nuclear|acids
20104269T4_20104269T22 CPR:3 (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (l_nmod) cdx2_27\NN\1740|of|and|muc2|cells
20104269T4_20104269T23 CPR:3 (cdca)-induced_24\JJ\1740|acid (r_amod) expression_25\NN\4679549|in|the|(cdca)-induced|cdx2 (l_nmod) cdx2_27\NN\1740|of|and|muc2|cells (l_conj) muc2_29\NN\1740|
20104269T5_20104269T24 CPR:5 cdca_5\NN\1740|with|or|gw4064|,|agonist|, (l_appos) agonist_11\NN\9613191|an|fxr (l_compound) fxr_10\NN\1740|
20104269T5_20104269T25 NONE cdca_5\NN\1740|with|or|gw4064|,|agonist|, (r_nmod) treated_3\VBN\2376958|cells|were|cdca|presence|. (l_nmod) presence_15\NN\13954253|in|the|or|absence|guggulsterone (l_nmod) guggulsterone_19\NN\1740|of|,|antagonist (l_appos) antagonist_23\NN\7846|an|fxr (l_compound) fxr_22\NN\1740|
20104269T6_20104269T24 CPR:5 gw4064_7\NN\1740| (r_conj) cdca_5\NN\1740|with|or|gw4064|,|agonist|, (l_appos) agonist_11\NN\9613191|an|fxr (l_compound) fxr_10\NN\1740|
20104269T6_20104269T25 NONE gw4064_7\NN\1740| (r_conj) cdca_5\NN\1740|with|or|gw4064|,|agonist|, (r_nmod) treated_3\VBN\2376958|cells|were|cdca|presence|. (l_nmod) presence_15\NN\13954253|in|the|or|absence|guggulsterone (l_nmod) guggulsterone_19\NN\1740|of|,|antagonist (l_appos) antagonist_23\NN\7846|an|fxr (l_compound) fxr_22\NN\1740|
20104269T7_20104269T24 NONE guggulsterone_19\NN\1740|of|,|antagonist (r_nmod) presence_15\NN\13954253|in|the|or|absence|guggulsterone (r_nmod) treated_3\VBN\2376958|cells|were|cdca|presence|. (l_nmod) cdca_5\NN\1740|with|or|gw4064|,|agonist|, (l_appos) agonist_11\NN\9613191|an|fxr (l_compound) fxr_10\NN\1740|
20104269T7_20104269T25 CPR:6 guggulsterone_19\NN\1740|of|,|antagonist (l_appos) antagonist_23\NN\7846|an|fxr (l_compound) fxr_22\NN\1740|
20104269T8_20104269T26 CPR:3 cdca_0\NN\1740| (r_nsubj) induced_1\VBD\1627355|cdca|expression|levels|. (l_dobj) expression_3\NN\4679549|dose-dependent|cdx2 (l_nmod) cdx2_5\NN\1740|of|and|muc2
20104269T8_20104269T27 CPR:3 cdca_0\NN\1740| (r_nsubj) induced_1\VBD\1627355|cdca|expression|levels|. (l_dobj) expression_3\NN\4679549|dose-dependent|cdx2 (l_nmod) cdx2_5\NN\1740|of|and|muc2 (l_conj) muc2_7\NN\1740|
20104269T9_20104269T28 CPR:3 cdca_10\NN\1740|by (r_nmod) induced_8\VBN\1627355|cdca (r_acl) cdx2_4\NN\1740|of|and|muc2|mrna|induced
20104269T9_20104269T29 CPR:3 cdca_10\NN\1740|by (r_nmod) induced_8\VBN\1627355|cdca (r_acl) cdx2_4\NN\1740|of|and|muc2|mrna|induced (l_conj) muc2_6\NN\1740|
20104269T1_20104269T12 NONE gw4064_5\NN\1740| (r_conj) cdca_3\NN\1740|of|and|gw4064 (r_nmod) effects_1\NNS\13245626|the|cdca|expression (l_nmod) expression_7\NN\4679549|on|cdx2 (l_nmod) cdx2_9\NN\1740|of|and|muc2
20104269T1_20104269T13 NONE gw4064_5\NN\1740| (r_conj) cdca_3\NN\1740|of|and|gw4064 (r_nmod) effects_1\NNS\13245626|the|cdca|expression (l_nmod) expression_7\NN\4679549|on|cdx2 (l_nmod) cdx2_9\NN\1740|of|and|muc2 (l_conj) muc2_11\NN\1740|
20104269T2_20104269T12 CPR:4 guggulsterone_15\NN\1740|by (r_nmod) abolished_13\VBN\1740|effects|were|guggulsterone|. (l_nsubjpass) effects_1\NNS\13245626|the|cdca|expression (l_nmod) expression_7\NN\4679549|on|cdx2 (l_nmod) cdx2_9\NN\1740|of|and|muc2
20104269T2_20104269T13 CPR:4 guggulsterone_15\NN\1740|by (r_nmod) abolished_13\VBN\1740|effects|were|guggulsterone|. (l_nsubjpass) effects_1\NNS\13245626|the|cdca|expression (l_nmod) expression_7\NN\4679549|on|cdx2 (l_nmod) cdx2_9\NN\1740|of|and|muc2 (l_conj) muc2_11\NN\1740|
20104269T11_20104269T12 NONE cdca_3\NN\1740|of|and|gw4064 (r_nmod) effects_1\NNS\13245626|the|cdca|expression (l_nmod) expression_7\NN\4679549|on|cdx2 (l_nmod) cdx2_9\NN\1740|of|and|muc2
20104269T11_20104269T13 NONE cdca_3\NN\1740|of|and|gw4064 (r_nmod) effects_1\NNS\13245626|the|cdca|expression (l_nmod) expression_7\NN\4679549|on|cdx2 (l_nmod) cdx2_9\NN\1740|of|and|muc2 (l_conj) muc2_11\NN\1740|
23619386
23619386T10_23619386T25 NONE rapamycin_0\NN\1740| (r_nsubj) inhibits_2\VBZ\2510337|rapamycin|allosterically|proteasome|. (l_dobj) proteasome_4\NN\1740|the
23619386T1_23619386T22 NONE rapamycin_0\NN\1740| (r_nsubj) inhibitor_5\NN\20090|rapamycin|is|a|canonical|allosteric|kinase|activities|. (l_nmod) kinase_9\NN\14732946|of|the|mtor (l_compound) mtor_8\NN\1740|
23619386T1_23619386T23 NONE rapamycin_0\NN\1740| (r_nsubj) inhibitor_5\NN\20090|rapamycin|is|a|canonical|allosteric|kinase|activities|. (l_nmod) kinase_9\NN\14732946|of|the|mtor
23619386T6_23619386T14 NONE rapamycin_5\NN\1740| (r_nsubj) regulates_7\VBZ\296178|that|in|rapamycin|also|proteasome (l_dobj) proteasome_9\NN\1740|the|,|protease
23619386T6_23619386T15 NONE rapamycin_5\NN\1740| (r_nsubj) regulates_7\VBZ\296178|that|in|rapamycin|also|proteasome (l_dobj) proteasome_9\NN\1740|the|,|protease (l_appos) protease_14\NN\14732946|an|essential|intracellular|pathway (l_nmod) pathway_18\NN\5483677|of|the|ubiquitin-proteasome (l_amod) ubiquitin-proteasome_17\NN\1740|
23619386T6_23619386T16 NONE rapamycin_5\NN\1740| (r_nsubj) regulates_7\VBZ\296178|that|in|rapamycin|also|proteasome (l_dobj) proteasome_9\NN\1740|the|,|protease (l_appos) protease_14\NN\14732946|an|essential|intracellular|pathway (l_nmod) pathway_18\NN\5483677|of|the|ubiquitin-proteasome (l_amod) ubiquitin-proteasome_17\NN\1740|
23619386T7_23619386T17 CPR:4 rapamycin_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|rapamycin|activities|concentrations|. (l_dobj) activities_6\NNS\30358|proteinase|proteasome (l_compound) proteinase_2\NN\14732946|and|peptidase
23619386T7_23619386T18 CPR:4 rapamycin_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|rapamycin|activities|concentrations|. (l_dobj) activities_6\NNS\30358|proteinase|proteasome (l_compound) proteinase_2\NN\14732946|and|peptidase (l_conj) peptidase_5\NN\14732946|selected
23619386T7_23619386T19 CPR:4 rapamycin_0\NN\1740| (r_nsubj) inhibits_1\VBZ\2510337|rapamycin|activities|concentrations|. (l_dobj) activities_6\NNS\30358|proteinase|proteasome (l_nmod) proteasome_11\NN\1740|of|the|core
23619386T2_23619386T24 NONE seco-rapamycin_34\NN\1740|with (r_conj) mimics_30\NNS\10200365|also|with|its|domain|,|and|seco-rapamycin (r_conj) analogs_19\NNS\4743605|only|with|other|two-domain|,|closed-ring|rapalogs|,|but|mimics (r_nmod) shares_6\VBZ\2660631|that|rapamycin|properties|analogs (l_dobj) properties_11\NNS\32613|all|the|proteasome|targeting (l_compound) proteasome_9\NN\1740|
23619386T9_23619386T24 NONE rapamycin_5\NN\1740| (r_nsubj) shares_6\VBZ\2660631|that|rapamycin|properties|analogs (l_dobj) properties_11\NNS\32613|all|the|proteasome|targeting (l_compound) proteasome_9\NN\1740|
23619386T3_23619386T11 NONE rapamycin_10\NN\1740|of (r_nmod) metabolite_8\NN\20090|latter|is|the|first|in|open-ring|rapamycin|affect|. (l_acl:relcl) affect_14\VB\126264|that|does|not|mtor (l_dobj) mtor_15\NNP\1740|
23619386T4_23619386T12 NONE rapamycin_4\NN\1740|the|and|compounds (r_nsubj) bind_8\VBP\1290422|that|rapamycin|face|and|impact (l_conj) impact_15\VBP\1527271|allosterically|function (l_dobj) function_18\NN\13783581|the|proteasome (l_compound) proteasome_17\NN\1740|
23619386T5_23619386T13 NONE rapamycin_12\NN\1740|of (r_nmod) actions_10\NNS\30358|of|in|rapamycin (r_nmod) mechanism_6\NN\13446390|for|actions|and|design (l_conj) design_15\NN\927261|for|drugs (l_nmod) drugs_19\NNS\14778436|of|novel|allosteric|targeting (l_acl) targeting_20\VBG\1151110|proteasome (l_dobj) proteasome_22\NN\1740|the
23297831
11732752
11732752T11_11732752T15 NONE leucine_12\NN\14605787| (r_compound) aminopeptidase_13\NN\1740|leucine (r_conj) n_10\NN\14622893|(|aminopeptidase|,|aminopeptidase|,|a|and|b|) (l_conj) a_16\NN\13649268|aminopeptidase
11732752T11_11732752T17 NONE leucine_12\NN\14605787| (r_compound) aminopeptidase_13\NN\1740|leucine (r_conj) n_10\NN\14622893|(|aminopeptidase|,|aminopeptidase|,|a|and|b|) (l_conj) b_19\NN\1355326|aminopeptidase
11732752T11_11732752T20 NONE leucine_12\NN\14605787| (r_compound) aminopeptidase_13\NN\1740|leucine (r_conj) n_10\NN\14622893|(|aminopeptidase|,|aminopeptidase|,|a|and|b|) (r_dep) aminopeptidases_7\NNS\1740|of|four|different|n
11732752T11_11732752T24 NONE leucine_12\NN\14605787| (r_compound) aminopeptidase_13\NN\1740|leucine (r_conj) n_10\NN\14622893|(|aminopeptidase|,|aminopeptidase|,|a|and|b|)
11732752T11_11732752T27 NONE leucine_12\NN\14605787| (r_compound) aminopeptidase_13\NN\1740|leucine
11732752T2_11732752T19 NONE 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T2_11732752T21 CPR:9 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T2_11732752T22 NONE 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_appos) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (l_nmod) aminopeptidase_29\NN\1740|for|leucine
11732752T2_11732752T23 NONE 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_conj) 4-methoxy-2-naphthylamide_31\NN\1740|acid (l_nmod) acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T2_11732752T25 NONE 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T3_11732752T19 NONE l-alanine_19\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T3_11732752T21 CPR:9 l-alanine_19\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T3_11732752T22 NONE l-alanine_19\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_appos) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (l_nmod) aminopeptidase_29\NN\1740|for|leucine
11732752T3_11732752T23 NONE l-alanine_19\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_conj) 4-methoxy-2-naphthylamide_31\NN\1740|acid (l_nmod) acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T3_11732752T25 NONE l-alanine_19\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T4_11732752T19 NONE 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T4_11732752T21 NONE 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T4_11732752T22 CPR:9 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (l_nmod) aminopeptidase_29\NN\1740|for|leucine
11732752T4_11732752T23 NONE 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_conj) 4-methoxy-2-naphthylamide_31\NN\1740|acid (l_nmod) acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T4_11732752T25 NONE 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T5_11732752T19 NONE l-leucine_26\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T5_11732752T21 NONE l-leucine_26\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T5_11732752T22 CPR:9 l-leucine_26\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (l_nmod) aminopeptidase_29\NN\1740|for|leucine
11732752T5_11732752T23 NONE l-leucine_26\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_conj) 4-methoxy-2-naphthylamide_31\NN\1740|acid (l_nmod) acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T5_11732752T25 NONE l-leucine_26\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T6_11732752T19 NONE leucine_28\NN\14605787| (r_compound) aminopeptidase_29\NN\1740|for|leucine (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T6_11732752T21 NONE leucine_28\NN\14605787| (r_compound) aminopeptidase_29\NN\1740|for|leucine (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T6_11732752T22 NONE leucine_28\NN\14605787| (r_compound) aminopeptidase_29\NN\1740|for|leucine
11732752T6_11732752T23 NONE leucine_28\NN\14605787| (r_compound) aminopeptidase_29\NN\1740|for|leucine (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_conj) 4-methoxy-2-naphthylamide_31\NN\1740|acid (l_nmod) acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T6_11732752T25 NONE leucine_28\NN\14605787| (r_compound) aminopeptidase_29\NN\1740|for|leucine (r_nmod) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (r_appos) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T7_11732752T19 NONE 4-methoxy-2-naphthylamide_31\NN\1740|acid (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T7_11732752T21 NONE 4-methoxy-2-naphthylamide_31\NN\1740|acid (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T7_11732752T22 NONE 4-methoxy-2-naphthylamide_31\NN\1740|acid (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_appos) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (l_nmod) aminopeptidase_29\NN\1740|for|leucine
11732752T7_11732752T23 CPR:9 4-methoxy-2-naphthylamide_31\NN\1740|acid (l_nmod) acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T7_11732752T25 NONE 4-methoxy-2-naphthylamide_31\NN\1740|acid (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T8_11732752T19 NONE acid_34\NN\14818238|of|l-glutamic|a (r_nmod) 4-methoxy-2-naphthylamide_31\NN\1740|acid (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T8_11732752T21 NONE acid_34\NN\14818238|of|l-glutamic|a (r_nmod) 4-methoxy-2-naphthylamide_31\NN\1740|acid (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T8_11732752T22 NONE acid_34\NN\14818238|of|l-glutamic|a (r_nmod) 4-methoxy-2-naphthylamide_31\NN\1740|acid (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_appos) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (l_nmod) aminopeptidase_29\NN\1740|for|leucine
11732752T8_11732752T23 CPR:9 acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T8_11732752T25 NONE acid_34\NN\14818238|of|l-glutamic|a (r_nmod) 4-methoxy-2-naphthylamide_31\NN\1740|acid (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T9_11732752T19 NONE 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T9_11732752T21 NONE 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T9_11732752T22 NONE 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_appos) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (l_nmod) aminopeptidase_29\NN\1740|for|leucine
11732752T9_11732752T23 NONE 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_conj) 4-methoxy-2-naphthylamide_31\NN\1740|acid (l_nmod) acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T9_11732752T25 CPR:9 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T10_11732752T19 NONE l-arginine_41\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_nmod) determination_11\NN\43195|for|the|activity (l_nmod) activity_15\NN\30358|of|aminopeptidase|enzymatic (l_compound) aminopeptidase_13\NN\1740|
11732752T10_11732752T21 NONE l-arginine_41\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_nmod) n_22\NN\14622893|for|aminopeptidase
11732752T10_11732752T22 NONE l-arginine_41\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_appos) 4-methoxy-2-naphthylamide_24\NN\1740|,|l-leucine|aminopeptidase|, (l_nmod) aminopeptidase_29\NN\1740|for|leucine
11732752T10_11732752T23 NONE l-arginine_41\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (l_conj) 4-methoxy-2-naphthylamide_31\NN\1740|acid (l_nmod) acid_34\NN\14818238|of|l-glutamic|a (l_nmod) a_37\NN\13649268|for|aminopeptidase
11732752T10_11732752T25 CPR:9 l-arginine_41\NN\1740|of (r_nmod) 4-methoxy-2-naphthylamide_39\NN\1740|l-arginine|aminopeptidase (r_conj) 4-methoxy-2-naphthylamide_17\NN\1740|l-alanine|n|4-methoxy-2-naphthylamide|4-methoxy-2-naphthylamide|and|4-methoxy-2-naphthylamide (r_dep) used_3\VBN\1156834|substrates|were|substrates|determination|:|4-methoxy-2-naphthylamide|b. (l_punct) b._44\.\1740|
11732752T12_11732752T28 CPR:4 bestatin_9\NN\1740|and (r_compound) inhibitors_12\NNS\20090|of|bestatin|puromycin (r_nmod) presence_7\NN\13954253|in|the|inhibitors (r_nmod) inhibition_1\NN\1068773|the|activity|presence (l_nmod) activity_4\NN\30358|of|aminopeptidase (l_compound) aminopeptidase_3\NN\1740|
11732752T13_11732752T28 CPR:4 puromycin_11\NN\1740| (r_compound) inhibitors_12\NNS\20090|of|bestatin|puromycin (r_nmod) presence_7\NN\13954253|in|the|inhibitors (r_nmod) inhibition_1\NN\1068773|the|activity|presence (l_nmod) activity_4\NN\30358|of|aminopeptidase (l_compound) aminopeptidase_3\NN\1740|
11732752T1_11732752T16 NONE 4-methoxy-2-naphthylamide_11\NN\1740| (r_compound) substrates_12\NNS\19613|of|the|4-methoxy-2-naphthylamide (r_nmod) hydrolysis_6\NN\13447361|of|the|and|inhibition|substrates (r_nmod) results_3\NNS\34213|based|on|the|hydrolysis (r_advcl) difficult_16\JJ\1740|results|,|it|was|have|. (l_xcomp) have_18\VB\2108377|to|decision (l_dobj) decision_21\NN\161243|an|exact|type (l_nmod) type_25\NN\5839024|on|the|aminopeptidase|homogenates (l_compound) aminopeptidase_24\NN\1740|
23537942
11156594
11156594T20_11156594T34 NONE hormone_6\NN\5404728| (r_compound) neurones_7\NNS\1740|in|gonadotrophin-releasing|hormone (r_nmod) receptors_3\NNS\5225602|alpha(1b|)|adrenergic|neurones|:|relation
11156594T20_11156594T35 NONE hormone_6\NN\5404728|
11156594T9_11156594T24 NONE prazosin_26\NN\2698769|by|unlabelled (r_nmod) displaceable_23\JJ\1740|is|prazosin|concentrations (r_conj) binds_13\VBZ\1290422|[(3)h]-prazosin|adrenoceptors|and|displaceable (l_nmod) adrenoceptors_17\NNS\1740|to|alpha(1|)|cells
11156594T12_11156594T24 NONE amines_3\NNS\14951377| (r_dobj) accumulate_2\VBP\2281093|neurones|amines|process|binds (l_parataxis) binds_13\VBZ\1290422|[(3)h]-prazosin|adrenoceptors|and|displaceable (l_nmod) adrenoceptors_17\NNS\1740|to|alpha(1|)|cells
11156594T19_11156594T24 NONE [(3)h]-prazosin_12\NN\1740| (r_nsubj) binds_13\VBZ\1290422|[(3)h]-prazosin|adrenoceptors|and|displaceable (l_nmod) adrenoceptors_17\NNS\1740|to|alpha(1|)|cells
11156594T17_11156594T31 NONE hormone_6\NN\5404728|(|gonadotrophin-releasing|,|gnrh|)
11156594T17_11156594T32 NONE hormone_6\NN\5404728|(|gonadotrophin-releasing|,|gnrh|) (l_appos) gnrh_8\NN\1740|
11156594T17_11156594T33 NONE hormone_6\NN\5404728|(|gonadotrophin-releasing|,|gnrh|) (r_dep) peptidergic_3\NN\1740|hormone (r_compound) line_12\NN\8426461|a|mouse|peptidergic|neuronal|cell|possesses (r_dobj) using_0\VBG\1156834|line (r_advcl) studied_19\VBN\630380|using|,|we|have|interaction (l_dobj) interaction_21\NN\37396|the|adrenoceptors|transport-p. (l_nmod) adrenoceptors_25\NNS\1740|of|alpha(1|)
11156594T18_11156594T31 NONE gnrh_8\NN\1740| (r_appos) hormone_6\NN\5404728|(|gonadotrophin-releasing|,|gnrh|)
11156594T18_11156594T32 NONE gnrh_8\NN\1740|
11156594T18_11156594T33 NONE gnrh_8\NN\1740| (r_appos) hormone_6\NN\5404728|(|gonadotrophin-releasing|,|gnrh|) (r_dep) peptidergic_3\NN\1740|hormone (r_compound) line_12\NN\8426461|a|mouse|peptidergic|neuronal|cell|possesses (r_dobj) using_0\VBG\1156834|line (r_advcl) studied_19\VBN\630380|using|,|we|have|interaction (l_dobj) interaction_21\NN\37396|the|adrenoceptors|transport-p. (l_nmod) adrenoceptors_25\NNS\1740|of|alpha(1|)
11156594T1_11156594T21 NONE gnrh_21\NN\1740| (r_compound) cells_22\NNS\3080309|in|gnrh (r_nmod) present_19\JJ\1740|that|sub-type|is|cells (l_nsubj) sub-type_15\NN\1740|only|the|alpha(1b|)|adrenoceptors (l_nmod) adrenoceptors_17\NNS\1740|of
11156594T1_11156594T22 NONE gnrh_21\NN\1740|
11156594T2_11156594T23 NONE [(3)h]-prazosin_22\NN\1740| (r_nsubjpass) displaced_24\VBN\1850315|cells|,|[(3)h]-prazosin|was|prazosin|process|,|paradox (l_nmod) cells_2\NNS\3080309|in|cos|transfected|and|cells (l_acl) transfected_3\VBN\1740|cdna (l_nmod) cdna_8\NN\14830364|with|alpha(1b|)|adrenoceptor (l_compound) adrenoceptor_7\NN\1740|
11156594T2_11156594T25 NONE [(3)h]-prazosin_22\NN\1740| (r_nsubjpass) displaced_24\VBN\1850315|cells|,|[(3)h]-prazosin|was|prazosin|process|,|paradox (l_nmod) cells_2\NNS\3080309|in|cos|transfected|and|cells (l_conj) cells_14\NNS\3080309|in|ddt(1|)|mf-2|express (l_acl:relcl) express_16\VBP\928630|which|adrenoceptors (l_dobj) adrenoceptors_20\NNS\1740|native|alpha(1b|)
11156594T3_11156594T23 NONE prazosin_27\NN\2698769|by|unlabelled (r_nmod) displaced_24\VBN\1850315|cells|,|[(3)h]-prazosin|was|prazosin|process|,|paradox (l_nmod) cells_2\NNS\3080309|in|cos|transfected|and|cells (l_acl) transfected_3\VBN\1740|cdna (l_nmod) cdna_8\NN\14830364|with|alpha(1b|)|adrenoceptor (l_compound) adrenoceptor_7\NN\1740|
11156594T3_11156594T25 NONE prazosin_27\NN\2698769|by|unlabelled (r_nmod) displaced_24\VBN\1850315|cells|,|[(3)h]-prazosin|was|prazosin|process|,|paradox (l_nmod) cells_2\NNS\3080309|in|cos|transfected|and|cells (l_conj) cells_14\NNS\3080309|in|ddt(1|)|mf-2|express (l_acl:relcl) express_16\VBP\928630|which|adrenoceptors (l_dobj) adrenoceptors_20\NNS\1740|native|alpha(1b|)
11156594T4_11156594T23 NONE prazosin_36\NN\2698769| (r_compound) paradox_37\NN\7206887|with|no|prazosin|concentrations (r_nmod) displaced_24\VBN\1850315|cells|,|[(3)h]-prazosin|was|prazosin|process|,|paradox (l_nmod) cells_2\NNS\3080309|in|cos|transfected|and|cells (l_acl) transfected_3\VBN\1740|cdna (l_nmod) cdna_8\NN\14830364|with|alpha(1b|)|adrenoceptor (l_compound) adrenoceptor_7\NN\1740|
11156594T4_11156594T25 NONE prazosin_36\NN\2698769| (r_compound) paradox_37\NN\7206887|with|no|prazosin|concentrations (r_nmod) displaced_24\VBN\1850315|cells|,|[(3)h]-prazosin|was|prazosin|process|,|paradox (l_nmod) cells_2\NNS\3080309|in|cos|transfected|and|cells (l_conj) cells_14\NNS\3080309|in|ddt(1|)|mf-2|express (l_acl:relcl) express_16\VBP\928630|which|adrenoceptors (l_dobj) adrenoceptors_20\NNS\1740|native|alpha(1b|)
11156594T5_11156594T26 NONE [(3)h]-prazosin_6\NN\1740| (r_nsubjpass) displaced_8\VBN\1850315|cells|,|[(3)h]-prazosin|was|likewise|series|. (l_nmod) series_12\NN\8456993|by|a|agonists (l_nmod) agonists_17\NNS\9613191|of|alpha(1|)|adrenergic|,|increased (l_punct) )_15\-RRB-\1740|
11156594T6_11156594T26 NONE [(3)h]-prazosin_26\NN\1740|of (r_nmod) binding_24\NN\4688246|the|[(3)h]-prazosin (r_dobj) increased_22\VBD\169651|none|binding (r_acl:relcl) agonists_17\NNS\9613191|of|alpha(1|)|adrenergic|,|increased (l_punct) )_15\-RRB-\1740|
11156594T7_11156594T27 NONE prazosin_3\NN\2698769| (r_compound) paradox_4\NN\7206887|the|prazosin (r_nsubj) due_7\JJ\1740|hence|,|paradox|is|not|function|. (l_nmod) function_10\NN\13783581|to|some|adrenoceptors|,|internalization (l_nmod) adrenoceptors_14\NNS\1740|of|alpha(1|)
11156594T8_11156594T28 NONE prazosin_22\NN\2698769| (r_compound) paradox_23\NN\7206887|the|prazosin (r_nsubj) unaltered_25\JJ\1740|paradox|was (r_conj) resulted_12\VBD\2633881|neurones|,|transfection|over-expression|,|but|unaltered|. (l_nsubj) transfection_6\NN\1740|cdna (l_nmod) cdna_11\NN\14830364|with|alpha(1b|)|adrenoceptor (l_compound) adrenoceptor_10\NN\1740|
11156594T8_11156594T29 NONE prazosin_22\NN\2698769| (r_compound) paradox_23\NN\7206887|the|prazosin (r_nsubj) unaltered_25\JJ\1740|paradox|was (r_conj) resulted_12\VBD\2633881|neurones|,|transfection|over-expression|,|but|unaltered|. (l_nmod) over-expression_14\NN\1740|in|adrenoceptors (l_nmod) adrenoceptors_18\NNS\1740|of|alpha(1b|)
23453071
23453071T2_23453071T10 CPR:4 brn-103_6\NN\1740|,|derivative|, (r_nsubj) inhibits_12\VBZ\2510337|that|brn-103|signaling (l_dobj) signaling_19\NN\33020|factor|(vegf)-mediated|angiogenesis|cells (l_punct) (vegf)-mediated_17\JJ\1740|
23453071T2_23453071T13 CPR:4 brn-103_6\NN\1740|,|derivative|, (r_nsubj) inhibits_12\VBZ\2510337|that|brn-103|signaling (l_dobj) signaling_19\NN\33020|factor|(vegf)-mediated|angiogenesis|cells (l_compound) factor_16\NN\7326557|vascular|endothelial|growth
23453071T4_23453071T10 CPR:4 nicotinamide_9\NN\1740| (r_compound) derivative_10\NN\5802185|a|nicotinamide (r_appos) brn-103_6\NN\1740|,|derivative|, (r_nsubj) inhibits_12\VBZ\2510337|that|brn-103|signaling (l_dobj) signaling_19\NN\33020|factor|(vegf)-mediated|angiogenesis|cells (l_punct) (vegf)-mediated_17\JJ\1740|
23453071T4_23453071T13 CPR:4 nicotinamide_9\NN\1740| (r_compound) derivative_10\NN\5802185|a|nicotinamide (r_appos) brn-103_6\NN\1740|,|derivative|, (r_nsubj) inhibits_12\VBZ\2510337|that|brn-103|signaling (l_dobj) signaling_19\NN\33020|factor|(vegf)-mediated|angiogenesis|cells (l_compound) factor_16\NN\7326557|vascular|endothelial|growth
23453071T6_23453071T11 CPR:4 brn-250_2\NN\1740| (r_nsubj) inhibited_3\VBD\2510337|furthermore|,|brn-250|phosphorylation|. (l_dobj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_amod) vegf-induced_5\JJ\1740|
23453071T6_23453071T12 CPR:4 brn-250_2\NN\1740| (r_nsubj) inhibited_3\VBD\2510337|furthermore|,|brn-250|phosphorylation|. (l_dobj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_conj) activity_11\NN\30358|intracellular|tyrosine|kinase (l_compound) kinase_10\NN\14732946|
23453071T6_23453071T14 CPR:4 brn-250_2\NN\1740| (r_nsubj) inhibited_3\VBD\2510337|furthermore|,|brn-250|phosphorylation|. (l_dobj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_nmod) receptor_14\NN\5225602|of|vegf|2|vegfr2 (l_nummod) 2_15\CD\13741022|
23453071T6_23453071T15 CPR:4 brn-250_2\NN\1740| (r_nsubj) inhibited_3\VBD\2510337|furthermore|,|brn-250|phosphorylation|. (l_dobj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_nmod) receptor_14\NN\5225602|of|vegf|2|vegfr2 (l_appos) vegfr2_17\NN\1740|(|)
23453071T6_23453071T16 CPR:4 brn-250_2\NN\1740| (r_nsubj) inhibited_3\VBD\2510337|furthermore|,|brn-250|phosphorylation|. (l_dobj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_conj) activation_21\NN\13561719|the|pathway (l_nmod) pathway_26\NN\5483677|of|its|downstream|akt (l_compound) akt_25\NN\1740|
23453071T7_23453071T11 NONE tyrosine_9\NN\14601829| (r_compound) activity_11\NN\30358|intracellular|tyrosine|kinase (r_conj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_amod) vegf-induced_5\JJ\1740|
23453071T7_23453071T12 NONE tyrosine_9\NN\14601829| (r_compound) activity_11\NN\30358|intracellular|tyrosine|kinase (l_compound) kinase_10\NN\14732946|
23453071T7_23453071T14 NONE tyrosine_9\NN\14601829| (r_compound) activity_11\NN\30358|intracellular|tyrosine|kinase (r_conj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_nmod) receptor_14\NN\5225602|of|vegf|2|vegfr2 (l_nummod) 2_15\CD\13741022|
23453071T7_23453071T15 NONE tyrosine_9\NN\14601829| (r_compound) activity_11\NN\30358|intracellular|tyrosine|kinase (r_conj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_nmod) receptor_14\NN\5225602|of|vegf|2|vegfr2 (l_appos) vegfr2_17\NN\1740|(|)
23453071T7_23453071T16 NONE tyrosine_9\NN\14601829| (r_compound) activity_11\NN\30358|intracellular|tyrosine|kinase (r_conj) phosphorylation_6\NN\1740|the|vegf-induced|and|activity|receptor|and|activation (l_conj) activation_21\NN\13561719|the|pathway (l_nmod) pathway_26\NN\5483677|of|its|downstream|akt (l_compound) akt_25\NN\1740|
17597612
17597612T7_17597612T13 NONE ne_9\NN\14622893|by|acting (l_acl) acting_10\VBG\1619354|receptors (l_nmod) receptors_13\NNS\5225602|at|beta2-adrenergic|beta2ar
17597612T7_17597612T14 NONE ne_9\NN\14622893|by|acting (l_acl) acting_10\VBG\1619354|receptors (l_nmod) receptors_13\NNS\5225602|at|beta2-adrenergic|beta2ar (l_appos) beta2ar_15\NN\1740|(|)
17597612T7_17597612T15 NONE ne_9\NN\14622893|by|acting (r_nmod) caused_7\VBN\1617192|effects|were|ne|and|reversed|. (l_conj) reversed_20\VBN\109660|could|be|using (l_xcomp) using_21\VBG\1156834|blockers (l_dobj) blockers_23\NNS\10101634|beta2ar (l_compound) beta2ar_22\NN\1740|
23564921
23564921T5_23564921T14 NONE thiazolidinediones_55\NNS\1740|with (r_nmod) changes_50\NNS\7283608|sensitivity|thiazolidinediones|and|changes (l_nmod) sensitivity_53\NN\5651971|in|insulin (l_compound) insulin_52\NN\5407119|
23564921T5_23564921T15 NONE thiazolidinediones_55\NNS\1740|with (r_nmod) changes_50\NNS\7283608|sensitivity|thiazolidinediones|and|changes (l_conj) changes_57\NNS\7283608|threshold|inhibition (l_nmod) inhibition_68\NN\1068773|with|transporter (l_compound) transporter_64\NN\4490091|sodium|glucose|sglt2
23564921T5_23564921T16 NONE thiazolidinediones_55\NNS\1740|with (r_nmod) changes_50\NNS\7283608|sensitivity|thiazolidinediones|and|changes (l_conj) changes_57\NNS\7283608|threshold|inhibition (l_nmod) inhibition_68\NN\1068773|with|transporter (l_compound) transporter_64\NN\4490091|sodium|glucose|sglt2 (l_appos) sglt2_66\NN\1740|(|)
23564921T6_23564921T14 NONE sodium_62\NN\14625458| (r_compound) transporter_64\NN\4490091|sodium|glucose|sglt2 (r_compound) inhibition_68\NN\1068773|with|transporter (r_nmod) changes_57\NNS\7283608|threshold|inhibition (r_conj) changes_50\NNS\7283608|sensitivity|thiazolidinediones|and|changes (l_nmod) sensitivity_53\NN\5651971|in|insulin (l_compound) insulin_52\NN\5407119|
23564921T6_23564921T15 NONE sodium_62\NN\14625458| (r_compound) transporter_64\NN\4490091|sodium|glucose|sglt2
23564921T6_23564921T16 NONE sodium_62\NN\14625458| (r_compound) transporter_64\NN\4490091|sodium|glucose|sglt2 (l_appos) sglt2_66\NN\1740|(|)
23564921T7_23564921T14 NONE glucose_63\NN\14710501| (r_compound) transporter_64\NN\4490091|sodium|glucose|sglt2 (r_compound) inhibition_68\NN\1068773|with|transporter (r_nmod) changes_57\NNS\7283608|threshold|inhibition (r_conj) changes_50\NNS\7283608|sensitivity|thiazolidinediones|and|changes (l_nmod) sensitivity_53\NN\5651971|in|insulin (l_compound) insulin_52\NN\5407119|
23564921T7_23564921T15 NONE glucose_63\NN\14710501| (r_compound) transporter_64\NN\4490091|sodium|glucose|sglt2
23564921T7_23564921T16 NONE glucose_63\NN\14710501| (r_compound) transporter_64\NN\4490091|sodium|glucose|sglt2 (l_appos) sglt2_66\NN\1740|(|)
23564921T9_23564921T17 NONE glucose_34\NN\14710501|on|fasting (r_nmod) effects_31\NNS\13245626|with|the|glucose|data (r_nmod) concordant_28\JJ\1740|that|effect|is|effects (r_ccomp) showing_22\VBG\2137132|concordant (r_advcl) exemplify_1\VBP\2697725|we|this|modeling|using|,|showing|. (l_nmod) modeling_6\NN\4157320|with|sglt2|inhibition|changing (l_compound) sglt2_4\NN\1740|
23564921T1_23564921T11 NONE glucose_11\NN\14710501|in|mean (r_nmod) decrease_8\NN\7296428|in|a|glucose|mmol/l. (r_nmod) resulted_5\VBD\2633881|inhibition|decrease|showed (l_nsubj) inhibition_1\NN\1068773|sglt2|modeled (l_compound) sglt2_0\NN\1740|
23564921T2_23564921T11 NONE glucose_21\NN\14710501|in|mmol/l. (r_nmod) decrease_19\NN\7296428|a|glucose (r_dobj) showed_17\VBD\2137132|data|decrease|was (r_parataxis) resulted_5\VBD\2633881|inhibition|decrease|showed (l_nsubj) inhibition_1\NN\1068773|sglt2|modeled (l_compound) sglt2_0\NN\1740|
23564921T4_23564921T13 NONE glucose_14\NN\14710501|on|fasting|and|insulin|and|function (l_conj) function_20\NN\13783581|on|β-cell|and|sensitivity (l_conj) sensitivity_23\NN\5651971|insulin (l_compound) insulin_22\NN\5407119|
15132128
15132128T2_15132128T20 CPR:9 carbamate_4\NN\15010703|the|fluoropyrimidine|capecitabine (r_nsubjpass) converted_9\VBN\126264|carbamate|is|5-fluorouracil|phosphorylase|. (l_nmod) phosphorylase_17\NN\1740|by|thymidine|tp|tissues (l_appos) tp_19\NN\1740|(|)
15132128T2_15132128T43 CPR:9 carbamate_4\NN\15010703|the|fluoropyrimidine|capecitabine (r_nsubjpass) converted_9\VBN\126264|carbamate|is|5-fluorouracil|phosphorylase|. (l_nmod) phosphorylase_17\NN\1740|by|thymidine|tp|tissues
15132128T8_15132128T20 CPR:9 capecitabine_6\NN\1740|(|) (r_appos) carbamate_4\NN\15010703|the|fluoropyrimidine|capecitabine (r_nsubjpass) converted_9\VBN\126264|carbamate|is|5-fluorouracil|phosphorylase|. (l_nmod) phosphorylase_17\NN\1740|by|thymidine|tp|tissues (l_appos) tp_19\NN\1740|(|)
15132128T8_15132128T43 CPR:9 capecitabine_6\NN\1740|(|) (r_appos) carbamate_4\NN\15010703|the|fluoropyrimidine|capecitabine (r_nsubjpass) converted_9\VBN\126264|carbamate|is|5-fluorouracil|phosphorylase|. (l_nmod) phosphorylase_17\NN\1740|by|thymidine|tp|tissues
15132128T10_15132128T20 CPR:9 5-fluorouracil_11\NN\1740|to|5-fu (r_nmod) converted_9\VBN\126264|carbamate|is|5-fluorouracil|phosphorylase|. (l_nmod) phosphorylase_17\NN\1740|by|thymidine|tp|tissues (l_appos) tp_19\NN\1740|(|)
15132128T10_15132128T43 CPR:9 5-fluorouracil_11\NN\1740|to|5-fu (r_nmod) converted_9\VBN\126264|carbamate|is|5-fluorouracil|phosphorylase|. (l_nmod) phosphorylase_17\NN\1740|by|thymidine|tp|tissues
15132128T11_15132128T20 CPR:9 5-fu_13\NN\1740|(|) (r_appos) 5-fluorouracil_11\NN\1740|to|5-fu (r_nmod) converted_9\VBN\126264|carbamate|is|5-fluorouracil|phosphorylase|. (l_nmod) phosphorylase_17\NN\1740|by|thymidine|tp|tissues (l_appos) tp_19\NN\1740|(|)
15132128T11_15132128T43 CPR:9 5-fu_13\NN\1740|(|) (r_appos) 5-fluorouracil_11\NN\1740|to|5-fu (r_nmod) converted_9\VBN\126264|carbamate|is|5-fluorouracil|phosphorylase|. (l_nmod) phosphorylase_17\NN\1740|by|thymidine|tp|tissues
15132128T12_15132128T20 NONE thymidine_16\NN\14964367| (r_compound) phosphorylase_17\NN\1740|by|thymidine|tp|tissues (l_appos) tp_19\NN\1740|(|)
15132128T12_15132128T43 NONE thymidine_16\NN\14964367| (r_compound) phosphorylase_17\NN\1740|by|thymidine|tp|tissues
15132128T3_15132128T26 CPR:4 5-fu_0\NN\1740| (r_nsubj) interferes_1\VBZ\2451370|5-fu|synthesis|blocking|but|inactivated|. (l_advcl) blocking_6\VBG\1476483|by|synthase (l_dobj) synthase_8\NN\1740|thymidylate|ts
15132128T3_15132128T27 CPR:4 5-fu_0\NN\1740| (r_nsubj) interferes_1\VBZ\2451370|5-fu|synthesis|blocking|but|inactivated|. (l_advcl) blocking_6\VBG\1476483|by|synthase (l_dobj) synthase_8\NN\1740|thymidylate|ts (l_appos) ts_10\NN\14999913|(|)
15132128T3_15132128T28 NONE 5-fu_0\NN\1740| (r_nsubj) interferes_1\VBZ\2451370|5-fu|synthesis|blocking|but|inactivated|. (l_conj) inactivated_14\VBN\1097743|is|dehydrogenase (l_nmod) dehydrogenase_17\NN\1740|by|dihydropyrimidine|dpd
15132128T3_15132128T29 NONE 5-fu_0\NN\1740| (r_nsubj) interferes_1\VBZ\2451370|5-fu|synthesis|blocking|but|inactivated|. (l_conj) inactivated_14\VBN\1097743|is|dehydrogenase (l_nmod) dehydrogenase_17\NN\1740|by|dihydropyrimidine|dpd (l_appos) dpd_19\NN\1740|(|)
15132128T5_15132128T26 NONE thymidylate_7\NN\1740| (r_compound) synthase_8\NN\1740|thymidylate|ts
15132128T5_15132128T27 NONE thymidylate_7\NN\1740| (r_compound) synthase_8\NN\1740|thymidylate|ts (l_appos) ts_10\NN\14999913|(|)
15132128T5_15132128T28 NONE thymidylate_7\NN\1740| (r_compound) synthase_8\NN\1740|thymidylate|ts (r_dobj) blocking_6\VBG\1476483|by|synthase (r_advcl) interferes_1\VBZ\2451370|5-fu|synthesis|blocking|but|inactivated|. (l_conj) inactivated_14\VBN\1097743|is|dehydrogenase (l_nmod) dehydrogenase_17\NN\1740|by|dihydropyrimidine|dpd
15132128T5_15132128T29 NONE thymidylate_7\NN\1740| (r_compound) synthase_8\NN\1740|thymidylate|ts (r_dobj) blocking_6\VBG\1476483|by|synthase (r_advcl) interferes_1\VBZ\2451370|5-fu|synthesis|blocking|but|inactivated|. (l_conj) inactivated_14\VBN\1097743|is|dehydrogenase (l_nmod) dehydrogenase_17\NN\1740|by|dihydropyrimidine|dpd (l_appos) dpd_19\NN\1740|(|)
15132128T6_15132128T26 NONE dihydropyrimidine_16\NN\1740| (r_compound) dehydrogenase_17\NN\1740|by|dihydropyrimidine|dpd (r_nmod) inactivated_14\VBN\1097743|is|dehydrogenase (r_conj) interferes_1\VBZ\2451370|5-fu|synthesis|blocking|but|inactivated|. (l_advcl) blocking_6\VBG\1476483|by|synthase (l_dobj) synthase_8\NN\1740|thymidylate|ts
15132128T6_15132128T27 NONE dihydropyrimidine_16\NN\1740| (r_compound) dehydrogenase_17\NN\1740|by|dihydropyrimidine|dpd (r_nmod) inactivated_14\VBN\1097743|is|dehydrogenase (r_conj) interferes_1\VBZ\2451370|5-fu|synthesis|blocking|but|inactivated|. (l_advcl) blocking_6\VBG\1476483|by|synthase (l_dobj) synthase_8\NN\1740|thymidylate|ts (l_appos) ts_10\NN\14999913|(|)
15132128T6_15132128T28 NONE dihydropyrimidine_16\NN\1740| (r_compound) dehydrogenase_17\NN\1740|by|dihydropyrimidine|dpd
15132128T6_15132128T29 NONE dihydropyrimidine_16\NN\1740| (r_compound) dehydrogenase_17\NN\1740|by|dihydropyrimidine|dpd (l_appos) dpd_19\NN\1740|(|)
15132128T7_15132128T30 CPR:9 5-fu_15\NN\1740|of (r_nmod) levels_13\NNS\4916342|high|intratumor|5-fu|effective (r_dobj) generate_10\VBP\1617192|profiles|levels|. (l_nsubj) profiles_2\NNS\6999802|favorable|enzyme|tp (l_dep) tp_5\NN\1740|(|high|and|dpd|)
15132128T7_15132128T31 CPR:9 5-fu_15\NN\1740|of (r_nmod) levels_13\NNS\4916342|high|intratumor|5-fu|effective (r_dobj) generate_10\VBP\1617192|profiles|levels|. (l_nsubj) profiles_2\NNS\6999802|favorable|enzyme|tp (l_dep) tp_5\NN\1740|(|high|and|dpd|) (l_conj) dpd_8\NN\1740|low
15132128T7_15132128T32 NONE 5-fu_15\NN\1740|of (r_nmod) levels_13\NNS\4916342|high|intratumor|5-fu|effective (l_acl:relcl) effective_18\JJ\1740|that|are|tumors (l_nmod) tumors_21\NNS\14234074|against|many|,|those (l_appos) those_24\DT\1740|especially|ts (l_nmod) ts_27\NN\14999913|with|low
15132128T9_15132128T33 NONE capecitabine_0\NN\1740| (r_nsubjpass) tested_4\VBN\670261|capecitabine|has|not|been|cancers|,|and|known (l_conj) known_13\VBN\2110220|it|is|not|express|. (l_ccomp) express_19\VBP\928630|extent|cancers|tp (l_dobj) tp_20\NN\1740|,|ts|or|dpd
15132128T9_15132128T34 NONE capecitabine_0\NN\1740| (r_nsubjpass) tested_4\VBN\670261|capecitabine|has|not|been|cancers|,|and|known (l_conj) known_13\VBN\2110220|it|is|not|express|. (l_ccomp) express_19\VBP\928630|extent|cancers|tp (l_dobj) tp_20\NN\1740|,|ts|or|dpd (l_conj) ts_22\NN\14999913|
15132128T9_15132128T35 NONE capecitabine_0\NN\1740| (r_nsubjpass) tested_4\VBN\670261|capecitabine|has|not|been|cancers|,|and|known (l_conj) known_13\VBN\2110220|it|is|not|express|. (l_ccomp) express_19\VBP\928630|extent|cancers|tp (l_dobj) tp_20\NN\1740|,|ts|or|dpd (l_conj) dpd_24\NN\1740|
15132128T1_15132128T18 NONE capecitabine_15\NN\1740| (r_compound) resistance_16\NN\37396|capecitabine (r_dobj) suggesting_14\VBG\1010118|resistance (r_advcl) expressed_11\VBD\928630|four|dpd|,|suggesting (r_conj) failed_3\VBD\1798936|tumors|express|but|expressed|. (l_xcomp) express_5\VB\928630|to|tp (l_dobj) tp_6\NN\1740|
15132128T1_15132128T19 NONE capecitabine_15\NN\1740| (r_compound) resistance_16\NN\37396|capecitabine (r_dobj) suggesting_14\VBG\1010118|resistance (r_advcl) expressed_11\VBD\928630|four|dpd|,|suggesting (l_dobj) dpd_12\NN\1740|
15132128T4_15132128T23 NONE capecitabine_6\NN\1740| (r_nsubjpass) activated_8\VBN\1641914|that|capecitabine|is|majority|and|have (l_conj) have_20\VBP\2108377|that|%|expression (l_dobj) expression_22\NN\4679549|favorable|enzymes (l_nmod) enzymes_26\NNS\14723628|of|all|three|tp (l_dep) tp_28\NN\1740|(|,|ts|,|and|dpd|)
15132128T4_15132128T24 NONE capecitabine_6\NN\1740| (r_nsubjpass) activated_8\VBN\1641914|that|capecitabine|is|majority|and|have (l_conj) have_20\VBP\2108377|that|%|expression (l_dobj) expression_22\NN\4679549|favorable|enzymes (l_nmod) enzymes_26\NNS\14723628|of|all|three|tp (l_dep) tp_28\NN\1740|(|,|ts|,|and|dpd|) (l_conj) ts_30\NN\14999913|
15132128T4_15132128T25 NONE capecitabine_6\NN\1740| (r_nsubjpass) activated_8\VBN\1641914|that|capecitabine|is|majority|and|have (l_conj) have_20\VBP\2108377|that|%|expression (l_dobj) expression_22\NN\4679549|favorable|enzymes (l_nmod) enzymes_26\NNS\14723628|of|all|three|tp (l_dep) tp_28\NN\1740|(|,|ts|,|and|dpd|) (l_conj) dpd_33\NN\1740|
19068776
19068776T17_19068776T21 CPR:6 naltrexone_8\NN\3808977|of|a|receptor|antagonist (l_compound) receptor_6\NN\5225602|mu-opioid
19068776T18_19068776T21 NONE alcohol_10\NN\7881800| (r_compound) dependence_11\NN\24720|on|alcohol (r_nmod) effects_2\NNS\13245626|[|pharmacological|naltrexone|dependence|]|. (l_nmod) naltrexone_8\NN\3808977|of|a|receptor|antagonist (l_compound) receptor_6\NN\5225602|mu-opioid
19068776T6_19068776T19 CPR:6 naltrexone_8\NN\3808977|a|mu-opioid|receptor|antagonist (l_compound) receptor_6\NN\5225602|
19068776T7_19068776T19 NONE alcohol_16\NN\7881800| (r_compound) dependence_17\NN\24720|of|alcohol (r_nmod) treatment_14\NN\654885|in|the|dependence (r_nmod) used_11\VBN\1156834|countries|,|naltrexone|has|been|treatment|. (l_nsubjpass) naltrexone_8\NN\3808977|a|mu-opioid|receptor|antagonist (l_compound) receptor_6\NN\5225602|
19068776T12_19068776T20 NONE acid_23\NN\14818238|gamma-aminobutyric (r_compound) interneurons_26\NNS\1740|of|the|acid|(gaba)-containing|inhibitory|area (r_nmod) inhibition_19\NN\1068773|through|the|interneurons (r_nmod) increase_9\VBP\169651|agonists|activity|inhibition|,|resulting|. (l_nsubj) agonists_3\NNS\9613191|the|endogenous|opioid|,|beta-endorphin|, (l_nmod) beta-endorphin_7\NN\1740|such
19068776T13_19068776T20 NONE (gaba)-containing_24\JJ\1740| (r_amod) interneurons_26\NNS\1740|of|the|acid|(gaba)-containing|inhibitory|area (r_nmod) inhibition_19\NN\1068773|through|the|interneurons (r_nmod) increase_9\VBP\169651|agonists|activity|inhibition|,|resulting|. (l_nsubj) agonists_3\NNS\9613191|the|endogenous|opioid|,|beta-endorphin|, (l_nmod) beta-endorphin_7\NN\1740|such
19068776T14_19068776T20 NONE alcohol_38\NN\7881800| (r_compound) reinforcement_39\NN\955060|of|alcohol|and/or|effect (r_nmod) expression_36\NN\4679549|in|the|reinforcement (r_nmod) resulting_33\VBG\2633881|expression (r_advcl) increase_9\VBP\169651|agonists|activity|inhibition|,|resulting|. (l_nsubj) agonists_3\NNS\9613191|the|endogenous|opioid|,|beta-endorphin|, (l_nmod) beta-endorphin_7\NN\1740|such
23357567
11692072
11692072T7_11692072T17 NONE alcohol_20\NN\7881800| (r_compound) withdrawal_21\NN\7206096|of|alcohol (r_nmod) outcome_18\NN\7291312|clinical|withdrawal (r_conj) efficacy_13\NN\5199286|on|tiapride|and|outcome (r_nmod) influence_0\NN\5190804|genotype|efficacy|. (l_nmod) genotype_11\NN\7941170|of|the|receptor|exon|8 (l_nummod) 8_10\CD\13741022|
11692072T8_11692072T17 NONE dopamine_3\NN\14807737| (r_compound) receptor_5\NN\5225602|dopamine|d2|drd2 (r_compound) genotype_11\NN\7941170|of|the|receptor|exon|8 (l_nummod) 8_10\CD\13741022|
11692072T9_11692072T17 NONE tiapride_15\NN\1740|of (r_nmod) efficacy_13\NN\5199286|on|tiapride|and|outcome (r_nmod) influence_0\NN\5190804|genotype|efficacy|. (l_nmod) genotype_11\NN\7941170|of|the|receptor|exon|8 (l_nummod) 8_10\CD\13741022|
11692072T1_11692072T10 NONE dopamine_21\NN\14807737| (r_compound) dose_25\NN\3740161|with|i|dopamine|d2|antagonist|tiapride|treatment|and|ii|anxiety (l_compound) d2_22\NN\1740|
11692072T1_11692072T12 NONE dopamine_21\NN\14807737| (r_compound) dose_25\NN\3740161|with|i|dopamine|d2|antagonist|tiapride|treatment|and|ii|anxiety (r_nmod) associated_16\VBN\628491|that|variants|are|dose (l_nsubjpass) variants_6\NNS\7366289|allelic|genotype (l_nmod) genotype_14\NN\7941170|of|the|human|dopamine|d2|receptor|e8 (l_compound) e8_13\NN\1740|
11692072T2_11692072T10 NONE alcohol_29\NN\7881800| (r_compound) withdrawal_30\NN\7206096|of|alcohol (r_nmod) treatment_27\NN\654885|in|withdrawal|= (r_nmod) dose_25\NN\3740161|with|i|dopamine|d2|antagonist|tiapride|treatment|and|ii|anxiety (l_compound) d2_22\NN\1740|
11692072T2_11692072T12 NONE alcohol_29\NN\7881800| (r_compound) withdrawal_30\NN\7206096|of|alcohol (r_nmod) treatment_27\NN\654885|in|withdrawal|= (r_nmod) dose_25\NN\3740161|with|i|dopamine|d2|antagonist|tiapride|treatment|and|ii|anxiety (r_nmod) associated_16\VBN\628491|that|variants|are|dose (l_nsubjpass) variants_6\NNS\7366289|allelic|genotype (l_nmod) genotype_14\NN\7941170|of|the|human|dopamine|d2|receptor|e8 (l_compound) e8_13\NN\1740|
11692072T4_11692072T10 NONE dopamine_10\NN\14807737| (r_compound) genotype_14\NN\7941170|of|the|human|dopamine|d2|receptor|e8 (r_nmod) variants_6\NNS\7366289|allelic|genotype (r_nsubjpass) associated_16\VBN\628491|that|variants|are|dose (l_nmod) dose_25\NN\3740161|with|i|dopamine|d2|antagonist|tiapride|treatment|and|ii|anxiety (l_compound) d2_22\NN\1740|
11692072T4_11692072T12 NONE dopamine_10\NN\14807737| (r_compound) genotype_14\NN\7941170|of|the|human|dopamine|d2|receptor|e8 (l_compound) e8_13\NN\1740|
11692072T3_11692072T11 NONE tiapride_10\NN\1740|of (r_nmod) dose_8\NN\3740161|with|increased|tiapride|therapy|and|scores (r_nmod) associated_5\VBN\628491|genotype|was|dose|. (l_nsubjpass) genotype_3\NN\7941170|drd2|e8|a/a (l_compound) e8_1\NN\1740|
11692072T5_11692072T14 NONE dopamine_16\NN\14807737| (r_compound) apomorphine_19\NN\3786417|to|the|dopamine|d2|agonist (r_nmod) responsiveness_13\NN\5652926|with|reduced|apomorphine (r_nmod) associated_10\VBN\628491|report|,|genotype|was|responsiveness|;|clear|. (l_nsubjpass) genotype_8\NN\7941170|drd2|e8|a/a (l_compound) drd2_5\NN\1740|
11692072T5_11692072T15 NONE dopamine_16\NN\14807737| (r_compound) apomorphine_19\NN\3786417|to|the|dopamine|d2|agonist (l_compound) d2_17\NN\1740|
11692072T6_11692072T14 NONE apomorphine_19\NN\3786417|to|the|dopamine|d2|agonist (r_nmod) responsiveness_13\NN\5652926|with|reduced|apomorphine (r_nmod) associated_10\VBN\628491|report|,|genotype|was|responsiveness|;|clear|. (l_nsubjpass) genotype_8\NN\7941170|drd2|e8|a/a (l_compound) drd2_5\NN\1740|
11692072T6_11692072T15 CPR:5 apomorphine_19\NN\3786417|to|the|dopamine|d2|agonist (l_compound) d2_17\NN\1740|
13129570
13129570T15_13129570T33 NONE ampa_6\NN\1740|and|kainate (r_compound) receptors_11\NNS\5225602|at|ampa|preferring|glutamate|analogues
13129570T16_13129570T33 NONE kainate_8\NN\1740| (r_conj) ampa_6\NN\1740|and|kainate (r_compound) receptors_11\NNS\5225602|at|ampa|preferring|glutamate|analogues
13129570T17_13129570T33 NONE glutamate_10\NN\15010703| (r_compound) receptors_11\NNS\5225602|at|ampa|preferring|glutamate|analogues
13129570T18_13129570T33 NONE glutamate_14\NN\15010703| (r_compound) analogues_15\NNS\4743605|of|4-heteroarylmethylidene|glutamate (r_nmod) receptors_11\NNS\5225602|at|ampa|preferring|glutamate|analogues
13129570T1_13129570T22 NONE acid_1\NN\14818238|2-amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic|1 (r_nsubj) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_nmod) affinity_13\NN\11426530|with|moderate|receptors (l_nmod) receptors_21\NNS\5225602|for|native|acid
13129570T1_13129570T23 NONE acid_1\NN\14818238|2-amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic|1 (r_nsubj) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_compound) glur5_34\NN\1740|
13129570T1_13129570T24 NONE acid_1\NN\14818238|2-amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic|1 (r_nsubj) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_nmod) receptors_38\NNS\5225602|of|ka
13129570T1_13129570T25 NONE acid_1\NN\14818238|2-amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic|1 (r_nsubj) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_compound) glur2_45\NN\1740|
13129570T1_13129570T26 NONE acid_1\NN\14818238|2-amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic|1 (r_nsubj) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_nmod) receptors_49\NNS\5225602|of|ampa
13129570T1_13129570T31 CPR:5 acid_1\NN\14818238|2-amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic|1 (r_nsubj) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_compound) receptor_9\NN\5225602|
13129570T4_13129570T22 NONE acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid
13129570T4_13129570T23 NONE acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_compound) glur5_34\NN\1740|
13129570T4_13129570T24 NONE acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_nmod) receptors_38\NNS\5225602|of|ka
13129570T4_13129570T25 NONE acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_compound) glur2_45\NN\1740|
13129570T4_13129570T26 NONE acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_nmod) receptors_49\NNS\5225602|of|ampa
13129570T4_13129570T31 NONE acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_compound) receptor_9\NN\5225602|
13129570T5_13129570T22 NONE ka_19\NN\1740|(|) (r_appos) acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid
13129570T5_13129570T23 NONE ka_19\NN\1740|(|) (r_appos) acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_compound) glur5_34\NN\1740|
13129570T5_13129570T24 NONE ka_19\NN\1740|(|) (r_appos) acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_nmod) receptors_38\NNS\5225602|of|ka
13129570T5_13129570T25 NONE ka_19\NN\1740|(|) (r_appos) acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_compound) glur2_45\NN\1740|
13129570T5_13129570T26 NONE ka_19\NN\1740|(|) (r_appos) acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_nmod) receptors_49\NNS\5225602|of|ampa
13129570T5_13129570T31 NONE ka_19\NN\1740|(|) (r_appos) acid_17\NN\14818238|kainic|ka (r_compound) receptors_21\NNS\5225602|for|native|acid (r_nmod) affinity_13\NN\11426530|with|moderate|receptors (r_nmod) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_compound) receptor_9\NN\5225602|
13129570T6_13129570T22 NONE acid_25\NN\14818238|(s)-e-4-(2,2-dimethylpropylidene)glutamic|3 (r_nsubj) show_29\VBP\2137132|acid|affinity (r_parataxis) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_nmod) affinity_13\NN\11426530|with|moderate|receptors (l_nmod) receptors_21\NNS\5225602|for|native|acid
13129570T6_13129570T23 NONE acid_25\NN\14818238|(s)-e-4-(2,2-dimethylpropylidene)glutamic|3 (r_nsubj) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_compound) glur5_34\NN\1740|
13129570T6_13129570T24 NONE acid_25\NN\14818238|(s)-e-4-(2,2-dimethylpropylidene)glutamic|3 (r_nsubj) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_nmod) receptors_38\NNS\5225602|of|ka
13129570T6_13129570T25 NONE acid_25\NN\14818238|(s)-e-4-(2,2-dimethylpropylidene)glutamic|3 (r_nsubj) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_compound) glur2_45\NN\1740|
13129570T6_13129570T26 NONE acid_25\NN\14818238|(s)-e-4-(2,2-dimethylpropylidene)glutamic|3 (r_nsubj) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_nmod) receptors_49\NNS\5225602|of|ampa
13129570T6_13129570T31 NONE acid_25\NN\14818238|(s)-e-4-(2,2-dimethylpropylidene)glutamic|3 (r_nsubj) show_29\VBP\2137132|acid|affinity (r_parataxis) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_compound) receptor_9\NN\5225602|
13129570T7_13129570T22 NONE ka_37\NN\1740| (r_compound) receptors_38\NNS\5225602|of|ka (r_nmod) subtype_35\NN\1740|for|the|glur5|receptors (r_nmod) affinity_31\NN\11426530|high|subtype|and|affinity (r_dobj) show_29\VBP\2137132|acid|affinity (r_parataxis) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_nmod) affinity_13\NN\11426530|with|moderate|receptors (l_nmod) receptors_21\NNS\5225602|for|native|acid
13129570T7_13129570T23 NONE ka_37\NN\1740| (r_compound) receptors_38\NNS\5225602|of|ka (r_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_compound) glur5_34\NN\1740|
13129570T7_13129570T24 NONE ka_37\NN\1740| (r_compound) receptors_38\NNS\5225602|of|ka
13129570T7_13129570T25 NONE ka_37\NN\1740| (r_compound) receptors_38\NNS\5225602|of|ka (r_nmod) subtype_35\NN\1740|for|the|glur5|receptors (r_nmod) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_compound) glur2_45\NN\1740|
13129570T7_13129570T26 NONE ka_37\NN\1740| (r_compound) receptors_38\NNS\5225602|of|ka (r_nmod) subtype_35\NN\1740|for|the|glur5|receptors (r_nmod) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_nmod) receptors_49\NNS\5225602|of|ampa
13129570T7_13129570T31 NONE ka_37\NN\1740| (r_compound) receptors_38\NNS\5225602|of|ka (r_nmod) subtype_35\NN\1740|for|the|glur5|receptors (r_nmod) affinity_31\NN\11426530|high|subtype|and|affinity (r_dobj) show_29\VBP\2137132|acid|affinity (r_parataxis) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_compound) receptor_9\NN\5225602|
13129570T8_13129570T22 NONE ampa_48\NN\1740| (r_compound) receptors_49\NNS\5225602|of|ampa (r_nmod) subtype_46\NN\1740|for|the|glur2|receptors (r_nmod) affinity_42\NN\11426530|lower|subtype (r_conj) affinity_31\NN\11426530|high|subtype|and|affinity (r_dobj) show_29\VBP\2137132|acid|affinity (r_parataxis) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_nmod) affinity_13\NN\11426530|with|moderate|receptors (l_nmod) receptors_21\NNS\5225602|for|native|acid
13129570T8_13129570T23 NONE ampa_48\NN\1740| (r_compound) receptors_49\NNS\5225602|of|ampa (r_nmod) subtype_46\NN\1740|for|the|glur2|receptors (r_nmod) affinity_42\NN\11426530|lower|subtype (r_conj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_compound) glur5_34\NN\1740|
13129570T8_13129570T24 NONE ampa_48\NN\1740| (r_compound) receptors_49\NNS\5225602|of|ampa (r_nmod) subtype_46\NN\1740|for|the|glur2|receptors (r_nmod) affinity_42\NN\11426530|lower|subtype (r_conj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_nmod) receptors_38\NNS\5225602|of|ka
13129570T8_13129570T25 NONE ampa_48\NN\1740| (r_compound) receptors_49\NNS\5225602|of|ampa (r_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_compound) glur2_45\NN\1740|
13129570T8_13129570T26 NONE ampa_48\NN\1740| (r_compound) receptors_49\NNS\5225602|of|ampa
13129570T8_13129570T31 NONE ampa_48\NN\1740| (r_compound) receptors_49\NNS\5225602|of|ampa (r_nmod) subtype_46\NN\1740|for|the|glur2|receptors (r_nmod) affinity_42\NN\11426530|lower|subtype (r_conj) affinity_31\NN\11426530|high|subtype|and|affinity (r_dobj) show_29\VBP\2137132|acid|affinity (r_parataxis) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_compound) receptor_9\NN\5225602|
13129570T13_13129570T22 NONE ampa_8\NN\1740| (r_compound) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_nmod) affinity_13\NN\11426530|with|moderate|receptors (l_nmod) receptors_21\NNS\5225602|for|native|acid
13129570T13_13129570T23 NONE ampa_8\NN\1740| (r_compound) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_compound) glur5_34\NN\1740|
13129570T13_13129570T24 NONE ampa_8\NN\1740| (r_compound) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_nmod) subtype_35\NN\1740|for|the|glur5|receptors (l_nmod) receptors_38\NNS\5225602|of|ka
13129570T13_13129570T25 NONE ampa_8\NN\1740| (r_compound) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_compound) glur2_45\NN\1740|
13129570T13_13129570T26 NONE ampa_8\NN\1740| (r_compound) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_parataxis) show_29\VBP\2137132|acid|affinity (l_dobj) affinity_31\NN\11426530|high|subtype|and|affinity (l_conj) affinity_42\NN\11426530|lower|subtype (l_nmod) subtype_46\NN\1740|for|the|glur2|receptors (l_nmod) receptors_49\NNS\5225602|of|ampa
13129570T13_13129570T31 NONE ampa_8\NN\1740| (r_compound) agonist_10\NN\9613191|acid|is|a|potent|ampa|receptor|affinity|,|whereas|show|. (l_compound) receptor_9\NN\5225602|
13129570T9_13129570T27 NONE acid_15\NN\14818238|(s)-e-4-(2-thiazolylmethylene)glutamic|4a (r_nsubjpass) designed_20\VBN\1631534|attempt|,|acid|was|hybrid|. (l_nmod) attempt_2\NN\407535|as|an|develop (l_acl) develop_4\VB\1753788|to|tools (l_dobj) tools_7\NNS\3563967|new|pharmacological|studies (l_nmod) studies_9\NNS\635850|for|receptors (l_nmod) receptors_12\NNS\5225602|of|glur5 (l_compound) glur5_11\NN\1740|
13129570T10_13129570T28 NONE ampa_20\NN\1740| (r_compound) subtypes_22\NNS\1740|to|the|ampa|receptor|glur1|-|4 (r_nmod) bind_17\VB\1290422|to|indiscriminately|subtypes|affinities (r_conj) agonist_8\NN\9613191|to|be|a|potent|glur5|and|ligand|and|bind (l_compound) glur5_7\NN\1740|
13129570T10_13129570T29 NONE ampa_20\NN\1740| (r_compound) subtypes_22\NNS\1740|to|the|ampa|receptor|glur1|-|4 (l_compound) receptor_21\NN\5225602|
13129570T10_13129570T30 NONE ampa_20\NN\1740| (r_compound) subtypes_22\NNS\1740|to|the|ampa|receptor|glur1|-|4 (l_nummod) 4_25\CD\13741022|
13129570T2_13129570T19 NONE ampa_32\NN\1740| (r_compound) analogues_33\NNS\4743605|of|the|corresponding|ampa|agonists (r_nmod) those_28\DT\1740|with|analogues (r_nmod) comparable_26\JJ\1740|those (r_amod) potencies_25\NNS\5196375|with|relative|comparable (r_nmod) ligands_16\NNS\20090|as|affinity|glur1|potencies (l_nmod) glur1_18\NN\1740|for|- (l_dep) -_19\NN\1740|4 (l_nummod) 4_20\CD\13741022|and|glur5 (l_conj) glur5_22\NN\1740|
13129570T2_13129570T20 NONE ampa_32\NN\1740| (r_compound) analogues_33\NNS\4743605|of|the|corresponding|ampa|agonists (l_nmod) agonists_37\NNS\9613191|as|ampa|receptor (l_compound) receptor_36\NN\5225602|
13129570T2_13129570T32 NONE ampa_32\NN\1740| (r_compound) analogues_33\NNS\4743605|of|the|corresponding|ampa|agonists (r_nmod) those_28\DT\1740|with|analogues (r_nmod) comparable_26\JJ\1740|those (r_amod) potencies_25\NNS\5196375|with|relative|comparable (r_nmod) ligands_16\NNS\20090|as|affinity|glur1|potencies (l_nmod) glur1_18\NN\1740|for|- (l_dep) -_19\NN\1740|4 (l_nummod) 4_20\CD\13741022|and|glur5
13129570T3_13129570T19 NONE ampa_35\NN\1740| (r_compound) agonists_37\NNS\9613191|as|ampa|receptor (r_nmod) analogues_33\NNS\4743605|of|the|corresponding|ampa|agonists (r_nmod) those_28\DT\1740|with|analogues (r_nmod) comparable_26\JJ\1740|those (r_amod) potencies_25\NNS\5196375|with|relative|comparable (r_nmod) ligands_16\NNS\20090|as|affinity|glur1|potencies (l_nmod) glur1_18\NN\1740|for|- (l_dep) -_19\NN\1740|4 (l_nummod) 4_20\CD\13741022|and|glur5 (l_conj) glur5_22\NN\1740|
13129570T3_13129570T20 NONE ampa_35\NN\1740| (r_compound) agonists_37\NNS\9613191|as|ampa|receptor (l_compound) receptor_36\NN\5225602|
13129570T3_13129570T32 NONE ampa_35\NN\1740| (r_compound) agonists_37\NNS\9613191|as|ampa|receptor (r_nmod) analogues_33\NNS\4743605|of|the|corresponding|ampa|agonists (r_nmod) those_28\DT\1740|with|analogues (r_nmod) comparable_26\JJ\1740|those (r_amod) potencies_25\NNS\5196375|with|relative|comparable (r_nmod) ligands_16\NNS\20090|as|affinity|glur1|potencies (l_nmod) glur1_18\NN\1740|for|- (l_dep) -_19\NN\1740|4 (l_nummod) 4_20\CD\13741022|and|glur5
23579178
23579178T13_23579178T29 NONE metformin_14\NN\2719105|with (r_conj) or_12\CC\3541091|alone|metformin (r_advmod) used_10\VBN\1156834|when|or|diabetes (r_advcl) mechanisms_0\NNS\13446390|lowering|used|:|study|. (l_nmod) lowering_3\NN\351638|of|glucose|sitagliptin (l_nmod) sitagliptin_8\NN\1740|of|dipeptidyl|peptidase-4|inhibitor (l_compound) peptidase-4_6\NN\1740|
23579178T14_23579178T29 NONE glucose_2\NN\14710501| (r_compound) lowering_3\NN\351638|of|glucose|sitagliptin (l_nmod) sitagliptin_8\NN\1740|of|dipeptidyl|peptidase-4|inhibitor (l_compound) peptidase-4_6\NN\1740|
23579178T15_23579178T29 CPR:4 sitagliptin_8\NN\1740|of|dipeptidyl|peptidase-4|inhibitor (l_compound) peptidase-4_6\NN\1740|
23579178T7_23579178T19 NONE glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) insulin_9\NN\5407119|fasting|plasma
23579178T7_23579178T20 NONE glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) c-peptide_11\NN\1740|rate
23579178T7_23579178T21 NONE glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) c-peptide_11\NN\1740|rate (l_dep) rate_15\NN\13815152|(|insulin|secretory|isr|) (l_compound) insulin_13\NN\5407119|
23579178T7_23579178T22 NONE glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) glucagon_23\NN\5407119|fasting|plasma
23579178T7_23579178T23 NONE glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) peptide_28\NN\14724264|bioactive|glucagon-like|glp-1|and|peptide
23579178T7_23579178T24 NONE glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) peptide_28\NN\14724264|bioactive|glucagon-like|glp-1|and|peptide (l_appos) glp-1_30\NN\1740|(|)
23579178T7_23579178T25 NONE glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) peptide_28\NN\14724264|bioactive|glucagon-like|glp-1|and|peptide (l_conj) peptide_35\NN\14724264|gastrointestinal|insulinotropic|gip
23579178T7_23579178T26 NONE glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) peptide_28\NN\14724264|bioactive|glucagon-like|glp-1|and|peptide (l_conj) peptide_35\NN\14724264|gastrointestinal|insulinotropic|gip (l_appos) gip_37\NN\1740|(|)
23579178T8_23579178T19 NONE c-peptide_11\NN\1740|rate (r_conj) glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) insulin_9\NN\5407119|fasting|plasma
23579178T8_23579178T20 NONE c-peptide_11\NN\1740|rate
23579178T8_23579178T21 NONE c-peptide_11\NN\1740|rate (l_dep) rate_15\NN\13815152|(|insulin|secretory|isr|) (l_compound) insulin_13\NN\5407119|
23579178T8_23579178T22 NONE c-peptide_11\NN\1740|rate (r_conj) glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) glucagon_23\NN\5407119|fasting|plasma
23579178T8_23579178T23 NONE c-peptide_11\NN\1740|rate (r_conj) glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) peptide_28\NN\14724264|bioactive|glucagon-like|glp-1|and|peptide
23579178T8_23579178T24 NONE c-peptide_11\NN\1740|rate (r_conj) glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) peptide_28\NN\14724264|bioactive|glucagon-like|glp-1|and|peptide (l_appos) glp-1_30\NN\1740|(|)
23579178T8_23579178T25 NONE c-peptide_11\NN\1740|rate (r_conj) glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) peptide_28\NN\14724264|bioactive|glucagon-like|glp-1|and|peptide (l_conj) peptide_35\NN\14724264|gastrointestinal|insulinotropic|gip
23579178T8_23579178T26 NONE c-peptide_11\NN\1740|rate (r_conj) glucose_2\NN\14710501|fasting|plasma|fpg|,|insulin|,|c-peptide|,|glucagon|,|and|peptide (l_conj) peptide_28\NN\14724264|bioactive|glucagon-like|glp-1|and|peptide (l_conj) peptide_35\NN\14724264|gastrointestinal|insulinotropic|gip (l_appos) gip_37\NN\1740|(|)
23579178T12_23579178T27 NONE post-mtt_4\JJ\1740| (r_amod) insulin_6\NN\5407119|in|mean|post-mtt|plasma
23579178T1_23579178T16 NONE post-mtt_3\JJ\1740| (r_amod) glp-1_6\NN\1740|mean|post-mtt|plasma|bioactive
23200255
23200255T1_23200255T11 CPR:4 (-)-6-(7-methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2h)-one_0\NN\1740|kca-1490 (r_nsubj) exhibits_4\VBZ\2632167|(-)-6-(7-methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2h)-one|activity|and|promises|. (l_dobj) activity_8\NN\30358|moderate|dual|pde3/4-inhibitory (l_amod) pde3/4-inhibitory_7\JJ\1740|
23200255T2_23200255T11 CPR:4 kca-1490_2\NN\1740|(|) (r_appos) (-)-6-(7-methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2h)-one_0\NN\1740|kca-1490 (r_nsubj) exhibits_4\VBZ\2632167|(-)-6-(7-methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2h)-one|activity|and|promises|. (l_dobj) activity_8\NN\30358|moderate|dual|pde3/4-inhibitory (l_amod) pde3/4-inhibitory_7\JJ\1740|
23200255T3_23200255T12 CPR:4 n-alkylation_0\NN\1740|ring (r_nsubj) enhances_6\VBZ\227165|n-alkylation|markedly|potency|pde4|but|suppresses|. (l_nmod) pde4_9\NN\1740|against
23200255T3_23200255T13 CPR:4 n-alkylation_0\NN\1740|ring (r_nsubj) enhances_6\VBZ\227165|n-alkylation|markedly|potency|pde4|but|suppresses|. (l_conj) suppresses_11\VBZ\2510337|inhibition (l_dobj) inhibition_13\NN\1068773|pde3 (l_compound) pde3_12\NN\1740|
23200255T4_23200255T12 CPR:4 pyridazinone_3\NN\1740| (r_compound) ring_4\NN\4981139|of|the|pyridazinone (r_nmod) n-alkylation_0\NN\1740|ring (r_nsubj) enhances_6\VBZ\227165|n-alkylation|markedly|potency|pde4|but|suppresses|. (l_nmod) pde4_9\NN\1740|against
23200255T4_23200255T13 CPR:4 pyridazinone_3\NN\1740| (r_compound) ring_4\NN\4981139|of|the|pyridazinone (r_nmod) n-alkylation_0\NN\1740|ring (r_nsubj) enhances_6\VBZ\227165|n-alkylation|markedly|potency|pde4|but|suppresses|. (l_conj) suppresses_11\VBZ\2510337|inhibition (l_dobj) inhibition_13\NN\1068773|pde3 (l_compound) pde3_12\NN\1740|
23200255T5_23200255T14 CPR:4 6-aryl-4,5-dihydropyridazin-3(2h)-one_3\NN\1740| (r_compound) extension_4\NN\15272029|of|a|6-aryl-4,5-dihydropyridazin-3(2h)-one (r_nmod) addition_0\NN\3081021|extension|group (r_nsubj) facilitates_9\VBZ\2547586|addition|enhancement|. (l_dobj) enhancement_11\NN\248977|both|activity|and|restoration (l_nmod) activity_14\NN\30358|of|pde4-inhibitory (l_amod) pde4-inhibitory_13\JJ\1740|
23200255T5_23200255T15 CPR:4 6-aryl-4,5-dihydropyridazin-3(2h)-one_3\NN\1740| (r_compound) extension_4\NN\15272029|of|a|6-aryl-4,5-dihydropyridazin-3(2h)-one (r_nmod) addition_0\NN\3081021|extension|group (r_nsubj) facilitates_9\VBZ\2547586|addition|enhancement|. (l_dobj) enhancement_11\NN\248977|both|activity|and|restoration (l_conj) restoration_16\NN\266806|inhibition (l_nmod) inhibition_20\NN\1068773|of|potent|pde3 (l_compound) pde3_19\NN\1740|
23200255T6_23200255T14 CPR:4 n-alkyl_7\JJ\1740| (r_amod) group_8\NN\2137|to|the|n-alkyl (r_nmod) addition_0\NN\3081021|extension|group (r_nsubj) facilitates_9\VBZ\2547586|addition|enhancement|. (l_dobj) enhancement_11\NN\248977|both|activity|and|restoration (l_nmod) activity_14\NN\30358|of|pde4-inhibitory (l_amod) pde4-inhibitory_13\JJ\1740|
23200255T6_23200255T15 CPR:4 n-alkyl_7\JJ\1740| (r_amod) group_8\NN\2137|to|the|n-alkyl (r_nmod) addition_0\NN\3081021|extension|group (r_nsubj) facilitates_9\VBZ\2547586|addition|enhancement|. (l_dobj) enhancement_11\NN\248977|both|activity|and|restoration (l_conj) restoration_16\NN\266806|inhibition (l_nmod) inhibition_20\NN\1068773|of|potent|pde3 (l_compound) pde3_19\NN\1740|
23200255T10_23200255T16 NONE histamine-induced_12\JJ\1740| (r_amod) bronchoconstriction_13\NN\1740|histamine-induced (r_dobj) suppress_11\VBP\2510337|that|bronchoconstriction|vivo|and|exhibit (r_acl:relcl) inhibitors_9\NNS\20090|potent|dual|pde3/4|suppress (l_compound) pde3/4_8\NN\1740|
17016711
17016711T7_17016711T18 NONE dexamethasone_0\NN\2721538| (r_nsubj) probes_1\VBZ\789138|dexamethasone|function|,|probes|. (l_dobj) function_7\NN\13783581|receptor (l_compound) receptor_3\NN\5225602|glucocorticoid|gr
17016711T7_17016711T19 NONE dexamethasone_0\NN\2721538| (r_nsubj) probes_1\VBZ\789138|dexamethasone|function|,|probes|. (l_dobj) function_7\NN\13783581|receptor (l_compound) receptor_3\NN\5225602|glucocorticoid|gr (l_appos) gr_5\NN\1740|(|)
17016711T7_17016711T20 NONE dexamethasone_0\NN\2721538| (r_nsubj) probes_1\VBZ\789138|dexamethasone|function|,|probes|. (l_advcl) probes_11\VBZ\789138|while|prednisolone|function (l_dobj) function_20\NN\13783581|gr (l_compound) gr_13\NN\1740|both|and|receptor
17016711T7_17016711T21 NONE dexamethasone_0\NN\2721538| (r_nsubj) probes_1\VBZ\789138|dexamethasone|function|,|probes|. (l_advcl) probes_11\VBZ\789138|while|prednisolone|function (l_dobj) function_20\NN\13783581|gr (l_compound) gr_13\NN\1740|both|and|receptor (l_conj) receptor_16\NN\5225602|mineralocorticoid|mr
17016711T7_17016711T22 NONE dexamethasone_0\NN\2721538| (r_nsubj) probes_1\VBZ\789138|dexamethasone|function|,|probes|. (l_advcl) probes_11\VBZ\789138|while|prednisolone|function (l_dobj) function_20\NN\13783581|gr (l_compound) gr_13\NN\1740|both|and|receptor (l_conj) receptor_16\NN\5225602|mineralocorticoid|mr (l_appos) mr_18\NN\6339416|(|)
17016711T8_17016711T18 NONE prednisolone_10\NN\2721538| (r_nsubj) probes_11\VBZ\789138|while|prednisolone|function (r_advcl) probes_1\VBZ\789138|dexamethasone|function|,|probes|. (l_dobj) function_7\NN\13783581|receptor (l_compound) receptor_3\NN\5225602|glucocorticoid|gr
17016711T8_17016711T19 NONE prednisolone_10\NN\2721538| (r_nsubj) probes_11\VBZ\789138|while|prednisolone|function (r_advcl) probes_1\VBZ\789138|dexamethasone|function|,|probes|. (l_dobj) function_7\NN\13783581|receptor (l_compound) receptor_3\NN\5225602|glucocorticoid|gr (l_appos) gr_5\NN\1740|(|)
17016711T8_17016711T20 NONE prednisolone_10\NN\2721538| (r_nsubj) probes_11\VBZ\789138|while|prednisolone|function (l_dobj) function_20\NN\13783581|gr (l_compound) gr_13\NN\1740|both|and|receptor
17016711T8_17016711T21 NONE prednisolone_10\NN\2721538| (r_nsubj) probes_11\VBZ\789138|while|prednisolone|function (l_dobj) function_20\NN\13783581|gr (l_compound) gr_13\NN\1740|both|and|receptor (l_conj) receptor_16\NN\5225602|mineralocorticoid|mr
17016711T8_17016711T22 NONE prednisolone_10\NN\2721538| (r_nsubj) probes_11\VBZ\789138|while|prednisolone|function (l_dobj) function_20\NN\13783581|gr (l_compound) gr_13\NN\1740|both|and|receptor (l_conj) receptor_16\NN\5225602|mineralocorticoid|mr (l_appos) mr_18\NN\6339416|(|)
17016711T4_17016711T17 NONE prednisolone_9\NN\2721538|of (r_nmod) effects_7\NNS\13245626|the|additional|prednisolone|mr (l_nmod) mr_12\NN\6339416|on|the
16365052
16365052T5_16365052T16 NONE pyruvate_8\NN\1740| (r_compound) gene_10\NN\8459252|of|the|l-type|pyruvate|kinase|liver (l_compound) kinase_9\NN\14732946|
16365052T2_16365052T9 NONE pyruvate_3\NN\1740| (r_compound) kinase_4\NN\14732946|of|l-type|pyruvate|l-pk
16365052T2_16365052T12 NONE pyruvate_3\NN\1740| (r_compound) kinase_4\NN\14732946|of|l-type|pyruvate|l-pk (l_appos) l-pk_6\NN\1740|(|)
16365052T4_16365052T9 CPR:3 carbohydrate_15\NN\14944888|by|dietary (r_nmod) upregulated_9\VBN\1740|expression|is|liver|carbohydrate|. (l_nsubjpass) expression_0\NN\4679549|kinase (l_nmod) kinase_4\NN\14732946|of|l-type|pyruvate|l-pk
16365052T4_16365052T12 CPR:3 carbohydrate_15\NN\14944888|by|dietary (r_nmod) upregulated_9\VBN\1740|expression|is|liver|carbohydrate|. (l_nsubjpass) expression_0\NN\4679549|kinase (l_nmod) kinase_4\NN\14732946|of|l-type|pyruvate|l-pk (l_appos) l-pk_6\NN\1740|(|)
16365052T1_16365052T6 NONE carbohydrate/insulin_3\NN\1740| (r_compound) elements_5\NNS\11524662|3|carbohydrate/insulin|response
16365052T1_16365052T11 NONE carbohydrate/insulin_3\NN\1740| (r_compound) elements_5\NNS\11524662|3|carbohydrate/insulin|response (r_nsubjpass) identified_7\VBN\699815|previously|,|elements|were|region|up|. (l_nmod) region_11\NN\27167|in|the|5'-flanking|gene (l_nmod) gene_15\NN\8459252|of|the|l-pk (l_compound) l-pk_14\NN\1740|
23542578
23542578T2_23542578T10 NONE gtx2,3-aldehyde_2\NN\1740|an|intermediate (r_nsubjpass) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_advcl) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin
23542578T2_23542578T11 NONE gtx2,3-aldehyde_2\NN\1740|an|intermediate (r_nsubjpass) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_advcl) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_appos) bsa_32\NN\1740|(|)
23542578T2_23542578T12 NONE gtx2,3-aldehyde_2\NN\1740|an|intermediate (r_nsubjpass) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_advcl) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh
23542578T2_23542578T13 NONE gtx2,3-aldehyde_2\NN\1740|an|intermediate (r_nsubjpass) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_advcl) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (l_appos) klh_40\NN\1740|(|)
23542578T2_23542578T14 NONE gtx2,3-aldehyde_2\NN\1740|an|intermediate (r_nsubjpass) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh
23542578T2_23542578T15 NONE gtx2,3-aldehyde_2\NN\1740|an|intermediate (r_nsubjpass) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh (l_conj) klh_52\NN\1740|
23542578T3_23542578T10 NONE nh2_9\NN\1740| (r_compound) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin
23542578T3_23542578T11 NONE nh2_9\NN\1740| (r_compound) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_appos) bsa_32\NN\1740|(|)
23542578T3_23542578T12 NONE nh2_9\NN\1740| (r_compound) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh
23542578T3_23542578T13 NONE nh2_9\NN\1740| (r_compound) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (l_appos) klh_40\NN\1740|(|)
23542578T3_23542578T14 NONE nh2_9\NN\1740| (r_compound) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh
23542578T3_23542578T15 NONE nh2_9\NN\1740| (r_compound) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh (l_conj) klh_52\NN\1740|
23542578T4_23542578T10 NONE acid_17\NN\14818238| (r_compound) residues_18\NNS\20827|of|the|2nd|amino|acid (r_nmod) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin
23542578T4_23542578T11 NONE acid_17\NN\14818238| (r_compound) residues_18\NNS\20827|of|the|2nd|amino|acid (r_nmod) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_appos) bsa_32\NN\1740|(|)
23542578T4_23542578T12 NONE acid_17\NN\14818238| (r_compound) residues_18\NNS\20827|of|the|2nd|amino|acid (r_nmod) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh
23542578T4_23542578T13 NONE acid_17\NN\14818238| (r_compound) residues_18\NNS\20827|of|the|2nd|amino|acid (r_nmod) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (l_nmod) aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (l_appos) klh_40\NN\1740|(|)
23542578T4_23542578T14 NONE acid_17\NN\14818238| (r_compound) residues_18\NNS\20827|of|the|2nd|amino|acid (r_nmod) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh
23542578T4_23542578T15 NONE acid_17\NN\14818238| (r_compound) residues_18\NNS\20827|of|the|2nd|amino|acid (r_nmod) group_10\NN\2137|the|nh2|residues (r_dobj) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh (l_conj) klh_52\NN\1740|
23542578T5_23542578T10 NONE aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin
23542578T5_23542578T11 NONE aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_appos) bsa_32\NN\1740|(|)
23542578T5_23542578T12 NONE aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh
23542578T5_23542578T13 NONE aldehydes_22\NNS\14727670|with|three|different|and|antigens (l_conj) antigens_27\NNS\20090|two|artificial|complete|albumin (l_dep) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (l_appos) klh_40\NN\1740|(|)
23542578T5_23542578T14 NONE aldehydes_22\NNS\14727670|with|three|different|and|antigens (r_nmod) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh
23542578T5_23542578T15 NONE aldehydes_22\NNS\14727670|with|three|different|and|antigens (r_nmod) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh (l_conj) klh_52\NN\1740|
23542578T6_23542578T10 NONE gtx2,3-aldehyde-bovine_28\NN\1740| (r_amod) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin
23542578T6_23542578T11 NONE gtx2,3-aldehyde-bovine_28\NN\1740| (r_amod) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_appos) bsa_32\NN\1740|(|)
23542578T6_23542578T12 NONE gtx2,3-aldehyde-bovine_28\NN\1740| (r_amod) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh
23542578T6_23542578T13 NONE gtx2,3-aldehyde-bovine_28\NN\1740| (r_amod) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_conj) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (l_appos) klh_40\NN\1740|(|)
23542578T6_23542578T14 NONE gtx2,3-aldehyde-bovine_28\NN\1740| (r_amod) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (r_dep) antigens_27\NNS\20090|two|artificial|complete|albumin (r_conj) aldehydes_22\NNS\14727670|with|three|different|and|antigens (r_nmod) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh
23542578T6_23542578T15 NONE gtx2,3-aldehyde-bovine_28\NN\1740| (r_amod) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (r_dep) antigens_27\NNS\20090|two|artificial|complete|albumin (r_conj) aldehydes_22\NNS\14727670|with|three|different|and|antigens (r_nmod) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh (l_conj) klh_52\NN\1740|
23542578T7_23542578T10 NONE gtx2,3-aldehyde-_35\NN\1740| (r_compound) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (r_conj) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin
23542578T7_23542578T11 NONE gtx2,3-aldehyde-_35\NN\1740| (r_compound) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (r_conj) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (l_appos) bsa_32\NN\1740|(|)
23542578T7_23542578T12 NONE gtx2,3-aldehyde-_35\NN\1740| (r_compound) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh
23542578T7_23542578T13 NONE gtx2,3-aldehyde-_35\NN\1740| (r_compound) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (l_appos) klh_40\NN\1740|(|)
23542578T7_23542578T14 NONE gtx2,3-aldehyde-_35\NN\1740| (r_compound) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (r_conj) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (r_dep) antigens_27\NNS\20090|two|artificial|complete|albumin (r_conj) aldehydes_22\NNS\14727670|with|three|different|and|antigens (r_nmod) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh
23542578T7_23542578T15 NONE gtx2,3-aldehyde-_35\NN\1740| (r_compound) hemocyanin_38\NN\1740|gtx2,3-aldehyde-|keyhole|limpet|klh (r_conj) albumin_30\NN\14736972|gtx2,3-aldehyde-bovine|serum|bsa|and|hemocyanin (r_dep) antigens_27\NNS\20090|two|artificial|complete|albumin (r_conj) aldehydes_22\NNS\14727670|with|three|different|and|antigens (r_nmod) activating_7\VBG\1641914|by|group|aldehydes (r_advcl) synthesized_5\VBN\193486|gtx2,3-aldehyde|was|first|activating|prepared|. (l_dep) prepared_44\VBN\126264|were|then|cross-linking (l_advcl) cross-linking_46\VBG\1291069|by|intermediate|bsa (l_nmod) bsa_50\NN\1740|with|or|klh (l_conj) klh_52\NN\1740|
23524316
23524316T1_23524316T7 NONE n-terminal_11\JJ\1740| (r_amod) kinase_12\NN\14732946|c-jun|n-terminal|jnk (r_conj) kinase_5\NN\14732946|extracellular|signal-regulated|erk|and|kinase
23524316T1_23524316T8 NONE n-terminal_11\JJ\1740| (r_amod) kinase_12\NN\14732946|c-jun|n-terminal|jnk (r_conj) kinase_5\NN\14732946|extracellular|signal-regulated|erk|and|kinase (l_appos) erk_7\NN\1740|(|)
23524316T1_23524316T9 NONE n-terminal_11\JJ\1740| (r_amod) kinase_12\NN\14732946|c-jun|n-terminal|jnk
23524316T1_23524316T10 NONE n-terminal_11\JJ\1740| (r_amod) kinase_12\NN\14732946|c-jun|n-terminal|jnk (l_appos) jnk_14\NN\1740|(|)
23524316T1_23524316T11 NONE n-terminal_11\JJ\1740| (r_amod) kinase_12\NN\14732946|c-jun|n-terminal|jnk (r_conj) kinase_5\NN\14732946|extracellular|signal-regulated|erk|and|kinase (r_compound) pathways_17\NNS\5483677|kinase|signaling|activated (l_acl) activated_18\VBN\1641914|treatment (l_nmod) treatment_21\NN\654885|by|thrombin (l_compound) thrombin_20\NN\14735953|
17567713
17567713T10_17567713T16 CPR:3 saccharin_24\NN\7858595|of|and|acesulfame-k. (r_nmod) sensation_22\NN\5708432|with|the|bitter|aftertaste|saccharin (r_nmod) involved_17\VBN\2676054|that|activation|is|partially|sensation (l_nsubjpass) activation_8\NN\13561719|the|receptors (l_nmod) receptors_14\NNS\5225602|of|particular|t2r|bitter|taste (l_compound) t2r_11\NN\1740|
17567713T10_17567713T17 NONE saccharin_24\NN\7858595|of|and|acesulfame-k. (r_nmod) sensation_22\NN\5708432|with|the|bitter|aftertaste|saccharin (r_nmod) involved_17\VBN\2676054|that|activation|is|partially|sensation (r_ccomp) shown_5\VBN\2137132|recently|,|it|has|been|involved|addressed (l_dep) addressed_38\VBN\740577|understand|we|have|question|. (l_dobj) question_40\NN\7193184|the|stimulate (l_acl) stimulate_45\VB\137313|of|whether|as|could|receptors|,|activated (l_dobj) receptors_53\NNS\5225602|transient|receptor|potential|vanilloid-1
17567713T11_17567713T16 CPR:3 acesulfame-k._26\NN\1740| (r_conj) saccharin_24\NN\7858595|of|and|acesulfame-k. (r_nmod) sensation_22\NN\5708432|with|the|bitter|aftertaste|saccharin (r_nmod) involved_17\VBN\2676054|that|activation|is|partially|sensation (l_nsubjpass) activation_8\NN\13561719|the|receptors (l_nmod) receptors_14\NNS\5225602|of|particular|t2r|bitter|taste (l_compound) t2r_11\NN\1740|
17567713T11_17567713T17 NONE acesulfame-k._26\NN\1740| (r_conj) saccharin_24\NN\7858595|of|and|acesulfame-k. (r_nmod) sensation_22\NN\5708432|with|the|bitter|aftertaste|saccharin (r_nmod) involved_17\VBN\2676054|that|activation|is|partially|sensation (r_ccomp) shown_5\VBN\2137132|recently|,|it|has|been|involved|addressed (l_dep) addressed_38\VBN\740577|understand|we|have|question|. (l_dobj) question_40\NN\7193184|the|stimulate (l_acl) stimulate_45\VB\137313|of|whether|as|could|receptors|,|activated (l_dobj) receptors_53\NNS\5225602|transient|receptor|potential|vanilloid-1
17567713T1_17567713T12 NONE )_3\-RRB-\1740| (r_punct) +_2\NN\1740|) (r_dep) ca(2_1\NN\1740|+ (r_compound) imaging_4\NN\5765159|ca(2|receptors (l_nmod) receptors_7\NNS\5225602|on|trpv1|expressed (l_compound) trpv1_6\NN\1740|
17567713T1_17567713T13 NONE )_3\-RRB-\1740| (r_punct) +_2\NN\1740|) (r_dep) ca(2_1\NN\1740|+ (r_compound) imaging_4\NN\5765159|ca(2|receptors (r_dobj) using_0\VBG\1156834|imaging (r_advcl) find_28\VBP\2163746|using|,|we|activate|. (l_ccomp) activate_35\VBP\1641914|that|systems|,|as|receptors|,|and|,|moreover|sensitize (l_dobj) receptors_37\NNS\5225602|trpv1 (l_compound) trpv1_36\NN\1740|
17567713T2_17567713T14 CPR:3 )_10\-RRB-\1740| (r_punct) cuso(4_9\NN\1740|by|)|,|znso(4|,|and|feso(4|,|salts (r_nmod) activated_7\VBN\1641914|that|receptors|are|cuso(4 (l_nsubjpass) receptors_5\NNS\5225602|trpv1 (l_compound) trpv1_4\NN\1740|
17567713T3_17567713T14 CPR:3 )_13\-RRB-\1740| (r_punct) znso(4_12\NN\1740|) (r_conj) cuso(4_9\NN\1740|by|)|,|znso(4|,|and|feso(4|,|salts (r_nmod) activated_7\VBN\1641914|that|receptors|are|cuso(4 (l_nsubjpass) receptors_5\NNS\5225602|trpv1 (l_compound) trpv1_4\NN\1740|
17567713T4_17567713T14 CPR:3 )_17\-RRB-\1740| (r_punct) feso(4_16\NN\1740|) (r_conj) cuso(4_9\NN\1740|by|)|,|znso(4|,|and|feso(4|,|salts (r_nmod) activated_7\VBN\1641914|that|receptors|are|cuso(4 (l_nsubjpass) receptors_5\NNS\5225602|trpv1 (l_compound) trpv1_4\NN\1740|
23386780
23386780T4_23386780T13 NONE ech-induced_0\JJ\1740| (r_amod) changes_2\NNS\7283608|ech-induced|apoptotic (r_nsubjpass) evaluated_4\VBN\670261|changes|were|assay|and|confirmed (l_nmod) assay_16\NN\5733583|by|labeling (l_compound) labeling_12\NN\1740|terminal|deoxynucleotidyl|transferase|dutp|nick|end|tunel (l_compound) transferase_8\NN\14732946|
23386780T5_23386780T13 NONE dutp_9\NN\1740| (r_compound) labeling_12\NN\1740|terminal|deoxynucleotidyl|transferase|dutp|nick|end|tunel (l_compound) transferase_8\NN\14732946|
23386780T6_23386780T17 NONE amino-terminal_12\JJ\1740| (r_amod) kinase_13\NN\14732946|phospho-c-jun|amino-terminal|p-jnk (r_compound) expression_17\NN\4679549|kinase (r_conj) kinase_5\NN\14732946|phospho-p38|mitogen-activated|protein|mapk|and|expression (l_compound) phospho-p38_2\NN\1740|
23386780T6_23386780T18 NONE amino-terminal_12\JJ\1740| (r_amod) kinase_13\NN\14732946|phospho-c-jun|amino-terminal|p-jnk (r_compound) expression_17\NN\4679549|kinase (r_conj) kinase_5\NN\14732946|phospho-p38|mitogen-activated|protein|mapk|and|expression
23386780T6_23386780T19 NONE amino-terminal_12\JJ\1740| (r_amod) kinase_13\NN\14732946|phospho-c-jun|amino-terminal|p-jnk (r_compound) expression_17\NN\4679549|kinase (r_conj) kinase_5\NN\14732946|phospho-p38|mitogen-activated|protein|mapk|and|expression (l_appos) mapk_8\NN\1740|(|p-p38|) (l_compound) p-p38_7\NN\1740|
23386780T6_23386780T20 NONE amino-terminal_12\JJ\1740| (r_amod) kinase_13\NN\14732946|phospho-c-jun|amino-terminal|p-jnk (r_compound) expression_17\NN\4679549|kinase (r_conj) kinase_5\NN\14732946|phospho-p38|mitogen-activated|protein|mapk|and|expression (l_appos) mapk_8\NN\1740|(|p-p38|)
23386780T6_23386780T21 NONE amino-terminal_12\JJ\1740| (r_amod) kinase_13\NN\14732946|phospho-c-jun|amino-terminal|p-jnk
23386780T6_23386780T22 NONE amino-terminal_12\JJ\1740| (r_amod) kinase_13\NN\14732946|phospho-c-jun|amino-terminal|p-jnk (l_appos) p-jnk_15\NN\1740|(|)
23542126
23542126T8_23542126T9 NONE carbonyls_20\NNS\14818238| (r_compound) levels_21\NNS\4916342|protein|carbonyls (r_nsubj) lower_24\JJR\1740|while|levels|were|significantly|survivors|non-survivors|1stday (r_advcl) higher_4\JJR\1740|activity|was|significantly|survivors|non-survivors|,|lower|. (l_nsubj) activity_1\NN\30358|catalase (l_compound) catalase_0\NN\14732946|
19708854
19708854T8_19708854T11 NONE vapreotide_0\NN\1740|:|analog|. (l_appos) analog_4\NN\4743605|a|somatostatin|treatment (l_compound) somatostatin_3\NN\1740|
19708854T9_19708854T11 NONE somatostatin_3\NN\1740|
19708854T4_19708854T10 NONE vapreotide_7\NNP\1740|between|and|analogues (l_conj) analogues_11\NNS\4743605|other|somatostatin (l_compound) somatostatin_10\NN\1740|
19708854T5_19708854T10 NONE somatostatin_10\NN\1740|
16343532
16343532T12_16343532T24 NONE motuporin_7\NN\1740|to|and|dihydromicrocystin-la (r_nmod) bound_5\VBN\1831531|motuporin (r_acl) structures_1\NNS\21939|crystal|phosphatase-1|bound|:|elucidation (l_nmod) phosphatase-1_4\NN\1740|of|protein
16343532T13_16343532T24 NONE dihydromicrocystin-la_9\NN\1740| (r_conj) motuporin_7\NN\1740|to|and|dihydromicrocystin-la (r_nmod) bound_5\VBN\1831531|motuporin (r_acl) structures_1\NNS\21939|crystal|phosphatase-1|bound|:|elucidation (l_nmod) phosphatase-1_4\NN\1740|of|protein
16343532T5_16343532T15 NONE ser/thr_7\NN\1740| (r_compound) phosphatases_9\NNS\14732946|specificity|ser/thr|protein|cells
16343532T6_16343532T15 NONE ser/thr_7\NN\1740| (r_compound) phosphatases_9\NNS\14732946|specificity|ser/thr|protein|cells
16343532T7_16343532T16 NONE microcystin_6\NN\1740|of|a|bound (l_acl) bound_7\VBN\1831531|subunit (l_nmod) subunit_11\NN\13604718|to|the|catalytic|phosphatase-1 (l_nmod) phosphatase-1_14\NN\1740|of|protein|pp-1c
16343532T7_16343532T17 NONE microcystin_6\NN\1740|of|a|bound (l_acl) bound_7\VBN\1831531|subunit (l_nmod) subunit_11\NN\13604718|to|the|catalytic|phosphatase-1 (l_nmod) phosphatase-1_14\NN\1740|of|protein|pp-1c (l_appos) pp-1c_16\NN\1740|(|)
16343532T7_16343532T18 NONE microcystin_6\NN\1740|of|a|bound (r_nmod) structure_3\NN\21939|a|previous|crystal|microcystin (r_nsubj) showed_18\VBD\2137132|structure|changes|region|compared|. (l_advcl) compared_27\VBN\644583|when|structures (l_nmod) structures_31\NNS\21939|with|protein|phosphatase-1|bound (l_compound) phosphatase-1_30\NN\1740|
16343532T9_16343532T19 NONE motuporin_10\NN\1740|nodularin-v|and|dihydromicrocystin-la (r_appos) cyanotoxins_8\NNS\1740|of|the|,|motuporin|bound
16343532T9_16343532T20 NONE motuporin_10\NN\1740|nodularin-v|and|dihydromicrocystin-la (r_appos) cyanotoxins_8\NNS\1740|of|the|,|motuporin|bound (l_acl) bound_16\VBN\1831531|phosphatase-1c (l_nmod) phosphatase-1c_20\NN\1740|to|human|protein|isoform (l_appos) isoform_23\NN\1740|(|gamma|) (l_punct) )_24\-RRB-\1740|
16343532T10_16343532T19 NONE nodularin-v_12\NN\1740|(|) (r_appos) motuporin_10\NN\1740|nodularin-v|and|dihydromicrocystin-la (r_appos) cyanotoxins_8\NNS\1740|of|the|,|motuporin|bound
16343532T10_16343532T20 NONE nodularin-v_12\NN\1740|(|) (r_appos) motuporin_10\NN\1740|nodularin-v|and|dihydromicrocystin-la (r_appos) cyanotoxins_8\NNS\1740|of|the|,|motuporin|bound (l_acl) bound_16\VBN\1831531|phosphatase-1c (l_nmod) phosphatase-1c_20\NN\1740|to|human|protein|isoform (l_appos) isoform_23\NN\1740|(|gamma|) (l_punct) )_24\-RRB-\1740|
16343532T11_16343532T19 NONE dihydromicrocystin-la_15\NN\1740| (r_conj) motuporin_10\NN\1740|nodularin-v|and|dihydromicrocystin-la (r_appos) cyanotoxins_8\NNS\1740|of|the|,|motuporin|bound
16343532T11_16343532T20 NONE dihydromicrocystin-la_15\NN\1740| (r_conj) motuporin_10\NN\1740|nodularin-v|and|dihydromicrocystin-la (r_appos) cyanotoxins_8\NNS\1740|of|the|,|motuporin|bound (l_acl) bound_16\VBN\1831531|phosphatase-1c (l_nmod) phosphatase-1c_20\NN\1740|to|human|protein|isoform (l_appos) isoform_23\NN\1740|(|gamma|) (l_punct) )_24\-RRB-\1740|
16343532T1_16343532T14 NONE microcystins_17\NNS\1740|not|nodularins (r_nsubj) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (l_dobj) targets_26\NNS\7258332|their|protein|phosphatase (l_compound) phosphatase_25\NN\14732946|
16343532T1_16343532T22 NONE microcystins_17\NNS\1740|not|nodularins (r_nsubj) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (r_acl:relcl) mechanism_14\NN\13446390|the|biochemical|modify (r_dobj) explain_11\VBP\831651|comparisons|mechanism|. (l_nsubj) comparisons_0\NNS\635850|structures (l_nmod) structures_3\NNS\21939|of|the|complexes (l_nmod) complexes_10\NNS\5869584|of|the|cyanobacterial|phosphatase (l_compound) phosphatase_9\NN\14732946|toxin|: (l_compound) toxin_7\NN\15032376|
16343532T1_16343532T23 NONE microcystins_17\NNS\1740|not|nodularins (r_nsubj) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (r_acl:relcl) mechanism_14\NN\13446390|the|biochemical|modify (r_dobj) explain_11\VBP\831651|comparisons|mechanism|. (l_nsubj) comparisons_0\NNS\635850|structures (l_nmod) structures_3\NNS\21939|of|the|complexes (l_nmod) complexes_10\NNS\5869584|of|the|cyanobacterial|phosphatase (l_compound) phosphatase_9\NN\14732946|toxin|:
16343532T2_16343532T14 NONE nodularins_20\NNS\1740| (r_conj) microcystins_17\NNS\1740|not|nodularins (r_nsubj) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (l_dobj) targets_26\NNS\7258332|their|protein|phosphatase (l_compound) phosphatase_25\NN\14732946|
16343532T2_16343532T22 NONE nodularins_20\NNS\1740| (r_conj) microcystins_17\NNS\1740|not|nodularins (r_nsubj) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (r_acl:relcl) mechanism_14\NN\13446390|the|biochemical|modify (r_dobj) explain_11\VBP\831651|comparisons|mechanism|. (l_nsubj) comparisons_0\NNS\635850|structures (l_nmod) structures_3\NNS\21939|of|the|complexes (l_nmod) complexes_10\NNS\5869584|of|the|cyanobacterial|phosphatase (l_compound) phosphatase_9\NN\14732946|toxin|: (l_compound) toxin_7\NN\15032376|
16343532T2_16343532T23 NONE nodularins_20\NNS\1740| (r_conj) microcystins_17\NNS\1740|not|nodularins (r_nsubj) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (r_acl:relcl) mechanism_14\NN\13446390|the|biochemical|modify (r_dobj) explain_11\VBP\831651|comparisons|mechanism|. (l_nsubj) comparisons_0\NNS\635850|structures (l_nmod) structures_3\NNS\21939|of|the|complexes (l_nmod) complexes_10\NNS\5869584|of|the|cyanobacterial|phosphatase (l_compound) phosphatase_9\NN\14732946|toxin|:
16343532T3_16343532T14 NONE cysteine_34\NN\14601829| (r_compound) residue_35\NN\20827|to|an|site|cysteine (r_nmod) addition_29\NN\3081021|by|covalent|residue (r_nmod) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (l_dobj) targets_26\NNS\7258332|their|protein|phosphatase (l_compound) phosphatase_25\NN\14732946|
16343532T3_16343532T22 NONE cysteine_34\NN\14601829| (r_compound) residue_35\NN\20827|to|an|site|cysteine (r_nmod) addition_29\NN\3081021|by|covalent|residue (r_nmod) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (r_acl:relcl) mechanism_14\NN\13446390|the|biochemical|modify (r_dobj) explain_11\VBP\831651|comparisons|mechanism|. (l_nsubj) comparisons_0\NNS\635850|structures (l_nmod) structures_3\NNS\21939|of|the|complexes (l_nmod) complexes_10\NNS\5869584|of|the|cyanobacterial|phosphatase (l_compound) phosphatase_9\NN\14732946|toxin|: (l_compound) toxin_7\NN\15032376|
16343532T3_16343532T23 NONE cysteine_34\NN\14601829| (r_compound) residue_35\NN\20827|to|an|site|cysteine (r_nmod) addition_29\NN\3081021|by|covalent|residue (r_nmod) modify_22\VBP\109660|which|microcystins|permanently|targets|addition (r_acl:relcl) mechanism_14\NN\13446390|the|biochemical|modify (r_dobj) explain_11\VBP\831651|comparisons|mechanism|. (l_nsubj) comparisons_0\NNS\635850|structures (l_nmod) structures_3\NNS\21939|of|the|complexes (l_nmod) complexes_10\NNS\5869584|of|the|cyanobacterial|phosphatase (l_compound) phosphatase_9\NN\14732946|toxin|:
9003761
9003761T11_9003761T30 NONE k+_13\NN\1740| (r_compound) channel_14\NN\6251781|of|a|novel|unconventional|outward|rectifier|k+
9003761T10_9003761T12 NONE k+_18\NN\1740| (r_compound) channel_19\NN\6251781|of|weak|inward|rectifier|k+ (r_nmod) type_13\NN\5839024|twik-1|is|a|new|structural|channel|. (l_nsubj) twik-1_1\NN\1740|human|,|cloned|,
9003761T10_9003761T25 NONE k+_18\NN\1740| (r_compound) channel_19\NN\6251781|of|weak|inward|rectifier|k+
9003761T2_9003761T16 NONE k+_14\NN\1740| (r_compound) channel_15\NN\6251781|a|mammalian|twik-1-related|k+ (r_appos) trek-1_9\NNP\1740|of|,|channel
9003761T2_9003761T17 NONE k+_14\NN\1740| (r_compound) channel_15\NN\6251781|a|mammalian|twik-1-related|k+
9003761T3_9003761T18 NONE acid_4\NN\14818238| (r_compound) identity_5\NN\4617562|despite|a|low|amino|acid|twik-1|% (l_nmod) twik-1_7\NN\1740|between|and|trek-1
9003761T3_9003761T19 NONE acid_4\NN\14818238| (r_compound) identity_5\NN\4617562|despite|a|low|amino|acid|twik-1|% (l_nmod) twik-1_7\NN\1740|between|and|trek-1 (l_conj) trek-1_9\NN\1740|
9003761T3_9003761T20 NONE acid_4\NN\14818238| (r_compound) identity_5\NN\4617562|despite|a|low|amino|acid|twik-1|% (r_nmod) share_19\VBP\2660631|identity|,|proteins|arrangement|. (l_dobj) arrangement_24\NN\5794694|the|same|overall|structural|consisting (l_acl) consisting_25\VBG\2603699|domains (l_nmod) domains_29\NNS\13934596|of|two|pore-forming|and|segments
9003761T4_9003761T21 NONE k+_0\NN\1740| (r_compound) currents_1\NNS\11449002|k+|generated (l_acl) generated_2\VBN\1617192|twik-1 (l_nmod) twik-1_4\NN\1740|by
9003761T4_9003761T22 NONE k+_0\NN\1740| (r_compound) currents_1\NNS\11449002|k+|generated (r_nsubj) rectifying_7\VBG\918872|currents|are|inwardly|rectifying|. (l_advcl) rectifying_16\VBG\918872|while|currents|are|outwardly (l_nsubj) currents_10\NNS\11449002|k+|generated (l_acl) generated_11\VBN\1617192|trek-1 (l_nmod) trek-1_13\NN\1740|by
9003761T5_9003761T21 NONE k+_9\NN\1740| (r_compound) currents_10\NNS\11449002|k+|generated (r_nsubj) rectifying_16\VBG\918872|while|currents|are|outwardly (r_advcl) rectifying_7\VBG\918872|currents|are|inwardly|rectifying|. (l_nsubj) currents_1\NNS\11449002|k+|generated (l_acl) generated_2\VBN\1617192|twik-1 (l_nmod) twik-1_4\NN\1740|by
9003761T5_9003761T22 NONE k+_9\NN\1740| (r_compound) currents_10\NNS\11449002|k+|generated (l_acl) generated_11\VBN\1617192|trek-1 (l_nmod) trek-1_13\NN\1740|by
9003761T6_9003761T23 NONE quinine_13\NN\2721948|such|and|quinidine (r_nmod) block_8\VBP\1476483|that|activity|quinine (r_acl:relcl) agents_6\NNS\7347|to|pharmacological|block (r_nmod) insensitive_3\JJ\1740|currents|are|agents|. (l_nsubj) currents_1\NNS\11449002|trek-1 (l_compound) trek-1_0\NN\1740|
9003761T6_9003761T24 CPR:4 quinine_13\NN\2721948|such|and|quinidine (r_nmod) block_8\VBP\1476483|that|activity|quinine (l_dobj) activity_10\NN\30358|twik-1 (l_compound) twik-1_9\NN\1740|
9003761T7_9003761T23 NONE quinidine_15\NN\2715941| (r_conj) quinine_13\NN\2721948|such|and|quinidine (r_nmod) block_8\VBP\1476483|that|activity|quinine (r_acl:relcl) agents_6\NNS\7347|to|pharmacological|block (r_nmod) insensitive_3\JJ\1740|currents|are|agents|. (l_nsubj) currents_1\NNS\11449002|trek-1 (l_compound) trek-1_0\NN\1740|
9003761T7_9003761T24 CPR:4 quinidine_15\NN\2715941| (r_conj) quinine_13\NN\2721948|such|and|quinidine (r_nmod) block_8\VBP\1476483|that|activity|quinine (l_dobj) activity_10\NN\30358|twik-1 (l_compound) twik-1_9\NN\1740|
9003761T8_9003761T28 NONE k+_6\NN\1740|to|extracellular|and|na+ (r_nmod) sensitive_3\JJ\1740|currents|are|k+|. (l_nsubj) currents_1\NNS\11449002|trek-1 (l_compound) trek-1_0\NN\1740|
9003761T9_9003761T28 NONE na+_8\NN\1740| (r_conj) k+_6\NN\1740|to|extracellular|and|na+ (r_nmod) sensitive_3\JJ\1740|currents|are|k+|. (l_nsubj) currents_1\NNS\11449002|trek-1 (l_compound) trek-1_0\NN\1740|
9003761T1_9003761T14 NONE k+_11\NN\1740| (r_compound) family_13\NN\8189659|of|a|k+|channel|tms|system (l_compound) channel_12\NN\6251781|
9003761T1_9003761T15 NONE k+_11\NN\1740| (r_compound) family_13\NN\8189659|of|a|k+|channel|tms|system (l_nmod) tms_16\NNS\14625458|with|four|and|domains (l_conj) domains_20\NNS\13934596|two|pore
23307557
23307557T1_23307557T5 NONE poly(adp-ribosyl)ation_14\NN\1740| (r_conj) phosphorylation_6\NN\1740|such|,|ubiquitination|,|sumoylation|,|methylation|and|poly(adp-ribosyl)ation (r_nmod) modifications_1\NNS\191142|post-translational|trf2|phosphorylation (l_nmod) trf2_3\NN\1740|of
23307557T2_23307557T6 NONE lysine_18\NN\14605787| (r_compound) residue_19\NN\20827|the|lysine|position (r_dobj) acetylates_16\VBZ\109660|that|p300|residue (r_conj) interacts_6\VBZ\2367363|that|trf2|specifically|p300|,|and|acetylates (l_nsubj) trf2_4\NN\1740|
23307557T2_23307557T7 NONE lysine_18\NN\14605787| (r_compound) residue_19\NN\20827|the|lysine|position (r_dobj) acetylates_16\VBZ\109660|that|p300|residue (r_conj) interacts_6\VBZ\2367363|that|trf2|specifically|p300|,|and|acetylates (l_nmod) p300_11\NN\1740|with|the|histone|acetyltransferase
23307557T2_23307557T9 NONE lysine_18\NN\14605787| (r_compound) residue_19\NN\20827|the|lysine|position (r_dobj) acetylates_16\VBZ\109660|that|p300|residue (l_nsubj) p300_15\NN\1740|
23307557T2_23307557T10 NONE lysine_18\NN\14605787| (r_compound) residue_19\NN\20827|the|lysine|position (l_nmod) position_21\NN\8620061|at|293|trf2 (l_nmod) trf2_24\NN\1740|of
23606523
23606523T6_23606523T17 NONE glucose_11\NN\14710501| (r_compound) data_12\NNS\7951464|early|phase|glucose|patients (r_dobj) using_8\VBG\1156834|data (r_acl) approach_2\NN\940842|a|model-based|predict|using|. (l_acl) predict_4\VB\916909|to|hba1c|, (l_dobj) hba1c_6\NN\1740|longitudinal
23606523T2_23606523T10 NONE glucose_20\NN\14710501|and|insulin (r_compound) concentrations_23\NNS\4916342|glucose (r_dobj) using_19\VBG\1156834|concentrations|study (r_dep) predicting_10\VBG\916909|for|hemoglobin|using (l_dobj) hemoglobin_12\NN\14888884|glycosylated|hba1c|phase
23606523T2_23606523T11 NONE glucose_20\NN\14710501|and|insulin (r_compound) concentrations_23\NNS\4916342|glucose (r_dobj) using_19\VBG\1156834|concentrations|study (r_dep) predicting_10\VBG\916909|for|hemoglobin|using (l_dobj) hemoglobin_12\NN\14888884|glycosylated|hba1c|phase (l_appos) hba1c_14\NN\1740|(|)
23606523T2_23606523T12 NONE glucose_20\NN\14710501|and|insulin (l_conj) insulin_22\NN\5407119|
23606523T3_23606523T13 NONE glucose_9\NN\14710501|integrated|and|insulin|igi (l_conj) insulin_11\NN\5407119|
23606523T3_23606523T14 NONE glucose_9\NN\14710501|integrated|and|insulin|igi (r_compound) model_15\NN\5888929|an|glucose|tests|and|model (l_conj) model_29\NN\5888929|an|cell-hba1c|predicting (l_compound) cell-hba1c_25\NN\1740|integrated|glucose-red|blood|igrh
23606523T3_23606523T15 NONE glucose_9\NN\14710501|integrated|and|insulin|igi (r_compound) model_15\NN\5888929|an|glucose|tests|and|model (l_conj) model_29\NN\5888929|an|cell-hba1c|predicting (l_acl) predicting_30\VBG\916909|formation (l_dobj) formation_32\NN\7938773|the|hba1c|concentration (l_nmod) hba1c_34\NN\1740|of
23606523T4_23606523T13 NONE glucose-red_23\NN\1740| (r_amod) cell-hba1c_25\NN\1740|integrated|glucose-red|blood|igrh (r_compound) model_29\NN\5888929|an|cell-hba1c|predicting (r_conj) model_15\NN\5888929|an|glucose|tests|and|model (l_compound) glucose_9\NN\14710501|integrated|and|insulin|igi (l_conj) insulin_11\NN\5407119|
23606523T4_23606523T14 NONE glucose-red_23\NN\1740| (r_amod) cell-hba1c_25\NN\1740|integrated|glucose-red|blood|igrh
23606523T4_23606523T15 NONE glucose-red_23\NN\1740| (r_amod) cell-hba1c_25\NN\1740|integrated|glucose-red|blood|igrh (r_compound) model_29\NN\5888929|an|cell-hba1c|predicting (l_acl) predicting_30\VBG\916909|formation (l_dobj) formation_32\NN\7938773|the|hba1c|concentration (l_nmod) hba1c_34\NN\1740|of
23606523T5_23606523T13 NONE glucose_38\NN\14710501| (r_compound) concentration_39\NN\4916342|from|the|average|glucose|cg (r_nmod) formation_32\NN\7938773|the|hba1c|concentration (r_dobj) predicting_30\VBG\916909|formation (r_acl) model_29\NN\5888929|an|cell-hba1c|predicting (r_conj) model_15\NN\5888929|an|glucose|tests|and|model (l_compound) glucose_9\NN\14710501|integrated|and|insulin|igi (l_conj) insulin_11\NN\5407119|
23606523T5_23606523T14 NONE glucose_38\NN\14710501| (r_compound) concentration_39\NN\4916342|from|the|average|glucose|cg (r_nmod) formation_32\NN\7938773|the|hba1c|concentration (r_dobj) predicting_30\VBG\916909|formation (r_acl) model_29\NN\5888929|an|cell-hba1c|predicting (l_compound) cell-hba1c_25\NN\1740|integrated|glucose-red|blood|igrh
23606523T5_23606523T15 NONE glucose_38\NN\14710501| (r_compound) concentration_39\NN\4916342|from|the|average|glucose|cg (r_nmod) formation_32\NN\7938773|the|hba1c|concentration (l_nmod) hba1c_34\NN\1740|of
23606523T1_23606523T8 NONE glucose_24\NN\14710501|and|insulin (r_compound) concentrations_27\NNS\4916342|glucose (r_nsubjpass) measured_29\VBN\697589|where|concentrations|were (r_acl:relcl) study_22\NN\635850|from|a|1-week|measured (r_nmod) information_18\NN\6598915|only|study (r_dobj) using_16\VBG\1156834|information (r_advcl) predicts_7\VBZ\916909|that|approach|well|response|using (l_dobj) response_11\NN\11410625|the|longitudinal|hba1c|study (l_compound) hba1c_10\NN\1740|
23606523T1_23606523T9 NONE glucose_24\NN\14710501|and|insulin (l_conj) insulin_26\NN\5407119|
17081103
17081103T7_17081103T39 NONE glutathione_0\NN\1740| (r_compound) peroxidases_1\NNS\14971234|glutathione|and|factors|.
17081103T4_17081103T10 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_dep) cgpx_17\NN\1740|(|,|gpx1|)
17081103T4_17081103T12 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_dep) cgpx_17\NN\1740|(|,|gpx1|) (l_appos) gpx1_19\NN\1740|
17081103T4_17081103T13 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_24\NN\1740|phospholipid|hydroperoxide|phgpx
17081103T4_17081103T18 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_24\NN\1740|phospholipid|hydroperoxide|phgpx (l_appos) phgpx_26\NN\1740|(|,|gpx4|)
17081103T4_17081103T19 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_24\NN\1740|phospholipid|hydroperoxide|phgpx (l_appos) phgpx_26\NN\1740|(|,|gpx4|) (l_appos) gpx4_28\NN\1740|
17081103T4_17081103T20 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_32\NN\1740|plasma|pgpx
17081103T4_17081103T21 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_32\NN\1740|plasma|pgpx (l_dep) pgpx_34\NN\1740|(|,|gpx3|)
17081103T4_17081103T22 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_32\NN\1740|plasma|pgpx (l_dep) pgpx_34\NN\1740|(|,|gpx3|) (l_appos) gpx3_36\NN\1740|
17081103T4_17081103T23 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_40\NN\1740|gastrointestinal|gi-gpx
17081103T4_17081103T24 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_40\NN\1740|gastrointestinal|gi-gpx (l_dep) gi-gpx_42\NN\1740|(|,|gpx2|)
17081103T4_17081103T25 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx_40\NN\1740|gastrointestinal|gi-gpx (l_dep) gi-gpx_42\NN\1740|(|,|gpx2|) (l_appos) gpx2_44\NN\1740|
17081103T4_17081103T26 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6 (l_conj) gpx6_51\NN\1740|,|restricted
17081103T4_17081103T28 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals
17081103T4_17081103T35 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (l_appos) gpxs_9\NNS\1740|(|)
17081103T4_17081103T38 NONE glutathione_6\NN\1740| (r_compound) peroxidases_7\NNS\14971234|five|glutathione|gpxs|mammals (r_dobj) identified_4\VBD\699815|analysis|peroxidases|:|gpx|. (l_dobj) gpx_15\NN\1740|cytosolic|cgpx|,|gpx|,|gpx|,|gpx|and|,|humans|,|gpx6
17081103T1_17081103T27 CPR:9 alcohols_6\NNS\7881800|to|the|corresponding (r_nmod) reduce_1\VBP\441445|gpxs|hydroperoxides|alcohols|means|. (l_nsubj) gpxs_0\NNS\1740|
17081103T2_17081103T27 NONE glutathione_10\NN\1740|of|gsh (r_nmod) means_8\NNS\44150|by|glutathione (r_nmod) reduce_1\VBP\441445|gpxs|hydroperoxides|alcohols|means|. (l_nsubj) gpxs_0\NNS\1740|
17081103T3_17081103T27 NONE gsh_12\NN\1740|(|) (r_appos) glutathione_10\NN\1740|of|gsh (r_nmod) means_8\NNS\44150|by|glutathione (r_nmod) reduce_1\VBP\441445|gpxs|hydroperoxides|alcohols|means|. (l_nsubj) gpxs_0\NNS\1740|
17081103T5_17081103T32 NONE leukotriene_10\NN\1740|and|prostanoid (r_compound) biosynthesis_13\NN\13565379|leukotriene (r_dobj) reduces_9\VBZ\441445|biosynthesis (r_conj) interferes_2\VBZ\2451370|phgpx|specifically|activation|,|reduces|,|prevents|,|and|indispensable|. (l_nsubj) phgpx_0\NN\1740|
17081103T5_17081103T33 NONE leukotriene_10\NN\1740|and|prostanoid (r_compound) biosynthesis_13\NN\13565379|leukotriene (r_dobj) reduces_9\VBZ\441445|biosynthesis (r_conj) interferes_2\VBZ\2451370|phgpx|specifically|activation|,|reduces|,|prevents|,|and|indispensable|. (l_nmod) activation_5\NN\13561719|with|nf-kappab|interleukin-1 (l_compound) nf-kappab_4\NN\1740|
17081103T5_17081103T34 NONE leukotriene_10\NN\1740|and|prostanoid (r_compound) biosynthesis_13\NN\13565379|leukotriene (r_dobj) reduces_9\VBZ\441445|biosynthesis (r_conj) interferes_2\VBZ\2451370|phgpx|specifically|activation|,|reduces|,|prevents|,|and|indispensable|. (l_nmod) activation_5\NN\13561719|with|nf-kappab|interleukin-1 (l_nmod) interleukin-1_7\NN\1740|by
17081103T5_17081103T36 NONE leukotriene_10\NN\1740|and|prostanoid (r_compound) biosynthesis_13\NN\13565379|leukotriene (r_dobj) reduces_9\VBZ\441445|biosynthesis (r_conj) interferes_2\VBZ\2451370|phgpx|specifically|activation|,|reduces|,|prevents|,|and|indispensable|. (l_conj) prevents_15\VBZ\1740|expression (l_dobj) expression_17\NN\4679549|cox-2 (l_compound) cox-2_16\NN\14737847|
17081103T6_17081103T32 NONE prostanoid_12\NN\1740| (r_conj) leukotriene_10\NN\1740|and|prostanoid (r_compound) biosynthesis_13\NN\13565379|leukotriene (r_dobj) reduces_9\VBZ\441445|biosynthesis (r_conj) interferes_2\VBZ\2451370|phgpx|specifically|activation|,|reduces|,|prevents|,|and|indispensable|. (l_nsubj) phgpx_0\NN\1740|
17081103T6_17081103T33 NONE prostanoid_12\NN\1740| (r_conj) leukotriene_10\NN\1740|and|prostanoid (r_compound) biosynthesis_13\NN\13565379|leukotriene (r_dobj) reduces_9\VBZ\441445|biosynthesis (r_conj) interferes_2\VBZ\2451370|phgpx|specifically|activation|,|reduces|,|prevents|,|and|indispensable|. (l_nmod) activation_5\NN\13561719|with|nf-kappab|interleukin-1 (l_compound) nf-kappab_4\NN\1740|
17081103T6_17081103T34 NONE prostanoid_12\NN\1740| (r_conj) leukotriene_10\NN\1740|and|prostanoid (r_compound) biosynthesis_13\NN\13565379|leukotriene (r_dobj) reduces_9\VBZ\441445|biosynthesis (r_conj) interferes_2\VBZ\2451370|phgpx|specifically|activation|,|reduces|,|prevents|,|and|indispensable|. (l_nmod) activation_5\NN\13561719|with|nf-kappab|interleukin-1 (l_nmod) interleukin-1_7\NN\1740|by
17081103T6_17081103T36 NONE prostanoid_12\NN\1740| (r_conj) leukotriene_10\NN\1740|and|prostanoid (r_compound) biosynthesis_13\NN\13565379|leukotriene (r_dobj) reduces_9\VBZ\441445|biosynthesis (r_conj) interferes_2\VBZ\2451370|phgpx|specifically|activation|,|reduces|,|prevents|,|and|indispensable|. (l_conj) prevents_15\VBZ\1740|expression (l_dobj) expression_17\NN\4679549|cox-2 (l_compound) cox-2_16\NN\14737847|
23229512
23229512T12_23229512T26 NONE k2_1\NN\1740|vitamin (r_nsubj) binds_3\VBZ\1290422|k2|covalently|bak|and|induces|. (l_nmod) bak_5\NN\1740|to
23229512T12_23229512T27 NONE k2_1\NN\1740|vitamin (r_nsubj) binds_3\VBZ\1290422|k2|covalently|bak|and|induces|. (l_conj) induces_7\VBZ\1627355|apoptosis (l_dobj) apoptosis_9\NN\11486178|bak-mediated (l_amod) bak-mediated_8\JJ\1740|
23229512T5_23229512T14 NONE vk2-induced_16\JJ\1740| (r_amod) apoptosis_17\NN\11486178|of|vk2-induced (r_nmod) target_14\NN\7258332|as|a|molecular|apoptosis (r_nmod) identified_3\VBD\699815|here|,|we|killer|target|. (l_dobj) killer_6\NN\7846|bcl-2|antagonist|1|bak (l_compound) bcl-2_4\NN\1740|
23229512T5_23229512T15 NONE vk2-induced_16\JJ\1740| (r_amod) apoptosis_17\NN\11486178|of|vk2-induced (r_nmod) target_14\NN\7258332|as|a|molecular|apoptosis (r_nmod) identified_3\VBD\699815|here|,|we|killer|target|. (l_dobj) killer_6\NN\7846|bcl-2|antagonist|1|bak (l_appos) bak_9\NN\1740|(|)
23229512T6_23229512T16 NONE vk2_0\NN\1740| (r_nsubj) interacts_2\VBZ\2367363|vk2|directly|bak|and|induces|. (l_nmod) bak_4\NN\1740|with
23229512T7_23229512T17 NONE vk2-induced_32\JJ\1740| (r_amod) c_34\NN\13714184|vk2-induced|cytochrome|c (r_compound) release_39\NN\3748886|for|c|and|death (r_nmod) necessary_28\JJ\1740|thought|,|bak|is|and|sufficient|release|. (l_advcl) thought_19\VBN\670261|although|bak|are|generally|redundant (l_nsubjpass) bak_1\NN\1740|and|protein|,
23229512T7_23229512T18 NONE vk2-induced_32\JJ\1740| (r_amod) c_34\NN\13714184|vk2-induced|cytochrome|c (r_compound) release_39\NN\3748886|for|c|and|death (r_nmod) necessary_28\JJ\1740|thought|,|bak|is|and|sufficient|release|. (l_advcl) thought_19\VBN\670261|although|bak|are|generally|redundant (l_nsubjpass) bak_1\NN\1740|and|protein|, (l_conj) protein_5\NN\14944888|bcl-2-associated|x|bax|,|member
23229512T7_23229512T19 NONE vk2-induced_32\JJ\1740| (r_amod) c_34\NN\13714184|vk2-induced|cytochrome|c (r_compound) release_39\NN\3748886|for|c|and|death (r_nmod) necessary_28\JJ\1740|thought|,|bak|is|and|sufficient|release|. (l_advcl) thought_19\VBN\670261|although|bak|are|generally|redundant (l_nsubjpass) bak_1\NN\1740|and|protein|, (l_conj) protein_5\NN\14944888|bcl-2-associated|x|bax|,|member (l_appos) bax_7\NN\1740|(|)
23229512T7_23229512T20 NONE vk2-induced_32\JJ\1740| (r_amod) c_34\NN\13714184|vk2-induced|cytochrome|c (r_compound) release_39\NN\3748886|for|c|and|death (r_nmod) necessary_28\JJ\1740|thought|,|bak|is|and|sufficient|release|. (l_advcl) thought_19\VBN\670261|although|bak|are|generally|redundant (l_nsubjpass) bak_1\NN\1740|and|protein|, (l_conj) protein_5\NN\14944888|bcl-2-associated|x|bax|,|member (l_appos) member_11\NN\9816771|another|family (l_nmod) family_15\NN\8189659|of|the|bcl-2 (l_compound) bcl-2_14\NN\1740|
23229512T7_23229512T21 NONE vk2-induced_32\JJ\1740| (r_amod) c_34\NN\13714184|vk2-induced|cytochrome|c (r_compound) release_39\NN\3748886|for|c|and|death (r_nmod) necessary_28\JJ\1740|thought|,|bak|is|and|sufficient|release|. (l_nsubj) bak_26\NN\1740|only
23229512T7_23229512T22 CPR:3 vk2-induced_32\JJ\1740| (r_amod) c_34\NN\13714184|vk2-induced|cytochrome|c
23229512T7_23229512T23 CPR:3 vk2-induced_32\JJ\1740| (r_amod) c_34\NN\13714184|vk2-induced|cytochrome|c (l_appos) c_37\NN\13714184|(|cyt|)
23229512T8_23229512T24 NONE epoxide_5\NN\1740|vk2|-|2,3|,|metabolite|, (r_nsubjpass) shown_14\VBN\2137132|moreover|,|epoxide|was|bind|. (l_xcomp) bind_17\VB\1290422|to|covalently|residue (l_nmod) residue_21\NN\20827|to|the|cysteine-166|bak (l_nmod) bak_23\NN\1740|of
23229512T9_23229512T24 NONE vk2_11\NN\1740|of (r_nmod) metabolite_9\NN\20090|an|intracellular|vk2 (r_appos) epoxide_5\NN\1740|vk2|-|2,3|,|metabolite|, (r_nsubjpass) shown_14\VBN\2137132|moreover|,|epoxide|was|bind|. (l_xcomp) bind_17\VB\1290422|to|covalently|residue (l_nmod) residue_21\NN\20827|to|the|cysteine-166|bak (l_nmod) bak_23\NN\1740|of
23229512T10_23229512T24 NONE cysteine-166_20\NN\1740| (r_compound) residue_21\NN\20827|to|the|cysteine-166|bak (l_nmod) bak_23\NN\1740|of
23229512T2_23229512T13 NONE vk2_10\NN\1740|of (r_nmod) effects_8\NNS\13245626|into|the|anticancer|vk2 (r_nmod) insight_4\NN\5710020|effects (r_dobj) provides_3\VBZ\2199590|study|also|insight|and|suggests|. (l_conj) suggests_12\VBZ\1010118|target (l_ccomp) target_19\NN\7258332|that|bak|may|be|a|potential|therapy (l_nsubj) bak_14\NN\1740|
23142538
23142538T5_23142538T15 CPR:4 tcdd_5\NN\1740|ng/kg/day (r_nsubj) induced_10\VBD\1627355|muscle|,|tcdd|increases|. (l_dobj) increases_11\NNS\13576355|methylation|and|decreases (l_conj) decreases_15\NNS\7296428|expression (l_nmod) expression_18\NN\4679549|in|mrna|igf2r (l_nmod) igf2r_20\NN\1740|of
23142538T6_23142538T16 NONE tcdd_8\NN\1740|of (r_nmod) effects_6\NNS\13245626|the|robust|tcdd|expression (l_nmod) expression_12\NN\4679549|on|the|mrna|snrpn (l_nmod) snrpn_14\NN\1740|of|,|peg3|genes|sperm|muscle
23142538T6_23142538T17 NONE tcdd_8\NN\1740|of (r_nmod) effects_6\NNS\13245626|the|robust|tcdd|expression (l_nmod) expression_12\NN\4679549|on|the|mrna|snrpn (l_nmod) snrpn_14\NN\1740|of|,|peg3|genes|sperm|muscle (l_conj) peg3_16\NN\1740|and|igf2r
23142538T6_23142538T18 NONE tcdd_8\NN\1740|of (r_nmod) effects_6\NNS\13245626|the|robust|tcdd|expression (l_nmod) expression_12\NN\4679549|on|the|mrna|snrpn (l_nmod) snrpn_14\NN\1740|of|,|peg3|genes|sperm|muscle (l_conj) peg3_16\NN\1740|and|igf2r (l_conj) igf2r_18\NN\1740|
23142538T6_23142538T19 NONE tcdd_8\NN\1740|of (r_nmod) effects_6\NNS\13245626|the|robust|tcdd|expression (l_nmod) expression_12\NN\4679549|on|the|mrna|snrpn (l_nmod) snrpn_14\NN\1740|of|,|peg3|genes|sperm|muscle (l_nmod) sperm_22\NN\5456945|in|the|and|igf2r (l_conj) igf2r_25\NN\1740|of
12047490
12047490T10_12047490T23 NONE nabumetone_7\NN\3828465|of|and|meloxicam|,|drugs|, (r_nmod) effects_5\NNS\13245626|the|nabumetone|activity (l_nmod) activity_27\NN\30358|on|platelet|cox-1|and|function (l_compound) cox-1_26\NN\14737847|
12047490T10_12047490T25 NONE nabumetone_7\NN\3828465|of|and|meloxicam|,|drugs|, (l_appos) drugs_19\NNS\14778436|two|cyclo-oxygenase-2|preferential|nonsteroidal|anti-inflammatory|nsaids (l_compound) cyclo-oxygenase-2_12\NN\1740|cox-2
12047490T10_12047490T26 NONE nabumetone_7\NN\3828465|of|and|meloxicam|,|drugs|, (l_appos) drugs_19\NNS\14778436|two|cyclo-oxygenase-2|preferential|nonsteroidal|anti-inflammatory|nsaids (l_compound) cyclo-oxygenase-2_12\NN\1740|cox-2 (l_appos) cox-2_14\NN\14737847|(|)
12047490T13_12047490T23 NONE meloxicam_9\NN\1740| (r_conj) nabumetone_7\NN\3828465|of|and|meloxicam|,|drugs|, (r_nmod) effects_5\NNS\13245626|the|nabumetone|activity (l_nmod) activity_27\NN\30358|on|platelet|cox-1|and|function (l_compound) cox-1_26\NN\14737847|
12047490T13_12047490T25 NONE meloxicam_9\NN\1740| (r_conj) nabumetone_7\NN\3828465|of|and|meloxicam|,|drugs|, (l_appos) drugs_19\NNS\14778436|two|cyclo-oxygenase-2|preferential|nonsteroidal|anti-inflammatory|nsaids (l_compound) cyclo-oxygenase-2_12\NN\1740|cox-2
12047490T13_12047490T26 NONE meloxicam_9\NN\1740| (r_conj) nabumetone_7\NN\3828465|of|and|meloxicam|,|drugs|, (l_appos) drugs_19\NNS\14778436|two|cyclo-oxygenase-2|preferential|nonsteroidal|anti-inflammatory|nsaids (l_compound) cyclo-oxygenase-2_12\NN\1740|cox-2 (l_appos) cox-2_14\NN\14737847|(|)
12047490T15_12047490T24 CPR:9 txb2_9\NN\1740| (r_compound) generation_10\NN\7942152|of|serum|txb2 (r_nmod) inhibition_6\NN\1068773|as|percentage|generation|blood|,|and|time (r_nmod) measured_3\VBN\697589|inhibition|was|inhibition|. (l_nsubjpass) inhibition_1\NN\1068773|cox-1 (l_compound) cox-1_0\NN\14737847|
12047490T5_12047490T22 CPR:4 nabumetone_8\NN\3828465| (r_nsubj) inhibits_9\VBZ\2510337|conclusions|:|dosage|,|nabumetone|production|more|,|signifying|. (l_advcl) signifying_17\VBG\955148|selectivity (l_dobj) selectivity_20\NN\4916342|less|cox-2|former (l_compound) cox-2_19\NN\14737847|
12047490T6_12047490T22 NONE thromboxane_10\NN\1740| (r_compound) production_11\NN\30358|thromboxane (r_dobj) inhibits_9\VBZ\2510337|conclusions|:|dosage|,|nabumetone|production|more|,|signifying|. (l_advcl) signifying_17\VBG\955148|selectivity (l_dobj) selectivity_20\NN\4916342|less|cox-2|former (l_compound) cox-2_19\NN\14737847|
23290487
23290487T1_23290487T6 NONE glucose_10\NN\14710501| (r_compound) transporter-4_11\NN\1740|marker|is|the|insulin|dependent|glucose|glut-4|responds|.
23290487T1_23290487T7 NONE glucose_10\NN\14710501| (r_compound) transporter-4_11\NN\1740|marker|is|the|insulin|dependent|glucose|glut-4|responds|. (l_appos) glut-4_13\NN\1740|(|)
23290487T2_23290487T6 NONE palmatine_36\NNP\1740| (r_conj) cordifolia_34\NN\1740|by|tinospora|and|palmatine (r_nmod) expressed_25\VBN\928630|is|over|5-|,|cordifolia|,|respectively (r_conj) responds_17\VBZ\2367363|which|also|chemicals|,|and|expressed (r_acl:relcl) transporter-4_11\NN\1740|marker|is|the|insulin|dependent|glucose|glut-4|responds|.
23290487T2_23290487T7 NONE palmatine_36\NNP\1740| (r_conj) cordifolia_34\NN\1740|by|tinospora|and|palmatine (r_nmod) expressed_25\VBN\928630|is|over|5-|,|cordifolia|,|respectively (r_conj) responds_17\VBZ\2367363|which|also|chemicals|,|and|expressed (r_acl:relcl) transporter-4_11\NN\1740|marker|is|the|insulin|dependent|glucose|glut-4|responds|. (l_appos) glut-4_13\NN\1740|(|)
23290487T3_23290487T8 CPR:9 glucose_8\NN\14710501| (r_compound) metabolism_9\NN\13526110|glucose (r_dobj) influencing_7\VBG\137313|metabolism (r_acl) protein_6\NN\14944888|the|predominant|influencing (r_nsubj) pparα_11\NN\1740|next|,|protein|is|and|γ|modulated|. (l_advmod) next_0\RB\1740|glut-4 (l_nmod) glut-4_2\NN\1740|to
23290487T3_23290487T9 NONE glucose_8\NN\14710501| (r_compound) metabolism_9\NN\13526110|glucose (r_dobj) influencing_7\VBG\137313|metabolism (r_acl) protein_6\NN\14944888|the|predominant|influencing (r_nsubj) pparα_11\NN\1740|next|,|protein|is|and|γ|modulated|. (l_conj) γ_13\NN\1740|
23290487T4_23290487T10 NONE glucose_8\NN\14710501| (r_compound) uptake_9\NN\13440063|glucose|mediated|shows (r_dobj) prevented_7\VBD\1740|further|,|inhibitors|uptake|. (l_nsubj) inhibitors_3\NNS\20090|the|pathway (l_nmod) pathway_6\NN\5483677|of|insulin (l_compound) insulin_5\NN\5407119|
23290487T4_23290487T11 NONE glucose_8\NN\14710501| (r_compound) uptake_9\NN\13440063|glucose|mediated|shows (l_acl:relcl) shows_17\VBZ\2137132|which|mediated (l_ccomp) mediated_23\VBN\761713|that|activity|is|majorly|pathway (l_nmod) pathway_26\NN\5483677|through|insulin (l_compound) insulin_25\NN\5407119|
23290487T5_23290487T10 NONE palmatine_15\NN\1740| (r_conj) cordifolia_13\FW\1740|by|tinospora|and|palmatine (r_nmod) mediated_10\VBN\761713|cordifolia (r_acl) uptake_9\NN\13440063|glucose|mediated|shows (r_dobj) prevented_7\VBD\1740|further|,|inhibitors|uptake|. (l_nsubj) inhibitors_3\NNS\20090|the|pathway (l_nmod) pathway_6\NN\5483677|of|insulin (l_compound) insulin_5\NN\5407119|
23290487T5_23290487T11 NONE palmatine_15\NN\1740| (r_conj) cordifolia_13\FW\1740|by|tinospora|and|palmatine (r_nmod) mediated_10\VBN\761713|cordifolia (r_acl) uptake_9\NN\13440063|glucose|mediated|shows (l_acl:relcl) shows_17\VBZ\2137132|which|mediated (l_ccomp) mediated_23\VBN\761713|that|activity|is|majorly|pathway (l_nmod) pathway_26\NN\5483677|through|insulin (l_compound) insulin_25\NN\5407119|
17499824
17499824T27_17499824T36 NONE serine_0\NN\14601829| (r_compound) racemases_1\NNS\1740|serine|barley
17499824T3_17499824T30 NONE serine_12\NN\14601829| (r_compound) racemase_13\NN\1740|a|serine|barley|contained
17499824T4_17499824T30 NONE acid_25\NN\14818238| (r_compound) residues_26\NNS\20827|337|amino|acid (r_dobj) encoding_22\VBG\115157|residues (r_acl) frame_21\NN\3391770|an|open|reading|encoding (r_dobj) contained_17\VBD\2632940|which|frame (r_acl:relcl) racemase_13\NN\1740|a|serine|barley|contained
17499824T5_17499824T31 NONE acid_3\NN\14818238| (r_compound) sequence_4\NN\8457976|the|deduced|amino|acid (r_nsubj) showed_5\VBD\2137132|sequence|identity|and|contained|. (l_dobj) identity_7\NN\4617562|significant|racemases (l_nmod) racemases_13\NNS\1740|to|plant|serine
17499824T6_17499824T31 NONE serine_12\NN\14601829| (r_compound) racemases_13\NNS\1740|to|plant|serine
17499824T7_17499824T31 NONE 5-phosphate_18\NN\1740|pyridoxal|(plp)-binding (r_compound) lysine_20\NN\14605787|5-phosphate|and|amino (r_compound) residues_25\NNS\20827|conserved|lysine|acid (r_dobj) contained_15\VBD\2632940|residues (r_conj) showed_5\VBD\2137132|sequence|identity|and|contained|. (l_dobj) identity_7\NN\4617562|significant|racemases (l_nmod) racemases_13\NNS\1740|to|plant|serine
17499824T8_17499824T31 NONE (plp)-binding_19\NN\1740| (r_amod) 5-phosphate_18\NN\1740|pyridoxal|(plp)-binding (r_compound) lysine_20\NN\14605787|5-phosphate|and|amino (r_compound) residues_25\NNS\20827|conserved|lysine|acid (r_dobj) contained_15\VBD\2632940|residues (r_conj) showed_5\VBD\2137132|sequence|identity|and|contained|. (l_dobj) identity_7\NN\4617562|significant|racemases (l_nmod) racemases_13\NNS\1740|to|plant|serine
17499824T9_17499824T31 NONE lysine_20\NN\14605787|5-phosphate|and|amino (r_compound) residues_25\NNS\20827|conserved|lysine|acid (r_dobj) contained_15\VBD\2632940|residues (r_conj) showed_5\VBD\2137132|sequence|identity|and|contained|. (l_dobj) identity_7\NN\4617562|significant|racemases (l_nmod) racemases_13\NNS\1740|to|plant|serine
17499824T10_17499824T31 NONE plp-interacting_22\JJ\1740| (r_amod) amino_23\NN\14621446|plp-interacting (r_conj) lysine_20\NN\14605787|5-phosphate|and|amino (r_compound) residues_25\NNS\20827|conserved|lysine|acid (r_dobj) contained_15\VBD\2632940|residues (r_conj) showed_5\VBD\2137132|sequence|identity|and|contained|. (l_dobj) identity_7\NN\4617562|significant|racemases (l_nmod) racemases_13\NNS\1740|to|plant|serine
17499824T11_17499824T31 NONE acid_24\NN\14818238| (r_compound) residues_25\NNS\20827|conserved|lysine|acid (r_dobj) contained_15\VBD\2632940|residues (r_conj) showed_5\VBD\2137132|sequence|identity|and|contained|. (l_dobj) identity_7\NN\4617562|significant|racemases (l_nmod) racemases_13\NNS\1740|to|plant|serine
17499824T15_17499824T32 NONE plp_3\NN\1740|and|cations|,|not|atp (r_dobj) requires_2\VBZ\754942|enzyme|plp|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|activity|is|atp (l_nsubjpass) activity_30\NN\30358|mammalian|serine|racemase (l_compound) racemase_29\NN\1740|
17499824T16_17499824T32 NONE )_11\-RRB-\1740| (r_punct) +_10\NN\1740|such|ca(2|)|,|+|)|,|or|+|) (r_nmod) cations_6\NNS\9315159|divalent|+ (r_conj) plp_3\NN\1740|and|cations|,|not|atp (r_dobj) requires_2\VBZ\754942|enzyme|plp|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|activity|is|atp (l_nsubjpass) activity_30\NN\30358|mammalian|serine|racemase (l_compound) racemase_29\NN\1740|
17499824T17_17499824T32 NONE )_15\-RRB-\1740| (r_punct) +_10\NN\1740|such|ca(2|)|,|+|)|,|or|+|) (r_nmod) cations_6\NNS\9315159|divalent|+ (r_conj) plp_3\NN\1740|and|cations|,|not|atp (r_dobj) requires_2\VBZ\754942|enzyme|plp|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|activity|is|atp (l_nsubjpass) activity_30\NN\30358|mammalian|serine|racemase (l_compound) racemase_29\NN\1740|
17499824T18_17499824T32 NONE )_20\-RRB-\1740| (r_punct) +_10\NN\1740|such|ca(2|)|,|+|)|,|or|+|) (r_nmod) cations_6\NNS\9315159|divalent|+ (r_conj) plp_3\NN\1740|and|cations|,|not|atp (r_dobj) requires_2\VBZ\754942|enzyme|plp|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|activity|is|atp (l_nsubjpass) activity_30\NN\30358|mammalian|serine|racemase (l_compound) racemase_29\NN\1740|
17499824T19_17499824T32 NONE atp_24\NN\14964590| (r_conj) plp_3\NN\1740|and|cations|,|not|atp (r_dobj) requires_2\VBZ\754942|enzyme|plp|,|increased|. (l_advcl) increased_32\VBN\169651|whereas|activity|is|atp (l_nsubjpass) activity_30\NN\30358|mammalian|serine|racemase (l_compound) racemase_29\NN\1740|
17499824T20_17499824T32 NONE serine_28\NN\14601829| (r_compound) activity_30\NN\30358|mammalian|serine|racemase (l_compound) racemase_29\NN\1740|
17499824T21_17499824T32 CPR:3 atp_34\NN\14964590|by (r_nmod) increased_32\VBN\169651|whereas|activity|is|atp (l_nsubjpass) activity_30\NN\30358|mammalian|serine|racemase (l_compound) racemase_29\NN\1740|
17499824T22_17499824T33 NONE atp_9\NN\14964590|of (r_nmod) effect_7\NN\34213|regarding|the|atp|activity|and|analysis (l_conj) analysis_16\NN\633864|the|phylogenetic|racemases (l_nmod) racemases_20\NNS\1740|of|eukaryotic|serine
17499824T22_17499824T34 NONE atp_9\NN\14964590|of (r_nmod) effect_7\NN\34213|regarding|the|atp|activity|and|analysis (r_nmod) results_4\NNS\34213|to|the|effect (r_nmod) addition_1\NN\3081021|in|results (r_nmod) form_30\VB\1617192|addition|,|antiserum|did|not|precipitate|racemases|. (l_nsubj) antiserum_23\NN\5403149|the|racemase (l_nmod) racemase_27\NN\1740|against|arabidopsis|serine
17499824T22_17499824T35 NONE atp_9\NN\14964590|of (r_nmod) effect_7\NN\34213|regarding|the|atp|activity|and|analysis (r_nmod) results_4\NNS\34213|to|the|effect (r_nmod) addition_1\NN\3081021|in|results (r_nmod) form_30\VB\1617192|addition|,|antiserum|did|not|precipitate|racemases|. (l_nmod) racemases_38\NNS\1740|with|barley|serine
17499824T24_17499824T33 NONE serine_19\NN\14601829| (r_compound) racemases_20\NNS\1740|of|eukaryotic|serine
17499824T24_17499824T34 NONE serine_19\NN\14601829| (r_compound) racemases_20\NNS\1740|of|eukaryotic|serine (r_nmod) analysis_16\NN\633864|the|phylogenetic|racemases (r_conj) effect_7\NN\34213|regarding|the|atp|activity|and|analysis (r_nmod) results_4\NNS\34213|to|the|effect (r_nmod) addition_1\NN\3081021|in|results (r_nmod) form_30\VB\1617192|addition|,|antiserum|did|not|precipitate|racemases|. (l_nsubj) antiserum_23\NN\5403149|the|racemase (l_nmod) racemase_27\NN\1740|against|arabidopsis|serine
17499824T24_17499824T35 NONE serine_19\NN\14601829| (r_compound) racemases_20\NNS\1740|of|eukaryotic|serine (r_nmod) analysis_16\NN\633864|the|phylogenetic|racemases (r_conj) effect_7\NN\34213|regarding|the|atp|activity|and|analysis (r_nmod) results_4\NNS\34213|to|the|effect (r_nmod) addition_1\NN\3081021|in|results (r_nmod) form_30\VB\1617192|addition|,|antiserum|did|not|precipitate|racemases|. (l_nmod) racemases_38\NNS\1740|with|barley|serine
17499824T25_17499824T33 NONE serine_26\NN\14601829| (r_compound) racemase_27\NN\1740|against|arabidopsis|serine (r_nmod) antiserum_23\NN\5403149|the|racemase (r_nsubj) form_30\VB\1617192|addition|,|antiserum|did|not|precipitate|racemases|. (l_nmod) addition_1\NN\3081021|in|results (l_nmod) results_4\NNS\34213|to|the|effect (l_nmod) effect_7\NN\34213|regarding|the|atp|activity|and|analysis (l_conj) analysis_16\NN\633864|the|phylogenetic|racemases (l_nmod) racemases_20\NNS\1740|of|eukaryotic|serine
17499824T25_17499824T34 NONE serine_26\NN\14601829| (r_compound) racemase_27\NN\1740|against|arabidopsis|serine
17499824T25_17499824T35 NONE serine_26\NN\14601829| (r_compound) racemase_27\NN\1740|against|arabidopsis|serine (r_nmod) antiserum_23\NN\5403149|the|racemase (r_nsubj) form_30\VB\1617192|addition|,|antiserum|did|not|precipitate|racemases|. (l_nmod) racemases_38\NNS\1740|with|barley|serine
17499824T26_17499824T33 NONE serine_37\NN\14601829| (r_compound) racemases_38\NNS\1740|with|barley|serine (r_nmod) form_30\VB\1617192|addition|,|antiserum|did|not|precipitate|racemases|. (l_nmod) addition_1\NN\3081021|in|results (l_nmod) results_4\NNS\34213|to|the|effect (l_nmod) effect_7\NN\34213|regarding|the|atp|activity|and|analysis (l_conj) analysis_16\NN\633864|the|phylogenetic|racemases (l_nmod) racemases_20\NNS\1740|of|eukaryotic|serine
17499824T26_17499824T34 NONE serine_37\NN\14601829| (r_compound) racemases_38\NNS\1740|with|barley|serine (r_nmod) form_30\VB\1617192|addition|,|antiserum|did|not|precipitate|racemases|. (l_nsubj) antiserum_23\NN\5403149|the|racemase (l_nmod) racemase_27\NN\1740|against|arabidopsis|serine
17499824T26_17499824T35 NONE serine_37\NN\14601829| (r_compound) racemases_38\NNS\1740|with|barley|serine
17499824T1_17499824T28 NONE serine_4\NN\14601829| (r_compound) racemases_5\NNS\1740|plant|serine
17499824T1_17499824T29 NONE serine_4\NN\14601829| (r_compound) racemases_5\NNS\1740|plant|serine (r_nsubj) represent_6\VBP\2664769|that|racemases|group|and|clustered (l_dobj) group_9\NN\2137|a|distinct|family (l_nmod) family_15\NN\8189659|in|the|eukaryotic|serine|racemase (l_compound) racemase_14\NN\1740|
17499824T2_17499824T28 NONE serine_13\NN\14601829| (r_compound) family_15\NN\8189659|in|the|eukaryotic|serine|racemase (r_nmod) group_9\NN\2137|a|distinct|family (r_dobj) represent_6\VBP\2664769|that|racemases|group|and|clustered (l_nsubj) racemases_5\NNS\1740|plant|serine
17499824T2_17499824T29 NONE serine_13\NN\14601829| (r_compound) family_15\NN\8189659|in|the|eukaryotic|serine|racemase (l_compound) racemase_14\NN\1740|
22445601
22445601T12_22445601T27 NONE ly541850_9\NN\1740|,|antagonist (r_dobj) using_8\VBG\1156834|ly541850 (r_advcl) differentiating_0\VBG\618878|roles|using|. (l_dobj) roles_2\NNS\719494|the|receptors (l_nmod) receptors_7\NNS\5225602|mglu2 (l_compound) mglu2_4\NN\1740|of|and|mglu3
22445601T12_22445601T28 NONE ly541850_9\NN\1740|,|antagonist (r_dobj) using_8\VBG\1156834|ly541850 (r_advcl) differentiating_0\VBG\618878|roles|using|. (l_dobj) roles_2\NNS\719494|the|receptors (l_nmod) receptors_7\NNS\5225602|mglu2 (l_compound) mglu2_4\NN\1740|of|and|mglu3 (l_conj) mglu3_6\NN\1740|
22445601T12_22445601T29 CPR:5 ly541850_9\NN\1740|,|antagonist (l_appos) antagonist_14\NN\7846|an|mglu2|agonist/mglu3 (l_compound) mglu2_12\NN\1740|
22445601T12_22445601T30 CPR:6 ly541850_9\NN\1740|,|antagonist (l_appos) antagonist_14\NN\7846|an|mglu2|agonist/mglu3 (l_compound) agonist/mglu3_13\NN\1740|
22445601T9_22445601T17 NONE glutamate_9\NN\15010703|mglu (r_compound) receptors_13\NNS\5225602|of|group|ii|metabotropic|glutamate|) (r_nmod) relevance_4\NN\13791389|despite|the|potential|therapeutic|receptors (r_nmod) been_17\VBN\836236|relevance|,|there|has|lack|. (l_attr) lack_19\NN\14449126|a|tools (l_nmod) tools_22\NNS\3563967|of|pharmacological|separating (l_acl) separating_24\VBG\1850315|for|roles (l_dobj) roles_26\NNS\719494|the|subtypes (l_nmod) subtypes_32\NNS\1740|of|mglu2|receptor (l_compound) mglu2_28\NN\1740|and|mglu3
22445601T9_22445601T18 NONE glutamate_9\NN\15010703|mglu (r_compound) receptors_13\NNS\5225602|of|group|ii|metabotropic|glutamate|) (r_nmod) relevance_4\NN\13791389|despite|the|potential|therapeutic|receptors (r_nmod) been_17\VBN\836236|relevance|,|there|has|lack|. (l_attr) lack_19\NN\14449126|a|tools (l_nmod) tools_22\NNS\3563967|of|pharmacological|separating (l_acl) separating_24\VBG\1850315|for|roles (l_dobj) roles_26\NNS\719494|the|subtypes (l_nmod) subtypes_32\NNS\1740|of|mglu2|receptor (l_compound) mglu2_28\NN\1740|and|mglu3 (l_conj) mglu3_30\NN\1740|
22445601T9_22445601T22 NONE glutamate_9\NN\15010703|mglu (r_compound) receptors_13\NNS\5225602|of|group|ii|metabotropic|glutamate|)
22445601T6_22445601T19 NONE ly541850_0\CD\1740| (r_nsubjpass) claimed_2\VBN\1011725|ly541850|was|receptors|agonist|. (l_nmod) receptors_6\NNS\5225602|from|human|mglu|expressed
22445601T6_22445601T20 CPR:5 ly541850_0\CD\1740| (r_nsubjpass) claimed_2\VBN\1011725|ly541850|was|receptors|agonist|. (l_xcomp) agonist_17\NN\9613191|to|be|a|selective|orthosteric|mglu2|and|antagonist (l_compound) mglu2_16\NN\1740|
22445601T6_22445601T21 CPR:6 ly541850_0\CD\1740| (r_nsubjpass) claimed_2\VBN\1011725|ly541850|was|receptors|agonist|. (l_xcomp) agonist_17\NN\9613191|to|be|a|selective|orthosteric|mglu2|and|antagonist (l_conj) antagonist_20\NN\7846|mglu3 (l_compound) mglu3_19\NN\1740|
22445601T8_22445601T23 NONE ly541850_29\NN\1740|by (r_nmod) inhibited_27\VBN\2510337|potentials|were|ly541850|mice|extent|but|affected|. (l_nmod) mice_32\NNS\2329401|in|mglu3-/-|nm|and|littermates (l_amod) mglu3-/-_31\JJ\1740|
22445601T8_22445601T24 NONE ly541850_29\NN\1740|by (r_nmod) inhibited_27\VBN\2510337|potentials|were|ly541850|mice|extent|but|affected|. (l_conj) affected_56\VBN\126264|were|not|significantly|mice (l_nmod) mice_59\NNS\2329401|in|mglu2-/- (l_amod) mglu2-/-_58\JJ\1740|
22445601T10_22445601T25 NONE ly541850_4\NN\1740| (r_conj) dcg-iv_2\NN\1740|of|and|ly541850 (r_nmod) co-application_0\NN\1740|dcg-iv|mglu3-/- (l_nmod) mglu3-/-_6\NN\1740|in|and|littermates
22445601T10_22445601T26 NONE ly541850_4\NN\1740| (r_conj) dcg-iv_2\NN\1740|of|and|ly541850 (r_nmod) co-application_0\NN\1740|dcg-iv|mglu3-/- (r_nsubj) resulted_10\VBD\2633881|co-application|effect|,|reversed|. (l_advcl) reversed_22\VBD\109660|whereas|mice|,|ly541850|action (l_nmod) mice_19\NNS\2329401|in|mglu2-/- (l_amod) mglu2-/-_18\JJ\1740|
22445601T11_22445601T25 NONE ly541850_21\NN\1740| (r_nsubj) reversed_22\VBD\109660|whereas|mice|,|ly541850|action (r_advcl) resulted_10\VBD\2633881|co-application|effect|,|reversed|. (l_nsubj) co-application_0\NN\1740|dcg-iv|mglu3-/- (l_nmod) mglu3-/-_6\NN\1740|in|and|littermates
22445601T11_22445601T26 NONE ly541850_21\NN\1740| (r_nsubj) reversed_22\VBD\109660|whereas|mice|,|ly541850|action (l_nmod) mice_19\NNS\2329401|in|mglu2-/- (l_amod) mglu2-/-_18\JJ\1740|
22445601T1_22445601T13 CPR:5 ly541850_12\NN\1740|of (r_nmod) agonist_6\NN\9613191|the|selective|mglu2|and|antagonist|actions|ly541850 (l_compound) mglu2_5\NN\1740|
22445601T1_22445601T14 CPR:6 ly541850_12\NN\1740|of (r_nmod) agonist_6\NN\9613191|the|selective|mglu2|and|antagonist|actions|ly541850 (l_conj) antagonist_9\NN\7846|mglu3 (l_compound) mglu3_8\NN\1740|
22445601T5_22445601T16 NONE glutamate_11\NN\15010703| (r_compound) receptors_12\NNS\5225602|'|metabotropic|glutamate|'
22537794
22537794T14_22537794T39 NONE (+/-)-modafinil_2\NN\1740|and|r-(-)- (r_nsubjpass) synthesized_9\VBN\193486|(+/-)-modafinil|were|and|tested|. (l_conj) tested_11\VBN\670261|inhibition (l_nmod) inhibition_13\NN\1068773|for|uptake|wild-type (l_nmod) wild-type_34\JJ\1740|in|transporter|and|mutants|equilibria (l_compound) transporter_30\NN\4490091|human|dopamine|dat
22537794T14_22537794T40 NONE (+/-)-modafinil_2\NN\1740|and|r-(-)- (r_nsubjpass) synthesized_9\VBN\193486|(+/-)-modafinil|were|and|tested|. (l_conj) tested_11\VBN\670261|inhibition (l_nmod) inhibition_13\NN\1068773|for|uptake|wild-type (l_nmod) wild-type_34\JJ\1740|in|transporter|and|mutants|equilibria (l_compound) transporter_30\NN\4490091|human|dopamine|dat (l_appos) dat_32\NN\2757810|(|)
22537794T15_22537794T39 CPR:9 dopamine_18\NN\14807737|da (r_compound) uptake_22\NN\13440063|of|[|(3)h|]|dopamine|and|binding (r_nmod) inhibition_13\NN\1068773|for|uptake|wild-type (l_nmod) wild-type_34\JJ\1740|in|transporter|and|mutants|equilibria (l_compound) transporter_30\NN\4490091|human|dopamine|dat
22537794T15_22537794T40 CPR:9 dopamine_18\NN\14807737|da (r_compound) uptake_22\NN\13440063|of|[|(3)h|]|dopamine|and|binding (r_nmod) inhibition_13\NN\1068773|for|uptake|wild-type (l_nmod) wild-type_34\JJ\1740|in|transporter|and|mutants|equilibria (l_compound) transporter_30\NN\4490091|human|dopamine|dat (l_appos) dat_32\NN\2757810|(|)
22537794T16_22537794T39 CPR:9 da_20\NN\10484858|(|) (r_appos) dopamine_18\NN\14807737|da (r_compound) uptake_22\NN\13440063|of|[|(3)h|]|dopamine|and|binding (r_nmod) inhibition_13\NN\1068773|for|uptake|wild-type (l_nmod) wild-type_34\JJ\1740|in|transporter|and|mutants|equilibria (l_compound) transporter_30\NN\4490091|human|dopamine|dat
22537794T16_22537794T40 CPR:9 da_20\NN\10484858|(|) (r_appos) dopamine_18\NN\14807737|da (r_compound) uptake_22\NN\13440063|of|[|(3)h|]|dopamine|and|binding (r_nmod) inhibition_13\NN\1068773|for|uptake|wild-type (l_nmod) wild-type_34\JJ\1740|in|transporter|and|mutants|equilibria (l_compound) transporter_30\NN\4490091|human|dopamine|dat (l_appos) dat_32\NN\2757810|(|)
22537794T17_22537794T39 NONE 35428_25\CD\1740| (r_compound) binding_26\NN\4688246|[(3)h]win|35428 (r_conj) uptake_22\NN\13440063|of|[|(3)h|]|dopamine|and|binding (r_nmod) inhibition_13\NN\1068773|for|uptake|wild-type (l_nmod) wild-type_34\JJ\1740|in|transporter|and|mutants|equilibria (l_compound) transporter_30\NN\4490091|human|dopamine|dat
22537794T17_22537794T40 NONE 35428_25\CD\1740| (r_compound) binding_26\NN\4688246|[(3)h]win|35428 (r_conj) uptake_22\NN\13440063|of|[|(3)h|]|dopamine|and|binding (r_nmod) inhibition_13\NN\1068773|for|uptake|wild-type (l_nmod) wild-type_34\JJ\1740|in|transporter|and|mutants|equilibria (l_compound) transporter_30\NN\4490091|human|dopamine|dat (l_appos) dat_32\NN\2757810|(|)
22537794T18_22537794T39 NONE dopamine_29\NN\14807737| (r_compound) transporter_30\NN\4490091|human|dopamine|dat
22537794T18_22537794T40 NONE dopamine_29\NN\14807737| (r_compound) transporter_30\NN\4490091|human|dopamine|dat (l_appos) dat_32\NN\2757810|(|)
22537794T24_22537794T41 NONE s-modafinil_7\NN\1740| (r_conj) (+/-)-_2\CC\1740|,|r-|,|and|s-modafinil (r_punct) bind_8\VBP\1290422|results|(+/-)-|dat|and|inhibit|. (l_nmod) dat_11\NN\2757810|to|the
22537794T25_22537794T41 CPR:9 da_14\NN\10484858| (r_compound) uptake_15\NN\13440063|da (r_dobj) inhibit_13\VBP\2510337|uptake|potently (r_conj) bind_8\VBP\1290422|results|(+/-)-|dat|and|inhibit|. (l_nmod) dat_11\NN\2757810|to|the
22537794T26_22537794T41 NONE cocaine_19\NN\3492717|than (r_nmod) potently_17\RB\1740|less|cocaine|,|having (r_advmod) inhibit_13\VBP\2510337|uptake|potently (r_conj) bind_8\VBP\1290422|results|(+/-)-|dat|and|inhibit|. (l_nmod) dat_11\NN\2757810|to|the
22537794T27_22537794T41 NONE r-modafinil_22\NN\1740| (r_nsubj) having_23\VBG\2108377|with|r-modafinil|affinity (r_advcl) potently_17\RB\1740|less|cocaine|,|having (r_advmod) inhibit_13\VBP\2510337|uptake|potently (r_conj) bind_8\VBP\1290422|results|(+/-)-|dat|and|inhibit|. (l_nmod) dat_11\NN\2757810|to|the
22537794T1_22537794T31 NONE r-modafinil_0\NN\1740| (r_nsubj) potent_4\JJ\1740|r-modafinil|was|significantly|less|mutant|dat|,|whereas|affected|. (l_nmod) mutant_9\NN\4475|in|the|dat|y156f (l_compound) dat_7\NN\2757810|
22537794T1_22537794T32 NONE r-modafinil_0\NN\1740| (r_nsubj) potent_4\JJ\1740|r-modafinil|was|significantly|less|mutant|dat|,|whereas|affected|. (l_nmod) mutant_9\NN\4475|in|the|dat|y156f (l_compound) y156f_8\NN\1740|
22537794T1_22537794T33 NONE r-modafinil_0\NN\1740| (r_nsubj) potent_4\JJ\1740|r-modafinil|was|significantly|less|mutant|dat|,|whereas|affected|. (l_advcl) dat_13\NN\2757810|compared|with|wild-type
22537794T2_22537794T31 NONE s-modafinil_16\NN\1740| (r_nsubjpass) affected_18\VBN\126264|s-modafinil|was|less (r_parataxis) potent_4\JJ\1740|r-modafinil|was|significantly|less|mutant|dat|,|whereas|affected|. (l_nmod) mutant_9\NN\4475|in|the|dat|y156f (l_compound) dat_7\NN\2757810|
22537794T2_22537794T32 NONE s-modafinil_16\NN\1740| (r_nsubjpass) affected_18\VBN\126264|s-modafinil|was|less (r_parataxis) potent_4\JJ\1740|r-modafinil|was|significantly|less|mutant|dat|,|whereas|affected|. (l_nmod) mutant_9\NN\4475|in|the|dat|y156f (l_compound) y156f_8\NN\1740|
22537794T2_22537794T33 NONE s-modafinil_16\NN\1740| (r_nsubjpass) affected_18\VBN\126264|s-modafinil|was|less (r_parataxis) potent_4\JJ\1740|r-modafinil|was|significantly|less|mutant|dat|,|whereas|affected|. (l_advcl) dat_13\NN\2757810|compared|with|wild-type
22537794T4_22537794T34 NONE cocaine_18\NN\3492717|than (r_nmod) better_16\RBR\1740|cocaine (r_advmod) tolerated_12\VBD\802318|that|r-|conformation|better|, (r_ccomp) showed_6\VBD\2137132|studies|tolerated|. (l_nsubj) studies_0\NNS\635850|mutant (l_nmod) mutant_5\NN\4475|with|the|y335a|dat (l_compound) y335a_3\NN\1740|
22537794T4_22537794T35 NONE cocaine_18\NN\3492717|than (r_nmod) better_16\RBR\1740|cocaine (r_advmod) tolerated_12\VBD\802318|that|r-|conformation|better|, (r_ccomp) showed_6\VBD\2137132|studies|tolerated|. (l_nsubj) studies_0\NNS\635850|mutant (l_nmod) mutant_5\NN\4475|with|the|y335a|dat (l_compound) dat_4\NN\2757810|
22537794T4_22537794T36 NONE cocaine_18\NN\3492717|than (r_nmod) better_16\RBR\1740|cocaine (r_advmod) tolerated_12\VBD\802318|that|r-|conformation|better|, (l_dobj) conformation_15\NN\13897996|the|inward-facing|supported (l_acl:relcl) supported_23\VBN\2199590|which|was|further|reactivity (l_nmod) reactivity_26\NN\5652926|by|[2-(trimethylammonium)ethyl]-methanethiosulfonate|i159c (l_nmod) i159c_31\NN\1740|on|the|dat|e2c (l_compound) dat_29\NN\2757810|
22537794T4_22537794T37 NONE cocaine_18\NN\3492717|than (r_nmod) better_16\RBR\1740|cocaine (r_advmod) tolerated_12\VBD\802318|that|r-|conformation|better|, (l_dobj) conformation_15\NN\13897996|the|inward-facing|supported (l_acl:relcl) supported_23\VBN\2199590|which|was|further|reactivity (l_nmod) reactivity_26\NN\5652926|by|[2-(trimethylammonium)ethyl]-methanethiosulfonate|i159c (l_nmod) i159c_31\NN\1740|on|the|dat|e2c (l_compound) e2c_30\NN\1740|
22537794T4_22537794T38 NONE cocaine_18\NN\3492717|than (r_nmod) better_16\RBR\1740|cocaine (r_advmod) tolerated_12\VBD\802318|that|r-|conformation|better|, (l_dobj) conformation_15\NN\13897996|the|inward-facing|supported (l_acl:relcl) supported_23\VBN\2199590|which|was|further|reactivity (l_nmod) reactivity_26\NN\5652926|by|[2-(trimethylammonium)ethyl]-methanethiosulfonate|i159c (l_nmod) i159c_31\NN\1740|on|the|dat|e2c
22537794T5_22537794T34 NONE [2-(trimethylammonium)ethyl]-methanethiosulfonate_25\NN\1740| (r_compound) reactivity_26\NN\5652926|by|[2-(trimethylammonium)ethyl]-methanethiosulfonate|i159c (r_nmod) supported_23\VBN\2199590|which|was|further|reactivity (r_acl:relcl) conformation_15\NN\13897996|the|inward-facing|supported (r_dobj) tolerated_12\VBD\802318|that|r-|conformation|better|, (r_ccomp) showed_6\VBD\2137132|studies|tolerated|. (l_nsubj) studies_0\NNS\635850|mutant (l_nmod) mutant_5\NN\4475|with|the|y335a|dat (l_compound) y335a_3\NN\1740|
22537794T5_22537794T35 NONE [2-(trimethylammonium)ethyl]-methanethiosulfonate_25\NN\1740| (r_compound) reactivity_26\NN\5652926|by|[2-(trimethylammonium)ethyl]-methanethiosulfonate|i159c (r_nmod) supported_23\VBN\2199590|which|was|further|reactivity (r_acl:relcl) conformation_15\NN\13897996|the|inward-facing|supported (r_dobj) tolerated_12\VBD\802318|that|r-|conformation|better|, (r_ccomp) showed_6\VBD\2137132|studies|tolerated|. (l_nsubj) studies_0\NNS\635850|mutant (l_nmod) mutant_5\NN\4475|with|the|y335a|dat (l_compound) dat_4\NN\2757810|
22537794T5_22537794T36 NONE [2-(trimethylammonium)ethyl]-methanethiosulfonate_25\NN\1740| (r_compound) reactivity_26\NN\5652926|by|[2-(trimethylammonium)ethyl]-methanethiosulfonate|i159c (l_nmod) i159c_31\NN\1740|on|the|dat|e2c (l_compound) dat_29\NN\2757810|
22537794T5_22537794T37 NONE [2-(trimethylammonium)ethyl]-methanethiosulfonate_25\NN\1740| (r_compound) reactivity_26\NN\5652926|by|[2-(trimethylammonium)ethyl]-methanethiosulfonate|i159c (l_nmod) i159c_31\NN\1740|on|the|dat|e2c (l_compound) e2c_30\NN\1740|
22537794T5_22537794T38 NONE [2-(trimethylammonium)ethyl]-methanethiosulfonate_25\NN\1740| (r_compound) reactivity_26\NN\5652926|by|[2-(trimethylammonium)ethyl]-methanethiosulfonate|i159c (l_nmod) i159c_31\NN\1740|on|the|dat|e2c
23383423
23383423T1_23383423T2 NONE acid_25\NN\14818238|(|74|77|amino (r_compound) fragments_27\NNS\9385911|of|small|acid|)|,|termed|,|chemoattractants (l_acl) termed_30\VBN\1028748|originally|anaphylatoxins (l_xcomp) anaphylatoxins_31\NNS\1740|
23383423T1_23383423T3 NONE acid_25\NN\14818238|(|74|77|amino (r_compound) fragments_27\NNS\9385911|of|small|acid|)|,|termed|,|chemoattractants (r_nmod) number_17\NN\5107765|a|fragments (r_dobj) produces_15\VBZ\1617192|activation|number|. (l_nsubj) activation_1\NN\13561719|the|cascade|,|cornerstone|, (l_nmod) cascade_5\NN\9475292|of|the|complement (l_compound) complement_4\NN\6313651|
15843826
15843826T6_15843826T18 NONE am80_0\NN\1740| (r_nsubj) specific_2\JJ\1740|am80|is|receptor-alpha/beta|,|and|has|. (l_nmod) receptor-alpha/beta_6\NN\1740|for|the|retinoic-acid
15843826T7_15843826T18 NONE retinoic-acid_5\JJ\1740| (r_amod) receptor-alpha/beta_6\NN\1740|for|the|retinoic-acid
15843826T8_15843826T18 NONE acid_15\NN\14818238| (r_nmod:npmod) resistant_16\JJ\1740|acid (r_amod) leukemia_19\NN\14239918|in|all-trans|retinoic|resistant|acute|promyelocytic (r_nmod) has_9\VBZ\2108377|effects|leukemia (r_conj) specific_2\JJ\1740|am80|is|receptor-alpha/beta|,|and|has|. (l_nmod) receptor-alpha/beta_6\NN\1740|for|the|retinoic-acid
15843826T9_15843826T19 CPR:4 am80_0\NN\1740| (r_nsubj) inhibited_2\VBD\2510337|am80|slightly|growth|,|and|inhibited|. (l_conj) inhibited_14\VBD\2510337|remarkably|growth (l_dobj) growth_16\NN\13526110|the|huvecs (l_nmod) huvecs_18\NNS\1740|of|stimulated (l_acl) stimulated_19\VBN\137313|vegf (l_nmod) vegf_21\NN\1740|by
15843826T11_15843826T15 CPR:4 am80_0\NN\1740| (r_nsubj) inhibited_1\VBD\2510337|am80|phosphorylation|. (l_dobj) phosphorylation_3\NN\1740|vegf-induced|receptor (l_nmod) receptor_6\NN\5225602|of|vegf
15843826T11_15843826T20 CPR:4 am80_0\NN\1740| (r_nsubj) inhibited_1\VBD\2510337|am80|phosphorylation|. (l_dobj) phosphorylation_3\NN\1740|vegf-induced|receptor (l_amod) vegf-induced_2\JJ\1740|
15843826T1_15843826T16 CPR:4 am80_19\NN\1740|by (r_nmod) inhibited_17\VBN\2510337|addition|,|formation|were|significantly|am80|. (l_nsubjpass) formation_4\NN\7938773|vegf-induced|structures|vitro|and|neovascularization (l_amod) vegf-induced_3\JJ\1740|
23270965
23270965T14_23270965T25 NONE safrole-2',3'-oxide_0\NN\1740| (r_nsubj) induces_1\VBZ\1627355|safrole-2',3'-oxide|vulnerability|mice|. (l_nmod) mice_8\NNS\2329401|in|apolipoprotein|e-knockout (l_amod) e-knockout_7\JJ\1740|
23270965T7_23270965T23 NONE sfo-induced_6\JJ\1740| (r_amod) vulnerability_9\NN\14540765|sfo-induced|atherosclerotic|plaque|possibility|mice (l_nmod) mice_22\NNS\2329401|in|e-knockout (l_amod) e-knockout_17\JJ\1740|apolipoprotein|apoe(-/-
23270965T7_23270965T24 NONE sfo-induced_6\JJ\1740| (r_amod) vulnerability_9\NN\14540765|sfo-induced|atherosclerotic|plaque|possibility|mice (l_nmod) mice_22\NNS\2329401|in|e-knockout (l_amod) e-knockout_17\JJ\1740|apolipoprotein|apoe(-/- (l_dep) apoe(-/-_19\JJ\1740|(|)|)
23270965T2_23270965T15 CPR:3 sfo-hd_28\NN\1740|by (r_nmod) increased_26\VBN\169651|level|was|17.4-fold|sfo-hd|. (r_conj) increased_16\VBN\169651|furthermore|,|groups|,|level|was|3-fold|and|increased (l_nsubjpass) level_10\NN\4916342|the|plaque|endothelium|p75(ntr (l_nmod) p75(ntr_12\NN\1740|of|) (l_punct) )_13\-RRB-\1740|
23270965T2_23270965T16 CPR:3 sfo-hd_28\NN\1740|by (r_nmod) increased_26\VBN\169651|level|was|17.4-fold|sfo-hd|. (l_nsubjpass) level_20\NN\4916342|the|liver|p75(ntr (l_nmod) p75(ntr_22\NN\1740|of|) (l_punct) )_23\-RRB-\1740|
23270965T3_23270965T17 CPR:3 sfo-hd_31\NN\1740| (r_compound) group_33\NN\2137|in|sfo-hd|treated (r_nmod) 357pg/ml_29\CD\1740|meanwhile|,|level|was|up|to|group|. (l_nsubj) level_4\NN\4916342|the|serum|kc|mice (l_nmod) kc_6\NN\15286249|of|homolog (l_dep) homolog_10\NN\1740|(|a|functional|il-8|) (l_nmod) il-8_12\NN\1740|of|and|chemokine
23270965T3_23270965T18 CPR:3 sfo-hd_31\NN\1740| (r_compound) group_33\NN\2137|in|sfo-hd|treated (r_nmod) 357pg/ml_29\CD\1740|meanwhile|,|level|was|up|to|group|. (l_nsubj) level_4\NN\4916342|the|serum|kc|mice (l_nmod) kc_6\NN\15286249|of|homolog (l_dep) homolog_10\NN\1740|(|a|functional|il-8|) (l_nmod) il-8_12\NN\1740|of|and|chemokine (l_conj) chemokine_18\NN\1740|the|main|proinflammatory|alpha|mice
23270965T3_23270965T19 NONE sfo-hd_31\NN\1740| (r_compound) group_33\NN\2137|in|sfo-hd|treated (r_nmod) 357pg/ml_29\CD\1740|meanwhile|,|level|was|up|to|group|. (l_nsubj) level_4\NN\4916342|the|serum|kc|mice (l_nmod) mice_25\NNS\2329401|in|apoe(-/- (l_amod) apoe(-/-_23\JJ\1740|)
23270965T4_23270965T20 NONE sfo_2\NN\1740| (r_nsubj) contributes_3\VBZ\126264|thus|,|sfo|instability|activating|. (l_nmod) instability_6\NN\13972797|to|the|plaque (l_nmod) plaque_9\NN\4682462|of|atherosclerotic|mice (l_nmod) mice_13\NNS\2329401|in|apoe(-/- (l_amod) apoe(-/-_11\JJ\1740|)
23270965T4_23270965T21 CPR:3 sfo_2\NN\1740| (r_nsubj) contributes_3\VBZ\126264|thus|,|sfo|instability|activating|. (l_advcl) activating_15\VBG\1641914|through|p75(ntr (l_dobj) p75(ntr_16\NN\1740|)|and|il-8|and|apoptosis (l_punct) )_17\-RRB-\1740|
23270965T4_23270965T22 CPR:3 sfo_2\NN\1740| (r_nsubj) contributes_3\VBZ\126264|thus|,|sfo|instability|activating|. (l_advcl) activating_15\VBG\1641914|through|p75(ntr (l_dobj) p75(ntr_16\NN\1740|)|and|il-8|and|apoptosis (l_conj) il-8_19\NN\1740|
16480505
16480505T7_16480505T15 NONE pregnane_13\NN\1740| (r_compound) receptor_15\NN\5225602|the|nuclear|pregnane|x
16480505T8_16480505T15 NONE rifampicin_2\NN\1740|of (r_nmod) roles_0\NNS\719494|rifampicin|interactions|:|mechanisms (l_dep) mechanisms_9\NNS\13446390|underlying|molecular|involving (l_acl) involving_10\VBG\2676054|receptor (l_dobj) receptor_15\NN\5225602|the|nuclear|pregnane|x
16480505T2_16480505T9 CPR:9 rifampicin_5\NN\1740|of (r_nmod) effects_3\NNS\13245626|the|administered|rifampicin|drugs (r_nsubj) result_10\VB\2633881|effects|can|metabolism|. (l_nmod) metabolism_14\NN\13526110|in|their|altered|or|transportation|metabolised (l_acl:relcl) metabolised_19\VBN\1740|that|are|p450|or|transported (l_nmod) p450_22\NN\1740|by|cytochromes
16480505T2_16480505T10 CPR:9 rifampicin_5\NN\1740|of (r_nmod) effects_3\NNS\13245626|the|administered|rifampicin|drugs (r_nsubj) result_10\VB\2633881|effects|can|metabolism|. (l_nmod) metabolism_14\NN\13526110|in|their|altered|or|transportation|metabolised (l_acl:relcl) metabolised_19\VBN\1740|that|are|p450|or|transported (l_conj) transported_24\VBN\1850315|p-glycoprotein (l_nmod) p-glycoprotein_26\NN\1740|by|tract
16480505T3_16480505T11 CPR:5 rifampicin_3\NN\1740| (r_nsubj) act_5\VB\1619354|general|,|rifampicin|can|pattern|:|activates (l_parataxis) activates_11\VBZ\1641914|rifampicin|receptor|. (l_dobj) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects
16480505T3_16480505T12 NONE rifampicin_3\NN\1740| (r_nsubj) act_5\VB\1619354|general|,|rifampicin|can|pattern|:|activates (l_parataxis) activates_11\VBZ\1641914|rifampicin|receptor|. (l_dobj) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein
16480505T3_16480505T13 NONE rifampicin_3\NN\1740| (r_nsubj) act_5\VB\1619354|general|,|rifampicin|can|pattern|:|activates (l_parataxis) activates_11\VBZ\1641914|rifampicin|receptor|. (l_dobj) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein (l_conj) glucuronosyltransferases_24\NNS\1740|
16480505T3_16480505T14 NONE rifampicin_3\NN\1740| (r_nsubj) act_5\VB\1619354|general|,|rifampicin|can|pattern|:|activates (l_parataxis) activates_11\VBZ\1641914|rifampicin|receptor|. (l_dobj) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein (l_conj) p-glycoprotein_26\NN\1740|
16480505T4_16480505T11 CPR:3 rifampicin_10\NN\1740| (r_nsubj) activates_11\VBZ\1641914|rifampicin|receptor|. (l_dobj) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects
16480505T4_16480505T12 NONE rifampicin_10\NN\1740| (r_nsubj) activates_11\VBZ\1641914|rifampicin|receptor|. (l_dobj) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein
16480505T4_16480505T13 NONE rifampicin_10\NN\1740| (r_nsubj) activates_11\VBZ\1641914|rifampicin|receptor|. (l_dobj) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein (l_conj) glucuronosyltransferases_24\NNS\1740|
16480505T4_16480505T14 NONE rifampicin_10\NN\1740| (r_nsubj) activates_11\VBZ\1641914|rifampicin|receptor|. (l_dobj) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein (l_conj) p-glycoprotein_26\NN\1740|
16480505T5_16480505T11 NONE pregnane_14\NN\1740| (r_compound) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects
16480505T5_16480505T12 NONE pregnane_14\NN\1740| (r_compound) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein
16480505T5_16480505T13 NONE pregnane_14\NN\1740| (r_compound) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein (l_conj) glucuronosyltransferases_24\NNS\1740|
16480505T5_16480505T14 NONE pregnane_14\NN\1740| (r_compound) receptor_16\NN\5225602|the|nuclear|pregnane|x|affects (l_acl:relcl) affects_20\VBZ\126264|that|turn|activities (l_dobj) activities_27\NNS\30358|p450 (l_compound) p450_22\NN\1740|cytochromes|,|glucuronosyltransferases|and|p-glycoprotein (l_conj) p-glycoprotein_26\NN\1740|
15126366
15126366T23_15126366T37 NONE 3-angelate_6\NNP\1740|of|ingenol (r_nmod) interaction_3\NN\37396|of|the|3-angelate|c. (l_nmod) c._10\.\1740|with|protein|kinase
15126366T9_15126366T28 NONE i3a_8\NN\1740|of (r_nmod) characterization_6\NN\6724763|the|initial|i3a|ligand (l_nmod) ligand_17\NN\20090|as|a|c (l_compound) c_13\NN\13714184|protein|kinase|pkc
15126366T9_15126366T29 NONE i3a_8\NN\1740|of (r_nmod) characterization_6\NN\6724763|the|initial|i3a|ligand (l_nmod) ligand_17\NN\20090|as|a|c (l_compound) c_13\NN\13714184|protein|kinase|pkc (l_appos) pkc_15\NN\1740|(|)
15126366T11_15126366T30 NONE i3a_0\NN\1740| (r_nsubj) bound_1\VBD\1831531|i3a|pkc-alpha|presence|;|observed (l_nmod) pkc-alpha_3\NN\1740|to
15126366T11_15126366T31 NONE i3a_0\NN\1740| (r_nsubj) bound_1\VBD\1831531|i3a|pkc-alpha|presence|;|observed (l_parataxis) observed_25\VBN\2163746|however|,|conditions|,|selectivity|was|. (l_nsubjpass) selectivity_23\NN\4916342|little|pkc|isoform (l_compound) pkc_21\NN\1740|
15126366T12_15126366T30 NONE phosphatidylserine_8\NN\1740|of|affinity (r_nmod) presence_6\NN\13954253|in|the|phosphatidylserine (r_nmod) bound_1\VBD\1831531|i3a|pkc-alpha|presence|;|observed (l_nmod) pkc-alpha_3\NN\1740|to
15126366T12_15126366T31 NONE phosphatidylserine_8\NN\1740|of|affinity (r_nmod) presence_6\NN\13954253|in|the|phosphatidylserine (r_nmod) bound_1\VBD\1831531|i3a|pkc-alpha|presence|;|observed (l_parataxis) observed_25\VBN\2163746|however|,|conditions|,|selectivity|was|. (l_nsubjpass) selectivity_23\NN\4916342|little|pkc|isoform (l_compound) pkc_21\NN\1740|
15126366T13_15126366T32 CPR:4 i3a_11\NN\1740|by|and|13-acetate (r_nmod) down-regulation_9\NN\1740|for|i3a|cells (r_nmod) sensitivity_5\NN\5651971|different|and|selectivity|down-regulation (r_dobj) show_3\VB\2137132|isoforms|did|sensitivity|. (l_nsubj) isoforms_1\NNS\1740|pkc (l_compound) pkc_0\NN\1740|
15126366T14_15126366T32 CPR:4 13-acetate_15\NN\1740|phorbol|12-myristate|pma (r_conj) i3a_11\NN\1740|by|and|13-acetate (r_nmod) down-regulation_9\NN\1740|for|i3a|cells (r_nmod) sensitivity_5\NN\5651971|different|and|selectivity|down-regulation (r_dobj) show_3\VB\2137132|isoforms|did|sensitivity|. (l_nsubj) isoforms_1\NNS\1740|pkc (l_compound) pkc_0\NN\1740|
15126366T15_15126366T32 CPR:4 pma_17\NN\1740|(|) (r_appos) 13-acetate_15\NN\1740|phorbol|12-myristate|pma (r_conj) i3a_11\NN\1740|by|and|13-acetate (r_nmod) down-regulation_9\NN\1740|for|i3a|cells (r_nmod) sensitivity_5\NN\5651971|different|and|selectivity|down-regulation (r_dobj) show_3\VB\2137132|isoforms|did|sensitivity|. (l_nsubj) isoforms_1\NNS\1740|pkc (l_compound) pkc_0\NN\1740|
15126366T18_15126366T33 NONE i3a_5\NN\1740| (r_nsubj) able_7\JJ\1740|cells|,|i3a|was|translocate|. (l_xcomp) translocate_9\VB\2012344|to|isoforms|,|potency (l_dobj) isoforms_15\NNS\1740|different|protein-tagged|pkc|,|visualized (l_amod) protein-tagged_13\JJ\1740|green|fluorescent
15126366T18_15126366T34 NONE i3a_5\NN\1740| (r_nsubj) able_7\JJ\1740|cells|,|i3a|was|translocate|. (l_xcomp) translocate_9\VB\2012344|to|isoforms|,|potency (l_dobj) isoforms_15\NNS\1740|different|protein-tagged|pkc|,|visualized (l_compound) pkc_14\NN\1740|
15126366T19_15126366T33 NONE pma_28\NN\1740|than (r_nmod) potency_26\NN\5196375|with|equal|pma (r_nmod) translocate_9\VB\2012344|to|isoforms|,|potency (l_dobj) isoforms_15\NNS\1740|different|protein-tagged|pkc|,|visualized (l_amod) protein-tagged_13\JJ\1740|green|fluorescent
15126366T19_15126366T34 NONE pma_28\NN\1740|than (r_nmod) potency_26\NN\5196375|with|equal|pma (r_nmod) translocate_9\VB\2012344|to|isoforms|,|potency (l_dobj) isoforms_15\NNS\1740|different|protein-tagged|pkc|,|visualized (l_compound) pkc_14\NN\1740|
15126366T20_15126366T35 NONE i3a_12\NN\1740|to|and|pma (r_nmod) response_10\NN\11410625|in|i3a (r_nmod) showed_3\VBD\2137132|pkc-delta|pattern|response|. (l_nsubj) pkc-delta_0\NN\1740|in
15126366T21_15126366T35 NONE pma_14\NN\1740| (r_conj) i3a_12\NN\1740|to|and|pma (r_nmod) response_10\NN\11410625|in|i3a (r_nmod) showed_3\VBD\2137132|pkc-delta|pattern|response|. (l_nsubj) pkc-delta_0\NN\1740|in
15126366T2_15126366T24 CPR:3 pma_15\NN\1740|compared|with (r_advcl) induced_1\VBD\1627355|i3a|level|pma|cells|and|displayed|. (l_dobj) level_4\NN\4916342|a|higher|secretion (l_nmod) secretion_6\NN\13526110|of|interleukin (l_nmod) interleukin_11\NN\14943950|of|the|inflammatory|cytokine|6 (l_nummod) 6_12\CD\13741022|
15126366T2_15126366T36 CPR:3 pma_15\NN\1740|compared|with (r_advcl) induced_1\VBD\1627355|i3a|level|pma|cells|and|displayed|. (l_dobj) level_4\NN\4916342|a|higher|secretion (l_nmod) secretion_6\NN\13526110|of|interleukin (l_nmod) interleukin_11\NN\14943950|of|the|inflammatory|cytokine|6 (l_compound) cytokine_10\NN\14728724|
15126366T22_15126366T24 CPR:3 i3a_0\NN\1740| (r_nsubj) induced_1\VBD\1627355|i3a|level|pma|cells|and|displayed|. (l_dobj) level_4\NN\4916342|a|higher|secretion (l_nmod) secretion_6\NN\13526110|of|interleukin (l_nmod) interleukin_11\NN\14943950|of|the|inflammatory|cytokine|6 (l_nummod) 6_12\CD\13741022|
15126366T22_15126366T36 CPR:3 i3a_0\NN\1740| (r_nsubj) induced_1\VBD\1627355|i3a|level|pma|cells|and|displayed|. (l_dobj) level_4\NN\4916342|a|higher|secretion (l_nmod) secretion_6\NN\13526110|of|interleukin (l_nmod) interleukin_11\NN\14943950|of|the|inflammatory|cytokine|6 (l_compound) cytokine_10\NN\14728724|
15126366T3_15126366T25 NONE i3a_0\NN\1740| (r_nsubj) unable_2\JJ\1740|i3a|was|cause|,|and|able|. (l_xcomp) cause_4\VB\1617192|to|extent|,|pma (l_dobj) extent_7\NN\13939892|the|same|association (l_nmod) association_9\NN\8008335|of|domain|lipids (l_nmod) domain_13\NN\13934596|of|the|c1b|pkc-delta
15126366T3_15126366T26 NONE i3a_0\NN\1740| (r_nsubj) unable_2\JJ\1740|i3a|was|cause|,|and|able|. (l_xcomp) cause_4\VB\1617192|to|extent|,|pma (l_dobj) extent_7\NN\13939892|the|same|association (l_nmod) association_9\NN\8008335|of|domain|lipids (l_nmod) domain_13\NN\13934596|of|the|c1b|pkc-delta (l_nmod) pkc-delta_15\NN\1740|of
15126366T4_15126366T25 NONE pma_21\NN\1740|compared|with|or|diacylglycerol (r_nmod) cause_4\VB\1617192|to|extent|,|pma (l_dobj) extent_7\NN\13939892|the|same|association (l_nmod) association_9\NN\8008335|of|domain|lipids (l_nmod) domain_13\NN\13934596|of|the|c1b|pkc-delta
15126366T4_15126366T26 NONE pma_21\NN\1740|compared|with|or|diacylglycerol (r_nmod) cause_4\VB\1617192|to|extent|,|pma (l_dobj) extent_7\NN\13939892|the|same|association (l_nmod) association_9\NN\8008335|of|domain|lipids (l_nmod) domain_13\NN\13934596|of|the|c1b|pkc-delta (l_nmod) pkc-delta_15\NN\1740|of
15126366T5_15126366T25 NONE diacylglycerol_26\NN\1740|the|physiological|regulator (r_conj) pma_21\NN\1740|compared|with|or|diacylglycerol (r_nmod) cause_4\VB\1617192|to|extent|,|pma (l_dobj) extent_7\NN\13939892|the|same|association (l_nmod) association_9\NN\8008335|of|domain|lipids (l_nmod) domain_13\NN\13934596|of|the|c1b|pkc-delta
15126366T5_15126366T26 NONE diacylglycerol_26\NN\1740|the|physiological|regulator (r_conj) pma_21\NN\1740|compared|with|or|diacylglycerol (r_nmod) cause_4\VB\1617192|to|extent|,|pma (l_dobj) extent_7\NN\13939892|the|same|association (l_nmod) association_9\NN\8008335|of|domain|lipids (l_nmod) domain_13\NN\13934596|of|the|c1b|pkc-delta (l_nmod) pkc-delta_15\NN\1740|of
15126366T6_15126366T27 CPR:3 i3a_9\NN\1740|by (r_nmod) induced_7\VBN\1627355|i3a (r_acl) activity_4\NN\30358|the|in|kinase|pkc-alpha|induced (l_nmod) pkc-alpha_6\NN\1740|of
15126366T7_15126366T27 CPR:3 pma_16\NN\1740|by (r_nmod) induced_14\VBN\1627355|pma (r_acl) that_13\DT\1740|than|induced (r_nmod) lower_11\JJR\1740|activity|was|that|. (l_nsubj) activity_4\NN\30358|the|in|kinase|pkc-alpha|induced (l_nmod) pkc-alpha_6\NN\1740|of
23178380
23178380T4_23178380T18 NONE paraoxon_12\NN\1740|against|aerosolized (r_nmod) protects_9\VBZ\1127795|delivery|paraoxon|macaques|. (l_nsubj) delivery_1\NN\315986|pulmonary|pretreatment (l_nmod) pretreatment_8\NN\1740|of|an|aerosolized|recombinant|human|butyrylcholinesterase (l_compound) butyrylcholinesterase_7\NN\1740|
23178380T3_23178380T5 NONE organophosphates_12\NNS\14919948|to|ops|,|pose (r_nmod) exposure_10\NN\5042871|against|organophosphates (r_nmod) candidate_8\NN\10450303|butyrylcholinesterase|is|the|leading|pretreatment|exposure|. (l_nsubj) butyrylcholinesterase_0\NN\1740|bche
23178380T3_23178380T10 NONE organophosphates_12\NNS\14919948|to|ops|,|pose (r_nmod) exposure_10\NN\5042871|against|organophosphates (r_nmod) candidate_8\NN\10450303|butyrylcholinesterase|is|the|leading|pretreatment|exposure|. (l_nsubj) butyrylcholinesterase_0\NN\1740|bche (l_appos) bche_2\NN\1740|(|)
23178380T1_23178380T6 NONE aer-paraoxon_32\NN\1740|of|px (r_nmod) ld50_30\NN\1740|to|1|aer-paraoxon (r_nmod) 40h_25\NN\1740|1|-|prior|ld50 (r_dobj) given_22\VBN\2327200|40h (r_acl) pretreatment_21\NN\1740|an|unmodified|aer-rbche|given (l_compound) aer-rbche_20\NN\1740|
23178380T1_23178380T7 CPR:3 aer-paraoxon_32\NN\1740|of|px (r_nmod) ld50_30\NN\1740|to|1|aer-paraoxon (r_nmod) 40h_25\NN\1740|1|-|prior|ld50 (r_dobj) given_22\VBN\2327200|40h (r_acl) pretreatment_21\NN\1740|an|unmodified|aer-rbche|given (r_nsubj) able_37\JJ\1740|contrast|,|pretreatment|was|prevent|. (l_xcomp) prevent_39\VB\1740|to|inhibition|manner (l_dobj) inhibition_40\NN\1068773|cholinesterase (l_nmod) cholinesterase_43\NN\14732946|of|circulating
23178380T1_23178380T17 NONE aer-paraoxon_32\NN\1740|of|px (r_nmod) ld50_30\NN\1740|to|1|aer-paraoxon (r_nmod) 40h_25\NN\1740|1|-|prior|ld50 (r_dobj) given_22\VBN\2327200|40h (r_acl) pretreatment_21\NN\1740|an|unmodified|aer-rbche|given (r_nsubj) able_37\JJ\1740|contrast|,|pretreatment|was|prevent|. (l_nmod) contrast_1\NN\13854649|in|delivery (l_nmod) delivery_4\NN\315986|to|parenteral|rbche|,|requires (l_nmod) rbche_6\NN\1740|of
23178380T2_23178380T8 NONE paraoxon_15\NN\1740|such (r_nmod) pesticide_12\NN\14806838|against|a|paraoxon (r_nmod) protection_7\NN\407535|rbche|pesticide (l_nmod) rbche_9\NNP\1740|by
23178380T2_23178380T9 NONE paraoxon_15\NN\1740|such (r_nmod) pesticide_12\NN\14806838|against|a|paraoxon (r_nmod) protection_7\NN\407535|rbche|pesticide (r_dobj) show_6\VB\2137132|to|protection|delivered|and|bode (l_conj) bode_23\VBP\921300|well|use (l_nmod) use_27\NN\407535|for|the|method (l_nmod) method_34\NN\5616786|of|a|non-invasive|delivery|treatment (l_nmod) delivery_37\NN\315986|of|rhubche (l_compound) rhubche_36\NN\1740|
19888514
19888514T2_19888514T8 NONE tinzaparin_5\NN\1740|of (r_nmod) recognition_3\NN\13932421|molecular|tinzaparin|vla-4 (l_nmod) vla-4_7\NN\1740|by
19888514T3_19888514T9 NONE tinzaparin_22\NN\1740|of (r_nmod) constants_20\NNS\5855125|of|kinetic|binding|tinzaparin (r_nmod) detection_16\NN\5708432|for|constants (r_nmod) allow_14\VB\797697|to|detection|compared (r_xcomp) immobilised_9\VBN\2213690|vla-4|was|sensors|allow|. (l_nsubjpass) vla-4_1\NN\1740|a|containing
19888514T3_19888514T10 NONE tinzaparin_22\NN\1740|of (r_nmod) constants_20\NNS\5855125|of|kinetic|binding|tinzaparin (r_nmod) detection_16\NN\5708432|for|constants (r_nmod) allow_14\VB\797697|to|detection|compared (l_prep) compared_23\VBN\644583|vcam-1 (l_nmod) vcam-1_25\NN\1740|to
19888514T4_19888514T11 NONE tinzaparin_0\NN\1740| (r_nsubj) binds_1\VBZ\1290422|tinzaparin|vla-4|affinity|range|,|indicates|. (l_nmod) vla-4_3\NN\1740|to
19888514T5_19888514T12 NONE tinzaparin_2\NN\1740| (r_nsubj) displays_3\VBZ\2137132|furthermore|,|tinzaparin|k(off|compared|evident|. (l_prep) compared_9\VBN\644583|vcam-1 (l_nmod) vcam-1_11\NNP\1740|to|s(-1
16636450
16636450T5_16636450T21 NONE acetyl-coa_6\NN\1740| (r_compound) alpha_8\NN\6828818|of|acetyl-coa|carboxylase
16636450T5_16636450T22 NONE acetyl-coa_6\NN\1740| (r_compound) alpha_8\NN\6828818|of|acetyl-coa|carboxylase (r_nmod) expression_4\NN\4679549|gene|alpha|pi|liver (l_nmod) pi_11\NN\13730756|from|promoter
16636450T1_16636450T6 NONE acetyl-coa_19\NN\1740| (r_compound) carboxylase_20\NN\1740|including|acetyl-coa|acc
16636450T1_16636450T7 NONE acetyl-coa_19\NN\1740| (r_compound) carboxylase_20\NN\1740|including|acetyl-coa|acc (l_appos) acc_22\NN\8190292|(|)
16636450T2_16636450T10 CPR:9 nitrogen_11\NN\14622893| (r_compound) source_12\NN\8620061|as|a|nitrogen (r_nmod) containing_5\VBG\2632940|spi|source (l_dobj) spi_6\NN\1740|or|casein (l_conj) casein_8\NN\14735225|
16636450T3_16636450T11 NONE triglyceride_13\NN\14885088|tg (r_compound) content_17\NN\7951464|triglyceride (r_conj) contents_5\NNS\6481320|the|hepatic|mrna|as|content (l_nmod) mrna_9\NN\14832193|of|total|acc (l_compound) acc_8\NN\8190292|
16636450T3_16636450T12 NONE triglyceride_13\NN\14885088|tg (r_compound) content_17\NN\7951464|triglyceride (r_conj) contents_5\NNS\6481320|the|hepatic|mrna|as|content (r_dobj) decreased_2\VBD\169651|feeding|contents|,|but|affected (l_conj) affected_22\VBD\126264|spi|amount|little|. (l_dobj) amount_24\NN\13329641|the|mrna (l_nmod) mrna_31\NN\14832193|of|protein|and|protein (l_compound) protein_29\NN\14944888|sterol-regulatory|element|binding|(srebp)-1 (l_punct) (srebp)-1_30\NN\1740|
16636450T4_16636450T11 NONE tg_15\NN\1740|(|) (r_appos) triglyceride_13\NN\14885088|tg (r_compound) content_17\NN\7951464|triglyceride (r_conj) contents_5\NNS\6481320|the|hepatic|mrna|as|content (l_nmod) mrna_9\NN\14832193|of|total|acc (l_compound) acc_8\NN\8190292|
16636450T4_16636450T12 NONE tg_15\NN\1740|(|) (r_appos) triglyceride_13\NN\14885088|tg (r_compound) content_17\NN\7951464|triglyceride (r_conj) contents_5\NNS\6481320|the|hepatic|mrna|as|content (r_dobj) decreased_2\VBD\169651|feeding|contents|,|but|affected (l_conj) affected_22\VBD\126264|spi|amount|little|. (l_dobj) amount_24\NN\13329641|the|mrna (l_nmod) mrna_31\NN\14832193|of|protein|and|protein (l_compound) protein_29\NN\14944888|sterol-regulatory|element|binding|(srebp)-1 (l_punct) (srebp)-1_30\NN\1740|
10340919
10340919T24_10340919T31 CPR:4 meloxicam_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|of|cyclooxygenase-1|meloxicam|,|reported (l_acl:relcl) reported_19\VBN\831651|which|has|been|inhibit (l_xcomp) inhibit_22\VB\2510337|to|preferentially|cyclooxygenase-2 (l_dobj) cyclooxygenase-2_23\NN\14737847|cox-2
10340919T24_10340919T32 CPR:4 meloxicam_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|of|cyclooxygenase-1|meloxicam|,|reported (l_acl:relcl) reported_19\VBN\831651|which|has|been|inhibit (l_xcomp) inhibit_22\VB\2510337|to|preferentially|cyclooxygenase-2 (l_dobj) cyclooxygenase-2_23\NN\14737847|cox-2 (l_appos) cox-2_25\NN\14737847|(|)
10340919T24_10340919T37 CPR:4 meloxicam_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|of|cyclooxygenase-1|meloxicam|,|reported (l_compound) cyclooxygenase-1_8\NN\14737847|human|cox-1
10340919T24_10340919T38 CPR:4 meloxicam_14\NN\1740|by (r_nmod) inhibition_12\NN\1068773|of|cyclooxygenase-1|meloxicam|,|reported (l_compound) cyclooxygenase-1_8\NN\14737847|human|cox-1 (l_appos) cox-1_10\NN\14737847|(|)
10340919T12_10340919T35 CPR:4 meloxicam_3\NN\1740|of (r_nmod) effects_1\NNS\13245626|the|meloxicam (r_nsubjpass) compared_5\VBN\644583|effects|were|those|. (l_nmod) those_7\DT\1740|with|diclofenac (l_nmod) diclofenac_9\NN\1740|of|,|inhibitor (l_appos) inhibitor_14\NN\20090|a|nonselective|cox (l_compound) cox_13\NN\14732946|
10340919T13_10340919T35 CPR:4 diclofenac_9\NN\1740|of|,|inhibitor (l_appos) inhibitor_14\NN\20090|a|nonselective|cox (l_compound) cox_13\NN\14732946|
10340919T14_10340919T36 NONE b2_9\NN\1740|thromboxane (r_compound) (txb2)-generation_10\NN\1740|b2|blood|vivo (r_dobj) measuring_7\VBG\697589|by|(txb2)-generation|doses (r_advcl) determined_5\VBN\1645601|inhibition|was|measuring|. (l_nsubjpass) inhibition_3\NN\1068773|cox-1 (l_compound) cox-1_2\NN\14737847|
10340919T15_10340919T36 NONE (txb2)-generation_10\NN\1740|b2|blood|vivo (r_dobj) measuring_7\VBG\697589|by|(txb2)-generation|doses (r_advcl) determined_5\VBN\1645601|inhibition|was|measuring|. (l_nsubjpass) inhibition_3\NN\1068773|cox-1 (l_compound) cox-1_2\NN\14737847|
10340919T16_10340919T36 CPR:4 meloxicam_26\NN\1740|of|mg|and|diclofenac (r_nmod) doses_20\NNS\3740161|after|single|oral|meloxicam|and|state (r_nmod) measuring_7\VBG\697589|by|(txb2)-generation|doses (r_advcl) determined_5\VBN\1645601|inhibition|was|measuring|. (l_nsubjpass) inhibition_3\NN\1068773|cox-1 (l_compound) cox-1_2\NN\14737847|
10340919T17_10340919T36 CPR:4 diclofenac_30\NN\1740|mg (r_conj) meloxicam_26\NN\1740|of|mg|and|diclofenac (r_nmod) doses_20\NNS\3740161|after|single|oral|meloxicam|and|state (r_nmod) measuring_7\VBG\697589|by|(txb2)-generation|doses (r_advcl) determined_5\VBN\1645601|inhibition|was|measuring|. (l_nsubjpass) inhibition_3\NN\1068773|cox-1 (l_compound) cox-1_2\NN\14737847|
10340919T18_10340919T36 CPR:4 meloxicam_38\NN\1740|(|mg|daily|and|diclofenac|) (r_dep) state_34\NN\8491826|at|steady|meloxicam (r_conj) doses_20\NNS\3740161|after|single|oral|meloxicam|and|state (r_nmod) measuring_7\VBG\697589|by|(txb2)-generation|doses (r_advcl) determined_5\VBN\1645601|inhibition|was|measuring|. (l_nsubjpass) inhibition_3\NN\1068773|cox-1 (l_compound) cox-1_2\NN\14737847|
10340919T19_10340919T36 CPR:4 diclofenac_43\NN\1740|mg|daily (r_conj) meloxicam_38\NN\1740|(|mg|daily|and|diclofenac|) (r_dep) state_34\NN\8491826|at|steady|meloxicam (r_conj) doses_20\NNS\3740161|after|single|oral|meloxicam|and|state (r_nmod) measuring_7\VBG\697589|by|(txb2)-generation|doses (r_advcl) determined_5\VBN\1645601|inhibition|was|measuring|. (l_nsubjpass) inhibition_3\NN\1068773|cox-1 (l_compound) cox-1_2\NN\14737847|
10340919T11_10340919T33 CPR:4 meloxicam_9\NN\1740|of (r_nmod) preference_7\NN\7497473|the|cox-2|meloxicam|observed (l_compound) cox-2_6\NN\14737847|
7526860
7526860T1_7526860T13 NONE 3h-thymidine_2\NN\1740| (r_compound) incorporation_3\NN\1237415|3h-thymidine|buds (r_dobj) stimulated_1\VBD\137313|kgf|incorporation|absence|. (l_nsubj) kgf_0\NN\1740|
7526860T1_7526860T14 NONE 3h-thymidine_2\NN\1740| (r_compound) incorporation_3\NN\1237415|3h-thymidine|buds (r_dobj) stimulated_1\VBD\137313|kgf|incorporation|absence|. (l_nmod) absence_10\NN\14449405|in|the|and|presence|factor (l_nmod) factor_16\NN\7326557|of|epidermal|growth
23500772
23500772T11_23500772T25 CPR:3 ethanol_4\NN\14708720|with (r_nmod) activation_0\NN\13561719|aldh2|ethanol (l_nmod) aldh2_2\NN\1740|of
23500772T1_23500772T15 CPR:3 ethanol_22\NN\14708720|with|aldh2|activator|etoh (l_compound) aldh2_20\NN\1740|
23500772T1_23500772T18 NONE ethanol_22\NN\14708720|with|aldh2|activator|etoh (r_nmod) pretreated_18\JJ\1740|ethanol (r_amod) rat_17\NN\2329401|particular|the|diabetic|pretreated (r_appos) rat_11\NN\2329401|in|the|diabetic|,|rat (r_nmod) expression_7\NN\4679549|in|myocardial|aldh2|rat (l_compound) aldh2_6\NN\1740|
23500772T2_23500772T15 CPR:3 etoh_24\NN\1740|(|) (r_appos) ethanol_22\NN\14708720|with|aldh2|activator|etoh (l_compound) aldh2_20\NN\1740|
23500772T2_23500772T18 NONE etoh_24\NN\1740|(|) (r_appos) ethanol_22\NN\14708720|with|aldh2|activator|etoh (r_nmod) pretreated_18\JJ\1740|ethanol (r_amod) rat_17\NN\2329401|particular|the|diabetic|pretreated (r_appos) rat_11\NN\2329401|in|the|diabetic|,|rat (r_nmod) expression_7\NN\4679549|in|myocardial|aldh2|rat (l_compound) aldh2_6\NN\1740|
23500772T5_23500772T16 NONE glucose_7\NN\14710501|fasting|blood|fbg|and|levels (l_conj) levels_17\NNS\4916342|hemoglobin (l_compound) hemoglobin_13\NN\14888884|glycosylated|hba1c
23500772T5_23500772T17 NONE glucose_7\NN\14710501|fasting|blood|fbg|and|levels (l_conj) levels_17\NNS\4916342|hemoglobin (l_compound) hemoglobin_13\NN\14888884|glycosylated|hba1c (l_appos) hba1c_15\NN\1740|(|)
23500772T6_23500772T19 NONE etoh+dm8w_15\NN\1740| (r_compound) group_16\NN\2137|in|etoh+dm8w (r_nmod) level_13\NN\4916342|hba1c|group (r_nsubj) lower_18\JJR\1740|higher|,|level|was|group|. (l_ccomp) higher_6\JJR\1740|level|was|group (l_nsubj) level_1\NN\4916342|hba1c|group (l_compound) hba1c_0\NN\1740|
23500772T6_23500772T20 CPR:4 etoh+dm8w_15\NN\1740| (r_compound) group_16\NN\2137|in|etoh+dm8w (r_nmod) level_13\NN\4916342|hba1c|group (l_compound) hba1c_12\NN\1740|
23500772T8_23500772T21 NONE mda_15\NN\1740| (r_compound) content_16\NN\7951464|mda (r_nsubjpass) increased_18\VBN\169651|reduced|,|content|was|group|;|decreased|. (l_ccomp) reduced_13\VBN\441445|groups|,|activity|were (l_nsubjpass) activity_5\NN\30358|sod|,|mrna|levels (l_compound) sod_4\NN\9335240|
23500772T8_23500772T22 NONE mda_15\NN\1740| (r_compound) content_16\NN\7951464|mda (r_nsubjpass) increased_18\VBN\169651|reduced|,|content|was|group|;|decreased|. (l_ccomp) reduced_13\VBN\441445|groups|,|activity|were (l_nsubjpass) activity_5\NN\30358|sod|,|mrna|levels (l_conj) mrna_8\NN\14832193|aldh2|and (l_compound) aldh2_7\NN\1740|
23500772T9_23500772T23 CPR:3 etoh+dm8w_9\NN\1740| (r_compound) group_10\NN\2137|in|etoh+dm8w (r_nmod) sod_5\NN\9335240|and|aldh2|group
23500772T9_23500772T24 CPR:3 etoh+dm8w_9\NN\1740| (r_compound) group_10\NN\2137|in|etoh+dm8w (r_nmod) sod_5\NN\9335240|and|aldh2|group (l_conj) aldh2_7\NN\1740|
23500772T10_23500772T23 NONE mda_14\NN\1740| (r_nsubjpass) decreased_16\VBN\169651|increased|,|mda|was|. (l_ccomp) increased_12\VBN\169651|group|,|sod|was (l_nsubjpass) sod_5\NN\9335240|and|aldh2|group
23500772T10_23500772T24 NONE mda_14\NN\1740| (r_nsubjpass) decreased_16\VBN\169651|increased|,|mda|was|. (l_ccomp) increased_12\VBN\169651|group|,|sod|was (l_nsubjpass) sod_5\NN\9335240|and|aldh2|group (l_conj) aldh2_7\NN\1740|
15736931
15736931T36_15736931T56 NONE arginine_2\NN\14605787|of|228 (r_nmod) mutation_0\NN\4475|arginine|lysine (r_nsubj) enhances_6\VBZ\227165|mutation|activity|i. (l_dobj) activity_9\NN\30358|the|glucosyltransferase (l_compound) glucosyltransferase_8\NN\1740|
15736931T36_15736931T57 NONE arginine_2\NN\14605787|of|228 (r_nmod) mutation_0\NN\4475|arginine|lysine (r_nsubj) enhances_6\VBZ\227165|mutation|activity|i. (l_punct) i._13\.\1740|beta-1,4-galactosyltransferase
15736931T37_15736931T56 CPR:3 lysine_5\NN\14605787|to (r_nmod) mutation_0\NN\4475|arginine|lysine (r_nsubj) enhances_6\VBZ\227165|mutation|activity|i. (l_dobj) activity_9\NN\30358|the|glucosyltransferase (l_compound) glucosyltransferase_8\NN\1740|
15736931T37_15736931T57 NONE lysine_5\NN\14605787|to (r_nmod) mutation_0\NN\4475|arginine|lysine (r_nsubj) enhances_6\VBZ\227165|mutation|activity|i. (l_punct) i._13\.\1740|beta-1,4-galactosyltransferase
15736931T3_15736931T38 NONE )_18\-RRB-\1740| (r_punct) ion_19\NN\9386422|of|mn(2|+|)|activity (r_nmod) presence_14\NN\13954253|in|the|ion (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T3_15736931T43 NONE )_18\-RRB-\1740| (r_punct) ion_19\NN\9386422|of|mn(2|+|)|activity (l_appos) activity_22\NN\30358|(|gal-t|) (l_compound) gal-t_21\NN\1740|
15736931T3_15736931T45 NONE )_18\-RRB-\1740| (r_punct) ion_19\NN\9386422|of|mn(2|+|)|activity (r_nmod) presence_14\NN\13954253|in|the|ion (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_conj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (l_nmod) glcnac_31\NN\1740|to|activity (l_appos) activity_34\NN\30358|(|glc-t|) (l_compound) glc-t_33\NN\1740|
15736931T3_15736931T49 NONE )_18\-RRB-\1740| (r_punct) ion_19\NN\9386422|of|mn(2|+|)|activity (r_nmod) presence_14\NN\13954253|in|the|ion (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T6_15736931T38 NONE gal-t_21\NN\1740| (r_compound) activity_22\NN\30358|(|gal-t|) (r_appos) ion_19\NN\9386422|of|mn(2|+|)|activity (r_nmod) presence_14\NN\13954253|in|the|ion (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T6_15736931T43 NONE gal-t_21\NN\1740|
15736931T6_15736931T45 NONE gal-t_21\NN\1740| (r_compound) activity_22\NN\30358|(|gal-t|) (r_appos) ion_19\NN\9386422|of|mn(2|+|)|activity (r_nmod) presence_14\NN\13954253|in|the|ion (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_conj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (l_nmod) glcnac_31\NN\1740|to|activity (l_appos) activity_34\NN\30358|(|glc-t|) (l_compound) glc-t_33\NN\1740|
15736931T6_15736931T49 NONE gal-t_21\NN\1740| (r_compound) activity_22\NN\30358|(|gal-t|) (r_appos) ion_19\NN\9386422|of|mn(2|+|)|activity (r_nmod) presence_14\NN\13954253|in|the|ion (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T13_15736931T38 NONE glc_27\NN\1740| (r_dobj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T13_15736931T43 NONE glc_27\NN\1740| (r_dobj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nmod) presence_14\NN\13954253|in|the|ion (l_nmod) ion_19\NN\9386422|of|mn(2|+|)|activity (l_appos) activity_22\NN\30358|(|gal-t|) (l_compound) gal-t_21\NN\1740|
15736931T13_15736931T45 NONE glc_27\NN\1740| (r_dobj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (l_nmod) glcnac_31\NN\1740|to|activity (l_appos) activity_34\NN\30358|(|glc-t|) (l_compound) glc-t_33\NN\1740|
15736931T13_15736931T49 NONE glc_27\NN\1740| (r_dobj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T15_15736931T38 NONE udp-glc_29\NN\1740|from (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T15_15736931T43 NONE udp-glc_29\NN\1740|from (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nmod) presence_14\NN\13954253|in|the|ion (l_nmod) ion_19\NN\9386422|of|mn(2|+|)|activity (l_appos) activity_22\NN\30358|(|gal-t|) (l_compound) gal-t_21\NN\1740|
15736931T15_15736931T45 CPR:9 udp-glc_29\NN\1740|from (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (l_nmod) glcnac_31\NN\1740|to|activity (l_appos) activity_34\NN\30358|(|glc-t|) (l_compound) glc-t_33\NN\1740|
15736931T15_15736931T49 NONE udp-glc_29\NN\1740|from (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T16_15736931T38 NONE glcnac_31\NN\1740|to|activity (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T16_15736931T43 NONE glcnac_31\NN\1740|to|activity (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nmod) presence_14\NN\13954253|in|the|ion (l_nmod) ion_19\NN\9386422|of|mn(2|+|)|activity (l_appos) activity_22\NN\30358|(|gal-t|) (l_compound) gal-t_21\NN\1740|
15736931T16_15736931T45 NONE glcnac_31\NN\1740|to|activity (l_appos) activity_34\NN\30358|(|glc-t|) (l_compound) glc-t_33\NN\1740|
15736931T16_15736931T49 NONE glcnac_31\NN\1740|to|activity (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T17_15736931T38 NONE glc-t_33\NN\1740| (r_compound) activity_34\NN\30358|(|glc-t|) (r_appos) glcnac_31\NN\1740|to|activity (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T17_15736931T43 NONE glc-t_33\NN\1740| (r_compound) activity_34\NN\30358|(|glc-t|) (r_appos) glcnac_31\NN\1740|to|activity (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nmod) presence_14\NN\13954253|in|the|ion (l_nmod) ion_19\NN\9386422|of|mn(2|+|)|activity (l_appos) activity_22\NN\30358|(|gal-t|) (l_compound) gal-t_21\NN\1740|
15736931T17_15736931T45 NONE glc-t_33\NN\1740|
15736931T17_15736931T49 NONE glc-t_33\NN\1740| (r_compound) activity_34\NN\30358|(|glc-t|) (r_appos) glcnac_31\NN\1740|to|activity (r_nmod) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (r_conj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T28_15736931T38 NONE gal_7\NN\13615235| (r_dobj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T28_15736931T43 NONE gal_7\NN\13615235| (r_dobj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nmod) presence_14\NN\13954253|in|the|ion (l_nmod) ion_19\NN\9386422|of|mn(2|+|)|activity (l_appos) activity_22\NN\30358|(|gal-t|) (l_compound) gal-t_21\NN\1740|
15736931T28_15736931T45 NONE gal_7\NN\13615235| (r_dobj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_conj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (l_nmod) glcnac_31\NN\1740|to|activity (l_appos) activity_34\NN\30358|(|glc-t|) (l_compound) glc-t_33\NN\1740|
15736931T28_15736931T49 NONE gal_7\NN\13615235| (r_dobj) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T30_15736931T38 CPR:9 udp-gal_9\NN\1740|from (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T30_15736931T43 CPR:9 udp-gal_9\NN\1740|from (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nmod) presence_14\NN\13954253|in|the|ion (l_nmod) ion_19\NN\9386422|of|mn(2|+|)|activity (l_appos) activity_22\NN\30358|(|gal-t|) (l_compound) gal-t_21\NN\1740|
15736931T30_15736931T45 NONE udp-gal_9\NN\1740|from (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_conj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (l_nmod) glcnac_31\NN\1740|to|activity (l_appos) activity_34\NN\30358|(|glc-t|) (l_compound) glc-t_33\NN\1740|
15736931T30_15736931T49 CPR:9 udp-gal_9\NN\1740|from (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T34_15736931T38 NONE glcnac_11\NN\1740|to (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_nummod) i_1\CD\14622893|
15736931T34_15736931T43 NONE glcnac_11\NN\1740|to (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nmod) presence_14\NN\13954253|in|the|ion (l_nmod) ion_19\NN\9386422|of|mn(2|+|)|activity (l_appos) activity_22\NN\30358|(|gal-t|) (l_compound) gal-t_21\NN\1740|
15736931T34_15736931T45 NONE glcnac_11\NN\1740|to (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_conj) transfers_26\VBZ\2391803|also|glc|udp-glc|glcnac (l_nmod) glcnac_31\NN\1740|to|activity (l_appos) activity_34\NN\30358|(|glc-t|) (l_compound) glc-t_33\NN\1740|
15736931T34_15736931T49 NONE glcnac_11\NN\1740|to (r_nmod) transfers_6\VBZ\2391803|beta-1,4-galactosyltransferase|normally|gal|udp-gal|glcnac|presence|and|transfers|,|efficiency|. (l_nsubj) beta-1,4-galactosyltransferase_0\NN\1740|i|beta4gal-t1 (l_appos) beta4gal-t1_3\NN\1740|(|)
15736931T18_15736931T46 NONE glc-t_9\NN\1740| (r_compound) activity_10\NN\30358|this|glc-t (r_dobj) enhances_7\VBZ\227165|addition|,|alpha-lactalbumin|activity|25|. (l_nsubj) alpha-lactalbumin_3\NN\1740|la
15736931T18_15736931T47 NONE glc-t_9\NN\1740| (r_compound) activity_10\NN\30358|this|glc-t (r_dobj) enhances_7\VBZ\227165|addition|,|alpha-lactalbumin|activity|25|. (l_nsubj) alpha-lactalbumin_3\NN\1740|la (l_appos) la_5\NN\14625458|(|)
15736931T18_15736931T48 NONE glc-t_9\NN\1740|
15736931T19_15736931T50 NONE udp-gal-_6\NN\1740|of|and|udp-glc-bound (r_amod) beta4gal-t1_9\NN\1740|udp-gal-
15736931T20_15736931T50 NONE udp-glc-bound_8\JJ\1740| (r_conj) udp-gal-_6\NN\1740|of|and|udp-glc-bound (r_amod) beta4gal-t1_9\NN\1740|udp-gal-
15736931T21_15736931T50 NONE hydroxyl_14\NN\14621446| (r_compound) group_15\NN\2137|the|o4|hydroxyl|moieties (r_nsubj) forms_22\VBZ\1617192|that|group|bond|group (r_ccomp) reveals_10\VBZ\2137132|comparison|forms|. (l_nsubj) comparison_0\NN\635850|structures (l_nmod) structures_4\NNS\21939|of|the|crystal|beta4gal-t1 (l_nmod) beta4gal-t1_9\NN\1740|udp-gal-
15736931T22_15736931T50 NONE gal_18\NN\13615235|in|both|and|glc (r_compound) moieties_21\NNS\13736799|gal (r_nmod) group_15\NN\2137|the|o4|hydroxyl|moieties (r_nsubj) forms_22\VBZ\1617192|that|group|bond|group (r_ccomp) reveals_10\VBZ\2137132|comparison|forms|. (l_nsubj) comparison_0\NN\635850|structures (l_nmod) structures_4\NNS\21939|of|the|crystal|beta4gal-t1 (l_nmod) beta4gal-t1_9\NN\1740|udp-gal-
15736931T23_15736931T50 NONE glc_20\NN\1740| (r_conj) gal_18\NN\13615235|in|both|and|glc (r_compound) moieties_21\NNS\13736799|gal (r_nmod) group_15\NN\2137|the|o4|hydroxyl|moieties (r_nsubj) forms_22\VBZ\1617192|that|group|bond|group (r_ccomp) reveals_10\VBZ\2137132|comparison|forms|. (l_nsubj) comparison_0\NN\635850|structures (l_nmod) structures_4\NNS\21939|of|the|crystal|beta4gal-t1 (l_nmod) beta4gal-t1_9\NN\1740|udp-gal-
15736931T24_15736931T50 NONE hydrogen_24\NN\14622893| (r_compound) bond_25\NN\11426530|a|hydrogen (r_dobj) forms_22\VBZ\1617192|that|group|bond|group (r_ccomp) reveals_10\VBZ\2137132|comparison|forms|. (l_nsubj) comparison_0\NN\635850|structures (l_nmod) structures_4\NNS\21939|of|the|crystal|beta4gal-t1 (l_nmod) beta4gal-t1_9\NN\1740|udp-gal-
15736931T25_15736931T50 NONE carboxylate_30\JJ\1740| (r_amod) group_31\NN\2137|with|the|side|chain|carboxylate|glu317 (r_nmod) forms_22\VBZ\1617192|that|group|bond|group (r_ccomp) reveals_10\VBZ\2137132|comparison|forms|. (l_nsubj) comparison_0\NN\635850|structures (l_nmod) structures_4\NNS\21939|of|the|crystal|beta4gal-t1 (l_nmod) beta4gal-t1_9\NN\1740|udp-gal-
15736931T26_15736931T51 NONE glucose_7\NN\14710501|of (r_nmod) hydroxyl_5\NN\14621446|of|the|o4|glucose (r_nmod) orientation_1\NN\1051331|the|hydroxyl (r_nsubj) causes_8\VBZ\1617192|orientation|hindrance|group|,|accounting|. (l_advcl) accounting_21\VBG\2604760|activity (l_nmod) activity_28\NN\30358|for|enzyme|low|glc-t (l_compound) glc-t_27\NN\1740|
15736931T27_15736931T51 NONE carboxylate_16\NN\1740| (r_compound) group_17\NN\2137|to|the|chain|carboxylate|glu317 (r_nmod) causes_8\VBZ\1617192|orientation|hindrance|group|,|accounting|. (l_advcl) accounting_21\VBG\2604760|activity (l_nmod) activity_28\NN\30358|for|enzyme|low|glc-t (l_compound) glc-t_27\NN\1740|
15736931T29_15736931T51 NONE glc-t_27\NN\1740|
15736931T31_15736931T52 NONE lysine_20\NN\14605787|to|r228k-gal-t1 (l_appos) r228k-gal-t1_22\NN\1740|(|)
15736931T31_15736931T53 NONE lysine_20\NN\14605787|to|r228k-gal-t1 (l_appos) r228k-gal-t1_22\NN\1740|(|)
15736931T31_15736931T54 NONE lysine_20\NN\14605787|to|r228k-gal-t1 (r_nmod) mutation_7\NN\4475|arg228|lysine (r_nsubj) results_24\VBZ\2633881|that|mutation|activity (l_nmod) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (l_compound) glc-t_29\NN\1740|
15736931T31_15736931T55 NONE lysine_20\NN\14605787|to|r228k-gal-t1 (r_nmod) mutation_7\NN\4475|arg228|lysine (r_nsubj) results_24\VBZ\2633881|that|mutation|activity (l_nmod) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (l_acl:relcl) enhanced_35\VBN\227165|which|is|further|la|% (l_nmod) %_41\NN\1740|to|25|activity (l_nmod) activity_45\NN\30358|of|the|gal-t|type (l_compound) gal-t_44\NN\1740|
15736931T32_15736931T52 NONE r228k-gal-t1_22\NN\1740|(|)
15736931T32_15736931T53 NONE r228k-gal-t1_22\NN\1740|(|)
15736931T32_15736931T54 NONE r228k-gal-t1_22\NN\1740|(|) (r_appos) lysine_20\NN\14605787|to|r228k-gal-t1 (r_nmod) mutation_7\NN\4475|arg228|lysine (r_nsubj) results_24\VBZ\2633881|that|mutation|activity (l_nmod) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (l_compound) glc-t_29\NN\1740|
15736931T32_15736931T55 NONE r228k-gal-t1_22\NN\1740|(|) (r_appos) lysine_20\NN\14605787|to|r228k-gal-t1 (r_nmod) mutation_7\NN\4475|arg228|lysine (r_nsubj) results_24\VBZ\2633881|that|mutation|activity (l_nmod) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (l_acl:relcl) enhanced_35\VBN\227165|which|is|further|la|% (l_nmod) %_41\NN\1740|to|25|activity (l_nmod) activity_45\NN\30358|of|the|gal-t|type (l_compound) gal-t_44\NN\1740|
15736931T33_15736931T52 NONE glc-t_29\NN\1740| (r_compound) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (r_nmod) results_24\VBZ\2633881|that|mutation|activity (l_nsubj) mutation_7\NN\4475|arg228|lysine (l_nmod) lysine_20\NN\14605787|to|r228k-gal-t1 (l_appos) r228k-gal-t1_22\NN\1740|(|)
15736931T33_15736931T53 NONE glc-t_29\NN\1740| (r_compound) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (r_nmod) results_24\VBZ\2633881|that|mutation|activity (l_nsubj) mutation_7\NN\4475|arg228|lysine (l_nmod) lysine_20\NN\14605787|to|r228k-gal-t1 (l_appos) r228k-gal-t1_22\NN\1740|(|)
15736931T33_15736931T54 NONE glc-t_29\NN\1740|
15736931T33_15736931T55 NONE glc-t_29\NN\1740| (r_compound) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (l_acl:relcl) enhanced_35\VBN\227165|which|is|further|la|% (l_nmod) %_41\NN\1740|to|25|activity (l_nmod) activity_45\NN\30358|of|the|gal-t|type (l_compound) gal-t_44\NN\1740|
15736931T35_15736931T52 NONE gal-t_44\NN\1740| (r_compound) activity_45\NN\30358|of|the|gal-t|type (r_nmod) %_41\NN\1740|to|25|activity (r_nmod) enhanced_35\VBN\227165|which|is|further|la|% (r_acl:relcl) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (r_nmod) results_24\VBZ\2633881|that|mutation|activity (l_nsubj) mutation_7\NN\4475|arg228|lysine (l_nmod) lysine_20\NN\14605787|to|r228k-gal-t1 (l_appos) r228k-gal-t1_22\NN\1740|(|)
15736931T35_15736931T53 NONE gal-t_44\NN\1740| (r_compound) activity_45\NN\30358|of|the|gal-t|type (r_nmod) %_41\NN\1740|to|25|activity (r_nmod) enhanced_35\VBN\227165|which|is|further|la|% (r_acl:relcl) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (r_nmod) results_24\VBZ\2633881|that|mutation|activity (l_nsubj) mutation_7\NN\4475|arg228|lysine (l_nmod) lysine_20\NN\14605787|to|r228k-gal-t1 (l_appos) r228k-gal-t1_22\NN\1740|(|)
15736931T35_15736931T54 NONE gal-t_44\NN\1740| (r_compound) activity_45\NN\30358|of|the|gal-t|type (r_nmod) %_41\NN\1740|to|25|activity (r_nmod) enhanced_35\VBN\227165|which|is|further|la|% (r_acl:relcl) activity_30\NN\30358|in|a|higher|glc-t|,|enhanced (l_compound) glc-t_29\NN\1740|
15736931T35_15736931T55 NONE gal-t_44\NN\1740|
15736931T1_15736931T39 NONE lysine_14\NN\14605787|to (r_nmod) mutation_10\NN\4475|of|the|arg228|lysine (r_nmod) effect_7\NN\34213|the|main|mutation (r_nsubj) that_4\IN\1740|effect|is|k(cat (l_nmod) k(cat_18\NN\1740|on|the|)|glc-t|,|increases (l_nmod) glc-t_21\NN\1740|of
15736931T1_15736931T40 NONE lysine_14\NN\14605787|to (r_nmod) mutation_10\NN\4475|of|the|arg228|lysine (r_nmod) effect_7\NN\34213|the|main|mutation (r_nsubj) that_4\IN\1740|effect|is|k(cat (r_ccomp) indicate_3\VBP\952524|parameters|that|;|reduced|. (l_parataxis) reduced_50\VBN\441445|simultaneously|,|k(cat|is|30-fold (l_nsubjpass) k(cat_43\NN\1740|the|)|reaction (l_nmod) reaction_48\NN\13446390|for|the|gal-t (l_compound) gal-t_47\NN\1740|
15736931T2_15736931T39 NONE glc-t_21\NN\1740|of
15736931T2_15736931T40 NONE glc-t_21\NN\1740|of (r_nmod) k(cat_18\NN\1740|on|the|)|glc-t|,|increases (r_nmod) that_4\IN\1740|effect|is|k(cat (r_ccomp) indicate_3\VBP\952524|parameters|that|;|reduced|. (l_parataxis) reduced_50\VBN\441445|simultaneously|,|k(cat|is|30-fold (l_nsubjpass) k(cat_43\NN\1740|the|)|reaction (l_nmod) reaction_48\NN\13446390|for|the|gal-t (l_compound) gal-t_47\NN\1740|
15736931T4_15736931T39 NONE gal-t_47\NN\1740| (r_compound) reaction_48\NN\13446390|for|the|gal-t (r_nmod) k(cat_43\NN\1740|the|)|reaction (r_nsubjpass) reduced_50\VBN\441445|simultaneously|,|k(cat|is|30-fold (r_parataxis) indicate_3\VBP\952524|parameters|that|;|reduced|. (l_ccomp) that_4\IN\1740|effect|is|k(cat (l_nmod) k(cat_18\NN\1740|on|the|)|glc-t|,|increases (l_nmod) glc-t_21\NN\1740|of
15736931T4_15736931T40 NONE gal-t_47\NN\1740|
15736931T5_15736931T41 NONE r228k-gal-t1_4\NN\1740|of
15736931T5_15736931T42 NONE r228k-gal-t1_4\NN\1740|of
15736931T7_15736931T41 NONE udp-gal_9\NN\1740| (r_conj) la_7\NN\14625458|with|,|udp-gal|,|and|+|determined (r_nmod) complexed_5\VBN\1740|la (r_acl) structure_2\NN\21939|the|crystal|r228k-gal-t1|complexed (l_nmod) r228k-gal-t1_4\NN\1740|of
15736931T7_15736931T42 NONE udp-gal_9\NN\1740| (r_conj) la_7\NN\14625458|with|,|udp-gal|,|and|+|determined (r_nmod) complexed_5\VBN\1740|la (r_acl) structure_2\NN\21939|the|crystal|r228k-gal-t1|complexed (l_nmod) r228k-gal-t1_4\NN\1740|of
15736931T8_15736931T41 NONE )_14\-RRB-\1740| (r_punct) +_13\NN\1740|mn(2|) (r_conj) la_7\NN\14625458|with|,|udp-gal|,|and|+|determined (r_nmod) complexed_5\VBN\1740|la (r_acl) structure_2\NN\21939|the|crystal|r228k-gal-t1|complexed (l_nmod) r228k-gal-t1_4\NN\1740|of
15736931T8_15736931T42 NONE )_14\-RRB-\1740| (r_punct) +_13\NN\1740|mn(2|) (r_conj) la_7\NN\14625458|with|,|udp-gal|,|and|+|determined (r_nmod) complexed_5\VBN\1740|la (r_acl) structure_2\NN\21939|the|crystal|r228k-gal-t1|complexed (l_nmod) r228k-gal-t1_4\NN\1740|of
15736931T9_15736931T44 NONE hydroxyl_11\NN\14621446| (r_compound) group_12\NN\2137|to|the|o4|hydroxyl|moiety (r_nmod) hindrance_7\NN\5686955|a|steric|group (r_dobj) causes_4\VBZ\1617192|conformation|now|hindrance|,|causing|. (l_advcl) causing_21\VBG\1617192|probably|dissociation (l_dobj) dissociation_23\NN\383606|the|udp-gal|and|k(cat (l_conj) k(cat_29\NN\1740|the|reduced|)|reaction (l_nmod) reaction_34\NN\13446390|of|the|gal-t (l_compound) gal-t_33\NN\1740|
15736931T10_15736931T44 NONE gal_15\NN\13615235| (r_compound) moiety_16\NN\13736799|of|the|gal|udp-gal (r_nmod) group_12\NN\2137|to|the|o4|hydroxyl|moiety (r_nmod) hindrance_7\NN\5686955|a|steric|group (r_dobj) causes_4\VBZ\1617192|conformation|now|hindrance|,|causing|. (l_advcl) causing_21\VBG\1617192|probably|dissociation (l_dobj) dissociation_23\NN\383606|the|udp-gal|and|k(cat (l_conj) k(cat_29\NN\1740|the|reduced|)|reaction (l_nmod) reaction_34\NN\13446390|of|the|gal-t (l_compound) gal-t_33\NN\1740|
15736931T11_15736931T44 NONE udp-gal_18\NN\1740|of (r_nmod) moiety_16\NN\13736799|of|the|gal|udp-gal (r_nmod) group_12\NN\2137|to|the|o4|hydroxyl|moiety (r_nmod) hindrance_7\NN\5686955|a|steric|group (r_dobj) causes_4\VBZ\1617192|conformation|now|hindrance|,|causing|. (l_advcl) causing_21\VBG\1617192|probably|dissociation (l_dobj) dissociation_23\NN\383606|the|udp-gal|and|k(cat (l_conj) k(cat_29\NN\1740|the|reduced|)|reaction (l_nmod) reaction_34\NN\13446390|of|the|gal-t (l_compound) gal-t_33\NN\1740|
15736931T12_15736931T44 NONE udp-gal_25\NN\1740|of (r_nmod) dissociation_23\NN\383606|the|udp-gal|and|k(cat (l_conj) k(cat_29\NN\1740|the|reduced|)|reaction (l_nmod) reaction_34\NN\13446390|of|the|gal-t (l_compound) gal-t_33\NN\1740|
15736931T14_15736931T44 NONE gal-t_33\NN\1740|
23305850
23305850T1_23305850T7 CPR:3 sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (r_nmod) response_24\NN\11410625|in|inducers (r_nmod) expression_15\NN\4679549|of|the|genes|response (l_nmod) genes_22\NNS\8459252|of|nrf2|target (l_compound) nrf2_20\NN\1740|30|reported
23305850T1_23305850T8 CPR:3 sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (l_compound) nrf2_26\NN\1740|
23305850T1_23305850T9 CPR:3 sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (r_nmod) response_24\NN\11410625|in|inducers (r_nmod) expression_15\NN\4679549|of|the|genes|response (r_nmod) measurement_12\NN\407535|the|expression (r_nsubj) showed_40\VBD\2137132|firstly|,|cells|,|measurement|inducible|. (l_ccomp) inducible_51\JJ\1740|that|1c1|is|highly|treatments (l_nsubj) 1c1_48\NN\1740|the|reductase
23305850T2_23305850T7 CPR:3 tert-butylhydroquinone_31\NN\1740| (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (r_nmod) response_24\NN\11410625|in|inducers (r_nmod) expression_15\NN\4679549|of|the|genes|response (l_nmod) genes_22\NNS\8459252|of|nrf2|target (l_compound) nrf2_20\NN\1740|30|reported
23305850T2_23305850T8 CPR:3 tert-butylhydroquinone_31\NN\1740| (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (l_compound) nrf2_26\NN\1740|
23305850T2_23305850T9 CPR:3 tert-butylhydroquinone_31\NN\1740| (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (r_nmod) response_24\NN\11410625|in|inducers (r_nmod) expression_15\NN\4679549|of|the|genes|response (r_nmod) measurement_12\NN\407535|the|expression (r_nsubj) showed_40\VBD\2137132|firstly|,|cells|,|measurement|inducible|. (l_ccomp) inducible_51\JJ\1740|that|1c1|is|highly|treatments (l_nsubj) 1c1_48\NN\1740|the|reductase
23305850T3_23305850T7 CPR:3 aldehyde_34\NN\14727670|cinnamic (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (r_nmod) response_24\NN\11410625|in|inducers (r_nmod) expression_15\NN\4679549|of|the|genes|response (l_nmod) genes_22\NNS\8459252|of|nrf2|target (l_compound) nrf2_20\NN\1740|30|reported
23305850T3_23305850T8 CPR:3 aldehyde_34\NN\14727670|cinnamic (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (l_compound) nrf2_26\NN\1740|
23305850T3_23305850T9 CPR:3 aldehyde_34\NN\14727670|cinnamic (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (r_nmod) response_24\NN\11410625|in|inducers (r_nmod) expression_15\NN\4679549|of|the|genes|response (r_nmod) measurement_12\NN\407535|the|expression (r_nsubj) showed_40\VBD\2137132|firstly|,|cells|,|measurement|inducible|. (l_ccomp) inducible_51\JJ\1740|that|1c1|is|highly|treatments (l_nsubj) 1c1_48\NN\1740|the|reductase
23305850T4_23305850T7 CPR:3 peroxide_38\NN\14780040|hydrogen (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (r_nmod) response_24\NN\11410625|in|inducers (r_nmod) expression_15\NN\4679549|of|the|genes|response (l_nmod) genes_22\NNS\8459252|of|nrf2|target (l_compound) nrf2_20\NN\1740|30|reported
23305850T4_23305850T8 CPR:3 peroxide_38\NN\14780040|hydrogen (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (l_compound) nrf2_26\NN\1740|
23305850T4_23305850T9 CPR:3 peroxide_38\NN\14780040|hydrogen (r_conj) sulforaphane_29\NN\1740|(|,|tert-butylhydroquinone|,|aldehyde|,|and|peroxide|) (r_dep) inducers_27\NNS\14778436|to|nrf2|sulforaphane (r_nmod) response_24\NN\11410625|in|inducers (r_nmod) expression_15\NN\4679549|of|the|genes|response (r_nmod) measurement_12\NN\407535|the|expression (r_nsubj) showed_40\VBD\2137132|firstly|,|cells|,|measurement|inducible|. (l_ccomp) inducible_51\JJ\1740|that|1c1|is|highly|treatments (l_nsubj) 1c1_48\NN\1740|the|reductase
23305850T5_23305850T17 CPR:3 sulforaphane_9\NN\1740|including (r_nmod) inducers_7\NNS\14778436|with|nrf2|sulforaphane (l_compound) nrf2_6\NN\1740|
23305850T5_23305850T18 CPR:3 sulforaphane_9\NN\1740|including (r_nmod) inducers_7\NNS\14778436|with|nrf2|sulforaphane (r_nmod) treatment_1\NN\654885|the|cells|inducers (r_nsubj) elevated_11\VBD\2391803|treatment|effectively|expression|. (l_dobj) expression_13\NN\4679549|the|akr1b1 (l_nmod) akr1b1_15\NN\1740|of|,|1b10|,|1c1|,|1c2|,|and|1c3 (l_conj) 1c3_24\NN\1740|
23305850T6_23305850T19 CPR:3 sulforaphane-inducible_9\JJ\1740| (r_conj) basal_7\JJ\1740|of|both|the|and|sulforaphane-inducible|expression|akr1c1 (l_nmod) akr1c1_12\NN\1740|of
23305850T6_23305850T20 NONE sulforaphane-inducible_9\JJ\1740| (r_conj) basal_7\JJ\1740|of|both|the|and|sulforaphane-inducible|expression|akr1c1 (r_nmod) levels_3\NNS\4916342|the|basal (r_nsubjpass) reduced_15\VBN\441445|whereas|,|levels|were|significantly|cells|cells|. (l_nmod) cells_20\NNS\3080309|in|nrf2-silenced|stable|u937 (l_amod) nrf2-silenced_17\JJ\1740|
23531488
23531488T3_23531488T17 NONE n-terminus_18\JJ\1740| (r_amod) acids_20\NNS\14818238|22|n-terminus|amino (r_dobj) lacking_16\VBG\1740|acids (r_acl) protein_15\NN\14944888|shortened|lacking|oatp2b-short (r_conj) length_9\NN\5093581|either|a|full|oatp2b1-fl|or|protein (l_appos) oatp2b1-fl_11\NN\1740|(|)
23531488T3_23531488T18 NONE n-terminus_18\JJ\1740| (r_amod) acids_20\NNS\14818238|22|n-terminus|amino (r_dobj) lacking_16\VBG\1740|acids (r_acl) protein_15\NN\14944888|shortened|lacking|oatp2b-short (l_appos) oatp2b-short_22\NN\1740|(|)
23531488T4_23531488T17 NONE acids_20\NNS\14818238|22|n-terminus|amino (r_dobj) lacking_16\VBG\1740|acids (r_acl) protein_15\NN\14944888|shortened|lacking|oatp2b-short (r_conj) length_9\NN\5093581|either|a|full|oatp2b1-fl|or|protein (l_appos) oatp2b1-fl_11\NN\1740|(|)
23531488T4_23531488T18 NONE acids_20\NNS\14818238|22|n-terminus|amino (r_dobj) lacking_16\VBG\1740|acids (r_acl) protein_15\NN\14944888|shortened|lacking|oatp2b-short (l_appos) oatp2b-short_22\NN\1740|(|)
23531488T5_23531488T19 NONE n-terminus_13\NN\1740| (r_compound) truncation_14\NN\5137557|with|n-terminus (r_nmod) activity_6\NN\30358|regarding|the|transport|and|regulation|variants|truncation (l_nmod) variants_11\NNS\7366289|of|oatp2b1 (l_compound) oatp2b1_10\NN\1740|
23531488T1_23531488T7 CPR:9 sulfate_22\NN\15010703|estrone|and|rosuvastatin (r_dep) substrates_20\NNS\19613|towards|sulfate (r_nmod) variant_18\NN\7366289|of|the|short|oatp2b1|substrates (l_compound) oatp2b1_17\NN\1740|
23531488T2_23531488T7 CPR:9 rosuvastatin_24\NN\1740| (r_conj) sulfate_22\NN\15010703|estrone|and|rosuvastatin (r_dep) substrates_20\NNS\19613|towards|sulfate (r_nmod) variant_18\NN\7366289|of|the|short|oatp2b1|substrates (l_compound) oatp2b1_17\NN\1740|
12560076
12560076T20_12560076T28 NONE serine_2\NN\14601829| (r_compound) racemase_3\NN\1740|brain|serine
12560076T21_12560076T28 CPR:9 l-serine_8\NN\1740|of (r_nmod) elimination_6\NN\391599|specific|l-serine|pyruvate (r_dobj) catalyzes_4\VBZ\146138|racemase|elimination|. (l_nsubj) racemase_3\NN\1740|brain|serine
12560076T22_12560076T28 CPR:9 pyruvate_10\NN\1740|to (r_nmod) elimination_6\NN\391599|specific|l-serine|pyruvate (r_dobj) catalyzes_4\VBZ\146138|racemase|elimination|. (l_nsubj) racemase_3\NN\1740|brain|serine
12560076T1_12560076T23 CPR:5 d-serine_0\NN\1740| (r_nsubjpass) identified_3\VBN\699815|d-serine|was|previously|brain|and|shown|. (l_conj) shown_9\VBN\2137132|was|co-agonist (l_xcomp) co-agonist_13\NN\1740|to|be|a|site (l_nmod) site_19\NN\8673395|at|the|'|glycine|'|receptors (l_nmod) receptors_24\NNS\5225602|of|the|n-methyl-d-aspartate|(nmda)-type
12560076T2_12560076T23 NONE n-methyl-d-aspartate_22\NN\1740| (r_compound) receptors_24\NNS\5225602|of|the|n-methyl-d-aspartate|(nmda)-type
12560076T3_12560076T23 NONE (nmda)-type_23\JJ\1740| (r_amod) receptors_24\NNS\5225602|of|the|n-methyl-d-aspartate|(nmda)-type
12560076T18_12560076T23 NONE glycine_17\NN\14601829| (r_compound) site_19\NN\8673395|at|the|'|glycine|'|receptors (l_nmod) receptors_24\NNS\5225602|of|the|n-methyl-d-aspartate|(nmda)-type
12560076T4_12560076T24 CPR:9 serine_2\NN\14601829|of (r_nmod) racemization_0\NN\1740|serine (r_nsubjpass) catalyzed_4\VBN\146138|racemization|is|racemase|. (l_nmod) racemase_7\NN\1740|by|serine|,|enzyme
12560076T5_12560076T24 NONE serine_6\NN\14601829| (r_compound) racemase_7\NN\1740|by|serine|,|enzyme
12560076T6_12560076T24 NONE 5'-phosphate-dependent_11\JJ\1740| (r_amod) enzyme_12\NN\14723628|a|pyridoxal|5'-phosphate-dependent|expressed (r_appos) racemase_7\NN\1740|by|serine|,|enzyme
12560076T7_12560076T25 NONE nmda_0\NN\1740| (r_compound) overactivation_2\NN\1740|nmda|receptor (l_compound) receptor_1\NN\5225602|
12560076T7_12560076T26 NONE nmda_0\NN\1740| (r_compound) overactivation_2\NN\1740|nmda|receptor (r_nsubjpass) implicated_5\VBN\2677097|overactivation|has|been|number|and|targets (l_conj) targets_21\NNS\7258332|inhibitors|are|thus|interesting|therapy|. (l_nsubj) inhibitors_13\NNS\20090|racemase (l_nmod) racemase_16\NN\1740|of|serine
12560076T8_12560076T25 NONE serine_15\NN\14601829| (r_compound) racemase_16\NN\1740|of|serine (r_nmod) inhibitors_13\NNS\20090|racemase (r_nsubj) targets_21\NNS\7258332|inhibitors|are|thus|interesting|therapy|. (r_conj) implicated_5\VBN\2677097|overactivation|has|been|number|and|targets (l_nsubjpass) overactivation_2\NN\1740|nmda|receptor (l_compound) receptor_1\NN\5225602|
12560076T8_12560076T26 NONE serine_15\NN\14601829| (r_compound) racemase_16\NN\1740|of|serine
12560076T9_12560076T27 NONE serine_4\NN\14601829| (r_compound) racemase_5\NN\1740|recombinant|mouse|serine
23474889
23474889T21_23474889T30 NONE ethanol-induced_14\JJ\1740| (r_amod) preference_16\NN\7497473|ethanol-induced|place (r_conj) consumption_12\NN\13440063|on|voluntary|alcohol|and|preference|mice (r_nmod) influence_0\NN\5190804|st1283|consumption|. (l_nmod) st1283_8\NN\1740|of|the|novel|histamine|h3|receptor|antagonist (l_compound) receptor_6\NN\5225602|
23474889T22_23474889T30 NONE histamine_4\NN\14739004| (r_compound) st1283_8\NN\1740|of|the|novel|histamine|h3|receptor|antagonist (l_compound) receptor_6\NN\5225602|
23474889T23_23474889T30 NONE alcohol_11\NN\7881800| (r_compound) consumption_12\NN\13440063|on|voluntary|alcohol|and|preference|mice (r_nmod) influence_0\NN\5190804|st1283|consumption|. (l_nmod) st1283_8\NN\1740|of|the|novel|histamine|h3|receptor|antagonist (l_compound) receptor_6\NN\5225602|
23474889T6_23474889T26 NONE alcohol-use_23\NN\1740| (r_compound) disorders_24\NNS\14034177|alcohol-use|particular (r_conj) addiction_19\NN\14034177|on|drug|general|and|disorders (r_nmod) have_13\VB\2108377|system|to|influence|addiction|receptors (l_nmod) receptors_30\NNS\5225602|through|histamine|h3|h3r
23474889T6_23474889T27 NONE alcohol-use_23\NN\1740| (r_compound) disorders_24\NNS\14034177|alcohol-use|particular (r_conj) addiction_19\NN\14034177|on|drug|general|and|disorders (r_nmod) have_13\VB\2108377|system|to|influence|addiction|receptors (l_nmod) receptors_30\NNS\5225602|through|histamine|h3|h3r (l_appos) h3r_32\NNS\1740|(|)
23474889T9_23474889T26 NONE histamine_28\NN\14739004| (r_compound) receptors_30\NNS\5225602|through|histamine|h3|h3r
23474889T9_23474889T27 NONE histamine_28\NN\14739004| (r_compound) receptors_30\NNS\5225602|through|histamine|h3|h3r (l_appos) h3r_32\NNS\1740|(|)
23474889T10_23474889T28 NONE ethanol_20\NN\14708720|etoh (r_compound) intake_25\NN\13440063|on|ethanol|voluntary|and|reward|mice (r_nmod) injection_11\NN\320852|of|systemic|st1283|intake (l_nmod) st1283_18\NN\1740|of|the|synthesized|h3r|antagonist (l_compound) h3r_16\NN\1740|
23474889T11_23474889T28 NONE etoh_22\NN\1740|(|) (r_appos) ethanol_20\NN\14708720|etoh (r_compound) intake_25\NN\13440063|on|ethanol|voluntary|and|reward|mice (r_nmod) injection_11\NN\320852|of|systemic|st1283|intake (l_nmod) st1283_18\NN\1740|of|the|synthesized|h3r|antagonist (l_compound) h3r_16\NN\1740|
23474889T12_23474889T28 NONE etoh-conditioned_27\JJ\1740| (r_amod) reward_28\NN\7294019|etoh-conditioned (r_conj) intake_25\NN\13440063|on|ethanol|voluntary|and|reward|mice (r_nmod) injection_11\NN\320852|of|systemic|st1283|intake (l_nmod) st1283_18\NN\1740|of|the|synthesized|h3r|antagonist (l_compound) h3r_16\NN\1740|
23474889T20_23474889T29 NONE alcohol_28\NN\7881800| (r_compound) consumption_29\NN\13440063|in|alcohol|and|preference (r_nmod) decrease_26\NN\7296428|a|significant|dose-dependent|consumption (r_nsubj) was_22\VBD\836236|administration|mg/kg|,|there|decrease|. (l_nmod) administration_3\NN\1133281|following|antagonist|5| (l_nmod) antagonist_7\NN\7846|of|the|h3r (l_compound) h3r_6\NN\1740|
23474889T3_23474889T24 CPR:5 r-(alpha)-methyl-histamine_13\NN\1740|with|the|agonist (l_compound) agonist_12\NN\9613191|selective|h3r (l_compound) h3r_11\NN\1740|
23474889T8_23474889T25 NONE etoh_16\NN\1740| (r_compound) addiction_17\NN\14034177|of|etoh (r_nmod) pharmacotherapy_14\NN\1740|in|the|addiction (r_nmod) modulation_11\NN\7044917|on|h3r|pharmacotherapy (l_compound) h3r_10\NN\1740|
17603755
17603755T3_17603755T8 CPR:4 miglustat_0\NN\1740|,|molecule|, (r_nsubj) inhibits_15\VBZ\2510337|miglustat|reversibly|synthase|. (l_dobj) synthase_17\NN\1740|glucosylceramide|,|catalyses
17603755T4_17603755T8 NONE glucosylceramide_16\NN\1740| (r_compound) synthase_17\NN\1740|glucosylceramide|,|catalyses
23589476
10606746
10606746T18_10606746T25 NONE (-)-galanthamine_5\NN\1740|with|resolution (r_nmod) complexed_3\VBN\1740|(-)-galanthamine (r_acl) structure_0\NN\21939|acetylcholinesterase|complexed|. (l_nmod) acetylcholinesterase_2\NN\1740|of
10606746T3_10606746T21 NONE choline-binding_18\JJ\1740| (r_amod) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket (r_nmod) interacting_14\VBG\2367363|site (r_advcl) binds_2\VBZ\1290422|inhibitor|base|,|interacting|. (l_nmod) base_5\NN\3763133|at|the|gorge (l_nmod) gorge_10\NN\9405787|of|the|active|site|tcache (l_nmod) tcache_12\NN\1740|of
10606746T3_10606746T22 NONE choline-binding_18\JJ\1740| (r_amod) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket
10606746T3_10606746T23 NONE choline-binding_18\JJ\1740| (r_amod) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket (l_conj) pocket_26\NN\3993180|the|acyl-binding|phe-288
10606746T4_10606746T21 NONE trp-84_21\NN\1740|(|) (r_appos) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket (r_nmod) interacting_14\VBG\2367363|site (r_advcl) binds_2\VBZ\1290422|inhibitor|base|,|interacting|. (l_nmod) base_5\NN\3763133|at|the|gorge (l_nmod) gorge_10\NN\9405787|of|the|active|site|tcache (l_nmod) tcache_12\NN\1740|of
10606746T4_10606746T22 NONE trp-84_21\NN\1740|(|) (r_appos) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket
10606746T4_10606746T23 NONE trp-84_21\NN\1740|(|) (r_appos) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket (l_conj) pocket_26\NN\3993180|the|acyl-binding|phe-288
10606746T5_10606746T21 NONE acyl-binding_25\JJ\1740| (r_amod) pocket_26\NN\3993180|the|acyl-binding|phe-288 (r_conj) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket (r_nmod) interacting_14\VBG\2367363|site (r_advcl) binds_2\VBZ\1290422|inhibitor|base|,|interacting|. (l_nmod) base_5\NN\3763133|at|the|gorge (l_nmod) gorge_10\NN\9405787|of|the|active|site|tcache (l_nmod) tcache_12\NN\1740|of
10606746T5_10606746T22 NONE acyl-binding_25\JJ\1740| (r_amod) pocket_26\NN\3993180|the|acyl-binding|phe-288 (r_conj) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket
10606746T5_10606746T23 NONE acyl-binding_25\JJ\1740| (r_amod) pocket_26\NN\3993180|the|acyl-binding|phe-288
10606746T6_10606746T21 NONE phe-288_28\NN\1740|(|,|phe-290|) (r_dep) pocket_26\NN\3993180|the|acyl-binding|phe-288 (r_conj) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket (r_nmod) interacting_14\VBG\2367363|site (r_advcl) binds_2\VBZ\1290422|inhibitor|base|,|interacting|. (l_nmod) base_5\NN\3763133|at|the|gorge (l_nmod) gorge_10\NN\9405787|of|the|active|site|tcache (l_nmod) tcache_12\NN\1740|of
10606746T6_10606746T22 NONE phe-288_28\NN\1740|(|,|phe-290|) (r_dep) pocket_26\NN\3993180|the|acyl-binding|phe-288 (r_conj) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket
10606746T6_10606746T23 NONE phe-288_28\NN\1740|(|,|phe-290|) (r_dep) pocket_26\NN\3993180|the|acyl-binding|phe-288
10606746T7_10606746T21 NONE phe-290_30\NN\1740| (r_appos) phe-288_28\NN\1740|(|,|phe-290|) (r_dep) pocket_26\NN\3993180|the|acyl-binding|phe-288 (r_conj) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket (r_nmod) interacting_14\VBG\2367363|site (r_advcl) binds_2\VBZ\1290422|inhibitor|base|,|interacting|. (l_nmod) base_5\NN\3763133|at|the|gorge (l_nmod) gorge_10\NN\9405787|of|the|active|site|tcache (l_nmod) tcache_12\NN\1740|of
10606746T7_10606746T22 NONE phe-290_30\NN\1740| (r_appos) phe-288_28\NN\1740|(|,|phe-290|) (r_dep) pocket_26\NN\3993180|the|acyl-binding|phe-288 (r_conj) site_19\NN\8673395|with|both|the|choline-binding|trp-84|and|pocket
10606746T7_10606746T23 NONE phe-290_30\NN\1740| (r_appos) phe-288_28\NN\1740|(|,|phe-290|) (r_dep) pocket_26\NN\3993180|the|acyl-binding|phe-288
23238784
23238784T7_23238784T12 NONE udp-glucuronosyltransferase_15\NN\1740| (r_compound) 1a1_16\NN\1740|(|udp-glucuronosyltransferase|)
23238784T7_23238784T13 NONE udp-glucuronosyltransferase_15\NN\1740| (r_compound) 1a1_16\NN\1740|(|udp-glucuronosyltransferase|) (r_appos) %_13\NN\1740|from|26|1a1|,|%|,|% (l_conj) %_20\NN\1740|47|cyp3a4 (l_appos) cyp3a4_22\NN\1740|(|)
23238784T7_23238784T14 NONE udp-glucuronosyltransferase_15\NN\1740| (r_compound) 1a1_16\NN\1740|(|udp-glucuronosyltransferase|) (r_appos) %_13\NN\1740|from|26|1a1|,|%|,|% (l_nmod) %_27\NN\1740|to|240|cyp2c9|hepatocytes (l_appos) cyp2c9_29\NN\1740|(|)
23238784T8_23238784T15 CPR:3 rifampicin_8\NN\1740|by (r_nmod) induced_5\VBN\1627355|activity|could|be|2-fold|rifampicin|,|remained|. (l_nsubjpass) activity_2\NN\30358|the|cyp3a4 (l_compound) cyp3a4_1\NN\1740|
23238784T8_23238784T16 CPR:3 rifampicin_8\NN\1740|by (r_nmod) induced_5\VBN\1627355|activity|could|be|2-fold|rifampicin|,|remained|. (l_advcl) remained_13\VBD\2604760|whereas|activity|high (l_nsubj) activity_12\NN\30358|cyp2c9 (l_compound) cyp2c9_11\NN\1740|
23177256
23177256T10_23177256T19 CPR:4 10074-g5_5\NN\1740| (r_dep) inhibitor_4\NN\20090|of|c-myc|10074-g5 (l_compound) c-myc_3\NN\1740|
23177256T1_23177256T11 NONE arginine_34\NN\14605787| (r_compound) residues_35\NNS\20827|by|arginine (r_nmod) flanked_32\VBN\2690708|that|is|residues (r_acl:relcl) oncoprotein_29\NN\1740|of|the|myc|flanked (l_compound) myc_28\NN\1740|
23177256T1_23177256T12 NONE arginine_34\NN\14605787| (r_compound) residues_35\NNS\20827|by|arginine (r_nmod) flanked_32\VBN\2690708|that|is|residues (r_acl:relcl) oncoprotein_29\NN\1740|of|the|myc|flanked (r_nmod) domain_25\NN\13934596|a|hydrophobic|oncoprotein (r_dobj) targets_22\VBZ\1151110|which|domain (r_acl:relcl) inhibitor_13\NN\20090|of|the|c-myc|10074-g5|-|targets (l_compound) c-myc_9\NN\1740|myc
23177256T1_23177256T15 NONE arginine_34\NN\14605787| (r_compound) residues_35\NNS\20827|by|arginine (r_nmod) flanked_32\VBN\2690708|that|is|residues (r_acl:relcl) oncoprotein_29\NN\1740|of|the|myc|flanked (r_nmod) domain_25\NN\13934596|a|hydrophobic|oncoprotein (r_dobj) targets_22\VBZ\1151110|which|domain (r_acl:relcl) inhibitor_13\NN\20090|of|the|c-myc|10074-g5|-|targets (l_compound) c-myc_9\NN\1740|myc (l_appos) myc_11\NN\1740|(|)
23177256T8_23177256T11 NONE 10074-g5_14\NN\1740|n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine (r_dep) inhibitor_13\NN\20090|of|the|c-myc|10074-g5|-|targets (l_acl:relcl) targets_22\VBZ\1151110|which|domain (l_dobj) domain_25\NN\13934596|a|hydrophobic|oncoprotein (l_nmod) oncoprotein_29\NN\1740|of|the|myc|flanked (l_compound) myc_28\NN\1740|
23177256T8_23177256T12 CPR:4 10074-g5_14\NN\1740|n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine (r_dep) inhibitor_13\NN\20090|of|the|c-myc|10074-g5|-|targets (l_compound) c-myc_9\NN\1740|myc
23177256T8_23177256T15 CPR:4 10074-g5_14\NN\1740|n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine (r_dep) inhibitor_13\NN\20090|of|the|c-myc|10074-g5|-|targets (l_compound) c-myc_9\NN\1740|myc (l_appos) myc_11\NN\1740|(|)
23177256T9_23177256T11 NONE n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine_16\NN\1740|(|,|1|) (r_dep) 10074-g5_14\NN\1740|n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine (r_dep) inhibitor_13\NN\20090|of|the|c-myc|10074-g5|-|targets (l_acl:relcl) targets_22\VBZ\1151110|which|domain (l_dobj) domain_25\NN\13934596|a|hydrophobic|oncoprotein (l_nmod) oncoprotein_29\NN\1740|of|the|myc|flanked (l_compound) myc_28\NN\1740|
23177256T9_23177256T12 CPR:4 n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine_16\NN\1740|(|,|1|) (r_dep) 10074-g5_14\NN\1740|n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine (r_dep) inhibitor_13\NN\20090|of|the|c-myc|10074-g5|-|targets (l_compound) c-myc_9\NN\1740|myc
23177256T9_23177256T15 CPR:4 n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine_16\NN\1740|(|,|1|) (r_dep) 10074-g5_14\NN\1740|n-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine (r_dep) inhibitor_13\NN\20090|of|the|c-myc|10074-g5|-|targets (l_compound) c-myc_9\NN\1740|myc (l_appos) myc_11\NN\1740|(|)
23177256T6_23177256T13 NONE 094_24\CD\1740| (r_nsubj) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_advcl) potent_4\JJ\1740|five|as|lead (l_nmod) lead_7\NN\5155821|as|the|ic(50|disruption (l_nmod) disruption_16\NN\1066163|for|heterodimer (l_nmod) heterodimer_20\NN\1740|of|the|myc-max (l_compound) myc-max_19\NN\1740|
23177256T6_23177256T14 NONE 094_24\CD\1740| (r_nsubj) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_advcl) potent_4\JJ\1740|five|as|lead (l_nmod) lead_7\NN\5155821|as|the|ic(50|disruption (l_nmod) disruption_16\NN\1066163|for|heterodimer (l_nmod) heterodimer_20\NN\1740|of|the|myc-max (l_compound) myc-max_19\NN\1740|
23177256T6_23177256T16 NONE 094_24\CD\1740| (r_nsubj) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_dobj) selectivity_27\NN\4916342|excellent|homodimers (l_nmod) homodimers_30\NNS\1740|over|max-max (l_compound) max-max_29\NN\1740|
23177256T6_23177256T17 NONE 094_24\CD\1740| (r_nsubj) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_dobj) selectivity_27\NN\4916342|excellent|homodimers (l_nmod) homodimers_30\NNS\1740|over|max-max (l_compound) max-max_29\NN\1740|
23177256T6_23177256T18 NONE 094_24\CD\1740| (r_nsubj) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_parataxis) improves_48\VBZ\126264|importantly|,|acid|properties|,|facilitate (l_dep) facilitate_59\VB\2547586|which|will|incorporation (l_dobj) incorporation_61\NN\1237415|the|hydrophobicity (l_nmod) hydrophobicity_64\NN\4916342|of|additional|enhance (l_acl:relcl) enhance_67\VB\227165|that|might|activity|further|still (l_dobj) activity_70\NN\30358|myc|inhibitory (l_compound) myc_68\NN\1740|
23177256T7_23177256T13 NONE 094_47\CD\1740| (r_nummod) acid_43\NN\14818238|the|carboxylic|jy-3|094 (r_nsubj) improves_48\VBZ\126264|importantly|,|acid|properties|,|facilitate (r_parataxis) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_advcl) potent_4\JJ\1740|five|as|lead (l_nmod) lead_7\NN\5155821|as|the|ic(50|disruption (l_nmod) disruption_16\NN\1066163|for|heterodimer (l_nmod) heterodimer_20\NN\1740|of|the|myc-max (l_compound) myc-max_19\NN\1740|
23177256T7_23177256T14 NONE 094_47\CD\1740| (r_nummod) acid_43\NN\14818238|the|carboxylic|jy-3|094 (r_nsubj) improves_48\VBZ\126264|importantly|,|acid|properties|,|facilitate (r_parataxis) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_advcl) potent_4\JJ\1740|five|as|lead (l_nmod) lead_7\NN\5155821|as|the|ic(50|disruption (l_nmod) disruption_16\NN\1066163|for|heterodimer (l_nmod) heterodimer_20\NN\1740|of|the|myc-max (l_compound) myc-max_19\NN\1740|
23177256T7_23177256T16 NONE 094_47\CD\1740| (r_nummod) acid_43\NN\14818238|the|carboxylic|jy-3|094 (r_nsubj) improves_48\VBZ\126264|importantly|,|acid|properties|,|facilitate (r_parataxis) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_dobj) selectivity_27\NN\4916342|excellent|homodimers (l_nmod) homodimers_30\NNS\1740|over|max-max (l_compound) max-max_29\NN\1740|
23177256T7_23177256T17 NONE 094_47\CD\1740| (r_nummod) acid_43\NN\14818238|the|carboxylic|jy-3|094 (r_nsubj) improves_48\VBZ\126264|importantly|,|acid|properties|,|facilitate (r_parataxis) demonstrated_25\VBD\2137132|potent|,|-|094|selectivity|,|effect|improves|. (l_dobj) selectivity_27\NN\4916342|excellent|homodimers (l_nmod) homodimers_30\NNS\1740|over|max-max (l_compound) max-max_29\NN\1740|
23177256T7_23177256T18 CPR:4 094_47\CD\1740| (r_nummod) acid_43\NN\14818238|the|carboxylic|jy-3|094 (r_nsubj) improves_48\VBZ\126264|importantly|,|acid|properties|,|facilitate (l_dep) facilitate_59\VB\2547586|which|will|incorporation (l_dobj) incorporation_61\NN\1237415|the|hydrophobicity (l_nmod) hydrophobicity_64\NN\4916342|of|additional|enhance (l_acl:relcl) enhance_67\VB\227165|that|might|activity|further|still (l_dobj) activity_70\NN\30358|myc|inhibitory (l_compound) myc_68\NN\1740|
16597615
16597615T4_16597615T8 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts
16597615T4_16597615T9 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (l_appos) cyp27b1_15\NN\1740|(|)
16597615T4_16597615T10 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (l_conj) kinase_19\NN\14732946|l-pyruvate|pklr
16597615T4_16597615T11 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (l_conj) kinase_19\NN\14732946|l-pyruvate|pklr (l_appos) pklr_21\NN\1740|(|)
16597615T4_16597615T12 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts
16597615T4_16597615T13 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts (l_appos) fn1_33\NN\1740|(|)
16597615T4_16597615T14 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts (l_conj) n-cadherin_36\NN\1740|cdh2
16597615T4_16597615T15 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts (l_conj) n-cadherin_36\NN\1740|cdh2 (l_appos) cdh2_38\NN\1740|(|)
16597615T4_16597615T16 NONE d_12\NN\15089472| (r_compound) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts (l_conj) transcripts_44\NNS\6362953|non-muscle-type|myosin (l_amod) myosin_43\NN\15022171|
16597615T5_16597615T8 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr (r_conj) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts
16597615T5_16597615T9 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr (r_conj) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (l_appos) cyp27b1_15\NN\1740|(|)
16597615T5_16597615T10 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr
16597615T5_16597615T11 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr (l_appos) pklr_21\NN\1740|(|)
16597615T5_16597615T12 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr (r_conj) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts
16597615T5_16597615T13 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr (r_conj) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts (l_appos) fn1_33\NN\1740|(|)
16597615T5_16597615T14 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr (r_conj) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts (l_conj) n-cadherin_36\NN\1740|cdh2
16597615T5_16597615T15 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr (r_conj) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts (l_conj) n-cadherin_36\NN\1740|cdh2 (l_appos) cdh2_38\NN\1740|(|)
16597615T5_16597615T16 NONE l-pyruvate_18\NN\1740| (r_compound) kinase_19\NN\14732946|l-pyruvate|pklr (r_conj) 1-hydroxylase_13\NN\1740|25-hydroxyvitamin|d|cyp27b1|and|kinase|,|transcripts (r_dep) transcripts_10\NNS\6362953|of|the|proximal|tubule-specific|1-hydroxylase|fibronectin (l_nmod) fibronectin_31\NN\1740|such|fn1|and|n-cadherin|,|and|transcripts (l_conj) transcripts_44\NNS\6362953|non-muscle-type|myosin (l_amod) myosin_43\NN\15022171|
16597615T1_16597615T6 NONE phosphate_22\NN\15010703| (r_compound) synthesis_23\NN\13446390|in|creatine|phosphate|and|transport|slc16a7 (r_nmod) involved_19\VBN\2676054|synthesis (r_acl) others_18\NNS\1740|involved (r_conj) those_12\DT\1740|myosins|,|and|others (l_nmod) myosins_15\NNS\15022171|of|muscle-type
16597615T1_16597615T7 NONE phosphate_22\NN\15010703| (r_compound) synthesis_23\NN\13446390|in|creatine|phosphate|and|transport|slc16a7 (l_appos) slc16a7_28\NN\1740|(|)
23643730
23643730T19_23643730T28 CPR:4 juglone_0\NN\1740|,|isolated|, (r_nsubj) induces_8\VBZ\1627355|juglone|apoptosis|down-regulation|. (l_nmod) down-regulation_11\NN\1740|via|expression (l_nmod) expression_14\NN\4679549|of|ar|cells (l_compound) ar_13\NN\14622893|
23643730T2_23643730T20 CPR:4 juglone_5\NN\1740| (r_nsubj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen
23643730T2_23643730T21 CPR:4 juglone_5\NN\1740| (r_nsubj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_appos) ar_15\NN\14622893|(|)
23643730T2_23643730T22 CPR:4 juglone_5\NN\1740| (r_nsubj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_conj) antigen_19\NN\20090|prostate-specific|psa
23643730T2_23643730T23 CPR:4 juglone_5\NN\1740| (r_nsubj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_conj) antigen_19\NN\20090|prostate-specific|psa (l_appos) psa_21\NN\14728724|(|)
23643730T2_23643730T24 CPR:4 juglone_5\NN\1740| (r_nsubj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_conj) abrogated_31\VBD\2427334|up-regulation (l_dobj) up-regulation_32\NN\1740|genes|dihydrotestosterone (l_nmod) genes_37\NNS\8459252|of|ar (l_compound) ar_34\NN\14622893|and|psa
23643730T2_23643730T25 CPR:4 juglone_5\NN\1740| (r_nsubj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_conj) abrogated_31\VBD\2427334|up-regulation (l_dobj) up-regulation_32\NN\1740|genes|dihydrotestosterone (l_nmod) genes_37\NNS\8459252|of|ar (l_compound) ar_34\NN\14622893|and|psa (l_conj) psa_36\NN\14728724|
23643730T3_23643730T20 NONE androgen_12\NN\14745635| (r_compound) receptor_13\NN\5225602|of|androgen|ar|and|antigen
23643730T3_23643730T21 NONE androgen_12\NN\14745635| (r_compound) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_appos) ar_15\NN\14622893|(|)
23643730T3_23643730T22 NONE androgen_12\NN\14745635| (r_compound) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_conj) antigen_19\NN\20090|prostate-specific|psa
23643730T3_23643730T23 NONE androgen_12\NN\14745635| (r_compound) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_conj) antigen_19\NN\20090|prostate-specific|psa (l_appos) psa_21\NN\14728724|(|)
23643730T3_23643730T24 NONE androgen_12\NN\14745635| (r_compound) receptor_13\NN\5225602|of|androgen|ar|and|antigen (r_nmod) levels_10\NNS\4916342|the|expression|receptor (r_dobj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_conj) abrogated_31\VBD\2427334|up-regulation (l_dobj) up-regulation_32\NN\1740|genes|dihydrotestosterone (l_nmod) genes_37\NNS\8459252|of|ar (l_compound) ar_34\NN\14622893|and|psa
23643730T3_23643730T25 NONE androgen_12\NN\14745635| (r_compound) receptor_13\NN\5225602|of|androgen|ar|and|antigen (r_nmod) levels_10\NNS\4916342|the|expression|receptor (r_dobj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_conj) abrogated_31\VBD\2427334|up-regulation (l_dobj) up-regulation_32\NN\1740|genes|dihydrotestosterone (l_nmod) genes_37\NNS\8459252|of|ar (l_compound) ar_34\NN\14622893|and|psa (l_conj) psa_36\NN\14728724|
23643730T5_23643730T20 NONE dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (r_dobj) abrogated_31\VBD\2427334|up-regulation (r_conj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen
23643730T5_23643730T21 NONE dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (r_dobj) abrogated_31\VBD\2427334|up-regulation (r_conj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_appos) ar_15\NN\14622893|(|)
23643730T5_23643730T22 NONE dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (r_dobj) abrogated_31\VBD\2427334|up-regulation (r_conj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_conj) antigen_19\NN\20090|prostate-specific|psa
23643730T5_23643730T23 NONE dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (r_dobj) abrogated_31\VBD\2427334|up-regulation (r_conj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_conj) antigen_19\NN\20090|prostate-specific|psa (l_appos) psa_21\NN\14728724|(|)
23643730T5_23643730T24 NONE dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (l_nmod) genes_37\NNS\8459252|of|ar (l_compound) ar_34\NN\14622893|and|psa
23643730T5_23643730T25 NONE dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (l_nmod) genes_37\NNS\8459252|of|ar (l_compound) ar_34\NN\14622893|and|psa (l_conj) psa_36\NN\14728724|
23643730T6_23643730T20 NONE dht_43\NN\1740|(|) (r_appos) dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (r_dobj) abrogated_31\VBD\2427334|up-regulation (r_conj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen
23643730T6_23643730T21 NONE dht_43\NN\1740|(|) (r_appos) dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (r_dobj) abrogated_31\VBD\2427334|up-regulation (r_conj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_appos) ar_15\NN\14622893|(|)
23643730T6_23643730T22 NONE dht_43\NN\1740|(|) (r_appos) dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (r_dobj) abrogated_31\VBD\2427334|up-regulation (r_conj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_conj) antigen_19\NN\20090|prostate-specific|psa
23643730T6_23643730T23 NONE dht_43\NN\1740|(|) (r_appos) dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (r_dobj) abrogated_31\VBD\2427334|up-regulation (r_conj) inhibited_7\VBD\2510337|that|juglone|significantly|levels|manner|,|as|abrogated (l_dobj) levels_10\NNS\4916342|the|expression|receptor (l_nmod) receptor_13\NN\5225602|of|androgen|ar|and|antigen (l_conj) antigen_19\NN\20090|prostate-specific|psa (l_appos) psa_21\NN\14728724|(|)
23643730T6_23643730T24 NONE dht_43\NN\1740|(|) (r_appos) dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (l_nmod) genes_37\NNS\8459252|of|ar (l_compound) ar_34\NN\14622893|and|psa
23643730T6_23643730T25 NONE dht_43\NN\1740|(|) (r_appos) dihydrotestosterone_41\NN\1740|with|without|dht (r_nmod) up-regulation_32\NN\1740|genes|dihydrotestosterone (l_nmod) genes_37\NNS\8459252|of|ar (l_compound) ar_34\NN\14622893|and|psa (l_conj) psa_36\NN\14728724|
23643730T7_23643730T26 CPR:4 juglone_7\NN\1740| (r_nsubj) induce_9\VB\1627355|that|juglone|might|apoptosis|down-regulation (l_nmod) down-regulation_16\NN\1740|via|expression (l_nmod) expression_19\NN\4679549|of|ar (l_compound) ar_18\NN\14622893|
17360707
17360707T3_17360707T5 NONE acetylcholine_13\NN\14807558| (r_compound) receptor_14\NN\5225602|brain|alpha7|nicotinic|acetylcholine|nachr (l_appos) nachr_17\NN\1740|(|alpha7|)
17360707T3_17360707T15 NONE acetylcholine_13\NN\14807558| (r_compound) receptor_14\NN\5225602|brain|alpha7|nicotinic|acetylcholine|nachr
17360707T2_17360707T8 NONE nicotine-induced_15\JJ\1740| (r_amod) seizures_16\NNS\14081375|to|nicotine-induced|and|gating (r_nmod) sensitivity_13\NN\5651971|with|animal|seizures (r_nmod) correlate_8\VB\2657219|to|sensitivity (r_xcomp) shown_6\VBN\2137132|variations|have|been|correlate|. (l_nsubjpass) variations_0\NNS\7296428|binding (l_nmod) binding_3\NN\4688246|in|alpha-bungarotoxin (l_compound) alpha-bungarotoxin_2\NN\1740|
16809928
16809928T8_16809928T24 NONE somatostatin_5\NN\1740| (r_compound) subtypes_7\NNS\1740|of|somatostatin|receptor (l_compound) receptor_6\NN\5225602|
16809928T3_16809928T9 NONE somatostatin_9\NN\1740| (r_compound) receptor_10\NN\5225602|somatostatin|sstr
16809928T3_16809928T10 NONE somatostatin_9\NN\1740| (r_compound) receptor_10\NN\5225602|somatostatin|sstr (l_appos) sstr_12\NN\1740|(|)
16809928T3_16809928T11 NONE somatostatin_9\NN\1740| (r_compound) receptor_10\NN\5225602|somatostatin|sstr (r_compound) density_14\NN\4941325|of|receptor (r_nmod) reduction_7\NN\351485|to|an|overall|density|or|expression (l_conj) expression_19\NN\4679549|to|a|differentiated|subtypes (l_nmod) subtypes_22\NNS\1740|of|sstr (l_compound) sstr_21\NN\1740|
16809928T4_16809928T13 NONE octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (r_conj) expressed_5\VBN\928630|sstr2|are|usually|tumors|,|and|bind (l_nsubjpass) sstr2_0\NN\1740|and|sstr5
16809928T4_16809928T14 NONE octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (r_conj) expressed_5\VBN\928630|sstr2|are|usually|tumors|,|and|bind (l_nsubjpass) sstr2_0\NN\1740|and|sstr5 (l_conj) sstr5_2\NN\1740|
16809928T4_16809928T15 NONE octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (r_conj) expressed_5\VBN\928630|sstr2|are|usually|tumors|,|and|bind (l_nmod) tumors_9\NNS\14234074|in|gh-secreting|pituitary (l_amod) gh-secreting_7\JJ\1740|
16809928T4_16809928T16 NONE octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (l_nmod) sstr2_19\NN\1740|to|and|sstr5
16809928T4_16809928T17 NONE octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (l_nmod) sstr2_19\NN\1740|to|and|sstr5 (l_conj) sstr5_28\NN\1740|,|extent|,|to
16809928T5_16809928T13 NONE lanreotide_15\NN\1740| (r_conj) octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (r_conj) expressed_5\VBN\928630|sstr2|are|usually|tumors|,|and|bind (l_nsubjpass) sstr2_0\NN\1740|and|sstr5
16809928T5_16809928T14 NONE lanreotide_15\NN\1740| (r_conj) octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (r_conj) expressed_5\VBN\928630|sstr2|are|usually|tumors|,|and|bind (l_nsubjpass) sstr2_0\NN\1740|and|sstr5 (l_conj) sstr5_2\NN\1740|
16809928T5_16809928T15 NONE lanreotide_15\NN\1740| (r_conj) octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (r_conj) expressed_5\VBN\928630|sstr2|are|usually|tumors|,|and|bind (l_nmod) tumors_9\NNS\14234074|in|gh-secreting|pituitary (l_amod) gh-secreting_7\JJ\1740|
16809928T5_16809928T16 NONE lanreotide_15\NN\1740| (r_conj) octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (l_nmod) sstr2_19\NN\1740|to|and|sstr5
16809928T5_16809928T17 NONE lanreotide_15\NN\1740| (r_conj) octreotide_13\NN\1740|both|and|lanreotide (r_nsubj) bind_16\VBP\1290422|octreotide|preferentially|sstr2|. (l_nmod) sstr2_19\NN\1740|to|and|sstr5 (l_conj) sstr5_28\NN\1740|,|extent|,|to
16809928T6_16809928T20 NONE somatostatin_4\NN\1740| (r_compound) analogs_6\NNS\4743605|of|specific|somatostatin|subtypes|,|sstr5 (l_nmod) sstr5_10\NN\1740|mainly|for|,|compound|,|and|analog
16809928T6_16809928T21 NONE somatostatin_4\NN\1740| (r_compound) analogs_6\NNS\4743605|of|specific|somatostatin|subtypes|,|sstr5 (l_nmod) sstr5_10\NN\1740|mainly|for|,|compound|,|and|analog (l_conj) compound_16\NN\5869584|of|a|sstr2-sstr5|bispecific (l_compound) sstr2-sstr5_14\NN\1740|
16809928T6_16809928T22 NONE somatostatin_4\NN\1740| (r_compound) analogs_6\NNS\4743605|of|specific|somatostatin|subtypes|,|sstr5 (l_nmod) sstr5_10\NN\1740|mainly|for|,|compound|,|and|analog (l_conj) compound_16\NN\5869584|of|a|sstr2-sstr5|bispecific (l_compound) sstr2-sstr5_14\NN\1740|
16809928T6_16809928T23 NONE somatostatin_4\NN\1740| (r_compound) analogs_6\NNS\4743605|of|specific|somatostatin|subtypes|,|sstr5 (l_nmod) sstr5_10\NN\1740|mainly|for|,|compound|,|and|analog (l_conj) analog_24\NN\4743605|of|a|universal|"|affinity (l_nmod) affinity_27\NN\11426530|with|high|sstr1 (l_nmod) sstr1_29\NN\1740|to|,|2|,|3|,|and|5 (l_conj) 5_36\CD\13741022|
23454149
23454149T13_23454149T22 CPR:4 dmbt_6\NN\1740|by (r_nmod) inhibition_0\NN\1068773|angiogenesis|dmbt (r_nsubjpass) mediated_8\VBN\761713|inhibition|is|downregulation|. (l_nmod) downregulation_10\NN\1740|by|vegf|pathway (l_nmod) pathway_17\NN\5483677|through|akt|cells (l_compound) akt_16\NN\1740|
23454149T13_23454149T23 CPR:4 dmbt_6\NN\1740|by (r_nmod) inhibition_0\NN\1068773|angiogenesis|dmbt (r_nsubjpass) mediated_8\VBN\761713|inhibition|is|downregulation|. (l_nmod) downregulation_10\NN\1740|by|vegf|pathway (l_nmod) vegf_12\NN\1740|of|and|mmp-9
23454149T13_23454149T24 CPR:4 dmbt_6\NN\1740|by (r_nmod) inhibition_0\NN\1068773|angiogenesis|dmbt (r_nsubjpass) mediated_8\VBN\761713|inhibition|is|downregulation|. (l_nmod) downregulation_10\NN\1740|by|vegf|pathway (l_nmod) vegf_12\NN\1740|of|and|mmp-9 (l_conj) mmp-9_14\NN\1740|
23454149T11_23454149T17 CPR:4 dmbt_4\NN\1740| (r_nsubj) inhibited_5\VBD\2510337|that|dmbt|secretion (l_dobj) secretion_6\NN\13526110|and|activity|mmp-9 (l_nmod) mmp-9_10\NN\1740|of
23454149T12_23454149T18 CPR:4 dmbt_4\NN\1740| (r_nsubj) suppressed_6\VBD\2510337|that|dmbt|effectively|expression (l_dobj) expression_8\NN\4679549|the|vegf (l_nmod) vegf_10\NN\1740|of|,|p-vegfr-2|,|p-egfr|,|and|p-akt
23454149T12_23454149T19 CPR:4 dmbt_4\NN\1740| (r_nsubj) suppressed_6\VBD\2510337|that|dmbt|effectively|expression (l_dobj) expression_8\NN\4679549|the|vegf (l_nmod) vegf_10\NN\1740|of|,|p-vegfr-2|,|p-egfr|,|and|p-akt (l_conj) p-vegfr-2_12\NN\1740|
23454149T12_23454149T20 CPR:4 dmbt_4\NN\1740| (r_nsubj) suppressed_6\VBD\2510337|that|dmbt|effectively|expression (l_dobj) expression_8\NN\4679549|the|vegf (l_nmod) vegf_10\NN\1740|of|,|p-vegfr-2|,|p-egfr|,|and|p-akt (l_conj) p-egfr_14\NN\1740|
23454149T12_23454149T21 CPR:4 dmbt_4\NN\1740| (r_nsubj) suppressed_6\VBD\2510337|that|dmbt|effectively|expression (l_dobj) expression_8\NN\4679549|the|vegf (l_nmod) vegf_10\NN\1740|of|,|p-vegfr-2|,|p-egfr|,|and|p-akt (l_conj) p-akt_17\NN\1740|
23454149T1_23454149T14 CPR:4 dmbt_4\NN\1740| (r_nsubj) inhibit_6\VB\2510337|that|dmbt|could|invasion|downregulation|,|resulting (l_nmod) downregulation_11\NN\1740|by|vegfand|mmp-9 (l_nmod) vegfand_13\NN\1740|of
23454149T1_23454149T15 CPR:4 dmbt_4\NN\1740| (r_nsubj) inhibit_6\VB\2510337|that|dmbt|could|invasion|downregulation|,|resulting (l_nmod) downregulation_11\NN\1740|by|vegfand|mmp-9 (l_conj) mmp-9_14\NN\1740|
23454149T1_23454149T16 CPR:4 dmbt_4\NN\1740| (r_nsubj) inhibit_6\VB\2510337|that|dmbt|could|invasion|downregulation|,|resulting (l_advcl) resulting_16\VBG\2633881|inhibition (l_nmod) inhibition_19\NN\1068773|from|the|pathway (l_nmod) pathway_22\NN\5483677|of|akt (l_compound) akt_21\NN\1740|
7959748
7959748T1_7959748T4 NONE morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (r_nmod) drugs_13\NNS\14778436|of|opioid|,|morphine (r_nmod) effect_10\NN\34213|the|pain-relieving|drugs (r_dobj) mediate_7\VBP\761713|that|effect (r_acl:relcl) proteins_5\NNS\14944888|receptors|are|the|membrane|mediate|. (l_nsubj) receptors_1\NNS\5225602|opioid
7959748T1_7959748T5 NONE morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (l_conj) enkephalins_26\NNS\14809057|peptides|and|endorphins (l_compound) peptides_25\NNS\14724264|endogenous|opioid
7959748T1_7959748T6 NONE morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (l_conj) enkephalins_26\NNS\14809057|peptides|and|endorphins
7959748T1_7959748T7 NONE morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (l_conj) enkephalins_26\NNS\14809057|peptides|and|endorphins (l_conj) endorphins_28\NNS\14807410|
7959748T2_7959748T4 NONE fentanyl_19\NN\2707683| (r_conj) morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (r_nmod) drugs_13\NNS\14778436|of|opioid|,|morphine (r_nmod) effect_10\NN\34213|the|pain-relieving|drugs (r_dobj) mediate_7\VBP\761713|that|effect (r_acl:relcl) proteins_5\NNS\14944888|receptors|are|the|membrane|mediate|. (l_nsubj) receptors_1\NNS\5225602|opioid
7959748T2_7959748T5 NONE fentanyl_19\NN\2707683| (r_conj) morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (l_conj) enkephalins_26\NNS\14809057|peptides|and|endorphins (l_compound) peptides_25\NNS\14724264|endogenous|opioid
7959748T2_7959748T6 NONE fentanyl_19\NN\2707683| (r_conj) morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (l_conj) enkephalins_26\NNS\14809057|peptides|and|endorphins
7959748T2_7959748T7 NONE fentanyl_19\NN\2707683| (r_conj) morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (l_conj) enkephalins_26\NNS\14809057|peptides|and|endorphins (l_conj) endorphins_28\NNS\14807410|
7959748T3_7959748T4 NONE enkephalins_26\NNS\14809057|peptides|and|endorphins (r_conj) morphine_17\NN\2707683|such|and|fentanyl|as|enkephalins (r_nmod) drugs_13\NNS\14778436|of|opioid|,|morphine (r_nmod) effect_10\NN\34213|the|pain-relieving|drugs (r_dobj) mediate_7\VBP\761713|that|effect (r_acl:relcl) proteins_5\NNS\14944888|receptors|are|the|membrane|mediate|. (l_nsubj) receptors_1\NNS\5225602|opioid
7959748T3_7959748T5 NONE enkephalins_26\NNS\14809057|peptides|and|endorphins (l_compound) peptides_25\NNS\14724264|endogenous|opioid
7959748T3_7959748T6 NONE enkephalins_26\NNS\14809057|peptides|and|endorphins
7959748T3_7959748T7 NONE enkephalins_26\NNS\14809057|peptides|and|endorphins (l_conj) endorphins_28\NNS\14807410|
15561973
15561973T32_15561973T41 NONE sodium_6\NN\14625458| (r_compound) cotransporter_8\NN\1740|of|the|human|renal|sodium|dicarboxylate|,|hnadc-3
15561973T32_15561973T42 NONE sodium_6\NN\14625458| (r_compound) cotransporter_8\NN\1740|of|the|human|renal|sodium|dicarboxylate|,|hnadc-3 (l_appos) hnadc-3_10\NN\1740|
15561973T6_15561973T33 NONE sodium_18\NN\14625458| (r_compound) cotransporter_20\NN\1740|[|sodium|dicarboxylate|nadc-1|]
15561973T6_15561973T35 NONE sodium_18\NN\14625458| (r_compound) cotransporter_20\NN\1740|[|sodium|dicarboxylate|nadc-1|] (l_appos) nadc-1_22\NN\1740|(|)
15561973T6_15561973T38 NONE sodium_18\NN\14625458| (r_compound) cotransporter_20\NN\1740|[|sodium|dicarboxylate|nadc-1|] (r_dep) border_16\NN\8512259|in|the|brush|cotransporter|and|membrane (l_conj) membrane_28\NN\4188643|basolateral|cell|nadc-3 (l_appos) nadc-3_30\NN\1740|(|)
15561973T7_15561973T34 CPR:4 lithium_14\NN\14625458| (r_compound) concentrations_15\NNS\4916342|by|lithium (r_nmod) inhibited_12\VBN\2510337|opposed|,|hnadc-3|was|hardly|concentrations|mm. (l_nsubjpass) hnadc-3_9\NNP\1740|
15561973T11_15561973T36 NONE alpha-ketoglutarate_23\NN\1740|with (r_nmod) support_16\NN\407535|sufficient|cells|alpha-ketoglutarate|secretion (r_dobj) ensures_14\VBZ\664483|support (r_conj) prevents_4\VBZ\1740|specificity|interaction|and|ensures|. (l_dobj) interaction_5\NN\37396|drugs|structure|hnadc-3 (l_nmod) hnadc-3_12\NN\1740|with
15561973T11_15561973T37 NONE alpha-ketoglutarate_23\NN\1740|with (r_nmod) support_16\NN\407535|sufficient|cells|alpha-ketoglutarate|secretion (l_nmod) secretion_26\NN\13526110|for|anion|transporter (l_nmod) transporter_30\NN\4490091|via|organic|anion|1 (l_dep) 1_31\CD\13741022|or|3 (l_conj) 3_33\CD\13741022|
20624440
20624440T12_20624440T20 NONE rasagiline_0\NN\1740| (r_nsubj) protects_1\VBZ\1127795|rasagiline|sensitivity|. (l_nmod) sensitivity_5\NN\5651971|against|induced|stress|cells (l_amod) induced_4\JJ\1740|alpha-synuclein (l_nmod:npmod) alpha-synuclein_3\NN\1740|
20624440T1_20624440T16 CPR:4 rasagiline_0\NN\1740| (r_nsubj) inhibitor_12\NN\20090|rasagiline|is|a|propargylamine|irreversible|b|used (l_compound) b_11\NN\1355326|oxidase|(|mao|)
20624440T6_20624440T16 CPR:4 propargylamine_3\NN\1740|and (r_compound) inhibitor_12\NN\20090|rasagiline|is|a|propargylamine|irreversible|b|used (l_compound) b_11\NN\1355326|oxidase|(|mao|)
20624440T7_20624440T16 NONE monoamine_6\NN\14739004| (r_compound) oxidase_7\NN\14732946|monoamine (r_compound) b_11\NN\1355326|oxidase|(|mao|)
20624440T8_20624440T15 NONE rasagiline_34\NN\1740| (r_compound) protection_35\NN\407535|rasagiline (r_dobj) mediate_33\VBP\761713|that|protection (r_acl:relcl) mechanisms_31\NNS\13446390|the|potential|molecular|mediate (r_dobj) investigate_27\VB\644583|in|to|mechanisms (r_advcl) provide_18\VB\2199590|to|model|investigate (r_advcl) used_2\VBN\1156834|we|have|combination|provide|. (l_dobj) combination_4\NN\7951464|a|alpha-synuclein (l_nmod) alpha-synuclein_6\NN\1740|of|and|toxicity|line
20624440T9_20624440T17 NONE rasagiline_3\NN\1740| (r_nsubj) protects_4\VBZ\1127795|that|rasagiline|death (l_nmod) death_7\NN\7296428|against|cell|induced (l_acl) induced_8\VBN\1627355|combination (l_nmod) combination_11\NN\7951464|by|the|radicals (l_nmod) radicals_14\NNS\9465459|of|free|generated|and|wild-type (l_conj) wild-type_20\JJ\1740|either|or|over-expression (l_conj) over-expression_26\NN\1740|a53|t|mutant|alpha-synuclein (l_compound) t_23\NN\14999913|
20624440T9_20624440T18 NONE rasagiline_3\NN\1740| (r_nsubj) protects_4\VBZ\1127795|that|rasagiline|death (l_nmod) death_7\NN\7296428|against|cell|induced (l_acl) induced_8\VBN\1627355|combination (l_nmod) combination_11\NN\7951464|by|the|radicals (l_nmod) radicals_14\NNS\9465459|of|free|generated|and|wild-type (l_conj) wild-type_20\JJ\1740|either|or|over-expression (l_conj) over-expression_26\NN\1740|a53|t|mutant|alpha-synuclein (l_compound) alpha-synuclein_25\NN\1740|
20624440T10_20624440T17 NONE paraquat_17\NN\14906850|by (r_nmod) generated_15\VBN\1617192|paraquat (r_acl) radicals_14\NNS\9465459|of|free|generated|and|wild-type (l_conj) wild-type_20\JJ\1740|either|or|over-expression (l_conj) over-expression_26\NN\1740|a53|t|mutant|alpha-synuclein (l_compound) t_23\NN\14999913|
20624440T10_20624440T18 NONE paraquat_17\NN\14906850|by (r_nmod) generated_15\VBN\1617192|paraquat (r_acl) radicals_14\NNS\9465459|of|free|generated|and|wild-type (l_conj) wild-type_20\JJ\1740|either|or|over-expression (l_conj) over-expression_26\NN\1740|a53|t|mutant|alpha-synuclein (l_compound) alpha-synuclein_25\NN\1740|
20624440T11_20624440T19 NONE superoxide_15\NN\14971519| (r_compound) generation_16\NN\7942152|in|superoxide (r_nmod) reduction_13\NN\351485|a|generation (r_conj) reduction_6\NN\351485|with|a|activation|,|reduction|and|trend (l_nmod) activation_10\NN\13561719|in|caspase|3 (l_nummod) 3_9\CD\13741022|
20624440T4_20624440T13 NONE rasagiline_6\NN\1740|for (r_nmod) role_4\NN\719494|a|rasagiline|protecting (l_acl) protecting_8\VBG\1127795|in|cells|damage|presence (l_nmod) presence_20\NN\13954253|in|the|over-expression (l_nmod) over-expression_23\NN\1740|of|alpha-synuclein (l_compound) alpha-synuclein_22\NN\1740|
23616352
23616352T3_23616352T4 NONE atp_9\NN\14964590| (r_compound) structure_12\NN\21939|of|the|atp|binding|pocket|kinases (l_nmod) kinases_17\NNS\14732946|of|pim|family|protein|pks (l_appos) pks_19\NNS\1740|(|)
23616352T3_23616352T10 NONE atp_9\NN\14964590| (r_compound) structure_12\NN\21939|of|the|atp|binding|pocket|kinases (l_nmod) kinases_17\NNS\14732946|of|pim|family|protein|pks (l_compound) pim_14\NN\1740|
23616352T3_23616352T11 NONE atp_9\NN\14964590| (r_compound) structure_12\NN\21939|of|the|atp|binding|pocket|kinases (l_nmod) kinases_17\NNS\14732946|of|pim|family|protein|pks
23616352T1_23616352T5 NONE arginine-rich_2\JJ\1740| (r_amod) peptides_3\NNS\14724264|of|arginine-rich (r_nmod) conjugates_0\NNS\14589223|peptides|scaffolds (r_nsubjpass) synthesized_10\VBN\193486|conjugates|were|and|tested|. (l_conj) tested_12\VBN\670261|inhibitors (l_nmod) inhibitors_14\NNS\20090|as|pim-1 (l_nmod) pim-1_16\NN\1740|of
23616352T2_23616352T5 NONE atp_6\NN\14964590| (r_compound) scaffolds_8\NNS\3961939|with|two|atp|mimetic (r_nmod) conjugates_0\NNS\14589223|peptides|scaffolds (r_nsubjpass) synthesized_10\VBN\193486|conjugates|were|and|tested|. (l_conj) tested_12\VBN\670261|inhibitors (l_nmod) inhibitors_14\NNS\20090|as|pim-1 (l_nmod) pim-1_16\NN\1740|of
1705137
1705137T43_1705137T51 CPR:4 moclobemide_15\NN\1740|and|toloxatone (r_dep) inhibitors_14\NNS\20090|of|two|reversible|monoamine|oxidase-a|moclobemide (r_nmod) properties_6\NNS\32613|of|the|oxidase|inhibiting|inhibitors (l_compound) oxidase_4\NN\14732946|monoamine
1705137T43_1705137T52 CPR:4 moclobemide_15\NN\1740|and|toloxatone (r_dep) inhibitors_14\NNS\20090|of|two|reversible|monoamine|oxidase-a|moclobemide (l_compound) oxidase-a_13\NN\1740|
1705137T44_1705137T51 CPR:4 toloxatone_17\NN\1740| (r_conj) moclobemide_15\NN\1740|and|toloxatone (r_dep) inhibitors_14\NNS\20090|of|two|reversible|monoamine|oxidase-a|moclobemide (r_nmod) properties_6\NNS\32613|of|the|oxidase|inhibiting|inhibitors (l_compound) oxidase_4\NN\14732946|monoamine
1705137T44_1705137T52 CPR:4 toloxatone_17\NN\1740| (r_conj) moclobemide_15\NN\1740|and|toloxatone (r_dep) inhibitors_14\NNS\20090|of|two|reversible|monoamine|oxidase-a|moclobemide (l_compound) oxidase-a_13\NN\1740|
1705137T45_1705137T51 NONE monoamine_3\NN\14739004| (r_compound) oxidase_4\NN\14732946|monoamine
1705137T45_1705137T52 NONE monoamine_3\NN\14739004| (r_compound) oxidase_4\NN\14732946|monoamine (r_compound) properties_6\NNS\32613|of|the|oxidase|inhibiting|inhibitors (l_nmod) inhibitors_14\NNS\20090|of|two|reversible|monoamine|oxidase-a|moclobemide (l_compound) oxidase-a_13\NN\1740|
1705137T46_1705137T51 NONE monoamine_12\NN\14739004| (r_compound) inhibitors_14\NNS\20090|of|two|reversible|monoamine|oxidase-a|moclobemide (r_nmod) properties_6\NNS\32613|of|the|oxidase|inhibiting|inhibitors (l_compound) oxidase_4\NN\14732946|monoamine
1705137T46_1705137T52 NONE monoamine_12\NN\14739004| (r_compound) inhibitors_14\NNS\20090|of|two|reversible|monoamine|oxidase-a|moclobemide (l_compound) oxidase-a_13\NN\1740|
1705137T9_1705137T48 CPR:4 toloxatone_25\NN\1740|day-1|) (r_conj) moclobemide_16\NN\1740|mg|times|)|and|toloxatone (r_conj) inhibitors_14\NNS\20090|of|two|reversible|,|predominantly|oxidase-a|,|moclobemide (l_compound) oxidase-a_10\NN\1740|monoamine|mao-a
1705137T9_1705137T49 NONE toloxatone_25\NN\1740|day-1|) (r_conj) moclobemide_16\NN\1740|mg|times|)|and|toloxatone (r_conj) inhibitors_14\NNS\20090|of|two|reversible|,|predominantly|oxidase-a|,|moclobemide (l_compound) oxidase-a_10\NN\1740|monoamine|mao-a (l_appos) mao-a_12\NN\1740|(|)
1705137T19_1705137T48 NONE monoamine_36\NN\14739004| (r_compound) metabolites_37\NNS\20090|on|monoamine|and|performance (r_nmod) effects_3\NNS\13245626|the|inhibitors|metabolites (l_nmod) inhibitors_14\NNS\20090|of|two|reversible|,|predominantly|oxidase-a|,|moclobemide (l_compound) oxidase-a_10\NN\1740|monoamine|mao-a
1705137T19_1705137T49 NONE monoamine_36\NN\14739004| (r_compound) metabolites_37\NNS\20090|on|monoamine|and|performance (r_nmod) effects_3\NNS\13245626|the|inhibitors|metabolites (l_nmod) inhibitors_14\NNS\20090|of|two|reversible|,|predominantly|oxidase-a|,|moclobemide (l_compound) oxidase-a_10\NN\1740|monoamine|mao-a (l_appos) mao-a_12\NN\1740|(|)
1705137T31_1705137T48 NONE monoamine_9\NN\14739004| (r_compound) oxidase-a_10\NN\1740|monoamine|mao-a
1705137T31_1705137T49 NONE monoamine_9\NN\14739004| (r_compound) oxidase-a_10\NN\1740|monoamine|mao-a (l_appos) mao-a_12\NN\1740|(|)
1705137T41_1705137T48 CPR:4 moclobemide_16\NN\1740|mg|times|)|and|toloxatone (r_conj) inhibitors_14\NNS\20090|of|two|reversible|,|predominantly|oxidase-a|,|moclobemide (l_compound) oxidase-a_10\NN\1740|monoamine|mao-a
1705137T41_1705137T49 NONE moclobemide_16\NN\1740|mg|times|)|and|toloxatone (r_conj) inhibitors_14\NNS\20090|of|two|reversible|,|predominantly|oxidase-a|,|moclobemide (l_compound) oxidase-a_10\NN\1740|monoamine|mao-a (l_appos) mao-a_12\NN\1740|(|)
1705137T1_1705137T50 NONE dhpg_16\NN\1740|of|and|hva (r_nmod) concentration_14\NN\4916342|the|plasma|dhpg (r_dobj) decreased_11\VBD\169651|compared|,|inhibitors|concentration|. (l_nsubj) inhibitors_10\NNS\20090|both|reversible|monoamine|oxidase (l_compound) oxidase_9\NN\14732946|
1705137T2_1705137T50 NONE hva_18\NN\1740| (r_conj) dhpg_16\NN\1740|of|and|hva (r_nmod) concentration_14\NN\4916342|the|plasma|dhpg (r_dobj) decreased_11\VBD\169651|compared|,|inhibitors|concentration|. (l_nsubj) inhibitors_10\NNS\20090|both|reversible|monoamine|oxidase (l_compound) oxidase_9\NN\14732946|
1705137T42_1705137T50 NONE monoamine_8\NN\14739004| (r_compound) inhibitors_10\NNS\20090|both|reversible|monoamine|oxidase (l_compound) oxidase_9\NN\14732946|
1705137T10_1705137T47 NONE dhpg_18\NN\1740| (r_compound) concentration_19\NN\4916342|of|plasma|dhpg (r_nmod) decrease_15\NN\7296428|by|the|concentration (r_nmod) judged_12\VBN\698855|as|decrease (r_advcl) different_23\JJ\1740|4|intake|,|inhibition|judged|,|was|significantly|placebo|moclobemide|. (l_nsubj) inhibition_9\NN\1068773|mao-a|, (l_compound) mao-a_8\NN\1740|
1705137T11_1705137T47 CPR:4 moclobemide_27\NN\1740|with|but|toloxatone (r_nmod) different_23\JJ\1740|4|intake|,|inhibition|judged|,|was|significantly|placebo|moclobemide|. (l_nsubj) inhibition_9\NN\1068773|mao-a|, (l_compound) mao-a_8\NN\1740|
1705137T12_1705137T47 CPR:4 toloxatone_31\NN\1740|not|with (r_conj) moclobemide_27\NN\1740|with|but|toloxatone (r_nmod) different_23\JJ\1740|4|intake|,|inhibition|judged|,|was|significantly|placebo|moclobemide|. (l_nsubj) inhibition_9\NN\1068773|mao-a|, (l_compound) mao-a_8\NN\1740|
15805193
15805193T5_15805193T14 NONE sodium_7\NN\14625458| (r_compound) channel_8\NN\6251781|of|the|sodium
15805193T5_15805193T15 NONE sodium_7\NN\14625458| (r_compound) channel_8\NN\6251781|of|the|sodium (r_nmod) alpha-subunit_4\NN\1740|the|channel|,|encoded (l_acl) encoded_10\VBN\115157|family (l_nmod) family_14\NN\8189659|by|the|scn|genes (l_compound) scn_13\NN\1740|
15805193T6_15805193T16 CPR:9 phenytoin_0\NN\3550533| (r_nsubjpass) metabolized_3\VBN\1740|phenytoin|is|principally|cyp2c9|,|and|substrates|. (l_nmod) cyp2c9_5\NN\1740|by
15805193T6_15805193T17 CPR:9 phenytoin_0\NN\3550533| (r_nsubjpass) metabolized_3\VBN\1740|phenytoin|is|principally|cyp2c9|,|and|substrates|. (l_conj) substrates_11\NNS\19613|both|are|probable|p-glycoprotein (l_nmod) p-glycoprotein_16\NN\1740|of|the|drug|transporter (l_compound) transporter_15\NN\4490091|
15805193T6_15805193T18 CPR:9 phenytoin_0\NN\3550533| (r_nsubjpass) metabolized_3\VBN\1740|phenytoin|is|principally|cyp2c9|,|and|substrates|. (l_conj) substrates_11\NNS\19613|both|are|probable|p-glycoprotein (l_nmod) p-glycoprotein_16\NN\1740|of|the|drug|transporter
15805193T9_15805193T19 NONE phenytoin_17\NN\3550533|of (r_nmod) dose_15\NN\3740161|with|the|maximum|phenytoin (r_nmod) associated_11\VBN\628491|that|polymorphism|is|highly|dose|= (l_nsubjpass) polymorphism_6\NN\11418750|a|known|functional|cyp2c9 (l_nmod) cyp2c9_8\NN\1740|in
15805193T10_15805193T20 NONE carbamazepine_22\NN\1740|of|both|and|phenytoin (r_nmod) usage_19\NN\407535|in|regular|carbamazepine (r_nmod) doses_16\NNS\3740161|with|maximum|usage (r_nmod) association_13\NN\8008335|significant|doses (r_dobj) shows_11\VBZ\2137132|that|polymorphism|association|= (l_nsubj) polymorphism_6\NN\11418750|an|intronic|gene (l_nmod) gene_10\NN\8459252|in|the|scn1a (l_compound) scn1a_9\NN\1740|
15805193T11_15805193T20 NONE phenytoin_24\NN\3550533| (r_conj) carbamazepine_22\NN\1740|of|both|and|phenytoin (r_nmod) usage_19\NN\407535|in|regular|carbamazepine (r_nmod) doses_16\NNS\3740161|with|maximum|usage (r_nmod) association_13\NN\8008335|significant|doses (r_dobj) shows_11\VBZ\2137132|that|polymorphism|association|= (l_nsubj) polymorphism_6\NN\11418750|an|intronic|gene (l_nmod) gene_10\NN\8459252|in|the|scn1a (l_compound) scn1a_9\NN\1740|
15974585
15974585T4_15974585T17 NONE 2-arylpropionic_0\JJ\1740| (r_amod) ligands_8\NNS\20090|2-arylpropionic|cxc|chemokine|receptor|inhibitors|. (l_compound) receptor_3\NN\5225602|1|cxcr1 (l_nummod) 1_4\CD\13741022|
15974585T4_15974585T18 NONE 2-arylpropionic_0\JJ\1740| (r_amod) ligands_8\NNS\20090|2-arylpropionic|cxc|chemokine|receptor|inhibitors|. (l_compound) receptor_3\NN\5225602|1|cxcr1 (l_appos) cxcr1_6\NN\1740|(|)
15974585T4_15974585T19 CPR:4 2-arylpropionic_0\JJ\1740| (r_amod) ligands_8\NNS\20090|2-arylpropionic|cxc|chemokine|receptor|inhibitors|. (l_nmod) inhibitors_13\NNS\20090|as|novel|noncompetitive|cxcl8 (l_compound) cxcl8_12\NN\1740|
15974585T1_15974585T13 CPR:4 (r)-ketoprofen_0\NN\1740|1 (r_nsubjpass) reported_6\VBN\831651|(r)-ketoprofen|was|previously|inhibitor|. (l_xcomp) inhibitor_14\NN\20090|to|be|a|potent|noncompetitive|chemotaxis (l_nmod) chemotaxis_19\NN\862686|of|cxcl8-induced|human|pmns (l_amod) cxcl8-induced_16\JJ\1740|
23085435
23085435T16_23085435T33 CPR:4 nitrogen-containing_0\JJ\1740| (r_amod) bisphosphonates_1\NNS\1740|nitrogen-containing (r_nsubj) induce_2\VBP\1627355|bisphosphonates|apoptosis|inhibition|. (l_nmod) inhibition_9\NN\1068773|via|pathways|and|activation (l_nmod) pathways_13\NNS\5483677|of|ras|signaling (l_compound) ras_11\NN\5501711|
23085435T16_23085435T34 CPR:3 nitrogen-containing_0\JJ\1740| (r_amod) bisphosphonates_1\NNS\1740|nitrogen-containing (r_nsubj) induce_2\VBP\1627355|bisphosphonates|apoptosis|inhibition|. (l_nmod) inhibition_9\NN\1068773|via|pathways|and|activation (l_conj) activation_16\NN\13561719|bim-mediated|pathway (l_amod) bim-mediated_15\JJ\1740|
23085435T17_23085435T33 CPR:4 bisphosphonates_1\NNS\1740|nitrogen-containing (r_nsubj) induce_2\VBP\1627355|bisphosphonates|apoptosis|inhibition|. (l_nmod) inhibition_9\NN\1068773|via|pathways|and|activation (l_nmod) pathways_13\NNS\5483677|of|ras|signaling (l_compound) ras_11\NN\5501711|
23085435T17_23085435T34 CPR:3 bisphosphonates_1\NNS\1740|nitrogen-containing (r_nsubj) induce_2\VBP\1627355|bisphosphonates|apoptosis|inhibition|. (l_nmod) inhibition_9\NN\1068773|via|pathways|and|activation (l_conj) activation_16\NN\13561719|bim-mediated|pathway (l_amod) bim-mediated_15\JJ\1740|
23085435T1_23085435T19 CPR:4 nitrogen-containing_0\JJ\1740| (r_amod) bisphosphonates_1\NNS\1740|nitrogen-containing|n-bps (r_nsubj) induce_5\VBP\1627355|bisphosphonates|apoptosis|cells|inhibiting|. (l_advcl) inhibiting_11\VBG\2510337|by|prenylation (l_dobj) prenylation_13\NN\1740|the|g-proteins (l_nmod) g-proteins_16\NNS\1740|of|small
23085435T3_23085435T19 CPR:4 bisphosphonates_1\NNS\1740|nitrogen-containing|n-bps (r_nsubj) induce_5\VBP\1627355|bisphosphonates|apoptosis|cells|inhibiting|. (l_advcl) inhibiting_11\VBG\2510337|by|prenylation (l_dobj) prenylation_13\NN\1740|the|g-proteins (l_nmod) g-proteins_16\NNS\1740|of|small
23085435T6_23085435T19 CPR:4 n-bps_3\NNS\1740|(|) (r_appos) bisphosphonates_1\NNS\1740|nitrogen-containing|n-bps (r_nsubj) induce_5\VBP\1627355|bisphosphonates|apoptosis|cells|inhibiting|. (l_advcl) inhibiting_11\VBG\2510337|by|prenylation (l_dobj) prenylation_13\NN\1740|the|g-proteins (l_nmod) g-proteins_16\NNS\1740|of|small
23085435T7_23085435T19 CPR:4 n-bps_3\NNS\1740|(|) (r_appos) bisphosphonates_1\NNS\1740|nitrogen-containing|n-bps (r_nsubj) induce_5\VBP\1627355|bisphosphonates|apoptosis|cells|inhibiting|. (l_advcl) inhibiting_11\VBG\2510337|by|prenylation (l_dobj) prenylation_13\NN\1740|the|g-proteins (l_nmod) g-proteins_16\NNS\1740|of|small
23085435T10_23085435T20 CPR:4 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_dobj) levels_5\NNS\4916342|the|kinase (l_nmod) kinase_10\NN\14732946|of|phosphorylated|extracellular|signal-regulated|erk|and|mtor
23085435T10_23085435T21 CPR:4 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_dobj) levels_5\NNS\4916342|the|kinase (l_nmod) kinase_10\NN\14732946|of|phosphorylated|extracellular|signal-regulated|erk|and|mtor (l_appos) erk_12\NN\1740|(|)
23085435T10_23085435T22 CPR:4 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_dobj) levels_5\NNS\4916342|the|kinase (l_nmod) kinase_10\NN\14732946|of|phosphorylated|extracellular|signal-regulated|erk|and|mtor (l_conj) mtor_15\NN\1740|
23085435T10_23085435T23 CPR:4 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_nmod) suppression_17\NN\13489037|via|prenylation (l_nmod) prenylation_20\NN\1740|of|ras (l_compound) ras_19\NN\5501711|
23085435T10_23085435T24 CPR:3 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_conj) enhanced_22\VBD\227165|expression (l_dobj) expression_24\NN\4679549|bim (l_compound) bim_23\NN\1740|
23085435T11_23085435T20 CPR:4 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_dobj) levels_5\NNS\4916342|the|kinase (l_nmod) kinase_10\NN\14732946|of|phosphorylated|extracellular|signal-regulated|erk|and|mtor
23085435T11_23085435T21 CPR:4 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_dobj) levels_5\NNS\4916342|the|kinase (l_nmod) kinase_10\NN\14732946|of|phosphorylated|extracellular|signal-regulated|erk|and|mtor (l_appos) erk_12\NN\1740|(|)
23085435T11_23085435T22 CPR:4 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_dobj) levels_5\NNS\4916342|the|kinase (l_nmod) kinase_10\NN\14732946|of|phosphorylated|extracellular|signal-regulated|erk|and|mtor (l_conj) mtor_15\NN\1740|
23085435T11_23085435T23 CPR:4 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_nmod) suppression_17\NN\13489037|via|prenylation (l_nmod) prenylation_20\NN\1740|of|ras (l_compound) ras_19\NN\5501711|
23085435T11_23085435T24 CPR:3 n-bps_2\NN\1740| (r_nsubj) decreased_3\VBD\169651|furthermore|,|n-bps|levels|suppression|and|enhanced|. (l_conj) enhanced_22\VBD\227165|expression (l_dobj) expression_24\NN\4679549|bim (l_compound) bim_23\NN\1740|
23085435T12_23085435T25 CPR:3 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_dobj) activation_17\NN\13561719|the|caspase-9 (l_nmod) caspase-9_19\NN\1740|of|and|caspase-3
23085435T12_23085435T26 CPR:3 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_dobj) activation_17\NN\13561719|the|caspase-9 (l_nmod) caspase-9_19\NN\1740|of|and|caspase-3 (l_conj) caspase-3_21\NN\1740|
23085435T12_23085435T27 CPR:3 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_dobj) expression_26\NN\4679549|bim (l_compound) bim_25\NN\1740|
23085435T12_23085435T28 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor
23085435T12_23085435T29 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor
23085435T12_23085435T30 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor
23085435T12_23085435T31 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor (l_conj) ras/mtor_33\NN\1740|
23085435T12_23085435T32 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor (l_conj) ras/mtor_33\NN\1740|
23085435T13_23085435T25 CPR:3 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_dobj) activation_17\NN\13561719|the|caspase-9 (l_nmod) caspase-9_19\NN\1740|of|and|caspase-3
23085435T13_23085435T26 CPR:3 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_dobj) activation_17\NN\13561719|the|caspase-9 (l_nmod) caspase-9_19\NN\1740|of|and|caspase-3 (l_conj) caspase-3_21\NN\1740|
23085435T13_23085435T27 CPR:3 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_dobj) expression_26\NN\4679549|bim (l_compound) bim_25\NN\1740|
23085435T13_23085435T28 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor
23085435T13_23085435T29 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor
23085435T13_23085435T30 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor
23085435T13_23085435T31 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor (l_conj) ras/mtor_33\NN\1740|
23085435T13_23085435T32 CPR:4 n-bps_5\NN\1740| (r_nsubj) induce_6\VBP\1627355|that|n-bps|apoptosis|decreasing (l_advcl) decreasing_9\VBG\169651|by|potential|,|increasing (l_conj) increasing_15\VBG\169651|activation|,|and|enhancing (l_conj) enhancing_24\VBG\227165|expression|inhibition (l_nmod) inhibition_28\NN\1068773|through|pathways (l_nmod) pathways_34\NNS\5483677|of|the|ras/mek/erk (l_compound) ras/mek/erk_31\NN\1740|and|ras/mtor (l_conj) ras/mtor_33\NN\1740|
23085435T14_23085435T18 NONE n-bps_3\NNS\1740|of (r_nmod) accumulation_1\NN\13497135|the|n-bps|bones (r_nsubj) suggests_6\VBZ\1010118|accumulation|act|. (l_ccomp) act_10\VB\1619354|that|they|may|effectively|tumors (l_nmod) tumors_14\NNS\14234074|on|spread|or|tumors (l_conj) tumors_23\NNS\14234074|on|ras-variable (l_amod) ras-variable_22\JJ\1740|
23085435T15_23085435T18 NONE n-bps_3\NNS\1740|of (r_nmod) accumulation_1\NN\13497135|the|n-bps|bones (r_nsubj) suggests_6\VBZ\1010118|accumulation|act|. (l_ccomp) act_10\VB\1619354|that|they|may|effectively|tumors (l_nmod) tumors_14\NNS\14234074|on|spread|or|tumors (l_conj) tumors_23\NNS\14234074|on|ras-variable (l_amod) ras-variable_22\JJ\1740|
1435788
1435788T2_1435788T10 NONE acid_15\NN\14818238| (r_compound) residues_16\NNS\20827|of|basic|amino|acid (r_nmod) pairs_11\NNS\7996689|at|specific|residues (r_nmod) cleavage_8\NN\24720|endoproteolytic|pairs (r_dobj) requires_6\VBZ\754942|part|cleavage|,|event|. (l_dobj) event_19\NN\23100|an|necessary (l_amod) necessary_20\JJ\1740|maturation (l_nmod) maturation_23\NN\13526110|for|the|variety (l_nmod) variety_26\NN\7951464|of|a|proteins (l_nmod) proteins_31\NNS\14944888|of|important|active|,|insulin (l_nmod) insulin_35\NN\5407119|such|and|factor
1435788T2_1435788T11 NONE acid_15\NN\14818238| (r_compound) residues_16\NNS\20827|of|basic|amino|acid (r_nmod) pairs_11\NNS\7996689|at|specific|residues (r_nmod) cleavage_8\NN\24720|endoproteolytic|pairs (r_dobj) requires_6\VBZ\754942|part|cleavage|,|event|. (l_dobj) event_19\NN\23100|an|necessary (l_amod) necessary_20\JJ\1740|maturation (l_nmod) maturation_23\NN\13526110|for|the|variety (l_nmod) variety_26\NN\7951464|of|a|proteins (l_nmod) proteins_31\NNS\14944888|of|important|active|,|insulin (l_nmod) insulin_35\NN\5407119|such|and|factor (l_conj) factor_39\NN\7326557|nerve|growth
23019138
23019138T17_23019138T29 CPR:5 δ(9)-tetrahydrocannabinol_5\NN\1740|including|,|win|,|am2389|,|and|am4054 (r_nmod) agonists_2\NNS\9613191|direct-acting|cb1|,|δ(9)-tetrahydrocannabinol|, (l_compound) cb1_1\NN\1740|
23019138T18_23019138T29 CPR:5 55,212_8\CD\1740| (r_nummod) win_7\NN\7473441|55,212|mesylate (r_conj) δ(9)-tetrahydrocannabinol_5\NN\1740|including|,|win|,|am2389|,|and|am4054 (r_nmod) agonists_2\NNS\9613191|direct-acting|cb1|,|δ(9)-tetrahydrocannabinol|, (l_compound) cb1_1\NN\1740|
23019138T19_23019138T29 CPR:5 mesylate_11\NN\1740|[|r-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone|] (r_appos) win_7\NN\7473441|55,212|mesylate (r_conj) δ(9)-tetrahydrocannabinol_5\NN\1740|including|,|win|,|am2389|,|and|am4054 (r_nmod) agonists_2\NNS\9613191|direct-acting|cb1|,|δ(9)-tetrahydrocannabinol|, (l_compound) cb1_1\NN\1740|
23019138T20_23019138T29 CPR:5 am2389_14\NN\1740|9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (r_conj) δ(9)-tetrahydrocannabinol_5\NN\1740|including|,|win|,|am2389|,|and|am4054 (r_nmod) agonists_2\NNS\9613191|direct-acting|cb1|,|δ(9)-tetrahydrocannabinol|, (l_compound) cb1_1\NN\1740|
23019138T21_23019138T29 CPR:5 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol_16\NN\1740|[|] (r_appos) am2389_14\NN\1740|9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (r_conj) δ(9)-tetrahydrocannabinol_5\NN\1740|including|,|win|,|am2389|,|and|am4054 (r_nmod) agonists_2\NNS\9613191|direct-acting|cb1|,|δ(9)-tetrahydrocannabinol|, (l_compound) cb1_1\NN\1740|
23019138T22_23019138T29 CPR:5 am4054_20\NN\1740|9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (r_conj) δ(9)-tetrahydrocannabinol_5\NN\1740|including|,|win|,|am2389|,|and|am4054 (r_nmod) agonists_2\NNS\9613191|direct-acting|cb1|,|δ(9)-tetrahydrocannabinol|, (l_compound) cb1_1\NN\1740|
23019138T23_23019138T29 CPR:5 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol_22\NN\1740|[|] (r_appos) am4054_20\NN\1740|9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (r_conj) δ(9)-tetrahydrocannabinol_5\NN\1740|including|,|win|,|am2389|,|and|am4054 (r_nmod) agonists_2\NNS\9613191|direct-acting|cb1|,|δ(9)-tetrahydrocannabinol|, (l_compound) cb1_1\NN\1740|
23019138T4_23019138T24 NONE methanandamide_0\NN\1740|mg/kg (r_nsubj) had_5\VBD\2108377|methanandamide|effect|agonists|,|and|have (l_conj) have_35\VB\2108377|agonist|did|not|effects|. (l_nsubj) agonist_16\NN\9613191|the|cb2|am1241|,|inhibitor|,|and|rimonabant (l_compound) cb2_15\NN\1740|
23019138T5_23019138T24 CPR:5 am1241_17\NN\1740|1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole (r_dep) agonist_16\NN\9613191|the|cb2|am1241|,|inhibitor|,|and|rimonabant (l_compound) cb2_15\NN\1740|
23019138T6_23019138T24 CPR:5 1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole_19\NN\1740|[|] (r_appos) am1241_17\NN\1740|1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole (r_dep) agonist_16\NN\9613191|the|cb2|am1241|,|inhibitor|,|and|rimonabant (l_compound) cb2_15\NN\1740|
23019138T7_23019138T24 NONE anandamide_23\NN\1740| (r_compound) inhibitor_25\NN\20090|the|anandamide|transport|am404 (r_conj) agonist_16\NN\9613191|the|cb2|am1241|,|inhibitor|,|and|rimonabant (l_compound) cb2_15\NN\1740|
23019138T8_23019138T24 CPR:5 am404_26\NNP\1740| (r_dep) inhibitor_25\NN\20090|the|anandamide|transport|am404 (r_conj) agonist_16\NN\9613191|the|cb2|am1241|,|inhibitor|,|and|rimonabant (l_compound) cb2_15\NN\1740|
23019138T9_23019138T24 NONE rimonabant_32\NN\1740|antagonist (r_conj) agonist_16\NN\9613191|the|cb2|am1241|,|inhibitor|,|and|rimonabant (l_compound) cb2_15\NN\1740|
23019138T10_23019138T25 CPR:5 am4054_11\NN\1740| (r_dep) agonist_10\NN\9613191|of|the|cb1|am4054 (l_compound) cb1_9\NN\1740|
23019138T10_23019138T26 NONE am4054_11\NN\1740| (r_dep) agonist_10\NN\9613191|of|the|cb1|am4054 (r_nmod) effects_6\NNS\13245626|the|diuretic|agonist (r_nsubj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_conj) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (l_nmod) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (l_conj) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (l_nummod) i_46\CD\14622893|
23019138T10_23019138T27 NONE am4054_11\NN\1740| (r_dep) agonist_10\NN\9613191|of|the|cb1|am4054 (r_nmod) effects_6\NNS\13245626|the|diuretic|agonist (r_nsubj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_conj) antagonized_57\VBN\1787955|were|effects|am630|] (l_nmod) am630_62\NN\1740|by|the|cb2|antagonist|methanone (l_compound) cb2_60\NN\1740|
23019138T11_23019138T25 CPR:6 rimonabant_37\NN\1740|with (r_nmod) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (r_nmod) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_nsubj) effects_6\NNS\13245626|the|diuretic|agonist (l_nmod) agonist_10\NN\9613191|of|the|cb1|am4054 (l_compound) cb1_9\NN\1740|
23019138T11_23019138T26 NONE rimonabant_37\NN\1740|with (r_nmod) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (l_conj) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (l_nummod) i_46\CD\14622893|
23019138T11_23019138T27 NONE rimonabant_37\NN\1740|with (r_nmod) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (r_nmod) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_conj) antagonized_57\VBN\1787955|were|effects|am630|] (l_nmod) am630_62\NN\1740|by|the|cb2|antagonist|methanone (l_compound) cb2_60\NN\1740|
23019138T12_23019138T25 NONE vanilloid_43\NN\1740| (r_compound) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (r_conj) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (r_nmod) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_nsubj) effects_6\NNS\13245626|the|diuretic|agonist (l_nmod) agonist_10\NN\9613191|of|the|cb1|am4054 (l_compound) cb1_9\NN\1740|
23019138T12_23019138T26 NONE vanilloid_43\NN\1740| (r_compound) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (l_nummod) i_46\CD\14622893|
23019138T12_23019138T27 NONE vanilloid_43\NN\1740| (r_compound) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (r_conj) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (r_nmod) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_conj) antagonized_57\VBN\1787955|were|effects|am630|] (l_nmod) am630_62\NN\1740|by|the|cb2|antagonist|methanone (l_compound) cb2_60\NN\1740|
23019138T13_23019138T25 NONE capsazepine_48\NN\1740| (r_dep) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (r_conj) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (r_nmod) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_nsubj) effects_6\NNS\13245626|the|diuretic|agonist (l_nmod) agonist_10\NN\9613191|of|the|cb1|am4054 (l_compound) cb1_9\NN\1740|
23019138T13_23019138T26 CPR:6 capsazepine_48\NN\1740| (r_dep) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (l_nummod) i_46\CD\14622893|
23019138T13_23019138T27 NONE capsazepine_48\NN\1740| (r_dep) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (r_conj) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (r_nmod) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_conj) antagonized_57\VBN\1787955|were|effects|am630|] (l_nmod) am630_62\NN\1740|by|the|cb2|antagonist|methanone (l_compound) cb2_60\NN\1740|
23019138T14_23019138T25 NONE 55,212_56\CD\1740| (r_nummod) win_55\NN\7473441|of|55,212 (r_nmod) effects_53\NNS\13245626|the|win (r_nsubjpass) antagonized_57\VBN\1787955|were|effects|am630|] (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_nsubj) effects_6\NNS\13245626|the|diuretic|agonist (l_nmod) agonist_10\NN\9613191|of|the|cb1|am4054 (l_compound) cb1_9\NN\1740|
23019138T14_23019138T26 NONE 55,212_56\CD\1740| (r_nummod) win_55\NN\7473441|of|55,212 (r_nmod) effects_53\NNS\13245626|the|win (r_nsubjpass) antagonized_57\VBN\1787955|were|effects|am630|] (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_conj) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (l_nmod) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (l_conj) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (l_nummod) i_46\CD\14622893|
23019138T14_23019138T27 CPR:5 55,212_56\CD\1740| (r_nummod) win_55\NN\7473441|of|55,212 (r_nmod) effects_53\NNS\13245626|the|win (r_nsubjpass) antagonized_57\VBN\1787955|were|effects|am630|] (l_nmod) am630_62\NN\1740|by|the|cb2|antagonist|methanone (l_compound) cb2_60\NN\1740|
23019138T15_23019138T25 NONE am630_62\NN\1740|by|the|cb2|antagonist|methanone (r_nmod) antagonized_57\VBN\1787955|were|effects|am630|] (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_nsubj) effects_6\NNS\13245626|the|diuretic|agonist (l_nmod) agonist_10\NN\9613191|of|the|cb1|am4054 (l_compound) cb1_9\NN\1740|
23019138T15_23019138T26 NONE am630_62\NN\1740|by|the|cb2|antagonist|methanone (r_nmod) antagonized_57\VBN\1787955|were|effects|am630|] (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_conj) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (l_nmod) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (l_conj) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (l_nummod) i_46\CD\14622893|
23019138T15_23019138T27 CPR:6 am630_62\NN\1740|by|the|cb2|antagonist|methanone (l_compound) cb2_60\NN\1740|
23019138T16_23019138T25 NONE )_68\-RRB-\1740| (r_punct) methanone_67\NN\1740|[|(|6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1h-indol-3-yl](4-methoxyphenyl|)|) (r_appos) am630_62\NN\1740|by|the|cb2|antagonist|methanone (r_nmod) antagonized_57\VBN\1787955|were|effects|am630|] (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_nsubj) effects_6\NNS\13245626|the|diuretic|agonist (l_nmod) agonist_10\NN\9613191|of|the|cb1|am4054 (l_compound) cb1_9\NN\1740|
23019138T16_23019138T26 NONE )_68\-RRB-\1740| (r_punct) methanone_67\NN\1740|[|(|6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1h-indol-3-yl](4-methoxyphenyl|)|) (r_appos) am630_62\NN\1740|by|the|cb2|antagonist|methanone (r_nmod) antagonized_57\VBN\1787955|were|effects|am630|] (r_conj) similar_13\JJ\1740|studies|,|effects|were|rats|,|displayed|,|and|antagonized|,|nor|antagonized|. (l_conj) antagonized_31\VBN\1787955|were|dose-dependently|pretreatment (l_nmod) pretreatment_35\NN\1740|by|minutes|rimonabant|,|antagonist (l_conj) antagonist_47\NN\7846|not|by|the|vanilloid|receptor|type|i|capsazepine (l_nummod) i_46\CD\14622893|
23019138T16_23019138T27 CPR:6 )_68\-RRB-\1740| (r_punct) methanone_67\NN\1740|[|(|6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1h-indol-3-yl](4-methoxyphenyl|)|) (r_appos) am630_62\NN\1740|by|the|cb2|antagonist|methanone (l_compound) cb2_60\NN\1740|
11278845
11278845T10_11278845T34 NONE atp-sensitive_12\JJ\1740|(|and|-insensitive|)|poisons (l_nmod) poisons_18\NNS\20090|of|top2 (l_compound) top2_17\NN\1740|
11278845T10_11278845T35 NONE atp-sensitive_12\JJ\1740|(|and|-insensitive|)|poisons (r_dep) classes_10\NNS\7951464|two|different|atp-sensitive (r_nsubjpass) identified_21\VBN\699815|that|classes|can|be|sensitivity (l_nmod) sensitivity_26\NN\5651971|based|on|their|differential|conformation (l_nmod) conformation_30\NN\13897996|to|the|atp-bound|top2 (l_nmod) top2_32\NN\1740|of
11278845T11_11278845T34 NONE atp-bound_29\JJ\1740| (r_amod) conformation_30\NN\13897996|to|the|atp-bound|top2 (r_nmod) sensitivity_26\NN\5651971|based|on|their|differential|conformation (r_nmod) identified_21\VBN\699815|that|classes|can|be|sensitivity (l_nsubjpass) classes_10\NNS\7951464|two|different|atp-sensitive (l_dep) atp-sensitive_12\JJ\1740|(|and|-insensitive|)|poisons (l_nmod) poisons_18\NNS\20090|of|top2 (l_compound) top2_17\NN\1740|
11278845T11_11278845T35 NONE atp-bound_29\JJ\1740| (r_amod) conformation_30\NN\13897996|to|the|atp-bound|top2 (l_nmod) top2_32\NN\1740|of
11278845T12_11278845T36 NONE atp_8\NN\14964590|in|the|presence|of|mm|or|gamma-imino)triphosphate (r_nmod) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T12_11278845T37 NONE atp_8\NN\14964590|in|the|presence|of|mm|or|gamma-imino)triphosphate (r_nmod) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_acl) induced_21\VBN\1627355|poisons (l_nmod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T12_11278845T38 NONE atp_8\NN\14964590|in|the|presence|of|mm|or|gamma-imino)triphosphate (r_nmod) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_parataxis) cleavage_45\NN\24720|dna|induced (l_acl) induced_46\VBN\1627355|poisons (l_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T13_11278845T36 NONE gamma-imino)triphosphate_16\NN\1740|the|nonhydrolyzable|analog|adenosine|5'-(beta|, (r_conj) atp_8\NN\14964590|in|the|presence|of|mm|or|gamma-imino)triphosphate (r_nmod) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T13_11278845T37 NONE gamma-imino)triphosphate_16\NN\1740|the|nonhydrolyzable|analog|adenosine|5'-(beta|, (r_conj) atp_8\NN\14964590|in|the|presence|of|mm|or|gamma-imino)triphosphate (r_nmod) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_acl) induced_21\VBN\1627355|poisons (l_nmod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T13_11278845T38 NONE gamma-imino)triphosphate_16\NN\1740|the|nonhydrolyzable|analog|adenosine|5'-(beta|, (r_conj) atp_8\NN\14964590|in|the|presence|of|mm|or|gamma-imino)triphosphate (r_nmod) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_parataxis) cleavage_45\NN\24720|dna|induced (l_acl) induced_46\VBN\1627355|poisons (l_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T14_11278845T36 NONE atp-sensitive_23\JJ\1740| (r_amod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T14_11278845T37 NONE atp-sensitive_23\JJ\1740| (r_amod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T14_11278845T38 NONE atp-sensitive_23\JJ\1740| (r_amod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (r_nsubjpass) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_parataxis) cleavage_45\NN\24720|dna|induced (l_acl) induced_46\VBN\1627355|poisons (l_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T15_11278845T36 CPR:4 doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T15_11278845T37 CPR:4 doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T15_11278845T38 NONE doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (r_nsubjpass) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_parataxis) cleavage_45\NN\24720|dna|induced (l_acl) induced_46\VBN\1627355|poisons (l_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T16_11278845T36 CPR:4 etoposide_30\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T16_11278845T37 CPR:4 etoposide_30\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T16_11278845T38 NONE etoposide_30\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (r_nsubjpass) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_parataxis) cleavage_45\NN\24720|dna|induced (l_acl) induced_46\VBN\1627355|poisons (l_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T17_11278845T36 CPR:4 mitoxantrone_32\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T17_11278845T37 CPR:4 mitoxantrone_32\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T17_11278845T38 NONE mitoxantrone_32\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (r_nsubjpass) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_parataxis) cleavage_45\NN\24720|dna|induced (l_acl) induced_46\VBN\1627355|poisons (l_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T18_11278845T36 CPR:4 4'-(9-acridinylamino)methanesulfon-m-anisidide_35\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T18_11278845T37 CPR:4 4'-(9-acridinylamino)methanesulfon-m-anisidide_35\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T18_11278845T38 NONE 4'-(9-acridinylamino)methanesulfon-m-anisidide_35\NN\1740| (r_conj) doxorubicin_28\NN\2716866|(|e.g.|,|etoposide|,|mitoxantrone|,|and|4'-(9-acridinylamino)methanesulfon-m-anisidide|) (r_dep) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (r_nmod) induced_21\VBN\1627355|poisons (r_acl) cleavage_20\NN\24720|top2-mediated|dna|induced (r_nsubjpass) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_parataxis) cleavage_45\NN\24720|dna|induced (l_acl) induced_46\VBN\1627355|poisons (l_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T19_11278845T36 NONE atp-insensitive_48\JJ\1740| (r_amod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (r_nmod) induced_46\VBN\1627355|poisons (r_acl) cleavage_45\NN\24720|dna|induced (r_parataxis) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T19_11278845T37 NONE atp-insensitive_48\JJ\1740| (r_amod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (r_nmod) induced_46\VBN\1627355|poisons (r_acl) cleavage_45\NN\24720|dna|induced (r_parataxis) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_acl) induced_21\VBN\1627355|poisons (l_nmod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T19_11278845T38 NONE atp-insensitive_48\JJ\1740| (r_amod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T20_11278845T36 NONE amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (r_nmod) induced_46\VBN\1627355|poisons (r_acl) cleavage_45\NN\24720|dna|induced (r_parataxis) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T20_11278845T37 NONE amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (r_nmod) induced_46\VBN\1627355|poisons (r_acl) cleavage_45\NN\24720|dna|induced (r_parataxis) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_acl) induced_21\VBN\1627355|poisons (l_nmod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T20_11278845T38 CPR:4 amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T21_11278845T36 NONE batracylin_55\NN\1740| (r_conj) amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (r_nmod) induced_46\VBN\1627355|poisons (r_acl) cleavage_45\NN\24720|dna|induced (r_parataxis) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T21_11278845T37 NONE batracylin_55\NN\1740| (r_conj) amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (r_nmod) induced_46\VBN\1627355|poisons (r_acl) cleavage_45\NN\24720|dna|induced (r_parataxis) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_acl) induced_21\VBN\1627355|poisons (l_nmod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T21_11278845T38 CPR:4 batracylin_55\NN\1740| (r_conj) amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T22_11278845T36 NONE menadione_58\NN\15092751| (r_conj) amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (r_nmod) induced_46\VBN\1627355|poisons (r_acl) cleavage_45\NN\24720|dna|induced (r_parataxis) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_18\JJ\1740|
11278845T22_11278845T37 NONE menadione_58\NN\15092751| (r_conj) amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (r_nmod) induced_46\VBN\1627355|poisons (r_acl) cleavage_45\NN\24720|dna|induced (r_parataxis) stimulated_41\VBN\137313|first|,|atp|,|cleavage|was|30|100-fold|,|whereas|cleavage|affected|. (l_nsubjpass) cleavage_20\NN\24720|top2-mediated|dna|induced (l_acl) induced_21\VBN\1627355|poisons (l_nmod) poisons_25\NNS\20090|by|atp-sensitive|top2|doxorubicin (l_compound) top2_24\NN\1740|
11278845T22_11278845T38 CPR:4 menadione_58\NN\15092751| (r_conj) amonafide_53\NN\1740|(|e.g.|,|batracylin|,|and|menadione|) (r_nmod) poisons_50\NNS\20090|by|atp-insensitive|top2|amonafide (l_compound) top2_49\NN\1740|
11278845T23_11278845T40 NONE adp_3\NN\14964590| (r_nsubjpass) shown_5\VBN\2137132|addition|,|adp|was|antagonize|. (l_xcomp) antagonize_8\VB\1787955|to|strongly|cleavage (l_dobj) cleavage_11\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_9\JJ\1740|
11278845T23_11278845T41 NONE adp_3\NN\14964590| (r_nsubjpass) shown_5\VBN\2137132|addition|,|adp|was|antagonize|. (l_xcomp) antagonize_8\VB\1787955|to|strongly|cleavage (l_dobj) cleavage_11\NN\24720|top2-mediated|dna|induced (l_acl) induced_12\VBN\1627355|poisons (l_nmod) poisons_19\NNS\20090|by|atp-sensitive|top2 (l_compound) top2_18\NN\1740|
11278845T24_11278845T40 CPR:3 atp-sensitive_14\JJ\1740|not|atp-insensitive (r_amod) poisons_19\NNS\20090|by|atp-sensitive|top2 (r_nmod) induced_12\VBN\1627355|poisons (r_acl) cleavage_11\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_9\JJ\1740|
11278845T24_11278845T41 NONE atp-sensitive_14\JJ\1740|not|atp-insensitive (r_amod) poisons_19\NNS\20090|by|atp-sensitive|top2 (l_compound) top2_18\NN\1740|
11278845T25_11278845T40 NONE atp-insensitive_17\JJ\1740| (r_conj) atp-sensitive_14\JJ\1740|not|atp-insensitive (r_amod) poisons_19\NNS\20090|by|atp-sensitive|top2 (r_nmod) induced_12\VBN\1627355|poisons (r_acl) cleavage_11\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_9\JJ\1740|
11278845T25_11278845T41 NONE atp-insensitive_17\JJ\1740| (r_conj) atp-sensitive_14\JJ\1740|not|atp-insensitive (r_amod) poisons_19\NNS\20090|by|atp-sensitive|top2 (l_compound) top2_18\NN\1740|
11278845T1_11278845T27 NONE atp-sensitive_20\JJ\1740|but|not|atp-insensitive (r_amod) poisons_25\NNS\20090|to|all|atp-sensitive|top2 (l_compound) top2_24\NN\1740|
11278845T1_11278845T42 NONE atp-sensitive_20\JJ\1740|but|not|atp-insensitive (r_amod) poisons_25\NNS\20090|to|all|atp-sensitive|top2 (r_nmod) cross-resistance_17\NN\1740|poisons (r_dobj) exhibit_16\VB\2632167|to|cross-resistance (r_xcomp) shown_14\VBN\2137132|second|,|top2alpha|was|exhibit|. (l_nsubjpass) top2alpha_5\NN\1740|mutant|human|,|exhibits|, (l_amod) mutant_3\JJ\1740|c427a (l_compound) c427a_2\NN\1740|
11278845T1_11278845T43 NONE atp-sensitive_20\JJ\1740|but|not|atp-insensitive (r_amod) poisons_25\NNS\20090|to|all|atp-sensitive|top2 (r_nmod) cross-resistance_17\NN\1740|poisons (r_dobj) exhibit_16\VB\2632167|to|cross-resistance (r_xcomp) shown_14\VBN\2137132|second|,|top2alpha|was|exhibit|. (l_nsubjpass) top2alpha_5\NN\1740|mutant|human|,|exhibits|,
11278845T1_11278845T44 NONE atp-sensitive_20\JJ\1740|but|not|atp-insensitive (r_amod) poisons_25\NNS\20090|to|all|atp-sensitive|top2 (r_nmod) cross-resistance_17\NN\1740|poisons (r_dobj) exhibit_16\VB\2632167|to|cross-resistance (r_xcomp) shown_14\VBN\2137132|second|,|top2alpha|was|exhibit|. (l_nsubjpass) top2alpha_5\NN\1740|mutant|human|,|exhibits|, (l_acl:relcl) exhibits_8\VBZ\2632167|which|activity (l_dobj) activity_11\NN\30358|reduced|atpase (l_compound) atpase_10\NN\1740|
11278845T2_11278845T27 NONE atp-insensitive_23\JJ\1740| (r_conj) atp-sensitive_20\JJ\1740|but|not|atp-insensitive (r_amod) poisons_25\NNS\20090|to|all|atp-sensitive|top2 (l_compound) top2_24\NN\1740|
11278845T2_11278845T42 NONE atp-insensitive_23\JJ\1740| (r_conj) atp-sensitive_20\JJ\1740|but|not|atp-insensitive (r_amod) poisons_25\NNS\20090|to|all|atp-sensitive|top2 (r_nmod) cross-resistance_17\NN\1740|poisons (r_dobj) exhibit_16\VB\2632167|to|cross-resistance (r_xcomp) shown_14\VBN\2137132|second|,|top2alpha|was|exhibit|. (l_nsubjpass) top2alpha_5\NN\1740|mutant|human|,|exhibits|, (l_amod) mutant_3\JJ\1740|c427a (l_compound) c427a_2\NN\1740|
11278845T2_11278845T43 NONE atp-insensitive_23\JJ\1740| (r_conj) atp-sensitive_20\JJ\1740|but|not|atp-insensitive (r_amod) poisons_25\NNS\20090|to|all|atp-sensitive|top2 (r_nmod) cross-resistance_17\NN\1740|poisons (r_dobj) exhibit_16\VB\2632167|to|cross-resistance (r_xcomp) shown_14\VBN\2137132|second|,|top2alpha|was|exhibit|. (l_nsubjpass) top2alpha_5\NN\1740|mutant|human|,|exhibits|,
11278845T2_11278845T44 CPR:4 atp-insensitive_23\JJ\1740| (r_conj) atp-sensitive_20\JJ\1740|but|not|atp-insensitive (r_amod) poisons_25\NNS\20090|to|all|atp-sensitive|top2 (r_nmod) cross-resistance_17\NN\1740|poisons (r_dobj) exhibit_16\VB\2632167|to|cross-resistance (r_xcomp) shown_14\VBN\2137132|second|,|top2alpha|was|exhibit|. (l_nsubjpass) top2alpha_5\NN\1740|mutant|human|,|exhibits|, (l_acl:relcl) exhibits_8\VBZ\2632167|which|activity (l_dobj) activity_11\NN\30358|reduced|atpase (l_compound) atpase_10\NN\1740|
11278845T3_11278845T28 NONE ciprofloxacin_3\NN\2716866| (r_compound) assay_5\NN\5733583|ciprofloxacin|competition (r_dobj) using_2\VBG\1156834|assay (r_advcl) shown_18\VBN\2137132|third|,|using|,|cleavage|was|antagonized|. (l_nsubjpass) cleavage_9\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_7\JJ\1740|
11278845T4_11278845T28 NONE atp-sensitive_12\JJ\1740|not|atp-insensitive (r_amod) poisons_16\NNS\20090|by|atp-sensitive (r_nmod) induced_10\VBN\1627355|poisons (r_acl) cleavage_9\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_7\JJ\1740|
11278845T5_11278845T28 NONE atp-insensitive_15\JJ\1740| (r_conj) atp-sensitive_12\JJ\1740|not|atp-insensitive (r_amod) poisons_16\NNS\20090|by|atp-sensitive (r_nmod) induced_10\VBN\1627355|poisons (r_acl) cleavage_9\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_7\JJ\1740|
11278845T6_11278845T28 NONE ciprofloxacin_23\NN\2716866|by (r_nmod) antagonized_21\VBN\1787955|to|be|ciprofloxacin (r_xcomp) shown_18\VBN\2137132|third|,|using|,|cleavage|was|antagonized|. (l_nsubjpass) cleavage_9\NN\24720|top2-mediated|dna|induced (l_amod) top2-mediated_7\JJ\1740|
11278845T7_11278845T29 NONE atp-bound_4\JJ\1740| (r_amod) top2_5\NN\1740|atp-bound
11278845T7_11278845T30 NONE atp-bound_4\JJ\1740| (r_amod) top2_5\NN\1740|atp-bound (r_nsubj) target_10\NN\7258332|that|top2|may|be|the|specific|poisons (l_nmod) poisons_14\NNS\20090|of|atp-sensitive|top2 (l_compound) top2_13\NN\1740|
11278845T8_11278845T29 NONE atp-sensitive_12\JJ\1740| (r_amod) poisons_14\NNS\20090|of|atp-sensitive|top2 (r_nmod) target_10\NN\7258332|that|top2|may|be|the|specific|poisons (l_nsubj) top2_5\NN\1740|atp-bound
11278845T8_11278845T30 NONE atp-sensitive_12\JJ\1740| (r_amod) poisons_14\NNS\20090|of|atp-sensitive|top2 (l_compound) top2_13\NN\1740|
11278845T9_11278845T31 NONE atp-bound_10\JJ\1740| (r_amod) top2_11\NN\1740|atp-bound (r_nsubj) acts_12\VBZ\1619354|that|top2|clamp (r_ccomp) show_8\VBP\2137132|we|acts (r_parataxis) using_0\VBG\1156834|complexes|roadblocks|,|show|. (l_dobj) complexes_3\NNS\5869584|lac|repressor-operator
11278845T9_11278845T32 NONE atp-bound_10\JJ\1740| (r_amod) top2_11\NN\1740|atp-bound
14507109
14507109T8_14507109T50 NONE oxygen_20\NN\14622893|singlet|1o2 (r_compound) donor_24\NN\9608709|oxygen (r_compound) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (r_acl:relcl) plasma_8\NN\5398023|with|pooled|patients|,|oxidized (r_nmod) incubated_5\VBN\252019|urokinase|was|also|plasma|. (l_nsubjpass) urokinase_2\NN\14999106|iu/ml
14507109T8_14507109T52 CPR:4 oxygen_20\NN\14622893|singlet|1o2 (r_compound) donor_24\NN\9608709|oxygen (r_compound) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (l_advcl) destroy_32\VB\1619231|to|pai-1 (l_dobj) pai-1_34\NN\1740|plasmatic|and|alpha2-antiplasmin
14507109T8_14507109T53 NONE oxygen_20\NN\14622893|singlet|1o2 (r_compound) donor_24\NN\9608709|oxygen (r_compound) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (l_advcl) destroy_32\VB\1619231|to|pai-1 (l_dobj) pai-1_34\NN\1740|plasmatic|and|alpha2-antiplasmin (l_conj) alpha2-antiplasmin_36\NN\1740|
14507109T9_14507109T50 NONE 1o2_22\NN\1740|(|) (r_appos) oxygen_20\NN\14622893|singlet|1o2 (r_compound) donor_24\NN\9608709|oxygen (r_compound) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (r_acl:relcl) plasma_8\NN\5398023|with|pooled|patients|,|oxidized (r_nmod) incubated_5\VBN\252019|urokinase|was|also|plasma|. (l_nsubjpass) urokinase_2\NN\14999106|iu/ml
14507109T9_14507109T52 CPR:4 1o2_22\NN\1740|(|) (r_appos) oxygen_20\NN\14622893|singlet|1o2 (r_compound) donor_24\NN\9608709|oxygen (r_compound) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (l_advcl) destroy_32\VB\1619231|to|pai-1 (l_dobj) pai-1_34\NN\1740|plasmatic|and|alpha2-antiplasmin
14507109T9_14507109T53 NONE 1o2_22\NN\1740|(|) (r_appos) oxygen_20\NN\14622893|singlet|1o2 (r_compound) donor_24\NN\9608709|oxygen (r_compound) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (l_advcl) destroy_32\VB\1619231|to|pai-1 (l_dobj) pai-1_34\NN\1740|plasmatic|and|alpha2-antiplasmin (l_conj) alpha2-antiplasmin_36\NN\1740|
14507109T10_14507109T50 NONE t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (r_acl:relcl) plasma_8\NN\5398023|with|pooled|patients|,|oxidized (r_nmod) incubated_5\VBN\252019|urokinase|was|also|plasma|. (l_nsubjpass) urokinase_2\NN\14999106|iu/ml
14507109T10_14507109T52 CPR:4 t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (l_advcl) destroy_32\VB\1619231|to|pai-1 (l_dobj) pai-1_34\NN\1740|plasmatic|and|alpha2-antiplasmin
14507109T10_14507109T53 CPR:4 t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (l_advcl) destroy_32\VB\1619231|to|pai-1 (l_dobj) pai-1_34\NN\1740|plasmatic|and|alpha2-antiplasmin (l_conj) alpha2-antiplasmin_36\NN\1740|
14507109T11_14507109T50 NONE ct_28\NN\901316|(|) (r_appos) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (r_acl:relcl) plasma_8\NN\5398023|with|pooled|patients|,|oxidized (r_nmod) incubated_5\VBN\252019|urokinase|was|also|plasma|. (l_nsubjpass) urokinase_2\NN\14999106|iu/ml
14507109T11_14507109T52 CPR:4 ct_28\NN\901316|(|) (r_appos) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (l_advcl) destroy_32\VB\1619231|to|pai-1 (l_dobj) pai-1_34\NN\1740|plasmatic|and|alpha2-antiplasmin
14507109T11_14507109T53 CPR:4 ct_28\NN\901316|(|) (r_appos) t_26\NN\14999913|with|the|donor|chloramine|ct (r_nmod) oxidized_16\VBN\109660|that|was|previously|t|,|destroy (l_advcl) destroy_32\VB\1619231|to|pai-1 (l_dobj) pai-1_34\NN\1740|plasmatic|and|alpha2-antiplasmin (l_conj) alpha2-antiplasmin_36\NN\1740|
14507109T2_14507109T13 CPR:9 arginine_16\NN\14605787|with|microl|m|,|ph|,|and (r_nmod) incubated_10\VBN\252019|determination|,|microl|was|arginine|microl|. (l_nmod) determination_1\NN\43195|for|activity (l_nmod) activity_4\NN\30358|of|plasmin (l_compound) plasmin_3\NN\14732946|
14507109T3_14507109T13 NONE ct_26\NN\901316|mm|preoxidized (r_dep) microl_23\NN\1740|100|ct|edta-plasma|minutes|c (r_dobj) incubated_10\VBN\252019|determination|,|microl|was|arginine|microl|. (l_nmod) determination_1\NN\43195|for|activity (l_nmod) activity_4\NN\30358|of|plasmin (l_compound) plasmin_3\NN\14732946|
14507109T4_14507109T13 NONE citrate_37\NN\14850483|normal (r_compound) edta-plasma_39\NN\1740|pooled|citrate|buffered (r_dep) microl_23\NN\1740|100|ct|edta-plasma|minutes|c (r_dobj) incubated_10\VBN\252019|determination|,|microl|was|arginine|microl|. (l_nmod) determination_1\NN\43195|for|activity (l_nmod) activity_4\NN\30358|of|plasmin (l_compound) plasmin_3\NN\14732946|
14507109T5_14507109T13 NONE edta-plasma_39\NN\1740|pooled|citrate|buffered (r_dep) microl_23\NN\1740|100|ct|edta-plasma|minutes|c (r_dobj) incubated_10\VBN\252019|determination|,|microl|was|arginine|microl|. (l_nmod) determination_1\NN\43195|for|activity (l_nmod) activity_4\NN\30358|of|plasmin (l_compound) plasmin_3\NN\14732946|
14507109T6_14507109T14 CPR:9 arginine_5\NN\14605787| (r_nsubjpass) added_7\VBN\156601|determination|,|arginine|was|incubation|. (l_nmod) determination_1\NN\43195|for|[pa+pli]-activity (l_nmod) [pa+pli]-activity_3\NN\1740|of
14507109T6_14507109T15 CPR:9 arginine_5\NN\14605787| (r_nsubjpass) added_7\VBN\156601|determination|,|arginine|was|incubation|. (l_nmod) determination_1\NN\43195|for|[pa+pli]-activity (l_nmod) [pa+pli]-activity_3\NN\1740|of
17148442
17148442T4_17148442T30 NONE creatine_11\NN\14601829| (r_compound) b_13\NN\1355326|creatine|kinase (r_dobj) targets_10\VBZ\1151110|repeat|b|degradation|. (l_nsubj) repeat_1\NN\7296190|ankyrin|and|suppressors (l_compound) ankyrin_0\NN\1740|
17148442T4_17148442T31 NONE creatine_11\NN\14601829| (r_compound) b_13\NN\1355326|creatine|kinase (r_dobj) targets_10\VBZ\1151110|repeat|b|degradation|. (l_nsubj) repeat_1\NN\7296190|ankyrin|and|suppressors (l_conj) suppressors_3\NNS\10525134|protein (l_nmod) protein_8\NN\14944888|of|cytokine|signaling|box|asb-9
17148442T4_17148442T32 NONE creatine_11\NN\14601829| (r_compound) b_13\NN\1355326|creatine|kinase (r_dobj) targets_10\VBZ\1151110|repeat|b|degradation|. (l_nsubj) repeat_1\NN\7296190|ankyrin|and|suppressors (l_conj) suppressors_3\NNS\10525134|protein (l_nmod) protein_8\NN\14944888|of|cytokine|signaling|box|asb-9 (l_dep) asb-9_9\NN\1740|
17148442T4_17148442T33 NONE creatine_11\NN\14601829| (r_compound) b_13\NN\1355326|creatine|kinase
17148442T1_17148442T9 NONE n-terminal_4\JJ\1740|to|the|and|domains|mediate (l_conj) domains_9\NNS\13934596|src|homology|2
17148442T1_17148442T10 NONE n-terminal_4\JJ\1740|to|the|and|domains|mediate (r_nmod) addition_1\NN\3081021|in|n-terminal (r_nmod) contain_17\VBP\2632940|addition|,|proteins|box|. (l_nsubj) proteins_16\NNS\14944888|socs (l_compound) socs_15\NN\1740|
17148442T1_17148442T11 NONE n-terminal_4\JJ\1740|to|the|and|domains|mediate (r_nmod) addition_1\NN\3081021|in|n-terminal (r_nmod) contain_17\VBP\2632940|addition|,|proteins|box|. (l_dobj) box_21\NN\3094503|a|c-terminal|socs
17148442T2_17148442T9 NONE c-terminal_19\JJ\1740| (r_amod) box_21\NN\3094503|a|c-terminal|socs (r_dobj) contain_17\VBP\2632940|addition|,|proteins|box|. (l_nmod) addition_1\NN\3081021|in|n-terminal (l_nmod) n-terminal_4\JJ\1740|to|the|and|domains|mediate (l_conj) domains_9\NNS\13934596|src|homology|2
17148442T2_17148442T10 NONE c-terminal_19\JJ\1740| (r_amod) box_21\NN\3094503|a|c-terminal|socs (r_dobj) contain_17\VBP\2632940|addition|,|proteins|box|. (l_nsubj) proteins_16\NNS\14944888|socs (l_compound) socs_15\NN\1740|
17148442T2_17148442T11 NONE c-terminal_19\JJ\1740| (r_amod) box_21\NN\3094503|a|c-terminal|socs
17148442T3_17148442T21 NONE creatine_8\NN\14601829| (r_compound) b_10\NN\1355326|creatine|kinase|ckb
17148442T3_17148442T22 NONE creatine_8\NN\14601829| (r_compound) b_10\NN\1355326|creatine|kinase|ckb (l_appos) ckb_12\NN\1740|(|)
17148442T3_17148442T23 NONE creatine_8\NN\14601829| (r_compound) b_10\NN\1355326|creatine|kinase|ckb (r_nsubj) interacts_14\VBZ\2367363|that|b|asb-9|manner (l_nmod) asb-9_16\NN\1740|with
17148442T3_17148442T24 NONE creatine_8\NN\14601829| (r_compound) b_10\NN\1355326|creatine|kinase|ckb (r_nsubj) interacts_14\VBZ\2367363|that|b|asb-9|manner (l_nmod) manner_23\NN\4916342|in|a|specific|,|box-independent (l_amod) box-independent_22\JJ\1740|socs
12244038
12244038T17_12244038T68 CPR:4 gemfibrozil_0\NN\3740161|,|drug|, (r_nsubj) inhibits_6\VBZ\2510337|gemfibrozil|induction|. (l_dobj) induction_8\NN\7450842|the|synthase|astrocytes (l_nmod) synthase_11\NN\1740|of|nitric-oxide
12244038T18_12244038T68 CPR:9 nitric-oxide_10\NN\1740| (r_amod) synthase_11\NN\1740|of|nitric-oxide
12244038T1_12244038T20 CPR:4 gemfibrozil_0\NN\3740161|,|drug|, (r_nsubj) inhibited_6\VBD\2510337|gemfibrozil|production|. (l_dobj) production_8\NN\30358|cytokine-induced|no|and|expression (l_conj) expression_13\NN\4679549|the|synthase (l_nmod) synthase_17\NN\1740|of|inducible|nitric-oxide|inos|cells
12244038T1_12244038T29 CPR:4 gemfibrozil_0\NN\3740161|,|drug|, (r_nsubj) inhibited_6\VBD\2510337|gemfibrozil|production|. (l_dobj) production_8\NN\30358|cytokine-induced|no|and|expression (l_conj) expression_13\NN\4679549|the|synthase (l_nmod) synthase_17\NN\1740|of|inducible|nitric-oxide|inos|cells (l_appos) inos_19\NN\1740|(|)
12244038T1_12244038T56 CPR:4 gemfibrozil_0\NN\3740161|,|drug|, (r_nsubj) inhibited_6\VBD\2510337|gemfibrozil|production|. (l_dobj) production_8\NN\30358|cytokine-induced|no|and|expression (l_amod) cytokine-induced_7\JJ\1740|
12244038T2_12244038T20 CPR:9 nitric-oxide_16\JJ\1740| (r_amod) synthase_17\NN\1740|of|inducible|nitric-oxide|inos|cells
12244038T2_12244038T29 CPR:9 nitric-oxide_16\JJ\1740| (r_amod) synthase_17\NN\1740|of|inducible|nitric-oxide|inos|cells (l_appos) inos_19\NN\1740|(|)
12244038T2_12244038T56 NONE nitric-oxide_16\JJ\1740| (r_amod) synthase_17\NN\1740|of|inducible|nitric-oxide|inos|cells (r_nmod) expression_13\NN\4679549|the|synthase (r_conj) production_8\NN\30358|cytokine-induced|no|and|expression (l_amod) cytokine-induced_7\JJ\1740|
12244038T14_12244038T20 CPR:9 no_10\NN\7204911|of (r_nmod) production_8\NN\30358|cytokine-induced|no|and|expression (l_conj) expression_13\NN\4679549|the|synthase (l_nmod) synthase_17\NN\1740|of|inducible|nitric-oxide|inos|cells
12244038T14_12244038T29 CPR:9 no_10\NN\7204911|of (r_nmod) production_8\NN\30358|cytokine-induced|no|and|expression (l_conj) expression_13\NN\4679549|the|synthase (l_nmod) synthase_17\NN\1740|of|inducible|nitric-oxide|inos|cells (l_appos) inos_19\NN\1740|(|)
12244038T14_12244038T56 NONE no_10\NN\7204911|of (r_nmod) production_8\NN\30358|cytokine-induced|no|and|expression (l_amod) cytokine-induced_7\JJ\1740|
12244038T6_12244038T53 CPR:4 gemfibrozil_2\NN\3740161|to (r_nmod) similar_0\JJ\1740|gemfibrozil (r_advmod) inhibited_11\VBD\2510337|similar|,|clofibrate|also|expression|. (l_dobj) expression_13\NN\4679549|the|inos (l_nmod) inos_15\NN\1740|of
12244038T8_12244038T53 CPR:4 clofibrate_4\NN\3740161|,|drug|, (r_nsubj) inhibited_11\VBD\2510337|similar|,|clofibrate|also|expression|. (l_dobj) expression_13\NN\4679549|the|inos (l_nmod) inos_15\NN\1740|of
12244038T9_12244038T53 CPR:4 fibrate_7\NN\1740| (r_compound) drug_8\NN\14778436|another|fibrate (r_appos) clofibrate_4\NN\3740161|,|drug|, (r_nsubj) inhibited_11\VBD\2510337|similar|,|clofibrate|also|expression|. (l_dobj) expression_13\NN\4679549|the|inos (l_nmod) inos_15\NN\1740|of
12244038T10_12244038T54 CPR:4 gemfibrozil_8\NN\3740161|by|cells (r_nmod) inhibition_0\NN\1068773|activity|gemfibrozil (l_nmod) activity_6\NN\30358|of|human|inos|promoter-driven|luciferase (l_amod) promoter-driven_4\JJ\1740|
12244038T10_12244038T55 NONE gemfibrozil_8\NN\3740161|by|cells (l_nmod) cells_13\NNS\3080309|in|cytokine-stimulated|u373mg|astroglial (l_amod) cytokine-stimulated_10\JJ\1740|
12244038T10_12244038T57 CPR:4 gemfibrozil_8\NN\3740161|by|cells (r_nmod) inhibition_0\NN\1068773|activity|gemfibrozil (r_nsubj) suggests_14\VBZ\1010118|inhibition|inhibits|. (l_ccomp) inhibits_18\VBZ\2510337|that|compound|transcription (l_dobj) transcription_20\NN\6349220|the|inos (l_nmod) inos_22\NN\1740|of
12244038T11_12244038T58 CPR:3 gemfibrozil_1\NN\3740161| (r_nsubjpass) known_3\VBN\2110220|since|gemfibrozil|is|activate (l_xcomp) activate_5\VB\1641914|to|receptor-alpha (l_dobj) receptor-alpha_8\NN\1740|peroxisome|proliferator-activated|ppar-alpha
12244038T11_12244038T59 CPR:3 gemfibrozil_1\NN\3740161| (r_nsubjpass) known_3\VBN\2110220|since|gemfibrozil|is|activate (l_xcomp) activate_5\VB\1641914|to|receptor-alpha (l_dobj) receptor-alpha_8\NN\1740|peroxisome|proliferator-activated|ppar-alpha (l_appos) ppar-alpha_10\NN\1740|(|)
12244038T11_12244038T60 NONE gemfibrozil_1\NN\3740161| (r_nsubjpass) known_3\VBN\2110220|since|gemfibrozil|is|activate (r_advcl) investigated_14\VBD\644583|known|,|we|role|. (l_dobj) role_16\NN\719494|the|ppar-alpha|inhibition (l_nmod) ppar-alpha_18\NN\1740|of
12244038T11_12244038T61 NONE gemfibrozil_1\NN\3740161| (r_nsubjpass) known_3\VBN\2110220|since|gemfibrozil|is|activate (r_advcl) investigated_14\VBD\644583|known|,|we|role|. (l_dobj) role_16\NN\719494|the|ppar-alpha|inhibition (l_nmod) inhibition_21\NN\1068773|in|gemfibrozil-mediated|inos (l_nmod) inos_23\NN\1740|of
12244038T12_12244038T58 NONE gemfibrozil-mediated_20\JJ\1740| (r_amod) inhibition_21\NN\1068773|in|gemfibrozil-mediated|inos (r_nmod) role_16\NN\719494|the|ppar-alpha|inhibition (r_dobj) investigated_14\VBD\644583|known|,|we|role|. (l_advcl) known_3\VBN\2110220|since|gemfibrozil|is|activate (l_xcomp) activate_5\VB\1641914|to|receptor-alpha (l_dobj) receptor-alpha_8\NN\1740|peroxisome|proliferator-activated|ppar-alpha
12244038T12_12244038T59 NONE gemfibrozil-mediated_20\JJ\1740| (r_amod) inhibition_21\NN\1068773|in|gemfibrozil-mediated|inos (r_nmod) role_16\NN\719494|the|ppar-alpha|inhibition (r_dobj) investigated_14\VBD\644583|known|,|we|role|. (l_advcl) known_3\VBN\2110220|since|gemfibrozil|is|activate (l_xcomp) activate_5\VB\1641914|to|receptor-alpha (l_dobj) receptor-alpha_8\NN\1740|peroxisome|proliferator-activated|ppar-alpha (l_appos) ppar-alpha_10\NN\1740|(|)
12244038T12_12244038T60 CPR:3 gemfibrozil-mediated_20\JJ\1740| (r_amod) inhibition_21\NN\1068773|in|gemfibrozil-mediated|inos (r_nmod) role_16\NN\719494|the|ppar-alpha|inhibition (l_nmod) ppar-alpha_18\NN\1740|of
12244038T12_12244038T61 CPR:4 gemfibrozil-mediated_20\JJ\1740| (r_amod) inhibition_21\NN\1068773|in|gemfibrozil-mediated|inos (l_nmod) inos_23\NN\1740|of
12244038T13_12244038T62 CPR:3 gemfibrozil_0\NN\3740161| (r_nsubj) induced_1\VBD\1627355|gemfibrozil|activity|. (l_dobj) activity_7\NN\30358|(ppre)-dependent|luciferase|,|inhibited (l_amod) (ppre)-dependent_5\JJ\1740|element (l_nmod:npmod) element_4\NN\5867413|peroxisome|proliferator-responsive
12244038T13_12244038T63 CPR:3 gemfibrozil_0\NN\3740161| (r_nsubj) induced_1\VBD\1627355|gemfibrozil|activity|. (l_dobj) activity_7\NN\30358|(ppre)-dependent|luciferase|,|inhibited (l_amod) (ppre)-dependent_5\JJ\1740|element
12244038T13_12244038T64 NONE gemfibrozil_0\NN\3740161| (r_nsubj) induced_1\VBD\1627355|gemfibrozil|activity|. (l_dobj) activity_7\NN\30358|(ppre)-dependent|luciferase|,|inhibited (l_acl:relcl) inhibited_11\VBN\2510337|which|was|expression (l_nmod) expression_14\NN\4679549|by|the|deltahppar-alpha (l_nmod) deltahppar-alpha_16\NN\1740|of|,|mutant
12244038T13_12244038T65 NONE gemfibrozil_0\NN\3740161| (r_nsubj) induced_1\VBD\1627355|gemfibrozil|activity|. (l_dobj) activity_7\NN\30358|(ppre)-dependent|luciferase|,|inhibited (l_acl:relcl) inhibited_11\VBN\2510337|which|was|expression (l_nmod) expression_14\NN\4679549|by|the|deltahppar-alpha (l_nmod) deltahppar-alpha_16\NN\1740|of|,|mutant (l_appos) mutant_20\NN\4475|the|dominant-negative|ppar-alpha (l_nmod) ppar-alpha_23\NN\1740|of|human
12244038T15_12244038T19 NONE gemfibrozil-mediated_7\JJ\1740| (r_amod) inhibition_8\NN\1068773|gemfibrozil-mediated|inos (r_dobj) abrogate_6\VB\2427334|to|inhibition (r_xcomp) unable_4\JJ\1740|however|,|deltahppar-alpha|was|abrogate|suggesting|. (l_xcomp) suggesting_11\VBG\1010118|inhibits (l_ccomp) inhibits_14\VBZ\2510337|that|gemfibrozil|inos (l_dobj) inos_15\NN\1740|independent
12244038T15_12244038T21 NONE gemfibrozil-mediated_7\JJ\1740| (r_amod) inhibition_8\NN\1068773|gemfibrozil-mediated|inos (r_dobj) abrogate_6\VB\2427334|to|inhibition (r_xcomp) unable_4\JJ\1740|however|,|deltahppar-alpha|was|abrogate|suggesting|. (l_xcomp) suggesting_11\VBG\1010118|inhibits (l_ccomp) inhibits_14\VBZ\2510337|that|gemfibrozil|inos (l_dobj) inos_15\NN\1740|independent (l_amod) independent_16\JJ\1740|ppar-alpha (l_nmod) ppar-alpha_18\NN\1740|of
12244038T15_12244038T66 NONE gemfibrozil-mediated_7\JJ\1740| (r_amod) inhibition_8\NN\1068773|gemfibrozil-mediated|inos (r_dobj) abrogate_6\VB\2427334|to|inhibition (r_xcomp) unable_4\JJ\1740|however|,|deltahppar-alpha|was|abrogate|suggesting|. (l_nsubj) deltahppar-alpha_2\NN\1740|
12244038T15_12244038T67 CPR:4 gemfibrozil-mediated_7\JJ\1740| (r_amod) inhibition_8\NN\1068773|gemfibrozil-mediated|inos (l_nmod) inos_10\NN\1740|of
12244038T16_12244038T19 CPR:4 gemfibrozil_13\NN\3740161| (r_nsubj) inhibits_14\VBZ\2510337|that|gemfibrozil|inos (l_dobj) inos_15\NN\1740|independent
12244038T16_12244038T21 NONE gemfibrozil_13\NN\3740161| (r_nsubj) inhibits_14\VBZ\2510337|that|gemfibrozil|inos (l_dobj) inos_15\NN\1740|independent (l_amod) independent_16\JJ\1740|ppar-alpha (l_nmod) ppar-alpha_18\NN\1740|of
12244038T16_12244038T66 NONE gemfibrozil_13\NN\3740161| (r_nsubj) inhibits_14\VBZ\2510337|that|gemfibrozil|inos (r_ccomp) suggesting_11\VBG\1010118|inhibits (r_xcomp) unable_4\JJ\1740|however|,|deltahppar-alpha|was|abrogate|suggesting|. (l_nsubj) deltahppar-alpha_2\NN\1740|
12244038T16_12244038T67 NONE gemfibrozil_13\NN\3740161| (r_nsubj) inhibits_14\VBZ\2510337|that|gemfibrozil|inos (r_ccomp) suggesting_11\VBG\1010118|inhibits (r_xcomp) unable_4\JJ\1740|however|,|deltahppar-alpha|was|abrogate|suggesting|. (l_xcomp) abrogate_6\VB\2427334|to|inhibition (l_dobj) inhibition_8\NN\1068773|gemfibrozil-mediated|inos (l_nmod) inos_10\NN\1740|of
12244038T3_12244038T22 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_nsubj) promoter_3\NN\9773962|the|human|inos
12244038T3_12244038T23 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding
12244038T3_12244038T24 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_appos) irf-1_22\NN\1740|(|)
12244038T3_12244038T25 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer
12244038T3_12244038T26 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_appos) isre_30\NN\1740|(|)
12244038T3_12244038T27 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_conj) transducer_34\NN\3269401|signal|and|activator|binding (l_conj) activator_36\NN\19613|transcription|stat (l_nmod) transcription_38\NN\6349220|of
12244038T3_12244038T28 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_conj) transducer_34\NN\3269401|signal|and|activator|binding (l_conj) activator_36\NN\19613|transcription|stat (l_appos) stat_40\NN\1740|(|)
12244038T3_12244038T30 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_conj) transducer_34\NN\3269401|signal|and|activator|binding (l_amod) binding_42\VBG\1290422|site (l_nmod) site_45\NN\8673395|to|gamma-activation|gas|,|factor-kappab|,|protein-1|,|and|beta (l_conj) factor-kappab_51\NN\1740|nuclear|nf-kappab
12244038T3_12244038T31 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_conj) transducer_34\NN\3269401|signal|and|activator|binding (l_amod) binding_42\VBG\1290422|site (l_nmod) site_45\NN\8673395|to|gamma-activation|gas|,|factor-kappab|,|protein-1|,|and|beta (l_conj) factor-kappab_51\NN\1740|nuclear|nf-kappab (l_appos) nf-kappab_53\NN\1740|(|)
12244038T3_12244038T32 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_conj) transducer_34\NN\3269401|signal|and|activator|binding (l_amod) binding_42\VBG\1290422|site (l_nmod) site_45\NN\8673395|to|gamma-activation|gas|,|factor-kappab|,|protein-1|,|and|beta (l_conj) protein-1_57\NN\1740|activator|ap-1
12244038T3_12244038T33 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_conj) transducer_34\NN\3269401|signal|and|activator|binding (l_amod) binding_42\VBG\1290422|site (l_nmod) site_45\NN\8673395|to|gamma-activation|gas|,|factor-kappab|,|protein-1|,|and|beta (l_conj) protein-1_57\NN\1740|activator|ap-1 (l_appos) ap-1_59\NN\1740|(|)
12244038T3_12244038T34 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_conj) transducer_34\NN\3269401|signal|and|activator|binding (l_amod) binding_42\VBG\1290422|site (l_nmod) site_45\NN\8673395|to|gamma-activation|gas|,|factor-kappab|,|protein-1|,|and|beta (l_conj) beta_65\NN\6828818|ccaat/enhancer-binding|protein|c/ebpbeta
12244038T3_12244038T35 NONE gemfibrozil_77\NN\3740161|of (r_nmod) effect_75\NN\34213|the|gemfibrozil|activation (r_dobj) investigated_73\VBD\644583|therefore|,|we|effect|. (r_parataxis) contains_4\VBZ\2632940|promoter|sequences|;|investigated (l_dobj) sequences_6\NNS\8457976|consensus|binding (l_nmod) binding_9\NN\4688246|for|the|factors (l_nmod) factors_12\NNS\7326557|of|transcription|,|factor-1 (l_nmod) factor-1_20\NN\1740|including|interferon-gamma|regulatory|irf-1|binding (l_acl) binding_24\VBG\1290422|element (l_nmod) element_28\NN\5867413|to|interferon-stimulated|responsive|isre|,|transducer (l_conj) transducer_34\NN\3269401|signal|and|activator|binding (l_amod) binding_42\VBG\1290422|site (l_nmod) site_45\NN\8673395|to|gamma-activation|gas|,|factor-kappab|,|protein-1|,|and|beta (l_conj) beta_65\NN\6828818|ccaat/enhancer-binding|protein|c/ebpbeta (l_appos) c/ebpbeta_67\NN\1740|(|)
12244038T4_12244038T45 CPR:4 gemfibrozil_2\NN\3740161| (r_nsubj) inhibited_4\VBD\2510337|interestingly|,|gemfibrozil|strongly|activation|. (l_dobj) activation_6\NN\13561719|the|nf-kappab|not|that (l_nmod) nf-kappab_8\NN\1740|of|,|ap-1|,|and|c/ebpbeta
12244038T4_12244038T46 CPR:4 gemfibrozil_2\NN\3740161| (r_nsubj) inhibited_4\VBD\2510337|interestingly|,|gemfibrozil|strongly|activation|. (l_dobj) activation_6\NN\13561719|the|nf-kappab|not|that (l_nmod) nf-kappab_8\NN\1740|of|,|ap-1|,|and|c/ebpbeta (l_conj) ap-1_10\NN\1740|
12244038T4_12244038T47 CPR:4 gemfibrozil_2\NN\3740161| (r_nsubj) inhibited_4\VBD\2510337|interestingly|,|gemfibrozil|strongly|activation|. (l_dobj) activation_6\NN\13561719|the|nf-kappab|not|that (l_nmod) nf-kappab_8\NN\1740|of|,|ap-1|,|and|c/ebpbeta (l_conj) c/ebpbeta_13\NN\1740|
12244038T4_12244038T48 NONE gemfibrozil_2\NN\3740161| (r_nsubj) inhibited_4\VBD\2510337|interestingly|,|gemfibrozil|strongly|activation|. (l_dobj) activation_6\NN\13561719|the|nf-kappab|not|that (l_conj) that_16\DT\1740|gas|cells (l_nmod) cells_22\NNS\3080309|in|cytokine-stimulated|astroglial (l_amod) cytokine-stimulated_20\JJ\1740|
12244038T5_12244038T49 CPR:4 gemfibrozil_4\NN\3740161| (r_nsubj) inhibits_5\VBZ\2510337|that|gemfibrozil|induction|inhibiting|and|find (l_dobj) induction_7\NN\7450842|the|inos (l_nmod) inos_9\NN\1740|of
12244038T5_12244038T50 CPR:4 gemfibrozil_4\NN\3740161| (r_nsubj) inhibits_5\VBZ\2510337|that|gemfibrozil|induction|inhibiting|and|find (l_advcl) inhibiting_12\VBG\2510337|probably|by|activation (l_dobj) activation_14\NN\13561719|the|nf-kappab (l_nmod) nf-kappab_16\NN\1740|of|,|ap-1|,|and|c/ebpbeta
12244038T5_12244038T51 CPR:4 gemfibrozil_4\NN\3740161| (r_nsubj) inhibits_5\VBZ\2510337|that|gemfibrozil|induction|inhibiting|and|find (l_advcl) inhibiting_12\VBG\2510337|probably|by|activation (l_dobj) activation_14\NN\13561719|the|nf-kappab (l_nmod) nf-kappab_16\NN\1740|of|,|ap-1|,|and|c/ebpbeta (l_conj) ap-1_18\NN\1740|
12244038T5_12244038T52 CPR:4 gemfibrozil_4\NN\3740161| (r_nsubj) inhibits_5\VBZ\2510337|that|gemfibrozil|induction|inhibiting|and|find (l_advcl) inhibiting_12\VBG\2510337|probably|by|activation (l_dobj) activation_14\NN\13561719|the|nf-kappab (l_nmod) nf-kappab_16\NN\1740|of|,|ap-1|,|and|c/ebpbeta (l_conj) c/ebpbeta_21\NN\1740|
12244038T7_12244038T49 NONE gemfibrozil_24\NN\3740161|,|drug|, (r_nsubj) find_34\VB\2163746|that|gemfibrozil|may|further|use (r_conj) inhibits_5\VBZ\2510337|that|gemfibrozil|induction|inhibiting|and|find (l_dobj) induction_7\NN\7450842|the|inos (l_nmod) inos_9\NN\1740|of
12244038T7_12244038T50 NONE gemfibrozil_24\NN\3740161|,|drug|, (r_nsubj) find_34\VB\2163746|that|gemfibrozil|may|further|use (r_conj) inhibits_5\VBZ\2510337|that|gemfibrozil|induction|inhibiting|and|find (l_advcl) inhibiting_12\VBG\2510337|probably|by|activation (l_dobj) activation_14\NN\13561719|the|nf-kappab (l_nmod) nf-kappab_16\NN\1740|of|,|ap-1|,|and|c/ebpbeta
12244038T7_12244038T51 NONE gemfibrozil_24\NN\3740161|,|drug|, (r_nsubj) find_34\VB\2163746|that|gemfibrozil|may|further|use (r_conj) inhibits_5\VBZ\2510337|that|gemfibrozil|induction|inhibiting|and|find (l_advcl) inhibiting_12\VBG\2510337|probably|by|activation (l_dobj) activation_14\NN\13561719|the|nf-kappab (l_nmod) nf-kappab_16\NN\1740|of|,|ap-1|,|and|c/ebpbeta (l_conj) ap-1_18\NN\1740|
12244038T7_12244038T52 NONE gemfibrozil_24\NN\3740161|,|drug|, (r_nsubj) find_34\VB\2163746|that|gemfibrozil|may|further|use (r_conj) inhibits_5\VBZ\2510337|that|gemfibrozil|induction|inhibiting|and|find (l_advcl) inhibiting_12\VBG\2510337|probably|by|activation (l_dobj) activation_14\NN\13561719|the|nf-kappab (l_nmod) nf-kappab_16\NN\1740|of|,|ap-1|,|and|c/ebpbeta (l_conj) c/ebpbeta_21\NN\1740|
12183670
12183670T1_12183670T40 CPR:4 bupropion_0\NN\1740|,|antidepressant|, (r_nsubj) inhibits_10\VBZ\2510337|bupropion|transporters|. (l_dobj) transporters_14\NNS\4490091|dopamine|dat (l_dep) dat_16\NNS\2757810|(|and|net|,|respectively|)
12183670T1_12183670T41 CPR:4 bupropion_0\NN\1740|,|antidepressant|, (r_nsubj) inhibits_10\VBZ\2510337|bupropion|transporters|. (l_dobj) transporters_14\NNS\4490091|dopamine|dat (l_dep) dat_16\NNS\2757810|(|and|net|,|respectively|) (l_conj) net_18\NN\3085333|
12183670T1_12183670T48 NONE bupropion_0\NN\1740|,|antidepressant|, (r_nsubj) inhibits_10\VBZ\2510337|bupropion|transporters|. (l_dobj) transporters_14\NNS\4490091|dopamine|dat
12183670T29_12183670T40 NONE dopamine_11\NN\14807737|and|norepinephrine (r_compound) transporters_14\NNS\4490091|dopamine|dat (l_dep) dat_16\NNS\2757810|(|and|net|,|respectively|)
12183670T29_12183670T41 NONE dopamine_11\NN\14807737|and|norepinephrine (r_compound) transporters_14\NNS\4490091|dopamine|dat (l_dep) dat_16\NNS\2757810|(|and|net|,|respectively|) (l_conj) net_18\NN\3085333|
12183670T29_12183670T48 NONE dopamine_11\NN\14807737|and|norepinephrine (r_compound) transporters_14\NNS\4490091|dopamine|dat
12183670T33_12183670T40 NONE norepinephrine_13\NN\14807929| (r_conj) dopamine_11\NN\14807737|and|norepinephrine (r_compound) transporters_14\NNS\4490091|dopamine|dat (l_dep) dat_16\NNS\2757810|(|and|net|,|respectively|)
12183670T33_12183670T41 NONE norepinephrine_13\NN\14807929| (r_conj) dopamine_11\NN\14807737|and|norepinephrine (r_compound) transporters_14\NNS\4490091|dopamine|dat (l_dep) dat_16\NNS\2757810|(|and|net|,|respectively|) (l_conj) net_18\NN\3085333|
12183670T33_12183670T48 NONE norepinephrine_13\NN\14807929| (r_conj) dopamine_11\NN\14807737|and|norepinephrine (r_compound) transporters_14\NNS\4490091|dopamine|dat
12183670T14_12183670T46 NONE bupropion_2\NN\1740| (r_nsubjpass) reported_5\VBN\831651|recently|,|bupropion|has|been|inhibit|. (l_xcomp) inhibit_8\VB\2510337|to|noncompetitively|receptors (l_dobj) receptors_17\NNS\5225602|alpha3beta2|nicotinic|acetylcholine|nachrs|expressed (l_appos) nachrs_19\NNS\1740|(|) (l_punct) )_20\-RRB-\1740|
12183670T19_12183670T46 NONE acetylcholine_16\NN\14807558| (r_compound) receptors_17\NNS\5225602|alpha3beta2|nicotinic|acetylcholine|nachrs|expressed (l_appos) nachrs_19\NNS\1740|(|) (l_punct) )_20\-RRB-\1740|
12183670T20_12183670T47 NONE bupropion-induced_4\JJ\1740| (r_amod) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T21_12183670T47 NONE nicotine-evoked_20\JJ\1740| (r_amod) [(3)h]overflow_21\NN\1740|nicotine-evoked|slices (r_conj) assays_18\NNS\5733583|functional|neurotransmitter|release|,|[(3)h]overflow (r_dobj) using_14\VBG\1156834|assays (r_xcomp) evaluated_3\VBD\670261|study|inhibition|using|. (l_dobj) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T22_12183670T47 NONE [(3)h]overflow_21\NN\1740|nicotine-evoked|slices (r_conj) assays_18\NNS\5733583|functional|neurotransmitter|release|,|[(3)h]overflow (r_dobj) using_14\VBG\1156834|assays (r_xcomp) evaluated_3\VBD\670261|study|inhibition|using|. (l_dobj) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T23_12183670T47 NONE [(3)h]dopamine_29\NN\1740|with|[(3)h]da|,|and|[(3)h]overflow (r_nmod) preloaded_27\VBN\1740|[(3)h]dopamine (r_acl) slices_26\NNS\13285176|from|superfused|rat|striatal|preloaded (r_nmod) [(3)h]overflow_21\NN\1740|nicotine-evoked|slices (r_conj) assays_18\NNS\5733583|functional|neurotransmitter|release|,|[(3)h]overflow (r_dobj) using_14\VBG\1156834|assays (r_xcomp) evaluated_3\VBD\670261|study|inhibition|using|. (l_dobj) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T24_12183670T47 NONE [(3)h]da_31\NN\1740|(|) (r_appos) [(3)h]dopamine_29\NN\1740|with|[(3)h]da|,|and|[(3)h]overflow (r_nmod) preloaded_27\VBN\1740|[(3)h]dopamine (r_acl) slices_26\NNS\13285176|from|superfused|rat|striatal|preloaded (r_nmod) [(3)h]overflow_21\NN\1740|nicotine-evoked|slices (r_conj) assays_18\NNS\5733583|functional|neurotransmitter|release|,|[(3)h]overflow (r_dobj) using_14\VBG\1156834|assays (r_xcomp) evaluated_3\VBD\670261|study|inhibition|using|. (l_dobj) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T25_12183670T47 NONE nicotine-evoked_35\JJ\1740| (r_amod) [(3)h]overflow_36\NN\1740|nicotine-evoked|slices (r_conj) [(3)h]dopamine_29\NN\1740|with|[(3)h]da|,|and|[(3)h]overflow (r_nmod) preloaded_27\VBN\1740|[(3)h]dopamine (r_acl) slices_26\NNS\13285176|from|superfused|rat|striatal|preloaded (r_nmod) [(3)h]overflow_21\NN\1740|nicotine-evoked|slices (r_conj) assays_18\NNS\5733583|functional|neurotransmitter|release|,|[(3)h]overflow (r_dobj) using_14\VBG\1156834|assays (r_xcomp) evaluated_3\VBD\670261|study|inhibition|using|. (l_dobj) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T26_12183670T47 NONE [(3)h]overflow_36\NN\1740|nicotine-evoked|slices (r_conj) [(3)h]dopamine_29\NN\1740|with|[(3)h]da|,|and|[(3)h]overflow (r_nmod) preloaded_27\VBN\1740|[(3)h]dopamine (r_acl) slices_26\NNS\13285176|from|superfused|rat|striatal|preloaded (r_nmod) [(3)h]overflow_21\NN\1740|nicotine-evoked|slices (r_conj) assays_18\NNS\5733583|functional|neurotransmitter|release|,|[(3)h]overflow (r_dobj) using_14\VBG\1156834|assays (r_xcomp) evaluated_3\VBD\670261|study|inhibition|using|. (l_dobj) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T27_12183670T47 NONE [(3)h]norepinephrine_42\NN\1740|with|[(3)h]ne (r_nmod) preloaded_40\VBN\1740|[(3)h]norepinephrine (r_acl) slices_39\NNS\13285176|from|hippocampal|preloaded (r_nmod) [(3)h]overflow_36\NN\1740|nicotine-evoked|slices (r_conj) [(3)h]dopamine_29\NN\1740|with|[(3)h]da|,|and|[(3)h]overflow (r_nmod) preloaded_27\VBN\1740|[(3)h]dopamine (r_acl) slices_26\NNS\13285176|from|superfused|rat|striatal|preloaded (r_nmod) [(3)h]overflow_21\NN\1740|nicotine-evoked|slices (r_conj) assays_18\NNS\5733583|functional|neurotransmitter|release|,|[(3)h]overflow (r_dobj) using_14\VBG\1156834|assays (r_xcomp) evaluated_3\VBD\670261|study|inhibition|using|. (l_dobj) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T28_12183670T47 NONE [(3)h]ne_44\NN\1740|(|) (r_appos) [(3)h]norepinephrine_42\NN\1740|with|[(3)h]ne (r_nmod) preloaded_40\VBN\1740|[(3)h]norepinephrine (r_acl) slices_39\NNS\13285176|from|hippocampal|preloaded (r_nmod) [(3)h]overflow_36\NN\1740|nicotine-evoked|slices (r_conj) [(3)h]dopamine_29\NN\1740|with|[(3)h]da|,|and|[(3)h]overflow (r_nmod) preloaded_27\VBN\1740|[(3)h]dopamine (r_acl) slices_26\NNS\13285176|from|superfused|rat|striatal|preloaded (r_nmod) [(3)h]overflow_21\NN\1740|nicotine-evoked|slices (r_conj) assays_18\NNS\5733583|functional|neurotransmitter|release|,|[(3)h]overflow (r_dobj) using_14\VBG\1156834|assays (r_xcomp) evaluated_3\VBD\670261|study|inhibition|using|. (l_dobj) inhibition_5\NN\1068773|bupropion-induced|* (l_nmod) *_9\NN\1740|of|alpha3beta2|and|alpha3beta4|*|nachrs (l_dep) nachrs_13\NNS\1740|
12183670T30_12183670T49 CPR:4 bupropion_5\NN\1740|of (r_nmod) interaction_3\NN\37396|the|bupropion|dat (l_nmod) dat_7\NN\2757810|with|or|net
12183670T30_12183670T50 CPR:4 bupropion_5\NN\1740|of (r_nmod) interaction_3\NN\37396|the|bupropion|dat (l_nmod) dat_7\NN\2757810|with|or|net (l_conj) net_9\NN\3085333|
12183670T31_12183670T49 NONE nomifensine_11\NN\1740|or|desipramine|, (r_nsubjpass) included_18\VBN\690614|eliminate|,|nomifensine|respectively|,|was|buffer|. (l_advcl) eliminate_1\VB\1619929|to|interaction (l_dobj) interaction_3\NN\37396|the|bupropion|dat (l_nmod) dat_7\NN\2757810|with|or|net
12183670T31_12183670T50 NONE nomifensine_11\NN\1740|or|desipramine|, (r_nsubjpass) included_18\VBN\690614|eliminate|,|nomifensine|respectively|,|was|buffer|. (l_advcl) eliminate_1\VB\1619929|to|interaction (l_dobj) interaction_3\NN\37396|the|bupropion|dat (l_nmod) dat_7\NN\2757810|with|or|net (l_conj) net_9\NN\3085333|
12183670T32_12183670T49 NONE desipramine_13\NN\4482543| (r_conj) nomifensine_11\NN\1740|or|desipramine|, (r_nsubjpass) included_18\VBN\690614|eliminate|,|nomifensine|respectively|,|was|buffer|. (l_advcl) eliminate_1\VB\1619929|to|interaction (l_dobj) interaction_3\NN\37396|the|bupropion|dat (l_nmod) dat_7\NN\2757810|with|or|net
12183670T32_12183670T50 NONE desipramine_13\NN\4482543| (r_conj) nomifensine_11\NN\1740|or|desipramine|, (r_nsubjpass) included_18\VBN\690614|eliminate|,|nomifensine|respectively|,|was|buffer|. (l_advcl) eliminate_1\VB\1619929|to|interaction (l_dobj) interaction_3\NN\37396|the|bupropion|dat (l_nmod) dat_7\NN\2757810|with|or|net (l_conj) net_9\NN\3085333|
12183670T17_12183670T42 NONE bupropion_2\NN\1740| (r_nsubj) acts_3\VBZ\1619354|thus|,|bupropion|antagonist|*|,|respectively|,|range|. (l_nmod) *_9\JJ\1740|at|alpha3beta2|and|alpha3beta4|*|nachrs|striatum (l_dep) nachrs_13\NNS\1740|
12183670T17_12183670T43 CPR:4 bupropion_2\NN\1740| (r_nsubj) acts_3\VBZ\1619354|thus|,|bupropion|antagonist|*|,|respectively|,|range|. (l_nmod) range_26\NN\5123416|across|the|same|concentration|inhibits (l_acl:relcl) inhibits_28\VBZ\2510337|that|dat (l_dobj) dat_29\NN\2757810|and|function
12183670T17_12183670T44 CPR:4 bupropion_2\NN\1740| (r_nsubj) acts_3\VBZ\1619354|thus|,|bupropion|antagonist|*|,|respectively|,|range|. (l_nmod) range_26\NN\5123416|across|the|same|concentration|inhibits (l_acl:relcl) inhibits_28\VBZ\2510337|that|dat (l_dobj) dat_29\NN\2757810|and|function (l_conj) function_32\NN\13783581|net (l_amod) net_31\JJ\1740|
12183670T18_12183670T45 CPR:4 bupropion_9\NN\1740|by (r_nmod) produced_7\VBN\1617192|bupropion (r_acl) inhibition_6\NN\1068773|transporter|produced (r_conj) nachr_3\NN\1740|of|and|inhibition
16851960
16851960T14_16851960T20 NONE methyl_0\NN\14617189| (r_compound) transfer_1\NN\280586|methyl|n-methyltransferase|. (l_nmod) n-methyltransferase_4\NN\1740|in|glycine
16851960T15_16851960T20 NONE glycine_3\NN\14601829| (r_compound) n-methyltransferase_4\NN\1740|in|glycine
16851960T16_16851960T20 NONE n-methyltransferase_4\NN\1740|in|glycine
16851960T1_16851960T17 CPR:9 methyl_15\NN\14617189| (r_compound) step_17\NN\168237|the|methyl|transfer|n-methyltransferase (l_nmod) n-methyltransferase_20\NN\1740|in|glycine|gnmt
16851960T1_16851960T18 CPR:9 methyl_15\NN\14617189| (r_compound) step_17\NN\168237|the|methyl|transfer|n-methyltransferase (l_nmod) n-methyltransferase_20\NN\1740|in|glycine|gnmt (l_appos) gnmt_22\NN\1740|(|)
16851960T2_16851960T17 NONE glycine_19\NN\14601829| (r_compound) n-methyltransferase_20\NN\1740|in|glycine|gnmt
16851960T2_16851960T18 NONE glycine_19\NN\14601829| (r_compound) n-methyltransferase_20\NN\1740|in|glycine|gnmt (l_appos) gnmt_22\NN\1740|(|)
16851960T3_16851960T17 NONE n-methyltransferase_20\NN\1740|in|glycine|gnmt
16851960T3_16851960T18 NONE n-methyltransferase_20\NN\1740|in|glycine|gnmt (l_appos) gnmt_22\NN\1740|(|)
16851960T8_16851960T19 CPR:9 sam_16\NN\3466162|with|and|acetate (r_nmod) complexed_14\VBN\1740|sam (r_acl) structure_11\NN\21939|point|is|the|recent|x-ray|crystal|gnmt|complexed|. (l_nmod) gnmt_13\NNP\1740|of
12213053
12213053T19_12213053T35 CPR:4 mazindol_0\NN\1740| (r_compound) analogues_1\NNS\4743605|mazindol|inhibitors|. (l_nmod) inhibitors_4\NNS\20090|as|potential|site (l_nmod) site_9\NN\8673395|of|the|cocaine|binding|transporter
12213053T19_12213053T36 CPR:4 mazindol_0\NN\1740| (r_compound) analogues_1\NNS\4743605|mazindol|inhibitors|. (l_nmod) inhibitors_4\NNS\20090|as|potential|site (l_nmod) site_9\NN\8673395|of|the|cocaine|binding|transporter (l_nmod) transporter_13\NN\4490091|at|the|dopamine
12213053T20_12213053T35 NONE cocaine_7\NN\3492717| (r_compound) site_9\NN\8673395|of|the|cocaine|binding|transporter
12213053T20_12213053T36 NONE cocaine_7\NN\3492717| (r_compound) site_9\NN\8673395|of|the|cocaine|binding|transporter (l_nmod) transporter_13\NN\4490091|at|the|dopamine
12213053T21_12213053T35 NONE dopamine_12\NN\14807737| (r_compound) transporter_13\NN\4490091|at|the|dopamine (r_nmod) site_9\NN\8673395|of|the|cocaine|binding|transporter
12213053T21_12213053T36 CPR:9 dopamine_12\NN\14807737| (r_compound) transporter_13\NN\4490091|at|the|dopamine
12213053T1_12213053T22 NONE mazindol_3\NN\1740|of|2|and|analogues (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes
12213053T1_12213053T23 NONE mazindol_3\NN\1740|of|2|and|analogues (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes (l_appos) dat_58\NN\2757810|(|)
12213053T2_12213053T22 NONE aryl_24\NN\1740| (r_amod) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes
12213053T2_12213053T23 NONE aryl_24\NN\1740| (r_amod) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes (l_appos) dat_58\NN\2757810|(|)
12213053T3_12213053T22 NONE benzo_28\NN\1740| (r_compound) c_30\NN\13714184|the|benzo|ring (r_conj) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes
12213053T3_12213053T23 NONE benzo_28\NN\1740| (r_compound) c_30\NN\13714184|the|benzo|ring (r_conj) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes (l_appos) dat_58\NN\2757810|(|)
12213053T4_12213053T22 NONE methoxy_37\NN\1740| (r_conj) h_35\NN\14622893|,|methoxy|,|and|alkyl (r_compound) groups_41\NNS\2137|h|replacing (r_conj) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes
12213053T4_12213053T23 NONE methoxy_37\NN\1740| (r_conj) h_35\NN\14622893|,|methoxy|,|and|alkyl (r_compound) groups_41\NNS\2137|h|replacing (r_conj) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes (l_appos) dat_58\NN\2757810|(|)
12213053T5_12213053T22 NONE alkyl_40\NN\14621446| (r_conj) h_35\NN\14622893|,|methoxy|,|and|alkyl (r_compound) groups_41\NNS\2137|h|replacing (r_conj) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes
12213053T5_12213053T23 NONE alkyl_40\NN\14621446| (r_conj) h_35\NN\14622893|,|methoxy|,|and|alkyl (r_compound) groups_41\NNS\2137|h|replacing (r_conj) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes (l_appos) dat_58\NN\2757810|(|)
12213053T6_12213053T22 NONE hydroxyl_44\NN\14621446| (r_compound) group_45\NN\2137|the|hydroxyl (r_dobj) replacing_42\VBG\1631072|group (r_acl) groups_41\NNS\2137|h|replacing (r_conj) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes
12213053T6_12213053T23 NONE hydroxyl_44\NN\14621446| (r_compound) group_45\NN\2137|the|hydroxyl (r_dobj) replacing_42\VBG\1631072|group (r_acl) groups_41\NNS\2137|h|replacing (r_conj) group_25\NN\2137|in|the|pendant|aryl|and|c|,|as|groups (r_nmod) variety_15\NN\7951464|with|a|groups|group (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes (l_appos) dat_58\NN\2757810|(|)
12213053T7_12213053T22 NONE homomazindol_8\NN\1740|3 (r_compound) analogues_12\NNS\4743605|homomazindol (r_conj) mazindol_3\NN\1740|of|2|and|analogues (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes
12213053T7_12213053T23 NONE homomazindol_8\NN\1740|3 (r_compound) analogues_12\NNS\4743605|homomazindol (r_conj) mazindol_3\NN\1740|of|2|and|analogues (r_nmod) series_1\NN\8456993|a|mazindol|variety (r_nsubjpass) synthesized_47\VBN\193486|series|were|,|and|determined|. (l_conj) determined_68\VBN\1645601|affinities|were (l_nsubjpass) affinities_52\NNS\11426530|their|binding|transporter (l_nmod) transporter_56\NN\4490091|at|the|dopamine|dat|membranes (l_appos) dat_58\NN\2757810|(|)
12213053T8_12213053T22 NONE dopamine_55\NN\14807737| (r_compound) transporter_56\NN\4490091|at|the|dopamine|dat|membranes
12213053T8_12213053T23 NONE dopamine_55\NN\14807737| (r_compound) transporter_56\NN\4490091|at|the|dopamine|dat|membranes (l_appos) dat_58\NN\2757810|(|)
12213053T9_12213053T24 CPR:9 da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet
12213053T9_12213053T25 NONE da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet (l_conj) hek-hsert_30\NN\1740|
12213053T9_12213053T26 NONE da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet (l_conj) hek-hnet_33\NN\1740|
12213053T10_12213053T24 NONE 5-ht_15\NN\1740| (r_conj) da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet
12213053T10_12213053T25 CPR:9 5-ht_15\NN\1740| (r_conj) da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet (l_conj) hek-hsert_30\NN\1740|
12213053T10_12213053T26 NONE 5-ht_15\NN\1740| (r_conj) da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet (l_conj) hek-hnet_33\NN\1740|
12213053T11_12213053T24 NONE ne_18\NNS\14622893| (r_conj) da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet
12213053T11_12213053T25 NONE ne_18\NNS\14622893| (r_conj) da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet (l_conj) hek-hsert_30\NN\1740|
12213053T11_12213053T26 CPR:9 ne_18\NNS\14622893| (r_conj) da_13\NN\10484858|of|,|5-ht|,|and|ne (r_nmod) uptake_11\NN\13440063|da (r_dobj) block_10\VB\1476483|to|uptake|and|inhibit (l_conj) inhibit_20\VB\2510337|binding (l_dobj) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet (l_conj) hek-hnet_33\NN\1740|
12213053T12_12213053T24 NONE rti-55_26\NN\1740|of|[|(125)i|] (r_nmod) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet
12213053T12_12213053T25 NONE rti-55_26\NN\1740|of|[|(125)i|] (r_nmod) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet (l_conj) hek-hsert_30\NN\1740|
12213053T12_12213053T26 NONE rti-55_26\NN\1740|of|[|(125)i|] (r_nmod) binding_21\NN\4688246|rti-55|cells (l_nmod) cells_34\NNS\3080309|hek-hdat (l_compound) hek-hdat_28\NN\1740|at|,|hek-hsert|,|and|hek-hnet (l_conj) hek-hnet_33\NN\1740|
12213053T13_12213053T27 NONE mazindane_0\NN\1740|(|26 (r_nsubjpass) found_5\VBN\2426171|mazindane|was|pro-drug|. (l_xcomp) pro-drug_9\NN\1740|to|be|a|,|oxidizing (l_advcl) oxidizing_11\VBG\109660|5-oh|mazindol|membranes (l_nmod) membranes_23\NNS\4188643|on|rat|striatal|and|cells (l_conj) cells_26\NNS\3080309|hek-hdat (l_compound) hek-hdat_25\NN\1740|
12213053T14_12213053T27 NONE 5-h_13\JJ\1740| (r_compound) 5-oh_16\NN\1740|(|5-h|--|>|) (r_dobj) oxidizing_11\VBG\109660|5-oh|mazindol|membranes (l_nmod) membranes_23\NNS\4188643|on|rat|striatal|and|cells (l_conj) cells_26\NNS\3080309|hek-hdat (l_compound) hek-hdat_25\NN\1740|
12213053T15_12213053T27 NONE 5-oh_16\NN\1740|(|5-h|--|>|) (r_dobj) oxidizing_11\VBG\109660|5-oh|mazindol|membranes (l_nmod) membranes_23\NNS\4188643|on|rat|striatal|and|cells (l_conj) cells_26\NNS\3080309|hek-hdat (l_compound) hek-hdat_25\NN\1740|
12213053T16_12213053T27 NONE mazindol_19\NN\1740|to (r_nmod) oxidizing_11\VBG\109660|5-oh|mazindol|membranes (l_nmod) membranes_23\NNS\4188643|on|rat|striatal|and|cells (l_conj) cells_26\NNS\3080309|hek-hdat (l_compound) hek-hdat_25\NN\1740|
12213053T17_12213053T28 NONE 4',7,8-trichloro_1\NN\1740| (r_amod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_nmod) cells_17\NNS\3080309|for|hek-hdat (l_compound) hek-hdat_16\NN\1740|
12213053T17_12213053T29 NONE 4',7,8-trichloro_1\NN\1740| (r_amod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_nsubj) k(i_20\NN\1740|(|dat|) (l_compound) dat_19\NN\2757810|
12213053T17_12213053T30 NONE 4',7,8-trichloro_1\NN\1740| (r_amod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_dep) =_27\JJ\1740|sert/dat|1283|and|=|) (l_nsubj) sert/dat_26\NN\1740|
12213053T17_12213053T31 NONE 4',7,8-trichloro_1\NN\1740| (r_amod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_dep) =_27\JJ\1740|sert/dat|1283|and|=|) (l_nsubj) sert/dat_26\NN\1740|
12213053T17_12213053T32 NONE 4',7,8-trichloro_1\NN\1740| (r_amod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_dep) =_27\JJ\1740|sert/dat|1283|and|=|) (l_conj) =_31\JJ\1740|net/dat|38 (l_nsubj) net/dat_30\NN\1740|
12213053T17_12213053T33 NONE 4',7,8-trichloro_1\NN\1740| (r_amod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_dep) =_27\JJ\1740|sert/dat|1283|and|=|) (l_conj) =_31\JJ\1740|net/dat|38 (l_nsubj) net/dat_30\NN\1740|
12213053T18_12213053T28 NONE mazindol_7\NN\1740|of (r_nmod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_nmod) cells_17\NNS\3080309|for|hek-hdat (l_compound) hek-hdat_16\NN\1740|
12213053T18_12213053T29 NONE mazindol_7\NN\1740|of (r_nmod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_nsubj) k(i_20\NN\1740|(|dat|) (l_compound) dat_19\NN\2757810|
12213053T18_12213053T30 NONE mazindol_7\NN\1740|of (r_nmod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_dep) =_27\JJ\1740|sert/dat|1283|and|=|) (l_nsubj) sert/dat_26\NN\1740|
12213053T18_12213053T31 NONE mazindol_7\NN\1740|of (r_nmod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_dep) =_27\JJ\1740|sert/dat|1283|and|=|) (l_nsubj) sert/dat_26\NN\1740|
12213053T18_12213053T32 NONE mazindol_7\NN\1740|of (r_nmod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_dep) =_27\JJ\1740|sert/dat|1283|and|=|) (l_conj) =_31\JJ\1740|net/dat|38 (l_nsubj) net/dat_30\NN\1740|
12213053T18_12213053T33 NONE mazindol_7\NN\1740|of (r_nmod) analogue_2\NN\4743605|the|4',7,8-trichloro|38|mazindol (r_nsubj) ligand_14\NN\20090|analogue|was|the|potent|cells|=|. (l_parataxis) =_22\JJ\1740|k(i|nm|;|= (l_dep) =_27\JJ\1740|sert/dat|1283|and|=|) (l_conj) =_31\JJ\1740|net/dat|38 (l_nsubj) net/dat_30\NN\1740|
16441928
16441928T11_16441928T30 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) albumin_24\NN\14736972|serum
16441928T11_16441928T31 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) transthyretin_26\NN\1740|
16441928T11_16441928T32 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a
16441928T11_16441928T33 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) hdl-cholesterol_34\NN\1740|
16441928T11_16441928T34 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_appos) a-i_41\NN\1740|apo|,|a-ii|,|b|,|c-ii|,|c-iii|,|e (l_conj) e_51\NN\14724645|
16441928T11_16441928T35 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) a_55\NN\13649268|lipoprotein|(|) (l_punct) )_56\-RRB-\1740|
16441928T11_16441928T36 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) status_59\NN\24720|oxidative|alpha-tocopherol (l_nmod) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (l_conj) peroxidase_68\NN\14971234|glutathione
16441928T11_16441928T37 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6
16441928T11_16441928T38 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_appos) orosomucoid_84\NN\1740|
16441928T11_16441928T39 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-2_86\NN\1740|
16441928T11_16441928T40 NONE creatinine_21\NN\1740|predialytic (r_conj) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (r_appos) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-6_88\NN\1740|
16441928T12_16441928T30 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) albumin_24\NN\14736972|serum
16441928T12_16441928T31 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) transthyretin_26\NN\1740|
16441928T12_16441928T32 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a
16441928T12_16441928T33 NONE hdl-cholesterol_34\NN\1740|
16441928T12_16441928T34 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_appos) a-i_41\NN\1740|apo|,|a-ii|,|b|,|c-ii|,|c-iii|,|e (l_conj) e_51\NN\14724645|
16441928T12_16441928T35 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) a_55\NN\13649268|lipoprotein|(|) (l_punct) )_56\-RRB-\1740|
16441928T12_16441928T36 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) status_59\NN\24720|oxidative|alpha-tocopherol (l_nmod) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (l_conj) peroxidase_68\NN\14971234|glutathione
16441928T12_16441928T37 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6
16441928T12_16441928T38 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_appos) orosomucoid_84\NN\1740|
16441928T12_16441928T39 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-2_86\NN\1740|
16441928T12_16441928T40 NONE hdl-cholesterol_34\NN\1740| (r_conj) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-6_88\NN\1740|
16441928T13_16441928T30 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) albumin_24\NN\14736972|serum
16441928T13_16441928T31 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) transthyretin_26\NN\1740|
16441928T13_16441928T32 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a
16441928T13_16441928T33 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) hdl-cholesterol_34\NN\1740|
16441928T13_16441928T34 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_appos) a-i_41\NN\1740|apo|,|a-ii|,|b|,|c-ii|,|c-iii|,|e (l_conj) e_51\NN\14724645|
16441928T13_16441928T35 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) a_55\NN\13649268|lipoprotein|(|) (l_punct) )_56\-RRB-\1740|
16441928T13_16441928T36 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) status_59\NN\24720|oxidative|alpha-tocopherol (l_nmod) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (l_conj) peroxidase_68\NN\14971234|glutathione
16441928T13_16441928T37 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6
16441928T13_16441928T38 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_appos) orosomucoid_84\NN\1740|
16441928T13_16441928T39 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-2_86\NN\1740|
16441928T13_16441928T40 NONE triacylglycerols_36\NNS\1740| (r_appos) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (r_nmod) metabolism_29\NN\13526110|lipid|ldl- (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-6_88\NN\1740|
16441928T14_16441928T30 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) albumin_24\NN\14736972|serum
16441928T14_16441928T31 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) transthyretin_26\NN\1740|
16441928T14_16441928T32 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a
16441928T14_16441928T33 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) hdl-cholesterol_34\NN\1740|
16441928T14_16441928T34 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_appos) a-i_41\NN\1740|apo|,|a-ii|,|b|,|c-ii|,|c-iii|,|e (l_conj) e_51\NN\14724645|
16441928T14_16441928T35 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) a_55\NN\13649268|lipoprotein|(|) (l_punct) )_56\-RRB-\1740|
16441928T14_16441928T36 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (l_conj) peroxidase_68\NN\14971234|glutathione
16441928T14_16441928T37 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6
16441928T14_16441928T38 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_appos) orosomucoid_84\NN\1740|
16441928T14_16441928T39 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-2_86\NN\1740|
16441928T14_16441928T40 NONE alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-6_88\NN\1740|
16441928T15_16441928T30 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) albumin_24\NN\14736972|serum
16441928T15_16441928T31 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) transthyretin_26\NN\1740|
16441928T15_16441928T32 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a
16441928T15_16441928T33 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) hdl-cholesterol_34\NN\1740|
16441928T15_16441928T34 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_appos) a-i_41\NN\1740|apo|,|a-ii|,|b|,|c-ii|,|c-iii|,|e (l_conj) e_51\NN\14724645|
16441928T15_16441928T35 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) a_55\NN\13649268|lipoprotein|(|) (l_punct) )_56\-RRB-\1740|
16441928T15_16441928T36 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (l_conj) peroxidase_68\NN\14971234|glutathione
16441928T15_16441928T37 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6
16441928T15_16441928T38 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_appos) orosomucoid_84\NN\1740|
16441928T15_16441928T39 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-2_86\NN\1740|
16441928T15_16441928T40 NONE retinol_63\NN\15089803| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-6_88\NN\1740|
16441928T16_16441928T30 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) albumin_24\NN\14736972|serum
16441928T16_16441928T31 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) transthyretin_26\NN\1740|
16441928T16_16441928T32 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a
16441928T16_16441928T33 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) hdl-cholesterol_34\NN\1740|
16441928T16_16441928T34 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_appos) a-i_41\NN\1740|apo|,|a-ii|,|b|,|c-ii|,|c-iii|,|e (l_conj) e_51\NN\14724645|
16441928T16_16441928T35 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) a_55\NN\13649268|lipoprotein|(|) (l_punct) )_56\-RRB-\1740|
16441928T16_16441928T36 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (l_conj) peroxidase_68\NN\14971234|glutathione
16441928T16_16441928T37 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6
16441928T16_16441928T38 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_appos) orosomucoid_84\NN\1740|
16441928T16_16441928T39 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-2_86\NN\1740|
16441928T16_16441928T40 NONE selenium_65\NN\14724645| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-6_88\NN\1740|
16441928T17_16441928T30 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) albumin_24\NN\14736972|serum
16441928T17_16441928T31 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) transthyretin_26\NN\1740|
16441928T17_16441928T32 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a
16441928T17_16441928T33 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) hdl-cholesterol_34\NN\1740|
16441928T17_16441928T34 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_appos) a-i_41\NN\1740|apo|,|a-ii|,|b|,|c-ii|,|c-iii|,|e (l_conj) e_51\NN\14724645|
16441928T17_16441928T35 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) a_55\NN\13649268|lipoprotein|(|) (l_punct) )_56\-RRB-\1740|
16441928T17_16441928T36 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione
16441928T17_16441928T37 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6
16441928T17_16441928T38 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_appos) orosomucoid_84\NN\1740|
16441928T17_16441928T39 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-2_86\NN\1740|
16441928T17_16441928T40 NONE glutathione_67\NN\1740| (r_compound) peroxidase_68\NN\14971234|glutathione (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-6_88\NN\1740|
16441928T18_16441928T30 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) albumin_24\NN\14736972|serum
16441928T18_16441928T31 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) rate_18\NN\13815152|normalized|protein|catabolic|,|creatinine|,|albumin|and|transthyretin (l_conj) transthyretin_26\NN\1740|
16441928T18_16441928T32 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a
16441928T18_16441928T33 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) hdl-cholesterol_34\NN\1740|
16441928T18_16441928T34 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_appos) a-i_41\NN\1740|apo|,|a-ii|,|b|,|c-ii|,|c-iii|,|e (l_conj) e_51\NN\14724645|
16441928T18_16441928T35 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_conj) metabolism_29\NN\13526110|lipid|ldl- (l_nmod) ldl-_32\NN\1740|by|plasma|and|hdl-cholesterol|,|triacylglycerols|,|phospholipids|,|a-i|and|a (l_conj) a_55\NN\13649268|lipoprotein|(|) (l_punct) )_56\-RRB-\1740|
16441928T18_16441928T36 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (l_conj) peroxidase_68\NN\14971234|glutathione
16441928T18_16441928T37 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6
16441928T18_16441928T38 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_appos) orosomucoid_84\NN\1740|
16441928T18_16441928T39 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-2_86\NN\1740|
16441928T18_16441928T40 NONE malondialdehyde_70\NN\1740| (r_conj) alpha-tocopherol_61\NN\1740|by|,|retinol|,|selenium|,|peroxidase|,|malondialdehyde|and|products (r_nmod) status_59\NN\24720|oxidative|alpha-tocopherol (r_conj) bmi_13\NN\6639674|by|,|rate|;|metabolism|;|status|;|status (l_appos) status_78\NN\24720|inflammatory|protein (l_nmod) protein_82\NN\14944888|by|serum|c-reactive|,|orosomucoid|,|il-2|and|il-6 (l_conj) il-6_88\NN\1740|
16441928T1_16441928T19 NONE creatinine_25\NN\1740|so (r_conj) albumin_21\NN\14736972|,|transthyretin|and|creatinine (r_conj) albumin_17\NN\14736972|(|oo|;|albumin|)|;|increased
16441928T1_16441928T20 NONE creatinine_25\NN\1740|so (r_conj) albumin_21\NN\14736972|,|transthyretin|and|creatinine
16441928T1_16441928T21 NONE creatinine_25\NN\1740|so (r_conj) albumin_21\NN\14736972|,|transthyretin|and|creatinine (l_conj) transthyretin_23\NN\1740|
16441928T1_16441928T22 NONE creatinine_25\NN\1740|so (r_conj) albumin_21\NN\14736972|,|transthyretin|and|creatinine (r_conj) albumin_17\NN\14736972|(|oo|;|albumin|)|;|increased (l_conj) increased_42\VBD\169651|ratio|groups (l_nsubj) ratio_41\NN\13815152|ldl-cholesterol (l_compound) ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii
16441928T1_16441928T23 NONE creatinine_25\NN\1740|so (r_conj) albumin_21\NN\14736972|,|transthyretin|and|creatinine (r_conj) albumin_17\NN\14736972|(|oo|;|albumin|)|;|increased (l_conj) increased_42\VBD\169651|ratio|groups (l_nsubj) ratio_41\NN\13815152|ldl-cholesterol (l_compound) ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii (l_conj) c-iii_37\NN\1740|
16441928T1_16441928T24 NONE creatinine_25\NN\1740|so (r_conj) albumin_21\NN\14736972|,|transthyretin|and|creatinine (r_conj) albumin_17\NN\14736972|(|oo|;|albumin|)|;|increased (l_conj) increased_42\VBD\169651|ratio|groups (l_nsubj) ratio_41\NN\13815152|ldl-cholesterol (l_compound) ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii (l_conj) a-i/a-ii_40\NN\1740|apo
16441928T2_16441928T19 NONE ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii (r_compound) ratio_41\NN\13815152|ldl-cholesterol (r_nsubj) increased_42\VBD\169651|ratio|groups (r_conj) albumin_17\NN\14736972|(|oo|;|albumin|)|;|increased
16441928T2_16441928T20 NONE ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii (r_compound) ratio_41\NN\13815152|ldl-cholesterol (r_nsubj) increased_42\VBD\169651|ratio|groups (r_conj) albumin_17\NN\14736972|(|oo|;|albumin|)|;|increased (l_conj) albumin_21\NN\14736972|,|transthyretin|and|creatinine
16441928T2_16441928T21 NONE ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii (r_compound) ratio_41\NN\13815152|ldl-cholesterol (r_nsubj) increased_42\VBD\169651|ratio|groups (r_conj) albumin_17\NN\14736972|(|oo|;|albumin|)|;|increased (l_conj) albumin_21\NN\14736972|,|transthyretin|and|creatinine (l_conj) transthyretin_23\NN\1740|
16441928T2_16441928T22 NONE ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii
16441928T2_16441928T23 NONE ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii (l_conj) c-iii_37\NN\1740|
16441928T2_16441928T24 NONE ldl-cholesterol_30\NN\1740|,|b|,|c-ii|,|c-iii|and|a-i/a-ii (l_conj) a-i/a-ii_40\NN\1740|apo
16441928T3_16441928T25 NONE hdl-cholesterol_0\NN\1740|
16441928T3_16441928T26 NONE hdl-cholesterol_0\NN\1740| (r_nsubj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_conj) increased_7\VBD\169651|e|and|decreased|;|increased (l_nsubj) e_6\NN\14724645|apo
16441928T3_16441928T27 NONE hdl-cholesterol_0\NN\1740| (r_nsubj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_conj) increased_7\VBD\169651|e|and|decreased|;|increased (l_conj) decreased_13\VBD\169651|a|so (l_nsubj) a_11\NN\13649268|lipoprotein|(|) (l_punct) )_12\-RRB-\1740|
16441928T3_16441928T28 NONE hdl-cholesterol_0\NN\1740| (r_nsubj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_conj) increased_30\VBD\169651|il-2|groups (l_nsubj) il-2_29\NN\1740|
16441928T4_16441928T25 NONE alpha-tocopherol/cholesterol_17\NN\1740| (r_compound) ratio_18\NN\13815152|alpha-tocopherol/cholesterol (r_nsubj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (r_conj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_nsubj) hdl-cholesterol_0\NN\1740|
16441928T4_16441928T26 NONE alpha-tocopherol/cholesterol_17\NN\1740| (r_compound) ratio_18\NN\13815152|alpha-tocopherol/cholesterol (r_nsubj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (l_nsubj) e_6\NN\14724645|apo
16441928T4_16441928T27 NONE alpha-tocopherol/cholesterol_17\NN\1740| (r_compound) ratio_18\NN\13815152|alpha-tocopherol/cholesterol (r_nsubj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (l_conj) decreased_13\VBD\169651|a|so (l_nsubj) a_11\NN\13649268|lipoprotein|(|) (l_punct) )_12\-RRB-\1740|
16441928T4_16441928T28 NONE alpha-tocopherol/cholesterol_17\NN\1740| (r_compound) ratio_18\NN\13815152|alpha-tocopherol/cholesterol (r_nsubj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (r_conj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_conj) increased_30\VBD\169651|il-2|groups (l_nsubj) il-2_29\NN\1740|
16441928T5_16441928T25 NONE alpha-tocopherol/cholesterol_17\NN\1740| (r_compound) ratio_18\NN\13815152|alpha-tocopherol/cholesterol (r_nsubj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (r_conj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_nsubj) hdl-cholesterol_0\NN\1740|
16441928T5_16441928T26 NONE alpha-tocopherol/cholesterol_17\NN\1740| (r_compound) ratio_18\NN\13815152|alpha-tocopherol/cholesterol (r_nsubj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (l_nsubj) e_6\NN\14724645|apo
16441928T5_16441928T27 NONE alpha-tocopherol/cholesterol_17\NN\1740| (r_compound) ratio_18\NN\13815152|alpha-tocopherol/cholesterol (r_nsubj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (l_conj) decreased_13\VBD\169651|a|so (l_nsubj) a_11\NN\13649268|lipoprotein|(|) (l_punct) )_12\-RRB-\1740|
16441928T5_16441928T28 NONE alpha-tocopherol/cholesterol_17\NN\1740| (r_compound) ratio_18\NN\13815152|alpha-tocopherol/cholesterol (r_nsubj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (r_conj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_conj) increased_30\VBD\169651|il-2|groups (l_nsubj) il-2_29\NN\1740|
16441928T6_16441928T25 NONE malondialdehyde_23\NN\1740| (r_nsubj) decreased_24\VBD\169651|malondialdehyde|groups (r_conj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (r_conj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_nsubj) hdl-cholesterol_0\NN\1740|
16441928T6_16441928T26 NONE malondialdehyde_23\NN\1740| (r_nsubj) decreased_24\VBD\169651|malondialdehyde|groups (r_conj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (l_nsubj) e_6\NN\14724645|apo
16441928T6_16441928T27 NONE malondialdehyde_23\NN\1740| (r_nsubj) decreased_24\VBD\169651|malondialdehyde|groups (r_conj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (l_conj) decreased_13\VBD\169651|a|so (l_nsubj) a_11\NN\13649268|lipoprotein|(|) (l_punct) )_12\-RRB-\1740|
16441928T6_16441928T28 NONE malondialdehyde_23\NN\1740| (r_nsubj) decreased_24\VBD\169651|malondialdehyde|groups (r_conj) increased_19\VBD\169651|ratio|oo|;|decreased (r_conj) increased_7\VBD\169651|e|and|decreased|;|increased (r_conj) decreased_1\VBD\169651|hdl-cholesterol|oo|;|increased|;|increased (l_conj) increased_30\VBD\169651|il-2|groups (l_nsubj) il-2_29\NN\1740|
16441928T7_16441928T29 NONE alpha-tocopherol/cholesterol_9\NN\1740| (r_nsubj) increased_10\VBD\169651|showed|:|alpha-tocopherol/cholesterol|oo (r_ccomp) decreased_18\VBD\169651|increased|;|a|so|. (l_nsubj) a_16\NN\13649268|lipoprotein|(|) (l_punct) )_17\-RRB-\1740|
16441928T8_16441928T29 NONE alpha-tocopherol/cholesterol_9\NN\1740| (r_nsubj) increased_10\VBD\169651|showed|:|alpha-tocopherol/cholesterol|oo (r_ccomp) decreased_18\VBD\169651|increased|;|a|so|. (l_nsubj) a_16\NN\13649268|lipoprotein|(|) (l_punct) )_17\-RRB-\1740|
23298258
23298258T10_23298258T27 CPR:3 acid_2\NN\14818238|all-trans|retinoic (r_nsubj) protects_3\VBZ\1127795|acid|cells|death|upregulating|. (l_advcl) upregulating_12\VBG\1740|by|8a2 (l_dobj) 8a2_14\NN\1740|collagen
23298258T7_23298258T20 NONE histidine_17\NN\14605787| (r_compound) protein_21\NN\14944888|histidine|triad|nucleotide|binding|3|hint3 (r_conj) polypeptide_11\NN\14743046|genes|are|family|26|subfamily|a|1|cyp26a1|,|protein|,|mir-1282|and|polypeptide|,|showed|. (l_nummod) 1_12\CD\13741022|
23298258T7_23298258T21 NONE histidine_17\NN\14605787| (r_compound) protein_21\NN\14944888|histidine|triad|nucleotide|binding|3|hint3 (r_conj) polypeptide_11\NN\14743046|genes|are|family|26|subfamily|a|1|cyp26a1|,|protein|,|mir-1282|and|polypeptide|,|showed|. (l_appos) cyp26a1_14\NN\1740|(|)
23298258T7_23298258T22 NONE histidine_17\NN\14605787| (r_compound) protein_21\NN\14944888|histidine|triad|nucleotide|binding|3|hint3 (l_nummod) 3_22\CD\13741022|
23298258T7_23298258T23 NONE histidine_17\NN\14605787| (r_compound) protein_21\NN\14944888|histidine|triad|nucleotide|binding|3|hint3 (l_appos) hint3_24\NN\1740|(|)
23298258T7_23298258T24 NONE histidine_17\NN\14605787| (r_compound) protein_21\NN\14944888|histidine|triad|nucleotide|binding|3|hint3 (r_conj) polypeptide_11\NN\14743046|genes|are|family|26|subfamily|a|1|cyp26a1|,|protein|,|mir-1282|and|polypeptide|,|showed|. (l_conj) mir-1282_27\NN\1740|
23298258T7_23298258T25 NONE histidine_17\NN\14605787| (r_compound) protein_21\NN\14944888|histidine|triad|nucleotide|binding|3|hint3 (r_conj) polypeptide_11\NN\14743046|genes|are|family|26|subfamily|a|1|cyp26a1|,|protein|,|mir-1282|and|polypeptide|,|showed|. (l_conj) polypeptide_35\NN\14743046|cytochrome|p450|family|26|subfamily|b|1|cyp26b1 (l_nummod) 1_36\CD\13741022|
23298258T7_23298258T26 NONE histidine_17\NN\14605787| (r_compound) protein_21\NN\14944888|histidine|triad|nucleotide|binding|3|hint3 (r_conj) polypeptide_11\NN\14743046|genes|are|family|26|subfamily|a|1|cyp26a1|,|protein|,|mir-1282|and|polypeptide|,|showed|. (l_conj) polypeptide_35\NN\14743046|cytochrome|p450|family|26|subfamily|b|1|cyp26b1 (l_appos) cyp26b1_38\NN\1740|(|)
23298258T1_23298258T13 NONE atra_13\NN\1740| (r_compound) treatment_14\NN\654885|by|atra (r_nmod) blocked_3\VBD\1476483|knockdown|enhancement|treatment|. (l_nsubj) knockdown_0\NN\1173038|col8a2 (l_nmod) col8a2_2\NN\1740|of
23298258T2_23298258T18 NONE atra_17\NN\1740|of (r_nmod) adhesion_15\NN\14204950|of|cell|atra (r_nmod) enhancement_12\NN\248977|in|the|adhesion|conditions (r_nmod) involved_9\VBN\2676054|enhancement (r_acl) protein_8\NN\14944888|as|the|key|involved (r_nmod) identified_4\VBN\699815|thus|,|col8a2|was|protein|. (l_nsubjpass) col8a2_2\NN\1740|
23298258T3_23298258T19 NONE atra_3\NN\1740| (r_nsubj) protects_4\VBZ\1127795|conclusion|,|atra|cells|death|enhancing|,|and|plays|. (l_conj) plays_18\VBZ\1072262|col8a2|role|cell (l_nsubj) col8a2_17\NN\1740|
23210783
23414802
23414802T4_23414802T12 CPR:4 2-hydroxydiarylamide_3\NN\1740| (r_compound) derivatives_4\NNS\5802185|of|novel|2-hydroxydiarylamide (r_nmod) discovery_0\NN\30358|derivatives|inhibitors|. (l_nmod) inhibitors_7\NNS\20090|as|tmprss4 (l_compound) tmprss4_6\NN\1740|
23414802T1_23414802T7 CPR:4 2-hydroxydiarylamide_8\NN\1740| (r_compound) derivatives_9\NNS\5802185|of|2-hydroxydiarylamide (r_nmod) series_6\NN\8456993|a|novel|derivatives (r_nsubjpass) synthesized_11\VBN\193486|study|,|series|were|and|evaluated|. (l_conj) evaluated_13\VBN\670261|inhibiting (l_advcl) inhibiting_15\VBG\2510337|for|activity|and|suppressing (l_dobj) activity_19\NN\30358|tmprss4|protease (l_compound) tmprss4_16\NN\1740|
23414802T1_23414802T8 CPR:4 2-hydroxydiarylamide_8\NN\1740| (r_compound) derivatives_9\NNS\5802185|of|2-hydroxydiarylamide (r_nmod) series_6\NN\8456993|a|novel|derivatives (r_nsubjpass) synthesized_11\VBN\193486|study|,|series|were|and|evaluated|. (l_conj) evaluated_13\VBN\670261|inhibiting (l_advcl) inhibiting_15\VBG\2510337|for|activity|and|suppressing (l_dobj) activity_19\NN\30358|tmprss4|protease (l_compound) protease_18\NN\14732946|serine
23414802T2_23414802T7 NONE serine_17\NN\14601829| (r_compound) protease_18\NN\14732946|serine (r_compound) activity_19\NN\30358|tmprss4|protease (l_compound) tmprss4_16\NN\1740|
23414802T2_23414802T8 NONE serine_17\NN\14601829| (r_compound) protease_18\NN\14732946|serine
23414802T3_23414802T9 NONE serine_8\NN\14601829| (r_compound) protease_9\NN\14732946|against|tmprss4|serine (l_compound) tmprss4_7\NN\1740|
23414802T3_23414802T10 NONE serine_8\NN\14601829| (r_compound) protease_9\NN\14732946|against|tmprss4|serine
23414802T3_23414802T11 NONE serine_8\NN\14601829| (r_compound) protease_9\NN\14732946|against|tmprss4|serine (r_nmod) activity_5\NN\30358|good|inhibitory|protease|,|correlated (l_acl:relcl) correlated_12\VBD\2657219|which|activity (l_nmod) activity_17\NN\30358|with|the|promising|anti-invasive|cells (l_nmod) cells_21\NNS\3080309|of|colon|cancer|overexpressing (l_acl) overexpressing_22\VBG\1740|tmprss4 (l_dobj) tmprss4_23\NN\1740|
23256472
23256472T5_23256472T11 NONE iodine-129_0\NN\1740| (r_compound) microdosing_1\NN\1740|iodine-129|development|:|erythropoietin|. (l_appos) erythropoietin_9\NN\14888310|study
23256472T2_23256472T8 NONE (129)i-labeled_7\NN\1740| (r_amod) epo_8\NN\1740|with|(129)i-labeled
23256472T2_23256472T9 NONE (129)i-labeled_7\NN\1740| (r_amod) epo_8\NN\1740|with|(129)i-labeled (r_nmod) study_5\NN\635850|in|an|animal|epo|rats (r_nmod) observed_18\VBN\2163746|study|,|increase|is|administration|. (l_nsubjpass) increase_14\NN\13576355|an|(129)i-epo (l_nmod) (129)i-epo_16\NN\1740|of
23256472T3_23256472T8 NONE (129)i-epo_16\NN\1740|of (r_nmod) increase_14\NN\13576355|an|(129)i-epo (r_nsubjpass) observed_18\VBN\2163746|study|,|increase|is|administration|. (l_nmod) study_5\NN\635850|in|an|animal|epo|rats (l_nmod) epo_8\NN\1740|with|(129)i-labeled
23256472T3_23256472T9 NONE (129)i-epo_16\NN\1740|of
23411246
23411246T8_23411246T29 NONE iron_0\NN\14625458|and|zinc (r_compound) bioavailability_3\NN\1740|iron|cells|:|influence|. (l_dep) influence_8\NN\5190804|caseinophosphopeptides (l_nmod) caseinophosphopeptides_10\NNS\1740|of
23411246T9_23411246T29 NONE zinc_2\NN\14625458| (r_conj) iron_0\NN\14625458|and|zinc (r_compound) bioavailability_3\NN\1740|iron|cells|:|influence|. (l_dep) influence_8\NN\5190804|caseinophosphopeptides (l_nmod) caseinophosphopeptides_10\NNS\1740|of
23411246T1_23411246T10 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (l_conj) β-casein_20\NN\1740|cn (l_appos) cn_22\NN\1740|(|)
23411246T1_23411246T11 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability
23411246T1_23411246T12 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_compound) β-cn(1_32\NN\1740|
23411246T1_23411246T13 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_conj) 74)4p_38\NN\1740|α(s1)-cn(64|- (l_compound) α(s1)-cn(64_36\NN\1740|
23411246T1_23411246T14 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_conj) 19)4p_42\NN\1740|α(s2)-cn(1|- (l_compound) α(s2)-cn(1_40\NN\1740|
23411246T1_23411246T15 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (l_appos) synthesis_50\NN\13446390|(|ferritin|) (l_compound) ferritin_49\NN\14728724|
23411246T1_23411246T22 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (r_nmod) obtained_16\VBN\2210855|α(s)- (r_acl) caseinophosphopeptides_12\NNS\1740|of|cpps|obtained
23411246T1_23411246T27 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (r_nmod) obtained_16\VBN\2210855|α(s)- (r_acl) caseinophosphopeptides_12\NNS\1740|of|cpps|obtained (l_appos) cpps_14\NNS\1740|(|)
23411246T1_23411246T28 NONE iron_46\NN\14625458| (r_compound) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (l_conj) β-casein_20\NN\1740|cn
23411246T2_23411246T10 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (l_conj) β-casein_20\NN\1740|cn (l_appos) cn_22\NN\1740|(|)
23411246T2_23411246T11 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability
23411246T2_23411246T12 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_compound) β-cn(1_32\NN\1740|
23411246T2_23411246T13 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_conj) 74)4p_38\NN\1740|α(s1)-cn(64|- (l_compound) α(s1)-cn(64_36\NN\1740|
23411246T2_23411246T14 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_conj) 19)4p_42\NN\1740|α(s2)-cn(1|- (l_compound) α(s2)-cn(1_40\NN\1740|
23411246T2_23411246T15 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (l_appos) synthesis_50\NN\13446390|(|ferritin|) (l_compound) ferritin_49\NN\14728724|
23411246T2_23411246T22 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (r_nmod) obtained_16\VBN\2210855|α(s)- (r_acl) caseinophosphopeptides_12\NNS\1740|of|cpps|obtained
23411246T2_23411246T27 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (r_nmod) obtained_16\VBN\2210855|α(s)- (r_acl) caseinophosphopeptides_12\NNS\1740|of|cpps|obtained (l_appos) cpps_14\NNS\1740|(|)
23411246T2_23411246T28 NONE zinc_53\NN\14625458| (r_compound) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (l_conj) β-casein_20\NN\1740|cn
23411246T3_23411246T10 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (l_conj) β-casein_20\NN\1740|cn (l_appos) cn_22\NN\1740|(|)
23411246T3_23411246T11 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability
23411246T3_23411246T12 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_compound) β-cn(1_32\NN\1740|
23411246T3_23411246T13 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_conj) 74)4p_38\NN\1740|α(s1)-cn(64|- (l_compound) α(s1)-cn(64_36\NN\1740|
23411246T3_23411246T14 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (l_dep) 25)4p_34\NN\1740|(|β-cn(1|-|,|74)4p|and|19)4p|) (l_conj) 19)4p_42\NN\1740|α(s2)-cn(1|- (l_compound) α(s2)-cn(1_40\NN\1740|
23411246T3_23411246T15 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (l_appos) synthesis_50\NN\13446390|(|ferritin|) (l_compound) ferritin_49\NN\14728724|
23411246T3_23411246T22 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (r_nmod) obtained_16\VBN\2210855|α(s)- (r_acl) caseinophosphopeptides_12\NNS\1740|of|cpps|obtained
23411246T3_23411246T27 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (r_nmod) obtained_16\VBN\2210855|α(s)- (r_acl) caseinophosphopeptides_12\NNS\1740|of|cpps|obtained (l_appos) cpps_14\NNS\1740|(|)
23411246T3_23411246T28 NONE zinc_62\NN\14625458|of (r_nmod) retention_56\NN\809465|(|,|transport|and|uptake|zinc|) (r_dep) bioavailability_54\NN\1740|zinc|retention (r_conj) bioavailability_47\NN\1740|on|iron|synthesis|and|bioavailability|cells (r_nmod) cpps_30\NNS\1740|of|three|specific|25)4p|,|bioavailability (r_conj) α(s)-_18\NN\1740|from|and|β-casein|fractions|,|and|cpps (l_conj) β-casein_20\NN\1740|cn
23411246T4_23411246T16 NONE sulphate_26\NN\15010703|iron|, (r_conj) showed_15\VBD\2137132|cpps|increase|sulphate|effective (r_conj) improve_6\VB\126264|pools|did|not|synthesis|,|but|showed|. (l_nsubj) pools_3\NNS\3302121|α-cpp (l_compound) α-cpp_0\NN\1740|and|β-cpp
23411246T4_23411246T17 NONE sulphate_26\NN\15010703|iron|, (r_conj) showed_15\VBD\2137132|cpps|increase|sulphate|effective (r_conj) improve_6\VB\126264|pools|did|not|synthesis|,|but|showed|. (l_nsubj) pools_3\NNS\3302121|α-cpp (l_compound) α-cpp_0\NN\1740|and|β-cpp (l_conj) β-cpp_2\NN\1740|
23411246T4_23411246T18 NONE sulphate_26\NN\15010703|iron|, (r_conj) showed_15\VBD\2137132|cpps|increase|sulphate|effective (r_conj) improve_6\VB\126264|pools|did|not|synthesis|,|but|showed|. (l_dobj) synthesis_8\NN\13446390|ferritin (l_compound) ferritin_7\NN\14728724|
23411246T4_23411246T19 NONE sulphate_26\NN\15010703|iron|, (r_conj) showed_15\VBD\2137132|cpps|increase|sulphate|effective (l_nsubj) cpps_14\NNS\1740|the|three|specific
23411246T4_23411246T20 NONE sulphate_26\NN\15010703|iron|, (r_conj) showed_15\VBD\2137132|cpps|increase|sulphate|effective (l_dobj) increase_17\NN\13576355|an|synthesis (l_nmod) synthesis_20\NN\13446390|in|ferritin|cells (l_compound) ferritin_19\NN\14728724|
23411246T4_23411246T21 NONE sulphate_26\NN\15010703|iron|, (r_conj) showed_15\VBD\2137132|cpps|increase|sulphate|effective (l_parataxis) effective_34\JJ\1740|25)4p|being|the|most (l_nsubj) 25)4p_30\NN\1740|- (l_compound) -_29\CD\1740|β-cn(1 (l_compound) β-cn(1_28\NN\1740|
23411246T5_23411246T23 NONE zinc_3\NN\14625458| (r_compound) bioavailability_4\NN\1740|to|zinc (r_nmod) relation_1\NN\2137|in|bioavailability (r_nmod) increased_17\VBD\169651|relation|,|α-cpps|uptake|. (l_nsubj) α-cpps_6\NNS\1740|,|β-cpps|,|74)4p|and|25)4p
23411246T5_23411246T24 NONE zinc_3\NN\14625458| (r_compound) bioavailability_4\NN\1740|to|zinc (r_nmod) relation_1\NN\2137|in|bioavailability (r_nmod) increased_17\VBD\169651|relation|,|α-cpps|uptake|. (l_nsubj) α-cpps_6\NNS\1740|,|β-cpps|,|74)4p|and|25)4p (l_conj) β-cpps_8\NNS\1740|
23411246T5_23411246T25 NONE zinc_3\NN\14625458| (r_compound) bioavailability_4\NN\1740|to|zinc (r_nmod) relation_1\NN\2137|in|bioavailability (r_nmod) increased_17\VBD\169651|relation|,|α-cpps|uptake|. (l_nsubj) α-cpps_6\NNS\1740|,|β-cpps|,|74)4p|and|25)4p (l_conj) 74)4p_12\NN\1740|α(s1)-cn(64|- (l_compound) α(s1)-cn(64_10\NN\1740|
23411246T5_23411246T26 NONE zinc_3\NN\14625458| (r_compound) bioavailability_4\NN\1740|to|zinc (r_nmod) relation_1\NN\2137|in|bioavailability (r_nmod) increased_17\VBD\169651|relation|,|α-cpps|uptake|. (l_nsubj) α-cpps_6\NNS\1740|,|β-cpps|,|74)4p|and|25)4p (l_conj) 25)4p_16\NN\1740|β-cn(1|- (l_compound) β-cn(1_14\NN\1740|
23411246T6_23411246T23 CPR:9 zinc_18\NN\14625458| (r_compound) uptake_19\NN\13440063|zinc (r_dobj) increased_17\VBD\169651|relation|,|α-cpps|uptake|. (l_nsubj) α-cpps_6\NNS\1740|,|β-cpps|,|74)4p|and|25)4p
23411246T6_23411246T24 CPR:9 zinc_18\NN\14625458| (r_compound) uptake_19\NN\13440063|zinc (r_dobj) increased_17\VBD\169651|relation|,|α-cpps|uptake|. (l_nsubj) α-cpps_6\NNS\1740|,|β-cpps|,|74)4p|and|25)4p (l_conj) β-cpps_8\NNS\1740|
23411246T6_23411246T25 CPR:9 zinc_18\NN\14625458| (r_compound) uptake_19\NN\13440063|zinc (r_dobj) increased_17\VBD\169651|relation|,|α-cpps|uptake|. (l_nsubj) α-cpps_6\NNS\1740|,|β-cpps|,|74)4p|and|25)4p (l_conj) 74)4p_12\NN\1740|α(s1)-cn(64|- (l_compound) α(s1)-cn(64_10\NN\1740|
23411246T6_23411246T26 CPR:9 zinc_18\NN\14625458| (r_compound) uptake_19\NN\13440063|zinc (r_dobj) increased_17\VBD\169651|relation|,|α-cpps|uptake|. (l_nsubj) α-cpps_6\NNS\1740|,|β-cpps|,|74)4p|and|25)4p (l_conj) 25)4p_16\NN\1740|β-cn(1|- (l_compound) β-cn(1_14\NN\1740|
23537582
23583806
23583806T8_23583806T19 NONE no_16\NN\7204911|of|and|cytokines (l_conj) cytokines_19\NNS\14728724|pro-inflammatory
23583806T9_23583806T19 NONE allicin_22\NN\1740| (r_compound) activity_23\NN\30358|allicin|macrophages (r_dobj) downregulating_21\VBG\1740|by|activity (r_advcl) reduces_2\VBZ\441445|heating|effects|downregulating|. (l_dobj) effects_5\NNS\13245626|the|anti-inflammatory|extracts|production (l_nmod) production_14\NN\30358|on|the|lps-induced|no (l_nmod) no_16\NN\7204911|of|and|cytokines (l_conj) cytokines_19\NNS\14728724|pro-inflammatory
23583806T4_23583806T12 NONE no_24\NN\7204911| (r_conj) increase_9\NN\13576355|the|lps-induced|concentration|and|no|upregulation (l_nmod) concentration_14\NN\4916342|in|the|pro-inflammatory|cytokine|tnf-α (l_compound) cytokine_13\NN\14728724|
23583806T4_23583806T13 NONE no_24\NN\7204911| (r_conj) increase_9\NN\13576355|the|lps-induced|concentration|and|no|upregulation (l_nmod) concentration_14\NN\4916342|in|the|pro-inflammatory|cytokine|tnf-α (l_dep) tnf-α_16\NN\1740|(|,|il-1β|,|and|il-6|)
23583806T4_23583806T14 NONE no_24\NN\7204911| (r_conj) increase_9\NN\13576355|the|lps-induced|concentration|and|no|upregulation (l_nmod) concentration_14\NN\4916342|in|the|pro-inflammatory|cytokine|tnf-α (l_dep) tnf-α_16\NN\1740|(|,|il-1β|,|and|il-6|) (l_conj) il-1β_18\NN\1740|
23583806T4_23583806T15 NONE no_24\NN\7204911| (r_conj) increase_9\NN\13576355|the|lps-induced|concentration|and|no|upregulation (l_nmod) concentration_14\NN\4916342|in|the|pro-inflammatory|cytokine|tnf-α (l_dep) tnf-α_16\NN\1740|(|,|il-1β|,|and|il-6|) (l_conj) il-6_21\NN\1740|
23583806T4_23583806T16 NONE no_24\NN\7204911| (r_conj) increase_9\NN\13576355|the|lps-induced|concentration|and|no|upregulation (l_nmod) upregulation_27\NN\1740|through|ho-1|macrophages (l_compound) ho-1_26\NN\1740|
23583806T6_23583806T17 CPR:4 allicin_0\NN\1740| (r_compound) treatment_1\NN\654885|allicin (r_nsubj) showed_2\VBD\2137132|treatment|production|and|activity|. (l_dobj) production_4\NN\30358|reduced|cytokines|and|no (l_nmod) cytokines_7\NNS\14728724|of|pro-inflammatory
23583806T6_23583806T18 CPR:3 allicin_0\NN\1740| (r_compound) treatment_1\NN\654885|allicin (r_nsubj) showed_2\VBD\2137132|treatment|production|and|activity|. (l_conj) activity_13\NN\30358|increased|ho-1 (l_compound) ho-1_12\NN\1740|
23583806T7_23583806T17 NONE no_9\NN\7204911| (r_conj) production_4\NN\30358|reduced|cytokines|and|no (l_nmod) cytokines_7\NNS\14728724|of|pro-inflammatory
23583806T7_23583806T18 NONE no_9\NN\7204911| (r_conj) production_4\NN\30358|reduced|cytokines|and|no (r_dobj) showed_2\VBD\2137132|treatment|production|and|activity|. (l_conj) activity_13\NN\30358|increased|ho-1 (l_compound) ho-1_12\NN\1740|
23583806T1_23583806T10 NONE no_8\NN\7204911|in|lps-induced|and|cytokines (l_conj) cytokines_11\NNS\14728724|pro-inflammatory
23583806T1_23583806T11 NONE no_8\NN\7204911|in|lps-induced|and|cytokines (r_nmod) decrease_5\NN\7296428|the|no|macrophages|induction (l_nmod) induction_18\NN\7450842|through|ho-1 (l_compound) ho-1_17\NN\1740|
23290724
23290724T9_23290724T15 NONE zinc_0\NN\14625458| (r_nsubj) drives_1\VBZ\1224744|zinc|fold|protein|interface|. (l_nmod) protein_8\NN\14944888|in|the|prion|sites
23290724T1_23290724T10 NONE copper_19\NN\14821043|and|zinc (r_compound) regulation_22\NN\6652242|in|copper (r_nmod) participates_17\VBZ\2367363|which|regulation (r_acl:relcl) domain_14\NN\13934596|a|flexible|n-terminal|,|participates|,|and|domain (r_appos) domains_9\NNS\13934596|of|two|--|domain (r_nmod) consists_6\VBZ\2603699|protein|domains|. (l_nsubj) protein_3\NN\14944888|the|cellular|prion|prp(c (l_dep) prp(c_4\NN\1740|) (l_punct) )_5\-RRB-\1740|
23290724T2_23290724T10 NONE zinc_21\NN\14625458| (r_conj) copper_19\NN\14821043|and|zinc (r_compound) regulation_22\NN\6652242|in|copper (r_nmod) participates_17\VBZ\2367363|which|regulation (r_acl:relcl) domain_14\NN\13934596|a|flexible|n-terminal|,|participates|,|and|domain (r_appos) domains_9\NNS\13934596|of|two|--|domain (r_nmod) consists_6\VBZ\2603699|protein|domains|. (l_nsubj) protein_3\NN\14944888|the|cellular|prion|prp(c (l_dep) prp(c_4\NN\1740|) (l_punct) )_5\-RRB-\1740|
23290724T3_23290724T10 NONE c-terminal_28\JJ\1740| (r_amod) domain_29\NN\13934596|a|helical|c-terminal|converts (r_conj) domain_14\NN\13934596|a|flexible|n-terminal|,|participates|,|and|domain (r_appos) domains_9\NNS\13934596|of|two|--|domain (r_nmod) consists_6\VBZ\2603699|protein|domains|. (l_nsubj) protein_3\NN\14944888|the|cellular|prion|prp(c (l_dep) prp(c_4\NN\1740|) (l_punct) )_5\-RRB-\1740|
23290724T8_23290724T10 NONE n-terminal_13\JJ\1740| (r_amod) domain_14\NN\13934596|a|flexible|n-terminal|,|participates|,|and|domain (r_appos) domains_9\NNS\13934596|of|two|--|domain (r_nmod) consists_6\VBZ\2603699|protein|domains|. (l_nsubj) protein_3\NN\14944888|the|cellular|prion|prp(c (l_dep) prp(c_4\NN\1740|) (l_punct) )_5\-RRB-\1740|
23290724T4_23290724T12 NONE zn²⁺-driven_5\JJ\1740| (r_amod) n-terminal_6\JJ\1740|zn²⁺-driven (r_amod) c-terminal_8\JJ\1740|n-terminal|to (r_amod) interaction_10\NN\37396|a|c-terminal|tertiary|prp(c (l_nmod) prp(c_12\NN\1740|in|) (l_punct) )_13\-RRB-\1740|
23290724T5_23290724T12 NONE n-terminal_6\JJ\1740|zn²⁺-driven (r_amod) c-terminal_8\JJ\1740|n-terminal|to (r_amod) interaction_10\NN\37396|a|c-terminal|tertiary|prp(c (l_nmod) prp(c_12\NN\1740|in|) (l_punct) )_13\-RRB-\1740|
23290724T6_23290724T12 NONE c-terminal_8\JJ\1740|n-terminal|to (r_amod) interaction_10\NN\37396|a|c-terminal|tertiary|prp(c (l_nmod) prp(c_12\NN\1740|in|) (l_punct) )_13\-RRB-\1740|
16357751
16357751T1_16357751T2 NONE methotrexate_31\NN\2722166|to|and|factor|therapies (l_conj) factor_35\NN\7326557|anti-tumor|necrosis
22749842
10480573
10480573T7_10480573T14 NONE b_3\NN\1355326|of|thiazinotrienomycin|,|antibiotic (r_nmod) effect_0\NN\34213|b|,|function|. (l_nmod) function_11\NN\13783581|on|the|receptor (l_nmod) receptor_16\NN\5225602|of|epidermal|growth|factor|cells
10480573T8_10480573T14 NONE ansamycin_6\NN\1740| (r_compound) antibiotic_7\NN\2716205|an|ansamycin (r_appos) b_3\NN\1355326|of|thiazinotrienomycin|,|antibiotic (r_nmod) effect_0\NN\34213|b|,|function|. (l_nmod) function_11\NN\13783581|on|the|receptor (l_nmod) receptor_16\NN\5225602|of|epidermal|growth|factor|cells
10480573T6_10480573T10 NONE tt-b_0\NN\1740|and|receptor (l_conj) receptor_5\NN\5225602|anti-epidermal|growth|factor|anti-egfr
10480573T6_10480573T11 NONE tt-b_0\NN\1740|and|receptor (l_conj) receptor_5\NN\5225602|anti-epidermal|growth|factor|anti-egfr (l_appos) anti-egfr_7\NN\1740|(|)
10480573T6_10480573T12 NONE tt-b_0\NN\1740|and|receptor (r_nsubj) antagonistic_10\JJ\1740|tt-b|were|other|inhibiting|,|suggesting|. (l_xcomp) suggesting_27\VBG\1010118|share (l_ccomp) share_32\VBP\2660631|that|compounds|target (l_dobj) target_35\NN\7258332|the|same|,|egfr (l_appos) egfr_37\NN\1740|
10480573T2_10480573T9 CPR:4 tt-b_9\NN\1740|by (r_nmod) inhibited_7\VBN\2510337|activity|was|little|tt-b|system|. (l_nsubjpass) activity_2\NN\30358|the|kinase|egfr (l_nmod) egfr_4\NN\1740|of
10480573T2_10480573T13 CPR:4 tt-b_9\NN\1740|by (r_nmod) inhibited_7\VBN\2510337|activity|was|little|tt-b|system|. (l_nsubjpass) activity_2\NN\30358|the|kinase|egfr (l_compound) kinase_1\NN\14732946|
12957216
12957216T1_12957216T19 NONE zuclopenthixol_7\NN\1740|of (r_nmod) effect_5\NN\34213|the|zuclopenthixol|levels|activity (l_nmod) activity_23\NN\30358|with|enzyme|,|known (l_compound) enzyme_19\NN\14723628|acetylcholinesterase|ache (l_compound) acetylcholinesterase_18\NN\1740|
12957216T1_12957216T20 NONE zuclopenthixol_7\NN\1740|of (r_nmod) effect_5\NN\34213|the|zuclopenthixol|levels|activity (l_nmod) activity_23\NN\30358|with|enzyme|,|known (l_compound) enzyme_19\NN\14723628|acetylcholinesterase|ache (l_appos) ache_21\NN\14322699|(|)
12957216T2_12957216T21 NONE zuclopenthixol_2\NN\1740|of|mg/kg (r_nmod) administration_0\NN\1133281|zuclopenthixol (r_nsubj) affected_11\VBD\126264|administration|neither|level|. (l_dobj) level_16\NN\4916342|dopamine|nor|activity|cortex (l_conj) activity_19\NN\30358|ache (l_compound) ache_18\NN\14322699|
12957216T3_12957216T21 NONE dopamine_12\NN\14807737|da (r_compound) level_16\NN\4916342|dopamine|nor|activity|cortex (l_conj) activity_19\NN\30358|ache (l_compound) ache_18\NN\14322699|
12957216T4_12957216T21 NONE da_14\NN\10484858|(|) (r_appos) dopamine_12\NN\14807737|da (r_compound) level_16\NN\4916342|dopamine|nor|activity|cortex (l_conj) activity_19\NN\30358|ache (l_compound) ache_18\NN\14322699|
17035524
17035524T6_17035524T21 NONE glycyl-trna_3\JJ\1740| (r_amod) synthetase_4\NN\1740|glycyl-trna
17035524T6_17035524T22 NONE glycyl-trna_3\JJ\1740| (r_amod) synthetase_4\NN\1740|glycyl-trna (r_compound) mutations_5\NNS\4475|of|synthetase (r_nmod) analyses_1\NNS\633864|functional|mutations (r_nsubj) suggest_6\VBP\1010118|analyses|role|. (l_dobj) role_9\NN\719494|a|key|enzymes|axons (l_nmod) enzymes_12\NNS\14723628|for|trna-charging
17035524T2_17035524T12 NONE glycyl-trna_8\JJ\1740| (r_amod) synthetase_9\NN\1740|glycyl-trna|gars
17035524T2_17035524T13 NONE glycyl-trna_8\JJ\1740| (r_amod) synthetase_9\NN\1740|glycyl-trna|gars (l_appos) gars_11\NN\2638596|(|)
17035524T2_17035524T14 NONE glycyl-trna_8\JJ\1740| (r_amod) synthetase_9\NN\1740|glycyl-trna|gars (r_dobj) encoding_7\VBG\115157|synthetase (r_acl) gene_6\NN\8459252|in|the|encoding (r_nmod) mutations_3\NNS\4475|gene (r_dobj) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_parataxis) member_23\NN\9816771|gars|is|a|family|;|ligates (l_nsubj) gars_20\NN\2638596|
17035524T2_17035524T15 NONE glycyl-trna_8\JJ\1740| (r_amod) synthetase_9\NN\1740|glycyl-trna|gars (r_dobj) encoding_7\VBG\115157|synthetase (r_acl) gene_6\NN\8459252|in|the|encoding (r_nmod) mutations_3\NNS\4475|gene (r_dobj) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_parataxis) member_23\NN\9816771|gars|is|a|family|;|ligates (l_nmod) family_26\NN\8189659|of|the|synthetases (l_nmod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible
17035524T2_17035524T16 NONE glycyl-trna_8\JJ\1740| (r_amod) synthetase_9\NN\1740|glycyl-trna|gars (r_dobj) encoding_7\VBG\115157|synthetase (r_acl) gene_6\NN\8459252|in|the|encoding (r_nmod) mutations_3\NNS\4475|gene (r_dobj) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_parataxis) member_23\NN\9816771|gars|is|a|family|;|ligates (l_parataxis) ligates_40\VBZ\1295275|gars|glycine|trna(gly (l_nsubj) gars_39\NN\2638596|
17035524T3_17035524T12 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible (r_nmod) family_26\NN\8189659|of|the|synthetases (r_nmod) member_23\NN\9816771|gars|is|a|family|;|ligates (r_parataxis) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_dobj) mutations_3\NNS\4475|gene (l_nmod) gene_6\NN\8459252|in|the|encoding (l_acl) encoding_7\VBG\115157|synthetase (l_dobj) synthetase_9\NN\1740|glycyl-trna|gars
17035524T3_17035524T13 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible (r_nmod) family_26\NN\8189659|of|the|synthetases (r_nmod) member_23\NN\9816771|gars|is|a|family|;|ligates (r_parataxis) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_dobj) mutations_3\NNS\4475|gene (l_nmod) gene_6\NN\8459252|in|the|encoding (l_acl) encoding_7\VBG\115157|synthetase (l_dobj) synthetase_9\NN\1740|glycyl-trna|gars (l_appos) gars_11\NN\2638596|(|)
17035524T3_17035524T14 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible (r_nmod) family_26\NN\8189659|of|the|synthetases (r_nmod) member_23\NN\9816771|gars|is|a|family|;|ligates (l_nsubj) gars_20\NN\2638596|
17035524T3_17035524T15 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible
17035524T3_17035524T16 NONE aminoacyl-trna_28\JJ\1740| (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible (r_nmod) family_26\NN\8189659|of|the|synthetases (r_nmod) member_23\NN\9816771|gars|is|a|family|;|ligates (l_parataxis) ligates_40\VBZ\1295275|gars|glycine|trna(gly (l_nsubj) gars_39\NN\2638596|
17035524T4_17035524T12 NONE acids_37\NNS\14818238|with|cognate|amino (r_nmod) charging_32\VBG\1119950|for|trna|acids (r_advcl) responsible_30\JJ\1740|charging (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible (r_nmod) family_26\NN\8189659|of|the|synthetases (r_nmod) member_23\NN\9816771|gars|is|a|family|;|ligates (r_parataxis) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_dobj) mutations_3\NNS\4475|gene (l_nmod) gene_6\NN\8459252|in|the|encoding (l_acl) encoding_7\VBG\115157|synthetase (l_dobj) synthetase_9\NN\1740|glycyl-trna|gars
17035524T4_17035524T13 NONE acids_37\NNS\14818238|with|cognate|amino (r_nmod) charging_32\VBG\1119950|for|trna|acids (r_advcl) responsible_30\JJ\1740|charging (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible (r_nmod) family_26\NN\8189659|of|the|synthetases (r_nmod) member_23\NN\9816771|gars|is|a|family|;|ligates (r_parataxis) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_dobj) mutations_3\NNS\4475|gene (l_nmod) gene_6\NN\8459252|in|the|encoding (l_acl) encoding_7\VBG\115157|synthetase (l_dobj) synthetase_9\NN\1740|glycyl-trna|gars (l_appos) gars_11\NN\2638596|(|)
17035524T4_17035524T14 NONE acids_37\NNS\14818238|with|cognate|amino (r_nmod) charging_32\VBG\1119950|for|trna|acids (r_advcl) responsible_30\JJ\1740|charging (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible (r_nmod) family_26\NN\8189659|of|the|synthetases (r_nmod) member_23\NN\9816771|gars|is|a|family|;|ligates (l_nsubj) gars_20\NN\2638596|
17035524T4_17035524T15 NONE acids_37\NNS\14818238|with|cognate|amino (r_nmod) charging_32\VBG\1119950|for|trna|acids (r_advcl) responsible_30\JJ\1740|charging (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible
17035524T4_17035524T16 NONE acids_37\NNS\14818238|with|cognate|amino (r_nmod) charging_32\VBG\1119950|for|trna|acids (r_advcl) responsible_30\JJ\1740|charging (r_amod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible (r_nmod) family_26\NN\8189659|of|the|synthetases (r_nmod) member_23\NN\9816771|gars|is|a|family|;|ligates (l_parataxis) ligates_40\VBZ\1295275|gars|glycine|trna(gly (l_nsubj) gars_39\NN\2638596|
17035524T5_17035524T12 NONE glycine_41\NN\14601829| (r_dobj) ligates_40\VBZ\1295275|gars|glycine|trna(gly (r_parataxis) member_23\NN\9816771|gars|is|a|family|;|ligates (r_parataxis) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_dobj) mutations_3\NNS\4475|gene (l_nmod) gene_6\NN\8459252|in|the|encoding (l_acl) encoding_7\VBG\115157|synthetase (l_dobj) synthetase_9\NN\1740|glycyl-trna|gars
17035524T5_17035524T13 NONE glycine_41\NN\14601829| (r_dobj) ligates_40\VBZ\1295275|gars|glycine|trna(gly (r_parataxis) member_23\NN\9816771|gars|is|a|family|;|ligates (r_parataxis) implicated_2\VBD\2677097|we|previously|mutations|cause|member|. (l_dobj) mutations_3\NNS\4475|gene (l_nmod) gene_6\NN\8459252|in|the|encoding (l_acl) encoding_7\VBG\115157|synthetase (l_dobj) synthetase_9\NN\1740|glycyl-trna|gars (l_appos) gars_11\NN\2638596|(|)
17035524T5_17035524T14 NONE glycine_41\NN\14601829| (r_dobj) ligates_40\VBZ\1295275|gars|glycine|trna(gly (r_parataxis) member_23\NN\9816771|gars|is|a|family|;|ligates (l_nsubj) gars_20\NN\2638596|
17035524T5_17035524T15 NONE glycine_41\NN\14601829| (r_dobj) ligates_40\VBZ\1295275|gars|glycine|trna(gly (r_parataxis) member_23\NN\9816771|gars|is|a|family|;|ligates (l_nmod) family_26\NN\8189659|of|the|synthetases (l_nmod) synthetases_29\NNS\1740|of|aminoacyl-trna|responsible
17035524T5_17035524T16 NONE glycine_41\NN\14601829| (r_dobj) ligates_40\VBZ\1295275|gars|glycine|trna(gly (l_nsubj) gars_39\NN\2638596|
17035524T1_17035524T8 NONE tyrosyl-trna_22\JJ\1740| (r_amod) gene_24\NN\8459252|(|tyrosyl-trna|synthetase|) (r_appos) yars_20\NN\1740|[|gene|] (r_dep) gene_18\NN\8459252|in|another|trna|synthetase|yars (l_compound) synthetase_17\NN\1740|
17035524T1_17035524T9 NONE tyrosyl-trna_22\JJ\1740| (r_amod) gene_24\NN\8459252|(|tyrosyl-trna|synthetase|) (r_appos) yars_20\NN\1740|[|gene|]
17035524T1_17035524T10 NONE tyrosyl-trna_22\JJ\1740| (r_amod) gene_24\NN\8459252|(|tyrosyl-trna|synthetase|) (l_compound) synthetase_23\NN\1740|
16494569
16494569T1_16494569T20 NONE pyridoxal_16\NN\15090742| (r_compound) kinase_17\NN\14732946|pyridoxal
16494569T2_16494569T20 NONE phosphate_33\NN\15010703|pyridoxal|5|plp (r_compound) levels_37\NNS\4916342|phosphate (r_nsubj) low_40\JJ\1740|2|levels|are|unusually|children (r_conj) had_18\VBD\2108377|that|:|1|kinase|activity|children|and|low (l_nsubj) kinase_17\NN\14732946|pyridoxal
16494569T3_16494569T20 NONE plp_35\NN\1740|(|) (r_appos) phosphate_33\NN\15010703|pyridoxal|5|plp (r_compound) levels_37\NNS\4916342|phosphate (r_nsubj) low_40\JJ\1740|2|levels|are|unusually|children (r_conj) had_18\VBD\2108377|that|:|1|kinase|activity|children|and|low (l_nsubj) kinase_17\NN\14732946|pyridoxal
16494569T8_16494569T21 NONE b6_4\NN\1740|total|vitamin (r_nsubj) high_7\JJ\1740|b6|is|abnormally|autism|,|consistent (l_advmod) consistent_11\JJ\1740|reports (l_nmod) reports_14\NNS\6470073|with|previous|kinase (l_nmod) kinase_19\NN\14732946|of|an|impaired|pyridoxal|conversion
16494569T9_16494569T21 NONE pyridoxal_18\NN\15090742| (r_compound) kinase_19\NN\14732946|of|an|impaired|pyridoxal|conversion
16494569T10_16494569T21 CPR:9 pyridoxine_24\NN\15090742|of|and|pyridoxal (r_nmod) conversion_22\NN\7359599|for|the|pyridoxine|plp (r_nmod) kinase_19\NN\14732946|of|an|impaired|pyridoxal|conversion
16494569T11_16494569T21 CPR:9 pyridoxal_26\NN\15090742| (r_conj) pyridoxine_24\NN\15090742|of|and|pyridoxal (r_nmod) conversion_22\NN\7359599|for|the|pyridoxine|plp (r_nmod) kinase_19\NN\14732946|of|an|impaired|pyridoxal|conversion
16494569T12_16494569T21 CPR:9 plp_28\NN\1740|to (r_nmod) conversion_22\NN\7359599|for|the|pyridoxine|plp (r_nmod) kinase_19\NN\14732946|of|an|impaired|pyridoxal|conversion
23330542
23330542T3_23330542T12 NONE pregnane_8\NN\1740| (r_compound) receptor_10\NN\5225602|pregnane|x|pxr (r_appos) receptor_3\NN\5225602|adopted|orphan|nuclear|nr|,|receptor|, (l_appos) nr_5\NN\1740|(|)
23330542T3_23330542T13 NONE pregnane_8\NN\1740| (r_compound) receptor_10\NN\5225602|pregnane|x|pxr
23330542T3_23330542T16 NONE pregnane_8\NN\1740| (r_compound) receptor_10\NN\5225602|pregnane|x|pxr (l_appos) pxr_12\NN\1740|(|)
23330542T3_23330542T18 NONE pregnane_8\NN\1740| (r_compound) receptor_10\NN\5225602|pregnane|x|pxr (r_appos) receptor_3\NN\5225602|adopted|orphan|nuclear|nr|,|receptor|,
23330542T4_23330542T14 NONE acetaminophen_22\NN\2707683| (r_compound) toxicity_23\NN\13576101|acetaminophen (r_dobj) enhances_21\VBZ\227165|(|e.g.|,|toxicity|) (r_dep) xeno-_17\NN\1740|of|adverse|enhances|and|endobiotic (r_amod) phenotypes_34\NNS\4933544|xeno-|metabolic (r_nmod) mediator_14\NN\10351874|that|pxr|is|also|an|important|phenotypes (l_nsubj) pxr_9\NN\1740|
23330542T1_23330542T6 CPR:6 azoles_5\NNS\1740| (r_compound) analogs_6\NNS\4743605|of|azoles (r_nmod) discovery_3\NN\30358|since|the|original|analogs|antagonists (l_nmod) antagonists_9\NNS\7846|as|pxr (l_compound) pxr_8\NN\1740|
23330542T1_23330542T7 CPR:6 azoles_5\NNS\1740| (r_compound) analogs_6\NNS\4743605|of|azoles (r_nmod) discovery_3\NN\30358|since|the|original|analogs|antagonists (r_nmod) defined_14\VBN\2604760|discovery|,|we|have|preliminarily|pharmacophore|and|developed|. (l_dobj) pharmacophore_19\NN\1740|an|important|pxr|antagonist (l_compound) pxr_17\NN\1740|
23330542T1_23330542T8 CPR:6 azoles_5\NNS\1740| (r_compound) analogs_6\NNS\4743605|of|azoles (r_nmod) discovery_3\NN\30358|since|the|original|analogs|antagonists (r_nmod) defined_14\VBN\2604760|discovery|,|we|have|preliminarily|pharmacophore|and|developed|. (l_conj) developed_21\VBN\1753788|antagonists (l_dobj) antagonists_24\NNS\7846|less-toxic|pxr (l_compound) pxr_23\NN\1740|
19836445
19836445T22_19836445T39 NONE androgen_36\NN\14745635| (r_compound) assay_39\NN\5733583|no|validated|human|transfected|androgen|sensitive|transactivation (r_nsubj) available_41\JJ\1740|despite|a|,|assay|is (l_nmod) a_3\DT\13649268|more|than|decade|research|field|,|and|obtained (l_nmod) field_9\NN\8673395|in|the|compounds (l_nmod) compounds_13\NNS\5869584|of|endocrine|active|targeting (l_acl) targeting_14\VBG\1151110|receptor (l_dobj) receptor_17\NN\5225602|the|androgen|ar (l_appos) ar_19\NN\14622893|(|)
19836445T22_19836445T42 NONE androgen_36\NN\14745635| (r_compound) assay_39\NN\5733583|no|validated|human|transfected|androgen|sensitive|transactivation (r_nsubj) available_41\JJ\1740|despite|a|,|assay|is (l_nmod) a_3\DT\13649268|more|than|decade|research|field|,|and|obtained (l_nmod) field_9\NN\8673395|in|the|compounds (l_nmod) compounds_13\NNS\5869584|of|endocrine|active|targeting (l_acl) targeting_14\VBG\1151110|receptor (l_dobj) receptor_17\NN\5225602|the|androgen|ar
19836445T33_19836445T39 NONE androgen_16\NN\14745635| (r_compound) receptor_17\NN\5225602|the|androgen|ar (l_appos) ar_19\NN\14622893|(|)
19836445T33_19836445T42 NONE androgen_16\NN\14745635| (r_compound) receptor_17\NN\5225602|the|androgen|ar
19836445T32_19836445T38 NONE 17alpha-methyltestosterone_4\NN\1740|17alpha-mt|,|vinclozolin|and|linuron (r_appos) compounds_2\NNS\5869584|a|few|,|17alpha-methyltestosterone|, (r_nsubjpass) studied_14\VBN\630380|compounds|were|using|:|used (l_xcomp) using_15\VBG\1156834|scenario|,|i.e.|,|assuming (l_advcl) assuming_23\VBG\719734|known (l_ccomp) known_32\VBN\2110220|that|interaction|was|not (l_nsubjpass) interaction_26\NN\37396|their|ar (l_nmod) ar_29\NNS\14622893|with|the
19836445T34_19836445T38 NONE 17alpha-mt_6\NN\1740|(|) (r_appos) 17alpha-methyltestosterone_4\NN\1740|17alpha-mt|,|vinclozolin|and|linuron (r_appos) compounds_2\NNS\5869584|a|few|,|17alpha-methyltestosterone|, (r_nsubjpass) studied_14\VBN\630380|compounds|were|using|:|used (l_xcomp) using_15\VBG\1156834|scenario|,|i.e.|,|assuming (l_advcl) assuming_23\VBG\719734|known (l_ccomp) known_32\VBN\2110220|that|interaction|was|not (l_nsubjpass) interaction_26\NN\37396|their|ar (l_nmod) ar_29\NNS\14622893|with|the
19836445T35_19836445T38 NONE vinclozolin_9\NN\1740| (r_conj) 17alpha-methyltestosterone_4\NN\1740|17alpha-mt|,|vinclozolin|and|linuron (r_appos) compounds_2\NNS\5869584|a|few|,|17alpha-methyltestosterone|, (r_nsubjpass) studied_14\VBN\630380|compounds|were|using|:|used (l_xcomp) using_15\VBG\1156834|scenario|,|i.e.|,|assuming (l_advcl) assuming_23\VBG\719734|known (l_ccomp) known_32\VBN\2110220|that|interaction|was|not (l_nsubjpass) interaction_26\NN\37396|their|ar (l_nmod) ar_29\NNS\14622893|with|the
19836445T36_19836445T38 NONE linuron_11\NN\14906850| (r_conj) 17alpha-methyltestosterone_4\NN\1740|17alpha-mt|,|vinclozolin|and|linuron (r_appos) compounds_2\NNS\5869584|a|few|,|17alpha-methyltestosterone|, (r_nsubjpass) studied_14\VBN\630380|compounds|were|using|:|used (l_xcomp) using_15\VBG\1156834|scenario|,|i.e.|,|assuming (l_advcl) assuming_23\VBG\719734|known (l_ccomp) known_32\VBN\2110220|that|interaction|was|not (l_nsubjpass) interaction_26\NN\37396|their|ar (l_nmod) ar_29\NNS\14622893|with|the
19836445T17_19836445T40 NONE lactate_6\NN\14850483| (r_compound) dehydrogenase_7\NN\1740|lactate
23122096
12955294
12955294T9_12955294T18 NONE serotonin_1\NN\14807737| (r_compound) polymorphism_3\NN\11418750|the|serotonin|transporter|,|5httlpr|, (l_appos) 5httlpr_5\NN\1740|
12955294T9_12955294T19 NONE serotonin_1\NN\14807737| (r_compound) polymorphism_3\NN\11418750|the|serotonin|transporter|,|5httlpr|, (l_compound) transporter_2\NN\4490091|
12955294T10_12955294T18 NONE sertraline_15\NN\4169152|to (r_nmod) time_13\NN\7308889|with|a|faster|response|sertraline|population (r_nmod) associated_8\VBN\628491|polymorphism|is|time|. (l_nsubjpass) polymorphism_3\NN\11418750|the|serotonin|transporter|,|5httlpr|, (l_appos) 5httlpr_5\NN\1740|
12955294T10_12955294T19 NONE sertraline_15\NN\4169152|to (r_nmod) time_13\NN\7308889|with|a|faster|response|sertraline|population (r_nmod) associated_8\VBN\628491|polymorphism|is|time|. (l_nsubjpass) polymorphism_3\NN\11418750|the|serotonin|transporter|,|5httlpr|, (l_compound) transporter_2\NN\4490091|
12955294T3_12955294T12 NONE serotonin_34\NN\14807737| (r_compound) inhibitors_36\NNS\20090|to|selective|serotonin|reuptake|ssris|subjects (r_nmod) response_31\NN\11410625|as|overall|inhibitors (r_conj) time_26\NN\7308889|response|response (r_dobj) influence_24\VB\137313|to|time (r_xcomp) shown_22\VBN\2137132|polymorphism|has|been|influence|. (l_nsubjpass) polymorphism_4\NN\11418750|a|common|5httlpr|region (l_nmod) region_11\NN\27167|within|the|promoter|gene (l_nmod) gene_16\NN\8459252|of|the|serotonin|transporter|lsc6a4 (l_appos) lsc6a4_18\NN\1740|(|)
12955294T3_12955294T14 NONE serotonin_34\NN\14807737| (r_compound) inhibitors_36\NNS\20090|to|selective|serotonin|reuptake|ssris|subjects (r_nmod) response_31\NN\11410625|as|overall|inhibitors (r_conj) time_26\NN\7308889|response|response (r_dobj) influence_24\VB\137313|to|time (r_xcomp) shown_22\VBN\2137132|polymorphism|has|been|influence|. (l_nsubjpass) polymorphism_4\NN\11418750|a|common|5httlpr|region (l_appos) 5httlpr_6\NN\1740|(|)
12955294T3_12955294T16 NONE serotonin_34\NN\14807737| (r_compound) inhibitors_36\NNS\20090|to|selective|serotonin|reuptake|ssris|subjects (r_nmod) response_31\NN\11410625|as|overall|inhibitors (r_conj) time_26\NN\7308889|response|response (r_dobj) influence_24\VB\137313|to|time (r_xcomp) shown_22\VBN\2137132|polymorphism|has|been|influence|. (l_nsubjpass) polymorphism_4\NN\11418750|a|common|5httlpr|region (l_nmod) region_11\NN\27167|within|the|promoter|gene (l_nmod) gene_16\NN\8459252|of|the|serotonin|transporter|lsc6a4 (l_compound) transporter_15\NN\4490091|
12955294T7_12955294T12 NONE serotonin_14\NN\14807737| (r_compound) gene_16\NN\8459252|of|the|serotonin|transporter|lsc6a4 (l_appos) lsc6a4_18\NN\1740|(|)
12955294T7_12955294T14 NONE serotonin_14\NN\14807737| (r_compound) gene_16\NN\8459252|of|the|serotonin|transporter|lsc6a4 (r_nmod) region_11\NN\27167|within|the|promoter|gene (r_nmod) polymorphism_4\NN\11418750|a|common|5httlpr|region (l_appos) 5httlpr_6\NN\1740|(|)
12955294T7_12955294T16 NONE serotonin_14\NN\14807737| (r_compound) gene_16\NN\8459252|of|the|serotonin|transporter|lsc6a4 (l_compound) transporter_15\NN\4490091|
12955294T5_12955294T15 NONE sertraline_22\NN\4169152|to (r_nmod) respond_18\VB\2367363|that|subjects|would|rapidly|sertraline|subjects (l_nsubj) subjects_7\NNS\6598915|homozygous (l_amod) homozygous_8\JJ\1740|allele (l_nmod) allele_12\NN\5436752|for|the|long|polymorphism (l_nmod) polymorphism_16\NN\11418750|at|the|5httlpr (l_compound) 5httlpr_15\NN\1740|
12955294T8_12955294T17 NONE sertraline_18\NN\4169152|and|placebo (r_compound) groups_21\NNS\2137|in|the|sertraline|n=206 (r_nmod) correlations_10\NNS\13841213|for|response|groups (r_nmod) test_8\VB\670261|to|correlations (r_xcomp) performed_6\VBN\2367363|genotyping|was|test|. (l_nsubjpass) genotyping_0\NN\1740|polymorphism (l_nmod) polymorphism_4\NN\11418750|of|the|5httlpr (l_compound) 5httlpr_3\NN\1740|
12955294T1_12955294T13 NONE serotonin_10\NN\14807737| (r_compound) gene_12\NN\8459252|in|the|serotonin|transporter (l_compound) transporter_11\NN\4490091|
12955294T2_12955294T13 NONE sertraline_18\NN\4169152|to (r_nmod) time_16\NN\7308889|the|response|sertraline (r_dobj) effects_13\VBZ\1645601|that|variation|time (l_nsubj) variation_7\NN\7296428|genetic|gene (l_nmod) gene_12\NN\8459252|in|the|serotonin|transporter (l_compound) transporter_11\NN\4490091|
17308037
17308037T7_17308037T25 NONE amp_23\NN\13633375|of (r_nmod) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (r_conj) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (l_conj) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (l_nmod) ecto-phosphodiesterase_18\NN\1740|by
17308037T7_17308037T39 CPR:9 amp_23\NN\13633375|of (r_nmod) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (l_nmod) ecto-5'-nucleotidase_27\NN\1740|by
17308037T7_17308037T54 NONE amp_23\NN\13633375|of (r_nmod) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (r_conj) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (r_dobj) causes_7\VBZ\1617192|kidneys|,|stimulation|egress|. (l_nsubj) stimulation_3\NN\242808|cyclase (l_nmod) cyclase_6\NN\1740|of|adenylyl
17308037T8_17308037T25 NONE adenosine_25\NN\14964367|to (r_nmod) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (r_conj) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (l_conj) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (l_nmod) ecto-phosphodiesterase_18\NN\1740|by
17308037T8_17308037T39 CPR:9 adenosine_25\NN\14964367|to (r_nmod) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (l_nmod) ecto-5'-nucleotidase_27\NN\1740|by
17308037T8_17308037T54 NONE adenosine_25\NN\14964367|to (r_nmod) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (r_conj) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (r_dobj) causes_7\VBZ\1617192|kidneys|,|stimulation|egress|. (l_nsubj) stimulation_3\NN\242808|cyclase (l_nmod) cyclase_6\NN\1740|of|adenylyl
17308037T16_17308037T25 NONE camp_10\NN\3763727|of (r_nmod) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (l_conj) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (l_nmod) ecto-phosphodiesterase_18\NN\1740|by
17308037T16_17308037T39 NONE camp_10\NN\3763727|of (r_nmod) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (l_conj) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (l_nmod) ecto-5'-nucleotidase_27\NN\1740|by
17308037T16_17308037T54 NONE camp_10\NN\3763727|of (r_nmod) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (r_dobj) causes_7\VBZ\1617192|kidneys|,|stimulation|egress|. (l_nsubj) stimulation_3\NN\242808|cyclase (l_nmod) cyclase_6\NN\1740|of|adenylyl
17308037T19_17308037T25 CPR:9 camp_14\NN\3763727|of (r_nmod) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (l_nmod) ecto-phosphodiesterase_18\NN\1740|by
17308037T19_17308037T39 NONE camp_14\NN\3763727|of (r_nmod) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (r_conj) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (l_conj) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (l_nmod) ecto-5'-nucleotidase_27\NN\1740|by
17308037T19_17308037T54 NONE camp_14\NN\3763727|of (r_nmod) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (r_conj) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (r_dobj) causes_7\VBZ\1617192|kidneys|,|stimulation|egress|. (l_nsubj) stimulation_3\NN\242808|cyclase (l_nmod) cyclase_6\NN\1740|of|adenylyl
17308037T22_17308037T25 CPR:9 amp_16\NN\13633375|to (r_nmod) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (l_nmod) ecto-phosphodiesterase_18\NN\1740|by
17308037T22_17308037T39 NONE amp_16\NN\13633375|to (r_nmod) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (r_conj) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (l_conj) metabolism_21\NN\13526110|amp|adenosine|ecto-5'-nucleotidase (l_nmod) ecto-5'-nucleotidase_27\NN\1740|by
17308037T22_17308037T54 NONE amp_16\NN\13633375|to (r_nmod) conversion_12\NN\7359599|camp|amp|ecto-phosphodiesterase (r_conj) egress_8\NN\7321967|camp|,|conversion|,|and|metabolism (r_dobj) causes_7\VBZ\1617192|kidneys|,|stimulation|egress|. (l_nsubj) stimulation_3\NN\242808|cyclase (l_nmod) cyclase_6\NN\1740|of|adenylyl
17308037T17_17308037T55 CPR:4 1,3-isobutyl-1-methylxanthine_8\NN\1740|(|,|microm|,|n=6|) (r_dep) inhibitor_6\NN\20090|a|broad-spectrum|phosphodiesterase|1,3-isobutyl-1-methylxanthine|and|inhibitor (l_compound) phosphodiesterase_2\NN\1740|pde
17308037T17_17308037T56 CPR:4 1,3-isobutyl-1-methylxanthine_8\NN\1740|(|,|microm|,|n=6|) (r_dep) inhibitor_6\NN\20090|a|broad-spectrum|phosphodiesterase|1,3-isobutyl-1-methylxanthine|and|inhibitor (l_compound) phosphodiesterase_2\NN\1740|pde (l_appos) pde_4\NN\1740|(|)
17308037T18_17308037T55 NONE 1,3-dipropyl-8-p-sulfophenylxanthine_20\NN\1740|(|,|mm|,|n=6|) (r_dep) inhibitor_18\NN\20090|an|ecto-phosphodiesterase|1,3-dipropyl-8-p-sulfophenylxanthine (r_conj) inhibitor_6\NN\20090|a|broad-spectrum|phosphodiesterase|1,3-isobutyl-1-methylxanthine|and|inhibitor (l_compound) phosphodiesterase_2\NN\1740|pde
17308037T18_17308037T56 NONE 1,3-dipropyl-8-p-sulfophenylxanthine_20\NN\1740|(|,|mm|,|n=6|) (r_dep) inhibitor_18\NN\20090|an|ecto-phosphodiesterase|1,3-dipropyl-8-p-sulfophenylxanthine (r_conj) inhibitor_6\NN\20090|a|broad-spectrum|phosphodiesterase|1,3-isobutyl-1-methylxanthine|and|inhibitor (l_compound) phosphodiesterase_2\NN\1740|pde (l_appos) pde_4\NN\1740|(|)
17308037T20_17308037T55 NONE camp-induced_29\JJ\1740| (r_amod) secretion_31\NN\13526110|camp-induced|amp (r_dobj) attenuated_28\VBD\224901|inhibitor|significantly|secretion|%|,|respectively|. (l_nsubj) inhibitor_6\NN\20090|a|broad-spectrum|phosphodiesterase|1,3-isobutyl-1-methylxanthine|and|inhibitor (l_compound) phosphodiesterase_2\NN\1740|pde
17308037T20_17308037T56 NONE camp-induced_29\JJ\1740| (r_amod) secretion_31\NN\13526110|camp-induced|amp (r_dobj) attenuated_28\VBD\224901|inhibitor|significantly|secretion|%|,|respectively|. (l_nsubj) inhibitor_6\NN\20090|a|broad-spectrum|phosphodiesterase|1,3-isobutyl-1-methylxanthine|and|inhibitor (l_compound) phosphodiesterase_2\NN\1740|pde (l_appos) pde_4\NN\1740|(|)
17308037T21_17308037T55 NONE amp_30\NN\13633375| (r_compound) secretion_31\NN\13526110|camp-induced|amp (r_dobj) attenuated_28\VBD\224901|inhibitor|significantly|secretion|%|,|respectively|. (l_nsubj) inhibitor_6\NN\20090|a|broad-spectrum|phosphodiesterase|1,3-isobutyl-1-methylxanthine|and|inhibitor (l_compound) phosphodiesterase_2\NN\1740|pde
17308037T21_17308037T56 NONE amp_30\NN\13633375| (r_compound) secretion_31\NN\13526110|camp-induced|amp (r_dobj) attenuated_28\VBD\224901|inhibitor|significantly|secretion|%|,|respectively|. (l_nsubj) inhibitor_6\NN\20090|a|broad-spectrum|phosphodiesterase|1,3-isobutyl-1-methylxanthine|and|inhibitor (l_compound) phosphodiesterase_2\NN\1740|pde (l_appos) pde_4\NN\1740|(|)
17308037T1_17308037T26 CPR:4 milrinone_20\NN\1740|(|,|microm|;|cgmp|) (r_dep) pde3_18\NN\1740|milrinone
17308037T1_17308037T27 NONE milrinone_20\NN\1740|(|,|microm|;|cgmp|) (r_dep) pde3_18\NN\1740|milrinone (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde4_31\NN\1740|ro
17308037T1_17308037T28 NONE milrinone_20\NN\1740|(|,|microm|;|cgmp|) (r_dep) pde3_18\NN\1740|milrinone (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast
17308037T1_17308037T29 NONE milrinone_20\NN\1740|(|,|microm|;|cgmp|) (r_dep) pde3_18\NN\1740|milrinone (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast (l_conj) pde6_47\NN\1740|
17308037T1_17308037T30 NONE milrinone_20\NN\1740|(|,|microm|;|cgmp|) (r_dep) pde3_18\NN\1740|milrinone (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde7_56\NN\1740|brl-50481
17308037T1_17308037T31 NONE milrinone_20\NN\1740|(|,|microm|;|cgmp|) (r_dep) pde3_18\NN\1740|milrinone (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (r_nmod) blockade_0\NN\952963|pde1 (r_nsubj) alter_70\VB\126264|blockade|did|not|activity|. (l_dobj) activity_73\NN\30358|renal|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_72\NN\1740|
17308037T1_17308037T57 NONE milrinone_20\NN\1740|(|,|microm|;|cgmp|) (r_dep) pde3_18\NN\1740|milrinone (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7
17308037T1_17308037T58 NONE milrinone_20\NN\1740|(|,|microm|;|cgmp|) (r_dep) pde3_18\NN\1740|milrinone (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine
17308037T2_17308037T26 NONE 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one_38\NN\1740|[|] (r_appos) ro_33\NN\6894544|(|20|-|1724|4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one|,|microm|) (r_dep) pde4_31\NN\1740|ro (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde3_18\NN\1740|milrinone
17308037T2_17308037T27 CPR:4 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one_38\NN\1740|[|] (r_appos) ro_33\NN\6894544|(|20|-|1724|4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one|,|microm|) (r_dep) pde4_31\NN\1740|ro
17308037T2_17308037T28 NONE 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one_38\NN\1740|[|] (r_appos) ro_33\NN\6894544|(|20|-|1724|4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one|,|microm|) (r_dep) pde4_31\NN\1740|ro (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast
17308037T2_17308037T29 NONE 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one_38\NN\1740|[|] (r_appos) ro_33\NN\6894544|(|20|-|1724|4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one|,|microm|) (r_dep) pde4_31\NN\1740|ro (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast (l_conj) pde6_47\NN\1740|
17308037T2_17308037T30 NONE 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one_38\NN\1740|[|] (r_appos) ro_33\NN\6894544|(|20|-|1724|4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one|,|microm|) (r_dep) pde4_31\NN\1740|ro (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde7_56\NN\1740|brl-50481
17308037T2_17308037T31 NONE 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one_38\NN\1740|[|] (r_appos) ro_33\NN\6894544|(|20|-|1724|4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one|,|microm|) (r_dep) pde4_31\NN\1740|ro (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (r_nmod) blockade_0\NN\952963|pde1 (r_nsubj) alter_70\VB\126264|blockade|did|not|activity|. (l_dobj) activity_73\NN\30358|renal|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_72\NN\1740|
17308037T2_17308037T57 NONE 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one_38\NN\1740|[|] (r_appos) ro_33\NN\6894544|(|20|-|1724|4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one|,|microm|) (r_dep) pde4_31\NN\1740|ro (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7
17308037T2_17308037T58 NONE 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one_38\NN\1740|[|] (r_appos) ro_33\NN\6894544|(|20|-|1724|4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one|,|microm|) (r_dep) pde4_31\NN\1740|ro (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine
17308037T3_17308037T26 NONE zaprinast_49\NN\1740|(|,|microm|) (r_dep) pde5_45\NN\1740|and|pde6|zaprinast (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde3_18\NN\1740|milrinone
17308037T3_17308037T27 NONE zaprinast_49\NN\1740|(|,|microm|) (r_dep) pde5_45\NN\1740|and|pde6|zaprinast (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde4_31\NN\1740|ro
17308037T3_17308037T28 CPR:4 zaprinast_49\NN\1740|(|,|microm|) (r_dep) pde5_45\NN\1740|and|pde6|zaprinast
17308037T3_17308037T29 CPR:4 zaprinast_49\NN\1740|(|,|microm|) (r_dep) pde5_45\NN\1740|and|pde6|zaprinast (l_conj) pde6_47\NN\1740|
17308037T3_17308037T30 NONE zaprinast_49\NN\1740|(|,|microm|) (r_dep) pde5_45\NN\1740|and|pde6|zaprinast (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde7_56\NN\1740|brl-50481
17308037T3_17308037T31 NONE zaprinast_49\NN\1740|(|,|microm|) (r_dep) pde5_45\NN\1740|and|pde6|zaprinast (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (r_nmod) blockade_0\NN\952963|pde1 (r_nsubj) alter_70\VB\126264|blockade|did|not|activity|. (l_dobj) activity_73\NN\30358|renal|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_72\NN\1740|
17308037T3_17308037T57 NONE zaprinast_49\NN\1740|(|,|microm|) (r_dep) pde5_45\NN\1740|and|pde6|zaprinast (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7
17308037T3_17308037T58 NONE zaprinast_49\NN\1740|(|,|microm|) (r_dep) pde5_45\NN\1740|and|pde6|zaprinast (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine
17308037T4_17308037T26 NONE brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde3_18\NN\1740|milrinone
17308037T4_17308037T27 NONE brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde4_31\NN\1740|ro
17308037T4_17308037T28 NONE brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast
17308037T4_17308037T29 NONE brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast (l_conj) pde6_47\NN\1740|
17308037T4_17308037T30 CPR:4 brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481
17308037T4_17308037T31 NONE brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (r_nmod) blockade_0\NN\952963|pde1 (r_nsubj) alter_70\VB\126264|blockade|did|not|activity|. (l_dobj) activity_73\NN\30358|renal|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_72\NN\1740|
17308037T4_17308037T57 NONE brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7
17308037T4_17308037T58 NONE brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine
17308037T5_17308037T26 NONE n-trimethylbenzenesulfonamide_62\NN\1740|(|5-nitro-2,n|,|) (r_appos) brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde3_18\NN\1740|milrinone
17308037T5_17308037T27 NONE n-trimethylbenzenesulfonamide_62\NN\1740|(|5-nitro-2,n|,|) (r_appos) brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde4_31\NN\1740|ro
17308037T5_17308037T28 NONE n-trimethylbenzenesulfonamide_62\NN\1740|(|5-nitro-2,n|,|) (r_appos) brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast
17308037T5_17308037T29 NONE n-trimethylbenzenesulfonamide_62\NN\1740|(|5-nitro-2,n|,|) (r_appos) brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast (l_conj) pde6_47\NN\1740|
17308037T5_17308037T30 CPR:4 n-trimethylbenzenesulfonamide_62\NN\1740|(|5-nitro-2,n|,|) (r_appos) brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481
17308037T5_17308037T31 NONE n-trimethylbenzenesulfonamide_62\NN\1740|(|5-nitro-2,n|,|) (r_appos) brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (r_nmod) blockade_0\NN\952963|pde1 (r_nsubj) alter_70\VB\126264|blockade|did|not|activity|. (l_dobj) activity_73\NN\30358|renal|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_72\NN\1740|
17308037T5_17308037T57 NONE n-trimethylbenzenesulfonamide_62\NN\1740|(|5-nitro-2,n|,|) (r_appos) brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7
17308037T5_17308037T58 NONE n-trimethylbenzenesulfonamide_62\NN\1740|(|5-nitro-2,n|,|) (r_appos) brl-50481_58\NN\1740|[|n-trimethylbenzenesulfonamide|,|microm|] (r_dep) pde7_56\NN\1740|brl-50481 (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine
17308037T23_17308037T26 NONE 8-methoxymethyl-3-isobutyl-1-methylxanthine_4\NN\1740|(|,|microm|) (r_dep) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde3_18\NN\1740|milrinone
17308037T23_17308037T27 NONE 8-methoxymethyl-3-isobutyl-1-methylxanthine_4\NN\1740|(|,|microm|) (r_dep) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde4_31\NN\1740|ro
17308037T23_17308037T28 NONE 8-methoxymethyl-3-isobutyl-1-methylxanthine_4\NN\1740|(|,|microm|) (r_dep) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast
17308037T23_17308037T29 NONE 8-methoxymethyl-3-isobutyl-1-methylxanthine_4\NN\1740|(|,|microm|) (r_dep) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast (l_conj) pde6_47\NN\1740|
17308037T23_17308037T30 NONE 8-methoxymethyl-3-isobutyl-1-methylxanthine_4\NN\1740|(|,|microm|) (r_dep) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde7_56\NN\1740|brl-50481
17308037T23_17308037T31 NONE 8-methoxymethyl-3-isobutyl-1-methylxanthine_4\NN\1740|(|,|microm|) (r_dep) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (r_nmod) blockade_0\NN\952963|pde1 (r_nsubj) alter_70\VB\126264|blockade|did|not|activity|. (l_dobj) activity_73\NN\30358|renal|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_72\NN\1740|
17308037T23_17308037T57 CPR:4 8-methoxymethyl-3-isobutyl-1-methylxanthine_4\NN\1740|(|,|microm|) (r_dep) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7
17308037T23_17308037T58 NONE 8-methoxymethyl-3-isobutyl-1-methylxanthine_4\NN\1740|(|,|microm|) (r_dep) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine
17308037T24_17308037T26 NONE erythro-9-(2-hydroxy-3-nonyl)adenine_12\NN\1740|[|,|microm|] (r_dep) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde3_18\NN\1740|milrinone
17308037T24_17308037T27 NONE erythro-9-(2-hydroxy-3-nonyl)adenine_12\NN\1740|[|,|microm|] (r_dep) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde4_31\NN\1740|ro
17308037T24_17308037T28 NONE erythro-9-(2-hydroxy-3-nonyl)adenine_12\NN\1740|[|,|microm|] (r_dep) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast
17308037T24_17308037T29 NONE erythro-9-(2-hydroxy-3-nonyl)adenine_12\NN\1740|[|,|microm|] (r_dep) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde5_45\NN\1740|and|pde6|zaprinast (l_conj) pde6_47\NN\1740|
17308037T24_17308037T30 NONE erythro-9-(2-hydroxy-3-nonyl)adenine_12\NN\1740|[|,|microm|] (r_dep) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (l_conj) pde7_56\NN\1740|brl-50481
17308037T24_17308037T31 NONE erythro-9-(2-hydroxy-3-nonyl)adenine_12\NN\1740|[|,|microm|] (r_dep) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7 (r_nmod) blockade_0\NN\952963|pde1 (r_nsubj) alter_70\VB\126264|blockade|did|not|activity|. (l_dobj) activity_73\NN\30358|renal|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_72\NN\1740|
17308037T24_17308037T57 NONE erythro-9-(2-hydroxy-3-nonyl)adenine_12\NN\1740|[|,|microm|] (r_dep) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine (r_conj) pde1_2\NN\1740|of|8-methoxymethyl-3-isobutyl-1-methylxanthine|,|pde2|,|pde3|,|pde4|,|pde5|,|and|pde7
17308037T24_17308037T58 CPR:4 erythro-9-(2-hydroxy-3-nonyl)adenine_12\NN\1740|[|,|microm|] (r_dep) pde2_10\NN\1740|erythro-9-(2-hydroxy-3-nonyl)adenine
17308037T6_17308037T32 CPR:4 dipyridamole_9\NN\1740|of|blocks (l_acl:relcl) blocks_11\VBZ\1476483|that|pde8 (l_dobj) pde8_12\NN\1740|
17308037T6_17308037T33 CPR:4 dipyridamole_9\NN\1740|of|blocks (r_nmod) concentration_3\NN\4916342|of|a|microm|dipyridamole (r_nmod) administration_0\NN\1133281|concentration (r_nsubj) inhibited_13\VBD\2510337|administration|activity|(|%|)|. (l_dobj) activity_15\NN\30358|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_14\NN\1740|
17308037T9_17308037T34 CPR:4 dipyridamole_6\NN\1740|of|microm|blocks (l_acl:relcl) blocks_12\VBZ\1476483|that|pde9 (l_dobj) pde9_13\NN\1740|,|pde10|,|and|pde11|,|not|pde8
17308037T9_17308037T35 CPR:4 dipyridamole_6\NN\1740|of|microm|blocks (l_acl:relcl) blocks_12\VBZ\1476483|that|pde9 (l_dobj) pde9_13\NN\1740|,|pde10|,|and|pde11|,|not|pde8 (l_conj) pde10_15\NN\1740|
17308037T9_17308037T36 CPR:4 dipyridamole_6\NN\1740|of|microm|blocks (l_acl:relcl) blocks_12\VBZ\1476483|that|pde9 (l_dobj) pde9_13\NN\1740|,|pde10|,|and|pde11|,|not|pde8 (l_conj) pde11_18\NN\1740|
17308037T9_17308037T37 NONE dipyridamole_6\NN\1740|of|microm|blocks (l_acl:relcl) blocks_12\VBZ\1476483|that|pde9 (l_dobj) pde9_13\NN\1740|,|pde10|,|and|pde11|,|not|pde8 (l_conj) pde8_22\NN\1740|
17308037T9_17308037T38 NONE dipyridamole_6\NN\1740|of|microm|blocks (r_nmod) concentration_4\NN\4916342|a|lower|dipyridamole|, (r_nsubj) inhibit_26\VB\2510337|however|,|concentration|did|not|activity|. (l_dobj) activity_28\NN\30358|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_27\NN\1740|
17308037T10_17308037T40 CPR:4 dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nsubjpass) activity_8\NN\30358|renal|ecto-phosphodiesterase (l_compound) ecto-phosphodiesterase_7\NN\1740|
17308037T10_17308037T41 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11
17308037T10_17308037T42 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde2_15\NN\1740|
17308037T10_17308037T43 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde3_17\NN\1740|
17308037T10_17308037T44 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde4_19\NN\1740|
17308037T10_17308037T45 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde5_21\NN\1740|
17308037T10_17308037T46 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde6_23\NN\1740|
17308037T10_17308037T47 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde7_25\NN\1740|
17308037T10_17308037T48 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde9_27\NN\1740|
17308037T10_17308037T49 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde10_29\NN\1740|
17308037T10_17308037T50 NONE dipyridamole_40\NN\1740|of (r_nmod) concentrations_38\NNS\4916342|by|high|dipyridamole (r_nmod) inhibited_35\VBN\2510337|is|concentrations (r_conj) mediated_11\VBN\761713|that|activity|is|not|pde1|and|inhibited (l_nmod) pde1_13\NN\1740|by|,|pde2|,|pde3|,|pde4|,|pde5|,|pde6|,|pde7|,|pde9|,|pde10|,|or|pde11 (l_conj) pde11_32\NN\1740|
15908512
15908512T8_15908512T22 NONE norepinephrine_9\NN\14807929|,|activation|, (l_nmod) activation_18\NN\13561719|via|receptor (l_compound) receptor_14\NN\5225602|beta|adrenergic|ar
15908512T8_15908512T25 NONE norepinephrine_9\NN\14807929|,|activation|, (l_nmod) activation_18\NN\13561719|via|receptor (l_compound) receptor_14\NN\5225602|beta|adrenergic|ar (l_appos) ar_16\NN\14622893|(|)
15908512T13_15908512T29 CPR:5 isoproterenol_4\NN\3740161|the|selective|betaar|agonist (l_amod) betaar_2\NN\1740|
15908512T2_15908512T17 NONE isoproterenol_33\NN\3740161|order|was|>|norepinephrine|epinephrine (r_conj) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (l_nsubjpass) beta1ar_19\NN\1740|a
15908512T2_15908512T30 NONE isoproterenol_33\NN\3740161|order|was|>|norepinephrine|epinephrine (r_conj) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (r_ccomp) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_nmod) presence_2\NN\13954253|in|the|blockade (l_nmod) blockade_5\NN\952963|of|alphaar (l_compound) alphaar_4\NN\1740|
15908512T3_15908512T17 NONE norepinephrine_35\NN\14807929| (r_conj) isoproterenol_33\NN\3740161|order|was|>|norepinephrine|epinephrine (r_conj) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (l_nsubjpass) beta1ar_19\NN\1740|a
15908512T3_15908512T30 NONE norepinephrine_35\NN\14807929| (r_conj) isoproterenol_33\NN\3740161|order|was|>|norepinephrine|epinephrine (r_conj) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (r_ccomp) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_nmod) presence_2\NN\13954253|in|the|blockade (l_nmod) blockade_5\NN\952963|of|alphaar (l_compound) alphaar_4\NN\1740|
15908512T4_15908512T17 NONE epinephrine_37\NN\14807929|= (r_conj) isoproterenol_33\NN\3740161|order|was|>|norepinephrine|epinephrine (r_conj) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (l_nsubjpass) beta1ar_19\NN\1740|a
15908512T4_15908512T30 NONE epinephrine_37\NN\14807929|= (r_conj) isoproterenol_33\NN\3740161|order|was|>|norepinephrine|epinephrine (r_conj) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (r_ccomp) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_nmod) presence_2\NN\13954253|in|the|blockade (l_nmod) blockade_5\NN\952963|of|alphaar (l_compound) alphaar_4\NN\1740|
15908512T14_15908512T17 NONE isoproterenol_10\NN\3740161|for|,|norepinephrine|,|and|epinephrine (r_nmod) curves_8\NNS\13863771|concentration-response|isoproterenol (r_nsubj) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_ccomp) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (l_nsubjpass) beta1ar_19\NN\1740|a
15908512T14_15908512T30 NONE isoproterenol_10\NN\3740161|for|,|norepinephrine|,|and|epinephrine (r_nmod) curves_8\NNS\13863771|concentration-response|isoproterenol (r_nsubj) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_nmod) presence_2\NN\13954253|in|the|blockade (l_nmod) blockade_5\NN\952963|of|alphaar (l_compound) alphaar_4\NN\1740|
15908512T15_15908512T17 NONE norepinephrine_12\NN\14807929| (r_conj) isoproterenol_10\NN\3740161|for|,|norepinephrine|,|and|epinephrine (r_nmod) curves_8\NNS\13863771|concentration-response|isoproterenol (r_nsubj) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_ccomp) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (l_nsubjpass) beta1ar_19\NN\1740|a
15908512T15_15908512T30 NONE norepinephrine_12\NN\14807929| (r_conj) isoproterenol_10\NN\3740161|for|,|norepinephrine|,|and|epinephrine (r_nmod) curves_8\NNS\13863771|concentration-response|isoproterenol (r_nsubj) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_nmod) presence_2\NN\13954253|in|the|blockade (l_nmod) blockade_5\NN\952963|of|alphaar (l_compound) alphaar_4\NN\1740|
15908512T16_15908512T17 NONE epinephrine_15\NN\14807929| (r_conj) isoproterenol_10\NN\3740161|for|,|norepinephrine|,|and|epinephrine (r_nmod) curves_8\NNS\13863771|concentration-response|isoproterenol (r_nsubj) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_ccomp) involved_21\VBN\2676054|that|beta1ar|was|response|,|and|isoproterenol (l_nsubjpass) beta1ar_19\NN\1740|a
15908512T16_15908512T30 NONE epinephrine_15\NN\14807929| (r_conj) isoproterenol_10\NN\3740161|for|,|norepinephrine|,|and|epinephrine (r_nmod) curves_8\NNS\13863771|concentration-response|isoproterenol (r_nsubj) suggested_16\VBD\1010118|presence|,|curves|involved|. (l_nmod) presence_2\NN\13954253|in|the|blockade (l_nmod) blockade_5\NN\952963|of|alphaar (l_compound) alphaar_4\NN\1740|
15908512T5_15908512T20 CPR:6 atenolol_4\NN\2832168|and|metoprolol (r_dep) antagonists_3\NNS\7846|the|selective|beta1ar|atenolol (l_compound) beta1ar_2\NN\1740|
15908512T6_15908512T20 CPR:6 metoprolol_6\NN\2832168| (r_conj) atenolol_4\NN\2832168|and|metoprolol (r_dep) antagonists_3\NNS\7846|the|selective|beta1ar|atenolol (l_compound) beta1ar_2\NN\1740|
15908512T7_15908512T20 CPR:5 isoproterenol-induced_8\JJ\1740| (r_amod) enhancement_9\NN\248977|isoproterenol-induced (r_dobj) blocked_7\VBD\1476483|antagonists|enhancement|,|values|respectively|. (l_nsubj) antagonists_3\NNS\7846|the|selective|beta1ar|atenolol (l_compound) beta1ar_2\NN\1740|
15908512T9_15908512T21 CPR:6 ici-118,551_7\NN\1740|and|butoxamine (r_dep) antagonists_6\NNS\7846|the|selective|beta2ar|ici-118,551 (l_compound) beta2ar_5\NN\1740|
15908512T10_15908512T21 CPR:6 butoxamine_9\NN\1740| (r_conj) ici-118,551_7\NN\1740|and|butoxamine (r_dep) antagonists_6\NNS\7846|the|selective|beta2ar|ici-118,551 (l_compound) beta2ar_5\NN\1740|
15908512T11_15908512T21 CPR:5 isoproterenol-mediated_11\JJ\1740| (r_amod) enhancement_12\NN\248977|isoproterenol-mediated (r_dobj) inhibited_10\VBD\2510337|contrast|,|antagonists|enhancement|affinities|. (l_nsubj) antagonists_6\NNS\7846|the|selective|beta2ar|ici-118,551 (l_compound) beta2ar_5\NN\1740|
15908512T12_15908512T23 NONE isoproterenol_28\NN\3740161|by (r_nmod) initiated_26\VBN\1617192|isoproterenol (r_acl) activity_25\NN\30358|for|the|enhanced|hippocampal|ca3|network|initiated (r_nmod) responsible_18\JJ\1740|that|model|,|activation|is|activity (r_ccomp) indicates_9\VBZ\952524|together|,|profile|responsible|. (l_nsubj) profile_4\NN\6999802|this|pharmacological|antagonists (l_nmod) antagonists_8\NNS\7846|of|subtype-selective|betaar (l_compound) betaar_7\NN\1740|
15908512T12_15908512T24 CPR:5 isoproterenol_28\NN\3740161|by (r_nmod) initiated_26\VBN\1617192|isoproterenol (r_acl) activity_25\NN\30358|for|the|enhanced|hippocampal|ca3|network|initiated (r_nmod) responsible_18\JJ\1740|that|model|,|activation|is|activity (l_nsubj) activation_16\NN\13561719|beta1ar (l_compound) beta1ar_15\NN\1740|
23487168
23487168T1_23487168T14 CPR:6 telmisartan_15\NN\1740|particularly (r_appos) arbs_12\NNS\9882007|some|,|telmisartan|, (r_nsubj) agonists_19\NNS\9613191|specific|,|arbs|are|partial|receptor-γ|. (l_advcl) specific_3\JJ\1740|although|generally|highly|receptors (l_nmod) receptors_9\NNS\5225602|for|angiotensin|ii|type|1
23487168T1_23487168T15 CPR:5 telmisartan_15\NN\1740|particularly (r_appos) arbs_12\NNS\9882007|some|,|telmisartan|, (r_nsubj) agonists_19\NNS\9613191|specific|,|arbs|are|partial|receptor-γ|. (l_nmod) receptor-γ_23\NN\1740|at|peroxisome|proliferator-activated
19370562
19370562T11_19370562T18 NONE acetylcholine_37\NN\14807558|of|released (r_nmod) breakdown_35\NN\553173|the|acetylcholine (r_dobj) delay_33\VB\439958|to|breakdown (r_acl) use_28\NN\407535|by|the|inhibitors|delay (l_nmod) inhibitors_31\NNS\20090|of|cholinesterase (l_compound) cholinesterase_30\NN\14732946|
19370562T13_19370562T19 CPR:4 tacrine_0\NN\1740|,|first|, (l_appos) first_3\JJ\1740|the|inhibitors|undergo (l_nmod) inhibitors_7\NNS\20090|of|the|cholinesterase (l_compound) cholinesterase_6\NN\14732946|
19370562T14_19370562T20 CPR:4 rivastigmine_5\NN\1740|including (r_nmod) inhibitors_2\NNS\20090|other|cholinesterase|,|rivastigmine|,|properties|, (l_compound) cholinesterase_1\NN\14732946|
17062721
17062721T2_17062721T15 NONE estrogens_0\NNS\14745635| (r_nsubj) play_1\VBP\1072262|estrogens|role|homeostasis|,|and|seems (l_conj) seems_20\VBZ\2604760|deficiency|responsible|. (l_xcomp) responsible_24\JJ\1740|to|be|primarily|effects (l_nmod) effects_29\NNS\13245626|for|the|adverse|skeletal|agonists (l_nmod) agonists_32\NNS\9613191|of|gnrh (l_compound) gnrh_31\NN\1740|
17062721T3_17062721T15 NONE estrogen_14\NN\14745635| (r_compound) deficiency_15\NN\14449126|estrogen|than|deficiency (r_nsubj) seems_20\VBZ\2604760|deficiency|responsible|. (l_xcomp) responsible_24\JJ\1740|to|be|primarily|effects (l_nmod) effects_29\NNS\13245626|for|the|adverse|skeletal|agonists (l_nmod) agonists_32\NNS\9613191|of|gnrh (l_compound) gnrh_31\NN\1740|
17062721T4_17062721T15 NONE testosterone_18\NN\14747587| (r_compound) deficiency_19\NN\14449126|testosterone (r_conj) deficiency_15\NN\14449126|estrogen|than|deficiency (r_nsubj) seems_20\VBZ\2604760|deficiency|responsible|. (l_xcomp) responsible_24\JJ\1740|to|be|primarily|effects (l_nmod) effects_29\NNS\13245626|for|the|adverse|skeletal|agonists (l_nmod) agonists_32\NNS\9613191|of|gnrh (l_compound) gnrh_31\NN\1740|
17062721T5_17062721T17 NONE bisphosphonates_5\NNS\1740|pamidronate|and|modulators (l_conj) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (l_compound) receptor_15\NN\5225602|
17062721T5_17062721T18 NONE bisphosphonates_5\NNS\1740|pamidronate|and|modulators (r_nsubj) increased_22\VBD\169651|trials|,|bisphosphonates|density|men|. (l_nmod) men_29\NNS\8208016|in|agonist-treated (l_amod) agonist-treated_28\JJ\1740|gnrh (l_nmod:npmod) gnrh_27\NN\1740|
17062721T6_17062721T17 NONE pamidronate_7\NN\1740|(|and|acid|) (r_dep) bisphosphonates_5\NNS\1740|pamidronate|and|modulators (l_conj) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (l_compound) receptor_15\NN\5225602|
17062721T6_17062721T18 NONE pamidronate_7\NN\1740|(|and|acid|) (r_dep) bisphosphonates_5\NNS\1740|pamidronate|and|modulators (r_nsubj) increased_22\VBD\169651|trials|,|bisphosphonates|density|men|. (l_nmod) men_29\NNS\8208016|in|agonist-treated (l_amod) agonist-treated_28\JJ\1740|gnrh (l_nmod:npmod) gnrh_27\NN\1740|
17062721T7_17062721T17 NONE acid_10\NN\14818238|zoledronic (r_conj) pamidronate_7\NN\1740|(|and|acid|) (r_dep) bisphosphonates_5\NNS\1740|pamidronate|and|modulators (l_conj) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (l_compound) receptor_15\NN\5225602|
17062721T7_17062721T18 NONE acid_10\NN\14818238|zoledronic (r_conj) pamidronate_7\NN\1740|(|and|acid|) (r_dep) bisphosphonates_5\NNS\1740|pamidronate|and|modulators (r_nsubj) increased_22\VBD\169651|trials|,|bisphosphonates|density|men|. (l_nmod) men_29\NNS\8208016|in|agonist-treated (l_amod) agonist-treated_28\JJ\1740|gnrh (l_nmod:npmod) gnrh_27\NN\1740|
17062721T8_17062721T17 NONE estrogen_14\NN\14745635| (r_compound) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (l_compound) receptor_15\NN\5225602|
17062721T8_17062721T18 NONE estrogen_14\NN\14745635| (r_compound) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (r_conj) bisphosphonates_5\NNS\1740|pamidronate|and|modulators (r_nsubj) increased_22\VBD\169651|trials|,|bisphosphonates|density|men|. (l_nmod) men_29\NNS\8208016|in|agonist-treated (l_amod) agonist-treated_28\JJ\1740|gnrh (l_nmod:npmod) gnrh_27\NN\1740|
17062721T9_17062721T17 NONE raloxifene_18\NN\1740|(|and|toremifene|) (r_dep) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (l_compound) receptor_15\NN\5225602|
17062721T9_17062721T18 NONE raloxifene_18\NN\1740|(|and|toremifene|) (r_dep) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (r_conj) bisphosphonates_5\NNS\1740|pamidronate|and|modulators (r_nsubj) increased_22\VBD\169651|trials|,|bisphosphonates|density|men|. (l_nmod) men_29\NNS\8208016|in|agonist-treated (l_amod) agonist-treated_28\JJ\1740|gnrh (l_nmod:npmod) gnrh_27\NN\1740|
17062721T10_17062721T17 NONE toremifene_20\NN\1740| (r_conj) raloxifene_18\NN\1740|(|and|toremifene|) (r_dep) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (l_compound) receptor_15\NN\5225602|
17062721T10_17062721T18 NONE toremifene_20\NN\1740| (r_conj) raloxifene_18\NN\1740|(|and|toremifene|) (r_dep) modulators_16\NNS\1740|selective|estrogen|receptor|raloxifene (r_conj) bisphosphonates_5\NNS\1740|pamidronate|and|modulators (r_nsubj) increased_22\VBD\169651|trials|,|bisphosphonates|density|men|. (l_nmod) men_29\NNS\8208016|in|agonist-treated (l_amod) agonist-treated_28\JJ\1740|gnrh (l_nmod:npmod) gnrh_27\NN\1740|
17062721T1_17062721T11 NONE toremifene_27\NN\1740| (r_appos) amg162_25\NN\1740|(|,|toremifene|) (r_appos) interventions_23\NNS\1239064|of|novel|pharmacologic|amg162|treatment (l_nmod) treatment_32\NN\654885|during|gnrh|agonist (l_compound) gnrh_30\NN\1740|
23592839
23592839T2_23592839T6 NONE rapamycin_3\NN\1740| (r_compound) complex_4\NN\5869584|of|rapamycin|1|mtorc1 (l_nummod) 1_5\CD\13741022|
23592839T2_23592839T7 NONE rapamycin_3\NN\1740| (r_compound) complex_4\NN\5869584|of|rapamycin|1|mtorc1 (l_appos) mtorc1_7\NN\1740|(|)
23592839T1_23592839T12 NONE rapamycin_24\NN\1740|of (r_nmod) effects_22\NNS\13245626|the|rapamycin|quality (r_dobj) attenuated_20\VBD\224901|loss|effects|. (l_nsubj) loss_0\NN\13252973|kinases (l_nmod) kinases_3\NNS\14732946|of|s6|,|not|proteins|,
23592839T1_23592839T13 NONE rapamycin_24\NN\1740|of (r_nmod) effects_22\NNS\13245626|the|rapamycin|quality (r_dobj) attenuated_20\VBD\224901|loss|effects|. (l_nsubj) loss_0\NN\13252973|kinases (l_nmod) kinases_3\NNS\14732946|of|s6|,|not|proteins|, (l_conj) proteins_9\NNS\14944888|4e-bp|family|,|involved (l_amod) 4e-bp_7\JJ\1740|
23318471
23318471T1_23318471T44 CPR:9 tes-stimulated_30\JJ\1740| (r_amod) production_32\NN\30358|of|tes-stimulated|superoxide (r_nmod) source_28\NN\8620061|as|the|likely|production (r_nmod) identified_24\VBN\699815|oxidase|was|source|. (l_nsubjpass) oxidase_22\NN\14732946|xanthine
23318471T2_23318471T44 CPR:9 superoxide_31\NN\14971519| (r_compound) production_32\NN\30358|of|tes-stimulated|superoxide (r_nmod) source_28\NN\8620061|as|the|likely|production (r_nmod) identified_24\VBN\699815|oxidase|was|source|. (l_nsubjpass) oxidase_22\NN\14732946|xanthine
23318471T29_23318471T44 NONE tes_3\NN\14622893| (r_nsubj) enhanced_4\VBD\227165|predicted|,|tes|production|,|and|identified (l_conj) identified_24\VBN\699815|oxidase|was|source|. (l_nsubjpass) oxidase_22\NN\14732946|xanthine
23318471T30_23318471T44 NONE peroxynitrite_9\NN\1740| (r_compound) precursors_10\NNS\14580897|of|both|peroxynitrite|(|superoxide (r_nmod) production_6\NN\30358|the|precursors (r_dobj) enhanced_4\VBD\227165|predicted|,|tes|production|,|and|identified (l_conj) identified_24\VBN\699815|oxidase|was|source|. (l_nsubjpass) oxidase_22\NN\14732946|xanthine
23318471T31_23318471T44 NONE superoxide_14\NN\14971519|i.e.|,|and|oxide|) (r_appos) precursors_10\NNS\14580897|of|both|peroxynitrite|(|superoxide (r_nmod) production_6\NN\30358|the|precursors (r_dobj) enhanced_4\VBD\227165|predicted|,|tes|production|,|and|identified (l_conj) identified_24\VBN\699815|oxidase|was|source|. (l_nsubjpass) oxidase_22\NN\14732946|xanthine
23318471T32_23318471T44 NONE oxide_17\NN\14818238|nitic (r_conj) superoxide_14\NN\14971519|i.e.|,|and|oxide|) (r_appos) precursors_10\NNS\14580897|of|both|peroxynitrite|(|superoxide (r_nmod) production_6\NN\30358|the|precursors (r_dobj) enhanced_4\VBD\227165|predicted|,|tes|production|,|and|identified (l_conj) identified_24\VBN\699815|oxidase|was|source|. (l_nsubjpass) oxidase_22\NN\14732946|xanthine
23318471T33_23318471T44 NONE xanthine_21\NN\14727670| (r_compound) oxidase_22\NN\14732946|xanthine
23318471T3_23318471T36 NONE tes_6\NN\14622893| (r_compound) signaling_7\NN\33020|tes (r_nsubj) involved_8\VBD\2676054|that|signaling|activity|and|culminated (l_dobj) activity_9\NN\30358|cascade (l_nmod) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt (l_compound) kinase-protein_17\NN\1740|
23318471T3_23318471T37 NONE tes_6\NN\14622893| (r_compound) signaling_7\NN\33020|tes (r_nsubj) involved_8\VBD\2676054|that|signaling|activity|and|culminated (l_dobj) activity_9\NN\30358|cascade (l_nmod) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt
23318471T3_23318471T38 NONE tes_6\NN\14622893| (r_compound) signaling_7\NN\33020|tes (r_nsubj) involved_8\VBD\2676054|that|signaling|activity|and|culminated (l_dobj) activity_9\NN\30358|cascade (l_nmod) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt (l_appos) akt_21\NN\1740|(|)
23318471T3_23318471T39 CPR:3 tes_6\NN\14622893| (r_compound) signaling_7\NN\33020|tes (r_nsubj) involved_8\VBD\2676054|that|signaling|activity|and|culminated (l_dobj) activity_9\NN\30358|cascade (l_nmod) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_acl) initiated_24\VBN\1617192|activation (l_nmod) activation_26\NN\13561719|by|receptor (l_nmod) receptor_30\NN\5225602|of|the|androgen
23318471T4_23318471T36 NONE phosphoinositide_12\NN\1740| (r_compound) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt (l_compound) kinase-protein_17\NN\1740|
23318471T4_23318471T37 NONE phosphoinositide_12\NN\1740| (r_compound) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt
23318471T4_23318471T38 NONE phosphoinositide_12\NN\1740| (r_compound) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt (l_appos) akt_21\NN\1740|(|)
23318471T4_23318471T39 NONE phosphoinositide_12\NN\1740| (r_compound) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_acl) initiated_24\VBN\1617192|activation (l_nmod) activation_26\NN\13561719|by|receptor (l_nmod) receptor_30\NN\5225602|of|the|androgen
23318471T5_23318471T36 NONE androgen_29\NN\14745635| (r_compound) receptor_30\NN\5225602|of|the|androgen (r_nmod) activation_26\NN\13561719|by|receptor (r_nmod) initiated_24\VBN\1617192|activation (r_acl) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt (l_compound) kinase-protein_17\NN\1740|
23318471T5_23318471T37 NONE androgen_29\NN\14745635| (r_compound) receptor_30\NN\5225602|of|the|androgen (r_nmod) activation_26\NN\13561719|by|receptor (r_nmod) initiated_24\VBN\1617192|activation (r_acl) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt
23318471T5_23318471T38 NONE androgen_29\NN\14745635| (r_compound) receptor_30\NN\5225602|of|the|androgen (r_nmod) activation_26\NN\13561719|by|receptor (r_nmod) initiated_24\VBN\1617192|activation (r_acl) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt (l_appos) akt_21\NN\1740|(|)
23318471T5_23318471T39 NONE androgen_29\NN\14745635| (r_compound) receptor_30\NN\5225602|of|the|androgen
23318471T6_23318471T36 NONE cgmp_37\NN\1740|of (r_nmod) production_35\NN\30358|in|enhanced|cgmp|and|vasodilation (r_nmod) culminated_32\VBD\2609764|production (r_conj) involved_8\VBD\2676054|that|signaling|activity|and|culminated (l_dobj) activity_9\NN\30358|cascade (l_nmod) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt (l_compound) kinase-protein_17\NN\1740|
23318471T6_23318471T37 NONE cgmp_37\NN\1740|of (r_nmod) production_35\NN\30358|in|enhanced|cgmp|and|vasodilation (r_nmod) culminated_32\VBD\2609764|production (r_conj) involved_8\VBD\2676054|that|signaling|activity|and|culminated (l_dobj) activity_9\NN\30358|cascade (l_nmod) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt
23318471T6_23318471T38 NONE cgmp_37\NN\1740|of (r_nmod) production_35\NN\30358|in|enhanced|cgmp|and|vasodilation (r_nmod) culminated_32\VBD\2609764|production (r_conj) involved_8\VBD\2676054|that|signaling|activity|and|culminated (l_dobj) activity_9\NN\30358|cascade (l_nmod) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_compound) b_19\NN\1355326|kinase-protein|kinase|akt (l_appos) akt_21\NN\1740|(|)
23318471T6_23318471T39 NONE cgmp_37\NN\1740|of (r_nmod) production_35\NN\30358|in|enhanced|cgmp|and|vasodilation (r_nmod) culminated_32\VBD\2609764|production (r_conj) involved_8\VBD\2676054|that|signaling|activity|and|culminated (l_dobj) activity_9\NN\30358|cascade (l_nmod) cascade_23\NN\9475292|of|the|phosphoinositide|3|(|pi3|)|b|initiated (l_acl) initiated_24\VBN\1617192|activation (l_nmod) activation_26\NN\13561719|by|receptor (l_nmod) receptor_30\NN\5225602|of|the|androgen
23318471T8_23318471T40 NONE androgen_22\NN\14745635| (r_compound) action_23\NN\30358|for|androgen|microvasculature (r_nmod) mechanism_20\NN\13446390|for|a|novel|nongenomic|signaling|action (r_nmod) evidence_14\NN\5816287|mechanism (r_dobj) provide_13\VBP\2199590|findings|evidence|:|vasodilation|. (l_dep) vasodilation_29\NN\365995|tes-stimulated|mediated (l_acl) mediated_30\VBN\761713|primarily|peroxynitrite (l_nmod) peroxynitrite_33\NN\1740|by|formed (l_acl) formed_34\VBN\1617192|superoxide (l_nmod) superoxide_38\NN\14971519|from|oxidase-generated|and|no (l_amod) oxidase-generated_37\JJ\1740|xanthine
23318471T9_23318471T40 NONE tes-stimulated_28\JJ\1740| (r_amod) vasodilation_29\NN\365995|tes-stimulated|mediated (l_acl) mediated_30\VBN\761713|primarily|peroxynitrite (l_nmod) peroxynitrite_33\NN\1740|by|formed (l_acl) formed_34\VBN\1617192|superoxide (l_nmod) superoxide_38\NN\14971519|from|oxidase-generated|and|no (l_amod) oxidase-generated_37\JJ\1740|xanthine
23318471T10_23318471T40 CPR:9 peroxynitrite_33\NN\1740|by|formed (l_acl) formed_34\VBN\1617192|superoxide (l_nmod) superoxide_38\NN\14971519|from|oxidase-generated|and|no (l_amod) oxidase-generated_37\JJ\1740|xanthine
23318471T11_23318471T40 NONE xanthine_36\NN\14727670| (r_nmod:npmod) oxidase-generated_37\JJ\1740|xanthine
23318471T12_23318471T40 CPR:9 superoxide_38\NN\14971519|from|oxidase-generated|and|no (l_amod) oxidase-generated_37\JJ\1740|xanthine
23318471T13_23318471T40 CPR:9 no_40\NN\7204911| (r_conj) superoxide_38\NN\14971519|from|oxidase-generated|and|no (l_amod) oxidase-generated_37\JJ\1740|xanthine
23318471T14_23318471T41 NONE androgen_17\NN\14745635| (r_compound) receptor_18\NN\5225602|of|the|androgen (r_nmod) activation_14\NN\13561719|by|receptor (r_nmod) initiated_12\VBN\1617192|activation (r_acl) cascade_11\NN\9475292|of|the|pi3|kinase-akt|signaling|initiated (l_compound) kinase-akt_9\NN\1740|
23318471T14_23318471T42 NONE androgen_17\NN\14745635| (r_compound) receptor_18\NN\5225602|of|the|androgen (r_nmod) activation_14\NN\13561719|by|receptor (r_nmod) initiated_12\VBN\1617192|activation (r_acl) cascade_11\NN\9475292|of|the|pi3|kinase-akt|signaling|initiated (l_compound) kinase-akt_9\NN\1740|
23318471T14_23318471T43 NONE androgen_17\NN\14745635| (r_compound) receptor_18\NN\5225602|of|the|androgen
12373423
12373423T26_12373423T39 NONE lisuride_2\NN\1740| (r_compound) pharmacology_3\NN\6043075|of|lisuride (r_nmod) re-evaluation_0\NN\1740|pharmacology|:|overlap (l_dep) overlap_9\VBP\2660442|effects|properties|rats (l_nsubj) effects_8\NNS\13245626|receptor-mediated|behavioral (l_amod) receptor-mediated_6\JJ\1740|5-hydroxytryptamine1a
12373423T27_12373423T39 NONE 5-hydroxytryptamine1a_5\NN\1740| (r_nmod:npmod) receptor-mediated_6\JJ\1740|5-hydroxytryptamine1a
12373423T20_12373423T38 NONE lisuride_7\NNP\1740| (r_nsubj) produce_9\VB\1617192|that|lisuride|can|effects (l_dobj) effects_10\NNS\13245626|linked (l_acl) linked_11\VBN\628491|occupancy (l_nmod) occupancy_16\NN\1053920|to|5-ht(1a|)|receptor (l_punct) )_14\-RRB-\1740|
12373423T14_12373423T33 NONE lisuride_14\NN\1740|of (r_nmod) action_12\NN\30358|of|lisuride (r_nmod) mechanism_10\NN\13446390|in|the|action (r_nmod) ignored_7\VBN\2514187|nevertheless|,|action|has|generally|been|mechanism|,|favor|. (l_nmod) favor_17\NN\34574|in|role (l_nmod) role_21\NN\719494|of|an|exclusive|receptors|considering|,|or|role (l_nmod) receptors_24\NNS\5225602|for|dopamine
12373423T14_12373423T34 NONE lisuride_14\NN\1740|of (r_nmod) action_12\NN\30358|of|lisuride (r_nmod) mechanism_10\NN\13446390|in|the|action (r_nmod) ignored_7\VBN\2514187|nevertheless|,|action|has|generally|been|mechanism|,|favor|. (l_nmod) favor_17\NN\34574|in|role (l_nmod) role_21\NN\719494|of|an|exclusive|receptors|considering|,|or|role (l_conj) role_34\NN\719494|an|exclusive|activation (l_nmod) activation_39\NN\13561719|of|5-ht(2a/2c|)|receptor|hallucinogenesis (l_punct) )_37\-RRB-\1740|
12373423T18_12373423T33 NONE dopamine_23\NN\14807737| (r_compound) receptors_24\NNS\5225602|for|dopamine
12373423T18_12373423T34 NONE dopamine_23\NN\14807737| (r_compound) receptors_24\NNS\5225602|for|dopamine (r_nmod) role_21\NN\719494|of|an|exclusive|receptors|considering|,|or|role (l_conj) role_34\NN\719494|an|exclusive|activation (l_nmod) activation_39\NN\13561719|of|5-ht(2a/2c|)|receptor|hallucinogenesis (l_punct) )_37\-RRB-\1740|
12373423T19_12373423T35 NONE lisuride_12\NN\1740|of (r_nmod) interaction_10\NN\37396|the|potent|lisuride|receptors (l_nmod) receptors_16\NNS\5225602|with|5-ht(1a|) (l_punct) )_15\-RRB-\1740|
12373423T19_12373423T36 NONE lisuride_12\NN\1740|of (r_nmod) interaction_10\NN\37396|the|potent|lisuride|receptors (r_nsubjpass) demonstrated_19\VBN\2137132|that|interaction|has|been|laboratories|and|modulate (l_conj) modulate_35\VB\1724459|that|activation|can|responses (l_nsubj) activation_26\NN\13561719|receptors (l_nmod) receptors_33\NNS\5225602|of|5-ht(1a (l_compound) 5-ht(1a_28\NN\1740|)|and|5-ht(1b (l_punct) )_29\-RRB-\1740|
12373423T19_12373423T37 NONE lisuride_12\NN\1740|of (r_nmod) interaction_10\NN\37396|the|potent|lisuride|receptors (r_nsubjpass) demonstrated_19\VBN\2137132|that|interaction|has|been|laboratories|and|modulate (l_conj) modulate_35\VB\1724459|that|activation|can|responses (l_nsubj) activation_26\NN\13561719|receptors (l_nmod) receptors_33\NNS\5225602|of|5-ht(1a (l_compound) 5-ht(1a_28\NN\1740|)|and|5-ht(1b (l_conj) 5-ht(1b_31\NN\1740|) (l_punct) )_32\-RRB-\1740|
12373423T2_12373423T28 CPR:5 lisuride_7\NN\1740| (r_nsubj) mimicked_9\VBD\1742886|results|:|studies|,|lisuride|fully|agonist|ly|,|substituted|. (l_dobj) agonist_13\NN\9613191|the|5-ht(1a (l_compound) 5-ht(1a_11\NN\1740|) (l_punct) )_12\-RRB-\1740|
12373423T3_12373423T28 CPR:5 293284_15\CD\1740| (r_nummod) ly_14\NN\1740|293284 (r_nmod:tmod) mimicked_9\VBD\1742886|results|:|studies|,|lisuride|fully|agonist|ly|,|substituted|. (l_dobj) agonist_13\NN\9613191|the|5-ht(1a (l_compound) 5-ht(1a_11\NN\1740|) (l_punct) )_12\-RRB-\1740|
12373423T4_12373423T28 NONE lsd_21\NN\3097890|for|and|doi (r_nmod) substituted_19\VBD\126264|partially|lsd|,|and|failed (r_conj) mimicked_9\VBD\1742886|results|:|studies|,|lisuride|fully|agonist|ly|,|substituted|. (l_dobj) agonist_13\NN\9613191|the|5-ht(1a (l_compound) 5-ht(1a_11\NN\1740|) (l_punct) )_12\-RRB-\1740|
12373423T5_12373423T28 NONE doi_23\NNP\8123167| (r_conj) lsd_21\NN\3097890|for|and|doi (r_nmod) substituted_19\VBD\126264|partially|lsd|,|and|failed (r_conj) mimicked_9\VBD\1742886|results|:|studies|,|lisuride|fully|agonist|ly|,|substituted|. (l_dobj) agonist_13\NN\9613191|the|5-ht(1a (l_compound) 5-ht(1a_11\NN\1740|) (l_punct) )_12\-RRB-\1740|
12373423T6_12373423T28 NONE (+)-amphetamine_30\NN\1740|for (r_nmod) substitute_28\VB\126264|to|(+)-amphetamine (r_xcomp) failed_26\VBD\1798936|substitute (r_conj) substituted_19\VBD\126264|partially|lsd|,|and|failed (r_conj) mimicked_9\VBD\1742886|results|:|studies|,|lisuride|fully|agonist|ly|,|substituted|. (l_dobj) agonist_13\NN\9613191|the|5-ht(1a (l_compound) 5-ht(1a_11\NN\1740|) (l_punct) )_12\-RRB-\1740|
12373423T7_12373423T29 NONE lisuride_0\NN\1740| (r_nsubj) produced_1\VBD\1617192|lisuride|increase|. (l_dobj) increase_5\NN\13576355|a|significant|dose-related|posture|reflect (l_acl:relcl) reflect_18\VBP\923793|which|modulation (l_dobj) modulation_20\NN\7044917|a|behavior|action (l_nmod) action_24\NN\30358|by|receptors (l_nmod) receptors_29\NNS\5225602|at|central|5-ht(1a|) (l_punct) )_28\-RRB-\1740|
12373423T8_12373423T30 CPR:6 hydrochloride_4\NN\14817592|[|4-iodo-n-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridynyl-benzamide|] (r_appos) pmppi_1\NN\1740|only|hydrochloride|,|antagonist|, (l_appos) antagonist_11\NN\7846|a|selective|5-ht(1a (l_compound) 5-ht(1a_9\NN\1740|) (l_punct) )_10\-RRB-\1740|
12373423T9_12373423T30 NONE 5-ht_18\NN\1740| (r_compound) behaviors_20\NNS\407535|all|5-ht|syndrome|produced (r_dobj) inhibiting_16\VBG\2510337|in|behaviors (r_advcl) effective_14\JJ\1740|pmppi|was|inhibiting|,|effect|. (l_nsubj) pmppi_1\NN\1740|only|hydrochloride|,|antagonist|, (l_appos) antagonist_11\NN\7846|a|selective|5-ht(1a (l_compound) 5-ht(1a_9\NN\1740|) (l_punct) )_10\-RRB-\1740|
12373423T10_12373423T30 NONE lisuride_23\NN\1740|by (r_nmod) produced_21\VBN\1617192|lisuride (r_acl) behaviors_20\NNS\407535|all|5-ht|syndrome|produced (r_dobj) inhibiting_16\VBG\2510337|in|behaviors (r_advcl) effective_14\JJ\1740|pmppi|was|inhibiting|,|effect|. (l_nsubj) pmppi_1\NN\1740|only|hydrochloride|,|antagonist|, (l_appos) antagonist_11\NN\7846|a|selective|5-ht(1a (l_compound) 5-ht(1a_9\NN\1740|) (l_punct) )_10\-RRB-\1740|
12373423T11_12373423T30 NONE lsd_35\NN\3097890|by (r_nmod) induced_33\VBN\1627355|lsd (r_acl) behavior_32\NN\407535|on|any|induced (r_nmod) effect_29\NN\34213|whereas|pmppi|was|without|behavior (r_parataxis) effective_14\JJ\1740|pmppi|was|inhibiting|,|effect|. (l_nsubj) pmppi_1\NN\1740|only|hydrochloride|,|antagonist|, (l_appos) antagonist_11\NN\7846|a|selective|5-ht(1a (l_compound) 5-ht(1a_9\NN\1740|) (l_punct) )_10\-RRB-\1740|
12373423T12_12373423T31 CPR:5 293284_21\CD\1740| (r_nummod) ly_20\NN\1740|293284 (r_nmod:tmod) agonist_19\NN\9613191|of|the|selective|5-ht(1a|)|ly (l_punct) )_18\-RRB-\1740|
12373423T17_12373423T32 NONE lisuride_13\NN\1740|of (r_nmod) doses_11\NNS\3740161|of|low|lisuride (r_nmod) effects_8\NNS\13245626|the|behavioral|doses (r_nsubjpass) mediated_16\VBN\761713|that|effects|are|clearly|stimulation (l_nmod) stimulation_18\NN\242808|by|receptors (l_nmod) receptors_22\NNS\5225602|of|5-ht(1a|) (l_punct) )_21\-RRB-\1740|
23468099
23468099T1_23468099T12 NONE choline_9\NN\15090742| (r_compound) acetyltransferase_10\NN\1740|and|choline|,|protein|,|and|protein (l_conj) protein_23\NN\14944888|protein|c/ebp|)|homologous
23468099T1_23468099T13 NONE choline_9\NN\15090742| (r_compound) acetyltransferase_10\NN\1740|and|choline|,|protein|,|and|protein
23468099T1_23468099T14 NONE choline_9\NN\15090742| (r_compound) acetyltransferase_10\NN\1740|and|choline|,|protein|,|and|protein (l_conj) protein_14\NN\14944888|78-kda|glucose-regulated
23468099T2_23468099T12 NONE glucose-regulated_13\JJ\1740| (r_amod) protein_14\NN\14944888|78-kda|glucose-regulated (r_conj) acetyltransferase_10\NN\1740|and|choline|,|protein|,|and|protein (l_conj) protein_23\NN\14944888|protein|c/ebp|)|homologous
23468099T2_23468099T13 NONE glucose-regulated_13\JJ\1740| (r_amod) protein_14\NN\14944888|78-kda|glucose-regulated (r_conj) acetyltransferase_10\NN\1740|and|choline|,|protein|,|and|protein
23468099T2_23468099T14 NONE glucose-regulated_13\JJ\1740| (r_amod) protein_14\NN\14944888|78-kda|glucose-regulated
23344974
23344974T1_23344974T2 NONE phenylalanine_43\NN\14605787|of|a|motif (l_nmod) motif_49\NN\3178782|from|the|conserved|fxxa|interaction|found
23344974T1_23344974T3 NONE phenylalanine_43\NN\14605787|of|a|motif (l_nmod) motif_49\NN\3178782|from|the|conserved|fxxa|interaction|found (l_acl) found_50\VBN\2426171|brca2 (l_nmod) brca2_52\NN\1740|in
25136065
25136065T4_25136065T16 NONE glucose-dependent_21\JJ\1740| (r_amod) secretion_23\NN\13526110|glucose-dependent|insulin (r_dobj) stimulating_20\VBG\137313|by|secretion|,|suppressing|,|and|promoting (r_advcl) reduces_17\VBZ\441445|weight|stimulating (r_conj) lowers_10\VBZ\1850315|that|hemoglobin|and|reduces (r_acl:relcl) ra_8\NN\14625458|albiglutide|is|a|long-acting|glp-1|lowers
25136065T4_25136065T17 NONE glucose-dependent_21\JJ\1740| (r_amod) secretion_23\NN\13526110|glucose-dependent|insulin (r_dobj) stimulating_20\VBG\137313|by|secretion|,|suppressing|,|and|promoting (r_advcl) reduces_17\VBZ\441445|weight|stimulating (r_conj) lowers_10\VBZ\1850315|that|hemoglobin|and|reduces (l_dobj) hemoglobin_12\NN\14888884|glycosylated|a1c
25136065T4_25136065T18 NONE glucose-dependent_21\JJ\1740| (r_amod) secretion_23\NN\13526110|glucose-dependent|insulin (r_dobj) stimulating_20\VBG\137313|by|secretion|,|suppressing|,|and|promoting (r_advcl) reduces_17\VBZ\441445|weight|stimulating (r_conj) lowers_10\VBZ\1850315|that|hemoglobin|and|reduces (l_dobj) hemoglobin_12\NN\14888884|glycosylated|a1c (l_appos) a1c_14\NN\1740|(|)
25136065T4_25136065T19 NONE glucose-dependent_21\JJ\1740| (r_amod) secretion_23\NN\13526110|glucose-dependent|insulin (l_compound) insulin_22\NN\5407119|
25136065T4_25136065T20 NONE glucose-dependent_21\JJ\1740| (r_amod) secretion_23\NN\13526110|glucose-dependent|insulin (r_dobj) stimulating_20\VBG\137313|by|secretion|,|suppressing|,|and|promoting (l_conj) suppressing_25\VBG\2510337|secretion|,|delaying (l_dobj) secretion_27\NN\13526110|glucagon (l_compound) glucagon_26\NN\5407119|
25136065T5_25136065T24 NONE metformin_10\NN\2719105|to|,|sulfonylureas|,|thiazolidinediones|,|glargine|,|and|combinations (l_conj) glargine_17\NN\1740|insulin (l_compound) insulin_16\NN\5407119|
25136065T6_25136065T24 NONE sulfonylureas_12\NNS\2719105| (r_conj) metformin_10\NN\2719105|to|,|sulfonylureas|,|thiazolidinediones|,|glargine|,|and|combinations (l_conj) glargine_17\NN\1740|insulin (l_compound) insulin_16\NN\5407119|
25136065T7_25136065T24 NONE thiazolidinediones_14\NNS\1740| (r_conj) metformin_10\NN\2719105|to|,|sulfonylureas|,|thiazolidinediones|,|glargine|,|and|combinations (l_conj) glargine_17\NN\1740|insulin (l_compound) insulin_16\NN\5407119|
25136065T1_25136065T8 NONE sitagliptin_11\NN\1740| (r_conj) placebo_9\NN\3740161|to|,|sitagliptin|,|and|glimepiride (r_nmod) superior_7\JJ\1740|albiglutide|to|be|placebo|and|noninferior|,|changes (l_conj) noninferior_16\NN\1740|glargine|reducing (l_nmod) glargine_19\NN\1740|to|insulin|and|lispro (l_compound) insulin_18\NN\5407119|
25136065T1_25136065T9 NONE sitagliptin_11\NN\1740| (r_conj) placebo_9\NN\3740161|to|,|sitagliptin|,|and|glimepiride (r_nmod) superior_7\JJ\1740|albiglutide|to|be|placebo|and|noninferior|,|changes (l_conj) noninferior_16\NN\1740|glargine|reducing (l_nmod) glargine_19\NN\1740|to|insulin|and|lispro (l_conj) lispro_22\NN\1740|insulin (l_compound) insulin_21\NN\5407119|
25136065T1_25136065T10 NONE sitagliptin_11\NN\1740| (r_conj) placebo_9\NN\3740161|to|,|sitagliptin|,|and|glimepiride (r_nmod) superior_7\JJ\1740|albiglutide|to|be|placebo|and|noninferior|,|changes (l_conj) noninferior_16\NN\1740|glargine|reducing (l_advcl) reducing_24\VBG\441445|at|a1c (l_dobj) a1c_25\NN\1740|patients
25136065T1_25136065T11 NONE sitagliptin_11\NN\1740| (r_conj) placebo_9\NN\3740161|to|,|sitagliptin|,|and|glimepiride (r_nmod) superior_7\JJ\1740|albiglutide|to|be|placebo|and|noninferior|,|changes (l_nmod) changes_32\NNS\7283608|with|a1c|baseline|ranging (l_compound) a1c_31\NN\1740|
25136065T2_25136065T8 NONE glimepiride_14\NN\1740| (r_conj) placebo_9\NN\3740161|to|,|sitagliptin|,|and|glimepiride (r_nmod) superior_7\JJ\1740|albiglutide|to|be|placebo|and|noninferior|,|changes (l_conj) noninferior_16\NN\1740|glargine|reducing (l_nmod) glargine_19\NN\1740|to|insulin|and|lispro (l_compound) insulin_18\NN\5407119|
25136065T2_25136065T9 NONE glimepiride_14\NN\1740| (r_conj) placebo_9\NN\3740161|to|,|sitagliptin|,|and|glimepiride (r_nmod) superior_7\JJ\1740|albiglutide|to|be|placebo|and|noninferior|,|changes (l_conj) noninferior_16\NN\1740|glargine|reducing (l_nmod) glargine_19\NN\1740|to|insulin|and|lispro (l_conj) lispro_22\NN\1740|insulin (l_compound) insulin_21\NN\5407119|
25136065T2_25136065T10 NONE glimepiride_14\NN\1740| (r_conj) placebo_9\NN\3740161|to|,|sitagliptin|,|and|glimepiride (r_nmod) superior_7\JJ\1740|albiglutide|to|be|placebo|and|noninferior|,|changes (l_conj) noninferior_16\NN\1740|glargine|reducing (l_advcl) reducing_24\VBG\441445|at|a1c (l_dobj) a1c_25\NN\1740|patients
25136065T2_25136065T11 NONE glimepiride_14\NN\1740| (r_conj) placebo_9\NN\3740161|to|,|sitagliptin|,|and|glimepiride (r_nmod) superior_7\JJ\1740|albiglutide|to|be|placebo|and|noninferior|,|changes (l_nmod) changes_32\NNS\7283608|with|a1c|baseline|ranging (l_compound) a1c_31\NN\1740|
